PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vempati, P; Karagiannis, ED; Popel, AS				Vempati, Prakash; Karagiannis, Emmanouil D.; Popel, Aleksander S.			A biochemical model of matrix metalloproteinase 9 activation and inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TISSUE INHIBITOR; IV COLLAGENASE; GELATINASE-A; MATRIX METALLOPROTEINASE-9; KINETIC-ANALYSIS; PROGELATINASE-B; 4-AMINOPHENYLMERCURIC ACETATE; ENZYMATIC-PROPERTIES; 92-KDA GELATINASE	Matrix metalloproteinases (MMPs) are a class of extracellular and membrane-bound proteases involved in an array of physiological processes, including angiogenesis. We present a detailed computational model of MMP9 activation and inhibition. Our model is validated to existing biochemical experimental data. We determine kinetic rate constants for the processes of MMP9 activation by MMP3, MMP10, MMP13, and trypsin; inhibition by the tissue inhibitors of metalloproteinases (TIMPs) 1 and 2; and MMP9 deactivation. This computational approach allows us to investigate discrepancies in our understanding of the interaction of MMP9 with TIMP1. Specifically, we find that inhibition due to a single binding event cannot describe MMP9 inhibition by TIMP1. Temporally accurate biphasic inhibition requires either an additional isomerization step or a second lower affinity isoform of MMP9. We also theoretically characterize the MMP3/ TIMP2/ pro-MMP9 and MMP3/ TIMP1/ pro-MMP9 systems. We speculate that these systems differ significantly in their time scales of activation and inhibition such that MMP9 is able to temporarily overshoot its final equilibrium value in the latter. Our numerical simulations suggest that the ability of pro-MMP9 to complex TIMP1 increases this overshoot. In all, our analysis serves as a summary of existing kinetic data for MMP9 and a foundation for future models utilizing MMP9 or other MMPs under physiologically well defined microenvironments.	[Vempati, Prakash; Karagiannis, Emmanouil D.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Vempati, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 613 Taylor Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	prakashvempati1@jhu.edu	Popel, Aleksander S/A-6724-2009; Karagiannis, Emmanouil D./CAA-0759-2022	Karagiannis, Emmanouil/0000-0003-0131-6552; Popel, Aleksander/0000-0002-6706-9235	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079653, R33HL087351] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079653, R33 HL087351] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; BARAGI VM, 1994, J BIOL CHEM, V269, P12692; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; FRIDMAN R, 1995, CANCER RES, V55, P2548; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Hahn-Dantona E, 1999, ANN NY ACAD SCI, V878, P372, DOI 10.1111/j.1749-6632.1999.tb07696.x; Hutton M, 1998, BIOCHEMISTRY-US, V37, P10094, DOI 10.1021/bi980616p; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; KOLKENBROCK H, 1995, BIOL CHEM H-S, V376, P495, DOI 10.1515/bchm3.1995.376.8.495; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Taylor KB, 1996, J BIOL CHEM, V271, P23938, DOI 10.1074/jbc.271.39.23938; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; WATANABE H, 1993, J CELL SCI, V104, P991; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023	34	73	76	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37585	37596		10.1074/jbc.M611500200	http://dx.doi.org/10.1074/jbc.M611500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17848556	hybrid			2022-12-27	WOS:000251833600034
J	Abbott, DW; Boraston, AB				Abbott, D. Wade; Boraston, Alisdair B.			A family 2 pectate lyase displays a rare fold and transition metal-assisted beta-elimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI 3937; RETICULUM QUALITY-CONTROL; CRYSTAL-STRUCTURE; YERSINIA-ENTEROCOLITICA; PECTIN METHYLESTERASE; ASPERGILLUS-NIGER; ACTIVE-SITE; PORIN KDGM; IDENTIFICATION; ALPHA-1,2-MANNOSIDASES	The family 2 pectate lyase from Yersinia enterocolitica (YePL2A), solved to 1.5 angstrom, reveals it to be the first prokaryotic protein reported to display the rare (alpha/alpha)(7) barrel fold. In addition to its apo form, we have also determined the structure of a metal-bound form of YePL2A ( to 2.0 angstrom) and a trigalacturonic acid-bound substrate complex ( to 2.1 angstrom). Although its fold is rare, the catalytic center of YePL2A can be superimposed with structurally unrelated families, underlining the conserved catalytic amino acid architecture of the beta-elimination mechanism. In addition to its overall structure, YePL2A also has two other unique features: 1) it utilizes a metal atom other than calcium for catalysis, and 2) its Bronstead base is in an alternate conformation and directly interacts with the uronate group of the substrate.	Univ Victoria, Victoria, BC V8W 3P6, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, PO Box 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Abbott, Wade/0000-0003-4893-5799; Boraston, Alisdair/0000-0001-6417-0592				Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; ABBOTT DW, 2007, IN PRESS J MOL BIOL; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BOWEN JH, 1979, AM J CLIN PATHOL, V72, P586; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Cocolin L, 2005, INT J FOOD MICROBIOL, V105, P71, DOI 10.1016/j.ijfoodmicro.2005.05.006; Coutinho PM, 1999, ROY SOC CH, P3; de Armas HN, 2004, ACTA CRYSTALLOGR D, V60, P999, DOI 10.1107/S090744490400602X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1125, DOI 10.1046/j.1365-2958.2001.02565.x; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1113, DOI 10.1046/j.1365-2958.2001.02564.x; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; KARAPINAR M, 1992, INT J FOOD MICROBIOL, V16, P261, DOI 10.1016/0168-1605(92)90086-I; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Liao CH, 1999, CAN J MICROBIOL, V45, P396, DOI 10.1139/cjm-45-5-396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellinen T, 2003, BIOCHEM J, V372, P329, DOI 10.1042/BJ20030027; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Selma MV, 2006, J FOOD PROTECT, V69, P2357, DOI 10.4315/0362-028X-69.10.2357; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Van Petegem F, 2001, J MOL BIOL, V312, P157, DOI 10.1006/jmbi.2001.4946; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7	46	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35328	35336		10.1074/jbc.M705511200	http://dx.doi.org/10.1074/jbc.M705511200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881361	hybrid			2022-12-27	WOS:000251155200076
J	Versees, W; Spaepen, S; Wood, MDH; Leeper, FJ; Vanderleyden, J; Steyaert, J				Versees, Wim; Spaepen, Stijn; Wood, Martin D. H.; Leeper, Finian J.; Vanderleyden, Jos; Steyaert, Jan			Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-DECARBOXYLASE; AZOSPIRILLUM-BRASILENSE; CRYSTAL-STRUCTURE; 1',4'-IMINOPYRIMIDINE TAUTOMER; PHENYLPYRUVATE DECARBOXYLASE; ZYMOMONAS-MOBILIS; STRUCTURAL BASIS; WILD-TYPE; ENZYMES; CATALYSIS	Thiamine diphosphate-dependent enzymes are involved in a wide variety of metabolic pathways. The molecular mechanism behind active site communication and substrate activation, observed in some of these enzymes, has since long been an area of debate. Here, we report the crystal structures of a phenylpyruvate decarboxylase in complex with its substrates and a covalent reaction intermediate analogue. These structures reveal the regulatory site and unveil the mechanism of allosteric substrate activation. This signal transduction relies on quaternary structure reorganizations, domain rotations, and a pathway of local conformational changes that are relayed from the regulatory site to the active site. The current findings thus uncover the molecular mechanism by which the binding of a substrate in the regulatory site is linked to the mounting of the catalytic machinery in the active site in this thiamine diphosphate-dependent enzyme.	Vrije Univ Brussels, Dept Ultrastruct, B-1050 Brussels, Belgium; VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium; Katholieke Univ Leuven, Ctr Microbial & Plant Genet, INPAC, B-3001 Heverlee, Belgium; Univ Chem Lab, Cambridge CB2 1EW, England	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Cambridge	Versees, W (corresponding author), Vrije Univ Brussels, Dept Ultrastruct, Pleinlaan 2, B-1050 Brussels, Belgium.	wversees@vub.ac.be	Steyaert, Jan/H-4662-2011; Leeper, Finian/B-4842-2012; Spaepen, Stijn/H-5646-2019; steyaert, jan/GQP-7811-2022; Versées, Wim/H-5518-2015	Steyaert, Jan/0000-0002-3825-874X; Spaepen, Stijn/0000-0001-5465-8287; Leeper, Finian James/0000-0003-3408-5199; Versees, Wim/0000-0002-4695-696X				Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; Berthold CL, 2005, J BIOL CHEM, V280, P41645, DOI 10.1074/jbc.M509921200; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COSTACURTA A, 1994, MOL GEN GENET, V243, P463, DOI 10.1007/BF00280477; DAVIES DD, 1967, BIOCHEM J, V104, pP50; DeLano W.L, PYMOL MOL GRAPHICS S; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kluger R, 2006, J AM CHEM SOC, V128, P15856, DOI 10.1021/ja066249j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; Leeper FJ, 2005, BIOCHEM SOC T, V33, P772, DOI 10.1042/BST0330772; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; Machius M, 2006, STRUCTURE, V14, P287, DOI 10.1016/j.str.2005.10.009; Mann S, 2004, ORG BIOMOL CHEM, V2, P1732, DOI 10.1039/b403619k; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schenk G, 1997, EUR J BIOCHEM, V248, P63, DOI 10.1111/j.1432-1033.1997.t01-1-00063.x; Schowen RL, 1998, COMPREHENSIVE BIOL C, V2, P217; Schutz A, 2005, BIOCHEMISTRY-US, V44, P6164, DOI 10.1021/bi0473354; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Spaepen S, 2007, J BACTERIOL, V189, P7626, DOI 10.1128/JB.00830-07; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WEISS PM, 1988, BIOCHEMISTRY-US, V27, P2197, DOI 10.1021/bi00406a058; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788	43	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35269	35278		10.1074/jbc.M706048200	http://dx.doi.org/10.1074/jbc.M706048200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905741	hybrid, Green Published			2022-12-27	WOS:000251155200071
J	Gerevich, Z; Zadori, ZS; Koles, L; Kopp, L; Milius, D; Wirkner, K; Gyires, K; Illes, P				Gerevich, Zoltan; Zadori, Zoltan S.; Koeles, Laszlo; Kopp, Laurenz; Milius, Doreen; Wirkner, Kerstin; Gyires, Klara; Illes, Peter			Dual effect of acid pH on purinergic P2X(3) receptors depends on the histidine 206 residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; P2X(3) RECEPTOR-CHANNELS; ION-CHANNEL; EXTRACELLULAR PH; TISSUE ACIDOSIS; MOLECULAR PHYSIOLOGY; CAPSAICIN RECEPTOR; ATP-RESPONSES; P2Y RECEPTORS; PAIN	Whole cell patch clamp investigations were carried out to clarify the pH sensitivity of native and recombinant P2X(3) receptors. In HEK293 cells permanently transfected with human (h) P2X(3) receptors (HEK293- hP2X(3) cells), an acidic pH shifted the concentration-response curve for alpha,beta- methylene ATP (alpha,beta-meATP) to the right and increased its maximum. An alkalic pH did not alter the effect of alpha,beta-meATP. Further, a low pH value increased the activation time constant (tau(on)) of the alpha,beta-meATP current; the fast and slow time constants of desensitization (tau(des1), tau(des2)) were at the same time also increased. Finally, acidification accelerated the recovery of P2X(3) receptors from the desensitized state. Replacement of histidine 206, but not histidine 45, by alanine abolished the pH-induced effects on hP2X(3) receptors transiently expressed in HEK293 cells. Changes in the intracellular pH had no effect on the amplitude or time course of the alpha,beta-meATP currents. The voltage sensitivity and reversal potential of the currents activated by alpha,beta-meATP were unaffected by extracellular acidification. Similar effects were observed in a subpopulation of rat dorsal root ganglion neurons expressing homomeric P2X(3) receptor channels. It is suggested that acidification may have a dual effect on P2X(3) channels, by decreasing the current amplitude at low agonist concentrations (because of a decrease in the rate of activation) and increasing it at high concentrations (because of a decrease in the rate of desensitization). Thereby, a differential regulation of pain sensation during e.g. inflammation may occur at the C fiber terminals of small DRG neurons in peripheral tissues.	Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1089 Budapest, Hungary	Leipzig University; Semmelweis University	Gerevich, Z (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	gerz@medizin.uni-leipzig.de	Zádori, Zoltán S/J-9144-2017	Zádori, Zoltán S/0000-0001-7312-618X				[Anonymous], 1929, KLIN WOCHENSCHR; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 1996, CIBA F SYMP, V198, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chizh BA, 2001, PHARMACOL REV, V53, P553; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Garber K, 2003, J NATL CANCER I, V95, P770, DOI 10.1093/jnci/95.11.770; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Gerevich Z, 2005, EUR J PHARMACOL, V521, P34, DOI 10.1016/j.ejphar.2005.08.001; Gerevich Z, 2004, J NEUROSCI, V24, P797, DOI 10.1523/JNEUROSCI.4019-03.2004; Grote A, 2005, MOL MEMBR BIOL, V22, P497, DOI 10.1080/09687860500370638; Hubscher CH, 2001, NEUROREPORT, V12, P2995, DOI 10.1097/00001756-200109170-00048; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Kao YH, 2000, BIOPHYS J, V79, P1637, DOI 10.1016/S0006-3495(00)76414-9; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; Lalo U, 2007, J CELL PHYSIOL, V212, P473, DOI 10.1002/jcp.21043; Li CY, 1996, J NEUROPHYSIOL, V76, P3048, DOI 10.1152/jn.1996.76.5.3048; Li CY, 1997, PFLUG ARCH EUR J PHY, V433, P446, DOI 10.1007/s004240050299; Li CY, 1996, NEUROREPORT, V7, P2151, DOI 10.1097/00001756-199609020-00018; Ma Bei, 2006, Purinergic Signal, V2, P481, DOI 10.1007/s11302-006-9017-z; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; North RA, 2004, J PHYSIOL-LONDON, V554, P301, DOI 10.1113/jphysiol.2003.048587; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pan HL, 1999, J PHYSIOL-LONDON, V518, P857, DOI 10.1111/j.1469-7793.1999.0857p.x; Peer Lyndon., 1955, TRANSPLANTATION TISS; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Revici E., 1949, B I APPL BIOL, V1, P21; Skorinkin A, 2003, J GEN PHYSIOL, V122, P33, DOI 10.1085/jgp.200308825; Sokolova E, 2004, BRIT J PHARMACOL, V141, P1048, DOI 10.1038/sj.bjp.0705701; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; Stoop R, 1997, J NEUROPHYSIOL, V78, P1837, DOI 10.1152/jn.1997.78.4.1837; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wildman SS, 1999, BRIT J PHARMACOL, V128, P486, DOI 10.1038/sj.bjp.0702802; Wildman SS, 1999, BRIT J PHARMACOL, V126, P762, DOI 10.1038/sj.bjp.0702325; Woo YC, 2004, ANESTHESIOLOGY, V101, P468, DOI 10.1097/00000542-200408000-00029; Xiang ZH, 1998, NEUROSCI LETT, V256, P105, DOI 10.1016/S0304-3940(98)00774-5; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004; Zhong Y, 2001, BRIT J PHARMACOL, V132, P221, DOI 10.1038/sj.bjp.0703778	50	30	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33949	33957		10.1074/jbc.M705840200	http://dx.doi.org/10.1074/jbc.M705840200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890225	hybrid			2022-12-27	WOS:000251145700008
J	Green, AK; Stratton, RC; Squires, PE; Simpson, AWM				Green, Anne K.; Stratton, Rebecca C.; Squires, Paul E.; Simpson, Alec W. M.			Atrial natriuretic peptide attenuates elevations in Ca2+ and protects hepatocytes by stimulating net plasma membrane Ca2+ efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ISCHEMIA-REPERFUSION INJURY; PARTICULATE GUANYLYL CYCLASE; ISOLATED RAT HEPATOCYTES; CGMP-INDUCED RELAXATION; FACTOR-KAPPA-B; INTRACELLULAR CALCIUM; CYTOSOLIC CALCIUM; NITRIC-OXIDE; BILE-ACIDS	Elevations in intracellular Ca2+ concentration and calpain activity are common early events in cellular injury, including that of hepatocytes. Atrial natriuretic peptide is a circulating hormone that has been shown to be hepatoprotective. The aim of this study was to examine the effects of atrial natriuretic peptide on potentially harmful elevations in cytosolic free Ca2+ and calpain activity induced by extracellular ATP in rat hepatocytes. We show that atrial natriuretic peptide, through protein kinase G, attenuated both the amplitude and duration of ATP-induced cytosolic Ca2+ rises in single hepatocytes. Atrial natriuretic peptide also prevented stimulation of calpain activity by ATP, taurolithocholate, or Ca2+ mobilization by thapsigargin and ionomycin. We therefore investigated the cellular Ca2+ handling mechanisms through which ANP attenuates this sustained elevation in cytosolic Ca2+. We show that atrial natriuretic peptide does not modulate the release from or re-uptake of Ca2+ into intracellular stores but, through protein kinase G, both stimulates plasma membrane Ca2+ efflux from and inhibits ATP-stimulated Ca2+ influx into hepatocytes. These findings suggest that stimulation of net plasma membrane Ca2+ efflux (to which both Ca2+ efflux stimulation and Ca2+ influx inhibition contribute) is the key process through which atrial natriuretic peptide attenuates elevations in cytosolic Ca2+ and calpain activity. Moreover we propose that plasma membrane Ca2+ efflux is a valuable, previously undiscovered, mechanism through which atrial natriuretic peptide protects rat hepatocytes, and perhaps other cell types, against Ca2+-dependent injury.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England	University of Warwick; University of Liverpool	Green, AK (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	A.K.Green@warwick.ac.uk		Squires, Paul/0000-0003-4547-6777	Wellcome Trust [065845/Z/01] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguilar HI, 1996, GASTROENTEROLOGY, V110, P558, DOI 10.1053/gast.1996.v110.pm8566604; Airhart N, 2003, J BIOL CHEM, V278, P38693, DOI 10.1074/jbc.M304098200; Ajamieh H, 2002, PHARMACOL RES, V45, P333, DOI 10.1006/phrs.2002.0952; ANWER MS, 1988, HEPATOLOGY, V8, P887, DOI 10.1002/hep.1840080430; Araujo IM, 2004, J NEUROCHEM, V91, P1322, DOI 10.1111/j.1471-4159.2004.02811.x; Arora AS, 1996, AM J PHYSIOL-GASTR L, V270, pG238, DOI 10.1152/ajpgi.1996.270.2.G238; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; BALTENSPERGER K, 1988, EUR J BIOCHEM, V172, P7, DOI 10.1111/j.1432-1033.1988.tb13848.x; BELLOMO G, 1984, EUR J BIOCHEM, V144, P19, DOI 10.1111/j.1432-1033.1984.tb08425.x; Benitah JP, 2003, J MUSCLE RES CELL M, V24, P275; BERTHON B, 1984, FEBS LETT, V167, P19, DOI 10.1016/0014-5793(84)80824-8; BILZER M, 1994, GASTROENTEROLOGY, V106, P143, DOI 10.1016/S0016-5085(94)94961-1; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Bilzer M, 2000, J HEPATOL, V32, P508, DOI 10.1016/S0168-8278(00)80404-3; BOKEMEYER D, 1994, CLIN SCI, V87, P383, DOI 10.1042/cs0870383; BOKEMEYER D, 1993, HYPERTENSION, V21, P166, DOI 10.1161/01.HYP.21.2.166; BOUSCAREL B, 1993, AM J PHYSIOL, V264, pG243, DOI 10.1152/ajpgi.1993.264.2.G243; BRENARD R, 1992, J HEPATOL, V14, P347, DOI 10.1016/0168-8278(92)90182-O; Calderone A, 1998, J CLIN INVEST, V101, P812, DOI 10.1172/JCI119883; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Carini R, 2003, HEPATOLOGY, V37, P277, DOI 10.1053/jhep.2003.50033; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Cataliotti A, 2005, CIRCULATION, V112, P836, DOI 10.1161/CIRCULATIONAHA.105.538520; Chow SC, 1997, NEUROPHARMACOLOGY, V36, P1149, DOI 10.1016/S0028-3908(97)00123-8; COBBOLD P, 1988, J RECEPTOR RES, V8, P481, DOI 10.3109/10799898809049006; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; COMBETTES L, 1988, J BIOL CHEM, V263, P2299; COQUIL JF, 1991, BIOCHEM J, V273, P153, DOI 10.1042/bj2730153; Cottart CH, 2003, NITRIC OXIDE-BIOL CH, V9, P57, DOI 10.1016/j.niox.2003.09.003; Crenesse D, 1999, PHARMACOLOGY, V58, P160, DOI 10.1159/000028278; De Vito P, 2003, MOL CELL BIOCHEM, V252, P353, DOI 10.1023/A:1025508828271; DEBOLD AJ, 1982, CAN J PHYSIOL PHARM, V60, P324, DOI 10.1139/y82-045; Dixon C. Jane, 2001, P65; Dixon CJ, 2005, J PHARMACOL EXP THER, V313, P1305, DOI 10.1124/jpet.104.082743; DIXON CJ, 1990, BIOCHEM J, V269, P499, DOI 10.1042/bj2690499; FERNANDO KC, 1995, BBA-MOL CELL RES, V1268, P97, DOI 10.1016/0167-4889(95)00041-P; FURUKAWA KI, 1988, J BIOL CHEM, V263, P8058; GASBARRINI A, 1993, BIOCHIM BIOPHYS ACTA, V1177, P1, DOI 10.1016/0167-4889(93)90149-J; Gerbes AL, 1998, HEPATOLOGY, V28, P1309, DOI 10.1002/hep.510280520; Gerwig T, 2003, J HEPATOL, V39, P341, DOI 10.1016/S0168-8278(03)00240-X; GLENNON MC, 1992, J BIOL CHEM, V267, P8230; Gorbig MN, 1999, HEPATOLOGY, V30, P501, DOI 10.1002/hep.510300201; GORES GJ, 1988, AM J PHYSIOL, V255, pC315, DOI 10.1152/ajpcell.1988.255.3.C315; Green AK, 2002, GASTROENTEROLOGY, V123, P1291, DOI 10.1053/gast.2002.35994; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; Haddad P, 1999, CRYOBIOLOGY, V39, P69, DOI 10.1006/cryo.1999.2186; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; Hasegawa C, 2003, HEPATO-GASTROENTEROL, V50, P972; He L, 2000, AM J PHYSIOL-CELL PH, V278, pC845, DOI 10.1152/ajpcell.2000.278.4.C845; Hemmings SJ, 2002, CELL BIOCHEM FUNCT, V20, P47, DOI 10.1002/cbf.934; HOUCHI H, 1995, LIFE SCI, V57, pPL211, DOI 10.1016/0024-3205(95)02111-U; HOWARD A, 1994, BIOCHEM J, V303, P275, DOI 10.1042/bj3030275; Howarth FC, 2005, PEPTIDES, V26, P691, DOI 10.1016/j.peptides.2004.12.003; Ikari A, 1997, JPN J PHYSIOL, V47, P235, DOI 10.2170/jjphysiol.47.235; Ikeda Y, 2002, AM J PHYSIOL-HEART C, V282, pH1421, DOI 10.1152/ajpheart.00626.2001; Isozaki H, 2000, EUR J GASTROEN HEPAT, V12, P291, DOI 10.1097/00042737-200012030-00006; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; JOHANSSON JS, 1992, BIOCHIM BIOPHYS ACTA, V1105, P40, DOI 10.1016/0005-2736(92)90160-N; JOSEPH SK, 1985, J BIOL CHEM, V260, P2508; KESSLER F, 1990, J BIOL CHEM, V265, P16012; Kobayashi S, 1999, TRANSPLANTATION, V67, P451, DOI 10.1097/00007890-199902150-00019; KOGA T, 1994, J BIOL CHEM, V269, P11640; Kohli V, 1999, GASTROENTEROLOGY, V116, P168, DOI 10.1016/S0016-5085(99)70241-6; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Land SC, 1997, J APPL PHYSIOL, V82, P776, DOI 10.1152/jappl.1997.82.3.776; Lehotsky J, 2002, GEN PHYSIOL BIOPHYS, V21, P31; LIDOFSKY SD, 1990, AM J PHYSIOL, V259, pG56, DOI 10.1152/ajpgi.1990.259.1.G56; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; LONG RM, 1986, J PHARMACOL EXP THER, V238, P186; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; McNulty TJ, 1999, BIOCHEM J, V339, P555, DOI 10.1042/0264-6021:3390555; Mikami M, 1997, HEPATOL RES, V7, P48, DOI 10.1016/S0928-4346(97)00372-1; Mikawa K, 1997, CLIN EXP PHARMACOL P, V24, P175, DOI 10.1111/j.1440-1681.1997.tb01804.x; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8; MOORE M, 1985, J BIOL CHEM, V260, P3035; Munagala VK, 2004, CURR PROB CARDIOLOGY, V29, P707, DOI 10.1016/j.cpcardiol.2004.07.002; MURATA M, 1994, HEPATOLOGY, V19, P1223, DOI 10.1016/0270-9139(94)90870-2; Musa-Aziz R, 2005, PFLUG ARCH EUR J PHY, V450, P405, DOI 10.1007/s00424-005-1459-6; Nascimentogomes G, 1995, BRAZ J MED BIOL RES, V28, P609; Nathanson M H, 1996, Prog Liver Dis, V14, P1; Oliveira-Souza M, 2004, AM J PHYSIOL-RENAL, V286, pF402, DOI 10.1152/ajprenal.00121.2003; Oliveira-Souza M, 2002, KIDNEY INT, V62, P1693, DOI 10.1046/j.1523-1755.2002.00604.x; Oliveira-Souza M, 2001, KIDNEY INT, V60, P1800, DOI 10.1046/j.1523-1755.2001.00993.x; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; PANDOL SJ, 1990, CELL CALCIUM, V11, P477, DOI 10.1016/0143-4160(90)90080-E; PELLA R, 1991, BIOCHEM BIOPH RES CO, V174, P549, DOI 10.1016/0006-291X(91)91452-I; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; POPESCU LM, 1985, EUR J PHARMACOL, V107, P393, DOI 10.1016/0014-2999(85)90269-9; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Rho EH, 2002, J APPL PHYSIOL, V92, P257, DOI 10.1152/jappl.2002.92.1.257; RodriguezPascual F, 1996, MOL PHARMACOL, V49, P1058; Roma MG, 1999, TOXICOL APPL PHARM, V161, P192, DOI 10.1006/taap.1999.8801; Rose S, 1997, HEPATOLOGY, V25, P379; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Rychkov GY, 2005, CELL CALCIUM, V37, P183, DOI 10.1016/j.ceca.2004.09.001; SAKAGUCHI S, 1993, BIOL PHARM BULL, V16, P808; SAKAIDA I, 1991, J BIOL CHEM, V266, P717; Sakon M, 2002, SURG TODAY, V32, P1, DOI 10.1007/s595-002-8105-8; SanchezBueno A, 1997, CELL CALCIUM, V21, P125, DOI 10.1016/S0143-4160(97)90036-1; Sansoe G, 2005, J HEPATOL, V43, P791, DOI 10.1016/j.jhep.2005.04.017; Schillinger KJ, 2005, P NATL ACAD SCI USA, V102, P13789, DOI 10.1073/pnas.0506807102; Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Squier MKT, 1996, CELL DEATH DIFFER, V3, P275; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Stoyanovsky DA, 1999, TOXICOL LETT, V106, P23, DOI 10.1016/S0378-4274(99)00009-0; Su J, 2005, EXP BIOL MED, V230, P242; Suttner Stefan W, 2004, Curr Opin Crit Care, V10, P336, DOI 10.1097/01.ccx.0000135513.26376.4f; Tao JC, 1999, J BIOL CHEM, V274, P23761, DOI 10.1074/jbc.274.34.23761; THIBAULT N, 1991, J BIOCHEM TOXICOL, V6, P237, DOI 10.1002/jbt.2570060310; THIBAULT N, 1993, BIOCHEM PHARMACOL, V45, P289, DOI 10.1016/0006-2952(93)90063-3; Tinton SA, 1996, EUR J BIOCHEM, V238, P576, DOI 10.1111/j.1432-1033.1996.0576z.x; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Vollmar AM, 1997, GUT, V40, P145, DOI 10.1136/gut.40.1.145; VONRUECKER AA, 1989, J CLIN CHEM CLIN BIO, V27, P531; VROLIX M, 1988, BIOCHEM J, V255, P855, DOI 10.1042/bj2550855; Wang CH, 2004, J BIOMED SCI, V11, P571, DOI 10.1159/000079668; Weber H, 2005, BIOCHEM PHARMACOL, V70, P1241, DOI 10.1016/j.bcp.2005.06.028; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; Yoshida Y, 1999, MOL CELL BIOCHEM, V190, P157, DOI 10.1023/A:1006991032073; YOSHIDA Y, 1992, J BIOCHEM-TOKYO, V111, P559, DOI 10.1093/oxfordjournals.jbchem.a123796; Yoshioka A, 2000, J NEUROCHEM, V74, P633, DOI 10.1046/j.1471-4159.2000.740633.x; Yoshizumi M, 1997, FEBS LETT, V419, P255, DOI 10.1016/S0014-5793(97)01470-1; ZOETEWEIJ JP, 1992, BIOCHEM J, V288, P207, DOI 10.1042/bj2880207; Zolle O, 2000, J BIOL CHEM, V275, P25892, DOI 10.1074/jbc.M000786200	134	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34542	34554		10.1074/jbc.M707115200	http://dx.doi.org/10.1074/jbc.M707115200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893148	hybrid			2022-12-27	WOS:000251145700069
J	Skaggs, HS; Xing, H; Wilkerson, DC; Murphy, LA; Hong, Y; Mayhew, CN; Sarge, KD				Skaggs, Hollie S.; Xing, Hongyan; Wilkerson, Donald C.; Murphy, Lynea A.; Hong, Yiling; Mayhew, Christopher N.; Sarge, Kevin D.			HSF1-TPR interaction facilitates export of stress-induced HSP70 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; HEAT-SHOCK; GENE-EXPRESSION; PROTEIN TPR; TRANSCRIPTION; BINDING; CELLS; IDENTIFICATION; LOCALIZATION; METABOLISM	Stress conditions inhibit mRNA export, but mRNAs encoding heat shock proteins continue to be efficiently exported from the nucleus during stress. How HSP mRNAs bypass this stress-associated export inhibition was not known. Here, we show that HSF1, the transcription factor that binds HSP promoters after stress to induce their transcription, interacts with the nuclear pore-associating TPR protein in a stress-responsive manner. TPR is brought into proximity of the HSP70 promoter after stress and preferentially associates with mRNAs transcribed from this promoter. Disruption of the HSF1-TPR interaction inhibits the export of mRNAs expressed from the HSP70 promoter, both endogenous HSP70 mRNA and a luciferase reporter mRNA. These results suggest that HSP mRNA export escapes stress inhibition via HSF1-mediated recruitment of the nuclear pore-associating protein TPR to HSP genes, thereby functionally connecting the first and last nuclear steps of the gene expression pathway, transcription and mRNA export.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Mol & Cellular Biochem, 741 S Limestone St, Lexington, KY 40536 USA.	kdsarge@uky.edu	Mayhew, Christopher N/AGB-4929-2022		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD050043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061053, R01GM064606] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 50043, F32 HD050043] Funding Source: Medline; NIEHS NIH HHS [T32 ES 007266] Funding Source: Medline; NIGMS NIH HHS [GM 61053, R01 GM064606-03, R01 GM064606-02, R01 GM061053-01A1, R01 GM061053-02, R01 GM061053-04, R01 GM064606-04, GM 64606, R01 GM061053, R01 GM061053-03, R01 GM064606, R01 GM064606-01A2] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bond U, 2006, FEMS YEAST RES, V6, P160, DOI 10.1111/j.1567-1364.2006.00032.x; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; HOBBS MV, 1993, J IMMUNOL, V150, P3602; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Liu Y, 1996, EMBO J, V15, P6750, DOI 10.1002/j.1460-2075.1996.tb01064.x; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SADIS S, 1988, J CELL PHYSIOL, V135, P377, DOI 10.1002/jcp.1041350304; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Tani T, 1996, MOL BIOL CELL, V7, P173, DOI 10.1091/mbc.7.1.173; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Zimowska G, 1997, J CELL SCI, V110, P927	25	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33902	33907		10.1074/jbc.M704054200	http://dx.doi.org/10.1074/jbc.M704054200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897941	Green Accepted, hybrid			2022-12-27	WOS:000251145700002
J	Webb, MR; Plank, JL; Long, DT; Hsieh, TS; Kreuzer, KN				Webb, Michael R.; Plank, Jody L.; Long, David T.; Hsieh, Tao-Shih; Kreuzer, Kenneth N.			The phage T4 protein UvsW drives Holliday Junction branch migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-III-ALPHA; DNA-REPLICATION; ESCHERICHIA-COLI; STRAND EXCHANGE; RECG HELICASE; FORK REVERSAL; BACTERIOPHAGE-T4; RECOMBINATION; REPAIR; MECHANISMS	The phage T4 UvsW protein has been shown to play a crucial role in the switch from origin-dependent to recombination-dependent replication in T4 infections through the unwinding of origin R-loop initiation intermediates. UvsW also functions with UvsX and UvsY to repair damaged DNA through homologous recombination, and, based on genetic evidence, has been proposed to act as a Holliday junction branch migration enzyme. Here we report the purification and characterization of UvsW. Using oligonucleotide-based substrates, we confirm that UvsW unwinds branched DNA substrates, including X and Y structures, but shows little activity in unwinding linear duplex substrates with blunt or single-strand ends. Using a novel Holliday junction-containing substrate, we also demonstrate that UvsW promotes the branch migration of Holliday junctions efficiently through more than 1000 bp of DNA. The ATP hydrolysis-deficient mutant protein, UvsW-K141R, is unable to promote Holliday junction branch migration. However, both UvsW and UvsW-K141R are capable of stabilizing Holliday junctions against spontaneous branch migration when ATP is not present. Using two-dimensional agarose gel electrophoresis we also show that UvsW acts on T4-generated replication intermediates, including Holliday junction-containing X-shaped intermediates and replication fork-shaped intermediates. Taken together, these results strongly support a role for UvsW in the branch migration of Holliday junctions that form during T4 recombination, replication, and repair.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Kreuzer, KN (corresponding author), Duke Univ, Med Ctr, Dept Biochem, BOx 3711, Durham, NC 27710 USA.	kenneth.kreuzer@duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012; Plank, Jody/B-4827-2009	Long, David/0000-0001-9232-0316	NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934, R01GM029006] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA 009111-30, T32 CA009111] Funding Source: Medline; NIGMS NIH HHS [R01 GM 066934, R01 GM029006, R01 GM 29006, R01 GM066934, R01 GM029006-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; BERNSTEIN H, 1989, J BACTERIOL, V171, P2265, DOI 10.1128/jb.171.5.2265-2270.1989; Bregeon D, 2004, BIOTECHNIQUES, V37, P760, DOI 10.2144/04375ST01; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Constantinou Angelos, 2004, Methods Mol Biol, V262, P239; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; DERR LK, 1990, MOL GEN GENET, V222, P257, DOI 10.1007/BF00633826; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; George JW, 2001, P NATL ACAD SCI USA, V98, P8290, DOI 10.1073/pnas.131007598; Grigoriev M, 1998, MOL CELL, V2, P373, DOI 10.1016/S1097-2765(00)80281-6; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kerr ID, 2007, J BIOL CHEM, V282, P34392, DOI 10.1074/jbc.M705900200; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Marians KJ, 2004, PHILOS T ROY SOC B, V359, P71, DOI 10.1098/rstb.2003.1366; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; SALINAS F, 1995, CELL, V82, P111, DOI 10.1016/0092-8674(95)90057-8; Sickmier EA, 2004, STRUCTURE, V12, P583, DOI 10.1016/j.str.2004.02.016; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SPICER EK, 1988, J BIOL CHEM, V263, P7478; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; ZHOU MY, 1994, BIOTECHNIQUES, V16, P58	45	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34401	34411		10.1074/jbc.M705913200	http://dx.doi.org/10.1074/jbc.M705913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17823128	Green Accepted, hybrid			2022-12-27	WOS:000251145700056
J	Claret, L; Miquel, S; Vieille, N; Ryjenkov, DA; Gomelsky, M; Darfeuille-Michaud, A				Claret, Laurent; Miquel, Sylvie; Vieille, Natacha; Ryjenkov, Dmitri A.; Gomelsky, Mark; Darfeuille-Michaud, Arlette			The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; EAL DOMAIN PROTEIN; C-DI-GMP; YERSINIA-ENTEROCOLITICA; LEGIONELLA-PNEUMOPHILA; GENE-EXPRESSION; ILEAL MUCOSA; TYPE-1 PILI; CAMPYLOBACTER-JEJUNI; VIBRIO-CHOLERAE	The invasion of intestinal epithelial cells by the Crohn disease-associated adherent-invasive Escherichia coli (AIEC) strain LF82 depends on surface appendages, such as type 1 pili and flagella. The absence of flagella in the AIEC strain LF82 results in a concomitant loss of type 1 pili. Here, we show that flagellar regulators, transcriptional activator FlhD(2)C(2), and sigma factor FliA are involved in the coordination of flagellar and type 1 pili synthesis. In the deletion mutants lacking these regulators, type 1 pili synthesis, adhesion, and invasion were severely decreased. FliA expressed alone in trans was sufficient to restore these defects in both the LF82-Delta flhD and LF82-Delta fliA mutants. We related the loss of type 1 pili to the decreased expression of the FliA-dependent yhjH gene in the LF82-Delta fliA mutant. YhjH is an EAL domain phosphodiesterase involved in degradation of the bacterial second messenger cyclic dimeric GMP (c-di-GMP). Increased expression of either yhjH or an alternative c-di-GMP phosphodiesterase, yahA, partially restored type 1 pili synthesis, adhesion, and invasion in the LF82-Delta fliA mutant. Deletion of the GGDEF domain diguanylate cyclase gene, yaiC, involved in c-di-GMP synthesis in the LF82-Delta fliA mutant also partially restored these defects, whereas overexpression of the c-di-GMP receptor YcgR had the opposite effect. These findings show that in the AIEC strain LF82, FliA is a key regulatory component linking flagellar and type 1 pili synthesis and that its effect on type 1 pili is mediated, at least in part, via a c-di-GMP-dependent pathway.	Univ Clermont Ferrand 1, Bacteriol Lab, Inst Natl Rech Agronom, Unite Sous Contrat 2018,USC INRA 2018, F-63001 Clermont Ferrand, France; Inst Univ Technol & Genie Biol, F-63172 Aubiere, France; Univ Wyoming, Dept Biol Mol, Laramie, WY 82071 USA	INRAE; Universite Clermont Auvergne (UCA); University of Wyoming	Claret, L (corresponding author), Univ Clermont Ferrand 1, Bacteriol Lab, Inst Natl Rech Agronom, Unite Sous Contrat 2018,USC INRA 2018, 28 Pl Henri Dunant, F-63001 Clermont Ferrand, France.	laurent.claret@u-clermont1.fr	gomelsky, mark/F-6209-2010	Miquel, Sylvie/0000-0001-8405-5073; Gomelsky, Mark/0000-0003-4077-3932				Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; ARNOSTI DN, 1989, P NATL ACAD SCI USA, V86, P830, DOI 10.1073/pnas.86.3.830; Barnich N, 2004, INFECT IMMUN, V72, P2484, DOI 10.1128/IAI.72.5.2484-2493.2004; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Bleves S, 2002, J BACTERIOL, V184, P3214, DOI 10.1128/JB.184.12.3214-3223.2002; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Fraser GM, 2002, MICROBIOL-SGM, V148, P2191, DOI 10.1099/00221287-148-7-2191; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Goon S, 2006, INFECT IMMUN, V74, P769, DOI 10.1128/IAI.74.1.769-772.2006; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Horne SM, 2006, ARCH MICROBIOL, V185, P115, DOI 10.1007/s00203-005-0077-1; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Krakowka S, 1996, VET IMMUNOL IMMUNOP, V52, P159, DOI 10.1016/0165-2427(95)05547-9; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; LEVINE MM, 1984, INFECT IMMUN, V44, P409, DOI 10.1128/IAI.44.2.409-420.1984; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; ORNDORFF PE, 1984, J BACTERIOL, V159, P736, DOI 10.1128/JB.159.2.736-744.1984; Park D, 2006, MOL MICROBIOL, V61, P1397, DOI 10.1111/j.1365-2958.2006.05320.x; Pruss BM, 2003, J BACTERIOL, V185, P534, DOI 10.1128/JB.185.2.534-543.2003; Rabaan AA, 2001, INFECT IMMUN, V69, P4257, DOI 10.1128/IAI.69.7.4257-4267.2001; RICHARDSON K, 1991, INFECT IMMUN, V59, P2727, DOI 10.1128/IAI.59.8.2727-2736.1991; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schmiel DH, 2000, J BACTERIOL, V182, P2314, DOI 10.1128/JB.182.8.2314-2320.2000; SCHWAN WR, 1992, J BACTERIOL, V174, P2367, DOI 10.1128/JB.174.7.2367-2375.1992; Shen L, 2006, J BACTERIOL, V188, P7364, DOI 10.1128/JB.01014-06; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999; Yu HHY, 2006, J BACTERIOL, V188, P8206, DOI 10.1128/JB.01082-06	57	71	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33275	33283		10.1074/jbc.M702800200	http://dx.doi.org/10.1074/jbc.M702800200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827157	hybrid, Green Published			2022-12-27	WOS:000250840200007
J	Pollak, N; Niere, M; Ziegler, M				Pollak, Nadine; Niere, Marc; Ziegler, Mathias			NAD kinase levels control the NADPH concentration in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; GENE; EXPRESSION; PEROXIREDOXIN; TRANSCRIPTION; PROTEINS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; IDENTIFICATION; ACTIVATION; RESPONSES	NAD kinases (NADKs) are vital, as they generate the cellular NADP pool. As opposed to three compartment-specific isoforms in plants and yeast, only a single NADK has been identified in mammals whose cytoplasmic localization we established by immunocytochemistry. To understand the physiological roles of the human enzyme, we generated and analyzed cell lines stably deficient in or overexpressing NADK. Short hairpin RNA mediated down-regulation led to similar ( about 70%) decrease of both NADK expression, activity, and the NADPH concentration and was accompanied by increased sensitivity toward H2O2. Overexpression of NADK resulted in a 4-5-fold increase in the NADPH, but not NADP(+), concentration, although the recombinant enzyme phosphorylated preferentially NAD(+). Surprisingly, NADK overexpression and the ensuing increase of the NADPH level only moderately enhanced protection against oxidant treatment. Apparently, to maintain the NADPH level for the regeneration of oxidative defense systems human cells depend primarily on NADP-dependent dehydrogenases ( which re-reduce NADP(+)), rather than on a net increase of NADP. The stable shifts of the NADPH level in the generated cell lines were also accompanied by alterations in the expression of peroxiredoxin 5 and Nrf2. Because the basal oxygen radical level in the cell lines was only slightly changed, the redox state of NADP may be a major transmitter of oxidative stress.	Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway	University of Bergen	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	Mathias.Ziegler@mbi.uib.no		Ziegler, Mathias/0000-0001-6961-2396				Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berrin JG, 2005, MOL GENET GENOMICS, V273, P10, DOI 10.1007/s00438-005-1113-1; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURCH HB, 1967, J BIOL CHEM, V242, P4546; Bykova NV, 2001, PHYSIOL PLANTARUM, V111, P448, DOI 10.1034/j.1399-3054.2001.1110404.x; Chai MF, 2006, PLANT J, V47, P665, DOI 10.1111/j.1365-313X.2006.02816.x; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kropotov A, 1999, EUR J BIOCHEM, V260, P336, DOI 10.1046/j.1432-1327.1999.00162.x; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Lee SH, 2004, INT J RADIAT BIOL, V80, P635, DOI 10.1080/09553000400007680; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeng O, 2004, BIOCHEM BIOPH RES CO, V317, P558, DOI 10.1016/j.bbrc.2004.03.075; Magni G, 2006, MINI-REV MED CHEM, V6, P739, DOI 10.2174/138955706777698688; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Takahashi H, 2006, PLANT CELL PHYSIOL, V47, P1678, DOI 10.1093/pcp/pcl029; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; WILLIAMS MB, 1985, ARCH BIOCHEM BIOPHYS, V237, P80, DOI 10.1016/0003-9861(85)90256-5; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	43	139	145	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33562	33571		10.1074/jbc.M704442200	http://dx.doi.org/10.1074/jbc.M704442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855339	Green Submitted, hybrid			2022-12-27	WOS:000250840200037
J	Vielreicher, M; Harms, G; Butt, E; Walter, U; Obergfell, A				Vielreicher, Martin; Harms, Gregory; Butt, Elke; Walter, Ulrich; Obergfell, Achim			Dynamic interaction between Src and C-terminal Src kinase in integrin alpha(IIb)beta(3)-mediated signaling to the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SINGLE-MOLECULE RESEARCH; TYROSINE KINASES; FLUORESCENT PROTEIN; IN-VIVO; ACTIN; CSK; TRANSDUCTION; ACTIVATION; PHOSPHORYLATION	Integrin-bound Src tyrosine kinase mediates alpha(IIb)beta(3)outside-in signaling to the cytoskeleton required for platelet adhesion and thrombus formation. Src activation ( signal initiation) by phosphorylation of Tyr-418 occurs at lamellipodia leading edges. However, little is known about Src inactivation mediated by C-terminal Src kinase (Csk) Tyr-529 phosphorylation. In an established platelet model cell line (A5-Chinese hamster ovary), we studied the inactivation of Src during alpha(IIb)beta(3) mediated adhesion to fibrinogen with live cell fluorescence resonance energy transfer ( FRET) microscopy. Imaging revealed highly dynamic Src-Csk interactions at the leading edges of active lamellipodia. The Src-Csk interaction followed a highly dynamic pattern. Every 2-3 min, Src-Csk complexes moved inward in the cell, reorganized, and formed stable focal adhesions. These accumulations were primarily seen during retraction of lamellipodia, whereas no interaction was observed during protrusions. Western blot analysis during the run time of FRET signaling revealed an increase in Csk-mediated SrcTyr-529 phosphorylation with a parallel decline of tyrosine 418 phosphorylation. Mutation analysis provided additional insights into the role of Src. Although inactivation of Csk (CskK222R) had no effect on cell adhesion and spreading efficiency, cells with constitutively active expressed Src (SrcY529F) exhibited hardly any adhesion and no spreading. The few adherent cells showed weak focal adhesions that were disorganized and oversized. The data clearly demonstrate the important role of tight Src control by Csk for functional cell adhesion and spreading. The novel experimental FRET approach reported here for the inactivation of Src can be readily applied to other integrin and signaling pathways, including closely related Src family kinase members.	Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; Univ Wurzburg, Mol Microscopy Grp, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Walter, U (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Rudolf Virchow Ctr, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	uwalter@klin-biochem.uni-wuerzburg.de	Vielreicher, Martin/L-1768-2013; Walter, ulrich/W-2478-2017	Vielreicher, Martin/0000-0002-7515-1431; Walter, ulrich/0000-0001-6784-2307				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; FROJMOVIC MM, 1991, BLOOD, V78, P369; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Steinmeyer R, 2005, J FLUORESC, V15, P707, DOI 10.1007/s10895-005-2978-4; THOMAS JE, 1991, SCIENCE, V254, P568, DOI 10.1126/science.1719633; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	33	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33623	10.1074/jbc.M704107200	http://dx.doi.org/10.1074/jbc.M704107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855352	hybrid			2022-12-27	WOS:000250840200043
J	Carlson, BA; Moustafa, ME; Sengupta, A; Schweizer, U; Shrimali, R; Rao, M; Zhong, N; Wang, S; Feigenbaum, L; Lee, BJ; Gladyshev, VN; Hatfield, DL				Carlson, Bradley A.; Moustafa, Mohamed E.; Sengupta, Aniruddha; Schweizer, Ulrich; Shrimali, Rajeev; Rao, Mahadev; Zhong, Nianxin; Wang, Shulin; Feigenbaum, Lionel; Lee, Byeong Jae; Gladyshev, Vadim N.; Hatfield, Dolph L.			Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; THIOREDOXIN REDUCTASE; TARGETED DISRUPTION; SELENIUM DEFICIENCY; MESSENGER-RNA; MICE LACKING; GENE; EXPRESSION; MECHANISM; LIVER	Novel mouse models were developed in which the hepatic selenoprotein population was targeted for removal by disrupting the selenocysteine (Sec) tRNA([Ser]Sec) gene (trsp), and selenoprotein expression was then restored by introducing wild type or mutant trsp transgenes. The selenoprotein population was partially replaced in liver with mutant transgenes encoding mutations at either position 34(34T -> A) or 37 ( 37A -> G) in tRNA[ Ser] Sec. The A34 transgene product lacked the highly modified 5- methoxy-carbonylmethyl-2' -O-methyluridine, and its mutant base A was converted to I34. The G37 transgene product lacked the highly modified N-6-isopentenyladenosine. Both mutant tRNAs lacked the 2'-methylribose at position 34 ( Um34), and both supported expression of housekeeping selenoproteins ( e. g. thioredoxin reductase 1) in liver but not stress- related proteins ( e. g. glutathione peroxidase 1). Thus, Um34 is responsible for synthesis of a select group of selenoproteins rather than the entire selenoprotein population. The ICA anticodon in the A34 mutant tRNA decoded Cys codons, UGU and UGC, as well as the Sec codon, UGA. However, metabolic labeling of A34 transgenic mice with Se-75 revealed that selenoproteins incorporated the label from the A34 mutant tRNA, whereas other proteins did not. These results suggest that the A34 mutant tRNA did not randomly insert Sec in place of Cys, but specifically targeted selected selenoproteins. High copy numbers of A34 transgene, but not G37 transgene, were not tolerated in the absence of wild type trsp, further suggesting insertion of Sec in place of Cys in selenoproteins.	NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Canc Res Ctr,Natl Inst Hlth, Bethesda, MD 20892 USA; Charite Univ Med Berlin, Inst Expt Endocrinol, Ctr Res Neurosci, D-10117 Berlin, Germany; NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Frederick, MD 21702 USA; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Seoul National University (SNU); Seoul National University (SNU); University of Nebraska System; University of Nebraska Lincoln	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Canc Res Ctr,Natl Inst Hlth, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Gladyshev, Vadim N/A-9894-2013; Moustafa, Mohamed E/E-9002-2018; Schweizer, Ulrich/E-8105-2013; Moustafa, Mohamed/AAM-2211-2021; Gladyshev, Vadim N/J-6187-2013	Schweizer, Ulrich/0000-0003-1380-4780; Moustafa, Mohamed/0000-0003-1308-6221; Sengupta, Aniruddha/0000-0001-5560-0837; Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BURK RF, 1980, BIOCHEM PHARMACOL, V29, P39, DOI 10.1016/0006-2952(80)90241-5; Carlson BA, 2005, TOP CURR GENET, V12, P431, DOI 10.1007/b106652; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chittum HS, 1997, BBA-MOL CELL RES, V1359, P25, DOI 10.1016/S0167-4889(97)00092-X; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, V2; HATFIELD DL, 2007, CCR FRONTIERS SCI, V6, P8; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hornberger TA, 2003, J NUTR, V133, P3091, DOI 10.1093/jn/133.10.3091; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Martin GW, 1996, RNA, V2, P171; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; NIRENBERG MW, 1964, SCIENCE, V145, P1399, DOI 10.1126/science.145.3639.1399; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rao M, 2003, RNA, V9, P923, DOI 10.1261/rna.5510503; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SCHOMBURG L, 2007, IN PRESS BIOL CHEM; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Sheridan PA, 2007, J NUTR, V137, P1466, DOI 10.1093/jn/137.6.1466; Shrimali RK, 2007, NEUROMUSCULAR DISORD, V17, P135, DOI 10.1016/j.nmd.2006.10.006; Tajsharghi H, 2005, NEUROMUSCULAR DISORD, V15, P299, DOI 10.1016/j.nmd.2004.11.004; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	52	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32591	32602		10.1074/jbc.M707036200	http://dx.doi.org/10.1074/jbc.M707036200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848557	hybrid			2022-12-27	WOS:000250625400008
J	Cohen, C				Cohen, Carolyn			Seeing and knowing in structural biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							POLYPEPTIDE CHAIN CONFIGURATION; TOBACCO MOSAIC VIRUS; OPTICAL ROTATION; STRIATED MUSCLE; MYOSIN; PROTEINS; TROPOMYOSIN; FILAMENTS; HELIX; TRANSDUCTION		Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Cohen, C (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.							Abad-Zapatero C, 2007, ACTA CRYSTALLOGR D, V63, P660, DOI 10.1107/S0907444907015053; BEAR RS, 1951, NATURE, V168, P684, DOI 10.1038/168684a0; CASPAR DLD, 1969, J MOL BIOL, V41, P87, DOI 10.1016/0022-2836(69)90128-4; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CASPAR DLD, 1969, J MOL BIOL, V46, P99, DOI 10.1016/0022-2836(69)90060-6; CASPAR DLD, 1969, NOBEL S, V2, P393; COCHRAN W, 1952, ACTA CRYSTALLOGR, V5, P581, DOI 10.1107/S0365110X52001635; COHEN C, 1971, J MOL BIOL, V56, P223, DOI 10.1016/0022-2836(71)90461-X; COHEN C, 1958, J BIOPHYS BIOCHEM CY, V4, P489, DOI 10.1083/jcb.4.4.489; Cohen C, 1998, BIOPHYS J, V74, P532, DOI 10.1016/S0006-3495(98)77810-5; COHEN C, 1955, J BIOPHYS BIOCHEM CY, V1, P203, DOI 10.1083/jcb.1.3.203; Cohen C, 1998, J STRUCT BIOL, V122, P3, DOI 10.1006/jsbi.1998.3975; COHEN C, 1953, J AM CHEM SOC, V75, P2783, DOI 10.1021/ja01107a523; COHEN C, 1961, J POLYM SCI, V49, P144; COHEN C, 1955, NATURE, V175, P129, DOI 10.1038/175129a0; COHEN C, 1966, SCIENCE, V152, P794, DOI 10.1126/science.152.3723.794; COHEN C, 1971, COLD SPRING HARB SYM, V36, P205, DOI 10.1101/SQB.1972.036.01.028; COHEN C, 1957, J AM CHEM SOC, V79, P248, DOI 10.1021/ja01558a066; COHEN C, 1960, P 4 INT C BIOCH VIEN, V8, P108; COHEN C, 1972, COLD SPRING HARB SYM, V37, P287; COHEN C, 1954, THESIS MIT; COHEN CAROLYN, 1966, CIBA FOUND SYMP, P101; COHEN CAROLYN, 1963, JOUR MOLECULAR BIOL, V6, P423; Cohen CI, 2000, AM J GERIAT PSYCHIAT, V8, P19, DOI 10.1097/00019442-200002000-00003; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; FRANKLIN RE, 1958, ACTA CRYSTALLOGR, V11, P213, DOI 10.1107/S0365110X58000529; FRANKLIN RE, 1956, NATURE, V177, P928; GIERER A, 2001, PREPRINT, V162, P1; Hanson J., 1955, S SOC EXP BIOL, V9, P228; Harrison SC, 2004, NAT STRUCT MOL BIOL, V11, P12, DOI 10.1038/nsmb0104-12; Hodge AJ, 1967, TREATISE COLLAGEN, P185; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; HUXLEY HE, 1952, NATURE, V170, P882, DOI 10.1038/170882a0; HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631; HUXLEY HE, 1953, BIOCHIM BIOPHYS ACTA, V12, P387, DOI 10.1016/0006-3002(53)90156-5; HUXLEY HE, 1963, J MOL BIOL, V7, P281, DOI 10.1016/S0022-2836(63)80008-X; Kendrew JC., 1967, SCI AM, V216, P141, DOI [10.1038/scientificamerican0367-141, DOI 10.1038/SCIENTIFICAMERICAN0367-141]; KIM SH, 2000, IUCR NEWSLETTER, V8, P19; Klug A, 2004, J MOL BIOL, V335, P3, DOI 10.1016/j.jmb.2003.11.015; LOWEY S, 1962, J MOL BIOL, V4, P293, DOI 10.1016/S0022-2836(62)80007-2; MCLACHLAN AD, 1984, ANNU REV BIOPHYS BIO, V13, P167; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P261, DOI 10.1073/pnas.37.5.261; PAULING L, 1974, NATURE, V248, P769, DOI 10.1038/248769a0; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; SLAYTER HS, 1967, P NATL ACAD SCI USA, V58, P1611, DOI 10.1073/pnas.58.4.1611; STRYER L, 1963, NATURE, V197, P793, DOI 10.1038/197793a0; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010	52	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32529	32538		10.1074/JBC.X700001200	http://dx.doi.org/10.1074/JBC.X700001200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848543	hybrid			2022-12-27	WOS:000250625400002
J	Kim, PY; Nesheim, ME				Kim, Paul Y.; Nesheim, Michael E.			Further evidence for two functional forms of prothrombinase each specific for either of the two prothrombin activation cleavages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK ANTICOAGULANT PEPTIDE; COAGULATION FACTOR-XA; BOVINE FACTOR-V; BLOOD-COAGULATION; PHOSPHOLIPID-VESICLES; BINDING-SITE; HEAVY-CHAIN; COMPLEX; SUBSTRATE; THROMBIN	Previous work showed that prothrombin derivatives cleavable only at Arg- 320 ( rMZ) or Arg- 271 ( rP2) are partial, rather than competitive, inhibitors of prothrombin activation by prothrombinase. A " ping- pong"- like model, which posits two equilibrating forms of prothrombinase, explained the inhibition pattern. The present studies were undertaken to further investigate this putative mechanism. Two models were developed, one allowing for one form of the enzyme and the other allowing for two forms. Both models also allowed channeling and ratcheting. The models were fit to full time courses of prothrombin, meizothrombin, prethrombin- 2, and the B- chain. In the absence of ratcheting and channeling, neither model fits the data. In their presence, however, both models fit very well, and thus they could not be distinguished. Therefore, inhibition of rMZ activation by rP2 was studied. Inhibition was partial and the two- form model fit the data with randomly distributed residuals, whereas the one-form model did not. Initial rates of fluorescein- labeled prothrombin cleavage in the presence of various prothrombin derivatives reported by Brufatto and Nesheim ( Brufatto, N., and Nesheim, M. E. ( 2003) J. Biol. Chem. 278, 6755 - 6764) were also analyzed using the two models. The two- form model fit the partial inhibition data well, whereas the one- form model did not. In addition, prothrombin at varying concentrations was activated, and subsequently, the initial rates were plotted with respect to the initial prothrombin concentration. When compared with the expected initial rates as determined by the simulation of the models, the two- form model fit the observed rates better than the one- form model. The results obtained here further support the existence of two functional forms of prothrombinase.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Nesheim, ME (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	nesheimm@post.queensu.ca	Kim, Paul/GYV-3258-2022	Kim, Paul/0000-0003-0943-4924	NHLBI NIH HHS [5P01 HL 046703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAJZAR L, 1990, J BIOL CHEM, V265, P16948; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; Boskovic DS, 2001, J BIOL CHEM, V276, P28686, DOI 10.1074/jbc.M101813200; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; CHURCH WR, 1991, J BIOL CHEM, V266, P8384; ESMON CT, 1975, J BIOL CHEM, V250, P4095; ESMON CT, 1974, J BIOL CHEM, V249, P7791; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HIBBARD LS, 1982, BIOCHEMISTRY-US, V21, P2285, DOI 10.1021/bi00539a003; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; MANN KG, 1991, ANN NY ACAD SCI, V614, P63; MANN KG, 1980, METHOD ENZYMOL, V23, P286; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; ROSING J, 1986, J BIOL CHEM, V261, P4224; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; SEGEL IH, 1975, ENZYME KINETICS, P606; Steen M, 2002, SCAND J CLIN LAB INV, V62, P5, DOI 10.1080/003655102762377439; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; VANDEWAART P, 1984, BIOCHEMISTRY-US, V23, P2838, DOI 10.1021/bi00307a047; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	44	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32568	32581		10.1074/jbc.M701781200	http://dx.doi.org/10.1074/jbc.M701781200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726029	hybrid			2022-12-27	WOS:000250625400006
J	Nilsson, P; Henriksson, N; Niedzwiecka, A; Balatsos, NAA; Kokkoris, K; Eriksson, J; Virtanen, A				Nilsson, Per; Henriksson, Niklas; Niedzwiecka, Anna; Balatsos, Nikolaos A. A.; Kokkoris, Kyriakos; Eriksson, Jens; Virtanen, Anders			A multifunctional RNA recognition motif in poly(A)-specific ribonuclease with cap and poly(A) binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; POLY(A)-BINDING PROTEIN; IN-VITRO; STRUCTURAL BASIS; 3' EXONUCLEASE; ACTIVE-SITE; COMPLEX; DEADENYLATION; TRANSLATION; PARN	Poly(A)-specific ribonuclease (PARN) is an oligomeric, processive and cap-interacting 3' exoribonuclease that efficiently degrades mRNA poly(A) tails. Here we show that the RNA recognition motif (RRM) of PARN harbors both poly(A) and cap binding properties, suggesting that the RRM plays an important role for the two critical and unique properties that are tightly associated with PARN activity, i.e. recognition and dependence on both the cap structure and poly(A) tail during poly(A) hydrolysis. We show that PARN and its RRM have micromolar affinity to the cap structure by using fluorescence spectroscopy and nanomolar affinity for poly(A) by using filter binding assay. We have identified one tryptophan residue within the RRM that is essential for cap binding but not required for poly(A) binding, suggesting that the cap-and poly(A)-binding sites associated with the RRM are both structurally and functionally separate from each other. RRM is one of the most commonly occurring RNA-binding domains identified so far, suggesting that other RRMs may have both cap and RNA binding properties just as the RRM of PARN.	Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; Polish Acad Sci, Inst Phys, Biol Phys Grp, PL-02668 Warsaw, Poland; Univ Warsaw, Inst Expt Phys, Dept Biophys, PL-02089 Warsaw, Poland	Uppsala University; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; University of Warsaw	Virtanen, A (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	Anders.Virtanen@icm.uu.se	Henriksson, Niklas/A-5898-2013; Niedzwiecka, Anna/E-8940-2010	Niedzwiecka, Anna/0000-0001-5208-0733; Eriksson, Jens/0000-0002-8945-2665; Balatsos, Nikolaos/0000-0002-1146-1174				ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Cai A, 1999, BIOCHEMISTRY-US, V38, P8538, DOI 10.1021/bi9830213; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Nilsson P, 2006, INT J BIOL MACROMOL, V39, P95, DOI 10.1016/j.ijbiomac.2006.02.025; Opyrchal M, 2005, INSECT BIOCHEM MOLEC, V35, P1321, DOI 10.1016/j.ibmb.2005.08.004; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Reverdatto SV, 2004, RNA, V10, P1200, DOI 10.1261/rna.7540204; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Worch R, 2005, RNA, V11, P1355, DOI 10.1261/rna.2850705; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869	51	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32902	32911		10.1074/jbc.M702375200	http://dx.doi.org/10.1074/jbc.M702375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785461	hybrid			2022-12-27	WOS:000250625400039
J	Salzman, DW; Shubert-Coleman, J; Furneaux, H				Salzman, David W.; Shubert-Coleman, Jonathan; Furneaux, Henry			P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HUMAN-CELLS; DROSHA-DGCR8 COMPLEX; PASSENGER-STRAND; DISTINCT ROLES; HUMAN RISC; PROTEIN; DICER; SIRNA; CLEAVAGE	MicroRNAs are short, single- stranded RNAs that arise from a transient precursor duplex. We have identified a novel activity in HeLa cell extracts that can unwind the let- 7 microRNA duplex. Using partially purified material, we have shown that microRNA helicase activity requires ATP and has a native molecular mass of similar to 68 kDa. Affinity purification of the unwinding activity revealed co- purification of P68 RNA helicase. Importantly, recombinant P68 RNA helicase was sufficient to unwind the let- 7 duplex. Moreover, like its native homolog, P68 RNA helicase did not unwind an analogous small interfering RNA duplex. We further showed that knockdown of P68 inhibited let- 7 microRNA function. From our data, we conclude that P68 RNA helicase is an essential component of the let- 7 microRNA pathway, and in conjunction with other factors, it may play a role in the loading of let- 7 microRNA into the silencing complex.	Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	Furneaux, H (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 235 Farmington Ave, Farmington, CT 06030 USA.	furneaux@nso.uchc.edu		furneaux, henry/0000-0003-2212-1017	NHLBI NIH HHS [P01 HL 70694] Funding Source: Medline; NIDA NIH HHS [R03 DA 022226] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA022226] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; LANE D, 1988, NATURE, V334, P478, DOI 10.1038/334478a0; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; RAY BK, 1985, J BIOL CHEM, V260, P7651; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	78	81	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32773	32779		10.1074/jbc.M705054200	http://dx.doi.org/10.1074/jbc.M705054200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17724023	hybrid			2022-12-27	WOS:000250625400026
J	Wawrzynow, B; Zylicz, A; Wallace, M; Hupp, T; Zylicz, M				Wawrzynow, Bartosz; Zylicz, Alicja; Wallace, Maura; Hupp, Ted; Zylicz, Maciej			MDM2 chaperones the p53 tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITINATION IN-VITRO; HEAT-SHOCK PROTEIN; WILD-TYPE P53; MOLECULAR CHAPERONES; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; MESSENGER-RNAS; CANCER MUTANTS; BINDING-SITE; CELL-GROWTH	The murine double minute ( mdm2) gene encodes an E3 ubiquitin ligase that plays a key role in the degradation of p53 tumor suppressor protein. Nevertheless recent data highlight other p53- independent functions of MDM2. Given that MDM2 protein binds ATP, can interact with the Hsp90 chaperone, plays a role in the modulation of transcription factors and protection and activation of DNA polymerases, and is involved in ribosome assembly and nascent p53 protein biosynthesis, we have evaluated and found MDM2 protein to possess an intrinsic molecular chaperone activity. MDM2 can substitute for the Hsp90 molecular chaperone in promoting binding of p53 to the p21- derived promoter sequence. This reaction is driven by recycling of MDM2 from the p53 complex, triggered by binding of ATP to MDM2. The ATP binding mutant MDM2 protein ( K454A) lacks the chaperone activity both in vivo and in vitro. Mdm2 cotransfected in the H1299 cell line with wild- type p53 stimulates efficient p53 folding in vivo but at the same time accelerates the degradation of p53. MDM2 in which one of the Zn2+ coordinating residues is mutated ( C478S or C464A) blocks degradation but enhances folding of p53. This is the first demonstration that MDM2 possesses an intrinsic molecular chaperone activity, indicating that the ATP binding function of MDM2 can mediate its chaperone function toward the p53 tumor suppressor.	Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Univ Edinburgh, Div Oncol, Canc Res UK, Cell Signalling Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Cancer Research UK; University of Edinburgh	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol, 4 Trojdena St, PL-02109 Warsaw, Poland.	mzylicz@iimcb.gov.pl		Zylicz, Alicja/0000-0003-4174-3073				Asahara H, 2003, NUCLEIC ACIDS RES, V31, P2451, DOI 10.1093/nar/gkg342; Bartel F, 2004, MOL CANCER RES, V2, P29; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2000, FEBS LETT, V472, P93, DOI 10.1016/S0014-5793(00)01427-7; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; CORDONCARDO C, 1994, CANCER RES, V54, P794; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Ellis R. J., 1993, P1; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hirano Y, 2006, CELL, V127, P675, DOI 10.1016/j.cell.2006.11.003; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Liang HL, 2004, GENE, V338, P217, DOI 10.1016/j.gene.2004.05.015; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; MILNER J, 1990, J MOL BIOL, V216, P481, DOI 10.1016/0022-2836(90)90371-R; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Shimizu H, 2003, TRENDS BIOCHEM SCI, V28, P346, DOI 10.1016/S0968-0004(03)00140-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	65	46	47	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32603	32612		10.1074/jbc.M702767200	http://dx.doi.org/10.1074/jbc.M702767200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848574	hybrid			2022-12-27	WOS:000250625400009
J	Saravanan, M; Vasu, K; Ghosh, S; Nagaraja, V				Saravanan, Matheshwaran; Vasu, Kommireddy; Ghosh, Soumitra; Nagaraja, Valakunja			Dual role for Zn2+ in maintaining structural integrity and inducing DNA sequence specificity in a promiscuous endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; ZINC-FINGER; RESTRICTION-ENDONUCLEASE; BINDING; ENZYMES; NUCLEASE; DOMAIN; DISCRIMINATION; CLEAVAGE; COMPLEX	We describe two uncommon roles for Zn2+ in enzyme KpnI restriction endonuclease (REase). Among all of the REases studied, KpnI REase is unique in its DNA binding and cleavage characteristics. The enzyme is a poor discriminator of DNA sequences, cleaving DNA in a promiscuous manner in the presence of Mg2+. Unlike most Type II REases, the active site of the enzyme comprises an HNH motif, which can accommodate Mg2+, Mn2+, or Ca2+. Among these metal ions, Mg2+ and Mn2+ induce promiscuous cleavage by the enzyme, whereas Ca2+ bound enzyme exhibits site-specific cleavage. Examination of the sequence of the protein revealed the presence of a zinc finger CCCH motif rarely found in proteins of prokaryotic origin. The zinc binding motif tightly coordinates zinc to provide a rigid structural framework for the enzyme needed for its function. In addition to this structural scaffold, another atom of zinc binds to the active site to induce high fidelity cleavage and suppress the Mg2+- and Mn2+-mediated promiscuous behavior of the enzyme. This is the first demonstration of distinct structural and catalytic roles for zinc in an enzyme, suggesting the distinct origin of KpnI REase.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in	Matheshwaran, Saravanan/E-9461-2010; Kommireddy, Vasu/C-3928-2018; Matheshwaran, Saravanan/CAG-9469-2022	Kommireddy, Vasu/0000-0002-7608-7566; Ghosh, Soumitra/0000-0002-8376-8677; MATHESHWARAN, SARAVANAN/0000-0001-6762-9928				Amann BT, 2003, BIOCHEMISTRY-US, V42, P217, DOI 10.1021/bi026988m; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; Boysen RI, 2001, J PEPT RES, V57, P19, DOI 10.1034/j.1399-3011.2001.00752.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bujnicki JM, 2000, MOL MICROBIOL, V37, P1280, DOI 10.1046/j.1365-2958.2000.02010.x; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Chandrashekaran S, 2004, J BIOL CHEM, V279, P49736, DOI 10.1074/jbc.M409483200; Chandrashekaran S, 1999, J BIOSCIENCE, V24, P269, DOI 10.1007/BF02941240; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; GITE S, 1992, EUR J BIOCHEM, V210, P437, DOI 10.1111/j.1432-1033.1992.tb17439.x; HANAS JS, 1983, J BIOL CHEM, V258, P4120; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Keilin D, 1940, BIOCHEM J, V34, P1163, DOI 10.1042/bj0341163; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lin YY, 2005, J BACTERIOL, V187, P7881, DOI 10.1128/JB.187.23.7881-7889.2005; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Sapranauskas R, 2000, J BIOL CHEM, V275, P30878, DOI 10.1074/jbc.M003350200; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Saravanan M, 2007, NUCLEIC ACIDS RES, V35, P2777, DOI 10.1093/nar/gkm114; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Van Roey P, 2001, EMBO J, V20, P3631, DOI 10.1093/emboj/20.14.3631; Vanamee ES, 2003, J MOL BIOL, V334, P595, DOI 10.1016/j.jmb.2003.09.043	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32320	32326		10.1074/jbc.M705927200	http://dx.doi.org/10.1074/jbc.M705927200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785455	hybrid			2022-12-27	WOS:000250480300055
J	Feng, H; Ren, M; Chen, L; Rubin, CS				Feng, Hui; Ren, Min; Chen, Lu; Rubin, Charles S.			Properties, regulation, and in vivo functions of a novel protein kinase D - Caenorhabditis elegans DKF-2 links diacylglycerol second messenger to the regulation of stress responses and life span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; CYSTEINE-RICH MOTIFS; D ACTIVATION; C-ELEGANS; EXPRESSION; GENE; DOMAINS; PATHWAY; DAF-16; FAMILY	Protein kinase D (PKD) isoforms are protein kinase C effectors in signaling cascades controlled by diacylglycerol (DAG). All PKDs are regulated by DAG/phorbol 12-myristate 13-acetate-binding C1 domains and an activation loop (A-loop). To understand how PKD isoforms diversify DAG signaling networks, it is essential to determine redundant and novel properties of their regulatory domains, characterize factors controlling PKD gene expression, and discover their in vivo physiological roles. Studies on a novel PKD, Caenorhabditis elegans DKF-2 (D kinase family-2), addressed these topics. The C1b domain mediates phorbol 12-myristate 13-acetate-induced translocation and activation of DKF-2. However, when DAG is elevated, C1a and C1b contribute equally to targeting/activation of DKF-2. DKF-2 C1 domains do not inhibit catalytic activity; they mediate delivery of DKF-2 to a membrane where protein kinase C phosphorylates Ser(925) and Ser(929) in the A-loop. This potently stimulates DKF-2 catalytic activity. Phosphorylation of Ser(925) alone switches on 70% of maximal kinase activity. Persistent phosphorylation of Ser (929) tags DKF-2 for proteasomal degradation; Ser(P)(925) plays a minor role in DKF-2 degradation. GATA enhancer sequences govern DKF-2 expression in intestine in vivo. Adult life span increases 40% in animals lacking DKF-2. In thermally stressed wild type animals, the DAF-16 transcription factor is segregated from the nuclei of adult intestinal cells. In contrast, DAF-16 enters adult intestinal nuclei of DKF-2-deficient, thermally stressed animals, where it can trigger gene transcription that protects against various insults. The results suggest a mechanism for increased longevity and show that a PKD links DAG signals to regulation of stress responses and life span.				rubin@aecom.yu.edu						Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; EGAN CR, 1995, DEV BIOL, V170, P397, DOI 10.1006/dbio.1995.1225; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; Huang P, 2005, CYTOKINE GROWTH F R, V16, P151, DOI 10.1016/j.cytogfr.2005.03.002; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; LAND M, 1994, J BIOL CHEM, V269, P9234; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohki-Hamazaki H, 2005, INT J DEV BIOL, V49, P293, DOI 10.1387/ijdb.041954ho; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Rennecke J, 1996, EUR J BIOCHEM, V242, P428, DOI 10.1111/j.1432-1033.1996.0428r.x; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2002, J BIOL CHEM, V277, P29431, DOI 10.1074/jbc.M200934200; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	57	35	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31273	31288		10.1074/jbc.M701532200	http://dx.doi.org/10.1074/jbc.M701532200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728253	hybrid			2022-12-27	WOS:000250309200017
J	Hubbard, PA; Padovani, D; Labunska, T; Mahlstedt, SA; Banerjee, R; Drennan, CL				Hubbard, Paul A.; Padovani, Dominique; Labunska, Tetyana; Mahlstedt, Sarah A.; Banerjee, Ruma; Drennan, Catherine L.			Crystal structure and mutagenesis of the metallochaperone MeaB - Insight into the causes of methylmalonic aciduria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA MUTASE; MAXIMUM-LIKELIHOOD; ACCESSORY PROTEINS; ESCHERICHIA-COLI; DIOL DEHYDRATASE; METAL-BINDING; NICKEL; HYPB; VITAMIN-B-12; COEFFICIENTS	MeaB is an auxiliary protein that plays a crucial role in the protection and assembly of the B-12-dependent enzyme methyl-malonyl-CoA mutase. Impairments in the human homologue of MeaB, MMAA, lead to methylmalonic aciduria, an inborn error of metabolism. To explore the role of this metallochaperone, its structure was solved in the nucleotide-free form, as well as in the presence of product, GDP. MeaB is a homodimer, with each subunit containing a central alpha/beta-core G domain that is typical of the GTPase family, as well as alpha-helical extensions at the N and C termini that are not found in other metalloenzyme chaperone GTPases. The C-terminal extension appears to be essential for nucleotide-independent dimerization, and the N-terminal region is implicated in protein-protein interaction with its partner protein, methylmalonyl-CoA mutase. The structure of MeaB confirms that it is a member of the G3E family of P-loop GTPases, which contains other putative metallochaperones HypB, CooC, and UreG. Interestingly, the so-called switch regions, responsible for signal transduction following GTP hydrolysis, are found at the dimer interface of MeaB instead of being positioned at the surface of the protein where its partner protein methylmalonyl-CoA mutase should bind. This observation suggests a large conformation change of MeaB must occur between the GDP- and GTP-bound forms of this protein. Because of their high sequence homology, the missense mutations in MMAA that result in methylmalonic aciduria have been mapped onto MeaB and, in conjunction with mutagenesis data, provide possible explanations for the pathology of this disease.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Nebraska System; University of Nebraska Lincoln	Drennan, CL (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065337] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK45776] Funding Source: Medline; NIEHS NIH HHS [P30 ES002109] Funding Source: Medline; NIGMS NIH HHS [GM65337] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Khil PP, 2004, PROTEINS, V54, P371, DOI 10.1002/prot.10430; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mori K, 1997, BIOSCI BIOTECH BIOCH, V61, P1729, DOI 10.1271/bbb.61.1729; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MULROONEY SB, 1990, J BACTERIOL, V172, P5837, DOI 10.1128/jb.172.10.5837-5843.1990; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; 1997, ACTA CRYSTALLOGR D B, V276, P307	35	35	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31308	31316		10.1074/jbc.M704850200	http://dx.doi.org/10.1074/jbc.M704850200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728257	hybrid			2022-12-27	WOS:000250309200020
J	Meier, R; Drepper, T; Svensson, V; Jaeger, KE; Baumann, U				Meier, Reto; Drepper, Thomas; Svensson, Vera; Jaeger, Karl-Erich; Baumann, Ulrich			A calcium-gated lid and a large beta-roll sandwich are revealed by the crystal structure of extracellular lipase from Serratia marcescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; ADENYLATE-CYCLASE TOXIN; I SECRETION SYSTEM; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; INTERFACIAL ACTIVATION; DIRECTED EVOLUTION; ALKALINE PROTEASE; LIPOLYTIC ENZYMES; OPEN CONFORMATION	Lipase LipA from Serratia marcescens is a 613-amino acid enzyme belonging to family I. 3 of lipolytic enzymes that has an important biotechnological application in the production of a chiral precursor for the coronary vasodilator diltiazem. Like other family I. 3 lipases, LipA is secreted by Gram-negative bacteria via a type I secretion system and possesses 13 copies of a calcium binding tandem repeat motif, GGXGXDXUX (U, hydrophobic amino acids), in the C-terminal part of the polypeptide chain. The 1.8-A crystal structure of LipA reveals a close relation to eukaryotic lipases, whereas family I. 1 and I. 2 enzymes appear to be more distantly related. Interestingly, the structure shows for the N-terminal lipase domain a variation on the canonical alpha/beta hydrolase fold in an open conformation, where the putative lid helix is anchored by a Ca2+ ion essential for activity. Another novel feature observed in this lipase structure is the presence of a helical hairpin additional to the putative lid helix that exposes a hydrophobic surface to the aqueous medium and might function as an additional lid. The tandem repeats form two separated parallel beta-roll domains that pack tightly against each other. Variations of the consensus sequence of the tandem repeats within the second beta-roll result in an asymmetric Ca2+ binding on only one side of the roll. The analysis of the properties of the beta-roll domains suggests an intramolecular chaperone function.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Univ Dusseldorf, Res Ctr, Inst Mol Enzyme Technol, D-52426 Julich, Germany	University of Bern; Heinrich Heine University Dusseldorf	Jaeger, KE (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.	karl-erich.jaeger@fz-juelich.de; ulrich.baumann@ibc.unibe.ch	jaeger, karl/ABB-1955-2020; Drepper, Thomas/ABA-8291-2020; drepper, thomas/ABB-4717-2020; Baumann, Ulrich/B-1220-2013	Drepper, Thomas/0000-0002-0096-8084; drepper, thomas/0000-0002-0096-8084; 				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Angkawidjaja C, 2005, FEBS LETT, V579, P4707, DOI 10.1016/j.febslet.2005.07.041; Angkawidjaja C, 2006, PROTEIN ENG DES SEL, V19, P337, DOI 10.1093/protein/gzl017; Angkawidjaja C, 2006, CELL MOL LIFE SCI, V63, P2804, DOI 10.1007/s00018-006-6172-x; Angkawidjaja C, 2007, ACTA CRYSTALLOGR F, V63, P187, DOI 10.1107/S1744309107004575; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; Becker S, 2005, FEBS LETT, V579, P1177, DOI 10.1016/j.febslet.2004.12.087; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P15071, DOI 10.1021/bi0013905; Cygler M, 1997, METHOD ENZYMOL, V284, P3; Debarbieux L, 2001, EMBO J, V20, P4657, DOI 10.1093/emboj/20.17.4657; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gentschev I, 2002, TRENDS MICROBIOL, V10, P39, DOI 10.1016/S0966-842X(01)02259-4; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kwon HJ, 2002, J BIOSCI BIOENG, V93, P157, DOI 10.1263/jbb.93.157; LESLIE AGW, 1996, JNT CCP4 ESF EAMCB N, V32, P7; LETOFFE S, 1994, J BACTERIOL, V176, P5372; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; LI XY, 1995, APPL ENVIRON MICROB, V61, P2674, DOI 10.1128/AEM.61.7.2674-2680.1995; Liebeton K, 2000, CHEM BIOL, V7, P709, DOI 10.1016/S1074-5521(00)00015-6; Liese A., 2006, IND BIOTRANSFORMATIO; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; MATSUMAE H, 1993, FERMENT BIOENG, V93, P93; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyajima Y, 1998, J BIOCHEM-TOKYO, V123, P24; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reetz MT, 2007, CHEMBIOCHEM, V8, P106, DOI 10.1002/cbic.200600359; Reetz MT, 2000, CHEM-EUR J, V6, P407, DOI 10.1002/(SICI)1521-3765(20000204)6:3<407::AID-CHEM407>3.3.CO;2-P; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; WANDERSMAN C, 1992, TRENDS GENET, V8, P317, DOI 10.1016/0168-9525(92)90264-5; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	55	82	85	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31477	31483		10.1074/jbc.M704942200	http://dx.doi.org/10.1074/jbc.M704942200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728256	Green Published, hybrid			2022-12-27	WOS:000250309200039
J	Muddasani, P; Norman, JC; Ellman, M; van Wijnen, AJ; Im, HJ				Muddasani, Prasuna; Norman, Jim C.; Ellman, Michael; van Wijnen, Andre J.; Im, Hee-Jeong			Basic fibroblast growth factor activates the MAPK and NF kappa B pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FACTOR-I; ALPHA-5-BETA-1 INTEGRINS; FIBRONECTIN FRAGMENTS; OSTEOGENIC PROTEIN-1; PLATE CHONDROCYTES; MMP-13 EXPRESSION; RESPONSE ELEMENT; COLLAGENASE-3; CARTILAGE	The pathology of joint destruction is associated with elevated production of basic fibroblast growth factor (bFGF) and matrix metalloproteinase-13 (MMP-13). In osteoarthritic joint disease, expression of bFGF and MMP-13 in chondrocytes and their release into the synovial fluid are significantly increased. We have previously found that the capacity for cartilage repair in human adult articular chondrocytes is severely compromised by minimal exposure to bFGF because bFGF reduces responsiveness to bone morphogenetic protein-7 and insulin-like growth factor-1 and induces MMP-13 through protein kinase C delta-dependent activation of multiple mitogen-activated protein kinase (MAPK) signaling pathways. Here we show using biochemical and molecular approaches that transcription factor Elk-1, a direct downstream target of MAPK, is a critical transcriptional activator of of MMP-13 by bFGF in human articular chondrocytes. We also provide evidence that Elk-1 is a direct target of NF kappa B and induces MMP-13 expression upon activation of the NF kappa B signaling pathway. Taken together, our results suggest that elevated expression of MMP-13 occurs through Elk-1 activation of both MAPK and NF kappa B signaling pathways, thus revealing a two-pronged biological mechanism by which bFGF controls the production of catabolic enzymes that are associated with excessive degradation of the cartilage matrix in degenerative joint diseases such as osteoarthritis.	Rush Univ, Ctr Med, Dept Biochem, Chicago, IL 60612 USA; Rush Univ, Dept Biochem, Chicago, IL 60612 USA; Rush Univ, Dept Internal Med, Chicago, IL 60612 USA; Rush Univ, Rheumatol Sect, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA	Rush University; Rush University; Rush University; Rush University; Rush University; Beatson Institute; University of Massachusetts System; University of Massachusetts Worcester	Im, HJ (corresponding author), Rush Univ, Ctr Med, Dept Biochem, Cohn Res BD 516,1735 W Harrison, Chicago, IL 60612 USA.	Jeong_Sampen@rush.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; NORMAN, Jim/0000-0002-0098-3014	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR053220] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049069, R01 AR053220] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Carreras I, 2001, AM J PHYSIOL-LUNG C, V281, pL766, DOI 10.1152/ajplung.2001.281.4.L766; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Fernandes JC, 1998, J RHEUMATOL, V25, P1585; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Fosang AJ, 1996, J CLIN INVEST, V98, P2292, DOI 10.1172/JCI119040; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200; Im HJ, 1999, BRAIN RES, V829, P174, DOI 10.1016/S0006-8993(99)01364-5; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Loeser RF, 2005, ARTHRITIS RHEUM-US, V52, P3910, DOI 10.1002/art.21472; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Miwa HE, 2006, BBA-GEN SUBJECTS, V1760, P472, DOI 10.1016/j.bbagen.2005.12.003; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; OKEEFE RJ, 1994, J ORTHOPAED RES, V12, P299, DOI 10.1002/jor.1100120302; OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; PELLETIER JP, 2001, ARTHRITIS ALLIED CON, P2195; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; ROSSELOT G, 1994, J BONE MINER RES, V9, P431; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Vincent T, 2002, P NATL ACAD SCI USA, V99, P8259, DOI 10.1073/pnas.122033199; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	40	80	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31409	31421		10.1074/jbc.M706508200	http://dx.doi.org/10.1074/jbc.M706508200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724016	hybrid			2022-12-27	WOS:000250309200031
J	St-Jean, M; Sygusch, J				St-Jean, Miguel; Sygusch, Jurgen			Stereospecific proton transfer by a mobile catalyst in mammalian fructose-1,6-bisphosphate aldolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE-BISPHOSPHATE ALDOLASE; DIHYDROXYACETONE PHOSPHATE; RABBIT MUSCLE; DIPHOSPHATE ALDOLASE; TERMINAL REGION; MECHANISM; CARBOXYPEPTIDASE; CRYSTALLOGRAPHY; COMPLEXES; CLEAVAGE	Class I fructose-1,6-bisphosphate aldolases catalyze the interconversion between the enamine and iminium covalent enzymatic intermediates by stereospecific exchange of the pro( S) proton of the dihydroxyacetone-phosphate C3 carbon, an obligatory reaction step during substrate cleavage. To investigate the mechanism of stereospecific proton exchange, high resolution crystal structures of native and a mutant Lys(146)-> Met aldolase were solved in complex with dihydroxyacetone phosphate. The structural analysis revealed trapping of the enamine intermediate at Lys(229) in native aldolase. Mutation of conserved active site residue Lys(146) to Met drastically decreased activity and enabled trapping of the putative iminium intermediate in the crystal structure showing active site attachment by C-terminal residues 360-363. Attachment positions the conserved C-terminal Tyr(363) hydroxyl within 2.9 angstrom of the C3 carbon in the iminium in an orientation consistent with incipient re face proton transfer. We propose a catalytic mechanism by which the mobile C-terminal Tyr(363) is activated by the iminium phosphate via a structurally conserved water molecule to yield a transient phenate, whose developing negative charge is stabilized by a Lys(146) positive charge, and which abstracts the C3 pro( S) proton forming the enamine. An identical C-terminal binding mode observed in the presence of phosphate in the native structure corroborates Tyr(363) interaction with Lys(146) and is consistent with transient C terminus binding in the enamine. The absence of charge stabilization and of a mobile C-terminal catalyst explains the extraordinary stability of enamine intermediates in transaldolases.	Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.CA		Sygusch, Jurgen/0000-0002-6629-2128				ADELMAN RC, 1968, ARCH BIOCHEM BIOPHYS, V126, P343, DOI 10.1016/0003-9861(68)90590-0; BARANOWSKI T, 1949, J BIOL CHEM, V180, P543; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; DeLano WL, 2004, PYMOL MOL GRAPHICS S; DRECHSLER ER, 1959, J BIOL CHEM, V234, P2627; GINSBURG A, 1966, BIOCHEMISTRY-US, V5, P2623, DOI 10.1021/bi00872a021; GRAZI E, 1974, BIOCHIM BIOPHYS ACTA, V364, P120, DOI 10.1016/0005-2744(74)90139-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V7, P250, DOI 10.1016/0006-291X(62)90184-5; GRAZI E, 1973, BIOCHEMISTRY-US, V12, P2583, DOI 10.1021/bi00738a006; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; IYENGAR R, 1981, BIOCHEMISTRY-US, V20, P1223, DOI 10.1021/bi00508a026; JAI J, 1997, PROTEIN SCI, V6, P119; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P120; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; Maurady A, 2002, J BIOL CHEM, V277, P9474, DOI 10.1074/jbc.M107600200; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; MUNGER C, 2002, ENZYMATIC MECH FRUCT; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENHOET EE, 1971, J BIOL CHEM, V246, P318; PERIANA RA, 1980, J AM CHEM SOC, V102, P3923, DOI 10.1021/ja00531a040; RACKER E, 1947, J BIOL CHEM, V167, P843; RAY BD, 1983, J AM CHEM SOC, V105, P3731, DOI 10.1021/ja00349a075; Richard JP, 2001, CURR OPIN CHEM BIOL, V5, P626, DOI 10.1016/S1367-5931(01)00258-7; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rios A, 2001, J AM CHEM SOC, V123, P7949, DOI 10.1021/ja016250c; Rios A, 2000, J AM CHEM SOC, V122, P9373, DOI 10.1021/ja001749c; ROSE IA, 1958, J AM CHEM SOC, V80, P5835, DOI 10.1021/ja01554a063; ROSE IA, 1965, J BIOL CHEM, V240, P1758; ROSE IA, 1958, J BIOL CHEM, V231, P315; ROSE IA, 1969, J BIOL CHEM, V244, P126; ROSE IA, 1985, BIOCHEMISTRY-US, V24, P3952, DOI 10.1021/bi00336a023; ROSE IA, 1987, J BIOL CHEM, V262, P692; RUTTER WJ, 1961, J BIOL CHEM, V236, P3193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; SYGUSCH J, 1990, ARCH BIOCHEM BIOPHYS, V283, P227, DOI 10.1016/0003-9861(90)90636-D; VENKATARAMAN R, 1961, J BIOL CHEM, V236, P1883	47	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31028	31037		10.1074/jbc.M704968200	http://dx.doi.org/10.1074/jbc.M704968200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728250	hybrid			2022-12-27	WOS:000250136300070
J	Huang, Y; Qiu, JH; Dong, S; Redell, MS; Poli, V; Mancini, MA; Tweardy, DJ				Huang, Ying; Qiu, Jihui; Dong, Shuo; Redell, Michele S.; Poli, Valeria; Mancini, Michael A.; Tweardy, David J.			Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of stat3 beta mapping to its unique C-terminal end	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION; INTERFERON-GAMMA; FACTOR-RECEPTOR; CANCER-THERAPY; GENE; ELEMENTS; CELLS	Two isoforms of Stat3 ( signal transducer and activator of transcription 3) are expressed in cells, alpha(p92) and beta (p83), both derived from a single gene by alternative mRNA splicing. The 55-residue C-terminal transactivation domain of Stat3 alpha is deleted in Stat3 beta and replaced by seven unique C-terminal residues (CT7) whose function remains uncertain. We subcloned the open reading frames of Stat3 alpha and Stat3 beta into the C terminus of green fluorescent protein (GFP). Fluorescent microscopic analysis of HEK293T cells transiently transfected with GFP-Stat3 alpha or GFP-Stat3 beta revealed similar kinetics and cytokine concentration dependence of nuclear accumulation; these findings were confirmed by high throughput microscope analysis of murine embryonic fibroblasts that lacked endogenous Stat3 but stably expressed either GFP-Stat3 alpha or GFP-Stat3 beta. However, although time to half-maximal cytoplasmic reaccumulation after cytokine withdrawal was 15 min for GFP-Stat3 alpha, it was > 180 min for GFP-Stat3 beta. Furthermore, although the intranuclear mobility of GFP-Stat3 alpha was rapid and increased with cytokine stimulation, the intranuclear mobility of GFP-Stat3 beta in unstimulated cells was slower than that of GFP-Stat3 alpha in unstimulated cells and was slowed further following cytokine stimulation. Deletion of the unique CT7 domain from Stat3 beta eliminated prolonged nuclear retention but did not alter its intranuclear mobility. Thus, Stat3 alpha and Stat3 beta have distinct intracellular dynamics, with Stat3 beta exhibiting prolonged nuclear retention and reduced intranuclear mobility especially following ligand stimulation. Prolonged nuclear retention, but not reduced intranuclear mobility, mapped to the CT7 domain of Stat3 beta.	Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Chinese Minist Educ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; Univ Turin, Dept Genet, I-10126 Turin, Italy; Univ Turin, Dept Biol, I-10126 Turin, Italy; Univ Turin, Dept Biochem, I-10126 Turin, Italy	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Shanghai Jiao Tong University; University of Turin; University of Turin; University of Turin	Tweardy, DJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, 1 Baylor Plaza,BCM 286,Rm N1319, Houston, TX 77030 USA.	dtweardy@bcm.edu	Tweardy, David/L-3929-2019; Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966; Redell, Michele/0000-0002-2515-3703	NCI NIH HHS [CA72261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Caldenhoven E, 1999, Mol Cell Biol Res Commun, V1, P95, DOI 10.1006/mcbr.1999.0114; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chakraborty A, 1998, J LEUKOCYTE BIOL, V64, P675, DOI 10.1002/jlb.64.5.675; Chakraborty A, 1996, BLOOD, V88, P2442, DOI 10.1182/blood.V88.7.2442.bloodjournal8872442; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; LIPPINCOTTSCHWA.J, 2003, NAT CELL BIOL S, V17, P7; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lokuta MA, 1998, J IMMUNOL, V161, P1594; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; Piazza F, 2000, BLOOD, V96, P1358, DOI 10.1182/blood.V96.4.1358.h8001358_1358_1365; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Sato N, 2005, BIOCHEM BIOPH RES CO, V336, P617, DOI 10.1016/j.bbrc.2005.08.145; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Shao H, 2006, J IMMUNOL, V176, P2933, DOI 10.4049/jimmunol.176.5.2933; Sherman MA, 1999, J IMMUNOL, V162, P2703; Sherman MA, 2002, J IMMUNOL, V169, P3811, DOI 10.4049/jimmunol.169.7.3811; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	59	45	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34958	34967		10.1074/jbc.M704548200	http://dx.doi.org/10.1074/jbc.M704548200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855361	hybrid			2022-12-27	WOS:000251155200040
J	Chang, YH; Chuang, LY; Hwang, CC				Chang, Yi-Hsun; Chuang, Lea-Yea; Hwang, Chi-Ching			Mechanism of proton transfer in the 3 alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; PSEUDOMONAS SP B-0831; ALCOHOL-DEHYDROGENASE; ENZYMATIC CATALYSIS; BRONSTED ANALYSIS; CHEMICAL RESCUE; HYDROGEN-BONDS; BASE CATALYSIS; ANHYDRASE-III; MUTANT	3 alpha-Hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni catalyzes the oxidation of androsterone with NAD(+) to form androstanedione and NADH with a concomitant releasing of protons to bulk solvent. To probe the proton transfer during the enzyme reaction, we used mutagenesis, chemical rescue, and kinetic isotope effects to investigate the release of protons. The kinetic isotope effects of V-D and V-D2O for wild-type enzyme are 1 and 2.1 at pL 10.4(where L represents H, H-2), respectively, and suggest a rate-limiting step in the intramolecular proton transfer. Substitution of alanine for Lys(159) changes therate-limiting step to the hydride transfer, evidenced by an equal deuterium isotope effect of 18 on V-max and V/K-androsterone and no solvent kinetic isotope effect at saturating 3-(cyclohexylamino)propanesulfonic acid (CAPS). However, a value of 4.4 on V-max is observed at 10mM CAPS at pL 10.4, indicating a rate-limiting proton transfer. The rate of the proton transfer is blocked in the K159A and K159M mutants but can be rescued using exogenous proton acceptors, such as buffers, small primary amines, and azide. The Bronsted relationship between the log( V/Kd-baseEt) of the external amine (corrected for molecular size effects) and pK(a) is linear for the K159A mutant-catalyzed reaction at pH 10.4 (beta = 0.85 +/- 0.09) at 5mM CAPS. These results show that proton transfer to the external base with a late transition state occurred in a rate-limiting step. Furthermore, a proton inventory on V/Et is bowl-shaped for both the wild-type and K159A mutant enzymes and indicates a two-proton transfer in the transition state from Tyr(155) to Lys(159) via 2'-OH of ribose.	Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung 80731, Taiwan	Kaohsiung Medical University	Hwang, CC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, 100 Shih Chuan 1st Rd, Kaohsiung 80731, Taiwan.	cchwang@kmu.edu.tw	Chuang, Lea-Yea/C-7450-2009; Hwang, Chi-Ching/K-7933-2012	Hwang, Chi-Ching/0000-0002-8328-674X				An HQ, 2002, BBA-PROTEINS PROTEOM, V1599, P21, DOI 10.1016/S0167-4838(02)00374-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzezinski P, 2000, BBA-BIOENERGETICS, V1458, P1, DOI 10.1016/S0005-2728(00)00056-6; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; EHRIG T, 1991, BIOCHEMISTRY-US, V30, P1062, DOI 10.1021/bi00218a026; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Hwang CC, 2005, J BIOL CHEM, V280, P3522, DOI 10.1074/jbc.M411751200; Jiang WJ, 2000, BIOCHEMISTRY-US, V39, P7990, DOI 10.1021/bi000630d; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Maser E, 2001, CHEM-BIOL INTERACT, V130, P707, DOI 10.1016/S0009-2797(00)00302-1; Mobus E, 1998, J BIOL CHEM, V273, P30888, DOI 10.1074/jbc.273.47.30888; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nakamura S, 2006, J BIOL CHEM, V281, P31876, DOI 10.1074/jbc.M604226200; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Relyea HA, 2005, BIOCHEMISTRY-US, V44, P6640, DOI 10.1021/bi047640p; Richard JP, 1998, BIOCHEMISTRY-US, V37, P4305, DOI 10.1021/bi972655r; ROSE IA, 1991, BIOCHEMISTRY-US, V30, P722, DOI 10.1021/bi00217a021; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P16695, DOI 10.1021/bi051603w; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SKALHEGG BA, 1975, EUR J BIOCHEM, V50, P603, DOI 10.1111/j.1432-1033.1975.tb09901.x; TAOKA S, 1994, J BIOL CHEM, V269, P17988; TONEY MD, 1992, PROTEIN SCI, V1, P107; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Tu C, 2001, J AM CHEM SOC, V123, P5861, DOI 10.1021/ja010301o; TU CK, 1990, BIOCHEMISTRY-US, V29, P6400, DOI 10.1021/bi00479a009; Ueda S, 2004, EUR J BIOCHEM, V271, P1774, DOI 10.1111/j.1432-1033.2004.04089.x; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; Zheng RJ, 2000, BIOCHEMISTRY-US, V39, P16244, DOI 10.1021/bi002134v	40	20	20	8	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34306	34314		10.1074/jbc.M706336200	http://dx.doi.org/10.1074/jbc.M706336200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893142	hybrid			2022-12-27	WOS:000251145700046
J	Le Stunff, H; Giussani, P; Maceyka, M; Lepine, S; Milstien, S; Spiegel, S				Le Stunff, Herve; Giussani, Paola; Maceyka, Michael; Lepine, Sandrine; Milstien, Sheldon; Spiegel, Sarah			Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATE PHOSPHATASES; EPIDERMAL-GROWTH-FACTOR; SPHINGOLIPID METABOLISM; GLUCOSYLCERAMIDE SYNTHASE; SACCHAROMYCES-CEREVISIAE; CERAMIDE GENERATION; MAMMALIAN-CELLS; KEY REGULATOR; RAT-LIVER; DE-NOVO	In yeast, the long-chain sphingoid base phosphate phosphohydrolase Lcb3p is required for efficient ceramide synthesis from exogenous sphingoid bases. Similarly, in this study, we found that incorporation of exogenous sphingosine into ceramide in mammalian cells was regulated by the homologue of Lcb3p, sphingosine-1-phosphate phosphohydrolase 1 (SPP-1), an endoplasmic reticulum resident protein. Sphingosine incorporation into endogenous long-chain ceramides was increased by SPP-1 overexpression, whereas recycling of C-6-ceramide into long-chain ceramides was not altered. The increase in ceramide was inhibited by fumonisin B-1, an inhibitor of ceramide synthase, but not by ISP-1, an inhibitor of serine palmitoyltransferase, the rate-limiting step in the de novo biosynthesis of ceramide. Mass spectrometry analysis revealed that SPP-1 expression increased the incorporation of sphingosine into all ceramide acyl chain species, particularly enhancing C16:0, C18:0, and C20:0 long-chain ceramides. The increased recycling of sphingosine into ceramide was accompanied by increased hexosylceramides and, to a lesser extent, sphingomyelins. Sphingosine kinase 2, but not sphingosine kinase 1, acted in concert with SPP-1 to regulate recycling of sphingosine into ceramide. Collectively, our results suggest that an evolutionarily conserved cycle of phosphorylation-dephosphorylation regulates recycling and salvage of sphingosine to ceramide and more complex sphingolipids.	Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Giussani, Paola/R-4268-2017; LE STUNFF, Hervé/AAA-6882-2019; Maceyka, Michael/B-9277-2008	Giussani, Paola/0000-0002-7793-1757; 	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 069338, GM 43880] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880, U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001039] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Bu Shizhong, 2006, FASEB J, V20, P184; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Funato K, 2003, J BIOL CHEM, V278, P7325, DOI 10.1074/jbc.M209925200; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Gorska M, 2005, MED SCI MONITOR, V11, pCR35; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Shayman JA, 2000, METHOD ENZYMOL, V311, P373; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stukey J, 1997, PROTEIN SCI, V6, P469; SULLARDS MC, 2001, SCI STKE, pL1; Sultan I, 2006, BIOCHEM J, V393, P513, DOI 10.1042/BJ20051083; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	52	77	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34372	34380		10.1074/jbc.M703329200	http://dx.doi.org/10.1074/jbc.M703329200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895250	hybrid			2022-12-27	WOS:000251145700053
J	Nickerson, NN; Prasad, L; Jacob, L; Delbaere, LT; McGavin, MJ				Nickerson, Nicholas N.; Prasad, Lata; Jacob, Latha; Delbaere, Louis T.; McGavin, Martin J.			Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-GRISEUS; ANGSTROM RESOLUTION; INTRAMOLECULAR CHAPERONE; EPIDERMIDIS STRAIN; BOVINE TRYPSINOGEN; KINETIC STABILITY; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; V8 PROTEASE; BINDING	The serine and cysteine proteases SspA and SspB of Staphylococcus aureus are secreted as inactive zymogens, zSspA and zSspB. Mature SspA is a trypsin-like glutamyl endopeptidase and is required to activate zSspB. Although a metalloprotease Aureolysin (Aur) is in turn thought to contribute to activation of zSspA, a specific role has not been demonstrated. We found that pre-zSspA is processed by signal peptidase at ANA(29) down arrow, releasing a Leu(30) isoform that is first processed exclusively through autocatalytic intramolecular cleavage within a glutamine-rich propeptide segment, (40)QQTQSSKQQTPKIQ(53). The preferred site is Gln(43) with secondary processing at Gln(47) and Gln(53). This initial processing is necessary for optimal and subsequent Aur-dependent processing at Leu(58) and then Val(69) to release mature SspA. Although processing by Aur is rate-limiting in zSspA activation, the first active molecules of Val(69)SspA promote rapid intermolecular processing of remaining zSspA at Glu(65), producing an N-terminal (66)HANVILP isoform that is inactive until removal of the HAN tripeptide by Aur. Modeling indicated that His(66) of this penultimate isoform blocks the active site by hydrogen bonding to Ser(237) and occlusion of substrate. Binding of glutamate within the active site of zSspA is energetically unfavorable, but glutamine fits into the primary specificity pocket and is predicted to hydrogen bond to Thr(232) proximal to Ser(237), permitting autocatalytic cleavage of the glutamine-rich propeptide segment. These and other observations suggest that zSspA is activated through a trypsinogen-like mechanism where supplementary features of the propeptide must be sequentially processed in the correct order to allow efficient activation.	Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Saskatchewan	McGavin, MJ (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	martin.mcgavin@sri.utoronto.ca		McGavin, Martin/0000-0001-5955-0689				Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chan PF, 1998, J BACTERIOL, V180, P6232; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; DeLano W.L, PYMOL MOL GRAPHICS S; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Filipek R, 2003, J BIOL CHEM, V278, P40959, DOI 10.1074/jbc.M302926200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GUY O, 1976, FEBS LETT, V62, P150, DOI 10.1016/0014-5793(76)80040-3; Hartleib J, 2000, BLOOD, V96, P2149; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kato JY, 2005, J BACTERIOL, V187, P286, DOI 10.1128/JB.187.1.286-295.2005; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Massimi I, 2002, J BIOL CHEM, V277, P41770, DOI 10.1074/jbc.M207162200; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Prasad L, 2004, ACTA CRYSTALLOGR D, V60, P256, DOI 10.1107/S090744490302599X; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Roussel A, 1992, TURBO FRODO BIOGRAPH; Rzychon M, 2003, MOL MICROBIOL, V49, P1051, DOI 10.1046/j.1365-2958.2003.03613.x; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; SUZUKI Y, 1994, GENE, V150, P149; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Yokoi K, 2001, GENE, V281, P115, DOI 10.1016/S0378-1119(01)00782-X; YUEN SW, 1989, BIOTECHNIQUES, V7, P74; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	53	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34129	34138		10.1074/jbc.M705672200	http://dx.doi.org/10.1074/jbc.M705672200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878159	hybrid			2022-12-27	WOS:000251145700027
J	Busse, M; Feta, A; Presto, J; Wilen, M; Gronning, M; Kjellen, L; Kusche-Gullberg, M				Busse, Marta; Feta, Almir; Presto, Jenny; Wilen, Maria; Gronning, Mona; Kjellen, Lena; Kusche-Gullberg, Marion			Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MULTIPLE EXOSTOSES; TUMOR SUPPRESSORS; BIOSYNTHESIS; POLYMERIZATION; EXPRESSION; PROTEINS; DEFICIENT; DIVERSITY; DISTINCT; DOMAIN	The exostosin (EXT) family of genes encodes glycosyltransferases involved in heparan sulfate biosynthesis. Five human members of this family have been cloned to date: EXT1, EXT2, EXTL1, EXTL2, and EXTL3. EXT1 and EXT2 are believed to form a Golgi-located hetero-oligomeric complex that catalyzes the chain elongation step in heparan sulfate biosynthesis, whereas the EXTL proteins exhibit overlapping glycosyltransferase activities in vitro, so that it is not apparent what reactions they catalyze in vivo. We used gene-silencing strategies to investigate the roles of EXT1, EXT2, and EXTL3 in heparan sulfate chain elongation. Small interfering RNAs (siRNAs) directed against the human EXT1, EXT2, or EXTL3 mRNAs were introduced into human embryonic kidney 293 cells. Compared with cells transfected with control siRNA, those transfected with EXT1 or EXT2 siRNA synthesized shorter heparan sulfate chains, and those transfected with EXTL3 siRNA synthesized longer chains. We also generated human cell lines overexpressing the EXT proteins. Overexpression of EXT1 resulted in increased HS chain length, which was even more pronounced in cells coexpressing EXT2, whereas overexpression of EXT2 alone had no detectable effect on heparan sulfate chain elongation. Mutations in either EXT1 or EXT2 are associated with hereditary multiple exostoses, a human disorder characterized by the formation of cartilage-capped bony outgrowths at the epiphyseal growth plates. To further investigate the role of EXT2, we generated human cell lines overexpressing mutant EXT2. One of the mutations, EXT2-Y419X, resulted in a truncated protein. Interestingly, the capacity of wild type EXT2 to enhance HS chain length together with EXT1 was not shared by the EXT2Y419X mutant.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Bergen; Uppsala University	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	Marion.Kusche@biomed.uib.no	Kusche-Gullberg, Marion/P-4466-2016; Kjellen, Lena/F-1362-2011	Kusche-Gullberg, Marion/0000-0002-5636-1695; Presto, Jenny/0000-0001-5102-6815				Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Francannet C, 2001, J MED GENET, V38, P430, DOI 10.1136/jmg.38.7.430; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Rong JH, 2000, BIOCHEM J, V346, P463, DOI 10.1042/0264-6021:3460463; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wei G, 2000, J BIOL CHEM, V275, P27733; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; ZHANG L, 1995, J BIOL CHEM, V270, P12557, DOI 10.1074/jbc.270.21.12557	37	138	145	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32802	32810		10.1074/jbc.M703560200	http://dx.doi.org/10.1074/jbc.M703560200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17761672	hybrid			2022-12-27	WOS:000250625400029
J	Sun, JM; Chen, HY; Davie, JR				Sun, Jian-Min; Chen, Hou Yu; Davie, James R.			Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; CORE HISTONE ACETYLATION; NUCLEAR-MATRIX; TRANSCRIPTION FACTORS; CHICKEN ERYTHROCYTES; CROSS-LINKING; IN-SITU; PROTEIN; DNA; IMMUNOPRECIPITATION	Histone deacetylase 2 ( HDAC2) is one of the histone-modifying enzymes that regulate gene expression by remodeling chromatin structure. Along with HDAC1, HDAC2 is found in the Sin3 and NuRD multiprotein complexes, which are recruited to promoters by DNA-binding proteins. In this study, we show that the majority of HDAC2 in human breast cancer cells is not phosphorylated. However, the minor population of HDAC2, preferentially cross-linked to DNA by cisplatin, is mono-, di-, or tri-phosphorylated. Furthermore, HDAC2 phosphorylation is required for formation of Sin3 and NuRD complexes and recruitment to promoters by transcription factors including p53, Rb, YY1, NF-kappa B, Sp1, and Sp3. Unmodified HDAC2 requires linker DNA to associate with chromatin but is not cross-linked to DNA by formaldehyde. We provide evidence that unmodified HDAC2 is associated with the coding region of transcribed genes, whereas phosphorylated HDAC2 is primarily recruited to promoters.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888				Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen HY, 1996, BIOCHEM J, V320, P257, DOI 10.1042/bj3200257; Ciccone DN, 2004, METHOD ENZYMOL, V376, P334; Clem BF, 2006, MOL ENDOCRINOL, V20, P100, DOI 10.1210/me.2004-0495; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DELCUVE GP, 1989, BIOCHEM J, V263, P179, DOI 10.1042/bj2630179; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; RIDSDALE JA, 1988, NUCLEIC ACIDS RES, V16, P5915, DOI 10.1093/nar/16.13.5915; Samuel SK, 1998, CANCER RES, V58, P3004; Samuel SK, 1997, CANCER RES, V57, P147; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Spencer VA, 2000, CANCER RES, V60, P288; Spencer VA, 2001, J BIOL CHEM, V276, P34810, DOI 10.1074/jbc.M104886200; Spencer VA, 2002, PROTEIN PROTOCOLS HD, P753; SPENCER VA, 2002, PROTEIN PROTOCOLS HD, P747; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Sun JM, 1996, J CELL BIOCHEM, V62, P454, DOI 10.1002/(SICI)1097-4644(19960915)62:4<454::AID-JCB3>3.0.CO;2-L; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wang XY, 2001, J BIOL CHEM, V276, P12764, DOI 10.1074/jbc.M100501200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	34	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33227	33236		10.1074/jbc.M703549200	http://dx.doi.org/10.1074/jbc.M703549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827154	hybrid			2022-12-27	WOS:000250625400070
J	Bee, MS; Hulme, EC				Bee, Mark S.; Hulme, Edward C.			Functional analysis of transmembrane domain 2 of the M-1 muscarinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; SCANNING MUTAGENESIS; 7-TRANSMEMBRANE RECEPTORS; CONSTITUTIVE ACTIVATION; RHODOPSIN FAMILY; AMINO-ACIDS; BINDING; IDENTIFICATION; ASPARTATE; RESIDUES	Ala substitution scanning mutagenesis has been used to probe the functional role of amino acids in transmembrane (TM) domain 2 of the M-1 muscarinic acetylcholine receptor, and of the highly conserved Asn(43) in TM1. The mutation of Asn(43), Asn(61), and Leu(64) caused an enhanced ACh affinity phenotype. Interpreted using a rhodopsin-based homology model, these results suggest the presence of a network of specific contacts between this group of residues and Pro(415) and Tyr(418) in the highly conserved NPXXY motif in TM7 that exhibit a similar mutagenic phenotype. These contacts may be rearranged or broken when ACh binds. D71A, like N414A, was devoid of signaling activity. We suggest that formation of a direct hydrogen bond between the highly conserved side chains of Asp(71) and Asn(414) may be a critical feature stabilizing the activated state of the M-1 receptor. Mutation of Leu(67), Ala(70), and Ile(74) also reduced the signaling efficacy of the ACh-receptor complex. The side chains of these residues are modeled as an extended surface that may help to orient and insulate the proposed hydrogen bond between Asp(71) and Asn(414). Mutation of Leu(72), Gly(75), and Met(79) in the outer half of TM2 primarily reduced the expression of functional receptor binding sites. These residues may mediate contacts with TM1 and TM7 that are preserved throughout the receptor activation cycle. Thermal inactivation measurements confirmed that a reduction in structural stability followed the mutation of Met(79) as well as Asp(71).	Natl Inst Med Res, MRC, Ridgeway, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research	Hulme, EC (corresponding author), Natl Inst Med Res, MRC, Ridgeway, Div Phys Biochem, Mill Hill, London NW7 1AA, England.	ehulme@nimr.mrc.ac.uk			MRC [MC_U117532184] Funding Source: UKRI; Medical Research Council [MC_U117532184] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allman K, 2000, MOL PHARMACOL, V58, P175, DOI 10.1124/mol.58.1.175; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donnelly D, 1999, BIOCHEM J, V339, P55, DOI 10.1042/0264-6021:3390055; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Geva A, 2000, J BIOL CHEM, V275, P35393, DOI 10.1074/jbc.M005602200; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; Hulme EC, 1999, EUR J PHARMACOL, V375, P247, DOI 10.1016/S0014-2999(99)00297-6; Hulme EC, 1998, J PHYSIOLOGY-PARIS, V92, P269, DOI 10.1016/S0928-4257(98)80031-4; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Hulme Edward C., 2006, P137; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; Lee YS, 2002, J PEDIATR ENDOCR MET, V15, P211; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman JH, 1997, J BIOL CHEM, V272, P11937, DOI 10.1074/jbc.272.18.11937; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Vogel WK, 1999, ARCH BIOCHEM BIOPHYS, V361, P283, DOI 10.1006/abbi.1998.0985; WARD WHJ, 1990, TRENDS PHARMACOL SCI, V11, P280, DOI 10.1016/0165-6147(90)90009-W; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Xu W, 1999, FEBS LETT, V447, P318, DOI 10.1016/S0014-5793(99)00316-6	44	12	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32471	32479		10.1074/jbc.M703909200	http://dx.doi.org/10.1074/jbc.M703909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823120	hybrid			2022-12-27	WOS:000250480300070
J	Vishnivetskiy, SA; Raman, D; Wei, J; Kennedy, MJ; Hurley, JB; Gurevich, VV				Vishnivetskiy, Sergey A.; Raman, Dayanidhi; Wei, Junhua; Kennedy, Matthew J.; Hurley, James B.; Gurevich, Vsevolod V.			Regulation of arrestin binding by rhodopsin phosphorylation level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGHT-DEPENDENT PHOSPHORYLATION; SINGLE-PHOTON RESPONSES; VISUAL ARRESTIN; MULTIPLE PHOSPHORYLATION; BETA-ARRESTIN; PHOTORECEPTOR-MEMBRANES; CRYSTAL-STRUCTURE; IN-VIVO; CONSTITUTIVE ACTIVATION	Arrestins ensure the timely termination of receptor signaling. The role of rhodopsin phosphorylation in visual arrestin binding was established more than 20 years ago, but the effects of the number of receptor-attached phosphates on this interaction remain controversial. Here we use purified rhodopsin fractions with carefully quantified content of individual phosphorylated rhodopsin species to elucidate the impact of phosphorylation level on arrestin interaction with three biologically relevant functional forms of rhodopsin: light-activated and dark phosphorhodopsin and phospho-opsin. We found that a single receptor-attached phosphate does not facilitate arrestin binding, two are necessary to induce high affinity interaction, and three phosphates fully activate arrestin. Higher phosphorylation levels do not increase the stability of arrestin complex with light-activated rhodopsin but enhance its binding to the dark phosphorhodopsin and phospho-opsin. The complex of arrestin with hyperphosphorylated light-activated rhodopsin is less sensitive to high salt and appears to release retinal faster. These data suggest that arrestin likely quenches rhodopsin signaling after the third phosphate is added by rhodopsin kinase. The complex of arrestin with heavily phosphorylated rhodopsin, which appears to form in certain disease states, has distinct characteristics that may contribute to the phenotype of these visual disorders.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Vanderbilt University; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,PRB 418, Nashville, TN 37232 USA.	jbhhh@u.washington.edu; vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NEI NIH HHS [EY11500, EY06641, R01 EY011500-12, R01 EY006641, F32 EY006641, R01 EY011500, R01 EY006641-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006641, F32EY006641, R01EY011500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ablonczy Z, 2005, PHOTOCHEM PHOTOBIOL, V81, P541, DOI 10.1562/2004-08-27-RA-294.1; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BINDER BM, 1990, J BIOL CHEM, V265, P15333; Binder BM, 1996, J BIOL CHEM, V271, P19826, DOI 10.1074/jbc.271.33.19826; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; GUREVICH VV, 2004, TIPS, V25, P59; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Imamoto Y, 2003, BIOPHYS J, V85, P1186, DOI 10.1016/S0006-3495(03)74554-8; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KIRKWOOD A, 1994, J GEN PHYSIOL, V103, P679, DOI 10.1085/jgp.103.4.679; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; MCDOWELL JH, 1977, BIOCHEMISTRY-US, V16, P4054, DOI 10.1021/bi00637a018; MCDOWELL JH, 2000, METHODS ENZYMOL, V315; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Niu L, 2002, P NATL ACAD SCI USA, V99, P13409, DOI 10.1073/pnas.212518899; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OHGURO H, 1994, BIOCHEMISTRY-US, V33, P1023, DOI 10.1021/bi00170a022; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	78	109	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32075	32083		10.1074/jbc.M706057200	http://dx.doi.org/10.1074/jbc.M706057200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848565	Green Accepted, hybrid			2022-12-27	WOS:000250480300028
J	Franco, R; Panayiotidis, MI; Cidlowski, JA				Franco, Rodrigo; Panayiotidis, Mihalis I.; Cidlowski, John A.			Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-MEDIATED APOPTOSIS; MITOCHONDRIAL PERMEABILITY TRANSITION; JURKAT T-CELLS; INTRACELLULAR GLUTATHIONE; OXIDATIVE STRESS; REDUCED GLUTATHIONE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; MEMBRANE-TRANSPORT; GSH EXTRUSION	Changes in the intracellular redox environment of cells have been reported to be critical for the activation of apoptotic enzymes and the progression of programmed cell death. Glutathione (GSH) depletion is an early hallmark observed in apoptosis, and we have demonstrated that GSH efflux during death receptor-mediated apoptosis occurs via a GSH transporter. We now evaluate the relationship between GSH depletion, the generation of reactive oxygen species (ROS), and the progression of apoptosis. Simultaneous single cell analysis of changes in GSH content and ROS formation by multiparametric FACS revealed that loss of intracellular GSH was paralleled by the generation of different ROS including hydrogen peroxide, superoxide anion, hydroxyl radical, and lipid peroxides. However, inhibition of ROS formation by a variety of antioxidants showed that GSH loss was independent from the generation of ROS. Furthermore, GSH depletion was observed to be necessary for ROS generation. Interestingly, high extracellular thiol concentration (GSH and N-acetyl-cysteine) inhibited apoptosis, whereas, inhibition of ROS generation by other non-thiol antioxidants was ineffective in preventing cell death. Finally, GSH depletion was shown to be a necessary for the progression of apoptosis activated by both extrinsic and intrinsic signaling pathways. These results document a necessary and critical role for GSH loss in apoptosis and clearly uncouple for the first time GSH depletion from ROS formation.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@mail.nih.gov	Cidlowski, John A/G-2548-2019; Franco, Rodrigo/D-9470-2013; Panagiotidis, Mihalis/AAG-6274-2020	Cidlowski, John A/0000-0003-1420-0516; Franco, Rodrigo/0000-0003-3241-8615; Panagiotidis, Mihalis/0000-0002-1450-3552; Panagiotidis, Mihalis/0000-0002-1130-5972	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090079, Z01ES090079] Funding Source: NIH RePORTER; Intramural NIH HHS [NIH0011756287] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Bajt ML, 2002, ANTIOXID REDOX SIGN, V4, P733, DOI 10.1089/152308602760598873; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Banki K, 1999, J IMMUNOL, V162, P1466; BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Beltran B, 2002, P NATL ACAD SCI USA, V99, P8892, DOI 10.1073/pnas.092259799; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Bernassola F, 2001, J CELL BIOCHEM, V82, P123, DOI 10.1002/jcb.1143; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Clement MV, 2003, CELL DEATH DIFFER, V10, P1273, DOI 10.1038/sj.cdd.4401302; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; Coppola S, 2000, BIOCHEM SOC T, V28, P56, DOI 10.1042/bst0280056; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; DOBBELSTEEN DJ, 1996, J BIOL CHEM, V271, P15420; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Furuke K, 1998, INT IMMUNOL, V10, P1261, DOI 10.1093/intimm/10.9.1261; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; Ghelli A, 1997, J BIOCHEM, V121, P746; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Girotti AW, 1998, J LIPID RES, V39, P1529; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gouaze V, 2002, J BIOL CHEM, V277, P42867, DOI 10.1074/jbc.M203067200; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gulbins E, 1996, IMMUNOLOGY, V89, P205, DOI 10.1046/j.1365-2567.1996.d01-743.x; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; HUG H, 1994, FEBS LETT, V351, P311, DOI 10.1016/0014-5793(94)00852-3; Iantomasi T, 1997, BBA-BIOMEMBRANES, V1330, P274; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jayanthi S, 1999, MOL BRAIN RES, V72, P158, DOI 10.1016/S0169-328X(99)00216-8; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Kohno T, 1996, J IMMUNOL, V156, P4722; LAUB R, 1985, BIOCHEM PHARMACOL, V34, P1175, DOI 10.1016/0006-2952(85)90492-7; Lee TK, 2001, TOXICOL APPL PHARM, V174, P207, DOI 10.1006/taap.2001.9208; Lewandowska H, 2007, J BIOL INORG CHEM, V12, P345, DOI 10.1007/s00775-006-0192-8; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; MAHAGITA C, 2007, AM J PHYSIOL, V293, pE271; Makrigiorgos GM, 1997, J BIOCHEM BIOPH METH, V35, P23, DOI 10.1016/S0165-022X(97)00020-1; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Medan D, 2005, J CELL PHYSIOL, V203, P78, DOI 10.1002/jcp.20201; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Ng KH, 2003, KIDNEY INT, V63, P976, DOI 10.1046/j.1523-1755.2003.00818.x; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Pardo M, 2006, FREE RADICAL BIO MED, V41, P1795, DOI 10.1016/j.freeradbiomed.2006.08.027; Perez-Cruz I, 2003, BLOOD, V102, P336, DOI 10.1182/blood-2002-11-3559; Perl A, 2002, ANTIOXID REDOX SIGN, V4, P427, DOI 10.1089/15230860260196227; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Ramakrishnan N, 1998, FREE RADICAL RES, V29, P283, DOI 10.1080/10715769800300321; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; ROEDERER M, 1993, ANN NY ACAD SCI, V677, P113, DOI 10.1111/j.1749-6632.1993.tb38770.x; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Serinkan BF, 2004, ANTIOXID REDOX SIGN, V6, P227, DOI 10.1089/152308604322899297; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shang F, 2003, FREE RADICAL BIO MED, V34, P521, DOI 10.1016/S0891-5849(02)01304-7; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; SZE G, 1993, AM J PHYSIOL, V265, pG1128, DOI 10.1152/ajpgi.1993.265.6.G1128; Tirosh O, 2003, BIOCHEM PHARMACOL, V66, P1331, DOI 10.1016/S0006-2952(03)00481-7; Ueda S, 1998, J IMMUNOL, V161, P6689; Um HD, 1996, J IMMUNOL, V156, P3469; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	98	210	214	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30452	30465		10.1074/jbc.M703091200	http://dx.doi.org/10.1074/jbc.M703091200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724027	Green Accepted, hybrid			2022-12-27	WOS:000250136300013
J	Gong, Y; Ishida-Takahashi, R; Villanueva, EC; Fingar, DC; Muenzberg, H; Myers, MG				Gong, Yusong; Ishida-Takahashi, Ryoko; Villanueva, Eneida C.; Fingar, Diane C.; Muenzberg, Heike; Myers, Martin G., Jr.			The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; UNITED-STATES; FOOD-INTAKE; FEEDBACK INHIBITION; SIGNALING PROTEINS; GROWTH-FACTOR; BODY-WEIGHT; OB-R; MICE; ACTIVATION	The action of leptin via the long form of its receptor (LepRb) is central to the control of body energy homeostasis and neuroendocrine function, but the mechanisms by which LepRb regulates intracellular signaling have remained incompletely understood. Here we demonstrate that leptin stimulates the phosphorylation of STAT5 and ribosomal protein S6 in the hypothalamic arcuate nucleus in mice. In cultured cells, we investigate the mechanisms by which leptin regulates each of these pathways. Our analysis reveals a dominant role for LepRb Tyr(1077) ( which we demonstrate to be phosphorylated during receptor activation) and a secondary role for LepRb Tyr(1138) in the acute phosphorylation of STAT5a and STAT5b. Tyr(1138) and STAT3 attenuate STAT5-dependent transcription over the long-term, however. In contrast, Tyr(985) ( the LepRb phosphorylation site required for ERK activation) mediates the phosphorylation of the ribosomal S6 kinase (RSK) and S6, as well as cap-dependent translation. Thus, these data demonstrate the phosphorylation of Tyr(1077) on LepRb during receptor activation, substantiate the hypothalamic regulation of STAT5 and S6 by leptin, and define the alternate LepRb signaling pathways that mediate each of these signals and their effects in cultured cells. Dissecting the contributions of these individual pathways to leptin action will be important for our ultimate understanding of the processes that regulate energy balance in vivo.	Univ Michigan, Dept Internal Med, Div Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), 5560 MSRB 2-0678,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu	Muenzberg-Gruening, Heike/N-1978-2017		NCI NIH HHS [P30CA046592] Funding Source: Medline; NIDDK NIH HHS [R01 DK56731, R01 DK57768, R01 DK78135, DK20572] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078135, P60DK020572, R01DK056731, R01DK057768] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 2004, PEPTIDES, V25, P331, DOI 10.1016/j.peptides.2004.02.014; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Farooqi IS, 2004, RECENT PROG HORM RES, V59, P409, DOI 10.1210/rp.59.1.409; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Hekerman P, 2005, FEBS J, V272, P109, DOI 10.1111/j.1432-1033.2004.04391.x; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; Marx J, 2003, SCIENCE, V299, P846, DOI 10.1126/science.299.5608.846; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyoshi K, 2001, GENOMICS, V71, P150, DOI 10.1006/geno.2000.6433; MONTOYE T, 2006, GROWTH REGULAT, V580, P3301; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; MUNZBERG H, 2004, ENDOCRINOLOGY, V145, P11797; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Rizk NM, 2001, ENDOCRINOLOGY, V142, P3027, DOI 10.1210/en.142.7.3027; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tierney EF, 2006, JAMA-J AM MED ASSOC, V295, P383, DOI 10.1001/jama.295.4.383-a; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	60	133	136	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31019	31027		10.1074/jbc.M702838200	http://dx.doi.org/10.1074/jbc.M702838200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726024	hybrid			2022-12-27	WOS:000250136300069
J	Kelleher, ZT; Matsumoto, A; Stamler, JS; Marshall, HE				Kelleher, Zachary T.; Matsumoto, Akio; Stamler, Jonathan S.; Marshall, Harvey E.			NOS2 regulation of NF-kappa B by S-nitrosylation of p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DNA-BINDING; INHIBITION; TRANSCRIPTION; GENE; NITROSATION; KINASE; INDUCTION; DISEASE; TRANSACTIVATION	Signal transduction in the NF-kappa B transcription factor pathway is inhibited by inducible nitric oxide synthase ( NOS2) activity, although the molecular mechanism( s) are incompletely understood. We have previously shown that nitric oxide ( NO), derived from NOS2 consequent upon cytokine stimulation, attenuates NF-kappa B p50-p65 heterodimer DNA binding and have identified the p50 monomer as a locus for inhibitory S-nitrosylation. We now show that the binding partner of p50, NF-kappa B p65, is also targeted by NO following cytokine stimulation of respiratory epithelial cells and macrophages and identify a conserved cysteine within the Rel homology domain that is the site for S-nitrosylation. S-Nitrosylation of p65 inhibits NF-kappa B-dependent gene transcription, and nuclear levels of S-nitrosylated p65 correlate with decreased DNA binding of the p50-p65 heterodimer. NOS2 regulates cytokine-induced S-nitrosylation of p65, resulting in decreased NF-kappa B binding to the NOS2 promoter, thereby inhibiting further NOS2 expression. Collectively, these findings delineate a mechanism by which NOS2 modulates NF-kappa B activity and regulates gene expression in inflammation.	Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA	Duke University	Marshall, HE (corresponding author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Box 2613,MSRB 201, Durham, NC 27710 USA.	marsh015@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572; Matsumoto, Akio/0000-0002-3402-6992	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08HL004287] Funding Source: Medline; NIEHS NIH HHS [U19 ES012496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Cieslik KA, 2006, MOL PHARMACOL, V70, P2004, DOI 10.1124/mol.106.026054; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cruz MT, 2001, IMMUNOL CELL BIOL, V79, P590, DOI 10.1046/j.1440-1711.2001.01041.x; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Dikopoulos N, 2001, EUR J CLIN INVEST, V31, P234, DOI 10.1046/j.1365-2362.2001.00802.x; Du C, 2007, AM J TRANSPLANT, V7, P17, DOI 10.1111/j.1600-6143.2006.01558.x; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; McCartney-Francis NL, 2001, J IMMUNOL, V166, P2734, DOI 10.4049/jimmunol.166.4.2734; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Peng HB, 1998, J IMMUNOL, V161, P1970; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Walley KR, 1999, AM J RESP CRIT CARE, V160, P698, DOI 10.1164/ajrccm.160.2.9809081; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Zeidler PC, 2004, TOXICOL APPL PHARM, V195, P45, DOI 10.1016/j.taap.2003.10.005	41	164	168	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30667	30672		10.1074/jbc.M705929200	http://dx.doi.org/10.1074/jbc.M705929200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720813	hybrid			2022-12-27	WOS:000250136300034
J	Paranjape, SM; Harris, E				Paranjape, Suman Marie; Harris, Eva			Y box-binding protein-1 binds to the dengue virus 3 '-untranslated region and mediates antiviral effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE EMBRYONIC-DEVELOPMENT; 3' UNTRANSLATED REGION; COLD SHOCK DOMAIN; RNA-SYNTHESIS; CELLULAR-PROTEINS; MESSENGER-RNA; BREAST-CANCER; 3'-TERMINAL REGIONS; GENE-EXPRESSION; GENOMIC RNA	Dengue virus, a member of the family Flaviviridae, poses a serious public health threat worldwide. Dengue virus is a positive-sense RNA virus that harbors a genome of similar to 10.7 kb. Replication of dengue virus is mediated coordinately by cis-acting genomic sequences, viral proteins, and host cell factors. We have isolated and identified several host cell factors from baby hamster kidney cell extracts that bind with high specificity and high affinity to sequences within the untranslated regions of the dengue virus genome. Among the factors identified, Ybox-binding protein-1 (YB-1) and the heterogeneous nuclear ribonucleoproteins (hnRNPs), hnRNP A1, hnRNP A2/B1, and hnRNP Q, bind to the dengue virus 3'-untranslated region. Further analysis indicated that YB-1 binds to the dengue virus 3' stem loop, a conserved structural feature located at the 3' terminus of the 3'-untranslated region of many flaviviruses. Analysis of the impact of YB-1 on replication of dengue virus in YB-1(+/+) and YB-1(-/-) mouse embryo fibroblasts indicated that host YB-1 mediates an antiviral effect. Further studies demonstrated that this antiviral impact is due, at least in part, to a repressive role of YB-1 on dengue virus translation via a mechanism that requires viral genomic sequences. These results suggest a novel role for YB-1 as an antiviral host cell factor.	Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, 50 Univ Hall, Berkeley, CA 94720 USA.	eharris@berkeley.edu						Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Asai K, 2003, VIROLOGY, V314, P229, DOI 10.1016/S0042-6822(03)00400-8; Bader AG, 2004, ONCOGENE, V23, P3145, DOI 10.1038/sj.onc.1207550; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Bieler A, 2006, HUM GENE THER, V17, P55, DOI 10.1089/hum.2006.17.55; Bienvenut WV, 2002, PROTEOMICS, V2, P868, DOI 10.1002/1615-9861(200207)2:7<868::AID-PROT868>3.0.CO;2-D; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Edgil D, 2003, VIROLOGY, V317, P275, DOI 10.1016/j.virol.2003.08.012; Edgil D, 2006, VIRUS RES, V119, P43, DOI 10.1016/j.virusres.2005.10.012; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; Gessner C, 2004, EUR RESPIR J, V23, P14, DOI 10.1183/09031936.03.00033203; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; Huang JX, 2005, INT J ONCOL, V26, P607; Ito Y, 2003, PATHOL INT, V53, P429, DOI 10.1046/j.1440-1827.2003.01494.x; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; JIMINEZ A, 1998, CURRENT PROTOCOLS PR; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kinney RM, 2005, J VIROL, V79, P5116, DOI 10.1128/JVI.79.8.5116-5128.2005; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Miwa A, 2006, BBA-GEN SUBJECTS, V1760, P1675, DOI 10.1016/j.bbagen.2006.08.027; Olsthoorn RCL, 2001, RNA, V7, P1370; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Princler GL, 2003, VIROLOGY, V317, P136, DOI 10.1016/j.virol.2003.09.010; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sawaya BE, 1998, J GEN VIROL, V79, P239, DOI 10.1099/0022-1317-79-2-239; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; UCHIDA T, 1967, J BIOCHEM-TOKYO, V61, P44, DOI 10.1093/oxfordjournals.jbchem.a128519; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Yano T, 2003, KIDNEY INT, V64, P2052, DOI 10.1046/j.1523-1755.2003.00335.x; Yasen M, 2005, CLIN CANCER RES, V11, P7354, DOI 10.1158/1078-0432.CCR-05-1027; Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042; Yocupicio-Monroy RME, 2003, J VIROL, V77, P3067, DOI 10.1128/JVI.77.5.3067-3076.2003; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005	63	116	122	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30497	30508		10.1074/jbc.M705755200	http://dx.doi.org/10.1074/jbc.M705755200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726010	hybrid			2022-12-27	WOS:000250136300017
J	Zhang, MM; Green, BR; Catlin, P; Fiedler, B; Azam, L; Chadwick, A; Terlau, H; McArthur, JR; French, RJ; Gulyas, J; Rivier, JE; Smith, BJ; Norton, RS; Olivera, BM; Yoshikami, D; Bulaj, G				Zhang, Min-Min; Green, Brad R.; Catlin, Philip; Fiedler, Brian; Azam, Layla; Chadwick, Ashley; Terlau, Heinrich; McArthur, Jeff R.; French, Robert J.; Gulyas, Josef; Rivier, Jean E.; Smith, Brian J.; Norton, Raymond S.; Olivera, Baldomero M.; Yoshikami, Doju; Bulaj, Grzegorz			Structure/Function characterization of mu-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY NEURONS; ACETYLCHOLINE-RECEPTORS; CHEMICAL-SYNTHESIS; POTENT INHIBITOR; CONUS-STRIATUS; TTX; PAIN; PEPTIDE; GIIIA; RAT	Peptide neurotoxins from one snails continue to supply compounds with therapeutic potential. Although several analgesic conotoxins have already reached human clinical trials, a continuing need exists for the discovery and development of novel nonopioid analgesics, such as subtype-selective sodium channel blockers. mu-Conotoxin KIIIA is representative of mu-conopeptides previously characterized as inhibitors of tetrodotoxin (TTX)-resistant sodium channels in amphibian dorsal root ganglion neurons. Here, we show that KIIIA has potent analgesin activity in the mouse pain model. Surprisingly, KIIIA was found to block most (>80%) of the TTX-sensitive, but only similar to 20% of the TTX-resistant, sodium current in mouse dorsal root ganglion neurons. KIIIA was tested on cloned mammalian channels expressed in Xenopus oocytes. Both Na(nu)1.2 and Na(nu)1.6 were strongly blocked; within experimental wash times of 40-60 min, block was reversed very little for Na(nu)1.2 and only partially for Na(nu)1.6. Other isoforms were blocked reversibly: Na(nu)1.3 (IC50 8 mu M), Na(nu)1.5 (IC50 284 mu M), and Na(nu)1.4 (IC50 80 nM). "Alanine-walk" and related analogs were snythesized and tested against both Na(nu)1.2 and Na(nu)1.4; replacement of Trp-8 resulted in reversible block of Na(nu)1.2, whereas replacement of Lys-7, Trp-8, or Asp-11 yielded a more profound effect on the block of Na(nu)1.4 than of Na(nu)1.2. Taken together, these data suggest that KIIIA is an effective tool to study structure and function of Na(nu)1.2 and that further engineering of mu-conopeptides belonging to the KIIIA group may provide subtype-selective pharmacological compounds for mammalian neuronal sodium channels and potential therapeutics for the treatment of pain.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; Univ Calgary, Dept Phys & Biophys, Calgary, AB T2N 4N1, Canada; Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Utah, Coll Pharm, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; University of Kiel; Schleswig Holstein University Hospital; University of Calgary; Salk Institute; Walter & Eliza Hall Institute; Utah System of Higher Education; University of Utah	Smith, BJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	bulaj@pharm.utah.edu	McArthur, Jeffrey/T-8018-2019; McArthur, Jeffrey R/E-7869-2014; Smith, Brian J/F-8282-2011	McArthur, Jeffrey/0000-0002-2546-7913; Smith, Brian J/0000-0003-0498-1910; Norton, Raymond/0000-0001-8893-0584	NIGMS NIH HHS [GM 48677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAM SE, 1994, ANESTHESIOLOGY, V80, P383, DOI 10.1097/00000542-199402000-00018; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Blackburn-Munro G, 2002, EUR J PHARMACOL, V445, P231, DOI 10.1016/S0014-2999(02)01765-X; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; FAINZILBER M, 1995, J BIOL CHEM, V270, P1123, DOI 10.1074/jbc.270.3.1123; FAINZILBER M, 1995, BIOCHEMISTRY-US, V34, P5364, DOI 10.1021/bi00016a007; French R J, 1999, Methods Enzymol, V294, P575; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Green BR, 2007, CHEM BIOL, V14, P399, DOI 10.1016/j.chembiol.2007.02.009; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; KRUEGER BK, 1986, ANN NY ACAD SCI, V479, P257, DOI 10.1111/j.1749-6632.1986.tb15574.x; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; Marcil J, 2006, BRIT J ANAESTH, V96, P761, DOI 10.1093/bja/ael096; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Priest BT, 2007, P NATL ACAD SCI USA, V104, P8205, DOI 10.1073/pnas.0703091104; Safo P, 2000, J NEUROSCI, V20, P76, DOI 10.1523/JNEUROSCI.20-01-00076.2000; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Shon KJ, 1998, J NEUROSCI, V18, P4473; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Weiser T, 2006, NEUROSCI LETT, V395, P179, DOI 10.1016/j.neulet.2005.10.058; West PJ, 2005, J NEUROPHYSIOL, V94, P3916, DOI 10.1152/jn.01304.2004; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	44	113	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30699	30706		10.1074/jbc.M704616200	http://dx.doi.org/10.1074/jbc.M704616200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724025	hybrid			2022-12-27	WOS:000250136300038
J	Muller, H; Stitz, L; Wille, H; Prusiner, SB; Riesner, D				Mueller, Henrik; Stitz, Lothar; Wille, Holger; Prusiner, Stanley B.; Riesner, Detlev			Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; MANUFACTURING PROCESS; RODS CONTAIN; PROTEIN; INFECTIVITY; RESISTANCE; DECONTAMINATION; STABILITY; SURVIVAL	Extending the recent analysis of the safety of industrial bovine fat-derived products for human consumption (Muller, H., Stitz, L., and Riesner, D. (2006) Eur. J. Lip. Sci. Technol. 108, 812 826), we investigated systematically the effects of fat, fatty acids, and glycerol on the heat destruction of prions. Prion destruction was qualitatively and quantitatively evaluated in PrP 27-30, or prion rods, by the inactivation of infectivity as well as by the degradation of the polypeptide backbone. Under all conditions analyzed, inactivation of prion infectivity was achieved more efficiently than backbone degradation by several orders of magnitude. The presence of fat enhanced prion inactivation and offers a mild treatment for prion decontamination. In contrast, the presence of fat, fatty acids, and especially glycerol protected the PrP 27-30 backbone against heat-induced degradation. Glycerol also protected against heat-induced inactivation of prion infectivity. A phase distribution analysis demonstrated that prions migrated to the interphase of a fat/water mixture at room temperature and accumulated in the water phase at higher temperatures. In a systematic study of the mechanism of prion destruction, we found an intermediate structure of PrP that has fewer fibrils in beta-sheet formation, lower resistance to protease digestion, greater aggregation, and reduced solubility compared with PrP 27-30 but retains residual infectivity. These findings suggest that prion infectivity depends on beta-sheet-rich fibrillar structure and that inactivation proceeds in a stepwise manner, which explains the tailing effect frequently observed during inactivation.	Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; Bundesforschungsinst Tiergesundheit, Friedrich Loeffler Inst, D-72076 Tubingen, Germany; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Heinrich Heine University Dusseldorf; Friedrich Loeffler Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Riesner, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, Gebaude 26-12-U1,Univ Str 1, D-40225 Dusseldorf, Germany.	riesner@biophys.uni-duesseldorf.de	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706	NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG002132] Funding Source: NIH RePORTER; NIA NIH HHS [AG10770, AG02132] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Appel TR, 2006, J GEN VIROL, V87, P1385, DOI 10.1099/vir.0.81426-0; Appel TR, 1999, BIOL CHEM, V380, P1295, DOI 10.1515/BC.1999.165; Appel TR, 2001, J GEN VIROL, V82, P465, DOI 10.1099/0022-1317-82-2-465; Bolton D C, 1991, Curr Top Microbiol Immunol, V172, P39; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1990, J INFECT DIS, V161, P467, DOI 10.1093/infdis/161.3.467; Brown P, 2000, P NATL ACAD SCI USA, V97, P3418, DOI 10.1073/pnas.050566797; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DICKINSO.AG, 1969, NATURE, V222, P892, DOI 10.1038/222892a0; DIMARTINO A, 1993, DEV BIOL STAND, V80, P187; Diringer H, 1997, INTERVIROLOGY, V40, P238, DOI 10.1159/000150553; Dumpitak C, 2005, BIOL CHEM, V386, P1149, DOI 10.1515/BC.2005.131; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Garcia AF, 2004, J GEN VIROL, V85, P261, DOI 10.1099/vir.0.19410-0; Golker CF, 1996, BIOLOGICALS, V24, P103; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; Hlodan R, 1991, Biotechnol Genet Eng Rev, V9, P47; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MOULD DL, 1970, J COMP PATHOL, V80, P595, DOI 10.1016/0021-9975(70)90057-5; Muller H, 2006, EUR J LIPID SCI TECH, V108, P812, DOI 10.1002/ejlt.200600068; Muller H, 2005, EUR J LIPID SCI TECH, V107, P833, DOI 10.1002/ejlt.200501189; Oberthur RC, 2007, PRIONS IN HUMANS AND ANIMALS, P515; Peano S, 2000, INTENS CARE MED, V26, P608, DOI 10.1007/s001340051211; POCCHIARI M, 1991, DEV BIOLOGICALS, V75, P87; POCCHIARI M, 1991, HORM RES, V35, P161, DOI 10.1159/000181894; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1999, PRION BIOL DIS; Riesner D, 2007, PRIONS IN HUMANS AND ANIMALS, P104; ROHWER RG, 1984, SCIENCE, V223, P600, DOI 10.1126/science.6420887; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; SENDHAJI AF, 1977, J FOOD TECHNOL, V12, P203; SENDHAJI AF, 1977, J FOOD TECHNOL, V12, P216; Somerville RA, 2002, J BIOL CHEM, V277, P11084, DOI 10.1074/jbc.M111766200; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Taylor D M, 2004, Contrib Microbiol, V11, P136; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1999, J HOSP INFECT, V43, pS69, DOI 10.1016/S0195-6701(99)90067-1; Taylor DM, 1995, VET REC, V137, P605; Taylor DM, 1996, J GEN VIROL, V77, P811, DOI 10.1099/0022-1317-77-4-811; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TAYLOR DM, 1986, ANN NEUROL, V20, P749, DOI 10.1002/ana.410200621; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343	56	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35855	35867		10.1074/jbc.M706883200	http://dx.doi.org/10.1074/jbc.M706883200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17878157	hybrid			2022-12-27	WOS:000251458100047
J	Li, YF; He, W; Jha, KN; Klotz, K; Kim, YH; Mandal, A; Pulido, S; Digilio, L; Flickinger, CJ; Herr, JC				Li, Yan-Feng; He, Wei; Jha, Kula N.; Klotz, Ken; Kim, Young-Hwan; Mandal, Arabinda; Pulido, Silvia; Digilio, Laura; Flickinger, Charles J.; Herr, John C.			FSCB, a novel protein kinase a-phosphorylated calcium-binding protein, is a CABYR-binding partner involved in late steps of fibrous sheath biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; HUMAN SPERM; ACROSOME REACTION; HAMSTER SPERMATOZOA; MAMMALIAN SPERM; CAPACITATION; MOUSE; HYPERACTIVATION; IDENTIFICATION; PENTOXIFYLLINE	We report characterization of a novel testis- and sperm-specific protein, FSCB ((f) under bar ibrous (s) under bar heath (C) under bar ABYR (b) under bar inding), that is expressed post- meiotically and localized in mouse sperm flagella. FSCB was identified as a binding partner of CABYR, a calcium-binding protein that is tyrosine-phosphorylated during capacitation. Orthologous genes of FSCB are present in other mammals, including rat and human, and conserved motifs in FSCB include PXXP, proline-rich and extensin-like regions. FSCB is phosphorylated by protein kinase A as shown by in vitro phosphorylation assay and also by determining phosphorylation sites in native FSCB from mouse sperm. Calcium overlay assay showed that FSCB is a calcium-binding protein from sperm. FSCB is a post meiotic protein first expressed at step 11 of mouse spermatogenesis in the elongating spermatids, and it subsequently incorporates into the flagellar principal piece of the sperm. Ultrastructurally, FSCB localized to a cortical layer of intermediate electron density at the surface of the ribs and longitudinal columns of the fibrous sheath. Due to its temporal appearance during spermiogenesis and location at the cortex of the fibrous sheath, FSCB is postulated to be involved in the later stages of fibrous sheath assembly.	Univ Virginia, Dept Cell Biol, Ctr Res Contracept & Reprod Hlth, Charlottesville, VA 22908 USA; Third Mil Med Univ, Daping Hosp, Dept Urol, Chongqing 400042, Peoples R China; Third Mil Med Univ, SW Hosp, Dept Obstet & Gynecol, Chongqing 400038, Peoples R China	University of Virginia; Army Medical University; Army Medical University	Herr, JC (corresponding author), Univ Virginia, Dept Cell Biol, Ctr Res Contracept & Reprod Hlth, POB 800732, Charlottesville, VA 22908 USA.	jch7k@virginia.edu	li, yan/GTI-4638-2022		NICHD NIH HHS [D43 TW/HD 000654] Funding Source: Medline; PHS HHS [U54 29099] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; Carrera A, 1996, DEV BIOL, V180, P284, DOI 10.1006/dbio.1996.0301; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; CLERMONT Y, 1990, ANAT RECORD, V227, P447, DOI 10.1002/ar.1092270408; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; EDDY EM, 1991, ANN NY ACAD SCI, V637, P224, DOI 10.1111/j.1749-6632.1991.tb27312.x; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; El-Alfy M, 1999, J ANDROL, V20, P307; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Fujita A, 2000, J CELL SCI, V113, P103; FULCHER KD, 1995, BIOL REPROD, V52, P41, DOI 10.1095/biolreprod52.1.41; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hsu HC, 2005, BIOCHEM BIOPH RES CO, V329, P1108, DOI 10.1016/j.bbrc.2005.02.089; IRONS MJ, 1982, AM J ANAT, V165, P121, DOI 10.1002/aja.1001650204; Jha KN, 2002, MOL REPROD DEV, V61, P258, DOI 10.1002/mrd.1155; Johnson LR, 1997, DEV BIOL, V192, P340, DOI 10.1006/dbio.1997.8767; Kim YH, 2005, DEV BIOL, V286, P46, DOI 10.1016/j.ydbio.2005.07.005; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Mandal A, 1999, BIOL REPROD, V61, P1184, DOI 10.1095/biolreprod61.5.1184; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Moseley FLC, 2005, MOL HUM REPROD, V11, P523, DOI 10.1093/molehr/gah188; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; Nassar A, 1999, FERTIL STERIL, V71, P919, DOI 10.1016/S0015-0282(99)00013-8; Nauc V, 2004, J ANDROL, V25, P573; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; O'Flaherty C, 2005, BIOL REPROD, V73, P94, DOI 10.1095/biolreprod.104.038794; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oko R, 1998, ANDROLOGIA, V30, P193; OKO R, 1989, ANAT REC, V225, P46, DOI 10.1002/ar.1092250108; OKUNO M, 1981, CELL MOTIL CYTOSKEL, V1, P349, DOI 10.1002/cm.970010306; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; SAKAI Y, 1986, ANAT REC, V215, P119, DOI 10.1002/ar.1092150205; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; Sen B, 2003, GENE, V310, P67, DOI 10.1016/S0378-1119(03)00495-5; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Turner RMO, 1999, MOL HUM REPROD, V5, P816, DOI 10.1093/molehr/5.9.816; Turner RMO, 1998, J BIOL CHEM, V273, P32135, DOI 10.1074/jbc.273.48.32135; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1989, BIOL REPROD, V40, P223, DOI 10.1095/biolreprod40.2.223; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Yeung CH, 1999, MOL REPROD DEV, V54, P194, DOI 10.1002/(SICI)1098-2795(199910)54:2<194::AID-MRD12>3.3.CO;2-3; YOVICH JM, 1990, FERTIL STERIL, V53, P715	54	34	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34104	34119		10.1074/jbc.M702238200	http://dx.doi.org/10.1074/jbc.M702238200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855365	hybrid			2022-12-27	WOS:000251145700025
J	Pruliere-Escabasse, V; Planes, C; Escudier, E; Fanen, P; Coste, A; Clerici, C				Pruliere-Escabasse, Virginie; Planes, Carole; Escudier, Estelle; Fanen, Pascale; Coste, Andre; Clerici, Christine			Modulation of epithelial sodium channel trafficking and function by sodium 4-phenylbutyrate in human nasal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SURFACE EXPRESSION; APICAL MEMBRANE; CFTR EXPRESSION; REGULATES ENAC; NA+ ABSORPTION; PROTEIN; DEGRADATION; TRANSPORT; SUBUNITS	Sodium 4-phenylbutyrate (4-PBA) has been shown to correct the cellular trafficking of several mutant or nonmutant plasma membrane proteins such as cystic fibrosis transmembrane conductance regulator through the expression of 70-kDa heat shock proteins. The objective of the study was to determine whether 4-PBA may influence the functional expression of epithelial sodium channels (ENaC) in human nasal epithelial cells (HNEC). Using primary cultures of HNEC, we demonstrate that 4-PBA (5 mM for 6 h) markedly stimulated amiloridesensitive sodium channel activity and that this was related to an increased abundance of alpha-,beta-, and gamma- ENaC subunits in the apical membrane. The increase in ENaC cell surface expression (i) was due to insertion of newly ENaC subunits as determined by brefeldin A experiments and (ii) was not associated with cell surface retention of ENaC subunits because endocytosis of ENaC subunits was unchanged. In addition, we find that ENaC co-immunoprecipitated with the heat shock protein constituvely expressed Hsc70, that has been reported to modulate ENaC trafficking, and that 4-PBA decreased Hsc70 protein level. Finally, we report that in cystic fibrosis HNEC obtained from two cystic fibrosis patients, 4-PBA increased functional expression of ENaC as demonstrated by the increase in amiloride-sensitive sodium transport and in alpha-, beta-, and gamma- ENaC subunit expression in the apical membrane. Our results suggest that in HNEC, 4-PBA increases the functional expression of ENaC through the insertion of new alpha-, beta-, and gamma- ENaC subunits into the apical membrane and also suggest that 4-PBA could modify ENaC trafficking by reducing Hsc70 protein expression.	Hop Henri Mondor & Intercommunal, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, F-94010 Creteil, France; INSERM, U 841, F-94000 Creteil, France; Univ Paris 12, F-94000 Creteil, France; Univ Versailles, F-78000 St Quentin en Yvelines, France; Hop Ambroise Pare, AP HP, Serv Physiol, F-92220 Boulogne, France; Univ Paris 07, INSERM, U 773, F-75018 Paris, France; Univ Paris 07, F-75013 Paris, France; Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Pruliere-Escabasse, V (corresponding author), Hop Henri Mondor & Intercommunal, AP HP, Serv Otorhinolaryngol & Chirurg Cervicofaciale, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France.	virginie.pruliere@creteil.inserm.fr	Escabasse, virginie VPE Pruliere/R-1949-2018	Escabasse, virginie VPE Pruliere/0000-0003-0208-7544; Fanen, Pascale/0000-0002-3273-5349; planes, carole/0000-0003-2286-366X; COSTE, Andre/0000-0002-8386-3455				Bercovich B, 1997, J BIOL CHEM, V272, P9002; Brouard M, 1999, J CELL SCI, V112, P3343; Brown CR, 1997, J BIOENERG BIOMEMBR, V29, P491, DOI 10.1023/A:1022491124939; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Huang Pingbo, 2004, Proc Am Thorac Soc, V1, P33, DOI 10.1513/pats.2306012; Iordache C, 2007, EXP CELL RES, V313, P305, DOI 10.1016/j.yexcr.2006.10.012; KNOWLES MR, 1995, AM J RESP CRIT CARE, V151, pS65, DOI 10.1164/ajrccm/151.3_Pt_2.S65; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Ling BN, 1997, J BIOL CHEM, V272, P594; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; LOW SH, 1992, J CELL BIOL, V118, P51, DOI 10.1083/jcb.118.1.51; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Moyer BD, 1999, AM J PHYSIOL-RENAL, V277, pF271, DOI 10.1152/ajprenal.1999.277.2.F271; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2002, J BIOL CHEM, V277, P47318, DOI 10.1074/jbc.M209158200; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Riordan M, 2005, AM J PHYSIOL-RENAL, V288, pF1236, DOI 10.1152/ajprenal.00438.2004; Rochat T, 2004, J CELL PHYSIOL, V201, P106, DOI 10.1002/jcp.20066; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	42	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34048	34057		10.1074/jbc.M702384200	http://dx.doi.org/10.1074/jbc.M702384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890229	hybrid			2022-12-27	WOS:000251145700019
J	Bochman, ML; Schwacha, A				Bochman, Matthew L.; Schwacha, Anthony			Differences in the single-stranded DNA binding activities of mcm2-7 and mcm467 - mcm2 and mcm5 define a slow atp-dependent step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; REPRESSOR-OPERATOR INTERACTION; HELICASE ACTIVITY; REPLICATION ORIGINS; ARCHAEAL MCM; MCM4/6/7 HELICASE; CONSERVED MOTIFS; FISSION YEAST; COMPLEX; THERMOAUTOTROPHICUM	The MCM2-7 complex, a hexamer containing six distinct and essential subunits, is postulated to be the eukaryotic replicative DNA helicase. Although all six subunits function at the replication fork, only a specific subcomplex consisting of the MCM4, 6, and 7 subunits (MCM467) and not the MCM2-7 complex exhibits DNA helicase activity in vitro. To understand why MCM2-7 lacks helicase activity and to address the possible function of the MCM2, 3, and 5 subunits, we have compared the biochemical properties of the Saccharomyces cerevisiae MCM2-7 and MCM467 complexes. We demonstrate that both complexes are toroidal and possess a similar ATP-dependent single-stranded DNA (ssDNA) binding activity, indicating that the lack of helicase activity by MCM2-7 is not due to ineffective ssDNA binding. We identify two important differences between them. MCM467 binds dsDNA better than MCM2-7. In addition, we find that the rate of MCM2-7/ssDNA association is slow compared with MCM467; the association rate can be dramatically increased either by preincubation with ATP or by inclusion of mutations that ablate the MCM2/5 active site. We propose that the DNA binding differences between MCM2-7 and MCM467 correspond to a conformational change at the MCM2/5 active site with putative regulatory significance.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schwacha, A (corresponding author), 4249 5th Ave,560 Crawford Hall, Pittsburgh, PA 15260 USA.	schwacha@pitt.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452				Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boulikas T, 1996, J CELL BIOCHEM, V60, P297, DOI 10.1002/(SICI)1097-4644(19960301)60:3<297::AID-JCB2>3.0.CO;2-R; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; Gomez EB, 2002, GENETICS, V160, P1305; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kawasaki Y, 2001, MOL CELLS, V12, P277; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MCMACKEN R, 1987, ESCHERICHIA COLI SAL, P564; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P537, DOI 10.1016/S0966-842X(00)01881-3; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Pucci B, 2004, J BIOL CHEM, V279, P49222, DOI 10.1074/jbc.M408967200; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P310; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Spradling AC, 1999, GENE DEV, V13, P2619, DOI 10.1101/gad.13.20.2619; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003	61	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33795	33804		10.1074/jbc.M703824200	http://dx.doi.org/10.1074/jbc.M703824200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895243	hybrid			2022-12-27	WOS:000250840200062
J	Cohen, TJ; Waddell, DS; Barrientos, T; Lu, Z; Feng, G; Cox, GA; Bodine, SC; Yao, TP				Cohen, Todd J.; Waddell, David S.; Barrientos, Tomasa; Lu, Zhonghua; Feng, Guoping; Cox, Gregory A.; Bodine, Sue C.; Yao, Tso-Pang			The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNA; CAM KINASE-II; SKELETAL-MUSCLE; INTRACELLULAR TRAFFICKING; GENE-EXPRESSION; IN-VIVO; IDENTIFICATION; MYOTUBES; MYOGENIN; CALCIUM	Neural activity actively regulates muscle gene expression. This regulation is crucial for specifying muscle functionality and synaptic protein expression. How neural activity is relayed into nuclei and connected to the muscle transcriptional machinery, however, is not known. Here we identify the histone deacetylase HDAC4 as the critical linker connecting neural activity to muscle transcription. We found that HDAC4 is normally concentrated at the neuromuscular junction (NMJ), where nerve innervates muscle. Remarkably, reduced neural input by surgical denervation or neuromuscular diseases dissociates HDAC4 from the NMJ and dramatically induces its expression, leading to robust HDAC4 nuclear accumulation. We present evidence that nuclear accumulated HDAC4 is responsible for the coordinated induction of synaptic genes upon denervation. Inactivation of HDAC4 prevents denervation-induced synaptic acetylcholine receptor ( nAChR) and MUSK transcription whereas forced expression of HDAC4 mimics denervation and activates ectopic nAChR transcription throughout myofibers. We determined that HDAC4 executes activity-dependent transcription by regulating the Dach2-myogenin transcriptional cascade where inhibition of the repressor Dach2 by HDAC4 permits the induction of the transcription factor myogenin, which in turn activates synaptic gene expression. Our findings establish HDAC4 as a neural activity-regulated deacetylase and a key signaling component that relays neural activity to the muscle transcriptional machinery.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Duke University; Duke University; University of California System; University of California Davis; Jackson Laboratory	Yao, TP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	yao00001@mc.duke.edu	Waddell, David/AAG-3774-2020; Feng, Guoping/Y-2827-2019; Waddell, David/J-7435-2015	Waddell, David/0000-0001-6749-4461; Waddell, David/0000-0001-6749-4461; Bodine, Sue/0000-0002-5742-9145				Adams L, 1998, J NEUROBIOL, V35, P245, DOI 10.1002/(SICI)1097-4695(19980605)35:3<245::AID-NEU2>3.0.CO;2-Z; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Garvey SM, 2006, HUM MOL GENET, V15, P2348, DOI 10.1093/hmg/ddl160; HUANG CF, 1994, FEBS LETT, V338, P277, DOI 10.1016/0014-5793(94)80283-1; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; Macpherson PCD, 2006, MOL CELL NEUROSCI, V31, P649, DOI 10.1016/j.mcn.2005.12.005; Maddatu TP, 2004, HUM MOL GENET, V13, P1105, DOI 10.1093/hmg/ddh129; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; NEVILLE C, 1991, NEUROREPORT, V2, P655, DOI 10.1097/00001756-199111000-00005; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	22	139	154	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33752	33759		10.1074/jbc.M706268200	http://dx.doi.org/10.1074/jbc.M706268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873280	hybrid			2022-12-27	WOS:000250840200057
J	Gillespie, RF; Gudas, LJ				Gillespie, Robert F.; Gudas, Lorraine J.			Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic acid response elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; UNION-OF-PHARMACOLOGY; GROUP PROTEIN SUZ12; NUCLEAR RECEPTORS; TARGET GENES; X-RECEPTOR; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAY; HISTONE H3; RAR-ALPHA	The retinoic acid receptor (RAR) alpha, beta(2), and gamma isotypes each regulate specific subsets of target genes in F9 teratocarcinoma stem cells. We used chromatin immunoprecipitation assays to monitor the association of RAR gamma, retinoic X receptor (RXR) alpha, and coregulators with the RAR beta(2), Hoxa1, and Cyp26A1 retinoic acid response elements (RAREs) in F9 wild type and RAR alpha, -beta(2), and -gamma null cells. Additionally we quantitatively monitored expression of the corresponding mRNAs. We demonstrated that the association of RAR gamma and/ or RXR alpha with a RARE was not sufficient for retinoic acid (RA)-mediated transcription of the corresponding target gene. However, the ability of RAR alpha and/ or RXR alpha to recruit pCIP (AIB1/ACTR/RAC-3/TRAM-1/SRC-3) and p300 to a RARE did correlate with RA-associated transcription of target mRNAs. Therefore, the specific functions of the RAR isotypes do not manifest at the level of their DNA binding but rather from a differential ability to recruit specific components of the transcriptional machinery. We also demonstrated that RA-mediated displacement of the polycomb group protein SUZ12 from a RARE was inhibited in the absence of RAR gamma. Thus, transcriptional components of the RAR signaling pathway are specifically required for displacement of SUZ12 from RAREs during RA-mediated differentiation of F9 cells.	Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, 1300 York Ave,Rm E-409, New York, NY 10021 USA.	ljgudas@med.cornell.edu			NCI NIH HHS [R01CA043796] Funding Source: Medline; NIDDK NIH HHS [R01DK454560] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chiba H, 1997, MOL CELL BIOL, V17, P3013, DOI 10.1128/MCB.17.6.3013; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Clifford J, 1996, EMBO J, V15, P4142, DOI 10.1002/j.1460-2075.1996.tb00789.x; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; DAMJANOV I, 1975, TERATOMAS DIFFERENTI, P209; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Glass CK, 2000, GENE DEV, V14, P121; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; Guenther MG, 2000, GENE DEV, V14, P1048; Hartman HB, 2005, EMBO REP, V6, P445, DOI 10.1038/sj.embor.7400391; Hauksdottir H, 2003, MOL ENDOCRINOL, V17, P373, DOI 10.1210/me.2002-0340; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Zhuang Y, 2003, MOL CANCER RES, V1, P619	58	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33421	33434		10.1074/jbc.M704845200	http://dx.doi.org/10.1074/jbc.M704845200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875646	hybrid			2022-12-27	WOS:000250840200022
J	Huang, J; Liang, Z; Yang, B; Tian, H; Ma, J; Zhang, H				Huang, Jialing; Liang, Zhihui; Yang, Bin; Tian, Heng; Ma, Jin; Zhang, Hui			Derepression of MicroRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN-CELLS; P-BODIES; ENDOGENOUS RETROVIRUSES; ALU RETROTRANSPOSITION; LTR-RETROTRANSPOSON; HUMAN HEPATOCYTES; HIV-1 INFECTION; STRESS GRANULES; VIF PROTEIN	The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G or A3G) and its fellow cytidine deaminase family members are potent restrictive factors for human immunodeficiency virus type 1 (HIV-1) and many other retroviruses. A3G interacts with a vast spectrum of RNA-binding proteins and is located in processing bodies and stress granules. However, its cellular function remains to be further clarified. Using a luciferase reporter gene and green fluorescent protein reporter gene, we demonstrate that A3G and other APOBEC family members can counteract the inhibition of protein synthesis by various microRNAs ( miRNAs) such as mir-10b, mir-16, mir-25, and let-7a. A3G could also enhance the expression level of miRNA-targeted mRNA. Further, A3G facilitated the association of microRNA-targeted mRNA with polysomes rather than with processing bodies. Intriguingly, experiments with a C288A/C291A A3G mutant indicated that this function of A3G is separable from its cytidine deaminase activity. Our findings suggest that the major cellular function of A3G, in addition to inhibiting the mobility of retrotransposons and replication of endogenous retroviruses, is most likely to prevent the decay of miRNA-targeted mRNA in processing bodies.	Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, H (corresponding author), Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, JAH334, Philadelphia, PA 19107 USA.	hui.zhang@jefferson.edu	Yang, Bin/J-4044-2015; Yang, Bin/W-7014-2019	Yang, Bin/0000-0003-4110-1513; Yang, Bin/0000-0003-1180-6184	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052732, R01AI058798] Funding Source: NIH RePORTER; NIAID NIH HHS [AI052732, AI058798] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; ARGYRIS EG, 2007, IN PRESS VIROLOGY; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bruno I, 2006, CELL, V125, P1036, DOI 10.1016/j.cell.2006.06.003; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	54	97	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33632	10.1074/jbc.M705116200	http://dx.doi.org/10.1074/jbc.M705116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848567	hybrid			2022-12-27	WOS:000250840200044
J	Kim, SH; Hisano, T; Takeda, K; Iwasaki, W; Ebihara, A; Miki, K				Kim, Seong-Hoon; Hisano, Tamao; Takeda, Kazuki; Iwasaki, Wakana; Ebihara, Akio; Miki, Kunio			Crystal Structure of the oxygenase component (HpaB) of the 4-hydroxyphenylacetate 3-Monooxygenase from Thermus thermophilus HB8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; ESCHERICHIA-COLI W; MOLECULAR CHARACTERIZATION; 2-COMPONENT MONOOXYGENASE; ACINETOBACTER-BAUMANNII; FUNCTIONAL-ANALYSIS; PHENOL HYDROXYLASE; CATABOLIC PATHWAY; MECHANISM	The 4-hydroxyphenylacetate ( 4HPA) 3-monooxygenase is involved in the initial step of the 4HPA degradation pathway and catalyzes 4HPA hydroxylation to 3,4-dihydroxyphenylacetate. This enzyme consists of two components, an oxygenase ( HpaB) and a reductase ( HpaC). To understand the structural basis of the catalytic mechanism of HpaB, crystal structures of HpaB from Thermus thermophilus HB8 were determined in three states: a ligand-free form, a binary complex with FAD, and a ternary complex with FAD and 4HPA. Structural analysis revealed that the binding and dissociation of flavin are accompanied by conformational changes of the loop between beta 5 and beta 6 and of the loop between beta 8 and beta 9, leading to preformation of part of the substrate-binding site ( Ser-197 and Thr-198). The latter loop further changes its conformation upon binding of 4HPA and obstructs the active site from the bulk solvent. Arg-100 is located adjacent to the putative oxygen-binding site and may be involved in the formation and stabilization of the C4-ahydroperoxyflavin intermediate.	Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; RIKEN Harima Inst, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Kyoto University; RIKEN	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021; Ebihara, Akio/AAI-6155-2020; Iwasaki, Wakana/C-4258-2017	Ebihara, Akio/0000-0002-1763-9084; Iwasaki, Wakana/0000-0002-0161-777X; Takeda, Kazuki/0000-0002-4094-6816				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; BACH RD, 1994, J AM CHEM SOC, V116, P5392, DOI 10.1021/ja00091a050; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; COOPER RA, 1980, J BACTERIOL, V143, P302, DOI 10.1128/JB.143.1.302-306.1980; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Duffner FM, 1998, FEMS MICROBIOL LETT, V161, P37, DOI 10.1016/S0378-1097(98)00047-0; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Fernandez-Medarde A, 1997, FEMS MICROBIOL LETT, V157, P47, DOI 10.1016/S0378-1097(97)00452-7; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Galan B, 2001, J BIOL CHEM, V276, P37060, DOI 10.1074/jbc.M103033200; Gibello A, 1997, ARCH MICROBIOL, V167, P160, DOI 10.1007/s002030050429; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kim SH, 2007, ACTA CRYSTALLOGR F, V63, P556, DOI 10.1107/S174430910702492X; KIM SH, 2007, IN PRESS PROTEINS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Nagpal A, 2006, BIOCHEMISTRY-US, V45, P1138, DOI 10.1021/bi051966w; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; SHOUN H, 1979, J BIOL CHEM, V254, P944; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; TAKIZAWA N, 1995, J FERMENT BIOENG, V80, P318, DOI 10.1016/0922-338X(95)94198-Z; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; van der Ploeg JR, 1998, MICROBIOL-SGM, V144, P2555, DOI 10.1099/00221287-144-9-2555; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213	49	48	54	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33107	33117		10.1074/jbc.M703440200	http://dx.doi.org/10.1074/jbc.M703440200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804419	hybrid			2022-12-27	WOS:000250625400059
J	Kolachala, VL; Bajaj, R; Wang, L; Yan, Y; Ritzenthaler, JD; Gewirtz, AT; Roman, J; Merlin, D; Sitaraman, SV				Kolachala, Vasantha L.; Bajaj, Rahul; Wang, Lixin; Yan, Yutao; Ritzenthaler, Jeff D.; Gewirtz, Andrew T.; Roman, Jesse; Merlin, Didier; Sitaraman, Shanthi V.			Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PLASMA FIBRONECTIN; CROHNS-DISEASE; CELL-ADHESION; EXPERIMENTAL COLITIS; IN-VITRO; INTEGRIN; RATS; FIBROBLASTS; ACTIVATION	Fibronectin (FN) is a multifunctional extracellular matrix protein that plays an important role in cell proliferation, adhesion, and migration. FN expression or its role in colitis is not known. The goal of this study is to characterize FN expression, regulation, and role during intestinal inflammation. Wild-type and transgenic mice expressing luciferase under the control of the human FN promoter, given water or 3% dextran sodium sulfate, were used as animal models of colitis. The Caco2-BBE model intestinal epithelial cell line was used for in vitro studies. FN protein is abundantly expressed by surface epithelial cells in the normal colon. Immunohistochemistry and luciferase assay in mice expressing the FN promoter linked to luciferase demonstrated that FN synthesis was up-regulated during colitis, during both the acute phase and the healing phase. In vitro experiments demonstrated that FN increased the expression of the FN integrin receptor alpha 5 beta 1 in a dose-and time-dependent manner. FN also induced the expression and activation of NF-kappa B. Further, FN potentiated Caco2-BBE cell attachment and wound healing, which was inhibited by RGD peptide as well as NF-kappa B inhibitors MG-132 and 1-pyrrolidinecarbodithioic acid, ammonium salt. In conclusion, FN is abundantly expressed and synthesized by colonic epithelial cells. FN is transcriptionally up-regulated in epithelial cells during both the dextran sodium sulfate-induced colitic and the recovery phase. FN enhances cell attachment and wound healing, which is dependent on binding to the integrin receptor and the NF-kappa B signaling. Together our data show that epithelial-derived FN potentiates cell attachment and wound healing through epithelial-matrix interactions and that FN expression may have important implications for maintaining normal epithelial integrity as well as regulating epithelial response to injury during colitis.	Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; Emory Univ, Div Pulm & Crit Care Med, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Sitaraman, SV (corresponding author), Emory Univ, Div Digest Dis, Rm 201-F,615 Michael St,Whitehead Res Bldg, Atlanta, GA 30322 USA.	ssitar2@emory.edu			NIDDK NIH HHS [DK 02831, 5R24 DK 064399-02, DK 06411] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, K01DK002831] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama S K, 1996, Hum Cell, V9, P181; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALLAN A, 1989, GUT, V30, P627, DOI 10.1136/gut.30.5.627; BASSON CT, 1990, J CELL BIOL, V110, P789, DOI 10.1083/jcb.110.3.789; Basson MD, 2001, LIFE SCI, V69, P3005, DOI 10.1016/S0024-3205(01)01408-4; Brenmoehl J, 2007, INT J COLORECTAL DIS, V22, P611, DOI 10.1007/s00384-006-0188-4; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Charrier L, 2005, AM J PHYSIOL-GASTR L, V288, pG346, DOI 10.1152/ajpgi.00262.2004; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; COOPER HS, 1993, LAB INVEST, V69, P238; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gewirtz AT, 2002, BEST PRACT RES CL GA, V16, P851, DOI 10.1053/bega.2002.0339; Goke M, 1996, AM J PHYSIOL-GASTR L, V271, pG729, DOI 10.1152/ajpgi.1996.271.5.G729; Jobin C, 2000, INFLAMM BOWEL DIS, V6, P206, DOI 10.1097/00054725-200008000-00007; Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z; Kaspar M, 2006, INT J CANCER, V118, P1331, DOI 10.1002/IJC.21677; Kwon AH, 2007, SURGERY, V141, P254, DOI 10.1016/j.surg.2006.06.036; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Loeser RF, 2002, BIORHEOLOGY, V39, P119; MCNEIL PL, 1990, J CELL SCI, V96, P549; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Nakajima K, 2006, NEUROSCI LETT, V401, P199, DOI 10.1016/j.neulet.2006.03.014; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Qiu ZY, 2007, J SURG RES, V138, P64, DOI 10.1016/j.jss.2006.06.034; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Ritchie CK, 2000, J CELL PHYSIOL, V184, P214, DOI 10.1002/1097-4652(200008)184:2<214::AID-JCP9>3.3.CO;2-Q; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; Strauch ED, 2003, ANN SURG, V237, P494, DOI 10.1097/00000658-200304000-00010; Tomic R, 2005, CHEST, V127, P257, DOI 10.1378/chest.127.1.257; VERSPAGET HW, 1991, HEPATO-GASTROENTEROL, V38, P231; Walia B, 2004, BIOCHEM J, V382, P589, DOI 10.1042/BJ20040021; Wang JH, 2003, J IMMUNOL, V170, P795, DOI 10.4049/jimmunol.170.2.795; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Watanabe K, 2006, PEPTIDES, V27, P1538, DOI 10.1016/j.peptides.2005.11.005; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007	46	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32965	32973		10.1074/jbc.M704388200	http://dx.doi.org/10.1074/jbc.M704388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855340	hybrid			2022-12-27	WOS:000250625400045
J	Zhai, PY; Gao, SM; Holle, E; Yu, XZ; Yatani, A; Wagner, T; Sadoshima, J				Zhai, Peiyong; Gao, Shumin; Holle, Eric; Yu, Xianzhong; Yatani, Atsuko; Wagner, Thomas; Sadoshima, Junichi			Glycogen synthase kinase-3 alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; TUBEROUS SCLEROSIS; ACTIVATION; PHOSPHORYLATION; DYSFUNCTION; OVEREXPRESSION; REQUIREMENT; PROTECTION; SURVIVAL; AGONISTS	Glycogen synthase kinase-3 ( GSK-3) is a serine/threonine kinase having multiple functions and consisting of two isoforms, GSK-3 alpha and GSK-3 beta. Pressure overload increases expression of GSK-3 alpha but not GSK-3 beta. Despite our wealth of knowledge about GSK-3 beta, the function of GSK-3 alpha in the heart is not well understood. To address this issue, we made cardiac-specific GSK-3 alpha transgenic mice ( Tg). Left ventricular weight and cardiac myocyte size were significantly smaller in Tg than in non-Tg ( NTg) mice, indicating that GSK-3 alpha inhibits cardiac growth. After 4 weeks of aortic banding ( transverse aortic constriction ( TAC)), increases in left ventricular weight and myocyte size were significantly smaller in Tg than in NTg, indicating that GSK-3 alpha inhibits cardiac hypertrophy. More severe cardiac dysfunction developed in Tg after TAC. Increases in fibrosis and apoptosis were greater in Tg than in NTg after TAC. Among signaling molecules screened, ERK phosphorylation was decreased in Tg. Adenovirus-mediated overexpression of GSK-3 alpha, but not GSK-3 beta, inhibited ERK in cultured cardiac myocytes. Knockdown of GSK-3 alpha increased ERK phosphorylation, an effect that was inhibited by PD98059, rottlerin, and protein kinase C epsilon ( PKC epsilon) inhibitor peptide, suggesting that GSK-3 alpha inhibits ERK through PKC-MEK-dependent mechanisms. Knockdown of GSK-3 alpha increased protein content and reduced apoptosis, effects that were abolished by PD98059, indicating that inhibition of ERK plays a major role in the modulation of cardiac growth and apoptosis by GSK-3 alpha. In conclusion, up-regulation of GSK-3 alpha inhibits cardiac growth and pressure overload-induced cardiac hypertrophy but increases fibrosis and apoptosis in the heart. The anti-hypertrophic and pro-apoptotic effect of GSK-3 alpha is mediated through inhibition of ERK.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Inst Cardiovasc Res, Newark, NJ 07103 USA; Oncol Res Inst, Greenville, SC USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), 185 S Orange Ave,MSB G609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu		Sadoshima, Junichi/0000-0003-3724-4132	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069020, F32HL080861, R01HL067727, P01HL059139, R01HL067724] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 69020, HL 67727, HL 73048, 1F32 HL 080861, HL 67724, HL 59139] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; GOODE N, 1992, J BIOL CHEM, V267, P16878; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Inagaki K, 2005, J MOL CELL CARDIOL, V39, P203, DOI 10.1016/j.yjmcc.2005.05.014; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Morgan HE, 1997, MOL CELL BIOCHEM, V176, P145, DOI 10.1023/A:1006855818855; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Ping PP, 1999, AM J PHYSIOL-HEART C, V277, pH1771, DOI 10.1152/ajpheart.1999.277.5.H1771; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; WATSON PA, 1989, AM J PHYSIOL, V256, pC1257, DOI 10.1152/ajpcell.1989.256.6.C1257; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 2001, SCI STKE, pRE12; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	41	56	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33181	33191		10.1074/jbc.M705133200	http://dx.doi.org/10.1074/jbc.M705133200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855351	hybrid			2022-12-27	WOS:000250625400065
J	Shimamoto, S; Yoshida, T; Inui, T; Gohda, K; Kobayashi, Y; Fujimori, K; Tsurumura, T; Aritake, K; Urade, Y; Ohkubo, T				Shimamoto, Shigeru; Yoshida, Takuya; Inui, Takashi; Gohda, Keigo; Kobayashi, Yuji; Fujimori, Ko; Tsurumura, Toshiharu; Aritake, Kosuke; Urade, Yoshihiro; Ohkubo, Tadayasu			NMR solution structure of lipocalin-type prostaglandin D synthase - Evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TRACE; CEREBROSPINAL-FLUID; PROTEIN; IDENTIFICATION; PURIFICATION; SYSTEM; FIELD	Lipocalin-type prostaglandin (PG) D synthase (L-PGDS) catalyzes the isomerization of PGH(2), a common precursor of various prostanoids, to produce PGD(2), an endogenous somnogen and nociceptive modulator, in the brain. L-PGDS is a member of the lipocalin superfamily and binds lipophilic substances, such as retinoids and bile pigments, suggesting that L-PGDS is a dual functional protein acting as a PGD(2)-synthesizing enzyme and a transporter for lipophilic ligands. In this study we determined by NMR the three-dimensional structure of recombinant mouse L-PGDS with the catalytic residue Cys-65. The structure of L-PGDS exhibited the typical lipocalin fold, consisting of an eight-stranded, antiparallel beta-barrel and a long alpha-helix associated with the outer surface of the barrel. The interior of the barrel formed a hydrophobic cavity opening to the upper end of the barrel, the size of which was larger than those of other lipocalins, and the cavity contained two pockets. Molecular docking studies, based on the result of NMR titration experiments with retinoic acid and PGH2 analog, revealed that PGH(2) almost fully occupied the hydrophilic pocket 1, in which Cys-65 was located and all-trans-retinoic acid occupied the hydrophobic pocket 2, in which amino acid residues important for retinoid binding in other lipocalins were well conserved. Mutational and kinetic studies provide the direct evidence for the PGH(2) binding mode. These results indicated that the two binding sites for PGH2 and retinoic acid in the large cavity of L-PGDS were responsible for the broad ligand specificity of L-PGDS and the non-competitive inhibition of L-PGDS activity by retinoic acid.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; Osaka Biosci Inst, Dept Biol Behav Mol, Suita, Osaka 5650874, Japan; Comp Aided Mol Modeling Res Ctr, Higashinada Ku, Kobe, Hyogo 6580012, Japan; Osaka Univ Pharmaceut Sci, Osaka 580, Japan	Osaka University; Osaka Metropolitan University; Osaka University of Pharmaceutical Sciences	Ohkubo, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	ohkubo@phs.osaka-u.ac.jp	Fujimori, Ko/AAD-5428-2021; Inui, Takashi/G-1069-2011	Fujimori, Ko/0000-0002-2506-0769; Yoshida, Takuya/0000-0002-3491-9344; Gohda, Keigo/0000-0002-9345-2377				BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Bertinia I, 2003, J BIOMOL NMR, V26, P355, DOI 10.1023/A:1024092421649; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Breustedt DA, 2005, J BIOL CHEM, V280, P484, DOI 10.1074/jbc.M410466200; Briand L, 2004, PEPTIDES, V25, P1545, DOI 10.1016/j.peptides.2003.10.026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LX, 1995, J BIOL CHEM, V270, P4518, DOI 10.1074/jbc.270.9.4518; CLAUSEN J, 1961, P SOC EXP BIOL MED, V107, P170; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craik D J, 1997, Methods Mol Biol, V60, P195; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2006, GENE, V375, P14, DOI 10.1016/j.gene.2006.01.037; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Irikura D, 2007, J BIOCHEM, V141, P173, DOI 10.1093/jb/mvm016; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pattanayek R, 1999, PROTEIN SCI, V8, P2027, DOI 10.1110/ps.8.10.2027; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; So SP, 2000, J BIOL CHEM, V275, P40679, DOI 10.1074/jbc.M005752200; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Toh H, 1996, PROTEIN ENG, V9, P1067, DOI 10.1093/protein/9.12.1067; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Urade Y, 2006, LIPOCALINS, P99; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRCH K, 1986, NMR PROTEINS NUCL AC	40	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31373	31379		10.1074/jbc.M700123200	http://dx.doi.org/10.1074/jbc.M700123200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715133	hybrid			2022-12-27	WOS:000250309200027
J	Strahl, T; Huttner, IG; Lusin, JD; Osawa, M; King, D; Thorner, J; Ames, JB				Strahl, Thomas; Huttner, Inken G.; Lusin, Jacqueline D.; Osawa, Masanori; King, David; Thorner, Jeremy; Ames, James B.			Structural insights into activation of phosphatidylinositol 4-kinase (Pik1) by yeast frequenin (Frq1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; PROTEIN-KINASE-C; KV4 K+ CHANNELS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING PROTEINS; MYRISTOYLATED RECOVERIN; SECONDARY STRUCTURE; GUANYLYL CYCLASE	Yeast frequenin (Frq1), a small N-myristoylated EF-hand protein, activates phosphatidylinositol 4-kinase Pik1. The NMR structure of Ca2+-bound Frq1 complexed to an N-terminal Pik1 fragment (residues 121-174) was determined. The Frq1 main chain is similar to that in free Frq1 and related proteins in the same branch of the calmodulin superfamily. The myristoyl group and first eight residues of Frq1 are solvent-exposed, and Ca2+ binds the second, third, and fourth EF-hands, which associate to create a groove with two pockets. The Pik1 peptide forms two helices (125-135 and 156-169) connected by a 20-residue loop. Side chains in the Pik1 N-terminal helix (Val-127, Ala-128, Val-131, Leu-132, and Leu135) interact with solvent-exposed residues in the Frq1 C-terminal pocket (Leu-101, Trp-103, Val-125, Leu-138, Ile-152, and Leu-155); side chains in the Pik1 C-terminal helix (Ala-157, Ala-159, Leu-160, Val-161, Met-165, and Met-167) contact solvent-exposed residues in the Frq1 N-terminal pocket (Trp-30, Phe-34, Phe-48, Ile-51, Tyr-52, Phe-55, Phe-85, and Leu- 89). This defined complex confirms that residues in Pik1 pinpointed as necessary for Frq1 binding by site-directed mutagenesis are indeed sufficient for binding. Removal of the Pik1 N-terminal region (residues 8-760) from its catalytic domain (residues 792-1066) abolishes lipid kinase activity, inconsistent with Frq1 binding simply relieving an autoinhibitory constraint. Deletion of the lipid kinase unique motif (residues 35-110) also eliminates Pik1 activity. In the complex, binding of Ca2+- bound Frq1 forces the Pik1 chain into a U-turn. Frq1 may activate Pik1 by facilitating membrane targeting via the exposed N-myristoyl group and by imposing a structural transition that promotes association of the lipid kinase unique motif with the kinase domain.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Osawa, Masanori/GRS-5726-2022; Strahl, Thomas/E-4315-2010; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X; Martin, Inken/0000-0002-8790-092X; Osawa, Masanori/0000-0002-1285-4316	NCRR NIH HHS [RR11973] Funding Source: Medline; NEI NIH HHS [EY012347] Funding Source: Medline; NIGMS NIH HHS [GM21841] Funding Source: Medline; NINDS NIH HHS [NS045909] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841, R37GM021841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045909] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; HENDRICKS KB, 1999, FRQU GENE PRODUCT PO; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; MCINTOSH LP, 1990, Q REV BIOPHYS, V23, P1, DOI 10.1017/S0033583500005400; Meyers R E, 1998, Methods Mol Biol, V105, P99; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; O'Callaghan DW, 2004, J BIOL CHEM, V279, P14347, DOI 10.1074/jbc.M310152200; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Simonsen A, 2001, NAT CELL BIOL, V3, pE179, DOI 10.1038/35087112; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tachibanaki S, 2000, J BIOL CHEM, V275, P3313, DOI 10.1074/jbc.275.5.3313; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	76	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30949	30959		10.1074/jbc.M705499200	http://dx.doi.org/10.1074/jbc.M705499200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720810	hybrid			2022-12-27	WOS:000250136300063
J	O'Keefe, SJ; Mudgett, JS; Cupo, S; Parsons, JN; Chartrain, NA; Fitzgerald, C; Chen, SL; Lowitz, K; Rasa, C; Visco, D; Luell, S; Carballo-Jane, E; Owens, K; Zaller, DM				O'Keefe, Stephen J.; Mudgett, John S.; Cupo, Susan; Parsons, Janey N.; Chartrain, Nicole A.; Fitzgerald, Catherine; Chen, Shiow-Ling; Lowitz, Karen; Rasa, Cordelia; Visco, Denise; Luell, Silvi; Carballo-Jane, Ester; Owens, Karen; Zaller, Dennis M.			Chemical genetics define the roles of p38 alpha and p38 beta in acute and chronic inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; MONOCLONAL-ANTIBODIES; INHIBITORS; STRESS; SPECIFICITY; EXPRESSION; INDUCTION; REGULATOR; MOLECULES	The p38 MAP kinase signal transduction pathway is an important regulator of proinflammatory cytokine production and inflammation. Defining the roles of the various p38 family members, specifically p38 alpha and p38 beta, in these processes has been difficult. Here we use a chemical genetics approach using knock-in mice in which either p38 alpha or p38 beta kinase has been rendered resistant to the effects of specific inhibitors along with p38 beta knock-out mice to dissect the biological function of these specific kinase isoforms. Mice harboring a T106M mutation in p38 alpha are resistant to pharmacological inhibition of LPS-induced TNF production and collagen antibody-induced arthritis, indicating that p38 beta activity is not required for acute or chronic inflammatory responses. LPS-induced TNF production, however, is still completely sensitive to p38 inhibitors in mice with a T106M point mutation in p38 beta. Similarly, p38 beta knock-out mice respond normally to inflammatory stimuli. These results demonstrate conclusively that specific inhibition of the p38 alpha isoform is necessary and sufficient for anti-inflammatory efficacy in vivo.	Merck Res Labs, Ctr Genet Engn Models, Dept Immunol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Lab Anim Res, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	O'Keefe, SJ (corresponding author), Merck Res Labs, Ctr Genet Engn Models, Dept Immunol, Rahway, NJ 07065 USA.	stephen_okeefe@merck.com						Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bao JM, 2006, BIOORG MED CHEM LETT, V16, P64, DOI 10.1016/j.bmcl.2005.09.065; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Crews CM, 1999, TRENDS BIOCHEM SCI, V24, P317, DOI 10.1016/S0968-0004(99)01425-5; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Fijen JW, 2001, CLIN EXP IMMUNOL, V124, P16, DOI 10.1046/j.1365-2249.2001.01485.x; Fischer PM, 2004, CURR MED CHEM, V11, P1563, DOI 10.2174/0929867043365062; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hynes J, 2005, CURR TOP MED CHEM, V5, P967, DOI 10.2174/1568026054985920; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; KEREN A, 2006, IMMUNOLOGY, V252, P224; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lisnock JM, 1998, BIOCHEMISTRY-US, V37, P16573, DOI 10.1021/bi981591x; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Natarajan SR, 2006, BIOORG MED CHEM LETT, V16, P5468, DOI 10.1016/j.bmcl.2006.06.084; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanaka D, 2006, IMMUNOLOGY, V119, P195, DOI 10.1111/j.1365-2567.2006.02424.x; TERATO K, 1992, J IMMUNOL, V148, P2103; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0	48	64	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34663	34671		10.1074/jbc.M704236200	http://dx.doi.org/10.1074/jbc.M704236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855341	hybrid			2022-12-27	WOS:000251155200008
J	Zhang, J				Zhang, Jiandi			The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; INCREASED DOSAGE; CELL-SURVIVAL; LIFE-SPAN; IRS-2; TRANSCRIPTION; PROTEIN; ADIPOCYTES; REGULATOR; SECRETION	NAD(+)-dependent Sir2 family deacetylases and insulin signaling pathway are both conserved across species to regulate aging process. The interplay between these two genetic programs is investigated in this study. Protein deacetylase activity of SirT1, the mammalian homologue of Sir2, was suppressed through either nicotinamide treatment or RNA interference in several cell lines, and these cells displayed impaired insulin responses. Suppression of SirT1 activity also selectively inhibited insulin-induced tyrosine phosphorylation of insulin receptor substrate 2(IRS-2), whereas it had minimal effect on that of IRS-1. Further analyses showed that both IRS-1 and IRS-2 interacted with SirT1, and the acetylation level of IRS-2 was down-regulated by insulin treatment. Inhibition of SirT1 activity prevented deacetylation and insulin-induced tyrosine phosphorylation of IRS-2. Mutations of four lysine residues to alanine in IRS-2 protein, on the other hand, led to its reduced basal level acetylation and insulin-induced tyrosine phosphorylation. These results suggest a possible regulatory effect of SirT1 on insulin-induced tyrosine phosphorylation of IRS-2, a vital step in insulin signaling pathway, through deacetylation of IRS-2 protein. More importantly, this study may imply a pathway through which Sir2 family protein deacetylases and insulin signaling pathway jointly regulate various metabolic processes, including aging and diabetes.	Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, J (corresponding author), Rigel Pharmaceut Co, 1180 Vet Blvd, San Francisco, CA 94080 USA.	jiandi.zhang@gmail.com		zhang, jiandi/0000-0002-9282-9443				Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Kahn CR, 1996, ANNU REV MED, V47, P509; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Neganova I, 2007, BIOL REPROD, V76, P1045, DOI 10.1095/biolreprod.106.059360; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	40	134	146	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34356	34364		10.1074/jbc.M706644200	http://dx.doi.org/10.1074/jbc.M706644200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901049	hybrid			2022-12-27	WOS:000251145700051
J	Baek, JH; Liu, YV; McDonald, KR; Wesley, JB; Zhang, HF; Semenza, GL				Baek, Jin H.; Liu, Ye V.; McDonald, Karin R.; Wesley, Jacob B.; Zhang, Huafeng; Semenza, Gregg L.			Spermidine/spermine N-1-acetyltransferase-1 binds to hypoxia-inducible factor-1 alpha (HIF-1 alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-DEPENDENT DEGRADATION; FACTOR-I; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; FACTOR 1-ALPHA; CANCER CELLS; HIF-1; VHL; PROTEIN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Hypoxia-inducible factor-1 (HIF-1) is a master regulator of oxygen homeostasis that controls the expression of genes encoding proteins that play key roles in angiogenesis, erythropoiesis, and glucose/energy metabolism. The stability of the HIF-1 alpha subunit is regulated by ubiquitination and proteasomal degradation. In aerobic cells, O-2-dependent prolyl hydroxylation of HIF-1 alpha is required for binding of the von Hippel-Lindau tumor suppressor protein VHL, which then recruits the Elongin C ubiquitin-ligase complex. SSAT2 (spermidine/spermine N-acetyltransferase-2) binds to HIF-1 alpha and promotes its ubiquitination/degradation by stabilizing the interaction of VHL and Elongin C. Treatment of cells with heat shock protein HSP90 inhibitors induces the degradation of HIF-1 alpha even under hypoxic conditions. HSP90 competes with RACK1 for binding to HIF-1 alpha, and HSP90 inhibition leads to increased binding of RACK1, which recruits the Elongin C ubiquitin-ligase complex to HIF-1 alpha in an O-2-independent manner. In this work, we demonstrate that SSAT1, which shares 46% amino acid identity with SSAT2, also binds to HIF-1 alpha and promotes its ubiquitination/degradation. However, in contrast to SSAT2, SSAT1 acts by stabilizing the interaction of HIF-1 alpha with RACK1. Thus, the paralogs SSAT1 and SSAT2 play complementary roles in promoting O-2-independent and O-2-dependent degradation of HIF-1 alpha.	Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, 733 N Broadway,Suite 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012		DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28180, R01-HL-553308] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen WL, 2007, MOL CANCER THER, V6, P128, DOI 10.1158/1535-7163.MCT-06-0303; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Comerford KM, 2002, CANCER RES, V62, P3387; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Kong XG, 2006, FEBS LETT, V580, P6182, DOI 10.1016/j.febslet.2006.10.019; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McNeill LA, 2002, BIOORG MED CHEM LETT, V12, P1547, DOI 10.1016/S0960-894X(02)00219-6; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhong H, 1999, CANCER RES, V59, P5830	47	58	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33358	33366		10.1074/jbc.M705627200	http://dx.doi.org/10.1074/jbc.M705627200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875644	hybrid			2022-12-27	WOS:000250840200015
J	Kanai, T; Akerboom, J; Takedomi, S; van de Werken, HJG; Blombach, F; van der Oost, J; Murakami, T; Atomi, H; Imanaka, T				Kanai, Tamotsu; Akerboom, Jasper; Takedomi, Shogo; van de Werken, Harmen J. G.; Blombach, Fabian; van der Oost, John; Murakami, Taira; Atomi, Haruyuki; Imanaka, Tadayuki			A global transcriptional regulator in Thermococcus kodakaraensis controls the expression levels of both glycolytic and gluconeogenic enzyme-encoding genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; EMBDEN-MEYERHOF PATHWAY; ADP-DEPENDENT PHOSPHOFRUCTOKINASE; CENTRAL CARBOHYDRATE-METABOLISM; HYPERTHERMOPHILIC ARCHAEON; THERMOPROTEUS-TENAX; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ABC TRANSPORTER; BINDING PROTEIN	We identified a novel regulator, Thermococcales glycolytic regulator (Tgr), functioning as both an activator and a repressor of transcription in the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1. Tgr (TK1769) displays similarity (28% identical) to Pyrococcus furiosus TrmB (PF1743), a transcriptional repressor regulating the trehalose/maltose ATP-binding cassette transporter genes, but is more closely related (67%) to a TrmB paralog in P. furiosus (PF0124). Growth of a tgr disruption strain (Delta tgr) displayed a significant decrease in growth rate under gluconeogenic conditions compared with the wild-type strain, whereas comparable growth rates were observed under glycolytic conditions. A whole genome microarray analysis revealed that transcript levels of almost all genes related to glycolysis and maltodextrin metabolism were at relatively high levels in the Delta tgr mutant even under gluconeogenic conditions. The Delta tgr mutant also displayed defects in the transcriptional activation of gluconeogenic genes under these conditions, indicating that Tgr functions as both an activator and a repressor. Genes regulated by Tgr contain a previously identified sequence motif, the Thermococcales glycolytic motif (TGM). The TGM was positioned upstream of the Transcription factor B-responsive element (BRE)/TATA sequence in gluconeogenic promoters and downstream of it in glycolytic promoters. Electrophoretic mobility shift assay indicated that recombinant Tgr protein specifically binds to promoter regions containing a TGM. Tgr was released from the DNA when maltotriose was added, suggesting that this sugar is most likely the physiological effector. Our results strongly suggest that Tgr is a global transcriptional regulator that simultaneously controls, in response to sugar availability, both glycolytic and gluconeogenic metabolism in T. kodakaraensis via its direct binding to the TGM.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands	Kyoto University; Wageningen University & Research	Imanaka, T (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp	van+der+Oost, John/Y-2548-2019; Werken, Harmen van de/G-8979-2013; Kanai, Tamotsu/I-5842-2012; Blombach, Fabian/AAT-9241-2020	Werken, Harmen van de/0000-0002-9794-1477; Kanai, Tamotsu/0000-0003-3537-2114; Blombach, Fabian/0000-0001-5337-8662; Atomi, Haruyuki/0000-0001-9687-6426				Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Baliga NS, 1999, J BACTERIOL, V181, P2513, DOI 10.1128/JB.181.8.2513-2518.1999; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Brunner NA, 1998, J BIOL CHEM, V273, P6149, DOI 10.1074/jbc.273.11.6149; Brunner NA, 2001, EXTREMOPHILES, V5, P101, DOI 10.1007/s007920100181; DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1987, ESCHERICHIA COLI SAL, V1, P142; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Goncalves P, 1998, TRENDS MICROBIOL, V6, P314, DOI 10.1016/S0966-842X(98)01305-5; Imanaka H, 2006, MOL MICROBIOL, V61, P898, DOI 10.1111/j.1365-2958.2006.05287.x; Itoh T, 2003, J BIOSCI BIOENG, V96, P203, DOI 10.1263/jbb.96.203; Kanai T, 2005, J BIOTECHNOL, V116, P271, DOI 10.1016/j.jbiotec.2004.11.002; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kletzin A, 1996, FEMS MICROBIOL REV, V18, P5, DOI 10.1016/0168-6445(95)00025-9; Koning Sonja M., 2002, Archaea, V1, P19, DOI 10.1155/2002/529610; Krug M, 2006, J BIOL CHEM, V281, P10976, DOI 10.1074/jbc.M512809200; Lee HS, 2006, J BACTERIOL, V188, P2115, DOI 10.1128/JB.188.6.2115-2125.2006; Lee SJ, 2005, MOL MICROBIOL, V57, P1797, DOI 10.1111/j.1365-2958.2005.04804.x; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; Lee SJ, 2007, MOL MICROBIOL, V65, P305, DOI 10.1111/j.1365-2958.2007.05780.x; Lee SJ, 2007, MOL MICROBIOL, V64, P1499, DOI 10.1111/j.1365-2958.2007.05737.x; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; MUKUND S, 1995, J BIOL CHEM, V270, P8389, DOI 10.1074/jbc.270.15.8389; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Ouhammouch M, 2005, MOL MICROBIOL, V56, P625, DOI 10.1111/j.1365-2958.2005.04563.x; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; Ouhammouch M, 2003, P NATL ACAD SCI USA, V100, P5097, DOI 10.1073/pnas.0837150100; Rashid N, 2004, J BACTERIOL, V186, P6070, DOI 10.1128/jb.186.18.6070-6076.2004; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Robb Frank T., 1995, P167; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Ronimus RS, 1999, EXTREMOPHILES, V3, P121, DOI 10.1007/s007920050107; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; SCHAFER T, 1993, ARCH MICROBIOL, V159, P354, DOI 10.1007/BF00290918; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; Tjaden B, 2006, MOL MICROBIOL, V60, P287, DOI 10.1111/j.1365-2958.2006.05098.x; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; van de Werken HJG, 2006, FEMS MICROBIOL LETT, V260, P69, DOI 10.1111/j.1574-6968.2006.00292.x; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Verhees CH, 2001, J BIOL CHEM, V276, P40926, DOI 10.1074/jbc.M104603200; WAYGOOD EB, 1976, BIOCHEMISTRY-US, V15, P277, DOI 10.1021/bi00647a006	56	67	68	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33659	10.1074/jbc.M703424200	http://dx.doi.org/10.1074/jbc.M703424200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875647	hybrid			2022-12-27	WOS:000250840200047
J	Thomas, C; Moreau, F; Dieterle, M; Hoffmann, C; Gatti, S; Hofmann, C; Van Troys, M; Ampe, C; Steinmetz, A				Thomas, Clement; Moreau, Flora; Dieterle, Monika; Hoffmann, Celine; Gatti, Sabrina; Hofmann, Christina; Van Troys, Marleen; Ampe, Christophe; Steinmetz, Andre			The LIM domains of WLIM1 define a new class of actin bundling modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH-PROTEIN; POLLEN-TUBE GROWTH; ROOT HAIR-CELLS; MUSCLE DIFFERENTIATION; BINDING PROTEINS; CROSS-LINKING; GENE-EXPRESSION; ALPHA-ACTININ; PLANT VILLIN; ORGANIZATION	Actin filament bundling, i.e. the formation of actin cables, is an important process that relies on proteins able to directly bind and cross-link subunits of adjacent actin filaments. Animal cysteine-rich proteins and their plant counterparts are two LIM domain-containing proteins that were recently suggested to define a new family of actin cytoskeleton regulators involved in actin filament bundling. We here identified the LIM domains as responsible for F-actin binding and bundling activities of the tobacco WLIM1. The deletion of one of the two LIM domains reduced significantly, but did not entirely abolish, the ability of WLIM1 to bind actin filaments. Individual LIM domains were found to interact directly with actin filaments, although with a reduced affinity compared with the native protein. Variants lacking the C-terminal or the inter-LIM domain were only weakly affected in their F-actin stabilizing and bundling activities and trigger the formation of thick cables containing tightly packed actin filaments as does the native protein. In contrast, the deletion of one of the two LIM domains negatively impacted both activities and resulted in the formation of thinner and wavier cables. In conclusion, we demonstrate that the LIM domains of WLIM1 are new autonomous actin binding and bundling modules that cooperate to confer WLIM1 high actin binding and bundling activities.	Ctr Rech Publ Sante, L-1526 Luxembourg, Luxembourg; CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Gent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; Fac Med & Hlth Sci, Dept Biochem, B-9052 Ghent, Belgium	Luxembourg Institute of Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Thomas, C (corresponding author), Ctr Rech Publ Sante, L-1526 Luxembourg, Luxembourg.	clement.thomas@crp-sante.lu	Thomas, Clément/AAK-4501-2020; Ampe, Christophe/B-5534-2012	Thomas, Clement/0000-0001-6720-5615; Van Troys, Marleen/0000-0003-4283-8103; Dieterle, Monika/0000-0002-9918-6022				Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Baluska F, 2001, DEV BIOL, V236, P478, DOI 10.1006/dbio.2001.0333; BANJOKO A, 1995, PLANT PHYSIOL, V107, P1201, DOI 10.1104/pp.107.4.1201; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen CY, 2002, PLANT CELL, V14, P2175, DOI 10.1105/tpc.003038; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; El-Assall SE, 2004, PLANT J, V38, P526, DOI 10.1111/j.1365-313X.2004.02065.x; Eliasson A, 2000, MOL GEN GENET, V264, P257, DOI 10.1007/s004380000312; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; HUNOLD R, 1995, PLANT SCI, V105, P95, DOI 10.1016/0168-9452(94)04038-I; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawaoka A, 2000, PLANT J, V22, P289, DOI 10.1046/j.1365-313x.2000.00737.x; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Konrat R, 1998, J BIOL CHEM, V273, P23233, DOI 10.1074/jbc.273.36.23233; Kovar DR, 2001, PLANTA, V213, P390, DOI 10.1007/s004250000494; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Le J, 2003, CURR BIOL, V13, P1341, DOI 10.1016/S0960-9822(03)00493-7; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; STAIGER CJ, 1994, CURR BIOL, V4, P215, DOI 10.1016/S0960-9822(00)00050-6; Sweetman J, 2000, SEX PLANT REPROD, V12, P339, DOI 10.1007/PL00009836; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2007, PLANT SIGNAL BEHAV, V2, P99, DOI 10.4161/psb.2.2.3614; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tran TC, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-45; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Van Troys M, 1999, BBA-MOL CELL RES, V1448, P323, DOI 10.1016/S0167-4889(98)00152-9; Vidali L, 2001, PROTOPLASMA, V215, P64, DOI 10.1007/BF01280304; Vidali L, 1999, PROTOPLASMA, V209, P283, DOI 10.1007/BF01453456; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Yao X, 1999, BIOCHEMISTRY-US, V38, P5701, DOI 10.1021/bi982036y; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132	48	35	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33599	10.1074/jbc.M703691200	http://dx.doi.org/10.1074/jbc.M703691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827159	hybrid			2022-12-27	WOS:000250840200041
J	Hofer, A; Bussiere, C; Johnson, AW				Hofer, Anne; Bussiere, Cyril; Johnson, Arlen W.			Mutational analysis of the ribosomal protein Rpl10 from yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NUCLEAR EXPORT; ANGSTROM RESOLUTION; INITIATION COMPLEX; SUBUNIT; NMD3P; ADAPTER; EVOLUTION; CYTOPLASM	Yeast Rpl10 belongs to the L10e family of ribosomal proteins. In the large ( 60 S) subunit, Rpl10 is positioned in a cleft between the central protuberance and the GTPase- activating center. It is loaded into the 60 S subunit at a late step in maturation. We have shown previously that Rpl10 is required for the release of the Crm1- dependent nuclear export adapter Nmd3, an event that also requires the cytoplasmic GTPase Lsg1. Here we have carried out an extensive mutational analysis of Rpl10 to identify mutations that would allow us to map activities to distinct domains of the protein to begin to understand the molecular interaction between Rpl10 and Nmd3. We found that mutations in a central loop ( amino acids 102 - 112) had a significant impact on the release of Nmd3. This loop is unstructured in the crystal and solution structures of prokaryotic Rpl10 orthologs. Thus, the loop is not necessary for stable interaction of Rpl10 with the ribosome, suggesting that it plays a dynamic role in ribosome function or regulating the association of other factors. We also found that mutant Rpl10 proteins were engineered to be unable to bind to the ribosome accumulated in the nucleus. This was unexpected and may suggest a nuclear role for Rpl10.	Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Johnson, AW (corresponding author), Univ Texas, Sect Mol Genet & Microbiol, 1 Univ Stn,A5000, Austin, TX 78712 USA.	arlen@mail.utexas.edu		Johnson, Arlen/0000-0002-4742-085X	NIGMS NIH HHS [R01 GM 53655] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Kaiser C., 1994, METHODS YEAST GENETI; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Karl T, 1999, CURR GENET, V34, P419, DOI 10.1007/s002940050416; KAZEMIE M, 1975, EUR J BIOCHEM, V58, P501, DOI 10.1111/j.1432-1033.1975.tb02398.x; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MOORE VG, 1975, P NATL ACAD SCI USA, V72, P844, DOI 10.1073/pnas.72.3.844; Nishimura M, 2004, J MOL BIOL, V344, P1369, DOI 10.1016/j.jmb.2004.10.011; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; TERAOKA H, 1978, FEBS LETT, V88, P223, DOI 10.1016/0014-5793(78)80179-3; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZINKER S, 1976, J BIOL CHEM, V251, P1799	27	30	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32630	32639		10.1074/jbc.M705057200	http://dx.doi.org/10.1074/jbc.M705057200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17761675	hybrid			2022-12-27	WOS:000250625400012
J	Meissner, B; Schleicher, E; Weber, S; Essen, LO				Meissner, Britta; Schleicher, Erik; Weber, Stefan; Essen, Lars-Oliver			The dodecin from Thermus thermophilus, a bifunctional cofactor storage protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; CRYSTAL-STRUCTURE; LIGHT; PHOTOLYASE; ENDOR; FAD	Dodecins are so far the smallest known flavoproteins ( 68 - 71 amino acids) and are most likely involved in prokaryotic flavin storage. The dodecin monomers adopt a simple beta alpha beta beta-fold and assemble to hollow sphere-like dodecameric complexes. Flavin binding by the dodecin from Thermus thermophilus showed a 1: 1 stoichiometry and apparent dissociation constants in the submicromolar to nanomolar range as characterized by isothermal titration calorimetry and fluorescence titrations. The x-ray structures of the flavin-prebound and FMN-reconstituted state of the T. thermophilus dodecin revealed binding of FMN dimers in a novel si-si-rather than the re-re-orientation of their isoalloxazine moieties as found before in an archaeal dodecin. Electron paramagnetic resonance studies demonstrated that upon reduction the excess electron is localized only on one flavin, thus making dodecin-bound flavins highly refractory to redox chemistry. Besides FMN dimers, trimers of coenzyme A are additionally bound to this eubacterial dodecin along the 3-fold symmetry face II of the dodecin complex. Therefore, dodecins can act as bifunctional cofactor storage proteins that sequester catalytic cofactors in prokaryotes very efficiently in an aggregated and unreactive state.	Univ Marburg, Dept Chem, D-35032 Marburg, Germany; Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	Philipps University Marburg; Free University of Berlin	Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Schleicher, Erik/C-9951-2010; Essen, Lars-Oliver/L-3862-2016; Weber, Stefan/G-6164-2010	Essen, Lars-Oliver/0000-0003-4272-4026; Schleicher, Erik/0000-0003-2953-050X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Cuello AO, 2000, J AM CHEM SOC, V122, P3517, DOI 10.1021/ja994204v; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; DeLano W, 2002, PYMOL 0 99; EDMONDSON DE, 1983, TOP CURR CHEM, V108, P109; EDMONDSON DE, 1985, BIOCHEM SOC T, V13, P593, DOI 10.1042/bst0130593; Edwards AM, 2001, J PHOTOCH PHOTOBIO B, V63, P126, DOI 10.1016/S1011-1344(01)00209-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; KAUFMANN U, 1975, J PHYS C SOLID STATE, V8, P381; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P389; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Medina M, 1999, BIOPHYS J, V77, P1712, DOI 10.1016/S0006-3495(99)77017-7; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS JR, 1971, P NATL ACAD SCI USA, V68, P625, DOI 10.1073/pnas.68.3.625; Schnegg A, 2006, APPL MAGN RESON, V30, P345, DOI 10.1007/BF03166205; Schnegg A, 2006, MOL PHYS, V104, P1627, DOI 10.1080/00268970600593108; Srivatsan N, 2003, J PHYS CHEM B, V107, P2127, DOI 10.1021/jp0255233; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433	35	23	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33142	33154		10.1074/jbc.M704951200	http://dx.doi.org/10.1074/jbc.M704951200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855371	hybrid			2022-12-27	WOS:000250625400062
J	Shi, B; Sepp-Lorenzino, L; Prisco, M; Linsley, P; DeAngelis, T; Baserga, R				Shi, Bin; Sepp-Lorenzino, Laura; Prisco, Marco; Linsley, Peter; DeAngelis, Tiziana; Baserga, Renato			Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MICRO-RNA; FACTOR-I; INSULIN-RECEPTOR-SUBSTRATE-1 IRS-1; DIFFERENTIATION; TRANSFORMATION; SIZE; PRINCIPLES	The insulin receptor substrate- 1 ( IRS- 1), a docking protein for both the type 1 insulin- like growth factor receptor ( IGF- IR) and the insulin receptor, is known to send a mitogenic, anti- apoptotic, and anti- differentiation signal. Several micro RNAs ( miRs) are suggested by the data base as possible candidates for targeting IRS- 1. We show here that one of the miRs predicted by the data base, miR145, whether transfected as a synthetic oligonucleotide or expressed from a plasmid, causes down- regulation of IRS- 1 in human colon cancer cells. IRS- 1 mRNA is not decreased by miR145, while it is down- regulated by an siRNA targeting IRS- 1. Targeting of the IRS- 1 3'-untranslated region (UTR) by miR145 was confirmed using a reporter gene ( luciferase) expressing the miR145 binding sites of the IRS- 1 3'-UTR. In agreement with the role of IRS- 1 in cell proliferation, we show that treatment of human colon cancer cells with miR145 causes growth arrest comparable to the use of an siRNA against IRS- 1. Taken together, these results identify miR145 as a micro RNA that down- regulates the IRS- 1 protein, and inhibits the growth of human cancer cells.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; Merck & Co Inc, West Point, PA 19486 USA	Jefferson University; Merck & Company	Shi, B (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA.	b_lupo@mail.jci.tju.edu			NCI NIH HHS [CA 089640, CA 78890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089640, P01CA078890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akao Y, 2006, ONCOL REP, V16, P845; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Baserga Renato, 2004, VVolume 42, P235; Belletti B, 2001, J BIOL CHEM, V276, P13867, DOI 10.1074/jbc.M010509200; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cesarone G, 2006, J CELL BIOCHEM, V98, P440, DOI 10.1002/jcb.20817; Chang Q, 2002, CANCER RES, V62, P6035; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cristofanelli B, 2000, ONCOGENE, V19, P3245, DOI 10.1038/sj.onc.1203664; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Michael MZ, 2003, MOL CANCER RES, V1, P882; Pete G, 1999, ENDOCRINOLOGY, V140, P5478, DOI 10.1210/en.140.12.5478; Prisco M, 2001, MOL CELL BIOL, V21, P5447, DOI 10.1128/MCB.21.16.5447-5458.2001; Reiss K, 1998, EXP CELL RES, V242, P361, DOI 10.1006/excr.1998.4113; Shi B, 2006, J CELL PHYSIOL, V207, P706, DOI 10.1002/jcp.20613; Sun HZ, 2006, CANCER RES, V66, P11106, DOI 10.1158/0008-5472.CAN-06-2641; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908	47	290	319	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32582	32590		10.1074/jbc.M702806200	http://dx.doi.org/10.1074/jbc.M702806200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827156	Green Submitted, hybrid			2022-12-27	WOS:000250625400007
J	Henry, BL; Monien, BH; Bock, PE; Desai, UR				Henry, Brian L.; Monien, Bernhard H.; Bock, Paul E.; Desai, Umesh R.			A novel allosteric pathway of thrombin inhibition - Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING EXOSITE; HEPARIN; ANTITHROMBIN; PROTEINASES; SUBSTRATE; RESIDUES; SITE	Thrombin and factor Xa, two important pro-coagulant proteinases, can be regulated through direct and indirect inhibition mechanisms. Recently, we designed sulfated dehydropolymers (DHPs) of 4-hydroxycinnamic acids that displayed interesting anticoagulant properties (Monien, B. H., Henry, B. L., Raghuraman, A., Hindle, M., and Desai, U. R. (2006) Bioorg. Med. Chem. 14, 7988 -7998). To better understand their mechanism of action, we studied the direct inhibition of thrombin, factor Xa, factor IXa, and factor VIIa by CDSO3, FDSO3, and SDSO3, three analogs of sulfated DHPs. All three sulfated DHPs displayed a 2 -3-fold preference for direct inhibition of thrombin over factor Xa, whereas this preference for inhibiting thrombin over factor IXa and factor VIIa increased to 17-300-fold, suggesting a high level of selectivity. Competitive binding studies with a thrombin-specific chromogenic substrate, a fluorescein-labeled hirudin peptide, bovine heparin, enoxaparin, and a heparin octasaccharide suggest that CDSO3 preferentially binds in or near anion-binding exosite II of thrombin. Studies of the hydrolysis of H-D-hexahydrotyrosol-Ala-Arg-p-nitroanilide indicate that CDSO3 inhibits thrombin through allosteric disruption of the catalytic apparatus, specifically through the catalytic step. Overall, designed sulfated DHPs appear to be the first molecules that bind primarily in the region defined by exosite II and allosterically induce thrombin inhibition. The molecules are radically different in structure from all the current clinically used anticoagulants and thus represent a novel class of potent dual thrombin and factor Xa inhibitors.	Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Virginia Commonwealth University; Virginia Commonwealth University; Vanderbilt University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, 410 N 12th St,POB 980540, Richmond, VA 23298 USA.	urdesai@vcu.edu	Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779, R41HL081972, R01HL069975] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL038779, R01 HL038779, R01 HL038779-20, R01 HL069975, R41 HL081972] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bauersachs RM, 2005, EUR J CLIN INVEST, V35, P27, DOI 10.1111/j.0960-135X.2005.01454.x; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; BERLINER LJ, 1977, BIOCHEMISTRY-US, V16, P4622, DOI 10.1021/bi00640a015; Bianchini EP, 2004, J BIOL CHEM, V279, P3671, DOI 10.1074/jbc.M309691200; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Desai UR, 2004, MED RES REV, V24, P151, DOI 10.1002/med.10058; Desai UR, 2005, CHEM BIOL HEPARIN HE, P483; Gerotziafas GT, 2005, CURR PHARM DESIGN, V11, P3855, DOI 10.2174/138161205774580552; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY NS, 2003, THROMBOSIS HEMORRHAG, P1; Kikelj D, 2003, PATHOPHYSIOL HAEMO T, V33, P487, DOI 10.1159/000083850; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LINHARDT RJ, 1990, J MED CHEM, V33, P1639, DOI 10.1021/jm00168a017; LIU LW, 1991, J BIOL CHEM, V266, P16977; MENAJOVSKY JB, 2005, AM J MED S8A, V118, P21; Monien BH, 2006, BIOORGAN MED CHEM, V14, P7988, DOI 10.1016/j.bmc.2006.07.066; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; Nutescu EA, 2006, CLIN GERIATR MED, V22, P33, DOI 10.1016/j.cger.2005.09.009; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Richardson JL, 2002, BIOCHEMISTRY-US, V41, P2535, DOI 10.1021/bi011605q; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SONDER SA, 1986, CLIN CHEM, V32, P934; Turpie Alexander G G, 2005, Expert Opin Drug Saf, V4, P707, DOI 10.1517/14740338.4.4.707; van Dongen CJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001100.PUB2; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; YE J, 1992, J BIOL CHEM, V267, P11023	40	68	69	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31891	31899		10.1074/jbc.M704257200	http://dx.doi.org/10.1074/jbc.M704257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804413	Green Accepted, hybrid			2022-12-27	WOS:000250480300009
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Suppressor mutations in the transmembrane segments of P-glycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDUCTANCE REGULATOR; PHARMACOLOGICAL CHAPERONES; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; CELL-SURFACE; ATP-BINDING; RESISTANCE; PROTEIN; DOMAIN; POCKET	Defective folding of cystic fibrosis transmembrane conductance regulator protein missing Phe(508) (Delta F508) is the major cause of cystic fibrosis. The folding defect in Delta F508 cystic fibrosis transmembrane conductance regulator might be correctable because misfolding of a P-glycoprotein (P-gp; ABCB1) mutant lacking the equivalent residue (Delta Y490) could be corrected with drug substrates or by introduction of an arginine residue into transmembrane (TM) segments 5 (I306R) or 6 (F343R). Possible mechanisms of arginine rescue were that they mimicked some of the effects of drug substrate interactions with P-gp or that they affected global folding such that all drug substrate/ modulator interactions with P-gp were altered. To distinguish between these mechanisms, we tested whether arginines introduced into other TMs predicted to line the drug-binding pocket (TM1 or TM3) would affect folding. It was found that mutation of L65R(TM1) or T199R(TM3) promoted maturation of processing mutants. Wethen tested whether arginine suppressor mutations had local or global effects on P-gp interactions with drug substrates and modulators. The L65R(TM1), T199R(TM3), I306R(TM5), or F343R(TM6) mutations were introduced into the P-gp mutant L339C(TM6)/F728C(TM7), and thiol crosslinking was carried out in the presence of various concentrations of vinblastine, cyclosporin A, or rhodamine B. The presence of arginine residues reduced the apparent affinity of P-gp for vinblastine (L65R, T199R, and I306R), cyclosporin (I306R and F343R), or rhodamine B (F343R) by 4 -60-fold. These results show that the arginine mutations affect a subset of drug-binding sites and suggest that they rescue processing mutants by mimicking drug substrate interactions with P-gp.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, Rm 7342,Med Sci Bld,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; HOOF T, 1994, J BIOL CHEM, V269, P20575; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Pleban K, 2005, MOL PHARMACOL, V67, P365, DOI 10.1124/mol.104.006973; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Song JM, 2001, MOL PHARMACOL, V60, P254, DOI 10.1124/mol.60.2.254; Taguchi Y, 1997, FEBS LETT, V413, P142, DOI 10.1016/S0014-5793(97)00899-5; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; WARD CL, 1994, J BIOL CHEM, V269, P25710; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	45	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32043	32052		10.1074/jbc.M706175200	http://dx.doi.org/10.1074/jbc.M706175200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848563	hybrid			2022-12-27	WOS:000250480300025
J	Akerstrom, B; Maghzal, GJ; Winterbourn, CC; Kettle, AJ				Akerstrom, Bo; Maghzal, Ghassan J.; Winterbourn, Christine C.; Kettle, Anthony J.			The lipocalin alpha(1)-microglobulin has radical scavenging activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; LIPID-PEROXIDATION; PROTEIN FAMILY; ALPHA-1-MICROGLOBULIN; CHROMOPHORE; HEMOGLOBIN; ACID); HEME; HC; REDUCTION	The lipocalin alpha(1)-microglobulin (alpha(1)m) is a 26-kDa glycoprotein present in plasma and in interstitial fluids of all tissues. The protein was recently shown to have reductase properties, reducing heme-proteins and other substrates, and was also reported to be involved in binding and scavenging of heme and tryptophan metabolites. To investigate its possible role as a reductant of organic radicals, we have studied the interaction of alpha(1)m with the synthetic radical, 2,2(')-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS radical). The lipocalin readily reacted with the ABTS radical forming reduced ABTS. The apparent rate constant for this reaction was 6.3 +/- 2.5 x 10(3) m(-1) s(-1). A second reaction product with an intense purple color and an absorbance maximum at 550 nm was formed at a similar rate. This was shown by liquid chromatography/mass spectrometry to be derived from covalent attachment of a portion of ABTS radical to tyrosine residues on alpha(1)m. The relative yields of reduced ABTS and the purple ABTS derivative bound to alpha(1)m were similar to 2:1. Both reactions were dependent on the thiolate group of the cysteine residue in position 34 of the alpha(1)m polypeptide. Our results indicate that alpha(1)m is involved in a sequential reduction of ABTS radicals followed by trapping of these radicals by covalent attachment. In combination with the reported physiological properties of the protein, our results suggest that alpha(1)m may be a radical reductant and scavenger in vivo.	Lund Univ, Dept Clin Sci, Lund 22184, Sweden; Univ Sydney, Ctr Vasc Res, Fac Med, Dept Pathol, Sydney, NSW 2006, Australia; Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, Christchurch 8140, New Zealand	Lund University; University of Sydney; University of Otago	Akerstrom, B (corresponding author), Lund Univ, Dept Clin Sci, Lund 22184, Sweden.	bo.akerstrom@med.lu.se	maghzal, ghassan/A-9692-2015; Kettle, Anthony J/A-8520-2008	Kettle, Anthony J/0000-0002-8218-7766				Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; AKERSTROM B, 1995, FEBS LETT, V362, P50, DOI 10.1016/0014-5793(95)00206-O; AKERSTROM B, 1990, TRENDS BIOCHEM SCI, V15, P240, DOI 10.1016/0968-0004(90)90037-C; Akerstrom Bo, 2006, P1; Aliaga C, 2000, CAN J CHEM, V78, P1052, DOI 10.1139/cjc-78-8-1052; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2003, J INVEST DERMATOL, V121, P640, DOI 10.1046/j.1523-1747.2003.12409.x; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; ARNAO MB, 1990, ANAL BIOCHEM, V185, P335, DOI 10.1016/0003-2697(90)90304-R; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Berggard T, 1998, J HISTOCHEM CYTOCHEM, V46, P887, DOI 10.1177/002215549804600803; Berggard T, 1999, AM J REPROD IMMUNOL, V41, P52; Berggard T, 1999, PROTEIN SCI, V8, P2611; BERGGARD T, 1987, EUR J BIOCHEM, V245, P676; BOUIC P, 1984, HISTOCHEM J, V16, P1311, DOI 10.1007/BF01003728; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; DAVIES MJ, 1997, RADICAL MEDIATED PRO, P95; DEMARS DD, 1989, CLIN CHEM, V35, P766; EKSTROM B, 1975, BIOCHEM BIOPH RES CO, V65, P1427, DOI 10.1016/S0006-291X(75)80388-3; EKSTROM B, 1977, J BIOL CHEM, V252, P8048; ESCRIBANO J, 1991, J BIOL CHEM, V266, P15758; Flower DR, 1996, BIOCHEM J, V318, P1; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; ISHII T, 1992, ARCH BIOCHEM BIOPHYS, V294, P616, DOI 10.1016/0003-9861(92)90733-D; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson J, 2004, ARCH BIOCHEM BIOPHYS, V432, P196, DOI 10.1016/j.abb.2004.09.021; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; LOGDBERG L, 1981, SCAND J IMMUNOL, V13, P383, DOI 10.1111/j.1365-3083.1981.tb00148.x; Logdberg LE, 2000, J HISTOCHEM CYTOCHEM, V48, P1545, DOI 10.1177/002215540004801111; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472; Miller NJ, 1997, FREE RADICAL RES, V26, P195, DOI 10.3109/10715769709097799; ODUM L, 1994, HISTOCHEM J, V26, P799; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Pattison DI, 2002, TOXICOLOGY, V177, P23, DOI 10.1016/S0300-483X(02)00193-2; Pawlak D., 2001, International Urology and Nephrology, V33, P399, DOI 10.1023/A:1015238418500; PE R, 1999, FREE RADIC BIOL MED, V26, P1231; PERVAIZ S, 1985, SCIENCE, V228, P335, DOI 10.1126/science.2580349; Prutz W A, 1986, Free Radic Res Commun, V2, P69, DOI 10.3109/10715768609088056; Sala A, 2004, J BIOL CHEM, V279, P51033, DOI 10.1074/jbc.M408242200; Sanchez D, 2002, MECH DEVELOP, V117, P293, DOI 10.1016/S0925-4773(02)00202-2; Santin M, 1999, SCAND J IMMUNOL, V50, P289; SHIN T, 1987, ANAL BIOCHEM, V166, P380, DOI 10.1016/0003-2697(87)90588-4; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; TEJLER L, 1976, BIOCHIM BIOPHYS ACTA, V439, P82, DOI 10.1016/0005-2795(76)90164-1; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vazquez S, 2000, FREE RADICAL RES, V32, P11, DOI 10.1080/10715760000300021; Villoutreix BO, 2000, BLOOD COAGUL FIBRIN, V11, P261; Wester L, 1998, SCAND J IMMUNOL, V48, P1; Wester L, 1997, PROTEIN EXPRES PURIF, V11, P95, DOI 10.1006/prep.1997.0760	55	86	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31493	31503		10.1074/jbc.M702624200	http://dx.doi.org/10.1074/jbc.M702624200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766242	hybrid			2022-12-27	WOS:000250309200041
J	Fort, J; de la Ballina, LR; Burghardt, HE; Ferrer-Costa, C; Turnay, J; Ferrer-Orta, C; Uson, I; Zorzano, A; Fernandez-Recio, J; Orozco, M; Lizarbe, MA; Fita, I; Palacin, M				Fort, Joana; de la Ballina, Laura R.; Burghardt, Hans E.; Ferrer-Costa, Carles; Turnay, Javier; Ferrer-Orta, Cristina; Uson, Isabel; Zorzano, Antonio; Fernandez-Recio, Juan; Orozco, Modesto; Lizarbe, Maria Antonia; Fita, Ignacio; Palacin, Manuel			The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ALPHA-AMYLASE; PROTEIN; CD98; ASSOCIATION; IDENTIFICATION; EXPRESSION; COMPLEX	4F2hc ( CD98hc) is a multifunctional type II membrane glycoprotein involved in amino acid transport and cell fusion, adhesion, and transformation. The structure of the ectodomain of human 4F2hc has been solved using monoclinic ( Protein Data Bank code 2DH2) and orthorhombic ( Protein Data Bank code 2DH3) crystal forms at 2.1 and 2.8 angstrom, respectively. It is composed of a (beta alpha)(8) barrel and an antiparallel beta(8) sandwich related to bacterial alpha- glycosidases, although lacking key catalytic residues and consequently catalytic activity. 2DH3 is a dimer with Zn2+ coordination at the interface. Human 4F2hc expressed in several cell types resulted in cell surface and Cys(109) disulfide bridge- linked homodimers with major architectural features of the crystal dimer, as demonstrated by cross- linking experiments. 4F2hc has no significant hydrophobic patches at the surface. Monomer and homodimer have a polarized charged surface. The N terminus of the solved structure, including the position of Cys(109) residue located four residues apart from the transmembrane domain, is adjacent to the positive face of the ectodomain. This location of the N terminus and the Cys(109)-intervening disulfide bridge imposes space restrictions sufficient to support a model for electrostatic interaction of the 4F2hc ectodomain with membrane phospholipids. These results provide the first crystal structure of heteromeric amino acid transporters and suggest a dynamic interaction of the 4F2hc ectodomain with the plasma membrane.	Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras, Inst Res Biomed, Fac Biol,Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain; Inst Mol Biol, ICREA, E-08028 Barcelona, Spain; Supercomp Ctr, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Palacin, M (corresponding author), Univ Barcelona, Ctr Invest Biomed Red Enfermedades Raras, Inst Res Biomed, Fac Biol,Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.	mpalacin@pcb.ub.es; ifrcri@ibmb.csic.es; mpalacin@pcb.ub.es	Fita, Ignasi/R-4515-2019; Fort, Joana/H-7018-2015; Calderon, Caterina/I-8471-2018; Lizarbe, M Antonia/K-5219-2014; Zorzano, Antonio/R-5479-2018; Turnay, Javier/AAB-1497-2022; Turnay, Javier/K-4551-2014	Fita, Ignasi/0000-0002-7521-2679; Fort, Joana/0000-0003-0399-2116; Calderon, Caterina/0000-0002-6956-9321; Lizarbe, M Antonia/0000-0003-1722-1240; Turnay, Javier/0000-0002-6135-2179; Turnay, Javier/0000-0002-6135-2179; Palacin, Manuel/0000-0002-8670-293X; Fernandez-Recio, Juan/0000-0002-3986-7686; Orozco Lopez, Modesto/0000-0002-8608-3278; Rodriguez de la Ballina, Laura/0000-0001-5363-7433; Ferrer Orta, Cristina/0000-0002-1072-8463	ICREA Funding Source: Custom	ICREA(ICREA)		BELLONE G, 1989, EUR J IMMUNOL, V19, P1, DOI 10.1002/eji.1830190102; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Broer A, 2001, BIOCHEM J, V355, P725, DOI 10.1042/bj3550725; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hara K, 2000, ONCOGENE, V19, P6209, DOI 10.1038/sj.onc.1204019; HEMLER ME, 1982, J IMMUNOL, V129, P623; Henderson NC, 2004, J BIOL CHEM, V279, P54731, DOI 10.1074/jbc.M408700200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kakugawa K, 2003, FEBS LETT, V552, P184, DOI 10.1016/S0014-5793(03)00924-4; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Shishido T, 2000, INT J CANCER, V87, P311, DOI 10.1002/1097-0215(20000801)87:3<311::AID-IJC1>3.0.CO;2-W; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Tsai ML, 2004, J STRUCT BIOL, V148, P290, DOI 10.1016/j.jsb.2004.07.002; Tsurudome M, 2000, CRIT REV IMMUNOL, V20, P167; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WIEGAND G, 1995, J MOL BIOL, V247, P99, DOI 10.1006/jmbi.1994.0125; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yoon JH, 2003, ANTICANCER RES, V23, P3877	54	84	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31444	31452		10.1074/jbc.M704524200	http://dx.doi.org/10.1074/jbc.M704524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724034	hybrid			2022-12-27	WOS:000250309200035
J	Fu, YC; Luo, LH; Luo, NL; Zhu, XL; Garvey, T				Fu, Yuchang; Luo, Liehong; Luo, Nanlan; Zhu, Xiaolin; Garvey, Timothy			NR4A orphan nuclear receptors modulate insulin action and the glucose transport system - Potential role in insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NGFI-B; DIFFERENT MECHANISMS; GROWTH-FACTORS; EXPRESSION; NOR-1; HETERODIMERIZATION; HYPERTENSION; ENDOCRINE; GENES	After observing that expression of two NR4A orphan nuclear receptors, NR4A3 and NR4A1, was altered by insulin in cDNA microarray analyses of human skeletal muscle, we studied whether these receptors could modulate insulin sensitivity. We found that both NR4A3 and NR4A1 were induced by insulin and by thiazolidinedione drugs (pioglitazone and troglitazone) in 3T3-L1 adipocytes. Furthermore, gene expression of NR4A3 and NR4A1 was reduced in skeletal muscles and adipose tissues from multiple rodent models of insulin resistance. To determine whether NR4A3 could modulate insulin sensitivity, 3T3-L1 adipocytes were stably transduced with NR4A3 or LacZ (control) lentiviral vectors. Compared with LacZ expressing cells, hyperexpression of NR4A3 increased the ability of insulin to augment glucose transport activity, and the mechanism involved increased recruitment of GLUT4 glucose transporters to the plasma membrane. NR4A3 hyperexpression also led to an increase in insulin-mediated tyrosine phosphorylation of insulin receptor substrate-1 as well as Akt phosphorylation. Suppression of NR4A3 using lentiviral short hairpin RNA constructs reduced the ability of insulin to stimulate glucose transport and phosphorylate Insulin receptor substrate-1 and Akt. Thus, NR4A3 and NR4A1 are attractive novel therapeutic targets for potential amelioration of insulin resistance, and treatment and prevention of type 2 diabetes and the metabolic syndrome.	Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Fu, YC (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, 1675 Univ Blvd, Birmingham, AL 35294 USA.	yfu@uab.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038765, P30DK056336, R01DK038765] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK-56336, DK-38765] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; FINGAR DC, 1993, J BIOL CHEM, V268, P3005; FROST SC, 1985, J BIOL CHEM, V260, P2646; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Hunter SJ, 1998, AM J MED, V105, P331, DOI 10.1016/S0002-9343(98)00300-3; Laflamme C, 2003, CANCER RES, V63, P449; Maltais A, 2000, DNA CELL BIOL, V19, P121, DOI 10.1089/104454900314636; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Maruyama K, 1997, NEUROENDOCRINOLOGY, V65, P2, DOI 10.1159/000127158; MAYOR P, 1992, DIABETES, V41, P274, DOI 10.2337/diabetes.41.3.274; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; OCURRA T, 1994, BIOCHEM BIOPH RES CO, V205, P1959; Ohkura N, 2001, DEV NEUROSCI-BASEL, V23, P17, DOI 10.1159/000048692; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Ponnio T, 2002, MOL CELL BIOL, V22, P935, DOI 10.1128/MCB.22.3.935-945.2002; REAVEN GM, 1991, DIABETES CARE, V14, P195, DOI 10.2337/diacare.14.3.195; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; SCEARCE LM, 1993, J BIOL CHEM, V268, P8855; Tofovic SP, 2003, METH MOLEC MED, V86, P29; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	32	93	97	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31525	31533		10.1074/jbc.M701132200	http://dx.doi.org/10.1074/jbc.M701132200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785466	hybrid			2022-12-27	WOS:000250309200044
J	Gatot, JS; Gioia, R; Chau, TL; Patrascu, F; Warnier, M; Close, P; Chapelle, JP; Muraille, E; Brown, K; Siebenlist, U; Piette, J; Dejardin, E; Chariot, A				Gatot, Jean-Stephane; Gioia, Romain; Chau, Tieu-Lan; Patrascu, Felicia; Warnier, Michael; Close, Pierre; Chapelle, Jean-Paul; Muraille, Eric; Brown, Keith; Siebenlist, Ulrich; Piette, Jacques; Dejardin, Emmanuel; Chariot, Alain			Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKK epsilon-dependent lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; UBIQUITIN-CONJUGATING ENZYME; KINASE-RELATED KINASES; IKK-EPSILON; ANTIVIRAL RESPONSE; NEMO/IKK-GAMMA; RIG-I; PATHWAY; TBK1	Type I interferon gene induction relies on IKK-related kinase TBK1 and IKK epsilon-mediated phosphorylations of IRF3/7 through the Toll-like receptor-dependent signaling pathways. The scaffold proteins that assemble these kinase complexes are poorly characterized. We show here that TANK/ITRAF is required for the TBK1- and IKK epsilon-mediated IRF3/7 phosphorylations through some Toll-like receptor-dependent pathways and is part of a TRAF3-containing complex. Moreover, TANK is dispensable for the early phase of double-stranded RNA-mediated IRF3 phosphorylation. Interestingly, TANK is heavily phosphorylated by TBK1-IKK epsilon upon lipopolysaccharide stimulation and is also subject to lipopolysaccharide- and TBK1-IKK epsilon-mediated Lys(63)-linked polyubiquitination, a mechanism that does not require TBK1-IKK epsilon kinase activity. Thus, we have identified TANK as a scaffold protein that assembles some but not all IRF3/7-phosphorylating TBK1-IKK epsilon complexes and demonstrated that these kinases possess two functions, namely the phosphorylation of both IRF3/7 and TANK as well as the recruitment of an E3 ligase for Lys63-linked polyubiquitination of their scaffold protein, TANK.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms ENS 3LD, Herts, England; Univ Liege, GIGA Res, Med Chem Unit, B-4000 Liege, Belgium; Univ Liege, Interdisciplinary Cluster Appl Genoproteom, B-4000 Liege, Belgium; Univ Liege, Virol Immunol Units, B-4000 Liege, Belgium; Free Univ Brussels, Parasitol Lab, B-1070 Brussels, Belgium; NIH, NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA	Cancer Research UK; University of Liege; University of Liege; University of Liege; Universite Libre de Bruxelles; Vrije Universiteit Brussel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chariot, A (corresponding author), Free Univ Brussels, Inst Mol Biol & Med, Dept Appl Genet, B-6041 Gossellies, Belgium.	Alain.chariot@ulg.ac.be	Mrl, Eric/ABC-5458-2021; Dejardin, Emmanuel/AAE-9076-2021	CLOSE, PIERRE/0000-0002-8844-9616; Chariot, Alain/0000-0002-1691-4347; Muraille, Eric/0000-0003-1250-5228				Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kaye KM, 1996, P NATL ACAD SCI USA, V93, P11085, DOI 10.1073/pnas.93.20.11085; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nomura F, 2000, GENES CELLS, V5, P191; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; ZHAO T, 2007, IN PRESS NAT IMMUNOL; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	57	68	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31131	31146		10.1074/jbc.M701690200	http://dx.doi.org/10.1074/jbc.M701690200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823124	hybrid, Green Submitted			2022-12-27	WOS:000250309200003
J	Li, QX; Kannan, A; Wang, W; DeMayo, FJ; Taylor, RN; Bagchi, MK; Bagchi, IC				Li, Quanxi; Kannan, Athilakshmi; Wang, Wei; DeMayo, Francesco J.; Taylor, Robert N.; Bagchi, Milan K.; Bagchi, Indrani C.			Bone morphogenetic protein 2 functions via a conserved signaling pathway involving Wnt4 to regulate uterine decidualization in the mouse and the human	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; PROLACTIN-RELATED PROTEIN; PROGESTERONE-RECEPTOR; HUMAN ENDOMETRIUM; STROMAL CELLS; EMBRYO IMPLANTATION; EXPRESSION; IDENTIFICATION; MECHANISMS; MICE	A critical role of progesterone (P) during early pregnancy is to induce differentiation of the endometrial stromal cells into specialized decidual cells that support the development of the implanting embryo. The P-induced signaling pathways that participate in the formation and function of the decidual cells remain poorly understood. We report here that the expression of the bone morphogenetic protein 2 (BMP2), a morphogen belonging to the TGF beta superfamily, is induced downstream of P action in the mouse uterine stroma during decidualization. To determine the function of BMP2 during this differentiation process, we employed a primary culture system in which undifferentiated stromal cells isolated from pregnant mouse uterus undergo decidualization. When recombinant BMP2 was added to these stromal cultures, it markedly advanced the differentiation program. We also found that siRNA-mediated silencing of BMP2 expression in these cells efficiently blocked the differentiation process. Gene expression profiling experiments identified Wnt4 as a downstream target of BMP2 regulation in stromal cells undergoing decidualization. Attenuation of Wnt4 expression by siRNAs greatly reduced stromal differentiation in vitro, indicating that it is a key mediator of BMP2-induced decidualization. We also observed a remarkable induction in the expression of BMP2 in human endometrial stromal cells during decidualization in vitro in response to steroids and cAMP. Addition of BMP2 to these cultures led to a robust enhancement of Wnt4 expression and stimulated the differentiation process. Collectively, our studies uncovered a unique conserved pathway involving BMP2 and Wnt4 that mediates P-induced stromal decidualization in the mouse and the human.	Univ Illinois, Dept Vet Biosci, Chicago, IL 60680 USA; Univ Illinois, Dept Mol & Integrat Physiol, Chicago, IL 60680 USA; Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University; Baylor College of Medicine	Bagchi, IC (corresponding author), Univ Illinois, Dept Vet Biosci, Chicago, IL 60680 USA.	ibagchi@uiuc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043381, R01HD044611] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR16515-01] Funding Source: Medline; NICHD NIH HHS [R01 HD-43381, R01 HD-44611, U54 HD055787] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; BAULIEU EE, 1991, TRENDS ENDOCRIN MET, V2, P233, DOI 10.1016/1043-2760(91)90030-Q; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Fischer L, 2002, J CELL BIOCHEM, V84, P816, DOI 10.1002/jcb.10091; GIUDICE LC, 1991, J CLIN ENDOCR METAB, V72, P779, DOI 10.1210/jcem-72-4-779; GIUDICE LC, 1999, ENCY REPROD, P1067; GLASSER SR, 1981, CELLULAR MOL ASPECTS, P217; GLASSER SR, 1990, TROPH RES, V4, P377; GU Y, 1999, ENCY REPROD, P836; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Irwin J. C., 1999, ENCY REPROD, V1, P823; LEE K, 2007, J MOL CELL BIOL, V27, P5468; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; LOCKWOOD CJ, 1994, J CLIN ENDOCR METAB, V79, P786, DOI 10.1210/jc.79.3.786; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Orwig KE, 1997, ENDOCRINOLOGY, V138, P5511, DOI 10.1210/en.138.12.5511; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; PARR MB, 1989, BIOL UTERUS, P133; PSYCHOYOS A, 1973, HDB PHYSL, P187; Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647; RYAN IP, 1994, J CLIN ENDOCR METAB, V78, P642, DOI 10.1210/jc.78.3.642; Strauss III F., 1991, REPROD ENDOCRINOLOGY, V3rd, P309; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; TSENG L, 1992, BIOL REPROD, V47, P441, DOI 10.1095/biolreprod47.3.441; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yang LJ, 2006, J DERMATOL SCI, V42, P111, DOI 10.1016/j.jdermsci.2005.12.011; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781	37	179	186	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31725	31732		10.1074/jbc.M704723200	http://dx.doi.org/10.1074/jbc.M704723200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711857	hybrid			2022-12-27	WOS:000250309200063
J	Liu, L; He, B; Liu, WM; Zhou, DM; Cox, JV; Zhang, XA				Liu, Li; He, Bo; Liu, Wei M.; Zhou, Dongming; Cox, John V.; Zhang, Xin A.			Tetraspanin CD151 promotes cell migration by regulating integrin trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE 4 SUPERFAMILY; PLASMA-MEMBRANE; DEPENDENT INTERNALIZATION; ALPHA-3-BETA-1 INTEGRIN; PROTEIN CD151; IN-VIVO; ADHESION; MEMBER; ASSOCIATION; ENDOCYTOSIS	Regulation of cell migration is an important feature of tetraspanin CD151. Although it is well established that CD151 physically associates with integrins, the mechanism by which CD151 regulates integrin-dependent cell migration is basically unknown. Given the fact that CD151 is localized in both the plasma membrane and intracellular vesicles, we found that CD151 and its associated alpha 3 beta 1, alpha 5 beta 1, and alpha 6 beta 1 integrins undergo endocytosis and accumulate in the same intracellular vesicular compartments. CD151 contains a YRSL sequence, a YXX phi type of endocytosis/sorting motif, in its C-terminal cytoplasmic domain. Mutation of this motif markedly attenuated CD151 internalization. The loss of CD151 trafficking completely abrogated CD151-promoted cell migration on extracellular matrices such as laminin and diminished the internalization of its associated integrins, indicating a critical role for integrin trafficking in regulating cell motility. In conclusion, the YXX phi motif-mediated internalization of CD151 promotes integrin-dependent cell migration by modulating the endocytosis and/or vesicular trafficking of its associated integrins.	Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Inst Canc,Dept Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Zhang, XA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr, Inst Canc,Dept Med, Memphis, TN 38163 USA.	xazhang@utmem.edu		Zhou, Dongming/0000-0002-5989-7591	NCI NIH HHS [CA96991] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Bonifacino J. S., 1998, CURRENT PROTOCOLS CE; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hasegawa H, 1998, J IMMUNOL, V161, P3087; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MCGRAW TE, CURRENT PROTOCOLS CE; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Pierini LM, 2000, BLOOD, V95, P2471; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shigeta M, 2003, J CELL BIOL, V163, P165, DOI 10.1083/jcb.200301075; Sincock PM, 1999, J CELL SCI, V112, P833; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2000, J CELL SCI, V113, P1871; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Testa JE, 1999, CANCER RES, V59, P3812; Thompson CRL, 2002, DEVELOPMENT, V129, P4185; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481	64	108	117	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31631	31642		10.1074/jbc.M701165200	http://dx.doi.org/10.1074/jbc.M701165200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716972	hybrid			2022-12-27	WOS:000250309200055
J	Nishiyama, Y; Mitsuda, Y; Taguchi, H; Planque, S; Salas, M; Hanson, CV; Paul, S				Nishiyama, Yasuhiro; Mitsuda, Yukie; Taguchi, Hiroaki; Planque, Stephanie; Salas, Maria; Hanson, Carl V.; Paul, Sudhir			Towards covalent vaccination - Improved polyclonal hiv neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYTIC ANTIBODY; LIGHT-CHAIN; ENVELOPE GLYCOPROTEINS; CATALYTIC ANTIBODIES; CHEMOKINE RECEPTOR; CRYSTAL-STRUCTURE; BINDING ACTIVITY; VARIABLE DOMAIN; TYPE-1	Rare monoclonal antibodies (Abs) can form irreversible complexes with antigens by enzyme-like covalent nucleophile-electrophile pairing. To determine the feasibility of applying irreversible antigen inactivation by Abs as the basis of vaccination against microbes, we studied the polyclonal nucleophilic Ab response induced by the electrophilic analog of a synthetic peptide corresponding to the principal neutralizing determinant (PND) of human immunodeficiency virus type-1 (HIV) gp120 located in the V3 domain. Abs from mice immunized with the PND analog containing electrophilic phosphonates (E-PND) neutralized a homologous HIV strain (MN) similar to 50-fold more potently than control Abs from mice immunized with PND. The IgG fractions displayed binding to intact HIV particles. HIV complexes formed by anti-E-PND IgG dissociated noticeably more slowly than the complexes formed by anti-PND IgG. The slower dissociation kinetics are predicted to maintain long-lasting blockade of host cell receptor recognition by gp120. Pretreatment of the anti-PND IgG with a haptenic electrophilic phosphonate compound resulted in more rapid dissociation of the HIV-IgG complexes, consistent with the hypothesis that enhanced Ab nucleophilic reactivity induced by electrophilic immunization imparts irreversible character to the complexes. These results suggest that electrophilic immunization induces a sufficiently robust nucleophilic Ab response to enhance the anti-microbial efficacy of candidate polypeptide vaccines.	Univ Texas, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA	University of Texas System; California Department of Public Health	Nishiyama, Y (corresponding author), Univ Texas, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA.	Yasuhiro.Nishiyama@uth.tmc.edu; Sudhir.Paul@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071951, R01AI067020, R21AI062455, R01AI058865] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI058865, R01AI067020, R21AI062455, R21AI071951] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUDET F, 1992, INT IMMUNOL, V4, P283, DOI 10.1093/intimm/4.2.283; BROLIDEN PA, 1992, P NATL ACAD SCI USA, V89, P461, DOI 10.1073/pnas.89.2.461; ESTAQUIER J, 1994, EUR J IMMUNOL, V24, P2789, DOI 10.1002/eji.1830241132; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; HANSON CV, 1990, J CLIN MICROBIOL, V28, P2030, DOI 10.1128/JCM.28.9.2030-2034.1990; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hill CM, 1997, J VIROL, V71, P6296, DOI 10.1128/JVI.71.9.6296-6304.1997; Hu QX, 2000, J MOL BIOL, V302, P359, DOI 10.1006/jmbi.2000.4076; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KALAGA R, 1995, J IMMUNOL, V155, P2695; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Lefevre S, 2001, FEBS LETT, V489, P25, DOI 10.1016/S0014-5793(01)02075-0; NEURATH AR, 1990, MOL IMMUNOL, V27, P539, DOI 10.1016/0161-5890(90)90073-9; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; VANCOTT TC, 1994, J IMMUNOL, V153, P449; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WARREN RQ, 1992, J VIROL, V66, P5210, DOI 10.1128/JVI.66.9.5210-5215.1992; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254	39	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31250	31256		10.1074/jbc.M706471200	http://dx.doi.org/10.1074/jbc.M706471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728243	hybrid			2022-12-27	WOS:000250309200014
J	Mandel, S; Gozes, I				Mandel, Shmuel; Gozes, Illana			Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE; TUBULIN; BRG1; TRANSCRIPTION; NEUROGENESIS; EXPRESSION; INDUCTION; INTERACTS; GENES; CELLS	Complete deficiency in activity-dependent neuroprotective protein (ADNP), a heterochromatin 1-binding protein, results in dramatic changes in gene expression, neural tube closure defects, and death at gestation day 9 in mice. To further understand the cellular roles played by ADNP, the HEK293 human embryonic kidney cell line that allows efficient transfection with recombinant DNA was used as a model for the identification of ADNP-interacting proteins. Recombinant green fluorescent protein (GFP)-ADNP was localized to cell nuclei. When nuclear extracts were subjected to immunoprecipitation with specific GFP antibodies followed by polyacrylamide gel electrophoresis, several minor protein bands were observed in addition to GFP-ADNP. In-gel protein digests followed by mass spectrometry identified BRG1, BAF250a, and BAF170, all components of the SWI/SNF (mating type switching/sucrose nonfermenting) chromatin remodeling complex, as proteins that co-immunoprecipitate with ADNP. These results were verified utilizing BRG1 antibodies. ADNP short hairpin RNA down-regulation resulted in microtubule reorganization and changes in cell morphology including reduction in cell process formation and cell number. These morphological changes are closely associated with the SWI/SNF complex multifunctionality. Taken together, the current study uncovers a molecular basis for the essential function of the ADNP gene and protein.	Tel Aviv Univ, Sackler Fac Med, LEG fMRI Inst, Adams Super Ctr Brain Res,Dept Human Mol Genet &, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, LEG fMRI Inst, Adams Super Ctr Brain Res,Dept Human Mol Genet &, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il						Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Furman S, 2005, NEUROSCI LETT, V373, P73, DOI 10.1016/j.neulet.2004.09.077; Furman S, 2004, NEURON GLIA BIOL, V1, P193, DOI 10.1017/S1740925X05000013; GOZES I, 1977, FEBS LETT, V73, P109, DOI 10.1016/0014-5793(77)80027-6; Gozes I, 2004, J MOL NEUROSCI, V24, P67, DOI 10.1385/JMN:24:1:067; GOZES I, 1982, P NATL ACAD SCI-BIOL, V79, P2579, DOI 10.1073/pnas.79.8.2579; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Gozes I, 2005, CNS DRUG REV, V11, P353; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Rosson GB, 2005, J CELL PHYSIOL, V205, P286, DOI 10.1002/jcp.20397; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Siddiqui H, 2007, J CELL PHYSIOL, V211, P131, DOI 10.1002/jcp.20913; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; VULIHSHULTZMAN I, 2007, IN PRESS J PHARM EXP; Zaltzman R, 2004, J MOL NEUROSCI, V24, P181, DOI 10.1385/JMN:24:2:181; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200	28	101	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34448	34456		10.1074/jbc.M704756200	http://dx.doi.org/10.1074/jbc.M704756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878164	hybrid			2022-12-27	WOS:000251145700060
J	Rusinova, R; Mirshahi, T; Logothetis, DE				Rusinova, Radda; Mirshahi, Tooraj; Logothetis, Diomedes E.			Specificity of g beta gamma signaling to kir3 channels depends on the helical domain of pertussis toxin-sensitive g alpha Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+-CHANNEL; HETEROTRIMERIC G-PROTEINS; POTASSIUM CHANNEL; INTERDOMAIN INTERACTIONS; MUSCARINIC RECEPTOR; INDUCED INHIBITION; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; I-KACH; ACTIVATION	Acetylcholine signaling through muscarinic type 2 receptors activates atrial G protein-gated inwardly rectifying K+ (Kir3) channels via the beta gamma subunits of G proteins (G beta gamma). Different combinations of recombinant G beta gamma subunits have been shown to activate Kir3 channels in a similar manner. In native systems, however, only G beta gamma subunits associated with the pertussis toxin-sensitive G alpha(i/o) subunits signal to K+ channels. Additionally, in vitro binding experiments supported the notion that the C terminus of Kir3 channels interacts preferentially with G alpha(i) over G alpha(q). In this study we confirmed in two heterologous expression systems a preference of G alpha(i) over G alpha(q) in the activation of K+ currents. To identify determinants of G beta gamma signaling specificity, we first exchanged domains of G alpha(i) and G alpha(q) subunits responsible for receptor coupling selectivity and swapped their receptor coupling partners. Our results established that the G proteins, regardless of the receptor type to which they coupled, conferred specificity to Kir3 activation. We next tested signaling through chimeras between the G alpha(i) and G alpha(q) subunits in which the N terminus, the helical, or the GTPase domains of theG alpha subunits were exchanged. Our results revealed that the helical domain of G alpha(i) (residues 63-175) in the background of G alpha(q) could support Kir3 activation, whereas the reverse chimera could not. Moreover, the helical domain of theG alpha(i) subunit conferred "G alpha(i)-like" binding of the Kir3 C terminus to the G alpha(q) subunits that contained it. These results implicate the helical domain of G alpha(i) proteins as a critical determinant of G beta gamma signaling specificity.	Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Logothetis, DE (corresponding author), Icahn Med Inst, Rm 16-20B,1 Gustave L Levy Pl,Box 1677, New York, NY 10029 USA.	Diomedes.Logothetis@mssm.edu			NHLBI NIH HHS [HL 54185, T32 HL 07824] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054185, T32HL007824] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; FUNG BKK, 1983, J BIOL CHEM, V258, P503; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Kawano T, 2007, MOL PHARMACOL, V71, P1179, DOI 10.1124/mol.106.032508; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kozasa Tohru, 2003, V237, P21; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu W, 1998, P NATL ACAD SCI USA, V95, P12878, DOI 10.1073/pnas.95.22.12878; Lober RM, 2006, J NEUROSCI, V26, P12602, DOI 10.1523/JNEUROSCI.4020-06.2006; LOGOTHETIS DE, 1993, NEURON, V10, P1121, DOI 10.1016/0896-6273(93)90060-5; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, pR4; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Remmers AE, 1999, BIOCHEMISTRY-US, V38, P13795, DOI 10.1021/bi990887f; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; STEHNOBITTEL L, 1995, J BIOL CHEM, V270, P30068; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WILSON PT, 1995, J BIOL CHEM, V270, P9667, DOI 10.1074/jbc.270.16.9667	68	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34019	34030		10.1074/jbc.M704928200	http://dx.doi.org/10.1074/jbc.M704928200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872944	hybrid			2022-12-27	WOS:000251145700016
J	Xie, Y; Kerscher, O; Kroetz, MB; McConchie, HF; Sung, P; Hochstrasser, M				Xie, Yang; Kerscher, Oliver; Kroetz, Mary B.; McConchie, Heather F.; Sung, Patrick; Hochstrasser, Mark			The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; RING-RING COMPLEX; SACCHAROMYCES-CEREVISIAE; SUMO MODIFICATION; MAT-ALPHA-2 REPRESSOR; RAD51 RECOMBINASE; DNA-REPLICATION; DEGRADATION; BINDING; GENE	Hex3 and Slx8 are Saccharomyces cerevisiae proteins with important functions in DNA damage control and maintenance of genomic stability. Both proteins have RING domains at their C termini. Such domains are common in ubiquitin and ubiquitin-like protein ligases (E3s), but little was known about the molecular functions of either protein. In this study we identified HEX3 as a high-copy suppressor of a temperature-sensitive small ubiquitin-related modifier (SUMO) protease mutant, ulp1ts, suggesting that it may affect cellular SUMO dynamics. Remarkably, even a complete deletion of ULP1 is strongly suppressed. Hex3 forms a heterodimer with Slx8. We found that the Hex3 center dot Slx8 complex has a robust substrate-specific E3 ubiquitin ligase activity. In this E3 complex, Slx8 appears to bear the core ligase function, with Hex3 strongly enhancing its activity. Notably, SUMO attachment to a substrate stimulates its Hex3 center dot Slx8 dependent ubiquitination, primarily through direct noncovalent interactions between SUMO and Hex3. Our data reveal a novel mechanism of substrate targeting in which sumoylation of a protein can help trigger its subsequent ubiquitination by recruiting a SUMO-binding ubiquitin ligase.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA	Yale University; Yale University; William & Mary	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053756, R01GM046904, R37GM046904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 053756, GM 046904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Boulton SJ, 2006, CELL CYCLE, V5, P1481, DOI 10.4161/cc.5.14.2930; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Dobson MJ, 2005, MOL CELL BIOL, V25, P4299, DOI 10.1128/MCB.25.10.4299-4310.2005; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GUTHRIE C, 1991, GUIDE YEAST GENETIC; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Mullen JR, 2001, GENETICS, V157, P103; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010	50	185	189	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34176	34184		10.1074/jbc.M706025200	http://dx.doi.org/10.1074/jbc.M706025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17848550	hybrid			2022-12-27	WOS:000251145700032
J	Wells, RC; Picton, LK; Williams, SCP; Tan, FJ; Hill, RB				Wells, Robert C.; Picton, Lora K.; Williams, Sarah C. P.; Tan, Frederick J.; Hill, R. Blake			Direct binding of the dynamin-like GTPase, dnm1, to mitochondrial dynamics protein fis1 is negatively regulated by the fis1 n-terminal arm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD REPEAT PROTEIN; PEROXISOMAL FISSION; MAMMALIAN-CELLS; COMPONENT FIS1P; BUDDING YEAST; LIVING CELLS; DIVISION; APOPTOSIS; MACHINERY; INTERACTS	Recruitment of a dynamin-like GTPase (Drp1/Dlp1/Dnm1) to membranes requires the mitochondrial dynamics protein Fis1. Mdv1 has been proposed to act as an adaptor between Fis1 and Dnm1 in Saccharomyces cerevisiae. We show that S. cerevisiae Fis1 binds directly to Dnm1 and to Mdv1. Two Fis1 regions have been previously implicated in Mdv1 recruitment: an N-terminal "arm" and a concave surface formed by evolutionarily conserved residues in the tetratricopeptide repeat domain. Perturbing either Fis1 region does not affect Mdv1 binding, but both regions influence Dnm1 binding. Fis1 lacking its N-terminal arm binds tightly to Dnm1, and binding is abolished by mutations to the Fis1 concave surface. The Fis1-Dnm1 interaction decreases more than 100-fold in the presence of the Fis1 arm, suggesting that the arm acts in an autoinhibitory manner to restrict access to the Dnm1 binding site on Fis1. Our data indicate that the concave surface of the Fis1 tetratricopeptide repeat-like domain is evolutionarily conserved to bind the dynamin-like GTPase Dnm1 and not Mdv1 as previously predicted.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Hill, RB (corresponding author), Johns Hopkins Univ, Dept Biol, Mudd Hall,3400 N Charles St, Baltimore, MD 21218 USA.	hill@jhu.edu		Hill, Blake/0000-0001-6228-3905	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM067180] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR020922, S10 RR020922-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007231, R01GM067180, R01 GM067180, R01 GM067180-04, T32GM007231] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Sambrook J., 2001, MOL CLONING LAB MANU; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scott SV, 2003, CURR OPIN CELL BIOL, V15, P482, DOI 10.1016/S0955-0674(03)00070-X; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	51	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33769	33775		10.1074/jbc.M700807200	http://dx.doi.org/10.1074/jbc.M700807200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884824	hybrid, Green Accepted			2022-12-27	WOS:000250840200059
J	Kang, NJ; Lee, KW; Rogozin, EA; Cho, YY; Heo, YS; Bode, AM; Lee, HJ; Dong, Z				Kang, Nam Joo; Lee, Ki Won; Rogozin, Evgeny A.; Cho, Yong-Yeon; Heo, Yong-Seok; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR PROTEIN-1; TEA POLYPHENOLS; GREEN TEA; AP-1 TRANSACTIVATION; KINASE KINASE; GROWTH; FLAVONOIDS; GENISTEIN; DAMAGE; DNA	Daidzein and genistein are isoflavones found in soybean. Genistein is known to exhibit anticarcinogenic activities and inhibit tyrosine kinase activity. However, the underlying molecular mechanisms of the chemopreventive activities of daidzein and its metabolite, equol, are not understood. Here we report that equol inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation of JB6 P+ mouse epidermal cells by targeting the MEK/ERK/p90RSK/activator protein-1 signaling pathway. TPA-induced neoplastic cell transformation was inhibited by equol, but not daidzein, at noncytotoxic concentrations in a dose-dependent manner. Equol dose-dependently attenuated TPA-induced activation of activator protein-1 and c-fos, whereas daidzein did not exert any effect when tested at the same concentrations. The TPA-induced phosphorylation of ERK1/2, p90RSK, and Elk, but not MEK or c-Jun N-terminal kinase, was inhibited by equol but not by daidzein. In vitro kinase assays revealed that equol greatly inhibited MEK1, but not Raf1, kinase activity, and an ex vivo kinase assay also demonstrated that equol suppressed TPA-induced MEK1 kinase activity in JB6 P+ cell lysates. Equol dose-dependently inhibited neoplastic transformation of JB6 P+ cells induced by epidermal growth factor or H-Ras. Both in vitro and ex vivo pull-down assays revealed that equol directly bound with glutathione S-transferase-MEK1 to inhibit MEK1 activity without competing with ATP. These results suggested that the antitumor-promoting effect of equol is due to the inhibition of cell transformation mainly by targeting a MEK signaling pathway. These findings are the first to reveal a molecular basis for the anticancer action of equol and may partially account for the reported chemopreventive effects of soybean.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; Konkuk Univ, Dept Chem, Seoul 143701, South Korea	University of Minnesota System; Seoul National University (SNU); Konkuk University; Konkuk University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lee, Ki Won/M-4114-2018; Heo, Yong-Seok/D-8244-2011; Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651	NCI NIH HHS [CA 88961, CA 120388, CA 81064, CA 111536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, P01CA088961, R01CA081064, R37CA081064] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abrams SI, 1996, SEMIN ONCOL, V23, P118; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Chang YC, 1995, J NAT PROD, V58, P1901, DOI 10.1021/np50126a016; Chung JY, 1999, CANCER RES, V59, P4610; Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 2002, SCI STKE 2002, pP67; Dong ZG, 1997, J BIOL CHEM, V272, P9962; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dong ZG, 1997, CANCER RES, V57, P4414; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; ELDRIDGE AC, 1983, J AGR FOOD CHEM, V31, P394, DOI 10.1021/jf00116a052; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Iwashita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1813, DOI 10.1271/bbb.64.1813; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KELLY GE, 1995, P SOC EXP BIOL MED, V208, P40, DOI 10.3181/00379727-208-43829; Kim H, 1998, AM J CLIN NUTR, V68, p1418S, DOI 10.1093/ajcn/68.6.1418S; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202; Lee KW, 2006, MECH AGEING DEV, V127, P424, DOI 10.1016/j.mad.2006.01.021; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Oikawa S, 2003, FREE RADICAL RES, V37, P881, DOI 10.1080/1071576031000150751; PETERSON G, 1995, J NUTR, V125, pS784, DOI 10.1093/jn/125.suppl_3.784S; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; Sang SM, 2005, ANTIOXID REDOX SIGN, V7, P1704, DOI 10.1089/ars.2005.7.1704; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Sierens J, 2001, MUTAT RES-DNA REPAIR, V485, P169, DOI 10.1016/S0921-8777(00)00069-0; SPINOZZI F, 1994, LEUKEMIA RES, V18, P431, DOI 10.1016/0145-2126(94)90079-5; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Verma SP, 1998, NUTR CANCER, V30, P232, DOI 10.1080/01635589809514669; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; Widyarini S, 2005, PHOTOCHEM PHOTOBIOL, V81, P32, DOI 10.1562/2004-06-02-RA-183.1; Widyarini S, 2006, J VET SCI, V7, P217, DOI 10.4142/jvs.2006.7.3.217; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9; Zhong SP, 2001, CANCER RES, V61, P4084	50	60	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32856	32866		10.1074/jbc.M701459200	http://dx.doi.org/10.1074/jbc.M701459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17724030	hybrid			2022-12-27	WOS:000250625400035
J	Schmidt, V; Sporbert, A; Rohe, M; Reimer, T; Rehm, A; Andersen, OM; Willnow, TE				Schmidt, Vanessa; Sporbert, Anje; Rohe, Michael; Reimer, Tatjana; Rehm, Armin; Andersen, Olav M.; Willnow, Thomas E.			SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; TRANS-GOLGI NETWORK; ALZHEIMER-DISEASE; CYTOPLASMIC DOMAIN; SORTING RECEPTOR; BETA-PEPTIDE; TRAFFICKING; GENERATION; CELLS; PATHOGENESIS	SorLA has been recognized as a novel sorting receptor that regulates trafficking and processing of the amyloid precursor protein (APP) and that represents a significant risk factor for sporadic Alzheimer disease. Here, we investigated the cellular mechanisms that control intracellular trafficking of sorLA and their relevance for APP processing. We demonstrate that sorLA acts as a retention factor for APP in trans-Golgi compartments/trans-Golgi network, preventing release of the precursor into regular processing pathways. Proper localization and activity of sorLA are dependent on functional interaction with GGA and PACS-1, adaptor proteins involved in protein transport to and from the trans-Golgi network. Aberrant targeting of sorLA to the recycling compartment or the plasma membrane causes faulty APP trafficking and imbalance in non-amyloidogenic and amyloidogenic processing fates. Thus, our findings identified altered routing of sorLA as a major cellular mechanism contributing to abnormal APP processing and enhanced amyloid alpha-peptide formation.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	willnow@mdc-berlin.de	Andersen, Olav/N-2777-2017	Andersen, Olav/0000-0003-4226-3354; Willnow, Thomas/0000-0001-9515-7921				Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; De Strooper B, 2000, J CELL SCI, V113, P1857; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Doray B, 2002, J BIOL CHEM, V277, P18477, DOI 10.1074/jbc.M201879200; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hampe W, 2000, J CELL SCI, V113, P4475; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Khvotchev M, 2004, J BIOL CHEM, V279, P47101, DOI 10.1074/jbc.M408474200; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Peraus GC, 1997, J NEUROSCI, V17, P7714; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Sudoh S, 2000, EUR J BIOCHEM, V267, P2036, DOI 10.1046/j.1432-1327.2000.01206.x; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431	34	136	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32956	32964		10.1074/jbc.M705073200	http://dx.doi.org/10.1074/jbc.M705073200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855360	hybrid			2022-12-27	WOS:000250625400044
J	Heyes, DJ; Sakuma, M; Scrutton, NS				Heyes, Derren J.; Sakuma, Michiyo; Scrutton, Nigel S.			Laser excitation studies of the product release steps in the catalytic cycle of the light-driven enzyme, protochlorophyllide oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLVENT VISCOSITY; DYNAMICS; NADPH; IDENTIFICATION; ENZYMOLOGY; REDUCTION; INSIGHTS	The latter stages of the catalytic cycle of the light- driven enzyme, protochlorophyllide oxidoreductase, have been investigated using novel laser photoexcitation methods. The formation of the ternary product complex was initiated with a 6- ns laser pulse, which allowed the product release steps to be kinetically accessed for the first time. Subsequent absorbance changes associated with the release of the NADP(+) and chlorophyllide products from the enzyme could be followed on a millisecond timescale. This has facilitated a detailed kinetic and thermodynamic characterization for the interconversion of all the various bound and unbound product species. Initially, NADP(+) is released from the enzyme in a biphasic process with rate constants of 1210 and 237 s(-1). The rates of both phases show a significant dependence on the viscosity of the solvent and become considerably slower at higher glycerol concentrations. The fast phase of this process exhibits no dependence on NADP(+) concentration, suggesting that conformational changes are required prior to NADP(+) release. Following NADP(+) release, the NADPH rebinds to the enzyme with a maximum rate constant of similar to 72 s(-1). At elevated temperatures (> 298 K) chlorophyllide is released from the enzyme to yield the free product with a maximum rate constant of 20 s(-1). The temperature dependencies of the rates of each of these steps were measured, and enthalpies and entropies of activation were calculated using the Eyring equation. A comprehensive kinetic and thermodynamic scheme for these final stages of the reaction mechanism is presented.	Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	derren.heyes@manchester.ac.uk		Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: Medline; BBSRC [BB/D01963X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Dirama TE, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1938191; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Lebedev N, 1999, P NATL ACAD SCI USA, V96, P9954, DOI 10.1073/pnas.96.17.9954; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Schoefs B, 2003, PHOTOCHEM PHOTOBIOL, V78, P543, DOI 10.1562/0031-8655(2003)078&lt;0543:PRMAE&gt;2.0.CO;2; Sierks MR, 1997, BIOTECHNOL PROGR, V13, P601, DOI 10.1021/bp9700824; VALERA V, 1987, BIOCHEM BIOPH RES CO, V148, P515, DOI 10.1016/0006-291X(87)91141-7; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724	21	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32015	32020		10.1074/jbc.M706098200	http://dx.doi.org/10.1074/jbc.M706098200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848549	hybrid			2022-12-27	WOS:000250480300022
J	Muramatsu, S; Wakabayashi, M; Ohno, T; Amano, K; Ooishi, R; Sugahara, T; Shiojiri, S; Tashiro, K; Suzuki, Y; Nishimura, R; Kuhara, S; Sugano, S; Yoneda, T; Matsuda, A				Muramatsu, Shuji; Wakabayashi, Makoto; Ohno, Takeshi; Amano, Katsuhiko; Ooishi, Rika; Sugahara, Toshinori; Shiojiri, Satoshi; Tashiro, Kosuke; Suzuki, Yutaka; Nishimura, Riko; Kuhara, Satoru; Sugano, Sumio; Yoneda, Toshiyuki; Matsuda, Akio			Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; PRO-ALPHA-1(II) COLLAGEN GENE; HEAT-EVOKED ACTIVATION; CELL-LINE; CONSTITUTIVE ACTIVATION; CARTILAGE FORMATION; SIGNALING PATHWAY; MAMMALIAN-CELLS; II COLLAGEN; SOX9	Sox9 is a transcription factor that is essential for chondrocyte differentiation and chondrocyte-specific gene expression. However, the precise mechanism of Sox9 activation during chondrogenesis is not fully understood. To investigate this mechanism, we performed functional gene screening to identify genes that activate SOX9-dependent transcription, using full-length cDNA libraries generated from a murine chondrogenic cell line, ATDC5. Screening revealed that TRPV4 ( (t) under bar ransient (r) under bar eceptor (p) under bar otential (v) under bar anilloid 4), a cation channel molecule, significantly elevates SOX9-dependent reporter activity. Microarray and quantitative real time PCR analyses demonstrated that during chondrogenesis in ATDC5 and C3H10T1/2 ( murine mesenchymal stem cell line), the expression pattern of TRPV4 was similar to the expression patterns of chondrogenic marker genes, such as type II collagen and aggrecan. Activation of TRPV4 by a pharmacological activator induced SOX9-dependent reporter activity, and this effect was abolished by the addition of the TRPV antagonist ruthenium red or by using a small interfering RNA for TRPV4. The SOX9-dependent reporter activity due to TRPV4 activation was abrogated by both EGTA and a calmodulin inhibitor, suggesting that the Ca2+/calmodulin signal is essential in this process. Furthermore, activation of TRPV4 in concert with insulin activity in ATDC5 cells or in concert with bone morphogenetic protein-2 in C3H10T1/2 cells promoted synthesis of sulfated glycosaminoglycan, but activation of TRPV4 had no effect alone. We showed that activation of TRPV4 increased the steady-state levels of SOX9 mRNA and protein and SOX6 mRNA. Taken together, our results suggest that TRPV4 regulates the SOX9 pathway and contributes to the process of chondrogenesis.	Asahi Kasei Pharma Corp, Lab Drug Discovery, Res Ctr, Shizuoka 4168501, Japan; Kyushu Univ, Fac Agr, Dept Genet Resources Technol, Higashi Ku, Fukuoka 8128581, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan	Asahi Kasei Pharma Corporation; Kyushu University; University of Tokyo; Osaka University	Muramatsu, S (corresponding author), Asahi Kasei Pharma Corp, Lab Drug Discovery, Res Ctr, 2-1 Samejima, Shizuoka 4168501, Japan.	muramatsu.sb@om.asahi-kasei.co.jp		Nishimura, Riko/0000-0001-7279-8363				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Giordano J, 2001, AM J MED GENET, V98, P176, DOI 10.1002/1096-8628(20010115)98:2<176::AID-AJMG1027>3.0.CO;2-Q; Guler AD, 2002, J NEUROSCI, V22, P6408; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jin EJ, 2006, MOL CELLS, V22, P353; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; MARUYAMA K, 1994, GENE, V138, P171; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Takahashi I, 1998, J CELL SCI, V111, P2067; Valhmu WB, 2002, BIOCHEM J, V361, P689, DOI 10.1042/0264-6021:3610689; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang P, 2003, J BIOL CHEM, V278, P117, DOI 10.1074/jbc.M208049200; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	40	153	163	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32158	32167		10.1074/jbc.M706158200	http://dx.doi.org/10.1074/jbc.M706158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804410	hybrid			2022-12-27	WOS:000250480300038
J	Yoon, H; Laxmikanthan, G; Lee, J; Blaber, SI; Rodriguez, A; Kogot, JM; Scarisbrick, IA; Blaber, M				Yoon, Hyesook; Laxmikanthan, Gurunathan; Lee, Jihun; Blaber, Sachiko I.; Rodriguez, Aaron; Kogot, Joshua M.; Scarisbrick, Isobel A.; Blaber, Michael			Activation profiles and regulatory cascades of the human kallikrein-related peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GLANDULAR KALLIKREIN; MYELENCEPHALON-SPECIFIC PROTEASE; CORNEUM CHYMOTRYPTIC ENZYME; NUCLEAR-MAGNETIC-RESONANCE; FIBROBLAST-GROWTH-FACTOR; SERINE-PROTEASE; GENE FAMILY; TISSUE KALLIKREIN; STRATUM-CORNEUM	The human kallikrein (KLK)-related peptidases are the largest family of serine peptidases, comprising 15 members (KLK1-15) and with the majority (KLK4-15) being identified only within the last decade. Members of this family are associated with important diseased states (including cancer, inflammation, and neurodegeneration) and have been utilized or proposed as clinically important biomarkers or therapeutic targets of interest. All human KLKs are synthesized as prepro-forms that are proteolytically processed to secreted pro-forms via the removal of an amino-terminal secretion signal peptide. The secreted inactive pro-KLKs are then activated extracellularly to mature peptidases by specific proteolytic release of their amino-terminal propeptide. Although a key step in the regulation of KLK function, details regarding the activation of the human pro-KLKs (i. e. the KLK " activome") are unknown, to a significant extent, but have been postulated to involve "activation cascades" with other KLKs and endopeptidases. To characterize more completely the KLK activome, we have expressed from Escherichia coli individual KLK propeptides fused to the amino terminus of a soluble carrier protein. The ability of 12 different mature KLKs to process the 15 different pro-KLK peptide sequences has been determined. Various autolytic and cross-activation relationships identified using this system have subsequently been characterized using recombinant pro-KLK proteins. The results demonstrate the potential for extensive KLK activation cascades and, when combined with available data for the tissue-specific expression of the KLK family, permit the construction of specific regulatory cascades. One such tissue-specific cascade is proposed for the central nervous system.	Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; Mayo Clin & Mayo Grad Sch Med, Program Mol Neurosci, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Grad Sch Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Blaber, M (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 3350G Biomed Sci Bldg, Tallahassee, FL 32306 USA.	michael.blaber@med.fsu.edu	Blaber, Michael/N-1083-2019; Blaber, Michael/ABA-5031-2021; Laxmikanthan, Gurunathan/D-1049-2012; Blaber, Michael/E-7478-2011	Blaber, Michael/0000-0002-6856-1643; Lee, Jihun/0000-0002-8803-7689				Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Anisowicz A, 1996, MOL MED, V2, P624, DOI 10.1007/BF03401646; BACK T, 1994, STROKE, V25, P494, DOI 10.1161/01.STR.25.2.494; Barrett AJ, 2003, BIOL CHEM, V384, P873, DOI 10.1515/BC.2003.098; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Blaber SI, 2007, BIOCHEMISTRY-US, V46, P5209, DOI 10.1021/bi6025006; Blaber SI, 2004, FASEB J, V18, P920, DOI 10.1096/fj.03-1212fje; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Breitenbach U, 2001, J INVEST DERMATOL, V117, P634, DOI 10.1046/j.0022-202x.2001.01437.x; Brych SR, 2004, J MOL BIOL, V344, P769, DOI 10.1016/j.jmb.2004.09.060; Brych SR, 2001, PROTEIN SCI, V10, P2587, DOI 10.1110/ps.ps.34701; Catalona WJ, 1997, J UROLOGY, V158, P2162, DOI 10.1016/S0022-5347(01)68187-4; CHAGAS JR, 1995, BIOCHEM J, V306, P63, DOI 10.1042/bj3060063; CHEN ZL, 1995, J NEUROSCI, V15, P5088; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; CLEMENTS JA, 1989, ENDOCR REV, V10, P393, DOI 10.1210/edrv-10-4-393; Darson MF, 1999, UROLOGY, V53, P939, DOI 10.1016/S0090-4295(98)00637-2; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DESHPANDE MS, 1992, J MED CHEM, V35, P3094, DOI 10.1021/jm00095a002; Diamandis E P, 2001, Expert Rev Mol Diagn, V1, P182, DOI 10.1586/14737159.1.2.182; Diamandis EP, 2000, TRENDS ENDOCRIN MET, V11, P54, DOI 10.1016/S1043-2760(99)00225-8; Fiedler F, 1979, Adv Exp Med Biol, V120A, P261; Fuessel S, 2003, INT J ONCOL, V23, P221; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Hooper JD, 2001, GENOMICS, V73, P117, DOI 10.1006/geno.2000.6490; Iwadate H, 2002, CAN J PHYSIOL PHARM, V80, P245, DOI 10.1139/Y02-026; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; KIRSHNAWAMI S, 2004, J THROMB HAEMOST, V3, P54; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Little SP, 1997, J BIOL CHEM, V272, P25135, DOI 10.1074/jbc.272.40.25135; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lovgren J, 1999, EUR J BIOCHEM, V266, P1050, DOI 10.1046/j.1432-1327.1999.00946.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Lozano RM, 2000, BIOCHEMISTRY-US, V39, P4982, DOI 10.1021/bi992544n; LUDERER AA, 1995, UROLOGY, V46, P187, DOI 10.1016/S0090-4295(99)80192-7; LUNDSTROM A, 1991, ACTA DERM-VENEREOL, V71, P471; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; LUO LY, 2006, HUM CANC BIOL, V12, P742; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Mikolajczyk SD, 1997, EUR J BIOCHEM, V246, P440, DOI 10.1111/j.1432-1033.1997.00440.x; Mitsui S, 2000, BIOCHEM BIOPH RES CO, V272, P205, DOI 10.1006/bbrc.2000.2761; NAKAYAMA A, 1992, J BIOTECHNOL, V23, P55, DOI 10.1016/0168-1656(92)90099-U; Okui A, 2001, NEUROREPORT, V12, P1345, DOI 10.1097/00001756-200105250-00011; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x; Recker F, 2000, UROLOGY, V55, P481, DOI 10.1016/S0090-4295(99)00611-1; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Schechter I, 1967, BIOCHEM BIOPH RES CO, V27, P156; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Silva JA, 2000, FASEB J, V14, P1858; SKYTT A, 1995, BIOCHEM BIOPH RES CO, V211, P586, DOI 10.1006/bbrc.1995.1853; Sotiropoulou G, 2003, ONCOL RES, V13, P381; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582; Tomasselli AG, 1997, BIOTECHNOL APPL BIOC, V26, P39; Uchida A, 2004, MOL BRAIN RES, V126, P129, DOI 10.1016/j.molbrainres.2004.04.009; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Yamanaka H, 1999, MOL BRAIN RES, V71, P217, DOI 10.1016/S0169-328X(99)00187-4; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; YOUNG CYF, 1995, J ANDROL, V16, P97; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346; Yousef GM, 2001, CANCER RES, V61, P3425; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	75	131	133	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31852	31864		10.1074/jbc.M705190200	http://dx.doi.org/10.1074/jbc.M705190200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823117	Green Submitted, hybrid			2022-12-27	WOS:000250480300005
J	Gaskell, AA; Crack, JC; Kelemen, GH; Hutchings, MI; Le Brun, NE				Gaskell, Alisa A.; Crack, Jason C.; Kelemen, Gabriella H.; Hutchings, Matthew I.; Le Brun, Nick E.			RsmA is an anti-sigma factor that modulates its activity through a [2Fe-2S] cluster cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SOXR PROTEIN; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; STRESS-RESPONSE; RNA-POLYMERASE; AZOTOBACTER-VINELANDII; FACTOR SPOIIAB; IN-VITRO	The rsmA gene of Streptomyces coelicolor lies directly upstream of the gene encoding the group 3 sigma factor sigma(M). The RsmA protein is a putative member of the HATPase_c family of anti-sigma factors but is unusual in that it contains seven cysteine residues. Bacterial two-hybrid studies demonstrate that it interacts specifically with sigma(M), and in vitro studies of the purified proteins by native PAGE and transcription assays confirmed that they form a complex. Characterization of RsmA revealed that it binds ATP and that, as isolated, it contains significant quantities of iron and inorganic sulfide, in equal proportion, with spectroscopic properties characteristic of a [2Fe-2S] cluster-containing protein. Importantly, the interaction between RsmA and sigma(M) is dependent on the presence of the iron-sulfur cluster. We propose a model in which RsmA regulates the activity of sigma(M). Loss of the cluster, in response to an as yet unidentified signal, activates sigma(M) by abolishing its interaction with the anti-sigma factor. This represents a major extension of the functional diversity of iron-sulfur cluster proteins.	Univ E Anglia, Sch Chem Sci, Ctr Metalloprotein Spectroscopy & Biol, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Pract, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia; University of East Anglia	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem Sci, Ctr Metalloprotein Spectroscopy & Biol, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	Hutchings, Matt/D-1923-2009; Kelemen, Gabriella/G-8486-2011	Hutchings, Matt/0000-0001-6628-5940; Le Brun, Nick/0000-0001-9780-4061; Crack, Jason C./0000-0002-4979-1910				Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; BUTTNER MJ, 1985, J MOL BIOL, V185, P177, DOI 10.1016/0022-2836(85)90189-5; Caldeira J, 2000, BIOCHEMISTRY-US, V39, P2700, DOI 10.1021/bi9921485; Campbell EA, 2000, J MOL BIOL, V300, P17, DOI 10.1006/jmbi.2000.3838; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; Choulet F, 2006, J BACTERIOL, V188, P6599, DOI 10.1128/JB.00734-06; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FEE JA, 1984, J BIOL CHEM, V259, P124; GIBSON JF, 1966, P NATL ACAD SCI USA, V56, P987, DOI 10.1073/pnas.56.3.987; GREEN J, 1993, FEMS MICROBIOL LETT, V113, P219, DOI 10.1111/j.1574-6968.1993.tb06517.x; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hugo N, 1998, J BIOL CHEM, V273, P9622, DOI 10.1074/jbc.273.16.9622; IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3; Jervis AJ, 2007, J BACTERIOL, V189, P2930, DOI 10.1128/JB.01921-06; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Lee EJ, 2004, J BACTERIOL, V186, P8490, DOI 10.1128/JB.186.24.8490-8498.2004; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sevcikova B, 2002, FEMS MICROBIOL LETT, V209, P229, DOI 10.1016/S0378-1097(02)00513-X; SHAW DJ, 1983, J MOL BIOL, V166, P241, DOI 10.1016/S0022-2836(83)80011-4; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TA DT, 1992, J BIOL CHEM, V267, P11120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; Xia B, 1996, BIOCHEMISTRY-US, V35, P9488, DOI 10.1021/bi960467f; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	55	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31812	31820		10.1074/jbc.M705160200	http://dx.doi.org/10.1074/jbc.M705160200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766240	hybrid			2022-12-27	WOS:000250309200071
J	McGugan, GC; Joshi, MB; Dwyer, DM				McGugan, Glen C., Jr.; Joshi, Manju B.; Dwyer, Dennis M.			Identification and biochemical characterization of unique secretory nucleases of the human enteric pathogen, Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RIBONUCLEASE; EXPRESSION; GENE; PURIFICATION; TROPHOZOITES; SEQUENCE; TRANSFECTION	The ancient eukaryotic human pathogen, Entamoeba histolytica, is a nucleo-base auxotroph (i.e. lacks the ability to synthesize purines or pyrimidines de novo) and therefore is totally dependent upon its host for the supply of these essential nutrients. In this study, we identified two unique 28- kDa, dithiothreitolsensitive nucleases and showed that they are constitutively released/secreted by parasites during axenic culture. Using several different molecular approaches, we identified and characterized the structure of EhNucI and EhNucII, genes that encode ribonuclease T2 family proteins. Homologous episomal expression of epitope-tagged EhNucI and EhNucII chimeric constructs was used to define the functional and biochemical properties of these released/secreted enzymes. Results of coupled immuno-precipitation-enzyme activity analyses demonstrated that these "secretory" enzymes could hydrolyze a variety of synthetic polynucleotides, as well as the natural nucleic acid substrate RNA. Furthermore, our results demonstrated that sera from acutely infected amebiasis patients recognized and immunoprecipitated these parasite secretory enzymes. Based on these observations, we hypothesize that within its host, these secretory nucleases could function, at a distance away from the parasite, to harness (i.e. hydrolyze/access) host-derived nucleic acids to satisfy the essential purine and pyrimidine requirements of these organisms. Thus, these enzymes might play an important role in facilitating the survival, growth, and development of this important human pathogen.	NIAID, Div Intramural Res, Parasit Dis Lab, Cell Biol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dwyer, DM (corresponding author), NIAID, Div Intramural Res, Parasit Dis Lab, Cell Biol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ddwyer@niaid.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000745, Z01AI000745, Z01AI000162] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Banuelos C, 2005, EXP PARASITOL, V110, P292, DOI 10.1016/j.exppara.2005.03.005; BATES PA, 1993, FEMS MICROBIOL LETT, V107, P53, DOI 10.1111/j.1574-6968.1993.tb06003.x; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BOODEN T, 1978, ARCH INVEST MED, V9, P133; BOODEN T, 1976, J PARASITOL, V62, P641, DOI 10.2307/3279435; BOONLAYANGOOR P, 1980, ARCH INVEST MED, V11, P83; BOONLAYANGOOR P, 1978, EXP PARASITOL, V45, P225, DOI 10.1016/0014-4894(78)90063-2; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Chacko R, 1998, BBA-GEN SUBJECTS, V1379, P264, DOI 10.1016/S0304-4165(97)00103-7; CLARK CG, 1991, MOL BIOCHEM PARASIT, V46, P11, DOI 10.1016/0166-6851(91)90194-B; Das P, 1997, PARASITOL RES, V83, P364, DOI 10.1007/s004360050263; DEBRABANT A, 1995, MOL BIOCHEM PARASIT, V71, P51, DOI 10.1016/0166-6851(95)00035-Y; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Esteban R., 1999, Plant Physiology, V119, P1149; Field J, 2000, J EUKARYOT MICROBIOL, V47, P511, DOI 10.1111/j.1550-7408.2000.tb00083.x; Fitzsimmons CM, 2005, MOL BIOCHEM PARASIT, V144, P123, DOI 10.1016/j.molbiopara.2005.08.003; Frisardi M, 2000, INFECT IMMUN, V68, P4217, DOI 10.1128/IAI.68.7.4217-4224.2000; GERBER LD, 1992, J BIOL CHEM, V267, P12168; Ghosh SK, 1999, INFECT IMMUN, V67, P3073, DOI 10.1128/IAI.67.6.3073-3081.1999; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Gonzalez E, 2002, AM J TROP MED HYG, V67, P636, DOI 10.4269/ajtmh.2002.67.636; GUYTON AC, 1996, TXB MED PHYSL, P793; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; HAMES BD., 1981, GEL ELECTROPHORESIS, P1; HORITSU H, 1980, CAN J BIOCHEM CELL B, V58, P489, DOI 10.1139/o80-065; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; Inokuchi N, 1998, J BIOCHEM, V124, P848, DOI 10.1093/oxfordjournals.jbchem.a022189; INOKUCHI N, 1993, J BIOCHEM-TOKYO, V113, P425, DOI 10.1093/oxfordjournals.jbchem.a124062; Joshi MB, 2007, J BIOL CHEM, V282, P10079, DOI 10.1074/jbc.M610770200; KAWATA Y, 1990, EUR J BIOCHEM, V187, P255, DOI 10.1111/j.1432-1033.1990.tb15303.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MANN BJ, 1991, P NATL ACAD SCI USA, V88, P3248, DOI 10.1073/pnas.88.8.3248; MAOURI A, 1987, EUR J BIOCHEM, V168, P523, DOI 10.1111/j.1432-1033.1987.tb13449.x; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McCombie W R, 1992, DNA Seq, V2, P289, DOI 10.3109/10425179209030961; MCKEON TA, 1991, ARCH BIOCHEM BIOPHYS, V290, P303, DOI 10.1016/0003-9861(91)90545-T; MCLAUGHLIN J, 1985, J PROTOZOOL, V32, P221; NICKEL R, 1994, P NATL ACAD SCI USA, V91, P7095, DOI 10.1073/pnas.91.15.7095; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ramos MA, 2000, ARCH MED RES, V31, pS173, DOI 10.1016/S0188-4409(00)00113-2; REED S, 1993, J CLIN INVEST, V91, P1532, DOI 10.1172/JCI116359; REED SL, 1990, J CLIN INVEST, V86, P1815, DOI 10.1172/JCI114911; REED SL, 1995, J IMMUNOL, V155, P266; ROJO MA, 1994, PLANTA, V194, P328, DOI 10.1007/BF00197532; ROSENBAUM RM, 1970, J CELL BIOL, V45, P367, DOI 10.1083/jcb.45.2.367; RUSHIZKY GW, 1963, J BIOL CHEM, V238, P371; Sanchez-Lopez R, 1998, MOL BIOCHEM PARASIT, V92, P355, DOI 10.1016/S0166-6851(98)00017-6; Sato D, 2006, FEBS LETT, V580, P5306, DOI 10.1016/j.febslet.2006.08.081; Shimizu T, 2001, GENE, V274, P227, DOI 10.1016/S0378-1119(01)00601-1; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALSH JA, 1986, REV INFECT DIS, V8, P228; WHO, 1997, WKLY EPIDEMIOL REC R, V72, P97	62	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31789	31802		10.1074/jbc.M705975200	http://dx.doi.org/10.1074/jbc.M705975200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766245	hybrid			2022-12-27	WOS:000250309200069
J	Hong, L; Fast, W				Hong, Lin; Fast, Walter			Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide - Analysis, quantification, and implications for hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE CYSTEINE; NITRIC-OXIDE; ASYMMETRIC DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; THIOL COMPOUNDS; BOVINE BRAIN; ADMA; MECHANISM; ANGIOGENESIS; KINETICS	The plasma concentrations of two cardiovascular risk factors, total homocysteine (tHcy) and asymmetric dimethylarginine (ADMA), correlate with decreased levels of endothelium-derived nitric oxide and subsequent endothelial dysfunction. Homocysteine has been proposed to inhibit the catabolic enzyme of ADMA, dimethylarginine dimethylaminohydrolase (DDAH), but the mechanism of this inhibition has not been fully elucidated. Here, the human DDAH isoform-1 (DDAH-1) is heterologously expressed and purified. Cys(274) and His(173) are identified as active site residues and the pH rate dependence is described. Because oxidation of the active site Cys has been suggested as an inhibitory mechanism in patients with hyperhomocysteinemia, the sensitivity of DDAH-1 to inhibition by L-homocysteine, H2O2, and S-nitroso-L-homocysteine is quantified. DDAH-1 is surprisingly insensitive to inactivation by the powerful oxidant, H2O2 (0.088 M-1 S-1), possibly because of a substrate-assisted mechanism that allows the active site cysteine to remain predominantly protonated and less reactive in the resting enzyme. In contrast, DDAH-1 is sensitive to inactivation by S-nitroso-L-homocysteine ( 3.79 M-1 S-1). This work illustrates how a particular catalytic mechanism can result in selective redox regulation and has possible implications for hyperhomocysteinemia.	Univ Texas, Coll Pharm, Texas Inst Drug & Diagnost Dev, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fast, W (corresponding author), Univ Texas, Coll Pharm, Texas Inst Drug & Diagnost Dev, Div Med Chem, Austin, TX 78712 USA.	WaltFast@mail.utexas.edu						Achan V, 2005, VASC MED, V10, P7, DOI 10.1191/1358863x05vm580oa; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Boger RH, 2005, VASC MED, V10, pS19, DOI 10.1191/1358863x05vm602oa; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Bogumil R, 1998, BIOCHEMISTRY-US, V37, P4791, DOI 10.1021/bi972312t; Braun O, 2007, PROTEIN SCI, V16, P1522, DOI 10.1110/ps.062718507; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Cooke JP, 2004, CAN J CARDIOL, V20, p7B; Cooke JP, 2005, VASC MED, V10, pS11, DOI 10.1191/1358863x05vm598oa; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; DUERRE JA, 1966, ANAL BIOCHEM, V17, P310, DOI 10.1016/0003-2697(66)90209-0; FEELISCH M, 1996, METHODS NITRIC OXIDE, P521; Frey D, 2006, STRUCTURE, V14, P901, DOI 10.1016/j.str.2006.03.006; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hampton MB, 2002, FEBS LETT, V517, P229, DOI 10.1016/S0014-5793(02)02629-7; Hogg N, 1999, ANAL BIOCHEM, V272, P257, DOI 10.1006/abio.1999.4199; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2000, J BIOL CHEM, V275, P21813, DOI 10.1074/jbc.C000280200; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Knipp M, 2005, J AM CHEM SOC, V127, P2372, DOI 10.1021/ja0430200; Knipp M, 2001, J BIOL CHEM, V276, P40449, DOI 10.1074/jbc.M104056200; Knipp M, 2006, CHEMBIOCHEM, V7, P879, DOI 10.1002/cbic.200500527; Knuckley B, 2007, BIOCHEMISTRY-US, V46, P6578, DOI 10.1021/bi700095s; Kostourou V, 2002, BRIT J CANCER, V87, P673, DOI 10.1038/sj.bjc.6600518; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514; Luo DY, 2005, J PHARM SCI-US, V94, P304, DOI 10.1002/jps.20253; Maas R, 2003, ATHEROSCLEROSIS SUPP, V4, P5, DOI 10.1016/S1567-5688(03)00028-X; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; OGAWA T, 1989, J BIOL CHEM, V264, P10205; RADI R, 1991, J BIOL CHEM, V266, P4244; Rossiter S, 2005, J MED CHEM, V48, P4670, DOI 10.1021/jm050187a; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; Stone EA, 2005, BIOCHEMISTRY-US, V44, P7069, DOI 10.1021/bi047407r; Stone EM, 2006, BIOCHEMISTRY-US, V45, P5618, DOI 10.1021/bi052595m; Stone EM, 2005, ANAL BIOCHEM, V343, P335, DOI 10.1016/j.ab.2005.05.006; Stuhlinger MC, 2005, CURR DRUG METAB, V6, P3, DOI 10.2174/1389200052997393; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Subramaniam S, 1998, PROTEINS, V32, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vallance P, 2005, CHEM COMMUN, P5563, DOI 10.1039/b510709a; VALLANCE P, 1992, LANCET, V339, P572; Vallance P, 2002, NAT REV DRUG DISCOV, V1, P939, DOI 10.1038/nrd960; Wang K, 2001, BIOORG MED CHEM LETT, V11, P433, DOI 10.1016/S0960-894X(00)00688-0; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Xian M, 2000, BIOCHEM BIOPH RES CO, V268, P310, DOI 10.1006/bbrc.2000.2117; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	59	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34684	34692		10.1074/jbc.M707231200	http://dx.doi.org/10.1074/jbc.M707231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895252	hybrid			2022-12-27	WOS:000251155200010
J	Jank, T; Giesemann, T; Aktories, K				Jank, Thomas; Giesemann, Torsten; Aktories, Klaus			Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-PROTEINS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GLYCOSYLTRANSFERASES; SITE; GLUCOSYLATION; CLEAVAGE; CELLS; MUTAGENESIS; MECHANISMS	Recently the crystal structure of the catalytic domain of Clostridium difficile toxin B was solved (Reinert, D. J., Jank, T., Aktories, K., and Schulz, G. E. (2005) J. Mol. Biol. 351, 973-981). On the basis of this structure, we studied the functional role of several amino acids located in the catalytic center of toxin B. Besides the (DXD288)-D-286 motif and Trp(102), which were shown to be necessary for Mn2+ and UDP binding, respectively, we identified by alanine scanning Asp(270), Arg(273), Tyr(284), Asn(384), and Trp(520) as being important for enzyme activity. The amino acids Arg(455), Asp(461), Lys(463), and Glu(472) and residues of helix alpha 17 (e. g. Glu(449)) of toxin B are essential for enzyme-protein substrate recognition. Introduction of helix alpha 17 of toxin B into Clostridium sordellii lethal toxin inhibited modification of Ras subfamily proteins but enabled glucosylation of RhoA, indicating that helix alpha 17 is involved in RhoA recognition by toxin B. The data allow the design of a model of the interaction of the glucosyltransferase domain of toxin B with its protein substrate RhoA.	Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt, Albertstr 25, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2006, J BIOL CHEM, V281, P19527, DOI 10.1074/jbc.M600863200; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	32	75	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35222	35231		10.1074/jbc.M703138200	http://dx.doi.org/10.1074/jbc.M703138200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901056	hybrid			2022-12-27	WOS:000251155200067
J	Rak, M; Tetaud, E; Duvezin-Caubet, S; Ezkurdia, N; Bietenhader, M; Rytka, J; di Rago, JP				Rak, Malgorzata; Tetaud, Emmanuel; Duvezin-Caubet, Stephane; Ezkurdia, Nahia; Bietenhader, Maielis; Rytka, Joanna; di Rago, Jean-Paul			A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C SUBUNIT OLIGOMER; SACCHAROMYCES-CEREVISIAE; LEIGH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; F1F0-ATP SYNTHASE; ESCHERICHIA-COLI; PROTON TRANSPORT; DNA MUTATION; MTDNA; F-1-ATPASE	NARP (neuropathy, ataxia, and retinitis pigmentosa) and MILS (maternally inherited Leigh syndrome) are mitochondrial disorders associated with point mutations of the mitochondrial DNA (mtDNA) in the gene encoding the Atp6p subunit of the ATP synthase. The most common and studied of these mutations is T8993G converting the highly conserved leucine 156 into arginine. We have introduced this mutation at the corresponding position (183) of yeast Saccharomyces cerevisiae mitochondrially encoded Atp6p. The "yeast NARP mutant" grew very slowly on respiratory substrates, possibly because mitochondrial ATP synthesis was only 10% of the wild type level. The mutated ATP synthase was found to be correctly assembled and present at nearly normal levels (80% of the wild type). Contrary to what has been reported for human NARP cells, the reverse functioning of the ATP synthase, i.e. ATP hydrolysis in the F-1 coupled to F-0-mediated proton translocation out of the mitochondrial matrix, was significantly compromised in the yeast NARP mutant. Interestingly, the oxygen consumption rate in the yeast NARP mutant was decreased by about 80% compared with the wild type, due to a selective lowering in cytochrome c oxidase (complex IV) content. This finding suggests a possible regulatory mechanism between ATP synthase activity and complex IV expression in yeast mitochondria. The availability of a yeast NARP model could ease the search for rescuing mechanisms against this mitochondrial disease.	Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France; Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	di Rago, JP (corresponding author), Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	jp.dirago@ibgc.u-bordeaux2.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Carrozzo R, 2000, FEBS LETT, V486, P297, DOI 10.1016/S0014-5793(00)02244-4; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Guerin B, 1979, Methods Enzymol, V55, P149; HARTZOG PE, 1993, J BIOL CHEM, V268, P12250; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Hosokawa H, 2005, J BIOL CHEM, V280, P23797, DOI 10.1074/jbc.M502650200; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Schwimmer Christine, 2006, Biotechnology Journal, V1, P270, DOI 10.1002/biot.200500053; Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t	49	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34039	34047		10.1074/jbc.M703053200	http://dx.doi.org/10.1074/jbc.M703053200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855363	hybrid			2022-12-27	WOS:000251145700018
J	Chemin, J; Mezghrani, A; Bidaud, I; Dupasquier, S; Marger, F; Barrere, C; Nargeot, J; Lory, P				Chemin, Jean; Mezghrani, Alexandre; Bidaud, Isabelle; Dupasquier, Sebastien; Marger, Fabrice; Barrere, Christian; Nargeot, Joel; Lory, Philippe			Temperature-dependent modulation of Ca(V)3 T-type calcium channels by protein kinases C and A in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; MOLECULAR-BASIS; INHIBITION; CURRENTS; MECHANISMS; ALPHA(1G); NEURONS; PHOSPHORYLATION; DETERMINANTS; SUBUNIT	Modulation of low voltage- activated Ca(V)3 T- type calcium channels remains poorly characterized compared with high voltage- activated Ca(V)1 and Ca(V)2 calcium channels. Notably, it is yet unresolved whether Ca(V)3 channels are modulated by protein kinases in mammalian cells. In this study, we demonstrate that protein kinase A ( PKA) and PKC ( but not PKG) activation induces a potent increase in Ca(V)3.1, Ca(V)3.2, and Ca(V)3.3 currents in various mammalian cell lines. Notably, we show that protein kinase effects occur at physiological temperature( similar to 30 - 37 degrees C) but not at room temperature ( similar to 22 - 27 C). This temperature dependence could involve kinase translocation, which is impaired at room temperature. A similar temperature dependence was observed for PKC- mediated increase in high voltage- activated Ca(V)2.3 currents. We also report that neither CaV3 surface expression nor T- current macroscopic properties are modified upon kinase activation. In addition, we provide evidence for the direct phosphorylation of Ca(V)3.2 channels by PKA in in vitro assays. Overall, our results clearly establish the role of PKA and PKC in the modulation of Ca(V)3 T- channels and further highlight the key role of the physiological temperature in the effects described.	Univ Montpellier I, Inst Federatif Rech 3, Inst Genom Fonct,U661, Dept Oncol Mol & Cellulaire,CNRS UMR 2503,INSERM, F-34094 Montpellier, France; Univ Montpellier 2, Inst Federatif Rech 3, Inst Genom Fonct,U661, Dept Oncol Mol & Cellulaire,CNRS UMR 2503,INSERM, F-34094 Montpellier, France; Univ Montpellier 2, Inst Federatif Rech 3, Dept Physiol, F-34094 Montpellier, France; Univ Montpellier I, Inst Federatif Rech 3, Dept Physiol, F-34094 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Chemin, J (corresponding author), Inst Genom Fonct, Dept Physiol, 141 Rue Cardonille, F-34094 Montpellier, France.	jean.chemin@igf.cnrs.fr		BIDAUD, Isabelle/0000-0002-1812-1447; Barrere, Christian/0000-0001-8710-0976; Nargeot, Joel/0000-0003-2893-5636; chemin, jean/0000-0002-6089-5964; LORY, philippe/0000-0002-1638-7604				ALVAREZ JL, 1992, J GEN PHYSIOL, V100, P519, DOI 10.1085/jgp.100.3.519; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, EUR J NEUROSCI, V14, P1678, DOI 10.1046/j.0953-816x.2001.01796.x; Chemin J, 2001, BIOPHYS J, V80, P1238, DOI 10.1016/S0006-3495(01)76100-0; Chemin J, 2007, J BIOL CHEM, V282, P2314, DOI 10.1074/jbc.M610033200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Lehel C, 1996, BIOCHEM BIOPH RES CO, V223, P98, DOI 10.1006/bbrc.1996.0852; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Mullner C, 2004, J BIOL CHEM, V279, P51844, DOI 10.1074/jbc.M408756200; Noma A, 1996, JPN HEART J, V37, P673; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Park JY, 2003, FEBS LETT, V547, P37, DOI 10.1016/S0014-5793(03)00665-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; SMITH BL, 1992, BIOCHEM BIOPH RES CO, V188, P1235, DOI 10.1016/0006-291X(92)91363-U; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VASSORT G, 1969, PFLUG ARCH EUR J PHY, V309, P70, DOI 10.1007/BF00592283; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wolfe JT, 2002, J PHYSIOL-LONDON, V538, P343, DOI 10.1113/jphysiol.2001.012839; Yao JL, 2006, J CLIN INVEST, V116, P2403, DOI 10.1172/JCI27918; Zhang Y, 2000, AM J PHYSIOL-HEART C, V278, pH184, DOI 10.1152/ajpheart.2000.278.1.H184; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	54	64	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32710	32718		10.1074/jbc.M702746200	http://dx.doi.org/10.1074/jbc.M702746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855364	hybrid			2022-12-27	WOS:000250625400019
J	Qi, ZH; Song, M; Wallace, MJ; Wang, D; Newton, PM; Mcmahon, T; Chou, WH; Zhang, C; Shokat, KM; Messing, RO				Qi, Zhan-Heng; Song, Maengseok; Wallace, Melisa J.; Wang, Dan; Newton, Philip M.; Mcmahon, Thomas; Chou, Wen-Hai; Zhang, Chao; Shokat, Kevan M.; Messing, Robert O.			Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma 2 subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; MICE LACKING; PKC-EPSILON; MAMMALIAN-CELLS; XENOPUS OOCYTES; WITHDRAWAL; RESPONSES; REQUIRES; SUBTYPES; BRAIN	Ethanol enhances gamma-aminobutyrate ( GABA) signaling in the brain, but its actions are inconsistent at GABA(A) receptors, especially at low concentrations achieved during social drinking. We postulated that the epsilon isoform of protein kinase C ( PKC epsilon) regulates the ethanol sensitivity of GABA(A) receptors, as mice lacking PKC epsilon show an increased behavioral response to ethanol. Here we developed an ATP analog-sensitive PKC epsilon mutant to selectively inhibit the catalytic activity of PKC epsilon. We used this mutant and PKC epsilon(-/-) mice to determine that PKC epsilon phosphorylates gamma 2 subunits at serine 327 and that reduced phosphorylation of this site enhances the actions of ethanol and benzodiazepines at alpha 1 beta 2 gamma 2 receptors, which is the most abundant GABA(A) receptor subtype in the brain. Our findings indicate that PKC epsilon phosphorylation of gamma 2 regulates the response of GABA(A) receptors to specific allosteric modulators, and, in particular, PKC epsilon inhibition renders these receptors sensitive to low intoxicating concentrations of ethanol.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Messing, RO (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	romes@gallo.ucsf.edu	Chou, Wen-Hai/H-1970-2016; Wallace, Melisa/C-5798-2009; Messing, Robert/D-3642-2015; Newton, Philip/C-5801-2009	Chou, Wen-Hai/0000-0002-7899-1129; Messing, Robert/0000-0002-5345-4431; Wallace, Melisa/0000-0001-7471-9833; Newton, Philip/0000-0002-5272-7979	NIAAA NIH HHS [AA 013588] Funding Source: Medline; NIAID NIH HHS [AI/CA 44009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013588, R37AA013588] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brunig I, 2002, J NEUROSCI, V22, P4805, DOI 10.1523/JNEUROSCI.22-12-04805.2002; Choi DS, 2002, J NEUROSCI, V22, P9905; Criswell HE, 2005, NEUROPSYCHOPHARMACOL, V30, P1407, DOI 10.1038/sj.npp.1300750; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Goslin K., 1998, CULTURING NERVE CELL, P339; HARRIS RA, 1995, ALCOHOL CLIN EXP RES, V19, P226, DOI 10.1111/j.1530-0277.1995.tb01496.x; Harris RA, 1997, ALCOHOL CLIN EXP RES, V21, P444; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hood HM, 2000, ALCOHOL CLIN EXP RES, V24, P1327, DOI 10.1111/j.1530-0277.2000.tb02100.x; Hood HM, 2006, GENES BRAIN BEHAV, V5, P1, DOI 10.1111/j.1601-183X.2005.00122.x; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; MARSZALEC W, 1994, J PHARMACOL EXP THER, V269, P157; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Olive MF, 2001, NEUROSCIENCE, V103, P171, DOI 10.1016/S0306-4522(00)00566-2; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; Proctor WR, 2003, J PHARMACOL EXP THER, V305, P264, DOI 10.1124/jpet.102.045450; Sapp DW, 1998, J PHARMACOL EXP THER, V284, P768; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; Song M, 2005, CELL MOL LIFE SCI, V62, P119, DOI 10.1007/s00018-004-4339-x; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; WAFFORD KA, 1992, FEBS LETT, V313, P113, DOI 10.1016/0014-5793(92)81424-K; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; Wallace MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P127, DOI 10.1038/sj.npp.1301059; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wang J, 2003, J NEUROSCI, V23, P826; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	43	78	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33052	33063		10.1074/jbc.M707233200	http://dx.doi.org/10.1074/jbc.M707233200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17875639	hybrid			2022-12-27	WOS:000250625400054
J	Bahari, L; Parlitz, R; Eitan, A; Stjepanovic, G; Bochkareva, ES; Sinning, I; Bibi, E				Bahari, Liat; Parlitz, Richard; Eitan, Asa; Stjepanovic, Goran; Bochkareva, Elena S.; Sinning, Irmgard; Bibi, Eitan			Membrane targeting of Ribosomes and their release require distinct and separable functions of ftsy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; SRP RECEPTOR FTSY; ESCHERICHIA-COLI; INNER MEMBRANE; ACIDIC PHOSPHOLIPIDS; CRYSTAL-STRUCTURE; GTPASE DOMAIN; NG DOMAIN; PROTEIN; BINDING	The mechanism underlying the interaction of the Escherichia coli signal recognition particle ( SRP) receptor FtsY with the cytoplasmic membrane is not fully understood. We investigated this issue by utilizing active ( NG + 1) and inactive ( NG) mutants of FtsY. In solution, the mutants comparably bind and hydrolyze nucleotides and associate with SRP. In contrast, a major difference was observed in the cellular distribution of NG and NG + 1. Unlike NG + 1, which distributes almost as the wild-type receptor, the inactive NG mutant accumulates on the membrane, together with ribosomes and SRP. The results suggest that NG function is compromised only at a later stage of the targeting pathway and that despite their identical behavior in solution, the membrane-bound NG-SRP complex is less active than NG + 1-SRP. This notion is strongly supported by the observation that lipids stimulate the GTPase activity of NG + 1-SRP, whereas no stimulation is observed with NG-SRP. In conclusion, we propose that the SRP receptor has two distinct and separable roles in ( i) mediating membrane targeting and docking of ribosomes and ( ii) promoting their productive release from the docking site.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Univ Heidelberg, Biochemiezentrum, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Stjepanovic, Goran/A-7902-2010; Sinning, Irmgard/A-2982-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bibi, Eitan/0000-0003-3700-2707				Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; KUSTERS R, 1995, FEBS LETT, V372, P253, DOI 10.1016/0014-5793(95)00997-N; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	37	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32168	32175		10.1074/jbc.M705429200	http://dx.doi.org/10.1074/jbc.M705429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726013	hybrid			2022-12-27	WOS:000250480300039
J	Beyer, KS; Beauchamp, RL; Lee, MF; Gusella, JF; Naar, AM; Ramesh, V				Beyer, Kim S.; Beauchamp, Roberta L.; Lee, Ming-Fen; Gusella, James F.; Naar, Anders M.; Ramesh, Vijaya			Mediator subunit MED28 (magicin) is a repressor of smooth muscle cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE EG-1; COMPLEX; TRANSCRIPTION; PROTEIN; IDENTIFICATION; COACTIVATORS; ACTIVATION; EXPRESSION; FAMILY	Magicin, a protein that we isolated earlier as an interactor of the neurofibromatosis 2 protein merlin, was independently identified as MED28, a subunit of the mammalian Mediator complex. Mediator complex is an evolutionarily conserved transcriptional cofactor, which plays an essential role in positive and negative gene regulation. Distinct Mediator subunit composition is thought to contribute to gene regulation specificity based on the interaction of specific subunits with subsets of transcription factors. Here we report that down-regulation of Med28 expression in NIH3T3 cells results in a significant induction of several genes associated with smooth muscle cell ( SMC) differentiation. Conversely, overexpression of MED28 represses expression of SMC genes, in concordance with our knockdown data. More importantly, multipotent mesenchymal-derived murine precursors can transdifferentiate into SMCs when Med28 is down-regulated. Our data also show that Med28 functions as a negative regulator of SMC differentiation in concert with other Mediator subunits including Med6, Med8, and Med18 within the Mediator head module. Our results provide strong evidence that MED28 may function as a scaffolding protein by maintaining the stability of a submodule within the head module and that components of this submodule act together in a gene regulatory program to suppress SMC differentiation. The results presented here demonstrate for the first time that the mammalian Mediator subunit MED28 functions as a repressor of SMC differentiation, which could have implications for disorders associated with abnormalities in SMC growth and differentiation, including atherosclerosis, asthma, hypertension, and smooth muscle tumors.	Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Cell Biol, Massachusetts Gen Hosp,Canc Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Simches Res Bldg,185 Cambridge ST, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279, P30NS045776] Funding Source: NIH RePORTER; NINDS NIH HHS [NS45776, NS24279] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Gu JY, 2002, J BIOL CHEM, V277, P27154, DOI 10.1074/jbc.M204144200; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee MF, 2006, BIOCHEM BIOPH RES CO, V348, P826, DOI 10.1016/j.bbrc.2006.07.126; Liu CH, 2002, BIOCHEM BIOPH RES CO, V290, P602, DOI 10.1006/bbrc.2001.6119; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu M, 2005, CANCER RES, V65, P6159, DOI 10.1158/0008-5472.CAN-04-4016; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang S, 2004, J BIOL CHEM, V279, P13593, DOI 10.1074/jbc.M312274200; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhang LP, 2004, CLIN CANCER RES, V10, P3504, DOI 10.1158/1078-0432.CCR-03-0467	28	20	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32152	32157		10.1074/jbc.M706592200	http://dx.doi.org/10.1074/jbc.M706592200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848560	hybrid			2022-12-27	WOS:000250480300037
J	Doppler, H; Storz, P				Doeppler, Heike; Storz, Peter			A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; NF-KAPPA-B; D-DEPENDENT ACTIVATION; MU PKC-MU; C-DELTA; LYSOPHOSPHATIDIC ACID; LOOP PHOSPHORYLATION; DOWNSTREAM TARGET; CELLS; BINDING	Protein kinase D1 (PKD1) is a mediator of oxidative stress signaling where it regulates cellular detoxification and survival. Critical for the regulation of PKD1 activity in response to oxidative stress are Src- and Abl- mediated tyrosine phosphorylations that eventually lead to protein kinase C delta(PKC delta)- mediated activation of PKD1. Here we identify Tyr95 in PKD1 as a previously undescribed phosphorylation site that is regulated by oxidative stress. Our data suggest that PKD1 phosphorylation at Tyr95 generates a binding motif for PKC delta, and that oxidative stress-mediated PKC delta/PKD interaction results in PKD1 activation loop phosphorylation and activation. We further analyzed all PKD isoforms for this mechanism and show that PKD enzymes PKD1 and PKD2 are targets for PKC delta in response to oxidative stress, and that PKD3 is not a target because it lacks the relevant tyrosine residue that generates a PKC delta interaction motif.	Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Griffin Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu						Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Dekker LV, 1997, J BIOL CHEM, V272, P12747, DOI 10.1074/jbc.272.19.12747; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; LI WQ, 1994, J BIOL CHEM, V269, P2349; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Storz P, 2005, BIOCHEM J, V387, P47, DOI 10.1042/BJ20041443; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan MQ, 2004, ARTERIOSCL THROM VAS, V24, P2271, DOI 10.1161/01.ATV.0000148449.92035.3a; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; ZANG Q, 1995, CELL GROWTH DIFFER, V6, P1367	49	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31873	31881		10.1074/jbc.M703584200	http://dx.doi.org/10.1074/jbc.M703584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804414	hybrid			2022-12-27	WOS:000250480300007
J	Gust, AA; Biswas, R; Lenz, HD; Rauhut, T; Ranf, S; Kemmerling, B; Gotz, F; Glawischnig, E; Lee, J; Felix, G; Nurnberger, T				Gust, Andrea A.; Biswas, Raja; Lenz, Heike D.; Rauhut, Thomas; Ranf, Stefanie; Kemmerling, Birgit; Goetz, Friedrich; Glawischnig, Erich; Lee, Justin; Felix, Georg; Nuernberger, Thorsten			Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-SYRINGAE; PROTEIN-KINASES; SALICYLIC-ACID; COLD-SHOCK; RECOGNITION; PLANTS; FLAGELLIN; THALIANA; CALCIUM; PERCEPTION	Pathogen-associated molecular pattern (PAMP)-triggered immunity constitutes the primary plant immune response that has evolved to recognize invariant structures of microbial surfaces. Here we show that Gram-positive bacteria-derived peptidoglycan (PGN) constitutes a novel PAMP of immune responses in Arabidopsis thaliana. Treatment with PGN from Staphylococcus aureus results in the activation of plant responses, such as medium alkalinization, elevation of cytoplasmic calcium concentrations, nitric oxide, and camalexin production and the post-translational induction of MAPK activities. Microarray analysis performed with RNA prepared from PGN-treated Arabidopsis leaves revealed enhanced transcript levels for 236 genes, many of which are also altered upon administration of flagellin. Comparison of cellular responses after treatment with bacteria-derived PGN and structurally related fungal chitin indicated that both PAMPs are perceived via different perception systems. PGN-mediated immune stimulation in Arabidopsis is based upon recognition of the PGN sugar backbone, while muramyldipeptide, which is inactive in this plant, triggers immunity-associated responses in animals. PGN adds to the list of PAMPs that induce innate immune programs in both plants and animals. However, we propose that PGN perception systems arose independently in both lineages and are the result of convergent evolution.	Univ Tubingen, Ctr Plant Mol Biol Plant Biochem, D-72076 Tubingen, Germany; Tech Univ Munich, Dept Genet, D-85350 Freising Weihenstephan, Germany; Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle, Germany	Eberhard Karls University of Tubingen; Technical University of Munich; Leibniz Institut fur Pflanzenbiochemie	Gust, AA (corresponding author), Univ Tubingen, Ctr Plant Mol Biol Plant Biochem, Morgenstelle 5, D-72076 Tubingen, Germany.	andrea.gust@zmbp.uni-tuebingen.de	poinssot, benoit/B-2569-2009; Ranf, Stefanie/J-2474-2016; Lee, Justin/B-6096-2012	poinssot, benoit/0000-0001-5890-4318; Ranf, Stefanie/0000-0003-2262-2938; Lee, Justin/0000-0001-8269-7494; Glawischnig, Erich/0000-0001-9280-5065				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; ATKINSON MM, 1985, PLANT PHYSIOL, V79, P843, DOI 10.1104/pp.79.3.843; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Fuerst RAUA, 1996, PLANT PHYSIOL, V112, P1023, DOI 10.1104/pp.112.3.1023; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi M, 2007, MOL PLANT MICROBE IN, V20, P599, DOI 10.1094/MPMI-20-6-0599; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KNIGHT MR, 1992, P NATL ACAD SCI USA, V89, P4967, DOI 10.1073/pnas.89.11.4967; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Laird J, 2004, PLANTA, V219, P1089, DOI 10.1007/s00425-004-1355-x; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Raacke IC, 2006, MOL PLANT MICROBE IN, V19, P1138, DOI 10.1094/MPMI-19-1138; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Reutter F, 2005, J PEPT RES, V65, P375, DOI 10.1111/j.1399-3011.2005.00242.X; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; STEWARTTULL DES, 1980, ANNU REV MICROBIOL, V34, P311, DOI 10.1146/annurev.mi.34.100180.001523; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Traub S, 2006, J ENDOTOXIN RES, V12, P69, DOI 10.1179/096805106X89044; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	77	217	228	3	58	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32338	32348		10.1074/jbc.M704886200	http://dx.doi.org/10.1074/jbc.M704886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761682	hybrid			2022-12-27	WOS:000250480300057
J	Lubyova, B; Kellum, MJ; Frisancho, JA; Pitha, PM				Lubyova, Barbora; Kellum, Merrill J.; Frisancho, Jose A.; Pitha, Paula M.			Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY EFFUSION LYMPHOMA; INTERFERON REGULATORY FACTORS; EPSTEIN-BARR-VIRUS; CELL-CYCLE; B-CELL; TUMOR-SUPPRESSOR; BINDING PROTEIN; EXPRESSED GENES; LANA PROTEIN; KAPPA-B	Kaposi sarcoma-associated herpesvirus is associated with two lymphoproliferative disorders, primary effusion lymphoma ( PEL) and Castleman disease. In PEL, Kaposi sarcoma-associated herpesvirus is present in a latent form expressing only few viral genes. Among them is a viral homologue of cellular interferon regulatory factors, vIRF-3. To study the role of vIRF-3 in PEL lymphomagenesis, we analyzed the interaction of vIRF-3 with cellular proteins. Using yeast two-hybrid screen, we detected the association between vIRF-3 and c-Myc suppressor, MM-1 alpha. The vIRF-3 and MM-1 alpha interaction was also demonstrated by glutathione S-transferase pulldown assay and coimmunoprecipitation of endogenous vIRF-3 and MM-1 alpha in PEL-derived cell lines. Overexpression of vIRF-3 enhanced the c-Myc-dependent transcription of the gene cdk4. Addressing the molecular mechanism of the vIRF-3-mediated stimulation, we demonstrated that the association between MM-1 alpha and c-Myc was inhibited by vIRF-3. Furthermore, the recruitment of vIRF-3 to the cdk4 promoter and the elevated levels of the histone H3 acetylation suggest the direct involvement of vIRF-3 in the activation of c-Myc-mediated transcription. These findings indicate that vIRF-3 can effectively stimulate c-Myc function in PEL cells and consequently contribute to de-regulation of B-cell growth and differentiation.	Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague 12800, Czech Republic; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Charles University Prague; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Lubyova, B (corresponding author), Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Studnickova 7, Prague 12800, Czech Republic.	bluby@lf1.cuni.cz	Lubyova, Barbora/G-5921-2014	Lubyova, Barbora/0000-0002-8714-0414	NATIONAL CANCER INSTITUTE [R01CA076946] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA76946] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; Borah S, 2004, J VIROL, V78, P10336, DOI 10.1128/JVI.78.19.10336-10347.2004; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; Burysek L, 1999, J HUMAN VIROL, V2, P19; Carbone A, 1998, BRIT J HAEMATOL, V102, P1081, DOI 10.1046/j.1365-2141.1998.00877.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Dittmer DP, 2003, CANCER RES, V63, P2010; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Fulmer-Smentek SB, 2001, HUM MOL GENET, V10, P645, DOI 10.1093/hmg/10.6.645; Gaidano G, 1996, ACTA HAEMATOL-BASEL, V95, P193; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Guo HG, 2003, J VIROL, V77, P2631, DOI 10.1128/JVI.77.4.2631-2639.2003; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HERMEKING H, 1995, ONCOGENE, V11, P1409; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Jones KD, 1999, BLOOD, V94, P2871; Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Li MT, 1997, J VIROL, V71, P1984, DOI 10.1128/JVI.71.3.1984-1991.1997; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Lubyova B, 2004, J BIOL CHEM, V279, P7643, DOI 10.1074/jbc.M309485200; Lubyova B, 2000, J VIROL, V74, P8194, DOI 10.1128/JVI.74.17.8194-8201.2000; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Munoz-Fontela C, 2007, J VIROL, V81, P1511, DOI 10.1128/JVI.01816-06; Muralidhar S, 1998, J VIROL, V72, P4980, DOI 10.1128/JVI.72.6.4980-4988.1998; Offermann MK, 2007, CURR TOP MICROBIOL, V312, P185; Rivas C, 2001, J VIROL, V75, P429, DOI 10.1128/JVI.75.1.429-438.2001; Rodriguez-Puebla ML, 2002, AM J PATHOL, V161, P405, DOI 10.1016/S0002-9440(10)64196-X; Rui LX, 2006, CURR MOL MED, V6, P291, DOI 10.2174/156652406776894563; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Seo T, 2004, ONCOGENE, V23, P6146, DOI 10.1038/sj.onc.1207807; Talbot SJ, 1999, VIROLOGY, V257, P84, DOI 10.1006/viro.1999.9672; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	66	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31944	31953		10.1074/jbc.M706430200	http://dx.doi.org/10.1074/jbc.M706430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728244	hybrid			2022-12-27	WOS:000250480300015
J	Wu, PY; Frit, P; Malivert, L; Revy, P; Biard, D; Salles, B; Calsou, P				Wu, Pei-Yu; Frit, Philippe; Malivert, Laurent; Revy, Patrick; Biard, Denis; Salles, Bernard; Calsou, Patrick			Interplay between Cernunnos-XLF and nonhomologous end-joining proteins at DNA ends in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CLASS SWITCH RECOMBINATION; LIGASE-IV; V(D)J RECOMBINATION; PHOSPHORYLATION SITES; CATALYTIC SUBUNIT; KINASE; COMPLEX; PK; AUTOPHOSPHORYLATION	Cernunnos-XLF is the most recently identified core component in the nonhomologous end-joining (NHEJ) pathway for the repair of DNA double strand breaks (DSBs) in mammals. It associates with the XRCC4/ligase IV ligation complex and stimulates its activity in a still unknown manner. NHEJ also requires the DNA-dependent protein kinase that contains a Ku70/Ku80 heterodimer and the DNA-dependent protein kinase catalytic subunit. To understand the interplay between Cernunnos-XLF and the other proteins implicated in the NHEJ process, we have analyzed the interactions of Cernunnos-XLF and NHEJ proteins in cells after treatment with DNA double strand-breaking agents by means of a detergent-based cellular fractionation protocol. We report that Cernunnos-XLF is corecruited with the core NHEJ components on chromatin damaged with DSBs in human cells and is phosphorylated by the DNA-dependent protein kinase catalytic subunit. Our data show a pivotal role for DNA ligase IV in the NHEJ ligation complex assembly and recruitment to DSBs because the association of Cernunnos-XLF with the XRCC4/ligase IV complex relies primarily on the DNA ligase IV component, and an intact XRCC4/ligase IV complex is necessary for Cernunnos-XLF mobilization to damaged chromatin. Conversely, a Cernunnos-XLF defect has no apparent impact on the XRCC4/ligase IV association and recruitment to the DSBs or on the stimulation of the DNA-dependent protein kinase on DNA ends.	Univ Toulouse 2, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse 4, France; Hop Necker Enfants Malad, INSERM, Unite Dev Normal & Pathol Syst Immunitaire, U768, F-75015 Paris, France; Univ Paris 05, Fac Med Rene Descartes, F-75005 Paris, France; Direct Sci Vivant, Inst Radiol Cellulaire & Mol, Lab Genet Radiosenibilite, Commissariat Energie Atom, F-92265 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Salles, B (corresponding author), Univ Toulouse 2, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse 4, France.	bernard.salles@ipbs.fr	salles, bernard/B-8531-2008; Revy, Patrick/H-8137-2017; calsou, patrick/AAB-5123-2020	Calsou, Patrick/0000-0001-7951-9806; BIARD, Denis Serge Francois/0000-0001-9697-4392; Revy, Patrick/0000-0003-0758-8022; Malivert, Laurent/0000-0002-0944-6573				Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Ahnesorg P, 2007, DNA REPAIR, V6, P190, DOI 10.1016/j.dnarep.2006.09.010; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Callebaut I, 2006, J BIOL CHEM, V281, P13857, DOI 10.1074/jbc.C500473200; Cantagrel V, 2007, HUM MUTAT, V28, P356, DOI 10.1002/humu.20450; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Despras E, 2007, CANCER RES, V67, P2526, DOI 10.1158/0008-5472.CAN-06-3371; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Drouet J, 2006, J BIOL CHEM, V281, P27784, DOI 10.1074/jbc.M603047200; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Hoppe BS, 2000, RADIAT RES, V153, P125, DOI 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2; Hsu HL, 2002, DNA REPAIR, V1, P225, DOI 10.1016/S1568-7864(01)00018-0; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee KJ, 2004, DNA REPAIR, V3, P267, DOI 10.1016/j.dnarep.2003.11.005; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Revy P, 2006, CURR OPIN ALLERGY CL, V6, P416, DOI 10.1097/01.all.0000246623.72365.43; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Salles B, 2006, PATHOL BIOL, V54, P185, DOI 10.1016/j.patbio.2006.01.012; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	43	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31937	31943		10.1074/jbc.M704554200	http://dx.doi.org/10.1074/jbc.M704554200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17720816	hybrid			2022-12-27	WOS:000250480300014
J	Mazzulli, JR; Armakola, M; Dumoulin, M; Parastatidis, I; Ischiropoulos, H				Mazzulli, Joseph R.; Armakola, Maria; Dumoulin, Michelle; Parastatidis, Ioannis; Ischiropoulos, Harry			Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a c-terminal sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; PARKINSONS-DISEASE; MUTATION; AGGREGATION; DOPAMINE; MICE; NEUROTOXICITY; PROTEIN; STABILIZATION; PROTEASOME	The mechanisms that govern the formation of alpha-synuclein (alpha-syn) aggregates are not well understood but are considered a central event in the pathogenesis of Parkinson's disease (PD). A critically important modulator of alpha-syn aggregation in vitro is dopamine and other catechols, which can prevent the formation of alpha-syn aggregates in cell-free and cellular model systems. Despite the profound importance of this interaction for the pathogenesis of PD, the processes by which catechols alter alpha-syn aggregation are unclear. Molecular and biochemical approaches were employed to evaluate the mechanism of catechol-alpha-syn interactions and the effect on inclusion formation. The data show that the intracellular inhibition of alpha-syn aggregation requires the oxidation of catechols and the specific noncovalent interaction of the oxidized catechols with residues (YEMPS129)-Y-125 in the C-terminal region of the protein. Cell-free studies using novel near infrared fluorescence methodology for the detection of covalent protein-ortho-quinone adducts showed that although covalent modification of alpha-syn occurs, this does not affect alpha-syn fibril formation. In addition, oxidized catechols are unable to prevent both thermal and acid- induced protein aggregation as well as fibrils formed from a protein that lacks a YEMPS amino acid sequence, suggesting a specific effect for alpha-syn. These results suggest that inappropriate C-terminal cleavage of alpha-syn, which is known to occur in vivo in PD brain or a decline of intracellular catechol levels might affect disease progression, resulting in accelerated alpha-syn inclusion formation and dopaminergic neurodegeneration.	Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ischiropoulos, H (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu		Bridi, Michelle/0000-0001-5533-5092	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013966] Funding Source: NIH RePORTER; NIA NIH HHS [AG13966] Funding Source: Medline; NIEHS NIH HHS [ES013508] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nakashima A, 2002, J NEUROCHEM, V82, P202, DOI 10.1046/j.1471-4159.2002.00921.x; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; PAZ MA, 1991, J BIOL CHEM, V266, P689; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	66	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31621	31630		10.1074/jbc.M704737200	http://dx.doi.org/10.1074/jbc.M704737200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785456	hybrid			2022-12-27	WOS:000250309200054
J	Kommagani, R; Payal, V; Kadakia, MP				Kommagani, Ramakrishna; Payal, Vandana; Kadakia, Madhavi P.			Differential regulation of vitamin D receptor (VDR) by the p53 family - p73-dependent induction of VDR upon DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HUMAN CANCERS; TARGET GENES; P73 FUNCTION; MUTANT P53; CELL-DEATH; IN-VIVO; P63; APOPTOSIS; ACTIVATION	p63 and p73, members of the p53 family, have been shown to be functionally distinct from p53. VitaminD receptor ( VDR) is a ligand ( vitamin D3)- dependent transcription factor, which is shown to play a major role in calcium homeostasis and keratinocyte differentiation. VitaminD and its analogues in combination with DNA- damaging agents are extensively used for cancer chemotherapy. In this report, we examined whether p53 affects p63- mediated induction of VDR and studied the effect of DNA damage on VDR induction in p53 null cell lines. Our results demonstrate that p53 itself does not induce VDR expression, nor does it affect p63- mediated VDR induction in the cell lines tested in this study. Furthermore, we observed p53- independent activation of VDR upon DNA damage and associated the induction of VDR to p73. We have demonstrated that ectopic expression of various p73 isoforms can induce VDR expression. Inhibition of p73 in cells treated with DNA- damaging agents exhibited decreased VDR expression. Finally, we show that upon DNA damage, induction of VDR sensitizes the cells to vitaminD treatment. In conclusion, our results indicate that VDR is regulated by p63 and p73 and that the induction of VDR expression upon DNA damage is p73- dependent.	Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Wright State Univ, Ctr Genom Res, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Kadakia, MP (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, 3640 Col Glenn Hwy, Dayton, OH 45435 USA.	madhavi.kadakia@wright.edu		Kommagani, Ramakrishna/0000-0003-0403-0971	NCI NIH HHS [R21 CA118315-01A1, R21 CA118315, CA118315-2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA118315] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Demay MB, 2006, ANN NY ACAD SCI, V1068, P204, DOI 10.1196/annals.1346.026; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dietz S, 2002, FEBS LETT, V525, P93, DOI 10.1016/S0014-5793(02)03093-4; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gombart AF, 2006, ANTICANCER RES, V26, P2531; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hawker NP, 2007, J INVEST DERMATOL, V127, P874, DOI 10.1038/sj.jid.5700624; Hershberger PA, 2002, MOL CANCER THER, V1, P821; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kang KH, 2002, FEBS LETT, V522, P161, DOI 10.1016/S0014-5793(02)02921-6; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Nezbedova P, 2004, Endocr Regul, V38, P29; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Prabhu NS, 1998, INT J ONCOL, V13, P5; Rashid SF, 2001, STEROIDS, V66, P433, DOI 10.1016/S0039-128X(00)00203-8; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Senoo M, 2002, ONCOGENE, V21, P2455, DOI 10.1038/sj.onc.1205330; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; Torres R, 2000, MOL CELL BIOCHEM, V208, P157, DOI 10.1023/A:1007089632152; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	48	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29847	29854		10.1074/jbc.M703641200	http://dx.doi.org/10.1074/jbc.M703641200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716971	Green Accepted, hybrid			2022-12-27	WOS:000249981200013
J	Xiong, YL; Burton, ZF				Xiong, Yalin; Burton, Zachary F.			A tunable ratchet driving human RNA polymerase II translocation adjusted by accurately templated nucleoside triphosphates loaded at downstream sites and by elongation factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NTP-DRIVEN TRANSLOCATION; 3.3 ANGSTROM RESOLUTION; STATE KINETIC-ANALYSIS; STRUCTURAL BASIS; TRANSCRIPTION ELONGATION; DEPENDENT RNA-POLYMERASE-(3D(POL)); RIBONUCLEOTIDE INCORPORATION; ALLOSTERIC BINDING; ACTIVE-CENTER; TRIGGER LOOP	When nucleoside triphosphate (NTP) substrates and alpha-amanitin are added to a human RNA polymerase II elongation complex simultaneously, the reaction becomes stalled in the core of the bond synthesis mechanism. The mode of stalling is influenced by NTP substrates at the active site and at downstream sites and by transcription factor IIF (TFIIF) and TFIIS. NTP substrates templated at i + 2, i + 3, and i + 4 downstream DNA sites can reverse the previously stable binding of an NTP loaded at the i + 1 substrate site. Deoxy-(d)NTPs and NDPs (nucleoside diphosphates) do not substitute for NTPs at the i + 2 and i + 3 positions (considered together) or the i + 4, i + 5, and i + 6 positions (considered together). The mode of stalling is altered by changing the number of downstream template sites that are accurately occupied by NTPs and by changing NTP concentration. In the presence of the translocation blocker alpha-amanitin, a steady state condition is established in which RNA polymerase II stably loads an NTP substrate at i + 1 and forms a phosphodiester bond but cannot rapidly complete bond synthesis by releasing pyrophosphate. These observations support a role for incoming NTP substrates in stimulating translocation; results appear inconsistent with the secondary pore being the sole route of NTP entry for human RNA polymerase II, and results indicate mechanisms of dynamic error avoidance and error correction during rapid RNA synthesis.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Burton, ZF (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	burton@msu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057461] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 057461] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Batada NN, 2004, P NATL ACAD SCI USA, V101, P17361, DOI 10.1073/pnas.0408168101; Burton ZF, 2005, BIOCHEM CELL BIOL, V83, P486, DOI 10.1139/O05-059; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kahl BF, 2000, J MOL BIOL, V299, P75, DOI 10.1006/jmbi.2000.3743; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	33	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36582	36592		10.1074/jbc.M707014200	http://dx.doi.org/10.1074/jbc.M707014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17875640	hybrid			2022-12-27	WOS:000251458300051
J	Kozlov, G; Nguyen, L; Lin, T; De Crescenzo, G; Park, M; Gehring, K				Kozlov, Guennadi; Nguyen, Long; Lin, Tong; De Crescenzo, Gregory; Park, Morag; Gehring, Kalle			Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; MEDIATED DIMERIZATION; BINDING-PROTEIN; CUE DOMAIN; COMPLEX; PATHWAY; SURFACE	EDD (or HYD) is an E3 ubiquitin ligase in the family of HECT (homologous to E6-AP C terminus) ligases. EDD contains an N-terminal ubiquitin-associated (UBA) domain, which is present in a variety of proteins involved in ubiquitin-mediated processes. Here, we use isothermal titration calorimetry (ITC), NMR titrations, and pull-down assays to show that the EDD UBA domain binds ubiquitin. The 1.85 angstrom crystal structure of the complex with ubiquitin reveals the structural basis of ubiquitin recognition by UBA helices alpha 1 and alpha 3. The structure shows a larger number of intermolecular hydrogen bonds than observed in previous UBA/ubiquitin complexes. Two of these involve ordered water molecules. The functional importance of residues at the UBA/ubiquitin interface was confirmed using site-directed mutagenesis. Surface plasmon resonance (SPR) measurements show that the EDDUBA domain does not have a strong preference for polyubiquitin chains over monoubiquitin. This suggests that EDD binds to monoubiquitinated proteins, which is consistent with its involvement in DNA damage repair pathways.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; Ecole Polytech, Dept Genie Chim, Montreal, PQ H3T 1J4, Canada	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Polytechnique Montreal	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Nguyen, Long/0000-0002-3347-438X				BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	47	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35787	35795		10.1074/jbc.M705655200	http://dx.doi.org/10.1074/jbc.M705655200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897937	hybrid			2022-12-27	WOS:000251458100040
J	Basile, JR; Gavard, J; Gutkind, JS				Basile, John R.; Gavard, Julie; Gutkind, J. Silvio			Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; FOCAL ADHESION KINASE; PDZ-RHOGEF; RECEPTOR PLEXIN-B1; AXON GUIDANCE; R-RAS; SEMAPHORIN; MECHANISM	The semaphorins are a family of proteins originally identified as axon-guiding molecules in the developing nervous system that have been recently shown to regulate many cellular functions, including motility, in a variety of cell types. We have previously shown that in endothelial cells Semaphorin 4D acts through its receptor, Plexin-B1, to elicit a pro-angiogenic phenotype that involves the activation of the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. Here we show through the use of a receptor chimeric approach, Plexin-B1 mutants, and dominant negative and pharmacological inhibitors that this response is dependent upon the activation of RhoA and its downstream target, Rho kinase (ROK). Indeed, we demonstrate that in endothelial cells, Semaphorin 4D promotes the formation of focal adhesion complexes, stress fibers, and the phosphorylation of myosin light chain, a response that was abolished by the use of ROK inhibitors and absent from cells expressing Plexin-B1 mutant constructs incapable of signaling to RhoA. Stress fiber polymerization and contraction are in turn necessary for RhoA-dependent pro-angiogenic signaling through Plexin-B1. Furthermore, we observed that in endothelial cells Plexin-B1 promotes the integrin-mediated activation of Pyk2, resulting in the stimulation of PI3K, Akt, and ERK. These findings provide evidence that Plexin-B1 promotes endothelial cell motility through RhoA and ROK by regulating the integrin-dependent signaling networks that result in the activation of PI3K and Akt.	NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gavard, Julie/I-5487-2012; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Gutkind, J. Silvio/0000-0002-5150-4482; Gavard, Julie/0000-0003-3107-2026	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALBINI A, 1987, J CELL BIOL, V105, P1867, DOI 10.1083/jcb.105.4.1867; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Aurandt J, 2006, BIOCHEM J, V394, P459, DOI 10.1042/BJ20051123; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BISMUTH G, 2002, SCI STKE, pRE4; BRETTI S, 1989, INT J CANCER, V43, P102, DOI 10.1002/ijc.2910430120; Brown CB, 2001, DEVELOPMENT, V128, P3071; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Christensen CRL, 1998, CANCER RES, V58, P1238; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Katz BZ, 2002, BBA-MOL CELL RES, V1592, P141, DOI 10.1016/S0167-4889(02)00308-7; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kreuter M, 2002, ANN HEMATOL, V81, pS74; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; OINUMA I, 2006, J CELL BIOL; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Spriggs MK, 1999, CURR OPIN IMMUNOL, V11, P387, DOI 10.1016/S0952-7915(99)80065-X; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2	54	94	108	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34888	34895		10.1074/jbc.M705467200	http://dx.doi.org/10.1074/jbc.M705467200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855350	hybrid			2022-12-27	WOS:000251155200031
J	Sugimoto, I; Futakawa, S; Oka, R; Ogawa, K; Marth, JD; Miyoshi, E; Taniguchi, N; Hashimoto, Y; Kitazume, S				Sugimoto, Ichiro; Futakawa, Satoshi; Oka, Ritsuko; Ogawa, Kazuko; Marth, Jamey D.; Miyoshi, Eiji; Taniguchi, Naoyuki; Hashimoto, Yasuhiro; Kitazume, Shinobu			beta-galactoside alpha 2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins - A novel regulatory mechanism for alpha 2,6-sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; HEREDITARY HEPATITIS; ASPARTYL PROTEASE; GOLGI-APPARATUS; KNOCKOUT MICE; ST6GAL I; SECRETASE; SIALYLTRANSFERASE; IDENTIFICATION	BACE1((beta) under bar -site (a) under bar myloid precursor protein-(c) under bar leaving (e) under bar nzyme-(1) under bar) is a membrane-bound aspartic protease that cleaves amyloid precursor protein to produce a neurotoxic peptide, amyloid beta-peptide, and has been implicated in triggering the pathogenesis of Alzheimer disease. We showed previously that BACE1 cleaves beta-galactoside alpha 2,6-sialyltransferase I (ST6Gal I) to initiate its secretion, but it remained unclear how BACE1 affects the cellular level of alpha 2,6-sialylation. Here, we found that BACE1 overexpression in Hep3B cells increased the sialylation of soluble secreted glycoproteins, but did not affect cell-surface sialylation. The sialylation of soluble glycoproteins was not increased by ST6Gal I overexpression alone, but was increased by co-overexpression of ST6Gal I and BACE1 or by expression of the soluble form of ST6Gal I, suggesting that soluble ST6Gal I produced by BACE1 plays, at least in part, a role in the sialylation of soluble glycoproteins. We also found that plasma glycoproteins from BACE1-deficient mice exhibited reduced levels of alpha 2,6-sialylation compared with those from wild-type mice. We propose a novel regulatory mechanism in which cleavage and secretion of ST6Gal I enhance the sialylation of soluble glycoprotein substrates.	RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Res Grp, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 5600082, Japan; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 565871, Japan; Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan	RIKEN; Japan Science & Technology Agency (JST); University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Osaka University; Fukushima Medical University	Kitazume, S (corresponding author), RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968				ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; ELHAMMER A, 1986, J BIOL CHEM, V261, P5249; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume-Kawaguchi S, 1999, GLYCOBIOLOGY, V9, P1397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mori M., 1991, LEC RAT NEW MODEL HE; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; SARNESTO A, 1990, J BIOL CHEM, V265, P15067; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; WEN DX, 1992, J BIOL CHEM, V267, P2512; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416	37	40	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34896	34903		10.1074/jbc.M704766200	http://dx.doi.org/10.1074/jbc.M704766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897958	hybrid			2022-12-27	WOS:000251155200032
J	Squires, RC; Muehlbauer, SM; Brojatsch, J				Squires, Raynal C.; Muehlbauer, Stefan M.; Brojatsch, Juergen			Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE REPAIR; CA2+-REGULATED EXOCYTOSIS; INFLAMMATORY CASPASES; IMMUNE-RESPONSE; KINASE-KINASE; MACROPHAGES; PROTEIN; APOPTOSIS; INACTIVATION; PATHOGENESIS	Activation of caspase-1 through the inflammasome protein Nalp1b controls anthrax lethal toxin (LT)-induced necrosis in murine macrophages. In this study we analyzed physiological changes controlled by caspase-1 in LT-treated murine macrophages. The caspase-1 inhibitor Boc-D-cmk blocked caspase-1 activity and membrane impairment in LT-treated cells. To determine the relationship between caspase-1 activation and membrane integrity, we added Boc-D-cmk to J774A.1 macrophages at different time points following LT exposure. Remarkably, Boc-D-cmk rescued LT-treated macrophages, even when added at the peak of caspase-1 activation. Late addition of the caspase-1 inhibitor reversed the losses of plasma membrane integrity and metabolic activity in these cells. Similar results were obtained with the proteasome inhibitor MG132, one of the most potent inhibitors of LT toxicity. LT-treated macrophages displaying evidence of membrane impairment recovered upon the addition of MG132, mirroring the Boc-D-cmk response. Strikingly, late addition of proteasome inhibitors also abrogated caspase-1 activity in LT-treated macrophages. Proteasomal control of caspase-1 activity and membrane impairment, however, was restricted to LT-induced cytolysis, because proteasome inhibitors did not block caspase-1 activation and cell death triggered by lipopolysaccharide and nigericin. Our findings indicate that proteasome inhibitors do not target caspase-1 directly but instead control an upstream event in LT-treated macrophages leading to caspase-1 activation. Taken together, caspase-1-mediated necrosis appears to be tightly controlled and differentially regulated by proteasomes depending on the source of caspase-1 induction.	Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	brojatsc@aecom.yu.edu		brojatsch, jurgen/0000-0002-7424-365X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 057158] Funding Source: Medline; NIGMS NIH HHS [T32 GM 007288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Andrews NW, 2005, EMBO REP, V6, P826, DOI 10.1038/sj.embor.7400505; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; HANNA PC, 1992, MOL BIOL CELL, V3, P1269, DOI 10.1091/mbc.3.11.1269; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498; Lin CG, 1996, CURR MICROBIOL, V33, P224, DOI 10.1007/s002849900104; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Miyake K, 2003, CRIT CARE MED, V31, pS496, DOI 10.1097/01.CCM.0000081432.72812.16; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Watters JW, 2001, CURR BIOL, V11, P1503, DOI 10.1016/S0960-9822(01)00476-6; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev	60	66	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34260	34267		10.1074/jbc.M705687200	http://dx.doi.org/10.1074/jbc.M705687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878154	hybrid			2022-12-27	WOS:000251145700041
J	Wiznerowicz, M; Jakobsson, J; Szulc, J; Liao, S; Quazzola, A; Beermann, F; Aebischer, P; Trono, D				Wiznerowicz, Maciej; Jakobsson, Johan; Szulc, Jolanta; Liao, Shunyao; Quazzola, Alexandra; Beermann, Friedrich; Aebischer, Patrick; Trono, Didier			The Kruppel-associated box repressor domain can trigger de Novo promoter methylation during mouse early embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; MAMMALIAN DEVELOPMENT; LENTIVIRAL VECTORS; PATERNAL GENOME; KRAB; COREPRESSOR; TIF1-BETA	The Kruppel-associated box (KRAB) domain is a transcriptional repression module responsible for the DNA binding-dependent gene silencing activity of hundreds of vertebrate zinc finger proteins. We previously exploited KRAB-mediated repression within the context of a tet repressor-KRAB fusion protein and of lentiviral vectors to create a method of external gene control. We demonstrated that with this system transcriptional silencing was fully reversible in cell culture as well as in vivo. Here we reveal that, in sharp contrast, KRAB-mediated repression results in irreversible gene silencing through promoter DNA methylation if it acts during the first few days of mouse development.	Ecole Polytech Fed Lausanne, Frontier Genet Natl Ctr Competence Res, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, EPFL SV DO, Stn 15, Bldg AAB, CH-1015 Lausanne, Switzerland.	dider.trono@epfl.ch	Aebischer, Patrick/E-1387-2013; Liao, Shunyao/M-4123-2018; Jakobsson, Johan/E-7745-2014	Jakobsson, Johan/0000-0003-0669-7673				Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cammas F, 2000, DEVELOPMENT, V127, P2955; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Fedorov LM, 2001, TRANSGENIC RES, V10, P247, DOI 10.1023/A:1016632110931; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Ikeda R, 2007, MOL CELL BIOL, V27, P1665, DOI 10.1128/MCB.01500-06; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ju HS, 2001, P NATL ACAD SCI USA, V98, P7469, DOI 10.1073/pnas.131147598; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nagy A, 2003, MANIPULATING MOUSE E, P453; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Ponger L, 2001, GENOME RES, V11, P1854, DOI 10.1101/gr.174501; Sanchez JP, 2006, PLANT BIOTECHNOL J, V4, P103, DOI 10.1111/j.1467-7652.2005.00161.x; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Weber P, 2002, DEVELOPMENT, V129, P2329; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	38	81	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34535	34541		10.1074/jbc.M705898200	http://dx.doi.org/10.1074/jbc.M705898200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893143	hybrid			2022-12-27	WOS:000251145700068
J	Chen, BB; Mallampalli, RK				Chen, Bill. B.; Mallampalli, Rama K.			Calmodulin binds and stabilizes the regulatory enzyme, CTP : Phosphocholine cytidylyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PHOSPHATIDYLCHOLINE SYNTHESIS; KAPPA-B-ALPHA; CALPAIN PROTEOLYSIS; PEST SEQUENCES; MU-CALPAIN; II CELLS; IN-VIVO; PROTEIN; MEMBRANE; GENE	CTP: phosphocholine cytidylyltransferase (CCT alpha) is a proteolytically sensitive enzyme essential for production of phosphatidylcholine, the major phospholipid of animal cell membranes. The molecular signals that govern CCT alpha protein stability are unknown. An NH2-terminal PEST sequence within CCT alpha did not serve as a degradation signal for the proteinase, calpain. Calmodulin (CaM) stabilized CCT alpha from calpain proteolysis. Adenoviral gene transfer of CaM in cells protected CCT alpha, whereas CaM small interfering RNA accentuated CCT alpha degradation by calpains. CaM bound CCT alpha as revealed by fluorescence resonance energy transfer and two-hybrid analysis. Mapping and site-directed mutagenesis of CCT alpha uncovered a motif (LQERVDKVK) harboring a vital recognition site, Gln(243), whereby CaM directly binds to the enzyme. Mutagenesis of CCT alpha Gln(243) not only resulted in loss of CaM binding but also led to complete calpain resistance in vitro and in vivo. Thus, calpains and CaM both access CCT alpha using a structurally similar molecular signature that profoundly affects CCT alpha levels. These data suggest that CaM, by antagonizing calpain, serves as a novel binding partner for CCT alpha that stabilizes the enzyme under proinflammatory stress.	Univ Iowa, Div Pulm & Crit Care, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs Med Ctr, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Mallampalli, RK (corresponding author), Univ Iowa, Div Pulm & Crit Care, Dept Internal Med, Roy J & Lucille A Carver Coll Med, C-33K,GH, Iowa City, IA 52242 USA.	ramamallampalli@uiowa.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080229, R01HL071040, R01HL068135, R01HL081784] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071040, HL068135, HL081784, HL080229] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; BEYNON RJ, 1986, AM J PHYSIOL, V251, pC141, DOI 10.1152/ajpcell.1986.251.2.C141; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BOTBOL V, 1983, J BIOL CHEM, V258, P1942; BRANDT NR, 1992, J MEMBRANE BIOL, V127, P35; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Choi I, 2005, J BIOTECHNOL, V120, P251, DOI 10.1016/j.jbiotec.2005.06.014; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Erdman DD, 2002, EMERG INFECT DIS, V8, P269, DOI 10.3201/eid0803.010190; Ferrington DA, 1997, BIOCHEM BIOPH RES CO, V237, P163, DOI 10.1006/bbrc.1997.7105; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; Gul A, 2006, NEUROGENETICS, V7, P105, DOI 10.1007/s10048-006-0042-4; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Henderson FC, 2006, J LIPID RES, V47, P2314, DOI 10.1194/jlr.M600284-JLR200; Ishii M, 2005, BIOCHEM BIOPH RES CO, V338, P839, DOI 10.1016/j.bbrc.2005.10.026; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; Lagace TA, 2005, BIOCHEM J, V392, P449, DOI 10.1042/BJ20051021; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; MOLINARI M, 1995, J BIOL CHEM, V270, P14576, DOI 10.1074/jbc.270.24.14576; OFULUE AF, 1993, PEDIATR PULM, V15, P145, DOI 10.1002/ppul.1950150304; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P441, DOI 10.1016/0005-2760(84)90170-X; POST M, 1984, BIOCHIM BIOPHYS ACTA, V795, P552, DOI 10.1016/0005-2760(84)90185-1; Rasouli M, 2004, BBA-MOL CELL BIOL L, V1682, P92, DOI 10.1016/j.bbalip.2004.02.002; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sugimoto H, 2005, J BIOL CHEM, V280, P40857, DOI 10.1074/jbc.M503578200; Sun H, 2001, BIOCHEMISTRY-US, V40, P9605, DOI 10.1021/bi0104266; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Walker G, 2001, BBA-GEN SUBJECTS, V1568, P216, DOI 10.1016/S0304-4165(01)00223-9; Wang JH, 1996, AM J PHYSIOL-LUNG C, V271, pL245, DOI 10.1152/ajplung.1996.271.2.L245; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	45	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33494	10.1074/jbc.M706472200	http://dx.doi.org/10.1074/jbc.M706472200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17804406	hybrid			2022-12-27	WOS:000250840200030
J	Kanayasu-Toyoda, T; Ishii-Watabe, A; Suzuki, T; Oshizawa, T; Yamaguchi, T				Kanayasu-Toyoda, Toshie; Ishii-Watabe, Akiko; Suzuki, Takayoshi; Oshizawa, Tadashi; Yamaguchi, Teruhide			A new role of thrombopoietin enhancing ex vivo expansion of endothelial precursor cells derived from AC133-positive cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; C-MPL; NEUTROPHILIC DIFFERENTIATION; 3-KINASE ACTIVATION; PERIPHERAL-BLOOD; HL-60 CELLS; PROLIFERATION; TRANSPLANTATION; ERYTHROPOIETIN	We previously reported that CD31(bright) cells, which were sorted from cultured AC133(+) cells of adult peripheral blood cells, differentiated more efficiently into endothelial cells than CD31(+) cells or CD31(-) cells, suggesting that CD31(bright) cells may be endothelial precursor cells. In this study, we found that CD31bright cells have a strong ability to release cytokines. The mixture of vascular endothelial growth factor ( VEGF), thrombopoietin (TPO), and stem cell factor stimulated ex vivo expansion of the total cell number from cultured AC133(+) cells of adult peripheral blood cells and cord blood cells, resulting in incrementation of the adhesion cells, in which endothelial nitric oxide synthase and kinase insert domain-containing receptor were positive. Moreover, the mixture of VEGF and TPO increased the CD31bright cell population when compared with VEGF alone or the mixture of VEGF and stem cell factor. These data suggest that TPO is an important growth factor that can promote endothelial precursor cells expansion ex vivo.	Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Yamaguchi, T (corresponding author), Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	yamaguch@nihs.go.jp	SUZUKI, TAKAYOSHI/ABA-2386-2020	SUZUKI, TAKAYOSHI/0000-0002-2261-5263				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Brizzi MF, 1999, CIRC RES, V84, P785; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; George J, 2005, ARTERIOSCL THROM VAS, V25, P2636, DOI 10.1161/01.ATV.0000188554.49745.9e; Gill M, 2001, CIRC RES, V88, P167; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kanayasu-Toyoda T, 2003, J CELL PHYSIOL, V195, P119, DOI 10.1002/jcp.10229; Kanayasu-Toyoda T, 1999, J BIOL CHEM, V274, P25471, DOI 10.1074/jbc.274.36.25471; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KAUSHANSKY K, 1995, J CLIN INVEST, V96, P1683, DOI 10.1172/JCI118210; Kaushansky K, 1996, EXP HEMATOL, V24, P265; Kawamoto A, 2001, CIRCULATION, V103, P634; KELEMEN E., 1958, ACTA HAEMATOL, V20, P350; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; KOBAYASHI M, 1995, BLOOD, V86, P2494; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Miyamoto K, 2006, CIRCULATION, V114, P2679, DOI 10.1161/CIRCULATIONAHA.106.644203; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Yamaguchi T, 1999, J BIOL CHEM, V274, P15575, DOI 10.1074/jbc.274.22.15575; YAMAMOTO S, 1957, ACTA HAEMATOL JPN, V20, P163; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433	44	7	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33507	10.1074/jbc.M703919200	http://dx.doi.org/10.1074/jbc.M703919200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827152	hybrid			2022-12-27	WOS:000250840200031
J	Kashiwayama, Y; Asahina, K; Morita, M; Imanaka, T				Kashiwayama, Yoshinori; Asahina, Kota; Morita, Masashi; Imanaka, Tsuneo			Hydrophobic regions adjacent to transmembrane domains 1 and 5 are important for the targeting of the 70-kDa peroxisomal membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADRENOLEUKODYSTROPHY PROTEIN; RAT-LIVER PEROXISOMES; ZELLWEGER-SYNDROME; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; ABC TRANSPORTERS; INTERNAL REGION; POTENTIAL ROLE; HUMAN PEX19P	The 70-kDa peroxisomal membrane protein (PMP70) is a major component of peroxisomal membranes. Human PMP70 consists of 659 amino acid residues and has six putative transmembrane domains (TMDs). PMP70 is synthesized on cytoplasmic ribosomes and targeted posttranslationally to peroxisomes by an unidentified peroxisomal membrane protein targeting signal (mPTS). In this study, to examine the mPTS within PMP70 precisely, we expressed various COOH-terminally or NH2-terminally deleted constructs of PMP70 fused with green fluorescent protein (GFP) in Chinese hamster ovary cells and determined their intracellular localization by immunofluorescence. In the COOH-terminally truncated PMP70, PMP70(AA.1-144)-GFP, including TMD1 and TMD2 of PMP70, was still localized to peroxisomes. However, by further removal of TMD2, PMP70(AA.1-124)-GFP lost the targeting ability, and PMP70( TMD2)-GFP did not target to peroxisomes by itself. The substitution of TMD2 in PMP70( AA.1-144)-GFP for TMD4 or TMD6 did not affect the peroxisomal localization, suggesting that PMP70(AA.1-124) contains the mPTS and an additional TMD is required for the insertion into the peroxisomal membrane. In the NH2-terminal 124-amino acid region, PMP70 possesses hydrophobic segments in the region adjacent to TMD1. By the disruption of these hydrophobic motifs by the mutation of L21Q/L22Q/L23QorI70N/L71Q, PMP70( AA.1-144)-GFP lost targeting efficiency. The NH2-terminally truncated PMP70, GFP-PMP70(AA.263-375), including TMD5 and TMD6, exhibited the peroxisomal localization. PMP70( AA.263-375) also possesses hydrophobic residues (Ile(307)/Leu(308)) in the region adjacent to TMD5, which were important for targeting. These results suggest that PMP70 possesses two distinct targeting signals, and hydrophobic regions adjacent to the first TMD of each region are important for targeting.	Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan	University of Toyama	Imanaka, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	imanaka@pha.u-toyama.ac.jp						Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Biermanns M, 2001, BIOCHEM BIOPH RES CO, V285, P649, DOI 10.1006/bbrc.2001.5220; Brosius U, 2002, J BIOL CHEM, V277, P774, DOI 10.1074/jbc.M108155200; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Chang CC, 1999, J CELL SCI, V112, P1579; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Girzalsky W, 2006, J BIOL CHEM, V281, P19417, DOI 10.1074/jbc.M603344200; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graf SA, 2004, J BIOL CHEM, V279, P42954, DOI 10.1074/jbc.M405040200; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; HARTL FU, 1987, ARCH BIOCHEM BIOPHYS, V255, P109, DOI 10.1016/0003-9861(87)90300-6; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Honsho M, 2001, J BIOL CHEM, V276, P9375, DOI 10.1074/jbc.M003304200; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 1996, J BIOL CHEM, V271, P3706; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Jones JM, 2001, J CELL BIOL, V153, P1141, DOI 10.1083/jcb.153.6.1141; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1994, METABOLIC BASIS INHE, P2287; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; MCCAMMON MT, 1994, J CELL BIOL, V124, P915, DOI 10.1083/jcb.124.6.915; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Pause B, 2000, FEBS LETT, V471, P23, DOI 10.1016/S0014-5793(00)01332-6; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Shani N, 1998, METHOD ENZYMOL, V292, P753; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Vizeacoumar FJ, 2006, J BIOL CHEM, V281, P14805, DOI 10.1074/jbc.M601808200; Wang XD, 2004, MOL BIOL CELL, V15, P1702, DOI 10.1091/mbc.E03-11-0810; Wang XD, 2001, J BIOL CHEM, V276, P10897, DOI 10.1074/jbc.M010883200; YOKOTA S, 1982, J HISTOCHEM CYTOCHEM, V29, P805	58	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33831	33844		10.1074/jbc.M703369200	http://dx.doi.org/10.1074/jbc.M703369200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17761678	hybrid			2022-12-27	WOS:000250840200065
J	Zhang, XM; Ling, MT; Wang, Q; Lau, CK; Leung, SCL; Lee, TK; Cheung, ALM; Wong, YC; Wang, XH				Zhang, Xiaomeng; Ling, Ming-Tat; Wang, Qi; Lau, Chi-Keung; Leung, Steve C. L.; Lee, Terence K.; Cheung, Annie L. M.; Wong, Yong-Chuan; Wang, Xianghong			Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; E-CADHERIN EXPRESSION; BREAST-CANCER; CELLULAR SENESCENCE; TUMOR PROGRESSION; MOLECULAR TARGET; DNA-BINDING; PATHWAY; ACTIVATION; OVEREXPRESSION	Recently, ID-1 (inhibitor of differentiation/DNA binding) is suggested as an oncogene and is reported to promote cell proliferation, invasion, and survival in several types of human cancer cells through multiple signaling pathways. However, how Id-1 interacts with these pathways and the immediate downstream effectors of the Id-1 protein are not known. In this study, using a yeast two-hybrid screening technique, we identified a novel Id-1-interacting protein, caveolin-1 (Cav-1), a cell membrane protein, and a positive regulator of cell survival and metastasis in prostate cancer. Using an immunoprecipitation method, we found that the helix-loop-helix domain of the Id-1 protein was essential for the physical interaction between Id-1 and Cav-1. In addition, we also demonstrated that the physical interaction between Id-1 and Cav-1 played a key role in the epithelial-mesenchymal transition and increased cell migration rate as well as resistance to taxol-induced apoptosis in prostate cancer cells. Furthermore, our results revealed that this effect was regulated by Id-1-induced Akt activation through promoting the binding activity between Cav-1 and protein phosphatase 2A. Our study demonstrates a novel Id-1 binding partner and suggests a molecular mechanism that mediates the function of Id-1 in promoting prostate cancer progression through activation of the Akt pathway leading to cancer cell invasion and resistance to anticancer drug-induced apoptosis.	Univ Hong Kong, Fac Med Bldg, Dept Anat, Canc Biol Grp, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Fac Med, Dept Surg, Canc Biol Grp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, YC (corresponding author), Univ Hong Kong, Fac Med Bldg, Dept Anat, Canc Biol Grp, 1-F,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	ycwong@hkucc.hku.hk; xhwang@hkucc.hku.hk	; /C-4230-2009	Lee, Kin Wah/0000-0003-0682-322X; /0000-0003-3217-1456				Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Aldred MA, 2003, CANCER RES, V63, P2864; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; Bender FC, 2000, CANCER RES, V60, P5870; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cheung HW, 2004, CARCINOGENESIS, V25, P881, DOI 10.1093/carcin/bgh087; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lin CQ, 2000, CANCER RES, V60, P1332; Lin JC, 2005, J UROLOGY, V174, P2022, DOI 10.1097/01.ju.0000176476.14572.39; Ling MT, 2006, CARCINOGENESIS, V27, P205, DOI 10.1093/carcin/bgi217; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Maruyama H, 1999, AM J PATHOL, V155, P815, DOI 10.1016/S0002-9440(10)65180-2; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; Norton JD, 2000, J CELL SCI, V113, P3897; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schindl M, 2001, CANCER RES, V61, P5703; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson TC, 1999, APOPTOSIS, V4, P233, DOI 10.1023/A:1009612708099; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wong YC, 2004, APOPTOSIS, V9, P279, DOI 10.1023/B:APPT.0000025804.25396.79; Yang G, 1999, CANCER RES, V59, P5719; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602; Zhang XM, 2007, CANCER SCI, V98, P308, DOI 10.1111/j.1349-7006.2007.00400.x; Zhang XM, 2006, INT J CANCER, V118, P2072, DOI 10.1002/ijc.21592; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	65	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33284	33294		10.1074/jbc.M705089200	http://dx.doi.org/10.1074/jbc.M705089200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855368	hybrid, Green Published			2022-12-27	WOS:000250840200008
J	Mosnier, LO; Yang, XV; Griffin, JH				Mosnier, Laurent O.; Yang, Xia V.; Griffin, John H.			Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VA; PROCARBOXYPEPTIDASE-B; CARBOXYPEPTIDASE-B; ENDOTHELIAL-CELLS; DISULFIDE BOND; BINDING-SITE; TAFI; EXOSITE; PLASMA; PLASMINOGEN	Activated protein C (APC) reduces mortality in severe sepsis patients and exhibits beneficial effects in multiple animal injury models. APC anticoagulant activity involves inactivation of factors Va and VIIIa, whereas APC cytoprotective activities involve the endothelial protein C receptor and protease-activated receptor-1 (PAR-1). The relative importance of the anticoagulant activity of APC versus the direct cytoprotective effects of APC on cells for the in vivo benefits is unclear. To distinguish cytoprotective from the anticoagulant activities of APC, a protease domain mutant, 5A-APC (RR229/230AA and KKK191 193AAA), was made and compared with recombinant wild-type (rwt)-APC. This mutant had minimal anticoagulant activity but normal cytoprotective activities that were dependent on endothelial protein C receptor and protease-activated receptor-1. Whereas anticoagulantly active rwt-APC inhibited secondary-extended thrombin generation and concomitant thrombin-dependent activation of thrombin activable fibrinolysis inhibitor (TAFI) in plasma, secondary-extended thrombin generation and the activation of TAFI were essentially unopposed by 5A-APC due to its low anticoagulant activity. Compared with rwt-APC, 5A-APC had minimal profibrinolytic activity and preserved TAFI-mediated anti-inflammatory carboxypeptidase activities toward bradykinin and presumably toward the anaphlatoxins, C3a and C5a, which are well known pathological mediators in sepsis. Thus, genetic engineering can selectively alter the multiple activities of APC and provide APC mutants that retain the beneficial cytoprotective effects of APC while diminishing bleeding risk due to reduction in APC's anticoagulant and APC-dependent profibrinolytic activities.	Scripps Res Inst, Dept Mol & Expt Med MEM 180, La Jolla, CA 92037 USA	Scripps Research Institute	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med MEM 180, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu	Yang, Xia V/F-6911-2011	Griffin, John/0000-0002-4302-2547	NHLBI NIH HHS [HL 52246, HL 31950, HL 087618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052246, R00HL087618, P01HL031950, R37HL052246, K99HL087618] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Asai S, 2004, J IMMUNOL, V173, P4669, DOI 10.4049/jimmunol.173.7.4669; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Bajzar L, 1996, J BIOL CHEM, V271, P22949, DOI 10.1074/jbc.271.38.22949; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; BRANSON HE, 1983, LANCET, V2, P1165; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Campbell WD, 2002, MICROBIOL IMMUNOL, V46, P131, DOI 10.1111/j.1348-0421.2002.tb02669.x; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; EATON DL, 1991, J BIOL CHEM, V266, P21833; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Fein AM, 1997, JAMA-J AM MED ASSOC, V277, P482, DOI 10.1001/jama.277.6.482; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Friedrich U, 2001, J BIOL CHEM, V276, P23105, DOI 10.1074/jbc.M103138200; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2004, PROTEINS, V54, P433, DOI 10.1002/prot.10627; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Guimaraes AHC, 2004, THROMB HAEMOSTASIS, V91, P473, DOI 10.1160/TH03-06-0377; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HENDRIKS D, 1989, J CLIN CHEM CLIN BIO, V27, P277; Herwald H, 2003, SCAND J INFECT DIS, V35, P604, DOI 10.1080/00365540310016268; Kerschen EJ, 2006, BLOOD, V108, p5A; Kerschen EJ, 2005, BLOOD, V106, p12A; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mansilla S, 2006, EUR J PHARMACOL, V540, P34, DOI 10.1016/j.ejphar.2006.04.035; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; Mattsson E, 2001, INFECT IMMUN, V69, P3877, DOI 10.1128/IAI.69.6.3877-3882.2001; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mosnier LO, 2006, FRONT BIOSCI-LANDMRK, V11, P2381, DOI 10.2741/1977; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Rezaie AR, 2003, TRENDS CARDIOVAS MED, V13, P8, DOI 10.1016/S1050-1738(02)00191-3; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scola AM, 2007, J BIOL CHEM, V282, P3664, DOI 10.1074/jbc.M609178200; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wilken HC, 1999, IMMUNOL LETT, V67, P141, DOI 10.1016/S0165-2478(99)00002-4; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; ZHANG L, 1990, BIOCHEMISTRY-US, V29, P10828, DOI 10.1021/bi00500a016	61	95	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33022	33033		10.1074/jbc.M705824200	http://dx.doi.org/10.1074/jbc.M705824200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17872949	hybrid			2022-12-27	WOS:000250625400051
J	Takeda, N; Maemura, K; Horie, S; Oishi, K; Imai, Y; Harada, T; Saito, T; Shiga, T; Amiya, E; Manabe, I; Ishida, N; Nagai, R				Takeda, Norihiko; Maemura, Koji; Horie, Shuichi; Oishi, Katsutaka; Imai, Yasushi; Harada, Tomohiro; Saito, Tetsuya; Shiga, Taro; Amiya, Eisuke; Manabe, Ichiro; Ishida, Norio; Nagai, Ryozo			Thrombomodulin is a clock-controlled gene in vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CIRCADIAN CLOCK; MOLECULAR-MECHANISMS; GROWTH-FACTOR; PAS DOMAIN; EXPRESSION; MUTANT; HEART; ONSET; TRANSACTIVATION	Cardiovascular diseases are closely related to circadian rhythm, which is under the control of an internal biological clock mechanism. Although a biological clock exists not only in the hypothalamus but also in each peripheral tissue, the biological relevance of the peripheral clock remains to be elucidated. In this study we searched for clock- controlled genes in vascular endothelial cells using microarray technology. The expression of a total of 229 genes was up- regulated by CLOCK/ BMAL2. Among the genes that we identified, we examined the thrombomodulin ( TM) gene further, because TM is an integral membrane glycoprotein that is expressed primarily in vascular endothelial cells and plays a major role in the regulation of intravascular coagulation. TM mRNA and protein expression showed a clear circadian oscillation in the mouse lung and heart. Reporter analyses, gel shift assays, and chromatin immunoprecipitation analyses using the TM promoter revealed that a heterodimer of CLOCK and BMAL2 binds directly to the E- box of the TM promoter, resulting in TM promoter transactivation. Indeed, the oscillation of TM gene expression was abolished in clock mutant mice, suggesting that TM expression is regulated by the clock gene in vivo. Finally, the phase of circadian oscillation of TM mRNA expression was altered by temporal feeding restriction, suggesting TM gene expression is regulated by the peripheral clock system. In conclusion, these data suggest that the peripheral clock in vascular endothelial cells regulates TM gene expression and that the oscillation of TM expression may contribute to the circadian variation of cardiovascular events.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Kagawa Nutr Univ, Saitama 3500288, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	University of Tokyo; Kagawa Nutrition University; National Institute of Advanced Industrial Science & Technology (AIST)	Maemura, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kmae-tky@umin.ac.jp	Amiya, Eisuke/O-4981-2019; Manabe, Ichiro/AAE-5105-2021; Manabe, Ichiro/E-1529-2014; Oishi, Katsutaka/L-6906-2018	Amiya, Eisuke/0000-0003-2810-8040; Oishi, Katsutaka/0000-0002-4870-0837				ANDREOTTI F, 1991, CHRONOBIOL INT, V8, P336, DOI 10.3109/07420529109059170; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BRAUNWALD E, 1995, CIRCULATION, V91, P1604, DOI 10.1161/01.CIR.91.5.1604; COLANTONIO D, 1989, AM J CARDIOL, V64, P403, DOI 10.1016/0002-9149(89)90548-1; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DeRisi J, 1996, NAT GENET, V14, P457; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P743; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Horie S, 2001, J BIOL CHEM, V276, P2440, DOI 10.1074/jbc.M004942200; Ishii H, 2003, BLOOD, V101, P4765, DOI 10.1182/blood-2002-08-2428; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Koyanagi S, 2003, CANCER RES, V63, P7277; LENTZ SR, 1991, BLOOD, V77, P542; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Maemura K, 2001, ANN NY ACAD SCI, V947, P398; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Mutch NJ, 2007, J THROMB HAEMOST, V5, P812, DOI 10.1111/j.1538-7836.2007.02430.x; Nonaka H, 2001, CIRCULATION, V104, P1746, DOI 10.1161/hc4001.098048; Ohlin AK, 1999, THROMB HAEMOSTASIS, V81, P338; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Oishi K, 1998, NEUROSCI LETT, V256, P117, DOI 10.1016/S0304-3940(98)00765-4; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4; Portman MA, 2001, CIRC RES, V89, P1084, DOI 10.1161/res.89.12.1084; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Sassone-Corsi P, 1998, NATURE, V392, P871, DOI 10.1038/31821; Schibler U, 2000, NATURE, V404, P25, DOI 10.1038/35003674; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yamamoto K, 1998, INT J HEMATOL, V68, P371; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190	46	87	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32561	32567		10.1074/jbc.M705692200	http://dx.doi.org/10.1074/jbc.M705692200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848551	hybrid			2022-12-27	WOS:000250625400005
J	Vandeput, F; Wolda, SL; Krall, J; Hambleton, R; Uher, L; Mccaw, KN; Radwanski, PB; Florio, V; Movsesian, MA				Vandeput, Fabrice; Wolda, Sharon L.; Krall, Judith; Hambleton, Ryan; Uher, Lothar; Mccaw, Kim N.; Radwanski, Przemyslaw B.; Florio, Vincent; Movsesian, Matthew A.			Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-I; NITRIC-OXIDE; NATRIURETIC-PEPTIDE; CA2+ CURRENT; SARCOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; ADENYLYL-CYCLASE; CALCIUM CURRENT; G(I) PROTEINS; RAT-HEART	Isoforms in the PDE1 family of cyclic nucleotide phosphodiesterases were recently found to comprise a significant portion of the cGMP- inhibited cAMP hydrolytic activity in human hearts. We examined the expression of PDE1 isoforms in human myocardium, characterized their catalytic activity, and quantified their contribution to cAMP hydrolytic and cGMP hydrolytic activity in subcellular fractions of this tissue. Western blotting with isoform- selective anti- PDE1 monoclonal antibodies showed PDE1C1 to be the principal isoform expressed in human myocardium. Immunohistochemical analysis showed that PDE1C1 is distributed along the Z- lines and M- lines of cardiac myocytes in a striated pattern that differs from that of the other major dual- specificity cyclic nucleotide phosphodiesterase in human myocardium, PDE3A. Most of the PDE1C1 activity was recovered in soluble fractions of human myocardium. It binds both cAMP and cGMP with Km values of similar to 1 mu M and hydrolyzes both substrates with similar catalytic rates. PDE1C1 activity in subcellular fractions was quantified using a new PDE1- selective inhibitor, IC295. At substrate concentrations of 0.1 mu M, PDE1C1 constitutes the great majority of cAMP hydrolytic and cGMP hydrolytic activity in soluble fractions and the majority of cGMP hydrolytic activity in microsomal fractions, whereas PDE3 constitutes the majority of cAMP hydrolytic activity in microsomal fractions. These results indicate that PDE1C1 is expressed at high levels in human cardiac myocytes with an intracellular distribution distinct from that of PDE3A and that it may have a role in the integration of cGMP-, cAMP- and Ca2+-mediated signaling in these cells.	Vet Affairs Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84148 USA; Univ Utah, Sch Med, Dept Internal Med Cardiol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pharmacotherapy, Salt Lake City, UT 84132 USA; ICOS Corp, Bothell, WA 98021 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Icos Corporation	Movsesian, MA (corresponding author), Vet Affairs Salt Lake City Hlth Care Syst, Cardiol Sect, 500 Foothill Blvd, Salt Lake City, UT 84148 USA.	matthew.movsesian@hsc.utah.edu		Radwanski, Przemyslaw/0000-0002-0750-2308				Armoundas AA, 2003, CIRC RES, V93, P46, DOI 10.1161/01.RES.0000080932.98903.D8; BEAULIEU P, 1997, AM J PHYSIOL-HEART C, V273, pH1933; BENDER AT, 2007, CYCLIC NUCLEOTIDE PH, P35; BODE DC, 1991, CIRC RES, V68, P1070, DOI 10.1161/01.RES.68.4.1070; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; EPSTEIN PM, 1987, BIOCHEM J, V243, P525, DOI 10.1042/bj2430525; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; FRACE AM, 1993, J GEN PHYSIOL, V101, P337, DOI 10.1085/jgp.101.3.337; GALAEV IY, 1994, J CHROMATOGR A, V662, P27, DOI 10.1016/0021-9673(94)85292-8; Georget M, 2002, FASEB J, V16, P1636, DOI 10.1096/fj.02-0292fje; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; HAN X, 1995, J GEN PHYSIOL, V106, P45, DOI 10.1085/jgp.106.1.45; Han X, 1996, CIRC RES, V78, P998, DOI 10.1161/01.RES.78.6.998; HANSEN RS, 1982, P NATL ACAD SCI-BIOL, V79, P2788, DOI 10.1073/pnas.79.9.2788; Harlow E., 1988, ANTIBODIES LAB MANUA; Hassan Madiha A. H., 2005, BMC Pharmacology, V5, P10, DOI 10.1186/1471-2210-5-10; Hirose M, 1998, J PHARMACOL EXP THER, V286, P70; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Kambayashi J, 2007, CYCLIC NUCLEOTIDE PH, P627; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; Kishimoto I, 2001, P NATL ACAD SCI USA, V98, P2703, DOI 10.1073/pnas.051625598; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; Kuschel M, 1999, J BIOL CHEM, V274, P22048, DOI 10.1074/jbc.274.31.22048; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; LEIBOWITZ MD, 1995, DIABETES, V44, P67, DOI 10.2337/diabetes.44.1.67; Loughney K, 1996, J BIOL CHEM, V271, P796, DOI 10.1074/jbc.271.2.796; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; MERY PF, 1993, J BIOL CHEM, V268, P26286; MOHINDRU A, 1982, BIOCHEM J, V205, P427, DOI 10.1042/bj2050427; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; MOVSESIAN MA, 1991, J CLIN INVEST, V88, P15, DOI 10.1172/JCI115272; MOVSESIAN MA, 1989, CIRC RES, V65, P1141, DOI 10.1161/01.RES.65.4.1141; MOVSESIAN MA, 2007, CYCLIC NUCLEOTIDE PH, P485; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Stehlik Josef, 2006, Expert Opin Investig Drugs, V15, P733, DOI 10.1517/13543784.15.7.733; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tkachuk V A, 1982, Adv Myocardiol, V3, P541; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; WEISHAAR RE, 1986, BIOCHEM PHARMACOL, V35, P787, DOI 10.1016/0006-2952(86)90247-9; Wollert KC, 2003, BRIT J PHARMACOL, V140, P1227, DOI 10.1038/sj.bjp.0705567; Wollert KC, 2002, HYPERTENSION, V39, P87, DOI 10.1161/hy1201.097292; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; XIAO RP, 1994, J BIOL CHEM, V269, P19151; Xiao RP, 1999, CIRC RES, V84, P43; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zahabi A, 2003, J BIOL CHEM, V278, P47694, DOI 10.1074/jbc.M309661200	58	83	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32749	32757		10.1074/jbc.M703173200	http://dx.doi.org/10.1074/jbc.M703173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726023	hybrid			2022-12-27	WOS:000250625400023
J	Kim, WJ; Rajasekaran, B; Brown, KD				Kim, Wan-Ju; Rajasekaran, Baskaran; Brown, Kevin D.			MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-Methyl-N '-nitro-N '-nitrosoguanidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR SYSTEM; JUN NH2-TERMINAL KINASE; DNA-DAMAGING AGENTS; CELL-CYCLE ARREST; PROTEIN-KINASE; TYROSINE KINASE; IONIZING-RADIATION; TRANSCRIPTIONAL ACTIVATION; INDUCED APOPTOSIS; GENOTOXIC STRESS	N-Methyl-N'-nitro-N'-nitrosoguanidine (MNNG) is a DNA-methylating agent, and deficiency in mismatch repair (MMR) results in lack of sensitivity to this genotoxin (termed alkylation tolerance). A number of DNA damage response pathways are activated in a MMR-dependent manner following MNNG, and several also require ATM kinase activity. Here we show that activation of the transcription factor c-Jun is dependent upon both the MMR component MLH1 and ATM, but not ATR, in response to MNNG. In addition to c-Jun, the upstream MAPKs JNK and MKK4 are also activated in a MLH1-and ATM-dependent manner. Wedocument that c-Jun activation is dependent on the MAPK kinase kinase MEKK1. Additionally, the tyrosine kinase c-Abl is required to activate this signaling cascade and forms a complex with MEKK1 and MLH1. This study indicates that an arm of DNA damage-activated MAPK signaling is activated in an MLH1- and ATM-dependent manner in response to MNNG and perhaps suggests that dysregulation of this signaling is responsible, in part, for alkylation tolerance.	Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Univ Florida Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1600 SW Archer Rd,Box 100245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu			NATIONAL CANCER INSTITUTE [R01CA102289] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA102289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; Aebi S, 1996, CANCER RES, V56, P3087; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Beardsley DI, 2005, MOL PHARMACOL, V68, P1049, DOI 10.1124/mol.105.013888; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Caporali S, 2004, MOL PHARMACOL, V66, P478; Catani MV, 2002, BIOCHEM J, V364, P441, DOI 10.1042/BJ20011713; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Cong F, 1999, P NATL ACAD SCI USA, V96, P13819, DOI 10.1073/pnas.96.24.13819; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dunkern T, 2003, MUTAT RES-REV MUTAT, V544, P167, DOI 10.1016/j.mrrev.2003.06.005; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Gong JG, 1999, NATURE, V399, P806; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Ho ELY, 2007, J BIOL CHEM, V282, P21913, DOI 10.1074/jbc.M610651200; KALAMEGHAM R, 1988, CARCINOGENESIS, V9, P1749, DOI 10.1093/carcin/9.10.1749; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kim WJ, 2005, TOXICOL APPL PHARM, V202, P84, DOI 10.1016/j.taap.2004.06.009; KOI M, 1994, CANCER RES, V54, P4308; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; Nehme A, 1997, CANCER RES, V57, P3253; Ochs K, 2000, CANCER RES, V60, P5815; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SHAFMAN TD, 1995, CANCER RES, V55, P3242; Shangary S, 2000, J BIOL CHEM, V275, P30163, DOI 10.1074/jbc.M004302200; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Umar A, 1997, CANCER RES, V57, P3949; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAN MH, 1994, NATURE, V372, P798; Yin F, 2004, ONCOGENE, V23, P4614, DOI 10.1038/sj.onc.1207598; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	86	28	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32021	32031		10.1074/jbc.M701451200	http://dx.doi.org/10.1074/jbc.M701451200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804421	hybrid			2022-12-27	WOS:000250480300023
J	Woodbury, EL; Morgan, DO				Woodbury, Erika L.; Morgan, David O.			The role of self-association in Fin1 function on the mitotic spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MICROTUBULE DYNAMICS; ANAPHASE-B; CHROMOSOME SEGREGATION; YEAST; SWITCH; PHOSPHORYLATION; EXPRESSION; FILAMENTS; PROTEINS	Stabilization of spindle microtubules during anaphase is essential for proper chromosome segregation. Fin1 is a budding yeast protein that localizes to the poles and microtubules of the spindle during anaphase and contributes to spindle stability. The N-terminal half of Fin1 is phosphorylated at multiple sites by the cyclin-dependent kinase Clb5-Cdk1, and dephosphorylation in anaphase triggers its localization to the spindle. The C-terminal half of Fin1 contains coiled-coil motifs that are required for its self-association. Here we investigated the functional importance of the two regions of Fin1. Fin1 mutants lacking the C-terminal coiled-coil domains localized to spindle pole bodies but not along spindle microtubules. These mutants failed to self-associate and displayed reduced binding to microtubules in vitro but were functional in vivo and stabilized anaphase spindles when dephosphorylated. Deletion of the Fin1 C terminus suppressed the lethal phenotypes of the phospho-mutant Fin1(5A). Our findings suggest that the N-terminal region of Fin1 is sufficient for its regulated function as a spindle-stabilizing factor and that this function involves association with the spindle pole body. The ability of the C-terminal region to promote Fin1 self-association and microtubule binding may underlie lethal effects of the deregulated Fin1(5A) mutant.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, Genetech Hall,Rm N312B,600 16th St, San Francisco, CA 94158 USA.	David.Morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [GM069901, R01 GM069901] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P477; Bloom K, 2002, P NATL ACAD SCI USA, V99, P4757, DOI 10.1073/pnas.092136999; Brust-Mascher I, 2004, P NATL ACAD SCI USA, V101, P15938, DOI 10.1073/pnas.0407044101; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cheerambathur DK, 2007, J CELL BIOL, V177, P995, DOI 10.1083/jcb.200611113; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guacci V, 1997, MOL BIOL CELL, V8, P957, DOI 10.1091/mbc.8.6.957; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Marino-Ramirez L, 2002, YEAST, V19, P641, DOI 10.1002/yea.867; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Hemert MJ, 2003, J BIOL CHEM, V278, P15049, DOI 10.1074/jbc.M212495200; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	29	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32138	32143		10.1074/jbc.M705344200	http://dx.doi.org/10.1074/jbc.M705344200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804403	hybrid			2022-12-27	WOS:000250480300035
J	Boassa, D; Ambrosi, C; Qiu, F; Dahl, G; Gaietta, G; Sosinsky, G				Boassa, Daniela; Ambrosi, Cinzia; Qiu, Feng; Dahl, Gerhard; Gaietta, Guido; Sosinsky, Gina			Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; INTERLEUKIN-1-BETA RELEASE; P2X(7) RECEPTOR; XENOPUS OOCYTES; EXPRESSION; FAMILY; ATP; BIOSYNTHESIS; LOCALIZATION; TRAFFICKING	Pannexins are newly discovered channel proteins expressed in many different tissues and abundantly in the vertebrate central nervous system. Based on membrane topology, folding and secondary structure prediction, pannexins are proposed to form gap junction-like structures. We show here that Pannexin1 forms a hexameric channel and reaches the cell surface but, unlike connexins, is N-glycosylated. Using site-directed mutagenesis we analyzed three putative N-linked glycosylation sites and examined the effects of each mutation on channel expression. Weshow for the first time that Pannexin1 is glycosylated at Asn-254 and that this residue is important for plasma membrane targeting. The glycosylation of Pannexin1 at its extracellular surface makes it unlikely that two oligomers could dock to form an intercellular channel. Ultrastructural analysis by electron microscopy confirmed that Pannexin1 junctional areas do not appear as canonical gap junctions. Rather, Pannexin1 channels are distributed throughout the plasma membrane. We propose that N-glycosylation of Pannexin1 could be a significant mechanism for regulating the trafficking of these membrane proteins to the cell surface in different tissues.	Univ Calif San Diego, Biol Res Ctr, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Miami	Boassa, D (corresponding author), BSB 1000,9500 Gilman Dr MC 0608, La Jolla, CA 92093 USA.	dboassa@gmail.com; gina@ncmir.ucsd.edu	Qiu, Feng/D-8223-2011		NCRR NIH HHS [P41 RR004050, P41 RR002250, RR04050] Funding Source: Medline; NIGMS NIH HHS [R01 GM048610, GM065937, R01 GM048610-14, GM48610, R01 GM072881, GM072881] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937, R01GM072881, R01GM048610] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Litvin O, 2006, J CELL MOL MED, V10, P613, DOI 10.1111/j.1582-4934.2006.tb00424.x; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; MOUS JM, 1982, J BIOL CHEM, V257, P1822; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; SPRAY DC, 1981, J GEN PHYSIOL, V77, P77, DOI 10.1085/jgp.77.1.77; THORNHILL WB, 1987, BIOCHEMISTRY-US, V26, P4381, DOI 10.1021/bi00388a029; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Verselis VK, 2000, BRAZ J MED BIOL RES, V33, P379, DOI 10.1590/S0100-879X2000000400003; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; [No title captured]	29	216	221	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31733	31743		10.1074/jbc.M702422200	http://dx.doi.org/10.1074/jbc.M702422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715132	hybrid			2022-12-27	WOS:000250309200064
J	Gharavi, NM; Alva, JA; Mouillesseaux, KP; Lai, C; Yeh, M; Yeung, W; Johnson, J; Szeto, WL; Hong, LS; Fishbein, M; Wei, L; Pfeffer, LM; Berliner, JA				Gharavi, Nima M.; Alva, Jackelyn A.; Mouillesseaux, Kevin P.; Lai, Chi; Yeh, Michael; Yeung, Winnie; Johnson, Jaclyn; Szeto, Wan Lam; Hong, Longsheng; Fishbein, Michael; Wei, Lai; Pfeffer, Lawrence M.; Berliner, Judith A.			Role of the JAK/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; DEPENDENT MECHANISM; SIGNALING PATHWAYS; INTERFERON-GAMMA; GENE-EXPRESSION; SRC ACTIVATION; STAT3; KINASES; IL-8; INDUCTION	Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) and its component phospholipid, 1-palmitoyl-2- epoxyisoprostane-sn-glycero-3-phosphorylcholine, induce endothelial cells (EC) to synthesize chemotactic factors, such as interleukin 8 (IL-8). Previously, we demonstrated a role for c-Src kinase activation in Ox-PAPC-induced IL-8 transcription. In this study, we have examined the mechanism regulating IL-8 transcription by Ox-PAPC downstream of c-Src. Our findings demonstrate an important role for JAK2 in the regulation of IL-8 transcription by Ox-PAPC. Treatment of human aortic EC with Ox-PAPC and 1-palmitoyl-2-epoxyisoprostane-sn-glycero-3- phosphorylcholine induced a rapid yet sustained activation of JAK2; activation of JAK2 by Ox-PAPC was dependent on c-Src kinase activity. Furthermore, pretreatment with selective JAK2 inhibitors significantly reduced Ox-PAPC-induced IL-8 transcription. In previous studies, we also demonstrated activation of STAT3 by Ox-PAPC. Here we provide evidence that STAT3 activation by Ox-PAPC is dependent on JAK2 activation and that STAT3 activation regulates IL-8 transcription by Ox-PAPC in human EC. Transfection with small interfering RNA against STAT3 significantly reduced Ox-PAPC-induced IL-8 transcription. Using chromatin immunoprecipitation assays, we demonstrated binding of activated STAT3 to the sequence flanking the consensus gamma-interferon activation sequence (GAS) in the IL-8 promoter; site-directed mutagenesis of GAS inhibited IL-8 transcription by Ox-PAPC. Finally, these studies demonstrate a role for STAT3 activation in atherosclerosis in vivo. We found increased staining for activated STAT3 in the inflammatory regions of human atherosclerotic lesions and reduced fatty streak formation in EC-specific STAT3 knock-out mice on the atherogenic diet. Taken together, these data demonstrate an important role for the JAK2/STAT3 pathway in Ox-PAPC-induced IL-8 transcription in vitro and in atherosclerosis in vivo.	Univ Calif Los Angeles, Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90024 USA; Univ Tennessee, Ctr Hlth Sci, Inst Canc, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center	Berliner, JA (corresponding author), 13-239 CHS-Pathol,650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	jberliner@mednet.ucla.edu	Wei, Lai/D-1088-2014; Gharavi, Nima/AAN-7890-2020	Pfeffer, Lawrence/0000-0003-2809-1234	NCI NIH HHS [R01 CA073753, CA73753, R01 CA133322] Funding Source: Medline; NHLBI NIH HHS [HL30568, HL064731] Funding Source: Medline; NIGMS NIH HHS [GM008042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073753, R01CA133322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL064731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Gharavi NM, 2006, CIRC RES, V98, P768, DOI 10.1161/01.RES.0000215343.89308.93; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Ingley E, 2006, GROWTH FACTORS, V24, P89, DOI 10.1080/08977190500368031; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kotanides H, 1996, J BIOL CHEM, V271, P25555, DOI 10.1074/jbc.271.41.25555; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3385, DOI 10.3748/wjg.v11.i22.3385; Maziere C, 2001, FREE RADICAL BIO MED, V31, P1334, DOI 10.1016/S0891-5849(01)00649-9; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Pramanik R, 2004, J BIOL CHEM, V279, P16121, DOI 10.1074/jbc.M313140200; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Qiao JH, 2003, HUM PATHOL, V34, P402, DOI 10.1053/hupa.2003.72; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI200113568; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Trevino Jose G., 2006, Angiogenesis, V9, P101, DOI 10.1007/s10456-006-9038-9; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; WONG P, 1994, MOL CELL BIOL, V14, P914, DOI 10.1128/MCB.14.2.914; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657	44	115	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31460	31468		10.1074/jbc.M704267200	http://dx.doi.org/10.1074/jbc.M704267200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726017	hybrid			2022-12-27	WOS:000250309200037
J	La, P; Yang, YQ; Karnik, SK; Silva, AC; Schnepp, RW; Kim, SK; Hua, XX				La, Ping; Yang, Yuqing; Karnik, Satyajit K.; Silva, Albert C.; Schnepp, Robert W.; Kim, Seung K.; Hua, Xianxin			Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; JUND-ACTIVATED TRANSCRIPTION; HOX GENE-EXPRESSION; TUMOR-SUPPRESSOR; CHILDHOOD NEUROBLASTOMAS; INDUCED APOPTOSIS; DNA-DAMAGE; PROTEIN; CELLS; DEACETYLASE	Multiple endocrine neoplasia type 1 (MEN1) is a familial tumor syndrome linked to mutation of the MEN1 gene, which encodes a tumor suppressor, menin. We previously reported that menin up-regulates the caspase 8 expression and promotes TNF-alpha-induced apoptosis. However, it remains unclear how menin up-regulates caspase 8 expression and whether menin-mediated caspase 8 expression plays a role in repressing MEN1 development. Here we show that menin binds the 5(')-untranslated region (5(')-UTR) of the Caspase 8 locus in vivo and activates transcription of a reporter gene through the 5(')-UTR. Menin directly binds the 5(')-UTR in a sequence-independent manner in vitro. Moreover, Men1 ablation in cells reduces acetylation of histones H3 and H4 at the 5(')-UTR of the caspase 8 locus bound by menin in vivo. Notably, the MEN1-derived menin point mutants lose their ability to bind the caspase 8 locus and fail to induce caspase 8 expression and TNF-alpha-mediated apoptosis. Consistent with these observations, the expression level of caspase 8 is markedly reduced in insulinomas from Men1(+/-) mice. Together, our results indicate that menin enhances the caspase 8 expression by binding the caspase 8 locus, and suggest that menin suppresses MEN1 tumorigenesis, at least in part, by up-regulating caspase 8 expression.	Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University	Hua, XX (corresponding author), Univ Penn, Abramson Canc Ctr, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu		Kim, Seung/0000-0001-6135-7810	NCI NIH HHS [R01 CA113962-04, R01 CA113962, R01 CA100912-04, R01 CA100912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113962, R01CA100912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Farley SM, 2006, J SURG RES, V133, P29, DOI 10.1016/j.jss.2006.02.021; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Grignani F, 1998, CANCER RES, V58, P14; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Hopkins-Donaldson S, 2000, MED PEDIATR ONCOL, V35, P608; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hussein N, 2007, EUR J CANCER, V43, P402, DOI 10.1016/j.ejca.2006.08.038; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim H, 2003, CANCER RES, V63, P6135; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Marx SJ, 2005, J INTERN MED, V257, P2, DOI 10.1111/j.1365-2796.2004.01419.x; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; OUELLETTE MM, 1992, ONCOGENE, V7, P1075; Pannett AAJ, 1999, ENDOCR-RELAT CANCER, V6, P449, DOI 10.1677/erc.0.0060449; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sayo Y, 2002, ENDOCRINOLOGY, V143, P2437, DOI 10.1210/en.143.6.2437; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schnepp RW, 2004, CANCER RES, V64, P6791, DOI 10.1158/0008-5472.CAN-04-0724; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	51	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31332	31340		10.1074/jbc.M609555200	http://dx.doi.org/10.1074/jbc.M609555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766243	hybrid, Green Accepted			2022-12-27	WOS:000250309200022
J	Nelson, TJ; Alkon, DL				Nelson, Thomas J.; Alkon, Daniel L.			Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-REACTIVE PROTEIN; IN-GEL DIGESTION; ALZHEIMERS-DISEASE; PRECURSOR-PROTEIN; A-BETA; ENDOPLASMIC-RETICULUM; INTRACEREBROVENTRICULAR INFUSION; NEUROFIBRILLARY TANGLES; COGNITIVE DEFICITS; DOWN-REGULATION	beta-Amyloid peptide produces apoptosis in neurons at micromolar concentrations, but the mechanism by which beta-amyloid exerts its toxic effect is unknown. The normal biological function of beta-amyloid is also unknown. We used phage display, coprecipitation, and mass spectrometry to examine the proteinprotein interactions of beta-amyloid in normal rabbit brain in order to identify the biochemical receptors for beta-amyloid. beta-Amyloid was found to bind primarily to proteins involved in low density lipoprotein and cholesterol transport and metabolism, including sortilin, endoplasmic reticulum-Golgi intermediate compartment 2 (ERGIC2), ERGIC-53, steroid 5 alpha-reductase, and apolipoprotein B. beta-Amyloid also bound to the C-reactive protein precursor, a protein involved in inflammation, and to 14-3-3, a protein that regulates glycogen synthase kinase-3 beta, the kinase involved in tau phosphorylation. Of eight synthetic peptides identified as targets of beta-amyloid, three were found to be effective blockers of the toxic effect of beta-amyloid on cultured neuronal cells. These peptides bound to the hydrophobic region (residues 17-21) or to the nearby protein kinase C pseudo-phosphorylation site (residues 26-30) of beta-amyloid, suggesting that these may be the most critical regions for beta-amyloid effector action and for aggregation. Peptides or other small molecules that bind to this region may protect against beta-amyloid toxic effect by competitively blocking its ability to bind beta-amyloid effector proteins such as sortilin and 14-3-3.	Blanchette Rockefeller Neurosci Inst, Rockville, MD 20850 USA; Blanchette Rockefeller Neurosci Inst, Rockville, MD 20850 USA		Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 317 Acad & Res Bldg,9601 Med Ctr Dr, Rockville, MD 20850 USA.	tjnelson@brni-jhu.org						ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; ALVAREZ R, 1992, ANAL BIOCHEM, V203, P76, DOI 10.1016/0003-2697(92)90045-9; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bae J, 2001, APOPTOSIS, V6, P319, DOI 10.1023/A:1011319901057; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bezdek J. C., 1973, Journal of Cybernetics, V3, P58, DOI 10.1080/01969727308546047; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Bjelik A, 2006, NEUROCHEM INT, V49, P393, DOI 10.1016/j.neuint.2006.01.026; Blanchard Barbara J., 2000, Journal of Alzheimer's Disease, V2, P137; Blanchard BJ, 1997, BRAIN RES, V776, P40, DOI 10.1016/S0006-8993(97)01003-2; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Boyd-Kimball D, 2005, NEUROSCIENCE, V132, P313, DOI 10.1016/j.neuroscience.2004.12.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chen C, 2006, FEBS LETT, V580, P813, DOI 10.1016/j.febslet.2005.12.097; Chen Xi, 2006, Current Alzheimer Research, V3, P515, DOI 10.2174/156720506779025215; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; Culvenor JG, 1997, J NEUROSCI RES, V49, P719, DOI 10.1002/(SICI)1097-4547(19970915)49:6<719::AID-JNR6>3.0.CO;2-A; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ETCHEBERRIGARAY R, 1994, SCIENCE, V264, P276, DOI 10.1126/science.8146663; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gomez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Grilli M, 2003, FUNCT NEUROL, V18, P145; HAAN MN, 2007, IN PRESS NEUROBIOL; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Higgins GA, 2003, BEHAV PHARMACOL, V14, P419, DOI 10.1097/01.fbp.0000088420.18414.ff; Holscher C, 2005, REV NEUROSCIENCE, V16, P181; Hughes SR, 1996, P NATL ACAD SCI USA, V93, P2065, DOI 10.1073/pnas.93.5.2065; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Islam K, 1997, AM J PATHOL, V151, P265; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaufman L, 1990, FINDING GROUP DATA I; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Kwok SCM, 2001, DNA CELL BIOL, V20, P349, DOI 10.1089/10445490152122460; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Luo Y, 1996, NEUROSCI LETT, V217, P125, DOI 10.1016/S0304-3940(96)13087-1; Malissein E, 2006, APOPTOSIS, V11, P1003, DOI 10.1007/s10495-006-6713-7; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Masters SC, 2002, BIOCHEM SOC T, V30, P360, DOI 10.1042/bst0300360; Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4; McGeer EG, 2001, NEUROBIOL AGING, V22, P843, DOI 10.1016/S0197-4580(01)00288-3; Mileusnic R, 2000, EUR J NEUROSCI, V12, P4487, DOI 10.1046/j.1460-9568.2000.01344.x; Morais VA, 2006, BBA-MOL BASIS DIS, V1762, P802, DOI 10.1016/j.bbadis.2006.06.018; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; MUJUMDAR A, 2007, IN PRESS NEUROBIOL A; Nakamura S, 2001, BRAIN RES, V912, P128, DOI 10.1016/S0006-8993(01)02704-4; NAMBA Y, 1992, NEUROSCI LETT, V134, P264, DOI 10.1016/0304-3940(92)90531-B; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462; Olariu A, 2002, BRAIN RES, V957, P278, DOI 10.1016/S0006-8993(02)03608-9; Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Plant LD, 2003, J NEUROSCI, V23, P5531; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rossner S, 2005, J NEUROCHEM, V92, P226, DOI 10.1111/j.1471-4159.2004.02857.x; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Small D H, 1999, J Alzheimers Dis, V1, P275; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Stepanichev MY, 2003, J NEUROSCI RES, V71, P110, DOI 10.1002/jnr.10469; Suram A, 2007, ARCH BIOCHEM BIOPHYS, V463, P245, DOI 10.1016/j.abb.2007.03.015; Verdier Y, 2005, J NEUROCHEM, V94, P617, DOI 10.1111/j.1471-4159.2005.03158.x; WEISSBARTH S, 1981, J NEUROCHEM, V37, P677; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 2001, NEUROBIOL DIS, V8, P299, DOI 10.1006/nbdi.2001.0386; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; YOUSSEF I, 2007, IN PRESS NEUROBIOL A; Yu JM, 1998, GENOMICS, V53, P90, DOI 10.1006/geno.1998.5500; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zheng L, 2006, ANN NY ACAD SCI, V1067, P248, DOI 10.1196/annals.1354.032	122	36	41	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31238	31249		10.1074/jbc.M705558200	http://dx.doi.org/10.1074/jbc.M705558200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761669	hybrid			2022-12-27	WOS:000250309200013
J	Watanabe, K; Bianco, C; Strizzi, L; Hamada, S; Mancino, M; Bailly, V; Mo, W; Wen, D; Miatkowski, K; Gonzales, M; Sanicola, M; Seno, M; Salomon, DS				Watanabe, Kazuhide; Bianco, Caterina; Strizzi, Luigi; Hamada, Shin; Mancino, Mario; Bailly, Veronique; Mo, Wenjun; Wen, Dingyi; Miatkowski, Konrad; Gonzales, Monica; Sanicola, Michele; Seno, Masaharu; Salomon, David S.			Growth factor induction of cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-CFC FAMILY; MAMMARY-GLAND; ANCHORED PROTEINS; TGF-BETA; RELEASE; CLEAVAGE; OVEREXPRESSION; MEMBRANES; PATHWAYS; BLOCKADE	Cripto-1 (CR-1) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that has been shown to play an important role in embryogenesis and cellular transformation. CR-1 is reported to function as a membrane-bound co-receptor and as a soluble ligand. Although a number of studies implicate the role of CR-1 as a soluble ligand in tumor progression, it is unclear how transition from the membrane-bound to the soluble form is physiologically regulated and whether differences in biological activity exist between these forms. Here, we demonstrate that CR-1 protein is secreted from tumor cells into the conditioned medium after treatment with serum, epidermal growth factor, or lysophosphatidic acid, and this soluble form of CR-1 exhibits the ability to promote endothelial cell migration as a paracrine chemoattractant. On the other hand, membranebound CR-1 can stimulate endothelial cell sprouting through direct cell-cell interaction. Shedding of CR-1 occurs at the GPI-anchorage site by the activity of GPI-phospholipase D (GPIPLD), because CR-1 shedding was suppressed by siRNA knockdown of GPI-PLD and enhanced by overexpression of GPI-PLD. These findings describe a novel molecular mechanism of CR-1 shedding, which may contribute to endothelial cell migration and possibly tumor angiogenesis.	NIH, NCI, Canc Res Ctr, Mammary Biol & Tumorgenesis Lab,Tumor Growth FS, Bethesda, MD 20892 USA; Biogen Inc, Cambridge, MA 02142 USA; Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Biogen; Okayama University	Salomon, DS (corresponding author), NIH, NCI, Canc Res Ctr, Mammary Biol & Tumorgenesis Lab,Tumor Growth FS, Bethesda, MD 20892 USA.	salomond@mail.nih.gov	Watanabe, Kazuhide/C-9667-2017; SENO, Masaharu/B-2092-2011; Hamada, Shin/Z-3023-2019	Watanabe, Kazuhide/0000-0002-5331-0593; SENO, Masaharu/0000-0001-8547-6259; Mancino, Mario/0000-0003-1957-3119	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Bianco C, 2005, J NATL CANCER I, V97, P132, DOI 10.1093/jnci/dji011; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; De Luca A, 2000, ONCOGENE, V19, P5863, DOI 10.1038/sj.onc.1203979; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kung M, 1997, BBA-MOL CELL RES, V1357, P329, DOI 10.1016/S0167-4889(97)00044-X; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lee JY, 1998, NEUROCHEM RES, V23, P899, DOI 10.1023/A:1022419314330; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; METZ CN, 1994, EMBO J, V13, P1741, DOI 10.1002/j.1460-2075.1994.tb06438.x; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Naghibalhossaini F, 2006, CANCER LETT, V234, P158, DOI 10.1016/j.canlet.2005.03.028; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; ROBERTS JM, 1990, FEBS LETT, V267, P213, DOI 10.1016/0014-5793(90)80927-B; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Sengupta S, 2004, SEMIN CELL DEV BIOL, V15, P503, DOI 10.1016/j.semcdb.2004.05.003; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Sun Y, 2005, AM J PATHOL, V167, P585, DOI 10.1016/S0002-9440(10)63000-3; van Cruijsen H, 2005, INT J CANCER, V117, P883, DOI 10.1002/ijc.21479; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Wechselberger C, 2005, ONCOGENE, V24, P4094, DOI 10.1038/sj.onc.1208417; Xing PX, 2004, CANCER RES, V64, P4018, DOI 10.1158/0008-5472.CAN-03-3888; Yamamoto Y, 2005, BIOCHEM BIOPH RES CO, V333, P223, DOI 10.1016/j.bbrc.2005.05.084; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	44	52	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31643	31655		10.1074/jbc.M702713200	http://dx.doi.org/10.1074/jbc.M702713200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720976	hybrid			2022-12-27	WOS:000250309200056
J	Cumming, RC; Dargusch, R; Fischer, WH; Schubert, D				Cumming, Robert C.; Dargusch, Richard; Fischer, Wolfgang H.; Schubert, David			Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ALZHEIMERS-DISEASE BRAIN; ACTIVE-SITE CYSTEINE; PROTEOMIC ANALYSIS; THIOREDOXIN REDUCTASE; GEL-ELECTROPHORESIS; HIPPOCAMPAL-NEURONS; GLUCOSE-METABOLISM; HYDROGEN-PEROXIDE; IN-VIVO	Peroxiredoxins (Prxs) are a ubiquitously expressed family of thiol peroxidases that reduce hydrogen peroxide, peroxynitrite, and hydroperoxides using a highly conserved cysteine. There is substantial evidence that oxidative stress elicited by amyloid beta (A beta) accumulation is a causative factor in the pathogenesis of Alzheimer disease (AD). Here we show that A beta-resistant PC12 cell lines exhibit increased expression of multiple Prx isoforms with reduced cysteine oxidation. A beta-resistant PC12 cells also display higher levels of thioredoxin and thioredoxin reductase, two enzymes critical for maintaining Prx activity. PC12 cells and rat primary hippocampal neurons transfected with wild type Prx1 exhibit increased A beta resistance, whereas mutant Prx1, lacking a catalytic cysteine, confers no protection. Using an antibody that specifically recognizes sulfinylated and sulfonylated Prxs, it is demonstrated that primary rat cortical nerve cells exposed to A beta display a time-dependent increase in cysteine oxidation of the catalytic site of Prxs that can be blocked by the addition of the thiol-antioxidant N-acetylcysteine. In support of previous findings, expression of Prx1 is higher in post-mortem human AD cortex tissues than in age-matched controls. In addition, two-dimensional gel electrophoresis and mass spectrometry analysis revealed that Prx2 exists in a more oxidized state in AD brains than in control brains. These findings suggest that increased Prx expression and resistance to sulfhydryl oxidation in A beta-resistant nerve cells is a compensatory response to the oxidative stress initiated by chronic pro-oxidant A beta exposure.	Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; Peptide Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Schubert, D (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schubert@salk.edu	Cumming, Robert/G-2185-2010		NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER; NIA NIH HHS [AG5142] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aksenov MY, 1998, J MOL NEUROSCI, V10, P181, DOI 10.1007/BF02761773; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Ichimiya S, 1997, DNA CELL BIOL, V16, P311, DOI 10.1089/dna.1997.16.311; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Krapfenbauer K, 2002, ELECTROPHORESIS, V23, P2541, DOI 10.1002/1522-2683(200208)23:15<2541::AID-ELPS2541>3.0.CO;2-1; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sagara Y, 1996, J NEUROSCI, V16, P497; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; WILLIAMS JF, 1980, TRENDS BIOCHEM SCI, V5, P315, DOI 10.1016/0968-0004(80)90139-5; Wilson KE, 2005, PROTEOMICS, V5, P3851, DOI 10.1002/pmic.200401255; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zitzler J, 2004, MOL CELL PROTEOMICS, V3, P834, DOI 10.1074/mcp.M400054-MCP200	46	45	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30523	30534		10.1074/jbc.M700869200	http://dx.doi.org/10.1074/jbc.M700869200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17761673	hybrid			2022-12-27	WOS:000250136300020
J	Harikumar, KG; Pinon, DI; Miller, LJ				Harikumar, Kaleeckal G.; Pinon, Delia I.; Miller, Laurence J.			Transmembrane segment IV contributes a functionally important interface for oligomerization of the class II G protein-coupled secretin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; RESONANCE ENERGY-TRANSFER; CHOLECYSTOKININ RECEPTORS; SPATIAL APPROXIMATION; CRYSTAL-STRUCTURE; AGONIST BINDING; AMINO-TERMINUS; DIMERIZATION; LIGAND; ACTIVATION	Oligomerization of the Class II G protein-coupled secretin receptor has been reported, but the molecular basis for this and its functional significance have not been determined. In the current work, we have examined the possible contribution of each of the transmembrane (TM) segments of this receptor to its homo-oligomerization, using the method of competitive disruption screening for inhibition of receptor bioluminescence resonance energy transfer signal. TM IV was the only segment that was found to disrupt receptor bioluminescence resonance energy transfer. Evaluation of predicted interhelical and lipid-exposed faces of this TM segment demonstrated that its lipid-exposed face represented the determinant for oligomerization. This was further confirmed by mutagenesis of the intact secretin receptor. Morphological FRET was utilized to demonstrate that secretin receptor oligomerization occurred at the cell surface and that this oligomerization was disrupted by mutating Gly(243) and Ile(247), key residues within the lipid-exposed face of TM IV. Although disruption of the receptor oligomerization interface had no effect on secretin binding parameters, it reduced the ability of secretin to stimulate intracellular cAMP. This supports a clear functional effect of oligomerization of this receptor. Such an effect might be particularly relevant to clinical situations in which this receptor is overexpressed, such as in certain neoplasms.	Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu		Harikumar, Kaleeckal/0000-0003-0411-5334	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46577] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Ding WQ, 2002, CANCER RES, V62, P5223; Dong MQ, 2005, MOL ENDOCRINOL, V19, P1821, DOI 10.1210/me.2004-0421; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frimurer TM, 1999, PROTEINS, V35, P375, DOI 10.1002/(SICI)1097-0134(19990601)35:4<375::AID-PROT1>3.0.CO;2-2; GOSSEN D, 1990, EUR J BIOCHEM, V193, P149, DOI 10.1111/j.1432-1033.1990.tb19316.x; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Langer I, 2006, BRIT J PHARMACOL, V148, P1051, DOI 10.1038/sj.bjp.0706816; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Lohse MJ, 2006, NAT METHODS, V3, P972, DOI 10.1038/nmeth1206-972; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	32	78	78	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30363	30372		10.1074/jbc.M702325200	http://dx.doi.org/10.1074/jbc.M702325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726027	hybrid			2022-12-27	WOS:000250136300004
J	Nara, N; Nakayama, Y; Okamoto, S; Tamura, H; Kiyono, M; Muraoka, M; Tanaka, K; Taya, C; Shitara, H; Ishii, R; Yonekawa, H; Minokoshi, Y; Hara, T				Nara, Noriko; Nakayama, Yuki; Okamoto, Shiki; Tamura, Hiroshi; Kiyono, Mari; Muraoka, Masatoshi; Tanaka, Kiyoko; Taya, Choji; Shitara, Hiroshi; Ishii, Rie; Yonekawa, Hiromichi; Minokoshi, Yasuhiko; Hara, Takahiko			Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; DENDRITIC CELLS; ADIPOSE-TISSUE; IKK-BETA; IN-VIVO; EXPRESSION; CLONING; BRAK; OVEREXPRESSION; LOCALIZATION	In obese individuals, white adipose tissue (WAT) is infiltrated by large numbers of macrophages, resulting in enhanced inflammatory responses that contribute to insulin resistance. Here we show that expression of the CXC motif chemokine ligand-14 (CXCL14), which targets tissue macrophages, is elevated in WAT of obese mice fed a high fat diet (HFD) compared with lean mice fed a regular diet. We found that HFD-fed CXCL14-deficient mice have impaired WAT macrophage mobilization and improved insulin responsiveness. Insulin-stimulated phosphorylation of Akt kinase in skeletal muscle was severely attenuated in HFD-fed CXCL14(+/-) mice but not in HFD-fed CXCL14(-/-) mice. The insulin-sensitive phenotype of CXCL14(-/-) mice after HFD feeding was prominent in female mice but not in male mice. HFD-fed CXCL14(+/-) mice were protected from hyperglycemia, hyperinsulinemia, and hypoadiponectinemia and did not exhibit increased levels of circulating retinol-binding protein-4 and increased expression of interleukin-6 in WAT. Transgenic overexpression of CXCL14 in skeletal muscle restored obesity-induced insulin resistance in CXCL14(+/-) mice. CXCL14 attenuated insulin-stimulated glucose uptake in cultured myocytes and to a lesser extent in cultured adipocytes. These results demonstrate that CXCL14 is a critical chemoattractant of WAT macrophages and a novel regulator of glucose metabolism that functions mainly in skeletal muscle.	Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Lab Mouse Model Human Heritable Dis, Bunkyo Ku, Tokyo 1138613, Japan; Natl Inst Physiol Sci, Div Endocrinol & Metab, Aichi 4448585, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Hara, T (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	thara@rinshoken.or.jp	Okamoto, Shiki/X-7274-2018	Okamoto, Shiki/0000-0002-2802-0527; Minokoshi, Yasuhiko/0000-0002-7119-4805				Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	33	128	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30794	30803		10.1074/jbc.M700412200	http://dx.doi.org/10.1074/jbc.M700412200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724031	hybrid			2022-12-27	WOS:000250136300048
J	Rider, L; Shatrova, A; Feener, EP; Webb, L; Diakonova, M				Rider, Leah; Shatrova, Alla; Feener, Edward P.; Webb, Leslie; Diakonova, Maria			JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NF-KAPPA-B; P21-ACTIVATED KINASE-1-INTERACTING SUBSTRATE; GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ACTIVATION; ADAPTER PROTEIN; P35/CDK5 KINASE; SH2-B-BETA; ACTIN; APOPTOSIS	The serine-threonine kinase PAK1 is activated by small GTPase-dependent and -independent mechanisms and promotes cell survival. However, the role of tyrosyl phosphorylation in the regulation of PAK1 function is poorly understood. In this study, we have shown that the prolactin-activated tyrosine kinase JAK2 phosphorylates PAK1 in vivo. Wild type, but not kinase-dead, JAK2 directly phosphorylates PAK1 in cells and in an in vitro kinase assay. PAK1 tyrosines 153, 201, and 285 were identified as sites of JAK2 tyrosyl phosphorylation by mass spectrometry and two-dimensional peptide mapping. Mutation of PAK1 tyrosines 153, 201, and 285 to phenylalanines individually or in combination implicated these PAK1 tyrosines in the regulation of PAK1 kinase activity. Tyrosyl phosphorylation by JAK2 significantly increases PAK1 kinase activity, whereas similar phosphorylation of the PAK1 Y153F, Y201F, Y285F mutant has no effect on PAK1 activity. Tyrosyl phosphorylation of wild type PAK1 decreases apoptosis induced by serum deprivation and staurosporine treatment and increases cell motility. In contrast, these parameters are unaltered in the PAK1 Y153F, Y201F, Y285F mutant. Our findings indicate that JAK2 phosphorylates PAK1 at these specific tyrosines and that this phosphorylation plays an important role in cell survival and motility.	Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; Univ Michigan, Sch Med, Dept Mol Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Integrat Physiol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Diakonova, M (corresponding author), 2801 W Bancroft St, Toledo, OH 43606 USA.	mdiakon@utnet.utoledo.edu	Shatrova, Alla/R-8042-2016	Diakonova, Maria/0000-0002-4554-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074689, P60DK020572, R01DK060165] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK074689, P60 DK20572, R01 DK60165, P60 DK020572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Argente J, 1996, HORM RES, V45, P1, DOI 10.1159/000184814; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Banerjee M, 2002, CURR BIOL, V12, P1233, DOI 10.1016/S0960-9822(02)00956-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Diakonova M, 2002, J BIOL CHEM, V277, P10669, DOI 10.1074/jbc.M111138200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; FIORUCCI G, 1995, J VIROL, V69, P5833, DOI 10.1128/JVI.69.9.5833-5837.1995; Foryst-Ludwig A, 2000, J BIOL CHEM, V275, P39779, DOI 10.1074/jbc.M007617200; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; GOUT PW, 1987, CANCER RES, V47, P1751; Humphreys RC, 2000, ONCOGENE, V19, P1085, DOI 10.1038/sj.onc.1203278; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Johnson K, 2005, J NEUROSCI RES, V79, P809, DOI 10.1002/jnr.20415; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; McManus MJ, 2000, J BIOL CHEM, V275, P35328, DOI 10.1074/jbc.M005399200; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; O'Brien KB, 2003, J BIOL CHEM, V278, P11970, DOI 10.1074/jbc.M210765200; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Renkema GH, 2002, MOL CELL BIOL, V22, P6719, DOI 10.1128/MCB.22.19.6719-6725.2002; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Ruchatz H, 2003, EXP HEMATOL, V31, P309, DOI 10.1016/S0301-472X(03)00007-9; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Rui LY, 2000, MOL CELL BIOL, V20, P3168, DOI 10.1128/MCB.20.9.3168-3177.2000; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	75	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30985	30996		10.1074/jbc.M701794200	http://dx.doi.org/10.1074/jbc.M701794200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726028	hybrid			2022-12-27	WOS:000250136300066
J	Kass, EM; Ahn, J; Tanaka, T; Freed-Pastor, WA; Keezer, S; Prives, C				Kass, Elizabeth M.; Ahn, Jinwoo; Tanaka, Tomoaki; Freed-Pastor, William A.; Keezer, Susan; Prives, Carol			Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHK2 PROTEIN-KINASE; DNA-DAMAGE RESPONSE; LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR; IN-VIVO; CHK2-DEPENDENT PHOSPHORYLATION; THREONINE-68 PHOSPHORYLATION; IONIZING-RADIATION; PROTEASOME PATHWAY; BREAST-CANCER	Checkpoint kinase 2 (Chk2), a DNA damage-activated protein kinase, is phosphorylated at Thr-68 by ataxia telangiectasia mutated leading to its activation by phosphorylation at several additional sites. Using mass spectrometry we identified a new Chk2 phosphorylation site at Ser-456. We show that phosphorylation of Ser-456 plays a role in the regulation of Chk2 stability particularly after DNA damage. Mutation of Ser-456 to alanine results in hyperubiquitination of Chk2 and dramatically reduced Chk2 stability. Furthermore, cells expressing S456A Chk2 show a reduction in the apoptotic response to DNA damage. These findings suggest a mechanism for stabilization of Chk2 in response to DNA damage via phosphorylation at Ser-456 and proteasome-dependent turnover of Chk2 protein via dephosphorylation of the same residue.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu		FREED-PASTOR, WILLIAM/0000-0002-7377-2111				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gibson SL, 2006, RADIAT RES, V166, P646, DOI 10.1667/RR0660.1; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; Haruki N, 2000, CANCER RES, V60, P4689; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2001, CANCER RES, V61, P5362; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shieh SY, 2000, GENE DEV, V14, P289; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tort F, 2002, BLOOD, V100, P4602, DOI 10.1182/blood-2002-04-1078; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhang PL, 2005, BIOCHEM BIOPH RES CO, V328, P567, DOI 10.1016/j.bbrc.2005.01.007; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	50	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30311	30321		10.1074/jbc.M704642200	http://dx.doi.org/10.1074/jbc.M704642200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715138	hybrid			2022-12-27	WOS:000249981200062
J	Wang, B; Bisello, A; Yang, YM; Romero, GG; Friedman, PA				Wang, Bin; Bisello, Alessandro; Yang, Yanmei; Romero, Guillermo G.; Friedman, Peter A.			NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; KAPPA-OPIOID RECEPTOR; CHRONIC-RENAL-FAILURE; OPOSSUM KIDNEY-CELLS; PTH-PTHRP RECEPTOR; BETA-ARRESTIN; KINASE-C; DOWN-REGULATION; PDZ-DOMAIN; INTERNALIZATION	Na/H exchange regulatory factor-1 (NHERF1) is a PDZ protein that regulates trafficking of several G protein-coupled receptors. The phenotype of NHERF1-null mice suggests that the parathyroid hormone (PTH) receptor (PTH1R) is the principal GPCR interacting with NHERF1. The effect of NHERF1 on receptor recycling is unknown. Here, we characterized NHERF1 effects on PTH1R membrane tethering and recycling by radio-ligand binding and recovery after maximal receptor endocytosis. Using Chinese hamster ovary cells expressing the PTH1R, where NHERF1 expression could be induced by tetracycline, NHERF1 inhibited PTH1R endocytosis and delayed PTH1R recycling. NHERF1 also inhibited PTH-induced receptor internalization in MC4 osteoblast cells. Reducing constitutive NHERF1 levels in HEK-293 cells with short hairpin RNA directed against NHERF1 augmented PTH1R endocytosis in response to PTH. Mutagenesis of the PDZ-binding domains or deletion of the MERM domain of NHERF1 demonstrated that both are required for inhibition of endocytosis and recycling. Likewise, an intact COOH-terminal PDZ recognition motif in PTH1R is needed. The effect of NHERF1 on receptor internalization and recycling was not associated with altered receptor expression or binding, activation, or phosphorylation but involved beta-arrestin and dynamin. We conclude that NHERF1 inhibits endocytosis without affecting PTH1R recycling in MC4 and PTH1R-expressing HEK-293 cells. Such an effect may protect against PTH resistance or PTH1R down-regulation in certain cells harboring NHERF1.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, E-1347 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu		Wang, Bin/0000-0002-5396-6111	NIDDK NIH HHS [DK-54171, DK-69998] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Flannery PJ, 2001, BIOCHEM PHARMACOL, V62, P1047, DOI 10.1016/S0006-2952(01)00749-3; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; FUKAYAMA S, 1992, ENDOCRINOLOGY, V131, P1757, DOI 10.1210/en.131.4.1757; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; LEE CW, 1994, ENDOCRINOLOGY, V135, P1488, DOI 10.1210/en.135.4.1488; LEE SK, 1994, J BONE MINER RES, V9, P781; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; TIAN J, 1994, AM J NEPHROL, V14, P41, DOI 10.1159/000168684; URENA P, 1994, KIDNEY INT, V45, P605, DOI 10.1038/ki.1994.79; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; Weinman EJ, 2001, J BIOL CHEM, V276, P42339, DOI 10.1074/jbc.M106153200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	49	76	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36214	36222		10.1074/jbc.M707263200	http://dx.doi.org/10.1074/jbc.M707263200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17884816	hybrid			2022-12-27	WOS:000251458300011
J	Anand, R; Marmorstein, R				Anand, Ruchi; Marmorstein, Ronen			Structure and mechanism of lysine-specific demethylase enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HISTONE DEMETHYLATION; SWIRM DOMAIN; DEPENDENT TRANSCRIPTION; OXIDATIVE DEMETHYLATION; ENZYMATIC METHYLATION; SUBSTRATE-SPECIFICITY; ARGININE METHYLATION; MONOAMINE-OXIDASE; ANDROGEN-RECEPTOR; ESCHERICHIA-COLI	The discovery of histone-demethylating enzymes has revealed yet another reversible histone modification mark. In this review, we describe the structural and chemical insights that we have now derived underlying the activity of these enzymes. The recent co-crystal structures of LSD1 bound to a proparylamine-derivatized histone H3 peptide and JHDM structures bound to two different methylated histone H3 peptides illustrate the steric requirements and structural basis for substrate specificity.	Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; Univ Penn, Wistar Inst, Program Gene Express & Regulat, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	marmor@wistar.org						Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iyer L. M, 2002, GENOME BIOL, V3; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2006, CURR OPIN GENET DEV, V16, P513, DOI 10.1016/j.gde.2006.08.013; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Olins DE, 2003, NAT REV MOL CELL BIO, V4, P809, DOI 10.1038/nrm1225; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; PAIK WK, 1969, ARCH BIOCHEM BIOPHYS, V134, P632, DOI 10.1016/0003-9861(69)90327-0; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Szewczuk LM, 2007, BIOCHEMISTRY-US, V46, P6892, DOI 10.1021/bi700414b; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Thomson T, 2005, CELL RES, V15, P281, DOI 10.1038/sj.cr.7290297; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yang MJ, 2007, NAT STRUCT MOL BIOL, V14, P535, DOI 10.1038/nsmb1255; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	50	89	121	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35425	35429		10.1074/jbc.R700027200	http://dx.doi.org/10.1074/jbc.R700027200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897944	hybrid			2022-12-27	WOS:000251458100001
J	Kouloumenta, A; Mavroidis, M; Capetanaki, Y				Kouloumenta, Asimina; Mavroidis, Manolis; Capetanaki, Yassemi			Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT CYTOSKELETON; HERMANSKY-PUDLAK-SYNDROME; MICE LACKING DESMIN; SKELETAL-MUSCLE; HEPATOCYTIC AUTOPHAGY; NULL MUTATION; OKADAIC ACID; KINASE-A; VIMENTIN; COMPLEX	Desmin, the muscle-specific intermediate filament protein, surrounds the Z disks and links the entire contractile apparatus to the sarcolemmal cytoskeleton, cytoplasmic organelles, and the nucleus. In an attempt to explore the molecular mechanisms of these associations, we performed a yeast two-hybrid screening of a cardiac cDNA library. We showed that the desmin amino-terminal domain (N-(1-103)) binds to a 413-kDa TRIM-like protein, myospryn, originally identified as the muscle-specific partner of dysbindin, a component of the (b)under bar>iogenesis of (l) under bar ysosome-(r) under bar elated (o) under bar rganelles (c) under bar omplex 1 (BLOC-1). Binding of desmin with myospryn was confirmed with glutathione S-transferase pulldown assays and coimmunoprecipitation experiments. Western blot analysis revealed that the complex immunoprecipitated by desmin antibodies, in addition to myospryn, contained the BLOC-1 components dysbindin and pallidin. Deletion analysis revealed that only the ( N-(1-103)) fragment of desmin binds to myospryn carboxyl terminus and that this association takes place through the 24-amino acid-long carboxyl-terminal end of the SPRY domain of myospryn. Using an antibody against the COOH terminus of myospryn, we demonstrated that myospryn colocalizes with desmin at the periphery of the nucleus, in close proximity to the endoplasmic reticulum, of mouse neonatal cardiomyocytes. In adult heart muscle, the two proteins colocalize, predominantly at intercalated disks and costameres. We also showed that myospryn colocalizes with lysosomes. Using desmin null hearts, we determined that desmin is required for both the proper perinuclear localization of myospryn, as well as the proper positioning of lysosomes, thus suggesting a potential role of desmin intermediate filaments in lysosomes and lysosome-related organelle biogenesis and/or positioning.	Acad Athens, Div Cell Biol, Ctr Basic Res, Biomed Res Fdn, Athens 11527, Greece	Academy of Athens	Capetanaki, Y (corresponding author), Acad Athens, Div Cell Biol, Ctr Basic Res, Biomed Res Fdn, Soranou Efesiou 4, Athens 11527, Greece.	ycapetanaki@bioacademy.gr		Mavroidis, Manolis/0000-0002-3870-3954				ALLEN RE, 1991, J CELL PHYSIOL, V149, P525, DOI 10.1002/jcp.1041490323; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; BLANKSON H, 1995, EXP CELL RES, V218, P522, DOI 10.1006/excr.1995.1187; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008; Gao YS, 2002, EUR J CELL BIOL, V81, P391, DOI 10.1078/0171-9335-00260; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gillard BK, 1998, EXP CELL RES, V242, P561, DOI 10.1006/excr.1998.4126; GILLARD BK, 1994, J CELL SCI, V107, P3545; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; HERRMANN H, 1989, DEVELOPMENT, V105, P279; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; O'Neill A, 2002, MOL BIOL CELL, V13, P2347, DOI 10.1091/mbc.01-12-0576; Ralston E, 2006, J CELL PHYSIOL, V209, P874, DOI 10.1002/jcp.20780; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070	48	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35211	35221		10.1074/jbc.M704733200	http://dx.doi.org/10.1074/jbc.M704733200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17872945	hybrid			2022-12-27	WOS:000251155200066
J	Lauberth, SM; Bilyeu, AC; Firulli, BA; Kroll, KL; Rauchman, M				Lauberth, Shannon M.; Bilyeu, Amy C.; Firulli, Beth A.; Kroll, Kristen L.; Rauchman, Michael			A phosphomimetic mutation in the Sall1 repression motif disrupts recruitment of the nucleosome remodeling and deacetylase complex and repression of Gbx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; RADIAL RAY SYNDROME; OKIHIRO-SYNDROME; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; CAUSATIVE GENE; CELL FATE; HETEROCHROMATIN; NURD; PHOSPHOPROTEINS	The multizinc finger transcription factor Sall1 is a critical developmental regulator that mediates repression through the recruitment of the nucleosome remodeling and deacetylase ( NuRD) complex. Although a short conserved peptide motif in Sall1 is sufficient to recruit NuRD, its ability to regulate native Sall1 target genes in vivo has not been demonstrated. In this report, we demonstrate an in vivo role for the Sall1 repression motif and describe a novel direct target gene of Sall1, Gbx2, that is directly repressed in a NuRD-dependent fashion. The ability of Sall1 to repress Gbx2 was impaired in Xenopus embryos expressing mutant forms of Sall1 that are defective for NuRD binding. Finally, we demonstrate that protein kinase C phosphorylates serine 2 of the Sall1 repression motif and reveal that a phosphomimetic mutation of serine 2 disrupts the ability of Sall1 to repress Gbx2 in cell culture and Xenopus embryos. Together, these studies establish that Sall1 recruits NuRD via the Sall1 repression motif to mediate repression of a native target gene and suggest a model in which dynamic control of gene expression by Sall1 is modulated by serine phosphorylation of the Sall1 repression motif.	St Louis Univ, Dept Biochem, St Louis, MO 63106 USA; St Louis Univ, Dept Biol Mol, St Louis, MO 63106 USA; Vet Affairs Med Ctr, St Louis, MO 63106 USA; Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63106 USA; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Saint Louis University; Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis	Rauchman, M (corresponding author), St Louis Vet Affairs Med Ctr, 657-111B-JC,915 N Grand Blvd, St Louis, MO 63106 USA.	rauchman@slu.edu		Kroll, Kristen/0000-0002-5450-6694; Lauberth, Shannon/0000-0003-4131-8536	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066815] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK067222] Funding Source: Medline; NIGMS NIH HHS [GM66815-01, R01 GM066815] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019901; Boube M, 2000, MECH DEVELOP, V91, P271, DOI 10.1016/S0925-4773(99)00315-9; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; Firulli Beth A., 2004, Biol Proced Online, V6, P16, DOI 10.1251/bpo69; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2003, J MED GENET, V40; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Martin K, 2003, COMB CHEM HIGH T SCR, V6, P331; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Netzer C, 2006, BBA-MOL BASIS DIS, V1762, P386, DOI 10.1016/j.bbadis.2005.12.005; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPUS, P162; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Onai T, 2004, DEV CELL, V7, P95, DOI 10.1016/j.devcel.2004.06.004; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Sato A, 2004, BIOCHEM BIOPH RES CO, V319, P103, DOI 10.1016/j.bbrc.2004.04.156; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Solari F, 1999, DEVELOPMENT, V126, P2483; Stasyk T, 2005, ELECTROPHORESIS, V26, P2850, DOI 10.1002/elps.200500026; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Toker AS, 2003, DEVELOPMENT, V130, P3831, DOI 10.1242/dev.00398; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wang X, 2002, EMBO J, V21, P5225, DOI 10.1093/emboj/cdf527; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	44	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34858	34868		10.1074/jbc.M703702200	http://dx.doi.org/10.1074/jbc.M703702200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895244	Green Submitted, hybrid			2022-12-27	WOS:000251155200028
J	Duong, N; Osborne, S; Bustamante, VH; Tomljenovic, AM; Puente, JL; Coombes, BK				Duong, Nancy; Osborne, Suzanne; Bustamante, Victor H.; Tomljenovic, Ana M.; Puente, Jose L.; Coombes, Brian K.			Thermosensing coordinates a cis-regulatory module for transcriptional activation of the intracellular virulence system in salmonella enterica serovar typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN H-NS; III SECRETION SYSTEM; BACTERIAL GENE-REGULATION; IN-VIVO OLIGOMERIZATION; PATHOGENICITY ISLAND 2; ESCHERICHIA-COLI; EXPRESSION; IDENTIFICATION; SSRB; HHA	The expression of bacterial virulence genes is tightly controlled by the convergence of multiple extracellular signals. As a zoonotic pathogen, virulence gene regulation in Salmonella enterica serovar Typhimurium must be responsive to multiple cues from the general environment as well as from multiple niches within animal and human hosts. Previous work has identified combined magnesium and phosphate limitation as an environmental cue that activates genes required for intracellular virulence. One unanswered question is how virulence genes that are expressed within the host are inhibited in non-host environments that satisfy the phosphate and magnesium limitation cues. We report here that thermosensing is the major mechanism controlling incongruous activation of the intracellular virulence phenotype. Bacteria grown at 30 degrees C or lower were unable to activate the intracellular type III secretion system even under strong inducing signals such as synthetic medium, contact with macrophages, and exposure to the murine gut. Thermoregulation was fully recapitulated in a Salmonella bongori strain engineered to contain the intracellular virulence genes of S. enterica sv. Typhimurium, suggesting that orthologous thermoregulators were available. Accordingly, virulence gene repression at the nonpermissive temperature required Hha and H-NS, two nucleoid-like proteins involved in virulence gene control. The use of combined environmental cues to control transcriptional "logic gates" allows for transcriptional selectivity of virulence genes that would otherwise be superfluous if activated in the non-host environment. Thus, thermosensing by Salmonella provides integrated control of host niche-specific virulence factors.	McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62251, Morelos, Mexico; Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON N1G 3W4, Canada	McMaster University; Universidad Nacional Autonoma de Mexico; Public Health Agency of Canada	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W,Hlth Sci Ctr 4H17, Hamilton, ON L8N 3Z5, Canada.	coombes@mcmaster.ca	Coombes, Brian K/A-1727-2009; Bustamante, Victor/GXF-0780-2022; Taylor, Graham/A-4027-2012	Coombes, Brian/0000-0001-9883-1010; Tomljenovic-Berube, Ana/0000-0003-4733-7164; Puente, Jose/0000-0002-8411-4974				Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Deiwick J, 1999, ELECTROPHORESIS, V20, P813, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<813::AID-ELPS813>3.0.CO;2-Q; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Hansen-Wester I, 2004, INFECT IMMUN, V72, P2879, DOI 10.1128/IAI.72.5.2879-2888.2004; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Hurme R, 1998, MOL MICROBIOL, V30, P1, DOI 10.1046/j.1365-2958.1998.01049.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Madrid C, 2002, INT J MED MICROBIOL, V291, P425; Madrid C, 2007, J BACTERIOL, V189, P265, DOI 10.1128/JB.01124-06; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Stella S, 2006, J MOL BIOL, V355, P169, DOI 10.1016/j.jmb.2005.10.034; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; *WHO, 2005, 139 WHO; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	46	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34077	34084		10.1074/jbc.M707352200	http://dx.doi.org/10.1074/jbc.M707352200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895240	hybrid			2022-12-27	WOS:000251145700022
J	Nakamata, K; Kurita, T; Bhuiyan, MSA; Sato, K; Noda, Y; Yoda, K				Nakamata, Kosuke; Kurita, Tomokazu; Bhuiyan, M. Shah Alam; Sato, Keisuke; Noda, Yoichi; Yoda, Koji			KEG1/YFR042w encodes a novel Kre6-binding endoplasmic reticulum membrane protein responsible for beta-1,6-glucan synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN SYNTHESIS; CELL-WALL; IN-VITRO; EXPLORATION; GENES; ACTIN; ROT1P	KEG1/YFR042w of Saccharomyces cerevisiae is an essential gene that encodes a 200-amino acid polypeptide with four predicted transmembrane domains. The green fluorescent protein or Myc(6)-tagged Keg1 protein showed the typical characteristics of an integral membrane protein and was found in the endoplasmic reticulum by fluorescence imaging. Immunoprecipitation from the Triton X-100-solubilized cell lysate revealed that Keg1 binds to Kre6, which has been known to participate in beta-1,6-glucan synthesis. To analyze the essential function of Keg1 in more detail, we constructed temperature-sensitive mutant alleles by error-prone polymerase chain reaction. The keg1-1 mutant cells showed a common phenotype with Delta kre6 mutant including hypersensitivity to Calcofluor white, reduced sensitivity to the K1 killer toxin, and reduced content of beta-1,6-glucan in the cell wall. These results suggest that Keg1 and Kre6 have a cooperative role in beta-1,6-glucan synthesis in S. cerevisiae.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp	Kurita, Tomokazu/E-6346-2012					Azuma M, 2002, YEAST, V19, P783, DOI 10.1002/yea.873; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Machi K, 2004, MICROBIOL-SGM, V150, P3163, DOI 10.1099/mic.0.27292-0; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Takeuchi M, 2006, J BIOCHEM, V139, P597, DOI 10.1093/jb/mvj063; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umeyama T, 2006, INFECT IMMUN, V74, P2373, DOI 10.1128/IAI.74.4.2373-2381.2006; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	26	17	19	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34315	34324		10.1074/jbc.M706486200	http://dx.doi.org/10.1074/jbc.M706486200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893149	hybrid			2022-12-27	WOS:000251145700047
J	Wang, Y; Cipriano, DJ; Forgac, M				Wang, Yanru; Cipriano, Daniel J.; Forgac, Michael			Arrangement of subunits in the proteolipid ring of the V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CROSS-LINKING; MUTATIONAL ANALYSIS; YEAST; ROTATION; BINDING; LOCALIZATION; SYNTHASE; MUTANTS; STALK	The vacuolar ATPases (V-ATPases) are multisubunit complexes containing two domains. The V-1 domain (subunits A-H) is peripheral and carries out ATP hydrolysis. The V-0 domain (subunits a, c, c', c '', d, and e) is membrane-integral and carries out proton transport. In yeast, there are three proteolipid subunits as follows: subunit c (Vma3p), subunit c' (Vma11p), and subunit c '' (Vma16p). The proteolipid subunits form a six-membered ring containing single copies of subunits c' and c '' and four copies of subunit c. To determine the possible arrangements of proteolipid subunits in V-0 that give rise to a functional V-ATPase complex, a series of gene fusions was constructed to constrain the arrangement of pairs of subunits in the ring. Fusions containing c '' employed a truncated version of this protein lacking the first putative transmembrane helix (which we have shown previously to be functional), to ensure that the N and C termini of all subunits were located on the luminal side of the membrane. Fusion constructs were expressed in strains disrupted in c', c '', or both but containing a wild copy of c to ensure the presence of the required number of copies of subunit c. The c-c ''(Delta TM1), c ''(Delta TM1)-c', and c'-c constructs all complemented the vma(-) phenotype and gave rise to complexes possessing greater than 25% of wild-type levels of activity. By contrast, neither the c-c', the c'-c ''(Delta TM1), nor the c ''(Delta TM1)-c constructs complemented the vma(-) phenotype. These results suggest that functionally assembled V-ATPase complexes contain the proteolipid subunits arranged in a unique order in the ring.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK034928, DK 34928] Funding Source: Medline; NIGMS NIH HHS [R37 GM034478-22, GM 34478, R37 GM034478-23, R37 GM034478-21, R37 GM034478, R01 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; ARAI H, 1988, J BIOL CHEM, V263, P8796; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2003, J BIOL CHEM, V278, P5821, DOI 10.1074/jbc.M209875200; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; SUPEK F, 1994, J BIOL CHEM, V269, P24102; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	47	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34058	34065		10.1074/jbc.M704331200	http://dx.doi.org/10.1074/jbc.M704331200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897940	Green Accepted, hybrid			2022-12-27	WOS:000251145700020
J	Geraghty, P; Greene, CM; O'Mahony, M; O'Neill, SJ; Taggart, CC; McElvaney, NG				Geraghty, Patrick; Greene, Catherine M.; O'Mahony, Michael; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.			Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; IFN-GAMMA; LEUCOPROTEASE INHIBITOR; DENDRITIC CELLS; MACROPHAGE ELASTASE; ANGSTROM RESOLUTION; CYSTEINE PROTEASE; T-LYMPHOCYTES; INFLAMMATION	We have demonstrated that bronchoalveolar lavage fluid from chronic obstructive pulmonary disease patients contains higher levels of interferon-gamma compared with controls. Interferon-gamma is a potent inducer of various cathepsins and matrix metalloproteases. Therefore, we postulated that interferon-gamma could induce protease expression by macrophages in acute and chronic lung disease. Chronic obstructive pulmonary disease patients had greater levels of cathepsin S and matrix metalloprotease-12 in their bronchoalveolar lavage fluid. Macrophages incubated with chronic obstructive pulmonary disease bronchoalveolar lavage fluid exhibited increased expression of cathepsin S and matrix metalloprotease-12, which was inhibited by the addition of interferon-gamma-neutralizing immunoglobulin. Human secretory leukocyte protease inhibitor is an 11.7-kDa cationic non-glycosylated antiprotease synthesized and secreted by cells at the site of inflammation. We have demonstrated that secretory leukocyte protease inhibitor can inhibit interferon-gamma-induced cathepsin S production by macrophages. Pretreatment of macrophages with secretory leukocyte protease inhibitor inhibited interferon-gamma-induced inhibitor kappa B beta degradation and activation of nuclear factor kappa B. Secretory leukocyte protease inhibitor may prove to be therapeutically important as a potential inhibitor of protease expression in chronic obstructive pulmonary disease.	Beaumont Hosp, RCSI Educ, Pulm Res Div, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Taggart, CC (corresponding author), Beaumont Hosp, RCSI Educ, Pulm Res Div, Smurfit Bldg, Dublin 9, Ireland.	ctaggart@rcsi.ie	McElvaney, Noel/A-6809-2010; Taggart, Clifford C/G-4492-2014; Greene, Catherine M/D-3513-2012	Greene, Catherine M/0000-0003-2549-2569; Geraghty, Patrick/0000-0003-1647-5505; mcelvaney, Noel/0000-0002-0152-4370; Taggart, Clifford/0000-0002-9930-2978				ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guncar G, 1998, STRUCTURE, V6, P51; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hiemstra PS, 2004, CURR PHARM DESIGN, V10, P2891, DOI 10.2174/1381612043383566; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Lams BEA, 2000, EUR RESPIR J, V15, P512, DOI 10.1034/j.1399-3003.2000.15.14.x; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; Ma B, 2005, J CLIN INVEST, V115, P3460, DOI 10.1172/JCI24858; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Moriuchi H, 2000, J VIROL, V74, P6849, DOI 10.1128/JVI.74.15.6849-6855.2000; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Odaka C, 2003, J IMMUNOL, V171, P1507, DOI 10.4049/jimmunol.171.3.1507; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pauwels R A, 2001, Respir Care, V46, P798; Puddu P, 1997, J IMMUNOL, V159, P3490; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wiendl H, 2003, J NEUROIMMUNOL, V138, P132, DOI 10.1016/S0165-5728(03)00093-6; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106	44	40	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33389	33395		10.1074/jbc.M706884200	http://dx.doi.org/10.1074/jbc.M706884200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878156	hybrid			2022-12-27	WOS:000250840200018
J	Iwamoto, N; Sumi, D; Ishii, T; Uchida, K; Cho, AK; Froines, JR; Kumagai, Y				Iwamoto, Noriko; Sumi, Daigo; Ishii, Takeshi; Uchida, Koji; Cho, Arthur K.; Froines, John R.; Kumagai, Yoshito			Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIESEL EXHAUST PARTICLES; PARTICULATE MATTER; EPITHELIAL-CELLS; QUINONES; ROLES; REDOX; 9,10-PHENANTHRAQUINONE; PHENANTHRAQUINONE; PHOSPHORYLATION; INACTIVATION	1,2-Naphthoquinone (1,2-NQ), an atmospheric contaminant, causes the contraction of guinea pig trachea through the activation of epidermal growth factor receptor (EGFR) by inhibiting protein-tyrosine phosphatases (PTPs). Phosphorylation of EGFR is negatively regulated by PTPs, but details of the mechanism by which 1,2-NQ inhibits PTPs have not been elucidated. Results described in this report demonstrate that 1,2-NQ forms covalent bonds with PTP1B after exposure to human epithelial A431 cells. In this study, a concentration-dependent phosphorylation of EGFR was found to be coupled to the reduction of PTP activity in the cells. The reduction in PTP activity was due to the irreversible modification of PTP1B, and when PTP1B was overexpressed by the cells, the 1,2-NQ-mediated EGFR phosphorylation was suppressed. Studies with purified PTP1B and 1,2-NQ showed that the reduction in enzyme activity was due to a nucleophilic attack by the quinone on the enzyme, to form covalent bonds. Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry analysis and mutation experiments revealed that PTP1B inactivation was primarily due to covalent attachment of the quinone to Cys-121 of the enzyme, with binding to His-25 and Cys-215 as well. Collectively, the results show that covalent attachment of 1,2-NQ to PTP1B is at least partially responsible for the reduction of PTP activity, which leads to prolonged transactivation of EGFR in the cells.	Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Programs Med Sci, Tsukuba, Ibaraki 3058575, Japan; Univ Shizuoka, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; Univ Shizuoka, Global COE Program, Shizuoka 4228526, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; Univ Calif Los Angeles, Inst Environm, So California Particle Ctr, Los Angeles, CA 90095 USA	University of Tsukuba; University of Shizuoka; University of Shizuoka; Nagoya University; University of California System; University of California Los Angeles	Kumagai, Y (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Programs Med Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	yk-em-tu@md.tsukuba.ac.jp		Sumi, Daigo/0000-0002-1585-8013; Uchida, Koji/0000-0003-3894-5299				Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bonner JC, 2002, AM J PHYSIOL-LUNG C, V283, pL528, DOI 10.1152/ajplung.00126.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNMARK A, 1989, FREE RADICAL BIO MED, V7, P435, DOI 10.1016/0891-5849(89)90126-3; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Chung MY, 2006, ENVIRON SCI TECHNOL, V40, P4880, DOI 10.1021/es0515957; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hansen SK, 2005, BIOCHEMISTRY-US, V44, P7704, DOI 10.1021/bi047417s; Inoue K, 2007, EUR RESPIR J, V29, P259, DOI 10.1183/09031936.00033106; Kar S, 2003, BIOCHEMISTRY-US, V42, P10490, DOI 10.1021/bi027418p; Kikuno S, 2006, TOXICOL APPL PHARM, V210, P47, DOI 10.1016/j.taap.2005.06.015; KUMAGAI Y, 1994, MOL PHARMACOL, V45, P359; Kumagai Y, 2002, CHEM RES TOXICOL, V15, P483, DOI 10.1021/tx0100993; Kumagai Y, 2001, AM J PHYSIOL-REG I, V281, pR25, DOI 10.1152/ajpregu.2001.281.1.R25; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sugimoto R, 2005, FREE RADICAL BIO MED, V38, P388, DOI 10.1016/j.freeradbiomed.2004.11.003; Taguchi K, 2007, FREE RADICAL BIO MED, V43, P789, DOI 10.1016/j.freeradbiomed.2007.05.021; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Valavanidis A, 2006, ENVIRON CHEM, V3, P118, DOI 10.1071/EN05089; Wu WD, 2001, AM J PHYSIOL-LUNG C, V281, pL483, DOI 10.1152/ajplung.2001.281.2.L483; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zheng J, 1996, CHEM RES TOXICOL, V9, P904, DOI 10.1021/tx960014b	36	89	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33396	33404		10.1074/jbc.M705224200	http://dx.doi.org/10.1074/jbc.M705224200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878162	hybrid			2022-12-27	WOS:000250840200019
J	Larkin, C; Haft, RJF; Harley, MJ; Traxler, B; Schildbach, JF				Larkin, Christopher; Haft, Rembrandt J. F.; Harley, Matthew J.; Traxler, Beth; Schildbach, Joel F.			Roles of active site residues and the HUH motif of the F plasmid TraI relaxase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; SEQUENCE-SPECIFIC BINDING; HELICASE-I CATALYZES; ESCHERICHIA-COLI; CONJUGATIVE RELAXASE; ORIGIN; PROTEINS; CLEAVAGE; DOMAIN; RECOGNITION	Bacterial conjugation, transfer of a single strand of a conjugative plasmid between bacteria, requires sequence-specific single-stranded DNA endonucleases called relaxases or nickases. Relaxases contain an HUH (His-hydrophobe-His) motif, part of a three-His cluster that binds a divalent cation required for the cleavage reaction. Crystal structures of the F plasmid TraI relaxase domain, with and without bound single-stranded DNA, revealed an extensive network of interactions involving HUH and other residues. Here we study the roles of these residues in TraI function. Whereas substitutions for the three His residues alter metal-binding properties of the protein, the same substitution at each position elicits different effects, indicating that the residues contribute asymmetrically to metal binding. Substitutions for a conserved Asp that interacts with one HUH His demonstrate that the Asp modulates metal affinity despite its distance from the metal. The bound metal enhances binding of ssDNA to the protein, consistent with a role for the metal in positioning the scissile phosphate for cleavage. Most substitutions tested caused significantly reduced in vitro cleavage activities and in vivo transfer efficiencies. In summary, the results suggest that the metal-binding His cluster in TraI is a finely tuned structure that achieves a sufficient affinity for metal while avoiding the unfavorable electrostatics that would result from placing an acidic residue near the scissile phosphate of the bound ssDNA.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Washington; University of Washington Seattle; Johns Hopkins University	Schildbach, JF (corresponding author), Mudd Hall 235,3400 N Charles St, Baltimore, MD 21218 USA.	joel@jhu.edu		Schildbach, Joel/0000-0002-3038-9745	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM061017] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61017, T32 GM07270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Byrd DR, 2002, J BIOL CHEM, V277, P42645, DOI 10.1074/jbc.M205984200; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; DeLano W.L, PYMOL MOL GRAPHICS S; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Fekete RA, 2000, J BACTERIOL, V182, P4022, DOI 10.1128/JB.182.14.4022-4027.2000; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Haft RJF, 2006, J BACTERIOL, V188, P6346, DOI 10.1128/JB.00462-06; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Larkin C, 2005, STRUCTURE, V13, P1533, DOI 10.1016/j.str.2005.06.013; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; MATSON SW, 1991, J BIOL CHEM, V266, P16232; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; NELSON WC, 1995, J BIOL CHEM, V270, P28374; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; REYGERS U, 1991, EMBO J, V10, P2689, DOI 10.1002/j.1460-2075.1991.tb07812.x; SHERMAN JA, 1994, J BIOL CHEM, V269, P26220; Stern JC, 2001, BIOCHEMISTRY-US, V40, P11586, DOI 10.1021/bi010877q; Stern JC, 2004, J BIOL CHEM, V279, P29155, DOI 10.1074/jbc.M402965200; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yoon-Robarts M, 2003, J BIOL CHEM, V278, P4912, DOI 10.1074/jbc.M209750200; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	34	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33707	33713		10.1074/jbc.M703210200	http://dx.doi.org/10.1074/jbc.M703210200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17890221	hybrid			2022-12-27	WOS:000250840200052
J	Brock, M; Fan, F; Mei, FC; Li, S; Gessner, C; Woods, VL; Cheng, X				Brock, Melissa; Fan, Fenghui; Mei, Fang C.; Li, Sheng; Gessner, Christopher; Woods, Virgil L., Jr.; Cheng, Xiaodong			Conformational analysis of Epac activation using amide hydrogen/deuterium exchange mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; DEPENDENT PROTEIN-KINASE; CAMP-BINDING DOMAINS; TERMINAL SRC KINASE; CYCLIC-AMP; REGULATORY SUBUNIT; II-BETA; STRUCTURAL DETERMINANTS; CELL-ADHESION; RI-ALPHA	Exchange proteins directly activated by cAMP ( Epac) play important roles in mediating the effects of cAMP through the activation of downstream small GTPases, Rap. To delineate the mechanism of Epac activation, we probed the conformation and structural dynamics of Epac using amide hydrogen/deuterium exchange and structural modeling. Our studies show that cAMP induces significant conformational changes that lead to a spatial rearrangement of the regulatory components of Epac and allows the exposure of the catalytic core for effector binding without imposing significant conformational change on the catalytic core. Homology modeling and comparative structural analyses of the cAMP binding domains of Epac and cAMP-dependent protein kinase ( PKA) lead to a model of Epac activation, in which Epac and PKA activation by cAMP employs the same underlying principle, although the detailed structural and conformational changes associated with Epac and PKA activation are significantly different.	Univ Calif San Diego, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brock, M (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Fan, Fenghui/A-2404-2011; Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NCI NIH HHS [CA099835, CA118595] Funding Source: Medline; NIAID NIH HHS [AI022160, AI0220221] Funding Source: Medline; NIGMS NIH HHS [GM066170, GM037684] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA099835, R33CA099835, R21CA118595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R01GM037684] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Derunes C, 2006, FEBS LETT, V580, P175, DOI 10.1016/j.febslet.2005.11.070; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Garcia RA, 2005, MOL PHARMACOL, V67, P1128, DOI 10.1124/mol.104.006346; Golynskiy M, 2007, J BIOL INORG CHEM, V12, P699, DOI 10.1007/s00775-007-0216-z; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y, 2002, J MOL BIOL, V321, P703, DOI 10.1016/S0022-2836(02)00419-9; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; JOHNSON RS, 1994, PROTEIN SCI, V3, P2411, DOI 10.1002/pro.5560031224; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Yu SN, 2004, BIOCHEMISTRY-US, V43, P1908, DOI 10.1021/bi0354435; Zawadzki KM, 2003, PROTEIN SCI, V12, P1980, DOI 10.1110/ps.03166903; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	59	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32256	32263		10.1074/jbc.M706231200	http://dx.doi.org/10.1074/jbc.M706231200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785454	hybrid			2022-12-27	WOS:000250480300048
J	Deshmukh, L; Tyukhtenko, S; Liu, JM; Fox, JEB; Qin, J; Vinogradova, O				Deshmukh, Lalit; Tyukhtenko, Sergiy; Liu, Jianmin; Fox, Joan E. B.; Qin, Jun; Vinogradova, Olga			Structural insight into the interaction between platelet integrin alpha(IIb)beta(3) and cytoskeletal protein skelemin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION; SEQUENCE; TITIN; REFINEMENT; MODULATION; ACTIVATION; EXPRESSION; COMPLEXES; MECHANISM; MOTIFS	Skelemin is a large cytoskeletal protein critical for cell morphology. Previous studies have suggested that its two-tandem immunoglobulin C2-like repeats (SkIgC4 and SkIgC5) are involved in binding to integrin beta(3) cytoplasmic tail (CT), providing a mechanism for skelemin to regulate integrin-mediated signaling and cell spreading. Using NMR spectroscopy, we have studied the molecular details of the skelemin IgC45 interaction with the cytoplasmic face of integrin alpha(IIb)beta(3). Here, we show that skelemin IgC45 domains form a complex not only with integrin beta(3) CT but also, surprisingly, with the integrin alpha(IIb) CT. Chemical shift mapping experiments demonstrate that both membrane-proximal regions of alpha(IIb) and beta(3) CTs are involved in binding to skelemin. NMR structural determinations, combined with homology modeling, revealed that SkIgC4 and SkIgC5 both exhibited a conserved Ig-fold and both repeats were required for effective binding to and attenuation of alpha(IIb)beta(3) cytoplasmic complex. These data provide the first molecular insight into how skelemin may interact with integrins and regulate integrin-mediated signaling and cell spreading.	Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT 06269 USA; Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Connecticut; Cleveland Clinic Foundation	Vinogradova, O (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Qin, Jun/D-5559-2009; Deshmukh, Lalit/C-5073-2015; Vinogradova, Olga/ABE-8367-2020	Vinogradova, Olga/0000-0001-5101-7361; Qin, Jun/0000-0002-2647-9270; TYUKHTENKO, SERGIY/0000-0002-0446-9979				AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; Bates PA, 2001, PROTEINS, P39; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jung JW, 2005, J BIOCHEM MOL BIOL, V38, P550; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; NOGUCHI J, 1992, J BIOL CHEM, V267, P20302; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; PRICE MG, 1993, J BIOL CHEM, V268, P21800; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; Reddy KB, 2001, J BIOL CHEM, V276, P28300, DOI 10.1074/jbc.M102794200; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Steiner F, 1999, GENOMICS, V56, P78, DOI 10.1006/geno.1998.5682; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	32	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32349	32356		10.1074/jbc.M704666200	http://dx.doi.org/10.1074/jbc.M704666200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804417	hybrid			2022-12-27	WOS:000250480300058
J	Hardman, RM; Stansfeld, PJ; Dalibalta, S; Sutcliffe, MJ; Mitcheson, JS				Hardman, Rachael M.; Stansfeld, Phillip J.; Dalibalta, Sarah; Sutcliffe, Michael J.; Mitcheson, John S.			Activation Gating of hERG potassium channels - S6 glycines are not required as gating hinges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S4-S5 LINKER; K+ CHANNEL; CRYSTAL-STRUCTURE; CONFORMATIONAL DYNAMICS; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; VOLTAGE SENSOR; GATE; PORE; HELICES	The opening of ion channels is proposed to arise from bending of the pore inner helices that enables them to pivot away from the central axis creating a cytosolic opening for ion diffusion. The flexibility of the inner helices is suggested to occur either at a conserved glycine located adjacent to the selectivity filter (glycine gating hinge) and/or at a second site occupied by glycine or proline containing motifs. Sequence alignment with other K+ channels shows that hERG possesses glycine residues (Gly(648) and Gly(657)) at each of these putative hinge sites. In apparent contrast to the hinge hypotheses, substitution of both glycine residues for alanine causes little effect on either the voltage-dependence or kinetics of channel activation, and open state block by intracellular blockers. Substitution of the glycines with larger hydrophobic residues causes a greater propensity for the channel to open. We propose that in contrast to Shaker the pore of hERG is intrinsically more stable in the open than the closed conformation and that substitution at Gly648 or Gly657 further shifts the gating equilibrium to favor the open state. Molecular dynamics simulations indicate the S6 helices of hERG are inherently flexible, even in the absence of the glycine residues. Thus hERG activation gating exhibits important differences to other K-V channels. Our findings indicate that the hERG inner helix glycine residues are required for the tight packing of the channel helices and that the flexibility afforded by glycine or proline residues is not universally required for activation gating.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7ND, Lancs, England	University of Leicester; University of Oxford; University of Manchester	Mitcheson, JS (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	jm109@le.ac.uk	Dalibalta, Sarah/AAJ-7479-2021; Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Dalibalta, Sarah/0000-0003-2288-9210; Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Mitcheson, John/0000-0002-2683-2839; Sutcliffe, Mike/0000-0003-0414-1700	MRC [G0001361] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C511305/1] Funding Source: Medline; Medical Research Council [G0001361] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Arcangeli Annarosa, 2005, V266, P225; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Claydon TW, 2003, J BIOL CHEM, V278, P50654, DOI 10.1074/jbc.M308183200; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DeLano W.L, PYMOL MOL GRAPHICS S; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2002, EUR BIOPHYS J BIOPHY, V31, P217, DOI 10.1007/s00249-002-0207-5; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shrivastava IH, 2000, BIOPHYS J, V78, P79, DOI 10.1016/S0006-3495(00)76574-X; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	56	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31972	31981		10.1074/jbc.M705835200	http://dx.doi.org/10.1074/jbc.M705835200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823114	hybrid			2022-12-27	WOS:000250480300018
J	Saijou, E; Itoh, T; Kim, KW; Iemura, SI; Natsume, T; Miyajima, A				Saijou, Eiko; Itoh, Tohru; Kim, Kyung-Woon; Iemura, Shun-Ichiro; Natsume, Tohru; Miyajima, Atsushi			Nucleocytoplasmic shuttling of the zinc finger protein EZI is mediated by importin-7-dependent nuclear import and CRM1-independent export mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LOCALIZATION SIGNAL; TRANSPORT RECEPTORS; BINDING-PROTEINS; CYTOPLASM; PATHWAY; BETA; IDENTIFICATION; DOMAIN; CRM1	Nucleocytoplasmic translocation constitutes a foundation for nuclear proteins to exert their proper functions and hence for various biological reactions to occur normally in eukaryotic cells. We reported previously that EZI/Zfp467, a 12 zinc finger motif-containing protein, localizes predominantly in the nucleus, yet the underlying mechanism still remains elusive. Here we constructed a series of mutant forms of EZI and examined their subcellular localization. The results delineated a non-canonical nuclear localization signal in the region covering the 9th to the 12th zinc fingers, which was necessary for nuclear accumulation of EZI as well as sufficient to confer nuclear localizing ability to a heterologous protein. We also found that the N-terminal domain of EZI is necessary for its nuclear export, the process of which was not sensitive to the CRM1 inhibitor leptomycin B. An interaction proteomics approach and the following co-immunoprecipitation experiments identified the nuclear import receptor importin-7 as a molecule that associated with EZI and, importantly, short interfering RNA-mediated knockdown of importin-7 expression completely abrogated nuclear accumulation of EZI. Taken together, these results identify EZI as a novel cargo protein for importin-7 and demonstrate a nucleocytoplasmic shuttling mechanism that is mediated by importin-7-dependent nuclear localization and CRM1-independent nuclear export.	Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; Japan Sci & Technol Agcy, Kawaguchi Shi, Saitama 3320012, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Itoh, T (corresponding author), Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp	Natsume, Tohru/M-7627-2018; Kim, Kyung-Woon/F-7287-2018; Itoh, Tohru/GYQ-8698-2022	Natsume, Tohru/0000-0002-1510-2582; Kim, Kyung-Woon/0000-0003-0225-9684; Itoh, Tohru/0000-0002-6579-1638				Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bruening W, 1996, FEBS LETT, V393, P41, DOI 10.1016/0014-5793(96)00853-8; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Nakayama K, 2002, EMBO J, V21, P6174, DOI 10.1093/emboj/cdf596; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; NISHI K, 1994, J BIOL CHEM, V269, P6320; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Yu Z, 1998, J ENDOCRINOL, V159, P53, DOI 10.1677/joe.0.1590053; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	36	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32327	32337		10.1074/jbc.M706793200	http://dx.doi.org/10.1074/jbc.M706793200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848547	hybrid			2022-12-27	WOS:000250480300056
J	Wanamaker, CP; Green, WN				Wanamaker, Christian P.; Green, William N.			Endoplasmic reticulum chaperones stabilize nicotinic receptor Subunits and regulate receptor assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; BINDING-SITES; MISFOLDED GLYCOPROTEINS; CONFORMATIONAL-CHANGE; SURFACE EXPRESSION; ATPASE ACTIVITY; ALPHA-SUBUNIT; BETA-SUBUNIT; IN-VIVO; CALNEXIN	We examined interactions between the endoplasmic reticulum (ER) chaperones calnexin (CN), ERp57, and immunological heavy chain-binding protein (BiP) and nicotinic acetylcholine receptor (nAChR) subunits. The three chaperones rapidly associate with newly synthesized nAChR subunits. Interactions between nAChR subunits and ERp57 occur via transient intermolecular disulfide bonds and do not require subunit N-linked glycosylation. The associations of ERp57 or CN with AChR subunits are long lived and prolong subunit lifetime similar to 10-fold. Co-expression of CN or ERp57 alone does not affect nAChR assembly or trafficking, but together they cause a significant decrease in nAChR expression and assembly. In contrast, associations with BiP are shorter lived and do not alter nAChR expression and assembly. However, a mutated BiP that slows its dissociation significantly increases its associations and decreases nAChR expression and assembly. Our results suggest that interactions with the chaperones regulate the levels of nAChRs assembled in the ER by stabilizing and sequestering subunits during assembly.	Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol & Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Green, WN (corresponding author), Univ Chicago, Dept Neurobiol, 947 E 58th St, Chicago, IL 60637 USA.	wgreen@uchicago.edu			NINDS NIH HHS [R01 NS032693, R01 NS032693-07, R01 NS032693-08, R01 NS032693-05A1, R01 NS032693-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; CLAUDIO T, 1989, J CELL BIOL, V108, P2277, DOI 10.1083/jcb.108.6.2277; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Eertmoed AL, 1998, METHOD ENZYMOL, V293, P564; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Gehle VM, 1997, MOL BRAIN RES, V45, P219, DOI 10.1016/S0169-328X(96)00256-2; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gething MJ., 1997, GUIDEBOOK MOL CHAPER; Green WN, 1998, J NEUROSCI, V18, P5555; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; GREEN WN, 1991, P NATL ACAD SCI USA, V88, P854, DOI 10.1073/pnas.88.3.854; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Mitra M, 2001, J NEUROSCI, V21, P3000, DOI 10.1523/JNEUROSCI.21-09-03000.2001; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MURRAY PJ, 1995, ANAL BIOCHEM, V229, P170, DOI 10.1006/abio.1995.1399; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; PAULSON HL, 1991, J CELL BIOL, V113, P1371, DOI 10.1083/jcb.113.6.1371; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Wanamaker CP, 2005, J BIOL CHEM, V280, P33800, DOI 10.1074/jbc.M501813200; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	50	37	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31113	31123		10.1074/jbc.M705369200	http://dx.doi.org/10.1074/jbc.M705369200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728248	Green Accepted, hybrid			2022-12-27	WOS:000250309200001
J	Wiertz, FGM; Richter, OMH; Ludwig, B; de Vries, S				Wiertz, Frank G. M.; Richter, Oliver-Matthias H.; Ludwig, Bernd; de Vries, Simon			Kinetic resolution of a tryptophan-radical intermediate in the reaction cycle of Paracoccus denitrificans cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN CHARACTERIZATION; FREEZE-HYPERQUENCHING MHQ; HIGH-FIELD EPR; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; RIBONUCLEOTIDE REDUCTASE; OXYGEN ACTIVATION; CATALYTIC CYCLE; PROTON PUMP	The catalytic mechanism, electron transfer coupled to proton pumping, of heme-copper oxidases is not yet fully understood. Microsecond freeze-hyperquenching single turnover experiments were carried out with fully reduced cytochrome aa(3) reacting with O-2 between 83 mu s and 6 ms. Trapped intermediates were analyzed by low temperature UV-visible, X-band, and Q-band EPR spectroscopy, enabling determination of the oxidation-reduction kinetics of Cu-A, heme a, heme a(3), and of a recently detected tryptophan radical (Wiertz, F. G. M., Richter, O. M. H., Cherepanov, A. V., MacMillan, F., Ludwig, B., and de Vries, S. (2004) FEBS Lett. 575, 127-130). Cu-B and heme a3 were EPR silent during all stages of the reaction. Cu-A and heme a are in electronic equilibrium acting as a redox pair. The reduction potential of Cu-A is 4.5 mV lower than that of heme a. Both redox groups are oxidized in two phases with apparent half-lives of 57 mu s and 1.2 ms together donating a single electron to the binuclear center in each phase. The formation of the heme a3 oxoferryl species PR (maxima at 430 nm and 606 nm) was completed in similar to 130 mu s, similar to the first oxidation phase of Cu-A and heme a. The intermediate F (absorbance maximum at 571 nm) is formed from PR and decays to a hitherto undetected intermediate named F-W*. F-W* harbors a tryptophan radical, identified by Q-band EPR spectroscopy as the tryptophan neutral radical of the strictly conserved Trp-272 (Trp-272*). The Trp-272* populates to 4-5% due to its relatively low rate of formation (t(1/2) = 1.2 ms) and rapid rate of breakdown (t(1/2) = 60 mu s), which represents electron transfer from Cu-A/ heme a to Trp-272*. The formation of the Trp-272* constitutes the major rate-determining step of the catalytic cycle. Our findings show that Trp-272 is a redox-active residue and is in this respect on an equal par to the metallo-centers of the cytochrome c oxidase. Trp-272 is the direct reductant either to the heme a3 oxoferryl species or to Cu-B(2+). The potential role of Trp-272 in proton pumping is discussed.	Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; JW Goethe Univ, Inst Biochem & Cluster Excellence Macromol Comple, D-60438 Frankfurt, Germany	Delft University of Technology; Goethe University Frankfurt	de Vries, S (corresponding author), Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands.	s.devries@tudelft.nl						Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; ADELROTH P, 1995, BIOCHEMISTRY-US, V34, P2844; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Ballou D P, 1978, Methods Enzymol, V54, P85; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; BLACKBURN NJ, 1994, BIOCHEMISTRY-US, V33, P10401, DOI 10.1021/bi00200a022; BLAIR DF, 1985, J AM CHEM SOC, V107, P7389, DOI 10.1021/ja00311a029; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Brzezinski P, 2004, TRENDS BIOCHEM SCI, V29, P380, DOI 10.1016/j.tibs.2004.05.008; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Einarsdottir O, 2004, BBA-BIOENERGETICS, V1655, P263, DOI 10.1016/j.bbabio.2003.07.011; ESPE MP, 1995, BIOCHEMISTRY-US, V34, P7593, DOI 10.1021/bi00023a005; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; Farver O, 2006, BIOPHYS J, V90, P2131, DOI 10.1529/biophysj.105.075440; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Florens L, 2001, BIOCHEMISTRY-US, V40, P7491, DOI 10.1021/bi0101188; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HANSSON O, 1982, EMBO J, V1, P1295, DOI 10.1002/j.1460-2075.1982.tb01313.x; HENDLER RW, 1991, BIOPHYS J, V60, P415, DOI 10.1016/S0006-3495(91)82067-7; Hendriks J, 2000, BBA-BIOENERGETICS, V1459, P266, DOI 10.1016/S0005-2728(00)00161-4; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kass H, 2000, J PHYS CHEM B, V104, P5362, DOI 10.1021/jp993133j; Kitagawa T, 2000, J INORG BIOCHEM, V82, P9, DOI 10.1016/S0162-0134(00)00155-0; Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r; Lu S, 2005, J RAMAN SPECTROSC, V36, P359, DOI 10.1002/jrs.1314; LUDWIG B, 1986, METHOD ENZYMOL, V126, P153; MacMillan F, 2006, FEBS LETT, V580, P1345, DOI 10.1016/j.febslet.2006.01.054; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Nyquist RM, 2003, P NATL ACAD SCI USA, V100, P8715, DOI 10.1073/pnas.1530408100; Ogura T, 2004, BBA-BIOENERGETICS, V1655, P290, DOI 10.1016/j.bbabio.2003.10.013; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pecoraro C, 2001, BIOCHEMISTRY-US, V40, P9695, DOI 10.1021/bi010115v; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Ribacka C, 2005, BIOCHEMISTRY-US, V44, P16502, DOI 10.1021/bi0511336; Rich PR, 2002, BBA-BIOENERGETICS, V1554, P137, DOI 10.1016/S0005-2728(02)00228-1; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; Rigby SEJ, 2000, BIOCHEMISTRY-US, V39, P5921, DOI 10.1021/bi992614q; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; Salomonsson L, 2005, P NATL ACAD SCI USA, V102, P17624, DOI 10.1073/pnas.0505431102; Schmidt B, 2004, BBA-BIOENERGETICS, V1655, P248, DOI 10.1016/j.bbabio.2003.11.008; Schmidt B, 2003, P NATL ACAD SCI USA, V100, P15539, DOI 10.1073/pnas.2633243100; Siletsky SA, 2006, BBA-BIOENERGETICS, V1757, P1122, DOI 10.1016/j.bbabio.2006.07.003; Sucheta A, 1997, BIOCHEMISTRY-US, V36, P554, DOI 10.1021/bi962422k; Sucheta A, 1998, BIOCHEMISTRY-US, V37, P17905, DOI 10.1021/bi981092w; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Svistunenko DA, 2004, BBA-BIOENERGETICS, V1655, P372, DOI 10.1016/j.bbabio.2003.06.006; Szundi I, 2004, BIOCHEMISTRY-US, V43, P15746, DOI 10.1021/bi049408p; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; Verkhovsky MI, 2006, BBA-BIOENERGETICS, V1757, P401, DOI 10.1016/j.bbabio.2006.05.026; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; Wiertz FGM, 2006, BIOCHEM SOC T, V34, P136, DOI 10.1042/BST0340136; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; WIKSTROM M, 2003, BIOCHIM BIOPHYS ACTA, V1757, P1047; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028; Zaslavsky D, 1999, BIOCHEMISTRY-US, V38, P2307, DOI 10.1021/bi9822832	76	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31580	31591		10.1074/jbc.M705520200	http://dx.doi.org/10.1074/jbc.M705520200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761680	hybrid			2022-12-27	WOS:000250309200050
J	Ueda, Y; Yamaguchi, R; Ikawa, M; Okabe, M; Morii, E; Maeda, Y; Kinoshita, T				Ueda, Yasutaka; Yamaguchi, Ryo; Ikawa, Masahito; Okabe, Masaru; Morii, Eiichi; Maeda, Yusuke; Kinoshita, Taroh			PGAP1 knock-out mice show otocephaly and male infertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GPI-ANCHORED PROTEINS; WINGLESS MORPHOGEN GRADIENT; DALLY-LIKE PROTEIN; CELL-SURFACE; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; DECAPACITATION FACTOR; VISCERAL ENDODERM; MONOCLONAL-ANTIBODIES; SPERM FERTILITY	A palmitate linked to the inositol in glycosylphosphatidylinositol (GPI) is removed in the endoplasmic reticulum immediately after the conjugation of GPI with proteins in most cells. Previously, we identified PGAP1 (post GPI attachment to proteins 1) as a GPI inositoldeacylase that removes the palmitate from inositol. A defect in PGAP1 caused a delay in the transport of GPI-anchored proteins (GPI-APs) from the endoplasmic reticulum to the cell surface in Chinese hamster ovary cells, although the cell-surface expression of GPI-APs in the steady state was normal. Nevertheless, in most cells, GPI-APs undergo deacylation. To elucidate the biological significance of PGAP1 in vivo, we established PGAP1 knock-out mice. Most PGAP1 knock-out mice showed otocephaly, a developmental defect, and died right after birth. However, some survived with growth retardation. Male knock-out mice showed severely reduced fertility despite the capability of ejaculation. Their spermatozoa were normal in number, motility, and ability to ascend the uterus, but were unable to go into the oviduct. In vitro, PGAP1-deficient spermatozoa showed weak attachment to the zona pellucida and a severely diminished rate of fertilization. Therefore, an extra acyl chain in GPI anchors caused severe deleterious effects to development and sperm function.	Osaka Univ, Dept Immunoregulat, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kinoshita, T (corresponding author), Osaka Univ, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Kinoshita, Taroh/C-7353-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044; Ueda, Yutaka/0000-0001-8760-6379				AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDFORD JM, 1962, AM J PHYSIOL, V202, P179, DOI 10.1152/ajplegacy.1962.202.1.179; BIXLER D, 1985, J CRAN GENET DEV BIO, P241; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; DEEG MA, 1992, J BIOL CHEM, V267, P18573; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; FRASER LR, 1984, J REPROD FERTIL, V72, P373, DOI 10.1530/jrf.0.0720373; Fraser LR, 1998, MOL REPROD DEV, V51, P193, DOI 10.1002/(SICI)1098-2795(199810)51:2&lt;193::AID-MRD9&gt;3.0.CO;2-L; Gibbons R, 2005, REPRODUCTION, V130, P497, DOI 10.1530/rep.1.00792; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Harris CL, 2003, IMMUNOLOGY, V109, P117, DOI 10.1046/j.1365-2567.2003.01628.x; Hide T, 2002, DEVELOPMENT, V129, P4347; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; JURILOFF DM, 1985, J CRAN GENET DEV BIO, V5, P121; Kessler SP, 2000, J BIOL CHEM, V275, P26259, DOI 10.1074/jbc.M004006200; Khare N, 2000, MECH DEVELOP, V99, P199, DOI 10.1016/S0925-4773(00)00502-5; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kimura C, 2001, DEV BIOL, V235, P12, DOI 10.1006/dbio.2001.0289; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Kravets FG, 2000, PROSTATE, V43, P169, DOI 10.1002/(SICI)1097-0045(20000515)43:3<169::AID-PROS2>3.0.CO;2-D; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McConville MJ, 2000, MOL MEMBR BIOL, V17, P1; Murakami Y, 2003, MOL BIOL CELL, V14, P4285, DOI 10.1091/mbc.E03-03-0193; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nozaki M, 1999, LAB INVEST, V79, P293; Ohta R, 1999, MICROBIOL IMMUNOL, V43, P1045, DOI 10.1111/j.1348-0421.1999.tb01234.x; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Rooney IA, 1996, J CLIN INVEST, V97, P1675, DOI 10.1172/JCI118594; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Saez F, 2003, J ANDROL, V24, P149; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Suda Y, 1996, GENES CELLS, V1, P1031, DOI 10.1046/j.1365-2443.1996.900288.x; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; WALTER EI, 1990, J IMMUNOL, V144, P1030; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]; Zakin L, 2000, P NATL ACAD SCI USA, V97, P14388, DOI 10.1073/pnas.011513398; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031	78	71	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30373	30380		10.1074/jbc.M705601200	http://dx.doi.org/10.1074/jbc.M705601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17711852	hybrid			2022-12-27	WOS:000250136300005
J	Xiao, F; Giavalisco, P; Martin, GB				Xiao, Fangming; Giavalisco, Patrick; Martin, Gregory B.			Pseudomonas syringae type III effector AvrPtoB is phosphorylated in plant cells on serine 258, promoting its virulence activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; PTO-MEDIATED RESISTANCE; RHIZOBIUM SP NGR234; PV. TOMATO; DISEASE RESISTANCE; INNATE IMMUNITY; SECRETION SYSTEM; PLASMA-MEMBRANE; PROTEIN-KINASE; DEATH	The Pseudomonas syringae pv. tomato protein AvrPtoB is translocated into plant cells via the bacterial type III secretion system. In resistant tomato leaves, AvrPtoB acts as an avirulence protein by interacting with the host Pto kinase and eliciting the host immune response. Pto-mediated immunity requires Prf, a Pto-interacting protein with a putative nucleotide-binding site and a region of leucine-rich repeats. In susceptible tomato plants, which lack either Pto or Prf, AvrPtoB acts as a virulence protein by promoting P. syringae pv. tomato growth and enhancing symptoms associated with bacterial speck disease. The N-terminal 307 amino acids of AvrPtoB ( designated AvrPtoB(1-307)) are sufficient for these virulence activities and for Pto-mediated avirulence. We report that AvrPtoB is phosphorylated by a Pto- and Prf-independent kinase activity that is conserved in several plant species, including tomato ( Solanum lycopersicum), Nicotiana benthamiana, and Arabidopsis thaliana. AvrPtoB(1-307) was phosphorylated in tomato protoplasts, and mass spectrometry identified serine 258 as the major in vivo phosphorylation site of this protein. An alanine substitution of Ser(258) resulted in the loss of virulence and the diminution of avirulence activity of AvrPtoB(1-307), whereas a phosphomimetic S258D mutant had activities similar to wild type AvrPtoB(1-307). These observations suggest that AvrPtoB has evolved to mimic a substrate of a conserved plant kinase, leading to enhancement of its virulence and avirulence activities in the host cell.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830	NIGMS NIH HHS [R01GM078021, R01 GM078021-02, R01 GM078021] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078021] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; Bartsev AV, 2003, FEBS LETT, V554, P271, DOI 10.1016/S0014-5793(03)01145-1; Chang JH, 2000, MOL PLANT MICROBE IN, V13, P568, DOI 10.1094/MPMI.2000.13.5.568; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; Desveaux D., 2007, PLOS PATHOG, V3, P0456; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lin NC, 2006, APPL ENVIRON MICROB, V72, P702, DOI 10.1128/AEM.72.1.702-712.2006; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Shan LB, 2000, MOL PLANT MICROBE IN, V13, P592, DOI 10.1094/MPMI.2000.13.6.592; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Skorpil P, 2005, MOL MICROBIOL, V57, P1304, DOI 10.1111/j.1365-2958.2005.04768.x; Wulf' J, 2004, STRUCTURE, V12, P1257, DOI 10.1016/j.str.2004.04.017; XIAO F, 2007, PLANT J; Xiao FM, 2003, PLANT PHYSIOL, V131, P1239, DOI 10.1104/pp.016113; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	39	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30737	30744		10.1074/jbc.M705565200	http://dx.doi.org/10.1074/jbc.M705565200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17711844	Green Accepted, hybrid			2022-12-27	WOS:000250136300042
J	Ogata, N; Kawaguchi, H; Chung, U; Roth, SI; Segre, GV				Ogata, Naoshi; Kawaguchi, Hiroshi; Chung, Ung-il; Roth, Sanford I.; Segre, Gino V.			Continuous activation of G alpha(q) in osteoblasts results in osteopenia through impaired osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; PARATHYROID-HORMONE; BONE-FORMATION; PHOSPHOLIPASE-C; TRANSGENIC MICE; ALPHA-SUBUNITS; GROWTH-PLATE; CELLS; EXPRESSION; RECEPTOR	We explored the role of G alpha(q)- mediated signaling on skeletal homeostasis by selectively expressing a constitutively active G alpha(q) ( mutation of Q209L) in osteoblasts. Continuous signaling via G alpha(q) in mouse osteoblastic MC3T3- E1 cells impaired differentiation. Mice that expressed the constitutively active G alpha(q) transgene in cells of the osteoblast lineage exhibited severe osteopenia in cortical and trabecular bones. Osteoblast number, bone volume, and trabecular thickness were reduced in transgenic mice, but the osteoclasts were unaffected. Osteoblasts from transgenic mice showed impaired differentiation and matrix formation. In the presence of a protein kinase C inhibitor GF109203X, this impairment was not seen, indicating mediation by the protein kinase C pathway. We propose that continuous activation of the G alpha(q) signal in osteoblasts plays a crucial, previously unrecognized role in bone formation.	Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA	University of Tokyo; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp			NIDDK NIH HHS [DK47034, DK11794] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOWLER WB, 1999, FRONT BIOSCI, V3, P769; BREUR GJ, 1991, J ORTHOPAED RES, V9, P348, DOI 10.1002/jor.1100090306; BREUR GJ, 1994, ANAT RECORD, V239, P255, DOI 10.1002/ar.1092390304; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; KEMBER NF, 1979, J THEOR BIOL, V78, P365, DOI 10.1016/0022-5193(79)90336-9; KEMBER NF, 1978, CELL TISSUE KINET, V11, P477, DOI 10.1111/j.1365-2184.1978.tb00820.x; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; MONIERFAUGERE MC, 1998, METABOLIC BONE DIS, P230; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; PARTRIDGE NC, 1989, MOL ENDOCRINOL, V3, P232, DOI 10.1210/mend-3-2-232; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Quarles LD, 1996, J BONE MINER RES, V11, P1375; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; SPIEGEL AM, 1993, J CLIN INVEST, V92, P1119, DOI 10.1172/JCI116680; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Swarthout JT, 2001, J BIOL CHEM, V276, P7586, DOI 10.1074/jbc.M007400200; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WEINSTEIN LS, PRINCIPLES BONE BIOL, P877; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; WU DQ, 1992, J BIOL CHEM, V267, P1811	34	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35757	35764		10.1074/jbc.M611902200	http://dx.doi.org/10.1074/jbc.M611902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17823129	hybrid			2022-12-27	WOS:000251458100037
J	Ren, Z; Schenk, D; Basi, GS; Shapiro, IP				Ren, Zhao; Schenk, Dale; Basi, Guriqbal S.; Shapiro, I. Paul			Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; A-BETA; PRESENILIN-1 MUTATIONS; INTRACELLULAR DOMAINS; TERMINAL FRAGMENTS; ASPARTYL PROTEASE; EPSILON-CLEAVAGE; ALPHA-SECRETASE; ZETA-CLEAVAGE	Amyloid beta-protein (A beta), the major component of cerebral plaques associated with Alzheimer disease, is derived from amyloid beta-protein precursor (APP) through sequential proteolytic cleavage involving beta- and gamma-secretase. The intramembrane cleavage of APP by gamma-secretase occurs at two major sites, gamma and epsilon, although the temporal and/or mechanistic relationships between these cleavages remain unknown. In our attempt to address this issue, we uncovered an important regulatory role for the APP luminal juxtamembrane domain. We demonstrated in cell-based assays that domain replacements in this region can greatly reduce secreted A beta resulting from gamma-cleavage without affecting the epsilon-cleavage product. This A beta reduction is likely due to impaired proteolysis at the gamma-cleavage site. Further analyses with site-directed mutagenesis identified two juxtamembrane residues, Lys-28 and Ser-26 ( A beta numbering), as the critical determinants for efficient intramembrane proteolysis at the gamma-site. Consistent with the growing evidence that epsilon-cleavage of APP precedes gamma- processing, longer A beta species derived from the gamma-cleavage-deficient substrates were detected intra-cellularly. These results indicate that the luminal juxtamembrane region of APP is an important regulatory domain that modulates gamma-secretase-dependent intramembrane proteolysis, particularly in differentiating beta- and gamma- cleavages.	Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Shapiro, IP (corresponding author), Elan Pharmaceut Inc, San Francisco, CA 94080 USA.	paul.shapiro@elan.com						Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kametani F, 2004, FEBS LETT, V570, P73, DOI 10.1016/j.febslet.2004.06.034; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Okochi M, 2000, J BIOL CHEM, V275, P40925, DOI 10.1074/jbc.M005254200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ramdya P, 2003, J NEUROCHEM, V87, P843, DOI 10.1046/j.1471-4159.2003.02030.x; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	60	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35350	35360		10.1074/jbc.M702739200	http://dx.doi.org/10.1074/jbc.M702739200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890228	hybrid			2022-12-27	WOS:000251155200078
J	Dong, JJ; Bloom, JD; Goncharov, V; Chattopadhyay, M; Millhauser, GL; Lynn, DG; Scheibel, T; Lindquist, S				Dong, Jijun; Bloom, Jesse D.; Goncharov, Vladimir; Chattopadhyay, Madhuri; Millhauser, Glenn L.; Lynn, David G.; Scheibel, Thomas; Lindquist, Susan			Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BINDS CU(II); IN-VITRO CONVERSION; SACCHAROMYCES-CEREVISIAE; OCTAREPEAT DOMAIN; OCTAPEPTIDE REPEATS; GENETIC-VARIATION; COPPER(II) IONS; TRANSGENIC MICE; FULL-LENGTH; BETA-SHEET	Oligopeptide repeats appear in many proteins that undergo conformational conversions to form amyloid, including the mammalian prion protein PrP and the yeast prion protein Sup35. Whereas the repeats in PrP have been studied more exhaustively, interpretation of these studies is confounded by the fact that many details of the PrP prion conformational conversion are not well understood. On the other hand, there is now a relatively good understanding of the factors that guide the conformational conversion of the Sup35 prion protein. To provide a general model for studying the role of oligopeptide repeats in prion conformational conversion and amyloid formation, we have substituted various numbers of the PrP octarepeats for the endogenous Sup35 repeats. The resulting chimeric proteins can adopt the [PSI+] prion state in yeast, and the stability of the prion state depends on the number of repeats. In vitro, these chimeric proteins form amyloid fibers, with more repeats leading to shorter lag phases and faster assembly rates. Both pH and the presence of metal ions modulate assembly kinetics of the chimeric proteins, and the extent of modulation is highly sensitive to the number of PrP repeats. This work offers new insight into the properties of the PrP octarepeats in amyloid assembly and prion formation. It also reveals new features of the yeast prion protein, and provides a level of control over yeast prion assembly that will be useful for future structural studies and for creating amyloid-based biomaterials.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Garching, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Emory University; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California Santa Cruz; Technical University of Munich	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Bloom, Jesse D/K-3695-2019; Bloom, Jesse D/C-6837-2013; Scheibel, Thomas/I-1170-2014	Bloom, Jesse D/0000-0003-1267-3408; Scheibel, Thomas/0000-0002-0457-2423	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874, R01GM065790] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM025874-27, GM 065790, R37 GM025874, R01 GM025874, GM 25874, R01 GM065790] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; del Pino P, 2007, EUR BIOPHYS J BIOPHY, V36, P239, DOI 10.1007/s00249-006-0124-0; Derkatch IL, 1996, GENETICS, V144, P1375; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Goldmann W, 1998, J GEN VIROL, V79, P3173, DOI 10.1099/0022-1317-79-12-3173; Hutter G, 2003, BIOL CHEM, V384, P1279, DOI 10.1515/BC.2003.142; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones S, 2005, BIOCHEM J, V392, P309, DOI 10.1042/BJ20051236; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Langella E, 2004, BIOPHYS J, V87, P3623, DOI [10.1529/biophysj.104.043448, 10.1529/biophysj.104.043449]; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2002, J BIOL CHEM, V277, P1981, DOI 10.1074/jbc.M108744200; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shiraishi N, 2000, BIOCHEM BIOPH RES CO, V267, P398, DOI 10.1006/bbrc.1999.1944; Shiraishi N, 2006, J BIOL CHEM, V281, P34880, DOI 10.1074/jbc.M606581200; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; SIKORSKI RS, 1989, GENETICS, V122, P19; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Treiber C, 2007, FEBS J, V274, P1304, DOI 10.1111/j.1742-4658.2007.05678.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Vital C, 1998, NEUROPATH APPL NEURO, V24, P125, DOI 10.1046/j.1365-2990.1998.00098.x; Watanabe Y, 2006, BIOCHEM BIOPH RES CO, V350, P549, DOI 10.1016/j.bbrc.2006.09.082; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	74	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34204	34212		10.1074/jbc.M704952200	http://dx.doi.org/10.1074/jbc.M704952200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893150	Green Accepted, hybrid			2022-12-27	WOS:000251145700035
J	Hanoulle, X; Melchior, A; Sibille, N; Parent, B; Denys, A; Wieruszeski, JM; Horvath, D; Allain, F; Lippens, G; Landrieu, I				Hanoulle, Xavier; Melchior, Aurelie; Sibille, Nathalie; Parent, Benjamin; Denys, Agnes; Wieruszeski, Jean-Michel; Horvath, Dragos; Allain, Fabrice; Lippens, Guy; Landrieu, Isabelle			Structural and functional characterization of the interaction between cyclophilin B and a heparin-derived oligosaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD T-LYMPHOCYTES; MOLECULAR-STRUCTURE DETERMINATION; RESIDUAL DIPOLAR COUPLINGS; X-RAY-STRUCTURE; DYNAMIC PROPERTIES; BINDING-SITES; CELL-SURFACE; XPLOR-NIH; PROTEIN; CD147	The chemotaxis and integrin-mediated adhesion of T lymphocytes triggered by secreted cyclophilin B (CypB) depend on interactions with both cell surface heparan sulfate proteoglycans (HSPG) and the extracellular domain of the CD147 membrane receptor. Here, we use NMR spectroscopy to characterize the interaction of CypB with heparin-derived oligosaccharides. Chemical shift perturbation experiments allowed the precise definition of the heparan sulfate (HS) binding site of CypB. The N-terminal extremity of CypB, which contains a consensus sequence for heparin-binding proteins was modeled on the basis of our experimental NMR data. Because the HS binding site extends toward the CypB catalytic pocket, we measured its peptidylprolyl cis-trans isomerase (PPIase) activity in the absence or presence of a HS oligosaccharide toward a CD147-derived peptide. We report the first direct evidence that CypB is enzymatically active on CD147, as it is able to accelerate the cis/trans isomerization of the Asp(179)-Pro(180) bond in a CD147-derived peptide. However, HS binding has no significant influence on this PPIase activity. We thus conclude that the glycanic moiety of HSPG serves as anchor for CypB at the cell surface, and that the signal could be transduced by CypB via its PPIase activity toward CD147.	Univ Sci & Technol Lille, CNRS, UMR 8576, IFR 147,Unite Glycobiol Struct & Fonctionnelle, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Landrieu, I (corresponding author), Univ Sci & Technol Lille, CNRS, UMR 8576, IFR 147,Unite Glycobiol Struct & Fonctionnelle, F-59655 Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Horvath, Dragos/W-9789-2018; Landrieu, Isabelle/AAF-8495-2019; Sibille, Nathalie/K-2905-2015; HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021	Horvath, Dragos/0000-0003-0173-5714; Landrieu, Isabelle/0000-0002-4883-2637; Sibille, Nathalie/0000-0001-8145-6795; Hanoulle, Xavier/0000-0002-3755-2680; Allain, Fabrice/0000-0002-4484-6302				Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Allain F, 1996, BIOCHEM J, V317, P565, DOI 10.1042/bj3170565; ALLAIN F, 1994, J BIOL CHEM, V269, P16537; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Angulo J, 2004, CHEMBIOCHEM, V5, P55, DOI 10.1002/cbic.200300696; Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Carpentier M, 2002, BIOCHEMISTRY-US, V41, P5222, DOI 10.1021/bi015951j; Conrad H. E., 1998, HEPARIN BINDING PROT; Delehedde M., 2002, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V1, P89, DOI 10.2174/1568014023355935; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Galat A, 1999, ARCH BIOCHEM BIOPHYS, V371, P149, DOI 10.1006/abbi.1999.1434; Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hakansson S, 2003, BIOCHEMISTRY-US, V42, P8999, DOI 10.1021/bi020715+; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Kaplan J.I., 1980, NMR CHEM EXCHANGING; KE HM, 1992, J MOL BIOL, V228, P539, DOI 10.1016/0022-2836(92)90841-7; Koharudin LMI, 2003, J MAGN RESON, V163, P228, DOI 10.1016/S1090-7807(03)00149-6; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Otting G, 2000, J BIOMOL NMR, V16, P343, DOI 10.1023/A:1008372630606; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; SPIK G, 1991, J BIOL CHEM, V266, P10735; SPITZFADEN C, 1994, J BIOMOL NMR, V4, P463, DOI 10.1007/BF00156614; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; Vanpouille C, 2004, BIOCHEM J, V382, P733, DOI 10.1042/BJ20031453; VANPOUILLE C, 2007, J BIOL CHEM; WISHART DS, 1994, J BIOMOL NMR, V4, P171; XU Q, 1992, J BIOL CHEM, V267, P11968; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Yurchenko V, 2001, BIOCHEM BIOPH RES CO, V288, P786, DOI 10.1006/bbrc.2001.5847	51	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34148	34158		10.1074/jbc.M706353200	http://dx.doi.org/10.1074/jbc.M706353200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855358	hybrid			2022-12-27	WOS:000251145700029
J	Tsuboi, S; Meerloo, J				Tsuboi, Shigeru; Meerloo, Jennifer			Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP-INTERACTING PROTEIN; B-CELL ACTIVATION; FC-GAMMA-R; N-WASP; ACTIN POLYMERIZATION; T-CELL; MEDIATED PHAGOCYTOSIS; FILOPODIUM FORMATION; TYROSINE KINASE; ARP2/3 COMPLEX	Phagocytosis is a vital first-line host defense mechanism against infection involving the ingestion and digestion of foreign materials such as bacteria by specialized cells, phagocytes. For phagocytes to ingest the foreign materials, they form an actin-based membrane structure called phagocytic cup at the plasma membranes. Formation of the phagocytic cup is impaired in phagocytes from patients with a genetic immunodeficiency disorder, Wiskott-Aldrich syndrome (WAS). The gene defective in WAS encodes Wiskott-Aldrich syndrome protein (WASP). Mutation or deletion of WASP causes impaired formation of the phagocytic cup, suggesting that WASP plays an important role in the phagocytic cup formation. However, the molecular details of its formation remain unknown. We have shown that the WASP C-terminal activity is critical for the phagocytic cup formation in macrophages. We demonstrated that WASP is phosphorylated on tyrosine 291 in macrophages, and the WASP phosphorylation is important for the phagocytic cup formation. In addition, we showed that WASP and WASP interacting protein (WIP) form a complex at the phagocytic cup and that the WASP center dot WIP complex plays a critical role in the phagocytic cup formation. Our results indicate that the phosphorylation of WASP and the complex formation of WASP with WIP are the essential molecular steps for the efficient formation of the phagocytic cup in macrophages, suggesting a possible disease mechanism underlying phagocytic defects and recurrent infections in WAS patients.	Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Cell Imaging Facil, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Tsuboi, S (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stsuboi@burnham.org			NICHD NIH HHS [R01 HD 042752] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042752] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALDRICH RA, 1954, PEDIATRICS, V13, P133; Anton IM, 2006, EUR J CELL BIOL, V85, P295, DOI 10.1016/j.ejcb.2005.08.004; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Aspenstrom P, 2002, EXP CELL RES, V279, P21, DOI 10.1006/excr.2002.5576; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Badolato R, 1998, J IMMUNOL, V161, P1026; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Caron E, 2002, CURR OPIN CELL BIOL, V14, P82, DOI 10.1016/S0955-0674(01)00298-8; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gross BS, 1999, BLOOD, V94, P4166, DOI 10.1182/blood.V94.12.4166.424k36_4166_4176; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Kato M, 2002, BIOCHEM BIOPH RES CO, V291, P41, DOI 10.1006/bbrc.2002.6406; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kedzierska K, 2001, J LEUKOCYTE BIOL, V70, P322; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Konno A, 2007, INT IMMUNOL, V19, P185, DOI 10.1093/intimm/dxl135; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2001, INFECT IMMUN, V69, P1739, DOI 10.1128/IAI.69.3.1739-1746.2001; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Oda A, 2001, BLOOD, V97, P2633, DOI 10.1182/blood.V97.9.2633; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Park JY, 2004, CLIN EXP IMMUNOL, V136, P104, DOI 10.1111/j.1365-2249.2004.02409.x; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rawlings SL, 1999, BLOOD, V94, P3872, DOI 10.1182/blood.V94.11.3872.423k37_3872_3882; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sawa M, 2006, BIOCHEM BIOPH RES CO, V340, P709, DOI 10.1016/j.bbrc.2005.12.056; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Tsuboi S, 2006, J IMMUNOL, V176, P6576, DOI 10.4049/jimmunol.176.11.6576; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	78	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34194	34203		10.1074/jbc.M705999200	http://dx.doi.org/10.1074/jbc.M705999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890224	hybrid			2022-12-27	WOS:000251145700034
J	Hessel, S; Eichinger, A; Isken, A; Amengual, J; Hunzelmann, S; Hoeller, U; Elste, V; Hunziker, W; Goralczyk, R; Oberhauser, V; von Lintig, J; Wyss, A				Hessel, Susanne; Eichinger, Anne; Isken, Andrea; Amengual, Jaume; Hunzelmann, Silke; Hoeller, Ulrich; Elste, Volker; Hunziker, Willi; Goralczyk, Regina; Oberhauser, Vitus; von Lintig, Johannes; Wyss, Adrian			CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; RETINOIC-ACID-RECEPTOR; DIET-INDUCED OBESITY; PEROXISOME PROLIFERATOR; INSULIN-RESISTANCE; PPAR-GAMMA; ENZYMATIC CLEAVAGE; NUCLEAR RECEPTORS; BETA,BETA-CAROTENE 15,15'-DIOXYGENASE; PROVITAMIN-A	Carotenoids are currently investigated regarding their potential to lower the risk of chronic disease and to combat vitamin A deficiency in humans. These plant-derived compounds must be cleaved and metabolically converted by intrinsic carotenoid oxygenases to support the panoply of vitamin A-dependent physiological processes. Two different carotenoid-cleaving enzymes were identified in mammals, the classical carotenoid-15,15' -oxygenase (CMO1) and a putative carotenoid-9',10'-oxygenase (CMO2). To analyze the role of CMO1 in mammalian physiology, here we disrupted the corresponding gene by targeted homologous recombination in mice. On a diet providing beta-carotene as major vitamin A precursor, vitamin A levels fell dramatically in several tissues examined. Instead, this mouse mutant accumulated the provitamin in large quantities ( e. g. as seen by an orange coloring of adipose tissues). Besides impairments in beta-carotene metabolism, CMO1 deficiency more generally interfered with lipid homeostasis. Even on a vitamin A-sufficient chow, CMO1(-/-) mice developed a fatty liver and displayed altered serum lipid levels with elevated serum unesterified fatty acids. Additionally, this mouse mutant was more susceptible to high fat diet-induced impairments in fatty acid metabolism. Quantitative reverse transcription-PCR analysis revealed that the expression of peroxisome proliferator-activated receptor gamma-regulated marker genes related to adipogenesis was elevated in visceral adipose tissues. Thus, our study identifies CMO1 as the key enzyme for vitamin A production and provides evidence for a role of carotenoids as more general regulators of lipid metabolism.	Univ Freiburg, Dept Neurobiol & Anim Physiol, Inst Biol 1, D-79104 Freiburg, Germany; DSM Nutr Prod Ltd, R&D Human Nutr & Hlth, CH-4002 Basel, Switzerland; Chemin Musee, Frimorfo SA, CH-1700 Fribourg, Switzerland	University of Freiburg; DSM NV	von Lintig, J (corresponding author), Univ Freiburg, Dept Neurobiol & Anim Physiol, Inst Biol 1, Hauptstr 1, D-79104 Freiburg, Germany.	lintig@biologie.uni-freiburg.de; adrian.wyss@dsm.com		von Lintig, Johannes/0000-0002-2079-2143	NEI NIH HHS [R01 EY020551] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY020551] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Blaner WS, 2001, J AM ACAD DERMATOL, V45, pS129, DOI 10.1067/mjd.2001.113714; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Krinsky N, 2001, NUTR REV, V59, P309; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lee MY, 2002, DIABETES, V51, P3400; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; LILLIE RD, 1977, CONNS BIOL STAINS, P66; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Simoni D, 2001, CURR PHARM DESIGN, V7, P1823, DOI 10.2174/1381612013397168; SU NY, 1991, SOCIOBIOLOGY, V19, P349; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wolf G, 2001, NUTR REV, V59, P116; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaripheh S, 2006, J NUTR, V136, P932, DOI 10.1093/jn/136.4.932; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	55	193	202	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33553	10.1074/jbc.M706763200	http://dx.doi.org/10.1074/jbc.M706763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855355	hybrid			2022-12-27	WOS:000250840200036
J	Mueller, GM; Kashlan, OB; Bruns, JB; Maarouf, AB; Aridor, M; Kleyman, TR; Hughey, RP				Mueller, Gunhild M.; Kashlan, Ossama B.; Bruns, James B.; Maarouf, Ahmad B.; Aridor, Meir; Kleyman, Thomas R.; Hughey, Rebecca P.			Epithelial sodium channel exit from the endoplasmic reticulum is regulated by a signal within the carboxyl cytoplasmic domain of the alpha subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CELL-SURFACE EXPRESSION; NA+ SELF-INHIBITION; N-LINKED GLYCANS; LIDDLES-SYNDROME; A6 CELLS; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY; APICAL MEMBRANE; GAMMA-SUBUNIT	Epithelial sodium channels ( ENaCs) are assembled in the endoplasmic reticulum ( ER) from alpha, beta, and gamma subunits, each with two transmembrane domains, a large extracellular loop, and cytoplasmic amino and carboxyl termini. ENaC maturation involves transit through the Golgi complex where Asn-linked glycans are processed to complex type and the channel is activated by furin-dependent cleavage of the alpha and gamma subunits. To identify signals in ENaC for ER retention/retrieval or ER exit/ release, chimera were prepared with the interleukin alpha subunit (Tac) and each of the three cytoplasmic carboxyl termini of mouse ENaC (Tac- Ct) or with gamma-glutamyltranspeptidase and each of the three cytoplasmic amino termini (Nt-GGT). By monitoring acquisition of endoglycosidase H resistance after metabolic labeling, we found no evidence of ER retention of any chimera when compared with control Tac or GGT, but we did observe enhanced exit of Tac-alpha Ct when compared with Tac. ER exit of ENaC was assayed after metabolic labeling by following the appearance of cleaved alpha as cleaved alpha subunit, but not non-cleaved alpha, is endoglycosidase H-resistant. Interestingly ER exit of epitope-tagged and truncated alpha(alpha Delta 624-699-V5) with full-length beta gamma was similar to wild type alpha(+beta gamma), whereas ER exit of ENaC lacking the entire cytoplasmic carboxyl tail of alpha (alpha Delta 613-699- V5+beta gamma) was significantly reduced. Subsequent analysis of ER exit for ENaCs with mutations within the intervening sequence (613)HRFRSRYWSPG(623) within the context of the full-length alpha revealed that mutation alpha RSRYW620 to AAAAA significantly reduced ER exit. These data indicate that ER exit of ENaC is regulated by a signal within the alpha subunit carboxyl cytoplasmic tail.	Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			NIDDK NIH HHS [F32 DK066883, R01 DK062318, DK65161] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062318, R01DK065161, F32DK066883, R56DK065161] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; de la Rosa DA, 2004, J GEN PHYSIOL, V124, P395, DOI 10.1085/jgp.200409120; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Eaton Douglas C, 2004, Proc Am Thorac Soc, V1, P10, DOI 10.1513/pats.2306008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Joyce-Brady M, 2001, J BIOL CHEM, V276, P9468, DOI 10.1074/jbc.M004352200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; May A, 1997, J AM SOC NEPHROL, V8, P1813; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Poland PA, 1997, GLYCOCONJUGATE J, V14, P89, DOI 10.1023/A:1018569100438; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; RENARD S, 1994, J BIOL CHEM, V269, P12981; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Volk KA, 2001, J BIOL CHEM, V276, P43887, DOI 10.1074/jbc.M108714200; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200	72	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33475	10.1074/jbc.M707339200	http://dx.doi.org/10.1074/jbc.M707339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855354	hybrid			2022-12-27	WOS:000250840200028
J	Zavros, Y; Waghray, M; Tessier, A; Bai, LC; Todisco, A; Gumucio, DL; Samuelson, LC; Dlugosz, A; Merchant, JL				Zavros, Yana; Waghray, Meghna; Tessier, Arthur; Bai, Longchuan; Todisco, Andrea; Gumucio, Deborah L.; Samuelson, Linda C.; Dlugosz, Andrzej; Merchant, Juanita L.			Reduced pepsin a processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-EXTENDED GASTRIN; TRANSGENIC MICE; ACID-SECRETION; DEFICIENT MICE; COLONIC PROLIFERATION; HELICOBACTER-PYLORI; CANCER-EPIDEMIOLOGY; OXYNTIC ATROPHY; ALPHA-SUBUNIT; LONG	Sonic hedgehog (Shh) is not only essential to the development of the gastrointestinal tract, but is also necessary to maintain the characteristic acid-secreting phenotype of the adult stomach. Gastrin is the only hormone capable of stimulating gastric acid and is thus required to maintain functional parietal cells. We have shown previously that gastrin-null mice display gastric atrophy and metaplasia prior to progression to distal, intestinal-type gastric cancer. Because reduced levels of Shh peptide correlate with gastric atrophy, we examined whether gastrin regulates Shh expression in parietal cells. We show here that gastrin stimulates Shh gene expression and acid-dependent processing of the 45-kDa Shh precursor to the 19-kDa secreted peptide in primary parietal cell cultures. This cleavage was blocked by the proton pump inhibitor omeprazole and mediated by the acid-activated protease pepsin A. Pepsin A was also the protease responsible for processing Shh in tissue extracts from human stomach. By contrast, extracts prepared from neoplastic gastric mucosa had reduced levels of pepsin A and did not process Shh. Therefore processing of Shh in the normal stomach is hormonally regulated, acid-dependent, and mediated by the aspartic protease pepsin A. Moreover parietal cell atrophy, a known preneoplastic lesion, correlates with loss of Shh processing.	Univ Michigan, Dept Internal Med Gastroenterol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merchant, JL (corresponding author), BSRB, 109 Zina Pitcher Pl,BSRB Rm 2051, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	NIDDK NIH HHS [P01 DK062041-05S1, P30 DK034933-219001, P30-DK32533, R01 DK061410-04, R01 DK061410, R01 DK056882, P30-DK34933, P30 DK034933, R01-DK61410, P01-DK62041, P01 DK062041] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056882, P01DK062041, R01DK061410, P30DK034933] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; Chen D, 2000, GASTROENTEROLOGY, V119, P756, DOI 10.1053/gast.2000.16480; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1992, CANCER RES, V52, P6735; Dimmler A, 2003, LAB INVEST, V83, P1829, DOI 10.1097/01.LAB.0000101729.25140.0C; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Friis-Hansen L, 1998, AM J PHYSIOL-GASTR L, V274, pG561, DOI 10.1152/ajpgi.1998.274.3.G561; Fruton JS, 2002, Q REV BIOL, V77, P127, DOI 10.1086/340729; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Goldenring JR, 2000, GASTROENTEROLOGY, V118, P1080, DOI 10.1016/S0016-5085(00)70361-1; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; Judd LM, 2005, J GASTROEN HEPATOL, V20, P1266, DOI 10.1111/j.1440-1746.2005.03867.x; KAISE M, 1995, J BIOL CHEM, V270, P18637, DOI 10.1074/jbc.270.31.18637; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Koh TJ, 1999, J CLIN INVEST, V103, P1119, DOI 10.1172/JCI4910; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Kokkola A, 2005, WORLD J GASTROENTERO, V11, P1032, DOI 10.3748/wjg.v11.i7.1032; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; LIN XL, 1989, J BIOL CHEM, V264, P4482; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Nomura AMY, 2005, J INFECT DIS, V191, P2075, DOI 10.1086/430353; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rembiasz K, 2005, DIGEST DIS SCI, V50, P474, DOI 10.1007/s10620-005-2461-8; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Shao JS, 1998, AM J PHYSIOL-GASTR L, V274, pG62, DOI 10.1152/ajpgi.1998.274.1.G62; Shiotani A, 2005, AM J GASTROENTEROL, V100, P581, DOI 10.1111/j.1572-0241.2005.41001.x; Shiotani A, 2005, INT J CANCER, V115, P463, DOI 10.1002/ijc.20852; SOLL AH, 1985, AM J PHYSIOL, V248, pG569, DOI 10.1152/ajpgi.1985.248.5.G569; SOLL AH, 1978, J CLIN INVEST, V61, P370, DOI 10.1172/JCI108947; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Stepan V, 2005, J BIOL CHEM, V280, P15700, DOI 10.1074/jbc.M413037200; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van den Brink GR, 2002, GUT, V51, P628, DOI 10.1136/gut.51.5.628; WALSH JH, 1990, DIGESTION, V47, P11, DOI 10.1159/000200509; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2002, GASTROENTEROLOGY, V122, P119, DOI 10.1053/gast.2002.30298; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	50	53	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33265	33274		10.1074/jbc.M707090200	http://dx.doi.org/10.1074/jbc.M707090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17872943	hybrid			2022-12-27	WOS:000250840200006
J	Browning, C; Martin, E; Loch, C; Wurtz, JM; Moras, D; Stote, RH; Dejaegere, AP; Billas, IML				Browning, Christopher; Martin, Elyette; Loch, Caroline; Wurtz, Jean-Marie; Moras, Dino; Stote, Roland H.; Dejaegere, Annick P.; Billas, Isabelle M. L.			Critical role of desolvation in the binding of 20-hydroxyecdysone to the ecdysone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GAS-PHASE; HETERODIMERIC COMPLEX; MOLECULAR REPLACEMENT; AQUEOUS-SOLUTION; MANDUCA-SEXTA; FREE-ENERGIES; ULTRASPIRACLE; PROTEINS; METAMORPHOSIS	The insect steroid hormone 20-hydroxyecdysone (20E) binds to its cognate nuclear receptor composed of the ecdysone receptor (EcR) and Ultraspiracle (USP) and triggers the main developmental transitions, in particular molting and metamorphosis. We present the crystal structure of the ligand-binding domains of EcR/USP in complex with 20E at 2.4 A resolution and compare it with published structures of EcR/USP bound to ponasterone A (ponA). ponA is essentially identical to 20E but lacks the 25-OH group of 20E. The structure of 20E-bound EcR indicates that an additional hydrogen bond is formed compared with the ponA-bound receptor, yet, paradoxically, ponA has a significantly higher affinity for EcR than 20E. Theoretical studies based on docking and free energy methods lead to a rationale for understanding the difference in binding affinities between 20E and ponA. Results of the calculations indicate that the favorable contribution from the extra H-bond made by 25-OH of 20E is counterbalanced by its larger desolvation cost compared with that of ponA. The contribution of 25-OH to the binding affinity is further compared with those of 20- and 22-OH groups. Ligands that lack the 20- or 22-OH group are indeed known to bind less favorably to EcR than 20E, an effect opposite to that observed for ponA. The results indicate that their respective contributions to receptor-ligand complex stability reside mostly in their different contributions to solvation/desolvation. Together, the data demonstrate the critical role of ligand desolvation in determining binding affinity, with general implications for the binding of hormones to their cognate nuclear receptors.	IGBMC, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg 1, Fac Sci Vie, F-67000 Strasbourg, France; Univ Strasbourg 1, Inst Chim Strasbourg, Mol Biophys Lab, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dejaegere, AP (corresponding author), IGBMC, Dept Biol & Genom Struct, 1 Rue Laurent Fries, F-67400 Illkirch Graffenstaden, France.	annick@igbmc.u-strasbg.fr	Billas, Isabelle M.L./I-2790-2016; Wurtz, Jean-Marie/P-4652-2016	Billas, Isabelle M.L./0000-0003-2323-4208; Wurtz, Jean-Marie/0000-0003-2963-8617				Billas IML, 2005, VITAM HORM, V73, P101, DOI 10.1016/S0083-6729(05)73004-1; Billas IML, 2003, NATURE, V426, P91, DOI 10.1038/nature02112; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; Champlin DT, 1998, DEVELOPMENT, V125, P269; Champlin DT, 1998, DEVELOPMENT, V125, P2009; CRAMER CJ, 1994, J AM CHEM SOC, V116, P3892, DOI 10.1021/ja00088a027; Crittenden DL, 2005, J PHYS CHEM A, V109, P2971, DOI 10.1021/jp045233h; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; DEJAEGERE A, 1994, J CHEM SOC FARADAY T, V90, P1763, DOI 10.1039/ft9949001763; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dinan L, 1999, J COMPUT AID MOL DES, V13, P185, DOI 10.1023/A:1008052320014; Fabian L, 2002, ACTA CRYSTALLOGR B, V58, P710, DOI 10.1107/S0108768102005608; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Hakansson K, 1996, INT J BIOL MACROMOL, V18, P189, DOI 10.1016/0141-8130(95)01068-8; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; LAPENNA S, 2007, J INSECT SCI, V57, P32; Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riddiford LM, 2001, VITAM HORM, V60, P1; Rizzo RC, 2006, J CHEM THEORY COMPUT, V2, P128, DOI 10.1021/ct050097l; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Trindle C, 2003, J PHYS CHEM A, V107, P6236, DOI 10.1021/jp034598j; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200	53	54	56	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32924	32934		10.1074/jbc.M705559200	http://dx.doi.org/10.1074/jbc.M705559200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848566	Green Published, hybrid			2022-12-27	WOS:000250625400041
J	Chen, YR; Chen, CL; Pfeiffer, DR; Zweier, JL				Chen, Yeong-Renn; Chen, Chwen-Lih; Pfeiffer, Douglas R.; Zweier, Jay L.			Mitochondrial complex II in the post-ischemic heart - Oxidative injury and the role of protein S-glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-REDUCTASE; REDOX SIGNAL-TRANSDUCTION; OXYGEN-FREE RADICALS; SUCCINATE-DEHYDROGENASE; NITRIC-OXIDE; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; SUBUNIT-IV; QUINONE OXIDOREDUCTASES	Mitochondrial superoxide (O-2(radical-anion)) is an important mediator of ischemia/ reperfusion ( I/ R) injury. The O-2(radical-anion) generated in mitochondria also acts as a redox signal triggering cellular apoptosis. The enzyme succinate ubiquinone reductase ( SQR or complex II) is one of the major mitochondrial components hosting regulatory thiols. Here the intrinsic protein S- glutathionylation ( PrSSG) at the 70- kDa FAD- binding subunit of SQR was detected in rat heart and in isolated SQR using an anti- GSH monoclonal antibody. When rats were subjected to 30 min of coronary ligation followed by 24 h of reperfusion, the electron transfer activity ( ETA) of SQR in post- ischemic myocardium was significantly decreased by 41.5 +/- 2.9%. The PrSSGs of SQR- 70 kDa were partially or completely eliminated in post- ischemic myocardium obtained from in vivo regional I/ R hearts or isolated global I/ R hearts, respectively. These results were further confirmed by using isolated succinate cytochrome c reductase ( complex II + complex III). In the presence of succinate, O-2(radical-anion) was generated and oxidized the SQR portion of SCR, leading to a 60 - 70% decrease in its ETA. The gel band of the S- glutathionylated SQR 70- kDa polypeptide was cut out and digested with trypsin, and the digests were subjected to liquid chromatography/ tandem mass spectrometry analysis. One cysteine residue, Cys(90), was involved in S- glutathionylation. These results indicate that the glutathione-binding domain, (77)AAFGLSEAGFNTACVTK(93) ( where underline indicates Cys90), is susceptible to redox change induced by oxidative stress. Furthermore, in vitro S- glutathionylation of purified SQR resulted in enhanced SQR- derived electron transfer efficiency and decreased formation of the 70- kDa- derived protein thiyl radical induced by O-2(radical-anion).Thus, the decreasing S- glutathionylation and ETA in mitochondrial complex II are marked during myocardial ischemia/ reperfusion. This redox- triggered impairment of complex II occurs in the post- ischemic heart and should be useful to identify disease pathogenesis related to reactive oxygen species- induced mitochondrial dysfunction.	Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Mol & Cellular Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 607, 473 W 12th Ave, Columbus, OH 43210 USA.	yeong-renn.chen@osumc.edu			NHLBI NIH HHS [R01 HL083237] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Altschuld R A, 1996, EXS, V76, P87; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BIRCHMACHIN MA, 1992, J BIOL CHEM, V267, P11553; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; CHEN YR, 1994, BIOCHEMISTRY-US, V33, P10207, DOI 10.1021/bi00199a050; CHEN YR, 1995, J BIOL CHEM, V270, P11496, DOI 10.1074/jbc.270.19.11496; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Chen YR, 1996, J BIOL CHEM, V271, P2057, DOI 10.1074/jbc.271.4.2057; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Doliba NM, 1999, J MOL CELL CARDIOL, V31, P543, DOI 10.1006/jmcc.1998.0890; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ferrari C, 1996, ANNU REV FLUID MECH, V28, P1; FERRARI R, 1995, AM J CARDIOL, V76, pB17; Ferrari R, 1998, AM J CARDIOL, V82, p2K, DOI 10.1016/S0002-9149(98)00531-1; FERRARI R, 1994, ADV EXP MED BIOL, V366, P99; Ferrari R, 1992, Am J Cardiovasc Pathol, V4, P103; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hatefi Y, 1978, Methods Enzymol, V53, P11; Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; KENNEY WC, 1975, J BIOL CHEM, V250, P3089; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shiva S, 2004, BIOCHEM J, V379, P359, DOI 10.1042/BJ20031758; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; VERCESI A, 1978, J BIOL CHEM, V253, P6379; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1; Welter R, 1996, ARCH BIOCHEM BIOPHYS, V331, P9, DOI 10.1006/abbi.1996.0276; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; YU L, 1982, J BIOL CHEM, V257, P2016; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; ZWEIER JL, 1991, J BIOL CHEM, V266, P20296; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	67	193	196	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32640	32654		10.1074/jbc.M702294200	http://dx.doi.org/10.1074/jbc.M702294200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848555	hybrid			2022-12-27	WOS:000250625400013
J	Kou, RQ; Michel, T				Kou, Ruqin; Michel, Thomas			Epinephrine regulation of the endothelial nitric-oxide synthase - Roles of RAC1 and beta(3)-adrenergic receptors in endothelial no signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; ADRENERGIC-RECEPTORS; CELL MIGRATION; HEART-FAILURE; IN-VITRO; ACTIVATION; PHOSPHORYLATION; AKT; STIMULATION; PATHWAYS	beta- Adrenergic receptors ( beta AR) play an important role in vasodilation, but the mechanisms whereby adrenergic pathways regulate the endothelial isoform of nitric- oxide synthase ( eNOS) are incompletely understood. We found that epinephrine significantly increases eNOS activity in cultured bovine aortic endothelial cells ( BAEC). Epinephrine- dependent eNOS activation was accompanied by an increase in phosphorylation of eNOS at Ser(1179) and with decreased eNOS phosphorylation at the inhibitory phosphoresidues Ser(116) and Thr(497). Epinephrine promoted activation of the small G protein Rac1 and also led to the activation of protein kinase A. All of these responses to epinephrine in BAEC were blocked by the beta(3)AR blocker SR59230A. We transfected and validated duplex small interfering RNA ( siRNA) constructs to selectively " knock down" specific signaling proteins in BAEC. siRNA- mediated knockdown of Rac1 completely blocked all beta(3)AR signaling to eNOS and also abrogated epinephrine- dependent cAMP- dependent protein kinase ( PKA) and Akt activation. However, siRNA- mediated knockdown of PKA did not affect Rac1 activation by epinephrine but did attenuate Akt activation by epinephrine. These findings indicate that Rac1 is an upstream regulator of beta(3)AR signaling to PKA and to eNOS and identify a novel beta(3)AR -> Rac1 -> PKA -> Akt pathway in endothelium. We exploited the p21- activated kinase pulldown assay to identify proteins associated with activated Rac1 and found that epinephrine stimulated the association of eNOS with Rac1; epinephrine- stimulated eNOS- Rac1 interactions were blocked by the beta(3)AR antagonist SR59230A. Co- transfection of eNOS cDNA with constitutively active Rac1 enhanced beta(3)AR- promoted eNOS- Rac1 association; co- transfection of eNOS with dominant negative Rac1 completely blocked the eNOS- Rac1 association. We also found that epinephrine-induced Rac1 -> PKA -> Akt pathway mediates beta(3)AR-mediated endothelial cell migration. Taken together, our data establish that the small G protein Rac1 is a key regulator of beta(3)AR signaling in cultured aortic endothelial cells with potentially important implications for the pathways involved in adrenergic modulation of eNOS pathways in the vascular wall.	Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Michel, T (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Thorn Bldg,Rm 1210A,75 Francis ST, Boston, MA 02115 USA.	tmichel@research.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 48743, HL 46457] Funding Source: Medline; NIGMS NIH HHS [GM 36259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACIC F, 1992, METAB BRAIN DIS, V7, P125, DOI 10.1007/BF01000158; Balligand JL, 2000, ACTA CLIN BELG, V55, P209, DOI 10.1080/17843286.2000.11754298; Balligand JL, 1997, ARTERIOSCL THROM VAS, V17, P1846, DOI 10.1161/01.ATV.17.10.1846; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; Brum PC, 2006, AN ACAD BRAS CIENC, V78, P485, DOI 10.1590/S0001-37652006000300009; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171, DOI 10.1152/ajpheart.1995.269.3.H1171; BUSCONI L, 1994, J BIOL CHEM, V269, P25016; Chen XH, 2007, CIRC J, V71, P574, DOI 10.1253/circj.71.574; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; Dessy C, 2004, CIRCULATION, V110, P948, DOI 10.1161/01.CIR.0000139331.85766.AF; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eckhart AD, 2001, J PHARMACOL EXP THER, V299, P1; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Ferro A, 2004, BRIT J PHARMACOL, V143, P397, DOI 10.1038/sj.bjp.0705933; Ferro A, 1999, BRIT J PHARMACOL, V126, P1872, DOI 10.1038/sj.bjp.0702512; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Gurdal HG, 2005, BRIT J PHARMACOL, V145, P203, DOI 10.1038/sj.bjp.0706177; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; JONES CJH, 1993, CIRCULATION, V87, P1264, DOI 10.1161/01.CIR.87.4.1264; KENDALL MJ, 1989, J CARDIOVASC PHARM, V14, pS4, DOI 10.1097/00005344-198906147-00003; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; LIAO JK, 1992, CIRC RES, V70, P1018, DOI 10.1161/01.RES.70.5.1018; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Pott C, 2006, PHARMAZIE, V61, P255; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Steinle JJ, 2003, J BIOL CHEM, V278, P20681, DOI 10.1074/jbc.M300368200; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003	41	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32719	32729		10.1074/jbc.M706815200	http://dx.doi.org/10.1074/jbc.M706815200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855349	hybrid			2022-12-27	WOS:000250625400020
J	Meyer, V; Damveld, RA; Arentshorst, M; Stahl, U; van den Hondel, CAMJJ; Ram, AFJ				Meyer, Vera; Damveld, Robbert A.; Arentshorst, Mark; Stahl, Ulf; van den Hondel, Cees A. M. J. J.; Ram, Arthur F. J.			Survival in the presence of antifungals - Genome-wide expression profiling of aspergillus niger in response to sublethal concentrations of caspofungin and fenpropimorph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; MAP-KINASE; TRANSCRIPTIONAL RESPONSE; CHITIN SYNTHASES; PLASMA-MEMBRANE; STRESS-RESPONSE; DOWN-REGULATION; ENCODING GENES	How yeast cells respond to cell wall stress is relatively well however, how filamentous fungi cope with cell wall is largely unexplored. Here we report the first transcriptome analysis of Aspergillus niger exposed to the antifungal caspofungin, an inhibitor of beta-1,3-glucan synthesis, fenpropimorph, which inhibits ergosterol synthesis. The of sublethal drug concentrations allowed A. niger to to the stress conditions and to continue growth by the of new polarity axes and formation of new germ By comparing the expression profile between caspofungin-exposed and nonexposed A. niger germlings, we identified a of 172 responsive genes out of 14,509 open reading frames on the Affymetrix microarray chips. Among 165 up-regulated genes, mainly genes predicted to function in (i) cell wall and remodeling, (ii) cytoskeletal organization, (iii) signaling, and (iv) oxidative stress response were affected. Fenpropimorph modulated expression of 43 genes, of which 41 enhanced expression. Here, genes predicted to function (i) membrane reconstruction, (ii) lipid signaling, (iii) cell wall and (iv) oxidative stress response were identified. analyses of selected genes were used to confirm the analyses. The results further show that expression of agsA gene encoding an alpha-1,3-glucan synthase is up-regulated by both compounds. Using two PagsA-GFP reporter of A. niger and subjecting them to 16 different antifungal including caspofungin and fenpropimorph, we show that agsA is specifically activated by compounds directly or indirectly with cell wall biosynthesis.	Berlin Univ Technol, Inst Biotechnol, Dept Genet & Microbiol, D-13355 Berlin, Germany; Leiden Univ, Inst Biol, Dept Biol Mol, NL-2333 AL Leiden, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Genet & Microbiol, Gustav Meyer Allee 25, D-13355 Berlin, Germany.	v.meyer@lb.tu-berlin.de	Ram, Arthur FJ/S-4648-2017	Ram, Arthur FJ/0000-0002-2487-8016; Van den Hondel, Kees/0000-0003-4782-2725; Meyer, Vera/0000-0002-2298-2258				Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alonso-Monge R, 2001, MOL MICROBIOL, V41, P717, DOI 10.1046/j.1365-2958.2001.02549.x; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Baudry K, 2001, J BIOL CHEM, V276, P12702, DOI 10.1074/jbc.M100274200; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Bennett JW, 1991, MORE GENE MANIPULATI; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; CABIB E, 1991, ANTIMICROB AGENTS CH, V35, P170, DOI 10.1128/AAC.35.1.170; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Chen CB, 2006, EUKARYOT CELL, V5, P155, DOI 10.1128/EC.5.1.155-166.2006; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; DAMVELD RA, 2005, THESIS U LEIDEN; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Ferreyra RG, 2006, ARCH BIOCHEM BIOPHYS, V453, P197, DOI 10.1016/j.abb.2006.06.024; Fisher N, 2004, EUR J BIOCHEM, V271, P2264, DOI 10.1111/j.1432-1033.2004.04169.x; Fontaine T, 2000, J BIOL CHEM, V275, P27594; FOURIE PJ, 2001, PFLANZENSCHUTZ NACHR, V3, P399; Franzot SP, 1997, ANTIMICROB AGENTS CH, V41, P331, DOI 10.1128/AAC.41.2.331; Fritz R, 1997, PESTIC SCI, V49, P40, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;40::AID-PS470&gt;3.0.CO;2-Y; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Hagen S, 2007, APPL ENVIRON MICROB, V73, P2128, DOI 10.1128/AEM.02497-06; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kale TA, 2003, CURR TOP MED CHEM, V3, P1043, DOI 10.2174/1568026033452087; Khalaj V, 2001, FUNGAL GENET BIOL, V32, P55, DOI 10.1006/fgbi.2000.1245; Kiso T, 2004, ANTIMICROB AGENTS CH, V48, P1739, DOI 10.1128/AAC.48.5.1739-1748.2004; Klahre U, 2006, PLANT CELL, V18, P3033, DOI 10.1105/tpc.106.045336; Klis F., 2007, BIOL FUNGAL CELL, P97; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; KLIS FM, 1998, METABOLISM MOL PHYSL, P117; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; KURTZ MB, 1994, ANTIMICROB AGENTS CH, V38, P1480, DOI 10.1128/AAC.38.7.1480; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Leber R, 2003, ANTIMICROB AGENTS CH, V47, P3890, DOI 10.1128/AAC.47.12.3890-3900.2003; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li RK, 1999, ANTIMICROB AGENTS CH, V43, P1401, DOI 10.1128/AAC.43.6.1401; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Lin WW, 2000, CELL SIGNAL, V12, P457, DOI 10.1016/S0898-6568(00)00090-5; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Michell RH, 2003, BIOCHEM SOC T, V31, P11, DOI 10.1042/bst0310011; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mizutani O, 2004, EUKARYOT CELL, V3, P1036, DOI 10.1128/EC.3.4.1036-1048.2004; Muller C, 2002, MICROBIOL-SGM, V148, P4025, DOI 10.1099/00221287-148-12-4025; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; NIKI T, 1994, YEAST, V10, P1467, DOI 10.1002/yea.320101110; Oestreich A, 1997, ARCH ENVIRON CON TOX, V33, P329, DOI 10.1007/s002449900261; OFFRINGA R, 1990, EMBO J, V9, P3077, DOI 10.1002/j.1460-2075.1990.tb07504.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Punt PJ, 2001, MOL MICROBIOL, V41, P513, DOI 10.1046/j.1365-2958.2001.02541.x; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RONCERO C, 1988, J BACTERIOL, V170, P1945, DOI 10.1128/jb.170.4.1945-1949.1988; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Schmidt A, 2002, MOL MICROBIOL, V45, P1433, DOI 10.1046/j.1365-2958.2002.03110.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Staudohar M, 2002, MICROBIOL-SGM, V148, P2635, DOI 10.1099/00221287-148-8-2635; Swain E, 2002, J BIOL CHEM, V277, P26177, DOI 10.1074/jbc.M204115200; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Terashima H, 2000, MOL GEN GENET, V264, P64, DOI 10.1007/s004380000285; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; Uhrig JF, 2006, CURR BIOL, V16, pR211, DOI 10.1016/j.cub.2006.02.028; Utsugi T, 2002, GENES CELLS, V7, P1, DOI 10.1046/j.1356-9597.2001.00495.x; Viaud M, 2003, MOL MICROBIOL, V50, P1451, DOI 10.1046/j.1365-2958.2003.03798.x; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Zhao W, 2006, INFECT IMMUN, V74, P4865, DOI 10.1128/IAI.00565-06	106	68	127	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32935	32948		10.1074/jbc.M705856200	http://dx.doi.org/10.1074/jbc.M705856200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804411	hybrid, Green Published			2022-12-27	WOS:000250625400042
J	Singh, AB; Sugimoto, K; Harris, RC				Singh, Amar B.; Sugimoto, Keisuke; Harris, Raymond C.			Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; BCL-X-L; UP-REGULATION; INTEGRIN ALPHA-3-BETA-1; MOLECULAR-MECHANISMS; CLUSTERIN PROTECTS; MEDIATED APOPTOSIS; PREVENT ANOIKIS; CARCINOMA-CELLS; DOWN-REGULATION	Loss of cell-matrix adhesion is often associated with acute epithelial injury, suggesting that "anoikis" may be an important contributor to cell death. Resistance against anoikis is a key characteristic of transformed cells. When nontransformed epithelia are injured, activation of the epidermal growth factor (EGF) receptor (EGFR) by paracrine/autocrine release of soluble ligands can induce a prosurvival program, but there is generally evidence for concomitant dedifferentiation. The EGFR ligand, heparin-binding EGF-like growth factor (HB-EGF), is synthesized as a membrane-anchored precursor that can activate the EGFR via juxtacrine signaling or can be released and act as a soluble growth factor. In Madin-Darby canine kidney cells, expression of membrane-anchored HB-EGF increases cell-cell and cell-matrix adhesion. Therefore, these studies were designed to test the effects of juxtacrine HB-EGF signaling upon cell survival and epithelial integrity when cells are denied proper cell-matrix interactions. Cells expressing a noncleavable mutated form of membrane-anchored HB-EGF demonstrated increased survival from anoikis, formed larger cell aggregates, and maintained epithelial characteristics even following prolonged detachment from the substratum. Physical association between membrane-anchored HB-EGF and EGFR was observed. Signaling studies indicated synergistic effects of EGFR activation and phosphatidylinositol 3-kinase signaling to regulate apoptotic and survival pathways. In contrast, although administration of exogenous EGF partially suppressed anoikis in wild type cells, it also led to an increased expression of mesenchymal markers, suggesting dedifferentiation. Taken together, we propose a novel role for membrane-anchored HB-EGF in the cytoprotection of epithelial cells.	Vanderbilt Univ, Dept Med, Med Ctr N, Nashville, TN 37232 USA	Vanderbilt University	Harris, RC (corresponding author), Vanderbilt Univ, Dept Med, Med Ctr N, C-3121, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 51265] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AMSLER K, 1982, AM J PHYSIOL, V242, pC94, DOI 10.1152/ajpcell.1982.242.1.C94; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chen JC, 2007, MOL CELL BIOL, V27, P3023, DOI 10.1128/MCB.01482-06; Devarajan P, 2005, CURR OPIN PEDIATR, V17, P193, DOI 10.1097/01.mop.0000152620.59425.eb; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Girton RA, 2002, AM J PHYSIOL-RENAL, V282, pF703, DOI 10.1152/ajprenal.00060.2001; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hacker G, 2006, INT IMMUNOL, V18, P1749, DOI 10.1093/intimm/dxl109; Hammerman MR, 1998, CURR OPIN NEPHROL HY, V7, P419, DOI 10.1097/00041552-199807000-00012; Harris R C, 1997, Adv Ren Replace Ther, V4, P43; Hasuwa H, 2001, BIOCHEM BIOPH RES CO, V289, P782, DOI 10.1006/bbrc.2001.6053; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Hise MK, 2000, RENAL FAILURE, V22, P423, DOI 10.1081/JDI-100100884; Hise MK, 2001, NEPHRON, V88, P71, DOI 10.1159/000045962; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Idogawa M, 2003, INT J CANCER, V107, P215, DOI 10.1002/ijc.11399; Iglesias-Serret D, 2007, LEUKEMIA, V21, P281, DOI 10.1038/sj.leu.2404483; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jin YS, 2006, MOL CANCER THER, V5, P1754, DOI 10.1158/1535-7163.MCT-06-0043; Jost M, 1999, J INVEST DERMATOL, V112, P443, DOI 10.1046/j.1523-1747.1999.00543.x; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Khwaja A, 1997, J CELL BIOL, V139, P1017, DOI 10.1083/jcb.139.4.1017; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; MOLITORIS BA, 1992, AM J PHYSIOL, V263, pF488, DOI 10.1152/ajprenal.1992.263.3.F488; Molitoris BA, 1997, PEDIATR NEPHROL, V11, P761, DOI 10.1007/s004670050385; Nakamura K, 2000, J BIOL CHEM, V275, P18284, DOI 10.1074/jbc.M907971199; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; Nakamura Y, 2001, J HISTOCHEM CYTOCHEM, V49, P439, DOI 10.1177/002215540104900403; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; NOUWEN EJ, 1994, RENAL FAILURE, V16, P49, DOI 10.3109/08860229409044847; PERANTONI A, 1979, IN VITRO CELL DEV B, V15, P446; Piechocki MP, 2006, INT J CANCER, V119, P441, DOI 10.1002/ijc.21837; Pullan S, 1996, J CELL SCI, V109, P631; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quadros MR, 2006, CANCER BIOL THER, V5, P498, DOI 10.4161/cbt.5.5.2567; RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Ramljak D, 2003, EXP CELL RES, V287, P397, DOI 10.1016/S0014-4827(03)00135-6; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Safirstein R, 1998, SEMIN NEPHROL, V18, P519; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Schwochau GB, 1998, KIDNEY INT, V53, P1647, DOI 10.1046/j.1523-1755.1998.00902.x; SHEIKHHAMAD D, 2000, AM J PHYSIOL, V279, pR136; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Silkensen JR, 1995, J CLIN INVEST, V96, P2646, DOI 10.1172/JCI118330; Singh AB, 2004, J CELL SCI, V117, P1365, DOI 10.1242/jcs.01037; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Takemura T, 1997, J BIOL CHEM, V272, P31036, DOI 10.1074/jbc.272.49.31036; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Valentinis B, 1998, J CELL PHYSIOL, V176, P648, DOI 10.1002/(SICI)1097-4652(199809)176:3<648::AID-JCP22>3.3.CO;2-6; Versteilen AMG, 2004, INT J ARTIF ORGANS, V27, P1019, DOI 10.1177/039139880402701203; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhuang SG, 2005, J BIOL CHEM, V280, P21036, DOI 10.1074/jbc.M413300200; Zuk A, 1998, AM J PHYSIOL-CELL PH, V275, pC711, DOI 10.1152/ajpcell.1998.275.3.C711	72	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32890	32901		10.1074/jbc.M702677200	http://dx.doi.org/10.1074/jbc.M702677200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848576	hybrid			2022-12-27	WOS:000250625400038
J	Tews, BA; Meyers, G				Tews, Birke Andrea; Meyers, Gregor			The pestivirus glycoprotein E-rns is anchored in plane in the membrane via an amphipathic helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DIARRHEA-VIRUS; SWINE-FEVER VIRUS; INTERFERON REGULATORY FACTOR-3; PROTEIN E-RNS; NEUTRALIZING MONOCLONAL-ANTIBODIES; DOUBLE-STRANDED-RNA; HOG-CHOLERA VIRUS; N-PRO; PROTEASOMAL DEGRADATION; ENVELOPE GLYCOPROTEINS	E-rns is a structural glycoprotein of pestiviruses found to be attached to the virion and to membranes within infected cells via its COOH terminus, although it lacks a hydrophobic anchor sequence. The COOH- terminal sequence was hypothesized to fold into an amphipathic alpha-helix. Alanine insertion scanning revealed that the ability of the Erns COOH terminus to bind membranes is considerably reduced by the insertion of a single amino acid at a wide variety of positions. Mutations decreasing the hydrophobicity of the apolar face of the putative helix led to reduction of membrane association. Proteinase K protection assays showed that Erns translated in vitro in the presence of microsomal membranes was protected, whereas a mutant with an artificial transmembrane region and a short cytosolic tag was shortened by the protease treatment. A tag fused to the COOH terminus of wild type Erns was not accessible for antibodies within digitonin- permeabilized cells, but the variant with the tag located downstream of the artificial transmembrane region was detected under the same conditions. These results are in accordance with the model that the COOH- terminal membrane anchor of Erns represents an amphipathic helix embedded in plane into the membrane. The integrity of the membrane important for recovery of infectious virus.	Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany.	gregor.meyers@fli.bund.de		Tews, Birke Andrea/0000-0002-8647-0497				Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; BOLIN S, 1988, ARCH VIROL, V99, P117, DOI 10.1007/BF01311029; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cocquerel L, 2002, EMBO J, V21, P2893, DOI 10.1093/emboj/cdf295; COLLETT MS, 1991, ARCH VIROL, P19; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Echeverri A, 1998, VIRUS RES, V54, P217, DOI 10.1016/S0168-1702(98)00016-1; Elbers K, 1996, J VIROL, V70, P4131, DOI 10.1128/JVI.70.6.4131-4135.1996; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Harada T, 2000, J VIROL, V74, P9498, DOI 10.1128/JVI.74.20.9498-9506.2000; Hausmann Y, 2004, J VIROL, V78, P5507, DOI 10.1128/JVI.78.10.5507-5512.2004; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HEINZ FX, 2000, VIRUS TAXONOMY 7 REP; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; Hulst MM, 2000, J VIROL, V74, P9553, DOI 10.1128/JVI.74.20.9553-9561.2000; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Hulst MM, 2001, METHOD ENZYMOL, V342, P431, DOI 10.1016/S0076-6879(01)42564-X; Iqbal M, 2000, J GEN VIROL, V81, P451, DOI 10.1099/0022-1317-81-2-451; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Iqbal M, 2002, J GEN VIROL, V83, P2153, DOI 10.1099/0022-1317-83-9-2153; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kessler S W, 1981, Methods Enzymol, V73, P442; KONIG M, 1995, J VIROL, V69, P6479; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; La Rocca SA, 2005, J VIROL, V79, P7239, DOI 10.1128/JVI.79.11.7239-7247.2005; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; LANGE Y, 1991, J LIPID RES, V32, P329; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; Langedijk JPM, 2002, J VIROL, V76, P10383, DOI 10.1128/JVI.76.20.10383-10392.2002; Langedijk JPM, 2001, J CLIN MICROBIOL, V39, P906, DOI 10.1128/JCM.39.3.906-912.2001; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, J VIROL, V70, P1588, DOI 10.1128/JVI.70.3.1588-1595.1996; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; Ruggli N, 2003, J VIROL, V77, P7645, DOI 10.1128/JVI.77.13.7645-7654.2003; RUMENAPF T, 1993, J VIROL, V67, P3288; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; STARK R, 1993, J VIROL, V67, P7088, DOI 10.1128/JVI.67.12.7088-7095.1993; Tautz N, 1999, J VIROL, V73, P9422, DOI 10.1128/JVI.73.11.9422-9432.1999; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Gennip HGP, 2000, VACCINE, V19, P447, DOI 10.1016/S0264-410X(00)00198-5; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WISKERCHEN M, 1991, J VIROL, V65, P4508, DOI 10.1128/JVI.65.8.4508-4514.1991; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997	68	40	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32730	32741		10.1074/jbc.M706803200	http://dx.doi.org/10.1074/jbc.M706803200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848558	hybrid			2022-12-27	WOS:000250625400021
J	Read, JT; Rahmani, M; Boroomand, S; Allahverdian, S; McManus, BM; Rennie, PS				Read, Jason T.; Rahmani, Maziar; Boroomand, Seti; Allahverdian, Sima; McManus, Bruce M.; Rennie, Paul S.			Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE MOTIFS; T-CELL FACTOR; BETA-CATENIN; PROSTATE-CANCER; EXTRACELLULAR-MATRIX; SQUAMOUS TRANSDIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; TUMOR-CELLS; DNA-BINDING	Versican, one of the key components of prostatic stroma, plays a central role in tumor initiation and progression. Here, we investigated promoter elements and mechanisms of androgen receptor (AR)-mediated regulation of the versican gene in prostate cancer cells. Using transient transfection assays in prostate cancer LNCaP and cervical cancer HeLa cells engineered to express the AR, we demonstrate that the synthetic androgen R1881 and dihydrotestosterone stimulate expression of a versican promoter-driven luciferase reporter vector (versican-Luc). Further, both basal and androgen-stimulated versican-Luc activities were significantly diminished in LNCaP cells, when AR gene expression was knocked down using a short hairpin RNA. Methylation-protection foot-printing analysis revealed an AR-protected element between positions +75 and +102 of the proximal versican promoter, which strongly resembled a consensus steroid receptor element. Electrophoretic mobility shift and supershift assays revealed strong and specific binding of the recombinant AR DNA binding domain to oligonucleotides corresponding to this protected DNA sequence. Site-directed mutagenesis of the steroid receptor element site markedly diminished R1881-stimulated versican-Luc activity. In contrast to the response seen using LNCaP cells, R1881 did not significantly induce versican promoter activity and mRNA levels in AR-positive prostate stromal fibroblasts. Interestingly, overexpression of beta catenin in the presence of androgen augmented versican promoter activity 10-and 30-fold and enhanced versican mRNA levels 2.8-fold in fibroblasts. In conclusion, we demonstrate that AR transactivates versican expression, which may augment tumor-stromal interactions and may contribute to prostate cancer progression.	Univ British Columbia, Prostate Ctr, Vancouver Gen Hosp, Dept Urol Sci, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Pathol & Lab Med, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Res Inst, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia; University of British Columbia	Rennie, PS (corresponding author), Univ British Columbia, Prostate Ctr, Vancouver Gen Hosp, Dept Urol Sci, Vancouver, BC V6T 2B5, Canada.	prennie@interchange.ubc.ca						Ang LC, 1999, J NEUROPATH EXP NEUR, V58, P597, DOI 10.1097/00005072-199906000-00004; BERCHEM GJ, 1995, CANCER RES, V55, P735; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; CUNHA GR, 1980, ENDOCRINOLOGY, V107, P1767, DOI 10.1210/endo-107-6-1767; CUNHA GR, 1991, ENDOCRINOLOGY, V128, P3293, DOI 10.1210/endo-128-6-3293; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Haelens A, 2001, BIOCHEM J, V353, P611, DOI 10.1042/0264-6021:3530611; Hamdy NAT, 2001, SEMIN NUCL MED, V31, P62, DOI 10.1053/snuc.2001.18767; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Kojima S, 2004, J UROLOGY, V171, P679, DOI 10.1097/01.ju.0000106190.32540.6c; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; McAlhany SJ, 2003, CANCER RES, V63, P5859; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mulholland DJ, 2003, ONCOGENE, V22, P5602, DOI 10.1038/sj.onc.1206802; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; NASO MF, 1994, J BIOL CHEM, V269, P32999; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rahmani M, 2004, CAN J CARDIOL, V20, p58B; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; Sakko AJ, 2003, CANCER RES, V63, P4786; Sakko AJ, 2001, CANCER RES, V61, P926; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; Shan JD, 2003, BIOCHEM BIOPH RES CO, V311, P864, DOI 10.1016/j.bbrc.2003.10.071; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Truica CI, 2000, CANCER RES, V60, P4709; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yeung LHY, 2003, BIOCHEM J, V371, P843, DOI 10.1042/BJ20021816; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	57	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31954	31963		10.1074/jbc.M702099200	http://dx.doi.org/10.1074/jbc.M702099200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728259	hybrid			2022-12-27	WOS:000250480300016
J	Levigne, S; Thiec, F; Cherel, G; Irving, JA; Fribourg, C; Christophe, OD				Levigne, Stephanie; Thiec, Fabrice; Cherel, Ghislaine; Irving, James A.; Fribourg, Caroline; Christophe, Olivier D.			Role of the alpha-helix 163-170 in factor xa catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR VA BINDING; PROTHROMBINASE COMPLEX; BLOOD-COAGULATION; FACTOR-IX; SUBSTRATE RECOGNITION; PROTEASE DOMAIN; CA2+ BINDING; FACTOR VIIA; S1 SITE; CALCIUM	Factor Xa (FXa) is a key protease of the coagulation pathway whose activity is known to be in part modulated by binding to factor Va (FVa) and sodium ions. Previous investigations have established that solvent-exposed, charged residues of the FXa alpha-helix 163-170 (h163-170), Arg(165) and Lys(169), participate in its binding to FVa. In the present study we aimed to investigate the role of the other residues of h163-170 in the catalytic functions of the enzyme. FX derivatives were constructed in which point mutations were made or parts of h163-170 were substituted with the corresponding region of either FVIIa or FIXa. Purified FXa derivatives were compared with wild-type FXa. Kinetic studies in the absence of FVa revealed that, compared with wild-type FXa, key functional parameters (catalytic activity toward prothrombin and tripeptidyl substrates and non-enzymatic interaction of a probe with the S1 site) were diminished by mutations in the NH2-terminal portion of h163-170. The defective amidolytic activity of these FXa derivatives appears to result from their impaired interaction with Na+ because using a higher Na+ concentration partially restored normal catalytic parameters. Furthermore, kinetic measurements with tripeptidyl substrates or prothrombin indicated that assembly of these FXa derivatives with an excess of FVa in the prothrombinase complex improves their low catalytic efficiency. These data indicate that residues in the NH2-terminal portion of the FVa-binding h163-170 are energetically linked to the S1 site and Na+-binding site of the protease and that residues Val(163) and Ser(167) play a key role in this interaction.	INSERM, Univ Paris Sud, F-94276 Le Kremlin Bicetre, France; Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Wellcome Centre for Human Genetics	Christophe, OD (corresponding author), Hop Bicetre, INSERM U770, Batiment Gregory Pincus, 80 rue Gen Lederc, F-94276 Le Kremlin Bicetre, France.	olivier@kb.inserm.fr	christophe, olivier/W-4268-2017; Irving, James A/I-8467-2015; Irving, James/P-3860-2019	christophe, olivier/0000-0002-9080-6336; Irving, James/0000-0003-3204-6356				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Christophe OD, 2001, BLOOD, V98, P1416, DOI 10.1182/blood.V98.5.1416; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DeLano W.L, PYMOL MOL GRAPHICS S; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE BC, 1976, J BIOL CHEM, V251, P3235; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; MANN KG, 1990, BLOOD, V76, P1; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PERSSON E, 1993, J BIOL CHEM, V268, P22531; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; ROSING J, 1980, J BIOL CHEM, V255, P274; Rudolph AE, 2000, BIOCHEMISTRY-US, V39, P2861, DOI 10.1021/bi992379b; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; Sabharwal AK, 1997, J BIOL CHEM, V272, P22037, DOI 10.1074/jbc.272.35.22037; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; SUGO T, 1984, J BIOL CHEM, V259, P5705; Thiec F, 2003, J BIOL CHEM, V278, P10393, DOI 10.1074/jbc.M212144200; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2	36	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31569	31579		10.1074/jbc.M704837200	http://dx.doi.org/10.1074/jbc.M704837200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726015	hybrid			2022-12-27	WOS:000250309200049
J	Cantin, L; Faucher, F; Couture, JF; de Jesus-Tran, KP; Legrand, P; Ciobanu, LC; Frechette, Y; Labrecque, R; Singh, SM; Labrie, F; Breton, R				Cantin, Line; Faucher, Frederick; Couture, Jean-Francois; de Jesus-Tran, Karine Pereira; Legrand, Pierre; Ciobanu, Liviu C.; Frechette, Yvon; Labrecque, Richard; Singh, Shankar Mohan; Labrie, Fernand; Breton, Rock			Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; CRYSTAL-STRUCTURES; HORMONE AGONISTS; COACTIVATOR; PROTEIN; MOTIFS; FXXLF; TETRAHYDROGESTRINONE; TRANSACTIVATION; SUPERFAMILY	Antiandrogens are commonly used to treat androgen-dependent disorders. The currently used drugs unfortunately possess very weak affinity for the human AR (hAR), thus indicating the need to develop new high-affinity steroidal antiandrogens. Our compounds are specially designed to impede repositioning of the mobile carboxyl-terminal helix 12, which blocks the ligand-dependent transactivation function (AF-2) located in the AR ligand-binding domain (ARLBD). Using crystal structures of the hARLBD, we first found that H12 could be directly reached from the ligand-binding pocket (LBP) by a chain positioned on the C18 atom of an androgen steroid nucleus. A set of 5 alpha-dihydrotestosterone- derived molecules bearing various C18 chains were thus synthesized and tested for their capacity to bind hAR and act as antagonists. Although most of those having very high affinity for hAR were agonists, several very potent antagonists were obtained, confirming the structural importance of the C18 chain. To understand the role of the C18 chain in their agonistic/antagonistic properties, the structure of the hARLBD complexed with one of these agonists, EM5744, was determined at a 1.65-angstrom resolution. We have identified new interactions involving Gln(738), Met(742), and His(874) that explain both the high affinity of this compound and the inability of its bulky chain to prevent the repositioning of H12. This structural information will be helpful to refine the structure of the chains placed on the C18 atom to obtain efficient H12-directed steroidal antiandrogens.	CHU Laval, Ctr Rech Endocrinol Mol & Oncol, Ste Foy, PQ G1V 4G2, Canada; Univ Laval, Ste Foy, PQ G1V 4G2, Canada; Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; Synchroton SOLEIL, F-91192 Gif Sur Yvette, France	Laval University; Laval University; University of Ottawa; SOLEIL Synchrotron	Breton, R (corresponding author), CHU Laval, Ctr Rech Endocrinol Mol & Oncol, 2705 Blvd Laurier, Ste Foy, PQ G1V 4G2, Canada.	rock.breton@crchul.ulaval.ca	LEGRAND, Pierre/G-7709-2011	LEGRAND, Pierre/0000-0003-2431-2255				ASSELIN J, 1980, CANCER RES, V40, P1612; Bagatell CJ, 1996, NEW ENGL J MED, V334, P707, DOI 10.1056/NEJM199603143341107; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; Death AK, 2004, J CLIN ENDOCR METAB, V89, P2498, DOI 10.1210/jc.2004-0033; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; GINSBURG J, 1976, BRIT MED J, V2, P737, DOI 10.1136/bmj.2.6038.737; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMMOND GL, 1978, J ENDOCRINOL, V78, P7, DOI 10.1677/joe.0.0780007; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Huang XF, 2001, J STEROID BIOCHEM, V77, P129, DOI 10.1016/S0960-0760(01)00038-3; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRIEG M, 1979, J STEROID BIOCHEM, V11, P615, DOI 10.1016/0022-4731(79)90090-6; LABRIE C, 1988, ENDOCRINOLOGY, V123, P1412, DOI 10.1210/endo-123-3-1412; Labrie F, 2005, ENDOCR REV, V26, P361, DOI 10.1210/er.2004-0017; Labrie F, 2005, J ENDOCRINOL, V184, P427, DOI 10.1677/joe.1.05997; LABRIE F, 1986, PROSTATE, V8, P293, DOI 10.1002/pros.2990080309; LABRIE F, 1985, BMJ-BRIT MED J, V291, P369, DOI 10.1136/bmj.291.6492.369; LABRIE F, 1988, JNCI-J NATL CANCER I, V80, P1138, DOI 10.1093/jnci/80.14.1138; LABRIE L, 2005, Patent No. 20050250749; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ONATE SA, 1995, SCIENCE, V270, P1354; Rager KM, 2006, THESCIENTIFICWORLDJO, V6, P116, DOI 10.1100/tsw.2006.23; Roy AK, 1999, VITAM HORM, V55, P309; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043	47	45	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30910	30919		10.1074/jbc.M705524200	http://dx.doi.org/10.1074/jbc.M705524200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17711855	hybrid			2022-12-27	WOS:000250136300059
J	Gong, M; Hay, S; Marshall, KR; Munro, AW; Scrutton, NS				Gong, Min; Hay, Sam; Marshall, Ker R.; Munro, Andrew W.; Scrutton, Nigel S.			DNA binding suppresses human AIF-M2 activity and provides a connection between redox chemistry, reactive oxygen species, and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; RIG-I; INFECTION; ACTIVATION; PROTEIN; INDUCTION; HOMOLOG; CANCER; STRESS; STATE	Human AIF-M2 is an unusual flavoprotein oxidoreductase that binds DNA, nicotinamide coenzyme, and the modified flavin 6-hydroxy- FAD. Using multiple solution methods to investigate the redox chemistry and binding interactions of AIF-M2, we demonstrate that binding of DNA and coenzyme to AIF-M2 is mutually exclusive. We also show that DNA binding does not perturb the redox chemistry of AIF-M2, but it has significant effects on the reduction kinetics of the 6-hydroxy- FAD cofactor by NAD(P)H. Based on quantitative analysis of ligand binding and redox chemistry, we propose a model for the function of AIF-M2. In this model, DNA binding suppresses the redox activity of AIF-M2 by preventing the binding of the reducing coenzyme NAD(P) H. This DNA- mediated suppression of AIF-M2 activity is expected to lower cellular levels of superoxide and peroxide, thereby lessening survival signaling by Ras, NF-kappa B, or AP-1, as suggested from knock-out studies of the related AIF in human colon cancer cell lines. We show marked differences between AIF-M2 and AIF. DNA and coenzyme binding activity is retained in the C-terminal deletion mutant AIF-M2-(Delta 319-613), whereas DNA binds to the C-terminal D3 domain of AIF. Our work provides the first analysis of AIF-M2 ligand interactions and redox chemistry and identifies an important mechanistic connection between coenzyme and DNA binding, redox activity, and the apoptotic function of AIF-M2. Through its DNA binding activity, we suggest that AIF-M2 lessens survival cell signaling in the presence of foreign ( e. g. bacterial and ( retro) viral) cytosolic DNA, thus contributing to the onset of apoptosis.	Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester; University of Leicester; University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk	Hay, Sam/D-5974-2012; Munro, Andrew/G-5639-2019	Hay, Sam/0000-0003-3274-0938; Munro, Andrew/0000-0002-4642-180X	Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: Medline; BBSRC [BB/D01963X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allsopp TE, 1998, CELL DEATH DIFFER, V5, P50, DOI 10.1038/sj.cdd.4400298; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Delhalle S, 2003, ANN NY ACAD SCI, V1010, P1, DOI 10.1196/annals.1299.001; Delhon GA, 2002, J GEN VIROL, V83, P2257, DOI 10.1099/0022-1317-83-9-2257; Despres P, 1998, J VIROL, V72, P823; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dutton P L, 1978, Methods Enzymol, V54, P411; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Horikoshi N, 1999, BIOCHEM BIOPH RES CO, V261, P864, DOI 10.1006/bbrc.1999.1123; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koyama AH, 1998, ARCH VIROL, V143, P2435, DOI 10.1007/s007050050473; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lin KI, 1999, J BIOL CHEM, V274, P13650, DOI 10.1074/jbc.274.19.13650; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Mei J, 2006, ONCOGENE, V25, P849, DOI 10.1038/sj.onc.1209121; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Ohiro Y, 2002, FEBS LETT, V524, P163, DOI 10.1016/S0014-5793(02)03049-1; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Pervaiz S, 1999, FEBS LETT, V459, P343, DOI 10.1016/S0014-5793(99)01258-2; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P957, DOI 10.1021/bi001665g; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Shigemori K, 1996, AM J PHYSIOL-LUNG C, V270, pL803, DOI 10.1152/ajplung.1996.270.5.L803; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang QH, 2002, SCIENCE, V295, P1895	46	25	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30331	30340		10.1074/jbc.M703713200	http://dx.doi.org/10.1074/jbc.M703713200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711848	hybrid			2022-12-27	WOS:000249981200064
J	Yin, HY; Brooks, JD; Gao, L; Porter, NA; Morrow, JD				Yin, Huiyong; Brooks, Joshua D.; Gao, Ling; Porter, Ned A.; Morrow, Jason D.			Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL; DOCOSAHEXAENOIC ACID; OXIDATION-PRODUCTS; MASS-SPECTROMETRY; OXIDIZED OMEGA-3-FATTY-ACIDS; ARACHIDONIC-ACID; OXIDANT STRESS; PPAR-ALPHA; N-3	Increased intake of fish oil rich in the omega- 3 fatty acids eicosapentaenoic acid (EPA, C22:6 omega- 3) and docosahexaenoic acid (DHA, C22: 6 omega- 3) reduces the incidence of human disorders such as atherosclerotic cardiovascular disease. However, mechanisms that contribute to the beneficial effects of fish oil consumption are poorly understood. Mounting evidence suggests that oxidation products of EPA andDHAmay be responsible, at least in part, for these benefits. Previously, we have defined the free radical- induced oxidation of arachidonic acid in vitro and in vivo and have proposed a unified mechanism for its peroxidation. Wehypothesize that the oxidation of EPA can be rationally defined but would be predicted to be significantly more complex than arachidonate because of the fact that EPA contains an addition carbon- carbon double bond. Herein, we present, for the first time, a unified mechanism for the peroxidation of EPA. Novel oxidation products were identified employing state- oftheart mass spectrometric techniques including Ag (+) coordination ionspray and atmospheric pressure chemical ionization mass spectrometry. Predicted compounds detected both in vitro and in vivo included monocylic peroxides, serial cyclic peroxides, bicyclic endoperoxides, and dioxolane- endoperoxides. Systematic study of the peroxidation of EPA provides the basis to examine the role of specific oxidation products as mediators of the biological effects of fish oil.	Vanderbilt Univ, Dept Med & Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Morrow, JD (corresponding author), Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Sch Med, 532 RRB,23rd & Pierce Ave, Nashville, TN 37232 USA.	Jason.morrow@vanderbilt.edu		yin, hui yong/0000-0001-7049-1560	NCI NIH HHS [CA77839.] Funding Source: Medline; NCRR NIH HHS [RR00096] Funding Source: Medline; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIEHS NIH HHS [ES31125, ES13125, ES000267] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard F, 1997, BIOCHEM BIOPH RES CO, V241, P513, DOI 10.1006/bbrc.1997.7848; Arita K, 2003, FREE RADICAL BIO MED, V35, P189, DOI 10.1016/S0891-5849(03)00310-1; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Connor SL, 1997, AM J CLIN NUTR, V66, P1020; Davis TA, 2006, J AM CHEM SOC, V128, P14897, DOI 10.1021/ja064399o; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Punta C, 2005, CHEM RES TOXICOL, V18, P349, DOI 10.1021/tx049685x; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; Seal JR, 2003, J AM SOC MASS SPECTR, V14, P872, DOI 10.1016/S1044-0305(03)00339-8; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sethi S, 2002, REDOX REP, V7, P369, DOI 10.1179/135100002125001144; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Takahashi M, 2002, AM J PHYSIOL-GASTR L, V282, pG338, DOI 10.1152/ajpgi.00376.2001; Vallve JC, 2002, ATHEROSCLEROSIS, V164, P45, DOI 10.1016/S0021-9150(02)00046-1; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wong KW, 2005, J AM DIET ASSOC, V105, P98, DOI 10.1016/j.jada.2004.10.009; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yin HY, 2005, J BIOL CHEM, V280, P26600, DOI 10.1074/jbc.M503088200; Yin HY, 2005, ANTIOXID REDOX SIGN, V7, P170, DOI 10.1089/ars.2005.7.170; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Yin HY, 2003, J BIOL CHEM, V278, P16720, DOI 10.1074/jbc.M300604200; Yin HY, 2002, J AM CHEM SOC, V124, P7745, DOI 10.1021/ja0201092; Yin HY, 2001, J AM SOC MASS SPECTR, V12, P449, DOI 10.1016/S1044-0305(01)00205-7; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	46	44	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29890	29901		10.1074/jbc.M703108200	http://dx.doi.org/10.1074/jbc.M703108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711863	hybrid			2022-12-27	WOS:000249981200018
J	Deb, R; Shakib, F; Reid, K; Clark, H				Deb, Roona; Shakib, Farouk; Reid, Kenneth; Clark, Howard			Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVITY; BRONCHOALVEOLAR LAVAGE; ASPERGILLUS-FUMIGATUS; HISTAMINE-RELEASE; CRYSTAL-STRUCTURE; P-I; DER-P-1; INFLAMMATION; COLLECTINS; BINDING	Lung surfactant proteins (SP) A and D are calcium-dependent carbohydrate-binding proteins. In addition to playing multiple roles in innate immune defense such as bacterial aggregation and modulation of leukocyte function, SP-A and SP-D have also been implicated in the allergic response. They interact with a wide range of inhaled allergens, competing with their binding to cell-sequestered IgE resulting in inhibition of mast cell degranulation, and exogenous administration of SP-A and SP-D diminishes allergic hypersensitivity in vivo. House dust mite allergens are a major cause of allergic asthma in the western world, and here we confirm the interaction of SP-A and SP-D with two major mite allergens, Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1, and show that the cysteine protease activity of these allergens results in the degradation of SP-A and SP-D under physiological conditions, with multiple sites of cleavage. A recombinant fragment of SP-D that is effective in diminishing allergic hypersensitivity in mouse models of dust mite allergy was more susceptible to degradation than the native full-length protein. Degradation was enhanced in the absence of calcium, with different sites of cleavage, indicating that the calcium associated with SP-A and SP-D influences accessibility to the allergens. Degradation of SP-A and SP-D was associated with diminished binding to carbohydrates and to D. pteronyssinus 1 itself and diminished capacity to agglutinate bacteria. Thus, the degradation and consequent inactivation of SP-A and SP-D may be a novel mechanism to account for the potent allergenicity of these common dust mite allergens.	[Clark, Howard] Univ Southampton, Southampton Gen Hosp, Sch Med, Dept Child Hlth,Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; [Deb, Roona; Reid, Kenneth] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Shakib, Farouk] Univ Nottingham, Inst Infect Immun & Inflammat, Queens Med Ctr, Nottingham NG7 2RD, England	University of Southampton; University of Oxford; University of Nottingham	Clark, H (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Dept Child Hlth,Div Infect Inflammat & Repair, MP 803 Level F,South Block, Southampton SO16 6YD, Hants, England.	h.w.clark@soton.ac.uk		Clark, Howard/0000-0001-7354-2028				CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Carlstedt F, 2001, CRIT CARE CLIN, V17, P139, DOI 10.1016/S0749-0704(05)70156-1; Cheng G, 2000, EUR RESPIR J, V16, P831, DOI 10.1183/09031936.00.16583100; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Erpenbeck VJ, 2006, ALLERGY, V61, P598, DOI 10.1111/j.1398-9995.2006.01062.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FERGUSON P, 1995, AM J RESP CRIT CARE, V151, P71, DOI 10.1164/ajrccm.151.1.7812575; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Ghaemmaghami AM, 2001, EUR J IMMUNOL, V31, P1211, DOI 10.1002/1521-4141(200104)31:4&lt;1211::AID-IMMU1211&gt;3.0.CO;2-R; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; HAAGSMAN HP, 1989, AM J PHYSIOL, V257, pL421, DOI 10.1152/ajplung.1989.257.6.L421; HAAGSMAN HP, 1990, BIOCHEMISTRY-US, V29, P8894, DOI 10.1021/bi00490a003; Haczku A, 2001, AM J RESP CELL MOL, V25, P45, DOI 10.1165/ajrcmb.25.1.4391; Haczku A, 2006, J IMMUNOL, V176, P3557, DOI 10.4049/jimmunol.176.6.3557; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Haley KJ, 2002, AM J PHYSIOL-LUNG C, V282, pL573, DOI 10.1152/ajplung.00117.2001; Hansen S, 2002, IMMUNOBIOLOGY, V205, P498, DOI 10.1078/0171-2985-00150; HAWGOOD S, 1989, AM J PHYSIOL, V257, pL13, DOI 10.1152/ajplung.1989.257.2.L13; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; KUROKI Y, 1991, J BIOL CHEM, V266, P3068; Liu CF, 2005, CLIN EXP ALLERGY, V35, P515, DOI 10.1111/j.1365-2222.2005.02205.x; Madan T, 1997, CLIN EXP IMMUNOL, V110, P241; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Masuda K, 1999, VET IMMUNOL IMMUNOP, V72, P303, DOI 10.1016/S0165-2427(99)00142-7; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; Nakamura T, 2006, J INVEST DERMATOL, V126, P2719, DOI 10.1038/sj.jid.5700584; Ohtani K, 1999, J BIOL CHEM, V274, P13681, DOI 10.1074/jbc.274.19.13681; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Palaniyar N, 1998, J STRUCT BIOL, V122, P297, DOI 10.1006/jsbi.1998.4004; PERSSON AV, 1992, BIOCHEMISTRY-US, V31, P12183, DOI 10.1021/bi00163a030; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SCHULZ O, 1995, EUR J IMMUNOL, V25, P3191, DOI 10.1002/eji.1830251131; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Shakib F, 1998, IMMUNOL TODAY, V19, P313, DOI 10.1016/S0167-5699(98)01284-5; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Strong P, 2003, CLIN EXP IMMUNOL, V134, P181, DOI 10.1046/j.1365-2249.2003.02281.x; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Strong P, 2002, CLIN EXP IMMUNOL, V130, P19, DOI 10.1046/j.1365-2249.2002.01968.x; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Suwabe A, 1996, ARCH BIOCHEM BIOPHYS, V327, P285, DOI 10.1006/abbi.1996.0123; Takai T, 2005, INT ARCH ALLERGY IMM, V137, P194, DOI 10.1159/000086331; Taneva S, 1997, BIOCHEMISTRY-US, V36, P8173, DOI 10.1021/bi963040h; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang JY, 1996, CLIN EXP IMMUNOL, V106, P367, DOI 10.1046/j.1365-2249.1996.d01-838.x; Wang JY, 1998, AM J RESP CRIT CARE, V158, P510, DOI 10.1164/ajrccm.158.2.9709111; Wang JY, 2001, CLIN EXP ALLERGY, V31, P652, DOI 10.1046/j.1365-2222.2001.01031.x; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	60	75	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36808	36819		10.1074/jbc.M702336200	http://dx.doi.org/10.1074/jbc.M702336200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17848554	hybrid			2022-12-27	WOS:000251646000005
J	Hyvonen, MT; Keinanen, TA; Cerrada-Gimenez, M; Sinervirta, R; Grigorenko, N; Khomutov, AR; Vepsalainen, J; Alhonen, L; Janne, J				Hyvonen, Mervi T.; Keinanen, Tuomo A.; Cerrada-Gimenez, Marc; Sinervirta, Riitta; Grigorenko, Nikolay; Khomutov, Alex R.; Vepsalainen, Jouko; Alhonen, Leena; Janne, Juhani			Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-METHYL POLYAMINES; ACUTE-PANCREATITIS; DEOXYHYPUSINE SYNTHASE; LIVER-REGENERATION; CELL-PROLIFERATION; DNA-REPLICATION; TRANSGENIC RATS; IN-VIVO; OXIDASE; CATABOLISM	We have earlier shown that alpha-methylated spermidine and spermine analogues rescue cells from polyamine depletion-induced growth inhibition and maintain pancreatic integrity under severe polyamine deprivation. However, because alpha-methylspermidine can serve as a precursor of hypusine, an integral part of functional eukaryotic translation initiation factor 5A required for cell proliferation, and because alpha,omega-bismethylspermine can be converted to methylspermidine, it is not entirely clear whether the restoration of cell growth is actually attributable to hypusine formed from these polyamine analogues. Here, we have used optically active isomers of methylated spermidine and spermine and show that polyamine depletion-induced acute cytostasis in cultured cells could be reversed by all the isomers of the methylpolyamines irrespective of whether they served or not as precursors of hypusine. In transgenic rats with activated polyamine catabolism, all the isomers similarly restored liver regeneration and reduced plasma alpha-amylase activity associated with induced pancreatitis. Under the above experimental conditions, the (S,S)-but not the (R,R)-isomer of bismethylspermine was converted to methylspermidine apparently through the action of spermine oxidase strongly preferring the (S,S)-isomer. Of the analogues, however, only (S)-methylspermidine sustained cell growth during prolonged (more than 1 week) inhibition of polyamine biosynthesis. It was also the only isomer efficiently converted to hypusine, indicating that deoxyhypusine synthase likewise possesses hidden stereospecificity. Taken together, the results show that growth inhibition in response to polyamine depletion involves two phases, an acute and a late hypusine-dependent phase.	Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Chem, FI-70211 Kuopio, Finland; Russian Acad Sci, Engelhardt Inst Mol Biol, R-117984 Moscow, Russia	University of Eastern Finland; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Janne, J (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Chem, PO Box 1627, FI-70211 Kuopio, Finland.	Juhani.Janne@uku.fi	Keinänen, Tuomo/AAC-5630-2019; Khomutov, Alex/G-2128-2015	Keinanen, Tuomo/0000-0002-0659-5573; Khomutov, Alex/0000-0001-6833-7855				Alhonen L, 2000, P NATL ACAD SCI USA, V97, P8290, DOI 10.1073/pnas.140122097; Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Bergeron RJ, 1998, J MED CHEM, V41, P3901, DOI 10.1021/jm980390o; Bernacki RJ, 1995, CLIN CANCER RES, V1, P847; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Fredlund JO, 1996, EUR J BIOCHEM, V237, P539, DOI 10.1111/j.1432-1033.1996.0539p.x; GALLO CJ, 1986, BIOCHEM J, V238, P37, DOI 10.1042/bj2380037; Grigorenko NA, 2007, TETRAHEDRON, V63, P2257, DOI 10.1016/j.tet.2006.12.065; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; Hyvonen MT, 2006, AM J PATHOL, V168, P115, DOI 10.2353/ajpath.2006.050518; HYVONEN T, 1992, J CHROMATOGR-BIOMED, V574, P17, DOI 10.1016/0378-4347(92)80093-6; JANNE J, 1971, J BIOL CHEM, V246, P1725; Janne J, 2006, J BIOCHEM, V139, P155, DOI 10.1093/jb/mvj035; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jarvinen A, 2006, J BIOL CHEM, V281, P4589, DOI 10.1074/jbc.M509959200; Jarvinen A, 2005, J BIOL CHEM, V280, P6595, DOI 10.1074/jbc.M412788200; Jarvinen AJ, 2006, J MED CHEM, V49, P399, DOI 10.1021/jm050872h; Keinanen TA, 2007, MINI-REV MED CHEM, V7, P813; Kramer DL, 2001, CANCER RES, V61, P7754; LAKANEN JR, 1992, J MED CHEM, V35, P724, DOI 10.1021/jm00082a013; Lee YB, 1998, BIOORGAN MED CHEM, V6, P253, DOI 10.1016/S0968-0896(97)10030-X; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Rasanen TL, 2002, J BIOL CHEM, V277, P39867, DOI 10.1074/jbc.M205967200; Schrader R, 2006, J BIOL CHEM, V281, P35336, DOI 10.1074/jbc.M601460200; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; Varnado BL, 2000, BIOORG CHEM, V28, P395, DOI 10.1006/bioo.2000.1195; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang YL, 2001, CANCER RES, V61, P5370	36	52	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34700	34706		10.1074/jbc.M704282200	http://dx.doi.org/10.1074/jbc.M704282200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901051	hybrid			2022-12-27	WOS:000251155200012
J	Kim, SJ; Nian, C; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; McIntosh, Christopher H. S.			Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PROTEIN-KINASE-B; ADIPOSE-TISSUE; CELL-PROLIFERATION; EXPRESSION; RECEPTOR; SECRETION; OBESITY; LEPTIN; INFLAMMATION	Studies on the physiological roles of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) have largely focused on its insulinotropic action and ability to regulate beta-cell mass. In previous studies on the stimulatory effect of GIP on adipocyte lipoprotein lipase (LPL), a pathway was identified involving increased phosphorylation of protein kinase B (PKB) and reduced phosphorylation of LKB1 and AMP-activated protein kinase ( AMPK). The slow time of onset of the responses suggested that GIP may have induced release of an intermediary molecule, and the current studies focused on the possible contribution of the adipokine resistin. In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/Jun amino-terminal kinase (SAPK/JNK). The other major incretin hormone, glucagon-like peptide-1 (GLP-1), exhibited no significant effects. Chronic elevation of circulating GIP levels in the Vancouver Diabetic Fatty (VDF) Zucker rat resulted in increases in circulating resistin levels and activation of p38 MAPK or SAPK/JNK in epididymal fat tissue, suggesting the existence of identical pathways in vivo as well as in vitro. Administration of resistin to 3T3-L1 adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. Knockdown of resistin using RNA interference attenuated the effect of GIP on the PKB/LKB1/AMPK/LPL pathway in 3T3-L1 adipocytes, supporting a role for resistin as a mediator.	Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca						Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barr VA, 1997, ENDOCRINOLOGY, V138, P4463, DOI 10.1210/en.138.10.4463; BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8; Bornstein SR, 2000, DIABETES, V49, P532, DOI 10.2337/diabetes.49.4.532; BROWN JC, 1989, HDB PHYSL 6, P403; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; Cammisotto PG, 2006, BIOCHEM CELL BIOL, V84, P207, DOI 10.1139/O06-032; Chen YH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1019, DOI 10.1152/ajpendo.00325.2004; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Gong HX, 2004, EUR J ENDOCRINOL, V150, P885, DOI 10.1530/eje.0.1500885; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Maebuchi M, 2003, ARCH BIOCHEM BIOPHYS, V416, P164, DOI 10.1016/S0003-9861(03)00279-0; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; McTernan PG, 2006, CURR OPIN LIPIDOL, V17, P170, DOI 10.1097/01.mol.0000217899.59820.9a; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Minn AH, 2003, BIOCHEM BIOPH RES CO, V310, P641, DOI 10.1016/j.bbrc.2003.09.061; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Morgan LM, 1996, BIOCHEM SOC T, V24, P585, DOI 10.1042/bst0240585; Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005; OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267; OHNEDA A, 1984, REGUL PEPTIDES, V8, P123, DOI 10.1016/0167-0115(84)90167-8; Ort T, 2005, ENDOCRINOLOGY, V146, P2200, DOI 10.1210/en.2004-1421; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Pederson RA, 1993, GUT PEPTIDES, P217; PEDERSON RA, 2004, ENCY ENDOCRINE DIS, V2, P202; Pereira RI, 2005, METABOLISM, V54, P1636, DOI 10.1016/j.metabol.2005.07.002; Pravenec M, 2006, INT J OBESITY, V30, P1157, DOI 10.1038/sj.ijo.0803237; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Roh C, 2000, AM J PHYSIOL-ENDOC M, V279, pE893, DOI 10.1152/ajpendo.2000.279.4.E893; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Shen YH, 2006, J BIOL CHEM, V281, P7727, DOI 10.1074/jbc.M511105200; SKURK T, 2007, ENDOCRINOLOGY, V92, P1023; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tappenden KA, 1996, JPEN-PARENTER ENTER, V20, P357, DOI 10.1177/0148607196020005357; Wang BH, 2006, PFLUG ARCH EUR J PHY, V452, P418, DOI 10.1007/s00424-006-0055-8; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zhong Q, 2002, BIOCHEM BIOPH RES CO, V296, P383, DOI 10.1016/S0006-291X(02)00882-3	56	94	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34139	34147		10.1074/jbc.M704896200	http://dx.doi.org/10.1074/jbc.M704896200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890220	hybrid			2022-12-27	WOS:000251145700028
J	Chen, D; Gould, C; Garza, R; Gao, T; Hampton, RY; Newton, AC				Chen, Dan; Gould, Christine; Garza, Renee; Gao, Tianyan; Hampton, Randolph Y.; Newton, Alexandra C.			Amplitude control of protein kinase c by RINCK, a novel e3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTORS; CELL LUNG-CANCER; DOWN-REGULATION; PKC ISOFORMS; BETA-II; DOMAIN; DEGRADATION; ALPHA; PHOSPHORYLATION; EPSILON	Protein kinase C (PKC) isozymes play a central role in cellular signaling. Levels of PKC control the amplitude of agonist-induced signaling and alterations in these levels are associated with disease states, most notably cancer, yet mechanisms that control the turnover of the protein are poorly understood. Here we identify an E3 ligase that catalyzes the ubiquitin-mediated degradation of PKC. Specifically, we identified a RING finger domain-containing protein, RINCK ( for RING-finger protein that interacts with C kinase) from a yeast two-hybrid screen using the amino terminus of PKC beta as bait. RINCK encodes a protein of 581 amino acids that contains a RING finger domain, a B-box, and two coiled-coil regions, the three domains that form the signature motif of the large family of diverse TRIM ( tripartite motif) proteins. Co-immunoprecipitation studies using tsA201 cells reveal that RINCK and PKC associate with each other in cells. Studies using fragments of PKC beta reveal that this interaction is mediated by the C1A domain of PKC. RINCK induces the ubiquitination of PKC both in vitro and in cells. Overexpression of RINCK reduces the levels of PKC in cells, whereas genetic knockdown of endogenous RINCK increases the levels of PKC. This increase was observed for all PKC isozymes examined ( including conventional, novel, and atypical). The RINCK-mediated degradation of PKC occurs independently of the classic phorbol ester-mediated down-regulation: genetic depletion of RINCK had no effect on the phorbol ester-mediated down-regulation and, additionally, up-regulated the levels of isozymes that cannot bind phorbol esters. Our data reveal a novel mechanism that provides amplitude control in PKC signaling through ubiquitination catalyzed by RINCK, an E3 ligase that specifically recognizes the C1 domain of PKC isoforms.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@csd.edu			NIDDK NIH HHS [P01 DK54441] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI Y, 1990, ADV SEC MESS PHOSPH, V24, P478; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Clark AS, 2003, CANCER RES, V63, P780; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; JAKEN S, 1981, CANCER RES, V41, P2175; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; OHNO S, 1990, J BIOL CHEM, V265, P6296; ORR JW, 1994, J BIOL CHEM, V269, P27715; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SOLANKI V, 1981, P NATL ACAD SCI-BIOL, V78, P1722, DOI 10.1073/pnas.78.3.1722; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Tanaka M, 2005, MOL BIOL REP, V32, P87, DOI 10.1007/s11033-004-6613-2; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	38	51	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33776	33787		10.1074/jbc.M703320200	http://dx.doi.org/10.1074/jbc.M703320200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893151	hybrid			2022-12-27	WOS:000250840200060
J	Matsuda, Y; Osaki, T; Hashii, T; Koshiba, T; Kawabata, SI				Matsuda, Yasuyuki; Osaki, Tsukasa; Hashii, Tomoyuki; Koshiba, Takumi; Kawabata, Shun-Ichiro			A cysteine-rich protein from an arthropod stabilizes clotting mesh and immobilizes bacteria at injury sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSESHOE-CRAB HEMOCYTES; AMINO-ACID-SEQUENCE; TACHYPLEUS-TRIDENTATUS HEMOCYTES; CORNIFIED CELL-ENVELOPE; LIMULUS BLOOD-CLOT; ANTIBACTERIAL ACTIVITY; CLOTTABLE PROTEIN; MOLECULAR-BASIS; GRAINY-HEAD; HEMOLYMPH	Hemolymph coagulation in arthropods plays key roles in host defense, including sealing wounds to staunch bleeding and immobilizing invading microorganisms. We have previously reported that horseshoe crab transglutaminase ( TGase) promotes cross-linking of a clotting protein ( coagulin) with hemocyte-derived proteins (proxins), resulting in the formation of stable coagulin fibrils. Here we show that TGase also cross-links proxins to another hemocyte-derived protein named stablin. Stablin is a cysteine-rich protein of 131 residues. Surface plasmon resonance analysis revealed the specific interaction of stablin with proxin-1 at K-d = 4.0 X 10(-9) M. Stablin was predominantly localized in the large granules of hemocytes and secreted by lipopolysaccharide-induced exocytosis. Interestingly, stablin bound to chitin at K-d = 1.5 x 10(-8) M, as determined by using a quartz-crystal microbalance. Stablin also interacted with lipopolysaccharides and lipoteichoic acids and exhibited bacterial agglutinating activity against Gram-positive and -negative bacteria. Immunostaining showed that stablin is co-localized with coagulin in the clotting fibrils that effectively trap bacteria. Moreover, an anti-stablin antibody strongly inhibited the proper formation of the clotting fibrils. These data suggest that stablin promotes the formation of the clotting mesh and the immobilization of invading microbes at injury sites. In arthropods, the TGase-mediated cross-linking may play an important role in the initial stage of host defense, wound closure, and healing, as in the case of mammals.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@mbox.nc.kyushu-u.ac.jp	Koshiba, Takumi/A-3996-2013	Osaki, Tsukasa/0000-0002-9487-3253; Koshiba, Takumi/0000-0001-8535-5043				Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Armstrong PB, 2003, BIOL BULL-US, V205, P201, DOI 10.2307/1543252; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; DONOVAN MA, 1991, J BIOL CHEM, V266, P2121; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; HAINE ER, 2007, COMP IMMUNOL, V31, P456; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; Harlow E., 1989, ANTIBODIES LAB MANUA; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kalinin A, 2001, J CELL SCI, V114, P3069; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; MANAB AR, 1989, J INVEST DERMATOL, V92, P263; Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007; NAKAMURA T, 1987, J BIOCHEM, V101, P1297, DOI 10.1093/oxfordjournals.jbchem.a121994; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Powell B C, 1997, EXS, V78, P59; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Shibuya K, 2004, GENOMICS, V83, P679, DOI 10.1016/j.ygeno.2003.09.024; SHIGENAGA T, 1993, J BIOCHEM-TOKYO, V114, P307, DOI 10.1093/oxfordjournals.jbchem.a124173; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; TOKUNAGA F, 1993, J BIOL CHEM, V268, P252; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262	44	23	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33545	10.1074/jbc.M705854200	http://dx.doi.org/10.1074/jbc.M705854200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855345	hybrid			2022-12-27	WOS:000250840200035
J	Toth, J; Varga, B; Kovacs, M; Malnasi-Csizmadia, A; Vertessy, BG				Toth, Judit; Varga, Balazs; Kovacs, Mihaly; Malnasi-Csizmadia, Andras; Vertessy, Beata G.			Kinetic mechanism of human dUTPase, an essential nucleotide pyrophosphatase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; DEOXYURIDINE TRIPHOSPHATASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; EXPRESSION; PHOSPHATE; BINDING; MYOSIN; NUCLEOTIDOHYDROLASE	Human dUTPase is essential in controlling relative cellular levels of dTTP/ dUTP, both of which can be incorporated into DNA. The nuclear isoform of the enzyme has been proposed as a promising novel target for anticancer chemotherapeutic strategies. The recently determined three-dimensional structure of this protein in complex with an isosteric substrate analogue allowed in-depth structural characterization of the active site. However, fundamental steps of the dUTPase enzymatic cycle have not yet been revealed. This knowledge is indispensable for a functional understanding of the molecular mechanism and can also contribute to the design of potential antagonists. Here we present detailed pre-steady-state and steady-state kinetic investigations using a single tryptophan fluorophore engineered into the active site of human dUTPase. This sensor allowed distinction of the apoenzyme, enzyme-substrate, and enzyme product complexes. We show that the dUTP hydrolysis cycle consists of at least four distinct enzymatic steps: (i) fast substrate binding, (ii) isomerization of the enzyme-substrate complex into the catalytically competent conformation, (iii) a hydrolysis (chemical) step, and (iv) rapid, nonordered release of the products. Independent quenched-flow experiments indicate that the chemical step is the rate-limiting step of the enzymatic cycle. To follow the reaction in the quenched-flow, we devised a novel method to synthesize gamma-(32) P-labeled dUTP. We also determined by indicator-based rapid kinetic assays that proton release is concomitant with the rate-limiting hydrolysis step. Our results led to a quantitative kinetic model of the human dUTPase catalytic cycle and to direct assessment of relative flexibilities of the C-terminal arm, critical for enzyme activity, in the enzyme-ligand complexes along the reaction pathway.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary; Eotvos Lorand Univ, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University	Toth, J (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Karolina Ut 29, H-1113 Budapest, Hungary.	tothj@enzim.hu; vertessy@enzim.hu	Kovacs, Mihaly/A-6841-2011; Csizmadia, András Málnási/K-7632-2018; Vertessy, Beata G/H-6202-2012	Csizmadia, András Málnási/0000-0002-2430-8398; Vertessy, Beata G./0000-0002-1288-2982; Kovacs, Mihaly/0000-0002-1200-4741	FIC NIH HHS [D43 TW006230, R01 TW007241-01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW006230, R01TW007241] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bekesi A, 2004, J BIOL CHEM, V279, P22362, DOI 10.1074/jbc.M313647200; Chano T, 2004, ONCOL REP, V11, P1257; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Kovacs M, 2002, J BIOL CHEM, V277, P28459, DOI 10.1074/jbc.M202180200; KOVARI J, 2007, IN PRESS PROTEINS; Ladner RD, 2000, CANCER RES, V60, P3493; Lakowicz JR, 1999, PRINCIPLES FLUORESCE, P291, DOI 10.1007/978-1-4757-3061-6; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Larsson G, 1996, NAT STRUCT BIOL, V3, P532, DOI 10.1038/nsb0696-532; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; MOLNAR J, 1961, ARCH BIOCHEM BIOPHYS, V93, P353, DOI 10.1016/0003-9861(61)90278-8; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2707; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Pearl LH, 1996, NAT STRUCT BIOL, V3, P485, DOI 10.1038/nsb0696-485; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Romeike BFM, 2005, PATHOL RES PRACT, V201, P727, DOI 10.1016/j.prp.2005.08.005; Sambrook J, 2001, MOL CLONING A LAB MA, V3rd; SHLOMAI J, 1978, J BIOL CHEM, V253, P3305; STRAHLER JR, 1993, P NATL ACAD SCI USA, V90, P4991, DOI 10.1073/pnas.90.11.4991; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h	33	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33572	10.1074/jbc.M706230200	http://dx.doi.org/10.1074/jbc.M706230200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848562	hybrid			2022-12-27	WOS:000250840200038
J	Hrizo, SL; Gusarova, V; Habiel, DM; Goeckeler, JL; Fisher, EA; Brodsky, JL				Hrizo, Stacy L.; Gusarova, Viktoria; Habiel, David M.; Goeckeler, Jennifer L.; Fisher, Edward A.; Brodsky, Jeffrey L.			The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-associated degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; APO-B; HSP90 COCHAPERONE; CYSTIC-FIBROSIS; HEPG2 CELLS; MECHANISTICALLY DISTINCT	Apolipoprotein B ( apoB) is the most abundant protein in low density lipoproteins and plays key roles in cholesterol homeostasis. The co- translational degradation of apoB is controlled by fatty acid levels in the endoplasmic reticulum ( ER) and is mediated by the proteasome. To define the mechanism of apoB degradation, we employed a cell- free system in which proteasome-dependent degradation is recapitulated with yeast cytosol, and we developed an apoB yeast expression system. We discovered that a yeast Hsp110, Sse1p, associates with and stabilizes apoB, which contrasts with data indicating that select Hsp70s and Hsp90s facilitate apoB degradation. However, the Ssb Hsp70 chaperones have no effect on apoB turnover. To determine whether our results are relevant in mammalian cells, Hsp110 was overexpressed in hepatocytes, and enhanced apoB secretion was observed. This study indicates that chaperones within distinct complexes can play unique roles during ER- associated degradation ( ERAD), establishes a role for Sse1/ Hsp110 in ERAD, and identifies Hsp110 as a target to lower cholesterol.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; NYU, Sch Med, Dept Med Cardiol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; New York University	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, 274 Crawford Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Fisher, Edward/ABE-7469-2020	Hrizo, Stacy/0000-0003-1723-720X; Goeckeler-Fried, Jennifer/0000-0001-5940-9917; Fisher, Edward/0000-0001-9802-143X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL058541, HL 058541] Funding Source: Medline; NIGMS NIH HHS [R01 GM075061, R01 GM075061-02, GM 75061] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adeli K, 1997, J BIOL CHEM, V272, P22489, DOI 10.1074/jbc.272.36.22489; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Du EZ, 1999, J BIOL CHEM, V274, P1856, DOI 10.1074/jbc.274.3.1856; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JONES EW, 1982, GENETICS, V102, P665; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Qiu W, 2005, ARTERIOSCL THROM VAS, V25, P571, DOI 10.1161/01.ATV.0000154142.61859.94; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rashid KA, 2002, J BIOL CHEM, V277, P22010, DOI 10.1074/jbc.M112448200; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Segrest JP, 2001, J LIPID RES, V42, P1346; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; SHIRAYAMA M, 1993, MOL GEN GENET, V240, P323, DOI 10.1007/BF00280382; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tietge UJF, 1999, J LIPID RES, V40, P2134; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Whitfield AJ, 2004, CLIN CHEM, V50, P1725, DOI 10.1373/clinchem.2004.038026; WU AL, 1981, J BIOL CHEM, V256, P3615; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; ZHANG HY, 1994, J BIOL CHEM, V269, P27799; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	65	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32665	32675		10.1074/jbc.M705216200	http://dx.doi.org/10.1074/jbc.M705216200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823116	hybrid, Green Accepted			2022-12-27	WOS:000250625400015
J	Meslin, F; Thiery, J; Richon, C; Jalil, A; Chouaib, S				Meslin, Franck; Thiery, Jerome; Richon, Catherine; Jalil, Abdelali; Chouaib, Salem			Granzyme B-induced cell death involves induction of p53 tumor suppressor gene and its activation in tumor target cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA FRAGMENTATION; APOPTOSIS; MITOCHONDRIA; LYMPHOCYTES; PERFORIN; PROTEIN; PUMA; CTL; BAX	In this study we investigated the involvement of p53 in cytotoxic T-lymphocyte (CTL)-induced tumor target cell killing mediated by the perforin/granzymes pathway. For this purpose we used a human CTL clone (LT12) that kills its autologous melanoma target cells (T1), harboring a wild type p53. We demonstrated initially that LT12 kills its T1 target in a perforin/granzymes-dependent manner. Confocal microscopy and Western blot analysis indicated that conjugate formed between LT12 and T1 resulted in rapid cytoplasmic accumulation of p53 and its activation in T1 target cells. Cytotoxic assay using recombinant granzyme B (GrB) showed that this serine protease is the predominant factor inducing such accumulation. Furthermore, RNA interference-mediated lowering of the p53 protein in T1 cells or pifithrin-alpha-induced p53-specific inhibition activity significantly decreased CTL-induced target killing mediated by CTL or recombinant GrB. This emphasizes that p53 is an important determinant in granzyme B-induced apoptosis. Our data show furthermore that when T1 cells were treated with streptolysin-O/granzyme B, specific phosphorylation of p53 at Ser-15 and Ser-37 residues was observed subsequent to the activation of the stress kinases ataxia telangiectasia mutated (ATM) and p38K. Treatment of T1 cells with pifithrin-alpha resulted in inhibition of p53 phosphorylation at these residues and in a significant decrease in GrB-induced apoptotic T1 cell death. Furthermore, small interference RNAs targeting p53 was also accompanied by an inhibition of streptolysin-O/granzyme B-induced apoptotic T1 cell death. The present study supports p53 induction after CTL-induced stress in target cells. These findings provide new insight into a potential role of p53 as a component involved in the dynamic regulation of the major pathway of CTL-mediated cell death and may have therapeutic implications.	Inst Gustave Roussy, INSERM, Lab Immunol Tumeurs Humaines Interact Effecteurs, U753,PR1,IFR 54, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Chouaib, S (corresponding author), Inst Gustave Roussy, INSERM, Lab Immunol Tumeurs Humaines Interact Effecteurs, U753,PR1,IFR 54, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	chouaib@igr.fr	Chouaib, Salem/F-7939-2016; THIERY, Jerome/N-2469-2018	THIERY, Jerome/0000-0002-0998-3627; RICHON, Catherine/0000-0002-3556-3941; JALIL, Abdelali/0000-0003-2710-8735				Abouzahr S, 2006, P NATL ACAD SCI USA, V103, P1428, DOI 10.1073/pnas.0510454103; Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brown JM, 1999, CANCER RES, V59, P1391; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dufour E, 1997, J IMMUNOL, V158, P3787; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PROSS HF, 1981, J CLIN IMMUNOL, V1, P51, DOI 10.1007/BF00915477; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Thiery J, 2005, J IMMUNOL, V174, P871, DOI 10.4049/jimmunol.174.2.871; Thiery J, 2003, J IMMUNOL, V170, P5919, DOI 10.4049/jimmunol.170.12.5919; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Webster GA, 1999, MOL CELL BIOL, V19, P3485	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32991	32999		10.1074/jbc.M705290200	http://dx.doi.org/10.1074/jbc.M705290200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855337	hybrid			2022-12-27	WOS:000250625400048
J	Birrell, MA; Catley, MC; Hardaker, E; Wong, S; Willson, TM; McCluskie, K; Leonard, T; Farrow, SN; Collins, JL; Haj-Yahia, S; Belvisi, MG				Birrell, Mark A.; Catley, Matthew C.; Hardaker, Elizabeth; Wong, Sissie; Willson, Timothy M.; McCluskie, Kerryn; Leonard, Thomas; Farrow, Stuart N.; Collins, Jon L.; Haj-Yahia, Saleem; Belvisi, Maria G.			Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LXR-ALPHA; KAPPA-B; CHOLESTEROL EFFLUX; NITRIC-OXIDE; MACROPHAGES; EXPRESSION; NEUTROPHILIA; INHIBITION; PATHWAY	The liver X receptors (LXR alpha/beta) are part of the nuclear receptor family and are believed to regulate cholesterol and lipid homeostasis. It has also been suggested that LXR agonists possess anti-inflammatory properties. The aim of this work was to determine the effect of LXR agonists on the innate immune response in human primary lung macrophages and a pre-clinical rodent model of lung inflammation. Before profiling the impact of the agonist, we established that both the human macrophages and the rodent lungs expressed LXR alpha/beta. We then used two structurally distinct LXR agonists to demonstrate that activation of this transcription factor reduces cytokine production in THP-1 cells and lung macrophages. Then, using the expression profile of ATP binding cassettes A1 (ABCA-1; a gene directly linked to LXR activation) as a biomarker for lung exposure of the compound, we demonstrated an LXR-dependent reduction in lung neutrophilia rodents in vivo. This inhibition was not associated with a suppression of c-Fos/c-Jun mRNA expression or NF-kappa B/AP-1 DNA binding, suggesting that any anti-inflammatory activity of LXR agonists is not via inhibition of NF-kappa B/AP-1 transcriptional activity. These data do not completely rule out an impact of these agonists on these two prominent transcription factors. In summary, this study is the first to demonstrate anti-inflammatory actions of LXRs in the lung. Chronic innate inflammatory responses observed in some airway diseases is thought to be central to disease pathogenesis. Therefore, data suggest that LXR ligands have utility in the treatment of lung diseases that involves chronic inflammation mediated by macrophages and neutrophils.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Dept,Resp Pharmacol Grp, London SW3 6LY, England; GlaxoSmithKline Inc, Discovery Res, High Throughput Chem, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline Inc, Ctr Excellence Drug Discovery, King Of Prussia, PA 19406 USA; GlaxoSmithKline Inc, Resp & Inflammat CEDD, Stevenage SG1 2NY, Herts, England; Royal Brompton & Harefield Hosp, London, England	Imperial College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Belvisi, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Dept,Resp Pharmacol Grp, Dovehouse St, London SW3 6LY, England.	m.belvisi@imperial.ac.uk	feinstein, doug/M-9414-2019; Belvisi, Maria G/A-3055-2009		Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: Medline; BBSRC [BB/E52708X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Birrell MA, 2006, J PHARMACOL EXP THER, V316, P1318, DOI 10.1124/jpet.105.093310; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Cao GQ, 2004, DRUG NEWS PERSPECT, V17, P35, DOI 10.1358/dnp.2004.17.1.829024; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Collins JL, 2004, CURR OPIN DRUG DISC, V7, P692; Costet P, 2000, J BIOL CHEM, V275, P28240; Englund MCO, 2001, ATHEROSCLEROSIS, V158, P61, DOI 10.1016/S0021-9150(01)00407-5; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liu SX, 1998, ATHEROSCLEROSIS, V136, P43, DOI 10.1016/S0021-9150(97)00185-8; McCluskie K, 2004, J PHARMACOL EXP THER, V311, P625, DOI 10.1124/jpet.104.068890; Michael LF, 2005, MINI-REV MED CHEM, V5, P729, DOI 10.2174/1389557054553767; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wagsater D, 2003, INT J MOL MED, V11, P419	26	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31882	31890		10.1074/jbc.M703278200	http://dx.doi.org/10.1074/jbc.M703278200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766241	hybrid			2022-12-27	WOS:000250480300008
J	Gibb, SL; Boston-Howes, W; Lavina, ZS; Gustincich, S; Brown, RH; Pasinelli, P; Trotti, D				Gibb, Stuart L.; Boston-Howes, William; Lavina, Zeno S.; Gustincich, Stefano; Brown, Robert H., Jr.; Pasinelli, Piera; Trotti, Davide			A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; SUMO-1 MODIFICATION; PROTEIN SUMOYLATION; 2-HYBRID SYSTEM; SPINAL-CORD; DNA-DAMAGE; PML BODIES; ALS; MICE; ACTIVATION	EAAT2 (excitatory amino acid transporter 2) is a high affinity, Na+-dependent glutamate transporter of glial origin that is essential for the clearance of synaptically released glutamate and prevention of excitotoxicity. During the course of human amyotrophic lateral sclerosis (ALS) and in a transgenic mutant SOD1 mouse model of the disease, expression and activity of EAAT2 is remarkably reduced. We previously showed that some of the mutant SOD1 proteins exposed to oxidative stress inhibit EAAT2 by triggering caspase-3 cleavage of EAAT2 at a single defined locus. This gives rise to two fragments that we termed truncated EAAT2 and COOH terminus of EAAT2 (CTE). In this study, we report that analysis of spinal cord homogenates prepared from mutant G93A-SOD1 mice reveals CTE to be of a higher molecular weight than expected because it is conjugated with SUMO-1. The sumoylated CTE fragment (CTE-SUMO-1) accumulates in the spinal cord of these mice as early as presymptomatic stage(70 days of age) andnot in other central nervous system areas unaffected by the disease. The presence and accumulation of CTE-SUMO-1 is specific to ALS mice, since it does not occur in the R6/2 mouse model for Huntington disease. Furthermore, using an astroglial cell line, primary culture of astrocytes, and tissue samples from G93A-SOD1 mice, we show that CTE-SUMO-1 is targeted to promyelocytic leukemia nuclear bodies. Since one of the proposed functions of promyelocytic leukemia nuclear bodies is regulation of gene transcription, we suggest a possible novel mechanism by which the glial glutamate transporter EAAT2 could contribute to the pathology of ALS.	Thomas Jefferson Univ, Weinberg Unit ALS Res, Farber Inst Neurosci, Philadelphia, PA 19107 USA; Massachusetts Gen Hosp, Cecil B Day Lab Neuromuscular Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Giovanni Armenise Harvard Fdn Lab, Sector Neurobiol, Scuola Int Super Studi Avanzati, I-34012 Basovizza, Italy	Jefferson University; Harvard University; Massachusetts General Hospital; Harvard University	Trotti, D (corresponding author), Thomas Jefferson Univ, Weinberg Unit ALS Res, Farber Inst Neurosci, 900 Walnut St, Philadelphia, PA 19107 USA.	davide.trotti@jefferson.edu	Longo, Kenneth A/A-5631-2010	Pasinelli, Piera/0000-0002-3385-2707; Gustincich, Stefano/0000-0002-2749-2514; Trotti, Davide/0000-0001-6338-6404	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044292] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS44292] Funding Source: Medline; Telethon [GGP06268] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Bendotti C, 2001, J NEUROCHEM, V79, P737, DOI 10.1046/j.1471-4159.2001.00572.x; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Janssen K, 2007, ONCOGENE, V26, P1557, DOI 10.1038/sj.onc.1209923; Johansson A, 2007, J NEUROL SCI, V255, P17, DOI 10.1016/j.jns.2007.01.057; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pederzoli M, 2005, J IMMUNOL, V174, P6381, DOI 10.4049/jimmunol.174.10.6381; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun YJ, 2003, GENOMICS, V82, P250, DOI 10.1016/S0888-7543(03)00075-2; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Taylor AR, 2007, J NEUROSCI, V27, P634, DOI 10.1523/JNEUROSCI.4947-06.2007; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	63	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32480	32490		10.1074/jbc.M704314200	http://dx.doi.org/10.1074/jbc.M704314200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823119	hybrid			2022-12-27	WOS:000250480300071
J	Pennington, SR; Foster, BJ; Hawley, SR; Jenkins, RE; Zolle, O; White, MRH; McNamee, CJ; Sheterline, P; Simpson, AWM				Pennington, Stephen R.; Foster, Brian J.; Hawley, Shaun R.; Jenkins, Rosalind E.; Zolle, Olga; White, Michael R. H.; McNamee, Christine J.; Sheterline, Peter; Simpson, Alec W. M.			Cell shape-dependent control of Ca2+ influx and cell cycle progression in swiss 3T3 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CALCIUM-ENTRY; PROTEIN-KINASE ACTIVITY; SERUM RESPONSE FACTOR; SMOOTH-MUSCLE-CELLS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; PHOSPHATASE-1 EXPRESSION; TRANSFORMED-CELLS; ENDOTHELIAL-CELLS; CHANNEL FUNCTION	The ability of adherent cells such as fibroblasts to enter the cell cycle and progress to S phase is strictly dependent on the extent to which individual cells can attach to and spread on a substratum. Here we have used microengineered adhesive islands of 22 and 45 mu m diameter surrounded by a nonadhesive substratum of polyhydroxyl methacrylate to accurately control the extent to which individual Swiss 3T3 fibroblasts may spread. The effect of cell shape on mitogen-evoked Ca2+ signaling events that accompany entry into the cell cycle was investigated. In unrestricted cells, the mitogens bombesin and fetal calf serum evoked a typical biphasic change in the cytoplasmic free Ca2+ concentration. However, when the spreading of individual cells was restricted, such that progression to S phase was substantially reduced, both bombesin and fetal calf serum caused a rapid transient rise in the cytoplasmic free Ca2+ concentration but failed to elicit the normal sustained influx of Ca2+ that follows Ca2+ release. As expected, restricting cell spreading led to the loss of actin stress fibers and the formation of a ring of cortical actin. Restricting cell shape did not appear to influence mitogen-receptor interactions, nor did it influence the presence of focal adhesions. Because Ca2+ signaling is an essential component of mitogen responses, these findings implicate Ca2+ influx as a necessary component of cell shape-dependent control of the cell cycle.	Univ Liverpool, Sch Biomed Sci, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England; Univ Liverpool, Sch Biol Sci, Ctr Cell Imaging, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Simpson, AWM (corresponding author), Univ Liverpool, Sch Biomed Sci, Dept Human Anat & Cell Biol, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	awms@liv.ac.uk	Pennington, Stephen R/C-7505-2015	White, Michael/0000-0002-3617-3232; Pennington, Stephen/0000-0001-7529-1015	BBSRC [BB/E012965/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012965/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bohmer RM, 1996, MOL BIOL CELL, V7, P101; BROOKS RF, 1976, NATURE, V260, P248, DOI 10.1038/260248a0; Burrell HE, 2005, J BIOL CHEM, V280, P29667, DOI 10.1074/jbc.M505381200; Conant AR, 1998, BRIT J PHARMACOL, V125, P357, DOI 10.1038/sj.bjp.0702082; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Cook SJ, 2000, BIOCHEM SOC T, V28, P233, DOI 10.1042/bst0280233; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Green AK, 2002, GASTROENTEROLOGY, V123, P1291, DOI 10.1053/gast.2002.35994; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hawley SR, 2000, CELL SIGNAL, V12, P619, DOI 10.1016/S0898-6568(00)00104-2; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X; IRELAND GW, 1989, CELL BIOL INT REP, V13, P781, DOI 10.1016/0309-1651(89)90055-6; IRELAND GW, 1987, J CELL SCI, P19; IWIG M, 1995, EUR J CELL BIOL, V67, P145; Jenkins RE, 2001, PROTEOMICS, V1, P1092, DOI 10.1002/1615-9861(200109)1:9<1092::AID-PROT1092>3.0.CO;2-S; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Krishan A, 1990, Methods Cell Biol, V33, P121; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marshall CJ, 1996, NATURE, V383, P127, DOI 10.1038/383127a0; MCNAMEE CJ, 1995, CELL BIOL INT, V19, P769, DOI 10.1006/cbir.1995.1128; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; MINETT TW, 1984, CELL BIOL INT REP, V8, P151, DOI 10.1016/0309-1651(84)90082-1; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MITCHELL FM, 1995, J BIOL CHEM, V270, P8623, DOI 10.1074/jbc.270.15.8623; Morales S, 2005, CELL SIGNAL, V17, P635, DOI 10.1016/j.cellsig.2004.10.002; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Munaron L, 2004, J CELL MOL MED, V8, P161, DOI 10.1111/j.1582-4934.2004.tb00271.x; Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680; ONEILL C, 1986, CELL, V44, P489, DOI 10.1016/0092-8674(86)90470-8; OTSUKA H, 1976, J CELL PHYSIOL, V87, P213, DOI 10.1002/jcp.1040870209; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Peppiatt CM, 2004, BIOCHEM J, V381, P929, DOI 10.1042/BJ20040097; Ribeiro CMP, 1997, J BIOL CHEM, V272, P26555, DOI 10.1074/jbc.272.42.26555; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Ryser S, 2001, J BIOL CHEM, V276, P33319, DOI 10.1074/jbc.M102326200; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sherr Charles J., 1994, Trends in Cell Biology, V4, P15, DOI 10.1016/0962-8924(94)90033-7; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; SIMPSON AWM, 1990, BIOCHEM J, V267, P277, DOI 10.1042/bj2670277; STOKER MGP, 1966, J CELL SCI, V1, P297; TAKUWA N, 1991, J BIOL CHEM, V266, P1403; Trielli MO, 1996, J CELL BIOL, V135, P689, DOI 10.1083/jcb.135.3.689; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	75	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32112	32120		10.1074/jbc.M705067200	http://dx.doi.org/10.1074/jbc.M705067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17711856	hybrid			2022-12-27	WOS:000250480300032
J	Savinov, AY; Rozanov, DV; Strongin, AY				Savinov, Alexei Y.; Rozanov, Dmitri V.; Strongin, Alex Y.			Specific inhibition of autoimmune T cell transmigration contributes to beta cell functionality and insulin synthesis in non-obese diabetic (NOD) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; LOW-DOSE STREPTOZOTOCIN; TISSUE INHIBITOR; MMP INHIBITOR; REGENERATION; CD44; EXPRESSION; MIGRATION; PANCREAS; MODEL	Human diabetes mellitus ( IDDM; type I diabetes) is a T cell-mediated disease that is closely modeled in non-obese diabetic ( NOD) mice. The pathogenesis of IDDM involves the transmigration of autoimmune T cells into the pancreatic islets and the subsequent destruction of insulin-producing beta cells. Therapeutic interventions leading to beta cell regeneration and the reversal of established IDDM are exceedingly limited. We report here that specific inhibition of T cell intra-islet transmigration by using a small molecule proteinase inhibitor restores beta cell functionality, increases insulin-producing beta cell mass, and alleviates the severity of IDDM in acutely diabetic NOD mice. As a result, acutely diabetic NOD mice do not require insulin injections for survival for a significant time period, thus providing a promising clue to effect IDDM reversal in humans. The extensive morphometric analyses and the measurements of both the C-peptide blood levels and the proinsulin mRNA levels in the islets support our conclusions. Diabetes transfer experiments suggest that the inhibitor specifically represses the T cell transmigration and homing processes as opposed to causing immunosuppression. Overall, our data provide a rationale for the pharmacological control of the T cell transmigration step in human IDDM.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056385, U01AI061139] Funding Source: NIH RePORTER; NCRR NIH HHS [RR020843] Funding Source: Medline; NIAID NIH HHS [AI056385, AI061139] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Annabi B, 2002, BBA-MOL CELL RES, V1542, P209, DOI 10.1016/S0167-4889(01)00187-2; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bresson D, 2007, AUTOIMMUN REV, V6, P315, DOI 10.1016/j.autrev.2006.09.013; Cappuzzo Federico, 2003, Expert Opin Emerg Drugs, V8, P179, DOI 10.1517/14728214.8.1.179; Chiang WC, 2006, ORAL DIS, V12, P27, DOI 10.1111/j.1601-0825.2005.01151.x; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Bedoui J, 2005, CARDIOVASC RES, V67, P317, DOI 10.1016/j.cardiores.2005.03.017; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gallegos AM, 2004, CELL, V117, P149, DOI 10.1016/S0092-8674(04)00340-X; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Ikejiri M, 2005, J ORG CHEM, V70, P5709, DOI 10.1021/jo050339+; Jiang HW, 2007, DIABETES, V56, P49, DOI 10.2337/db06-0710; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kohnert KD, 1997, ACTA DIABETOL, V34, P301, DOI 10.1007/s005920050092; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Liu MJ, 2007, MOL THER, V15, P86, DOI 10.1038/sj.mt.6300005; Marhaba R, 2006, EUR J IMMUNOL, V36, P3017, DOI 10.1002/eji.200636158; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Pelegri C, 2001, MOL MED, V7, P311, DOI 10.1007/BF03402214; Rood PPM, 2006, PHARM RES-DORDR, V23, P227, DOI 10.1007/s11095-005-9095-6; Savinov AY, 2007, IUBMB LIFE, V59, P6, DOI 10.1080/15216540601187795; Savinov AY, 2006, FASEB J, V20, P1793, DOI 10.1096/fj.06-6207com; Savinov AY, 2005, J BIOL CHEM, V280, P27755, DOI 10.1074/jbc.M506016200; Savinov AY, 2001, J IMMUNOL, V167, P6637, DOI 10.4049/jimmunol.167.11.6637; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shalinsky DR, 1999, ANN NY ACAD SCI, V878, P236, DOI 10.1111/j.1749-6632.1999.tb07689.x; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trucco M, 2006, CELL TRANSPLANT, V15, pS75; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Wong FS, 1999, J AUTOIMMUN, V13, P290, DOI 10.1006/jaut.1999.0322; Woods CC, 2006, J AUTOIMMUN, V27, P28, DOI 10.1016/j.jaut.2006.04.004; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	43	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32106	32111		10.1074/jbc.M705348200	http://dx.doi.org/10.1074/jbc.M705348200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761671	hybrid			2022-12-27	WOS:000250480300031
J	Zhang, L; Wang, Y; Olive, AJ; Smith, ND; Picking, WD; De Guzman, RN; Picking, WL				Zhang, Lingling; Wang, Yu; Olive, Andrew J.; Smith, Nathan D.; Picking, William D.; De Guzman, Roberto N.; Picking, Wendy L.			Identification of the MxiH needle protein residues responsible for anchoring invasion plasmid antigen D to the type III secretion needle tip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-FLEXNERI; SYSTEM NEEDLE; BURKHOLDERIA-PSEUDOMALLEI; STRUCTURAL-ANALYSIS; EPITHELIAL-CELLS; IPAD; BIPD; SALMONELLA; MECHANISM; PATHOGENS	The pathogenesis of Shigella flexneri requires a functional type III secretion apparatus to serve as a conduit for injecting host-altering effector proteins into the membrane and cytoplasm of the targeted cell. The type III secretion apparatus is composed of a basal body and an exposed needle that is an extended polymer of MxiH with a 2.0-nm inner channel. Invasion plasmid antigen D ( IpaD) resides at the tip of the needle to control type III secretion. The atomic structures of MxiH and IpaD have been solved. MxiH ( 8.3 kDa) is a helix-turn-helix, whereas IpaD ( 36.6 kDa) has a dumbbell shape with two globular domains flanking a central coiled-coil that stabilizes the protein. These structures alone, however, have not been sufficient to produce a workable in silico model by which IpaD docks at the needle tip. Thus, the work presented here provides an initial step in understanding this important protein-protein interaction. We have identified key MxiH residues located in its PSNP loop and the contiguous surface that uniquely contribute to the formation of the IpaD-needle interface as determined by NMR chemical shift mapping. Mutation of Asn-43, Leu-47, and Tyr-50 residues severely affects the stable maintenance of IpaD at the Shigella surface and thus compromises the invasive phenotype of S. flexneri. Other residues could be mutated to give rise to intermediate phenotypes, suggesting they have a role in tip complex stabilization while not being essential for tip complex formation. Initial in vitro fluorescence polarization studies confirmed that specific amino acid changes adversely affect the MxiH-IpaD interaction. Meanwhile, none of the mutations appeared to have a negative effect on the MxiH-MxiH interactions required for efficient needle assembly.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Picking, WL (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pickingw@ku.edu	Zhang, Lingling/A-1100-2015; wang, yu/A-3473-2011	Olive, Andrew/0000-0003-3441-3113	NCRR NIH HHS [RR017708] Funding Source: Medline; NIAID NIH HHS [AI057927, AI067858, AI034428] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034428, R01AI057927, R29AI034428, R01AI067858] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Darboe N, 2006, PROTEIN SCI, V15, P543, DOI 10.1110/ps.051733506; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Deane JE, 2006, ACTA CRYSTALLOGR F, V62, P302, DOI 10.1107/S1744309106006555; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutta S, 2003, J CLIN MICROBIOL, V41, P5833, DOI 10.1128/JCM.41.12.5833-5834.2003; Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Harrington AT, 2003, INFECT IMMUN, V71, P1255, DOI 10.1128/IAI.71.3.1255-1264.2003; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MARQUART ME, 1995, BIOCHEM BIOPH RES CO, V214, P963, DOI 10.1006/bbrc.1995.2380; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; MOHLEBOETANI JC, 1995, AM J PUBLIC HEALTH, V85, P812, DOI 10.2105/AJPH.85.6.812; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Picking WL, 2001, MOL MICROBIOL, V39, P100, DOI 10.1046/j.1365-2958.2001.02210.x; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	32	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32144	32151		10.1074/jbc.M703403200	http://dx.doi.org/10.1074/jbc.M703403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827155	hybrid, Green Published			2022-12-27	WOS:000250480300036
J	Bakre, MM; Hoi, A; Mong, JCY; Koh, YY; Wong, KY; Stanton, LW				Bakre, Manjiri Manohar; Hoi, Aina; Mong, Jamie Chen Yee; Koh, Yvonne Yiling; Wong, Kee Yew; Stanton, Lawrence W.			Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; TYROSINE KINASE; DIVERGING POINT; AXIS FORMATION; GERM LAYER; CATENIN; MESODERM; LINEAGES; CULTURE; FATE	Pluripotent embryonic stem cells (ESCs) are capable of differentiating into cell types belonging to all three germ layers within the body, which makes them an interesting and intense field of research. Inefficient specific differentiation and contamination with unwanted cell types are the major issues in the use of ESCs in regenerative medicine. Lineage-specific progenitors generated from ESCs could be utilized to circumvent the issue. We demonstrate here that sustained activation of the Wnt pathway ( using Wnt3A or an inhibitor of glycogen synthase kinase 3 beta) in multiple mouse and human ESCs results in meso/endodermspecific differentiation. Using monolayer culture conditions, we have generated multipotential "mesendodermal progenitor clones" (MPC) from mouse ESCs by sustained Wnt pathway activation. MPCs express increased levels of meso/endodermal and mesendodermal markers and exhibit a stable phenotype in culture over a year. The MPCs have enhanced potential to differentiate along endothelial, cardiac, vascular smooth muscle, and skeletal lineages than undifferentiated ESCs. In conclusion, we demonstrate that the Wnt pathway activation can be utilized to generate lineage-specific progenitors from ESCs, which can be further differentiated into desired organ-specific cells.	Gen Inst Singapore, Stem Cell & Dev Biol, Singapore, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Bakre, MM (corresponding author), Gen Inst Singapore, Stem Cell & Dev Biol, 60,Biopolis St gen 02-01, Singapore, Singapore.	bakre@gis.a-star.edu.sg	Mong, Jamie/AFU-5649-2022	Mong, Jamie/0000-0003-0312-4482				ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Choi K, 1998, DEVELOPMENT, V125, P725; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; DADUE P, 2006, P NATL ACAD SCI USA, V103, P16806; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Li F, 2006, HISTOL HISTOPATHOL, V21, P103, DOI 10.14670/HH-21.103; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shibamoto S, 1998, GENES CELLS, V3, P659; SHIBUYA M, 1990, ONCOGENE, V5, P519; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	51	98	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31703	31712		10.1074/jbc.M704287200	http://dx.doi.org/10.1074/jbc.M704287200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711862	hybrid			2022-12-27	WOS:000250309200061
J	Johnson, CM; Tapping, RI				Johnson, Christopher M.; Tapping, Richard I.			Microbial products stimulate human toll-like receptor 2 expression through histone modification surrounding a proximal NF-kappa b-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; DIFFERENTIAL EXPRESSION; GENE; LEUKOCYTES; MONOCYTES; ACTIVATION; LIPOPOLYSACCHARIDE; TRANSCRIPTION; INFLAMMATION; MACROPHAGES	Previous studies have yielded conflicting results regarding the ability of microbial products to activate TLR2 gene expression in human monocytes. In this study, we found that TLR2 mRNA was rapidly up-regulated in human monocytes treated with TLR2 and TLR4 agonists, and this corresponded to an increase in cell surface receptor levels. This induction was abrogated by actinomycin D as well as a pharmacologic inhibitor of NF-kappa B, suggesting that the TLR2 gene is transcriptionally activated via NF-kappa B. Microbial agonists were found to shift the transcription initiation site of the TLR2 gene, and sequence examination revealed a near-consensus NF-kappa B-binding element immediately upstream of this site. Electromobility shift assays confirmed that NF-kappa B bound to this putative site in vitro. However, luciferase reporter plasmids driven by the TLR2 promoter were not responsive to TLR2 agonists. Overexpression of the NF-kappa B p65 subunit was sufficient to induce expression of the endogenous TLR2 mRNA, and co-transfection of the CREB-binding protein and p300 co-activators further increased TLR2 mRNA levels. Chromatin immunoprecipitation analysis revealed that p65, CREB-binding protein, and p300 are recruited to the TLR2 promoter upon stimulation of human monocytes followed by histone hyperacetylation. Taken together, these results define a mechanism whereby histone modification and increased promoter access induce expression of human TLR2 following infection.	Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA; Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), Univ Illinois, Dept Microbiol, B103 Chem & Life Sci Bldg,C 110,601 Goodwin Ave, Urbana, IL 61801 USA.	tapping@life.uiuc.edu			NIAID NIH HHS [AI052344] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Goodman RH, 2000, GENE DEV, V14, P1553; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; JEONG S, 1994, J BIOL CHEM, V269, P2197; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Magner WJ, 2000, J REPROD IMMUNOL, V48, P1, DOI 10.1016/S0165-0378(00)00066-8; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marsik C, 2003, BRIT J HAEMATOL, V121, P653, DOI 10.1046/j.1365-2141.2003.04350.x; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Orihara K, 2007, CLIN EXP IMMUNOL, V148, P260, DOI 10.1111/j.1365-2249.2007.03352.x; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Siedlar M, 2004, J IMMUNOL, V173, P2736, DOI 10.4049/jimmunol.173.4.2736; Sumegi A, 2007, INT ARCH ALLERGY IMM, V143, P177, DOI 10.1159/000099309; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Viemann D, 2005, PEDIATR RES, V58, P654, DOI 10.1203/01.PDR.0000180544.02537.FD; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wang TY, 2000, J IMMUNOL, V165, P6308, DOI 10.4049/jimmunol.165.11.6308; Wang TY, 2002, J IMMUNOL, V169, P795, DOI 10.4049/jimmunol.169.2.795; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	44	37	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31197	31205		10.1074/jbc.M705151200	http://dx.doi.org/10.1074/jbc.M705151200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728249	hybrid			2022-12-27	WOS:000250309200009
J	Weaver, AK; Olsen, ML; McFerrin, MB; Sontheimer, H				Weaver, Amy K.; Olsen, Michelle L.; McFerrin, Michael B.; Sontheimer, Harald			BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts - A novel mechanism for coupling [Ca2+](i) to ion channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLIOMA-CELLS; CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; SMOOTH-MUSCLE; MUSCARINIC RECEPTORS; RYANODINE RECEPTORS; CHOLESTEROL CONTENT; SIGNALING COMPLEX; MEMBRANE DOMAINS; CA2+ CHANNELS	Glioma cells prominently express a unique splice variant of a large conductance, calcium-activated potassium channel (BK channel). These channels transduce changes in intracellular calcium to changes of K+ conductance in the cells and have been implicated in growth control of normal and malignant cells. The Ca2+ increase that facilitates channel activation is thought to occur via activation of intracellular calcium release pathways or influx of calcium through Ca2+-permeable ion channels. We show here that BK channel activation involves the activation of inositol 1,4,5-triphosphate receptors (IP3R), which localize near BK channels in specialized membrane domains called lipid rafts. Disruption of lipid rafts with methyl-beta-cyclodextrin disrupts the functional association of BK channel and calcium source resulting in a > 50% reduction in K+ conductance mediated by BK channels. The reduction of BK current by lipid raft disruption was overcome by the global elevation of intracellular calcium through inclusion of 750 nM Ca2+ in the pipette solution, indicating that neither the calcium sensitivity of the channel nor their overall number was altered. Additionally, pretreatment of glioma cells with 2-aminoethoxydiphenyl borate to inhibit IP(3)Rs negated the effect of methyl-beta-cyclodextrin, providing further support that IP(3)Rs are the calcium source for BK channels. Taken together, these data suggest a privileged association of BK channels in lipid raft domains and provide evidence for a novel coupling of these Ca2+-sensitive channels to their second messenger source.	Univ Alabama, Ctr Glial Biol Med, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), 1719 6th Ave, CIRC 425, Birmingham, AL 35294 USA.	hws@uab.edu		Sontheimer, Harald/0000-0002-5843-9871; Olsen, Michelle/0000-0003-1394-664X	NCI NIH HHS [P50 CA097247-05, P50 CA097247] Funding Source: Medline; NINDS NIH HHS [R01-NS31234, R01 NS036692, R01 NS031234-14A1, R01-NS36692, R01 NS031234, R01 NS036692-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031234, R01NS036692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; BOMBEN VC, 2007, IN PRESS CELL PROLIF; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Catlin MC, 2000, CYTOMETRY, V41, P123; CHANG HM, 1995, J MEMBRANE BIOL, V145, P13; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Christian AE, 1997, J LIPID RES, V38, P2264; Delling M, 2002, J NEUROSCI, V22, P7154; Doheny HC, 2005, J CLIN ENDOCR METAB, V90, P5786, DOI 10.1210/jc.2005-0574; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Grunnet M, 2004, J BIOL CHEM, V279, P36445, DOI 10.1074/jbc.M402254200; Guizzetti M, 1998, EUR J PHARMACOL, V359, P223, DOI 10.1016/S0014-2999(98)00620-7; Guizzetti M, 2001, NEUROREPORT, V12, P1639, DOI 10.1097/00001756-200106130-00025; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; KUNERTRADEK J, 1989, ACTA NEUROL SCAND, V79, P166, DOI 10.1111/j.1600-0404.1989.tb03731.x; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Ningaraj NS, 2002, J PHARMACOL EXP THER, V301, P838, DOI 10.1124/jpet.301.3.838; OHI Y, 2001, J PHYSIOL-LONDON, V534, P2; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; PATTERSON RL, 2004, ANNU REV BIOCHEM, V73, P18; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rujoi M, 2003, INVEST OPHTH VIS SCI, V44, P1634, DOI 10.1167/iovs.02-0786; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177	50	77	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31558	31568		10.1074/jbc.M702866200	http://dx.doi.org/10.1074/jbc.M702866200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711864	Green Accepted, hybrid			2022-12-27	WOS:000250309200048
J	Jeudy, S; Schwartz, TU				Jeudy, Sandra; Schwartz, Thomas U.			Crystal structure of nucleoporin Nic96 reveals a novel, intricate helical domain architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; N-TERMINAL DOMAIN; NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON TOMOGRAPHY; MESSENGER-RNA; IN-VIVO; PROTEIN; YEAST; INTERACTS; RECONSTRUCTION	The nuclear pore complex (NPC) is an elaborate protein machine that mediates macromolecular transport across the nuclear envelope in all eukaryotes. The NPC is formed by nucleoporins that assemble in multiple copies around an 8-fold symmetry axis. Homology modeling suggests that most architectural nucleoporins are composed of simple beta- propeller and alpha- helical repeat domains. Here we present the crystal structure of Nic96, the Nup93 homolog in Saccharomyces cerevisiae, one of the major components of the NPC. This is the first structure of an alpha- helical nucleoporin domain. The protein folds into an elongated, mostly alpha- helical structure. Characteristically, non-canonical architectural features define the Nic96 structure. Sequence conservation among Nup93 homologs across all eukaryotes strongly suggests that the distinct topology is evolutionarily well maintained. We propose that the unique Nic96/Nup93 fold has a conserved function in all eukaryotes.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-480, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; jeudy, sandra/0000-0002-5297-0135	NIGMS NIH HHS [GM077537] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gomez-Ospina N, 2000, J STRUCT BIOL, V132, P1, DOI 10.1006/jsbi.2000.4305; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-17; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	55	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34904	34912		10.1074/jbc.M705479200	http://dx.doi.org/10.1074/jbc.M705479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897938	hybrid			2022-12-27	WOS:000251155200033
J	Cheng, JZ; Zhang, JQ; Merched, A; Zhang, LP; Zhang, P; Truong, L; Boriek, AM; Du, J				Cheng, Jizhong; Zhang, Jiqiang; Merched, Aksam; Zhang, Liping; Zhang, Ping; Truong, Luan; Boriek, Aladin M.; Du, Jie			Mechanical stretch inhibits oxidized low density lipoprotein-induced apoptosis in vascular smooth muscle cells by up-regulating integrin alpha V beta 3 and stablization of PINCH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; INTEGRIN-LINKED KINASE; SHAPE MODULATION; ATHEROGENESIS; ILK; SURVIVAL; LDL; BAX	To determine the mechanisms involved in regulating the balance between apoptosis and survival in vascular smooth muscle cells (VSMC), we studied anti-apoptotic stimuli that can counteract pro-apoptotic events in the process of early atherosclerotic lesions formation. Such a process involves VSMC accumulation even in the presence of oxidized low density lipoprotein (Ox-LDL). In the arch of the aorta, we find that integrin beta 3 is higher than in descending arteries. In the advanced atherosclerosis lesion, we found an inverse correlation between the level of integrin beta 3 and apoptosis (deoxynucleotidyltransferase- mediated dUTP nick end labeling-positive). We also found an increase in integrin alpha V beta 3 (but not integrin beta 1) expression in VSMC that are subjected to cyclic stretch. VSMC subjected to stretch as well as VSMC with forced expression of alpha V beta 3 were demonstrated to be resistant to Ox-LDL induced cytoskeleton disruption and apoptosis. The anti-apoptotic effect of stretch was abolished by treatment of VSMC with small interfering RNA against integrin beta 3 as well as VSMC isolated from integrin beta 3 knock-out mice. Disruption of the cytoskeleton abolished the protective effect of stretch or alpha V beta 3 overexpression on Ox-LDL-induced activation of Bax and apoptosis. We also demonstrated that stretch-mediated protection of Ox-LDL-induced apoptosis involved stabilization of PINCH-1; Ox-LDL decreased the level of PINCH-1, but the application of mechanical stretch or overexpression of either integrin beta 1 or integrin beta 3 prevented its down-regulation. In the arteries of integrin beta 3 null mice, there were lower levels of PINCH-1 and ILK-1. Moreover, deletion of integrin beta 3 in VSMC abolished the stretch protective effect on PINCH-1. Small interfering RNA-mediated knockdown of PINCH-1 disrupted the cytoskeleton and caused apoptosis of VSMC. These findings provided experimental evidence that mechanical stretch acted as a survival factor in the arches of aortas. Furthermore, mechanical stretch prevented VSMC from apoptosis via a mechanism that involves alpha V beta 3 integrin expression, stabilization of PINCH-1, and remodeling of the cytoskeleton.	Baylor Coll Med, Div Nephrol, Dept Internal Med, Houston, TX 77030 USA	Baylor College of Medicine	Du, J (corresponding author), Baylor Coll Med, Div Nephrol, Dept Internal Med, 1 Baylor Plaza,BCM N-520, Houston, TX 77030 USA.	jdu@bcm.edu	Zhang, Jiqiang/B-4488-2008	Zhang, Jiqiang/0000-0002-1905-8750; Merched, Aksam/0000-0003-4030-4538	NHLBI NIH HHS [R01 HL 70762, HL 63134] Funding Source: Medline; NIDDK NIH HHS [P50 DK 064233, R01 DK095867] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134, R01HL070762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHENG J, 2007, ARTERIOSCLER THROMB; Cheng JZ, 2007, ENDOCRINOLOGY, V148, P2085, DOI 10.1210/en.2006-1709; CHIEN S, 1976, ANN NY ACAD SCI, V275, P10, DOI 10.1111/j.1749-6632.1976.tb43335.x; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Merched AJ, 2004, CIRCULATION, V110, P3830, DOI 10.1161/01.CIR.0000148681.01282.89; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Murase T, 1998, CIRC RES, V83, P328, DOI 10.1161/01.RES.83.3.328; Napoli C, 2003, ANN NY ACAD SCI, V1010, P698, DOI 10.1196/annals.1299.127; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shaw Anthony, 2003, Current Vascular Pharmacology, V1, P41, DOI 10.2174/1570161033386745; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 1999, J CELL SCI, V112, P4485; Xu QB, 2000, TRENDS CARDIOVAS MED, V10, P35, DOI 10.1016/S1050-1738(00)00042-6; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200	26	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34268	34275		10.1074/jbc.M703115200	http://dx.doi.org/10.1074/jbc.M703115200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878168	hybrid			2022-12-27	WOS:000251145700042
J	Tang, MJ; Tai, IT				Tang, Michelle J.; Tai, Isabella T.			A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-INDUCED APOPTOSIS; CELL LUNG-CANCER; EXTRACELLULAR-MATRIX; 1ST-LINE TREATMENT; GROWTH-INHIBITION; DEATH RECEPTOR; TUMOR-GROWTH; EXPRESSION; PROTEIN; CASPASE-8	Chemotherapy resistance accounts for the high mortality rates in patients with advanced cancers. We previously used a genomics approach to determine novel genes associated with this phenomenon and identified (s) under bar ecreted (p) under bar rotein (a) under bar cidic and (r) under bar ich in (c) under bar ysteine (SPARC) as a chemosensitizer capable of reversing therapy resistance in colorectal cancer cells by enhancing apoptosis in vitro and tumor regression in vivo. Here, we examined the mechanisms by which SPARC enhances apoptosis in the presence of chemotherapy. We show that SPARC potentiates apoptosis by augmenting the signaling cascade in a caspase-8-dependent manner, because apoptosis can be abolished by caspase 8 small interfering RNA in the presence of SPARC. This occurs independently of death receptor activation and leads to downstream involvement of Bid and subsequent apoptosis. Interestingly, this results from an interaction between SPARC and the N terminus of the procaspase-8 DED-containing domain. These exciting findings provide an initial map of the apoptosis signaling events mediated by SPARC and how this can ultimately result in the reversal of chemotherapy resistance and enhanced tumor regression. This signaling cascade can be exploited therapeutically and may have potential clinical implications for patients with advanced and therapy-refractory cancers.	Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; British Columbia Cancer Agency	Tai, IT (corresponding author), Univ British Columbia, Div Gastroenterol, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	itai@bcgsc.ca	Tai, Isabella T/E-8035-2012					ARAKI S, 1990, BIOCHEM BIOPH RES CO, V168, P1194, DOI 10.1016/0006-291X(90)91155-L; Basu A, 2006, CANCER RES, V66, P4309, DOI 10.1158/0008-5472.CAN-05-2657; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; ENGLISH HF, 1989, PROSTATE, V15, P233, DOI 10.1002/pros.2990150304; Ferreira CG, 2000, CLIN CANCER RES, V6, P203; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; FRANCHIMONT C, 1980, J CUTAN PATHOL, V7, P387, DOI 10.1111/j.1600-0560.1980.tb01212.x; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Fulda S, 2004, ANN NY ACAD SCI, V1028, P150, DOI 10.1196/annals.1322.016; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Gilles C, 1998, CANCER RES, V58, P5529; Graf D, 2007, ARCH BIOCHEM BIOPHYS, V462, P162, DOI 10.1016/j.abb.2007.03.029; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Koukourakis MI, 2003, CANCER RES, V63, P5376; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Machover D, 1996, ANN ONCOL, V7, P95; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; Mok SC, 1996, ONCOGENE, V12, P1895; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Poulaki V, 2001, CANCER RES, V61, P4864; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Reed WP, 2004, SURG ENDOSC, V18, P11, DOI 10.1007/s00464-003-8913-3; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Seol DW, 2001, CANCER RES, V61, P1138; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Taghizadeh F, 2007, MOL CANCER THER, V6, P309, DOI 10.1158/1535-7163.MCT-06-0517; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Toyozumi Y, 2004, INT J ONCOL, V25, P721; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Wang WJ, 2006, NEPHROL DIAL TRANSPL, V21, P1278, DOI 10.1093/ndt/gfk036; Yang LL, 2003, CANCER RES, V63, P831; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4	48	61	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34457	34467		10.1074/jbc.M704459200	http://dx.doi.org/10.1074/jbc.M704459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897953	hybrid			2022-12-27	WOS:000251145700061
J	Hall, JP; Kurdi, Y; Hsu, S; Cuozzo, J; Liu, J; Telliez, JB; Seidl, KJ; Winkler, A; Hu, Y; Green, N; Askew, GR; Tam, S; Clark, JD; Lin, LL				Hall, J. Perry; Kurdi, Yahya; Hsu, Sang; Cuozzo, John; Liu, Julie; Telliez, Jean-Baptiste; Seidl, Katherine J.; Winkler, Aaron; Hu, Yonghan; Green, Neal; Askew, G. Roger; Tam, Steve; Clark, James D.; Lin, Lih-Ling			Pharmacologic inhibition of Tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; EARLY RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CYCLOOXYGENASE-2 EXPRESSION; ACTIVATE ERK; KINASE; PROGRESSION; INDUCTION; PROTEIN	Tumor necrosis factor alpha(TNF alpha) is a pro-inflammatory cytokine that controls the initiation and progression of inflammatory diseases such as rheumatoid arthritis. Tpl2 is a MAPKKK in the MAPK (i. e. ERK) pathway, and the Tpl2-MEK-ERK signaling pathway is activated by the pro-inflammatory mediators TNF alpha, interleukin (IL)-1 beta, and bacterial endotoxin (lipopolysaccharide (LPS)). Moreover, Tpl2 is required for TNF alpha expression. Thus, pharmacologic inhibition of Tpl2 should be a valid approach to therapeutic intervention in the pathogenesis of rheumatoid arthritis and other inflammatory diseases in humans. We have developed a series of highly selective and potent Tpl2 inhibitors, and in the present study we have used these inhibitors to demonstrate that the catalytic activity of Tpl2 is required for the LPS-induced activation of MEK and ERK in primary human monocytes. These inhibitors selectively target Tpl2 in these cells, and they block LPS- and IL-1 beta-induced TNF alpha production in both primary human monocytes and human blood. In rheumatoid arthritis fibroblast-like synoviocytes these inhibitors block ERK activation, cyclooxygenase-2 expression, and the production of IL-6, IL-8, and prostaglandin E-2, and the matrix metalloproteinases MMP-1 and MMP-3. Taken together, our results show that inhibition of Tpl2 in primary human cell types can decrease the production of TNF alpha and other pro-inflammatory mediators during inflammatory events, and they further support the notion that Tpl2 is an appropriate therapeutic target for rheumatoid arthritis and other human inflammatory diseases.	Wyeth Ayerst Res, Dept Inflammat, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer; Pfizer	Hall, JP (corresponding author), 200 CambridgePkDr,T4017N, Cambridge, MA 02140 USA.	jphall@wyeth.com; llin@wyeth.com		Cuozzo, John/0000-0002-6229-0395; Clark, James D./0000-0002-4801-0123				AGGARWAL BB, 2001, CYTOKINE REFERENCE, P413; Caivano M, 2003, J BIOL CHEM, V278, P52124, DOI 10.1074/jbc.M306583200; Channavajhala PL, 2003, J BIOL CHEM, V278, P47089, DOI 10.1074/jbc.M306002200; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; CLOSE DR, 2001, ANN RHEUM DIS     S3, V60, P62; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Jia Y, 2006, ANAL BIOCHEM, V350, P268, DOI 10.1016/j.ab.2005.11.010; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Posthumus MD, 2000, J RHEUMATOL, V27, P2761; Rodriguez C, 2006, CELL SIGNAL, V18, P1376, DOI 10.1016/j.cellsig.2005.10.016; Roux-Lombard P, 2001, RHEUMATOLOGY, V40, P544, DOI 10.1093/rheumatology/40.5.544; Schottelius AJG, 2004, EXP DERMATOL, V13, P193, DOI 10.1111/j.0906-6705.2004.00205.x; Simmons DL, 2006, DRUG DISCOV TODAY, V11, P210, DOI 10.1016/S1359-6446(05)03721-9; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; WOOLLEY DE, 1977, ARTHRITIS RHEUM, V20, P1231, DOI 10.1002/art.1780200612	33	67	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33295	33304		10.1074/jbc.M703694200	http://dx.doi.org/10.1074/jbc.M703694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848581	hybrid			2022-12-27	WOS:000250840200009
J	Caglic, D; Pungercar, JR; Pejler, G; Turk, V; Turk, B				Caglic, Dejan; Pungercar, Jerica Rozman; Pejler, Gunnar; Turk, Vito; Turk, Boris			Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATHEPSIN-B; LYSOSOMAL CYSTEINE PROTEASES; MAST-CELL TRYPTASE; CONFORMATIONAL-CHANGE; HEPARAN-SULFATE; IN-VITRO; CRYSTAL-STRUCTURE; OCCLUDING LOOP; BINDING; PH	Lysosomal cysteine cathepsin B participates in numerous diverse cellular processes. In acquiring its activity, the proregion, which blocks the substrate-binding site in the proenzyme, needs to be cleaved off. Here we demonstrate that polyanionic polysaccharides, glycosaminoglycans ( GAGs), can accelerate the autocatalytic removal of the propeptide and subsequent activation of cathepsin B. We show that naturally occurring GAGs such as chondroitin sulfates and heparin, as well as the synthetic analog dextran sulfate, accelerate the processing in a concentration-dependent manner. Heparin oligosaccharides down to the size of tetrasaccharides were efficient in accelerating the procathepsin B processing, whereas disaccharides were without effect. Further, the ability of the GAGs to accelerate procathepsin B processing was sensitive to increasing NaCl concentrations, indicating that electrostatic interaction between the GAGs and procathepsin B are operative in the accelerating effect. Also the processing of the catalytic procathepsin B mutant by wild type cathepsin B was enhanced in the presence of GAGs, suggesting that GAGs induce a conformational change in procathepsin B, converting it into a better substrate. Site-directed mutagenesis showed that His(28), Lys(39), and Arg(40), located within the procathepsin B propeptide, have significant roles in the acceleration of procathepsin B activation induced by short GAGs. Because procathepsin B and GAGs often co-localize in vivo, we propose that GAGs may play a physiological role in the activation of procathepsin B.	Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; Swedish Univ Agr Sci, Dept Mol Biosci, S-75123 Uppsala, Sweden	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swedish University of Agricultural Sciences	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Jamova 39, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si	Caglic, Dejan/A-1868-2009	Turk, Boris/0000-0002-9007-5764				Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; BAICI A, 1995, ANN RHEUM DIS, V54, P289, DOI 10.1136/ard.54.4.289; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Cunnane G, 1999, RHEUMATOLOGY, V38, P34, DOI 10.1093/rheumatology/38.1.34; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Edavettal SC, 2004, BIOCHEMISTRY-US, V43, P4680, DOI 10.1021/bi0499112; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Ishidoh K, 1995, BIOCHEM BIOPH RES CO, V217, P624, DOI 10.1006/bbrc.1995.2820; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; MACH L, 1994, J BIOL CHEM, V269, P13030; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1994, SEMIN THROMB HEMOST, V20, P373, DOI 10.1055/s-2007-1001928; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pejler G, 1996, BIOCHEM J, V320, P897, DOI 10.1042/bj3200897; PEJLER G, 1994, J BIOL CHEM, V269, P14451; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; RECKLIES AD, 1982, BIOCHEM J, V207, P633, DOI 10.1042/bj2070633; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Schedin-Weiss S, 2004, BIOCHEMISTRY-US, V43, P675, DOI 10.1021/bi030173b; Serveau C, 2003, BIOL CHEM, V384, P921, DOI 10.1515/BC.2003.103; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK B, 1993, J BIOL CHEM, V268, P7323; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vanwildemeersch M, 2006, J BIOL CHEM, V281, P10298, DOI 10.1074/jbc.M508483200; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Winchester B G, 1996, Subcell Biochem, V27, P191	46	71	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33076	33085		10.1074/jbc.M705761200	http://dx.doi.org/10.1074/jbc.M705761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17726009	hybrid			2022-12-27	WOS:000250625400056
J	Gonzalez-Gronow, M; Kaczowka, SJ; Payne, S; Wang, F; Gawdi, G; Pizzo, SV				Gonzalez-Gronow, Mario; Kaczowka, Steven J.; Payne, Sturgis; Wang, Fang; Gawdi, Govind; Pizzo, Salvatore V.			Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS-INFECTION; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ACTIVATION SYSTEM; TUMOR INVASION; CA2+ CHANNELS; PROTEIN GRP78; BINDING-SITE	Both the voltage-dependent anion channel and the glucose-regulated protein 78 have been identified as plasminogen kringle 5 receptors on endothelial cells. In this study, we demonstrate that kringle 5 binds to a region localized in the N-terminal domain of the glucose-regulated protein 78, whereas microplasminogen does so through the C-terminal domain of the glucose-regulated protein 78. Both plasminogen fragments induce Ca2+ signaling cascades; however, kringle 5 acts through voltage-dependent anion channel and microplasminogen does so via the glucose-regulated protein 78. Because trafficking of voltage-dependent anion channel to the cell surface is associated with heat shock proteins, we investigated a possible association between voltage-dependent anion channel and glucose-regulated protein 78 on the surface of 1-LN human prostate tumor cells. We demonstrate that these proteins co-localize, and changes in the expression of the glucose-regulated protein 78 affect the expression of voltage-dependent anion channel. To differentiate the functions of these receptor proteins, either when acting singly or as a complex, we employed human hexokinase I as a specific ligand for voltage-dependent anion channel, in addition to kringle 5. We show that kringle 5 inhibits 1-LN cell proliferation and promotes caspase-7 activity by a mechanism that requires binding to cell surface voltage-dependent anion channel and is inhibited by human hexokinase I.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Gonzalez-Gronow, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	gonza002@mc.duke.edu			NCI NIH HHS [CA 86344] Funding Source: Medline; NHLBI NIH HHS [HL 24066] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086344] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL024066, R01HL024066] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anastasiadis Aristotelis G, 2002, Curr Urol Rep, V3, P222, DOI 10.1007/s11934-002-0068-6; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Botto L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-7; Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; Chen GD, 2007, HEARING RES, V226, P14, DOI 10.1016/j.heares.2006.06.007; CHUNGUE E, 1994, J INFECT DIS, V170, P1304, DOI 10.1093/infdis/170.5.1304; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dudani AK, 2007, MOL CELL BIOCHEM, V300, P197, DOI 10.1007/s11010-006-9384-3; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Gonzalez-Gronow M, 2005, EXP CELL RES, V303, P22, DOI 10.1016/j.yexcr.2004.09.008; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2001, BIOCHEM J, V355, P397, DOI 10.1042/0264-6021:3550397; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hooft L, 2005, J CLIN ENDOCR METAB, V90, P328, DOI 10.1210/jc.2004-0779; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; Lee ATC, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-16; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; MARKOFF LJ, 1991, J INFECT DIS, V164, P294, DOI 10.1093/infdis/164.2.294; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1982; Misra UK, 2005, J LEUKOCYTE BIOL, V78, P187, DOI 10.1189/jlb.1104685; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reuning U, 1998, INT J ONCOL, V13, P893; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; SHI GY, 1988, J BIOL CHEM, V263, P17071; Shimoda LA, 2006, MICROCIRCULATION, V13, P657, DOI 10.1080/10739680600930305; SILVERSTEIN RL, 1988, J CLIN INVEST, V82, P1948, DOI 10.1172/JCI113814; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; THEWES T, 1987, BIOCHIM BIOPHYS ACTA, V912, P254, DOI 10.1016/0167-4838(87)90096-3; THORSEN S, 1981, BIOCHIM BIOPHYS ACTA, V668, P377, DOI 10.1016/0005-2795(81)90171-9; Tohma T, 2005, HEPATO-GASTROENTEROL, V52, P486; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; VARADY A, 1981, BIOCHEM BIOPH RES CO, V103, P91; WALLEN P, 1970, BIOCHIM BIOPHYS ACTA, V221, P20, DOI 10.1016/0005-2795(70)90194-7; Wouters BG, 2003, SEMIN RADIAT ONCOL, V13, P31, DOI 10.1053/srao.2003.50004; WU HL, 1990, J BIOL CHEM, V265, P19658; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2	59	44	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32811	32820		10.1074/jbc.M703342200	http://dx.doi.org/10.1074/jbc.M703342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848573	hybrid			2022-12-27	WOS:000250625400030
J	Oh, E; Heise, CJ; English, JM; Cobb, MH; Thurmond, DC				Oh, Eunjin; Heise, Charles J.; English, Jessie M.; Cobb, Melanie H.; Thurmond, Debbie C.			WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; PANCREATIC BETA-CELLS; TYROSINE PHOSPHORYLATION; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; ACTIVATES SGK1; BLOOD-PRESSURE; T-SNARE; KINASE; MUNC18C	Defects in soluble NSF attachment protein receptor ( SNARE)mediated granule exocytosis occur in islet beta cells, adipocytes, and/ or skeletal muscle cells correlate with increased susceptibility to insulin resistance and diabetes. The serine/ threonine kinase WNK1 ( with no K ( lysine)) has recently been implicated in exocytosis and is expressed in all three of these cell types. To search for WNK1 substrates related to exocytosis, we conducted a WNK1 two- hybrid screen, which yielded Munc18c. Munc18c is known to be a key regulator of accessibility of the target membrane (t-SNARE) protein syntaxin 4 to participate in SNARE core complex assembly, although a paucity of Munc18c- binding factors has precluded discovery of its precise functions. To validate WNK1 as a new Munc18c- interacting partner, the direct interaction between WNK1 and Munc18c was confirmed using in vitro binding analysis, and endogenous WNK1- Munc18c complexes were detected in the cytosolic and plasma membrane compartments of the islet beta cell line MIN6. This binding interaction is mediated through the N- terminal 172 residues of Munc18c and the kinase domain residues of WNK1 ( residues 159 - 491). Expression of either of these two minimal interaction domains resulted in inhibition of glucose- stimulated insulin secretion, consistent with a functional importance for the endogenous WNK1- Munc18c complex in exocytosis. Interestingly, Munc18c failed to serve as a WNK1 substrate in kinase activity assays, suggesting that WNK1 functions in SNARE complex assembly outside its role as a kinase. Taken together, these data support a novel role for WNK1 and a new mechanism for the regulation of SNARE complex assembly by WNK1- Munc18c complexes.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, Indianapolis, IN 46202 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Pfizer Res Technol Ctr, Cambridge, MA 02139 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; Pfizer; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Thurmond, DC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, 635 Barnhill Dr,MS4053, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu		Cobb, Melanie/0000-0003-0833-5473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK067912-04, DK 067912, R01 DK067912] Funding Source: Medline; NIGMS NIH HHS [R01 GM053032, GM 53032] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Chan CB, 1999, DIABETES, V48, P997, DOI 10.2337/diabetes.48.5.997; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Perez-Branguli F, 2002, MOL CELL NEUROSCI, V20, P169, DOI 10.1006/mcne.2002.1122; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2005, CELL RES, V15, P6, DOI 10.1038/sj.cr.7290256; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	48	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32613	32622		10.1074/jbc.M706591200	http://dx.doi.org/10.1074/jbc.M706591200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848561	hybrid, Green Accepted			2022-12-27	WOS:000250625400010
J	Pinnola, A; Naumova, N; Shah, M; Tulin, AV				Pinnola, Aaron; Naumova, Natasha; Shah, Meera; Tulin, Alexei V.			Nucleosomal core Histones mediate dynamic regulation of Poly(ADP-ribose) polymerase 1 protein binding to chromatin and induction of its enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOBILITY; DNA-BINDING; PARP; GENE; SEQUENCE; DOMAIN	Poly(ADP-ribose) polymerase 1 protein (PARP1) mediates chromatin loosening and activates the transcription of inducible genes, but the mechanism of PARP1 regulation in chromatin is poorly understood. We have found that PARP1 interaction with chromatin is dynamic and that PARP1 is exchanged continuously between chromatin and nucleoplasm, as well as between chromatin domains. Specifically, the PARP1 protein preferentially interacts with nucleosomal particles, and although the nucleosomal linker DNA is not necessary for this interaction, we have shown that the core histones, H3 and H4, are critical for PARP1 binding. We have also demonstrated that the histones H3 and H4 interact preferentially with the C-terminal portion of PARP1 protein and that the N-terminal domain of PARP1 negatively regulates these interactions. Finally, we have found that interaction with the N-terminal tail of the H4 histone triggers PARP1 enzymatic activity. Therefore, our data collectively suggests a model in which both the regulation of PARP1 protein binding to chromatin and the enzymatic activation of PARP1 protein depend on the dynamics of nucleosomal core histone mediation.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Tulin, AV (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Alexei.Tulin@fccc.edu			NIGMS NIH HHS [GM27875, R01 GM077452] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027875, R01GM027875] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Aoufouchi S, 1997, BIOCHEM J, V325, P543, DOI 10.1042/bj3250543; AUBIN RJ, 1983, EMBO J, V2, P1685, DOI 10.1002/j.1460-2075.1983.tb01643.x; Babiychuk E, 1998, PLANT J, V15, P635, DOI 10.1046/j.1365-313x.1998.00240.x; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Casso D, 2000, MECH DEVELOP, V91, P449; Chandler S, 1999, METH MOL B, V119, P103; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Ellen TP, 2004, BIOCHEMISTRY-US, V43, P7867, DOI 10.1021/bi0497704; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hanai S, 1998, J BIOL CHEM, V273, P11881, DOI 10.1074/jbc.273.19.11881; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; KRUPITZA G, 1989, BIOCHEMISTRY-US, V28, P4054, DOI 10.1021/bi00435a063; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; Luger K, 1999, METHOD ENZYMOL, V304, P3; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pirrotta V, 2003, SCIENCE, V299, P528, DOI 10.1126/science.1081520; POIRIER GG, 1982, EUR J BIOCHEM, V127, P437; PROKHOROVA AV, 1994, GENETIKA+, V30, P874; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2006, GENETICS, V172, P363, DOI 10.1534/genetics.105.049239; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Wolffe AP, 2001, ESSAYS BIOCHEM, V37, P45, DOI 10.1042/bse0370045; YAMANAKA H, 1988, J BIOL CHEM, V263, P3879	41	88	88	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32511	32519		10.1074/jbc.M705989200	http://dx.doi.org/10.1074/jbc.M705989200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827147	hybrid			2022-12-27	WOS:000250480300074
J	Wang, L; Dai, W; Lu, L				Wang, Ling; Dai, Wei; Lu, Luo			Stress-induced c-Jun activation mediated by polo-like kinase 3 in corneal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-3; UV-LIGHT; SERINE/THREONINE KINASE; CYCLE ARREST; APOPTOSIS; PHOSPHORYLATION; PATHWAYS; GENE; IDENTIFICATION; IRRADIATION	Polo-like kinase 3 (Plk3) activation occurs after exposure to environmental or genotoxic stresses. Plk3 regulates cell fate through regulating cell cycle progression. UV irradiation is one of the major environmental stresses that affect corneal epithelial wound healing. In the present study, we report that UV irradiation activated Plk3 and that Plk3 interacts with AP-1 and c-Jun, which appears to be important to mediate corneal epithelial cell apoptosis after UV irradiation. Recombinant Plk3, as well as Plk3 immunoprecipitated from UV-irradiated cells, phosphorylated c-Jun in vitro. The phosphorylation of c-Jun by Plk3 immunoprecipitates was not altered by the pre-removal of JNK from the cell lysates. In addition, the effect of UV irradiation-induced phosphorylation of c-Jun and apoptosis were not significantly affected by knockdown of JNK mRNA. Co-immunoprecipitation reveals that Plk3 and c-Jun directly interacted with each other. Consistently, Plk3 co-localized with c-Jun to the nucleus after UV irradiation. Further, modulating Plk3 activities by overexpressing Plk3 or its mutants significantly affected UV irradiation-induced c-Jun activity and subsequent apoptosis. Our results thus provide for the first time that Plk3 mediates UV irradiation-induced c-Jun activation by phosphorylating c-Jun, suggesting that Plk3 plays an important role in mediating programmed cell death of corneal epithelial cells after UV irradiation.	Univ Calif Los Angeles, Harbor UCLA Med Ctr, Dept Med, David Geffen Sc, Torrance, CA 90502 USA; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, Harbor UCLA Med Ctr, Dept Med, David Geffen Sc, 1124 W Carson St,C-2, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012953] Funding Source: NIH RePORTER; NCI NIH HHS [CA074229] Funding Source: Medline; NEI NIH HHS [EY12953] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler V, 1996, CARCINOGENESIS, V17, P2073, DOI 10.1093/carcin/17.9.2073; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Bodero AJ, 2003, BIOCHEM BIOPH RES CO, V301, P923, DOI 10.1016/S0006-291X(03)00063-9; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; BUSCHER M, 1988, ONCOGENE, V3, P301; Conn CW, 2000, CANCER RES, V60, P6826; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Holbrook N J, 1996, EXS, V77, P273; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Merienne K, 2000, ONCOGENE, V19, P4221, DOI 10.1038/sj.onc.1203712; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ruan Q, 2004, EXP CELL RES, V294, P51, DOI 10.1016/j.yexcr.2003.10.022; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Wang L, 2004, INVEST OPHTH VIS SCI, V45, P1796, DOI 10.1167/iovs.03-1056; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P5095, DOI 10.1167/iovs.03-0590; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271	31	22	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32121	32127		10.1074/jbc.M702791200	http://dx.doi.org/10.1074/jbc.M702791200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804415	hybrid			2022-12-27	WOS:000250480300033
J	Halasz, K; Kassner, A; Morgelin, M; Heinegard, D				Halasz, Krisztina; Kassner, Anja; Morgelin, Matthias; Heinegard, Dick			COMP acts as a catalyst in collagen fibrillogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; NATIVE COLLAGEN; POLYACRYLAMIDE GELS; ELECTRON-MICROSCOPY; FIBRIL FORMATION; CORE PROTEINS; IX COLLAGEN; TENDON; FIBROMODULIN	We have previously reported that COMP (cartilage oligomeric matrix protein) is prominent in cartilage but is also present in tendon and binds to collagens I and II with high affinity. Here we show that COMP influences the fibril formation of these collagens. Fibril formation in the presence of pentameric COMP was much faster, and the amount of collagen in fibrillar form was markedly increased. Monomeric COMP, lacking the N-terminal coiled-coil linker domain, decelerated fibrillogenesis. The data show that stimulation of collagen fibrillogenesis depends on the pentameric nature of COMP and not only on collagen binding. COMP interacts primarily with free collagen I and II molecules, bringing several molecules to close proximity, apparently promoting further assembly. These assemblies further join in discrete steps to a narrow distribution of completed fibril diameters of 149 +/- 16 nm with a banding pattern of 67 nm. COMP is not found associated with the mature fibril and dissociates from the collagen molecules or their early assemblies. However, a few COMP molecules are found bound to more loosely associated molecules at the tip/end of the growing fibril. Thus, COMP appears to catalyze the fibril formation by promoting early association of collagen molecules leading to increased rate of fibrillogenesis and more distinct organization of the fibrils.	Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Heinegard, D (corresponding author), Biomed Ctr, Dept Expt Med Sci, BMC C 12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se						BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Birk DE, 1997, EUR J CELL BIOL, V72, P352; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; CHAPMAN JA, 1989, BIOPOLYMERS, V28, P1367, DOI 10.1002/bip.360280803; COOPER A, 1970, BIOCHEM J, V118, P355, DOI 10.1042/bj1180355; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; ENGEL J, 1987, STRUCTURAL CONTRACTI, P3; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEDLUND H, 1993, APMIS, V101, P133, DOI 10.1111/j.1699-0463.1993.tb00092.x; HEINEGARD D, 1985, BIOCHEM J, V230, P181, DOI 10.1042/bj2300181; Heinegard D., 2002, CONNECTIVE TISSUE IT, P271; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; KUHN K, 1987, STRUCTURE FUNCTION C, P1; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE JM, 1975, ARTHRITIS RHEUM-US, V18, P553, DOI 10.1002/art.1780180605; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; MILLER EJ, 1984, EXTRACELLULAR MATRIX, P67; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Narouz-Ott L, 2000, J BIOL CHEM, V275, P37110, DOI 10.1074/jbc.M007223200; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PARRY DAD, 1979, NATURE, V282, P213, DOI 10.1038/282213a0; PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Shen ZX, 1995, MATRIX BIOL, V14, P773, DOI 10.1016/S0945-053X(05)80020-4; SMITH JW, 1968, NATURE, V219, P157, DOI 10.1038/219157a0; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; STENBERG M, 1991, BIOPHYS CHEM, V41, P131, DOI 10.1016/0301-4622(91)80013-H; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUS BL, 1980, NATURE, V286, P300, DOI 10.1038/286300a0; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WOTTON SF, 1988, FEBS LETT, V234, P79, DOI 10.1016/0014-5793(88)81307-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zaia J, 1997, J BIOL CHEM, V272, P14120, DOI 10.1074/jbc.272.22.14120	54	220	228	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31166	31173		10.1074/jbc.M705735200	http://dx.doi.org/10.1074/jbc.M705735200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716974	hybrid			2022-12-27	WOS:000250309200006
J	Gao, Z; Tian, Y; Wang, J; Yin, Q; Wu, H; Li, YM; Jiang, X				Gao, Zhonghua; Tian, Yuan; Wang, Junru; Yin, Qian; Wu, Hao; Li, Yue-Ming; Jiang, Xuejun			A dimeric Smac/Diablo peptide directly relieves caspase-3 inhibition by XIAP - Dynamic and cooperative regulation of xiap by Smac/Diablo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE OMI/HTRA2; CYTOCHROME-C; STRUCTURAL BASIS; BCL-2 FAMILY; CELL-DEATH; BIR DOMAIN; APOPTOSIS; ACTIVATION; PROTEINS; BINDING	Caspase activation, the executing event of apoptosis, is under deliberate regulation. IAP proteins inhibit caspase activity, whereas Smac/Diablo antagonizes IAP. XIAP, a ubiquitous IAP, can inhibit both caspase-9, the initiator caspase of the mitochondrial apoptotic pathway, and the downstream effector caspases, caspase-3 and caspase-7. Smac neutralizes XIAP inhibition of caspase-9 by competing for binding of the BIR3 domain of XIAP with caspase-9, whereas how Smac liberates effector caspases from XIAP inhibition is not clear. It is generally believed that binding of Smac with IAP generates a steric hindrance that prevents XIAP from inhibiting effector caspases, and therefore small molecule mimics of Smac are not able to reverse inhibition of the effector caspases. Surprisingly, we show here that binding of a dimeric Smac N-terminal peptide with the BIR2 domain of XIAP effectively antagonizes inhibition of caspase-3 by XIAP. Further, we defined the dynamic and cooperative interaction of Smac with XIAP: binding of Smac with the BIR3 domain anchors the subsequent binding of Smac with the BIR2 domain, which in turn attenuates the caspase-3 inhibitory function of XIAP. We also show that XIAP homotrimerizes via its C-terminal Ring domain, making its inhibitory activity toward caspase-3 more susceptible to Smac.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Grad Sch Biomed Sci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Jiang, X (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	jiangx@mskcc.org	LI, Yue/GRS-8071-2022		NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R01AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113890] Funding Source: Medline; NIAID NIH HHS [R01 AI050872, R01 AI045937] Funding Source: Medline; NIA NIH HHS [R01 AG026660] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Huang YH, 2004, CANCER CELL, V5, P1, DOI 10.1016/S1535-6108(03)00340-4; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; SCHIMMER AD, 2005, AM SOC HEMATOLOGY ED, P215; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Verhagen AM, 2001, GENOME BIOL, V2; Wang ZL, 2004, J BIOL CHEM, V279, P48168, DOI 10.1074/jbc.M405022200; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	47	82	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30718	30727		10.1074/jbc.M705258200	http://dx.doi.org/10.1074/jbc.M705258200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724022	Green Accepted, hybrid			2022-12-27	WOS:000250136300040
J	Asano, Y; Czuwara, J; Trojanowska, M				Asano, Yoshihide; Czuwara, Joanna; Trojanowska, Maria			Transforming growth factor-beta regulates DNA binding activity of transcription factor fli1 by p300/CREB-binding protein-associated factor-dependent acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2(I) COLLAGEN GENE; HUMAN DERMAL FIBROBLASTS; HISTONE ACETYLTRANSFERASES; ETS FAMILY; TGF-BETA; SCLERODERMA FIBROBLASTS; SIGNALING PATHWAY; FACTOR GATA-1; EXPRESSION; ACTIVATION	Fli1, a member of Ets transcriptional factors, has been shown to be a negative regulator of collagen gene expression in dermal fibroblasts. Although Fli1 down-regulation is implicated in pathological matrix remodeling such as cutaneous fibrosis in scleroderma, very little is known about the post-translational mechanisms regulating Fli1 function. The aim of this study was to investigate the role of acetylation, one of the main post-translational regulatory mechanisms, in regulating Fli1 activity. We initially demonstrated that Fli1 is acetylated by transforming growth factor (TGF)-beta 1 in dermal fibroblasts. An in vivo acetylation assay using 293T cells revealed that Fli1 is mainly acetylated by the histone acetyltransferase activity of p300/CBP- associated factor (PCAF) at lysine 380. Acetylation of Fli1 resulted in a decreased stability of Fli1 protein. More importantly, reduced binding of acetylated Fli1 to the human alpha 2( I) collagen (COL1A2) promoter was observed in DNA affinity precipitation and chromatin immunoprecipitation. Conversely, a Fli1 K380R mutant that is resistant to acetylation by PCAF showed increased DNA binding ability. Furthermore, PCAF overexpression reversed the inhibitory effect of Fli1 on TGF-beta 1-mediated COL1A2 promoter activity. In contrast, the Fli1 K380R mutant had a greater inhibitory effect on TGF-beta 1-induced COL1A2 promoter activity than wild-type Fli1, and PCAF failed to reverse this effect. These results indicate that PCAF-dependent acetylation of lysine 380 abrogates repressor function of Fli1 with respect to collagen gene expression. Furthermore, these data strongly suggest that the TGF-beta-dependent acetylation of Fli1 may represent the principal mechanism responsible for the TGF-beta-induced dissociation of Fli1 from the collagen promoter.	Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Trojanowska, M (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	trojanme@musc.edu	Czuwara, Joanna/AAK-4504-2020	Trojanowska, Maria/0000-0001-9550-7178	NCI NIH HHS [P01 CA78582] Funding Source: Medline; NIAMS NIH HHS [AR42334] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Bai YC, 2005, J IMMUNOL, V175, P5160, DOI 10.4049/jimmunol.175.8.5160; Bannister AJ, 2000, CURR BIOL, V10, P467, DOI 10.1016/S0960-9822(00)00445-0; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jinnin M, 2006, J CELL PHYSIOL, V206, P718, DOI 10.1002/jcp.20527; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P1337, DOI 10.1093/nar/gki275; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Mager AM, 1998, INT J DEV BIOL, V42, P561; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Masuya M, 2005, BLOOD, V105, P95, DOI 10.1182/blood-2003-12-4345; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Ogryzko VV, 2001, CELL MOL LIFE SCI, V58, P683, DOI 10.1007/PL00000892; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shirasaki F, 1999, ONCOGENE, V18, P7755, DOI 10.1038/sj.onc.1203360; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang YQ, 2006, ARTHRITIS RHEUM-US, V54, P2271, DOI 10.1002/art.21948; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	51	75	76	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34672	34683		10.1074/jbc.M703907200	http://dx.doi.org/10.1074/jbc.M703907200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884818	hybrid			2022-12-27	WOS:000251155200009
J	Bubenik, JL; Driscoll, DM				Bubenik, Jodi L.; Driscoll, Donna M.			Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN-N GENE; MAMMALIAN SELENOCYSTEINE; MUSCULAR-DYSTROPHY; THIOREDOXIN REDUCTASE; SECONDARY STRUCTURE; RIGID SPINE; PROTEIN; RECOGNITION; SELENIUM; SECIS	The expression of selenoproteins requires the translational recoding of the UGA stop codon to selenocysteine. In eukaryotes, this requires an RNA stem loop structure in the 3' -untranslated region, termed a selenocysteine insertion sequence ( SECIS), and SECIS-binding protein 2 (SBP2). This study implicates SBP2 in dictating the hierarchy of selenoprotein expression, because it is the first to show that SBP2 distinguishes between SECIS elements in vitro. Using RNA electrophoretic mobility shift assays, we demonstrate that a naturally occurring mutation in SBP2, which correlates with abnormal thyroid hormone function in humans, lies within a novel, bipartite RNA-binding domain. This mutation alters the RNA binding affinity of SBP2 such that it no longer stably interacts with a subset of SECIS elements. Assays performed under competitive conditions to mimic intracellular conditions suggest that the differential affinity of SBP2 for various SECIS elements will determine the expression pattern of the selenoproteome. We hypothesize that the selective loss of a subset of selenoproteins, including some involved in thyroid hormone homeostasis, is responsible for the abnormal thyroid hormone metabolism previously observed in the affected individuals.	Case Western Reserve Univ, Coll Med, Lerner Res Inst, Cleveland Clin,Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Driscoll, DM (corresponding author), Case Western Reserve Univ, Coll Med, Lerner Res Inst, Cleveland Clin,Dept Cell Biol, Cleveland, OH 44195 USA.	driscod@ccf.org			NHLBI NIH HHS [HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Berry MJ, 2005, NAT GENET, V37, P1162, DOI 10.1038/ng1105-1162; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Driscoll DM, 2004, EMBO REP, V5, P140, DOI 10.1038/sj.embor.7400080; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fletcher JE, 2001, RNA, V7, P1442; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Hoffmann PR, 2005, THYROID, V15, P769, DOI 10.1089/thy.2005.15.769; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kohrle J, 2000, CELL MOL LIFE SCI, V57, P1853, DOI 10.1007/PL00000667; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Okamoto Y, 2006, NEUROGENETICS, V7, P175, DOI 10.1007/s10048-006-0046-0; Ramos A, 2004, NUCLEIC ACIDS RES, V32, P1746, DOI 10.1093/nar/gkh331; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; SQUIRES JE, 2007, IN PRESS MOL CELL BI; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tajsharghi H, 2005, NEUROMUSCULAR DISORD, V15, P299, DOI 10.1016/j.nmd.2004.11.004; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	41	56	57	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34653	34662		10.1074/jbc.M707059200	http://dx.doi.org/10.1074/jbc.M707059200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901054	hybrid			2022-12-27	WOS:000251155200007
J	Ballar, P; Zhong, Y; Nagahama, M; Tagaya, M; Shen, Y; Fang, S				Ballar, Petek; Zhong, Yongwang; Nagahama, Masami; Tagaya, Mitsuo; Shen, Yuxian; Fang, Shengyun			Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; QUALITY-CONTROL; RING FINGER; GP78; COMPLEX; PROTEASOME; E3; ATPASE	Misfolded proteins in the endoplasmic reticulum (ER) are eliminated by a process known as ER- associated degradation (ERAD), which starts with misfolded protein recognition, followed by ubiquitination, retrotranslocation to the cytosol, deglycosylation, and targeting to the proteasome for degradation. Actions of multisubunit protein machineries in the ER membrane integrate these steps. We hypothesized that regulation of the multisubunit machinery assembly is a mechanism by which ERAD activity is regulated. To test this hypothesis, we investigated the potential regulatory role of the small p97/VCP-interacting protein (SVIP) on the formation of the ERAD machinery that includes ubiquitin ligase gp78, AAA ATPase p97/VCP, and the putative channel Derlin1. We found that SVIP is anchored to microsomal membrane via myristoylation and co-fractionated with gp78, Derlin1, p97/VCP, and calnexin to the ER. Like gp78, SVIP also physically interacts with p97/VCP and Derlin1. Overexpression of SVIP blocks unassembled CD3 delta from association with gp78 and p97/VCP, which is accompanied by decreases in CD3 delta ubiquitination and degradation. Silencing SVIP expression markedly enhances the formation of gp78-p97/VCP-Derlin1 complex, which correlates with increased degradation of CD3 delta and misfolded Z variant of alpha-1-antitrypsin, established substrates of gp78. These results suggest that SVIP is an endogenous inhibitor of ERAD that acts through regulating the assembly of the gp78-p97/VCP-Derlin1 complex.	Univ Maryland, Maryland Biotechnol Inst, Ctr Med Biotechnol, Baltimore, MD 21201 USA; Univ Tokushima, Tokushima 7708506, Japan; Tokyo Univ Pharm & Life Sci, Tokyo 1920392, Japan; Univ Maryland, Sch Med, Grad Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Tokushima University; Tokyo University of Pharmacy & Life Sciences; University System of Maryland; University of Maryland Baltimore	Fang, S (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Med Biotechnol, UMBI Bldg,N359,725 W Lombard St, Baltimore, MD 21201 USA.	fangs@umbi.umd.edu	Zhong, Yongwang/A-2527-2012; Fang, Shengyun/H-3802-2011; Kirmizibayrak, Petek Ballar/Y-6869-2018	Kirmizibayrak, Petek Ballar/0000-0002-6189-1818; Fang, Shengyun/0000-0001-7280-5463; Shen, Yuxian/0000-0002-0916-0743	NIGMS NIH HHS [R01 GM069967, R01 GM 69967] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	37	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33908	33914		10.1074/jbc.M704446200	http://dx.doi.org/10.1074/jbc.M704446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872946	hybrid			2022-12-27	WOS:000251145700003
J	Ratner, GA; Hodel, AE; Powers, MA				Ratner, Gary A.; Hodel, Alec E.; Powers, Maureen A.			Molecular determinants of binding between gly-leu-phe-gly nucleoporins and the nuclear pore complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS PATHWAY; TARGETING DOMAIN; NUP98; ARCHITECTURE; PROTEINS; LOCALIZATION; MECHANISMS; TRANSPORT; PRECURSOR; DYNAMICS	The vertebrate nucleoporin Nup98 can be expressed in two distinct forms from differentially spliced mRNAs, either as a 98-kDa protein or as the 195-kDa Nup98/Nup96 polyprotein. Both forms undergo autoproteolytic processing to generate the 90-kDa Nup98 and either an 8-kDa tail or the nucleoporin Nup96. An equivalent cleavage event occurs in one yeast ortholog, Nup145, to produce Nup145N and Nup145C. We previously proposed that Nup145N, and possibly the other orthologs Nup116 and Nup100, might bind to Nup145C as demonstrated for Nup98 and Nup96. Here we have further investigated the interaction of both yeast and vertebrate Gly-Leu-Phe-Gly nucleoporins with the nuclear pore. We find that dynamic Nup98 binding can be recapitulated in vitro and that simultaneous translation and folding as a polyprotein are not required to allow subsequent binding between Nup98 and Nup96. We show that Nup145N and Nup145C do indeed bind to each other, and we have determined the dissociation constants for these interactions in vitro. Additionally, we characterize two sites of molecular interaction for each binding pair. Of the yeast orthologs, Nup116 binds far less robustly to Nup145C than does Nup145N, and Nup100 binding is barely detectable. Thus, we conclude that Nup116 and Nup100 likely use means of incorporation into the nuclear pore complex that are distinct from those used by Nup145N.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Powers, MA (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 615 Michael St, Atlanta, GA 30322 USA.	mpowers@cellbio.emory.edu			NIGMS NIH HHS [GM 59975, GM 58692] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058692, R01GM059975] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Bucci M, 1998, MOL BIOL CELL, V9, P2439, DOI 10.1091/mbc.9.9.2439; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Ho AK, 2000, MOL CELL BIOL, V20, P5736, DOI 10.1128/MCB.20.15.5736-5748.2000; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Peters Reiner, 2006, V322, P235; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; RIIKONEN A, 1995, J BIOL CHEM, V270, P4903, DOI 10.1074/jbc.270.9.4903; Robinson MA, 2005, J BIOL CHEM, V280, P35723, DOI 10.1074/jbc.M505068200; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stochaj U, 2006, EXP CELL RES, V312, P2490, DOI 10.1016/j.yexcr.2006.04.007; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5	34	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33968	33976		10.1074/jbc.M707911200	http://dx.doi.org/10.1074/jbc.M707911200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897945	hybrid			2022-12-27	WOS:000251145700010
J	Renda, M; Baglivo, I; Burgess-Beusse, B; Esposito, S; Fattorusso, R; Felsenfeld, G; Pedone, PV				Renda, Mario; Baglivo, Ilaria; Burgess-Beusse, Bonnie; Esposito, Sabrina; Fattorusso, Roberto; Felsenfeld, Gary; Pedone, Paolo V.			Critical DNA binding interactions of the insulator protein CTCF - A small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BLOCKING ACTIVITY; PROMOTER; TRANSCRIPTION; METHYLATION; BOUNDARIES; REPRESSOR; UPSTREAM; SEQUENCE; SILENCER; ELEMENT	The DNA-binding protein CTCF (CCCTC binding factor) mediates enhancer blocking insulation at sites throughout the genome and plays an important role in regulating allele-specific expression at the Igf2/H19 locus and at other imprinted loci. Evidence is also accumulating that CTCF is involved in large scale organization of genomic chromatin. Although CTCF has 11 zinc fingers, we show here that only 4 of these are essential to strong binding and that they recognize a core 12-bp DNA sequence common to most CTCF sites. By deleting individual fingers and mutating individual sites, we determined the orientation of binding. Furthermore, we were able to identify the specific finger and its point of DNA interaction that are responsible for the loss of CTCF binding when CpG residues are methylated in the imprinted Igf2/H19 locus. This single interaction appears to be critical for allele-specific binding and insulation by CTCF.	NIDDK, NIH, Mol Biol Lab, Bethesda, MD 20892 USA; Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Universita della Campania Vanvitelli	Felsenfeld, G (corresponding author), NIDDK, NIH, Mol Biol Lab, Bldg 5 Rm 212, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov; paolov.pedone@unina2.it	Baglivo, Ilaria/U-2444-2017	Fattorusso, Roberto/0000-0002-3539-5343; Pedone, Paolo Vincenzo/0000-0002-0828-5843; Baglivo, Ilaria/0000-0002-3746-3880; ESPOSITO, Sabrina/0000-0001-6750-7365	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036148, ZIADK036148] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fitzpatrick GV, 2007, MOL CELL BIOL, V27, P2636, DOI 10.1128/MCB.02036-06; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; ISERNIA C, 2006, RECENT DEV BIOINORGA; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Vostrov AA, 2002, J BIOL CHEM, V277, P1619, DOI 10.1074/jbc.M109748200; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	32	115	120	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33336	33345		10.1074/jbc.M706213200	http://dx.doi.org/10.1074/jbc.M706213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827499	hybrid			2022-12-27	WOS:000250840200013
J	Harikumar, KG; Lam, PCH; Dong, M; Sexton, PM; Abagyan, R; Miller, LJ				Harikumar, Kaleeckal G.; Lam, Polo C. -H.; Dong, Maoqing; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Fluorescence resonance energy transfer analysis of secretin docking to its receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AMINO-TERMINUS; PEPTIDE AGONIST; CHOLECYSTOKININ RECEPTOR; SPATIAL APPROXIMATION; CALCITONIN RECEPTOR; RESIDUES; BINDING; REGION; DOMAIN	Full structural characterization of G protein-coupled receptors has been limited to rhodopsin, with its uniquely stable structure and ability to be crystallized. For other members of this important superfamily, direct structural insights have been limited to NMR structures of soluble domains. Two members of the Class II family have recently had the structures of their isolated amino-terminal regions solved by NMR, yet it remains unclear how that domain is aligned with the heptahelical transmembrane bundle domain of those receptors. Indeed, three distinct orientations have been suggested for different members of this family. In the current work, we have utilized fluorescence resonance energy transfer to establish the distances between four residues distributed throughout fully biologically active, high affinity analogues of secretin and distinct residues in each of four extracellular regions of the intact secretin receptor. These 16 distance constraints were utilized along with nine photoaffinity labeling spatial approximation constraints to study the three proposed orientations of the peptide-binding amino terminus and helical bundle domains of this receptor. In the best model, the carboxyl terminus of secretin was found to bind in a groove above the beta-hairpin region of the receptor amino terminus, with its amino-terminal end adjacent to the third extracellular loop and top of transmembrane segment VI. This refined model of the intact receptor was also fully consistent with the spatial approximation of the Trp(48)-Asp(49)-Asn(50) endogenous agonist segment with the third extracellular loop region that it has been shown to photolabel. This provides strong evidence for the orientation of peptide-binding and signaling domains of a prototypic Class II G protein-coupled receptor.	Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Molsoft LLC, La Jolla, CA 92037 USA	Mayo Clinic; Mayo Clinic Phoenix; Monash University; Scripps Research Institute	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 46577] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Dong MQ, 2002, MOL ENDOCRINOL, V16, P2490, DOI 10.1210/me.2002-0111; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Harikumar KG, 2006, J BIOL CHEM, V281, P2543, DOI 10.1074/jbc.M509197200; Harikumar KG, 2005, J BIOL CHEM, V280, P18631, DOI 10.1074/jbc.M410834200; Harikumar KG, 2004, MOL PHARMACOL, V65, P28, DOI 10.1124/mol.65.1.28; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lisenbee CS, 2005, J BIOL CHEM, V280, P12330, DOI 10.1074/jbc.M414016200; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200	28	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32834	32843		10.1074/jbc.M704563200	http://dx.doi.org/10.1074/jbc.M704563200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827151	hybrid			2022-12-27	WOS:000250625400033
J	Hoshino, T; Nakaya, T; Homan, T; Tanaka, KI; Sugimoto, Y; Araki, W; Narita, M; Narumiya, S; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Nakaya, Tadashi; Homan, Takashi; Tanaka, Ken-Ichiro; Sugimoto, Yukihiko; Araki, Wataru; Narita, Masami; Narumiya, Shuh; Suzuki, Toshiharu; Mizushima, Tohru			Involvement of prostaglandin E-2 in production of amyloid-beta peptides both in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; E-RECEPTOR SUBTYPES; GAMMA-SECRETASE ACTIVITY; PRECURSOR PROTEIN APP; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CYCLOOXYGENASE (COX)-2; SELECTIVE INHIBITOR; EP2 RECEPTOR; HUMAN BRAIN	Amyloid-beta peptides (A beta), generated by proteolysis of the beta- amyloid precursor protein ( APP) by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease ( AD). Inflammation is also believed to be integral to the pathogenesis of AD. Here we show that prostaglandin E-2 (PGE(2)), a strong inducer of inflammation, stimulates the production of A beta in cultured human embryonic kidney ( HEK) 293 or human neuroblastoma ( SH- SY5Y) cells, both of which express a mutant type of APP. We have demonstrated using subtype- specific agonists that, of the four main subtypes of PGE(2) receptors (EP1-4), EP4 receptors alone or EP2 and EP4 receptors together are responsible for this PGE(2)- stimulated production of A beta in HEK293 or SH-SY5Y cells, respectively. An EP4 receptor antagonist suppressed the PGE2- stimulated production of A beta in HEK293 cells. This stimulation was accompanied by an increase in cellular cAMP levels, and an analogue of cAMP stimulated the production of A beta, demonstrating that increases in the cellular level of cAMP are responsible for the PGE2- stimulated production of A beta. Immunoblotting experiments and direct measurement of gamma-secretase activity suggested that PGE2- stimulated production of A beta is mediated by activation of gamma-secretase but not of beta-secretase. Transgenic mice expressing the mutant type of APP showed lower levels of A beta in the brain, when they were crossed with mice lacking either EP2 or EP4 receptors, suggesting that PGE2- mediated activation of EP2 and EP4 receptors is involved in the production of A beta in vivo and in the pathogenesis of AD.	Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Kyoto 6068501, Japan; Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan	Kumamoto University; Hokkaido University; Kyoto University; Kyoto University; National Center for Neurology & Psychiatry - Japan; Ono Pharmaceutical Co Ltd	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp	Sugimoto, Yukihiko/AAV-6470-2021; Tanaka, Ken-ichiro/J-8557-2013; Narita, Masami/AAF-1079-2019; Araki, Wataru/G-7913-2014; Suzuki, Toshiharu/B-5342-2013	Sugimoto, Yukihiko/0000-0001-6973-932X; Araki, Wataru/0000-0001-8467-6937; 				Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Andreasson KI, 2001, J NEUROSCI, V21, P8198; Araki H, 2000, ALIMENT PHARM THERAP, V14, P116, DOI 10.1046/j.1365-2036.2000.014s1116.x; Belton O, 2000, CIRCULATION, V102, P840; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Crider JY, 2000, PROSTAG LEUKOTR ESS, V62, P21, DOI 10.1054/plef.1999.0120; Echeverria V, 2005, EUR J NEUROSCI, V22, P2199, DOI 10.1111/j.1460-9568.2005.04427.x; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Ma H, 2001, CIRCULATION, V104, P1176, DOI 10.1161/hc3601.094003; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; MILLER TA, 1983, AM J PHYSIOL, V245, pG601, DOI 10.1152/ajpgi.1983.245.5.G601; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Quadros A, 2003, NEUROSCI LETT, V353, P66, DOI 10.1016/j.neulet.2003.08.076; Ray WA, 2004, NEW ENGL J MED, V351, P2767, DOI 10.1056/NEJMc045711; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Singh D, 2004, BRIT MED J, V329, P816, DOI 10.1136/bmj.329.7470.816-a; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Srinivasan B D, 1989, Prog Clin Biol Res, V312, P229; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takeuchi K, 1997, GASTROENTEROLOGY, V113, P1553, DOI 10.1053/gast.1997.v113.pm9352857; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; Vane JR, 1996, SCAND J RHEUMATOL, P9; VELD BA, 2001, NEW ENGL J MED, V348, P1515; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe K, 2000, CANCER LETT, V156, P57, DOI 10.1016/S0304-3835(00)00440-7; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yan Q, 2003, J NEUROSCI, V23, P7504; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	75	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32676	32688		10.1074/jbc.M703087200	http://dx.doi.org/10.1074/jbc.M703087200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17767011	hybrid			2022-12-27	WOS:000250625400016
J	Nakajima, M; Kizawa, H; Saitoh, M; Kou, I; Miyazono, K; Ikegawa, S				Nakajima, Masahiro; Kizawa, Hideki; Saitoh, Masao; Kou, Ikuyo; Miyazono, Kohei; Ikegawa, Shiro			Mechanisms for asporin function and regulation in articular cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MATRIX PROTEOGLYCAN SYNTHESIS; ACID REPEAT POLYMORPHISM; ATDC5 IN-VITRO; TGF-BETA; EXPERIMENTAL OSTEOARTHRITIS; PROTEIN FAMILY; II RECEPTOR; DECORIN; CELLS	Osteoarthritis ( OA), the most prevalent form of skeletal disease, represents a leading cause of disability following middle age. OA is characterized by the loss of articular cartilage; however, the details of its etiology and pathogenesis remain unclear. Recently, we demonstrated a genetic association between the cartilage extracellular matrix protein asporin and OA ( Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., Uchida, A., Nakamura, K., Notoya, K., Nakamura, Y., and Ikegawa, S. ( 2005) Nat. Genet. 37, 138-144). Furthermore, we showed that asporin binds to transforming growth factor-beta (TGF-beta), a key cytokine in OA pathogenesis, and inhibits TGF-beta-induced chondrogenesis. To date, functional data for asporin have come primarily from mouse cell culture models of developing cartilage rather than from human articular cartilage cells, in which OA occurs. Here, we describe mechanisms for asporin function and regulation in human articular cartilage. Asporin blocks chondrogenesis and inhibits TGF-beta 1-induced expression of matrix genes and the resulting chondrocyte phenotypes. Small interfering RNA-mediated knockdown of asporin increases the expression of cartilage marker genes and TGF-beta 1; in turn, TGF-beta 1 stimulates asporin expression in articular cartilage cells, suggesting that asporin and TGF-beta 1 form a regulatory feedback loop. Asporin inhibits TGF-beta/Smad signaling upstream of TGF-beta type I receptor activation in vivo by co-localizing with TGF-beta 1 on the cell surface and blocking its interaction with the TGF-beta type II receptor. Our results provide a basis for elucidating the role of asporin in the molecular pathogenesis of OA.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147				Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Comalada M, 2003, J IMMUNOL, V170, P4450, DOI 10.4049/jimmunol.170.9.4450; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kawai J, 1999, EUR J CELL BIOL, V78, P707, DOI 10.1016/S0171-9335(99)80039-9; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Lafeber FPJG, 1997, J RHEUMATOL, V24, P536; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Mustafa Z, 2005, ARTHRITIS RHEUM-US, V52, P3502, DOI 10.1002/art.21399; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Noble Nancy A., 1992, Progress in Growth Factor Research, V4, P369, DOI 10.1016/0955-2235(92)90017-C; Peach CA, 2005, TRENDS MOL MED, V11, P186, DOI 10.1016/j.molmed.2005.02.005; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Sokol JP, 2004, MOL CANCER RES, V2, P183; Spector T. D., 2004, Osteoarthritis and Cartilage, V12, P39, DOI 10.1016/j.joca.2003.09.005; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YAN WQ, 1990, J BIOL CHEM, V265, P10125; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	40	114	125	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32185	32192		10.1074/jbc.M700522200	http://dx.doi.org/10.1074/jbc.M700522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827158	hybrid			2022-12-27	WOS:000250480300041
J	Venugopal, SK; Chen, J; Zhang, Y; Clemens, D; Follenzi, A; Zern, MA				Venugopal, Senthil K.; Chen, Jenny; Zhang, Yanhong; Clemens, Dahn; Follenzi, Antonia; Zern, Mark A.			Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; STRESS-INDUCED APOPTOSIS; INNATE IMMUNE-RESPONSES; OXIDATIVE STRESS; RAT HEPATOCYTES; TNF-ALPHA; TRANSGENE EXPRESSION; SIGNAL-TRANSDUCTION; PROTEASOME ACTIVITY; LENTIVIRAL VECTOR	Ethanol metabolism plays a central role in activating the mitogen- activated protein kinase (MAPK) cascade leading to inflammation and apoptosis. Sustained activation of c- Jun N-terminal kinase (JNK), one of the MAPKs, has been shown to induce apoptosis in hepatocytes. MAPK phosphatase-1 (MKP-1) has been shown to dephosphorylate MAPKs in several cells. The aim of the study is to evaluate the role of MKP-1 in sustained JNK activation as a mechanism to explain ethanol-induced hepatocyte apoptosis. VL-17A cells (HepG2 cells overexpressing alcohol dehydrogenase and cytochrome P450-2E1) were exposed to ethanol for different time periods. Western blots were performed for MKP-1, phospho-JNK, phosphotyrosine, and protein kinase C delta(PKC delta). Electrophoretic mobility shift assays for AP-1 were performed. Apoptosis was measured by caspase-3 activity assay, TUNEL, and 4',6-diamidino-2-phenylindole staining. Reactive oxygen species were neutralized by overexpressing both superoxide dismutase-3 and catalase genes using lentiviral vectors in VL-17A cells. Ethanol incubation markedly decreased the MKP-1 protein levels to 15% of control levels and was associated with sustained phosphorylation of p46 JNK and p54 JNK, as well as increased apoptosis. VL-17A cells overexpressing superoxide dismutase-3 and catalase, treatment with a tyrosine kinase inhibitor, or incubation of the cells with PKC delta small interference RNAs significantly inhibited the ethanol-induced MKP-1 degradation and apoptosis. Ethanol-induced oxidative stress enhanced the tyrosine phosphorylation of PKC delta, which in turn caused the proteasomal degradation of MKP-1, leading to sustained JNK activation and increased apoptosis in VL-17A cells.	Univ Calif Davis, Med Ctr, Dept Internal Med, Transplant Res Program, Sacramento, CA 95817 USA; Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	University of California System; University of California Davis; University of Nebraska System; University of Nebraska Medical Center; Yeshiva University; Albert Einstein College of Medicine	Zern, MA (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Transplant Res Program, 4635 2nd Ave,Rm 1001, Sacramento, CA 95817 USA.	mazern@ucdavis.edu		Follenzi, Antonia/0000-0001-9780-300X	NIAAA NIH HHS [R01 AA006386] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006386] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Bardag-Gorce F, 2000, BIOCHEM BIOPH RES CO, V279, P23, DOI 10.1006/bbrc.2000.3889; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cardin R, 2002, ALCOHOL ALCOHOLISM, V37, P43, DOI 10.1093/alcalc/37.1.43; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Chen JP, 1998, BIOCHEM J, V334, P669, DOI 10.1042/bj3340669; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Condiotti R, 2004, BIOCHEM BIOPH RES CO, V320, P998, DOI 10.1016/j.bbrc.2004.06.044; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; Devaraj S, 2005, DIABETES, V54, P85, DOI 10.2337/diabetes.54.1.85; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Hoek JB, 2004, SEMIN LIVER DIS, V24, P257, DOI 10.1055/s-2004-832939; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jarvis WD, 1997, FEBS LETT, V412, P9, DOI 10.1016/S0014-5793(97)00705-9; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lee YJ, 2005, EUR J PHARMACOL, V508, P31, DOI 10.1016/j.ejphar.2004.12.006; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu HL, 2002, AM J PHYSIOL-GASTR L, V282, pG257, DOI 10.1152/ajpgi.00304.2001; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Luo J, 1999, J NEUROSCI, V19, P10014, DOI 10.1523/jneurosci.19-22-10014.1999; Maher P, 2001, J NEUROSCI, V21, P2929, DOI 10.1523/JNEUROSCI.21-09-02929.2001; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Osna NA, 2005, HEPATOLOGY, V42, P1109, DOI 10.1002/hep.20909; Osna NA, 2003, BIOCHEM PHARMACOL, V66, P697, DOI 10.1016/S0006-2952(03)00252-1; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Venugopal SK, 2002, DIABETES, V51, P3049, DOI 10.2337/diabetes.51.10.3049; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725; Wu J, 2004, HEPATOLOGY, V40, P195, DOI 10.1002/hep.20288; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	53	44	48	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31900	31908		10.1074/jbc.M703729200	http://dx.doi.org/10.1074/jbc.M703729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848570	hybrid			2022-12-27	WOS:000250480300010
J	Carvalho, AF; Pinto, MP; Grou, CP; Alencastre, IS; Fransen, M; Sa-Miranda, C; Azevedo, JE				Carvalho, Andreia F.; Pinto, Manuel P.; Grou, Claudia P.; Alencastre, Ines S.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			Ubiquitination of mammalian pex5p, the peroxisomal import receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TYPE-1 RECEPTOR; FUNCTIONAL-CHARACTERIZATION; CONSERVED CYSTEINE; CYCLING RECEPTOR; PROTEIN IMPORT; PTS1 RECEPTOR; IDENTIFICATION; BIOGENESIS; MECHANISM; MEMBRANE	Protein translocation across the peroxisomal membrane requires the concerted action of numerous peroxins. One central component of this machinery is Pex5p, the cycling receptor for matrix proteins. Pex5p recognizes newly synthesized proteins in the cytosol and promotes their translocation across the peroxisomal membrane. After this translocation step, Pex5p is recycled back into the cytosol to start a new protein transport cycle. Here, we show that mammalian Pex5p is ubiquitinated at the peroxisomal membrane. Two different types of ubiquitination were detected, one of which is thoil-sensitive, involves Cys(11) of Pex5p, and is necessary for the export of the receptor back into the cytosol. Together with mechanistic data recently described for yeast Pex5p, these findings provide strong evidence for the existence of Pex4p- and Pex22p-like proteins in mammals.	Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4009003 Oporto, Portugal; Katholieke Univ Leuven, Fac Geneeskunde, Dept Mol Celbiol, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Fransen, Marc/C-6262-2008; Pinto, Manuel/K-6425-2013; Carvalho, Andreia/J-9013-2015; Fransen, Marc/ADL-0723-2022; Azevedo, Jorge E/A-4113-2008; sá Miranda, Maria Clara/K-3920-2013; Grou, Claudia P/K-5472-2013	Fransen, Marc/0000-0001-9284-1197; Pinto, Manuel/0000-0001-9778-2093; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; sá Miranda, Maria Clara/0000-0003-0123-5525; Grou, Claudia P/0000-0001-5197-2270; Alencastre, Ines/0000-0002-5591-5596				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Baker A, 2005, CURR OPIN PLANT BIOL, V8, P640, DOI 10.1016/j.pbi.2005.09.009; Born LJ, 1996, HEPATOLOGY, V23, P1556, DOI 10.1002/hep.510230636; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FERRO A, 2007, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBARNCR.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1987, J BIOL CHEM, V262, P345; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; KIEL JA, 2006, J CELL BIOL, V7, P1291; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; SCHEFFNER M, 1992, EMBO J, V11, P2425, DOI 10.1002/j.1460-2075.1992.tb05307.x; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; WALKER J, 1993, MOL BIOCHEM PARASIT, V61, P255, DOI 10.1016/0166-6851(93)90071-5; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	40	134	137	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31267	31272		10.1074/jbc.M706325200	http://dx.doi.org/10.1074/jbc.M706325200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726030	hybrid			2022-12-27	WOS:000250309200016
J	Walker, D; Moshbahi, K; Vankemmelbeke, M; James, R; Kleanthous, C				Walker, Daniel; Moshbahi, Khedidja; Vankemmelbeke, Mireille; James, Richard; Kleanthous, Colin			The role of electrostatics in colicin nuclease domain translocation into bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PROTEASE FTSH; NEGATIVELY CHARGED PHOSPHOLIPIDS; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHOLERA-TOXIN; RIBONUCLEASE COLICIN-E3; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; IMMUNITY PROTEIN; RECEPTOR-BINDING	The mechanism(s) by which nuclease colicins translocate distinct cytotoxic enzymes (DNases, rRNases, and tRNases) to the cytoplasm of Escherichia coli is unknown. Previous in vitro investigations on isolated colicin nuclease domains have shown that they have a strong propensity to associate with anionic phospholipid vesicles, implying that electrostatic interactions with biological membranes play a role in their import. In the present work we set out to test this hypothesis in vivo. We show that cell killing by the DNase toxin colicin E9 of E. coli HDL11, a strain in which the level of anionic phospholipid and hence inner membrane charge is regulated by isopropyl beta-D-thiogalactopyranoside induction, is critically dependent on the level of inducer, whereas this is not the case for pore-forming colicins that take the same basic route into the periplasm. Moreover, there is a strong correlation between the level and rate of HDL11 cell killing and the net positive charge on a colicin DNase, with similar effects seen for wild type E. coli cells, data that are consistent with a direct, electrostatically mediated interaction between colicin nucleases and the bacterial inner membrane. We next sought to identify how membrane-associated colicin nucleases might be translocated into the cell. We show that neither the Sec or Tat systems are involved in nuclease colicin uptake but that nuclease colicin toxicity is instead dependent on functional FtsH, an inner membrane AAA(+) ATPase and protease that dislocates misfolded membrane proteins to the cytoplasm for destruction.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Nottingham, Ctr Biomol Sci, Inst Infect, Nottingham NG7 2RD, England	University of York - UK; University of Nottingham	Kleanthous, C (corresponding author), Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.	ck11@york.ac.uk	James, Richard/B-2252-2009	Walker, Daniel/0000-0002-4206-2942; Vankemmelbeke, Mireille/0000-0002-8100-813X	Biotechnology and Biological Sciences Research Council [BB/C516236/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; James R, 2002, BIOCHIMIE, V84, P381, DOI 10.1016/S0300-9084(02)01450-5; Kadner R. J., 1996, ESCHERICHIA COLI SAL, P58; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karata K, 2001, MOL MICROBIOL, V39, P890, DOI 10.1046/j.1365-2958.2001.02301.x; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Masaki H, 2002, BIOCHIMIE, V84, P433, DOI 10.1016/S0300-9084(02)01425-6; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; Matsumoto G, 2000, GENES CELLS, V5, P991, DOI 10.1046/j.1365-2443.2000.00388.x; MATSUZAWA H, 1984, J BACTERIOL, V160, P733, DOI 10.1128/JB.160.2.733-739.1984; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; POGLIANO KJ, 1993, GENETICS, V133, P763; Pommer AJ, 1999, J BIOL CHEM, V274, P27153, DOI 10.1074/jbc.274.38.27153; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; Qu JN, 1996, J BACTERIOL, V178, P3457, DOI 10.1128/jb.178.12.3457-3461.1996; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; SHIBUYA I, 1985, J BACTERIOL, V161, P1086, DOI 10.1128/JB.161.3.1086-1092.1985; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; van den Bremer ETJ, 2004, PROTEIN SCI, V13, P1391, DOI 10.1110/ps.03508204; Vankemmelbeke M, 2005, J BACTERIOL, V187, P4900, DOI 10.1128/JB.187.14.4900-4907.2005; Walker D, 2003, BIOCHEMISTRY-US, V42, P4161, DOI 10.1021/bi0273720; Walker D, 2004, J BACTERIOL, V186, P866, DOI 10.1128/JB.186.3.866-869.2004; WALLIS R, 1992, EUR J BIOCHEM, V207, P687, DOI 10.1111/j.1432-1033.1992.tb17096.x; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0	54	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31389	31397		10.1074/jbc.M705883200	http://dx.doi.org/10.1074/jbc.M705883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720814	hybrid			2022-12-27	WOS:000250309200029
J	Isgandarova, S; Jones, L; Forsberg, D; Loncar, A; Dawson, J; Tedrick, K; Eitzen, G				Isgandarova, Sabina; Jones, Lynden; Forsberg, Daniel; Loncar, Ana; Dawson, John; Tedrick, Kelly; Eitzen, Gary			Stimulation of actin polymerization by vacuoles via Cdc42p-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; MEMBRANE-FUSION; BINDING SITE; YEAST ACTIN; PROTEIN; DOCKING; CYTOSKELETON; ACTIVATION; CDC42; ATP	We have previously shown that actin ligands inhibit the fusion of yeast vacuoles in vitro, which suggests that actin remodeling is a subreaction of membrane fusion. Here, we demonstrate the presence of vacuole-associated actin polymerization activity, and its dependence on Cdc42p and Vrp1p. Using a sensitive in vitro pyrene-actin polymerization assay, we found that vacuole membranes stimulated polymerization, and this activity increased when vacuoles were preincubated under conditions that support membrane fusion. Vacuoles purified from a VRP1-gene deletion strain showed reduced polymerization activity, which could be recovered when reconstituted with excess Vrp1p. Cdc42p regulates this activity because overexpression of dominant-negative Cdc42p significantly reduced vacuole-associated polymerization activity, while dominant-active Cdc42p increased activity. We also used size-exclusion chromatography to directly examine changes in yeast actin induced by vacuole fusion. This assay confirmed that actin undergoes polymerization in a process requiring ATP. To further confirm the need for actin polymerization during vacuole fusion, an actin polymerization-deficient mutant strain was examined. This strain showed in vivo defects in vacuole fusion, and actin purified from this strain inhibited in vitro vacuole fusion. Affinity isolation of vacuole-associated actin and in vitro binding assays revealed a polymerization-dependent interaction between actin and the SNARE Ykt6p. Our results suggest that actin polymerization is a subreaction of vacuole membrane fusion governed by Cdc42p signal transduction.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Alberta; University of Guelph	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, 5-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca	Eitzen, Gary/D-3682-2009					Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; AUNIS D, 1988, J EXP BIOL, V139, P253; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bittner MA, 2005, MOL PHARMACOL, V67, P1089, DOI 10.1124/mol.104.008474; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; JANSEN G, 2004, GENE, V344, P43; Jeremic A, 2003, BIOPHYS J, V85, P2035, DOI 10.1016/S0006-3495(03)74631-1; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lejen T, 2001, J NEUROCHEM, V76, P768, DOI 10.1046/j.1471-4159.2001.00024.x; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Marcu MG, 1998, J BIOL CHEM, V273, P3661, DOI 10.1074/jbc.273.6.3661; May RC, 2001, J CELL SCI, V114, P1061; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; RURKEVICH LA, 2006, CAN J PHYSL PHARM, V84, P111; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Teal DJ, 2007, BIOCHEM CELL BIOL, V85, P319, DOI 10.1139/O07-047; Tedrick K, 2004, MOL BIOL CELL, V15, P4609, DOI 10.1091/mbc.E04-03-0194; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; Vaduva G, 1999, J BIOL CHEM, V274, P17103, DOI 10.1074/jbc.274.24.17103; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Weber A, 1999, MOL CELL BIOCHEM, V190, P67, DOI 10.1023/A:1006984010267; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527; Zhang L, 1996, NEURON, V17, P287, DOI 10.1016/S0896-6273(00)80160-9	57	29	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30466	30475		10.1074/jbc.M704117200	http://dx.doi.org/10.1074/jbc.M704117200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726018	hybrid			2022-12-27	WOS:000250136300014
J	Lin, JJ; Dutta, A				Lin, Jie Jessie; Dutta, Anindya			ATR pathway is the primary pathway for activating G(2)/m checkpoint induction after re-replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; DNA-DAMAGE; CELL-CYCLE; GEMININ; COMPLEXES; PROTEIN; CLAMP; PHOSPHORYLATION; REREPLICATION; KINASE	DNA replication is tightly controlled to ensure accurate chromosome duplication and segregation in each cell cycle. Inactivation of Geminin, an inhibitor of origin licensing, leads to re-replication in human tumor cells within the same cell cycle and triggers a G(2)/M checkpoint. We find that the primary pathway to signal that re-replication has been detected is the ATR kinase and the Rad9-Rad1-Hus1 (9-1-1) clamp complex together with Rad17-RFC clamp loader. ATM kinase and the Mre11-Rad50-Nbs1 complex do not appear to play significant roles in the checkpoint. Chk1 activation occurs at early stages, whereas Chk2 activation occurs much later. Overall we conclude that ATR/Chk1 pathway is activated at an early time point after the loss of Geminin and contributes to checkpoint arrest essential for the accumulation of re-replicated cells, whereas activation of the ATM/Chk2 pathway is a by-product of DNA re-replication at a later period.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733,1300 Jefferson Pk Ave,Jordan 1240, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA060499, R01 CA060499-14, R01 CA60499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lei M, 2001, J CELL SCI, V114, P1447; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu QH, 2000, GENE DEV, V14, P1448; Lygerou Z, 2000, SCIENCE, V290, P2271; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Shiomi Y, 2002, GENES CELLS, V7, P861, DOI 10.1046/j.1365-2443.2002.00566.x; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhou JQ, 2006, CANCER LETT, V243, P9, DOI 10.1016/j.canlet.2006.01.026; Zhu WG, 2006, CELL CYCLE, V5, P2306, DOI 10.4161/cc.5.20.3364; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	44	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30357	30362		10.1074/jbc.M705178200	http://dx.doi.org/10.1074/jbc.M705178200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17716975	hybrid			2022-12-27	WOS:000250136300003
J	Row, PE; Liu, H; Hayes, S; Welchman, R; Charalabous, P; Hofmann, K; Clague, MJ; Sanderson, CM; Urbe, S				Row, Paula E.; Liu, Han; Hayes, Sebastian; Welchman, Rebecca; Charalabous, Panagoula; Hofmann, Kay; Clague, Michael J.; Sanderson, Christopher M.; Urbe, Sylvie			The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCRT-III COMPLEX; UBIQUITIN ISOPEPTIDASE; DEUBIQUITINATING ENZYME; PROTEIN INTERACTIONS; DOWN-REGULATION; YEAST; AMSH; TRAFFICKING; STAM	We have identified and characterized a Microtubule Interacting and Transport (MIT) domain at the N terminus of the deubiquitinating enzyme UBPY/USP8. In common with other MIT containing proteins such as AMSH and VPS4, UBPY can interact with CHMP proteins, which are known to regulate endosomal sorting of ubiquitinated receptors. Comparison of binding preferences for the 11 members of the human CHMP family between the UBPY MIT domain and another ubiquitin isopeptidase, AMSH, reveals common interactions with CHMP1A and CHMP1B but a distinct selectivity of AMSH for CHMP3/VPS24, a core subunit of the ESCRT-III complex, and UBPY for CHMP7. We also show that in common with AMSH, UBPY deubiquitinating enzyme activity can be stimulated by STAM but is unresponsive to its cognate CHMPs. The UBPY MIT domain is dispensable for its catalytic activity but is essential for its localization to endosomes. This is functionally significant as an MIT-deleted UBPY mutant is unable to rescue its binding partner STAM from proteasomal degradation or reverse a block to epidermal growth factor receptor degradation imposed by small interfering RNA-mediated depletion of UBPY.	Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England; Miltenyi Biotec GmbH, Bioinformat Grp, D-50829 Cologne, Germany	University of Liverpool; Miltenyi Biotec	Urbe, S (corresponding author), Univ Liverpool, Sch Biomed Sci, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	urbe@liv.ac.uk	Hofmann, Kay/D-6714-2011; Clague, Michael J/A-7199-2008; Urbe, Sylvie/S-1433-2018	Hofmann, Kay/0000-0002-2289-9083; Clague, Michael J/0000-0003-3355-9479; Urbe, Sylvie/0000-0003-4735-9814; Liu, Han/0000-0002-0014-4675; HAYES, SEBASTIAN/0000-0002-2383-9461	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2002, CURR BIOL, V12, pR529, DOI 10.1016/S0960-9822(02)01030-8; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Horii M, 2006, BIOCHEM J, V400, P23, DOI 10.1042/BJ20060897; Howard TL, 2001, J CELL SCI, V114, P2395; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Scheel H., 2005, COMP ANAL UBIQUITIN; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Shtiegman K, 2003, SEMIN CANCER BIOL, V13, P29, DOI 10.1016/S1044-579X(02)00097-4; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	51	126	128	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30929	30937		10.1074/jbc.M704009200	http://dx.doi.org/10.1074/jbc.M704009200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17711858	Green Published, hybrid			2022-12-27	WOS:000250136300061
J	Wu, SC; Solaro, RJ				Wu, Steven C.; Solaro, R. John			Protein kinase C zeta - A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I PHOSPHORYLATION; MYOFILAMENT PROPERTIES; ALPHA-TROPOMYOSIN; PKC-BETA; SITES; IDENTIFICATION; ACTIVATION; MYOCYTES; HEART; OVEREXPRESSION	Our experiments investigated associations of specific isoforms of protein kinase C (PKC) with individual proteins in the cardiac troponin complex. Troponin I (cTnI) associated with PKC epsilon and zeta and troponin T (cTnT) associated with PKC alpha, delta, and epsilon. Based on its association with cTnI, we hypothesized that PKC zeta is a major regulator of myofilament protein phosphorylation. To test this, we infected adult cardiac myocytes with adenoviral constructs containing DsRed monomer-tagged wild type (WT) and the following constitutively active forms of PKC zeta: the pseudo-substrate region (A119E), 3'-phospho-inositide-dependent kinase-1 (T410E), and auto-phosphorylation (T560E). The A119E and T410E mutants displayed increased localization to the Z-discs compared with WT and T560E. Immunoprecipitations were performed in myocytes expression PKC zeta using PKC phospho-motif antibodies to determine the phosphophorylation of cTnI, cTnT, tropomyosin, myosin-binding protein C, and desmin. We did not find serine (Ser) phosphorylation of cTnI or cTnT. However, we observed a significant decrease in threonine (Thr) phosphorylation of tropomyosin was increased by all three active mutants of PKC zeta. Ser/Thr phosphorylation of myosin-binding protein C increased primarily by PKC zeta A119E. Both PKC zeta A119E and T410E mutants increased desmin Ser/Thr phosphorylation. To explain the apparent Thr dephosphorylation of cTnI and cTnT, we hypothesized that PKC zeta exists as a complex with p21-activated kinase-1 (Pak1) and protein phosphates 2A (PP2A), and this was confirmed by immunoprecipitation Western blot. Our data demonstrate that PKC zeta is a novel regulator of myofilament protein phosphorylation.	Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Solaro, RJ (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, Cardiovasc Res Ctr, 835 S Wolcott Ave, Chicago, IL 60612 USA.	solarorj@uic.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, T32HL007692, P01HL062426] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007692-17, R01 HL064035, T32 HL07692-17, T32 HL007692, P01 HL062426, R01 HL064035-08, P01 HL62426, P01 HL062426-09, R01 HL64035] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Engel PL, 2007, J BIOL CHEM, V282, P183, DOI 10.1074/jbc.M512337200; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HEELEY DH, 1994, EUR J BIOCHEM, V221, P129, DOI 10.1111/j.1432-1033.1994.tb18721.x; Huang L, 2001, AM J PHYSIOL-CELL PH, V280, pC1114, DOI 10.1152/ajpcell.2001.280.5.C1114; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; KITAMURA S, 1989, J BIOL CHEM, V264, P5674; Kobayashi T, 2005, J MOL CELL CARDIOL, V38, P213, DOI 10.1016/j.yjmcc.2004.10.014; Malhotra A, 2001, DIABETES, V50, P1918, DOI 10.2337/diabetes.50.8.1918; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; NOLAND TA, 1991, J BIOL CHEM, V266, P4974; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; ONO Y, 1988, J BIOL CHEM, V263, P6927; Pyle WG, 2002, CIRC RES, V90, P1299, DOI 10.1161/01.RES.0000024389.03152.22; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Solaro RJ, 2002, J NUCL CARDIOL, V9, P523, DOI 10.1067/mnc.2002.127626; SOLARO RJ, 2001, HDB PHYSL, P264; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Takeishi Y, 2000, CIRC RES, V86, P1218, DOI 10.1161/01.RES.86.12.1218; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250	35	49	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30691	30698		10.1074/jbc.M703670200	http://dx.doi.org/10.1074/jbc.M703670200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724026	Green Accepted, hybrid			2022-12-27	WOS:000250136300037
J	Copeland, SJ; Green, BJ; Burchat, S; Papalia, GA; Banner, D; Copeland, JW				Copeland, Sarah J.; Green, Brenda J.; Burchat, Sarah; Papalia, Giuseppe A.; Banner, David; Copeland, John W.			The diaphanous inhibitory domain/diaphanous autoregulatory domain interaction is able to mediate heterodimerization between mDia1 and mDia2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; FORMIN HOMOLOGY PROTEIN; ACTIN DYNAMICS; FISSION YEAST; CELL-MIGRATION; SRF ACTIVITY; RHO-GTPASE; C-ELEGANS; PROFILIN; NUCLEATION	Formins are multidomain proteins that regulate numerous cytoskeleton-dependent cellular processes. These effects are mediated by the presence of two regions of homology, formin homology 1 and FH2. The diaphanous-related formins (DRFs) are distinguished by the presence of interacting N- and C-terminal regulatory domains. The GTPase binding domain and diaphanous inhibitory domain ( DID) are found in the N terminus and bind to the diaphanous autoregulatory domain ( DAD) found in the C terminus. Adjacent to the DID is an N- terminal dimerization motif ( DD) and coiled-coil region ( CC). The N terminus of Dia1 is also proposed to contain a Rho-independent membrane-targeting motif. We undertook an extensive structure/function analysis of the mDia1 N terminus to further our understanding of its role in vivo. We show here that both DID and DD are required for efficient autoinhibition in the context of full-length mDia1 and that the DD of mDia1 and mDia2, like formin homology 2, mediates homo- but not heterodimerization with other DRF family members. In contrast, our results suggest that the DID/DAD interaction mediates heterodimerization of full-length mDia1 and mDia2 and that the auto-inhibited conformation of DRFs is oligomeric. In addition, we also show that the DD/CC region is required for the Rho-independent membrane targeting of the isolated N terminus.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84312 USA	University of Ottawa; Utah System of Higher Education; University of Utah	Copeland, JW (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	john.copeland@uottawa.ca		Green, Brenda/0000-0002-4274-0969				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Menard I, 2006, APOPTOSIS, V11, P1863, DOI 10.1007/s10495-006-0087-8; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452	47	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30120	30130		10.1074/jbc.M703834200	http://dx.doi.org/10.1074/jbc.M703834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716977				2022-12-27	WOS:000249981200042
J	Baden, KN; Murray, J; Capaldi, RA; Guillemin, K				Baden, Katrina N.; Murray, James; Capaldi, Roderick A.; Guillemin, Karen			Early developmental pathology due to cytochrome c oxidase deficiency is revealed by a new zebrafish model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIGH-SYNDROME PATIENTS; PERIPHERAL NEUROPATHY; MITOCHONDRIAL DISEASE; OXIDATIVE-PHOSPHORYLATION; CELL-DEATH; IDENTIFIED MOTONEURONS; BRAIN MITOCHONDRIA; PRENATAL-DIAGNOSIS; RESPIRATORY-CHAIN; ASSEMBLY GENE	Deficiency of cytochrome c oxidase (COX) is associated with significant pathology in humans. However, the consequences for organogenesis and early development are not well understood. We have investigated these issues using a zebrafish model. COX deficiency was induced using morpholinos to reduce expression of CoxVa, a structural subunit, and Surf1, an assembly factor, both of which impaired COX assembly. Reduction of COX activity to 50% resulted in developmental defects in endodermal tissue, cardiac function, and swimming behavior. Cellular investigations revealed different underlying mechanisms. Apoptosis was dramatically increased in the hindbrain and neural tube, and secondary motor neurons were absent or abnormal, explaining the motility defect. In contrast, the heart lacked apoptotic cells but showed increasingly poor performance over time, consistent with energy deficiency. The zebrafish model has revealed tissue-specific responses to COX deficiency and holds promise for discovery of new therapies to treat mitochondrial diseases in humans.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Mitosci Inc, Eugene, OR 97403 USA	University of Oregon	Guillemin, K (corresponding author), Univ Oregon, Inst Mol Biol, 1370 Franklin Blvd, Eugene, OR 97403 USA.	guillemin@molbio.uoregon.edu		Guillemin, Karen/0000-0001-6004-9955	NICHD NIH HHS [HD22486] Funding Source: Medline; NIDDK NIH HHS [R01 DK075549-01, R21 DK067065-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007759] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067065, R01DK075549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; BARAK Y, 1995, ISRAEL J MED SCI, V31, P224; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Capaldi RA, 2004, MITOCHONDRION, V4, P417, DOI 10.1016/j.mito.2004.07.006; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davey GP, 1996, J NEUROCHEM, V66, P1617; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 1991, REV NEUROL, V147, P443; DiMauro S, 2000, NEUROL SCI, V21, pS901; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239; Gogvadze V, 2006, CHEM-BIOL INTERACT, V163, P4, DOI 10.1016/j.cbi.2006.04.010; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Houstek J, 1999, PRENATAL DIAG, V19, P552, DOI 10.1002/(SICI)1097-0223(199906)19:6<552::AID-PD588>3.0.CO;2-C; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; JOHNS DR, 1994, J NEURO-OPHTHALMOL, V14, P135; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1; Melberg A, 1996, MUSCLE NERVE, V19, P751; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; MIZUSAWA H, 1988, J NEUROL SCI, V86, P171, DOI 10.1016/0022-510X(88)90096-2; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Papadopoulou LC, 1999, NAT GENET, V23, P333; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; PEZESHKPOUR G, 1987, J NEUROL SCI, V77, P285, DOI 10.1016/0022-510X(87)90129-8; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028; RANMAN S, 1996, ANN NEUROL, V39, P343; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Salviati L, 2002, ARCH NEUROL-CHICAGO, V59, P862, DOI 10.1001/archneur.59.5.862; Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Stickler DE, 2006, PEDIATR NEUROL, V34, P127, DOI 10.1016/j.pediatrneurol.2005.08.006; SWEENEY MG, 1994, J NEUROL SCI, V121, P57, DOI 10.1016/0022-510X(94)90157-0; Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P84, DOI 10.1007/BF01800349; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	80	44	45	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34839	34849		10.1074/jbc.M703528200	http://dx.doi.org/10.1074/jbc.M703528200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17761683	hybrid			2022-12-27	WOS:000251155200026
J	Culyba, MJ; Minkah, N; Hwang, Y; Benhamou, OMJ; Bushman, FD				Culyba, Matthew J.; Minkah, Nana; Hwang, Young; Benhamou, Ori-Michael J.; Bushman, Frederic D.			DNA branch nuclease activity of vaccinia A22 resolvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; CRYSTAL-STRUCTURE; VIRUS-DNA; HIV-1 INTEGRASE; SLICER ACTIVITY; VIRAL-DNA; IN-VITRO; L-CELLS; REPLICATION; ENDONUCLEASE	DNA replication, recombination, and repair can result in formation of diverse branched DNA structures. Many large DNA viruses are known to encode DNA branch nucleases, but several of the expected activities have not previously been found among poxvirus enzymes. Vaccinia encodes an enzyme, A22 resolvase, which is known to be active on four-stranded DNA junctions (Holliday junctions) or Holliday junction-like structures containing three of the four strands. Here we report that A22 resolvase in fact has a much wider substrate specificity than previously appreciated. A22 resolvase cleaves Y-junctions, single-stranded DNA flaps, transitions from double strands to unpaired single strands ("splayed duplexes"), and DNA bulges in vitro. We also report site-directed mutagenesis studies of candidate active site residues. The results identify the likely active site and support a model in which a single active site is responsible for cleavage on Holliday junctions and splayed duplexes. Lastly, we describe possible roles for the A22 resolvase DNA-branch nuclease activity in DNA replication and repair.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168, T32AI007324] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI 07324, U54 AI057168] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Diamond TL, 2006, NUCLEIC ACIDS RES, V34, P6116, DOI 10.1093/nar/gkl862; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ESTEBAN M, 1977, VIROLOGY, V83, P467, DOI 10.1016/0042-6822(77)90197-0; ESTEBAN M, 1977, VIROLOGY, V78, P57, DOI 10.1016/0042-6822(77)90078-2; ESTEBAN M, 1977, VIROLOGY, V82, P163, DOI 10.1016/0042-6822(77)90040-X; Gao K, 2004, J VIROL, V78, P6715, DOI 10.1128/JVI.78.13.6715-6722.2004; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; Garcia AD, 2006, J BIOL CHEM, V281, P11618, DOI 10.1074/jbc.M600182200; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Maxam A M, 1980, Methods Enzymol, V65, P499; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MERCHLINSKY M, 1988, J MOL BIOL, V199, P399, DOI 10.1016/0022-2836(88)90613-4; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; Moss B, 2001, VIROLOGY, P2637; MOYER RW, 1981, CELL, V27, P391, DOI 10.1016/0092-8674(81)90422-0; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; PENNINGTON TH, 1974, J VIROL, V13, P488, DOI 10.1128/JVI.13.2.488-493.1974; POGO BGT, 1978, VIROLOGY, V84, P1, DOI 10.1016/0042-6822(78)90213-1; PRESCOTT DM, 1971, J MOL BIOL, V59, P505, DOI 10.1016/0022-2836(71)90313-5; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; SAITO A, 1995, P NATL ACAD SCI USA, V92, P7470, DOI 10.1073/pnas.92.16.7470; Schofield MJ, 1998, BIOCHEMISTRY-US, V37, P7733, DOI 10.1021/bi980399s; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao XD, 2001, J VIROL, V75, P6923, DOI 10.1128/JVI.75.15.6923-6932.2001	41	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34644	34652		10.1074/jbc.M705322200	http://dx.doi.org/10.1074/jbc.M705322200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890227	Green Published, hybrid			2022-12-27	WOS:000251155200006
J	McCarthy, TL; Hochberg, RB; Labaree, DC; Centrella, M				McCarthy, Thomas L.; Hochberg, Richard B.; Labaree, David C.; Centrella, Michael			3-ketosteroid reductase activity and expression by fetal rat Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; BINDING PROTEIN-DELTA; ESTROGEN-RECEPTOR MODULATORS; ALDO-KETO REDUCTASES; BONE CELL-CULTURES; DIHYDRODIOL DEHYDROGENASE; GENE-EXPRESSION; FACTOR-BETA; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASES	In addition to reproductive tissue, sex hormones induce transcriptional events in many connective tissue cells, including osteoblasts. Some sex hormone receptor modulators with bone sparing effects selectively target estrogen or androgen receptors, whereas others appear more promiscuous, in part through enzymatic metabolism. Rat osteoblasts express significant oxidative 3 alpha-hydroxysteroid dehydrogenase activity, which can convert precursor substrates to potent androgen receptor agonists. Here we show that they also express 3-ketosteroid reductase activity, exemplified by 7-methyl-17ethynyl-19-norandrostan-5 (10)en-3-one (tibolone) conversion to potent estrogen receptor alpha agonists. Conversion was rapid and quantitative, with 3 alpha-hydroxytibolone as the primary metabolite. Consistently, tibolone induced estrogen receptor alpha-dependent gene promoter activity through cis-acting estrogen response elements, increased the stimulatory effect of TGF-beta on Smad-dependent gene promoter activity, and enhanced prostaglandin E2-induced activity of transcription factor Runx2. Rat osteoblasts express the 3-ketosteroid reductase AKR1C9, an aldo-keto reductase gene family member. Exposure to prostaglandin E2 increased AKR1C9 gene promoter activity and mRNA expression. AKR1C9 promoter activity was also enhanced by overexpression of protein kinase A catalytic subunit or transcription factor C/EBP delta, and the effect of PGE2 was reduced by dominant negative C/EBP delta competition or C/EBP delta antisense expression. Moreover, prostaglandin E2 increased the amount of functional endogenous nuclear C/EBP delta that could bind specifically to a distinct domain similar to 1.8-kb upstream from the start site of AKR1C9 transcription. In summary, in addition to 3 alpha-hydroxysteroid dehydrogenase, rat osteoblasts express significant and regulatable 3-ketosteroid reductase activity. Through these enzymes, they may selectively metabolize precursor compounds into potent steroid receptor agonists locally within bone.	Yale Univ, Sch Med, Dept Surg, Sect Plast Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University; Yale University	Centrella, M (corresponding author), 333 Cedar St,MS 208041, New Haven, CT 06520 USA.	michael.centrella@yale.edu			NATIONAL CANCER INSTITUTE [R01CA037799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR039201, R01AR039201] Funding Source: NIH RePORTER; NCI NIH HHS [CA 37799] Funding Source: Medline; NHLBI NIH HHS [HL 61432] Funding Source: Medline; NIAMS NIH HHS [AR 39201] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Atalla A, 2000, XENOBIOTICA, V30, P755, DOI 10.1080/00498250050119826; Billiard J, 2001, J BIOL CHEM, V276, P15354, DOI 10.1074/jbc.M009973200; Bland R, 1999, J ENDOCRINOL, V161, P455, DOI 10.1677/joe.0.1610455; Blok LJ, 2003, J CLIN ENDOCR METAB, V88, P2327, DOI 10.1210/jc.2002-021737; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Carpenter TO, 1998, ENDOCRINOLOGY, V139, P35, DOI 10.1210/en.139.1.35; CENTRELLA M, 1994, ENDOCRINOLOGY, V135, P1611, DOI 10.1210/en.135.4.1611; Centrella M, 1996, ANN NY ACAD SCI, V785, P224, DOI 10.1111/j.1749-6632.1996.tb56267.x; Centrella M, 2004, MOL ENDOCRINOL, V18, P1120, DOI 10.1210/me.2003-0491; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Chang WZ, 2005, GENE, V345, P225, DOI 10.1016/j.gene.2004.11.017; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Chen Y, 1998, J CELL BIOCHEM, V71, P351, DOI 10.1002/(SICI)1097-4644(19981201)71:3<351::AID-JCB4>3.0.CO;2-5; Cirigliano M, 2007, J WOMENS HEALTH, V16, P600, DOI 10.1089/jwh.2006.0311; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Col N F, 2005, Minerva Med, V96, P331; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Eyre LJ, 1998, J BONE MINER RES, V13, P996, DOI 10.1359/jbmr.1998.13.6.996; Gennari L, 2007, DRUG AGING, V24, P361, DOI 10.2165/00002512-200724050-00002; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; HAKEDA Y, 1987, ENDOCRINOLOGY, V121, P1966, DOI 10.1210/endo-121-6-1966; Hou YT, 1998, MOL PHARMACOL, V53, P459, DOI 10.1124/mol.53.3.459; HOU YT, 1994, CANCER RES, V54, P247; Hung CF, 1999, MOL ENDOCRINOL, V13, P1704, DOI 10.1210/me.13.10.1704; Ishida Y, 2002, OSTEOPOROSIS INT, V13, P235, DOI 10.1007/s001980200020; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Ji CH, 1996, J CELL BIOCHEM, V63, P478; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Ji CH, 2003, MOL ENDOCRINOL, V17, P1834, DOI 10.1210/me.2002-0235; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kuwano Y, 1997, ENDOCR J, V44, P847, DOI 10.1507/endocrj.44.847; Lin HK, 1999, J STEROID BIOCHEM, V71, P29, DOI 10.1016/S0960-0760(99)00122-3; LIN HK, 1995, CANCER RES, V55, P4105; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Manolagas SC, 2004, KIDNEY INT, V66, pS41, DOI 10.1111/j.1523-1755.2004.09107.x; McCarthy TL, 2000, ENDOCRINOLOGY, V141, P127, DOI 10.1210/en.141.1.127; MCCARTHY TL, 1995, ENDOCRINOLOGY, V136, P3901, DOI 10.1210/en.136.9.3901; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McCarthy TL, 2003, J BIOL CHEM, V278, P43121, DOI 10.1074/jbc.M306531200; McCarthy TL, 1997, J BIOL CHEM, V272, P18132, DOI 10.1074/jbc.272.29.18132; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; McCarthy TL, 1998, J CELL BIOCHEM, V68, P446, DOI 10.1002/(SICI)1097-4644(19980315)68:4<446::AID-JCB5>3.0.CO;2-Q; MCCARTHY TL, 2007, IN PRESS ENDOCRINOL; Musa MA, 2007, CURR MED CHEM, V14, P1249, DOI 10.2174/092986707780598023; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2004, MOL CELL ENDOCRINOL, V215, P63, DOI 10.1016/j.mce.2003.11.006; Penning TM, 2003, J STEROID BIOCHEM, V85, P247, DOI 10.1016/S0960-0760(03)00236-X; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Rosemond MJC, 2004, CHEM-BIOL INTERACT, V147, P129, DOI 10.1016/j.cbi.2003.12.001; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; SMITHGALL TE, 1985, BIOCHEM PHARMACOL, V34, P831, DOI 10.1016/0006-2952(85)90763-4; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, MOL PHARMACOL, V66, P1702, DOI 10.1124/mol.104.004515; STRAVITZ RT, 1994, J LIPID RES, V35, P239; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Thomas MJ, 1996, J BIOL CHEM, V271, P21835, DOI 10.1074/jbc.271.36.21835; TOKUDA H, 1992, J CELL BIOCHEM, V48, P262, DOI 10.1002/jcb.240480306; Tsuruda L, 2001, CHEM RES TOXICOL, V14, P856, DOI 10.1021/tx0100035; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; UHLER MD, 1987, J BIOL CHEM, V262, P15202; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006	72	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34003	34012		10.1074/jbc.M707502200	http://dx.doi.org/10.1074/jbc.M707502200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17905737	hybrid			2022-12-27	WOS:000251145700014
J	Puri, V; Konda, S; Ranjit, S; Aouadi, M; Chawla, A; Chouinard, M; Chakladar, A; Czech, MP				Puri, Vishwajeet; Konda, Silvana; Ranjit, Srijana; Aouadi, Myriam; Chawla, Anil; Chouinard, My; Chakladar, Abhijit; Czech, Michael P.			Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DNA-FRAGMENTATION-FACTOR; ADIPOCYTE-SPECIFIC GENE; TUMOR-NECROSIS-FACTOR; PERILIPIN-A; 3T3-L1 ADIPOCYTES; TRANSCRIPTIONAL REGULATION; LIPOLYTIC STIMULATION; OBESE GENE; EXPRESSION	Fat-specific protein (FSP)27/Cidec is most highly expressed in white and brown adipose tissues and increases in abundance by over 50-fold during adipogenesis. However, its function in adipocytes has remained elusive since its discovery over 15 years ago. Here we demonstrate that FSP27/Cidec localizes to lipid droplets in cultured adipocytes and functions to promote lipid accumulation. Ectopically expressed FSP27-GFP surrounds lipid droplets in 3T3-L1 adipocytes and colocalizes with the known lipid droplet protein perilipin. Immunostaining of endogenous FSP27 in 3T3-L1 adipocytes also confirmed its presence on lipid droplets. FSP27-GFP expression also markedly increases lipid droplet size and enhances accumulation of total neutral lipids in 3T3-L1 preadipocytes as well as other cell types such as COS cells. Conversely, RNA interference-based FSP27/Cidec depletion in mature adipocytes significantly stimulates lipolysis and reduces the size of lipid droplets. These data reveal FSP27/Cidec as a novel adipocyte lipid droplet protein that negatively regulates lipolysis and promotes triglyceride accumulation.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu		Puri, Vishwajeet/0000-0002-0757-6067	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060837, R01DK030898, R37DK030898] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 60837, DK 30898] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Bergeron R, 2006, ENDOCRINOLOGY, V147, P4252, DOI 10.1210/en.2005-1535; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Boden G, 2006, EXPERT OPIN INV DRUG, V15, P243, DOI 10.1517/13543784.15.3.243; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Clifford GM, 1997, BIOCHEM SOC T, V25, pS672, DOI 10.1042/bst025s672; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; DANESCH U, 1992, J BIOL CHEM, V267, P7185; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lazar HL, 2002, J THORAC CARDIOV SUR, V123, P842, DOI 10.1067/mtc.2002.121041; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puri V, 2007, J LIPID RES, V48, P465, DOI 10.1194/jlr.D600033-JLR200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Savkur Rajesh S, 2006, Expert Opin Investig Drugs, V15, P763, DOI 10.1517/13543784.15.7.763; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SHILLABEER G, 1989, J CLIN INVEST, V84, P381, DOI 10.1172/JCI114177; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TOBE K, 1987, FEBS LETT, V215, P345, DOI 10.1016/0014-5793(87)80175-8; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; WILLIAMS PM, 1992, MOL ENDOCRINOL, V6, P1135, DOI 10.1210/me.6.7.1135; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	45	237	250	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34213	34218		10.1074/jbc.M707404200	http://dx.doi.org/10.1074/jbc.M707404200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884815	hybrid			2022-12-27	WOS:000251145700036
J	Uzunova, K; Gottsche, K; Miteva, M; Weisshaar, SR; Glanemann, C; Schnellhardt, M; Niessen, M; Scheel, H; Hofmann, K; Johnson, ES; Praefcke, GJK; Dohmen, RJ				Uzunova, Kristina; Goettsche, Kerstin; Miteva, Maria; Weisshaar, Stefan R.; Glanemann, Christoph; Schnellhardt, Marion; Niessen, Michaela; Scheel, Hartmut; Hofmann, Kay; Johnson, Erica S.; Praefcke, Gerrit J. K.; Dohmen, R. Juergen			Ubiquitin-dependent proteolytic control of SUMO conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE DEGRADATION; BINDING MOTIF; DNA-REPAIR; SNURF RNF4; PROTEIN; NUCLEAR; COMPLEX; LIGASE; IDENTIFICATION; PCNA	Posttranslational protein modification with small ubiquitin-related modifier (SUMO) is an important regulatory mechanism implicated in many cellular processes, including several of biomedical relevance. We report that inhibition of the proteasome leads to accumulation of proteins that are simultaneously conjugated to both SUMO and ubiquitin in yeast and in human cells. A similar accumulation of such conjugates was detected in Saccharomyces cerevisiae ubc4 ubc5 cells as well as in mutants lacking two RING finger proteins, Ris1 and Hex3/Slx5-Slx8, that bind to SUMO as well as to the ubiquitin-conjugating enzyme Ubc4. In vitro, Hex3-Slx8 complexes promote Ubc4-dependent ubiquitylation. Together these data identify a previously unrecognized pathway that mediates the proteolytic down-regulation of sumoylated proteins. Formation of substrate-linked SUMO chains promotes targeting of SUMO-modified substrates for ubiquitin-mediated proteolysis. Genetic and biochemical evidence indicates that SUMO conjugation can ultimately lead to inactivation of sumoylated substrates by polysumoylation and/or ubiquitin-dependent degradation. Simultaneous inhibition of both mechanisms leads to severe phenotypic defects.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany; Miltenyi Biotec GmbH, Bioinformat Dept, MACSmol Business Unit, D-50829 Cologne, Germany; Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Cologne; University of Cologne; Miltenyi Biotec; Jefferson University	Dohmen, RJ (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de	Hofmann, Kay/D-6714-2011; Dohmen, R. Jürgen/AAD-6649-2022	Hofmann, Kay/0000-0002-2289-9083; Dohmen, R. Jürgen/0000-0002-5756-6780; Praefcke, Gerrit/0000-0001-8818-1499	NIGMS NIH HHS [GM 62268] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062268] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bai C, 1997, METHOD ENZYMOL, V283, P141; Biggins S, 2001, GENETICS, V159, P453; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; James P, 1996, GENETICS, V144, P1425; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mullen JR, 2001, GENETICS, V157, P103; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhang Z, 1997, MOL CELL BIOL, V17, P6147, DOI 10.1128/MCB.17.10.6147; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	63	246	255	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34167	34175		10.1074/jbc.M706505200	http://dx.doi.org/10.1074/jbc.M706505200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17728242	hybrid			2022-12-27	WOS:000251145700031
J	Willoughby, D; Baillie, GS; Lynch, MJ; Ciruela, A; Houslay, MD; Cooper, DMF				Willoughby, Debbie; Baillie, George S.; Lynch, Martin J.; Ciruela, Antonio; Houslay, Miles D.; Cooper, Dermot M. F.			Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during beta(2)-adrenoceptor and prostanoid receptor cAMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; AIRWAY SMOOTH-MUSCLE; NUCLEOTIDE-GATED CHANNELS; RESONANCE ENERGY-TRANSFER; CARDIAC MYOCYTES; BETA-ARRESTIN; COUPLED RECEPTORS; IN-VIVO; COMPARTMENTALIZED PHOSPHODIESTERASES; VENTRICULAR MYOCYTES	Dynamic and localized actions of cAMP are central to the generation of discrete cellular events in response to a range of G(s)-coupled receptor agonists. In the present study we have employed a cyclic nucleotide-gated channel sensor to report acute changes in cAMP in the restricted cellular microdomains adjacent to two different G(s)-coupled receptor pathways, beta(2)-adrenoceptors and prostanoid receptors that are expressed endogenously in HEK293 cells. We probed by either selective small interference RNA-mediated knockdown or dominant negative overexpression the contribution of key signaling components in the rapid attenuation of the local cAMP signaling and subsequent desensitization of each of these G-protein-coupled receptor signaling pathways immediately following receptor activation. Direct measurements of cAMP changes just beneath the plasma membrane of single HEK293 cells reveal novel insights into key regulatory roles provided by protein kinase A-RII, beta-arrestin2, cAMP phosphodiesterase-4D3, and cAMP phosphodiesterase-4D5. We provide new evidence for distinct modes of cAMP down-regulation in these two Gs-linked pathways and show that these distinct G-protein-coupled receptor signaling systems are subject to unidirectional, heterologous desensitization that allows for limited cross-talk between distinct, dynamically regulated pools of cAMP.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Cambridge; University of Glasgow	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028389] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 28389] Funding Source: Medline; Wellcome Trust [RG 31760] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bastepe M, 1999, BRIT J PHARMACOL, V126, P365, DOI 10.1038/sj.bjp.0702291; Billington CK, 2003, RESP RES, V4; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; HSIA JA, 1985, J BIOL CHEM, V260, P4922; Jurevicius J, 2003, J PHYSIOL-LONDON, V551, P239, DOI 10.1113/jphysiol.2003.045211; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Mundell SJ, 1999, BIOCHEMISTRY-US, V38, P8723, DOI 10.1021/bi990361v; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113	44	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34235	34249		10.1074/jbc.M706765200	http://dx.doi.org/10.1074/jbc.M706765200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855344	hybrid			2022-12-27	WOS:000251145700039
J	Campbell, DR; Chapman, KE; Waldron, KJ; Tottey, S; Kendall, S; Cavallaro, G; Andreini, C; Hinds, J; Stoker, NG; Robinson, NJ; Cavet, JS				Campbell, Duncan R.; Chapman, Kaye E.; Waldron, Kevin J.; Tottey, Stephen; Kendall, Sharon; Cavallaro, Gabriele; Andreini, Claudia; Hinds, Jason; Stoker, Neil G.; Robinson, Nigel J.; Cavet, Jennifer S.			Mycobacterial cells have dual nickel-cobalt sensors - Sequence relationships and metal sites of metal-responsive repressors are not congruent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; STAPHYLOCOCCUS-AUREUS; MACROPHAGE PROTEIN-1; NATURAL-RESISTANCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; METALLOREGULATORY PROTEIN; SMTB/ARSR FAMILY; BINDING SITES; ZINC SENSOR	A novel ArsR-SmtB family transcriptional repressor, KmtR, has been characterized from mycobacteria. Mutants of Mycobacterium tuberculosis lacking kmtR show elevated expression of Rv2025c encoding a deduced CDF-family metal exporter. KmtR-dependent repression of the cdf and kmtR operator-promoters was alleviated by nickel and cobalt in minimal medium. Electrophoretic mobility shift assays and fluorescence anisotropy show binding of purified KmtR to nucleotide sequences containing a region of dyad symmetry from the cdf and kmtR operator-promoters. Incubation of KmtR with cobalt inhibits DNA complex assembly and metal-protein binding was confirmed. KmtR is the second, to NmtR, characterized ArsR-SmtB sensor of nickel and cobalt from M. tuberculosis suggesting special significance for these ions in this pathogen. KmtR-dependent expression is elevated in complete medium with no increase in response to metals, whereas NmtR retains a response to nickel and cobalt under these conditions. KmtR has tighter affinities for nickel and cobalt than NmtR consistent with basal levels of these metals being sensed by KmtR but not NmtR in complete medium. More than a thousand genes encoding ArsR-SmtB-related proteins are listed in databases. KmtR has none of the previously defined metal-sensing sites. Substitution of His(88), Glu(101), His(102), His(110), or His(111) with Gln generated KmtR variants that repress the cdf and kmtR operator-promoters even in elevated nickel and cobalt, revealing a new sensory site. Importantly, ArsR-SmtB sequence groupings do not correspond with the different sensory motifs revealing that only the latter should be used to predict metal sensing.	Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Manchester, Manchester M13 9PT, Lancs, England; Univ London Royal Vet Coll, London NW1 0TU, England; Univ Florence, Magnet Resonance Ctr, Florence, Italy; Consorzio Interuniv Risonanze Magnet Metalloprote, Florence, Italy; St George Hosp, Bacterial Microarray Grp, London SW17 0RE, England	Newcastle University - UK; University of Manchester; University of London; University of London Royal Veterinary College; University of Florence; St Georges University London	Cavet, JS (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jennifer.s.cavet@manchester.ac.uk	Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Andreini, Claudia/D-5614-2014; Cavallaro, Gabriele/C-6991-2008; Robinson, Nigel J/J-6363-2012; Cavallaro, Gabriele/GRE-9439-2022; Stoker, Neil G/L-8812-2016	Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Andreini, Claudia/0000-0003-4329-8225; Robinson, Nigel J/0000-0001-5586-1092; Stoker, Neil G/0000-0001-7055-6184; Kendall, Sharon/0000-0003-3277-3035; Cavet, Jennifer/0000-0001-5913-7157; Hinds, Jason/0000-0002-2739-1908	Biotechnology and Biological Sciences Research Council [D19920, P18581] Funding Source: Medline; Wellcome Trust [080039] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agranoff D, 2004, FRONT BIOSCI-LANDMRK, V9, P2996, DOI 10.2741/1454; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; CLEMENS DL, 1995, J BACTERIOL, V177, P5644, DOI 10.1128/jb.177.19.5644-5652.1995; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; Hoal EG, 2004, INT J TUBERC LUNG D, V8, P1464; Hotter GS, 2001, FEMS MICROBIOL LETT, V200, P151, DOI 10.1016/S0378-1097(01)00214-2; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; KARASSEVA V, 1977, ZBL BAKT-INT J MED M, V239, P514; Kuroda M, 1999, MICROBIOL IMMUNOL, V43, P115, DOI 10.1111/j.1348-0421.1999.tb02382.x; Liu T, 2005, BIOCHEMISTRY-US, V44, P8673, DOI 10.1021/bi050450+; Liu T, 2004, J BIOL CHEM, V279, P17810, DOI 10.1074/jbc.M310560200; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Manabe YC, 1999, P NATL ACAD SCI USA, V96, P12844, DOI 10.1073/pnas.96.22.12844; Mandal S, 2007, MICROBIOL-SGM, V153, P80, DOI 10.1099/mic.0.29197-0; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Milano A, 2004, RES MICROBIOL, V155, P192, DOI 10.1016/j.resmic.2003.11.009; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VanZile ML, 2002, BIOCHEMISTRY-US, V41, P9776, DOI 10.1021/bi020178t; Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Xu C, 1996, J BIOL CHEM, V271, P2427, DOI 10.1074/jbc.271.5.2427; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang WH, 2005, CLIN INFECT DIS, V40, P1232, DOI 10.1086/428726	51	83	87	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32298	32310		10.1074/jbc.M703451200	http://dx.doi.org/10.1074/jbc.M703451200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726022	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000250480300053
J	Manna, D; Albanese, A; Park, WS; Cho, W				Manna, Debasis; Albanese, Alexandra; Park, Wei Sun; Cho, Wonhwa			Mechanistic basis of differential cellular responses of phosphatidylinositol 3,4-bisphosphate- and phosphatidylinositol 3,4,5-trisphosphate-binding pleckstrin homology domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; MEMBRANE-PROTEIN INTERACTIONS; PHOSPHOINOSITIDE-BINDING; C2 DOMAINS; PH-DOMAIN; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; STRUCTURAL BASIS; MOLECULAR-BASIS; PX DOMAINS; ACTIVATION	Phosphatidylinositol 3,4-bisphosphate ( PtdIns( 3,4) P-2) and phosphatidylinositol 3,4,5-trisphosphate ( PtdIns( 3,4,5) P-3) are lipid second messengers that regulate various cellular processes by recruiting a wide range of downstream effector proteins to membranes. Several pleckstrin homology ( PH) domains have been reported to interact with PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3. To understand how these PH domains differentially respond to PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3 signals, we quantitatively determined the PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P3 binding properties of several PH domains, including Akt, ARNO, Btk, DAPP1, Grp1, and C-terminal TAPP1 PH domains by surface plasmon resonance and monolayer penetration analyses. The measurements revealed that these PH domains have significant different phosphoinositide specificities and affinities. Btk-PH and TAPP1-PH showed genuine PtdIns( 3,4,5) P-3 and PtdIns( 3,4) P2 specificities, respectively, whereas other PH domains exhibited less pronounced specificities. Also, the PH domains showed different degrees of membrane penetration, which greatly affected the kinetics of their membrane dissociation. Mutational studies showed that the presence of two proximal hydrophobic residues on the membrane-binding surface of the PH domain is important for membrane penetration and sustained membrane residence. When NIH 3T3 cells were stimulated with platelet-derived growth factor to generate PtdIns( 3,4,5) P-3, reversible translocation of Btk-PH, Grp1-PH, ARNO-PH, DAPP1-PH, and its L177A mutant to the plasma membrane was consistent with their in vitro membrane binding properties. Collectively, these studies provide new insight into how various PH domains would differentially respond to cellular PtdIns( 3,4) P-2 and PtdIns( 3,4,5) P-3 signals.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Stanford Univ, Med Ctr, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University	Cho, W (corresponding author), Univ Illinois, Dept Chem, MC 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu		Manna, Debasis/0000-0002-6920-9000	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68849] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; Banfic H, 1998, J BIOL CHEM, V273, P11630, DOI 10.1074/jbc.273.19.11630; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Flesch FM, 2005, BIOCHEM J, V389, P435, DOI 10.1042/BJ20041721; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malkova S, 2006, BIOCHEMISTRY-US, V45, P13566, DOI 10.1021/bi061133l; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Thomas CC, 2001, BIOCHEM J, V358, P287, DOI 10.1042/0264-6021:3580287; Tuzi S, 2003, J BIOL CHEM, V278, P28019, DOI 10.1074/jbc.M300101200; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	75	111	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32093	32105		10.1074/jbc.M703517200	http://dx.doi.org/10.1074/jbc.M703517200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823121	hybrid			2022-12-27	WOS:000250480300030
J	Takeda, AN; Gautschi, I; van Bemmelen, MX; Schild, L				Takeda, Armelle-Natsuo; Gautschi, Ivan; van Bemmelen, Miguel X.; Schild, Laurent			Cadmium trapping in an epithelial sodium channel pore mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVITY FILTER; AMILORIDE BLOCK; REGION; RESIDUES; SUBUNIT	The putative selectivity filter of the epithelial sodium channel (ENaC) comprises a three- residue sequence G/ SXS, but it remains uncertain whether the backbone atoms of this sequence or whether their side chains are lining the pore. It has been reported that the S589C mutation in the selectivity filter of alpha ENaC renders the channel sensitive to block by externally applied Cd2+; this was interpreted as evidence for Cd2+ coordination with the thiol group of the side chain of alpha 589C, pointing toward the pore lumen. Because the alpha S589C mutation alters the monovalent to divalent cation selectivity ratio of ENaC and because internally applied Cd2+ blocks wild-type ENaC with high affinity, we hypothesized that the inhibition of alpha S589C ENaC by Cd2+ results rather from the coordination of this cation with native cysteine residues located in the internal pore of ENaC. We show here that Cd2+ inhibits not only ENaC alpha S589C and alpha S589D but also alpha S589N mutants and that Ca2+ weakly interacts with the S589D mutant. The block of alpha S589C, - D, and - N mutants is characterized by a slow on- rate, is nearly irreversible, is voltage- dependent, and can be prevented by amiloride. The C546S mutation in the second transmembrane helix of gamma subunit in the background of the ENaC alpha S589C, - D, or - N mutants reduces the sensitivity to block by Cd2+ and renders the block rapidly reversible. We conclude therefore that the block by Cd2+ of the alpha S589C, - D, and - N mutants results from the trapping of Cd2+ ions in the internal pore of the channel and involves Cys-546 in the second transmembrane helix of the gamma ENaC subunit.	Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, Bugnon 27, CH-1005 Lausanne, Switzerland.	Schild@unil.ch	TAKEDA, Armelle-Natsuo/B-6031-2009; van Bemmelen, Miguel Xavier/A-8660-2014; van Bemmelen, Miguel/B-5971-2009	van Bemmelen, Miguel Xavier/0000-0003-2762-6153; 				Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kellenberger S, 2003, MOL PHARMACOL, V64, P848, DOI 10.1124/mol.64.4.848; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; PALMER LG, 1990, RENAL PHYSIOL BIOCH, V13, P51; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; RAVINDRAN A, 1991, J GEN PHYSIOL, V97, P89, DOI 10.1085/jgp.97.1.89; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484	20	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31928	31936		10.1074/jbc.M700733200	http://dx.doi.org/10.1074/jbc.M700733200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804416	hybrid			2022-12-27	WOS:000250480300013
J	Wang, Y; Rosen, H; Madtes, DK; Shao, B; Martin, TR; Heinecke, JW; Fu, X				Wang, Yi; Rosen, Henry; Madtes, David K.; Shao, Baohai; Martin, Thomas R.; Heinecke, Jay W.; Fu, Xiaoyun			Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue - An oxidative mechanism for regulating proteolysis during inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; HYPOCHLOROUS ACID; METHIONINE RESIDUES; HYDROGEN-PEROXIDE; OXIDANTS; PEPTIDE; DOMAIN; NEUTROPHILS; GENERATION	An imbalance between the proteolytic activity of matrix metalloproteinases (MMPs) and the activity of tissue inhibitors of metalloproteinases (TIMPs) is implicated in tissue injury during inflammation. The N-terminal cysteine of TIMP-1 plays a key role in the inhibitory activity of the protein because it coordinates the essential catalytic Zn2+ of the MMP, preventing the metal ion from functioning. An important mechanism for controlling the interaction of TIMPs with MMPs might involve hypochlorous acid (HOCl), a potent oxidant produced by the myeloperoxidase (MPO) system of phagocytes. Here, we show that HOCl generated by the MPO-H2O2-chloride system inactivates TIMP-1 by oxidizing its N-terminal cysteine. The product is a novel 2-oxo acid. Liquid chromatography-mass spectrometry and tandem mass spectrometry analyses demonstrated that methionine and N-terminal cysteine residues were rapidly oxidized by MPO-derived HOCl but only oxidation of the N-terminal cysteine of TIMP-1 correlated well with loss of inhibitory activity. Importantly, we detected the signature 2-oxo-acid N-terminal peptide in tryptic digests of bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome, demonstrating that TIMP-1 oxidation occurs in vivo. Loss of the N-terminal amino group and disulfide structure are crucial for preventing TIMP-1 from inhibiting MMPs. Our findings suggest that pericellular production of HOCl by phagocytes is a pathogenic mechanism for impairing TIMP-1 activity during inflammation.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Vet Affairs Puget Sound Hlth Care Syst, Med Res Serv, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Fu, X (corresponding author), Univ Washington, Dept Med, Box 356426, Seattle, WA 98195 USA.	xyfu@u.washington.edu	Wang, Yi/C-2871-2013	Shao, Baohai/0000-0001-8832-2845	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086, R01HL078527, P50HL073996, R01HL075381, R01HL063994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL030086, R01 HL075381, HL075381, P50HL073996, HL063994, R01 HL078527, HL078527, P50 HL073996, R01 HL063994] Funding Source: Medline; NIEHS NIH HHS [P30 ES007033, P30ES07033] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; BODDEN MK, 1994, ANN NY ACAD SCI, V732, P403, DOI 10.1111/j.1749-6632.1994.tb24767.x; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Drapeau G R, 1977, Methods Enzymol, V47, P189; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Frears ER, 1996, FEBS LETT, V381, P21, DOI 10.1016/0014-5793(96)00065-8; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grenier D, 2001, FEMS MICROBIOL LETT, V203, P161, DOI 10.1016/S0378-1097(01)00351-2; Haji R, 2007, J PATHOL, V211, P340, DOI 10.1002/path.2118; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heinecke JW, 1999, J LAB CLIN MED, V133, P321, DOI 10.1016/S0022-2143(99)90061-6; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; KALYANARAMAN B, 1985, J CLIN INVEST, V75, P1618, DOI 10.1172/JCI111868; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kobayashi T, 2004, METH MOL B, V289, P201; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lee Y, 2001, STAT MODEL, V1, P3, DOI 10.1177/1471082X0100100102; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Melnyk O, 2001, J ORG CHEM, V66, P4153, DOI 10.1021/jo001509f; Melnyk O, 2000, BIOPOLYMERS, V55, P165, DOI 10.1002/1097-0282(2000)55:2<165::AID-BIP50>3.0.CO;2-#; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Okarvi SM, 2002, J LABELLED COMPD RAD, V45, P407, DOI 10.1002/jlcr.568; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; RAY JM, 1994, EUR RESPIR J, V7, P2062; Ricou B, 1996, AM J RESP CRIT CARE, V154, P346, DOI 10.1164/ajrccm.154.2.8756805; Shabani F, 1998, FREE RADICAL RES, V28, P115, DOI 10.3109/10715769809065797; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Woessner J.F., 2000, PROTEIN PROFILE SER	51	96	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31826	31834		10.1074/jbc.M704894200	http://dx.doi.org/10.1074/jbc.M704894200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726014	hybrid, Green Accepted			2022-12-27	WOS:000250480300002
J	Baltzis, D; Pluquet, O; Papadakis, AI; Kazemi, S; Qu, LK; Koromilas, AE				Baltzis, Dionissios; Pluquet, Olivier; Papadakis, Andreas I.; Kazemi, Shirin; Qu, Li-Ke; Koromilas, Antonis E.			The elF2 alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-SYNTHASE KINASE-3; RIBOSOME ENTRY SITES; TRANSLATIONAL CONTROL; MUTANT P53; P53-DEPENDENT APOPTOSIS; GENE-EXPRESSION; TUMOR-CELLS; IN-VIVO; KAPPA-B	Phosphorylation of eukaryotic initiation factor 2 alpha(eIF2 alpha) is mediated by a family of kinases that respond to various forms of environmental stress. The eIF2 alpha kinases are critical for mRNA translation, cell proliferation, and apoptosis. Activation of the tumor suppressor p53 results in cell cycle arrest and apoptosis in response to various types of stress. We previously showed that, unlike the majority of stress responses that stabilize and activate p53, induction of endoplasmic reticulum stress leads to p53 degradation through an Mdm2-dependent mechanism. Here, we demonstrate that the endoplasmic reticulum-resident eIF2 alpha kinase PERK mediates the proteasomal degradation of p53 independently of translational control. This role is not specific for PERK, because the eIF2 alpha kinase PKR also promotes p53 degradation in response to double-stranded RNA. We further establish that the eIF2 alpha kinases induce glycogen synthase kinase 3 to promote the nuclear export and proteasomal degradation of p53. Our findings reveal a novel cross- talk between the eIF2 alpha kinases and p53 with implications in cell proliferation and tumorigenesis.	INSERM, Bordeaux 33076, France; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania; Pennsylvania Medicine; Lady Davis Institute; McGill University	Koromilas, AE (corresponding author), 3755 Cote-Ste-Catherine St, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca						Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Arava Yoav, 2003, Methods Mol Biol, V224, P79; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Corcoran CA, 2004, CANCER BIOL THER, V3, P721, DOI 10.4161/cbt.3.8.1068; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; GANNON JV, 1991, NATURE, V349, P802; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huang S, 2004, CELL CYCLE, V3, P1043; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jonkers J, 1997, EMBO J, V16, P441, DOI 10.1093/emboj/16.3.441; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Norman KL, 2001, CYTOKINE GROWTH F R, V12, P271, DOI 10.1016/S1359-6101(00)00024-1; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu L, 2004, CELL CYCLE, V3, P567, DOI 10.4161/cc.3.5.872; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Roh MS, 2005, BIOL PSYCHIAT, V57, P278, DOI 10.1016/j.biopsych.2004.10.039; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; van Amerongen R, 2005, CELL CYCLE, V4, pE89; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wenger RH, 1998, CANCER RES, V58, P5678; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	79	90	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31675	31687		10.1074/jbc.M704491200	http://dx.doi.org/10.1074/jbc.M704491200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785458	hybrid			2022-12-27	WOS:000250309200059
J	Kitago, Y; Karita, S; Watanabe, N; Kamiya, M; Aizawa, T; Sakka, K; Tanaka, I				Kitago, Yu; Karita, Shuichi; Watanabe, Nobuhisa; Kamiya, Masakatsu; Aizawa, Tomoyasu; Sakka, Kazuo; Tanaka, Isao			Crystal structure of Cel44A, a glycoside hydrolase family 44 endoglucanase from Clostridium thermocellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; CLAN GH-A; MACROMOLECULAR STRUCTURES; GLYCOSIDE HYDROLASES; BETA-GLUCOSIDASE; REFINEMENT; CELLULOSOME; CELJ; CLASSIFICATION; XYLOSIDASE	The crystal structure of Cel44A, which is one of the enzymatic components of the cellulosome of Clostridium thermocellum, was solved at a resolution of 0.96 angstrom. This enzyme belongs to glycoside hydrolase family (GH family) 44. The structure reveals that Cel44A consists of a TIM-like barrel domain and a beta-sandwich domain. The wild-type and the E186Q mutant structures complexed with substrates suggest that two glutamic acid residues, Glu(186) and Glu(359), are the active residues of the enzyme. Biochemical experiments were performed to confirm this idea. The structural features indicate that GH family 44 belongs to clan GH-A and that the reaction catalyzed by Cel44A is retaining type hydrolysis. The stereochemical course of hydrolysis was confirmed by a H-1 NMR experiment using the reduced cellooligosaccharide as a substrate.	Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Mie University; Hokkaido University	Watanabe, N (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	nobuhisa@sci.hokudai.ac.jp	Aizawa, Tomoyasu/F-5278-2011; Watanabe, Nobuhisa/B-1187-2008; Kamiya, Masakatsu/F-5274-2011	Aizawa, Tomoyasu/0000-0001-9134-7576; Watanabe, Nobuhisa/0000-0002-0118-5815; Kitago, Yu/0000-0003-2325-6917				Ahsan MM, 1997, BIOSCI BIOTECH BIOCH, V61, P427, DOI 10.1271/bbb.61.427; Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; BAYER EA, 1986, J BACTERIOL, V167, P823; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coutinho PM, 1999, ROY SOC CH, P3; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; Durand P, 1997, GLYCOBIOLOGY, V7, P277, DOI 10.1093/glycob/7.2.277; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; Madkour M, 2003, CELL BIOL INT, V27, P831, DOI 10.1016/S1065-6995(03)00166-5; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ryttersgaard C, 2002, BIOCHEMISTRY-US, V41, P15135, DOI 10.1021/bi026238c; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; SCHOU C, 1993, EUR J BIOCHEM, V217, P947, DOI 10.1111/j.1432-1033.1993.tb18325.x; Shaw A, 2002, J MOL BIOL, V320, P303, DOI 10.1016/S0022-2836(02)00387-X; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick G.M., 2003, SHELXC; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Zhou Y, 2006, J APPL CRYSTALLOGR, V39, P57, DOI 10.1107/S0021889805039270	35	36	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35703	35711		10.1074/jbc.M706835200	http://dx.doi.org/10.1074/jbc.M706835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17905739	hybrid			2022-12-27	WOS:000251458100031
J	Lin, MT; Chang, CC; Lin, BR; Yang, HY; Chu, CY; Wu, MH; Kuo, ML				Lin, Ming-Tsan; Chang, Cheng-Chi; Lin, Been-Ren; Yang, Hsin-Yu; Chu, Chia-Yu; Wu, Ming-Hsun; Kuo, Min-Liang			Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha(2)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(2)BETA(1) INTEGRIN; ALPHA-2-BETA-1 INTEGRIN; GENE-EXPRESSION; ACTIVATION; ADHESION; IDENTIFICATION; CARCINOMA; PROMOTES; ALPHA(1)BETA(1); ALPHA(6)BETA(1)	Cysteine-rich 61 (Cyr61/CCN1) is involved in human gastric cancer development and progression. Nonetheless, the role of Cyr61 as regards peritoneal dissemination of such cancers has not yet been completely characterized. We used liposome-mediated transfection to establish Cyr61, or antisense Cyr61, expression vectors into gastric cancer AGS or MKN45 cell lines. Transfectants were tested by means of a cancer-cell adhesion assay in vitro and ex vivo. Furthermore, a functional integrin fluorescence-activated cell sorting assay, reverse transcription-PCR, and an AP-1 reporter assay were performed to investigate the potential signaling pathway of Cyr61. It was shown that stable transfection of Cyr61 into the AGS cell line strongly enhanced its adhesion ability. The overexpression of Cyr61 within AGS cells significantly increased the functional expression of integrin alpha(2)beta(1). Function-neutralizing antibody to integrin alpha(2)beta(1) effectively suppressed the Cyr61-mediated enhanced adhesion of AGS cells to peritoneal tissue. Promoter assays of integrin alpha(2) gene further revealed that the AP-1 pathway was evidently activated within Cyr61-expressing AGS cells. Animal studies have revealed that mice injected with Cyr61-overexpressed AGS cells featured a greater number of peritoneal seeding nodules and a lower survival rate than the Neo control cell lines, and when such cells were treated with functional blocking antibody to integrin alpha(2)beta(1), they were able to elicit a decline in the peritoneal dissemination. The data suggest that Cyr61 may contribute to the peritoneal dissemination of gastric cancer by promoting tumor-cell adhesion ability through the up-regulation of the functional integrin alpha(2)beta(1) via an AP-1-dependent pathway.	Natl Taiwan Univ, Coll Med, Inst Toxicol, Lab Mol & Cellular Toxicol, Taipei 100, Taiwan; Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Primary Care Med, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, ML (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Lab Mol & Cellular Toxicol, 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.	toxkml@ha.mc.ntu.edu.tw	wu, larry/AAV-5282-2021; Kuo, Min-Liang/C-4872-2009	wu, larry/0000-0002-8811-9203; CHU, CHIA-YU/0000-0002-9370-3279; KUO, MIN-LIANG/0000-0002-7139-0144; LIN, MING-TSAN/0000-0001-7313-7057; LIN, BEEN-REN/0000-0001-8354-1758				Ajisaka H, 2004, HEPATO-GASTROENTEROL, V51, P900; Aoyagi Keishiro, 2005, Gastric Cancer, V8, P155, DOI 10.1007/s10120-005-0329-4; ASAO T, 1994, CANCER LETT, V78, P57, DOI 10.1016/0304-3835(94)90031-0; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chiu SJ, 2002, J BIOMED SCI, V9, P261, DOI 10.1159/000059427; Cooper CR, 2002, CLIN EXP METASTAS, V19, P25, DOI 10.1023/A:1013849123736; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Gamble J, 1999, ENDOTHELIUM-NEW YORK, V7, P23, DOI 10.3109/10623329909165309; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; HATHORN RW, 1994, CANCER, V74, P1904, DOI 10.1002/1097-0142(19941001)74:7<1904::AID-CNCR2820740713>3.0.CO;2-B; Holloway SE, 2005, J AM COLL SURGEONS, V200, P371, DOI 10.1016/j.jamcollsurg.2004.10.005; Horiuchi H, 2004, J EXP CLIN CANC RES, V23, P599; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; Kobayashi Michiya, 2006, Gastric Cancer, V9, P114, DOI 10.1007/s10120-006-0364-9; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Liang CC, 2001, J BIOL CHEM, V276, P21146, DOI 10.1074/jbc.M010669200; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Lundberg S, 2006, INFLAMM BOWEL DIS, V12, P172, DOI 10.1097/01.MIB.0000217765.96604.83; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Paraskeva PA, 2005, TUMOR BIOL, V26, P94, DOI 10.1159/000085816; Park HB, 2004, BIOCHEM J, V378, P559, DOI 10.1042/BJ20031392; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Sakakura C, 2002, BRIT J CANCER, V87, P1153, DOI 10.1038/sj.bjc.6600580; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Takatsuki H, 2004, CANCER RES, V64, P6065, DOI 10.1158/0008-5472.CAN-04-0321; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Ura H, 1998, SURG TODAY, V28, P1001, DOI 10.1007/BF02483952; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yokoyama F, 2005, BIOCHEMISTRY-US, V44, P9581, DOI 10.1021/bi050598t; Yokoyama T, 2004, CLIN EXP METASTAS, V21, P223, DOI 10.1023/B:CLIN.0000037704.72028.72; Yoo CH, 2000, BRIT J SURG, V87, P236, DOI 10.1046/j.1365-2168.2000.01360.x; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Znoyko I, 2006, MOL CELL BIOCHEM, V282, P89, DOI 10.1007/s11010-006-1400-0; Zutter MM, 1997, BLOOD, V90, P678, DOI 10.1182/blood.V90.2.678.678_678_689; ZUTTER MM, 1994, J BIOL CHEM, V269, P463; ZUTTER MM, 1995, BLOOD, V86, P3006	45	43	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34594	34604		10.1074/jbc.M706600200	http://dx.doi.org/10.1074/jbc.M706600200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17905740	hybrid			2022-12-27	WOS:000251145700073
J	Slutsky-Leiderman, O; Marom, M; Iosefson, O; Levy, R; Maoz, S; Azem, A				Slutsky-Leiderman, Olga; Marom, Milit; Iosefson, Ohad; Levy, Ran; Maoz, Sharon; Azem, Abdussalam			The interplay between components of the mitochondrial protein translocation motor studied using purified components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIM23 PREPROTEIN TRANSLOCASE; INNER MEMBRANE; IMPORT MOTOR; PRESEQUENCE TRANSLOCASE; J-DOMAIN; HSP70; TIM50; COCHAPERONE; COMPLEX; TIM44	The final step of protein translocation across the mitochondrial inner membrane is mediated by a translocation motor composed of 1) the matrix-localized, ATP-hydrolyzing, 70-kDa heat shock protein mHsp70; 2) its anchor to the import channel, Tim44; 3) the nucleotide exchange factor Mge1; and 4) a J-domain-containing complex of co-chaperones, Tim14/Pam18-Tim16/Pam16. Despite its essential role in the biogenesis of mitochondria, the mechanism by which the translocation motor functions is still largely unknown. The goal of this work was to carry out a structure-function analysis of the mitochondrial translocation motor utilizing purified components, with an emphasis on the formation of the Tim44-mHsp70 complex. To this end, we purified Tim44 and monitored its interaction with other components of the motor using cross-linking with bifunctional reagents. The effects of nucleotides, the J-domain-containing components, and the P5 peptide (CALLSAPRR, representing part of the mitochondrial targeting signal of aspartate aminotransferase) on the formation of the translocation motor were examined. Our results show that only the peptide and nucleotides, but not J-domain-containing proteins, affect the Tim44-mHsp70 interaction. Additionally, binding of Tim44 to mHsp70 prevents the formation of a complex between the latter and Tim14/Pam18-Tim16/Pam16. Thus, mutually exclusive interactions between various components of the motor with mHsp70 regulate its functional cycle. The results are discussed in light of known models for the function of the mitochondrial translocation motor.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel	Tel Aviv University	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	azema@tauex.tau.ac.il						Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Deloche O, 1996, J BIOL CHEM, V271, P23960, DOI 10.1074/jbc.271.39.23960; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Josyula R, 2006, J MOL BIOL, V359, P798, DOI 10.1016/j.jmb.2006.04.020; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; LOSEFSON O, 2007, PROTEIN SCI, V16, P316; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VONAHSEN O, 1995, J BIOL CHEM, V270, P29848; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Weiss C, 1999, P NATL ACAD SCI USA, V96, P8890, DOI 10.1073/pnas.96.16.8890; Weiss C, 2002, PROTEIN EXPRES PURIF, V24, P268, DOI 10.1006/prep.2001.1563; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	38	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33935	33942		10.1074/jbc.M704435200	http://dx.doi.org/10.1074/jbc.M704435200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881357	hybrid			2022-12-27	WOS:000251145700006
J	Hanover, JA; Love, DC; DeAngelis, N; O'Kane, ME; Lima-Miranda, R; Schulz, T; Yen, YM; Johnson, RC; Prinz, WA				Hanover, John A.; Love, Dona C.; DeAngelis, Nikki; O'Kane, Meghan E.; Lima-Miranda, Raquel; Schulz, Timothy; Yen, Yi-Meng; Johnson, Reid C.; Prinz, William A.			The high mobility group box transcription factor Nhp6Ap enters the nucleus by a calmodulin-dependent, ran-independent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; SEX REVERSAL; PROTEIN IMPORT; TRANSPORT; BIOLOGY; SRY; RECOGNITION; INHIBITION; DOMAINS; SOX9	A gradient of Ran center dot GTP typically regulates traffic through the nuclear pore by modulating association of receptors with cargo. However, here we demonstrate that the yeast high mobility group box transcription factor Nhp6Ap enters the nucleus via a novel nuclear localization signal recognized by calcium calmodulin in a process that does not require Ran. Calmodulin is strictly required for the nondiffusional nuclear entry of Nhp6Ap. Calmodulin and DNA exhibit mutually exclusive binding to NHP6A, indicating that the directionality of Nhp6Ap nuclear accumulation may be driven by DNA-dependent dissociation of calmodulin. Our findings demonstrate that calmodulin can serve as a molecular switch triggering nuclear entry with subsequent dissociation of calmodulin binding upon interaction of cargo with chromatin. This pathway appears to be evolutionarily conserved; mammalian high mobility group box transcription factors often have two nuclear localization signals: one a classical Ran-dependent signal and a second that binds calmodulin. The finding that Nhp6Ap nuclear entry requires calmodulin but not Ran indicates that Nhp6Ap is a good model for studying this poorly understood but evolutionarily conserved calmodulin-dependent nuclear import pathway.	NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prinz, WA (corresponding author), NIDDK, Lab Cell Biochem & Biol, NIH, 8 Ctr Dr,MSC 0851, Bethesda, MD 20892 USA.	wprinz@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060001, ZIADK060106, Z01DK060106] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; AU KT, 1998, PLANT PHYSIOL, V118, P965; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Au TK, 2000, INT J BIOCHEM CELL B, V32, P1173, DOI 10.1016/S1357-2725(00)00058-3; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Harley VR, 2002, NOVART FDN SYMP, V244, P57; Koopman P, 2003, NATURE, V426, P241, DOI 10.1038/426241a; Larsson G, 2001, PROTEIN SCI, V10, P169, DOI 10.1110/ps.28401; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Paschal BM, 1997, J BIOL CHEM, V272, P21534, DOI 10.1074/jbc.272.34.21534; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Sreenivasan A, 2003, SCIENCE, V302, P2050; Stochaj U, 1999, BIOESSAYS, V21, P579, DOI 10.1002/(SICI)1521-1878(199907)21:7<579::AID-BIES6>3.0.CO;2-E; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x	28	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33743	33751		10.1074/jbc.M705875200	http://dx.doi.org/10.1074/jbc.M705875200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878171	hybrid			2022-12-27	WOS:000250840200056
J	Healy-Fried, ML; Funke, T; Priestman, MA; Han, H; Schonbrunn, E				Healy-Fried, Martha L.; Funke, Todd; Priestman, Melanie A.; Han, Huijong; Schoenbrunn, Ernst			Structural basis of glyphosate tolerance resulting from mutations of Pro(101) in Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; SHIKIMATE PATHWAY; LOLIUM-RIGIDUM; PROTEIN MODELS; SUBSTITUTION; GENE; INHIBITION; PNEUMONIAE	Glyphosate, the world's most used herbicide, is a massive success because it enables efficient weed control with minimal animal and environmental toxicity. The molecular target of glyphosate is 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which catalyzes the sixth step of the shikimate pathway in plants and microorganisms. Glyphosate-tolerant variants of EPSPS constitute the basis of genetically engineered herbicide-tolerant crops. A single-site mutation of Pro(101) in EPSPS (numbering according to the enzyme from Escherichia coli) has been implicated in glyphosate-resistant weeds, but this residue is not directly involved in glyphosate binding, and the basis for this phenomenon has remained unclear in the absence of further kinetic and structural characterization. To probe the effects of mutations at this site, E. coli EPSPS enzymes were produced with glycine, alanine, serine, or leucine substituted for Pro(101). These mutant enzymes were analyzed by steady-state kinetics, and the crystal structures of the substrate binary and substrate . glyphosate ternary complexes of P101S and P101L EPSPS were determined to between 1.5- and 1.6-angstrom resolution. It appears that residues smaller than leucine may be substituted for Pro(101) without decreasing catalytic efficiency. Any mutation at this site results in a structural change in the glyphosate-binding site, shifting Thr(97) and Gly(96) toward the inhibitor molecule. We conclude that the decreased inhibitory potency observed for glyphosate is a result of these mutation-induced long-range structural changes. The implications of our findings concerning the development and spread of glyphosate-resistant weeds are discussed.	Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Schonbrunn, E (corresponding author), H Lee Moffitt Canc Res Inst, Drug Discovery Program, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org		Han, Huijong/0000-0002-1197-3014	NIGMS NIH HHS [1R01 GM 70633-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070633] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMRHEIN N, 1983, FEBS LETT, V157, P191, DOI 10.1016/0014-5793(83)81143-0; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; BOOCOCK MR, 1983, FEBS LETT, V154, P127, DOI 10.1016/0014-5793(83)80888-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; Eichholtz D.A., 2001, U.S. Patent, Patent No. 6225114; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANZ JE, 1997, GLYPHOSATE UNIQUE GL, P441; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; HASLAM E, 1993, SHIKIMIC ACIDS METAB; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Ng CH, 2003, WEED RES, V43, P108, DOI 10.1046/j.1365-3180.2003.00322.x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Perez-Jones A, 2007, PLANTA, V226, P395, DOI 10.1007/s00425-007-0490-6; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Reddy KN, 2004, WEED TECHNOL, V18, P131, DOI 10.1614/WT-03-059R; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1984, EUR J BIOCHEM, V143, P351, DOI 10.1111/j.1432-1033.1984.tb08379.x; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Wakelin AM, 2004, WEED RES, V44, P453, DOI 10.1111/j.1365-3180.2004.00421.x; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3; [No title captured], Patent No. 6040497	37	67	75	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32949	32955		10.1074/jbc.M705624200	http://dx.doi.org/10.1074/jbc.M705624200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855366	hybrid			2022-12-27	WOS:000250625400043
J	Molday, LL; Wu, WWH; Molday, RS				Molday, Laurie L.; Wu, Winco W. H.; Molday, Robert S.			Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE RETINOSCHISIS; ADHESION MOLECULE; FACTOR-VIII; C2 DOMAIN; FACTOR-VA; DISCOIDIN; EXPRESSION; FAMILY; MUTATIONS; MOUSE	Retinoschisin or RS1 is a discoidin domain-containing protein encoded by the gene responsible for X-linked retinoschisis (XLRS), an early onset macular degeneration characterized by a splitting of the retina. Retinoschisin, expressed and secreted from photoreceptors and bipolar cells as a homo-octameric complex, associates with the surface of these cells where it serves to maintain the cellular organization of the retina and the photoreceptor-bipolar synaptic structure. To gain insight into the role of retinoschisin in retinal cell adhesion and the pathogenesis of XLRS, we have investigated membrane components in retinal extracts that interact with retinoschisin. Unlike the discoidin domain-containing blood coagulation proteins Factor V and Factor VIII, retinoschisin did not bind to phospholipids or retinal lipids reconstituted into unilamellar vesicles or immobilized on microtiter plates. Instead, co-immunoprecipitation studies together with mass spectrometric-based proteomics and Western blotting showed that retinoschisin is associated with a complex consisting of Na/K ATPase (alpha 3, beta 2 isoforms) and the sterile alpha and TIR motif-containing protein SARM1. Double labeling studies for immunofluorescence microscopy confirmed the co-localization of retinoschisin with Na/K ATPase and SARM1 in photoreceptors and bipolar cells of retina tissue. We conclude that retinoschisin binds to Na/K ATPase on photoreceptor and bipolar cells. This interaction may be part of a novel SARM1-mediated cell signaling pathway required for the maintenance of retinal cell organization and photoreceptor-bipolar synaptic structure.	Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Molday, LL (corresponding author), Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	molday@interchange.ubc.ca			NEI NIH HHS [EY 02422] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; CONSORTIUM R, 1998, HUM MOL GENET, V7, P1185; Dyka FM, 2007, INVEST OPHTH VIS SCI, V48, P2491, DOI 10.1167/iovs.06-1465; Fraternali F, 2003, FEBS LETT, V544, P21, DOI 10.1016/S0014-5793(03)00433-2; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; GEORGE NDL, 1995, BRIT J OPHTHALMOL, V79, P697, DOI 10.1136/bjo.79.7.697; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Hiriyanna KT, 1999, HUM MUTAT, V14, P423, DOI 10.1002/(SICI)1098-1004(199911)14:5<423::AID-HUMU8>3.0.CO;2-D; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Lee CC, 2003, STRUCTURE, V11, P99, DOI 10.1016/S0969-2126(02)00941-3; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Molday RS, 2007, EXP EYE RES, V84, P227, DOI 10.1016/j.exer.2005.12.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; ORTEL TL, 1992, J BIOL CHEM, V267, P4189; POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Sikkink SK, 2007, J MED GENET, V44, P225, DOI 10.1136/jmg.2006.047340; SIMPSON DL, 1974, BIOCHEMISTRY-US, V13, P3487, DOI 10.1021/bi00714a011; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; Tantri A, 2004, SURV OPHTHALMOL, V49, P214, DOI 10.1016/j.survophthal.2003.12.007; VANDEWAART P, 1983, BIOCHEMISTRY-US, V22, P2427, DOI 10.1021/bi00279a019; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Weinberg DV, 2001, ARCH OPHTHALMOL-CHIC, V119, P1719; Wetzel RK, 1999, J NEUROSCI, V19, P9878; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Zeibdawi AR, 2001, J BIOL CHEM, V276, P19929, DOI 10.1074/jbc.M004711200	41	90	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32792	32801		10.1074/jbc.M706321200	http://dx.doi.org/10.1074/jbc.M706321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804407	hybrid			2022-12-27	WOS:000250625400028
J	Coster, G; Hayouka, Z; Argaman, L; Strauss, C; Friedler, A; Brandeis, M; Goldberg, M				Coster, Gideon; Hayouka, Zvi; Argaman, Liron; Strauss, Carmit; Friedler, Assaf; Brandeis, Michael; Goldberg, Michal			The DNA damage response mediator MDC1 directly interacts with the anaphase-promoting complex/cyclosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; DEPENDENT PROTEOLYSIS; GENOMIC INSTABILITY; MASS-SPECTROMETRY; BRCT DOMAIN; FHA DOMAIN; CHECKPOINT; PROTEIN; COMPLEX; PHOSPHORYLATION	MDC1 (NFBD1), a mediator of the cellular response to DNA damage, plays an important role in checkpoint activation and DNA repair. Here we identified a cross-talk between the DNA damage response and cell cycle regulation. We discovered that MDC1 binds the anaphase-promoting complex/cyclosome ( APC/C), an E3 ubiquitin ligase that controls the cell cycle. The interaction is direct and is mediated by the tandem BRCA1 C-terminal domains of MDC1 and the C terminus of the Cdc27 ( APC3) subunit of the APC/C. It requires the phosphorylation of Cdc27 and is enhanced after induction of DNA damage. We show that the tandem BRCA1 C-terminal domains of MDC1, known to directly bind the phosphorylated form of histone H2AX (gamma-H2AX), also bind the APC/C by the same mechanism, as phosphopeptides that correspond to the C termini of gamma-H2AX and Cdc27 competed with each other for the binding to MDC1. Our results reveal a link between the cellular response to DNA damage and cell cycle regulation, suggesting that MDC1, known to have a role in checkpoint regulation, executes part of this role by binding the APC/C.	Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Organ Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il	Coster, Gideon/L-6319-2019; Coster, Gideon/B-2781-2009	Coster, Gideon/0000-0002-1449-6655; Goldberg, Michal/0000-0001-9397-2383				Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Malavazi I, 2005, MOL MICROBIOL, V57, P222, DOI 10.1111/j.1365-2958.2005.04671.x; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Mochan TA, 2003, CANCER RES, V63, P8586; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	41	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32053	32064		10.1074/jbc.M705890200	http://dx.doi.org/10.1074/jbc.M705890200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827148	hybrid			2022-12-27	WOS:000250480300026
J	Huang, CH; Lin, TY; Pan, RL; Juang, JL				Huang, Chiu-Hui; Lin, Tzu-Yang; Pan, Rong-Long; Juang, Jyh-Lyh			The involvement of Abl and PTP61F in the regulation of Abi protein localization and stability and lamella formation in Drosophila S2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WAVE2 SIGNALING COMPLEX; C-ABL; TYROSINE KINASE; ACTIN POLYMERIZATION; ENDOPLASMIC-RETICULUM; TRANSFORMING ACTIVITY; BOUND PTP1B; PHOSPHORYLATION; ACTIVATION; ADAPTER	Most aspects of cellular events are regulated by a series of protein phosphorylation and dephosphorylation processes. Abi (Abl interactor protein) functions as a substrate adaptor protein for Abl and a core member of the WAVE complex, relaying signals from Rac to Arp2/3 complex and regulating actin dynamics. It is known that the recruitment of Abi into the lamella promotes polymerization of actin, although how it does this is unclear. In this study, we found PTP61F, a Drosophila homolog of mammalian PTP1B, can reverse the Abl phosphorylation of Abi and colocalizes with Abi in Drosophila S2 cells. Abi can be translocalized from the cytosol to the cell membrane by either increasing Abl or reducing endogenous PTP61F. This reciprocal regulation of Abi phosphorylation is also involved in modulating Abi protein level, which is thought to affect the stability of the WAVE complex. Using mass spectrometry, we identified several important tyrosine phosphorylation sites in Abi. We compared the translocalization and protein half-life of wild type (wt) and phosphomutant Abi and their abilities to restore the lamellipodia structure of the Abi-reduced cells. We found the phosphomutant to have reduced ability to translocalize and to have a protein half-life shorter than that of wt Abi. We also found that although the wt Abi could fully restore the lamellipodia structure, the phosphomutant could not. Together, these findings suggest that the reciprocal regulation of Abi phosphorylation by Abl and PTP61F may regulate the localization and stability of Abi and may regulate the formation of lamella.	Natl Inst Res Inst, Div Mol & Genom Med, Zhunan Town 35053, Miaoli County, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30043, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan	National Tsing Hua University; National Defense Medical Center	Juang, JL (corresponding author), Natl Inst Res Inst, Div Mol & Genom Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	juang@nhri.org.tw	Lin, Tzu-Yang/U-6553-2018; Huang, Chiu-Hui/O-1061-2018; Juang, Jyh-Lyh/E-3944-2010; Lin, Tzu-Yang/D-8300-2013	Lin, Tzu-Yang/0000-0002-1968-177X; Huang, Chiu-Hui/0000-0003-1485-5731; 				Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Cherezova L, 2002, FRONT BIOSCI-LANDMRK, V7, pD164, DOI 10.2741/cherezov; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Maruoka M, 2005, FEBS LETT, V579, P2986, DOI 10.1016/j.febslet.2005.04.052; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038	49	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32442	32452		10.1074/jbc.M702583200	http://dx.doi.org/10.1074/jbc.M702583200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804420	hybrid			2022-12-27	WOS:000250480300067
J	Smith, TK; Kimmel, J; Azzouz, N; Shams-Eldin, H; Schwarz, RT				Smith, Terry K.; Kimmel, Juergen; Azzouz, Nahid; Shams-Eldin, Hosam; Schwarz, Ralph T.			The role of inositol acylation and inositol deacylation in the Toxoplasma gondii glycosylphosphatidylinositol Biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; VARIANT SURFACE GLYCOPROTEIN; MOLECULAR-WEIGHT ANTIGEN; TRYPANOSOMA-BRUCEI; PLASMODIUM-FALCIPARUM; AFRICAN TRYPANOSOMES; SUBSTRATE-SPECIFICITY; STRUCTURAL-ANALYSIS; PROTEIN ANCHORS; PRECURSORS	Toxoplasma gondii is a ubiquitous parasitic protozoan that invades nucleated cells in a process thought to be in part due to several surface glycosylphosphatidylinositol (GPI)-anchored proteins, like the major surface antigenSAG1(P30), which dominates the plasma membrane. The serine protease inhibitors phenylmethylsulfonyl fluoride and diisopropyl fluoride were found to have a profound effect on the T. gondii GPI biosynthetic pathway, leading to the observation and characterization of novel inositol-acylated mannosylated GPI intermediates. This inositol acylation is acyl-CoA-dependent and takes place before mannosylation, but uniquely for this class of inositol-acyltransferase, it is inhibited by phenylmethylsulfonyl fluoride. The subsequent inositol deacylation of fully mannosylated GPI intermediates is inhibited by both phenylmethylsulfonyl fluoride and diisopropyl fluoride. The use of these serine protease inhibitors allows observations as to the timing of inositol acylation and subsequent inositol deacylation of the GPI intermediates. Inositol acylation of the non-mannosylated GPI intermediate D-GlcN alpha 1-6-D-myo-inositol-1HPO4-sn-lipid precedes mannosylation. Inositol deacylation of the fully mannosylated GPI intermediate allows further processing, i. e. addition of GalNAc side chain to the first mannose. Characterization of the phosphatidylinositol moieties present on both free GPIs and GPI-anchored proteins shows the presence of a diacylglycerol lipid, whose sn-2 position contains almost exclusively an C18: 1 acyl chain. The data presented here identify key novel inositol-acylated mannosylated intermediates, allowing the formulation of an updated T. gondii GPI biosynthetic pathway along with identification of the putative genes involved.	Univ Dundee, Coll Life Sci, BCDD, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; Univ Marburg, Med Zentrum Hyg & Med Mikrobiol, D-35043 Marburg, Germany; Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonct UMR CNRS USTL 8576, IFR 147, F-59655 Villeneuve Dascq, France	University of Dundee; Philipps University Marburg; Universite de Lille - ISITE; Universite de Lille	Smith, TK (corresponding author), Univ Dundee, Coll Life Sci, BCDD, Div Biol Chem & Drug Discovery, Dow St, Dundee DD1 5EH, Scotland.	k.smith@dundee.ac.uk			Wellcome Trust [067441] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Azzouz N, 2005, ANAL BIOCHEM, V343, P152, DOI 10.1016/j.ab.2005.04.030; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Boska MD, 2004, CURR HIV RES, V2, P61, DOI 10.2174/1570162043485095; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; DOERING TL, 1989, J BIOL CHEM, V264, P11168; ECKERT V, 1996, GLYCOSCIENCES STATUS, P223; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferguson MAJ, 1999, BBA-MOL BASIS DIS, V1455, P327, DOI 10.1016/S0925-4439(99)00058-7; Flury I, 2000, J BIOL CHEM, V275, P24458, DOI 10.1074/jbc.M003844200; Gerold P, 1999, BIOCHEM J, V344, P731, DOI 10.1042/0264-6021:3440731; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Guther MLS, 2003, BIOCHEMISTRY-US, V42, P14532, DOI 10.1021/bi034869g; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; Heise N, 1996, J BIOL CHEM, V271, P16877, DOI 10.1074/jbc.271.28.16877; HIROSE S, 1992, J BIOL CHEM, V267, P16968; Hong Y, 2006, J BIOL CHEM, V281, P11595, DOI 10.1074/jbc.M513061200; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Kimmel J, 2006, EUKARYOT CELL, V5, P1420, DOI 10.1128/EC.00078-06; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Kravetz JD, 2005, AM J MED, V118, P212, DOI 10.1016/j.amjmed.2004.08.023; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; McConville MJ, 2000, MOL MEMBR BIOL, V17, P1; MCDOWELL W, 1988, POSTTRANSLATIONAL MO, P99; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MENON AK, 2004, ENCY BIOL CHEM, V2, P308; MILNE KG, 1992, EUR J BIOCHEM, V208, P309, DOI 10.1111/j.1432-1033.1992.tb17188.x; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Morita YS, 2000, J BIOL CHEM, V275, P14147, DOI 10.1074/jbc.275.19.14147; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; PUOTI A, 1993, J BIOL CHEM, V268, P7215; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Robinson SA, 2004, PARASITOLOGY, V128, P391, DOI 10.1017/S0031182003004736; SHARMA SD, 1983, J IMMUNOL, V131, P977; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smith TK, 1997, BIOCHEM J, V326, P393, DOI 10.1042/bj3260393; Smith TK, 1997, EMBO J, V16, P6667, DOI 10.1093/emboj/16.22.6667; Smith TK, 1996, J BIOL CHEM, V271, P6476, DOI 10.1074/jbc.271.11.6476; Smith TK, 2002, BIOCHEMISTRY-US, V41, P12395, DOI 10.1021/bi020351l; Smith TK, 1999, EMBO J, V18, P5922, DOI 10.1093/emboj/18.21.5922; Striepen B, 1999, BIOCHEMISTRY-US, V38, P1478, DOI 10.1021/bi981884q; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Sutterlin C, 1998, BIOCHEM J, V332, P153; TOMAVO S, 1992, J BIOL CHEM, V267, P21446; TOMAVO S, 1992, J BIOL CHEM, V267, P11721; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; TOMAVO S, 1993, BIOL CELL, V78, P155, DOI 10.1016/0248-4900(93)90126-Y; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185	56	17	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32032	32042		10.1074/jbc.M703784200	http://dx.doi.org/10.1074/jbc.M703784200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804418	hybrid			2022-12-27	WOS:000250480300024
J	Gazzerro, E; Smerdel-Ramoya, A; Zanotti, S; Stadmeyer, L; Durant, D; Economides, AN; Canalis, E				Gazzerro, Elisabetta; Smerdel-Ramoya, Anna; Zanotti, Stefano; Stadmeyer, Lisa; Durant, Deena; Economides, Aris N.; Canalis, Ernesto			Conditional deletion of gremlin causes a transient increase in bone formation and bone mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEINS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; SKELETAL OVEREXPRESSION; CELL-DIFFERENTIATION; SIGNAL-TRANSDUCTION; RNA INTERFERENCE; TRANSGENIC MICE; BMP ANTAGONIST; STROMAL CELLS	Gremlin is a glycoprotein that binds bone morphogenetic proteins (BMPs) 2, 4, and 7, antagonizing their actions. Gremlin opposes BMP effects on osteoblastic differentiation and function in vitro and in vivo, and its overexpression causes osteopenia. To define the function of gremlin in the skeleton, we generated gremlin 1 (grem1) conditional null mice by mating mice where grem1 was flanked by lox(P) sequences with mice expressing the Cre recombinase under the control of the osteocalcin promoter. grem1 null male mice displayed increased trabecular bone volume due to enhanced osteoblastic activity, because mineral apposition and bone formation rates were increased. Osteoblast number and bone resorption were not altered. Marrow stromal cells from grem1 conditional null mice expressed higher levels of alkaline phosphatase activity. Gremlin down-regulation by RNA interference in ST-2 stromal and MC3T3 osteoblastic cells increased the BMP-2 stimulatory effect on alkaline phosphatase activity, on Smad 1/5/8 phosphorylation, and on the transactivation of the BMP/Smad reporter construct 12 x SBE-Oc-pGL3. Gremlin down-regulation also enhanced osteocalcin and Runx-2 expression, Wnt 3a signaling, and activity in ST-2 cells. In conclusion, deletion of grem1 in the bone microenvironment results in sensitization of BMP signaling and activity and enhanced bone formation in vivo.	St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; Univ Connecticut, Sch Med, Farmington, CT 06030 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Saint Francis Hospital & Medical Center; University of Connecticut; Regeneron	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org		Economides, Aris/0000-0002-6508-8942	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR021707, R37AR021707] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR21707] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams NC, 2006, PRIN PRACT, P131; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Devlin RD, 2002, ENDOCRINOLOGY, V143, P3955, DOI 10.1210/en.2002-220129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Frenkel B, 1997, ENDOCRINOLOGY, V138, P2109, DOI 10.1210/en.138.5.2109; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gazzerro E, 1999, ENDOCRINOLOGY, V140, P562, DOI 10.1210/en.140.2.562; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; HARRIS SE, 1994, J BONE MINER RES, V9, P389; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RC, 2000, J CELL PHYSIOL, V182, P239, DOI 10.1002/(SICI)1097-4652(200002)182:2<239::AID-JCP13>3.0.CO;2-W; Pereira RC, 2000, ENDOCRINOLOGY, V141, P4558, DOI 10.1210/en.141.12.4558; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	56	84	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31549	31557		10.1074/jbc.M701317200	http://dx.doi.org/10.1074/jbc.M701317200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785465	hybrid			2022-12-27	WOS:000250309200047
J	Leclerc, E; Fritz, G; Weibel, M; Heizmann, CW; Galichet, A				Leclerc, Estelle; Fritz, Gunter; Weibel, Mirjam; Heizmann, Claus W.; Galichet, Arnaud			S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; NF-KAPPA-B; NEURITE OUTGROWTH; TRANSGENIC MICE; ALZHEIMERS-DISEASE; SURFACE RECEPTOR; SPLICE VARIANTS; GROWTH-FACTOR; EXPRESSION; ACTIVATION	S100 proteins are EF-hand calcium-binding proteins with various intracellular functions including cell proliferation, differentiation, migration, and apoptosis. Some S100 proteins are also secreted and exert extracellular paracrine and autocrine functions. Experimental results suggest that the receptor for advanced glycation end products (RAGE) plays important roles in mediating S100 protein-induced cellular signaling. Here we compared the interaction of two S100 proteins, S100B and S100A6, with RAGE by in vitro assay and in culture of human SH-SY5Y neuroblastoma cells. Our in vitro binding data showed that S100B and S100A6, although structurally very similar, interact with different RAGE extracellular domains. Our cell assay data demonstrated that S100B and S100A6 differentially modulate cell survival. At micromolar concentration, S100B increased cellular proliferation, whereas at the same concentration, S100A6 triggered apoptosis. Although both S100 proteins induced the formation of reactive oxygen species, S100B recruited phosphatidylinositol 3-kinase/AKT and NF-kappa B, whereas S100A6 activated JNK. More importantly, we showed that S100B and S100A6 modulate cell survival in a RAGE-dependent manner; S100B specifically interacted with the RAGE V and C-1 domains and S100A6 specifically interacted with the C1 and C-2 RAGE domains. Altogether these results highlight the complexity of S100/RAGE cellular signaling.	Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Zurich; State University System of Florida; Florida Atlantic University; University of Konstanz	Galichet, A (corresponding author), Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	arnaud.galichet@kispi.uzh.ch	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812				Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; BRETT J, 1993, AM J PATHOL, V143, P1699; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Duarte WR, 1999, BIOCHEM BIOPH RES CO, V255, P416, DOI 10.1006/bbrc.1999.0214; FRIEND WC, 1992, J NEUROSCI, V12, P4337; FRITZ G, 2004, HDB METALLOPROTEINS, V3, P529; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Heizmann C. W., 2007, V45, P93; Heizmann CW, 2005, J PEDIATR-US, V147, P731, DOI 10.1016/j.jpeds.2005.08.046; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hoyaux D, 2002, J NEUROPATH EXP NEUR, V61, P736, DOI 10.1093/jnen/61.8.736; Hoyaux D, 2000, BBA-MOL CELL RES, V1498, P264, DOI 10.1016/S0167-4889(00)00101-4; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mbeunkui F, 2007, J PROTEOME RES, V6, P2993, DOI 10.1021/pr060629m; Mikkelsen SE, 2001, J NEUROCHEM, V79, P767, DOI 10.1046/j.1471-4159.2001.00605.x; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ostendorp T, 2006, BIOCHEM BIOPH RES CO, V347, P4, DOI 10.1016/j.bbrc.2006.04.077; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sajithlal G, 2002, J BIOL CHEM, V277, P6888, DOI 10.1074/jbc.M107627200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tiu SC, 2000, DEV BRAIN RES, V119, P159, DOI 10.1016/S0165-3806(99)00151-0; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; VANELDIK LJ, 1984, P NATL ACAD SCI-BIOL, V81, P6034; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wainwright MS, 2004, ANN NEUROL, V56, P61, DOI 10.1002/ana.20142; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamashita N, 1997, BRAIN RES, V778, P388, DOI 10.1016/S0006-8993(97)01025-1; Yamashita N, 1999, J COMP NEUROL, V404, P235; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	67	207	218	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31317	31331		10.1074/jbc.M703951200	http://dx.doi.org/10.1074/jbc.M703951200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726019	hybrid			2022-12-27	WOS:000250309200021
J	Repetto, E; Yoon, IS; Zheng, H; Kang, DE				Repetto, Emanuela; Yoon, Il-Sang; Zheng, Hui; Kang, David E.			Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; TRANSGENIC MOUSE MODELS; BETA-CATENIN; EGF RECEPTOR; TYROSINE PHOSPHORYLATION; MISSENSE MUTATIONS; CELL-SURFACE; MICE LACKING	Mutations in the gene encoding presenilin 1 (PS1) cause the most aggressive form of early-onset familial Alzheimer disease. In addition to its well established role in A beta production and Notch proteolysis, PS1 has been shown to mediate other physiological activities, such as regulation of the Wnt/beta-catenin signaling pathway, modulation of phosphatidylinositol 3-kinase/Akt and MEK/ERK signaling, and trafficking of select membrane proteins and/or intracellular vesicles. In this study, we present evidence that PS1 is a critical regulator of a key signaling receptor tyrosine kinase, epidermal growth factor receptor (EGFR). Specifically, EGFR levels were robustly increased in fibroblasts deficient in both PS1 and PS2 (PS-/-) due to delayed turnover of EGFR protein. Stable transfection of wild-type PS1 but not PS2 corrected EGFR to levels comparable to PS+/+ cells, while FAD PS1 mutations showed partial loss of activity. The C-terminal fragment of PS1 was sufficient to fully reduce EGFR levels. In addition, the rapid ligand-induced degradation of EGFR was markedly delayed in PS+/+ cells, resulting in prolonged signal activation. Despite the defective turnover of EGFR, ligand-induced autophosphorylation, ubiquitination, and endocytosis of EGFR were not affected by the lack of PS1. Instead, the trafficking of EGFR from early endosomes to lysosomes was severely delayed by PS1 deficiency. Elevation of EGFR was also seen in brains of adult mice conditionally ablated in PS1 and in skin tumors associated with the loss of PS1. These findings demonstrate a critical role of PS1 in the trafficking and turnover of EGFR and suggest potential pathogenic effects of elevated EGFR as well as perturbed endosomal-lysosomal trafficking in cell cycle control and Alzheimer disease.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci, Leichtag Biomed Res 380,9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	REPETTO, EMANUELA/0000-0002-6270-3540; Kang, David E./0000-0002-7132-821X				Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; BIRECREE E, 1988, J NEUROPATH EXP NEUR, V47, P549, DOI 10.1097/00005072-198809000-00006; Burke PM, 1999, J CELL PHYSIOL, V180, P448, DOI 10.1002/(SICI)1097-4652(199909)180:3<448::AID-JCP16>3.0.CO;2-8; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; CASPER D, 1995, J NEUROCHEM, V65, P1016; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cha YK, 2000, J NEUROCHEM, V75, P298, DOI 10.1046/j.1471-4159.2000.0750298.x; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ghanevati M, 2005, J MOL NEUROSCI, V25, P79, DOI 10.1385/JMN:25:1:079; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kil SJ, 1999, J BIOL CHEM, V274, P3141, DOI 10.1074/jbc.274.5.3141; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; MAIESE K, 1995, J CEREBR BLOOD F MET, V15, P440, DOI 10.1038/jcbfm.1995.55; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Park KHJ, 2007, J NEUROSCI, V27, P2969, DOI 10.1523/JNEUROSCI.0186-07.2007; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Pigino G, 2003, J NEUROSCI, V23, P4499; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Takahashi K, 1997, ONCOGENE, V15, P71, DOI 10.1038/sj.onc.1201160; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Uemura K, 2003, J NEUROSCI RES, V74, P184, DOI 10.1002/jnr.10753; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yang Y, 2006, J NEUROSCI, V26, P775, DOI 10.1523/JNEUROSCI.3707-05.2006; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	60	64	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31504	31516		10.1074/jbc.M704273200	http://dx.doi.org/10.1074/jbc.M704273200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716970	hybrid			2022-12-27	WOS:000250309200042
J	Casi, G; Hilvert, D				Casi, Giulio; Hilvert, Donald			Reinvestigation of a selenopeptide with purportedly high glutathione peroxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE CHEMICAL LIGATION; SYNTHETIC ORGANOSELENIUM COMPOUNDS; CYCLIC-PEPTIDES; SELENOCYSTEINE; CHEMISTRY; CHYMOTRYPSIN; SPECIFICITY; RESOLUTION; ENZYMES; TRYPSIN	A 15-amino acid long selenopeptide (15SeP) was recently reported to possess nearly the same catalytic activity as glutathione peroxidase (Gpx) for the reduction of hydrogen peroxide by glutathione (Sun, Y., Li, T. Y., Chen, H., Zhang, K., Zheng, K. Y., Mu, Y., Yan, G. L., Li, W., Shen, J. C., and Luo, G. M. (2004) J. Biol. Chem. 279, 37235-37240). Such a finding is startling considering the high efficiency of the natural enzyme and the modest catalytic properties of most short peptides. As 15SeP had been subjected only to limited chemical characterization, we prepared it by a new route involving selenocysteine-mediated native chemical ligation. High resolution matrix-assisted laser desorption ionization mass spectrometry confirmed the identity of the reaction product, whereas circular dichroism spectroscopy showed that 15SeP assumes a random coil conformation in solution. Although low levels of peroxidase activity were detectable under standard assay conditions, the peptide is >5 orders of magnitude less active than native Gpx. Our observations are incompatible with claims ascribing remarkable catalytic properties to 15SeP and suggest that the efficiency of Gpx derives from its well defined three-dimensional structure.	ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, Honggerberg HCI F 339, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch						[Anonymous], 1980, ENZYMATIC BASIS DETO; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; ATASSI MZ, 1993, P NATL ACAD SCI USA, V90, P8282, DOI 10.1073/pnas.90.17.8282; Boschi-Muller S, 1998, FEBS LETT, V439, P241, DOI 10.1016/S0014-5793(98)01377-5; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COREY DR, 1994, P NATL ACAD SCI USA, V91, P4106, DOI 10.1073/pnas.91.10.4106; Corey MJ, 1996, P NATL ACAD SCI USA, V93, P11428, DOI 10.1073/pnas.93.21.11428; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; FLOHE L, 1972, H-S Z PHYSIOL CHEM, V353, P987, DOI 10.1515/bchm2.1972.353.1.987; FLOHE L, 1969, BIOCHIM BIOPHYS ACTA, V191, P541, DOI 10.1016/0005-2744(69)90347-7; GANTHER HE, 1984, METHOD ENZYMOL, V107, P593; Gieselman MD, 2001, ORG LETT, V3, P1331, DOI 10.1021/ol015712o; HAHN KW, 1990, SCIENCE, V248, P1544, DOI 10.1126/science.2360048; HANCOCK WS, 1976, ANAL BIOCHEM, V71, P260, DOI 10.1016/0003-2697(76)90034-8; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; KNORR R, 1989, TETRAHEDRON LETT, V30, P1927, DOI 10.1016/S0040-4039(00)99616-3; MATTHEWS BW, 1994, P NATL ACAD SCI USA, V91, P4103, DOI 10.1073/pnas.91.10.4103; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; Mugesh G, 2000, CHEM SOC REV, V29, P347, DOI 10.1039/a908114c; Mugesh G, 2001, CHEM REV, V101, P2125, DOI 10.1021/cr000426w; Quaderer R, 2001, HELV CHIM ACTA, V84, P1197, DOI 10.1002/1522-2675(20010516)84:5<1197::AID-HLCA1197>3.0.CO;2-#; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Sies H, 1997, Adv Pharmacol, V38, P229; Sun Y, 2004, J BIOL CHEM, V279, P37235, DOI 10.1074/jbc.M403032200; URSINI F, 1995, METHOD ENZYMOL, V252, P38; von Eggelkraut-Gottanka R, 2003, TETRAHEDRON LETT, V44, P3551, DOI 10.1016/S0040-4039(03)00582-3; WELLS JA, 1994, P NATL ACAD SCI USA, V91, P4110, DOI 10.1073/pnas.91.10.4110; Wendel A, 1981, Methods Enzymol, V77, P325; WU ZP, 1990, J AM CHEM SOC, V112, P5647, DOI 10.1021/ja00170a043; Yu HJ, 2005, J BIOL CHEM, V280, P11930, DOI 10.1074/jbc.M408574200	30	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30518	30522		10.1074/jbc.M705528200	http://dx.doi.org/10.1074/jbc.M705528200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724019	hybrid			2022-12-27	WOS:000250136300019
J	Marron, MB; Singh, H; Tahir, TA; Kavumkal, J; Kim, HZ; Koh, GY; Brindle, NPJ				Marron, Marie B.; Singh, Harprit; Tahir, Tariq A.; Kavumkal, Jais; Kim, Hak-Zoo; Koh, Gou Young; Brindle, Nicholas P. J.			Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE CLEAVAGE; GAMMA-SECRETASE; INTRACELLULAR DOMAIN; CONVERTING-ENZYME; DISINTEGRIN-METALLOPROTEASE; SOLUBLE TIE; NOTCH; ANGIOPOIETIN-1	Regulated ectodomain shedding followed by intramembrane proteolysis has recently been recognized as important in cell signaling and for degradation of several type I transmembrane proteins. The receptor-tyrosine kinase Tie1 is known to undergo ectodomain cleavage generating a membrane-tethered endodomain. Here we show Tie1 is a substrate for regulated intramembrane proteolysis. After Tie1 ectodomain cleavage the newly formed 45-kDa endodomain undergoes additional proteolytic processing mediated by gamma-secretase to generate an amino-terminal-truncated 42-kDa fragment that is subsequently degraded by proteasomal activity. This sequential processing occurs constitutively and is stimulated by phorbol ester and vascular endothelial growth factor. To assess the biological significance of regulated Tie1 processing, we analyzed its effects on angiopoietin signaling. Activation of ectodomain cleavage causes loss of phosphorylated Tie1 holoreceptor and generation of phosphorylated receptor fragments in the presence of cartilage oligomeric protein angiopoietin 1. A key function of gamma-secretase is in preventing accumulation of these phosphorylated fragments. We also find that regulated Tie1 processing modulates ligand responsiveness of the Tie-1-associated receptor Tie2. Activation of Tie1 ectodomain cleavage increases cartilage oligomeric protein angiopoietin 1 activation of Tie2. This correlates with increased ability of Tie2 to bind ligand after shedding of the Tie1 extracellular domain. A similar enhancement of ligand activation of Tie2 is seen when Tie1 expression is suppressed by RNA interference. Together these data indicate that Tie1, via its extracellular domain, limits the ability of ligand to bind and activate Tie2. Furthermore the data suggest that regulated processing of Tie1 may be an important mechanism for controlling signaling by Tie2.	Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England; Korea Adv Inst Sci & Technol, Biomed Ctr, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	University of Leicester; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Brindle, NPJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, POB 65, Leicester LE2 7LX, Leics, England.	npjb1@le.ac.uk	Koh, Gou Young/C-1615-2011	Tahir, Tariq/0000-0002-3992-6877; Brindle, Nicholas/0000-0002-4221-677X; Singh, Harprit/0000-0003-2337-3523	British Heart Foundation [PG/03/094/15787, PG/05/028/18599] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; Hooper NM, 2000, BIOCHEM SOC T, V28, P441, DOI 10.1042/0300-5127:0280441; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MATTHEWS JA, 1985, ANAL BIOCHEM, V151, P205, DOI 10.1016/0003-2697(85)90073-9; McCarthy MJ, 1999, LAB INVEST, V79, P889; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Partanen J, 1996, DEVELOPMENT, V122, P3013; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Porat RM, 2004, CIRC RES, V94, P394, DOI 10.1161/01.RES.0000111803.92923.D6; Price CJ, 2000, ARTERIOSCL THROM VAS, V20, P2051, DOI 10.1161/01.ATV.20.9.2051; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Wajih N, 2002, CIRC RES, V90, P46, DOI 10.1161/hh0102.102756; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yabkowitz R, 1997, BLOOD, V90, P706, DOI 10.1182/blood.V90.2.706.706_706_715; Yang XH, 2003, TUMOR BIOL, V24, P61, DOI 10.1159/000071078; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966	56	86	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30509	30517		10.1074/jbc.M702535200	http://dx.doi.org/10.1074/jbc.M702535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728252	Green Accepted, hybrid			2022-12-27	WOS:000250136300018
J	Teuscher, F; Lowther, J; Skinner-Adams, TS; Spielmann, T; Dixon, MWA; Stack, CM; Donnelly, S; Mucha, A; Kafarski, P; Vassiliou, S; Gardiner, DL; Dalton, JP; Trenholme, KR				Teuscher, Franka; Lowther, Jonathan; Skinner-Adams, Tina S.; Spielmann, Tobias; Dixon, Matthew W. A.; Stack, Colin M.; Donnelly, Sheila; Mucha, Artur; Kafarski, Pawel; Vassiliou, Stamatia; Gardiner, Donald L.; Dalton, John P.; Trenholme, Katharine R.			The m18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEASES; INHIBITION; IDENTIFICATION; DIGESTION; ACID; GENE	A member of the M18 family of aspartyl aminopeptidases is expressed by all intra-erythrocytic stages of the human malaria parasite Plasmodium falciparum ( PfM18AAP), with highest expression levels in rings. Functionally active recombinant enzyme, rPfM18AAP, and native enzyme in cytosolic extracts of malaria parasites are 560-kDa octomers that exhibit optimal activity at neutral pH and require the presence of metal ions to maintain enzymatic activity and stability. Like the human aspartyl aminopeptidase, the exopeptidase activity of PfM18AAP is exclusive to N-terminal acidic amino acids, glutamate and aspartate, making this enzyme of particular interest and suggesting that it may function alongside the malaria cytosolic neutral aminopeptidases in the release of amino acids from host hemoglobin-derived peptides. Whereas immunocytochemical studies using transgenic P. falciparum parasites show that PfM18AAP is expressed in the cytosol, immunoblotting experiments revealed that the enzyme is also trafficked out of the parasite into the surrounding parasitophorous vacuole. Antisense-mediated knockdown of PfM18AAP results in a lethal phenotype as a result of significant intracellular damage and validates this enzyme as a target at which novel antimalarial drugs could be directed. Novel phosphinic derivatives of aspartate and glutamate showed modest inhibition of rPfM18AAP but did not inhibit malaria growth in culture. However, we were able to draw valuable observations concerning the structure-activity relationship of these inhibitors that can be employed in future inhibitor optimization studies.	Queensland Inst Med Res, Malaria Biol Lab, Brisbane, Qld 4006, Australia; Univ Technol Sydney, IBID, Sydney, NSW 2007, Australia; Univ Queensland, Dept Med, Cent Clin Div, Brisbane, Qld 4072, Australia; Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland; Univ Athens, Dept Chem, Organ Chem Lab, GR-15771 Athens, Greece	QIMR Berghofer Medical Research Institute; University of Technology Sydney; University of Queensland; Wroclaw University of Science & Technology; National & Kapodistrian University of Athens	Vassiliou, S (corresponding author), Queensland Inst Med Res, Malaria Biol Lab, 300 Herston Rd, Brisbane, Qld 4006, Australia.	Katharine.Trenholme@qimr.edu.au	Dixon, Matthew/N-4503-2019; Gardiner, Don/G-4717-2010; Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Dixon, Matthew/A-2412-2009; Skinner-Adams, Tina S/A-9798-2012; Kafarski, Paweł/AAA-9112-2019; Trenholme, Katharine/C-9244-2013; Vassiliou, Stamatia/AAD-5048-2020	Dixon, Matthew/0000-0001-9732-9686; Skinner-Adams, Tina S/0000-0001-7011-3850; Mucha, Artur/0000-0002-6421-1371; Spielmann, Tobias/0000-0002-3968-4601; Donnelly, Sheila/0000-0003-2005-3698; Vassiliou, Stamatia/0000-0002-0734-6579; Stack, Colin/0000-0002-7539-7677				Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Becker K, 2004, TRENDS PARASITOL, V20, P590, DOI 10.1016/j.pt.2004.09.004; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Chen XC, 2006, P NATL ACAD SCI USA, V103, P14548, DOI 10.1073/pnas.0604101103; CHULAY JD, 1987, J IMMUNOL, V139, P2768; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Gardiner DL, 2000, MOL BIOCHEM PARASIT, V110, P33, DOI 10.1016/S0166-6851(00)00254-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gardiner DL, 2004, PARASITOL RES, V93, P590, DOI 10.1007/s00436-004-1098-4; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Georgiadis D, 1999, TETRAHEDRON, V55, P14635, DOI 10.1016/S0040-4020(99)00910-2; GLAUERT AM, 1974, PRACTICAL METHODS EL, V3, P1; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Grembecka J, 2003, J MED CHEM, V46, P2641, DOI 10.1021/jm030795v; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; KAFARSKI P, 2000, AMINOPHOSPHONIC AMIN, P33; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lauterbach SB, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-47; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Nankya-Kitaka MF, 1998, PARASITOL RES, V84, P552, DOI 10.1007/s004360050447; NWAGWU M, 1992, EXP PARASITOL, V75, P399, DOI 10.1016/0014-4894(92)90253-7; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2006, INT J PARASITOL, V36, P1245, DOI 10.1016/j.ijpara.2006.06.017; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; Vartak DG, 2007, J DRUG TARGET, V15, P1, DOI 10.1080/10611860600968967; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Wilk S, 2002, ARCH BIOCHEM BIOPHYS, V407, P176, DOI 10.1016/S0003-9861(02)00494-0; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Wright JW, 1997, BRAIN RES REV, V25, P96, DOI 10.1016/S0165-0173(97)00019-2; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x	36	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30817	30826		10.1074/jbc.M704938200	http://dx.doi.org/10.1074/jbc.M704938200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720817	hybrid			2022-12-27	WOS:000250136300050
J	Kim, BJ; Kim, SY; Lee, H				Kim, Byung Ju; Kim, So-Young; Lee, Hoyun			Identification and characterization of human Cdc7 nuclear retention and export sequences in the context of chromatin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CELL-CYCLE; PROTEIN-KINASE; S-PHASE; CYTOPLASMIC LOCALIZATION; MAMMALIAN-CELLS; LEPTOMYCIN B; INITIATION; COMPLEX; SIGNAL	The Cdc7 serine/threonine kinase activates the initiation of DNA replication by phosphorylating MCM proteins that are bound to the origins of DNA replication. We reported previously that human Cdc7 nuclear import is mediated directly by importin-beta through its binding to the Cdc7 nuclear localization sequence (NLS). Here, we report that human Cdc7 nuclear localization is regulated by two additional elements: nuclear retention (NRS) and export sequences (NES). Cdc7 proteins imported into the nucleus are retained in the nucleus by associating with chromatin, for which NRS-(306-326) is essential. Importantly, this binding appears to be specific to the origin of DNA replication, because the binding of wild-type Cdc7 to origin is 2.4-fold higher than to non-origin DNA. Furthermore, an NRS- defective Cdc7 mutant could not be retained in the nucleus, although it was imported into the nucleus normally. Together, our data suggest that NRS plays an important role in the activation of DNA replication by Cdc7. The Cdc7 proteins unassociated with chromatin are bound by CRM1 via two NES elements: NES1 at 458 467 within kinase insert III, and NES2 at 545-554 within the kinase IX domain. The primary function of the Cdc7-CRM1 association may be to translocate nuclear Cdc7 to the cytoplasm. However, the binding of CRM1 with Cdc7 at NES2 raises an interesting possibility that CRM1 may also down-regulate Cdc7 by masking its kinase domain.	Sudbury Reg Hosp, NE Ontario Reg Canc Program, Tumour Biol Grp, Sudbury, ON P3E 5J1, Canada; Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1M 8M5, Canada; No Ontario Sch Med, Dept Med Sci, Sudbury, ON P3E 2C6, Canada	Health Sciences North; University of Ottawa; Northern Ontario School of Medicine	Lee, H (corresponding author), Sudbury Reg Hosp, NE Ontario Reg Canc Program, Tumour Biol Grp, Sudbury, ON P3E 5J1, Canada.	hlee@hrsrh.on.ca						Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Guo BQ, 1999, SOMAT CELL MOLEC GEN, V25, P159, DOI 10.1023/A:1018841506868; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; Kanwal C, 2002, AAPS PHARMSCI, V4; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kim JM, 2003, MUTAT RES-FUND MOL M, V532, P29, DOI 10.1016/j.mrfmmm.2003.08.008; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Lei M, 2001, J CELL SCI, V114, P1447; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H., 1999, FRONT BIOSCI, V4, pD834; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; RYSECK RP, 1995, MOL CELL BIOL, V15, P3100; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Young MR, 1997, MOL BIOL CELL, V8, P1587, DOI 10.1091/mbc.8.8.1587	49	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30029	30038		10.1074/jbc.M703705200	http://dx.doi.org/10.1074/jbc.M703705200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711849	hybrid			2022-12-27	WOS:000249981200033
J	Ji, ZY; Mei, FC; Johnson, BH; Thompson, EB; Cheng, XD				Ji, Zhenyu; Mei, Fang C.; Johnson, Betty H.; Thompson, E. Brad; Cheng, Xiaodong			Protein kinase a, not Epac, suppresses Hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; INDUCED APOPTOSIS; LYMPHOID-CELLS; CEM CELLS; EVOKED APOPTOSIS; CYCLIC-AMP; T-CELLS; ACTIVATION; CAMP; PATHWAY	Cyclic AMP synergizes strongly with glucocorticoids (GC) to induce apoptosis in normal or malignant lymphoid cells. We examined the individual roles that cAMP-dependent protein kinase (PKA) and Epac (exchange protein directly activated by cAMP), two intracellular cAMP receptors, play in this synergistic effect. Our studies demonstrate that PKA is responsible for the observed synergism with GC, whereas Epac exerts a weak antagonistic effect against GC-induced apoptosis. We find that endogenous PKA activity is higher in the GC-sensitive clone than in the GC-resistant clone. In the GC-sensitive clone, higher PKA activity is associated with lower Hedgehog (Hh) activity. Moreover, inhibition of Hh activity by Hh pathway-specific inhibitors leads to cell cycle arrest and apoptosis in CEM (human acute lymphoblastic leukemia, T lineage) cells, and the GC-sensitive clone is more sensitive to Hh inhibition. These results suggest that Hh activity is critical for leukemia cell growth and survival and that the level of Hh activity is in part responsible for the synergism between cAMP and GC.	[Ji, Zhenyu; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Sch Med, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Johnson, Betty H.; Thompson, E. Brad] Univ Texas Med Branch, Sch Med, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cheng, XD (corresponding author), Univ Texas Med Branch, Sch Med, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NCI NIH HHS [CA041407] Funding Source: Medline; NIDDK NIH HHS [1 R90 DK071505-01, 1 T90 DK070109-01] Funding Source: Medline; NIEHS NIH HHS [ES06676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505, T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Benazeraf B, 2006, DEV BIOL, V294, P133, DOI 10.1016/j.ydbio.2006.02.035; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chen BY, 2006, J BIOMED SCI, V13, P373, DOI 10.1007/s11373-005-9050-x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Coffino P, 1976, Recent Prog Horm Res, V32, P669; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Medh RD, 1998, CANCER RES, V58, P3684; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Medh RD, 2001, ONCOGENE, V20, P4629, DOI 10.1038/sj.onc.1204680; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Mei FC, 2005, FASEB J, V19, P497, DOI 10.1096/fj.05-4586fje; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Oancea Marcela, 2006, V129, P279; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; SIMONS SS, 1980, P NATL ACAD SCI-BIOL, V77, P5167, DOI 10.1073/pnas.77.9.5167; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thompson EB, 1999, J STEROID BIOCHEM, V69, P453, DOI 10.1016/S0960-0760(99)00063-1; Thompson EB, 1999, TRENDS ENDOCRIN MET, V10, P353, DOI 10.1016/S1043-2760(99)00187-3; THULASI R, 1993, J BIOL CHEM, V268, P18306; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; ZAWYDIWSKI R, 1983, CANCER RES, V43, P3865; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhou F, 2000, J STEROID BIOCHEM, V73, P195, DOI 10.1016/S0960-0760(00)00080-7	49	42	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37370	37377		10.1074/jbc.M703697200	http://dx.doi.org/10.1074/jbc.M703697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17895245	hybrid			2022-12-27	WOS:000251833600011
J	Chrencik, JE; Brooun, A; Recht, MI; Nicola, G; Davis, LK; Abagyan, R; Widmer, H; Pasquale, EB; Kuhn, P				Chrencik, Jill E.; Brooun, Alexei; Recht, Michael I.; Nicola, George; Davis, Leila K.; Abagyan, Ruben; Widmer, Hans; Pasquale, Elena B.; Kuhn, Peter			Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EPH RECEPTORS; EXPRESSION; MECHANISMS; EPHRIN-B2; MIGRATION; INVASION; MUTATION; LIGANDS; GROWTH	The Eph family of receptor tyrosine kinases has been implicated in tumorigenesis as well as pathological forms of angiogenesis. Understanding how to modulate the interaction of Eph receptors with their ephrin ligands is therefore of critical interest for the development of therapeutics to treat cancer. Previous work identified a set of 12-mer peptides that displayed moderate binding affinity but high selectivity for the EphB2 receptor. The SNEW antagonistic peptide inhibited the interaction of EphB2 with ephrinB2, with an IC50 of similar to 15 mu M. To gain a better molecular understanding of how to inhibit Eph/ephrin binding, we determined the crystal structure of the EphB2 receptor in complex with the SNEW peptide to 2.3-angstrom resolution. The peptide binds in the hydrophobic ligand-binding cleft of the EphB2 receptor, thus competing with the ephrin ligand for receptor binding. However, the binding interactions of the SNEW peptide are markedly different from those described for the TNYLRAW peptide, which binds to the ligand-binding cleft of EphB4, indicating a novel mode of antagonism. Nevertheless, we identified a conserved structural motif present in all known receptor/ligand interfaces, which may serve as a scaffold for the development of therapeutic leads. The EphB2-SNEW complex crystallized as a homodimer, and the residues involved in the dimerization interface are similar to those implicated in mediating tetramerization of EphB2-ephrinB2 complexes. The structure of EphB2 in complex with the SNEW peptide reveals novel binding determinants that could serve as starting points in the development of compounds that modulate Eph receptor/ephrin interactions and biological activities.	Scripps Res Inst, Dept Cellular Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Palo Alto Res Ctr, Scripps PARC, Inst Adv Biomed Sci, Palo Alto, CA 94304 USA; Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; Burnham Inst Med Res, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Novartis; Sanford Burnham Prebys Medical Discovery Institute	Kuhn, P (corresponding author), 10550 N Torrey Pines Rd, San Diego, CA 92037 USA.	pkuhn@scripps.edu			NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NIAID NIH HHS [5T32/AI07354-16] Funding Source: Medline; NIGMS NIH HHS [GM074961, U54 GM074961, Y1-GM-1104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; [Anonymous], 1997, Cell, V90, P403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Davalos V, 2007, ONCOGENE, V26, P308, DOI 10.1038/sj.onc.1209780; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Ogawa K, 2006, J CELL SCI, V119, P559, DOI 10.1242/jcs.02777; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Song JH, 2007, APMIS, V115, P164, DOI 10.1111/j.1600-0463.2007.apm_543.x; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Wu QH, 2006, GYNECOL ONCOL, V102, P15, DOI 10.1016/j.ygyno.2005.11.034	44	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36505	36513		10.1074/jbc.M706340200	http://dx.doi.org/10.1074/jbc.M706340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17897949	hybrid, Green Accepted			2022-12-27	WOS:000251458300043
J	Jager, D; Schmalenbach, C; Prilla, S; Schrobang, J; Kebig, A; Sennwitz, M; Heller, E; Trankle, C; Holzgrabe, U; Holtje, HD; Mohr, K				Jaeger, Dorothea; Schmalenbach, Caroline; Prilla, Stefanie; Schrobang, Jasmin; Kebig, Anna; Sennwitz, Matthias; Heller, Eberhard; Traenkle, Christian; Holzgrabe, Ulrike; Hoeltje, Hans-Dieter; Mohr, Klaus			Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; MUSCARINIC ACETYLCHOLINE-RECEPTORS; AMINO-ACIDS; SUBTYPE SELECTIVITIES; BINDING-SITES; MODULATION; STRYCHNINE; ENHANCERS; GALLAMINE; RESIDUES	G protein-coupled receptors represent the largest superfamily of cell membrane-spanning receptors. We used allosteric small molecules as a novel approach to better understand conformational changes underlying the inactive-to-active switch in native receptors. Allosteric molecules bind outside the orthosteric area for the endogenous receptor activator. The human muscarinic M-2 acetylcholine receptor is prototypal for the study of allosteric interactions. We measured receptor-mediated G protein activation, applied a series of structurally diverse muscarinic allosteric agents, and analyzed their cooperative effects with orthosteric receptor agonists. A strong negative cooperativity of receptor binding was observed with acetylcholine and other full agonists, whereas a pronounced negative cooperativity of receptor activation was observed with the partial agonist pilocarpine. Applying a newly synthesized allosteric tool, point mutated receptors, radioligand binding, and a three-dimensional receptor model, we found that the deviating allosteric/orthosteric interactions are mediated through the core region of the allosteric site. A key epitope is M(2)Trp(422) in position 7.35 that is located at the extracellular top of transmembrane helix 7 and that contacts, in the inactive receptor, the extracellular loop E2. Trp 7.35 is critically involved in the divergent allosteric/orthosteric cooperativities with acetylcholine and pilocarpine, respectively. In the absence of allosteric agents, Trp 7.35 is essential for receptor binding of the full agonist and for receptor activation by the partial agonist. This study provides first evidence for a role of an allosteric E2/transmembrane helix 7 contact region for muscarinic receptor activation by orthosteric agonists.	Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, D-53121 Bonn, Germany; Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany; Univ Wurzburg, Inst Pharm, Dept Pharmaceut Chem, D-97074 Wurzburg, Germany	University of Bonn; Heinrich Heine University Dusseldorf; University of Wurzburg	Mohr, K (corresponding author), Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, Gerhard Domagk Str 3, D-53121 Bonn, Germany.	k.mohr@uni-bonn.de		Holzgrabe, Ulrike/0000-0002-0364-7278				Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Buller S, 2002, MOL PHARMACOL, V61, P160, DOI 10.1124/mol.61.1.160; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grossmuller M, 2006, N-S ARCH PHARMACOL, V372, P267, DOI 10.1007/s00210-005-0023-4; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; HILF G, 1989, EUR J BIOCHEM, V186, P725, DOI 10.1111/j.1432-1033.1989.tb15266.x; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Jakubik J, 2005, J PHARMACOL EXP THER, V313, P688, DOI 10.1124/jpet.104.080358; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Lazareno S, 1999, Methods Mol Biol, V106, P231; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; MATSUI H, 1995, MOL PHARMACOL, V47, P88; Mohr M, 2004, J MED CHEM, V47, P3324, DOI 10.1021/jm031095t; Muth M, 2005, J MED CHEM, V48, P2212, DOI 10.1021/jm049616f; Muth M, 2003, J MED CHEM, V46, P1031, DOI 10.1021/jm021017q; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schroter A, 2000, N-S ARCH PHARMACOL, V362, P512, DOI 10.1007/s002100000316; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	37	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34968	34976		10.1074/jbc.M705563200	http://dx.doi.org/10.1074/jbc.M705563200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890226	hybrid			2022-12-27	WOS:000251155200041
J	Saito, Y; Imazeki, H; Miura, S; Yoshimura, T; Okutsu, H; Harada, Y; Ohwaki, T; Nagao, O; Kamiya, S; Hayashi, R; Kodama, H; Handa, H; Yoshida, T; Fukai, F				Saito, Yohei; Imazeki, Hisae; Miura, Shogo; Yoshimura, Tomohisa; Okutsu, Hiroaki; Harada, Yosei; Ohwaki, Toshiyuki; Nagao, Osamu; Kamiya, Sadahiro; Hayashi, Ryo; Kodama, Hiroaki; Handa, Hiroshi; Yoshida, Toshimichi; Fukai, Fumio			A peptide derived from tenascin-C induces beta 1 integrin activation through syndecan-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CELL-ADHESION; ANTIADHESIVE SITE; SPLICE VARIANTS; BINDING DOMAIN; FIBRONECTIN; EXPRESSION; PROTEINS; HEPARIN; DIFFERENTIATION	Tenascin-C (TN-C) is unique for its cell adhesion modulatory function. We have shown that TNIIIA2, a synthetic 22-mer peptide derived from TN-C, stimulated beta 1 integrin-mediated cell adhesion of nonadherent and adherent cell types, by inducing activation of beta 1 integrin. The active site of TNIIIA2 appeared cryptic in the TN-C molecule but was exposed by MMP-2 processing of TN-C. The following results suggest that cell surface heparan sulfate (HS) proteoglycan ( HSPG), including syndecan-4, participated in TNIIIA2-induced beta 1 integrin activation: 1) TNIIIA2 bound to cell surface HSPG via its HS chains, as examined by photoaffinity labeling; 2) heparitinase I treatment of cells abrogated beta 1 integrin activation induced by TNIIIA2; 3) syndecan-4 was isolated by affinity chromatography using TNIIIA2-immobilized beads; 4) small interfering RNA-based down-regulation of syndecan-4 expression reduced TNIIIA2-induced beta 1 integrin activation, and consequent cell adhesion to fibronectin; 5) overexpression of syndecan-4 core protein enhanced TNIIIA2-induced activation of beta 1 integrin. However, treatments that targeted the cytoplasmic region of syndecan-4, including ectopic expression of its mutant truncated with the cytoplasmic domains and treatment with protein kinase C alpha inhibitor Go6976, did not influence the TNIIIA2 activity. These results suggest that a TNIIIA2-related matricryptic site of the TN-C molecule, exposed by MMP-2 processing, may have bound to syndecan-4 via its HS chains and then induced conformational change in beta 1 integrin necessary for its functional activation. A lateral interaction of beta 1 integrin with the extracellular region of the syndecan-4 molecule may be involved in this conformation change.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Chiba 2788510, Japan; Saga Univ, Fac Sci & Engn, Dept Biochem, Saga 8490922, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie 5148507, Japan	Tokyo University of Science; Saga University; Tokyo Institute of Technology; Mie University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp	Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217				Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Ghert MA, 2001, ONCOLOGY-BASEL, V61, P306, DOI 10.1159/000055338; HAYASHI R, 2004, PEPTIDE SCI, V2003, P289; Hindermann W, 1999, J PATHOL, V189, P475; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huang WT, 2001, CANCER RES, V61, P8586; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; JOSHI P, 1993, J CELL SCI, V106, P389; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kato R, 2002, CLIN CANCER RES, V8, P2455; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; LIGHTNER VA, 1990, ANN NY ACAD SCI, V580, P260, DOI 10.1111/j.1749-6632.1990.tb17935.x; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; MACKIE EJ, 1992, J CELL SCI, V103, P765; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; OCKLIND G, 1993, J HISTOCHEM CYTOCHEM, V41, P1163, DOI 10.1177/41.8.7687262; Orend G, 2003, ONCOGENE, V22, P3917, DOI 10.1038/sj.onc.1206618; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; SIRI A, 1995, J BIOL CHEM, V270, P8650, DOI 10.1074/jbc.270.15.8650; Sobel M, 2001, J VASC SURG, V33, P587, DOI 10.1067/mva.2001.112696; StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345; Takagi J, 1997, J BIOCHEM, V121, P914; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230	46	69	72	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34929	34937		10.1074/jbc.M705608200	http://dx.doi.org/10.1074/jbc.M705608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901052	hybrid			2022-12-27	WOS:000251155200036
J	Ganguly, S; Grodzki, C; Sugden, D; Moller, M; Odom, S; Gaildrat, P; Gery, I; Siraganian, RP; Rivera, J; Klein, DC				Ganguly, Surajit; Grodzki, Cristina; Sugden, David; Moller, Morten; Odom, Sandra; Gaildrat, Pascaline; Gery, Igal; Siraganian, Reuben P.; Rivera, Juan; Klein, David C.			Neural adrenergic/cyclic AMP regulation of the immunoglobulin e receptor alpha-subunit expression in the mammalian pinealocyte a - Neuroendocrine/immune response link?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; ISOFORM MESSENGER-RNAS; AFFINITY IGE RECEPTOR; REAL-TIME PCR; N-ACETYLTRANSFERASE; CIRCADIAN EXPRESSION; GLAND; RAT; CELL; MELATONIN	The high affinity immunoglobulin E receptor (Fc epsilon RI) complex is dedicated to immunoglobulin E- mediated allergic responses. Expression of the Fc epsilon RI receptor is thought to be relatively stable and limited to mast cells, basophils, eosinophils, monocytes, Langerhans cells, platelets, and neutrophils. We now report that the Fc epsilon RI alpha and Fc epsilon RI gamma polypeptides are expressed in the pinealocyte, the melatonin- secreting cell of the pineal gland. Moreover, Fcer1a mRNA levels increased similar to 100-fold at night to levels that were higher than in other tissues examined. Pineal Fc epsilon RI alpha protein also increased markedly at night from nearly undetectable daytime levels. Our studies indicate that pineal Fcer1a mRNA levels are controlled by a well described neural pathway that controls pineal function. This pathway includes the master circadian oscillator in the suprachiasmatic nucleus and passes through central and peripheral structures. The circadian expression of Fc epsilon RI alpha in the pineal gland is driven by this neural circuit via an adrenergic/ cyclic AMP mechanism. Pineal Fc epsilon RI alpha and Fc epsilon RI gamma may represent a previously unrealized molecular link between the neuroendocrine and immune systems.	NICHD, Sect Neuroendocrinol, Off Sci Director, Natl Inst Hlth, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; NIDCR, Oral Infect & Immun Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England; Univ Copenhagen, Panum Inst, Dept Neurobiol & Pharmacol, DK-2200 Copenhagen, Denmark; NIAMS, Mol Inflammat Sect, Mol Immunol & Inflammat Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; NEI, Immunol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of London; King's College London; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Klein, DC (corresponding author), NICHD, Sect Neuroendocrinol, Off Sci Director, Natl Inst Hlth, Bldg 49,Rm 6A82, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Ganguly, Surajit/0000-0002-1876-9147; Klein, David/0000-0002-1792-5806	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000095, ZIAHD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041101, ZIAAR041101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696, Z01DE000696] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ajpru S, 2002, MOL BRAIN RES, V105, P29, DOI 10.1016/S0169-328X(02)00387-X; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; CAROLEO MC, 1992, AUTOIMMUNITY, V13, P303; Cauvi DM, 2006, J BIOL CHEM, V281, P10448, DOI 10.1074/jbc.M510751200; Fedyk ER, 1996, CLIN IMMUNOL IMMUNOP, V81, P101, DOI 10.1006/clin.1996.0165; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Gaildrat P, 2005, J BIOL CHEM, V280, P16851, DOI 10.1074/jbc.M414587200; Ganguly S, 2002, CELL TISSUE RES, V309, P127, DOI 10.1007/s00441-002-0579-y; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335; Kim JS, 2005, J BIOL CHEM, V280, P677, DOI 10.1074/jbc.M408438200; Kinet JP, 1999, CURR OPIN IMMUNOL, V11, P603, DOI 10.1016/S0952-7915(99)00023-0; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Kuhlwein E, 2001, J NEUROIMMUNOL, V117, P51, DOI 10.1016/S0165-5728(01)00325-3; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; MEFFORD IN, 1983, ENDOCRINOLOGY, V113, P1582, DOI 10.1210/endo-113-5-1582; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Moller M, 2006, CHRONOBIOL INT, V23, P393, DOI 10.1080/07420520500521855; MOLLER M, 1978, CELL TISSUE RES, V195, P1; Moller M, 1997, CELL TISSUE RES, V288, P279, DOI 10.1007/s004410050813; Mosenson JA, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-1; Nadler M J, 2000, Adv Immunol, V76, P325; Novak N, 2004, CURR ALLERGY ASTHM R, V4, P263, DOI 10.1007/s11882-004-0069-2; PARFITT A, 1976, NEUROPHARMACOLOGY, V15, P353, DOI 10.1016/0028-3908(76)90083-6; Pongratz G, 2006, J IMMUNOL, V177, P2926, DOI 10.4049/jimmunol.177.5.2926; REDECKER P, 1993, J NEUROSCI RES, V34, P79, DOI 10.1002/jnr.490340109; Redecker P, 1999, INT REV CYTOL, V191, P201, DOI 10.1016/S0074-7696(08)60160-6; Reiter RJ, 2000, ANN NY ACAD SCI, V917, P376; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; SCHAAD NC, 1993, BRAIN RES, V614, P251, DOI 10.1016/0006-8993(93)91042-Q; Seminario MC, 1999, J IMMUNOL, V162, P6893; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; Silva SO, 2004, J NEUROIMMUNOL, V156, P146, DOI 10.1016/j.jneuroim.2004.07.015; Sugden D, 2003, J NEUROCHEM, V86, P1308, DOI 10.1046/j.1471-4159.2003.01959.x; TAMOTSU S, 1995, CELL TISSUE RES, V282, P219, DOI 10.1007/s004410050474; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0	45	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32758	32764		10.1074/jbc.M705950200	http://dx.doi.org/10.1074/jbc.M705950200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17728245	hybrid			2022-12-27	WOS:000250625400024
J	Belotserkovskii, BP; De Silva, E; Tornaletti, S; Wang, G; Vasquez, KM; Hanawalt, PC				Belotserkovskii, Boris P.; De Silva, Erandi; Tornaletti, Silvia; Wang, Guliang; Vasquez, Karen M.; Hanawalt, Philip C.			A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; CLASS SWITCH RECOMBINATION; H-DNA; MAMMALIAN-CELLS; HELIX FORMATION; COUPLED REPAIR; REPEAT; ELONGATION; TEMPLATE; REGIONS	Naturally occurring DNA sequences that are able to form unusual DNA structures have been shown to be mutagenic, and in some cases the mutagenesis induced by these sequences is enhanced by their transcription. It is possible that transcription-coupled DNA repair induced at sites of transcription arrest might be involved in this mutagenesis. Thus, it is of interest to determine whether there are correlations between the mutagenic effects of such noncanonical DNA structures and their ability to arrest transcription. We have studied T7 RNA polymerase transcription through the sequence from the nuclease-sensitive element of the human c-MYC promoter, which is mutagenic in mammalian cells (Wang, G., and Vasquez, K. M. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 13448 -13453). This element has two mirror-symmetric homopurine-homopyrimidine blocks that potentially can form either DNA triplex (H-DNA) or quadruplex structures. We detected truncated transcription products indicating partial transcription arrest within and closely downstream of the element. The arrest required negative supercoiling and was much more pronounced when the pyrimidine-rich strand of the element served as the template. The exact positions of arrest sites downstream from the element depended upon the downstream flanking sequences. We made various nucleotide substitutions in the wild-type sequence from the c-MYC nuclease-sensitive element that specifically destabilize either the triplex or the quadruplex structure. When these substitutions were ranked for their effects on transcription, the results implicated the triplex structure in the transcription arrest. We suggest that transcription induced triplex formation enhances pre-existing weak transcription pause sites within the flanking sequences by creating ;steric obstacles for the transcription machinery.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center	Hanawalt, PC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	hanawalt@stanford.edu		Belotserkovskii, Boris/0000-0002-1570-9923	NCI NIH HHS [CA93729, CA77712, R01 CA077712] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093729, R56CA077712, R01CA077712] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; ALUNNIFABBRONI M, 1994, EUR J BIOCHEM, V226, P831, DOI 10.1111/j.1432-1033.1994.00831.x; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; BELOTSERKOVSKII BP, 1992, NUCLEIC ACIDS RES, V20, P1903, DOI 10.1093/nar/20.8.1903; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; EICK D, 1990, ONCOGENE, V5, P1397; FIRULLI AB, 1992, BIOCHEM BIOPH RES CO, V185, P264, DOI 10.1016/S0006-291X(05)80985-4; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Gyi JI, 1996, BIOCHEMISTRY-US, V35, P12538, DOI 10.1021/bi960948z; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; He B, 1998, J BIOL CHEM, V273, P18802, DOI 10.1074/jbc.273.30.18802; Hoover R G, 1995, Curr Top Microbiol Immunol, V194, P257; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; Nelson P, 1999, P NATL ACAD SCI USA, V96, P14342, DOI 10.1073/pnas.96.25.14342; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; RANDO RF, 1994, NUCLEIC ACIDS RES, V22, P678, DOI 10.1093/nar/22.4.678; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; SAXOWSKY TT, 2006, TRENDS GENET, V106, P474; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Tornaletti S, 2003, J BIOL CHEM, V278, P35791, DOI 10.1074/jbc.M305394200; VESELKOV AG, 1993, NATURE, V364, P496, DOI 10.1038/364496a0; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	46	113	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32433	32441		10.1074/jbc.M704618200	http://dx.doi.org/10.1074/jbc.M704618200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785457	hybrid			2022-12-27	WOS:000250480300066
J	Dicker, IB; Samanta, HK; Li, ZF; Hong, Y; Tian, Y; Banville, J; Remillard, RR; Walker, MA; Langley, DR; Krystal, M				Dicker, Ira B.; Samanta, Himadri K.; Li, Zhufang; Hong, Yang; Tian, Yuan; Banville, Jacques; Remillard, Roger R.; Walker, Michael A.; Langley, David R.; Krystal, Mark			Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA INTEGRATION; PROTEIN IN-VITRO; VIRAL-DNA; CATALYTIC DOMAIN; MOLECULAR-DYNAMICS; CORE DOMAIN; CONCERTED INTEGRATION; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURES	Human immunodeficiency virus (HIV) integrase enzyme is required for the integration of viral DNA into the host cell chromosome. Integrase complex assembly and subsequent strand transfer catalysis are mediated by specific interactions between integrase and bases at the end of the viral long terminal repeat (LTR). The strand transfer reaction can be blocked by the action of small molecule inhibitors, thought to bind in the vicinity of the viral LTR termini. This study examines the contributions of the terminal four bases of the nonprocessed strand (G(2)T(1)C(-1)A(-2)) of the HIV LTR on complex assembly, specific strand transfer activity, and inhibitor binding. Base substitutions and abasic replacements at the LTR terminus provided a means to probe the importance of each nucleotide on the different functions. An approach is described wherein the specific strand transfer activity for each integrase/LTR variant is derived by normalizing strand transfer activity to the concentration of active sites. The key findings of this study are as follows. 1) The G(2):C-2 base pair is necessary for efficient assembly of the complex and for maintenance of an active site architecture, which has high affinity for strand transfer inhibitors. 2) Inhibitor-resistant enzymes exhibit greatly increased sensitivity to LTR changes. 3) The strand transfer and inhibitor binding defects of a Q148R mutant are due to a decreased affinity of the complex for magnesium. 4) Gln(148) interacts with G(2), T-1, and C-1 at the 5(') end of the viral LTR, with these four determinants playing important and overlapping roles in assembly, strand transfer catalysis and high affinity inhibitor binding.	Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Med Chem, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Comp Assisted Drug Design, Wallingford, CT 06492 USA; Pharmaceut Res Inst, Dept Synthet Chem, Radiochem Grp, Princeton, NJ 08540 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Dicker, IB (corresponding author), Bristol Myers Squibb Co, 5 Res Pkwy, Wallingford, CT 06492 USA.	Ira.Dicker@BMS.com		Langley, David/0000-0002-0820-3190				Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Agapkina J, 2004, EUR J BIOCHEM, V271, P205, DOI 10.1046/j.1432-1033.2003.03921.x; ASSANTEAPPIAH E, 1999, ADV VIRUS RES, P351; Barreca ML, 2003, BIOPHYS J, V84, P1450, DOI 10.1016/S0006-3495(03)74958-3; Brigo A, 2005, PROTEINS, V59, P723, DOI 10.1002/prot.20447; BUSHMAN FD, 1992, P NATL ACAD SCI USA, V89, P3458, DOI 10.1073/pnas.89.8.3458; BUSHMAN FD, 1990, SCIENCE, V249, P1555, DOI 10.1126/science.2171144; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; COOPER D, 2007, 14 C RETR OPP INF FE; Cox Arthur G., 2006, Antiviral Chemistry & Chemotherapy, V17, P343; DELESUS E, 2006, J ACQ IMMUN DEF SYND, V43, P1; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fikkert V, 2004, AIDS, V18, P2019, DOI 10.1097/00002030-200410210-00006; Fikkert V, 2003, J VIROL, V77, P11459, DOI 10.1128/JVI.77.21.11459-11470.2003; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Gerton JL, 1999, J BIOL CHEM, V274, P33480, DOI 10.1074/jbc.274.47.33480; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hindmarsh P, 1999, ADV VIRUS RES, V52, P397, DOI 10.1016/S0065-3527(08)60308-5; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Kehlenbeck S, 2006, J VIROL, V80, P6883, DOI 10.1128/JVI.00306-06; King PJ, 2003, VIROLOGY, V306, P147, DOI 10.1016/S0042-6822(02)00042-9; KULKOSKY J, 1994, PHARMACOL THERAPEUT, V61, P185, DOI 10.1016/0163-7258(94)90062-0; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; LAFEMINA RL, 1991, J VIROL, V65, P5624, DOI 10.1128/JVI.65.10.5624-5630.1991; LEAVITT AD, 1992, J VIROL, V66, P2359, DOI 10.1128/JVI.66.4.2359-2368.1992; Lee DJ, 2006, ANTIMICROB AGENTS CH, V50, P134, DOI 10.1128/AAC.50.1.134-142.2006; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Lins RD, 1999, BIOPHYS J, V76, P2999, DOI 10.1016/S0006-3495(99)77453-9; Lins RD, 2000, PHARMACOL THERAPEUT, V85, P123, DOI 10.1016/S0163-7258(99)00059-5; Lins RD, 2000, BIOPOLYMERS, V53, P308, DOI 10.1002/(SICI)1097-0282(20000405)53:4<308::AID-BIP3>3.0.CO;2-H; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; MAZUMDER A, 1995, NUCLEIC ACIDS RES, V23, P2865, DOI 10.1093/nar/23.15.2865; McColl DJ, 2007, 16 INT DRUG RES WORK; Neamati N, 2002, EXPERT OPIN THER PAT, V12, P709, DOI 10.1517/13543776.12.5.709; Pais GCG, 2002, J MED CHEM, V45, P3184, DOI 10.1021/jm020037p; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Renisio JG, 2005, NUCLEIC ACIDS RES, V33, P1970, DOI 10.1093/nar/gki346; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; SHERMAN PA, 1992, J VIROL, V66, P3593, DOI 10.1128/JVI.66.6.3593-3601.1992; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; VANDENENT FMI, 1994, J VIROL, V68, P7825, DOI 10.1128/JVI.68.12.7825-7832.1994; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WAI J, 2007, 12 C RETR OPP INF FE; Wang T, 1999, BIOCHEMISTRY-US, V38, P3624, DOI 10.1021/bi982124i; Weber W, 1998, J BIOMOL STRUCT DYN, V16, P733, DOI 10.1080/07391102.1998.10508285; Wlodawer A, 1999, ADV VIRUS RES, V52, P335, DOI 10.1016/S0065-3527(08)60305-X; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	70	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31186	31196		10.1074/jbc.M704935200	http://dx.doi.org/10.1074/jbc.M704935200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715137	hybrid			2022-12-27	WOS:000250309200008
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL; ENDOSOMAL ACIDIFICATION; H+-ATPASE; CFTR; PHAGOCYTOSIS; MATURATION; MEMBRANE; PH; HYPERACIDIFICATION	It was reported recently that the cystic fibrosis transmembrane conductance regulator (CFTR) is required for acidification of phagosomes in alveolar macrophages (Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., Palfrey, H. C., and Nelson, D. J. (2006) Nat. Cell Biol. 8, 933-944). Here we determined whether the CFTR chloride channel is a generalized pathway for chloride entry into phagosomes in macrophages and whether mutations in CFTR could contribute to alveolar macrophage dysfunction. The pH of mature phagolysosomes in macrophages was measured by fluorescence ratio imaging using a zymosan conjugate containing Oregon Green((R)) 488 and tetramethylrhodamine. Acidification of phagolysosomes in J774A.1 macrophages (pH similar to 5.1 at 45 min), murine alveolar macrophages (pH similar to 5.3), and human alveolar macrophages (pH similar to 5.3) was insensitive to CFTR inhibition by the thiazolidinone CFTRinh-172. Acidification of phagolysosomes in alveolar macrophages isolated from mice homozygous for Delta F508-CFTR, the most common mutation in cystic fibrosis, was not different compared with that in alveolar macrophages isolated from wild-type mice. We also measured the kinetics of phagosomal acidification in J774A. 1 and murine alveolar macrophages using a zymosan conjugate containing fluorescein and tetramethylrhodamine. Phagosomal acidification began within 3 min of zymosan binding and was complete within similar to 15 min of internalization. The rate of phagosomal acidification in J774A. 1 cells was not slowed by CFTRinh-172 and was not different in alveolar macrophages from wild-type versus similar to F508-CFTR mice. Our data indicate that phagolysosomal acidification in macrophages is not dependent on CFTR channel activity and do not support a proposed mechanism for cystic fibrosis lung disease involving defective phagosomal acidification and bacterial killing in alveolar macrophages.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Canc Res Inst, 1246 Hlth Sci E Tower,PO Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, P30DK072517, R37DK035124] Funding Source: NIH RePORTER; NEI NIH HHS [EY13574] Funding Source: Medline; NHLBI NIH HHS [HL59198, HL73856] Funding Source: Medline; NIBIB NIH HHS [EB00415] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK72517] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Biwersi J, 1996, P NATL ACAD SCI USA, V93, P12484, DOI 10.1073/pnas.93.22.12484; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; de Jonge HR, 2007, J PHYSIOL-LONDON, V580, P7, DOI 10.1113/jphysiol.2007.129361; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DUNN KW, 1994, J BIOL CHEM, V269, P5336; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; O'Connor N, 2007, METHOD CELL BIOL, V81, P415, DOI 10.1016/S0091-679X(06)81019-8; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Poschet JF, 2006, EMBO REP, V7, P553, DOI 10.1038/sj.embor.7400674; Poschet JF, 2002, J BIOL CHEM, V277, P13959, DOI 10.1074/jbc.M105441200; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seksek O, 1996, J BIOL CHEM, V271, P15542, DOI 10.1074/jbc.271.26.15542; SHERRY AM, 1994, AM J PHYSIOL, V266, pC870, DOI 10.1152/ajpcell.1994.266.3.C870; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Swanson J, 2006, NAT CELL BIOL, V8, P908, DOI 10.1038/ncb0906-908; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Thelin WR, 2007, CURR OPIN PHARMACOL, V7, P290, DOI 10.1016/j.coph.2007.01.004; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VANDYKE RW, 1992, BIOCHEM BIOPH RES CO, V184, P300, DOI 10.1016/0006-291X(92)91192-S; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	59	97	99	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31422	31428		10.1074/jbc.M705296200	http://dx.doi.org/10.1074/jbc.M705296200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724021	hybrid			2022-12-27	WOS:000250309200032
J	Cheng, JW; Yu, DV; Zhou, JH; Shapiro, DJ				Cheng, Jingwei; Yu, David V.; Zhou, Jian-Hua; Shapiro, David J.			Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HUMAN ESTROGEN-RECEPTOR; C/EBP-ALPHA; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; DOWN-REGULATION; PROLIFERATION; INHIBITION; EXPRESSION; DOMAINS	Low concentrations of tamoxifen or its active metabolite 4-hydroxytamoxifen (OHT) induce estrogen receptor alpha(ER alpha)-dependent apoptosis. To analyze the pathway of OHT-ER alpha-induced apoptosis, we developed stably transfected lines of HeLa cells expressing wild-type ER and an inactive mutant ER alpha unable to bind estrogen response elements. HeLa cells expressing the mutant ER alpha and HeLa cells expressing wild-type ER alpha in which the ER was knocked down with an ER-specific small interfering RNA were not killed by Tam or OHT, suggesting that estrogen response element-mediated transcription is required for Tam- and OHT-induced apoptosis. Microarray analysis to identify a gene(s) whose expression is important in OHT-ER-mediated apoptosis identified 19 mRNAs that OHT up-regulated by > 1.6-fold and 15 down-regulated mRNAs. Gene function and the time course of induction by OHT-ER alpha led us to further investigate CCAAT enhancer-binding protein alpha (C/EBP alpha), which has roles in cell cycle progression and apoptosis, and p21. Quantitative reverse transcription-PCR, Western blot analysis, and RNA interference knockdown suggest that cell cycle arrest resulting from OHT-ER alpha induction of p21 may facilitate apoptosis. OHT-ER alpha, but not E-2-ER alpha, induced C/EBP alpha mRNA and protein. RNA interference knockdown of C/EBP alpha nearly abolished OHT-ER alpha-induced apoptosis. We isolated stable cell lines that were resistant to OHT-induced apoptosis, contain full-length functional ER alpha, and undergo apoptosis in response to etoposide. In these OHT-resistant cell lines both before and after OHT treatment, C/EBP alpha levels are much lower than in OHT-sensitive cells. These studies establish a novel molecular site responsible for Tam- and OHT-ER alpha-induced apoptosis of cancer cells.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, 413 RAL,Box B4,600 S Mathews, Urbana, IL 61801 USA.	djshapir@uiuc.edu			NCI NIH HHS [CA90371] Funding Source: Medline; NICHD NIH HHS [HD16720] Funding Source: Medline; NIDDK NIH HHS [DK071909] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Bjornstrom L, 2002, J BIOL CHEM, V277, P48479, DOI 10.1074/jbc.C200570200; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Calkhoven CF, 2000, GENE DEV, V14, P1920; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Ferlini C, 1999, BRIT J CANCER, V79, P257, DOI 10.1038/sj.bjc.6690042; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Halmos B, 2002, CANCER RES, V62, P528; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Kim JA, 1999, CANCER LETT, V147, P115, DOI 10.1016/S0304-3835(99)00284-0; Klinge CM, 1997, J STEROID BIOCHEM, V63, P283, DOI 10.1016/S0960-0760(97)00091-5; KOSZEWSKI NJ, 1991, MOL ENDOCRINOL, V5, P1129, DOI 10.1210/mend-5-8-1129; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; Linford N, 2000, J NEUROCYTOL, V29, P367, DOI 10.1023/A:1007113323582; Mandlekar S, 2000, CANCER RES, V60, P6601; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McEwen B, 2001, P NATL ACAD SCI USA, V98, P7093, DOI 10.1073/pnas.121146898; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Otto AM, 1996, J CANCER RES CLIN, V122, P603, DOI 10.1007/BF01221192; PERRY RR, 1995, BRIT J CANCER, V72, P1441, DOI 10.1038/bjc.1995.527; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Toran-Allerand C D, 2000, Novartis Found Symp, V230, P56, DOI 10.1002/0470870818.ch6; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang F, 1997, BIOCHEMISTRY-US, V36, P7793, DOI 10.1021/bi963100j; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WEBSTER NJG, 1989, EMBO J, V8, P1441, DOI 10.1002/j.1460-2075.1989.tb03526.x; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Williams SC, 1997, GENE EXPRESSION, V6, P371; XU LX, 1994, CHINESE MED J-PEKING, V107, P596; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632; Zhang GJ, 1999, CLIN CANCER RES, V5, P2971	59	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30535	30543		10.1074/jbc.M704829200	http://dx.doi.org/10.1074/jbc.M704829200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17716978	hybrid			2022-12-27	WOS:000250136300021
J	von Hahn, T; Rice, CM				von Hahn, Thomas; Rice, Charles M.			Hepatitis C virus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DENSITY-LIPOPROTEIN RECEPTOR; CELL-SURFACE EXPRESSION; SERUM AMYLOID-A; B TYPE-I; DC-SIGN; ENVELOPE GLYCOPROTEIN; HYPERVARIABLE REGION-1; CANDIDATE RECEPTOR; TETRASPANIN WEB; CD81		[von Hahn, Thomas; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA	Rockefeller University	von Hahn, T (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@rockefeller.edu						Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Agnello V, 1997, ARTHRITIS RHEUM, V40, P2007, DOI 10.1002/art.1780401113; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P14067, DOI 10.1073/pnas.0405695101; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Monazahian M, 1999, J MED VIROL, V57, P223, DOI 10.1002/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Saunier B, 2003, J VIROL, V77, P546, DOI 10.1128/JVI.77.1.546-559.2003; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Stangl H, 2002, J ENDOCRINOL, V175, P663, DOI 10.1677/joe.0.1750663; Takyar ST, 2000, HEPATOLOGY, V32, P382, DOI 10.1053/jhep.2000.9094; TIMPE JM, 2007, IN PRESS HEPATOLOGY; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; von Hahn T, 2007, J HEPATOL, V46, P355, DOI 10.1016/j.jhep.2006.12.004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	78	72	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3689	3693		10.1074/jbc.R700024200	http://dx.doi.org/10.1074/jbc.R700024200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	17881349	hybrid			2022-12-27	WOS:000253083500001
J	Odat, O; Matta, S; Khalil, H; Kampranis, SC; Pfau, R; Tsichlis, PN; Makris, AM				Odat, Osama; Matta, Samer; Khalil, Hadi; Kampranis, Sotirios C.; Pfau, Raymond; Tsichlis, Philip N.; Makris, Antonios M.			Old yellow enzymes, highly homologous FMN oxidoreductases with modulating roles in oxidative stress and programmed cell death in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; REGULATES APOPTOSIS; PROTEIN COMPLEXES; BAX LETHALITY; MITOCHONDRIAL; GLUTATHIONE; SUPPRESSES; EXPRESSION	In a genetic screen to identify modifiers of Bax-dependent lethality in yeast, the C terminus of OYE2 was isolated based on its capacity to restore sensitivity to a Bax-resistant yeast mutant strain. Overexpression of full-length OYE2 suppresses Bax lethality in yeast, lowers endogenous reactive oxygen species (ROS), increases resistance to H2O2-induced programmed cell death (PCD), and significantly lowers ROS levels generated by organic prooxidants. Reciprocally, Delta oye2 yeast strains are sensitive to prooxidant-induced PCD. Overexpression and knock-out analysis indicate these OYE2 antioxidant activities are opposed by OYE3, a highly homologous heterodimerizing protein, which functions as a prooxidant promoting H2O2-induced PCD in wild type yeast. To exert its effect OYE3 requires the presence of OYE2. Deletion of the 12 C-terminal amino acids and catalytic inactivation of OYE2 by a Y197F mutation enhance significantly survival upon H2O2-induced PCD in wild type cells, but accelerate PCD in Delta oye3 cells, implicating the oye2p-oye3p heterodimer for promoting cell death upon oxidative stress. Unexpectedly, a strain with a double knock-out of these genes (Delta oye2oye3) is highly resistant to H2O2-induced PCD, exhibits increased respiratory capacity, and undergoes less cell death during the adaptive response in chronological aging. Simultaneous deletion of OYE2 and other antioxidant genes hyperinduces endogenous levels of ROS, promoting H2O2-induced cell death: in Delta oye2glr1 yeast high levels of oxidized glutathione elicited gross morphological aberrations involving the actin cytoskeleton and defects in organelle partitioning. Altering the ratio of reduced to oxidized glutathione by exogenous addition of GSH fully reversed these alterations. Based on this work, OYE proteins are firmly placed in the signaling network connecting ROS generation, PCD modulation, and cytoskeletal dynamics in yeast.	Mediterranean Agron Inst Chania, Dept Nat Prod, Khania 73100, Greece; Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	CIHEAM; CIHEAM IAM Chania; Tufts Medical Center	Makris, AM (corresponding author), Alsyll Agrokepiou, Khania 73100, Greece.	antoniosmakris@yahoo.gr	Kampranis, Sotirios C/G-8374-2016	Kampranis, Sotirios C/0000-0001-6208-1684; Khalil, Hadi/0000-0003-3860-5331				Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Belhocine S, 2004, CELL DEATH DIFFER, V11, P946, DOI 10.1038/sj.cdd.4401422; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Breitenbach M, 2005, TRENDS CELL BIOL, V15, P637, DOI 10.1016/j.tcb.2005.09.011; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; COLLINSON LP, 1995, GENE, V156, P123, DOI 10.1016/0378-1119(95)00026-3; CORNILLON S, 1994, J CELL SCI, V107, P2691; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Del Carratore R, 2002, MUTAT RES-GEN TOX EN, V513, P183, DOI 10.1016/S1383-5718(01)00310-2; Dimitrova I, 2004, FEBS LETT, V566, P100, DOI 10.1016/j.febslet.2004.04.012; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; GUELMAN R, 2002, BONE, V30, P23; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Kampranis SC, 2000, J BIOL CHEM, V275, P29207, DOI 10.1074/jbc.M002359200; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Karplus PA, 1995, FASEB J, V9, P1518, DOI 10.1096/fasebj.9.15.8529830; Kilili KG, 2004, J BIOL CHEM, V279, P24540, DOI 10.1074/jbc.M309882200; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Moon H, 2002, BIOCHEM BIOPH RES CO, V290, P457, DOI 10.1006/bbrc.2001.6208; Muller A, 2007, BIOTECHNOL BIOENG, V98, P22, DOI 10.1002/bit.21415; Niwa T, 2000, CLIN CHEM, V46, P82; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Reekmans R, 2005, FEMS YEAST RES, V5, P711, DOI 10.1016/j.femsyr.2004.12.010; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; STOTT K, 1993, J BIOL CHEM, V268, P6097; Trotter EW, 2006, APPL ENVIRON MICROB, V72, P4885, DOI 10.1128/AEM.00526-06; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	61	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36010	36023		10.1074/jbc.M704058200	http://dx.doi.org/10.1074/jbc.M704058200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897954	hybrid			2022-12-27	WOS:000251458100061
J	Gonzalez-Begne, M; Nakamoto, T; Nguyen, HV; Stewart, AK; Alper, SL; Melvin, JE				Gonzalez-Begne, Mireya; Nakamoto, Tetsuji; Nguyen, Ha-Van; Stewart, Andrew K.; Alper, Seth L.; Melvin, James E.			Enhanced formation of a HCO3- transport metabolon in exocrine cells of Nhe1(-/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; ANION-EXCHANGER AE1; ACINAR-CELLS; TARGETED DISRUPTION; NA+/H+ EXCHANGER; CL-/HCO3-EXCHANGER; CYTOPLASMIC CALCIUM; EPITHELIAL-CELLS; FLUID SECRETION; PLASMA-MEMBRANE	Cl- influx across the basolateral membrane is a limiting step in fluid production in exocrine cells and often involves functionally linked Cl-/HCO3- (Ae) and Na+/H+ (Nhe) exchange mechanisms. The dependence of this major Cl- uptake pathway on Na+/H+ exchanger expression was examined in the parotid acinar cells of Nhe1(-)/(-) and Nhe2(-)/(-) mice, both of which exhibited impaired fluid secretion. No change in Cl-/HCO3- exchanger activity was detected in Nhe2-deficient mice. Conversely, Cl-/HCO3- exchanger activity increased nearly 4-fold in Nhe1-deficient mice, despite only minimal or any change in mRNA and protein levels of the anion exchanger Ae2. Acetazolamide completely blocked the increase in Cl-/HCO3- exchanger activity in Nhe1-null mice suggesting that increased anion exchange required carbonic anhydrase activity. Indeed, the parotid glands of Nhe1(-)/(-) mice expressed higher levels of carbonic anhydrase 2 (Car2) polypeptide. Moreover, the enhanced Cl-/HCO3- exchange activity was accompanied by an increased abundance of Car2 center dot Ae2 complexes in the parotid plasma membranes of Nhe1(-)/(-) mice. Anion exchanger activity was also significantly reduced in Car2-deficient mice, consistent with an important role of a putative Car2 center dot Ae2HCO(3)(-) transport metabolon in parotid exocrine cell function. Increased abundance of this HCO3- transport metabolon is likely one of the multiple compensatory changes in the exocrine parotid gland of Nhe1(-)/(-) mice that together attenuate the severity of in vivo electrolyte and acid-base balance perturbations.	Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Rochester; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Box 611,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009692, R37DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043495, R01DK043495] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08921, DE09692] Funding Source: Medline; NIDDK NIH HHS [DK43495] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Alper SL, 1997, AM J PHYSIOL-RENAL, V273, pF601, DOI 10.1152/ajprenal.1997.273.4.F601; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; ARREOLA J, 1995, J MEMBRANE BIOL, V147, P95; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Brown DA, 2003, AM J PHYSIOL-GASTR L, V285, pG804, DOI 10.1152/ajpgi.00150.2003; Chernova MN, 2003, AM J PHYSIOL-CELL PH, V284, pC1235, DOI 10.1152/ajpcell.00522.2002; COUSIN JL, 1975, J PHYSIOL-LONDON, V253, P385, DOI 10.1113/jphysiol.1975.sp011195; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; DISSING S, 1990, AM J PHYSIOL, V259, pG1044, DOI 10.1152/ajpgi.1990.259.6.G1044; Evans RL, 1999, J BIOL CHEM, V274, P29025, DOI 10.1074/jbc.274.41.29025; Evans RL, 2000, J BIOL CHEM, V275, P26720; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; GERBOTH GD, 1993, AM J PHYSIOL, V264, pL448, DOI 10.1152/ajplung.1993.264.5.L448; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; IKEDA K, 1991, AM J PHYSIOL, V261, pC231, DOI 10.1152/ajpcell.1991.261.2.C231; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MELVIN JE, 1992, AM J PHYSIOL, V262, pG393, DOI 10.1152/ajpgi.1992.262.3.G393; NAUNTOFTE B, 1992, AM J PHYSIOL, V263, P823; Nguyen HV, 2004, AM J PHYSIOL-GASTR L, V286, pG312, DOI 10.1152/ajpgi.00158.2003; Nguyen HV, 2000, J PHYSIOL-LONDON, V523, P139, DOI 10.1111/j.1469-7793.2000.t01-2-00139.x; Park K, 2001, J BIOL CHEM, V276, P27042, DOI 10.1074/jbc.M102901200; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; Piermarini PM, 2007, J BIOL CHEM, V282, P1409, DOI 10.1074/jbc.M608261200; Roussa E, 1999, AM J PHYSIOL-GASTR L, V277, pG1288, DOI 10.1152/ajpgi.1999.277.6.G1288; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Scozzafava A, 2002, BIOORG MED CHEM LETT, V12, P1177, DOI 10.1016/S0960-894X(02)00121-X; SNOWDOWNE KW, 1992, BIOCHIM BIOPHYS ACTA, V1108, P145, DOI 10.1016/0005-2736(92)90019-I; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, JOP, V2, P165; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Sterling D, 2002, AM J PHYSIOL-CELL PH, V283, pC1522, DOI 10.1152/ajpcell.00115.2002; Stewart AK, 2002, J GEN PHYSIOL, V120, P707, DOI 10.1085/jgp.20028641; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wu Q, 1998, J MEMBRANE BIOL, V162, P31, DOI 10.1007/s002329900339; Wu RY, 2004, INVEST OPHTH VIS SCI, V45, P3213, DOI 10.1167/iovs.03-1252; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35125	35132		10.1074/jbc.M707266200	http://dx.doi.org/10.1074/jbc.M707266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17890222	hybrid			2022-12-27	WOS:000251155200057
J	Donato, H; Krupenko, NI; Tsybovsky, Y; Krupenko, SA				Donato, Henry; Krupenko, Natalia I.; Tsybovsky, Yaroslav; Krupenko, Sergey A.			10-formyltetrahydrofolate dehydrogenase requires a 4 '-phosphopantetheine prosthetic group for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; CARBOXYL-TERMINAL DOMAIN; ALKALINE-PHOSPHATASE; PHOSPHODIESTERASE ACTIVITY; ALDEHYDE DEHYDROGENASE; ESCHERICHIA-COLI; HYDROLASE DOMAIN; PURIFICATION; EXPRESSION; ENZYMES	10- Formyltetrahydrofolate dehydrogenase (FDH) consists of two independent catalytic domains, N- and C-terminal, connected by a 100-amino acid residue linker (intermediate domain). Our previous studies on structural organization and enzymatic properties of rat FDH suggest that the overall enzyme reaction, i.e. NADP(+) -dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and CO2, consists of two steps: (i) hydrolytic cleavage of the formyl group in the N-terminal catalytic domain, followed by (ii) NADP(+) -dependent oxidation of the formyl group to CO2 in the C-terminal aldehyde dehydrogenase domain. In this mechanism, it was not clear how the formyl group is transferred between the two catalytic domains after the first step. This study demonstrates that the intermediate domain functions similarly to an acyl carrier protein. A 4'-phosphopantetheine swinging arm bound through a phosphoester bond to Ser(354) of the intermediate domain transfers the formyl group between the catalytic domains of FDH. Thus, our study defines the intermediate domain of FDH as a novel carrier protein and provides the previously lacking component of the FDH catalytic mechanism.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Coll Charleston, Dept Chem & Biochem, Charleston, SC 29424 USA	Medical University of South Carolina; College of Charleston	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu			NIDDK NIH HHS [DK 54388] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; COOK RJ, 1991, J BIOL CHEM, V266, P4965; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Guo SJ, 2001, J BACTERIOL, V183, P7120, DOI 10.1128/JB.183.24.7120-7125.2001; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 1997, J BIOL CHEM, V272, P10273; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; KRUPENKO SA, 1995, J BIOL CHEM, V270, P519, DOI 10.1074/jbc.270.2.519; Krupenko SA, 2001, J BIOL CHEM, V276, P24030, DOI 10.1074/jbc.M009257200; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Krupenko SA, 1999, J BIOL CHEM, V274, P35777, DOI 10.1074/jbc.274.50.35777; Kursula P, 2006, ACTA CRYSTALLOGR D, V62, P1294, DOI 10.1107/S0907444906026849; KUTZBACH C, 1971, METHODS ENZYMOL B, V18, P793; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; Reuland SN, 2003, J BIOL CHEM, V278, P22894, DOI 10.1074/jbc.M302948200; REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SCRUTTON MC, 1979, BIOCHEM J, V177, P833, DOI 10.1042/bj1770833; Thomas J, 2005, J BIOL CHEM, V280, P34675, DOI 10.1074/jbc.M505736200; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Wagner C, 1995, FOLATE HLTH DIS, P23; Walsh C., 2006, POSTTRANSLATIONAL MO; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r	45	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34159	34166		10.1074/jbc.M707627200	http://dx.doi.org/10.1074/jbc.M707627200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884809	hybrid			2022-12-27	WOS:000251145700030
J	Hintze, KJ; Katoh, Y; Igarashi, K; Theil, EC				Hintze, Korry J.; Katoh, Yasutake; Igarashi, Kazuhiko; Theil, Elizabeth C.			Bach1 repression of ferritin and thioredoxin reductase1 is heme-sensitive in cells and in vitro and coordinates expression with heme oxygenase1, beta-globin, and NADP(H) quinone (oxido) reductase1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; MESSENGER-RNA REGULATION; LOCUS-CONTROL REGION; HUMAN HEPATOMA-CELLS; COBALT-PROTOPORPHYRIN; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; TRANSLATIONAL REGULATION; REGULATORY PROTEIN-2; OXIDATIVE STRESS	Ferritin gene transcription is regulated by heme as is ferritin mRNA translation, which is mediated by the well studied mRNA.IRE/IRP protein complex. The heme-sensitive DNA sequence in ferritin genes is the maf recognition/antioxidant response element present in several other genes that are induced by heme and repressed by Bach1. We now report that chromatin immunoprecipitated with Bach1 antiserum contains ferritin DNA sequences. In addition, overexpression of Bach1 protein in the transfected cells decreased ferritin expression, indicating insufficient endogenous Bach1 for full repression; decreasing Bach1 with antisense RNA increased ferritin expression. Thioredoxin reductase1, a gene that also contains a maf recognition/antioxidant response element but is less studied, responded similarly to ferritin, as did the positive controls heme oxygenase1 and NADP(H) quinone (oxido) reductase1. Bach1-DNA promoter interactions in cells were confirmed in vitro with soluble, recombinant Bach1 protein and revealed a quantitative range of Bach1/DNA stabilities: ferritin L similar to ferritin H similar to beta-globin, beta-globin similar to 2-fold > heme oxygenase1 = quinone reductase beta-globin similar to 4-fold > thioredoxin reductase1. Such results indicate the possibility that modulation of cellular Bach1 concentrations will have variable effects among the genes coordinately regulated by maf recognition/ antioxidant response elements in iron/oxygen/antioxidant metabolism.	Childrens Hosp Oakland, Res Inst, Council Bioiron, Oakland, CA 94609 USA; Tohoku Univ, Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Tohoku University; University of California System; University of California Berkeley	Theil, EC (corresponding author), Childrens Hosp Oakland, Res Inst, Council Bioiron, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org	Hintze, Korry/A-7079-2008; Hintze, Korry/E-4619-2011	Igarashi, Kazuhiko/0000-0002-2470-2475; Hintze, Korry/0000-0003-0135-0478	NIDDK NIH HHS [DK 20251] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Fletcher JE, 2001, RNA, V7, P1442; Ghaziani T, 2006, J HEPATOL, V45, P5, DOI 10.1016/j.jhep.2005.12.020; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LIN JJ, 1991, P NATL ACAD SCI USA, V88, P6068, DOI 10.1073/pnas.88.14.6068; LIN JJ, 1990, SCIENCE, V247, P74, DOI 10.1126/science.2294594; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MASCOTTI DP, 1995, ANNU REV NUTR, V15, P239, DOI 10.1146/annurev.nu.15.070195.001323; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Otterbein LE, 2002, AM J RESP CELL MOL, V26, P161, DOI 10.1165/ajrcmb.26.2.f226; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; SMITH A, 1993, J BIOL CHEM, V268, P7365; SMITH TJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P221, DOI 10.1016/0304-4165(91)90206-V; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sun JY, 2001, J BIOCHEM, V130, P385, DOI 10.1093/oxfordjournals.jbchem.a002997; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	49	86	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34365	34371		10.1074/jbc.M700254200	http://dx.doi.org/10.1074/jbc.M700254200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901053	hybrid			2022-12-27	WOS:000251145700052
J	Shimura, K; Okada, A; Okada, K; Jikumaru, Y; Ko, KW; Toyomasu, T; Sassa, T; Hasegawa, M; Kodama, O; Shibuya, N; Koga, J; Nojiri, H; Yamane, H				Shimura, Kazuhiro; Okada, Atsushi; Okada, Kazunori; Jikumaru, Yusuke; Ko, Kwang-Wook; Toyomasu, Tomonobu; Sassa, Takeshi; Hasegawa, Morifumi; Kodama, Osamu; Shibuya, Naoto; Koga, Jinichiro; Nojiri, Hideaki; Yamane, Hisakazu			Identification of a biosynthetic gene cluster in rice for momilactones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; DITERPENE PHYTOALEXIN; PLASMA-MEMBRANE; ORYZALEXINS-A; ENT-COPALYL; CLONING; CELLS; GIBBERELLIN; EXPRESSION; ELICITOR	Rice diterpenoid phytoalexins such as momilactones and phytocassanes are produced in suspension-cultured rice cells treated with a chitin oligosaccharide elicitor and in rice leaves irradiated with UV light. The common substrate geranylgeranyl diphosphate is converted into diterpene hydrocarbon precursors via a two-step sequential cyclization and then into the bioactive phytoalexins via several oxidation steps. It has been suggested that microsomal cytochrome P-450 monooxygenases (P-450s) are involved in the downstream oxidation of the diterpene hydrocarbons leading to the phytoalexins and that a dehydrogenase is involved in momilactone biosynthesis. However, none of the enzymes involved in the downstream oxidation of the diterpene hydrocarbons have been identified. In this study, we found that a putative dehydrogenase gene (AK103462) and two functionally unknown P-450 genes (CYP99A2 and CYP99A3) form a chitin oligosaccharide elicitor- and UV-inducible gene cluster, together with OsKS4 and OsCyc1, the diterpene cyclase genes involved in momilactone biosynthesis. Functional analysis by heterologous expression in Escherichia coli followed by enzyme assays demonstrated that the AK103462 protein catalyzes the conversion of 3 beta-hydroxy- 9 beta H-pimara-7,15-dien-19,6 beta-olide into momilactone A. The double knockdown of CYP99A2 and CYP99A3 specifically suppressed the elicitor-inducible production of momilactones, strongly suggesting that CYP99A2, CYP99A3, or both are involved in momilactone biosynthesis. These results provide strong evidence for the presence on chromosome 4 of a gene cluster involved in momilactone biosynthesis.	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Yamagata Univ, Dept Bioresource Engn, Yamagata 9978555, Japan; Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan; Meiji Univ, Dept Life Sci, Kanagawa 2148571, Japan; Meiji Seika Kaisha Ltd, Food & Hlth Res & Dev Labs, Sakado, Saitama 3500289, Japan	University of Tokyo; Yamagata University; Ibaraki University; Meiji University; Meiji Holdings Co., Ltd.	Yamane, H (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ayamane@mail.ecc.u-tokyo.ac.jp	Hasegawa, Morifumi/G-6053-2011	Hasegawa, Morifumi/0000-0001-9829-2811; Koga, Jinichiro/0000-0003-2106-9894; Nojiri, Hideaki/0000-0003-3091-8691				AKATSUKA T, 1985, AGR BIOL CHEM TOKYO, V49, P1689, DOI 10.1080/00021369.1985.10866951; Atawong A, 2002, BIOSCI BIOTECH BIOCH, V66, P566, DOI 10.1271/bbb.66.566; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; CARTWRIGHT DW, 1981, PHYTOCHEMISTRY, V20, P535, DOI 10.1016/S0031-9422(00)84189-8; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; KATO H, 1995, ARCH BIOCHEM BIOPHYS, V316, P707, DOI 10.1006/abbi.1995.1094; KATO H, 1993, PHYTOCHEMISTRY, V33, P79, DOI 10.1016/0031-9422(93)85399-C; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; KATO T, 1977, J CHEM SOC PERK T 1, P250, DOI 10.1039/p19770000250; KATO T, 1977, PHYTOCHEMISTRY, V16, P45, DOI 10.1016/0031-9422(77)83010-0; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Nemoto T, 2004, FEBS LETT, V571, P182, DOI 10.1016/j.febslet.2004.07.002; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; Otomo K, 2004, BIOSCI BIOTECH BIOCH, V68, P2001, DOI 10.1271/bbb.68.2001; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; TAMOGAMI S, 1993, TETRAHEDRON, V49, P2025, DOI 10.1016/S0040-4020(01)86302-X; Toyomasu T, 2004, BIOSCI BIOTECH BIOCH, V68, P146, DOI 10.1271/bbb.68.146; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; Umemura K, 2002, PLANT CELL PHYSIOL, V43, P778, DOI 10.1093/pcp/pcf090; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Xia ZQ, 2001, J BIOL CHEM, V276, P12614, DOI 10.1074/jbc.M008622200; Xiang CB, 1997, PLANT MOL BIOL, V34, P403, DOI 10.1023/A:1005873500238; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; YAMADA A, 1993, BIOSCI BIOTECH BIOCH, V57, P405, DOI 10.1271/bbb.57.405	35	202	212	7	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34013	34018		10.1074/jbc.M703344200	http://dx.doi.org/10.1074/jbc.M703344200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17872948	hybrid			2022-12-27	WOS:000251145700015
J	Trosky, JE; Li, Y; Mukherjee, S; Keitany, G; Ball, H; Orth, K				Trosky, Jennifer E.; Li, Yan; Mukherjee, Sohini; Keitany, Gladys; Ball, Haydn; Orth, Kim			VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA EFFECTOR; VIBRIO-PARAHAEMOLYTICUS; YOPJ; ACTIVATION; RESPONSES; PROTEINS; RESIDUES; TARGET; MEK2	The bacterial pathogen Vibrio parahemeolyticus manipulates host signaling pathways during infections by injecting type III effectors. One of these effectors, Vibrio outer protein A (VopA), inhibits MAPK signaling via a novel mechanism, distinct from those described for other bacterial toxins, that disrupts this signaling pathway. VopA is an acetyltransferase that potently inhibits MAPK signaling pathways not only by preventing the activation of MAPK kinases (MKKs) but also by inhibiting the activity of activated MKKs. VopA acetylates a conserved lysine found in the catalytic loop of all kinases and blocks the binding of ATP, but not ADP, on the MKKs, resulting in an inactive phosphorylated kinase. Acetylation of this conserved lysine inhibits kinase activity by a new mechanism of regulation that has not been observed previously. Identifying the target of VopA reveals a way that the reversible post-translational modification of lysine acetylation can be used to regulate the activity of an enzyme.	Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Dinalo, Jennifer/AAN-8708-2020; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Dinalo, Jennifer/0000-0001-5174-5756	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 056404] Funding Source: Medline; NIDDK NIH HHS [1R21 DK 072134-01] Funding Source: Medline; NIGMS NIH HHS [5T32 GM 08203] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aubol BE, 2003, BIOCHEMISTRY-US, V42, P12813, DOI 10.1021/bi035200c; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Morrison DK, 2001, J CELL SCI, V114, P1609; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; ORTH K, 2007, MICROBE, V2, P183; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	20	95	101	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34299	34305		10.1074/jbc.M706970200	http://dx.doi.org/10.1074/jbc.M706970200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881352	hybrid			2022-12-27	WOS:000251145700045
J	Woods, WS; Boettcher, JM; Zhou, DH; Kloepper, KD; Hartman, KL; Ladror, DT; Qi, Z; Rienstra, CM; George, JM				Woods, Wendy S.; Boettcher, John M.; Zhou, Donghua H.; Kloepper, Kathryn D.; Hartman, Kevin L.; Ladror, Daniel T.; Qi, Zhi; Rienstra, Chad M.; George, Julia M.			Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; K-ATP CHANNELS; SYNTHETIC MEMBRANES; INCLUSION FORMATION; SECONDARY STRUCTURE; MOLECULAR-CLONING; DOWN-SYNDROME; WILD-TYPE; ENDOSULFINE; EXPRESSION	alpha-Synuclein (AS) is an intrinsically unstructured protein in aqueous solution but is capable of forming beta-sheet-rich fibrils that accumulate as intracytoplasmic inclusions in Parkinson disease and certain other neurological disorders. However, AS binding to phospholipid membranes leads to a distinct change in protein conformation, stabilizing an extended amphipathic alpha-helical domain reminiscent of the exchangeable apolipoproteins. To better understand the significance of this conformational change, we devised a novel bacteriophage display screen to identify protein binding partners of helical AS and have identified 20 proteins with roles in diverse cellular processes related to membrane trafficking, ion channel modulation, redox metabolism, and gene regulation. To verify that the screen identifies proteins with specificity for helical AS, we further characterized one of these candidates, endosulfine alpha (ENSA), a small cAMP-regulated phosphoprotein implicated in the regulation of insulin secretion but also expressed abundantly in the brain. We used solution NMR to probe the interaction between ENSA and AS on the surface of SDS micelles. Chemical shift perturbation mapping experiments indicate that ENSA interacts specifically with residues in the N-terminal helical domain of AS in the presence of SDS but not in aqueous buffer lacking SDS. The ENSA-related protein ARPP-19 (cAMP-regulated phosphoprotein 19) also displays specific interactions with helical AS. These results confirm that the helical N terminus of AS can mediate specific interactions with other proteins and suggest that membrane binding may regulate the physiological activity of AS in vivo.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	George, JM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	j-george@uiuc.edu	Woods, Wendy/B-6602-2008; George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914; Zhou, Donghua/0000-0002-6638-4014	NIA NIH HHS [R01 AG 13762] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BOETTCHER JM, 2007, IN PRESS BIOMOL NMR; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou JT, 2003, J NEUROCHEM, V87, P1086, DOI 10.1046/j.1471-4159.2003.02094.x; Dulubova I, 2001, J NEUROCHEM, V77, P229, DOI 10.1046/j.1471-4159.2001.00191.x; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Elkon H, 2002, J MOL NEUROSCI, V18, P229, DOI 10.1385/JMN:18:3:229; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; GODDARD TD, 2005, SPARKY3 VESION 3 112; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Gros L, 2002, DIABETOLOGIA, V45, P703, DOI 10.1007/s00125-002-0794-9; Heron L, 1998, P NATL ACAD SCI USA, V95, P8387, DOI 10.1073/pnas.95.14.8387; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Huang HB, 2001, J BIOMOL NMR, V19, P383, DOI 10.1023/A:1011214512601; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Kim SH, 2001, J NEURAL TRANSM-SUPP, P263; Kim SH, 2001, NEUROSCI LETT, V310, P77, DOI 10.1016/S0304-3940(01)02025-0; Kim SH, 2001, J NEURAL TRANSM-SUPP, P1; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Naciff JM, 1996, AM J PHYSIOL-CELL PH, V271, pC2004; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Palmer AG, 1996, J PHYS CHEM-US, V100, P13293, DOI 10.1021/jp9606117; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pontius J., 2003, NCBI HDB, P1; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; SEGREST JP, 1992, J LIPID RES, V33, P141; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Thameem F, 2004, MOL GENET METAB, V81, P16, DOI 10.1016/j.ymgme.2003.09.013; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Virsolvy A, 2002, BRIT J PHARMACOL, V135, P1810, DOI 10.1038/sj.bjp.0704635; VIRSOLVYVERGINE A, 1992, P NATL ACAD SCI USA, V89, P6629, DOI 10.1073/pnas.89.14.6629; WALAAS SI, 1983, J NEUROSCI, V3, P302; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	76	60	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34555	34567		10.1074/jbc.M705283200	http://dx.doi.org/10.1074/jbc.M705283200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17893145	hybrid			2022-12-27	WOS:000251145700070
J	Chen, M; Guerrero, AD; Huang, L; Shabier, Z; Pan, M; Tan, TH; Wang, J				Chen, Min; Guerrero, Alan D.; Huang, Li; Shabier, Zainuer; Pan, Michael; Tan, Tse-Hua; Wang, Jin			Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; CYTOCHROME-C RELEASE; CELL-DEATH; IMMUNE-SYSTEM; ACTIVATION; PROTEIN; MCL-1; REQUIREMENT; EXECUTIONER; APOPTOSOME	Mitochondrial disruption during apoptosis results in the release of cytochrome c that forms apoptosomes with Apaf-1 and caspase-9. Activation of caspase-9 by dimerization in apoptosomes then triggers a caspase signaling cascade. In addition, other apoptosis signaling molecules released from the mitochondrion, such as apoptosis-inducing factor and endonuclease G, may induce caspase-9-independent apoptosis. To determine the signaling events induced by caspase-9, we used chemically induced dimerization for specific activation of caspase-9. We observed that caspase-9 dimerization resulted in the loss of mitochondrial membrane potential and the cleavage of anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1. Moreover, cleavage-resistant Bcl-2, Bcl-xL, or Mcl-1 potently inhibited caspase-9-dependent loss of mitochondrial membrane potential and the release of cytochrome c. Our data suggest that a caspase-9 signaling cascade induces feedback disruption of the mitochondrion through cleavage of anti-apoptotic Bcl-2, Bcl-xL, and Mcl-1.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Wang, J (corresponding author), Baylor Coll Med, Dept Immunol, 1 Baylor Plaza,N920, Houston, TX 77030 USA.	jinwang@bcm.edu	Tan, Tse-Hua/ABD-7080-2021; Tan, Tse-Hua/E-3983-2010	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Chen, Min/0000-0002-0093-9056; Wang, Jin/0000-0002-3116-0838				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI P, 2004, CELL, V116, P57; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Rathore N, 2004, J BIOL CHEM, V279, P39358, DOI 10.1074/jbc.M406712200; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; YANG J, 1997, SCIENCE, V275, P1132; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	44	81	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33888	33895		10.1074/jbc.M702969200	http://dx.doi.org/10.1074/jbc.M702969200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893147	hybrid			2022-12-27	WOS:000250840200070
J	Lecuyer, E; Lariviere, S; Sincennes, MC; Haman, A; Lahlil, R; Todorova, M; Tremblay, M; Wilkes, BC; Hoang, T				Lecuyer, Eric; Lariviere, Simon; Sincennes, Marie-Claude; Haman, Andre; Lahlil, Rachid; Todorova, Margarita; Tremblay, Mathieu; Wilkes, Brian C.; Hoang, Trang			Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; C-KIT EXPRESSION; SCL GENE-PRODUCT; LIM-DOMAIN; ERYTHROID-DIFFERENTIATION; APTEROUS ACTIVITY; BINDING PROTEINS; LINEAGE CHOICE; ADULT-MOUSE; LMO2 ACT	Gene expression programs are established by networks of interacting transcription factors. The basic helix-loop-helix factor SCL and the LIM-only protein LMO2 are components of transcription factor complexes that are essential for hematopoiesis. Here we show that LMO2 and SCL are predominant interaction partners in hematopoietic cells and that this interaction occurs through a conserved interface residing in the loop and helix 2 of SCL. This interaction nucleates the assembly of SCL complexes on DNA and is required for target gene induction and for the stimulation of erythroid and megakaryocytic differentiation. We also demonstrate that SCL determines LMO2 protein levels in hematopoietic cells and reveal that interaction with SCL prevents LMO2 degradation by the proteasome. We propose that the SCL-LMO2 interaction couples protein stabilization with higher order protein complex assembly, thus providing a powerful means of modulating the stoichiometry and spatiotemporal activity of SCL complexes. This interaction likely provides a rate-limiting step in the transcriptional control of hematopoiesis and leukemia, and similar mechanisms may operate to control the assembly of diverse protein modules.	Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Mol Biol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 2J7, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3C 2J7, Canada; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Hoang, T (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, POB 6128,Downtown Branch, Montreal, PQ H3C 2J7, Canada.	Trang.hoang@umontreal.ca	Lahlil, Rachid/AAK-1654-2020	Lahlil, Rachid/0000-0003-2966-6386; Sincennes, Marie-Claude/0000-0002-1961-426X				APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; Bao JX, 2000, DEVELOPMENT, V127, P425; Begley CG, 1999, BLOOD, V93, P2760; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Hiratani I, 2003, DEVELOPMENT, V130, P4161, DOI 10.1242/dev.00621; Hoang T, 1996, BLOOD, V87, P102; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Krosl G, 1998, J EXP MED, V188, P439, DOI 10.1084/jem.188.3.439; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mead PE, 2001, DEVELOPMENT, V128, P2301; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 2000, DEVELOPMENT, V127, P3069; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Schlaeger TM, 2004, MOL CELL BIOL, V24, P7491, DOI 10.1128/MCB.24.17.7491-7502.2004; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Silver L, 1997, BLOOD, V89, P1154, DOI 10.1182/blood.V89.4.1154; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Teranoa T, 2005, EXP HEMATOL, V33, P641, DOI 10.1016/j.exphem.2005.01.018; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Tremblay M, 2003, J BIOL CHEM, V278, P12680, DOI 10.1074/jbc.M209870200; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Weihe U, 2001, DEVELOPMENT, V128, P4615; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Xu ZX, 2006, BIOCHEM J, V399, P297, DOI 10.1042/BJ20060873; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	61	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33649	10.1074/jbc.M703939200	http://dx.doi.org/10.1074/jbc.M703939200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878155	hybrid			2022-12-27	WOS:000250840200046
J	Wiley, JC; Smith, EA; Hudson, MP; Ladiges, WC; Bothwell, M				Wiley, Jesse C.; Smith, Elise A.; Hudson, Mark P.; Ladiges, Warren C.; Bothwell, Mark			Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRONIC BIALLELIC POLYMORPHISM; PHOSPHOTYROSINE-BINDING DOMAIN; RECEPTOR-RELATED PROTEIN; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; ADAPTER PROTEIN; NUCLEAR TRANSLOCATION; SECRETASE CLEAVAGE; TERMINAL FRAGMENT; CANDIDATE GENES	The beta-amyloid precursor protein (APP)-binding protein Fe65 is involved in APP nuclear signaling and several steps in APP proteolytic processing. In this study, we show that Fe65 stimulates gamma-secretase-mediated liberation of the APP intracellular domain (AICD). The mechanism of Fe65-mediated stimulation of AICD formation appears to be through enhanced production of the carboxyl-terminal fragment substrates of gamma-secretase and direct stimulation of processing by gamma-secretase. The stimulatory capacity of Fe65 is isoform-dependent, as the non-neuronal and a2 isoforms promote APP processing more effectively than the exon 9 inclusive neuronal form of Fe65. Intriguingly, Fe65 stimulation of AICD production appears to be inversely related to pathogenic beta-amyloid production as the Fe65 isoforms profoundly stimulate AICD production and simultaneously decreaseA beta 42 production. Despite the capacity of Fe65 to stimulate gamma-secretase-mediated APP proteolysis, it does not rescue the loss of proteolytic function associated with the presenilin-1 familial Alzheimer disease mutations. These data suggest that Fe65 regulation of APP proteolysis may be integrally associated with its nuclear signaling function, as all antecedent proteolytic steps prior to release of Fe65 from the membrane are fostered by the APP-Fe65 interaction.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bothwell, M (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	mab@u.washington.edu		Bothwell, Mark/0000-0001-5423-2702	NIA NIH HHS [AG21127, AG26476] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021127, R21AG026476] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barnes NY, 1998, J NEUROSCI, V18, P5869; Bertram L, 2000, EXP GERONTOL, V35, P1353, DOI 10.1016/S0531-5565(00)00193-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; Hu QB, 1998, HUM GENET, V103, P295, DOI 10.1007/s004390050820; Hu QB, 1999, J NEUROSCI RES, V58, P632, DOI 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P; Hu QB, 2000, J NEUROSCI RES, V60, P73, DOI 10.1002/(SICI)1097-4547(20000401)60:1<73::AID-JNR8>3.0.CO;2-S; Hu QB, 2002, HUM MOL GENET, V11, P465, DOI 10.1093/hmg/11.4.465; Jolly-Tornetta C, 2000, BIOCHEMISTRY-US, V39, P15282, DOI 10.1021/bi001723y; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lambert JC, 2000, NEUROSCI LETT, V293, P29, DOI 10.1016/S0304-3940(00)01477-4; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Papassotiropoulos A, 2000, INT J MOL MED, V6, P587; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Prince JA, 2001, EUR J HUM GENET, V9, P437, DOI 10.1038/sj.ejhg.5200651; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	49	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33313	33325		10.1074/jbc.M706024200	http://dx.doi.org/10.1074/jbc.M706024200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855370	hybrid			2022-12-27	WOS:000250840200011
J	Masaki, H; Nishida, T; Kitajima, S; Asahina, K; Teraoka, H				Masaki, Hisaharu; Nishida, Tomohiro; Kitajima, Shigetaka; Asahina, Kinji; Teraoka, Hirobumi			Developmental pluripotency-associated 4 (DPPA4) localized in active chromatin inhibits mouse embryonic stem cell differentiation into a primitive ectoderm lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; ENDODERM DIFFERENTIATION; ES CELLS; PLURIPOTENCY; NANOG; EXPRESSION; GENES; SOX2; ACTIVATION	Because embryonic stem (ES) cells can proliferate indefinitely in an undifferentiated state and differentiate into various cell types, ES cells are expected to be useful for cell replacement therapy and basic research on early embryogenesis. Although molecular mechanisms of ES cell self-renewal have been studied, many uncharacterized genes expressed in ES cells remain to be clarified. Developmental pluripotency associated 4 (Dppa4) is one such gene highly expressed in both ES cells and early embryos. Here, we investigated the role of Dppa4 in mouse ES cell self-renewal and differentiation. We generated Dppa4-overexpressing ES cells under the control of tetracycline. Dppa4 overexpression suppressed cell proliferation and formation of embryoid bodies and caused massive cell death in differentiating ES cells. Quantitative reverse transcription-PCR analysis showed that Dppa4 overexpression does not support ES cell self-renewal but partially inhibits ES cell differentiation. Suppression of Dppa4 expression by short hairpin RNA induced ES cell differentiation into a primitive ectoderm lineage. DPPA4 protein was localized in the ES cell nucleus associated with chromatin. Micrococcal nuclease digestion analysis and immunocytochemistry revealed that DPPA4 is associated with transcriptionally active chromatin. These findings indicate that DPPA4 is a nuclear factor associated with active chromatin and that it regulates differentiation of ES cells into a primitive ectoderm lineage.	Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Asahina, K (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA.	asahina@usc.edu	Asahina, Kinji/X-8794-2019	Asahina, Kinji/0000-0003-0398-8395				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lake JA, 2000, J CELL SCI, V113, P555; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Remboutsika E, 1999, J CELL SCI, V112, P1671; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	50	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33034	33042		10.1074/jbc.M703245200	http://dx.doi.org/10.1074/jbc.M703245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855347	hybrid			2022-12-27	WOS:000250625400052
J	Wang, H; Gilham, D; Lehner, R				Wang, Huajin; Gilham, Dean; Lehner, Richard			Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver Microsomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEIN; TRIACYLGLYCEROL HYDROLASE; ENDOPLASMIC-RETICULUM; APO-B; FATTY-ACIDS; SECRETION; CELL; GOLGI; LOCALIZATION	The assembly of very low density lipoproteins involves the formation of a primordial, poorly lipidated apoB-containing particle in the endoplasmic reticulum, followed by the addition of neutral lipid from luminal lipid droplets ( LLD). However, the lipid and protein compositions of LLD have not been determined. We have isolated LLD from mouse liver microsomes and analyzed their lipid and protein compositions. LLD are variably sized particles relatively poor in triacylglycerol ( TG) content when compared with the lipid composition of cytosolic lipid droplets ( CLD). They are devoid of apoB, adipophilin, and albumin but contain numerous proteins different from those found on CLD, including TG hydrolase ( TGH), carboxylesterase 1 ( Ces1), microsomal triglyceride transfer protein ( MTP), and apoE. Ectopic expression of TGH in McArdle RH7777 hepatoma cells resulted in decreased cellular TG levels, demonstrating a role for TGH in the mobilization of hepatic neutral lipid stores. The isolation and characterization of LLD provide new supporting evidence for the two-step assembly of very low density lipoproteins.	Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Pediat, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Lehner, R (corresponding author), Univ Alberta, CIHR Grp Mol & Cell Biol Lipids, Dept Cell Biol, 328 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	richard.lehner@ualberta.ca		Lehner, Richard/0000-0002-6008-1805; Wang, Huajin/0000-0003-0121-4257				Alam M, 2002, PROTEIN EXPRES PURIF, V24, P33, DOI 10.1006/prep.2001.1553; ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Dolinsky VW, 2004, CELL MOL LIFE SCI, V61, P1633, DOI 10.1007/s00018-004-3426-3; Ellinghaus P, 1998, BBA-GENE STRUCT EXPR, V1397, P175, DOI 10.1016/S0167-4781(98)00023-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; Gilham D, 2005, MOL BIOL CELL, V16, P984, DOI 10.1091/mbc.e04-03-0224; Gilham D, 2004, REV ENDOCR METAB DIS, V5, P303, DOI 10.1023/B:REMD.0000045101.42431.c7; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; Hamilton RL, 1998, J LIPID RES, V39, P1543; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Hussain MM, 1997, BIOCHEMISTRY-US, V36, P13060, DOI 10.1021/bi971395a; Jonas A., 2002, BIOCH LIPIDS LIPOPRO, P483; Kuipers F, 1996, HEPATOLOGY, V24, P241; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lankester DL, 1998, J LIPID RES, V39, P1889; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Lehner R, 1997, BIOCHEMISTRY-US, V36, P1861, DOI 10.1021/bi962186d; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Maugeais C, 2000, J LIPID RES, V41, P1673; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; MORIMURA S, 1992, CELL GROWTH DIFFER, V3, P685; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Pease RJ, 1999, BIOCHEM J, V341, P453, DOI 10.1042/0264-6021:3410453; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; RUSTAEUS S, 1995, J BIOL CHEM, V270, P28879, DOI 10.1074/jbc.270.48.28879; Rustaeus S, 1998, J BIOL CHEM, V273, P5196, DOI 10.1074/jbc.273.9.5196; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; SPOONER PJR, 1987, BIOCHEMISTRY-US, V26, P5820, DOI 10.1021/bi00392a036; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Valyi-Nagy K, 2002, LIPIDS, V37, P879, DOI 10.1007/s11745-002-0974-3; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yamamoto M, 2001, J BIOCHEM MOL TOXIC, V15, P76, DOI 10.1002/jbt.2; Yang LY, 1996, J LIPID RES, V37, P262	65	63	63	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33218	33226		10.1074/jbc.M706841200	http://dx.doi.org/10.1074/jbc.M706841200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848546	hybrid			2022-12-27	WOS:000250625400069
J	Xu, K; Kitchen, CM; Shu, HKG; Murphy, TJ				Xu, Kaiming; Kitchen, Chad M.; Shu, Hui-Kuo G.; Murphy, Thomas J.			Platelet-derived growth factor-induced stabilization of cyclooxygenase 2 mRNA in rat smooth muscle cells requires the c-Src family of protein-tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; BINDING PROTEINS; 3'-UNTRANSLATED REGION; INCREASES EXPRESSION; C/EBP-BETA; PDGF-BB; P38; STABILITY; TRISTETRAPROLIN; INVOLVEMENT	Cyclooxygenases ( COXs) are crucial rate- limiting enzymes required for the biosynthesis of prostaglandins. COX- 2 is an inducible isoform of this enzyme, which is believed to play important roles in the development of atherosclerotic vascular disease. We found that COX- 2 expression rapidly increases in response to various signaling events, including activation of the platelet- derived growth factor ( PDGF) pathway. Activation of PDGF receptor ( PDGFR) in rat aortic vascular smooth muscle cells leads to c- Src- dependent stabilization of COX- 2 mRNA requiring an AU- rich region within the 3'-untranslated region of this transcript. This regulation correlates with tyrosine phosphorylation of the RNA- associated protein, CUG- binding protein 2 ( CUGBP2), which appears to enhance its interaction with COX-2 mRNA. Site-directed mutagenesis of putative tyrosine phosphorylation sites in CUGBP2 identified tyrosine 39 as a c-Src target, and a CUGBP2 with a mutated tyrosine 39 displayed an attenuated ability to bind COX- 2 mRNA. We further show that silencing of CUGBP2 with specific small interference RNAs significantly reduces PDGF- dependent induction of COX- 2 at both mRNA and protein levels. Furthermore, forced expression of CUGBP2 or constitutively active c- Src leads to stabilization of co- expressed COX- 2 mRNA. Finally, in vitro RNA decay assay demonstrates that CUGBP2 is functionally required for the stabilization of COX- 2 mRNA. Therefore, our data suggest that tyrosine phosphorylation of CUGBP2 is an important underlying mechanism for the ability of PDGFR/ c- Src signaling to control the stability of COX- 2 mRNA.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Xu, K (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	kxu@emory.edu			NHLBI NIH HHS [HL 56107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Bromann PA, 2005, J BIOL CHEM, V280, P10253, DOI 10.1074/jbc.M413806200; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen CY, 2000, GENE DEV, V14, P1236; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Englesbe MJ, 2004, J VASC SURG, V39, P1091, DOI 10.1016/j.jvs.2004.01.041; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Good PJ, 2000, J BIOL CHEM, V275, P28583, DOI 10.1074/jbc.M003083200; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Liang HY, 1999, J BIOL CHEM, V274, P19846, DOI 10.1074/jbc.274.28.19846; Liu B, 2006, J MOL CELL CARDIOL, V41, P160, DOI 10.1016/j.yjmcc.2006.03.426; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mifflin RC, 2004, MOL PHARMACOL, V65, P470, DOI 10.1124/mol.65.2.470; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Montero L, 1999, CANCER RES, V59, P5286; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Poon M, 1999, MOL CELL BIOL, V19, P6471; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Robida AM, 2000, MOL PHARMACOL, V58, P701, DOI 10.1124/mol.58.4.701; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Singh G, 2004, NUCLEIC ACIDS RES, V32, P1232, DOI 10.1093/nar/gkh275; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tamura M, 2003, J MOL ENDOCRINOL, V31, P95, DOI 10.1677/jme.0.0310095; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Vane JR, 1998, INFLAMM RES, V47, pS78; Wang SW, 1999, INFLAMM RES, V48, P533, DOI 10.1007/s000110050499; Wang XF, 1997, MOL PHARMACOL, V52, P781, DOI 10.1124/mol.52.5.781; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Xu KM, 2000, J BIOL CHEM, V275, P7604, DOI 10.1074/jbc.275.11.7604; Xu KM, 2000, J BIOL CHEM, V275, P23012, DOI 10.1074/jbc.M001611200; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhang ZH, 2000, NEOPLASIA, V2, P523, DOI 10.1038/sj.neo.7900117	56	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32699	32709		10.1074/jbc.M705272200	http://dx.doi.org/10.1074/jbc.M705272200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855367	hybrid			2022-12-27	WOS:000250625400018
J	Eckermann, K; Mocanu, MM; Khlistunova, I; Biernat, J; Nissen, A; Hofmann, A; Schonig, K; Bujard, H; Haemisch, A; Mandelkow, E; Zhou, L; Rune, G; Mandelkow, EM				Eckermann, Katrin; Mocanu, Maria-Magdalena; Khlistunova, Inna; Biernat, Jacek; Nissen, Astrid; Hofmann, Anne; Schoenig, Kai; Bujard, Hermann; Haemisch, Andreas; Mandelkow, Eckhard; Zhou, Lepu; Rune, Gabriele; Mandelkow, Eva-Maria			The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; HUMAN BRAIN TAU; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; REGULATED EXPRESSION; P301L TAU; A-BETA	Neurofibrillary lesions are characteristic for a group of human diseases, named tauopathies, which are characterized by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein Tau. The tauopathies are accompanied by abnormal changes in Tau protein, including pathological conformation, somatodendritic mislocalization, hyperphosphorylation, and aggregation, whose interdependence is not well understood. To address these issues we have created transgenic mouse lines in which different variants of full-length Tau are expressed in a regulatable fashion, allowing one to switch the expression on and off at defined time points. The Tau variants differ by small mutations in the hexapeptide motifs that control the ability of Tau to adopt a beta-structure conformation and hence to aggregate. The "pro-aggregation" mutant Delta K280, derived from one of the mutations observed in frontotemporal dementias, aggregates avidly in vitro, whereas the "anti-aggregation" mutant Delta K280/PP cannot aggregate because of two beta-breaking prolines. In the transgenic mice, the pro-aggregation Tau induces a pathological conformation and pre-tangle aggregation, even at low expression levels, the antiaggregation mutant does not. This illustrates that abnormal aggregation is primarily controlled by the molecular structure of Tau in vitro and in the organism. Both variants of Tau become mislocalized and hyperphosphorylated independently of aggregation, suggesting that localization and phosphorylation are mainly a consequence of increased concentration. These pathological changes are reversible when the expression of Tau is switched off. The pro-aggregation Tau causes a strong reduction in spine synapses.	Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; Univ Heidelberg, Ctr Mol Biol, ZMBH, Heidelberg, Germany; Univ Hamburg, Sch Med, Cent Anim Facil, Hamburg 20146, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; University of Hamburg	Mandelkow, EM (corresponding author), Max Planck Unit Struct Mol Biol, Notkestrasse 85, D-22607 Hamburg, Germany.	mandelkow@mpasmb.desy.de	Mocanu, Maria-Magdalena/B-5911-2011	Mocanu, Maria-Magdalena/0000-0002-1381-0649				Allen B, 2002, J NEUROSCI, V22, P9340; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Muyllaert D, 2006, REV NEUROL-FRANCE, V162, P903, DOI 10.1016/S0035-3787(06)75098-6; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Prange-Kiel J, 2004, EUR J NEUROSCI, V19, P309, DOI 10.1111/j.0953-816X.2003.03124.x; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	65	117	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31755	31765		10.1074/jbc.M705282200	http://dx.doi.org/10.1074/jbc.M705282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716969	hybrid			2022-12-27	WOS:000250309200066
J	Heroux, M; Hogue, M; Lemieux, S; Bouvier, M				Heroux, Madeleine; Hogue, Mireille; Lemieux, Sebastien; Bouvier, Michel			Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; LIVING CELLS; VISUALIZATION; COMPLEXES; CHANNELS; STOICHIOMETRY; HETERODIMERS; MICROSCOPY; TRANSPORT; FAMILY	In addition to their interactions with hetero-trimeric G proteins, seven-transmembrane domain receptors are now known to form multimeric complexes that can include receptor homoor hetero-oligomers and/or accessory proteins that modulate their activity. The calcitonin gene-related peptide ( CGRP) receptor requires the assembly of the seven-transmembrane domain calcitonin receptor-like receptor with the single-transmembrane domain receptor activity-modifying protein-1 to reach the cell surface and be active. However, the relative stoichiometric arrangement of these two proteins within a receptor complex remains unknown. Despite recent advances in the development of protein-protein interactions assays, determining the composition and stoichiometric arrangements of such signaling complexes in living cells remains a challenging task. In the present study, we combined bimolecular fluorescence complementation (BiFC) with bioluminescence resonance energy transfer (BRET) to probe the stoichiometric arrangement of the CGRP receptor complex. Together with BRET competition assays, co-immunoprecipitation experiments, and BiFC imaging, dual BRET/BiFC revealed that functional CGRP receptors result from the association of a homo-oligomer of the calcitonin receptor-like receptor with a monomer of the accessory protein receptor activity-modifying protein-1. In addition to revealing the existence of an unexpected asymmetric oligomeric organization for a G protein-coupled receptor, our study illustrates the usefulness of dual BRET/BiFC as a powerful tool for analyzing constitutive and dynamically regulated multiprotein complexes.	Univ Medicament, Dept Biochem, Grp Rech, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Inst Res Immunol & Canc, Dept Comp sci & Operat Res, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bouvier, M (corresponding author), Univ Medicament, Dept Biochem, Grp Rech, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100				Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Efron B., 1994, INTRO BOOTSTRAP; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; Heroux M, 2007, BIOCHEMISTRY-US, V46, P7022, DOI 10.1021/bi0622470; Hilaire S, 2001, J BIOL CHEM, V276, P42182, DOI 10.1074/jbc.M107323200; Hilairet S, 2001, J BIOL CHEM, V276, P29575, DOI 10.1074/jbc.M102722200; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Leuthauser K, 2000, BIOCHEM J, V351, P347, DOI 10.1042/0264-6021:3510347; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P441; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Michnick SW, 2001, CURR OPIN STRUC BIOL, V11, P472, DOI 10.1016/S0959-440X(00)00235-9; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Press WH., 2002, NUMERICAL RECIPES C, V2; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Sexton PM, 2001, CELL SIGNAL, V13, P73, DOI 10.1016/S0898-6568(00)00143-1; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3	29	65	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31610	31620		10.1074/jbc.M701790200	http://dx.doi.org/10.1074/jbc.M701790200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17785463	hybrid			2022-12-27	WOS:000250309200053
J	Kovacheva, VP; Mellott, TJ; Davison, JM; Wagner, N; Lopez-Coviella, I; Schnitzler, AC; Blusztajn, JK				Kovacheva, Vesela P.; Mellott, Tiffany J.; Davison, Jessica M.; Wagner, Nicholas; Lopez-Coviella, Ignacio; Schnitzler, Aletta C.; Blusztajn, Jan K.			Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of dnmt1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; ADENOSYL-L-METHIONINE; CPG-BINDING-PROTEINS; S-ADENOSYLMETHIONINE; FOLATE-DEFICIENCY; HISTONE DEACETYLASE; DIETARY-FOLATE; TISSUE-LEVELS; RAT-LIVER; HYPOMETHYLATION	During gestation there is a high demand for the essential nutrient choline. Adult rats supplemented with choline during embryonic days ( E) 11-17 have improved memory performance and do not exhibit age-related memory decline, whereas prenatally choline-deficient animals have memory deficits. Choline, via betaine, provides methyl groups for the production of S-adenosylmethionine, a substrate of DNA methyltransferases (DNMTs). We describe an apparently adaptive epigenomic response to varied gestational choline supply in rat fetal liver and brain. S-Adenosylmethionine levels increased in both organs of E17 fetuses whose mothers consumed a choline-supplemented diet. Surprisingly, global DNA methylation increased in choline-deficient animals, and this was accompanied by overexpression of Dnmt1 mRNA. Previous studies showed that the prenatal choline supply affects the expression of multiple genes, including insulin-like growth factor 2 (Igf2), whose expression is regulated in aDNA methylation-dependent manner. The differentially methylated region 2 of Igf2 was hypermethylated in the liver of E17 choline-deficient fetuses, and this as well as Igf2 mRNA levels correlated with the expression of Dnmt1 and with hypomethylation of a regulatory CpG within the Dnmt1 locus. Moreover, mRNA expression of brain and liver Dnmt3a and methyl CpG-binding domain 2 (Mbd2) protein as well as cerebral Dnmt3l was inversely correlated to the intake of choline. Thus, choline deficiency modulates fetal DNA methylation machinery in a complex fashion that includes hypomethylation of the regulatory CpGs within the Dnmt1 gene, leading to its overexpression and the resultant increased global and gene- specific ( e. g. Igf2) DNA methylation. These epigenomic responses to gestational choline supply may initiate the long term developmental changes observed in rats exposed to varied choline intake in utero.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, 715 Albany St,L804, Boston, MA 02118 USA.	jbluszta@bu.edu		/0000-0001-8438-3122; Wagner, Nicholas/0000-0002-4192-4774; Mellott, Tiffany/0000-0003-3287-9374	NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER; NIA NIH HHS [AG009525, P01 AG009525] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AlonsoAperte E, 1996, INT J VITAM NUTR RES, V66, P232; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; BECK F, 1987, DEVELOPMENT, V101, P175; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BHAVE MR, 1988, CARCINOGENESIS, V9, P343, DOI 10.1093/carcin/9.3.343; BIERI JG, 1977, J NUTR, V107, P1394; Bieri JG., 1980, J NUTR, V110, P1726, DOI [10.1093/jn/110.8.1726, DOI 10.1093/JN/110.8.1726]; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BONDY CA, 1990, MOL ENDOCRINOL, V4, P1386, DOI 10.1210/mend-4-9-1386; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Esfandiari F, 2003, CARCINOGENESIS, V24, P1935, DOI 10.1093/carcin/bgg163; FAROOQUI JZ, 1983, BIOCHIM BIOPHYS ACTA, V757, P342; FEIL R, 1994, DEVELOPMENT, V120, P2933; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GARNER SC, 1995, J NUTR, V125, P2851; GEHRKE CW, 1984, J CHROMATOGR, V301, P199, DOI 10.1016/S0021-9673(01)89189-5; GHARIB A, 1982, J NEUROCHEM, V38, P810, DOI 10.1111/j.1471-4159.1982.tb08702.x; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HOFFMAN DR, 1979, CAN J BIOCHEM CELL B, V57, P56, DOI 10.1139/o79-007; HOFFMAN DR, 1981, CAN J BIOCHEM CELL B, V59, P543, DOI 10.1139/o81-075; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mellott TJ, 2007, BRAIN RES, V1151, P1, DOI 10.1016/j.brainres.2007.03.004; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 2002, J NUTR, V132, p2462S, DOI 10.1093/jn/132.8.2462S; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Pogribny IP, 2004, MUTAT RES-FUND MOL M, V548, P53, DOI 10.1016/j.mrfmmm.2003.12.014; POIRIER LA, 1977, CANCER RES, V37, P744; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Ross SA, 2003, ANN NY ACAD SCI, V983, P197, DOI 10.1111/j.1749-6632.2003.tb05974.x; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Singal R, 2001, BLOOD, V98, P3441, DOI 10.1182/blood.V98.12.3441; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Sohn KJ, 2003, CARCINOGENESIS, V24, P81, DOI 10.1093/carcin/24.1.81; Song J, 2000, CANCER RES, V60, P3191; STYLIANOPOULOU F, 1988, DEVELOPMENT, V103, P497; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; WAINFAN E, 1989, CANCER RES, V49, P4094; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; WATERLAND RA, 2007, IN PRESS FASEB J; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; ZEISEL SH, 1995, J NUTR, V125, P3049; ZEISEL SH, 1989, BIOCHEM J, V259, P725, DOI 10.1042/bj2590725; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	88	160	167	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31777	31788		10.1074/jbc.M705539200	http://dx.doi.org/10.1074/jbc.M705539200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724018	hybrid			2022-12-27	WOS:000250309200068
J	Qi, XM; Pohl, NM; Loesch, M; Hou, SW; Li, RS; Qin, JZ; Cuenda, A; Chen, G				Qi, Xiaomei; Pohl, Nicole M.; Loesch, Mathew; Hou, Songwang; Li, Rongshan; Qin, Jian-Zhong; Cuenda, Ana; Chen, Guan			P38 alpha antagonizes p38 gamma activity through c-jun-dependent ubiquitin-proteasome pathways in regulating ras transformation and stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D-RECEPTOR; N-TERMINAL KINASE; MAP KINASE; P38 MAPK; CELL-DEATH; SUSTAINED ACTIVATION; ESTROGEN-RECEPTOR; CANCER CELLS; JNK	p38 MAPK family consists of four isoform proteins (alpha, beta, gamma, and delta) that are activated by the same stimuli, but the information about how these proteins act together to yield a biological response is missing. Here we show a feed-forward mechanism by which p38 alpha may regulate Ras transformation and stress response through depleting its family member p38 gamma protein via c-Jun-dependent ubiquitin-proteasome pathways. Analyses of MAPK kinase 6 (MKK6)-p38 fusion proteins showed that constitutively active p38 alpha (MKK6-p38 alpha) and p38 gamma (MKK6-p38 gamma) stimulates and inhibits c-Jun phosphorylation respectively, leading to a distinct AP-1 regulation. Depending on cell type and/or stimuli, p38 alpha phosphorylation results in either Rastransformation inhibition or a cell-death escalation that invariably couples with a decrease in p38 gamma protein expression. p38 gamma, on the other hand, increases Ras-dependent growth or inhibits stress induced cell-death independent of phosphorylation. In cells expressing both proteins, p38 alpha phosphorylation decreases p38 gamma protein expression, whereas its inhibition increases cellular p38 gamma concentrations, indicating an active role of p38 gamma phosphorylation in negatively regulating p38 gamma protein expression. Mechanistic analyses show that p38 alpha requires c-Jun activation to deplete p38 gamma proteins by ubiquitin-proteasome pathways. These results suggest that p38 alpha may, upon phosphorylation, act as a gatekeeper of the p38 MAPK family to yield a coordinative biological response through disrupting its antagonistic p38 gamma family protein.	Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; Loyola Univ, Ctr Canc, Dept Pathol, Maywood, IL 60153 USA; Univ Dundee, MRC, Protein Phosphorlat Unit, Dundee DD1 5EH, Scotland	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Loyola University Chicago; University of Dundee	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu			Medical Research Council [MC_U127015387] Funding Source: Medline; NCI NIH HHS [2R01 CA91576] Funding Source: Medline; MRC [MC_U127015387] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jehan F, 1997, P NATL ACAD SCI USA, V94, P10138, DOI 10.1073/pnas.94.19.10138; Johnson R, 1996, MOL CELL BIOL, V16, P4504; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; LAINE A, 2005, SCI STKE, P1; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shi GX, 2005, J BIOL CHEM, V280, P37599, DOI 10.1074/jbc.M507364200; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	55	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31398	31408		10.1074/jbc.M703857200	http://dx.doi.org/10.1074/jbc.M703857200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724032	hybrid			2022-12-27	WOS:000250309200030
J	Tanimura, S; Hirano, AI; Hashizume, J; Yasunaga, M; Kawabata, T; Ozaki, KI; Kohno, M				Tanimura, Susumu; Hirano, A-i; Hashizume, Junya; Yasunaga, Masahiro; Kawabata, Takumi; Ozaki, Kei-ichi; Kohno, Michiaki			Anticancer drugs up-regulate HspBP1 and thereby antagonize the prosurvival function of hsp70 in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; KINASE SIGNALING PATHWAY; MOLECULAR CHAPERONES; COCHAPERONE HSPBP1; APOPTOSIS; HEAT-SHOCK-PROTEIN-70; LYSOSOMES; STRESS; CANCER; EXPRESSION	The 70-kDa heat shock protein (Hsp70) is up-regulated in a wide variety of tumor cell types and contributes to the resistance of these cells to the induction of cell death by anticancer drugs. Hsp70 binding protein 1 (HspBP1) modulates the activity of Hsp70 but its biological significance has remained unclear. We have now examined whether HspBP1 might interfere with the prosurvival function of Hsp70, which is mediated, at least in part, by inhibition of the death-associated permeabilization of lysosomal membranes. HspBP1 was found to be expressed at a higher level than Hsp70 in all normal and tumor cell types examined. Tumor cells with a high HspBP1/Hsp70 molar ratio were more susceptible to anticancer drugs than were those with a low ratio. Ectopic expression of HspBP1 enhanced this effect of anticancer drugs in a manner that was both dependent on the ability of HspBP1 to bind to Hsp70 and sensitive to the induction of Hsp70 by mild heat shock. Furthermore, anticancer drugs up-regulated HspBP1 expression, whereas prevention of such up-regulation by RNA interference reduced the susceptibility of tumor cells to anticancer drugs. Overexpression of HspBP1 promoted the permeabilization of lysosomal membranes, the release of cathepsins from lysosomes into the cytosol, and the activation of caspase-3 induced by anticancer drugs. These results suggest that HspBP1, by antagonizing the prosurvival activity of Hsp70, sensitizes tumor cells to cathepsin-mediated cell death.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, Nagasaki 8528521, Japan	Nagasaki University	Kohno, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kohnom@nagasaki-u.ac.jp	Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059				Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fujiwara Y, 2007, MOL CANCER THER, V6, P1133, DOI 10.1158/1535-7163.MCT-06-0639; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gottwald E, 2006, CELL BIOL INT, V30, P553, DOI 10.1016/j.cellbi.2006.03.005; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Gurbuxani S, 2001, ONCOGENE, V20, P7478, DOI 10.1038/sj.onc.1204948; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raynes DA, 2003, TUMOR BIOL, V24, P281, DOI 10.1159/000076459; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	37	27	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35430	35439		10.1074/jbc.M707547200	http://dx.doi.org/10.1074/jbc.M707547200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17855353	hybrid			2022-12-27	WOS:000251458100002
J	Chaptal, V; Vincent, F; Gueguen-Chaignon, V; Monedero, V; Poncet, S; Deutscher, J; Nessler, S; Morera, S				Chaptal, Vincent; Vincent, Fanny; Gueguen-Chaignon, Virginie; Monedero, Vicente; Poncet, Sandrine; Deutscher, Josef; Nessler, Sylvie; Morera, Solange			Structural analysis of the bacterial HPr kinase/phosphorylase V267F mutant gives insights into the allosteric regulation mechanism of this bifunctional enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; X-RAY STRUCTURE; PHOSPHOTRANSFERASE SYSTEM; CATABOLITE REPRESSION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; COMPLEX; BINDING; ATP	The HPr kinase/phosphorylase (HPrK/P) is a bifunctional enzyme that controls the phosphorylation state of the phosphocarrier protein HPr, which regulates the utilization of carbon sources in Gram-positive bacteria. It uses ATP or pyrophosphate for the phosphorylation of serine 46 of HPr and inorganic phosphate for the dephosphorylation of Ser(P)-46-HPr via a phosphorolysis reaction. HPrK/P is a hexameric protein kinase of a new type with a catalytic core belonging to the family of nucleotide-binding protein with Walker A motif. It exhibits no structural similarity to eukaryotic protein kinases. So far, HPrK/P structures have shown the enzyme in its phosphorylase conformation. They permitted a detailed characterization of the phosphorolysis mechanism. In the absence of a structure with bound nucleotide, we used the V267F mutant enzyme to assess the kinase conformation. Indeed, the V267F replacement was found to cause an almost entire loss of the phosphorylase activity of Lactobacillus casei HPrK/P. In contrast, the kinase activity remained conserved. To elucidate the structural alterations leading to this drastic change of activity, the x-ray structure of the catalytic domain of L. casei HPrK/P-V267F was determined at 2.6 angstrom resolution. A comparison with the structure of the wild type enzyme showed that the mutation induces conformation changes compatible with the switch from phosphorylase to kinase function. Together with nucleotide binding fluorescence measurements, these results allowed us to decipher the cooperative behavior of the protein and to gain new insights into the allosteric regulation mechanism of HPrK/P.	CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France; CNRS INRA AgroParis Tech, Microbiol & Genet Mol, F-78850 Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE	Nessler, S (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	nessler@lebs.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Nessler, Sylvie/R-4296-2016; Monedero, Vicente/H-3876-2012	Nessler, Sylvie/0000-0003-4973-9941; Monedero, Vicente/0000-0001-7461-8047; chaptal, vincent/0000-0003-2603-0294; PONCET, Sandrine/0000-0002-2813-0793; morera, solange/0000-0001-7781-0448				Allen GS, 2003, J MOL BIOL, V326, P1203, DOI 10.1016/S0022-2836(02)01378-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Choi ID, 2006, BIOSCI BIOTECH BIOCH, V70, P1089, DOI 10.1271/bbb.70.1089; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1984, FEMS MICROBIOL LETT, V23, P157; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dossonnet V, 2000, J BACTERIOL, V182, P2582, DOI 10.1128/JB.182.9.2582-2590.2000; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; FUJITA Y, 1995, MOL MICROBIOL, V17, P953, DOI 10.1111/j.1365-2958.1995.mmi_17050953.x; Galinier A, 2002, J BIOL CHEM, V277, P11362, DOI 10.1074/jbc.M109527200; Herro R, 2005, J MOL MICROB BIOTECH, V9, P224, DOI 10.1159/000089650; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; JULLIEN M, 1988, BIOCHIMIE, V70, P1807, DOI 10.1016/0300-9084(88)90042-9; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Marquez JA, 2002, P NATL ACAD SCI USA, V99, P3458, DOI 10.1073/pnas.052461499; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; Pompeo F, 2003, BIOCHEMISTRY-US, V42, P6762, DOI 10.1021/bi034405i; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RODIER FJL, 1982, EUR J BIOCHEM, V128, P451; Russell RB, 2002, FEBS LETT, V517, P1, DOI 10.1016/S0014-5793(02)02518-8; Tari LW, 1996, NAT STRUCT BIOL, V3, P355, DOI 10.1038/nsb0496-355; VERSTAETE IM, 1999, J BACTERIOL, V181, P2966; Yang QH, 2001, J BIOL CHEM, V276, P24608, DOI 10.1074/jbc.M102366200; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	38	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34952	34957		10.1074/jbc.M705979200	http://dx.doi.org/10.1074/jbc.M705979200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17878158	Green Published, hybrid			2022-12-27	WOS:000251155200039
J	Conz, C; OttoO, H; PeiskerO, K; Gautschi, M; Wolfle, T; Mayer, MP; Rospert, S				Conz, Charlotte; OttoO, Hendrik; PeiskerO, Kristin; Gautschi, Matthias; Woelfle, Tina; Mayer, Matthias P.; Rospert, Sabine			Functional characterization of the atypical Hsp70 subunit of yeast ribosome-associated complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; DNAK CHAPERONE; PROTEINS; HSP110; TRANSLATION; SPECIFICITY; BINDING; LACKING; FAMILY	Eukaryotic ribosomes carry a stable chaperone complex termed ribosome-associated complex consisting of the J-domain protein Zuo1 and the Hsp70 Ssz1. Zuo1 and Ssz1 together with the Hsp70 homolog Ssb1/2 form a functional triad involved in translation and early polypeptide folding processes. Strains lacking one of these components display slow growth, cold sensitivity, and defects in translational fidelity. Ssz1 diverges from canonical Hsp70s insofar that neither the ability to hydrolyze ATP nor binding to peptide substrates is essential in vivo. The exact role within the chaperone triad and whether or not Ssz1 can hydrolyze ATP has remained unclear. We now find that Ssz1 is not an ATPase in vitro, and even its ability to bind ATP is dispensable in vivo. Furthermore, Ssz1 function was independent of ribosome-associated complex formation, indicating that Ssz1 is not merely a structural scaffold for Zuo1. Finally, Ssz1 function in vivo was inactivated when both nucleotide binding and Zuo1 interaction via the C-terminal domain were disrupted in the same mutant. The two domains of this protein thus cooperate in a way that allows for severe interference in either but not in both of them.	ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Heidelberg Univ, ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany	University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Rospert, S (corresponding author), ZBMZ, Inst Biochem & Mol Biol, Herrmann Herder Str 7, D-79104 Freiburg, Germany.	sabine.rospert@biochemie.uni-freiburg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Rospert, Sabine/0000-0002-3089-9614				Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CRAIG EA, 1985, MOL CELL BIOL, V5, P3517, DOI 10.1128/MCB.5.12.3517; Dragovic Z, 2006, BIOL CHEM, V387, P1593, DOI 10.1515/BC.2006.198; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HAID A, 1983, METHOD ENZYMOL, V96, P192; Hatin I, 2007, GENETICS, V177, P1527, DOI 10.1534/genetics.107.070771; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Muldoon-Jacobs KL, 2006, EUKARYOT CELL, V5, P762, DOI 10.1128/EC.5.4.762-770.2006; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Rauch T, 2005, MOL MICROBIOL, V57, P357, DOI 10.1111/j.1365-2958.2005.04690.x; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rospert S, 2005, REV PHYSIOL BIOCH P, V155, P1, DOI 10.1007/s10254-005-0039-7; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; Rospert S, 1995, METHOD ENZYMOL, V260, P287, DOI 10.1016/0076-6879(95)60145-7; Schonfeld HJ, 1995, PROG COLL POL SCI S, V99, P7; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Sherman F., 1986, METHODS YEAST GENETI; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	41	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33977	33984		10.1074/jbc.M706737200	http://dx.doi.org/10.1074/jbc.M706737200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17901048	hybrid			2022-12-27	WOS:000251145700011
J	Izaguirre, G; Swanson, R; Raja, SM; Rezaie, AR; Olson, ST				Izaguirre, Gonzalo; Swanson, Richard; Raja, Srikumar M.; Rezaie, Alireza R.; Olson, Steven T.			Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CENTER LOOP; TARGET PROTEINASE SPECIFICITY; FACTOR-XA REACTION; CONFORMATIONAL-CHANGE; BINDING EXOSITE; FACTOR-IXA; PLASMINOGEN-ACTIVATOR; RAPID INHIBITION; TERNARY COMPLEX; BASIC RESIDUES	Heparin activates the serpin, antithrombin, to inhibit its target blood-clotting proteases by generating new protease interaction exosites. To resolve the effects of these exosites on the initial Michaelis docking step and the subsequent acylation and conformational change steps of antithrombin-protease reactions, we compared the reactions of catalytically inactive S195A and active proteases with site-specific fluorophore-labeled antithrombins that allow monitoring of these reaction steps. Heparin bound to N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-3-oxa-1,3diazol- 4-yl)ethylenediamine (NBD)-fluorophore-labeled antithrombins and accelerated the reactions of the labeled inhibitor with thrombin and factor Xa similar to wild type. Equilibrium binding of NBD- labeled antithrombins to S195A proteases showed that exosites generated by conformationally activating antithrombin with a heparin pentasaccharide enhanced the affinity of the serpin for S195A factor Xa minimally 100-fold. Moreover, additional bridging exosites provided by a hexadecasaccharide heparin activator enhanced antithrombin affinity for both S195A factor Xa and thrombin at least 1000-fold. Rapid kinetic studies showed that these exosite-mediated enhancements in Michaelis complex affinity resulted from increases in k(on) and decreases in k(off) and caused antithrombin-protease reactions to become diffusion-controlled. Competitive binding and kinetic studies with exosite mutant antithrombins showed that Tyr-253 was a critical mediator of exosite interactions with S195A factor Xa; that Glu-255, Glu-237, and Arg-399 made more modest contributions to these interactions; and that exosite interactions reduced koff for the Michaelis complex interaction. Together these results show that exosites generated by heparin activation of antithrombin function both to promote the formation of an initial antithrombin-protease Michaelis complex and to favor the subsequent acylation of this complex.	Univ Illinois, Ctr Mol Biol & Oral Dis, Chicago, IL 60612 USA; St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol & Oral Dis, Rm 530C Dent M-C 860,801 S Paulina St, Chicago, IL 60612 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565, R01HL039888, R37HL039888, R29HL039888] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-62565, HL-39888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492, DOI 10.1016/0006-291X(83)90550-8; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; MILETICH JP, 1981, METHOD ENZYMOL, V80, P221; MILLER DM, 1980, J BIOL CHEM, V255, P2465; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1995, J BIOL CHEM, V270, P30007; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; OWEN W G, 1973, Thrombosis Research, V3, P705, DOI 10.1016/0049-3848(73)90017-0; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Pike RN, 1997, J BIOL CHEM, V272, P19652, DOI 10.1074/jbc.272.32.19652; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P2898, DOI 10.1021/bi036145a; Rezaie AR, 1996, BIOCHEMISTRY-US, V35, P1918, DOI 10.1021/bi952065y; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; SUN XJ, 1989, J BIOL CHEM, V264, P11288; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200	50	25	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33609	10.1074/jbc.M702462200	http://dx.doi.org/10.1074/jbc.M702462200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875649	hybrid			2022-12-27	WOS:000250840200042
J	Brock, C; Oueslati, N; Soler, S; Boudier, L; Rondard, P; Pin, JP				Brock, Carsten; Oueslati, Nadia; Soler, Stephan; Boudier, Laure; Rondard, Philippe; Pin, Jean-Philippe			Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; POSITIVE ALLOSTERIC MODULATORS; GABA(B) RECEPTOR; ERYTHROPOIETIN RECEPTOR; HEPTAHELICAL DOMAIN; BINDING DOMAINS; CLASS-A; RHODOPSIN; MECHANISM; DIMERIZATION	Although many G protein-coupled receptors (GPCRs) can form dimers, a possible role of this phenomenon in their activation remains elusive. A recent and exciting proposal is that a dynamic intersubunit interplay may contribute to GPCR activation. Here, we examined this possibility using dimeric metabotropic glutamate receptors (mGluRs). We first developed a system to perfectly control their subunit composition and show that mGluR dimers do not form larger oligomers. We then examined an mGluR dimer containing one subunit in which the extracellular agonist-binding domain was uncoupled from the G protein-activating transmembrane domain. Despite this uncoupling in one protomer, agonist stimulation resulted in symmetric activation of either transmembrane domain in the dimer with the same efficiency. This, plus other data, can only be explained by an intersubunit rearrangement as the activation mechanism. Although well established for other types of receptors such as tyrosine kinase and guanylate cyclase receptors, this is the first clear demonstration that such a mechanism may also apply to GPCRs.	Univ Montpellier 1 & 2, CNRS, Inst Funct Genom, UMR5203, F-34094 Montpellier, France; CNRS, INSERM, U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pin, JP (corresponding author), Univ Montpellier 1 & 2, CNRS, Inst Funct Genom, UMR5203, 141 Rue Cardonille, F-34094 Montpellier, France.	jppin@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019; Rondard, Philippe/N-9720-2018	Pin, Jean-Philippe/0000-0002-1423-345X; RONDARD, Philippe/0000-0003-1134-2738				Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Calver AR, 2001, J NEUROSCI, V21, P1203; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Jeoung M, 2007, MOL CELL ENDOCRINOL, V260, P137, DOI 10.1016/j.mce.2005.09.015; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kubo Y, 2005, CURR OPIN NEUROBIOL, V15, P289, DOI 10.1016/j.conb.2005.05.011; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Pagano A, 2001, J NEUROSCI, V21, P1189; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Pin JP, 1999, EUR J PHARMACOL, V375, P277, DOI 10.1016/S0014-2999(99)00258-7; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rondard P, 2006, J BIOL CHEM, V281, P24653, DOI 10.1074/jbc.M602277200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	47	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33000	33008		10.1074/jbc.M702542200	http://dx.doi.org/10.1074/jbc.M702542200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855348	Green Submitted, hybrid			2022-12-27	WOS:000250625400049
J	Bussen, W; Raynard, S; Busygina, V; Singh, AK; Sung, P				Bussen, Wendy; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick			Holliday junction processing activity of the BLM-topo III alpha-BLAP75 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; BLOOMS-SYNDROME HELICASE; SYNDROME GENE-PRODUCT; DAMAGED REPLICATION FORKS; TOPOISOMERASE-III-ALPHA; HOMOLOGOUS RECOMBINATION; DNA HELICASE; RECQ HELICASES; CHROMOSOMAL TRANSLOCATIONS; SYNDROME PROTEINS	BLM, the protein mutated in Bloom's syndrome, possesses a helicase activity that can dissociate DNA structures, including the Holliday junction, expected to arise during homologous recombination. BLM is stably associated with topoisomerase III alpha (Topo III alpha) and the BLAP75 protein. The BLM-Topo III alpha-BLAP75 (BTB) complex can efficiently resolve a DNA substrate that harbors two Holliday junctions (the double Holliday junction) in a non-crossover manner. Here we show that the Holliday junction unwinding activity of BLM is greatly enhanced as a result of its association with Topo III alpha and BLAP75. Enhancement of this BLM activity requires both Topo III alpha and BLAP75. Importantly, Topo III alpha cannot be substituted by Escherichia coli Top3, and the Holliday junction unwinding activity of BLM-related helicases WRN and RecQ is likewise impervious to Topo III alpha and BLAP75. However, the topoisomerase activity of Topo III alpha is dispensable for the enhancement of the DNA unwinding reaction. We have also ascertained the requirement for the BLM ATPase activity in double Holliday junction dissolution and DNA unwinding by constructing, purifying, and characterizing specific mutant variants that lack this activity. These results provide valuable information concerning how the functional integrity of the BTB complex is governed by specific protein-protein interactions among the components of this complex and the enzymatic activities of BLM and Topo III alpha.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,C130 Sterling Hall Med, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu			NATIONAL CANCER INSTITUTE [R01CA110415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES015252] Funding Source: NIH RePORTER; NCI NIH HHS [CA110415] Funding Source: Medline; NIEHS NIH HHS [ES015632, ES015252] Funding Source: Medline; NIGMS NIH HHS [T32 GM08735] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; GERMAN J, 1974, CHROMOSOMA, V48, P361, DOI 10.1007/BF00290993; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mankouri HW, 2004, BIOCHEM SOC T, V32, P957, DOI 10.1042/BST0320957; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Miyajima A, 2000, MOL CELL BIOL, V20, P6399, DOI 10.1128/MCB.20.17.6399-6409.2000; Miyajima A, 2000, GENES GENET SYST, V75, P319, DOI 10.1266/ggs.75.319; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2000, GENETICS, V154, P1101; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	51	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31484	31492		10.1074/jbc.M706116200	http://dx.doi.org/10.1074/jbc.M706116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728255	hybrid			2022-12-27	WOS:000250309200040
J	Choi, HS; Carman, GM				Choi, Hyeon-Son; Carman, George M.			Respiratory deficiency mediates the regulation of CHO1-encoded phosphatidylserine synthase by mRNA stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; DEPENDENT PROTEIN-KINASE; PHOSPHOLIPID BIOSYNTHESIS; COORDINATE REGULATION; CARDIOLIPIN BIOSYNTHESIS; ETHANOLAMINE KINASE; GENETIC-REGULATION; SHUTTLE VECTORS; GROWTH-PHASE; CYTOCHROME-C	The CHO1-encoded phosphatidylserine synthase (CDP-diacylglycerol: L-serine O-phosphatidyltransferase, EC 2.7.8.8) is one of the most highly regulated phospholipid biosynthetic enzymes in the yeast Saccharomyces cerevisiae. CHO1 expression is regulated by nutrient availability through a regulatory circuit involving a UAS(INO) cis-acting element in the CHO1 promoter, the positive transcription factors Ino2p and Ino4p, and the transcriptional repressor Opi1p. In this work, we examined the post-transcriptional regulation of CHO1 by mRNA stability. CHO1 mRNA was stabilized in mutants defective in deadenylation (ccr4 Delta), mRNA decapping (dcp1), and the 5(')-3(')-exonuclease (xrn1), indicating that the CHO1 transcript is primarily degraded through the general 5(')-3(') mRNA decay pathway. In respiratory-sufficient cells, the CHO1 transcript was moderately stable with a half-life of 12 min. However, the CHO1 transcript was stabilized to a half-life of >45 min in respiratory-deficient (rho-and rho(o)) cells, the cox4 Delta mutant defective in the cytochrome c oxidase, and wild type cells treated with KCN(acytochrome coxidase inhibitor). The increased CHO1 mRNA stability in response to respiratory deficiency caused increases in CHO1 mRNA abundance, phosphatidylserine synthase protein and activity, and the synthesis of phosphatidylserine in vivo. Respiratory deficiency also caused increases in the activities of CDP-diacylglycerol synthase, phosphatidylserine decarboxylase, and the phospholipid methyltransferases. Phosphatidylinositol synthase and choline kinase activities were not affected by respiratory deficiency. This work advances our understanding of phosphatidylserine synthase regulation and underscores the importance of mitochondrial respiration to the regulation of phospholipid synthesis in S. cerevisiae.	Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050679, GM-50679, R01 GM050679-14] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOLPHUS, 1983, EMBO J, V2, P1765, DOI 10.1002/j.1460-2075.1983.tb01655.x; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; AUSUBEL FM, 1993, CURRENT PROTOLS MOL; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CARMAN GM, 1992, METHOD ENZYMOL, V209, P242; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Cause G F, 1970, Experientia, V26, P209; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; CULBERTSON MR, 1975, GENETICS, V80, P23; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Elabbadi N, 1997, BIOCHEM J, V324, P435, DOI 10.1042/bj3240435; GARETT RH, 1999, BIOCHEMISTRY; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1988, MOL CELL BIOL, V8, P4773, DOI 10.1128/MCB.8.11.4773; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HROMY JM, 1986, J BIOL CHEM, V261, P5572; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; Kaiser C., 1994, METHODS YEAST GENETI; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kersting MC, 2004, J BIOL CHEM, V279, P35353, DOI 10.1074/jbc.M405704200; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KINNEY AJ, 1990, J BACTERIOL, V172, P1133, DOI 10.1128/jb.172.2.1133-1136.1990; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; LAMPING E, 1994, GENETICS, V137, P55; LAMPING E, 1991, J BACTERIOL, V173, P6432, DOI 10.1128/jb.173.20.6432-6437.1991; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; MESKAUSKAS A, 1985, FEBS LETT, V182, P413, DOI 10.1016/0014-5793(85)80344-6; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; NIKAWA J, 1987, EUR J BIOCHEM, V167, P7, DOI 10.1111/j.1432-1033.1987.tb13297.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Vemula M, 2003, J BIOL CHEM, V278, P45269, DOI 10.1074/jbc.M308812200; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Yamashita S, 1997, BBA-LIPID LIPID MET, V1348, P228, DOI 10.1016/S0005-2760(97)00102-1; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	100	6	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31217	31227		10.1074/jbc.M705098200	http://dx.doi.org/10.1074/jbc.M705098200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761681	hybrid, Green Accepted			2022-12-27	WOS:000250309200011
J	Zaccagnini, G; Martelli, F; Magenta, A; Cencioni, C; Fasanaro, P; Nicoletti, C; Biglioli, P; Pelicci, PG; Capogrossi, MC				Zaccagnini, Germana; Martelli, Fabio; Magenta, Alessandra; Cencioni, Chiara; Fasanaro, Pasquale; Nicoletti, Carmine; Biglioli, Paolo; Pelicci, Pier Giuseppe; Capogrossi, Maurizio C.			P66(ShcA) and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; SIGNALING PATHWAY; GENE PROTECTS; NITRIC-OXIDE; MOUSE MODEL; STEM-CELLS; DELETION; PROLIFERATION; ACTIVATION; EXPRESSION	Oxidative stress plays a pivotal role in ischemic injury, and p66(ShcA)ko mice exhibit both lower oxidative stress and decreased tissue damage following hind limb ischemia. Thus, it was investigated whether tissue regeneration following acute hind limb ischemia was altered in p66(ShcA)ko mice. Upon femoral artery dissection, muscle regeneration started earlier and was completed faster than in wild-type (WT) control. Moreover, faster regeneration was associated with decreased oxidative stress. Unlike ischemia, cardiotoxin injury induced similar skeletal muscle damage in both genotypes. However, p66(ShcA)ko mice regenerated faster, in agreement with the regenerative advantage upon ischemia. Since no difference between p66(ShcA)wt and knock-out (ko) mice was found in blood perfusion recovery after ischemia, satellite cells (SCs), a resident population of myogenic progenitors, were examined. Similar SCs numbers were present in WT and ko mice. However, in vitro cultured p66(ShcA)ko SCs displayed lower oxidative stress levels and higher proliferation rate and differentiated faster than WT. Furthermore, when exposed to sublethal H2O2 doses, p66(ShcA)ko SCs were resistant to H2O2-induced inhibition of differentiation. Finally, myogenic conversion induced by MyoD overexpression was more efficient in p66(ShcA)ko fibroblasts compared with WT. The present work demonstrates that oxidative stress and p66(ShcA) play a crucial role in the regenerative pathways activated by acute ischemia.	Ist Dermopatico Immacol, IRSS, Lab Patol Vasc, I-00167 Rome, Italy; Ctr Cardiol, Lab Biol Vascolare, Milan 20138, Italy; Ctr Cardiol, Inst Ricovero & Cura Carattere Sci, Dipartimento Chirurgia Vascolare, Milan 20138, Italy; Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, Rome 00185, Italy; Ist Europeo Oncol, Milan 20141, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome; IRCCS European Institute of Oncology (IEO)	Martelli, F (corresponding author), Ist Dermopatico Immacol, IRSS, Lab Patol Vasc, Via dei Monti Creta 104, I-00167 Rome, Italy.	f.martelli@idi.it	Zaccagnini, Germana/J-7722-2016; Martelli, Fabio/AAL-3788-2020; Cencioni, Chiara/I-8490-2018; Pelicci, Pier Giuseppe/AAL-6572-2020; magenta, alessandra/A-9473-2017; Franzeck, Fabian C/B-5055-2011	Zaccagnini, Germana/0000-0002-9441-4735; Martelli, Fabio/0000-0002-8624-7738; Cencioni, Chiara/0000-0001-6284-539X; magenta, alessandra/0000-0002-9054-337X; NICOLETTI, Carmine/0000-0001-5896-2040				Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fasanaro P, 2006, FASEB J, V20, P1242, DOI 10.1096/fj.05-4695fje; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Martelli F, 1999, P NATL ACAD SCI USA, V96, P2858, DOI 10.1073/pnas.96.6.2858; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Turrini P, 2002, NEUROSCI LETT, V323, P109, DOI 10.1016/S0304-3940(02)00090-3; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Yagi K, 1998, Methods Mol Biol, V108, P107; Yamamori T, 2005, J MOL CELL CARDIOL, V39, P992, DOI 10.1016/j.yjmcc.2005.09.003; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046	51	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31453	31459		10.1074/jbc.M702511200	http://dx.doi.org/10.1074/jbc.M702511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726026	hybrid			2022-12-27	WOS:000250309200036
J	Garlatti, V; Martin, L; Gout, E; Reiser, JB; Fujita, T; Arlaud, GJ; Thielens, NM; Gaboriaud, C				Garlatti, Virginie; Martin, Lydie; Gout, Evelyne; Reiser, Jean-Baptiste; Fujita, Teizo; Arlaud, Gerard J.; Thielens, Nicole M.; Gaboriaud, Christine			Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING LECTIN; CRYSTAL-STRUCTURE; LDL RECEPTOR; RECOGNITION; PROTEIN; PATHWAY; ACID; BACTERIA; PROVIDES; SYSTEM	Ficolins are soluble oligomeric proteins with lectin-like activity, assembled from collagen fibers prolonged by fibrinogen-like recognition domains. They act as innate immune sensors by recognizing conserved molecular markers exposed on microbial surfaces and thereby triggering effector mechanisms such as enhanced phagocytosis and inflammation. In humans, L-and H-ficolins have been characterized in plasma, whereas a third species, M-ficolin, is secreted by monocytes and macrophages. To decipher the molecular mechanisms underlying their recognition properties, we previously solved the structures of the recognition domains of L-and H-ficolins, in complex with various model ligands (Garlatti, V., Belloy, N., Martin, L., Lacroix, M., Matsushita, M., Endo, Y., Fujita, T., Fontecilla-Camps, J. C., Arlaud, G. J., Thielens, N. M., and Gaboriaud, C. (2007) EMBO J. 24, 623-633). We now report the ligand-bound crystal structures of the recognition domain of M-ficolin, determined at high resolution (1.75-1.8 angstrom), which provides the first structural insights into its binding properties. Interaction with acetylated carbohydrates differs from the one previously described for L-ficolin. This study also reveals the structural determinants for binding to sialylated compounds, a property restricted to human M-ficolin and its mouse counterpart, ficolin B. Finally, comparison between the ligand-bound structures obtained at neutral pH and nonbinding conformations observed at pH 5.6 reveals how the ligand binding site is dislocated at acidic pH. This means that the binding function of M-ficolin is subject to a pH-sensitive conformational switch. Considering that the homologous ficolin B is found in the lysosomes of activated macrophages (Runza, V. L., Hehlgans, T., Echtenacher, B., Zahringer, U., Schwaeble, W. J., and Mannel, D. N. (2006) J. Endotoxin Res. 12, 120-126), we propose that this switch could play a physiological role in such acidic compartments.	Univ Grenoble 1, Commissariat Energie Atom, Cristallog & Cristallogenese Prot Lab, CNRS,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Univ Grenoble 1, Commissariat Energie Atom, Lab Enzymol Mol, CNRS,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Fukushima Med Univ, Dept Biochem, Fukushima, Japan	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Fukushima Medical University	Gaboriaud, C (corresponding author), Univ Grenoble 1, Commissariat Energie Atom, Cristallog & Cristallogenese Prot Lab, CNRS,Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	christine.gaboriaud@ibs.fr	Reiser, Jean-Baptiste/W-7683-2019; Thielens, Nicole M/F-2512-2013	Reiser, Jean-Baptiste/0000-0001-6926-9137; Thielens, Nicole M/0000-0002-7354-0302				Aoyagi Y, 2005, J IMMUNOL, V174, P418, DOI 10.4049/jimmunol.174.1.418; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo Y, 2005, IMMUNOGENETICS, V57, P837, DOI 10.1007/s00251-005-0058-1; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Endo Y, 2006, ADV EXP MED BIOL, V586, P265; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Runza VL, 2006, J ENDOTOXIN RES, V12, P120, DOI 10.1179/096805106X102147; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2006, ACTA CRYSTALLOGR F, V62, P652, DOI 10.1107/S1744309106019786; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400	37	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35814	35820		10.1074/jbc.M705741200	http://dx.doi.org/10.1074/jbc.M705741200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897951	hybrid			2022-12-27	WOS:000251458100043
J	Partridge, JJ; Madsen, MA; Ardi, VC; Papagiannakopoulos, T; Kupriyanova, TA; Quigley, JP; Deryugina, EI				Partridge, Juneth J.; Madsen, Mark A.; Ardi, Veronica C.; Papagiannakopoulos, Thales; Kupriyanova, Tatyana A.; Quigley, James P.; Deryugina, Elena I.			Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA-CELL INVASION; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; TUMOR-GROWTH; IN-VIVO; CHORIOALLANTOIC MEMBRANE; ANGIOGENIC SWITCH; MATRIX-METALLOPROTEINASE-9; MMP-9	The role of tumor-derived matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) in cancer cell dissemination was analyzed by employing two variants of human HT-1080 fibrosarcoma, HT-hi/diss and HT-lo/diss, which differ by 50 - 100-fold in their ability to intravasate and metastasize in the chick embryo. HT-hi/diss and HT-lo/diss were compared by quantitative reverse transcription-PCR and Western blot analyses for mRNA and protein expression of nine MMPs (MMP-1, - 2, - 3, - 7, - 8, - 9, - 10, - 13, and - 14) and three TIMPs (TIMP-1, - 2, and - 3) in cultured cells in vitro and in primary tumors in vivo. MMP-1 and MMP-9 were more abundant in the HT-hi/diss variant, both in cultures and in tumors, whereas the HT-lo/diss variant consistently expressed higher levels of MMP-2, TIMP-1, and TIMP-2. Small interfering RNA-mediated down-regulation of MMP-2 and TIMP-2 increased intravasation of HT-lo/diss cells. Coordinately, treatment of the developing HT-hi/diss tumors with recombinant TIMP-1 and TIMP-2 significantly reduced HT-hi/diss cell intravasation. However, a substantial increase of HT-hi/diss dissemination was observed upon small interfering RNA-mediated down-regulation of three secreted MMPs, including the interstitial collagenase MMP-1 and the two gelatinases, MMP-2 and MMP-9, but not the membrane-tethered MMP-14. The addition of recombinant pro-MMP-9 protein to the HT-hi/diss tumors reversed the increased intravasation of HT-hi/diss cells, in which MMP-9 was stably down-regulated by short hairpin RNA interference. This rescue did not occur if the pro-MMP-9 was stoichiometrically complexed with TIMP-1, pointing to a direct role of the MMP-9 enzyme in regulation of HT-hi/diss intravasation. Collectively, these findings demonstrate that tumor-derived MMPs may have protective functions in cancer cell intravasation, i.e. not promoting but rather catalytically interfering with the early stages of cancer dissemination.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Quigley, JP (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jquigley@scripps.edu; deryugin@scripps.edu			NCI NIH HHS [CA55852, CA105412, 5F31CA117058] Funding Source: Medline; NHLBI NIH HHS [T32HL07195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105412, F31CA117058, R01CA055852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Agarwal D, 2003, DIFFERENTIATION, V71, P114, DOI 10.1046/j.1432-0436.2003.710202.x; Andarawewa KL, 2003, CANCER RES, V63, P5844; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chantrain CF, 2006, EUR J CANCER, V42, P310, DOI 10.1016/j.ejca.2005.11.010; Chen JJW, 2001, CANCER RES, V61, P5223; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; GORDON JR, 1986, INT J CANCER, V38, P437, DOI 10.1002/ijc.2910380321; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Heljasvaara R, 2005, EXP CELL RES, V307, P292, DOI 10.1016/j.yexcr.2005.03.021; Hofmann UB, 2003, CANCER RES, V63, P8221; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Hua J, 1996, CANCER RES, V56, P5279; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lakka SS, 2003, CANCER RES, V63, P2454; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lugassy C, 2006, AM J DERMATOPATH, V28, P187, DOI 10.1097/00000372-200606000-00001; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mira E, 2002, CLIN EXP METASTAS, V19, P313, DOI 10.1023/A:1015563031769; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; OSSOWSKI L, 1980, CANCER RES, V40, P2300; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; SCHER CD, 1976, CELL, V8, P373, DOI 10.1016/0092-8674(76)90149-5; Seftor REB, 2001, CANCER RES, V61, P6322; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; TSUCHIYA Y, 1994, INT J CANCER, V56, P46; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang WG, 2002, CANCER RES, V62, P6278; WATANABE H, 1993, J CELL SCI, V104, P991; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yu Q, 2000, GENE DEV, V14, P163; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458; Zijlstra A, 2002, CANCER RES, V62, P7083	73	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35964	35977		10.1074/jbc.M705993200	http://dx.doi.org/10.1074/jbc.M705993200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895241	hybrid			2022-12-27	WOS:000251458100057
J	Chen, Y; Hu, Y; Lu, K; Flannery, JG; Ma, JX				Chen, Ying; Hu, Yang; Lu, Kangmo; Flannery, John G.; Ma, Jian-xing			Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; FAMILIAL EXUDATIVE VITREORETINOPATHY; SUBRETINAL NEOVASCULARIZATION; VASCULAR DEVELOPMENT; CELL PROLIFERATION; FACTOR EXPRESSION; MOUSE MODEL; GENE; ANGIOGENESIS	Choroidal neovascularization (CNV) in age-related macular degeneration is a leading cause of blindness. Very low density lipoprotein receptor gene knock-out (Vldlr(-/-)) mice have been shown to develop subretinal neovascularization (NV) with an unknown mechanism. The present study showed that in Vldlr(-/-) mice, NV initiated in the choroid and progressed to penetrate the retinal pigment epithelium layer, proliferating in the subretinal space. This phenotype recapitulated what is seen in wet age-related macular degeneration, suggesting that this is a CNV model. The CNV correlated with overexpression of vascular endothelial growth factor in Vldlr(-/-) eyecups and was blocked by a neutralizing antibody against vascular endothelial growth factor receptor-2. The wnt co-receptor LRP5/6 expression was significantly up-regulated in Vldlr(-/-) eyecups compared with that in wild-type mice. Significantly, Vldlr(-/-) mice showed impaired phosphorylation of downstream effectors of the wnt signaling pathway, glycogen synthase kinase-3 beta (GSK-3 beta), and beta-catenin, concomitant with increased levels of free GSK-3 beta and beta-catenin, suggesting an increased activity of the wnt pathway. Down-regulation of VLDLR by small interference RNA resulted in up-regulation of LRP5/6 expression and activation of beta-catenin in cultured endothelial cells. Furthermore, Dickkopf-1, a specific inhibitor of the wnt pathway, effectively decreased vascular endothelial growth factor and beta-catenin levels in the retinal pigment epithelium of Vldlr(-/-) mice and in cells transfected with the VLDLR small interference RNA. These results suggest that VLDLR functions as a negative regulator of CNV, and this function is mediated through the wnt pathway.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Vis Sci & Neurosci Div, Berkeley, CA 94720 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Berkeley	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu		Flannery, John/0000-0002-0720-8897	NATIONAL EYE INSTITUTE [R01EY012231, R21EY015650, R33EY015650] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; COGAN D G, 1963, Trans Ophthalmol Soc U K, V83, P465; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; CONNOLLY SE, 1988, MICROVASC RES, V36, P275, DOI 10.1016/0026-2862(88)90028-3; Cursiefen C, 1997, KLIN MONATSBL AUGENH, V210, P341, DOI 10.1055/s-2008-1035072; Dale TC, 1998, BIOCHEM J, V329, P209; Easwaran V, 2003, CANCER RES, V63, P3145; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hembrough TA, 2001, J BIOL CHEM, V276, P12241, DOI 10.1074/jbc.M010395200; Ida H, 2003, INVEST OPHTH VIS SCI, V44, P5430, DOI 10.1167/iovs.03-0609; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KAPUSTINA E. V., 1960, ARKH ANAT GISTOL I EMBRIOL, V39, P16; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kondo H, 2003, BRIT J OPHTHALMOL, V87, P1291, DOI 10.1136/bjo.87.10.1291; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Millar JBA, 2002, GENOME BIOL, V3; Miller JW, 1997, AM J PATHOL, V151, P13; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Nilsson L, 1999, J LIPID RES, V40, P913; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Ojesina AI, 2004, J PEDIATR SURG, V39, P1446, DOI 10.1016/j.jpedsurg.2004.06.003; Orlandini M, 2003, J BIOL CHEM, V278, P44650, DOI 10.1074/jbc.M304255200; Orsulic S, 1996, CURR BIOL, V6, P1363, DOI 10.1016/S0960-9822(96)00731-2; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Tachikawa K, 2004, P NATL ACAD SCI USA, V101, P15225, DOI 10.1073/pnas.0406473101; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Takahashi Sadao, 2004, J Atheroscler Thromb, V11, P200; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tiebel O, 1999, ATHEROSCLEROSIS, V145, P239, DOI 10.1016/S0021-9150(99)00068-4; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zhang XB, 2001, CANCER RES, V61, P6050; 2004, MORB MORTAL WKLY REP, V53, P1069	54	89	91	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34420	34428		10.1074/jbc.M611289200	http://dx.doi.org/10.1074/jbc.M611289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890782	hybrid			2022-12-27	WOS:000251145700058
J	Gu, S; He, J; Ho, WT; Ramineni, S; Thal, DM; Natesh, R; Tesmer, JJG; Hepler, JR; Heximer, SP				Gu, Steven; He, Janet; Ho, Wing-Ting; Ramineni, Suneela; Thal, David M.; Natesh, Ramanathan; Tesmer, John J. G.; Hepler, John R.; Heximer, Scott P.			Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; TERMINAL CYSTEINE RESIDUES; 3RD-INTRACELLULAR LOOP; ALPHA-SUBUNITS; SIGNALING RGS; RECEPTOR; PALMITOYLATION; IDENTIFICATION; DETERMINANTS; ASSOCIATION	RGS2 and RGS5 are inhibitors of G-protein signaling belonging to the R4/B subfamily of RGS proteins. We here show that RGS2 is a much more potent attenuator of M1 muscarinic receptor signaling than RGS5. We hypothesize that this difference is mediated by variation in their ability to constitutively associate with the plasma membrane ( PM). Compared with full-length RGS2, the RGS-box domains of RGS2 and RGS5 both show reduced PM association and activity. Prenylation of both RGS-box domains increases activity to RGS2 levels, demonstrating that lipid bilayer targeting increases RGS domain function. Amino-terminal domain swaps confirm that key determinants of localization and function are found within this important regulatory domain. An RGS2 amphipathic helix domain mutant deficient for phospholipid binding ( L45D) shows reduced PM association and activity despite normal binding to the M1 muscarinic receptor third intracellular loop and activated G alpha(q). Replacement of a unique dileucine motif adjacent to the RGS2 helix with corresponding RGS5 residues disrupts both PMlocalization and function. These data suggest that RGS2 contains a hydrophobic extension of its helical domain that imparts high efficiency binding to the inner leaflet of the lipid bilayer. In support of this model, disruption of membrane phospholipid composition with N-ethylmaleimide reduces PM association of RGS2, without affecting localization of the M1 receptor or G(alpha)q. Together, these data indicate that novel features within the RGS2 amphipathic alpha helix facilitate constitutive PM targeting and more efficient inhibition of M1 muscarinic receptor signaling than RGS5 and other members of the R4/B subfamily.	Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Dept Physiol, Toronto, ON M5S 1A8, Canada; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30329 USA; Univ Michigan, Inst Life Sci, Chem Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Toronto; Emory University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Heximer, SP (corresponding author), Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.heximer@utoronto.ca	NATESH, Ramanathan/C-4488-2008; Thal, David/GXH-4911-2022	NATESH, Ramanathan/0000-0002-1145-5962; Thal, David/0000-0002-0325-2524; Tesmer, John/0000-0003-1125-3727	NHLBI NIH HHS [R01 HL 071818, HL 086865] Funding Source: Medline; NIGMS NIH HHS [R01 GM 61847] Funding Source: Medline; NINDS NIH HHS [R01 NS 37112] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Barker SA, 2001, GENOMICS, V78, P223, DOI 10.1006/geno.2001.6659; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Druey KM, 1999, J BIOL CHEM, V274, P18836, DOI 10.1074/jbc.274.26.18836; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jones TLZ, 2004, METHOD ENZYMOL, V389, P33; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Tovey SC, 2004, MOL PHARMACOL, V66, P1453, DOI 10.1124/mol.104.005827; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549	30	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33064	33075		10.1074/jbc.M702685200	http://dx.doi.org/10.1074/jbc.M702685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848575	hybrid			2022-12-27	WOS:000250625400055
J	Wang, XD; Hayes, JJ				Wang, Xiaodong; Hayes, Jeffrey J.			Site-specific binding affinities within the H2B tail domain indicate specific effects of lysine acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; NUCLEOSOME CORE PARTICLES; HIGHER-ORDER STRUCTURE; HISTONE ACETYLATION; CHROMATIN FIBER; THERMAL-DENATURATION; MAGNETIC-RESONANCE; DNA INTERACTIONS; GENE-REGULATION; MODEL SYSTEM	Acetylation of specific lysines within the core histone tail domains plays a critical role in regulating chromatin-based activities. However, the structures and interactions of the tail domains and the molecular mechanisms by which acetylation directly alters chromatin structures are not well understood. To address these issues we developed a chemical method to quantitatively determine binding affinities of specific regions within the individual tail domains in model chromatin complexes. Examinations of specific sites within the H2B tail domain indicate that this tail contains distinct structural elements and binds within nucleosomes with affinities that would reduce the activity of tail-binding proteins 10-50-fold from that deduced from peptide binding studies. Moreover, we find that mutations mimicking lysine acetylation do not cause a global weakening of tail-DNA interactions but rather the results suggest that acetylation leads to a much more subtle and specific alteration in tail interactions than has been assumed. In addition, we provide evidence that acetylation at specific sites in the tail is not additive with several events resulting in similar, localized changes in tail binding.			Hayes, JJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 52426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Ballestar E, 1997, BIOCHEMISTRY-US, V36, P5963, DOI 10.1021/bi9626620; Baneres JL, 1997, J MOL BIOL, V273, P503, DOI 10.1006/jmbi.1997.1297; Becker PB, 2006, NATURE, V442, P31, DOI 10.1038/442031a; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; CARY PD, 1982, EUR J BIOCHEM, V127, P137, DOI 10.1111/j.1432-1033.1982.tb06847.x; CARY PD, 1978, EUR J BIOCHEM, V89, P475, DOI 10.1111/j.1432-1033.1978.tb12551.x; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Gloss LM, 2002, BIOCHEMISTRY-US, V41, P14951, DOI 10.1021/bi026282s; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; HILLIARD PR, 1986, J BIOL CHEM, V261, P5992; HONG L, 1993, J BIOL CHEM, V268, P305; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Lee KM, 1998, BIOCHEMISTRY-US, V37, P8622, DOI 10.1021/bi980499y; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mangenot S, 2002, BIOPHYS J, V82, P345, DOI 10.1016/S0006-3495(02)75399-X; Mizzen CA, 2000, SCIENCE, V289, P2290, DOI 10.1126/science.289.5488.2290; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SMITH RM, 1989, J BIOL CHEM, V264, P10574; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; USACHENKO SI, 1994, P NATL ACAD SCI USA, V91, P6845, DOI 10.1073/pnas.91.15.6845; van Holde KE., 1989, SPRINGER SERIES MOL; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; WALKER IO, 1984, BIOCHIM BIOPHYS ACTA, V785, P97, DOI 10.1016/0167-4838(84)90132-8; WALKER IO, 1984, BIOCHEMISTRY-US, V23, P5622, DOI 10.1021/bi00318a037; Wang XD, 2006, BIOCHEM CELL BIOL, V84, P578, DOI 10.1139/O06-076; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303	60	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32867	32876		10.1074/jbc.M706035200	http://dx.doi.org/10.1074/jbc.M706035200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17711854	hybrid			2022-12-27	WOS:000250625400036
J	Kauskot, A; Adam, F; Mazharian, A; Ajzenberg, N; Berrou, E; Bonnefoy, A; Rosa, JP; Hoylaerts, MF; Bryckaert, M				Kauskot, Alexandre; Adam, Frederic; Mazharian, Alexandra; Ajzenberg, Nadine; Berrou, Eliane; Bonnefoy, Arnaud; Rosa, Jean-Philippe; Hoylaerts, Marc F.; Bryckaert, Marijke			Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; N-TERMINAL KINASE; P38 MAP KINASE; PLATELET-ADHESION; ERK2 ACTIVATION; INTEGRIN ALPHA(IIB)BETA(3); SIGNALING PATHWAY; SHEAR-STRESS; ADP RECEPTOR; COLLAGEN	The involvement of the mitogen-activated protein kinase c- Jun NH2-terminal kinase-1 (JNK1) has never been investigated in hemostasis and thrombosis. Using two JNK inhibitors (SP600125 and 60), we have demonstrated that JNK1 is involved in collagen-induced platelet aggregation dependent on ADP. In these conditions, JNK1 activation requires the coordinated signaling pathways of collagen receptors (alpha 2 beta 1 and glycoprotein (GP)VI) and ADP. In contrast, JNK1 is not required for platelet adhesion on a collagen matrix in static or blood flow conditions (300-1500 s(-1)) involving collagen receptors (alpha 2 beta 1 and GPVI). Importantly, at 1500 s(-1), JNK1 acts on thrombus formation on a collagen matrix dependent on GPIb- von Willebrand factor (vWF) interaction but not ADP receptor activation. This is confirmed by the involvement of JNK1 in shear-induced platelet aggregation at 4000 s(-1). We also provide evidence during rolling and adhesion of platelets to vWF that platelet GPIb-vWF interaction triggers alpha IIb beta 3 activation in a JNK1-dependent manner. This was confirmed with a Glanzmann thrombastenic patient lacking alpha IIb beta 3. Finally, in vivo, JNK1 is involved in arterial but not in venular thrombosis in mice. Overall, our in vitro studies define a new role of JNK1 in thrombus formation in flowing blood that is relevant to thrombus development in vivo.	Hop Lariboisiere, INSERM, U689 E4, Ctr Rech Cardiovasc, F-75010 Paris, France; Hop X Bichat, INSERM, U698, F-75018 Paris, France; INSERM, U743, Montreal, PQ H2X 1P1, Canada; Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; Hop X Bichat, AP HP, F-75018 Paris, France; Univ Paris 07, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bryckaert, M (corresponding author), Hop Lariboisiere, INSERM, U689 E4, Ctr Rech Cardiovasc, 8 Rue Guy Patin, F-75010 Paris, France.	marijke.bryckaert@larib.inserm.fr	ROSA, JEAN-PHILIPPE/B-6245-2018; Kauskot, Alexandre/J-6794-2015	ROSA, JEAN-PHILIPPE/0000-0001-7342-0389; Kauskot, Alexandre/0000-0002-4064-8114; Hoylaerts, Marc/0000-0002-6474-3933; ADAM, Frederic/0000-0001-6603-2687; Bryckaert, Marijke/0000-0003-3398-0976; Mazharian, Alexandra/0000-0002-0204-3325; ajzenberg, nadine/0000-0001-8960-1766				Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Canobbio I, 2004, THROMB HAEMOSTASIS, V91, P102, DOI 10.1160/TH03-02-0083; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Depraetere H, 1998, BLOOD, V91, P3792; Falker K, 2004, THROMB HAEMOSTASIS, V92, P114, DOI 10.1160/th03-12-0729; GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415; Greco F, 2004, J THROMB HAEMOST, V2, P2223, DOI 10.1111/j.1538-7836.2004.01018.x; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Matsui H, 2002, BLOOD, V100, P3604, DOI 10.1182/blood-2002-02-0508; Mazharian A, 2005, J BIOL CHEM, V280, P26002, DOI 10.1074/jbc.M414083200; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; Melis E, 2004, J THROMB HAEMOST, V2, P993, DOI 10.1111/j.1538-7836.2004.00747.x; Moroi M, 1997, BLOOD, V90, P4413; Nadal F, 1997, J BIOL CHEM, V272, P22381, DOI 10.1074/jbc.272.36.22381; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; NURDEN AT, 1985, BLOOD, V65, P1021; Oury C, 2006, J THROMB HAEMOST, V4, P443, DOI 10.1111/j.1538-7836.2006.01745.x; Oury C, 2002, BLOOD, V100, P2499, DOI 10.1182/blood-2002-03-0812; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROUX SP, 1991, ARTERIOSCLER THROMB, V11, P1182, DOI 10.1161/01.ATV.11.5.1182; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sakurai K, 2004, J RECEPT SIG TRANSD, V24, P283, DOI 10.1081/RRS-200040324; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Song S, 2000, BRIT J HAEMATOL, V109, P851, DOI 10.1046/j.1365-2141.2000.02126.x; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Theilmeier G, 1999, BLOOD, V94, P2725, DOI 10.1182/blood.V94.8.2725.420k18_2725_2734; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Toth-Zsamboki E, 2003, J BIOL CHEM, V278, P46661, DOI 10.1074/jbc.M308452200; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200	50	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31990	31999		10.1074/jbc.M701596200	http://dx.doi.org/10.1074/jbc.M701596200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785464	hybrid			2022-12-27	WOS:000250480300020
J	Kligys, K; Claiborne, JN; Debiase, PJ; Hopkinson, SB; Wu, Y; Mizuno, K; Jones, JCR				Kligys, Kristina; Claiborne, Jessica N.; Debiase, Phillip J.; Hopkinson, Susan B.; Wu, Yvonne; Mizuno, Kensaku; Jones, Jonathan C. R.			The slingshot family of Phosphatases mediates rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility Behavior of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL MOTILITY; NF-KAPPA-B; LIM-KINASE; ALPHA-6-BETA-4 INTEGRIN; ACTIN REORGANIZATION; PROTEIN-KINASES; MIGRATION; HEMIDESMOSOMES; ADHESION; ACTIVATION	The motility of keratinocytes is an essential component of wound closure and the development of epidermal tumors. In vitro, the specific motile behavior of keratinocytes is dictated by the assembly of laminin-332 tracks, a process that is dependent upon alpha 6 beta 4 integrin signaling to Rac1 and the actin-severing protein cofilin. Here we have analyzed how cofilin phosphorylation is regulated by phosphatases (slingshot (SSH) or chronophin (CIN)) downstream of signaling by alpha 6 beta 4 integrin/Rac1 in human keratinocytes. Keratinocytes express all members of the SSH family (SSH1, SSH2, and SSH3) and CIN. However, expression of phosphatase-dead versions of all three SSH proteins, but not dominant inactive CIN, results in phosphorylation/ inactivation of cofilin, changes in actin cytoskeleton organization, loss of cell polarity, and assembly of aberrant arrays of laminin-332 in human keratinocytes. SSH activity is regulated by 14-3-3 protein binding, and intriguingly, 14-3-3/alpha 6 beta 4 integrin protein interaction is required for keratinocyte migration. We wondered whether 14-3-3 proteins function as regulators of Rac1-mediated keratinocyte migration patterns. In support of this hypothesis, inhibition of Rac1 results in an increase in 14-3-3 protein association with SSH. Thus, we propose a novel mechanism in which alpha 6 beta 4 integrin signaling via Rac1, 14-3-3 proteins, and SSH family members regulates cofilin activation, cell polarity, and matrix assembly, leading to specific epidermal cell migration behavior.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Northwestern University; Feinberg School of Medicine; Tohoku University	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Mizuno, Kensaku/G-8631-2015; Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	NHLBI NIH HHS [T32 HL076139] Funding Source: Medline; NIAMS NIH HHS [R01 AR054184, R01 AR054184-18] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; Giannelli G, 2002, CLIN EXP METASTAS, V19, P217, DOI 10.1023/A:1015579204607; Gilcrease MZ, 2004, CANCER RES, V64, P7395, DOI 10.1158/0008-5472.CAN-04-1809; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Qin P, 1998, EXP EYE RES, V66, P569, DOI 10.1006/exer.1997.0455; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang K, 1996, EXP CELL RES, V227, P309, DOI 10.1006/excr.1996.0280	47	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32520	32528		10.1074/jbc.M707041200	http://dx.doi.org/10.1074/jbc.M707041200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848544	Green Accepted, hybrid			2022-12-27	WOS:000250480300075
J	Lee, HR; Johnson, KA				Lee, Harold R.; Johnson, Kenneth A.			Fidelity and processivity of reverse transcription by the human mitochondrial DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; STRAND ORIGIN; GAMMA; EXONUCLEASE; MECHANISM; SUBUNIT; HYBRIDS; SITES	We have characterized, by transient-state kinetic methods, the polymerase and exonuclease activities of the human mitochondrialDNApolymerase (pol gamma) during reverse transcription, employing a synthetic oligonucleotide consisting of a DNA primer and an RNA template. In comparison with the kinetic parameters observed with a DNA template, the rate of correct deoxynucleotide incorporation was reduced 25-fold (5.5 +/- 0.2 s(-1)), whereas the dissociation constant ( Kd) for nucleotide binding was increased 4-fold (12 +/- 1 M). In addition, discrimination against mismatches was reduced similar to 20-fold to only 15,000 on average. The proofreading exonuclease favored the removal of an incorrect nucleotide (0.0021 +/- 0.0002 s(-1) for correct versus 0.034 +/- 0.004 s(-1) for incorrect), and the partitioning between incorporation beyond a mismatch (5.5 x 10(-5) +/- 0.4 x 10(-5) s(-1)), and exonuclease removal of that mismatch favors removal of the mismatch. These data suggest that the "reverse transcriptase activity" of mitochondrial polymerase could be physiologically relevant. However, the enzyme stalls and is unable to efficiently incorporate beyond a single nucleotide with an RNA template. Additionally, we present a refined method for calculating net discrimination, which more accurately describes the contributions of correct and incorrect incorporation. The biological and biotechnological significance of these results are discussed.	Univ Texas, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas, Inst Cellular & Mol Biol, Dept Chem & Biochem, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 044613] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Gyi JI, 1998, BIOCHEMISTRY-US, V37, P73, DOI 10.1021/bi9719713; ITO K, 1975, J VIROL, V15, P1507, DOI 10.1128/JVI.15.6.1507-1510.1975; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9	25	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31982	31989		10.1074/jbc.M705392200	http://dx.doi.org/10.1074/jbc.M705392200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17711845	hybrid			2022-12-27	WOS:000250480300019
J	Maliekal, P; Sokolova, T; Vertommen, D; Veiga-Da-Cunha, M; Van Schaftingen, E				Maliekal, Pushpa; Sokolova, Tatiana; Vertommen, Didier; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RED-BLOOD-CELLS; FRUCTOSE 2,6-BISPHOSPHATE; MUSCLE PHOSPHOGLUCOMUTASE; GLUCOSE 1,6-BISPHOSPHATE; RIBOSE 1,5-BISPHOSPHATE; ENZYME; PURIFICATION; METABOLISM; 1,6-DIPHOSPHATE	The molecular identity of mammalian phosphopentomutase has not yet been established unequivocally. That of glucose-1,6bisphosphate synthase, the enzyme that synthesizes a cofactor for phosphomutases and putative regulator of glycolysis, is completely unknown. In the present work, we have purified phosphopentomutase from human erythrocytes and found it to copurify with a 68-kDa polypeptide that was identified by mass spectrometry as phosphoglucomutase 2 (PGM2), a protein of the alpha-D-phosphohexomutase family and sharing about 20% identity with mammalian phosphoglucomutase 1. Data base searches indicated that vertebrate genomes contained, in addition to PGM2, a homologue (PGM2L1, for PGM2-like 1) sharing about 60% sequence identity with this protein. Both PGM2 and PGM2L1 were overexpressed in Escherichia coli, purified, and their properties were studied. Using catalytic efficiency as a criterion, PGM2 acted more than 10-fold better as a phosphopentomutase (both on deoxyribose 1-phosphate and on ribose 1-phosphate) than as a phosphoglucomutase. PGM2L1 showed only low (< 5%) phosphopentomutase and phosphoglucomutase activities compared with PGM2, but was about 5-20-fold better than the latter enzyme in catalyzing the 1,3-bisphosphoglycerate-dependent synthesis of glucose 1,6-bisphosphate and other aldosebisphosphates. Furthermore, quantitative real-time PCR analysis indicated that PGM2L1 was mainly expressed in brain where glucose1,6-bisphosphate synthase activity was previously shown to be particularly high. We conclude that mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase correspond to two closely related proteins, PGM2 and PGM2L1, encoded by two genes that separated early in vertebrate evolution.	Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, 7539 Ave Hippocrate 75, B-1200 Brussels, Belgium.	vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282				ACCORSI A, 1989, PREP BIOCHEM, V19, P251, DOI 10.1080/10826068908544915; Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARSKY DL, 1983, BIOCHIM BIOPHYS ACTA, V743, P162, DOI 10.1016/0167-4838(83)90430-2; BEITNER R, 1979, BIOCHIM BIOPHYS ACTA, V583, P266, DOI 10.1016/0304-4165(79)90434-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRANE RK, 1954, J BIOL CHEM, V210, P597; DAI JB, 1992, J BIOL CHEM, V267, P6322; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; Fortpied J, 2005, BIOCHEM J, V388, P795, DOI 10.1042/BJ20041976; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; GIBLETT ER, 1972, LANCET, V2, P1067; GIBLETT ER, 1985, ANN NY ACAD SCI, V451, P1, DOI 10.1111/j.1749-6632.1985.tb27090.x; GUHA SK, 1982, J BIOL CHEM, V257, P6634; GUHA SK, 1986, ARCH BIOCHEM BIOPHYS, V250, P513, DOI 10.1016/0003-9861(86)90756-3; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; ISHIKAWA E, 1990, J BIOL CHEM, V265, P18875; KAMMEN HO, 1969, J BIOL CHEM, V244, P4888; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KOSTER JF, 1972, BIOCHIM BIOPHYS ACTA, V258, P763, DOI 10.1016/0005-2744(72)90177-5; MARCUS CJ, 1976, J BIOL CHEM, V251, P2963; MORINO H, 1991, J NEUROCHEM, V56, P1049, DOI 10.1111/j.1471-4159.1991.tb02028.x; PASSONNEAU JV, 1969, J BIOL CHEM, V244, P902; QUICK CB, 1972, ANN HUM GENET, V35, P445, DOI 10.1111/j.1469-1809.1957.tb01869.x; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; RAY WJ, 1983, J BIOL CHEM, V258, P9166; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; ROSE IA, 1975, J BIOL CHEM, V250, P3466; ROSE IA, 1974, BIOCHEM BIOPH RES CO, V59, P1333, DOI 10.1016/0006-291X(74)90460-4; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; WIJNEN LMM, 1977, HUM GENET, V37, P271, DOI 10.1007/BF00393608; WONG LJ, 1976, J BIOL CHEM, V251, P5431; YIP V, 1988, J NEUROCHEM, V50, P594, DOI 10.1111/j.1471-4159.1988.tb02952.x	38	38	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31844	31851		10.1074/jbc.M706818200	http://dx.doi.org/10.1074/jbc.M706818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804405	hybrid			2022-12-27	WOS:000250480300004
J	Smith, AJ; Thompson, BR; Sanders, MA; Bernlohr, DA				Smith, Anne J.; Thompson, Brian R.; Sanders, Mark A.; Bernlohr, David A.			Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase - Regulation by fatty acids and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BINDING; TRANSLOCATION; LIPOLYSIS; DROPLETS	Adipocyte fatty acid-binding protein (AFABP/aP2) forms a physical complex with the hormone-sensitive lipase (HSL) and AFABP/aP2-null mice exhibit reduced basal and hormone-stimulated lipolysis. To identify the determinants affecting the interaction fluorescence resonance energy transfer (FRET) imaging was used in conjunction with a mutagenesis strategy to evaluate the roles AFABP/aP2 fatty acid binding and HSL phosphorylation have in complex formation as well as determine the HSL binding site on AFABP/aP2. The nonfatty acid binding mutant of AFABP/aP2 (R126Q) failed to form a FRET-competent complex with HSL either under basal or forskolin-stimulated conditions, indicating that lipid binding is required for association. Once bound to HSL and on the surface of the lipid droplet, YFP-AFABP/aP2 (but not YFP-HSL) exhibited energy transfer between the fusion protein and BODIPY-C12-labeled triacylglycerol. Serine to alanine mutations at the two PKA phosphorylation sites of HSL (659 and 660), or at the AMPK phosphorylation sites (565), blocked FRET between HSL and AFABP/aP2. Substitution of isoleucine for lysine at position 21 of AFABP/aP2 (K21I), but not 31 (K31I), resulted in a non-HSL-binding protein indicating that residues on helix alpha I of AFABP/ aP2 define a component of the HSL binding site. These results indicate that the ligand-bound form of AFABP/aP2. interacts with the activated, phosphorylated HSL and that the association is likely to be regulatory; either delivering FA to inhibit HSL (facilitating feedback inhibition) or affecting multicomponent complex formation on the droplet surface.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Imaging Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Twin Cities 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Bernl001@umn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053189] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK053189] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; CLIFFORD GM, 1997, BIOCHEM SOC T, V25, P56; Coe NR, 1999, J LIPID RES, V40, P967; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kleinfeld AM, 2004, J AM SOC MASS SPECTR, V15, P1572, DOI 10.1016/j.jasms.2004.07.010; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; SHA RS, 1993, J BIOL CHEM, V268, P7885; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; XU ZH, 1991, J BIOL CHEM, V266, P14367; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200	30	85	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32424	32432		10.1074/jbc.M703730200	http://dx.doi.org/10.1074/jbc.M703730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785468	hybrid			2022-12-27	WOS:000250480300065
J	Kramer, A; Ludwig, Y; Shahin, V; Oberleithner, H				Kramer, Armin; Ludwig, Yvonne; Shahin, Victor; Oberleithner, Hans			A pathway separate from the central channel through the nuclear pore complex for inorganic ions and small macromolecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; FORCE MICROSCOPY; ARCHITECTURE; ENVELOPE; PERMEABILITY; KARYOPHERINS; NUCLEOPORINS; INHIBITION; DIFFUSION; MEMBRANE	Nuclear pore complexes (NPCs) are supramolecular nanomachines that mediate the exchange of macromolecules and inorganic ions between the nucleus and the cytosol. Although there is no doubt that large cargo is transported through the centrally located channel, the route of ions and small molecules remains debatable. We thus tested the hypothesis that there are two separate pathways by imaging NPCs using atomic force microscopy, NPC electrical conductivity measurements, and macromolecule permeability assays. Our data indicate a spatial separation between the active transport of macromolecules through the central channel and the passive transport of ions and small macromolecules through the pore periphery.	Univ Munster, Inst Physiol 2, D-48149 Munster, Germany	University of Munster	Kramer, A (corresponding author), Univ Munster, Inst Physiol 2, Robert-Koch Str 27b, D-48149 Munster, Germany.	kramercom@gmail.com	Kramer, Armin/C-1382-2010					AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5; BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P239; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530; Danker T, 1997, CELL BIOL INT, V21, P747, DOI 10.1006/cbir.1997.0219; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Enss K, 2003, J MEMBRANE BIOL, V196, P147, DOI 10.1007/s00232-003-0632-0; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Jaggi RD, 2003, BIOPHYS J, V85, P4093, DOI 10.1016/S0006-3495(03)74821-8; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Ludwig Y, 2006, CELL PHYSIOL BIOCHEM, V17, P181, DOI 10.1159/000094123; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Saitoh H, 1996, MOL BIOL CELL, V7, P1319, DOI 10.1091/mbc.7.9.1319; Santella L, 1997, FASEB J, V11, P1091, DOI 10.1096/fasebj.11.13.9367344; Shahin V, 2005, J CELL SCI, V118, P2881, DOI 10.1242/jcs.02429; Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com; Singh S, 2006, NATURE, V442, P526, DOI 10.1038/442526a; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	41	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31437	31443		10.1074/jbc.M703720200	http://dx.doi.org/10.1074/jbc.M703720200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17726020	hybrid			2022-12-27	WOS:000250309200034
J	Rajeev, L; Segall, A; Gardner, J				Rajeev, Lara; Segall, Anca; Gardner, Jeffrey			The Bacteroides NBU1 integrase performs a homology-independent strand exchange to form a Holliday junction intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; CONJUGATIVE TRANSPOSON CTNDOT; LOXP SPACER REGION; LAMBDA-INTEGRASE; MEDIATED RECOMBINATION; INSERTION ELEMENT; SENSING HOMOLOGY; DNA; MECHANISM; SEQUENCES	The Bacteroides mobilizable transposon NBU1 uses an integrase (IntN1) that is a tyrosine recombinase for its integration and excision from the host chromosome. Previously we showed that IntN1 makes 7-bp staggered cuts within the NBU1 att sites, and certain mismatches within the crossover region of the attN1 site (G(-2)C attN1) or the chromosomal target site (C(-3) G attBT1-1) enhanced the in vivo integration efficiency. Here we describe an in vitro integration system for NBU1. We used nicked substrates and a Holliday junction trapping peptide to show that NBU1 integration proceeds via formation of a Holliday junction intermediate that is formed by exchange of bottom strands. Some mismatches next to the first strand exchange site (in reactions with C(-3) G attBT1-1 or G(-2) C attN1 with their wild-type partner site) not only allowed formation of the Holliday junction intermediate but also increased the rate of recombinant formation. The second strand exchange appears to be homology-dependent. IntN1 is the only tyrosine recombinase known to catalyze a reaction that is more efficient in the presence of mismatches and where the first strand exchange is homology-independent. The possible mechanisms by which the mismatches stimulate recombination are discussed.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; San Diego State Univ, Ctr Microbial Sci, Dept Biol, San Diego, CA 92182 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; San Diego State Univ, Ctr Microbial Sci, Dept Biol, San Diego, CA 92182 USA	University of Illinois System; University of Illinois Urbana-Champaign; California State University System; San Diego State University; University of Illinois System; University of Illinois Urbana-Champaign; California State University System; San Diego State University	Rajeev, L (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave,B322 CLSL, Urbana, IL 61801 USA.	rajeev@uiuc.edu		Segall, Anca/0000-0002-8454-5248; Rajeev, Lara/0000-0002-0106-9195	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028717, R01GM052847] Funding Source: NIH RePORTER; NIAID NIH HHS [AI58253] Funding Source: Medline; NIGMS NIH HHS [GM52847, GM28717] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS BJ, 1986, MOL CELL BIOL, V6, P2482, DOI 10.1128/MCB.6.7.2482; BAUER CE, 1985, J MOL BIOL, V181, P187, DOI 10.1016/0022-2836(85)90084-1; Blakely GW, 2000, J BIOL CHEM, V275, P9930, DOI 10.1074/jbc.275.14.9930; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Cheng Q, 2002, J BACTERIOL, V184, P4829, DOI 10.1128/JB.184.17.4829-4837.2002; DiChiara JM, 2007, J BACTERIOL, V189, P2692, DOI 10.1128/JB.01796-06; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0; KITTS PA, 1988, NUCLEIC ACIDS RES, V16, P6839, DOI 10.1093/nar/16.14.6839; KITTS PA, 1988, J MOL BIOL, V204, P95, DOI 10.1016/0022-2836(88)90602-X; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; LEE J, 1995, J BIOL CHEM, V270, P4042, DOI 10.1074/jbc.270.8.4042; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; NunesDuby SE, 1997, J MOL BIOL, V272, P493, DOI 10.1006/jmbi.1997.1260; Rajeev L, 2006, MOL MICROBIOL, V61, P978, DOI 10.1111/j.1365-2958.2006.05282.x; Schmidt JW, 2006, MOL MICROBIOL, V60, P152, DOI 10.1111/j.1365-2958.2006.05073.x; SENECOFF JF, 1986, J BIOL CHEM, V261, P7380; SHOEMAKER NB, 1988, J BACTERIOL, V170, P1651, DOI 10.1128/jb.170.4.1651-1657.1988; SHOEMAKER NB, 1993, J BACTERIOL, V175, P6578, DOI 10.1128/jb.175.20.6578-6587.1993; Shoemaker NB, 1996, J BACTERIOL, V178, P3594, DOI 10.1128/jb.178.12.3594-3600.1996; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; WEISBERG RA, 1983, J MOL BIOL, V170, P319, DOI 10.1016/S0022-2836(83)80151-X	29	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31228	31237		10.1074/jbc.M705370200	http://dx.doi.org/10.1074/jbc.M705370200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17766246	hybrid			2022-12-27	WOS:000250309200012
J	Jain, S; Stanford, N; Bhagwat, N; Seiler, B; Costanzo, M; Boone, C; Oelkers, P				Jain, Shilpa; Stanford, NaTaza; Bhagwat, Neha; Seiler, Brian; Costanzo, Michael; Boone, Charles; Oelkers, Peter			Identification of a novel lysophospholipid acyltransferase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; FATTY-ACIDS; II CELLS; FUNCTIONAL-CHARACTERIZATION; ENZYMATIC-ACTIVITY; ARACHIDONIC-ACID; LIPID-SYNTHESIS; GENE STRUCTURE; ACYL-COA	The incorporation of unsaturated acyl chains into phospholipids during de novo synthesis is primarily mediated by the 1-acyl-sn-glycerol-3-phosphate acyltransferase reaction. In Saccharomyces cerevisiae, Slc1 has been shown to mediate this reaction, but distinct activity remains after its removal from the genome. To identify the enzyme that mediates the remaining activity, we performed synthetic genetic array analysis using a slc1 Delta strain. One of the genes identified by the screen, LPT1, was found to encode for an acyltransferase that uses a variety of lysophospholipid species, including 1-acyl-sn-glycerol-3-phosphate. Deletion of LPT1 had a minimal effect on 1-acyl-sn-glycerol-3-phosphate acyltransferase activity, but overexpression increased activity 7-fold. Deletion of LPT1 abrogated the esterification of other lysophospholipids, and overexpression increased lysophosphatidylcholine acyltransferase activity 7-fold. The majority of this activity co-purified with microsomes. To test the putative role for this enzyme in selectively incorporating unsaturated acyl chains into phospholipids in vitro, substrate concentration series experiments were performed with the four acyl-CoA species commonly found in yeast. Although the saturated palmitoyl-CoA and stearoyl-CoA showed a lower apparent Km, the monounsaturated palmitoleoyl-CoA and oleoyl-CoA showed a higher apparent V-max. Arachidonyl-CoA, although not abundant in yeast, also had a high apparent V-max. Pulse- labeling of lpt1 Delta strains showed a 30% reduction in [H-3] oleate incorporation into phosphatidylcholine only. Therefore, Lpt1p, a member of the membrane-bound o-acyltransferase gene family, seems to work in conjunction with Slc1 to mediate the incorporation of unsaturated acyl chains into the sn-2 position of phospholipids.	Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Mol Genet & Microbiol, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	Drexel University; University of Toronto; University of Toronto	Oelkers, P (corresponding author), Drexel Univ, Dept Biosci & Biotechnol, 3141 Chestnut St, Philadelphia, PA 19104 USA.	pmo24@drexel.edu		Oelkers, Peter/0000-0002-2421-472X				ADAMS A, 1997, METHODS YEAST GENETI, P148; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHILTON FH, 1987, BIOCHIM BIOPHYS ACTA, V917, P48, DOI 10.1016/0005-2760(87)90282-7; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; HANAHAN DJ, 1960, J BIOL CHEM, V235, P1917; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1963, J BIOL CHEM, V238, P898; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PHILLIPS MC, 1972, CHEM PHYS LIPIDS, V8, P127, DOI 10.1016/0009-3084(72)90024-2; PIK JR, 1978, CAN J BIOCHEM CELL B, V56, P765, DOI 10.1139/o78-115; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; RESNICK RJ, 1994, J BIOL CHEM, V269, P32336; Richard MG, 1998, LIPIDS, V33, P1229, DOI 10.1007/s11745-998-0328-1; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUBIN RP, 1983, BIOCHEM BIOPH RES CO, V112, P502, DOI 10.1016/0006-291X(83)91493-6; SANJANWALA M, 1989, ARCH BIOCHEM BIOPHYS, V271, P407, DOI 10.1016/0003-9861(89)90290-7; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; YAMADA K, 1977, ARCH BIOCHEM BIOPHYS, V183, P281, DOI 10.1016/0003-9861(77)90441-6; Yamashita S, 1981, Methods Enzymol, V71 Pt C, P528; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200	52	80	92	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30562	30569		10.1074/jbc.M706326200	http://dx.doi.org/10.1074/jbc.M706326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726007	hybrid			2022-12-27	WOS:000250136300024
J	Bagai, I; Liu, W; Rensing, C; Blackburn, NJ; McEvoy, MM				Bagai, Ireena; Liu, Wenbo; Rensing, Christopher; Blackburn, Ninian J.; McEvoy, Megan M.			Substrate-linked conformational change in the periplasmic component of a Cu(I)/Ag(I) efflux system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEIN; RAY-ABSORPTION SPECTROSCOPY; GRAM-NEGATIVE BACTERIA; CURVED-WAVE THEORY; ESCHERICHIA-COLI; DRUG EFFLUX; MULTIDRUG TRANSPORTER; COPPER HOMEOSTASIS; EXAFS CALCULATIONS; RESISTANCE	Gram-negative bacteria utilize dual membrane resistance nodulation division-type efflux systems to export a variety of substrates. These systems contain an essential periplasmic component that is important for assembly of the protein complex. We show here that the periplasmic protein CusB from the Cus copper/silver efflux system has a critical role in Cu(I) and Ag(I) binding. Isothermal titration calorimetry experiments demonstrate that one Ag(I) ion is bound per CusB molecule with high affinity. X-ray absorption spectroscopy data indicate that the metal environment is an all-sulfur 3-coordinate environment. Candidates for the metal-coordinating residues were identified from sequence analysis, which showed four conserved methionine residues. Mutations of three of these methionine residues to isoleucine resulted in significant effects on CusB metal binding in vitro. Cells containing these CusB variants also show a decrease in their ability to grow on copper-containing plates, indicating an important functional role for metal binding by CusB. Gel filtration chromatography demonstrates that upon binding metal, CusB undergoes a conformational change to a more compact structure. Based on these structural and functional effects of metal binding, we propose that the periplasmic component of resistance nodulation division-type efflux systems plays an active role in export through substrate-linked conformational changes.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; Oregon Hlth & Sci Univ, Oregon Grad Inst Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA	University of Arizona; University of Arizona; Oregon Health & Science University	McEvoy, MM (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, 1041 E Lowell St, Tucson, AZ 85721 USA.	mcevoy@email.arizona.edu	Rensing, Christopher/D-3947-2011	Rensing, Christopher/0000-0002-5012-7953	NIGMS NIH HHS [GM079192, R01 GM079192, GM54803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054803, R01GM079192] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; BINSTED N, 1998, EXCURVE 9 2; Blackburn NJ, 2000, BIOCHEMISTRY-US, V39, P2316, DOI 10.1021/bi992334a; Borges-Walmsley MI, 2003, J BIOL CHEM, V278, P12903, DOI 10.1074/jbc.M209457200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; George G. N., 1990, STANFORD SYNCHROTRON; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; GURMAN SJ, 1984, J PHYS C SOLID STATE, V17, P143, DOI 10.1088/0022-3719/17/1/019; GURMAN SJ, 1986, J PHYS C SOLID STATE, V19, P1845, DOI 10.1088/0022-3719/19/11/021; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Ip H, 2003, J BIOL CHEM, V278, P50474, DOI 10.1074/jbc.M305152200; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; MCROIE DK, 1993, SELF ASS SYSTEMS ANA, P1; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido H, 1998, J BACTERIOL, V180, P4686, DOI 10.1128/JB.180.17.4686-4692.1998; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Solioz M, 2002, BIOCHEM SOC T, V30, P688, DOI 10.1042/bst0300688; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vaccaro L, 2006, BIOPHYS J, V91, P558, DOI 10.1529/biophysj.105.080010; Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	42	79	79	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35695	35702		10.1074/jbc.M703937200	http://dx.doi.org/10.1074/jbc.M703937200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17893146	hybrid			2022-12-27	WOS:000251458100030
J	Corradi, GR; Adamo, HP				Corradi, Gerardo R.; Adamo, Hugo P.			Intramolecular fluorescence resonance energy transfer between fused autofluorescent proteins reveals rearrangements of the N- and C-terminal segments of the plasma membrane Ca2+ pump involved in the activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; CALCIUM-PUMP; ERYTHROCYTE CA-2+-ATPASE; MONOCLONAL-ANTIBODIES; CATALYTIC CORE; ISOFORM 4B; SITE; INTERACTS; REGION; OLIGOMERIZATION	The blue and green fluorescent proteins (BFP and GFP) have been fused at the N- and C-terminal ends, respectively, of the plasma membrane Ca2+ pump (PMCA) isoform 4xb (hPMCA4xb). The fusion protein was successfully expressed in yeast and purified by calmodulin affinity chromatography. Despite the presence of the fused autofluorescent proteins BFP-PMCA-GFP performed similarly to the wild-type enzyme with respect to Ca2+-ATPase activity and sensitivity to calmodulin activation. In the autoinhibited state BFP-PMCA-GFP exhibited a significant intramolecular fluorescence resonance energy transfer (FRET) consistent with the location of the fluorophores at an average distance of 45 angstrom. The FRET intensity in BFP-PMCA-GFP decreased when the enzyme was activated either by Ca2+-calmodulin, partial proteolysis, or acidic lipids. Moreover, FRET decreased and became insensitive to calmodulin when hPMCA4xb was activated by mutation D170N in BFP-PMCA(D170N)-GFP. The results suggest that the ends of the PMCA are in close proximity in the autoinhibited conformation, and they separate or reorient when the PMCA achieves its final activated conformation.	Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Corradi, Gerardo Raul/0000-0003-0354-7709				Adamo HP, 1998, BIOCHEM J, V331, P763, DOI 10.1042/bj3310763; Adamo HP, 2000, BIOCHEMISTRY-US, V39, P14893, DOI 10.1021/bi001222c; ADAMO HP, 1992, J BIOL CHEM, V267, P14244; Adamo HP, 2000, BBA-BIOMEMBRANES, V1464, P127, DOI 10.1016/S0005-2736(99)00253-9; AXELSEN KB, 1998, BIOCHIM BIOPHYS ACTA, V1365, P37; Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; COELHOSAMPAIO T, 1991, J BIOL CHEM, V266, P22266; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, BIOL CHEM, V266, P2930; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; HAO LN, 1994, J BIOL CHEM, V269, P14268; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; MAGOCSI M, 1991, BIOCHIM BIOPHYS ACTA, V1063, P7, DOI 10.1016/0005-2736(91)90346-A; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; Paszty K, 2002, J BIOL CHEM, V277, P36146, DOI 10.1074/jbc.M205457200; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Pinto FD, 2006, FEBS LETT, V580, P1576, DOI 10.1016/j.febslet.2006.01.088; REMEDIOS D, 1995, J STRUCT BIOL, V115, P175; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Verma AK, 1996, J BIOL CHEM, V271, P3714	44	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35440	35448		10.1074/jbc.M703377200	http://dx.doi.org/10.1074/jbc.M703377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17901055	hybrid			2022-12-27	WOS:000251458100003
J	Gosmain, Y; Avril, I; Mamin, A; Philippe, J				Gosmain, Yvan; Avril, Isabelle; Mamin, Aline; Philippe, Jacques			Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEIN CDX-2/3; PANCREATIC ENDOCRINE-CELLS; BETA-CELL; PROGLUCAGON GENE; TRANSCRIPTION FACTORS; RESPONSIVE ELEMENT; ACTIVATE GLUCAGON; BINDING-PROTEIN; ISLET CELLS; INSULIN	Specific expression of the glucagon gene in the rat pancreas requires the presence of the G1 element localized at -100/-49 base pairs on the promoter. Although it is known that multiple transcription factors such as Pax-6, Cdx-2/3, c-Maf, Maf-B, and Brain-4 can activate the glucagon gene promoter through G1, their relative importance in vivo is unknown. We first studied the expression of Maf-B, c-Maf, and Cdx-2/3 in the developing and adult mouse pancreas. Although Maf-B was detectable in a progressively increasing number of alpha-cells throughout development and in adulthood, c-Maf and Cdx-2/3 were expressed at low and very low levels, respectively. However, c-Maf but not Cdx-2/3 was detectable in adult islets by Western blot analyses. We then demonstrated the in vivo interactions of Pax-6, Cdx2/3, Maf-B, and c-Maf but not Brain-4 with the glucagon gene promoter in glucagon-producing cells. Although Pax-6, Cdx2/3, Maf-B, and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx2/3 and activate transcription of the glucagon gene promoter. Overexpression of dominant negative forms of Cdx-2/3 and Mafs in alpha-cell lines indicated that Cdx-2/3 and the Maf proteins interact on an overlapping site within G1 and that this binding site is critical in the activation of the glucagon gene promoter. Finally, we show that specific inhibition of Pax-6 and c-Maf but not Cdx-2/3 or Maf-B led to decreases in endogenous glucagon gene expression and that c-Maf binds the glucagon gene promoter in mouse islets. We conclude that Pax-6 and c-Maf interact with G1 to activate basal expression of the glucagon gene.	Univ Geneva, Sch Med, Diabet Unit, Div Endocrinol Diabet & Nutr,Univ Hosp, CH-1211 Geneva 14, Switzerland	University of Geneva	Gosmain, Y (corresponding author), Univ Geneva, Sch Med, Diabet Unit, Div Endocrinol Diabet & Nutr,Univ Hosp, CH-1211 Geneva 14, Switzerland.	Yvan.Gosmain@hcuge.ch						Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andersen FG, 1999, FEBS LETT, V445, P306, DOI 10.1016/S0014-5793(99)00145-3; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; CORDIERBUSSAT M, 1995, MOL CELL BIOL, V15, P3904; DRUCKER DJ, 1987, J BIOL CHEM, V262, P15659; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Hill ME, 1999, MOL ENDOCRINOL, V13, P1474, DOI 10.1210/me.13.9.1474; Hussain MA, 1997, MOL CELL BIOL, V17, P7186, DOI 10.1128/MCB.17.12.7186; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Jin TR, 1996, MOL CELL BIOL, V16, P19; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; La Rosa S, 2004, VIRCHOWS ARCH, V445, P248, DOI 10.1007/s00428-004-1080-7; Laser B, 1996, J BIOL CHEM, V271, P28984, DOI 10.1074/jbc.271.46.28984; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; MOREL C, 1995, J BIOL CHEM, V270, P3046, DOI 10.1074/jbc.270.7.3039; Nishimura W, 2006, DIABETES, V55, pA362; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; PHILIPPE J, 1994, DIABETES, V43, P523, DOI 10.2337/diabetes.43.4.523; PHILIPPE J, 1991, ENDOCR REV, V12, P252, DOI 10.1210/edrv-12-3-252; PHILIPPE J, 1991, P NATL ACAD SCI USA, V88, P7224, DOI 10.1073/pnas.88.16.7224; PHILIPPE J, 1995, J BIOL CHEM, V270, P3039, DOI 10.1074/jbc.270.7.3039; Planque N, 2001, J BIOL CHEM, V276, P35751, DOI 10.1074/jbc.M104523200; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; Ritz-Laser B, 2002, DIABETOLOGIA, V45, P97, DOI 10.1007/s125-002-8249-9; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rosanas-Urgell A, 2005, MOL CELL ENDOCRINOL, V237, P59, DOI 10.1016/j.mce.2005.03.008; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SCHISLER JC, 2005, P NATL ACAD SCI USA, V102, P7927; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TAKAKI R, 1984, DIABETES, V33, P879, DOI 10.2337/diabetes.33.9.879; Tsuchiya M, 2007, DIABETES, V56, pA430; Tsuchiya M, 2006, PANCREAS, V32, P408, DOI 10.1097/01.mpa.0000220867.64787.99; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang PX, 2006, ENDOCRINOLOGY, V147, P1950, DOI 10.1210/en.2005-0910; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072	49	41	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35024	35034		10.1074/jbc.M702795200	http://dx.doi.org/10.1074/jbc.M702795200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901057	hybrid			2022-12-27	WOS:000251155200047
J	Mathew, LK; Sengupta, S; Kawakami, A; Andreasen, EA; Lohr, CV; Loynes, CA; Renshaw, SA; Peterson, RT; Tanguay, RL				Mathew, Lijoy K.; Sengupta, Sumitra; Kawakami, Atsushi; Andreasen, Eric A.; Loehr, Christiane V.; Loynes, Catherine A.; Renshaw, Stephen A.; Peterson, Randall T.; Tanguay, Robert L.			Unraveling tissue regeneration pathways using chemical genetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR ISOFORMS; CAUDAL FIN REGENERATION; APPENDAGE REGENERATION; EXPRESSION ANALYSIS; ZEBRAFISH; MECHANISMS; DISCOVERY; GROWTH; INFLAMMATION; SPECIFICITY	Identifying the molecular pathways that are required for regeneration remains one of the great challenges of regenerative medicine. Although genetic mutations have been useful for identifying some molecular pathways, small molecule probes of regenerative pathways might offer some advantages, including the ability to disrupt pathway function with precise temporal control. However, a vertebrate regeneration model amenable to rapid throughput small molecule screening is not currently available. We report here the development of a zebrafish early life stage fin regeneration model and its use in screening for small molecules that modulate tissue regeneration. By screening 2000 biologically active small molecules, we identified 17 that specifically inhibited regeneration. These compounds include a cluster of glucocorticoids, and we demonstrate that transient activation of the glucocorticoid receptor is sufficient to block regeneration, but only if activation occurs during wound healing/blastema formation. In addition, knockdown of the glucocorticoid receptor restores regenerative capability to nonregenerative, glucocorticoid-exposed zebrafish. To test whether the classical anti-inflammatory action of glucocorticoids is responsible for blocking regeneration, we prevented acute inflammation following amputation by antisense repression of the Pu.1 gene. Although loss of Pu.1 prevents the inflammatory response, regeneration is not affected. Collectively, these results indicate that signaling from exogenous glucocorticoids impairs blastema formation and limits regenerative capacity through an acute inflammation-independent mechanism. These studies also demonstrate the feasibility of exploiting chemical genetics to define the pathways that govern vertebrate regeneration.	Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; Oregon State Univ, Marine & Freshwater Biomed Sci Ctr, Corvallis, OR 97331 USA; Oregon State Univ, Dept Vet Med, Corvallis, OR 97331 USA; Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; Massachusetts Gen Hosp, Dev Biol Lab, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Tokyo Institute of Technology; University of Sheffield; Harvard University; Massachusetts General Hospital	Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, 1007 ALS, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu	Sengupta, Sumitra/G-1814-2017; Renshaw, Steve/E-6192-2010; Löhr, C. V./AAU-4902-2020; Kawakami, Atsushi/D-3785-2019	Sengupta, Sumitra/0000-0003-2861-5608; Renshaw, Steve/0000-0003-1790-1641; Löhr, C. V./0000-0003-3787-5583; Kawakami, Atsushi/0000-0001-9461-6372; Peterson, Randall/0000-0003-0727-3469	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES003850, R01ES010820, P30ES000210, P30ES003850] Funding Source: NIH RePORTER; MRC [G108/595] Funding Source: UKRI; Medical Research Council [G108/595] Funding Source: Medline; NIEHS NIH HHS [R01 ES010820, ES00210, ES03850, P30 ES000210, ES10820] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; CARLSTEDTDUKE J, 1987, J STEROID BIOCHEM, V27, P99, DOI 10.1016/0022-4731(87)90299-8; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Croxtall JD, 2002, BRIT J PHARMACOL, V135, P511, DOI 10.1038/sj.bjp.0704474; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Fujisawa T, 2003, DEV DYNAM, V226, P182, DOI 10.1002/dvdy.10221; Goulding NJ, 2004, CURR OPIN PHARMACOL, V4, P629, DOI 10.1016/j.coph.2004.06.009; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; Hsu K, 2004, BLOOD, V104, P1291, DOI 10.1182/blood-2003-09-3105; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oakley RH, 1999, J BIOL CHEM, V274, P27857, DOI 10.1074/jbc.274.39.27857; Oyewumi MO, 2003, BIOCONJUGATE CHEM, V14, P404, DOI 10.1021/bc0340013; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sbafizadeh E, 2004, COMP BIOCHEM PHYS C, V138, P245, DOI 10.1016/j.cca.2004.05.003; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schier AF, 1997, DEVELOPMENT, V124, P327; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Sekiya I, 2001, J ENDOCRINOL, V169, P573, DOI 10.1677/joe.0.1690573; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	46	140	142	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35202	35210		10.1074/jbc.M706640200	http://dx.doi.org/10.1074/jbc.M706640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17848559	hybrid			2022-12-27	WOS:000251155200065
J	Sawasdikosol, S; Pyarajan, S; Alzabin, S; Matejovic, G; Burakoff, SJ				Sawasdikosol, Sansana; Pyarajan, Saiju; Alzabin, Saba; Matejovic, Gabriel; Burakoff, Steven J.			Prostaglandin E-2 activates HPK1 kinase activity via a PKA-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR KINASE-1; N-TERMINAL KINASE; ADAPTER PROTEINS; GENE-EXPRESSION; T-LYMPHOCYTES; EP4 RECEPTOR; CELLS; TRANSCRIPTION; GROWTH; AP-1	Hematopoietic progenitor kinase 1 (HPK1) is a hematopoietic cell-restricted member of the Ste20 serine/threonine kinase super family. We recently reported that the immunosuppressive eicosanoid, prostaglandin E-2 (PGE(2)), is capable of activating HPK1 in T cells. In this report, we demonstrate that unlike the TCR-induced activation of HPK1 kinase activity, the induction of HPK1 catalytic activity by PGE(2) does not require the presence of phosphotyrosine-based signaling molecules such as Lck, ZAP-70, SLP-76, and Lat. Nor does the PGE(2)-induced HPK1 activation require the intermolecular interaction between its proline-rich regions and the SH3 domain-containing adaptor proteins, as required by the signaling from the TCR to HPK1. Instead, our study reveals that PGE(2) signal to HPK1 via a 3'-5'-cyclic adenosine monophosphate-regulated, PKA-dependent pathway. Consistent with this observation, changing the serine 171 residue that forms the optimal PKA phosphorylation site within the "activation loop" of HPK1 to alanine completely prevents this mutant from responding to PGE(2)-generated stimulation signals. Moreover, the inability of HPK1 to respond to PGE(2) stimulation in PKA-deficient S49 cells further supports the importance of PKA in this signaling pathway. We speculate that this unique signaling pathway enables PGE(2) signals to engage a proven negative regulator of TCR signal transduction pathway and uses it to inhibit T cell activation.	NYU, Sch Med, Inst Canc, New York, NY 10016 USA	New York University	Sawasdikosol, S (corresponding author), NYU, Sch Med, Inst Canc, New York, NY 10016 USA.	sawasdik@saturn.med.nyu.edu		Alzabin, Saba/0000-0003-3474-1846				Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; BETZ M, 1991, J IMMUNOL, V146, P108; Blaschke V, 1996, FEBS LETT, V394, P39, DOI 10.1016/0014-5793(96)00928-3; Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; BOSSEMEYER D, 1995, FEBS LETT, V369, P57, DOI 10.1016/0014-5793(95)00580-3; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; CHOUAIB S, 1985, J IMMUNOL, V135, P1172; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Giannouli CC, 2006, CELL SIGNAL, V18, P1417, DOI 10.1016/j.cellsig.2005.11.002; Gu CH, 2000, J BIOL CHEM, V275, P20726, DOI 10.1074/jbc.M000152200; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Mori K, 1996, J MOL MED-JMM, V74, P333, DOI 10.1007/BF00207510; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Paliogianni F, 1996, CELL IMMUNOL, V171, P95, DOI 10.1006/cimm.1996.0178; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2003, BLOOD, V101, P3687, DOI 10.1182/blood-2002-07-2316; Schulze-Luehrmann J, 2002, BLOOD, V100, P954, DOI 10.1182/blood-2002-01-0089; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	40	25	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34693	34699		10.1074/jbc.M707425200	http://dx.doi.org/10.1074/jbc.M707425200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17895239	hybrid			2022-12-27	WOS:000251155200011
J	Nagai, R; Brock, JW; Blatnik, M; Baatz, JE; Bethard, J; Walla, MD; Thorpe, SR; Baynes, JW; Frizzell, N				Nagai, Ryoji; Brock, Jonathan W.; Blatnik, Matthew; Baatz, John E.; Bethard, Jennifer; Walla, Michael D.; Thorpe, Suzanne R.; Baynes, John W.; Frizzell, Norma			Succination of protein thiols during adipocyte maturation - A biomarker of mitochondrial stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-MODIFICATION; HUMAN MUSCLE; CELLS; IDENTIFICATION; METHYLGLYOXAL; GLYCATION; OXIDATION	Although obesity is a risk factor for development of type 2 diabetes and chemical modification of proteins by advanced glycoxidation and lipoxidation end products is implicated in the development of diabetic complications, little is known about the chemical modification of proteins in adipocytes or adipose tissue. In this study we show that S-(2-succinyl) cysteine (2SC), the product of chemical modification of proteins by the Krebs cycle intermediate, fumarate, is significantly increased during maturation of 3T3-L1 fibroblasts to adipocytes. Fumarate concentration increased >= 5-fold during adipogenesis in medium containing 30 mM glucose, producing a >= 10-fold increase in 2SC-proteins in adipocytes compared with undifferentiated fibroblasts grown in the same high glucose medium. The elevated glucose concentration in the medium during adipocyte maturation correlated with the increase in 2SC, whereas the concentration of the advanced glycoxidation and lipoxidation end products, N-is an element of-(carboxymethyl)lysine and N-is an element of-(carboxyethyl)lysine, was unchanged under these conditions. Adipocyte proteins were separated by one- and two-dimensional electrophoresis and similar to 60 2SC-proteins were detected using an anti-2SC polyclonal antibody. Several of the prominent and well resolved proteins were identified by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry. These include cytoskeletal proteins, enzymes, heat shock and chaperone proteins, regulatory proteins, and a fatty acid-binding protein. We propose that the increase in fumarate and 2SC is the result of mitochondrial stress in the adipocyte during adipogenesis and that 2SC may be a useful biomarker of mitochondrial stress in obesity, insulin resistance, and diabetes.	Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29243 USA; Childrens Res Hosp, Charleston, SC 29243 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Baynes, JW (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St GSRC, Columbia, SC 29208 USA.	john.baynes@sc.edu			NIDDK NIH HHS [DK 19971] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019971, R01DK019971] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Alt N, 2004, ARCH BIOCHEM BIOPHYS, V425, P200, DOI 10.1016/j.abb.2004.03.012; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Das K, 1999, BIOCHEM J, V344, P313, DOI 10.1042/0264-6021:3440313; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gibala MJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE239, DOI 10.1152/ajpendo.1997.272.2.E239; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; JUNG G, 1972, EUR J BIOCHEM, V24, P438, DOI 10.1111/j.1432-1033.1972.tb19704.x; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1992, METABOLISM, V41, P545, DOI 10.1016/0026-0495(92)90216-W; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCDEVITT J, 1990, METABOLISM, V39, P1012, DOI 10.1016/0026-0495(90)90159-A; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; ROGERS KR, 1991, BIOCHEM J, V275, P789, DOI 10.1042/bj2750789; ROGERS KR, 1989, INT J TISSUE REACT, V11, P309; RUBIN AH, 1978, P NATL ACAD SCI USA, V75, P4379, DOI 10.1073/pnas.75.9.4379; Shaw J Nikki, 2002, Methods Mol Biol, V186, P129; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; TANAKA A, 1980, J CHROMATOGR, V194, P21, DOI 10.1016/S0021-9673(00)81046-8; TBARKA N, 1993, FEBS LETT, V322, P125, DOI 10.1016/0014-5793(93)81551-A; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Yu YH, 2004, AM J PHYSIOL-ENDOC M, V286, pE402, DOI 10.1152/ajpendo.00247.2003; Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019	35	86	87	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34219	34228		10.1074/jbc.M703551200	http://dx.doi.org/10.1074/jbc.M703551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17726021	hybrid			2022-12-27	WOS:000251145700037
J	Jacobs, AT; Marnett, LJ				Jacobs, Aaron T.; Marnett, Lawrence J.			Heat shock factor 1 attenuates 4-hydroxynonenal-mediated apoptosis - Critical role for heat shock protein 70 induction and stabilization of Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; TRANSCRIPTION FACTOR HSF1; DNA-BINDING ACTIVITY; OXIDATIVE STRESS; LIPID-PEROXIDATION; GENE-EXPRESSION; CELL-DEATH; MOLECULAR CHAPERONES; NEGATIVE REGULATION; MAMMALIAN-CELLS	Lipid peroxidation is a consequence of both normal physiology and oxidative stress that generates various reactive metabolites, a principal end product being 4-hydroxynonenal (HNE). As a diffusible electrophile, HNE reacts extensively with cellular nucleophiles. Consequently, HNE alters cellular signaling and activates the intrinsic apoptotic cascade. We have previously demonstrated that in addition to promoting apoptosis, HNE activates stress response pathways, including the antioxidant, endoplasmic reticulum stress, DNA damage, and heat shock responses. Here we demonstrate that activation of the heat shock response by HNE is dependent on the expression and nuclear translocation of heat shock factor 1 (HSF1), which promotes the expression of heat shock protein 40 (Hsp40) and Hsp70-1. Ectopic expression and immunoprecipitation of c-Myc-tagged Hsp70-1 indicates that HNE disrupts the inhibitory interaction between Hsp70-1 and HSF1, leading to the activation heat shock gene expression. Using siRNA to silence HSF1 expression, we observe that HSF1 is necessary for the induction of Hsp40 and Hsp70-1 by HNE, and the lack of Hsp expression is correlated with an increase in apoptosis. Nrf2, the transcription factor that mediates the antioxidant response, was also silenced using siRNA. Silencing Nrf2 also enhanced the cytotoxicity of HNE, but not as effectively as HSF1. Silencing HSF1 expression facilitates the activation of JNK pro-apoptotic signaling and selectively decreases expression of the anti-apoptotic Bcl-2 family member Bcl-XL. Overexpression of Bcl-XL attenuates HNE-mediated apoptosis in HSF1-silenced cells. Overall, activation of HSF1 and stabilization of Bcl-XL mediate a protective response that may contribute significantly to the cellular biology of lipid peroxidation.	Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Vanderbit Inst Chem Biol,Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbit Ingram Comprehens Cancer Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Vanderbit Inst Chem Biol,Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			NIEHS NIH HHS [P01ES013125] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Biasi F, 2006, FREE RADICAL BIO MED, V41, P443, DOI 10.1016/j.freeradbiomed.2006.04.005; CAJELLI E, 1987, MUTAT RES, V190, P169, DOI 10.1016/0165-7992(87)90050-9; CAJONE F, 1989, BIOCHEM J, V262, P977, DOI 10.1042/bj2620977; CAJONE F, 1989, FREE RADICAL RES COM, V7, P189, DOI 10.3109/10715768909087941; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; CHEN HJC, 1994, CHEM RES TOXICOL, V7, P857, DOI 10.1021/tx00042a021; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chen SR, 2003, FREE RADICAL BIO MED, V34, P1315, DOI 10.1016/S0891-5849(03)00146-1; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Cheng JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P29, DOI 10.1006/abbi.1999.1479; Cheng JZ, 2001, ARCH BIOCHEM BIOPHYS, V392, P197, DOI 10.1006/abbi.2001.2452; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Douki T, 2004, FREE RADICAL BIO MED, V37, P62, DOI 10.1016/j.freeradbiomed.2004.04.013; Fujimura Satoshi, 2003, Hematol J, V4, P328, DOI 10.1038/sj.thj.6200321; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Gibbons NB, 2000, PROSTATE, V45, P58; GRUNE T, 1993, INT J TISSUE REACT, V15, P145; HAHN GM, 1982, RADIAT RES, V92, P452, DOI 10.2307/3575917; Herbst U, 1999, J CELL PHYSIOL, V181, P295, DOI 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kalinich JF, 2000, FREE RADICAL RES, V33, P349, DOI 10.1080/10715760000300891; Kruman I, 1997, J NEUROSCI, V17, P5089; Kuo CC, 2006, J BIOL CHEM, V281, P38200, DOI 10.1074/jbc.M605439200; Kutuk O, 2007, REDOX REP, V12, P30, DOI 10.1179/135100007X162329; Lau SS, 2000, AM J PHYSIOL-HEART C, V278, pH1439, DOI 10.1152/ajpheart.2000.278.5.H1439; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lytle RA, 2004, J NEURO-ONCOL, V68, P233, DOI 10.1023/B:NEON.0000033382.40601.5a; MARINARI UM, 1984, CELL BIOCHEM FUNCT, V2, P243, DOI 10.1002/cbf.290020411; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Nakagawa Y, 2002, J BIOCHEM MOL BIOL, V35, P452; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Singleton KD, 2006, AM J PHYSIOL-LUNG C, V290, pL956, DOI 10.1152/ajplung.00466.2005; Soh YJ, 2000, MOL PHARMACOL, V58, P535, DOI 10.1124/mol.58.3.535; Sowell J, 2004, P NATL ACAD SCI USA, V101, P17964, DOI 10.1073/pnas.0408433102; Sowell J, 2005, J CHROMATOGR B, V827, P139, DOI 10.1016/j.jchromb.2005.05.046; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; WINKLER P, 1984, BIOCHIM BIOPHYS ACTA, V796, P232, DOI 10.1016/0005-2760(84)90122-X; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557	68	85	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33412	33420		10.1074/jbc.M706799200	http://dx.doi.org/10.1074/jbc.M706799200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873279	hybrid			2022-12-27	WOS:000250840200021
J	Goransson, O; McBride, A; Hawley, SA; Ross, FA; Shpiro, N; Foretz, M; Viollet, B; Hardie, DG; Sakamoto, K				Goeransson, Olga; McBride, Andrew; Hawley, Simon A.; Ross, Fiona A.; Shpiro, Natalia; Foretz, Marc; Viollet, Benoit; Hardie, D. Grahame; Sakamoto, Kei			Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; GLUCOSE-HOMEOSTASIS; UPSTREAM KINASE; SKELETAL-MUSCLE; FATTY-ACID; RAT-LIVER; METFORMIN; PHOSPHORYLATION; INSULIN; AICAR	We have studied the mechanism of A- 769662, a new activator of AMP- activated protein kinase ( AMPK). Unlike other pharmacological activators, it directly activates native rat AMPK by mimicking both effects of AMP, i. e. allosteric activation and inhibition of dephosphorylation. We found that it has no effect on the isolated alpha subunit kinase domain, with or without the associated autoinhibitory domain, or on interaction of glycogen with the beta subunit glycogen- binding domain. Although it mimics actions of AMP, it has no effect on binding of AMP to the isolated Bateman domains of the gamma subunit. The addition of A- 769662 to mouse embryonic fibroblasts or primary mouse hepatocytes stimulates phosphorylation of acetyl- CoA carboxylase ( ACC), effects that are completely abolished in AMPK- alpha 1(-/-) alpha 2(-/-) cells but not in TAK1(-/-) mouse embryonic fibroblasts. Phosphorylation of AMPK and ACC in response to A- 769662 is also abolished in isolated mouse skeletal muscle lacking LKB1, a major upstream kinase for AMPK in this tissue. However, in HeLa cells, which lack LKB1 but express the alternate upstream kinase calmodulin- dependent protein kinase kinase-beta, phosphorylation of AMPK and ACC in response to A- 769662 still occurs. These results show that in intact cells, the effects of A- 769662 are independent of the upstream kinase utilized. We propose that this direct and specific AMPK activator will be a valuable experimental tool to understand the physiological roles of AMPK.	Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Lund Univ, Dept Expt Med Sci, Div Endocrinol Diabet & Metab, S-22184 Lund, Sweden; Univ Dundee, Coll Life Sci, Div Mol Phys, Dundee DD1 5EH, Scotland; Univ Dundee, Coll Life Sci, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland; Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; Inst Natl Sante & Rech Med, U567, F-75014 Paris, France	University of Dundee; Lund University; University of Dundee; University of Dundee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sakamoto, K (corresponding author), Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dow St, Dundee DD1 5EH, Scotland.	k.sakamoto@dundee.ac.uk	sakamoto, kei/C-8806-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Hardie, David/Z-1979-2019	sakamoto, kei/0000-0001-8839-5980; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Hardie, Grahame/0000-0002-8373-7379; Goransson, Olga/0000-0002-7209-8022	Medical Research Council [MC_U127088492] Funding Source: Medline; Wellcome Trust [080982] Funding Source: Medline; MRC [MC_U127088492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY CJ, 1992, BRIT J PHARMACOL, V105, P1009, DOI 10.1111/j.1476-5381.1992.tb09093.x; BAIN J, 2007, IN PRESS BIOCH J; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iyengar R. R., 2005, U.S. Patent, Patent No. [0,038,068 A1, 0038068]; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KOEPSELL H, 2007, PHARM RES; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	60	332	344	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32549	32560		10.1074/jbc.M706536200	http://dx.doi.org/10.1074/jbc.M706536200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855357	hybrid, Green Accepted			2022-12-27	WOS:000250625400004
J	Xie, Y; Luo, J; Kennedy, S; Davidson, NO				Xie, Yan; Luo, Jianyang; Kennedy, Susan; Davidson, Nicholas O.			Conditional intestinal lipotoxicity in Apobec-1(-/-) Mttp-IKO mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL TRANSFER PROTEIN; ENDOPLASMIC-RETICULUM STRESS; APOLIPOPROTEIN-B; CELL-DEATH; APO-B; DEVELOPMENTAL REGULATION; CATALYTIC SUBUNIT; SECRETION; LIVER	Mammalian small intestinal lipid absorption requires the coordinated interactions of apolipoprotein B ( apoB) and the microsomal triglyceride transfer protein ( Mttp). The observation that apoB100 displays greater dependence on Mttp availability than does apoB48 prompted us to examine the phenotype of Mttp deletion in an Apobec-1(-/-) background ( i. e. apoB100 Mttp-IKO). 20% apoB100 Mttp-IKO mice died on a chow diet, and > 90% died following high fat feeding ( versus 0 and 11% apoB48 Mttp-IKO mice, respectively). Intestinal adaptation occurred in apoB48 Mttp-IKO mice in response to high fat feeding, evidenced by increased bromodeoxyuridine incorporation and villus lengthening, changes that did not occur in apoB100 Mttp-IKO mice. There was an exaggerated unfolded protein response ( UPR), which became more pronounced in apoB100 Mttp-IKO mice. To examine the role of endoplasmic reticulum stress and the UPR in the lipotoxic effects of Mttp deletion, we administered tauroursodeoxycholate to apoB100 Mttp-IKO mice upon initiation of high fat feeding. Tauroursodeoxycholate administration abrogated the UPR but produced an unexpected acceleration in the onset of lethality in apoB100 Mttp-IKO mice. The findings demonstrate that there is activation of the UPR with lethal lipotoxicity in conditional intestinal apoB100 Mttp-IKO mice. Together the data provide the first plausible biological evidence for a survival advantage for mammalian intestinal apoB mRNA editing.	Washington Univ, Sch Med, GI Div, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, GI Div, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, GI Div, Dept Mol Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, GI Div, Dept Med, 660 S Euclid, St Louis, MO 63110 USA.	nod@wustl.edu			NHLBI NIH HHS [HL 38180, R01 HL038180] Funding Source: Medline; NIDDK NIH HHS [R01 DK056260, P30 DK056341-06, P30 DK056341, P30 DK056341-07, DK 52574, DK 56260] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK056341, P30DK052574] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chen ZG, 2007, AM J PHYSIOL-GASTR L, V292, pG53, DOI 10.1152/ajpgi.00118.2006; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Di Leo E, 2005, ATHEROSCLEROSIS, V180, P311, DOI 10.1016/j.athersclerosis.2004.12.004; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FUNAHASHI T, 1995, J LIPID RES, V36, P414; GIANNONI F, 1995, J LIPID RES, V36, P1664; GLICKMAN RM, 1986, P NATL ACAD SCI USA, V83, P5296, DOI 10.1073/pnas.83.14.5296; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Kendrick JS, 2001, BIOCHEM J, V356, P821, DOI 10.1042/0264-6021:3560821; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Larsson SL, 2004, J BIOL CHEM, V279, P831, DOI 10.1074/jbc.M303057200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu S, 2002, J LIPID RES, V43, P1303, DOI 10.1194/jlr.M200035-JLR200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rava P, 2006, J BIOL CHEM, V281, P11019, DOI 10.1074/jbc.M512823200; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Rubin DC, 1998, GASTROENTEROLOGY, V115, P1291, DOI 10.1016/S0016-5085(98)70105-2; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; Shelton JM, 2000, J LIPID RES, V41, P532; Smith HC, 1997, RNA, V3, P1105; Tang YZ, 2004, GASTROENTEROLOGY, V126, P220, DOI 10.1053/j.gastro.2003.10.077; TENG BB, 1990, J BIOL CHEM, V265, P20616; TENG BB, 1990, BIOCHEM BIOPH RES CO, V173, P74, DOI 10.1016/S0006-291X(05)81023-X; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	42	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33043	33051		10.1074/jbc.M705386200	http://dx.doi.org/10.1074/jbc.M705386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855359	hybrid			2022-12-27	WOS:000250625400053
J	Chang, J; Sonoyama, W; Wang, Z; Jin, QM; Zhang, CF; Krebsbach, PH; Giannobile, W; Shi, ST; Wang, CY				Chang, Jia; Sonoyama, Wataru; Wang, Zhuo; Jin, Qiming; Zhang, Chengfei; Krebsbach, Paul H.; Giannobile, William; Shi, Songtao; Wang, Cun-Yu			Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES OSTEOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; BETA-CATENIN; PROMOTES PROLIFERATION; PROTEIN-KINASE; MECHANISMS; EXPRESSION; DICKKOPF-1; DELIVERY; DENSITY	Mesenchymal stem cells (MSCs) are multipotent cells that can be differentiated into osteoblasts and provide an excellent cell source for bone regeneration and repair. Recently, the canonical Wnt/beta-catenin signaling pathway has been found to play a critical role in skeletal development and osteogenesis, implying that Wnts can be utilized to improve de novo bone formation mediated by MSCs. However, it is unknown whether noncanonical Wnt signaling regulates osteogenic differentiation. Here, we find that Wnt-4 enhanced in vitro osteogenic differentiation of MSCs isolated from human adult craniofacial tissues and promoted bone formation in vivo. Whereas Wnt-4 did not stabilize beta-catenin, it activated p38 MAPK in a novel noncanonical signaling pathway. The activation of p38 was dependent on Axin and was required for the enhancement of MSC differentiation by Wnt-4. Moreover, using two different models of craniofacial bone injury, we found that MSCs genetically engineered to express Wnt-4 enhanced osteogenesis and improved the repair of craniofacial defects in vivo. Taken together, our results reveal that noncanonical Wnt signaling could also play a role in osteogenic differentiation. Wnt-4 may have a potential use in improving bone regeneration and repair of craniofacial defects.	Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90095 USA; Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Peking Univ, Hlth Sci Ctr, Sch Stomatol, Beijing 100081, Peoples R China; Peking Univ, Hlth Sci Ctr, Hosp Stomatol, Beijing 100081, Peoples R China; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Peking University; Peking University; University of Southern California	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu	Krebsbach, Paul H./AAC-4765-2021; Sonoyama, Wataru/B-2160-2011	Zhang, Chengfei/0000-0002-6016-9436; Giannobile, William/0000-0002-7102-9746	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013397, R01DE016513] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE13397, DE16513, R01 DE013397] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Canalis E, 2005, J Endocrinol Invest, V28, P3; Chien KR, 2005, CELL, V121, P153, DOI 10.1016/j.cell.2005.03.020; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregory C. A., 2005, SCI STKE, ppe37; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016; Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nussenbaum B, 2005, LARYNGOSCOPE, V115, P1170, DOI 10.1097/01.MLG.0000166513.74247.CC; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Ross FP, 2006, J CLIN INVEST, V116, P1140, DOI 10.1172/JCI28605; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sottile V, 2002, BONE, V30, P699, DOI 10.1016/S8756-3282(02)00674-9; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhao M, 2004, J PERIODONTOL, V75, P154, DOI 10.1902/jop.2004.75.1.154	51	180	194	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30938	30948		10.1074/jbc.M702391200	http://dx.doi.org/10.1074/jbc.M702391200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720811	hybrid			2022-12-27	WOS:000250136300062
J	Collins, QF; Liu, HY; Pi, JB; Liu, ZQ; Quon, MJ; Cao, WH				Collins, Qu Fan; Liu, Hui-Yu; Pi, Jingbo; Liu, Zhenqi; Quon, Michael J.; Cao, Wenhong			Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5 '-AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; CATECHIN-POLYPHENOLS; CELL-SURVIVAL; NITRIC-OXIDE; GALLATE; ACTIVATION; RECEPTOR; MECHANISMS; CANCER; OBESITY	Epigallocatechin-3-gallate (EGCG), a main catechin of green tea, has been suggested to inhibit hepatic gluconeogenesis. However, the exact role and related mechanism have not been established. In this study, we examined the role of EGCG in hepatic gluconeogenesis at concentrations that are reachable by ingestion of pure EGCG or green tea, and are not toxic to hepatocytes. Our results show in isolated hepatocytes that EGCG at relatively low concentrations (<= 1 mu M) inhibited glucose production via gluconeogenesis and expression of key gluconeogenic genes. EGCG was not toxic at these concentrations while demonstrating significant cytotoxicity at 10 mu M and higher concentrations. EGCG at 1 mu M or lower concentrations effective in suppressing hepatic gluconeogenesis did not activate the insulin signaling pathway, but activated 5 '-AMP-activated protein kinase (AMPK). The EGCG suppression of hepatic gluconeogenesis was prevented by blockade of AMPK activity. In defining the mechanism by which EGCG activates AMPK, we found that the EGCG activation of AMPK was mediated by the Ca2+/calmodulin-dependent protein kinase kinase ( CaMKK). Furthermore, our results show that the EGCG activation of AMPK and EGCG suppression of hepatic gluconeogenesis were both dependent on production of reactive oxygen species (ROS), which was a known activator of CaMKK. Together, our results demonstrate an inhibitory role for EGCG in hepatic gluconeogenesis and shed new light on the mechanism by which EGCG suppresses gluconeogenesis.	Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; Univ Virginia, Hlth Sci Ctr, Dept Internal Med, Div Endocrinol, Charlottesville, VA 22908 USA; NIH, Diabet Unit, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Internal Med, Div Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, 6 Davis Dr,POB 12137, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org	Quon, Michael/B-1970-2008; PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041; QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	NIDDK NIH HHS [R01 DK076039-01A2, R01 DK076039, R01DK076039] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z01AT000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c; Anton S, 2007, CELL SIGNAL, V19, P378, DOI 10.1016/j.cellsig.2006.07.008; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chung JH, 2003, FASEB J, V17, P1913, DOI 10.1096/fj.02-0914fje; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980; Koh SH, 2004, TOXICOLOGY, V202, P213, DOI 10.1016/j.tox.2004.05.008; Koh SH, 2004, NEUROTOXICOLOGY, V25, P793, DOI 10.1016/j.neuro.2004.02.001; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koyama Y, 2004, PLANTA MED, V70, P1100, DOI 10.1055/s-2004-832659; Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3368, DOI 10.3748/wjg.v11.i22.3368; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nelson-Dooley C, 2005, CURR MED CHEM, V12, P2215, DOI 10.2174/0929867054864886; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Sah JF, 2004, J BIOL CHEM, V279, P12755, DOI 10.1074/jbc.M312333200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	52	266	284	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30143	30149		10.1074/jbc.M702390200	http://dx.doi.org/10.1074/jbc.M702390200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17724029	hybrid, Green Accepted			2022-12-27	WOS:000249981200044
J	Kerr, ID; Sivakolundu, S; Li, Z; Buchsbaum, JC; Knox, LA; Kriwacki, R; White, SW				Kerr, Iain D.; Sivakolundu, Sivashankar; Li, Zhenmei; Buchsbaum, Jeffrey C.; Knox, Luke A.; Kriwacki, Richard; White, Stephen W.			Crystallographic and NMR analyses of UvsW and UvsW.1 from bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNA-REPLICATION; GENOME INSTABILITY; FORK REVERSAL; RNA HELICASE; PROTEIN; DOMAIN; RECOMBINATION; REPAIR; RESTRAINTS	The uvsWXY system is implicated in the replication and repair of the bacteriophage T4 genome. Whereas the roles of the recombinase (UvsX) and the recombination mediator protein (UvsY) are known, the precise role of UvsW is unclear. Sequence analysis identifies UvsW as a member of the monomeric SF2 helicase superfamily that translocates nucleic acid substrates via the action of two RecA-like motor domains. Functional homologies to Escherichia coli RecG and biochemical analyses have shown that UvsW interacts with branched nucleic acid substrates, suggesting roles in recombination and the rescue of stalled replication forks. A sequencing error at the 3'-end of the uvsW gene has revealed a second, short open reading frame that encodes a protein of unknown function called UvsW.1. We have determined the crystal structure of UvsW to 2.7 angstrom and the NMR solution structure of UvsW.1. UvsW has a four-domain architecture with structural homology to the eukaryotic SF2 helicase, Rad54. A model of the UvsW-ssDNA complex identifies structural elements and conserved residues that may interact with nucleic acid substrates. The NMR solution structure of UvsW.1 reveals a dynamic four-helix bundle with homology to the structure-specific nucleic acid binding module of RecQ helicases.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Radiat Oncol, Hershey, PA 17033 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, R (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.Kriwacki@stjude.org; Stephen.White@stjude.org	White, Stephen W/N-8164-2018; Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018	NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 66934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; BERNSTEIN H, 1989, J BACTERIOL, V171, P2265, DOI 10.1128/jb.171.5.2265-2270.1989; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERR LK, 1990, MOL GEN GENET, V222, P257, DOI 10.1007/BF00633826; DERR LK, 1990, J MOL BIOL, V214, P643, DOI 10.1016/0022-2836(90)90283-R; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li N, 2002, MOL MICROBIOL, V43, P1079, DOI 10.1046/j.1365-2958.2002.02809.x; Liu Z, 1999, STRUCTURE, V7, P1557, DOI 10.1016/S0969-2126(00)88346-X; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sickmier EA, 2004, STRUCTURE, V12, P583, DOI 10.1016/j.str.2004.02.016; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; SNOW R, 1967, J BACTERIOL, V94, P571, DOI 10.1128/JB.94.3.571-575.1967; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729	60	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34392	34400		10.1074/jbc.M705900200	http://dx.doi.org/10.1074/jbc.M705900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878153	hybrid			2022-12-27	WOS:000251145700055
J	Benziane, B; Demaretz, S; Defontaine, N; Zaarour, N; Cheval, L; Bourgeois, S; Klein, C; Froissart, M; Blanchard, A; Paillard, M; Gamba, G; Houillier, P; Laghmani, K				Benziane, Boubacar; Demaretz, Sylvie; Defontaine, Nadia; Zaarour, Nancy; Cheval, Lydie; Bourgeois, Soline; Klein, Christophe; Froissart, Marc; Blanchard, Anne; Paillard, Michel; Gamba, Gerardo; Houillier, Pascal; Laghmani, Kamel			NKCC2 surface expression in mammalian cells - down-regulation by novel interaction with aldolase b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; THICK ASCENDING LIMB; N-TERMINAL RESIDUE; HEREDITARY FRUCTOSE INTOLERANCE; VACUOLAR H+-ATPASE; NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; MOLECULAR-CLONING; RAT-KIDNEY; F-ACTIN	Apical bumetanide-sensitive Na+-K+-2Cl(+) co-transporter, termed NKCC2, is the major salt transport pathway in kidney thick ascending limb. NKCC2 surface expression is subject to regulation by intracellular protein trafficking. However, the protein partners involved in the intracellular trafficking of NKCC2 remain unknown. Moreover, studies aimed at understanding the post-translational regulation of NKCC2 have been hampered by the difficulty to express NKCC2 protein in mammalian cells. Here we were able to express NKCC2 protein in renal epithelial cells by tagging its N-terminal domain. To gain insights into the regulation of NKCC2 trafficking, we screened for interaction partners of NKCC2 with the yeast two-hybrid system, using the C-terminal tail of NKCC2 as bait. Aldolase B was identified as a dominant and novel interacting protein. Real time PCR on renal microdissected tubules demonstrated the expression of aldolase B in the thick ascending limb. Co-immunoprecipitation and co-immunolocalization experiments confirmed NKCC2-aldolase interaction in renal cells. Biotinylation assays showed that aldolase co-expression reduces NKCC2 surface expression. In the presence of aldolase substrate, fructose 1,6-bisphosphate, aldolase binding was disrupted, and aldolase co-expression had no further effect on the cell surface level of NKCC2. Finally, functional studies demonstrated that aldolase-induced down-regulation of NKCC2 at the plasma membrane was associated with a decrease in its transport activity. In summary, we identified aldolase B as a novel NKCC2 binding partner that plays a key role in the modulation of NKCC2 surface expression, thereby revealing a new regulatory mechanism governing the co-transporter intracellular trafficking. Furthermore, NKCC2 protein expression in mammalian cells and its regulation by protein-protein interactions, described here, may open new and important avenues in studying the cell biology and post-transcriptional regulation of the co-transporter.	Univ Paris 06, CNRS, UMR7134, F-75006 Paris, France; Inst Biomed Cordeliers, IFR58, F-75006 Paris, France; Univ Paris 05, F-75006 Paris, France; Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 14000, DF, Mexico; Hop Europeen Georges Pompidou, AP HP, Dept Physiol, F-75015 Paris, France; INSERM, U652, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Laghmani, K (corresponding author), INSERM, U652, 15 Rue Ecole Med, F-75270 Paris 06, France.	Kamel.Laghmani@bhdc.jussieu.fr	Froissart, Marc/L-7493-2014; Laghmani, Kamel/AIE-9621-2022; Houillier, Pascal/AAD-4903-2019; Gamba, Gerardo/P-4873-2016	Froissart, Marc/0000-0002-4010-3173; Laghmani, Kamel/0000-0002-2167-5766; Houillier, Pascal/0000-0003-4953-6917; klein, christophe/0000-0001-8015-287X; CHEVAL, LYDIE/0000-0003-2957-6487; BLANCHARD, Anne/0000-0002-0815-0586; Gamba, Gerardo/0000-0002-4378-9043				Ali M, 1998, J MED GENET, V35, P353, DOI 10.1136/jmg.35.5.353; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; AMLAL H, 1994, J BIOL CHEM, V269, P21962; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Bourgeois S, 2003, PFLUG ARCH EUR J PHY, V446, P672, DOI 10.1007/s00424-003-1108-x; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; BRONSTEIN WW, 1981, CAN J BIOCHEM CELL B, V59, P494, DOI 10.1139/o81-069; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; CHEN JG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P299, DOI 10.1016/0005-2736(93)90214-K; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Christova TY, 1996, BIOCHEM BIOPH RES CO, V228, P272, DOI 10.1006/bbrc.1996.1652; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; Ehringer WD, 2000, MOL CELL BIOCHEM, V210, P35, DOI 10.1023/A:1007059214754; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1998, P NATL ACAD SCI USA, V95, P7179, DOI 10.1073/pnas.95.12.7179; Juergens TM, 1996, MOL CELL BIOCHEM, V154, P83; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kurtz CL, 1997, J AM SOC NEPHROL, V8, P1706; Laghmani K, 2005, AM J PHYSIOL-RENAL, V288, pF732, DOI 10.1152/ajprenal.00300.2004; LAZZARINO G, 1984, CLIN BIOCHEM, V17, P42, DOI 10.1016/S0009-9120(84)90480-6; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Lopes A I, 1998, Acta Med Port, V11, P1121; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; McReynolds MR, 2005, AM J PHYSIOL-RENAL, V288, pF315, DOI 10.1152/ajprenal.00207.2004; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mikalsen T, 2005, INT J BIOCHEM CELL B, V37, P2513, DOI 10.1016/j.biocel.2005.06.007; MIYAUCHI A, 1990, AM J PHYSIOL, V259, pF485, DOI 10.1152/ajprenal.1990.259.3.F485; MOE OW, 1991, J CLIN INVEST, V88, P1703, DOI 10.1172/JCI115487; MORRIS RC, 1968, J CLIN INVEST, V47, P1389, DOI 10.1172/JCI105830; Mount DB, 1999, AM J PHYSIOL-RENAL, V276, pF347, DOI 10.1152/ajprenal.1999.276.3.F347; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; OREILLY G, 1993, FEBS LETT, V321, P69, DOI 10.1016/0014-5793(93)80623-3; OROSZ F, 1988, MOL PHARMACOL, V33, P678; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Plata C, 1999, AM J PHYSIOL-RENAL, V276, pF359, DOI 10.1152/ajprenal.1999.276.3.F359; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Plata C, 2001, AM J PHYSIOL-RENAL, V280, pF574, DOI 10.1152/ajprenal.2001.280.4.F574; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; REZNICK AZ, 1985, P NATL ACAD SCI USA, V82, P6114, DOI 10.1073/pnas.82.18.6114; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Saez DE, 2000, J CELL BIOCHEM, V78, P62, DOI 10.1002/(SICI)1097-4644(20000701)78:1<62::AID-JCB6>3.3.CO;2-N; Salvatore F, 1986, Horiz Biochem Biophys, V8, P611; Simard CF, 2004, J BIOL CHEM, V279, P48449, DOI 10.1074/jbc.M407012200; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; STEWART M, 1980, BIOCHEM J, V186, P99, DOI 10.1042/bj1860099; VALLET V, 1995, EXP CELL RES, V216, P363, DOI 10.1006/excr.1995.1046; WACHSMUTH ED, 1975, HISTOCHEMISTRY, V45, P143, DOI 10.1007/BF00495158; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wheeler TJ, 2004, MOL CELL BIOCHEM, V259, P105, DOI 10.1023/B:MCBI.0000021356.89867.0d; WU MS, 1994, J MEMBRANE BIOL, V142, P323; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yanez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183	77	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33817	33830		10.1074/jbc.M700195200	http://dx.doi.org/10.1074/jbc.M700195200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848580	hybrid			2022-12-27	WOS:000250840200064
J	Liu, H; Jiravanichpaisal, P; Cerenius, L; Lee, BL; Sorderhall, I; Soderhall, K				Liu, Haipeng; Jiravanichpaisal, Pikul; Cerenius, Lage; Lee, Bok Luel; Soerderhaell, Irene; Soederhaell, Kenneth			Phenoloxidase is an important component of the Defense against Aeromonas hydrophila infection in a crustacean, Pacifastacus leniusculus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRESH-WATER CRAYFISH; PROPHENOLOXIDASE-ACTIVATING SYSTEM; IMMUNE-RESPONSIVE SERPIN; DROSOPHILA HOST-DEFENSE; CELL-ADHESION FACTOR; ANOPHELES-GAMBIAE; MELANIZATION CASCADE; ARMIGERES-SUBALBATUS; RECOGNITION PROTEIN; APHANOMYCES-ASTACI	The melanization cascade, in which phenoloxidase is the terminal enzyme, appears to play a key role in recognition of and defense against microbial infections in invertebrates. Here, we show that phenoloxidase activity and melanization are important for the immune defense toward a highly pathogenic bacterium, Aeromonas hydrophila, in the freshwater crayfish, Pacifastacus leniusculus. RNA interference-mediated depletion of crayfish prophenoloxidase leads to increased bacterial growth, lower phagocytosis, lower phenoloxidase activity, lower nodule formation, and higher mortality when infected with this bacterium. In contrast, if RNA interference of pacifastin, an inhibitor of the crayfish prophenoloxidase activation cascade, is performed, it results in lower bacterial growth, increased phagocytosis, increased nodule formation, higher phenoloxidase activity, and delayed mortality. Our data therefore suggest that phenoloxidase is required in crayfish defense against an infection by A. hydrophila, a highly virulent and pathogenic bacterium to crayfish.	Uppsala Univ, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Mol Aquat Biol & Genet Lab, Bangkok 10400, Thailand; Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	Uppsala University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Pusan National University	Soderhall, K (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, SE-75236 Uppsala, Sweden.	Kenneth.Soderhall@ebc.uu.se	Liu, HP/G-4633-2010					Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Asada N, 1999, DEV COMP IMMUNOL, V23, P535, DOI 10.1016/S0145-305X(99)00035-X; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2003, CELL MICROBIOL, V5, P353, DOI 10.1046/j.1462-5822.2003.00282.x; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; CHRISTENSEN BM, 1984, J INVERTEBR PATHOL, V44, P267, DOI 10.1016/0022-2011(84)90024-7; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Hed J, 1986, Methods Enzymol, V132, P198; Hillyer JF, 2004, MICROBES INFECT, V6, P448, DOI 10.1016/j.micinf.2004.01.005; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Johansson M.W., 1996, Progress in Molecular and Subcellular Biology, V15, P46; JOHANSSON MW, 1988, J CELL BIOL, V106, P1795, DOI 10.1083/jcb.106.5.1795; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lambrechts L, 2004, EVOLUTION, V58, P2377, DOI 10.1111/j.0014-3820.2004.tb01611.x; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Lin XH, 2007, BBA-GEN SUBJECTS, V1770, P87, DOI 10.1016/j.bbagen.2006.06.018; Mavrouli MD, 2005, BBA-MOL CELL RES, V1744, P145, DOI 10.1016/j.bbamcr.2005.04.011; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Nappi AJ, 2005, J INSECT PHYSIOL, V51, P197, DOI 10.1016/j.jinsphys.2004.10.013; PASKEWITZ SM, 1988, J PARASITOL, V74, P432, DOI 10.2307/3282053; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; SODERHALL K, 1982, J INVERTEBR PATHOL, V39, P105, DOI 10.1016/0022-2011(82)90164-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Tamang D, 2004, INSECT MOL BIOL, V13, P595, DOI 10.1111/j.0962-1075.2004.00516.x; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; Vass E, 2000, J PARASITOL, V86, P1259, DOI 10.1645/0022-3395(2000)086[1259:DAIAOD]2.0.CO;2; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vernick Kenneth D., 1998, P261; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200	48	178	186	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33593	10.1074/jbc.M706113200	http://dx.doi.org/10.1074/jbc.M706113200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855335	hybrid			2022-12-27	WOS:000250840200040
J	Inouye, S; Fujimoto, M; Nakamura, T; Takaki, E; Hayashida, N; Hai, T; Nakai, A				Inouye, Sachiye; Fujimoto, Mitsuaki; Nakamura, Tamami; Takaki, Eiichi; Hayashida, Naoki; Hai, Tsonwin; Nakai, Akira			Heat shock transcription factor 1 opens chromatin structure of interleukin-6 promoter to facilitate binding of an activator or a repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; FACTOR-I; RESPONSIVE ELEMENT; LENS DEVELOPMENT; GENE; PROTEINS; HSF1; MICE; LIPOPOLYSACCHARIDE	Heat shock transcription factor 1 ( HSF1) not only regulates expression of heat shock genes in response to elevated temperature, but is also involved in developmental processes by regulating genes such as cytokine genes. However, we did not know how HSF1 regulates non-heat shock genes. Here, we show that constitutive HSF1 binding to the interleukin ( IL)-6 promoter is necessary for its maximal induction by lipopolysaccharide ( LPS) stimulation in mouse embryo fibroblasts and peritoneal macrophages. Lack of HSF1 inhibited LPS-induced in vivo binding of an activator NF-kappa B and a repressor ATF3 to IL-6 promoter. Neither NF-kappa B nor ATF3 binds to the IL-6 promoter in unstimulated HSF1-null cells even if they were overexpressed. Treatment with histone deacetylase inhibitor or a DNA methylation inhibitor restored LPS-induced IL-6 expression in HSF1-null cells, and histone modification enzymes were recruited on the IL-6 promoter in the presence of HSF1. Consistently, chromatin structure of the IL-6 promoter in the presence of HSF1 was more open than that in its absence. These results indicate that HSF1 partially opens the chromatin structure of the IL-6 promoter for an activator or a repressor to bind to it, and provides a novel mechanism of gene regulation by HSF1.	Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7558505, Japan; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Yamaguchi University; University System of Ohio; Ohio State University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022; Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Hayashida, Naoki/0000-0002-8785-8012				Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Franchimont N, 1999, J BIOL CHEM, V274, P6783, DOI 10.1074/jbc.274.10.6783; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	45	85	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33210	33217		10.1074/jbc.M704471200	http://dx.doi.org/10.1074/jbc.M704471200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17766920	hybrid			2022-12-27	WOS:000250625400068
J	Kaasik, A; Safiulina, D; Choubey, V; Kuum, M; Zharkovsky, A; Veksler, V				Kaasik, Allen; Safiulina, Dzhamilja; Choubey, Vinay; Kuum, Malle; Zharkovsky, Alexander; Veksler, Vladimir			Mitochondrial swelling impairs the transport of organelles in cerebellar granule neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AXONAL-TRANSPORT; TRANSGENIC MICE; HUMAN SOD1; DISEASE; NEUROFILAMENTS; GLUTAMATE; ACCUMULATION; DEGENERATION; DYSFUNCTION	Organelle transport in neuronal processes is central to the organization, developmental fate, and functions of neurons. Organelles must be transported through the slender, highly branched neuronal processes, making the axonal transport vulnerable to any perturbation. However, some intracellular structures like mitochondria are able to considerably modify their volume. We therefore hypothesized that swollen mitochondria could impair the traffic of other organelles in neurite shafts. To test this hypothesis, we have investigated the effects of mitochondrial swellers on the organelle traffic. Our data demonstrate that treatment of neurons with potassium ionophore valinomycin led to the fast time-dependent inhibition of organelle movement in cerebellar granule neurons. Similar inhibition was observed in neurons treated with the inhibitors of the mitochondrial respiratory chain, sodium azide and antimycin, which also induced swelling. No decrease in the motility of organelles was observed in cultures treated with inhibitors of ATP production or transport, oligomycin or bongkrekic acid, suggesting that inhibition of the ATP-generating activity itself without swelling does not affect the motility of organelles. The effect of swellers on the traffic was more important in thin processes, thus indicating the role of steric hindrance of swollen mitochondria. We propose that the size and morphology of the transported cargo is also relevant for seamless axonal transport and speculate that mitochondrial swelling could be one of the reasons for impaired organelle transport in neuronal processes.	Univ Tartu, Dept Pharmacol, Ctr Mol & Clin Med, EE-51014 Tartu, Estonia; INSERM, U 769, F-92296 Chatenay Malabry, France; Univ Paris Sud, F-92296 Chatenay Malabry, France	University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Kaasik, A (corresponding author), Univ Tartu, Dept Pharmacol, Ctr Mol & Clin Med, Ravila 19, EE-51014 Tartu, Estonia.	Allen.Kaasik@ut.ee	Safiulina, Dzamilja/I-7336-2015; Kaasik, Allen/I-2738-2015; Choubey, Vinay/H-3170-2015	Choubey, Vinay/0000-0002-1953-5692; Veksler, Vladimir/0000-0002-8869-9594; Safiulina, Dzhamilja/0000-0002-4188-4207; Kaasik, Allen/0000-0002-4850-3198				Benquet P, 2002, J NEUROPHYSIOL, V88, P1475, DOI 10.1152/jn.2002.88.3.1475; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Budd SL, 1996, J NEUROCHEM, V67, P2282; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; MUNOZ DG, 1988, J NEUROPATH EXP NEUR, V47, P9, DOI 10.1097/00005072-198801000-00002; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Safiulina D, 2006, J CELL PHYSIOL, V206, P347, DOI 10.1002/jcp.20476; Shah SB, 2005, BIOPHYS J, V88, p400A; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vanden Berghe P, 2004, AM J PHYSIOL-GASTR L, V286, pG671, DOI 10.1152/ajpgi.00283.2003; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	26	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32821	32826		10.1074/jbc.M702295200	http://dx.doi.org/10.1074/jbc.M702295200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785462	hybrid			2022-12-27	WOS:000250625400031
J	von Horsten, HH; Johnson, SS; SanFrancisco, SK; Hastert, MC; Whelly, SM; Cornwall, GA				von Horsten, Hans H.; Johnson, Seethal S.; SanFrancisco, Susan K.; Hastert, Mary Catherine; Whelly, Sandra M.; Cornwall, Gail A.			Oligomerization and transglutaminase cross-linking of the cystatin CRES in the mouse epididymal lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; AMYLOID-BETA PROTEIN; SPERM MATURATION; COMMON MECHANISM; FIBRIL FORMATION; HUMAN-SEMEN; AGGREGATION; ANGIOPATHY; INHIBITION; PEPTIDE	CRES (cystatin-related epididymal spermatogenic), a member of the cystatin superfamily of cysteine protease inhibitors, is expressed in the epididymis and spermatozoa, suggesting specialized roles in reproduction. Several cystatin family members oligomerize, including cystatin C that forms amyloid deposits associated with cerebral amyloid angiopathy. Our studies demonstrate that CRES also forms oligomers. Size exclusion chromatography revealed the presence of multiple forms of CRES in the epididymal luminal fluid, including SDS-sensitive and SDS-resistant high molecular mass complexes. In vitro experiments demonstrated that CRES is a substrate for transglutaminase and that an endogenous transglutaminase activity in the epididymal lumen catalyzed the formation of SDS-resistant CRES complexes. The use of a conformation-dependent antibody that recognizes only the oligomeric precursors to amyloid, negative stain electron microscopy, and Congo Red staining showed that CRES adopted similar oligomeric and fibrillar structures during its aggregation as other amyloidogenic proteins, suggesting that CRES has the potential to form amyloid in the epididymal lumen. The addition of transglutaminase, however, prevented the formation of CRES oligomers recognized by the conformation antibody by cross-linking CRES into an amorphous structure. We propose that transglutaminase activity in the epididymal lumen may function as a mechanism of extracellular quality control by diverting proteins such as CRES from the amyloidogenic pathway.	Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; Texas Tech Univ, Dept Sci Biol, Imaging Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, 3601 4th St, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu			NICHD NIH HHS [HD 44669, HD 33903] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033903, R29HD033903, K02HD044669] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACEVEDO F, 1995, ELECTROPHORESIS, V16, P1394, DOI 10.1002/elps.11501601231; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; AUERSWALD EA, 1992, EUR J BIOCHEM, V209, P837, DOI 10.1111/j.1432-1033.1992.tb17355.x; Aumuller G, 1990, Acta Histochem Suppl, V38, P209; BARSIGIAN C, 1991, J BIOL CHEM, V266, P22501; BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Boros S, 2004, FEBS LETT, V576, P57, DOI 10.1016/j.febslet.2004.08.062; Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CASELLA R, 2002, UROLOGY, V59; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chae KY, 2005, J BIOCHEM, V137, P407, DOI 10.1093/jb/mvi051; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Cornwall GA, 2003, ENDOCRINOLOGY, V144, P901, DOI 10.1210/en.2002-220997; CORNWALL GA, 1992, MOL ENDOCRINOL, V6, P1653, DOI 10.1210/me.6.10.1653; Cuasnicu P. S., 2002, EPIDIDYMIS MOL CLIN, P389, DOI DOI 10.1007/978-1-4615-0679-9_; Dacheux J. -L., 2002, EPIDIDYMIS MOL CLIN, P151, DOI [10.1007/978-1-4615-0679-9_9, DOI 10.1007/978-1-4615-0679-9_9]; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; DELAMIRANDE E, 1989, GAMETE RES, V22, P179, DOI 10.1002/mrd.1120220206; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P6446, DOI 10.1073/pnas.0731893100; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P2391, DOI 10.1073/pnas.0335642100; FONTANA A, 1983, METHOD ENZYMOL, V91, P311; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; GRASSO P, 1987, ENDOCRINOLOGY, V121, P459, DOI 10.1210/endo-121-2-459; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jeitner TM, 2005, BIOCHEM PHARMACOL, V69, P961, DOI 10.1016/j.bcp.2004.12.011; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Konno T, 2005, J BIOL CHEM, V280, P17520, DOI 10.1074/jbc.M413988200; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; MACHLEIDT W, 1991, BIOMED BIOCHIM ACTA, V50, P613; Madi A, 2005, ANAL BIOCHEM, V343, P256, DOI 10.1016/j.ab.2005.05.034; Merz GS, 1997, J CELL PHYSIOL, V173, P423; MUKHERJEE DC, 1983, SCIENCE, V219, P989, DOI 10.1126/science.6130601; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Nagai A, 1998, MOL CHEM NEUROPATHOL, V33, P63, DOI 10.1007/BF02815860; NISTAL M, 1989, Applied Pathology, V7, P2; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Olofsson A, 2002, CLIN CHEM LAB MED, V40, P1266, DOI 10.1515/CCLM.2002.219; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Peter A, 1998, EUR J BIOCHEM, V252, P216, DOI 10.1046/j.1432-1327.1998.2520216.x; PORTA R, 1986, BIOL REPROD, V35, P965, DOI 10.1095/biolreprod35.4.965; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Sodhi R, 2003, ANAL BIOCHEM, V315, P141, DOI 10.1016/S0003-2697(02)00656-5; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; TAKAHASHI M, 1992, FEBS LETT, V308, P79, DOI 10.1016/0014-5793(92)81055-Q; von Horsten HH, 2003, ANAL BIOCHEM, V316, P139, DOI 10.1016/S0003-2697(03)00023-X; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	62	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32912	32923		10.1074/jbc.M703956200	http://dx.doi.org/10.1074/jbc.M703956200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855342	hybrid			2022-12-27	WOS:000250625400040
J	Steinberg, R; Harari, OA; Lidington, EA; Boyle, JJ; Nohadani, M; Samarel, AM; Ohba, M; Haskard, DO; Mason, JC				Steinberg, Rivka; Harari, Olivier A.; Lidington, Elaine A.; Boyle, Joseph J.; Nohadani, Mahrokh; Samarel, Allen M.; Ohba, Motoi; Haskard, Dorian O.; Mason, Justin C.			A protein kinase C epsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; GROWTH-FACTOR; PKC-EPSILON; ATHEROSCLEROTIC PLAQUES; IN-VIVO; ACTIVATION; DELTA; SURVIVAL; PATHWAY; CANCER	Endothelial cell apoptosis is associated with vascular injury and predisposes to atherogenesis. Endothelial cells express antiapoptotic genes including Bcl-2, Bcl-XL and survivin, which also contribute to angiogenesis and vascular remodeling. We report a central role for protein kinase C epsilon(PKC epsilon) in the regulation of Bcl-2 expression and cytoprotection of human vascular endothelium against apoptosis. Using myristoylated inhibitory peptides, a predominant role for PKC epsilon in vascular endothelial growth factor-mediated endothelial resistance to apoptosis was revealed. Immunoblotting of endothelial cells infected with an adenovirus expressing a constitutively active form of PKC epsilon (Adv-PKC epsilon-CA) or control Adv-beta-galactosidase demonstrated a 3-fold, PKC epsilon-dependent increase in Bcl-2 expression, with no significant change in Bcl-X-L, Bad, Bak, or Bax. The induction of Bcl-2 inhibited apoptosis induced by serum starvation or etoposide, and PKC epsilon activation attenuated etoposide-induced caspase-3 cleavage. The functional role of Bcl-2 was confirmed with Bcl-2 antagonist HA-14-1. Inhibition of phosphoinositide 3-kinase attenuated vascular endothelial growth factor-induced protection against apoptosis, and this was rescued by overexpression of constitutively active PKC epsilon, suggesting PKC epsilon acts downstream of phosphoinositide 3-kinase. Co-immunoprecipitation studies demonstrated a physical interaction between PKC epsilon and Akt, which resulted in formation of a signaling complex, leading to optimal induction of Bcl-2. This study reveals a pivotal role for PKC epsilon in endothelial cell cytoprotection against apoptosis. We demonstrate that PKC epsilon forms a signaling complex and acts co-operatively with Akt to protect human vascular endothelial cells against apoptosis through induction of the anti-apoptotic protein Bcl-2 and inhibition of caspase-3 cleavage.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Histopathol Sect, London W12 0NN, England; Loyola Univ, Chicago Stritch Sch Med, Cardiovasc Inst, Maywood, IL 60153 USA; Showa Univ, Inst Mol Oncol, Tokyo 1428555, Japan	Imperial College London; Imperial College London; Loyola University Chicago; Showa University	Mason, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, Cane Rd, London W12 0NN, England.	justin.mason@imperial.ac.uk	Samarel, Allen/Q-9810-2019	Harari, Olivier/0000-0001-8214-489X; Boyle, Joseph J/0000-0002-4337-3320; Samarel, Allen/0000-0001-8765-9884; Mason, Justin/0000-0001-7783-1660	British Heart Foundation [FS/13/12/30037] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; CACACE AM, 1993, ONCOGENE, V8, P2095; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dimmeler S, 2002, CURR OPIN LIPIDOL, V13, P531, DOI 10.1097/00041433-200210000-00009; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Gubina E, 1998, BLOOD, V91, P823, DOI 10.1182/blood.V91.3.823.823_823_829; GUSTAFSSON AB, 2006, AM J PHYSIOL-CELL PH, V292, P45; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haskard DO, 2004, SCAND J RHEUMATOL, V33, P281, DOI 10.1080/03009740410010281; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; Hurwitz H, 2006, SEMIN ONCOL, V33, pS26, DOI 10.1053/j.seminoncol.2006.08.001; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li LW, 1999, MOL CELL BIOL, V19, P8547; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; LINDINGTON EA, 2005, AM J PHYSIOL-CELL PH, V289, P1437; Littler CM, 2005, AM J PHYSIOL-LUNG C, V289, pL1083, DOI 10.1152/ajplung.00472.2004; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Mason JC, 2001, ARTHRITIS RHEUM, V44, P138, DOI 10.1002/1529-0131(200101)44:1<138::AID-ANR18>3.0.CO;2-G; Matsumoto M, 2001, J BIOL CHEM, V276, P14400, DOI 10.1074/jbc.M011093200; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; NEWTON AC, 2005, CHEM REV, V165, P2353; Ni CW, 2003, J CELL PHYSIOL, V195, P428, DOI 10.1002/jcp.10259; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Ramalingam R, 1999, BLOOD, V93, P2936; Saurin AT, 2002, CARDIOVASC RES, V55, P672, DOI 10.1016/S0008-6363(02)00325-5; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Venkatesan BA, 2006, CELL SIGNAL, V18, P508, DOI 10.1016/j.cellsig.2005.05.022; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wu DQ, 2004, ONCOGENE, V23, P8659, DOI 10.1038/sj.onc.1207900; Wu DQ, 2002, CANCER RES, V62, P2423; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	71	44	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32288	32297		10.1074/jbc.M704001200	http://dx.doi.org/10.1074/jbc.M704001200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785460	hybrid			2022-12-27	WOS:000250480300052
J	Wood, KS; Dunn, SD				Wood, Kristi S.; Dunn, Stanley D.			Role of the asymmetry of the homodimeric b(2) stator stalk in the interaction with the F-1 sector of Escherichia coli ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANDED COILED-COIL; B-SUBUNIT; DIMERIZATION DOMAIN; MONOCLONAL-ANTIBODIES; F1F0-ATP SYNTHASE; DELTA SUBUNITS; BINDING; ALPHA; PROTEINS; RESIDUES	The b subunit dimer in the peripheral stator stalk of Escherichia coli ATP synthase is essential for enzyme assembly and the rotational catalytic mechanism. Recent protein chemical evidence revealed the dimerization domain of b to contain a novel two-stranded right-handed coiled coil with offset helices. Here, the existence of this structure in more complete constructs of b containing the C-terminal domain, and therefore capable of binding to the peripheral F1-ATPase, was supported by the more efficient formation of intersubunit disulfide bonds between cysteine residues that are proximal only in the offset arrangement and by the greater thermal stabilities of crosslinked heterodimers trapped in the offset configuration as opposed to homodimers with the helices trapped in-register. F1-ATPase binding analyses revealed the offset heterodimers to bind F1 more tightly than in-register homodimers. Mutations near the C terminus of b were incorporated specifically into either the N-terminally or the C-terminally shifted polypeptide, bN or bC, respectively, to determine the contribution of each position to F1 binding. Deletion of the last four residues of bN substantially weakened F1 binding, whereas the effect of the deletion in bC was modest. Similarly, benzophenone maleimide introduced at the C terminus of bN, but not bC, mediated cross-linking to the delta subunit of F1. These results imply that the polypeptide in the bN position is more important for F1 binding than the one in the bC position and illustrate the significance of the asymmetry of the b dimer in the enzyme.	Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Dunn, SD (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada.	sdunn@uwo.ca	Dunn, Stanley/D-3418-2013					AGGELER R, 1992, ARCH BIOCHEM BIOPHYS, V296, P685, DOI 10.1016/0003-9861(92)90627-9; Bhatt D, 2005, J BIOENERG BIOMEMBR, V37, P67, DOI 10.1007/s10863-005-4129-7; Briere LAK, 2006, BIOCHEMISTRY-US, V45, P8607, DOI 10.1021/bi0606997; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; Cipriano DJ, 2006, J BIOL CHEM, V281, P12408, DOI 10.1074/jbc.M513368200; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Diez M, 2004, BIOCHEMISTRY-US, V43, P1054, DOI 10.1021/bi0357098; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Dunn S. D., 2004, HDB ATPASES, P311; Dunn SD, 2000, BBA-BIOENERGETICS, V1459, P521, DOI 10.1016/S0005-2728(00)00192-4; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; Dunn SD, 2001, BIOCHEMISTRY-US, V40, P187, DOI 10.1021/bi001821j; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McLachlin DT, 1996, PROTEIN EXPRES PURIF, V7, P275, DOI 10.1006/prep.1996.0039; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; Nakanishi-Matsui M, 2006, IUBMB LIFE, V58, P318, DOI 10.1080/15216540600702255; Penefsky H S, 1979, Methods Enzymol, V56, P527; Peng GH, 2006, FEBS LETT, V580, P5934, DOI 10.1016/j.febslet.2006.09.062; Revington M, 2002, PROTEIN SCI, V11, P1227, DOI 10.1110/ps.3200102; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; TAKEYAMA M, 1988, J BIOL CHEM, V263, P16106; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Weber J, 2004, J BIOL CHEM, V279, P11253, DOI 10.1074/jbc.M312576200; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8	46	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31920	31927		10.1074/jbc.M706259200	http://dx.doi.org/10.1074/jbc.M706259200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766239	hybrid			2022-12-27	WOS:000250480300012
J	Takahashi, S; Yeo, YS; Zhao, YX; O'Maille, PE; Greenhagen, BT; Noel, JP; Coates, RM; Chappell, J				Takahashi, Shunji; Yeo, Yun-Soo; Zhao, Yuxin; O'Maille, Paul E.; Greenhagen, Bryan T.; Noel, Joseph P.; Coates, Robert M.; Chappell, Joe			Functional characterization of premnaspirodiene oxygenase, a cytochrome P450 catalyzing regio- and stereo-specific hydroxylations of diverse sesquiterpene substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUALENE SYNTHETASE; AMINO-ACID; EXPRESSION; BIOSYNTHESIS; CULTURES; ENZYMES; CLONING; CYCLASE; GENE; IDENTIFICATION	Solavetivone, a potent antifungal phytoalexin, is derived from a vetispirane-type sesquiterpene, premnaspirodiene, by a putative regio- and stereo-specific hydroxylation, followed by a second oxidation to yield the alpha, beta-unsaturated ketone. Mechanistically, these reactions could occur via a single, multifunctional cytochrome P450 or some combination of cytochrome P450s and a dehydrogenase. We report here the characterization of a single cytochrome P450 enzyme, Hyoscyamus muticus premnaspirodiene oxygenase (HPO), that catalyzes these successive reactions at carbon 2 (C-2) of the spirane substrate. HPO also catalyzes the equivalent regio- specific (C-2) hydroxylation of several eremophilane-type ( decalin ring system) sesquiterpenes, such as with 5-epi-aristolochene. Moreover, HPO displays interesting comparisons to other sesquiterpene hydroxylases. 5-Epi-aristolochene di-hydroxylase (EAH) differs catalytically from HPO by introducing hydroxyl groups first at C-1, then C-3 of 5-epi-aristolochene. HPO and EAH also differ from one another by 91-amino acid differences, with four of these differences mapping to putative substrate recognition regions 5 and 6. These four positions were mutagenized alone and in various combinations in both HPO and EAH and the mutant enzymes were characterized for changes in substrate selectivity, reaction product specificity, and kinetic properties. These mutations did not alter the regio- or stereo-specificity of either HPO or EAH, but specific combinations of the mutations did improve the catalytic efficiencies 10-15- fold. Molecular models and comparisons between HPO and EAH provide insights into the catalytic properties of these enzymes of specialized metabolism in plants.	Univ Kentucky, Dept Plant & Soil Sci, Plant Biol program, Lexington, KY 40546 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; Salk Institute	Chappell, J (corresponding author), 1405 Vet Dr, Lexington, KY USA.	chappell@uky.edu	Noel, Joseph P/A-9459-2009; Takahashi, Shunji/GLT-3245-2022; Takahashi, Shunji/N-6921-2015	Takahashi, Shunji/0000-0003-1684-9298; Takahashi, Shunji/0000-0003-1684-9298	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM054029, R01 GM013956, GM54029, GM13956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054029, R01GM013956] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AYERS AR, 1976, PLANT PHYSIOL, V57, P760, DOI 10.1104/pp.57.5.760; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Bell SG, 2003, J AM CHEM SOC, V125, P705, DOI 10.1021/ja028460a; Bellucci G, 1996, CHEM RES TOXICOL, V9, P871, DOI 10.1021/tx9600053; BIRNBAUM GI, 1974, CAN J CHEM, V52, P993, DOI 10.1139/v74-159; BUCKINGHAM J, 1994, DICT NATURAL PRODUCT; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; de Kraker JW, 2003, TETRAHEDRON, V59, P409, DOI 10.1016/S0040-4020(02)01479-5; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Engstrom K, 1999, POTATO RES, V42, P43, DOI 10.1007/BF02358390; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; GOTOH O, 1992, J BIOL CHEM, V267, P83; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Greenhagen BT, 2003, ARCH BIOCHEM BIOPHYS, V409, P385, DOI 10.1016/S0003-9861(02)00613-6; Hansen B, 2005, PLANTA, V221, P603, DOI 10.1007/s00425-005-1553-1; He XY, 2004, ARCH BIOCHEM BIOPHYS, V427, P143, DOI 10.1016/j.abb.2004.03.016; Hilser VJ, 1998, P NATL ACAD SCI USA, V95, P9903, DOI 10.1073/pnas.95.17.9903; Kaspera R, 2005, APPL MICROBIOL BIOT, V67, P477, DOI 10.1007/s00253-004-1794-0; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kuroyanagi M, 1998, J NAT PROD, V61, P1516, DOI 10.1021/np980214i; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pan LP, 2004, ARCH BIOCHEM BIOPHYS, V422, P31, DOI 10.1016/j.abb.2003.09.047; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Rising KA, 2000, J AM CHEM SOC, V122, P1861, DOI 10.1021/ja993584h; Sakamaki H, 2005, J MOL CATAL B-ENZYM, V32, P103, DOI 10.1016/j.molcatb.2004.10.004; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; SHAFFER GW, 1975, J ORG CHEM, V40, P2181, DOI 10.1021/jo00903a010; Takahashi S, 2005, J BIOL CHEM, V280, P3686, DOI 10.1074/jbc.M411870200; THRELFALL DR, 1988, PHYTOCHEMISTRY, V27, P2567, DOI 10.1016/0031-9422(88)87028-6; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VOGELI U, 1988, PLANT PHYSIOL, V88, P1291, DOI 10.1104/pp.88.4.1291; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; Weyerstahl P, 2000, FLAVOUR FRAG J, V15, P153, DOI 10.1002/1099-1026(200005/06)15:3&lt;153::AID-FFJ885&gt;3.0.CO;2-5; Yao MK, 2003, MYCORRHIZA, V13, P333, DOI 10.1007/s00572-003-0267-0; Yokose T, 2004, BIOSCI BIOTECH BIOCH, V68, P2640, DOI 10.1271/bbb.68.2640; Zhao YX, 2004, J ORG CHEM, V69, P7428, DOI 10.1021/jo049058c	46	78	97	1	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31744	31754		10.1074/jbc.M703378200	http://dx.doi.org/10.1074/jbc.M703378200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17715131	Green Accepted, hybrid			2022-12-27	WOS:000250309200065
J	Uvarov, P; Ludwig, A; Markkanen, M; Pruunsild, P; Kaila, K; Delpire, E; Timmusk, T; Rivera, C; Airaksinen, MS				Uvarov, Pavel; Ludwig, Anastasia; Markkanen, Marika; Pruunsild, Priit; Kaila, Kai; Delpire, Eric; Timmusk, Tonis; Rivera, Claudio; Airaksinen, Matti S.			A novel N-terminal isoform of the neuron-specific K-Cl cotransporter KCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; GENOME-WIDE ANALYSIS; ALANINE-RICH KINASE; ALTERNATIVE PROMOTERS; UP-REGULATION; RAT-BRAIN; EXPRESSION; GENE; DISRUPTION; PATTERNS	The neuronal K-Cl cotransporter KCC2 maintains the low intracellular chloride concentration required for the hyperpolarizing actions of inhibitory neurotransmitters gamma-aminobutyric acid and glycine in the central nervous system. This study shows that the mammalian KCC2 gene ( alias Slc12a5) generates two neuron-specific isoforms by using alternative promoters and first exons. The novel KCC2a isoform differs from the only previously known KCC2 isoform (now termed KCC2b) by 40 unique N-terminal amino acid residues, including a putative Ste20-related proline alanine-rich kinase-binding site. Ribonuclease protection and quantitative PCR assays indicated that KCC2a contributes 20-50% of total KCC2 mRNA expression in the neonatal mouse brain stem and spinal cord. In contrast to the marked increase in KCC2b mRNA levels in the cortex during postnatal development, the overall expression of KCC2a remains relatively constant and makes up only 5-10% of total KCC2 mRNA in the mature cortex. A rubidium uptake assay in human embryonic kidney 293 cells showed that the KCC2a isoform mediates furosemide-sensitive ion transport activity comparable with that of KCC2b. Mice that lack both KCC2 isoforms die at birth due to severe motor defects, including disrupted respiratory rhythm, whereas mice with a targeted disruption of the first exon of KCC2b survive for up to 2 weeks but eventually die due to spontaneous seizures. We show that these mice lack KCC2b but retain KCC2a mRNA. Thus, distinct populations of neurons show a differential dependence on the expression of the two isoforms: KCC2a expression in the absence of KCC2b is presumably sufficient to support vital neuronal functions in the brain stem and spinal cord but not in the cortex.	Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA	University of Helsinki; University of Helsinki; University of Helsinki; Tallinn University of Technology; Vanderbilt University	Uvarov, P (corresponding author), Univ Helsinki, Ctr Neurosci, Villkinkaari 4, FIN-00014 Helsinki, Finland.	pavel.uvarov@helsinki.fi; matti.airaksinen@helsinki.fi	Kaila, Kai K/R-8528-2016; Rivera, Claudio/ABE-2499-2021; Uvarov, Pavel/AGR-2614-2022; Ludwig, Anastasia/N-1837-2016; Timmusk, Tonis/H-4889-2015	Kaila, Kai K/0000-0003-0668-5955; Rivera, Claudio/0000-0003-2462-6561; Uvarov, Pavel/0000-0001-8439-6150; Ludwig, Anastasia/0000-0003-4849-8074; Pruunsild, Priit/0000-0001-6823-6683; Timmusk, Tonis/0000-0002-1015-3348; Airaksinen, Matti/0000-0002-7199-4984	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Di Fulvio M, 2003, NITRIC OXIDE-BIOL CH, V9, P165, DOI 10.1016/j.niox.2003.11.004; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Karadsheh MF, 2001, J NEUROPHYSIOL, V85, P995, DOI 10.1152/jn.2001.85.2.995; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Le Rouzic P, 2006, BRAIN RES, V1110, P39, DOI 10.1016/j.brainres.2006.06.055; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Uvarov P, 2005, J NEUROCHEM, V95, P1144, DOI 10.1111/j.1471-4159.2005.03434.x; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85	35	100	104	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30570	30576		10.1074/jbc.M705095200	http://dx.doi.org/10.1074/jbc.M705095200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17715129	hybrid			2022-12-27	WOS:000250136300025
J	Yamasaki, S; Stoecklin, G; Kedersha, N; Simarro, M; Anderson, P				Yamasaki, Satoshi; Stoecklin, Georg; Kedersha, Nancy; Simarro, Maria; Anderson, Paul			T-cell intracellular antigen-1 (TIA-1)-induced translational silencing promotes the decay of selected mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BINDING PROTEIN TIAR; CYCLOOXYGENASE-2 EXPRESSION; STRESS GRANULES; IDENTIFICATION; REPRESSION; TRISTETRAPROLIN; MECHANISMS; COMPLEXES; ARTHRITIS	Gene array analysis revealed that a subset of mRNAs overexpressed in macrophages lacking the destabilizing factor TTP are also overexpressed in macrophages lacking the translational silencer TIA-1. We confirmed that a representative transcript, apobec-1, is significantly stabilized in cells lacking TIA-1. Tethering TIA-1 to a reporter transcript also promotes mRNA decay, suggesting that TIA-1- mediated translational silencing can render mRNA susceptible to the decay machinery. TIA-1- mediated decay is inhibited by small interfering RNAs targeting components of either the 5 '-3 ' ( e. g. DCP2) or the 3 '-5 ' ( e. g. exosome component Rrp46) decay pathways, suggesting that TIA-1 renders mRNA susceptible to both major decay pathways. TIA-1 mediated decay is inhibited by cycloheximide and emetine, drugs that stabilize polysomes, but is unaffected by puromycin, a drug that disassembles polysomes. These results suggest that TIA-1-induced polysome disassembly is required for enhanced mRNA decay and that TIA-1-induced translational silencing promotes the decay of selected mRNAs.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; German Canc Res Ctr, D-69120 Heidelberg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ)	Anderson, P (corresponding author), Smith 652,1 Jimmy Fund Way, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu	; Simarro, Maria/M-3947-2015	Stoecklin, Georg/0000-0001-9284-9834; Simarro, Maria/0000-0001-8917-7328	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R56AI033600, R01AI033600] Funding Source: NIH RePORTER; NIAID NIH HHS [AI033600, AI065858] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fechir M, 2005, CELL MOL BIOL, V51, P299, DOI 10.1170/T631; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Le Guiner C, 2003, J BIOL CHEM, V278, P10465, DOI 10.1074/jbc.M212378200; Liu HD, 2005, MOL CELL BIOL, V25, P9764, DOI 10.1128/MCB.25.22.9764-9772.2005; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tong X, 2007, MOL CELL BIOL, V27, P283, DOI 10.1128/MCB.01282-06; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Yang F, 2006, MOL CELL BIOL, V26, P8803, DOI 10.1128/MCB.00090-06; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200	41	58	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30070	30077		10.1074/jbc.M706273200	http://dx.doi.org/10.1074/jbc.M706273200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711853	hybrid			2022-12-27	WOS:000249981200037
J	Shibolet, O; Giallourakis, C; Rosenberg, I; Mueller, T; Xavier, RJ; Podolsky, DK				Shibolet, Oren; Giallourakis, Cosmas; Rosenberg, Ian; Mueller, Tobias; Xavier, Ramnik J.; Podolsky, Daniel K.			AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PROTEIN-KINASE-A; VAV PROTEINS; INVOLVEMENT; RECEPTOR-3; PATHOGENS; RESPONSES	Members of the guanine exchange factor (GEF) family of scaffold proteins are involved in the integration of signal flow downstream of many receptors in adaptive immunity. However, the full complement of GEFs that function downstream of Toll-like receptors (TLRs) requires further identification and functional understanding. By systematically integrating expression profiles from immune and epithelial cells with functional studies, we demonstrate that protein kinase A anchoring protein 13 (AKAP13), a scaffold protein with GEF activity, is an activator of NF-kappa B downstream of TLR2 signaling. Stimulation of the human macrophage cell line THP-1 and epithelial cells with a TLR2 ligand caused a significant up-regulation in AKAP13 mRNA, corresponding to an increase in protein expression. Analysis of TLR2 reporter cell lines deficient in AKAP 13 expression revealed significantly reduced NF-kappa B activation and reduced secretion of interleukin-8 and MCP-1 in response to specific ligand stimulation. Furthermore, NF-kappa B activation was partially inhibited by a GEF-deficient AKAP13 mutant. AKAP13 was also involved in phosphorylation of JNK but not of extracellular signal-regulated kinase ERK1 and -2 following ligand stimulation. Together, our results suggest that AKAP13 plays a role in TLR2-mediated NF-kappa B activation and suggest that GEF-containing scaffold proteins may confer specificity to innate immune responses downstream of TLRs.	Massachusetts Gen Hosp, Gastroenterol Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Podolsky, DK (corresponding author), Massachusetts Gen Hosp, Gastroenterol Unit, Ctr Study Inflammatory Bowel Dis, Jackson Bldg,Rm 719,55 Fruit St, Boston, MA 02114 USA.	dpodolsky@partners.org		Mueller, Tobias/0000-0003-3426-5421	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, R01DK060049] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK060049, P30 DK040561, DK043351, DK060049, P30 DK040561-12] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hebeis B, 2005, BLOOD, V106, P635, DOI 10.1182/blood-2004-10-3919; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Stovall SH, 2004, J BIOL CHEM, V279, P13809, DOI 10.1074/jbc.M311434200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Teusch N, 2004, J IMMUNOL, V173, P507, DOI 10.4049/jimmunol.173.1.507	36	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35308	35317		10.1074/jbc.M704426200	http://dx.doi.org/10.1074/jbc.M704426200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17878165	hybrid			2022-12-27	WOS:000251155200074
J	Daiho, T; Yamasaki, K; Danko, S; Suzuki, H				Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi			Critical role of glu(40)-ser(48) loop linking actuator domain and first transmembrane helix of Ca2+-ATPase in Ca2+ deocclusion and release from ADP-insensitive phosphoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; PHOSPHORYLATED INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE; SKELETAL-MUSCLE; A-DOMAIN; CONFORMATIONAL TRANSITION; TRANSPORT ACTIVITY; KINETIC-PROPERTIES; REACTION-MECHANISM	The functional importance of the length of the A/M1 linker (Glu(40)-Ser(48)) connecting the actuator domain and the first transmembrane helix of sarcoplasmic reticulum Ca2+-ATPase was explored by its elongation with glycine insertion at Pro(42)/Ala(43) and Gly(46)/Lys(47). Two or more glycine insertions at each site completely abolished ATPase activity. The isomerization of phosphoenzyme (EP) intermediate from the ADP-sensitive form (E1P) to the ADP-insensitive form (E2P) was markedly accelerated, but the decay of EP was completely blocked in these mutants. The E2P accumulated was therefore demonstrated to be E2PCa(2) possessing two occluded Ca2+ ions at the transport sites, and the Ca2+ deocclusion and release into lumen were blocked in the mutants. By contrast, the hydrolysis of the Ca2+-free form of E2P produced from Pi without Ca2+ was as rapid in the mutants as in the wild type. Analysis of resistance against trypsin and proteinase K revealed that the structure of E2PCa(2) accumulated is an intermediate state between E1PCa(2) and the Ca2+-released E2P state. Namely in E2PCa(2), the actuator domain is already largely rotated from its position in E1PCa(2) and associated with the phosphorylation domain as in the Ca2+-released E2P state; however, in E2PCa(2), the hydrophobic interactions among these domains and Leu(119)/Tyr(122) on the top of second transmembrane helix are not yet formed properly. This is consistent with our previous finding that these interactions at Tyr(122) are critical for formation of the Ca2+-released E2P structure. Results showed that the EP isomerization/Ca2+-release process consists of the following two steps: E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+); and the intermediate state E2PCa(2) was identified for the first time. Results further indicated that the A/M1 linker with its appropriately short length, probably because of the strain imposed in E2PCa(2), is critical for the correct positioning and interactions of the actuator and phosphorylation domains to cause structural changes for the Ca2+ deocclusion and release.	Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp						Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; FROEHLICH JP, 1985, BIOCHEMISTRY-US, V24, P126, DOI 10.1021/bi00322a018; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INAO S, 1986, BIOCHIM BIOPHYS ACTA, V857, P28, DOI 10.1016/0005-2736(86)90095-7; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1988, METHOD ENZYMOL, V157, P154; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER M, 1986, ADV PINEAL RES, V1, P51; MYUNG J, 1995, BIOCHEMISTRY-US, V34, P3077, DOI 10.1021/bi00009a039; NAKAMURA Y, 1984, J BIOL CHEM, V259, P8183; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; PICK U, 1982, J BIOL CHEM, V257, P6120; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	59	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34429	34447		10.1074/jbc.M707665200	http://dx.doi.org/10.1074/jbc.M707665200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881350	Green Submitted, hybrid			2022-12-27	WOS:000251145700059
J	Sonoda, H; Okada, T; Jahangeer, S; Nakamura, SI				Sonoda, Hirofumi; Okada, Taro; Jahangeer, Saleem; Nakamura, Shun-Ichi			Requirement of phospholipase D for ilimaquinone-induced golgi membrane fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-KINASE-C; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; CELL-SURFACE; ACTIVATION; TRANSPORT; ALPHA; NETWORK	Although organelles such as the endoplasmic reticulum and Golgi apparatus are highly compartmentalized, these organelles are interconnected through a network of vesicular trafficking. The marine sponge metabolite ilimaquinone (IQ) is known to induce Golgi membrane fragmentation and is widely used to study the mechanism of vesicular trafficking. Although IQ treatment causes protein kinase D (PKD) activation, the detailed mechanism of IQ-induced Golgi membrane fragmentation remains unclear. In this work, we found that IQ treatment of cells caused a robust activation of phospholipase D (PLD). In the presence of 1-butanol but not 2-butanol, IQ-induced Golgi membrane fragmentation was completely blocked. In addition, IQ failed to induce Golgi membrane fragmentation in PLD knock-out DT40 cells. Furthermore, IQ-induced PKD activation was completely blocked by treatment with either 1-butanol or propranolol. Notably, IQ-induced Golgi membrane fragmentation was also blocked by propranolol treatment. These results indicate that PLD-catalyzed formation of phosphatidic acid is a prerequisite for IQ-induced Golgi membrane fragmentation and that enzymatic conversion of phosphatidic acid to diacylglycerol is necessary for subsequent activation of PKD and IQ-induced Golgi membrane fragmentation.	Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, SI (corresponding author), Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Biochem, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp	Nakamura, Shun/GVN-8593-2022	Sonoda, Hirofumi/0000-0003-3353-1783				Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; Cremona O, 2001, J CELL SCI, V114, P1041; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kam Y, 2004, BIOCHEM BIOPH RES CO, V315, P139, DOI 10.1016/j.bbrc.2004.01.034; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Nakamura S, 1995, P NATL ACAD SCI USA, V92, P12319, DOI 10.1073/pnas.92.26.12319; Oka M, 2002, BIOCHEM BIOPH RES CO, V294, P1109, DOI 10.1016/S0006-291X(02)00614-9; Oka M, 2003, FEBS LETT, V554, P179, DOI 10.1016/S0014-5793(03)01158-X; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P129, DOI 10.1080/0968768031000084172; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roth MG, 1999, CHEM PHYS LIPIDS, V98, P141, DOI 10.1016/S0009-3084(99)00026-2; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Singer WD, 1996, J BIOL CHEM, V271, P4504; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587	29	30	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34085	34092		10.1074/jbc.M705593200	http://dx.doi.org/10.1074/jbc.M705593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897952	hybrid			2022-12-27	WOS:000251145700023
J	Johnson, LA; Prevo, R; Clasper, S; Jackson, DG				Johnson, Louise A.; Prevo, Remko; Clasper, Steven; Jackson, David G.			Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN LIGAND; MAJOR E-SELECTIN; BINDING PROTEINS; GENE-EXPRESSION; DENDRITIC CELLS; TNF-ALPHA; CD44; LYMPHANGIOGENESIS; CANCER	The hyaluronan receptor LYVE-1 is selectively expressed in the endothelium of lymphatic capillaries, where it has been proposed to function in hyaluronan clearance and hyaluronan-mediated leukocyte adhesion. However, recent studies suggest that hyaluronan homeostasis is unperturbed in LYVE-1(-/-) mice and that lymphatic adhesion/transmigration may be largely mediated by ICAM-1 and VCAM-1 rather than LYVE-1. Here we have explored the possibility that LYVE-1 functions during inflammation and report that the receptor is down-regulated by pro-inflammatory cytokines. Using cultured primary lymphatic endothelial cells, we show that surface expression of LYVE-1 is rapidly and reversibly lost after exposure to tumor necrosis factor-alpha( TNF alpha) and TNF beta via internalization and degradation of the receptor in lysosomes, coupled with a shutdown in gene expression. Curiously, internalization does not result in significant uptake of hyaluronan, a process that is largely insensitive to the novel LYVE-1 adhesion blocking monoclonal antibody 3A, and proceeds almost equally in resting and inflammation-activated lymphatic endothelial cells. Finally, we show that TNF can induce down-modulation of LYVE-1 in ex vivo murine dermal tissue explants and present evidence that the process occurs in vivo, in the context of murine allergen-induced skin inflammation. These findings suggest that LYVE-1 can function independently of hyaluronan and have implications for the use of LYVE-1 as a histological marker for lymphangiogenesis in human pathology.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	djackson@hammer.imm.ox.ac.uk		, david/0000-0002-4133-9364; Johnson, Louise/0000-0001-6667-8912	MRC [MC_U137884182] Funding Source: UKRI; Medical Research Council [MC_U137884182, G0801186] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; FAULKNER CB, 1995, INFECT IMMUN, V63, P4084, DOI 10.1128/IAI.63.10.4084-4090.1995; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; JACKSON DG, 2004, GLYCOFORUM; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Levesque MC, 1999, CELL IMMUNOL, V193, P209, DOI 10.1006/cimm.1999.1456; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Meyer K, 1934, J BIOL CHEM, V107, P629; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; Mummert DI, 2004, J INVEST DERMATOL, V122, P846, DOI 10.1046/j.0022-202X.2004.22127.x; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; NIGHTINGALE T, 2005, HYALURONAN STRUCTURE, V2, P615; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pullinger BD, 1937, J PATHOL BACTERIOL, V45, P157, DOI 10.1002/path.1700450115; Rubbia-Brandt L, 2004, CLIN CANCER RES, V10, P6919, DOI 10.1158/1078-0432.CCR-04-0397; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van Trappen PO, 2001, GYNECOL ONCOL, V82, P1, DOI 10.1006/gyno.2001.6292; VANDERAUWERA I, 2006, BE J CANC, P1; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200; West D. C., 1989, CIBA F SYMP, V143, P201; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	59	112	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33671	10.1074/jbc.M702889200	http://dx.doi.org/10.1074/jbc.M702889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884820	hybrid			2022-12-27	WOS:000250840200048
J	Nikolic, DM; Gong, MC; Turk, J; Post, SR				Nikolic, Dejan M.; Gong, Ming C.; Turk, John; Post, Steven R.			Class a scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A(2) and 12/15-lipoxygenase to rac and Cdc42 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID LIBERATION; PROTEIN-KINASE; ACTIN POLYMERIZATION; LIPID-PEROXIDATION; PROSTAGLANDIN E-2; MONOCYTE ADHESION; PANCREATIC-ISLETS; MESSENGER-RNA; EXPRESS GROUP; NITRIC-OXIDE	Class A scavenger receptors (SR-A) participate in multiple macrophage functions including adhesion to modified extracellular matrix proteins present in various inflammatory disorders such as atherosclerosis and diabetes. By mediating macrophage adhesion to modified proteins and increasing macrophage retention, SR-A may contribute to the inflammatory process. Eicosanoids produced after phospholipase A(2) (PLA2)-catalyzed release of arachidonic acid (AA) are important regulators of macrophage function and inflammatory responses. The potential roles of AA release and metabolism in SR-A-mediated macrophage adhesion were determined using macrophages adherent to modified protein. SR-A-dependent macrophage adhesion was abolished by selectively inhibiting calcium-independent PLA2 (iPLA(2)) activity and absent in macrophages isolated from iPLA(2)beta(-/-) mice. Our results further demonstrate that 12/15lipoxygenase (12/15-LOX)-derived, but not cyclooxygenase- or cytochrome P450-dependent epoxygenase-derived AA metabolites, are specifically required for SR-A-dependent adhesion. Because of their role in regulating actin polymerization and cell adhesion, Rac and Cdc42 activation were also examined and shown to be increased via an iPLA(2)- and LOX-dependent pathway. Together, our results identify a novel role for iPLA(2)-catalyzed AA release and its metabolism by 12/15-LOX in coupling SR-A-mediated macrophage adhesion to Rac and Cdc42 activation.	Univ Kentucky, Dept Mol & Biomed Pharmacol, UK Med Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Post, SR (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, UK Med Ctr, MS305, Lexington, KY 40536 USA.	spost@uky.edu		Post, Steven/0000-0002-4711-1723	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR00954, P41 RR000954-30, P41 RR000954] Funding Source: Medline; NHLBI NIH HHS [HL075241, R01 HL075241] Funding Source: Medline; NIDDK NIH HHS [P60 DK020579, P60 DK020579-269005, P30 DK056341-06, R37-DK34388, R37 DK034388-23, R37 DK034388, P60-DK20579, P30-DK56341, P30 DK056341-069003, P30 DK056341, P30 DK056341-07] Funding Source: Medline; NIGMS NIH HHS [P41 GM103422] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiba S, 2002, BIOCHEM PHARMACOL, V63, P1969, DOI 10.1016/S0006-2952(02)00988-7; Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Chinnici CM, 2005, AM J PATHOL, V167, P1371, DOI 10.1016/S0002-9440(10)61224-2; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Daugherty A, 2001, J LIPID RES, V42, P1049; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; ELKHOURY J, 1994, J BIOL CHEM, V269, P10197; ElKhoury J, 1996, NATURE, V382, P716; Fleming I, 2007, PROSTAG OTH LIPID M, V82, P60, DOI 10.1016/j.prostaglandins.2006.05.003; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; Fukuhara-Takaki K, 2005, J BIOL CHEM, V280, P3355, DOI 10.1074/jbc.M408715200; Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HILTUNEN T, 1995, CIRCULATION, V92, P3297, DOI 10.1161/01.CIR.92.11.3297; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Horiuchi S, 2005, ANN NY ACAD SCI, V1043, P671, DOI 10.1196/annals.1333.076; Hsu HY, 1998, J BIOL CHEM, V273, P1240, DOI 10.1074/jbc.273.2.1240; Huber J, 2006, J LIPID RES, V47, P1054, DOI 10.1194/jlr.M500555-JLR200; Jacobson DA, 2007, J BIOL CHEM, V282, P7442, DOI 10.1074/jbc.M607858200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kirkham PA, 2003, FREE RADICAL BIO MED, V35, P697, DOI 10.1016/S0891-5849(03)00390-3; LEFKOWITH JB, 1992, J IMMUNOL, V149, P1729; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Miki S, 1996, FEBS LETT, V399, P241, DOI 10.1016/S0014-5793(96)01332-4; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nikolic DM, 2007, AM J PHYSIOL-CELL PH, V292, pC1450, DOI 10.1152/ajpcell.00401.2006; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; PETERSGOLDEN M, 1993, AM J PHYSIOL-LUNG C, V264, P438; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pollaud-Cherion C, 1998, EUR J BIOCHEM, V253, P345, DOI 10.1046/j.1432-1327.1998.2530345.x; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; ROSOLOWSKY M, 1993, AM J PHYSIOL, V264, pH327, DOI 10.1152/ajpheart.1993.264.2.H327; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Santiago-Garcia J, 2001, J BIOL CHEM, V276, P30655, DOI 10.1074/jbc.M102879200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Teslenko V, 1997, BBA-LIPID LIPID MET, V1344, P189, DOI 10.1016/S0005-2760(96)00137-3; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; van Velzen AG, 1999, EXP CELL RES, V250, P264, DOI 10.1006/excr.1999.4530; Whitman SC, 2000, J LIPID RES, V41, P807; Woo CH, 2000, BIOCHEM BIOPH RES CO, V268, P231, DOI 10.1006/bbrc.2000.2102; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yamada M, 1997, J PHARMACOL EXP THER, V281, P1005; Zamir E, 2001, J CELL SCI, V114, P3583; Zamora R, 1998, EUR J PHARMACOL, V349, P307, DOI 10.1016/S0014-2999(98)00211-8	81	36	36	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33405	33411		10.1074/jbc.M704133200	http://dx.doi.org/10.1074/jbc.M704133200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873277	hybrid, Green Accepted			2022-12-27	WOS:000250840200020
J	Jiang, XN; Borgesi, RA; McKnight, NC; Kaur, R; Carpenter, CL; Balk, SP				Jiang, Xinnong; Borgesi, Robert A.; McKnight, Nicole C.; Kaur, Ramneet; Carpenter, Christopher L.; Balk, Steven P.			Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAIN; FOCAL ADHESION KINASE; TEC FAMILY; INTRAEPITHELIAL NEOPLASIA; ANDROGEN RECEPTOR; CELL-MIGRATION; PH-DOMAIN; ETK/BMX; BMX; BTK	Pathways activated downstream of constitutively active phosphatidylinositol ( PI) 3- kinase in PTEN- deficient prostate cancer ( PCa) cells are possible therapeutic targets. We found that the nonreceptor Tec family tyrosine kinase Bmx/ Etk was activated by tyrosine phosphorylation downstream of Src and PI 3- kinase in PTEN- deficient LNCaP and PC3 PCa cells and that Bmx down- regulation by short interfering RNA markedly inhibited LNCaP cell growth. Bmx also associated with ErbB3 in LNCaP cells, and heregulin-beta 1 enhanced this interaction and further stimulated Bmx activity. Epidermal growth factor ( EGF) similarly stimulated an interaction between Bmx and EGF receptor and rapidly increased Bmx kinase activity. Bmx stimulation in response to heregulin-beta 1 and EGF was Src- dependent, and heregulin-beta 1 stimulation of Bmx was also PI 3-kinase-dependent. In contrast, the rapid tyrosine phosphorylation and activation of Bmx in response to EGF was PI3-kinase-independent. Taken together, these results demonstrate that Bmx is a critical downstream target of the constitutively active PI 3- kinase in PTEN- deficient PCa cells and further show that Bmx is recruited by the EGF receptor and ErbB3 and activated in response to their respective ligands. Therefore, Bmx may be a valuable therapeutic target in PCa and other epithelial malignancies in which PI 3- kinase or EGF receptor family pathways are activated.	Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Canc Biol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Balk, SP (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Canc Biol Program, HIM Bldg,Rm 1050,330 Brookline Ave, Boston, MA 02115 USA.	sbalk@bidmc.harvard.edu		McKnight, Nicole/0000-0003-4269-3960				Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Chau CH, 2002, ONCOGENE, V21, P8817, DOI 10.1038/sj.onc.1206032; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Deocampo N D, 2003, Minerva Endocrinol, V28, P145; Ekman N, 2000, ONCOGENE, V19, P4151, DOI 10.1038/sj.onc.1203763; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Rajantie I, 2001, MOL CELL BIOL, V21, P4647, DOI 10.1128/MCB.21.14.4647-4655.2001; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Saharinen P, 1997, BLOOD, V90, P4341; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Stoletov KV, 2004, BIOCHEM BIOPH RES CO, V320, P70, DOI 10.1016/j.bbrc.2004.05.134; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Vargas L, 2002, J BIOL CHEM, V277, P9351, DOI 10.1074/jbc.M108537200; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200	45	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32689	32698		10.1074/jbc.M703412200	http://dx.doi.org/10.1074/jbc.M703412200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823122	hybrid			2022-12-27	WOS:000250625400017
J	Dreux, M; Boson, B; Ricard-Blum, S; Molle, J; Lavillette, D; Bartosch, B; Pecheur, EI; Cosset, FL				Dreux, Marlene; Boson, Bertrand; Ricard-Blum, Sylvie; Molle, Jennifer; Lavillette, Dimitri; Bartosch, Birke; Pecheur, Eve-Isabelle; Cosset, Francois-Loic			The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HIGH-DENSITY-LIPOPROTEINS; B TYPE-I; RECEPTOR CLASS-B; CELL-SURFACE EXPRESSION; HYPERVARIABLE REGION 1; SCAVENGER-RECEPTOR; VERY-LOW; A-I; VIRAL-INFECTION; NEUTRALIZING ANTIBODIES	Cell entry of hepatitis C virus (HCV) is strikingly linked to lipoproteins and their receptors. Particularly, high density lipoprotein (HDL) enhances infectivity of HCV by involving the lipid-transfer function of the scavenger receptor BI, a receptor for both HDL and HCV. Here, we demonstrate that apoC-I, an exchangeable apolipoprotein that predominantly resides in HDL, specifically enhances HCVcc and HCVpp infectivity and increases the fusion rates between viral and target membranes via a direct interaction with the HCV surface. We identify the hypervariable region 1, located at the N terminus of the HCV E2 glycoprotein, as an essential viral component that modulates apoC-I-mediated enhancement of HCV fusion properties. The affinity of apoC-I for the HCV membrane may predispose it for fusion with a target membrane via alterations of its outer phospholipid layer. Conversely, we found that excess apoC-I provided as lipoprotein-free protein induces the disruption of the HCV membrane and subsequent loss of infectivity. Furthermore, our data indicate that HDL neither interacts nor spontaneously exchanges apoC-I with HCV virions. Because apoC-I is not present in serum as a lipoprotein-free form, our results suggest that HDL-embedded apoC-I could be released from the lipoprotein particle through a fine-tuned mechanism regulated via a triple interplay between hypervariable region 1, HDL, and scavenger receptor BI, resulting in optimal apoC-I recruitment on the viral membrane. These results provide the first description of a host serum factor helping the fusion process of an enveloped virus.	Univ Lyon, UCB Lyon 1, INSERM, IFR128,U758, F-69007 Lyon, France; Ecole Normale Super Lyon, F-69007 Lyon, France; CNRS UCB, IBCP, UMR5086, F-69007 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Cosset, FL (corresponding author), ENS Lyon, 46 Allee Italie, F-69007 Lyon, France.	flcosset@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Bartosch, Birke/I-7255-2018; Dreux, Marlene/M-7295-2014	Cosset, François-Loïc/0000-0001-8842-3726; Bartosch, Birke/0000-0001-6354-4660; Dreux, Marlene/0000-0002-6607-4796; RICARD-BLUM, Sylvie/0000-0001-9263-1851; Boson, Bertrand/0000-0003-1920-5172; Pecheur, Eve/0000-0002-8613-862X; Lavillette, Dimitri/0000-0002-4706-1519				Agnello V, 1997, ARTHRITIS RHEUM, V40, P2007, DOI 10.1002/art.1780401113; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; ASZTALOS BF, 1995, ARTERIOSCL THROM VAS, V15, P1419, DOI 10.1161/01.ATV.15.9.1419; Barter PJ, 1996, CURR OPIN LIPIDOL, V7, P82, DOI 10.1097/00041433-199604000-00006; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Barth H, 2006, HEPATOLOGY, V44, P527, DOI 10.1002/hep.21321; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benjwal S, 2005, BIOCHEMISTRY-US, V44, P10218, DOI 10.1021/bi050781m; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; CLAY MA, 1991, ARTERIOSCLER THROMB, V11, P415, DOI 10.1161/01.ATV.11.2.415; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cohn JS, 2002, J LIPID RES, V43, P1680, DOI 10.1194/jlr.M200055-JLR200; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dreux M, 2006, HEPATOLOGY, V43, P903, DOI 10.1002/hep.21202; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gursky O, 2002, BIOCHEMISTRY-US, V41, P7373, DOI 10.1021/bi025588w; Gursky O, 2001, BIOCHEMISTRY-US, V40, P12178, DOI 10.1021/bi0111505; Heo TH, 2006, VIRUS RES, V121, P58, DOI 10.1016/j.virusres.2006.04.002; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; JACKSON RL, 1974, J BIOL CHEM, V249, P5314; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2001, J VIROL, V75, P3685, DOI 10.1128/JVI.75.8.3685-3695.2001; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; LIANG HQ, 1994, J LIPID RES, V35, P1187; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MALMENDIER CL, 1986, ATHEROSCLEROSIS, V62, P167, DOI 10.1016/0021-9150(86)90063-8; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mehta R, 2003, BIOCHEMISTRY-US, V42, P4751, DOI 10.1021/bi0341253; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; MOLINA S, 2007, H HEPATOL, V46, P411; Monazahian M, 2000, MED MICROBIOL IMMUN, V188, P177, DOI 10.1007/s004300000032; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nieland TJF, 2004, J LIPID RES, V45, P1256, DOI 10.1194/jlr.M300358-JLR200; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oram JF, 1996, J LIPID RES, V37, P2473; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SEGREST JP, 1992, J LIPID RES, V33, P141; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Shimizu YK, 1996, VIROLOGY, V223, P409, DOI 10.1006/viro.1996.0497; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; Taylor GM, 1999, MOL BIOL CELL, V10, P2803, DOI 10.1091/mbc.10.9.2803; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Webb NR, 2002, J LIPID RES, V43, P1890, DOI 10.1194/jlr.M200173-JLR200; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	102	75	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32357	32369		10.1074/jbc.M705358200	http://dx.doi.org/10.1074/jbc.M705358200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761674	hybrid			2022-12-27	WOS:000250480300059
J	Ma, LH; Takanishi, CL; Wood, MJ				Ma, Li-Hua; Takanishi, Christina L.; Wood, Matthew J.			Molecular mechanism of oxidative stress perception by the Orp1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYR TRANSCRIPTION FACTOR; DISULFIDE BOND FORMATION; CYSTEINE-SULFENIC ACID; REDOX REGULATION; GLUTATHIONE PEROXIDASES; CHEMICAL CARCINOGENESIS; STRUCTURAL BASIS; YEAST; DAMAGE; YAP1	In this study we investigated the molecular mechanism by which the Orp1 (Gpx3) protein in Saccharomyces cerevisiae senses and reacts with hydrogen peroxide. Upon exposure to H2O2 Orp1(Cys36) forms a disulfide-bonded complex with the C-terminal domain of the Yap1 protein (Yap1-cCRD). We used 4-nitrobenzo-2-oxa-1,3-diazole to identify a cysteine sulfenic acid (Cys-SOH) modification that forms on Cys(36) of Orp1(Cys36) upon exposure to H2O2. Under similar conditions, neither Cys(82) of Orp1(Cys82) nor Cys(598) of Yap1 forms Cys-SOH. A homology-based molecular model of Orp1 suggests that the structure of the active site of Orp1 is similar to that found in mammalian selenocysteine glutathione peroxidases. Proposed active site residues Gln(70) and Trp(125) form a catalytic triad with Cys36 in the Orp1 molecular model. The remainder of the active site pocket is formed by Phe(38), Asn(126), and Phe(127), which are evolutionarily conserved residues. We made Q70A and W125A mutants and tested the ability of these mutants to form Cys-SOH in response to H2O2. Both mutants were unable to form Cys-SOH and did not form a H2O2-inducible disulfide-bonded complex with Yap1-cCRD. The pK(a) of Cys(36) was determined to be 5.1, which is 3.2 pH units lower than that of a free cysteine (8.3). In contrast, Orp1 Cys(82) (the resolving cysteine) has a pKa value of 8.3. The pKa of Cys(36) in the Q70A and W125A mutants is also 8.3, demonstrating the importance of these residues in modulating the nucleophilic character of Cys(36). Finally, we show that S. cerevisiae strains with ORP1 Q70A and W125A mutations are less tolerant to H2O2 than those containing wild-type ORP1. The results of our study suggest that attempts to identify novel redox-regulated proteins and signal transduction pathways should focus on characterization of low pKa cysteines.	Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Wood, MJ (corresponding author), Univ Calif Davis, Dept Environm Toxicol, One Shields Ave, Davis, CA 95616 USA.	mjwood@ucdavis.edu	Wood, Matthew/HDN-1469-2022					Avery AM, 2004, J BIOL CHEM, V279, P46652, DOI 10.1074/jbc.M408340200; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Flohe L., 1989, GLUTATHIONE CHEM BIO, P643; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gladysheva T, 1996, J BIOL CHEM, V271, P33256, DOI 10.1074/jbc.271.52.33256; Hampton MB, 2006, REDOX PROTEOMICS, P253; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; OESTERHELT D, 1977, EUR J BIOCHEM, V79, P173, DOI 10.1111/j.1432-1033.1977.tb11795.x; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; SLUYTERMAN LA, 1967, BIOCHIM BIOPHYS ACTA, V139, P439, DOI 10.1016/0005-2744(67)90047-2; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; TRUSH MA, 1991, FREE RADICAL BIO MED, V10, P201, DOI 10.1016/0891-5849(91)90077-G; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; WEMMIE A, 1994, J BIOL CHEM, V269, P14690; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	50	67	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31429	31436		10.1074/jbc.M705953200	http://dx.doi.org/10.1074/jbc.M705953200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17720812	hybrid			2022-12-27	WOS:000250309200033
J	Nagy, T; Wei, HJ; Shen, TL; Peng, X; Liang, CC; Gan, B; Guan, JL				Nagy, Tamas; Wei, Huijun; Shen, Tang-Long; Peng, Xu; Liang, Chun-Chi; Gan, Boyi; Guan, Jun-Lin			Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; FAK; REVEALS; PHOSPHORYLATION; BETA-1-INTEGRIN; DIFFERENTIATION; ACTIVATION; D1; PROLIFERATION; DISRUPTION	Integrin-mediated cell adhesion and signaling is required for mammary gland development and functions. As a major mediator of integrin signaling, focal adhesion kinase (FAK) has been implicated to play a role in the survival, proliferation, and differentiation of mammary epithelial cells in previously studies in vitro. To assess the role of FAK in vivo, we created mice in which FAK is selectively deleted in mammary epithelial cells. The mammary gland FAK conditional knock-out (MFCKO) mice are viable, fertile, and macroscopically indistinguishable from the control littermates. In virgin MFCKO mice, mammary ductal elongation is retarded at 5 weeks of age but reaches the full extent by 8 weeks of age compared with the control mice. However, the MFCKO females are unable to nurse their pups due to severe lobulo-alveolar hypoplasia and secretory immaturity during pregnancy and lactation. Analysis of the mammary epithelial cells in MFCKO mice showed reduced Erk phosphorylation, expression of cyclin D1, and a corresponding decrease in proliferative capability compared with the littermate controls. In addition, phosphorylation of STAT5 and expression of whey acidic protein are significantly reduced in the mammary glands of MFCKO mice, suggesting defective secretory maturation in these mice. Therefore, the combination of the severe lobulo-alveolar hypoplasia and defective secretory differentiation is responsible for the inability of the MFCKO females to nurse their pups. Together, these results provide strong support for a role of FAK in the mammary gland development and function in vivo.	Univ Michigan, Sch Med, Div Med & Mol Genet, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Univ Michigan, Sch Med, Div Med & Mol Genet, Dept Internal Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Cornell University; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Div Med & Mol Genet, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Liang, Chun-Chi/D-7986-2016; Gan, Boyi/HDM-4206-2022; Shen, Tang-Long/C-7460-2011; Liang, Richard Chun-Chi/C-6989-2013	Liang, Chun-Chi/0000-0002-8345-8564; Shen, Tang-Long/0000-0001-6264-3608	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048050] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48050] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbi S, 2002, HISTOL HISTOPATHOL, V17, P1163, DOI 10.14670/HH-17.1163; Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; COX BD, 2003, J CELL BIOCHEM, V99, P35; Daniel C. W., 1987, The mammary gland. Development, regulation, and function., P3; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fantl V, 1999, DEV BIOL, V212, P1, DOI 10.1006/dbio.1999.9329; Faraldo MM, 2005, J MAMMARY GLAND BIOL, V10, P211, DOI 10.1007/s10911-005-9582-8; Faraldo MM, 2002, MOL BIOL CELL, V13, P3521, DOI 10.1091/mbc.E02-02-0086; FURUTA Y, 1995, ONCOGENE, V11, P1989; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; ILLC D, 1995, NATURE, V377, P539; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	37	59	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31766	31776		10.1074/jbc.M705403200	http://dx.doi.org/10.1074/jbc.M705403200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17716968	Green Published, hybrid			2022-12-27	WOS:000250309200067
J	Baker, LMS; Baker, PRS; Golin-Bisello, F; Schopfer, FJ; Fink, M; Woodcock, SR; Branchaud, BP; Radi, R; Freeman, BA				Baker, Laura M. S.; Baker, Paul R. S.; Golin-Bisello, Franca; Schopfer, Francisco J.; Fink, Mitchell; Woodcock, Steven R.; Branchaud, Bruce P.; Radi, Rafael; Freeman, Bruce A.			Nitro-fatty acid reaction with glutathione and cysteine - Kinetic analysis of thiol alkylation by a Michael addition reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; NITROLINOLEIC ACID; KAPPA-B; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; ANTIINFLAMMATORY PROPERTIES; STRUCTURAL-CHARACTERIZATION; COVALENT MODIFICATION; NITRATION PRODUCTS; LIPID OXIDATION	Fatty acid nitration by nitric oxide-derived species yields electrophilic products that adduct protein thiols, inducing changes in protein function and distribution. Nitro-fatty acid adducts of protein and reduced glutathione (GSH) are detected in healthy human blood. Kinetic and mass spectrometric analyses reveal that nitroalkene derivatives of oleic acid (OA-NO2) and linoleic acid (LNO2) rapidly react with GSH and Cys via Michael addition reaction. Rates of OA-NO2 and LNO2 reaction with GSH, determined via stopped flow spectrophotometry, displayed second-order rate constants of 183 M-1 s(-1) and 355 M(-1)s(-1), respectively, at pH 7.4 and 37 degrees C. These reaction rates are significantly greater than those for GSH reaction with hydrogen peroxide and non-nitrated electrophilic fatty acids including 8-iso-prostaglandin A(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2). Increasing reaction pH from 7.4 to 8.9 enhanced apparent second-order rate constants for the thiol reaction with OA-NO2 and LNO2, showing dependence on the thiolate anion of GSH for reactivity. Rates of nitroalkene reaction with thiols decreased as the pK(a) of target thiols increased. Increasing concentrations of the detergent octyl-beta-D-glucopyranoside decreased rates of nitroalkene reaction with GSH, indicating that the organization of nitro-fatty acids into micellar or membrane structures can limit Michael reactivity with more polar nucleophilic targets. In aggregate, these results reveal that the reversible adduction of thiols by nitro-fatty acids is a mechanism for reversible post-translational regulation of protein function by nitro-fatty acids.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oregon; Universidad de la Republica, Uruguay	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol, Thomas E Starzl Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco Jose/AAE-8125-2020; Schopfer, Francisco/AAW-6505-2021; Woodcock, Steven/AAE-9199-2020; Freeman, Bruce A/H-9342-2012	Schopfer, Francisco Jose/0000-0001-9526-695X; 	NHLBI NIH HHS [R01 HL064937, HL64937, R01 HL058115, R01 HL058115-10, HL58115, R01 HL064937-07, R37 HL058115] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL064937, R01HL058115] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BERNASCONI CF, 1988, J AM CHEM SOC, V110, P7506, DOI 10.1021/ja00230a038; Bogaards JJP, 1997, CHEM RES TOXICOL, V10, P310, DOI 10.1021/tx9601770; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; d'Ischia M, 1999, TETRAHEDRON, V55, P9297, DOI 10.1016/S0040-4020(99)00491-3; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Fink MP, 2003, CRIT CARE MED, V31, P2400, DOI 10.1097/01.CCM.0000084860.49412.10; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gong PF, 2002, ANTIOXID REDOX SIGN, V4, P249, DOI 10.1089/152308602753666307; Gorczynski MJ, 2006, ORG LETT, V8, P2305, DOI 10.1021/ol060548w; Han D, 2005, BIOCHEMISTRY-US, V44, P11986, DOI 10.1021/bi0509393; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; LoPachin RM, 2006, TOXICOL SCI, V94, P240, DOI 10.1093/toxsci/kfl066; Lowry T. H., 1987, MECH THEORY ORGANIC; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Napolitano A, 2002, TETRAHEDRON, V58, P5061, DOI 10.1016/S0040-4020(02)00460-X; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; PEARSON RG, 1968, J AM CHEM SOC, V90, P319, DOI 10.1021/ja01004a021; Phan TB, 2006, ANGEW CHEM INT EDIT, V45, P3869, DOI 10.1002/anie.200600542; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; RADI R, 1991, J BIOL CHEM, V266, P4244; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sappington PL, 2005, BIOCHEM PHARMACOL, V70, P1579, DOI 10.1016/j.bcp.2005.08.015; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Song MC, 2004, J PHARMACOL EXP THER, V308, P307, DOI 10.1124/jpet.103.056622; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	61	153	163	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31085	31093		10.1074/jbc.M704085200	http://dx.doi.org/10.1074/jbc.M704085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720974	Green Accepted, hybrid			2022-12-27	WOS:000250136300076
J	Gonzalez, MI; Krizman-Genda, E; Robinson, MB				Gonzalez, Marco I.; Krizman-Genda, Elizabeth; Robinson, Michael B.			Caveolin-1 regulates the delivery and endocytosis of the glutamate transporter, excitatory amino acid carrier 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-SURFACE EXPRESSION; LONG-TERM POTENTIATION; LIPID RAFTS; PLASMA-MEMBRANE; VESICLE FUSION; GROWTH-FACTOR; ENDOPLASMIC-RETICULUM; SNARE PROTEINS; GLT-1 SUBTYPE	The sodium- dependent glutamate transporter, excitatory amino acid carrier 1 ( EAAC1), has been implicated in the regulation of excitatory signaling and prevention of cell death in the nervous system. There is evidence that EAAC1 constitutively cycles on and off the plasma membrane and that under steady state conditions up to 80% of the transporter is intracellular. As is observed with other neurotransmitter transporters, the activity of EAAC1 is regulated by a variety of molecules, and some of these effects are associated with redistribution ofEAAC1on and off the plasma membrane. In the present study we tested the hypothesis that a structural component of lipid rafts, caveolin- 1 ( Cav- 1), may participate in EAAC1 trafficking. Using C6 glioma cells as a model system, co- expression of Cav- 1 S80E ( a dominant negative variant) or small interfering RNA- mediated knock- down of caveolin- 1 reduced cell surface expression of myc epitope- tagged EAAC1 or endogenous EAAC1, respectively. Cav- 1 S80E slowed the constitutive delivery and endocytosis of myc- EAAC1. In primary cultures derived from caveolin-1 knock- out mice, a similar reduction in delivery and internalization of endogenous EAAC1 was observed. We also found that caveolin- 1, caveolin- 2, or Cav- 1 S80E formed immuno-precipitable complexes with EAAC1 in C6 glioma and/ or transfected HEK cells. Together, these data provide strong evidence that caveolin- 1 contributes to the trafficking of EAAC1 on and off the plasma membrane and that these effects are associated with formation of EAAC1- caveolin complexes.	Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Robinson, MB (corresponding author), 502N Abramson Pediat Res Bldg,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Robinson@pharm.med.upenn.edu			NINDS NIH HHS [NS39011] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039011] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; BECKMAN ML, 2005, 35 ANN M SOC NEUR WA; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Cha SH, 2004, IUBMB LIFE, V56, P621, DOI 10.1080/15216540400020353; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fournier KM, 2006, NEUROCHEM INT, V48, P596, DOI 10.1016/j.neuint.2005.12.030; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; GONZALEZ MI, 2004, 34 ANN M SOC NEUR SA; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He Y, 2000, J COMP NEUROL, V418, P255; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kinoshita N, 2004, GENES CELLS, V9, P1, DOI 10.1111/j.1356-9597.2004.00696.x; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Marchand S, 2002, J NEUROSCI, V22, P8891; Marie H, 2002, MOL CELL NEUROSCI, V19, P152, DOI 10.1006/mcne.2001.1066; Miller BT, 1997, PEPTIDES, V18, P1585, DOI 10.1016/S0196-9781(97)00225-8; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Morpurgo M, 1999, J BIOCHEM BIOPH METH, V38, P17, DOI 10.1016/S0165-022X(98)00027-X; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Najimi M, 2002, FEBS LETT, V523, P224, DOI 10.1016/S0014-5793(02)02981-2; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pita-Almenar JD, 2006, J NEUROSCI, V26, P10461, DOI 10.1523/JNEUROSCI.2579-06.2006; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Schniepp R, 2004, INVEST OPHTH VIS SCI, V45, P1442, DOI 10.1167/iovs.03-0062; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Sheldon AL, 2006, J BIOL CHEM, V281, P4876, DOI 10.1074/jbc.M504983200; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Xue MS, 2002, P NATL ACAD SCI USA, V99, P13359, DOI 10.1073/pnas.232565999; Yu YX, 2006, J CELL SCI, V119, P3776, DOI 10.1242/jcs.03151; Zhu Y, 2005, J NEUROSCI RES, V79, P503, DOI 10.1002/jnr.20385	70	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29855	29865		10.1074/jbc.M704738200	http://dx.doi.org/10.1074/jbc.M704738200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715130	hybrid			2022-12-27	WOS:000249981200014
J	Nilsson, MB; Armaiz-Pena, G; Takahashi, R; Lin, YG; Trevino, J; Li, Y; Jennings, N; Arevalo, J; Lutgendorf, SK; Gallick, GE; Sanguino, AM; Lopez-Berestein, G; Cole, SW; Sood, AK				Nilsson, Monique B.; Armaiz-Pena, Guillermo; Takahashi, Rie; Lin, Yvonne G.; Trevino, Jose; Li, Yang; Jennings, Nicholas; Arevalo, Jesusa; Lutgendorf, Susan K.; Gallick, Gary E.; Sanguino, Angela M.; Lopez-Berestein, Gabriel; Cole, Steven W.; Sood, Anil K.			Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERFERING RNA DELIVERY; HUMAN LUNG FIBROBLASTS; TYROSINE KINASE; GENE-EXPRESSION; FAMILY KINASES; SOCIAL SUPPORT; CANCER CELLS; TUMOR-GROWTH; NOREPINEPHRINE	Recent studies have demonstrated that chronic stress promotes tumor growth, angiogenesis, and metastasis. In ovarian cancer, levels of the pro- angiogenic cytokine, interleukin 6 ( IL6), are known to be elevated in individuals experiencing chronic stress, but the mechanism( s) by which this cytokine is regulated and its role in tumor growth remain under investigation. Here we show that stress hormones such as norepinephrine lead to increased expression of IL- 6mRNAand protein levels in ovarian carcinoma cells. Furthermore, we demonstrate that norepinephrine stimulation activates Src tyrosine kinase and this activation is required for increased IL- 6 expression. These results demonstrate that stress hormones activate signaling pathways known to be critical in ovarian tumor progression.	Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52241 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa	Sood, AK (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, 1515 Herman Pressler,Unit 1362, Houston, TX 77030 USA.	asood@mdanderson.org		Armaiz-Pena, Guillermo N/0000-0002-9081-5339	NCI NIH HHS [P50 CA 083639, CA109298, CA110793] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083639, R01CA109298, R01CA110793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Briest W, 2003, PFLUG ARCH EUR J PHY, V446, P437, DOI 10.1007/s00424-003-1043-x; Conze D, 2001, CANCER RES, V61, P8851; Costanzo ES, 2005, CANCER-AM CANCER SOC, V104, P305, DOI 10.1002/cncr.21147; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fidler IJ, 2001, JNCI-J NATL CANCER I, V93, P1040, DOI 10.1093/jnci/93.14.1040; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Keller P, 2004, J APPL PHYSIOL, V97, P1309, DOI 10.1152/japplphysiol.00284.2004; KEMP VH, 1989, RES NURS HEALTH, V12, P331, DOI 10.1002/nur.4770120509; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Landen CN, 2006, J NATL CANCER I, V98, P1558, DOI 10.1093/jnci/djj414; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lara HE, 2002, MICROSC RES TECHNIQ, V59, P495, DOI 10.1002/jemt.10229; Lara HE, 2001, ENDOCRINE, V15, P187, DOI 10.1385/ENDO:15:2:187; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Obata NH, 1997, ANTICANCER RES, V17, P337; Parker J, 2004, J AM ACAD DERMATOL, V51, P919, DOI 10.1016/j.jaad.2004.08.042; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; RILEY V, 1975, SCIENCE, V189, P465, DOI 10.1126/science.168638; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; SCAMBIA G, 1994, INT J CANCER, V57, P318, DOI 10.1002/ijc.2910570305; Schmidt C, 1996, Eur J Med Res, V1, P528; Summy JM, 2005, MOL CANCER THER, V4, P1900, DOI 10.1158/1535-7163.MCT-05-0171; Tempfer C, 1997, GYNECOL ONCOL, V66, P27, DOI 10.1006/gyno.1997.4726; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Trevino JG, 2005, CANCER RES, V65, P7214, DOI 10.1158/0008-5472.CAN-04-3858; Weiner H., 1992, PERTURBING ORGANISM; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; WU S, 1992, AM J OBSTET GYNECOL, V166, P997, DOI 10.1016/0002-9378(92)91379-O; Yan LZ, 2000, AM J PHYSIOL-CELL PH, V279, pC1665, DOI 10.1152/ajpcell.2000.279.5.C1665; YU DH, 1993, CANCER RES, V53, P891	45	114	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29919	29926		10.1074/jbc.M611539200	http://dx.doi.org/10.1074/jbc.M611539200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716980	hybrid			2022-12-27	WOS:000249981200021
J	Huang, K; Chan, SJ; Hua, QX; Chu, YC; Wang, RY; Klaproth, B; Jia, WH; Whittaker, J; De Meyts, P; Nakagawa, SH; Steiner, DF; Katsoyannis, PG; Weiss, MA				Huang, Kun; Chan, Shu Jin; Hua, Qing-xin; Chu, Ying-Chi; Wang, Run-ying; Klaproth, Birgit; Jia, Wenhua; Whittaker, Jonathan; De Meyts, Pierre; Nakagawa, Satoe H.; Steiner, Donald F.; Katsoyannis, Panayotis G.; Weiss, Michael A.			The A-chain of insulin contacts the insert domain of the insulin receptor: Photo-cross-linking and mutagenesis of a diabetes-related crevice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; LIGAND-BINDING DOMAIN; NEGATIVE COOPERATIVITY; SIDE-CHAIN; GROWTH-FACTOR; ALPHA-HELIX; AMINO-ACIDS; B-CHAIN; STRUCTURAL SWITCH; CRYSTAL-STRUCTURE	The contribution of the insulin A-chain to receptor binding is investigated by photo-cross-linking and nonstandard mutagenesis. Studies focus on the role of Val(A3), which projects within a crevice between the A- and B-chains. Engineered receptor alpha-subunits containing specific protease sites ("midi- receptors") are employed to map the site of photo-cross-linking by an analog containing a photoactivable A3 side chain (para-azido-Phe ( Pap)). The probe cross-links to a C-terminal peptide (residues 703-719 of the receptor A isoform, KT (FE) under barD (YLHN) under bar VV (FV) under bar PRPS) containing side chains critical for hormone binding ( underlined); the corresponding segment of the holoreceptor was shown previously to cross-link to a Pap(B25)- insulin analog. Because Pap is larger than Val and so may protrude beyond the A3-associated crevice, we investigated analogs containing A3 substitutions comparable in size to Val as follows: Thr, allo-Thr, and alpha-aminobutyric acid (Aba). Substitutions were introduced within an engineered monomer. Whereas previous studies of smaller substitutions (Gly(A3) and Ser(A3)) encountered nonlocal conformational perturbations, NMR structures of the present analogs are similar to wild-type insulin; the variant side chains are accommodated within a native-like crevice with minimal distortion. Receptor binding activities of Aba(A3) and allo-Thr(A3) analogs are reduced at least 10-fold; the activity of Thr(A3)-DKP-insulin is reduced 5-fold. The hormone-receptor interface is presumably destabilized either by a packing defect (Aba(A3)) or by altered polarity (allo-Thr(A3) and Thr(A3)). Our results provide evidence that Val(A3), a site of mutation causing diabetes mellitus, contacts the insert domain-derived tail of the alpha-subunit in a hormone-receptor complex.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark	Case Western Reserve University; Case Western Reserve University; University of Chicago; Icahn School of Medicine at Mount Sinai; New York University; Novo Nordisk; Hagedorn Research Institute	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	De Meyts, Pierre/0000-0001-6214-0824	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK013914, R01DK056673, R37DK013914, R01DK040949, R01DK065890, P30DK020595] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20595, DK13914, DK065890, DK40949, DK56673, R01 DK040949] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; Bayley H., 1984, AZIDES NITRENES REAC, P433; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Brunger A. T, 1993, XPLOR MANUAL VERSION; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CARA JF, 1990, J BIOL CHEM, V265, P17820; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; Chen H, 1998, BBA-PROTEIN STRUCT M, V1429, P69, DOI 10.1016/S0167-4838(98)00219-2; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; CHU YC, 1994, BIOCHEMISTRY-US, V33, P11278, DOI 10.1021/bi00203a025; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Cosgrove L, 1995, PROTEIN EXPRES PURIF, V6, P789, DOI 10.1006/prep.1995.0010; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Guo ZY, 2001, IUBMB LIFE, V52, P309, DOI 10.1080/152165401317291165; Henrichs T, 2005, P NATL ACAD SCI USA, V102, P4246, DOI 10.1073/pnas.0408520102; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1993, J MOL BIOL, V230, P387, DOI 10.1006/jmbi.1993.1156; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li MY, 2002, IUBMB LIFE, V53, P57, DOI 10.1080/15216540210808; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MARSHALL RN, 1974, J CLIN ENDOCR METAB, V39, P283, DOI 10.1210/jcem-39-2-283; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Nanjo K, 1986, Trans Assoc Am Physicians, V99, P132; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pace CN, 2000, PROTEINS, P1; PAUL JI, 1990, J BIOL CHEM, V265, P13074; Qiao ZS, 2003, J BIOL CHEM, V278, P17800, DOI 10.1074/jbc.M300906200; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Toth G, 2001, PROTEIN ENG, V14, P543, DOI 10.1093/protein/14.8.543; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	93	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35337	35349		10.1074/jbc.M705996200	http://dx.doi.org/10.1074/jbc.M705996200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884811	hybrid			2022-12-27	WOS:000251155200077
J	Hayashi, A; Kasahara, T; Iwamoto, K; Ishiwata, M; Kametani, M; Kakiuchi, C; Furuichi, T; Kato, T				Hayashi, Akiko; Kasahara, Takaoki; Iwamoto, Kazuya; Ishiwata, Mizuho; Kametani, Mizue; Kakiuchi, Chihiro; Furuichi, Teiichi; Kato, Tadafumi			The role of brain-derived neurotrophic factor (BDNF)- induced XBP1 splicing during brain development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR XBP-1; PLASMA-CELL DIFFERENTIATION; TRANSGENIC MOUSE MODEL; MESSENGER-RNA; GROWTH CONES; ER STRESS; IN-VIVO; NEURONS	Accumulation of unfolded proteins in the endoplasmic reticulum initiates intracellular signaling termed the unfolded protein response (UPR). Although Xbp1 serves as a pivotal transcription factor for the UPR, the physiological role of UPR signaling and Xbp1 in the central nervous system remains to be elucidated. Here, we show that Xbp1 mRNA was highly expressed during neurodevelopment and activated Xbp1 protein was distributed throughout developing neurons, including neurites. The isolated neurite culture system and time-lapse imaging demonstrated that Xbp1 was activated in neurites in response to brain-derived neurotrophic factor (BDNF), followed by subsequent translocation of the active Xbp1 into the nucleus. BDNF-dependent neurite outgrowth was significantly attenuated in Xbp1(-/-) neurons. These findings suggest that BDNF initiates UPR signaling in neurites and that Xbp1, which is activated as part of the UPR, conveys the local information from neurites to the nucleus, contributing the neurite outgrowth.	RIKEN, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Kato, T (corresponding author), Hirosawa 2-1, Wako, Saitama 3510198, Japan.	kato@brain.riken.jp	Kato, Tadafumi/J-3583-2014; Kakiuchi, Chihiro/AAO-1103-2020; Furuichi, Teiichi/B-5086-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Furuichi, Teiichi/0000-0002-9676-1888; Kasahara, Takaoki/0000-0002-0953-5146				Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Bassell GJ, 1998, J NEUROSCI, V18, P251; BUNGE MB, 1973, J CELL BIOL, V56, P713, DOI 10.1083/jcb.56.3.713; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; DAILEY ME, 1989, J NEUROSCI, V9, P1897; Di Nardo AA, 2007, MOL CELL NEUROSCI, V35, P230, DOI 10.1016/j.mcn.2007.02.015; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Goffinet A., 2000, MOUSE BRAIN DEV; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OBATA K, 1987, BRAIN RES, V404, P169, DOI 10.1016/0006-8993(87)91368-0; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TORRE ER, 1992, J NEUROSCI, V12, P762; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	42	88	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34525	34534		10.1074/jbc.M704300200	http://dx.doi.org/10.1074/jbc.M704300200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890727	hybrid			2022-12-27	WOS:000251145700067
J	Martin, MJ; Tanos, T; Garcia, AB; Martin, D; Gutkind, JS; Coso, OA; Marinissen, MJ				Martin, Maria Jose; Tanos, Tamara; Garcia, Ana Belen; Martin, Daniel; Gutkind, J. Silvio; Coso, Omar A.; Marinissen, Maria Julia			The G alpha(12/13) family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi Sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; LEUKEMIA-ASSOCIATED RHO; FACTOR-KAPPA-B; GENE-EXPRESSION; UP-REGULATION; TRANSFORMING ACTIVITY; TRANSCRIPTION FACTOR; CHEMOKINE RECEPTOR; MULTIPLE PATHWAYS; VEGF SYNTHESIS	Heme oxygenase-1 (HO-1), an inducible enzyme that metabolizes the heme group, is highly expressed in human Kaposi sarcoma lesions. Its expression is up-regulated by the G protein-coupled receptor from the Kaposi sarcoma-associated herpes virus (vGPCR). Although recent evidence shows that HO-1 contributes to vGPCR-induced tumorigenesis and vascular endothelial growth factor (VEGF) expression, the molecular steps that link vGPCR to HO-1 remain unknown. Here we show that vGPCR induces HO-1 expression and transformation through the G alpha(12/13) family of heterotrimeric G proteins and the small GTPase RhoA. Targeted small hairpin RNA knockdown expression of G alpha(12), G alpha(13), or RhoA and inhibition of RhoA activity impair vGPCR- induced transformation and ho-1 promoter activity. Knockdown expression of RhoA also reduces vGPCR-induced VEFG-A secretion and blocks tumor growth in a murine allograft tumor model. NIH-3T3 cells expressing constitutively activated G alpha(13) or RhoA implanted in nude mice develop tumors displaying spindle-shaped cells that express HO-1 and VEGF-A, similarly to vGPCR-derived tumors. RhoAQL-induced tumor growth is reduced 80% by small hairpin RNA-mediated knockdown expression of HO-1 in the implanted cells. Likewise, inhibition of HO-1 activity by chronic administration of the HO-1 inhibitor tin protoporphyrin IX to mice reduces RhoAQL-induced tumor growth by 70%. Our study shows that vGPCR induces HO-1 expression through the G alpha(12/13)/RhoA axes and shows for the first time a potential role for HO-1 as a therapeutic target in tumors where RhoA has oncogenic activity.	Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed A Sols, E-28029 Madrid, Spain; Univ Buenos Aires, IFYBYNE CONICET, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	Autonomous University of Madrid; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Marinissen, MJ (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed A Sols, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	mjmarinissen@iib.uam.es	Gutkind, J. Silvio/A-1053-2009; Martin, Maria Jose/E-5105-2011; Gutkind, J. Silvio/J-1201-2016; soler, martha maricel m gomez/L-6025-2014	Martin, Maria Jose/0000-0002-0202-7309; Gutkind, J. Silvio/0000-0002-5150-4482; soler, martha maricel m gomez/0000-0002-4412-8108; Martin Izquierdo, Daniel/0000-0002-8880-9087; Tanos, Tamara/0000-0002-3217-3104; Martin, Maria Jose/0000-0001-6988-0761	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alam J, 2004, ANTIOXID REDOX SIGN, V6, P924, DOI 10.1089/1523086041798114; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; ANDERSON KE, 1984, J PHARMACOL EXP THER, V228, P327; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Caballero F, 2004, INT J EXP PATHOL, V85, P213, DOI 10.1111/j.0959-9673.2004.00391.x; Cannon ML, 2004, ONCOGENE, V23, P514, DOI 10.1038/sj.onc.1207021; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; CORNELIUS CE, 1984, PEDIATR RES, V18, P728, DOI 10.1203/00006450-198408000-00010; Couty JP, 2001, J BIOL CHEM, V276, P33805, DOI 10.1074/jbc.M104631200; Dadke D, 2003, CANCER RES, V63, P8837; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Drummond GS, 2004, SEMIN PERINATOL, V28, P365, DOI 10.1053/j.semperi.2004.09.004; Dulak J, 2004, ANTIOXID REDOX SIGN, V6, P858, DOI 10.1089/1523086041797980; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hamden KE, 2005, LEUKEMIA, V19, P18, DOI 10.1038/sj.leu.2403532; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Ishizaka N, 1997, HYPERTENSION, V29, P790, DOI 10.1161/01.HYP.29.3.790; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jensen KK, 2005, J IMMUNOL, V174, P3686, DOI 10.4049/jimmunol.174.6.3686; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Kappas A, 2001, PEDIATRICS, V108, P25, DOI 10.1542/peds.108.1.25; Kiemer AK, 2003, ENDOCRINOLOGY, V144, P802, DOI 10.1210/en.2002-220610; Kruger AL, 2006, J PHARMACOL EXP THER, V319, P1144, DOI 10.1124/jpet.106.107482; Lam CW, 2005, J IMMUNOL, V174, P2297, DOI 10.4049/jimmunol.174.4.2297; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121; Malaguarnera L, 2004, J CELL BIOCHEM, V93, P197, DOI 10.1002/jcb.20167; Marinissen MJ, 2006, J BIOL CHEM, V281, P11332, DOI 10.1074/jbc.M512199200; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Matsuoka Y, 1999, NEUROPHARMACOLOGY, V38, P825, DOI 10.1016/S0028-3908(99)00020-9; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; McAllister SC, 2004, BLOOD, V103, P3465, DOI 10.1182/blood-2003-08-2781; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Okamoto I, 2006, INT J CANCER, V119, P1312, DOI 10.1002/ijc.21937; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Polson AG, 2002, CANCER RES, V62, P4525; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; Shepard LW, 2001, J BIOL CHEM, V276, P45979, DOI 10.1074/jbc.M104783200; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Sun J, 2005, FEBS LETT, V579, P5494, DOI 10.1016/j.febslet.2005.08.080; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Xu HS, 2006, AM J PHYSIOL-RENAL, V291, pF995, DOI 10.1152/ajprenal.00092.2006; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yanagawa T, 2004, ORAL ONCOL, V40, P21, DOI 10.1016/S1368-8375(03)00128-3; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	89	20	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34510	34524		10.1074/jbc.M703043200	http://dx.doi.org/10.1074/jbc.M703043200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881360	Green Published, hybrid			2022-12-27	WOS:000251145700066
J	Charbonneau, M; Harper, K; Grondin, F; Pelmus, M; McDonald, PP; Dubois, CM				Charbonneau, Martine; Harper, Kelly; Grondin, Francine; Pelmus, Manuela; McDonald, Patrick P.; Dubois, Claire M.			Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TNF-ALPHA; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTION FACTORS; BREAST-CANCER; NITRIC-OXIDE; DNA-BINDING	Chronic hypoxia and inflammatory cytokines are hallmarks of inflammatory joint diseases like rheumatoid arthritis ( RA), suggesting a link between this microenvironment and central pathological events. Because TACE/ADAM17 is the predominant protease catalyzing the release of tumor necrosis factor alpha (TNF alpha), a cytokine that triggers a cascade of events leading to RA, we examined the regulation of this metalloprotease in response to hypoxia and TNF alpha itself. We report that low oxygen concentrations and TNF alpha enhance TACE mRNA levels in synovial cells through direct binding of hypoxia-inducible factor-1 (HIF-1) to the 5' promoter region. This is associated with elevated TACE activity as shown by the increase in TNF alpha shedding rate. By the use of HIF-1-deficient cells and by obliterating NF-kappa B activation, it was determined that the hypoxic TACE response is mediated by HIF-1 signaling, whereas the regulation by TNF alpha also requires NF-kappa B activation. As a support for the in vivo relevance of the HIF-1 axis for TACE regulation, immunohistological analysis of TACE and HIF-1 expression in RA synovium indicates that TACE is up-regulated in both fibroblast- and macrophage-like synovial cells where it localizes with elevated expression of both HIF-1 and TNF alpha. These findings suggest a mechanism by which TACE is increased in RA-affected joints. They also provide novel mechanistic clues on the influence of the hypoxic and inflammatory microenvironment on joint diseases.	Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Fac Med, Dept Pathol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Fac Med, Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Dubois, CM (corresponding author), Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada.	Claire.M.Dubois@usherbrooke.ca						Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Amin AR, 1999, OSTEOARTHR CARTILAGE, V7, P392, DOI 10.1053/joca.1998.0221; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINGLE JTM, 1956, BRIT J EXP PATHOL, V37, P318; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; FIRESTEIN GS, 1987, ARTHRITIS RHEUM, V30, P864, DOI 10.1002/art.1780300804; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Granet C, 2004, ARTHRITIS RES THER, V6, pR190, DOI 10.1186/ar1159; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hashimoto A, 2007, ARTHRITIS RHEUM, V56, P1094, DOI 10.1002/art.22450; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; KOONG AC, 1994, CANCER RES, V54, P5273; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; McDonald PP, 1999, J IMMUNOL, V163, P6164; Miyazawa K, 1998, AM J PATHOL, V152, P793; Mizui Y, 1999, GENE, V233, P67, DOI 10.1016/S0378-1119(99)00155-9; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Moss ML, 2001, DRUG DISCOV TODAY, V6, P417, DOI 10.1016/S1359-6446(01)01738-X; NAGASHIMA M, 1995, J RHEUMATOL, V22, P1624; Ohta S, 2001, J RHEUMATOL, V28, P1756; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Patel IR, 1998, J IMMUNOL, V160, P4570; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peters CL, 2004, ARTHRITIS RHEUM-US, V50, P291, DOI 10.1002/art.11473; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schlondorff J, 1999, J CELL SCI, V112, P3603; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xu HS, 2006, ARTHRITIS RHEUM-US, V54, P3441, DOI 10.1002/art.22169; Zhou J, 2003, AM J PHYSIOL-CELL PH, V284, pC439, DOI 10.1152/ajpcell.00294.2002	59	84	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33714	33724		10.1074/jbc.M704041200	http://dx.doi.org/10.1074/jbc.M704041200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884817	hybrid			2022-12-27	WOS:000250840200053
J	Haugstetter, J; Maurer, MA; Blicher, T; Pagac, M; Wider, G; Ellgaard, L				Haugstetter, Johannes; Maurer, Michael Andreas; Blicher, Thomas; Pagac, Martin; Wider, Gerhard; Ellgaard, Lars			Structure-function analysis of the endoplasmic reticulum oxidoreductase TMX3 reveals interdomain stabilization of the n-terminal redox-active domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; THIOREDOXIN-LIKE DOMAINS; CRYSTAL-STRUCTURE; BOND FORMATION; TRANSMEMBRANE PROTEIN; PH-DEPENDENCE; BINDING SITE; B' DOMAIN; PEPTIDE; ERP57	Disulfide bond formation in the endoplasmic reticulum is catalyzed by enzymes of the protein disulfide-isomerase family that harbor one or more thioredoxin-like domains. We recently discovered the transmembrane protein TMX3, a thiol-disulfide oxidoreductase of the protein disulfide-isomerase family. Here, we show that the endoplasmic reticulum-luminal region of TMX3 contains three thioredoxin-like domains, an N-terminal redox-active domain ( named a) followed by two enzymatically inactive domains (b and b'). Using the recombinantly expressed TMX3 domain constructs a, ab, and abb', we compared structural stability and enzymatic properties. By structural and biophysical methods, we demonstrate that the reduced a domain has features typical of a globular folded domain that is, however, greatly destabilized upon oxidization. Importantly, interdomain stabilization by the b domain renders the a domain more resistant toward chemical denaturation and proteolysis in both the oxidized and reduced form. In combination with molecular modeling studies of TMX3 abb', the experimental results provide a new understanding of the relationship between the multidomain structure of TMX3 and its function as a redox enzyme. Overall, the data indicate that in addition to their role as substrate and co-factor binding domains, redox-inactive thioredoxin-like domains also function in stabilizing neighboring redox-active domains.	ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Mol Biol, August Krogh Bldg, DK-2100 Copenhagen, Denmark.	lellgaard@aki.ku.dk	Ellgaard, Lars/I-9034-2014	Ellgaard, Lars/0000-0002-7018-0137; Wider, Gerhard/0000-0001-9366-7645; Maurer, Michael/0000-0003-1504-7285				Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; APPENZELLERHERZ.C, 2007, ANTIOX REDOX SIGNAL, V10; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; DeLano W.L, PYMOL MOL GRAPHICS S; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GIVOL D, 1964, J BIOL CHEM, V239, pC3116; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Meng XF, 2003, BIOCHEM GENET, V41, P99, DOI 10.1023/A:1022073917044; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Monsellier E, 2005, PROTEIN ENG DES SEL, V18, P445, DOI 10.1093/protein/gzi046; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Zahn R, 1996, P NATL ACAD SCI USA, V93, P15024, DOI 10.1073/pnas.93.26.15024; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	43	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33859	33867		10.1074/jbc.M706442200	http://dx.doi.org/10.1074/jbc.M706442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881353	hybrid			2022-12-27	WOS:000250840200067
J	Kimura, M; Yamamoto, T; Zhang, J; Itoh, K; Kyo, M; Kamiya, T; Aburatani, H; Katsuoka, F; Kurokawa, H; Tanaka, T; Motohashi, H; Yamamoto, M				Kimura, Momoko; Yamamoto, Tae; Zhang, Jianyong; Itoh, Ken; Kyo, Motoki; Kamiya, Terue; Aburatani, Hiroyuki; Katsuoka, Fumiki; Kurokawa, Hirofumi; Tanaka, Toshiyuki; Motohashi, Hozumi; Yamamoto, Masayuki			Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of maf homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; GROWTH-FACTOR; PROTEINS; DOMAIN; DIFFERENTIATION; RECOGNITION; ACTIVATION; ELEMENT	Nrf2-small Maf heterodimer activates the transcription of many cytoprotective genes through the antioxidant response element and serves as a key factor in xenobiotic and oxidative stress responses. Our surface plasmon resonance-microarray binding analysis revealed that both Nrf2-MafG heterodimer and MafG homodimer bind to the consensus Maf recognition element with high affinity but bind differentially to the suboptimal binding sequences degenerated from the consensus. We examined the molecular basis distinguishing the binding profile of Nrf2- MafG heterodimer from that of MafG homodimer and found that the Ala-502 residue in the basic region of Nrf2 is a critical determinant of its binding specificity. In Maf proteins, a tyrosine resides in the position corresponding to Ala-502 in Nrf2. We prepared a mutant Nrf2 molecule in which Ala- 502 was replaced with tyrosine. In surface plasmon resonance-microarray analysis, heterodimer of Nrf2(A502Y) and MafG displayed a binding specificity similar to that of MafG homodimer. The target genes activated by mutant Nrf2( A502Y)- small Maf heterodimer were largely different, albeit with some overlap, from those activated by wild-type Nrf2-small Maf, indicating that the array of target genes regulated by Nrf2- small Maf heterodimer differs substantially from that regulated by Maf homodimer in vivo. These results suggest that the distinct DNA binding profile of Nrf2- Maf heterodimer is biologically significant for Nrf2 to function as a key regulator of cytoprotective genes. Our contention is supported that the differential DNA binding specificity between Maf homodimers and Nrf2-Maf heterodimers establishes the differential gene regulation by these dimer-forming transcription factors.	Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Hirosaki Univ, Sch Med, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; TOYOBO Co Ltd, Biotechnol Frontier Project, Tsuruga 9140047, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Grad Sch Med, Environm Response Project, ERATO JST, Sendai, Miyagi 9808575, Japan	Tohoku University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Hirosaki University; Toyobo Co., Ltd; University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Motohashi, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	hozumim@mail.tains.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; ZHANG, Jianyong/L-5934-2015; Kurokawa, Hirofumi/A-7231-2010; Itoh, Ken/B-9506-2013; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Itoh, Ken/0000-0002-5518-0729; Katsuoka, Fumiki/0000-0003-0939-7887				Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; ITOH K, 1997, BIOCHEM BIOPH RES CO, V236, P4184; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; Kataoka K, 2001, J BIOL CHEM, V276, P36849, DOI 10.1074/jbc.M102234200; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; NEY PA, 1990, NUCLEIC ACIDS RES, V18, P6011, DOI 10.1093/nar/18.20.6011; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06	31	79	81	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33681	10.1074/jbc.M706863200	http://dx.doi.org/10.1074/jbc.M706863200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875642	hybrid			2022-12-27	WOS:000250840200049
J	Weiner, BE; Huang, H; Dattilo, BM; Nilges, MJ; Fanning, E; Chazin, WJ				Weiner, Brian E.; Huang, Hao; Dattilo, Brian M.; Nilges, Mark J.; Fanning, Ellen; Chazin, Walter J.			An iron-sulfur cluster in the C-terminal domain of the p58 subunit of human DNA primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA-PRIMASE; REPLICATION IN-VITRO; HUMAN GINS COMPLEX; ENDONUCLEASE-III; B-SUBUNIT; ESCHERICHIA-COLI; PRIMER SYNTHESIS; REPAIR; INITIATION; PROTEIN	DNA primase synthesizes short RNA primers that are required to initiate DNA synthesis on the parental template strands during DNA replication. Eukaryotic primase contains two subunits, p48 and p58, and is normally tightly associated with DNA polymerase alpha. Despite the fundamental importance of primase in DNA replication, structural data on eukaryotic DNA primase are lacking. The p48/p58 dimer was subjected to limited proteolysis, which produced two stable structural domains: one containing the bulk of p48 and the other corresponding to the C-terminal fragment of p58. These domains were identified by mass spectrometry and N-terminal sequencing. The C-terminal p58 domain (p58C) was expressed, purified, and characterized. CD and NMR spectroscopy experiments demonstrated that p58C forms a well folded structure. The protein has a distinctive brownish color, and evidence from inductively coupled plasma mass spectrometry, UV-visible spectrophotometry, and EPR spectroscopy revealed characteristics consistent with the presence of a [4Fe-4S] high potential iron protein cluster. Four putative cysteine ligands were identified using a multiple sequence alignment, and substitution of just one was sufficient to cause loss of the iron-sulfur cluster and a reduction in primase enzymatic activity relative to the wildtype protein. The discovery of an iron-sulfur cluster in DNA primase that contributes to enzymatic activity provides the first suggestion that the DNA replication machinery may have redox-sensitive activities. Our results offer new horizons in which to investigate the function of high potential [4Fe-4S] clusters in DNA-processing machinery.	Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Chazin, WJ (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 465 21st Ave S,Ste 5140, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, T32GM008320, R01GM065484] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA68485] Funding Source: Medline; NIEHS NIH HHS [P50 ES00267] Funding Source: Medline; NIGMS NIH HHS [R01 GM065484, GM65484, GM52948, T32 GM008320] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Boon EM, 2003, P NATL ACAD SCI USA, V100, P12543, DOI 10.1073/pnas.2035257100; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chepanoske CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P11, DOI 10.1006/abbi.2000.1890; Coldren CD, 1997, P NATL ACAD SCI USA, V94, P6635, DOI 10.1073/pnas.94.13.6635; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dilg AWE, 1999, J BIOL INORG CHEM, V4, P727, DOI 10.1007/s007750050345; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Foiani M, 1997, TRENDS BIOCHEM SCI, V22, P424; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; HEMMINGA MA, 2007, ESR SPECTROSCOPY MEM, P261; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kamada K, 2007, NAT STRUCT MOL BIOL, V14, P388, DOI 10.1038/nsmb1231; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; LePape L, 1997, J AM CHEM SOC, V119, P9757, DOI 10.1021/ja963349o; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; LONGHESE MP, 1993, GENETICS, V133, P183; Lukianova OA, 2005, CURR OPIN CHEM BIOL, V9, P145, DOI 10.1016/j.cbpa.2005.02.006; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; Schub O, 2001, J BIOL CHEM, V276, P38076; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	59	93	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33444	33451		10.1074/jbc.M705826200	http://dx.doi.org/10.1074/jbc.M705826200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893144	hybrid			2022-12-27	WOS:000250840200024
J	Kim, S; Yun, HM; Baik, JH; Chung, KC; Nah, SY; Rhim, H				Kim, Sunoh; Yun, Hyung-Mun; Baik, Ja-Hyun; Chung, Kwang Chul; Nah, Seung-Yeol; Rhim, Hyewhon			Functional interaction of neuronal ca(v)1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; NMDA RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; DIHYDROPYRIDINE RECEPTOR; CREB PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; INSULIN-SECRETION; STRIATAL NEURONS; BETA-CELLS	Neuronal L-type Ca2+ channels do not support synaptic transmission, but they play an essential role in synaptic activity-dependent gene expression. Ca(v)1.2 and Ca(v)1.3 are the two most widely expressed L-type Ca2+ channels in neurons and have different biophysical and subcellular distributions. The function of the Ca(v)1.3 L-type Ca2+ channel and its cellular mechanisms in the central nervous system are poorly understood. In this study, using a yeast two-hybrid assay, we found that the N terminus of the rat Ca(v)1.3 alpha(1) subunit interacts with a partial N-terminal amino acid sequence of ryanodine receptor type 2 (RyR2). Reverse transcription-PCR and Western blot assays revealed high expression of both Ca(v)1.3 and RyR2 in the rat hippocampus. We also demonstrate a physical association of Ca(v)1.3 with RyR2 using co-immunoprecipitation assays. Moreover, immunocytochemistry revealed prominent co-localization between Ca(v)1.3 and RyR2 in hippocampal neurons. Depolarizing cells by an acute treatment of a high concentration of KCl (high-K, 60 mM) showed that the activation of L-type Ca2+ channels induced RyR opening and led to RyR-dependent Ca2+ release, even in the absence of extracellular Ca2+. Furthermore, we found that RyR2 mRNA itself is increased by long term treatment of high-K via activation of L-type Ca2+ channels. These acute and long term effects of high-K on RyRs were selectively blocked by small interfering RNA-mediated silencing of Ca(v)1.3. These results suggest a physical and functional interaction between Ca(v)1.3 and RyR2 and important implications of Ca(v)1.3/RyR2 clusters in translating synaptic activity into alterations in gene expression.	Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; Konkuk Univ, Coll Vet Med, Dept Physiol, Seoul 143701, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Yonsei University; Konkuk University	Rhim, H (corresponding author), Korea Inst Sci & Technol, Div Life Sci, 39-1 Hawholgok Dong, Seoul 136791, South Korea.	hrhim@kist.re.kr		Lee, Junho/0000-0003-0913-8578				ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; Biao X, 2002, BRIT J PHARMACOL, V136, P375, DOI 10.1038/sj.bjp.0704753; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; del Valle-Rodriguez A, 2003, EMBO J, V22, P4337; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Finkbeiner S, 1997, BIOESSAYS, V19, P657, DOI 10.1002/bies.950190803; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; Hirasawa M, 2003, P NATL ACAD SCI USA, V100, P6139, DOI 10.1073/pnas.0936131100; Kim S, 2004, BIOCHEM BIOPH RES CO, V323, P416, DOI 10.1016/j.bbrc.2004.08.106; Kim S, 2004, ARCH PHARM RES, V27, P524, DOI 10.1007/BF02980126; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LarssonNyren G, 1996, BIOCHEM J, V314, P167, DOI 10.1042/bj3140167; LEBRUN P, 1985, BIOPHYS J, V48, P919, DOI 10.1016/S0006-3495(85)83855-8; Leong P, 1998, BIOCHEM CELL BIOL, V76, P681, DOI 10.1139/bcb-76-5-681; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu GH, 2006, J PHARMACOL EXP THER, V318, P152, DOI 10.1124/jpet.105.097477; Liu QY, 1996, J NEUROSCI, V16, P2912; LU XY, 1994, J BIOL CHEM, V269, P6511; Ludwig A, 1997, J NEUROSCI, V17, P1339; Macias W, 2001, BRAIN RES, V890, P222, DOI 10.1016/S0006-8993(00)03163-2; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Reyes M, 1996, J NEUROSCI, V16, P5951; SHMIGOL A, 1995, NEUROSCIENCE, V65, P1109, DOI 10.1016/0306-4522(94)00553-H; Sukhareva M, 2002, J NEUROPHYSIOL, V88, P1077, DOI 10.1152/jn.2002.88.3.1077; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang Y, 1996, J PHYSIOL-LONDON, V495, P755, DOI 10.1113/jphysiol.1996.sp021631; Weick JP, 2003, J NEUROSCI, V23, P3446; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x; Zhao WQ, 2000, FASEB J, V14, P290, DOI 10.1096/fasebj.14.2.290	53	64	64	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32877	32889		10.1074/jbc.M701418200	http://dx.doi.org/10.1074/jbc.M701418200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17823125	hybrid			2022-12-27	WOS:000250625400037
J	Borzok, MA; Catino, DH; Nicholson, JD; Kontrogianni-Konstantopoulos, A; Bloch, RJ				Borzok, Maegen A.; Catino, Dawn H.; Nicholson, James D.; Kontrogianni-Konstantopoulos, Aikaterini; Bloch, Robert J.			Mapping the binding site on small ankyrin 1 for obscurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ISOFORM SPECIFICITY; DOMAIN; MEMBRANE; REPEATS; GENE; ORGANIZATION; CONTRACTION	Small ankyrin 1 (sAnk1), an integral protein of the sarcoplasmic reticulum encoded by the ANK1 gene, binds with nanomolar affinity to the C terminus of obscurin, a giant protein surrounding the contractile apparatus in striated muscle. We used site-directed mutagenesis to characterize the binding site on sAnk1, specifically addressing the role of two putative amphipathic, positively charged helices. We measured binding qualitatively by blot overlay assays and quantitatively by surface plasmon resonance and showed that both positively charged sequences are required for activity. We showed further that substitution of a lysine or arginine with an alanine or glutamate located at the same position along either of the two putative helices has similar inhibitory or stimulatory effects on binding and that the effects of a particular mutation depended on the position of the mutated amino acid in each helix. We modeled the structure of the binding region of sAnk1 by homology with ankyrin repeats of human Notch1, which have a similar pattern of charged and hydrophobic residues. Our modeling suggested that each of the two positively charged sequences forms pairs of amphipathic, anti-parallel alpha-helices flanked by beta-hairpin-like turns. Most of the residues in homologous positions along each helical unit have similar, though not identical, orientations. CD spectroscopy confirmed the alpha-helical content of sAnk1, similar to 33%, predicted by the model. Thus, structural and mutational studies of the binding region on sAnk1 for obscurin suggest that it consists of two ankyrin repeats with very similar structures.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052768] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL64304] Funding Source: Medline; NIAMS NIH HHS [R01 AR52768] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Cammett TJ, 2003, J MOL BIOL, V327, P285, DOI 10.1016/S0022-2836(03)00043-3; Desrosiers DC, 2005, J MOL BIOL, V354, P375, DOI 10.1016/j.jmb.2005.09.045; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Franzini-Armstrong C, 1999, FASEB J, V13, pS266, DOI 10.1096/fasebj.13.9002.S266; FRANZINIARMSTRO.C, 1981, J CELL BIOL, V91, P166; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; GAY NJ, 1993, FEBS LETT, V335, P155, DOI 10.1016/0014-5793(93)80720-F; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; KONTROGIANNIKON.A, 2006, J MUSCLE RES CELL M, V26, P419; Kordeli E, 1998, J CELL SCI, V111, P2197; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TAKEKURA H, 1994, J MUSCLE RES CELL M, V15, P102, DOI 10.1007/BF00130422; Tani S, 2001, NUCLEIC ACIDS RES, V29, P1373, DOI 10.1093/nar/29.6.1373; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h	46	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32384	32396		10.1074/jbc.M704089200	http://dx.doi.org/10.1074/jbc.M704089200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17720975	hybrid			2022-12-27	WOS:000250480300061
J	Kou, I; Nakajima, M; Ikegawa, S				Kou, Ikuyo; Nakajima, Masahiro; Ikegawa, Shiro			Expression and regulation of the osteoarthritis-associated protein asporin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LEUCINE-RICH PROTEOGLYCANS; ACID REPEAT POLYMORPHISM; BIGLYCAN GENE-EXPRESSION; TGF-BETA; TRANSCRIPTIONAL REGULATION; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; LINK PROTEIN; CELL-LINES	Asporin ( ASPN) is a small leucine-rich proteoglycan that is involved in pathological processes of osteoarthritis. Previously, we showed that asporin can inhibit transforming growth factor-beta 1 ( TGF-beta 1)-mediated expression of cartilage matrix genes and chondrogenesis in vitro (Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., Uchida, A., Nakamura, K., Notoya, K., Nakamura, Y., and Ikegawa, S. ( 2005) Nat. Genet. 37, 138 -144). However, details about regulation of asporin itself are not yet known. Here, we examined ASPN expression in skeletal tissue and potential regulation of ASPN by TGF-beta. In situ hybridization revealed the presence of ASPN mRNA in the perichondrium/periosteum of long bones, but its absence in articular cartilage and growth plates. Immunohistochemical analysis also showed ASPN protein expression predominantly in the perichondrium/periosteum. TGF-beta 1 induced endogenous ASPN mRNA expression over time in vitro, and this induction was suppressed by the TGF-beta type I receptor kinase inhibitor SB431542. Inhibition of Smad3 significantly reduced TGF-beta 1induced ASPN expression, whereas overexpression of Smad3 augmented the induction. Characterization of the human ASPN promoter region revealed a region from -126 to -82 that is sufficient for full promoter activity; however, TGF-beta 1 failed to increase activity through the ASPN promoter. Our findings indicate that TGF-beta 1 induces ASPN through Smad3 but that this induction is indirect.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan	RIKEN	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147				BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Demoor-Fossard M, 2001, J BIOL CHEM, V276, P36983, DOI 10.1074/jbc.M011442200; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi H, 2000, J BIOL CHEM, V275, P21185, DOI 10.1074/jbc.M907862199; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; SANTRA M, 1994, J BIOL CHEM, V269, P579; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; Ungefroren H, 1996, J BIOL CHEM, V271, P15787, DOI 10.1074/jbc.271.26.15787; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; WESTERGRENTHORSSON G, 1991, MATRIX, V11, P177, DOI 10.1016/S0934-8832(11)80156-3; Wilda M, 2000, J BONE MINER RES, V15, P2187, DOI 10.1359/jbmr.2000.15.11.2187; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	39	41	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32193	32199		10.1074/jbc.M706262200	http://dx.doi.org/10.1074/jbc.M706262200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804408	hybrid			2022-12-27	WOS:000250480300042
J	Li, T; Wen, H; Brayton, C; Das, P; Smithson, LA; Fauq, A; Fan, X; Crain, BJ; Price, DL; Golde, TE; Eberhart, CG; Wong, PC				Li, Tong; Wen, Hongjin; Brayton, Cory; Das, Pritam; Smithson, Lisa A.; Fauq, Abdul; Fan, Xing; Crain, Barbara J.; Price, Donald L.; Golde, Todd E.; Eberhart, Charles G.; Wong, Philip C.			Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-CATENIN; CYCLIN D2; C-ELEGANS; CANCER; PRESENILIN-1; SKIN; OVEREXPRESSION; PROLIFERATION; EXPRESSION	gamma-Secretase, a unique aspartyl protease, is required for the regulated intramembrane proteolysis of Notch and APP, pathways that are implicated, respectively, in the pathogenesis of cancer and Alzheimer disease. However, the mechanism whereby reduction of gamma-secretase causes tumors such as squamous cell carcinoma ( SCC) remains poorly understood. Here, we demonstrate that gamma-secretase functions in epithelia as a tumor suppressor in an enzyme activity-dependent manner. Notch signaling is down-regulated and epidermal growth factor receptor ( EGFR) is activated in SCC caused by genetic reduction of gamma-secretase. Moreover, the level of EGFR is inversely correlated with the level of gamma-secretase in fibroblasts, suggesting that the up-regulation of EGFR stimulates hyperproliferation in epithelia of mice with genetic reduction of gamma-secretase. Supporting this notion is our finding that the proliferative response of fibroblasts lacking gamma-secretase activity is more sensitive when challenged by either EGF or an inhibitor of EGFR as compared with wild type cells. Interestingly, the up-regulation of EGFR is independent of Notch signaling, suggesting that the EGFR pathway functions in parallel with Notch in the tumorigenesis of SCC. Collectively, our results establish a novel mechanism linking the EGFR pathway to the tumor suppressor role of gamma-secretase and that mice with genetic reduction of gamma-secretase represent an excellent rodent model for clarifying pathogenesis of SCC and for testing therapeutic strategy to ameliorate this type of human cancer.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic	Golde, TE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	tli1@jhmi.edu; wong@jhmi.edu	Brayton, Cory/AAW-4681-2021	Brayton, Cory/0000-0002-6666-6548	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG05146] Funding Source: Medline; NINDS NIH HHS [P01 NS047308, R01 NS45150] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brayton C, 2001, VET PATHOL, V38, P1, DOI 10.1354/vp.38-1-1; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2003, AM J PATHOL, V162, P1763, DOI 10.1016/S0002-9440(10)64311-8; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Lewis SJ, 2005, BIOORG MED CHEM LETT, V15, P373, DOI 10.1016/j.bmcl.2004.10.062; Li T, 2003, J NEUROSCI, V23, P3272; LI T, 2007, IN PRESS J NEUROSCI; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Rogers SJ, 2005, CANCER METAST REV, V24, P47, DOI 10.1007/s10555-005-5047-1; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Takano Y, 1999, J PATHOL, V189, P194; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; WONG PC, 2005, NEUROBIOLOGY ALZHEIM; WONG WT, 1994, ONCOGENE, V9, P3057; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu ZW, 2005, CLIN CANCER RES, V11, P2471, DOI 10.1158/1078-0432.CCR-04-2199; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	38	73	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32264	32273		10.1074/jbc.M703649200	http://dx.doi.org/10.1074/jbc.M703649200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827153	hybrid			2022-12-27	WOS:000250480300049
J	Parlitz, R; Eitan, A; Stjepanovic, G; Bahari, L; Bange, G; Bibi, E; Sinning, I				Parlitz, Richard; Eitan, Asa; Stjepanovic, Goran; Bahari, Liat; Bange, Gert; Bibi, Eitan; Sinning, Irmgard			Escherichia coli signal recognition particle receptor FtsY contains an essential and autonomous membrane-binding amphipathic helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; TARGETING PATHWAY; SRP RECEPTOR; NG DOMAIN; PROTEIN; ASSOCIATION; RIBOSOME; SEQUENCE; PHOSPHOLIPIDS; BIOGENESIS	Escherichia coli membrane protein biogenesis is mediated by a signal recognition particle and its membrane-associated receptor ( FtsY). Although crucial for its function, it is still not clear how FtsY interacts with the membrane. Analysis of the structure/function differences between severely truncated active ( NG + 1) and inactive ( NG) mutants of FtsY enabled us to identify an essential membrane-interacting determinant. Comparison of the three-dimensional structures of the mutants, combined with site-directed mutagenesis, modeling, and liposome-binding assays, revealed that FtsY contains a conserved autonomous lipid-binding amphipathic alpha-helix at the N-terminal end of the N domain. Deletion experiments showed that this helix is essential for FtsY function in vivo, thus offering, for the first time, clear evidence for the functionally important, physiologically relevant interaction of FtsY with lipids.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, POB 26, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Bange, Gert/AAB-3734-2021; Stjepanovic, Goran/A-7902-2010; Sinning, Irmgard/A-2982-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bange, Gert/0000-0002-7826-0932; Bibi, Eitan/0000-0003-3700-2707				Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DeLano W.L, PYMOL MOL GRAPHICS S; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Montoya G, 1997, PROTEINS, V28, P285, DOI 10.1002/(SICI)1097-0134(199706)28:2<285::AID-PROT15>3.0.CO;2-E; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	45	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32176	32184		10.1074/jbc.M705430200	http://dx.doi.org/10.1074/jbc.M705430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726012	hybrid			2022-12-27	WOS:000250480300040
J	Sha, Z; Yen, HCS; Scheel, H; Suo, JF; Hofmann, K; Chang, EC				Sha, Zhe; Yen, Hsueh-Chi S.; Scheel, Hartmut; Suo, Jinfeng; Hofmann, Kay; Chang, Eric C.			Isolation of the Schizosaccharomyces pombe proteasome subunit rpn7 and a structure-function study of the Proteasome-COP9-Initiation factor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; 26S PROTEASOME; INT6; HOMOLOGS; GENE; LOCALIZATION; COMPLEXES; PROTEINS; SEQUENCE; MOE1	Proper assembly of the 26 S proteasome is required to efficiently degrade polyubiquitinated proteins. Many proteasome subunits contain the proteasome-COP9-initiation factor (PCI) domain, thus raising the possibility that the PCI domain may play a role in mediating proteasome assembly. We have previously characterized the PCI protein Yin6, a fission yeast ortholog of the mammalian Int6 that has been implicated in breast oncogenesis, and demonstrated that it binds and regulates the assembly of the proteasome. In this study, we isolated another PCI proteasome subunit, Rpn7, as a high copy suppressor that rescued the proteasome defects in yin6 null cells. To better define the function of the PCI domain, we aligned protein sequences to identify a conserved leucine residue that is present in nearly all known PCI domains. Replacing it with aspartate in yeast Rpn7, Yin6, and Rpn5 inactivated these proteins, and mutant human Int6 mislocalized in HeLa cells. Rpn7 and Rpn5 bind Rpn9 with high affinity, but their mutant versions do not. Our data suggest that this leucine may interact with several hydrophobic amino acid residues to influence the spatial arrangement either within the N-terminal tandem alpha-helical repeats or between these repeats and the more C-terminal winged helix subdomain. Disruption of such an arrangement in the PCI domain may substantially inactivate many PCI proteins and block their binding to other proteins.	Baylor Coll Med, Dept Mol & Cell Biol, Lester & Sue Smith Brest Ctr, Houston, TX 77030 USA; Miltenyi Biotec GmbH, MACSmol Business Unit, Bioinformat Dept, D-50829 Cologne, Germany	Baylor College of Medicine; Miltenyi Biotec	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Lester & Sue Smith Brest Ctr, 1 Baylor Plaza,BCM 600, Houston, TX 77030 USA.	echang1@bcm.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021; Hofmann, Kay/D-6714-2011	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414; Hofmann, Kay/0000-0002-2289-9083	NCI NIH HHS [R01 CA090464-06, R01 CA107187-04, R01 CA107187, CA107187, CA90464, R01 CA090464-05, R01 CA090464, R01 CA090464-07] Funding Source: Medline; NCRR NIH HHS [P41 RR001081, P41 RR-01081] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090464, R01CA107187] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alfa C., 1993, EXPT FISSION YEAST; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chang Eric C, 2004, EMBO Rep, V5, P1041, DOI 10.1038/sj.embor.7400275; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Isono E, 2004, J BIOL CHEM, V279, P27168, DOI 10.1074/jbc.M314231200; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Leggett David S., 2005, V301, P57; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Norbury C, 1997, METHOD ENZYMOL, V283, P44; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; SAP J, 2005, AFCS NATURE MOL PAGE, DOI DOI 10.1038/MP.A003493.01; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watkins SJ, 2004, CELL PROLIFERAT, V37, P149, DOI 10.1111/j.1365-2184.2004.00305.x; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yen HCS, 2003, J BIOL CHEM, V278, P30669, DOI 10.1074/jbc.M302093200; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340	32	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32414	32423		10.1074/jbc.M706276200	http://dx.doi.org/10.1074/jbc.M706276200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761670	hybrid, Green Accepted			2022-12-27	WOS:000250480300064
J	Siddiqui, K; Stillman, B				Siddiqui, Khalid; Stillman, Bruce			ATP-dependent assembly of the human origin recognition complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; WALKER-A MOTIF; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; CELL-CYCLE; IN-VITRO; HEXAMERIC HELICASE; T-ANTIGEN; CHROMATIN; PROTEINS	The origin recognition complex (ORC) was initially discovered in budding yeast extracts as a protein complex that binds with high affinity to autonomously replicating sequences in an ATP-dependent manner. We have cloned and expressed the human homologs of the ORC subunits as recombinant proteins. In contrast to other eukaryotic initiators examined thus far, assembly of human ORC in vitro is dependent on ATP binding. Mutations in the ATP-binding sites of Orc4 or Orc5 impair complex assembly, whereas Orc1 ATP binding is not required. Immunofluorescence staining of human cells with anti-Orc3 antibodies demonstrate cell cycle-dependent association with a nuclear structure. Immunoprecipitation experiments show that ORC disassembles as cells progress through S phase. The Orc6 protein binds directly to the Orc3 subunit and interacts as part of ORC in vivo. These data suggest that the assembly and disassembly of ORC in human cells is uniquely regulated and may contribute to restricting DNA replication to once in every cell division cycle.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; /0000-0001-6448-0902	NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA013106, P01 CA013106-38S10025, CA13106, P30 CA045508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; DEAN FB, 1992, J BIOL CHEM, V267, P14129; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; HARLOW E, 1988, ANTIBODIES LAB MANUA, P138; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Neuwald AF, 1999, GENOME RES, V9, P27; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Podobnik M, 2003, STRUCTURE, V11, P253, DOI 10.1016/S0969-2126(03)00027-3; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rowles A, 1999, J CELL SCI, V112, P2011; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, J BIOL CHEM, V266, P12041; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Stefanovic D, 2003, J BIOL CHEM, V278, P42737, DOI 10.1074/jbc.M307058200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takahashi N, 2004, J BIOL CHEM, V279, P8469, DOI 10.1074/jbc.M305531200; Takenaka H, 2002, BIOL PHARM BULL, V25, P652, DOI 10.1248/bpb.25.652; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0	65	69	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32370	32383		10.1074/jbc.M705905200	http://dx.doi.org/10.1074/jbc.M705905200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17716973	Green Accepted, hybrid			2022-12-27	WOS:000250480300060
J	Schwartz, A; Margeat, E; Rahmouni, AR; Boudvillain, M				Schwartz, Annie; Margeat, Emmanuel; Rahmouni, A. Rachid; Boudvillain, Marc			Transcription termination factor rho can displace streptavidin from biotinylated RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE ACTIVITY; ESCHERICHIA-COLI RHO; DEPENDENT TERMINATION; SECONDARY STRUCTURE; ELONGATION COMPLEX; DELETION ANALYSIS; MESSENGER-RNA; BINDING-SITE; NASCENT RNA; IN-VIVO	In Escherichia coli, binding of the hexameric Rho protein to naked C-rich Rut (Rho utilization) regions of nascent RNA transcripts initiates Rho-dependent termination of transcription. Although the ring-shaped Rho factor exhibits in vitro RNA-dependent ATPase and directional RNA-DNA helicase activities, the actual molecular mechanisms used by Rho to disrupt the intricate network of interactions that cement the ternary transcription complex remain elusive. Here, we show that Rho is a molecular motor that can apply significant disruptive forces on heterologous nucleoprotein assemblies such as streptavidin bound to biotinylated RNA molecules. ATP-dependent disruption of the biotin-streptavidin interaction demonstrates that Rho is not mechanistically limited to the melting of nucleic acid base pairs within molecular complexes and confirms that specific interactions with the roadblock target are not required for Rho to operate properly. We also show that Rho-induced streptavidin displacement depends significantly on the identity of the biotinylated transcript as well as on the position, nature, and length of the biotin link to the RNA chain. Altogether, our data are consistent with a "snow plough" type of mechanism of action whereby an early rearrangement of the Rho-substrate complex (activation) is rate-limiting, physical force (pulling) is exerted on the RNA chain by residues of the central Rho channel, and removal of structural obstacles from the RNA track stems from their nonspecific steric exclusion from the hexamer central hole. In this context, a simple model for the regulation of Rho-dependent termination based on the modulation of disruptive dynamic loading by secondary factors is proposed.	CNRS, Ctr Biophys Mol, UPR4301, F-45071 Orleans, France; CNRS, Ctr Biochim Struct, UMR5048, F-34090 Montpellier, France; INSERM, F-34090 Montpellier, France; Univ Montpellier I, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Boudvillain, M (corresponding author), CNRS, Ctr Biophys Mol, UPR4301, F-45071 Orleans, France.	marc.boudvillain@cnrs-orleans.fr	Margeat, Emmanuel/AAY-9167-2021	Margeat, Emmanuel/0000-0001-6063-6420; Boudvillain, Marc/0000-0002-6398-9122				Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ALIFANO P, 1991, CELL, V64, P553; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Burns CM, 1999, J BIOL CHEM, V274, P5245, DOI 10.1074/jbc.274.8.5245; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; CERUZZI MAF, 1985, J BIOL CHEM, V260, P9412; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Guerin M, 1998, NUCLEIC ACIDS RES, V26, P4895, DOI 10.1093/nar/26.21.4895; HART CM, 1994, J MOL BIOL, V237, P255, DOI 10.1006/jmbi.1994.1229; HART CM, 1991, J BIOL CHEM, V266, P24140; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hyeon C, 2007, BIOPHYS J, V92, P731, DOI 10.1529/biophysj.106.093062; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; JANKOWSKY PH, 2006, NAT STRUCT MOL BIOL, V34, P4181; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kainz M, 1998, J MOL BIOL, V284, P1379, DOI 10.1006/jmbi.1998.2272; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Knowlton JR, 2003, BIOCHEMISTRY-US, V42, P2275, DOI 10.1021/bi0272508; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Nowatzke W, 1996, METHOD ENZYMOL, V274, P353; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Persson T, 2005, HDB RNA BIOCH, P53; Qin PZF, 1999, METHODS, V18, P60, DOI 10.1006/meth.1999.0757; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Richardson JP, 2006, MOL CELL, V22, P711, DOI 10.1016/j.molcel.2006.06.002; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; SCHMIDT MC, 1984, J BIOL CHEM, V259, P5000; Schwartz A, 2003, EMBO J, V22, P3385, DOI 10.1093/emboj/cdg310; Schwartz A, 2007, BIOCHEMISTRY-US, V46, P9366, DOI 10.1021/bi700493m; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; STEINMETZ EJ, 1990, J BIOL CHEM, V265, P18408; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vieu E, 2004, J MOL BIOL, V339, P1077, DOI 10.1016/j.jmb.2004.04.022; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; Walmacq C, 2004, J MOL BIOL, V342, P403, DOI 10.1016/j.jmb.2004.07.026; Walmacq C, 2006, BIOCHEMISTRY-US, V45, P5885, DOI 10.1021/bi0600648; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7980, DOI 10.1021/bi963179s; Walstrom KM, 1998, J MOL BIOL, V279, P713, DOI 10.1006/jmbi.1998.1814; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; ZALATAN F, 1992, J BIOL CHEM, V267, P19082; ZALATAN F, 1993, J BIOL CHEM, V268, P17051	67	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31469	31476		10.1074/jbc.M706935200	http://dx.doi.org/10.1074/jbc.M706935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17724015	hybrid, Green Published			2022-12-27	WOS:000250309200038
J	Llarrull, LI; Tioni, MF; Kowalski, J; Bennett, B; Vila, AJ				Llarrull, Leticia I.; Tioni, Mariana F.; Kowalski, Jason; Bennett, Brian; Vila, Alejandro J.			Evidence for a dinuclear active site in the metallo-ss-lactamase BcII with substoichiometric Co(II) - A new model for metal uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBALT-BETA-LACTAMASE; BACILLUS-CEREUS; COORDINATION GEOMETRY; PARAMAGNETIC H-1-NMR; CATALYTIC EFFICIENCY; COPPER SITES; SHIFTED NMR; BINDING; HYDROLYSIS; IMIS	Metallo-beta-lactamases are zinc-dependent enzymes that constitute one of the main resistance mechanisms to beta-lactam antibiotics. Metallo-beta-lactamases have been characterized both in mono- and dimetallic forms. Despite many studies, the role of each metal binding site in substrate binding and catalysis is still unclear. This is mostly due to the difficulties in assessing the metal content and site occupancy in solution. For this reason, Co( II) has been utilized as a useful probe of the active site structure. We have employed UV-visible, EPR, and NMR spectroscopy to study Co( II) binding to the metallo-beta-lactamase BcII from Bacillus cereus. The spectroscopic features were attributed to the two canonical metal binding sites, the 3H ( His(116), His(118), and His(196)) and DCH ( Asp(120), Cys(221), and His(263)) sites. These data clearly reveal the coexistence of mononuclear and dinuclear Co( II)-loaded forms at Co( II)/enzyme ratios as low as 0.6. This picture is consistent with the macroscopic dissociation constants here determined from competition binding experiments. A spectral feature previously assigned to the DCH site in the dinuclear species corresponds to a third, weakly bound Co( II) site. The present work emphasizes the importance of using different spectroscopic techniques to follow the metal content and localization during metallo-beta-lactamase turnover.	Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol Celular Rosario,Mol Biol Div, RA-2000 Rosario, Argentina; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Biophys Sect, RA-2000 Rosario, Argentina; Med Coll Wisconsin, Dept Biophys, Natl Biomed EPR Ctr, Milwaukee, WI 53226 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Medical College of Wisconsin	Vila, AJ (corresponding author), Supacha 531,S2002LRK, Rosario, Argentina.	vila@ibr.gov.ar		Vila, Alejandro/0000-0002-7978-3233	NIAID NIH HHS [AI056231] Funding Source: Medline; NIBIB NIH HHS [EB001980] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Badarau A, 2007, BIOCHEM J, V401, P197, DOI 10.1042/BJ20061002; Badarau A, 2006, BIOCHEMISTRY-US, V45, P10654, DOI 10.1021/bi060934l; Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BERTINI I, 1983, ACCOUNTS CHEM RES, V16, P272, DOI 10.1021/ar00092a002; BICKNELL R, 1986, BIOCHEMISTRY-US, V25, P7208, DOI 10.1021/bi00370a066; BICKNELL R, 1985, BIOCHEMISTRY-US, V24, P6876, DOI 10.1021/bi00345a021; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Crawford PA, 2005, BIOCHEMISTRY-US, V44, P5168, DOI 10.1021/bi047463s; Crawford PA, 2004, PROTEIN EXPRES PURIF, V36, P272, DOI 10.1016/j.pep.2004.04.017; Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Donaire A, 1998, BIOCHEMISTRY-US, V37, P8659, DOI 10.1021/bi971974f; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fernandez CO, 2003, J BIOL INORG CHEM, V8, P75, DOI 10.1007/s00775-002-0390-y; Fernandez CO, 2001, J AM CHEM SOC, V123, P11678, DOI 10.1021/ja0162515; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; GROWDER MW, 2006, ACCOUNTS CHEM RES, V39, P721; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; INUBUSHI T, 1983, J MAGN RESON, V51, P128, DOI 10.1016/0022-2364(83)90109-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Periyannan GR, 2006, BIOCHEMISTRY-US, V45, P1313, DOI 10.1021/bi051105n; Rasia RM, 2002, BIOCHEMISTRY-US, V41, P1853, DOI 10.1021/bi010933n; Riley EA, 2006, INORG CHEM, V45, P10016, DOI 10.1021/ic061207h; SALGADO J, 1995, EUR J BIOCHEM, V231, P358, DOI 10.1111/j.1432-1033.1995.tb20708.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; VILA AJ, 1994, FEBS LETT, V355, P15, DOI 10.1016/0014-5793(94)01141-9; Vila AJ, 1996, J AM CHEM SOC, V118, P7291, DOI 10.1021/ja9601346; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200	45	54	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30586	30595		10.1074/jbc.M704613200	http://dx.doi.org/10.1074/jbc.M704613200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17715135	hybrid			2022-12-27	WOS:000250136300027
J	Moss, ML; Bomar, M; Liu, Q; Sage, H; Dempsey, P; Lenhart, PM; Gillispie, PA; Stoeck, A; Wildeboer, D; Bartsch, JW; Palmisano, R; Zhou, P				Moss, Marcia L.; Bomar, Martha; Liu, Qian; Sage, Harvey; Dempsey, Peter; Lenhart, Patricia M.; Gillispie, Patricia A.; Stoeck, Alexander; Wildeboer, Dirk; Bartsch, Joerg W.; Palmisano, Ralf; Zhou, Pei			The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; CLEAVAGE; METALLOPROTEINASES; RECEPTOR; ADAM-10; PROTEIN; DOMAIN	ADAM10 is a disintegrin metalloproteinase that processes amyloid precursor protein and ErbB ligands and is involved in the shedding of many type I and type II single membrane-spanning proteins. Like tumor necrosis factor-alpha-converting enzyme (TACE or ADAM17), ADAM10 is expressed as a zymogen, and removal of the prodomain results in its activation. Here we report that the recombinant mouse ADAM10 prodomain, purified from Escherichia coli, is a potent competitive inhibitor of the human ADAM10 catalytic/disintegrin domain, with a K-i of 48 nM. Moreover, the mouse ADAM10 prodomain is a selective inhibitor as it only weakly inhibits other ADAM family proteinases in the micromolar range and does not inhibit members of the matrix metalloproteinase family under similar conditions. Mouse prodomains of TACE and ADAM8 do not inhibit their respective enzymes, indicating that ADAM10 inhibition by its prodomain is unique. In cell-based assays we show that the ADAM10 prodomain inhibits betacellulin shedding, demonstrating that it could be of potential use as a therapeutic agent to treat cancer.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; BioZyme Inc, Apex, NC 27523 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Kings Coll London, Dept Biochem, London SE1 9NH, England; Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany	Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; King's College London; University of Bielefeld	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Rm 242,Nanaline Bldg,Res Dr, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019; Bartsch, Joerg Walter/AAB-2951-2020	Zhou, Pei/0000-0002-7823-3416; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357; Palmisano, Ralf/0000-0003-4283-2115	NIDDK NIH HHS [DK63363, DK59778] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059778, R01DK063363] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Koizumi M, 2002, GASTROENTEROLOGY, V122, pA245; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Moss ML, 2002, ESSAYS BIOCHEM, V38, P141, DOI 10.1042/bse0380141; Naus S, 2006, BIOL CHEM, V387, P337, DOI 10.1515/BC.2006.045; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rasmussen FH, 2004, BIOCHEMISTRY-US, V43, P2987, DOI 10.1021/bi036063m; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Zhou BBS, 2005, EXPERT OPIN INV DRUG, V14, P591, DOI 10.1517/13543784.14.6.591	31	112	112	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35712	35721		10.1074/jbc.M703231200	http://dx.doi.org/10.1074/jbc.M703231200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895248	hybrid			2022-12-27	WOS:000251458100032
J	Ohoka, N; Hattori, T; Kitagawa, M; Onozaki, K; Hayashi, H				Ohoka, Nobumichi; Hattori, Takayuki; Kitagawa, Masatoshi; Onozaki, Kikuo; Hayashi, Hidetoshi			Critical and functional regulation of CHOP (c/EBP homologous protein) through the N-terminal portion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; INITIATION FACTOR-2-ALPHA; MAMMALIAN-CELLS; GENE-EXPRESSION; STRESS; DEGRADATION; UBIQUITIN; KINASE; P53	C/EBP homologous protein (CHOP) is an endoplasmic reticulum stress-inducible protein that plays a critical role in the regulation of programmed cell death; however, the regulation of its function has not been well characterized. We have previously demonstrated that CHOP is regulated by the ubiquitin-proteasome system. In this study, during the process of clarifying the mechanism of the degradation of CHOP, we identified a novel regulation domain of CHOP in its N-terminal portion that is involved in various regulations and functions. The CHOP N-terminal domain is necessary not only for protein degradation but also for its transactivity and interaction with p300. In addition, trichostatin A, a histone deacetylase inhibitor, repressed the degradation of CHOP protein via the N-terminal domain. TRB3, a mammalian tribbles homolog that functions as a repressor of CHOP, also interacted with CHOP via the N-terminal portion and significantly blocked the association of p300 with CHOP. These results suggest that the N-terminal portion of CHOP plays a crucial role in its functional regulation and enable us to identify a novel function of TRB3 as an intracellular antagonist of the p300-binding domain of CHOP.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Nagoya, Aichi 4678603, Japan; Hamamatsu Univ Sch Med, Dept Biochem 1, Hamamatsu, Shizuoka 4313192, Japan	Nagoya City University; Hamamatsu University School of Medicine	Hayashi, H (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	hhayashi@phar.nagoya-cu.ac.jp						Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rorth P, 2000, MOL CELL, V6, P23; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Ubeda M, 2003, J BIOL CHEM, V278, P40514, DOI 10.1074/jbc.M306404200; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	31	61	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35687	35694		10.1074/jbc.M703735200	http://dx.doi.org/10.1074/jbc.M703735200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17872950	hybrid			2022-12-27	WOS:000251458100029
J	Bunka, DHJ; Mantle, BJ; Morten, IJ; Tennent, GA; Radford, SE; Stockley, PG				Bunka, David H. J.; Mantle, Benjamin J.; Morten, Isobel J.; Tennent, Glenys A.; Radford, Sheena E.; Stockley, Peter G.			Production and characterization of RNA aptamers specific for amyloid fibril epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; FORMATION IN-VITRO; PRION-PROTEIN; SYSTEMIC AMYLOIDOSIS; MOLECULAR-MECHANISM; SECONDARY STRUCTURE; ALZHEIMER-DISEASE; CRYSTAL-STRUCTURE; OPERATOR COMPLEX; NEUTRAL PH	One of the most fascinating features of amyloid fibrils is their generic cross-beta architecture that can be formed from many different and completely unrelated proteins. Nonetheless, amyloid fibrils with diverse structural and phenotypic properties can form, both in vivo and in vitro, from the same protein sequence. Here, we have exploited the power of RNA selection techniques to isolate small, structured, single-stranded RNA molecules known as aptamers that were targeted specifically to amyloid-like fibrils formed in vitro from beta(2)-microglobulin (beta(2)m), the amyloid fibril protein associated with dialysis-related amyloidosis. The aptamers bind with high affinity (apparent K-D similar to nM) to beta(2)m fibrils with diverse morphologies generated under different conditions in vitro, as well as to amyloid fibrils isolated from tissues of dialysis-related amyloidosis patients, demonstrating that they can detect conserved epitopes between different fibrillar species of beta(2)m. Interestingly, the aptamers also recognize some other, but not all, amyloid fibrils generated in vitro or isolated from ex vivo sources. Based on these observations, we have shown that although amyloid fibrils share many common structural properties, they also have features that are unique to individual fibril types.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; UCL, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	University of Leeds; University of London; University College London	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk; stockley@bmb.leeds.ac.uk		Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039	Biotechnology and Biological Sciences Research Council [G19036] Funding Source: Medline; Medical Research Council [G0200529] Funding Source: Medline; Wellcome Trust [075099] Funding Source: Medline; MRC [G0200529] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cox JC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf107; Cribbs DH, 1997, J BIOL CHEM, V272, P7431, DOI 10.1074/jbc.272.11.7431; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ellingham M, 2006, RNA, V12, P1970, DOI 10.1261/rna.161006; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Floege J, 1996, NEPHRON, V72, P9, DOI 10.1159/000188801; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, NEW ENGL J MED, V314, P585; GILLMORE JP, 2005, NAT CLIN PRACT, V263, P263; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Jahn TR, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P667, DOI 10.1002/9783527619344.ch26; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; JAHN TR, 2007, IN PRESS ARCH BIOCH; Johansson AS, 2007, FEBS J, V274, P990, DOI 10.1111/j.1742-4658.2007.05647.x; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kreplak L, 2006, ADV PROTEIN CHEM, V73, P217, DOI 10.1016/S0065-3233(06)73007-8; LeVine III H., 1995, INT J EXP CLIN INVES, V2, P1, DOI DOI 10.3109/13506129509031881; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McGregor A, 1999, J BIOL CHEM, V274, P2255, DOI 10.1074/jbc.274.4.2255; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; PARSONS ID, 1995, NUCLEIC ACIDS RES, V23, P211, DOI 10.1093/nar/23.2.211; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Radford SE, 2005, BBA-PROTEINS PROTEOM, V1753, P51, DOI 10.1016/j.bbapap.2005.07.006; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; SAMBROOK I, 2001, MOL CLONING LAB MANU, V2; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Schaffer J, 2000, KIDNEY INT, V58, P873, DOI 10.1046/j.1523-1755.2000.00237.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Tennent GA, 1999, METHOD ENZYMOL, V309, P26; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; VANYPERSELE C, 1996, DIALYSIS AMYLOID, P34; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; White JT, 2001, P NATL ACAD SCI USA, V98, P13019, DOI 10.1073/pnas.241406698; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Wlotzka B, 2002, P NATL ACAD SCI USA, V99, P8898, DOI 10.1073/pnas.132067399; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34500	34509		10.1074/jbc.M703679200	http://dx.doi.org/10.1074/jbc.M703679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878167	Green Published, hybrid			2022-12-27	WOS:000251145700065
J	Qin, J; Fu, HL; Ye, J; Bencze, KZ; Stemmler, TL; Rawlings, DE; Rosen, BP				Qin, Jie; Fu, Hsueh-Liang; Ye, Jun; Bencze, Krisztina Z.; Stemmler, Timothy L.; Rawlings, Douglas E.; Rosen, Barry P.			Convergent evolution of a new arsenic binding site in the ArsR/SmtB family of metalloregulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; ARS OPERON; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; REPRESSOR; PROTEINS; FERROOXIDANS; SELECTIVITY; RESISTANCE; SMTB	Acidithiobacillus ferrooxidans has an arsenic resistance operon that is controlled by an As(III)-responsive transcriptional repressor, AfArsR, a member of the ArsR/SmtB family of metalloregulators. AfArsR lacks the As(III) binding site of the ArsRs from plasmid R773 and Escherichia coli, which have a Cys(32)-Val-Cys(34)-Asp-Leu-Cys(37) sequence in the DNA binding site. In contrast, it has three cysteine residues, Cys(95), Cys(96), and Cys(102), that are not present in the R773 and E. coli ArsRs. The results of direct As(III) binding measurements and x-ray absorption spectroscopy show that these three cysteine residues form a 3-coordinate As(III) binding site. DNA binding studies indicate that binding of As(III) to these cysteine residues produces derepression. Homology modeling indicates that As(III) binding sites in AfArsR are located at the ends of antiparallel C-terminal helices in each monomer that form a dimerization domain. These results suggest that the As(III)-S-3 binding sites in AfArsR and R773 ArsR arose independently at spatially distinct locations in their three-dimensional structures.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Univ Stellenbosch, Dept Microbiol, ZA-7602 Matieland, South Africa	Wayne State University; Stellenbosch University	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	brosen@med.wayne.edu	Ye, Jun/J-8823-2012	Rosen, Barry P./0000-0002-5230-4271	NIAID NIH HHS [R01 AI043428, R01 AI 043428] Funding Source: Medline; NIDDK NIH HHS [R01 DK068139, R01 DK 068139, R01 DK068139-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banci L, 2007, J BIOL CHEM, V282, P30181, DOI 10.1074/jbc.M701119200; BHATTACHARJEE H, 1995, J BIOL CHEM, V270, P11245, DOI 10.1074/jbc.270.19.11245; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; DeLano W. L., 2001, PYMOL USERS MANUAL; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Ramirez-Solis A, 2004, INORG CHEM, V43, P2954, DOI 10.1021/ic0351592; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; SHI WP, 1994, J BIOL CHEM, V269, P19826; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu C, 1999, METALS AND GENETICS, P5; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005	23	65	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34346	34355		10.1074/jbc.M706565200	http://dx.doi.org/10.1074/jbc.M706565200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897948	Green Accepted, hybrid			2022-12-27	WOS:000251145700050
J	Yamaguchi, T; Kimura, J; Miki, Y; Yoshida, K				Yamaguchi, Tomoko; Kimura, Junko; Miki, Yoshio; Yoshida, Kiyotsugu			The deubiquitinating enzyme USP11 controls an I kappa B kinase alpha(IKK alpha)-p53 signaling pathway in response to tumor necrosis factor alpha(TNF alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; P53 TUMOR-SUPPRESSOR; LYN TYROSINE KINASE; APOPTOTIC RESPONSE; IKK-ALPHA; C-DELTA; CELL-DEATH; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION	Post-translational modification and degradation of proteins by the ubiquitin-proteasome system are key regulatory events in cellular responses to various stimuli. The NF-kappa B B signaling pathway is controlled by the ubiquitin-mediated proteolysis. Although mechanisms of ubiquitination in the NF-kappa B pathway have been extensively studied, deubiquitination-mediated regulation of the NF-kappa B signaling remains poorly understood. The present studies show that a deubiquitinating enzyme, USP11, specifically regulates I kappa B kinase alpha (IKK alpha) among the NF-kappa B signaling molecules. Knocking down USP11 attenuates expression of IKK alpha in the transcriptional, but not the post- translational, level. However, down-regulation of USP11 dramatically enhances NF-kappa B activity in response to tumor necrosis factor-alpha, indicating that IKK alpha does not require activation of NF-kappa B. Instead, knock down of USP11 or IKK alpha is associated with abrogation of p53 expression upon exposure to tumor necrosis factor-alpha. In concert with these results, silencing of USP11 is associated with transcriptional attenuation of the p53- responsive genes, such as p21 or Bax. Importantly, the ectopic expression of IKK alpha into cells silenced for USP11 restores p53 expression, demonstrating that USP11 functions as an upstream regulator of an IKK alpha-p53 signaling pathway.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Yoshida, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	yos.mgen@mri.tmd.ac.jp						Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GOTLIEB WH, 1994, AM J OBSTET GYNECOL, V170, P1121, DOI 10.1016/S0002-9378(94)70106-7; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Ladiwala U, 1999, J NEUROCHEM, V73, P605, DOI 10.1046/j.1471-4159.1999.0730605.x; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Yamaguchi T, 2007, CELL SIGNAL, V19, P2088, DOI 10.1016/j.cellsig.2007.06.002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002	35	61	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33943	33948		10.1074/jbc.M706282200	http://dx.doi.org/10.1074/jbc.M706282200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897950	hybrid			2022-12-27	WOS:000251145700007
J	Zhao, KH; Zhang, J; Tu, JM; Boehm, S; Ploescher, M; Eichacker, L; Bubenzer, C; Scheer, H; Wang, X; Zhou, M				Zhao, Kai-Hong; Zhang, Juan; Tu, Jun-Ming; Boehm, Stephan; Ploescher, Matthias; Eichacker, Lutz; Bubenzer, Claudia; Scheer, Hugo; Wang, Xing; Zhou, Ming			Lyase activities of CpcS- and CpcT-like proteins from Nostoc PCC7120 and sequential reconstitution of binding sites of phycoerythrocyanin and phycocyanin beta-subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ATTACHMENT; ANABAENA SP PCC-7120; HOLO-ALPHA SUBUNIT; C-PHYCOCYANIN; CHROMOPHORE ATTACHMENT; CRYSTAL-STRUCTURE; PHYCOBILIPROTEIN LYASE; BILIN LYASE; PHYCOVIOLOBILIN; PHYCOBILISOME	Genes all5292 (cpcS2) and alr0617 (cpcS1) in the cyanobacterium Nostoc PCC7120 are homologous to the biliprotein lyase cpcS, and genes all5339 (cpcT1) and alr0647 (cpcT2) are homologous to the lyase cpcT. The functions of the encoded proteins were screened in vitro and in a heterologous Escherichia coli system with plasmids conferring biosynthesis of the phycocyanobilin chromophore and of the acceptor proteins beta-phycoerythrocyanin (PecB) or beta-phycocyanin (CpcB). CpcT1 is a regioselective biliprotein lyase attaching phycocyanobilin exclusively to cysteine beta 155 but does not discriminate between CpcB and PecB. The in vitro reconstitutions required no cofactors, and kinetic constants were determined for CpcT1 under in vitro conditions. No lyase activity was found for the lyase homologues CpcS2 and CpcT2, but complexes are formed in vitro between CpcT1 and CpcS1, CpcT2, or PecE (subunit of phycoviolobilin: alpha-phycoerythrocyanin isomerase lyase). The genes coding the inactive homologues, cpcS2 and cpcT2, are transcribed in N-starved Nostoc. In sequential binding experiments with CpcT1 and CpcS1, a chromophore at cysteine 84 inhibited the subsequent attachment to cysteine 155, whereas the inverse sequence generates subunits carrying both chromophores.	Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; Huazhong Univ Sci & Technol, Coll Environm Sci & Engn, Wuhan 430074, Hubei, Peoples R China; Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Munich	Zhao, KH (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	khzhao@163.com						Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai YA, 2001, ANAL BIOCHEM, V290, P186, DOI 10.1006/abio.2000.4979; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; DEBRECZENY MP, 1995, J PHYS CHEM-US, V99, P8412, DOI 10.1021/j100020a080; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; EBERLEIN M, ISOLIERUNG SEQUENZIE; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Glazer A. N, 1994, ADV MOL CELL BIOL, V10, P119; GLAZER AN, 1973, J BIOL CHEM, V248, P659; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGARIAS JC, 1988, J BIOL CHEM, V263, P12977; Landgraf FT, 2001, FEBS LETT, V508, P459, DOI 10.1016/S0014-5793(01)02988-X; MOHAMED A, 1989, PLANT MOL BIOL, V13, P693, DOI 10.1007/BF00016024; NAGY JO, 1985, J BIOL CHEM, V260, P4864; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parbel A, 1997, PHOTOSYNTH RES, V54, P25, DOI 10.1023/A:1005877531271; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAUER K, 1988, BIOCHIM BIOPHYS ACTA, V936, P157, DOI 10.1016/0005-2728(88)90232-0; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Shen G., 2004, PS 2004 LIGHT HARV S, P14; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; Wang XQ, 2001, ACTA CRYSTALLOGR D, V57, P784, DOI 10.1107/S0907444901004528; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2002, EUR J BIOCHEM, V269, P4542, DOI 10.1046/j.1432-1033.2002.03148.x; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	60	51	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34093	34103		10.1074/jbc.M703038200	http://dx.doi.org/10.1074/jbc.M703038200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895251	hybrid			2022-12-27	WOS:000251145700024
J	Garcia-Saez, AJ; Chiantia, S; Schwille, P				Garcia-Saez, Ana J.; Chiantia, Salvatore; Schwille, Petra			Effect of line tension on the lateral organization of lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-SEPARATION; DOMAIN MICROSTRUCTURE; PORE FORMATION; RAFTS; MODEL; CHOLESTEROL; DYNAMICS; BAX; SPHINGOMYELIN; UNSATURATION	The principles of organization and functioning of cellular membranes are currently not well understood. The raft hypothesis suggests the existence of domains or rafts in cell membranes, which behave as protein and lipid platforms. They have a functional role in important cellular processes, like protein sorting or cell signaling, among others. Theoretical work suggests that the interfacial energy at the domain edge, also known as line tension, is a key parameter determining the distribution of domain sizes, but there is little evidence of how line tension affects membrane organization. We have investigated the effects of the line tension on the formation and stability of liquid ordered domains in model lipid bilayers with raft-like composition by means of time-lapse confocal microscopy coupled to atomic force microscopy. We varied the hydrophobic mismatch between the two phases, and consequently the line tension, by modifying the thickness of the disordered phase with phosphatidylcholines of different acyl chain length. The temperature of domain formation, the dynamics of domain growth, and the distribution of domain sizes depend strongly on the thickness difference between the domains and the surrounding membrane, which is related to line tension. When considering line tension calculated from a theoretical model, our results revealed a linear increase of the temperature of domain formation and domain growth rate with line tension. Domain budding was also shown to depend on height mismatch. Our experiments contribute significantly to our knowledge of the physical-chemical parameters that control membrane organization. Importantly, the general trends observed can be extended to cellular membranes.	Tech Univ Dresden, Biotechnol Zentrum, D-1307 Dresden, Germany	Technische Universitat Dresden	Schwille, P (corresponding author), Tatzberg 47-51, D-1307 Dresden, Germany.	petra.schwille@biotec.tu-dresden.de	Saez, Ana J. Garcia/U-1611-2019; Chiantia, Salvatore/A-4546-2010; Schwille, Petra/A-4983-2010; Chiantia, Salvatore/U-6363-2019	Chiantia, Salvatore/0000-0003-0791-967X				Akimov SA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011919; Ayton GS, 2005, BIOPHYS J, V88, P3855, DOI 10.1529/biophysj.105.059436; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Blanchette CD, 2007, LANGMUIR, V23, P5875, DOI 10.1021/la7004584; Blanchette CD, 2006, BIOPHYS J, V90, P4466, DOI 10.1529/biophysj.105.072744; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chiantia S, 2006, CHEMPHYSCHEM, V7, P2409, DOI 10.1002/cphc.200600464; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Frolov VAJ, 2006, BIOPHYS J, V91, P189, DOI 10.1529/biophysj.105.068502; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; GARCIASAEZ AJ, 2007, APPL MICROBIOL BIOTE; Hamm M, 1998, EUR PHYS J B, V6, P519, DOI 10.1007/s100510050579; Hamm M, 2000, EUR PHYS J E, V3, P323, DOI 10.1007/s101890070003; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hu YF, 2006, BIOPHYS J, V91, P444, DOI 10.1529/biophysj.106.081000; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; JORGENSEN K, 1995, BIOPHYS J, V69, P942, DOI 10.1016/S0006-3495(95)79968-4; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kohyama T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061905; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Laradji M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198105; Laradji M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.040901; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lin WC, 2007, BIOPHYS J, V92, P2831, DOI 10.1529/biophysj.106.095422; Maulik PR, 1996, BIOPHYS J, V70, P2256, DOI 10.1016/S0006-3495(96)79791-6; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; MOURITSEN OG, 1990, INT J MOD PHYS B, V4, P1925, DOI 10.1142/S0217979290000954; Nicolini C, 2006, J AM CHEM SOC, V128, P192, DOI 10.1021/ja055779x; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Staneva G, 2004, CHEM PHYS LIPIDS, V129, P53, DOI 10.1016/j.chemphyslip.2003.11.005; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wallace EJ, 2006, BIOPHYS J, V90, P4104, DOI 10.1529/biophysj.105.062778; Yanagisawa M, 2007, BIOPHYS J, V92, P115, DOI 10.1529/biophysj.106.087494	50	293	294	4	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33537	10.1074/jbc.M706162200	http://dx.doi.org/10.1074/jbc.M706162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848582	hybrid			2022-12-27	WOS:000250840200034
J	Semtner, M; Schaefer, M; Pinkenburg, O; Plant, TD				Semtner, Marcus; Schaefer, Michael; Pinkenburg, Olaf; Plant, Tim D.			Potentiation of TRPC5 by protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; CAPSAICIN RECEPTOR; HEK293 CELLS; MICE LACKING; ACTIVATION; CURRENTS; TRPV1; NOMENCLATURE; SENSATION; BINDING	Mammalian members of the classical transient receptor potential channel subfamily ( TRPC) are Ca2+-permeable cation channels involved in receptor-mediated increases in intracellular Ca2+. TRPC4 and TRPC5 form a group within the TRPC subfamily and are activated in a phospholipase C-dependent manner by an unidentified messenger. Unlike most other Ca2+-permeable channels, TRPC4 and -5 are potentiated by micromolar concentrations of La3+ and Gd3+. This effect results from an action of the cations at two glutamate residues accessible from the extracellular solution. Here, we show that TRPC4 and -5 respond to changes in extracellular pH. Lowering the pH increased both G protein-activated and spontaneous TRPC5 currents. Both effects were already observed with small reductions in pH ( from 7.4 to 7.0) and increased up to pH 6.5. TRPC4 was also potentiated by decreases in pH, whereas TRPC6 was only inhibited, with a pIC(50) of 5.7. Mutation of the glutamate residues responsible for lanthanoid sensitivity of TRPC5 (E543Q and E595Q) modified the potentiation of TRPC5 by acid. Further evidence for a similarity in the actions of lanthanoids and H+ on TRPC5 is the reduction in single channel conductance and dramatic increase in channel open probability in the presence of either H+ or Gd3+ that leads to larger integral currents. In conclusion, the high sensitivity of TRPC5 to H+ indicates that, in addition to regulation by phospholipase C and other factors, the channel may act as a sensor of pH that links decreases in extracellular pH to Ca2+ entry and depolarization.	Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, D-35032 Marburg, Germany; Charite Campus Benjamin Franklin, Inst Pharmakol, D-14195 Berlin, Germany	Philipps University Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Plant, TD (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Fachbereich Med, Karl Von Frisch Str 1, D-35032 Marburg, Germany.	plant@staff.uni-marburg.de						Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Baumann TK, 2000, J NEUROSCI, V20; Beech D. J., 2007, V179, P109; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; RAMANAN SV, 1992, J NEUROSCI METH, V42, P91, DOI 10.1016/0165-0270(92)90139-5; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Ryu SJ, 2003, J GEN PHYSIOL, V122, P45, DOI 10.1085/jgp.200308847; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Schaefer M, 2001, FASEB J, V15, P1634, DOI 10.1096/fj.00-0824fje; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tousova K, 2005, MOL CELL NEUROSCI, V30, P207, DOI 10.1016/j.mcn.2005.07.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Walker RL, 2001, AM J PHYSIOL-CELL PH, V280, pC1184, DOI 10.1152/ajpcell.2001.280.5.C1184; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zholos AV, 1997, AM J PHYSIOL-GASTR L, V272, pG215, DOI 10.1152/ajpgi.1997.272.2.G215	45	69	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33868	33878		10.1074/jbc.M702577200	http://dx.doi.org/10.1074/jbc.M702577200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884814	hybrid			2022-12-27	WOS:000250840200068
J	Tsutsumi, S; Sugiura, R; Ma, Y; Tokuoka, H; Ohta, K; Ohte, R; Noma, A; Suzuki, T; Kuno, T				Tsutsumi, Satoshi; Sugiura, Reiko; Ma, Yan; Tokuoka, Hideki; Ohta, Kazuki; Ohte, Rieko; Noma, Akiko; Suzuki, Tsutomu; Kuno, Takayoshi			Wobble inosine tRNA modification is essential to cell cycle progression in G(1)/S and G(2)/M transitions in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-DEAMINASE; CYTIDINE DEAMINASE; SEQUENCES; PATHWAY; COMPLEX	Inosine (I) at position 34 (wobble position) of tRNA is formed by the hydrolytic deamination of a genomically encoded adenosine (A). The enzyme catalyzing this reaction, termed tRNA A: 34 deaminase, is the heterodimeric Tad2p/ADAT2 center dot Tad3p/ADAT3 complex in eukaryotes. In budding yeast, deletion of each subunitis lethal, indicating that the wobble inosine tRNA modification is essential for viability; however, most of its physiological roles remain unknown. To identify novel cell cycle mutants in fission yeast, we isolated the tad3-1 mutant that is allelic to the tad3(+) gene encoding a homolog of budding yeast Tad3p. Interestingly, the tad3-1 mutant cells principally exhibited cell cycle-specific phenotype, namely temperature-sensitive and irreversible cell cycle arrest both in G(1) and G(2). Further analyses revealed that in the tad3-1 mutant cells, the S257N mutation that occurred in the catalytically inactive Tad3 subunit affected its association with catalytically active Tad2 subunit, leading to an impairment in the A to I conversion at position 34 of tRNA. In tad3-1 mutant cells, the over expression of the tad3(+) gene completely suppressed the decreased tRNA inosine content. Notably, the overexpression of the tad2(+) gene partially suppressed the temperature-sensitive phenotype and the decreased tRNA inosine content, indicating that the tad3-1 mutant phenotype is because of the insufficient I-34 formation of tRNA. These results suggest that the wobble inosine tRNA modification is essential for cell cycle progression in the G1/S and G2/M transitions in fission yeast.	Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogenom,Chuo Ku, Kobe, Hyogo 6500017, Japan; Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogenom, Higashiosaka, Osaka 5778502, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Kobe University; Kindai University (Kinki University); University of Tokyo	Kuno, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogenom,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tkuno@med.kobe-u.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731				BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bjork Glenn R., 1995, P165; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Curran J. F., 1998, MODIFICATION EDITING, P493; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; HOLLEY RW, 1965, J BIOL CHEM, V240, P2122; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; KOHLI J, 1977, GENETICS, V87, P471; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; OLEINICK NL, 1977, ARCH BIOCHEM BIOPHYS, V182, P171, DOI 10.1016/0003-9861(77)90296-X; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Toda T, 1996, MOL CELL BIOL, V16, P6752; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	23	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33459	10.1074/jbc.M706869200	http://dx.doi.org/10.1074/jbc.M706869200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875641	hybrid			2022-12-27	WOS:000250840200026
J	Goehring, AS; Pedroja, BS; Hinke, SA; Langeberg, LK; Scott, JD				Goehring, April S.; Pedroja, Benjamin S.; Hinke, Simon A.; Langeberg, Lorene K.; Scott, John D.			MyRIP anchors protein kinase a to the exocyst complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; HIGH-AFFINITY BINDING; AKAP SIGNALING COMPLEXES; SLP HOMOLOGY DOMAIN; MOLECULAR CHARACTERIZATION; INSULIN-SECRETION; LINKER PROTEIN; RAB EFFECTOR; MYOSIN VIIA; CAMP	The movement of signal transduction enzymes in and out of multi-protein complexes coordinates the spatial and temporal resolution of cellular events. Anchoring and scaffolding proteins are key to this process because they sequester protein kinases and phosphatases with a subset of their preferred substrates. The protein kinase A-anchoring family of proteins ( AKAPs), which target the cAMP-dependent protein kinase ( PKA) and other enzymes to defined subcellular microenvironments, represent a well studied group of these signal-organizing molecules. In this report we demonstrate that the Rab27a GTPase effector protein MyRIP is a member of the AKAP family. The zebrafish homolog of MyRIP ( Ze-AKAP2) was initially detected in a two-hybrid screen for AKAPs. A combination of biochemical, cell-based, and immunofluorescence approaches demonstrate that the mouse MyRIP ortholog targets the type II PKA holoenzyme via an atypical mechanism to a specific perinuclear region of insulin-secreting cells. Similar approaches show that MyRIP interacts with the Sec6 and Sec8 components of the exocyst complex, an evolutionarily conserved protein unit that controls protein trafficking and exocytosis. These data indicate that MyRIP functions as a scaffolding protein that links PKA to components of the exocytosis machinery.	Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA	Howard Hughes Medical Institute; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	scott@ohsu.edu	Hinke, Simon/R-7120-2019		NHLBI NIH HHS [F32 HL074647, 5F32 HL 074647] Funding Source: Medline; NIGMS NIH HHS [GM 48231, R37 GM048231, R01 GM048231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL074647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Bajjalieh S, 2004, NAT GENET, V36, P216, DOI 10.1038/ng0304-216; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; COGHLAN VM, 1995, BIOCHEM SOC T, V23, P591; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Corbin J D, 1974, Methods Enzymol, V38, P287; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Goldfine ID, 1997, NAT BIOTECHNOL, V15, P1378, DOI 10.1038/nbt1297-1378; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Hisatomi M, 1996, ENDOCRINOLOGY, V137, P4644, DOI 10.1210/en.137.11.4644; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; INAGAKI N, 1994, TRENDS BIOCHEM SCI, V19, P448, DOI 10.1016/0968-0004(94)90128-7; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kuroda TS, 2005, J BIOL CHEM, V280, P28015, DOI 10.1074/jbc.M501465200; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lester LB, 1997, RECENT PROG HORM RES, V52, P409; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Morrison DK, 2001, J CELL SCI, V114, P1609; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 1997, J BIOL CHEM, V272, P23637, DOI 10.1074/jbc.272.38.23637; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Scott JD., 1985, PROC NATLACAD SCI US, V84, P703; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Tegge WJ, 1998, METH MOL B, V87, P99; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	84	37	49	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33155	33167		10.1074/jbc.M705167200	http://dx.doi.org/10.1074/jbc.M705167200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17827149	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000250625400063
J	Hacisalihoglu, A; Panizzi, P; Bock, PE; Camire, RM; Krishnaswamy, S				Hacisalihoglu, Ayse; Panizzi, Peter; Bock, Paul E.; Camire, Rodney M.; Krishnaswamy, Sriram			Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-XA; MACROMOLECULAR SUBSTRATE; BLOOD-COAGULATION; BINDING-SITE; FACTOR-VA; ACTIVATION; COMPLEX; RECOGNITION; SPECIFICITY; PROTEINASE	The preferred pathway for prothrombin activation by prothrombinase involves initial cleavage at Arg(320) to produce meizothrombin, which is then cleaved at Arg(271) to liberate thrombin. Exosite binding drives substrate affinity and is independent of the bond being cleaved. The pathway for cleavage is determined by large differences in V-max for cleavage at the two sites within intact prothrombin. By fluorescence binding studies in the absence of catalysis, we have assessed the ability of the individual cleavage sites to engage the active site of Xa within prothrombinase at equilibrium. Using a panel of recombinant cleavage site mutants, we show that in intact prothrombin, the Arg(320) site effectively engages the active site in a 1: 1 interaction between substrate and enzyme. In contrast, the Arg(271) site binds to the active site poorly in an interaction that is similar to 600-fold weaker. Perceived substrate affinity is independent of active site engagement by either cleavage site. We further show that prior cleavage at the 320 site or the stabilization of the uncleaved zymogen in a proteinase-like state facilitates efficient docking of Arg(271) at the active site of prothrombinase. Therefore, we establish direct relationships between docking of either cleavage site at the active site of the catalyst, the V-max for cleavage at that site, substrate conformation, and the resulting pathway for prothrombin cleavage. Exosite tethering of the substrate in either the zymogen or proteinase conformation dictates which cleavage site can engage the active site of the catalyst and enforces the sequential cleavage of prothrombin by prothrombinase.	Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA	Vanderbilt University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Krishnaswamy, S (corresponding author), 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Panizzi, Peter/A-6072-2019; Krishnaswamy, Sriram/Z-4380-2019	Panizzi, Peter/0000-0003-0141-8807; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, R01HL071544, R37HL071544, R29HL038779, R01HL038779, R00HL094533, P01HL074124] Funding Source: NIH RePORTER; NHLBI NIH HHS [R00 HL094533, P01 HL074124, HL 47465, R01 HL047465, HL 038779, R01 HL038779-21, HL 071544, HL 74124, R01 HL038779, R01 HL071544, R37 HL071544] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKO H, 1974, BIOCHEMISTRY-US, V13, P132, DOI 10.1021/bi00698a021; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Bevington P. R., 1992, DATA REDUCTION ERROR, P161; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire R.M., 2006, HEMOSTASIS THROMBOSI, P59; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FERSHT A, 1977, ENZYME STRUCTURE MEC, P109; Furie B.C., 1976, Methods Enzymol, V45, P191; Hosokawa K, 2001, BIOCHEM J, V354, P309, DOI 10.1042/0264-6021:3540309; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; VINCENT JP, 1974, BIOCHEMISTRY-US, V13, P4205, DOI 10.1021/bi00717a023; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Warshel A, 1998, P NATL ACAD SCI USA, V95, P5950, DOI 10.1073/pnas.95.11.5950; Warshel A, 2001, CHEMBIOCHEM, V2, P109, DOI 10.1002/1439-7633(20010202)2:2<109::AID-CBIC109>3.0.CO;2-9	44	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32974	32982		10.1074/jbc.M706529200	http://dx.doi.org/10.1074/jbc.M706529200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848548	Green Accepted, hybrid			2022-12-27	WOS:000250625400046
J	Chen, X; Molino, C; Liu, L; Gumbiner, BM				Chen, Xuejun; Molino, Caitlyn; Liu, Li; Gumbiner, Barry M.			Structural elements necessary for oligomerization, trafficking, and cell sorting function of paraxial protocadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN SUPERFAMILY; NF-PROTOCADHERIN; C-CADHERIN; TISSUE MORPHOGENESIS; ADHESION ACTIVITY; XENOPUS; DIVERSITY; DIMERIZATION; TAF1/SET; DOMAIN	Protocadherins have been shown to regulate cell adhesion, cell migration, cell survival, and tissue morphogenesis in the embryo and the central nervous system, but little is known about the mechanism of protocadherin function. We previously showed that Xenopus paraxial protocadherin ( PAPC) mediates cell sorting and morphogenesis by down-regulating the adhesion activity of a classical cadherin, C-cadherin. Classical cadherins function by forming lateral dimers that are necessary for their adhesive function. However, it is not known whether oligomerization also plays a role in protocadherin function. We show here that PAPC forms oligomers that are stabilized by disulfide bonds formed between conserved Cys residues in the extracellular domain. Disruption of these disulfide bonds by dithiothreitol or mutation of the conserved cysteines results in defects in oligomerization, post-translational modification, trafficking to the cell surface and cell sorting function of PAPC. Furthermore, none of the residues in the cytoplasmic domain of PAPC is required for its cell sorting activity, whereas both the transmembrane domain and the extracellular domain are necessary. Therefore, protein oligomerization and/or protein interactions via the extracellular and transmembrane domains of PAPC are required for its cell sorting function.	Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Gumbiner, BM (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, POB 800732, Charlottesville, VA 22908 USA.	Gumbiner@virginia.edu	Liu, Li/C-3130-2012		NIGMS NIH HHS [R01-GM052717, F32-GM67752] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067752, R01GM052717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angst BD, 2001, J CELL SCI, V114, P629; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; FREEZE HH, 2006, CURRENT PROTOCOLS PR; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heggem MA, 2003, DEV CELL, V4, P419, DOI 10.1016/S1534-5807(03)00036-4; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rashid D, 2006, DEV BIOL, V291, P170, DOI 10.1016/j.ydbio.2005.12.027; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Suzuki ST, 1996, J CELL SCI, V109, P2609; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5	23	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32128	32137		10.1074/jbc.M705337200	http://dx.doi.org/10.1074/jbc.M705337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823115	hybrid			2022-12-27	WOS:000250480300034
J	Fang, JM; Ruiz, FA; Docampo, M; Luo, SH; Rodrigues, JCF; Motta, LS; Rohloff, P; Docampo, R				Fang, Jianmin; Ruiz, Felix A.; Docampo, Melissa; Luo, Shuhong; Rodrigues, Juliany C. F.; Motta, Lucimar S.; Rohloff, Peter; Docampo, Roberto			Overexpression of a Zn2+-sensitive soluble exopolyphosphatase from Trypanosoma cruzi depletes polyphosphate and affects osmoregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; ALGA DUNALIELLA-SALINA; SACCHAROMYCES-CEREVISIAE; INORGANIC POLYPHOSPHATE; CYTOSOLIC EXOPOLYPHOSPHATASE; H+-PYROPHOSPHATASE; ESCHERICHIA-COLI; ACIDIC VACUOLES; P-31 NMR; ACIDOCALCISOMES	We report the cloning, expression, purification, and characterization of the Trypanosoma cruzi exopolyphosphatase (TcPPX). The product of this gene (TcPPX), has 383 amino acids and a molecular mass of 43.1 kDa. TcPPX differs from most exopolyphosphatases in its preference for short-chain polyphosphate (poly P). Heterologous expression of TcPPX in Escherichia coli produced a functional enzyme that had a neutral optimum pH and was dramatically inhibited by low concentrations of Zn2+, high concentrations of basic amino acids (lysine and arginine), and heparin. TcPPX is a processive enzyme and does not hydrolyze ATP, pyrophosphate, or p-nitrophenyl phosphate, although it hydrolyzes guanosine 5 '-tetraphosphate very efficiently. Overexpression of TcPPX resulted in a dramatic decrease in total short-chain poly P and partial decrease in long-chain poly P. This was accompanied by a delayed regulatory volume decrease after hyposmotic stress. These results support the role of poly P in T. cruzi osmoregulation.	Univ Georgia, Paul D Coverdell Biomed & Hlth Sci Ctr, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Paul D Coverdell Biomed & Hlth Sci Ctr, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@cb.uga.edu	Rodrigues, Juliany Cola Fernandes/X-4977-2019; Ruiz, Felix A./B-1032-2008; Rodrigues, Juliany Cola Fernandes/H-2836-2012; Rohloff, Peter/P-8722-2017	Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; Ruiz, Felix A./0000-0003-0748-5015; Rohloff, Peter/0000-0001-7274-8315	NIAID NIH HHS [R01 AI068647, R01 AI068647-02, AI68647] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIYAMA M, 1993, J BIOL CHEM, V268, P633; ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Andreeva N, 1998, YEAST, V14, P383, DOI 10.1002/(SICI)1097-0061(19980315)14:4<383::AID-YEA232>3.0.CO;2-S; Andreeva NA, 2000, MICROBIOLOGY+, V69, P411, DOI 10.1007/BF02756765; ANDREEVA NA, 1993, YEAST, V9, P127, DOI 10.1002/yea.320090204; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BENTAL M, 1990, EUR J BIOCHEM, V188, P111, DOI 10.1111/j.1432-1033.1990.tb15377.x; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; CASTRO CD, 1995, APPL ENVIRON MICROB, V61, P4448, DOI 10.1128/AEM.61.12.4448-4453.1995; Castrol CD, 1999, BIOTECHNOL PROGR, V15, P65, DOI 10.1021/bp9800743; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; Kulaev IS, 1997, MICROBIOL RES, V152, P221; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lemercier G, 2003, J CHROMATOGR B, V786, P305, DOI 10.1016/S1570-0232(02)00745-6; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lichko LP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P355; Lichko LP, 2003, FEMS YEAST RES, V3, P233, DOI 10.1016/S1567-1356(02)00205-2; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; PICK U, 1991, PLANT PHYSIOL, V97, P1226, DOI 10.1104/pp.97.3.1226; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Sambrook F., 1989, MOL CLONING LAB MANU; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; SHATTON JB, 1983, ANAL BIOCHEM, V130, P114, DOI 10.1016/0003-2697(83)90657-7; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Tammenkoski M, 2007, J BIOL CHEM, V282, P9302, DOI 10.1074/jbc.M609423200; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; WEISS M, 1991, PLANT PHYSIOL, V97, P1241, DOI 10.1104/pp.97.3.1241; WURST H, 1994, J BIOL CHEM, V269, P10996; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; YANG YC, 1993, BIOCHIM BIOPHYS ACTA, V1179, P141, DOI 10.1016/0167-4889(93)90135-C	59	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32501	32510		10.1074/jbc.M704841200	http://dx.doi.org/10.1074/jbc.M704841200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827150	hybrid			2022-12-27	WOS:000250480300073
J	Kimura, N; Ohmori, K; Miyazaki, K; Izawa, M; Matsuzaki, Y; Yasuda, Y; Takematsu, H; Kozutsumi, Y; Moriyama, A; Kannagi, R				Kimura, Naoko; Ohmori, Katsuyuki; Miyazaki, Keiko; Izawa, Mineko; Matsuzaki, Yuji; Yasuda, Yosuke; Takematsu, Hiromu; Kozutsumi, Yasunori; Moriyama, Akihiko; Kannagi, Reiji			Human B-lymphocytes express alpha 2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; SIALYL-LEWIS-X; ADHESION MOLECULE CD22-BETA; N-GLYCOLYLNEURAMINIC ACID; HIGH ENDOTHELIAL VENULES; CELL ACTIVATION; INHIBITORY RECEPTOR; GLYCOSYL FLUORIDES; ANTIGEN RECEPTOR; NATURAL LIGANDS	CD22/Siglec-2, an important inhibitory co-receptor on B-lymphocytes, is known to recognize alpha 2-6-sialylated glycan as a specific ligand. Here we propose that the alpha 2-6-sialylated and 6-GlcNAc-sulfated determinant serves as a preferred ligand for CD22 because the binding of a human B-cell line to CD22 was almost completely abrogated after incubating the cells with NaClO3, an inhibitor of cellular sulfate metabolism, and was also significantly inhibited by a newly generated monoclonal antibody specific to the alpha 2-6-sialylated 6-sulfo-N-acetyllactosamine ( LacNAc) determinant ( KN343, murine IgM). The alpha 2-6-sialylated 6-sulfo-LacNAc determinant defined by the antibody was significantly expressed on a majority of normal human peripheral B-lymphocytes as well as follicular B-lymphocytes in peripheral lymph nodes. The determinant was also expressed in endothelial cells of high endothelial venules of secondary lymphoid tissues, including lymph nodes, tonsils, and intestine-associated lymphoid tissues, more strongly than on B-lymphocytes, suggesting a role for CD22 in B-cell interaction with blood vessels and trafficking. These results indicate that the alpha 2-6-sialylated 6-sulfo-LacNAc determinant serves as an endogenous ligand for human CD22 and suggest the possibility that 6-GlcNAc sulfation as well as alpha 2-6-sialylation may regulate CD22/Siglec-2 functions in humans.	Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Nagoya, Aichi 4648681, Japan; Kyoto Univ, Sch Med, Dept Clin Pathol, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan; Nagoya City Univ, Grad Sch Nat Sci, Div Biomol Sci, Nagoya, Aichi 4678601, Japan	Aichi Cancer Center; Kyoto University; Japan Science & Technology Agency (JST); Seikagaku Corporation; Kyoto University; Nagoya City University	Kannagi, R (corresponding author), Aichi Canc Ctr, Res Inst, Dept Mol Pathol, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	rkannagi@aichi-cc.jp	Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921; Ohmori, Katsuyuki/0000-0002-3794-6970				Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; HELFERICH B, 1952, ADV CARBOHYD CHEM, V7, P209; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUHN R, 1966, CHEM BER-RECL, V99, P611, DOI 10.1002/cber.19660990235; LASZLO G, 1993, J IMMUNOL, V150, P5252; Le Marer N, 1999, J CELL PHYSIOL, V179, P315, DOI 10.1002/(SICI)1097-4652(199906)179:3<315::AID-JCP9>3.0.CO;2-U; MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P3567, DOI 10.1016/0040-4039(88)85294-8; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 2004, TRENDS IMMUNOL, V25, P543, DOI 10.1016/j.it.2004.08.002; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Ohmori K, 2006, BLOOD, V107, P3197, DOI 10.1182/blood-2005-05-2185; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; ROSENBROOK W, 1985, TETRAHEDRON LETT, V26, P3, DOI 10.1016/S0040-4039(00)98450-8; Sato M, 2007, J IMMUNOL, V178, P2901, DOI 10.4049/jimmunol.178.5.2901; SATO S, 1988, TETRAHEDRON LETT, V29, P4097, DOI 10.1016/S0040-4039(00)80426-8; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; TAKADA A, 1993, CANCER RES, V53, P354; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963	44	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32200	32207		10.1074/jbc.M702341200	http://dx.doi.org/10.1074/jbc.M702341200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728258	hybrid			2022-12-27	WOS:000250480300043
J	Joseph, JW; Odegaard, ML; Ronnebaum, SM; Burgess, SC; Muehlbauer, J; Sherry, AD; Newgard, CB				Joseph, Jamie W.; Odegaard, Matthew L.; Ronnebaum, Sarah M.; Burgess, Shawn C.; Muehlbauer, Jeffrey; Sherry, A. Dean; Newgard, Christopher B.			Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; METABOLIC COUPLING FACTORS; NMR ISOTOPOMER ANALYSIS; COENZYME-A ESTERS; MALONYL-COA; PROTEIN ACYLATION; REGULATED ANAPLEROSIS; MAMMALIAN-CELLS; PYRUVATE; ISLETS	It has been proposed that de novo synthesis of long-chain acyl-CoA (LC-CoA) is a signal for glucose-stimulated insulin secretion (GSIS). Key enzymes involved in synthesis of fatty acids from glucose include ATP-citrate lyase ( CL) and fatty acid synthase (FAS). An inhibitor of CL, hydroxycitrate (HC), has been reported to inhibit insulin secretion in some laboratories but not in others. Here we show that high concentrations of NaCl created during preparation of HC by standard methods explain the inhibition of GSIS, and that removal of the excess NaCl prevents the effect. To further investigate the role of CL, two small interfering RNA adenoviruses (Ad-siCL2 and Ad-siCL3) were generated. Ad-siCL3 reduced CLmRNA levels by 92 +/- 6% and CL protein levels by 75 +/- 4% but did not affect GSIS in 832/13 cells compared with cells treated with a control adenovirus (Ad-siControl). Similar results were obtained with Ad-siCL2. Ad-siCL3-treated cells also exhibited a 52 +/- 7% reduction in cytosolic oxaloacetate, an 83 +/- 4% reduction in malonyl-CoA levels, and inhibition of [U-C-14] glucose incorporation into lipid by 43 +/- 4%, all expected metabolic outcomes of CL suppression. Similarly, treatment of 832/ 13 cells with a recombinant adenovirus specific to FAS(Ad-siFAS) reduced FAS mRNA levels by 81 +/- 2% in 832/13 cells, resulting in a 59 +/- 4% decreasein[U-C-14] glucose incorporation intolipid, without affecting GSIS. Finally, treatment of primary rat islets with Ad-siCL3 or Ad-siFAS reduced CL and FAS mRNA levels by 65 +/- 4% and 52 +/- 3%, respectively, but had no effect on GSIS relative to Ad-siControl-treated islets. These findings demonstrate that a normal rate of flux of glucose carbons through CL and FAS is not required for GSIS in insulinoma cell lines or rat islets.	Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; Univ Texas, SW Med Ctr, Ralph & Mary Nell Rogers NMR Ctr, Dept Radiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Adv Imaging Res Ctr, Dept Internal Med, Dallas, TX 75235 USA	Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA.	newga002@mc.duke.edu	Muehlbauer, Jeffrey/G-3607-2011; Sherry, Dean/P-2348-2018	Muehlbauer, Jeffrey/0000-0003-1808-580X; Ronnebaum, Sarah/0000-0003-4787-754X; Sherry, Dean/0000-0001-7150-8301	NIDDK NIH HHS [DK42583, DK58398] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHEN SY, 1994, DIABETES, V43, P878, DOI 10.2337/diabetes.43.7.878; Cheng HY, 2003, AM J PHYSIOL-ENDOC M, V285, pE287, DOI 10.1152/ajpendo.00535.2002; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Fox JEM, 2004, MOL ENDOCRINOL, V18, P679, DOI 10.1210/me.2003-0431; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lawrence DS, 1999, J MED CHEM, V42, P4932, DOI 10.1021/jm980591s; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Matschinsky F.M., 2001, HDB PHYSL 7, P125; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PARVIN R, 1980, ANAL BIOCHEM, V104, P296, DOI 10.1016/0003-2697(80)90078-0; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1991, BIOCHIMIE, V73, P1287, DOI 10.1016/0300-9084(91)90090-N; SRERE PA, 1959, J BIOL CHEM, V234, P2544; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Straub SG, 2002, DIABETES, V51, pS91, DOI 10.2337/diabetes.51.2007.S91; Straub SG, 2007, DIABETES-METAB RES, V23, P146, DOI 10.1002/dmrr.649; Zhao Y, 2007, BIOCHEM PHARMACOL, V74, P273, DOI 10.1016/j.bcp.2007.04.012	53	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31592	31600		10.1074/jbc.M706080200	http://dx.doi.org/10.1074/jbc.M706080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823126	hybrid			2022-12-27	WOS:000250309200051
J	Ling, Y; Li, ZH; Miranda, K; Oldfield, E; Moreno, SNJ				Ling, Yan; Li, Zhu-Hong; Miranda, Kildare; Oldfield, Eric; Moreno, Silvia N. J.			The Farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-LENGTH DETERMINATION; T-CELL-ACTIVATION; IN-VIVO; PYROPHOSPHATE SYNTHASE; ARABIDOPSIS-THALIANA; TRYPANOSOMA-CRUZI; LEISHMANIA-DONOVANI; POTENTIAL ROUTE; BONE-RESORPTION; EXPRESSION	Farnesyl-diphosphate synthase ( FPPS) catalyzes the synthesis of farnesyl diphosphate, an important precursor of sterols, dolichols, ubiquinones, and prenylated proteins. We report the cloning and characterization of two Toxoplasma gondii farnesyldiphosphate synthase ( TgFPPS) homologs. A single genetic locus produces two transcripts, TgFPPS and TgFPPSi, by alternative splicing. Both isoforms were heterologously expressed in Escherichia coli, but only TgFPPS was active. The protein products predicted from the nucleotide sequences have 646 and 605 amino acids and apparent molecular masses of 69.5 and 64.5 kDa, respectively. Several conserved sequence motifs found in other prenyl-diphosphate synthases are present in both TgFPPSs. TgFPPS was also expressed in the baculovirus system and was biochemically characterized. In contrast to the FPPS of other eukaryotic organisms, TgFPPS is bifunctional, catalyzing the formation of both farnesyl diphosphate and geranylgeranyl diphosphate. TgFPPS localizes to the mitochondria, as determined by the co-localisation of the affinity-purified antibodies against the protein with MitoTracker, and in accord with the presence of an N-terminal mitochondria-targeting signal in the protein. This enzyme is an attractive target for drug development, because the order of inhibition of the enzyme by a number of bisphosphonates is the same as that for inhibition of parasite growth. In summary, we report the first bifunctional farnesyl-diphosphate/geranylgeranyl-diphosphate synthase identified in eukaryotes, which, together with previous results, establishes this enzyme as a valid target for the chemotherapy of toxoplasmosis.	Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Moreno, SNJ (corresponding author), Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	smoreno@cb.uga.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045806, Z01AI005093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065307] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR16515-01] Funding Source: Medline; NIAID NIH HHS [AI1968467, 1R01AI045806, AI05093] Funding Source: Medline; NIGMS NIH HHS [GM65307] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON MS, 1989, J BIOL CHEM, V264, P19176; APPELKVIST EL, 1989, EUR J BIOCHEM, V185, P503, DOI 10.1111/j.1432-1033.1989.tb15142.x; Biardi L, 1996, J BIOL CHEM, V271, P1784, DOI 10.1074/jbc.271.3.1784; BLANCHARD L, 1993, GENE, V125, P185, DOI 10.1016/0378-1119(93)90326-X; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Chaudhary K, 2005, J BIOL CHEM, V280, P22053, DOI 10.1074/jbc.M503178200; CHEN AJ, 1993, J BIOL CHEM, V268, P11002; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Fujiwara S, 2004, BIOCHEM BIOPH RES CO, V325, P1066, DOI 10.1016/j.bbrc.2004.10.129; Gossman W, 2002, J MED CHEM, V45, P4868, DOI 10.1021/jm020224n; Grunler J, 1999, FEBS LETT, V455, P233, DOI 10.1016/S0014-5793(99)00892-3; Hemmi H, 2003, EUR J BIOCHEM, V270, P2186, DOI 10.1046/j.1432-1033.2003.03583.x; Hugueney P, 1996, PLANT PHYSIOL, V111, P619, DOI 10.1104/pp.111.2.619; Ibrahim M, 2001, INT J PARASITOL, V31, P1489, DOI 10.1016/S0020-7519(01)00268-5; Kuzuguchi T, 1999, J BIOL CHEM, V274, P5888, DOI 10.1074/jbc.274.9.5888; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; Ling Y, 2005, J MED CHEM, V48, P3130, DOI 10.1021/jm040132t; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Montalvetti A, 2003, J BIOL CHEM, V278, P17075, DOI 10.1074/jbc.M210467200; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Ortiz-Gomez A, 2006, EUKARYOT CELL, V5, P1057, DOI 10.1128/EC.00034-06; Parmryd I, 1999, ARCH BIOCHEM BIOPHYS, V364, P153, DOI 10.1006/abbi.1999.1134; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8; Roullet E, 1999, J NEUROL, V246, P237, DOI 10.1007/s004150050341; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; SHEARES BT, 1989, BIOCHEMISTRY-US, V28, P8129, DOI 10.1021/bi00446a025; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Szabo CM, 2002, J MED CHEM, V45, P2894, DOI 10.1021/jm010279+; Szabo CM, 2002, J MED CHEM, V45, P2185, DOI 10.1021/jm010412y; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; Toursel C, 2000, MOL BIOCHEM PARASIT, V111, P319, DOI 10.1016/S0166-6851(00)00324-8; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang K, 1999, TRENDS BIOCHEM SCI, V24, P445, DOI 10.1016/S0968-0004(99)01464-4; Yardley V, 2002, ANTIMICROB AGENTS CH, V46, P929, DOI 10.1128/AAC.46.3.929-931.2002; Zhu XF, 1997, PLANT MOL BIOL, V35, P331, DOI 10.1023/A:1005898805326	51	72	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30804	30816		10.1074/jbc.M703178200	http://dx.doi.org/10.1074/jbc.M703178200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724033	hybrid			2022-12-27	WOS:000250136300049
J	Dong, XY; Patino-Lopez, G; Candotti, F; Shaw, S				Dong, Xiaoyun; Patino-Lopez, Genaro; Candotti, Fabio; Shaw, Stephen			Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation - Evidence that WIP-WASP dissociation is not required and that the WIPNH2 terminus is inhibitory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; SYNDROME PROTEIN WASP; ACTIN POLYMERIZATION; INTERACTING PROTEIN; NUCLEAR TRANSLOCATION; MOLECULAR-BASIS; EVH1 DOMAIN; N-WASP; GENE; COMPLEX	WASP and its binding partner WIP play important roles in T cells both in actin polymerization and in interleukin-2 transcription. Aberrations thereof contribute to the pathology of Wiskott-Aldrich syndrome ( WAS). To directly evaluate the cooperativity of WIP and WASP in interleukin-2 transcription, we investigated how the WIP-WASP complex regulates NF-AT-mediated gene transcription. We developed an improved model system for analysis, using WIP and WASP cotransfection into Jurkat cells, in which strong induction of NFAT reporter activation is observed with anti-T cell receptor (TCR) antibody without the phorbol 12-myristate 13-acetate usually used previously. Using this system, our findings contradict a prevailing conceptual model of TCR-induced WIP-WASP dissociation by showing in three ways that the WIP-WASP complex mediates TCR-induced NFAT activation without dissociation. First, phosphorylation of WIP Ser(488) does not cause dissociation of the WIP-WASP complex. Second, WIP-WASP complexes do not dissociate demonstrably after TCR stimulation. Third, a fusion protein of WIP to WASP efficiently mediates NFAT activation. Next, our studies clarify that WIP stabilization of WASP explains otherwise unexpected results in TCR-induced NFAT activation. Finally, we find that the NH2 terminus of WIP is a highly inhibitory region for TCR-mediated transcriptional activation in which at least two elements contribute: the NH2-terminal polyproline and the NH2-terminal actin-binding WH2 domain. This suggests that WIP, like WASP, is subject to autoinhibition. Our data indicate that the WIP-WASP complex plays an important role in WASP stabilization and NFAT activation.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Shaw, S (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36,10 Ctr Dr,MSC 1360, Bethesda, MD 20892 USA.	sshaw@nih.gov	Patino-Lopez, Genaro/O-3484-2018; Patiño López, Genaro/GQI-4414-2022	Patino-Lopez, Genaro/0000-0002-8716-722X; Candotti, Fabio/0000-0001-6399-6042	Intramural NIH HHS [Z01 BC009257-31, Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009257, Z01BC010272] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000122] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abo A, 1998, CELL MOL LIFE SCI, V54, P1145, DOI 10.1007/s000180050242; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Huang W, 2005, J IMMUNOL, V174, P2602, DOI 10.4049/jimmunol.174.5.2602; Imai K, 2003, CURR OPIN ALLERGY CL, V3, P427, DOI 10.1097/01.all.0000104452.09202.9c; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kettner A, 2004, J EXP MED, V199, P357, DOI 10.1084/jem.20030652; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Koduru S, 2007, BIOCHEM BIOPH RES CO, V353, P875, DOI 10.1016/j.bbrc.2006.12.079; Konno A, 2007, INT IMMUNOL, V19, P185, DOI 10.1093/intimm/dxl135; Meng L, 2007, BIOCHEM BIOPH RES CO, V357, P289, DOI 10.1016/j.bbrc.2007.03.144; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Rajmohan R, 2006, BIOCHEM BIOPH RES CO, V342, P529, DOI 10.1016/j.bbrc.2006.01.160; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sato M, 2005, FEBS J, V272, P6131, DOI 10.1111/j.1742-4658.2005.05011.x; Sato M, 2001, J IMMUNOL, V167, P4701, DOI 10.4049/jimmunol.167.8.4701; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Sawa M, 2006, BIOCHEM BIOPH RES CO, V340, P709, DOI 10.1016/j.bbrc.2005.12.056; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; Stewart DM, 1999, J IMMUNOL, V162, P5019; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Wada T, 2002, HUM GENE THER, V13, P1039, DOI 10.1089/104303402753812449	33	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30303	30310		10.1074/jbc.M704972200	http://dx.doi.org/10.1074/jbc.M704972200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711847	Green Accepted, hybrid			2022-12-27	WOS:000249981200061
J	Wu, XL; Ge, HF; Gupte, J; Weiszmann, J; Shimamoto, G; Stevens, J; Hawkins, N; Lemon, B; Shen, WY; Xu, J; Veniant, MM; Li, YS; Lindberg, R; Chen, JL; Tian, H; Li, Y				Wu, Xinle; Ge, Hongfei; Gupte, Jamila; Weiszmann, Jennifer; Shimamoto, Grant; Stevens, Jennitte; Hawkins, Nessa; Lemon, Bryan; Shen, Wenyan; Xu, Jing; Veniant, Murielle M.; Li, Yue-Sheng; Lindberg, Richard; Chen, Jin-Long; Tian, Hui; Li, Yang			Co-receptor requirements for fibroblast growth factor-19 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; METABOLIC-RATE; RECEPTOR; KLOTHO; MICE; SPECIFICITY; SUPPRESSION; FAMILY	FGF19 is a unique member of the fibroblast growth factor (FGF) family of secreted proteins that regulates bile acid homeostasis and metabolic state in an endocrine fashion. Here we investigate the cell surface receptors required for signaling by FGF19. We show that beta Klotho, a single-pass transmembrane protein highly expressed in liver and fat, induced ERK1/2 phosphorylation in response to FGF19 treatment and significantly increased the interactions between FGF19 and FGFR4. Interestingly, our results show that alpha Klotho, another Klotho family protein related to beta Klotho, also induced ERK1/2 phosphorylation in response to FGF19 treatment and increased FGF19-FGFR4 interactions in vitro, similar to the effects of beta Klotho. In addition, heparin further enhanced the effects of both beta Klotho and beta Klotho in FGF19 signaling and interaction experiments. These results suggest that a functional FGF19 receptor may consist of FGF receptor (FGFR) and heparan sulfate complexed with either alpha Klotho or beta Klotho.	Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA.	yangl@amgen.com	LI, Yue/GRS-8071-2022					Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukagawa M, 2005, CURR OPIN NEPHROL HY, V14, P325, DOI 10.1097/01.mnh.0000172717.49476.80; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houten SM, 2006, CELL METAB, V4, P423, DOI 10.1016/j.cmet.2006.11.006; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	24	111	129	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2007	282	40					29069	29072		10.1074/jbc.C700130200	http://dx.doi.org/10.1074/jbc.C700130200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	215DH	17711860	hybrid			2022-12-27	WOS:000249788000001
J	Nika, K; Tautz, L; Arimura, Y; Vang, T; Williams, S; Mustelin, T				Nika, Konstantina; Tautz, Lutz; Arimura, Yutaka; Vang, Torkel; Williams, Scott; Mustelin, Tomas			A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; TERMINAL SRC KINASE; LEUKOCYTE-COMMON ANTIGEN; SH2 DOMAIN; ZETA-CHAIN; PHOSPHOTYROSINE PHOSPHATASE; NEGATIVE REGULATION; HOMOLOGY-2 DOMAIN; ADAPTER PROTEIN; ZAP-70 KINASE	Src family kinases are suppressed by a "tail bite" mechanism, in which the binding of a phosphorylated tyrosine in the C terminus of the protein to the Src homology (SH)2 domain in the N-terminal half of the protein forces the catalytic domain into an inactive conformation stabilized by an additional SH3 interaction. In addition to this intramolecular suppressive function, the SH2 domain also mediates intermolecular interactions, which are crucial for T cell antigen receptor (TCR) signaling. To better understand the relative importance of these two opposite functions of the SH2 domain of the Src family kinase Lck in TCR signaling, we created three mutants of Lck in which the intramolecular binding of the C terminus to the SH2 domain was strengthened. The mutants differed from wild-type Lck only in one to three amino acid residues following the negative regulatory tyrosine 505, which was normally phosphorylated by Csk and dephosphorylated by CD45 in the mutants. In the Lck-negative JCaM1 cell line, the Lck mutants had a much reduced ability to transduce signals from the TCR in a manner that directly correlated with SH2-Tyr(P)(505) affinity. The mutant with the strongest tail bite was completely unable to support any ZAP-70 phosphorylation, mitogen-activated protein kinase activation, or downstream gene activation in response to TCR ligation, whereas other mutants had intermediate abilities. Lipid raft targeting was not affected. We conclude that Lck is regulated by a weak tail bite to allow for its activation and service in TCR signaling, perhaps through a competitive SH2 engagement mechanism.	Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Program Signal Transduct, Ctr Canc, La Jolla, CA 92037 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of Oxford	Nika, K (corresponding author), Burnham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	konstantina.nika@path.ox.ac.uk; tomasm@amgen.com	Tautz, Lutz/M-9989-2014	Tautz, Lutz/0000-0002-4075-6238; Mustelin, Tomas/0000-0001-5912-8840; Nika, Konstantina/0000-0002-9620-0263	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035603, R01AI053585] Funding Source: NIH RePORTER; NIAID NIH HHS [AI53585, AI35603] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Ayrapetov MK, 2006, J BIOL CHEM, V281, P23776, DOI 10.1074/jbc.M604219200; BANIYASH M, 1988, J BIOL CHEM, V263, P18225; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Choi YB, 1999, J IMMUNOL, V163, P5242; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Couture C, 1996, J BIOL CHEM, V271, P24294, DOI 10.1074/jbc.271.39.24294; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Hardwick JS, 1997, J BIOL CHEM, V272, P25429, DOI 10.1074/jbc.272.41.25429; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; LUO K, 1990, ONCOGENE, V5, P921; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; Marti F, 2001, J EXP MED, V193, P1425, DOI 10.1084/jem.193.12.1425; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1989, IMMUNOL TODAY, V10, P189, DOI 10.1016/0167-5699(89)90322-8; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; MUSTELIN T, 1990, ONCOGENE, V5, P809; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; MUSTELIN T, 1994, SRC FAMILY TYROSINE, P1; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Nika K, 2006, MOL CELL BIOL, V26, P1806, DOI 10.1128/MCB.26.5.1806-1816.2006; OETKEN C, 1994, MOL IMMUNOL, V31, P1295, DOI 10.1016/0161-5890(94)90047-7; OSTERGAARD HL, 1990, J EXP MED, V172, P347, DOI 10.1084/jem.172.1.347; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Perez-Villar JJ, 1999, J IMMUNOL, V163, P6435; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SEFTON BM, 1991, ONCOGENE, V6, P683; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TAKEMOTO Y, 1995, EMBO J, V14, P3403, DOI 10.1002/j.1460-2075.1995.tb07346.x; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang YM, 2003, MOL CELL BIOL, V23, P7667, DOI 10.1128/MCB.23.21.7667-7677.2003; Yaqub S, 2003, BIOCHEM J, V372, P271, DOI 10.1042/BJ20030021; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhou J, 1998, EUR J IMMUNOL, V28, P1645, DOI 10.1002/(SICI)1521-4141(199805)28:05<1645::AID-IMMU1645>3.0.CO;2-D; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	68	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36000	36009		10.1074/jbc.M702779200	http://dx.doi.org/10.1074/jbc.M702779200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897955	hybrid			2022-12-27	WOS:000251458100060
J	Brooks, NL; Trent, CM; Raetzsch, CF; Flurkey, K; Boysen, G; Perfetti, MT; Jeong, YC; Klebanov, S; Patel, KB; Khodush, VR; Kupper, LL; Carling, D; Swenberg, JA; Harrison, DE; Combs, TP				Brooks, Natasha L.; Trent, Chad M.; Raetzsch, Carl F.; Flurkey, Kevin; Boysen, Gunnar; Perfetti, Michael T.; Jeong, Yo-Chan; Klebanov, Simon; Patel, Kajal B.; Khodush, Valerie R.; Kupper, Lawrence L.; Carling, David; Swenberg, James A.; Harrison, David E.; Combs, Terry P.			Low utilization of circulating glucose after food withdrawal in Snell dwarf mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; LIFE-SPAN; PLASMA-GLUCOSE; CALORIC RESTRICTION; OXIDATIVE STRESS; GENE-EXPRESSION; AGING RATS; COMPLEX I	Glucose metabolism is altered in long-lived people and mice. Although it is clear that there is an association between altered glucose metabolism and longevity, it is not known whether this link is causal or not. Our current hypothesis is that decreased fasting glucose utilization may increase longevity by reducing oxygen radical production, a potential cause of aging. We observed that whole body fasting glucose utilization was lower in the Snell dwarf, a long-lived mutant mouse. Whole body fasting glucose utilization may be reduced by a decrease in the production of circulating glucose. Our isotope labeling analysis indicated both gluconeogenesis and glycogenolysis were suppressed in Snell dwarfs. Elevated circulating adiponectin may contribute to the reduction of glucose production in Snell dwarfs. Adiponectin lowered the appearance of glucose in the media over hepatoma cells by suppressing gluconeogenesis and glycogenolysis. The suppression of glucose production by adiponectin in vitro depended on AMP-activated protein kinase, a cell mediator of fatty acid oxidation. Elevated fatty acid oxidation was indicated in Snell dwarfs by increased utilization of circulating oleic acid, reduced intracellular triglyceride content, and increased phosphorylation of acetyl-CoA carboxylase. Finally, protein carbonyl content, a marker of oxygen radical damage, was decreased in Snell dwarfs. The correlation between high glucose utilization and elevated oxygen radical production was also observed in vitro by altering the concentrations of glucose and fatty acids in the media or pharmacologic inhibition of glucose and fatty acid oxidation with 4-hydroxycyanocinnamic acid and etomoxir, respectively.	Univ N Carolina, Sch Publ Hlth, Dept Nutr, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Jackson Lab, Bar Harbor, ME 04609 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10025 USA; Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; Columbia University; Imperial College London	Combs, TP (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Nutr, Sch Med, Chapel Hill, NC 27599 USA.	terrycombs@unc.edu	Carling, David/F-1943-2014; Boysen, Gunnar/U-3272-2019	Carling, David/0000-0002-2316-1830; Boysen, Gunnar/0000-0001-8364-9881	Medical Research Council [MC_U120027537] Funding Source: Medline; NIA NIH HHS [AG18003, AG025007] Funding Source: Medline; NIDDK NIH HHS [DK075573, DK056350] Funding Source: Medline; NIEHS NIH HHS [ES10126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075573, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018003, R01AG025007] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Regaiey KA, 2007, J GERONTOL A-BIOL, V62, P18, DOI 10.1093/gerona/62.1.18; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; BARON AD, 1985, J CLIN INVEST, V76, P1782, DOI 10.1172/JCI112169; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Basu R, 2004, AM J PHYSIOL-ENDOC M, V287, pE55, DOI 10.1152/ajpendo.00549.2003; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BORG KE, 1995, P SOC EXP BIOL MED, V210, P126; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; CHERRINGTON AD, 1978, METABOLISM, V27, P787, DOI 10.1016/0026-0495(78)90213-5; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; DACOSTA KA, 1993, J BIOL CHEM, V268, P2100; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985; HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1; Hauck SJ, 2001, EXP BIOL MED, V226, P552; Hill AG, 1998, BRIT J SURG, V85, P884; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P9913, DOI 10.1073/pnas.171319498; Knutson VP, 2000, ENDOCRINOLOGY, V141, P693, DOI 10.1210/en.141.2.693; KRUSZYNSKA YT, 1987, BIOCHEM PHARMACOL, V36, P3917, DOI 10.1016/0006-2952(87)90458-8; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LANG CH, 1987, METABOLISM, V36, P180, DOI 10.1016/0026-0495(87)90015-1; Leiser SF, 2006, MECH AGEING DEV, V127, P821, DOI 10.1016/j.mad.2006.08.003; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0; MCCARTER R, 1985, AM J PHYSIOL, V248, pE488; Merrill CL, 2002, TOXICOL SCI, V68, P93, DOI 10.1093/toxsci/68.1.93; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; MIRAND EA, 1953, P SOC EXP BIOL MED, V82, P746; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Paolisso G, 1996, AM J PHYSIOL-ENDOC M, V270, pE890, DOI 10.1152/ajpendo.1996.270.5.E890; PINKERTON W, 1964, P SOC EXP BIOL MED, V116, P959, DOI 10.3181/00379727-116-29420; Previs SF, 1996, J MASS SPECTROM, V31, P639, DOI 10.1002/(SICI)1096-9888(199606)31:6<639::AID-JMS336>3.0.CO;2-S; ROSSETTI L, 1991, DIABETES, V40, P444, DOI 10.2337/diabetes.40.4.444; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; ROYLE GT, 1983, J SURG RES, V34, P187, DOI 10.1016/0022-4804(83)90059-8; SHIPLEY RA, 1972, TRACER METHODS IN VI, P1; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VERDONK CA, 1981, DIABETES, V30, P535, DOI 10.2337/diabetes.30.6.535; WITTERS LA, 1991, BIOCHEM BIOPH RES CO, V181, P1486, DOI 10.1016/0006-291X(91)92107-U; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	70	37	37	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35069	35077		10.1074/jbc.M700484200	http://dx.doi.org/10.1074/jbc.M700484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905742	Green Published, hybrid			2022-12-27	WOS:000251155200051
J	Pothacharoen, P; Kalayanamitra, K; Deepa, SS; Fukui, S; Hattori, T; Fukushima, N; Hardingham, T; Kongtawelert, P; Sugahara, K				Pothacharoen, Peraphan; Kalayanamitra, Kittiwan; Deepa, Sarama S.; Fukui, Shigeyuki; Hattori, Tomohide; Fukushima, Nobuhiro; Hardingham, Timothy; Kongtawelert, Prachya; Sugahara, Kazuyuki			Two related but distinct chondroitin sulfate mimetope octasaccharide sequences recognized by monoclonal antibody WF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHARK CARTILAGE; NEURITE OUTGROWTH; DERMATAN SULFATE; SYNOVIAL-FLUID; D-ORBITALS; TESTICULAR HYALURONIDASE; PROTEOGLYCAN METABOLISM; FORCE-FIELD; OSTEOARTHRITIS; EPITOPE	Chondroitin sulfate (CS) proteoglycans are major components of cartilage and other connective tissues. The monoclonal antibody WF6, developed against embryonic shark cartilage CS, recognizes an epitope in CS chains, which is expressed in ovarian cancer and variably in joint diseases. To elucidate the structure of the epitope, we isolated oligosaccharide fractions from a partial chondroitinase ABC digest of shark cartilage CS-C and established their chain length, disaccharide composition, sulfate content, and sulfation pattern. These structurally defined oligosaccharide fractions were characterized for binding to WF6 by enzyme-linked immunosorbent assay using an oligosaccharide microarray prepared with CS oligosaccharides derivatized with a fluorescent aminolipid. The lowest molecular weight fraction recognized by WF6 contained octasaccharides, which were split into five subfractions. The most reactive subfraction contained several distinct octasaccharide sequences. Two octasaccharides, Delta D-C-C-C and Delta C-C-A-D ( where A represents GlcUA beta 1-3GalNAc(4-O-sulfate), C is GlcUA beta 1-3GalNAc(6-O-sulfate), D is GlcUA(2-O-sulfate)beta 1-3GalNAc(6-Osulfate), Delta C is Delta(4,5)HexUA alpha 1-3GalNAc(6-O-sulfate), and Delta D is Delta(4,5)HexUA(2-O-sulfate)alpha 1-3GalNAc(6-O-sulfate)), were recognized by WF6, but other related octasaccharides, Delta C-A- D-C and Delta C-C-C-C, were not. The structure and sequences of both the binding and nonbinding octasaccharides were compared by computer modeling, which revealed a remarkable similarity between the shape and distribution of the electrostatic potential in the two different octasaccharide sequences that bound to WF6 and that differed from the nonbinding octasaccharides. The strong similarity in structure predicted for the two binding CS octasaccharides (Delta D-C-C-C and Delta C-C-A-D) provided a possible explanation for their similar affinity for WF6, although they differed in sequence and thus form two specific mimetopes for the antibody.	Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan; Chiang Mai Univ, Thailand Excellence Ctr Tissue Engn, Dept Biochem, Fac Med, Chiang Mai 50200, Thailand; Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Kyoto Sangyo Univ, Dept Biotechnol, Fac Engn, Kyoto 6038558, Japan; Sci & Technol Syst Inc, Shibuya Ku, Tokyo 1500002, Japan; Univ Manchester, United Kingdom Ctr Tissue Engn, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	Hokkaido University; Chiang Mai University; Kobe Pharmaceutical University; Kyoto Sangyo University; University of Manchester; University of Manchester	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Nishi 11 Choume,Kita 21 Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	Pothacharoen, Peraphan/GZG-6521-2022	Pothacharoen, Peraphan/0000-0002-8560-553X; kongtawelert, prachya/0000-0002-5963-2796; Hardingham, Timothy/0000-0001-8271-6763; Deepa, Sathyaseelan/0000-0002-3669-4820	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BAKER J, 1986, J COMPUT CHEM, V7, P385, DOI 10.1002/jcc.540070402; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brown MP, 1998, AM J VET RES, V59, P786; CATERSON B, 1990, J CELL SCI, V97, P411; CATERSON B, 1990, BIOCHEM SOC T, V18, P820, DOI 10.1042/bst0180820; Caterson B, 1995, ACTA ORTHOP SCAND, V66, P121, DOI 10.3109/17453679509157666; Clark T, 1995, J MOL MODEL, V1, P22, DOI 10.1007/s008940050004; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; FernaudEspinosa I, 1996, J NEUROBIOL, V30, P410, DOI 10.1002/(SICI)1097-4695(199607)30:3<410::AID-NEU9>3.0.CO;2-7; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HARDINGHAM TE, 1994, CARBOHYD RES, V255, P241, DOI 10.1016/S0008-6215(00)90982-0; HAZELL PK, 1995, ARTHRITIS RHEUM, V38, P953, DOI 10.1002/art.1780380711; HEINEGARD D, 1977, J BIOL CHEM, V252, P1980; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Johnson KA, 2002, AM J VET RES, V63, P775, DOI 10.2460/ajvr.2002.63.775; JUHASZ P, 1995, CARBOHYD RES, V270, P131, DOI 10.1016/0008-6215(94)00012-5; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; KONGTAWELERT P, 2005, Patent No. 2005118645; Letourneau PC, 1992, CURR OPIN GENET DEV, V2, P625, DOI 10.1016/S0959-437X(05)80183-2; Lewis S, 1999, ANN RHEUM DIS, V58, P441, DOI 10.1136/ard.58.7.441; Li H, 1995, J MOL EVOL, V41, P878; LOHMANDER LS, 1991, ACTA ORTHOP SCAND, V62, P623, DOI 10.3109/17453679108994513; Lohmander LS, 1997, J RHEUMATOL, V24, P782; MARK MP, 1989, DEV BIOL, V133, P475, DOI 10.1016/0012-1606(89)90051-1; MARK MP, 1990, DIFFERENTIATION, V43, P37, DOI 10.1111/j.1432-0436.1990.tb00428.x; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Nadanaka S, 1997, GLYCOBIOLOGY, V7, P253, DOI 10.1093/glycob/7.2.253; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Politzer P, 1991, REV COMPUTATIONAL CH, V2, P273, DOI [10.1002/wcms.1326, DOI 10.1002/9780470125793.CH7]; Pothacharoen P, 2006, OSTEOARTHR CARTILAGE, V14, P299, DOI 10.1016/j.joca.2005.10.005; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; RAPPE AK, 1993, INORG CHEM, V32, P3438, DOI 10.1021/ic00068a012; RAUHUT G, 1993, J COMPUT CHEM, V14, P503, DOI 10.1002/jcc.540140502; RAUHUT G, 1993, J AM CHEM SOC, V115, P9174, DOI 10.1021/ja00073a036; RAUHUT G, 1993, J AM CHEM SOC, V115, P9127, DOI 10.1021/ja00073a031; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393, DOI 10.1177/38.3.1689338; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, GLYCOCONJUGATE J, V13, P609, DOI 10.1007/BF00731449; Sugahara K, 1996, EUR J BIOCHEM, V239, P871, DOI 10.1111/j.1432-1033.1996.0871u.x; THIEL W, 1992, THEOR CHIM ACTA, V81, P391, DOI 10.1007/BF01134863; THIEL W, 1994, J MOL STRUC-THEOCHEM, V119, P141, DOI 10.1016/0166-1280(94)85037-2; Thiel W, 1996, J PHYS CHEM-US, V100, P616, DOI 10.1021/jp952148o; TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013; Voityuk AA, 2000, J PHYS CHEM A, V104, P4089, DOI 10.1021/jp994394w; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamaguchi K, 2006, GLYCOCONJUGATE J, V23, P513, DOI 10.1007/s10719-006-7151-z	65	32	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35232	35246		10.1074/jbc.M702255200	http://dx.doi.org/10.1074/jbc.M702255200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884822	Green Submitted, hybrid			2022-12-27	WOS:000251155200068
J	Wei, L; Laurence, A; Elias, KM; O'Shea, JJ				Wei, Lai; Laurence, Arian; Elias, Kevin M.; O'Shea, John J.			IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; GENE-EXPRESSION; RECEPTOR; DIFFERENTIATION; CYTOKINE; INTERLEUKIN-21; INFLAMMATION; INTERFERON; ACTIVATION; MECHANISMS	CD4(+) helper T cells can differentiate into several possible fates including: Th1, Th2, T regulatory, and Th17 cells. Although, cytokine production by non-T cells is an important factor in helper T cell differentiation, a characteristic feature of both Th1 and Th2 lineages is their ability to secrete cytokines that promote their respective differentiation. However, cytokines produced by T cells that help to sustain Th17 cells have not yet been identified. Here we show that IL-21 is a product of Th17 cells, which is induced in a Stat3-dependent manner. Additionally, Stat3 can directly bind the Il21 promoter. IL-21 also induces IL-17 production and expression of the transcription factor, ROR gamma t. Furthermore, generation of Th17 cells in the conventional manner is attenuated by blocking IL-21. IL-21 is known to activate Stat3 and its ability to induce Th17 differentiation is abrogated in the absence of Stat3. These data argue that IL-21 serves as an autocrine factor secreted by Th17 cells that promotes or sustains Th17 lineage commitment.	NIH, NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; NIH, Howard Hughes Med Inst, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Wei, L (corresponding author), NIH, NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	weil2@mail.nih.gov	Laurence, Arian/A-8770-2009; Wei, Lai/D-1088-2014	Laurence, Arian/0000-0003-0942-8292; Elias, Kevin/0000-0003-1502-5553	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, Z01AR041159] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AR041106-13] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	28	487	522	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34605	34610		10.1074/jbc.M705100200	http://dx.doi.org/10.1074/jbc.M705100200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884812	Green Accepted, hybrid			2022-12-27	WOS:000251155200002
J	Zhou, YB; Yang, W; Lurtz, MM; Ye, YM; Huang, Y; Lee, HW; Chen, YY; Louis, CF; Yang, JJ				Zhou, Yubin; Yang, Wei; Lurtz, Monica M.; Ye, Yiming; Huang, Yun; Lee, Hsiau-Wei; Chen, Yanyi; Louis, Charles F.; Yang, Jenny J.			Identification of the calmodulin binding domain of connexin 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; GAP-JUNCTION CHANNELS; SPECTROSCOPIC CHARACTERIZATION; SECONDARY STRUCTURE; TARGET RECOGNITION; PEPTIDE; CALCIUM; COMPLEX; CA2+; AFFINITY	Calmodulin (CaM) has been implicated in mediating the Ca2+-dependent regulation of gap junctions. This report identifies a CaM-binding motif comprising residues 136-158 in the intracellular loop of Cx43. A 23-mer peptide encompassing this CaM-binding motif was shown to bind Ca2+-CaM with 1: 1 stoichiometry by using various biophysical approaches, including surface plasmon resonance, circular dichroism, fluorescence spectroscopy, and NMR. Far UV circular dichroism studies indicated that the Cx43-derived peptide increased its alpha-helical contents on CaM binding. Fluorescence and NMR studies revealed conformational changes of both the peptide and CaM following formation of the CaM-peptide complex. The apparent dissociation constant of the peptide binding to CaM in physiologic K+ is in the range of 0.7-1 mu M. Upon binding of the peptide to CaM, the apparent K-d of Ca2+ for CaM decreased from 2.9 +/- 0.1 to 1.6 +/- 0.1 mu M, and the Hill coefficient n(H) increased from 2.1 +/- 0.1 to 3.3 +/- 0.5. Transient expression in HeLa cells of two different mutant Cx43-EYFP constructs without the putative Cx43 CaM-binding site eliminated the Ca2+- dependent inhibition of Cx43 gap junction permeability, confirming that residues 136-158 in the intracellular loop of Cx43 contain the CaM-binding site that mediates the Ca2+-dependent regulation of Cx43 gap junctions. Our results provide the first direct evidence that CaM binds to a specific region of the ubiquitous gap junction protein Cx43 in a Ca2+-dependent manner, providing a molecular basis for the well characterized Ca2+-dependent inhibition of Cx43-containing gap junctions.	Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; Ctr Dis Control & Prevent, Proteom Lab, Biotechnol Core Facil Branch, Atlanta, GA 30333 USA; Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University System of Georgia; Georgia State University; Centers for Disease Control & Prevention - USA; University of California System; University of California Riverside	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Univ Plaza, Atlanta, GA 30302 USA.	chejjy@langate.gsu.edu	Chen, Yanyi/H-7096-2013; Zhou, Yubin/D-4748-2011; LEE, HSIAU-WEI/A-1415-2012	Chen, Yanyi/0000-0002-7755-0882; Zhou, Yubin/0000-0001-7962-0517; Lee, Hsiau-Wei/0000-0002-6060-6341; Huang, Yun/0000-0001-5950-9168	NATIONAL EYE INSTITUTE [R01EY005684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999] Funding Source: NIH RePORTER; NEI NIH HHS [EY-05684] Funding Source: Medline; NIGMS NIH HHS [GM62999, R01 GM062999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2001, EUR J BIOCHEM, V268, P4544, DOI 10.1046/j.1432-1327.2001.02380.x; Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brokx RD, 2004, J STRUCT BIOL, V146, P272, DOI 10.1016/j.jsb.2003.12.007; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Churchill GC, 2001, AM J PHYSIOL-CELL PH, V281, pC972, DOI 10.1152/ajpcell.2001.281.3.C972; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; GANDOLFI SA, 1990, CURR EYE RES, V9, P533, DOI 10.3109/02713689008999593; Gomes AV, 2000, ARCH BIOCHEM BIOPHYS, V379, P28, DOI 10.1006/abbi.2000.1827; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; LAPORTE DC, 1981, BIOCHEMISTRY-US, V20, P3965, DOI 10.1021/bi00517a004; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Martin SR, 1996, BIOCHEMISTRY-US, V35, P3508, DOI 10.1021/bi952522a; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Mayer BJ, 2001, J CELL SCI, V114, P1253; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Nicol S, 1997, BIOCHEMISTRY-US, V36, P11487, DOI 10.1021/bi970709r; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; OLWIN BB, 1984, J BIOL CHEM, V259, P949; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Torok K, 1997, BIOCHEM J, V326, P479; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; URBAUER JL, 1995, BIOCHEMISTRY-US, V34, P8099, DOI 10.1021/bi00025a016; WALLACE RW, 1983, METHOD ENZYMOL, V102, P39; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; YANG JJ, 1995, J MOL BIOL, V252, P483, DOI 10.1006/jmbi.1995.0513; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHAN Q, 1991, J BIOL CHEM, V266, P21810; ZHANG MJ, 1994, BIOCHEMISTRY-US, V33, P1163, DOI 10.1021/bi00171a016; ZHANG MJ, 1993, PROTEIN SCI, V2, P1931, DOI 10.1002/pro.5560021114; Zhang XR, 2005, ARCH BIOCHEM BIOPHYS, V440, P111, DOI 10.1016/j.abb.2005.06.004	65	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35005	35017		10.1074/jbc.M707728200	http://dx.doi.org/10.1074/jbc.M707728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17901047	hybrid			2022-12-27	WOS:000251155200045
J	Hageman, J; Vos, MJ; van Waarde, MAWH; Kampinga, HH				Hageman, Jurre; Vos, Michel J.; van Waarde, Maria A. W. H.; Kampinga, Harm H.			Comparison of intra-organellar chaperone capacity for dealing with stress-induced protein unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; RED FLUORESCENT PROTEIN; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MOLECULAR CHAPERONES; BINDING-PROTEIN; HUMAN HOMOLOG; IN-VIVO; FIREFLY LUCIFERASE; TARGETING SIGNAL	Molecular chaperones are essential for cells to prevent that partially unfolded proteins form non-functional, toxic aggregates. This requirement is increased when cells experience protein unfolding stresses and such could affect all compartments in the eukaryotic cell. Whether all organelles are equipped with comparable chaperone capacities is largely unknown, mainly due to the lack of suitable reporters that allow such a comparison. Here we describe the development of fluorescent luciferase reporters that are sorted to various cellular locations (nucleus, cytoplasm, endoplasmic reticulum, and peroxisomes) and that differ minimally in their intrinsic thermal stability properties. When heating living cells, the rate of inactivation was most rapid for the nuclear-targeted luciferase, indicating that the nucleus is the most sensitive organelle toward heat-induced denaturing stress. Post-heat re-activation, however, occurred at equal kinetics irrespective of luciferase localization. Also, induction of thermotolerance by a priming heat treatment, that coordinately up-regulates all heat-inducible chaperones, resulted in a transient heat resistance of the luciferase in all organelles in a comparable manner. Overexpression of the main heat-inducible Hsp70 family member, HspA1A, protected only the cytosolic and nuclear, but not the other luciferases. Together, our data suggest that in each compartment investigated, including the peroxisome in which so far no chaperones could be detected, chaperone machines are present and can be induced with activities similar to those present in the cytosolic/nuclear compartment.	Univ Groningen, Univ Med Ctr Groningen, Sect Radiat & Stress Cell Biol, Dept Cell Biol, NL-9713 AV Groningen, Netherlands	University of Groningen	Kampinga, HH (corresponding author), Ant Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	h.h.kampinga@med.umcg.nl		Vos, Michel/0000-0001-9379-2219; Kampinga, Harm/0000-0002-8966-8466				ANDRES DA, 1991, J BIOL CHEM, V266, P14277; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; BURGMAN PWJJ, 1992, J CELL PHYSIOL, V153, P88, DOI 10.1002/jcp.1041530112; CHELLAIAH A, 1993, BIOCHIM BIOPHYS ACTA, V1174, P111, DOI 10.1016/0167-4781(93)90103-K; Chevalier SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-70; Crookes WJ, 1998, J BIOL CHEM, V273, P17236, DOI 10.1074/jbc.273.27.17236; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Diefenbach J, 2000, EUR J BIOCHEM, V267, P746, DOI 10.1046/j.1432-1327.2000.01053.x; ELLIOTT BM, 1986, CARCINOGENESIS, V7, P795, DOI 10.1093/carcin/7.5.795; Fischer M, 2006, FEBS LETT, V580, P2495, DOI 10.1016/j.febslet.2006.03.082; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heyrovska N, 1998, BIOL CHEM, V379, P301, DOI 10.1515/bchm.1998.379.3.301; JAMSA E, 1995, EMBO J, V14, P6028, DOI 10.1002/j.1460-2075.1995.tb00291.x; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KAMPINGA HH, 1995, EXP CELL RES, V219, P536, DOI 10.1006/excr.1995.1262; Kampinga HH, 2006, HANDB EXP PHARM, V172, P1; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; KELLER GA, 1987, P NATL ACAD SCI USA, V84, P3264, DOI 10.1073/pnas.84.10.3264; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; LEE YJ, 1991, BIOCHEM BIOPH RES CO, V176, P1525, DOI 10.1016/0006-291X(91)90460-O; Lepock JR, 2001, CELL STRESS CHAPERON, V6, P136, DOI 10.1379/1466-1268(2001)006<0136:TNMIAT>2.0.CO;2; LEUSTEK T, 1989, P NATL ACAD SCI USA, V86, P7805, DOI 10.1073/pnas.86.20.7805; Ma CL, 2006, PLANT PHYSIOL, V141, P47, DOI 10.1104/pp.105.073841; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Miskovic D, 1999, DEV GENET, V25, P31, DOI 10.1002/(SICI)1520-6408(1999)25:1<31::AID-DVG4>3.0.CO;2-M; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Muller-Taubenberger A, 2006, EUR J CELL BIOL, V85, P1119, DOI 10.1016/j.ejcb.2006.05.006; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; OHTSUKA K, 1992, EXP CELL RES, V202, P507, DOI 10.1016/0014-4827(92)90106-I; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Venkatesh B, 2004, BIOSCI BIOTECH BIOCH, V68, P2096, DOI 10.1271/bbb.68.2096; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Wimmer B, 1997, P NATL ACAD SCI USA, V94, P13624, DOI 10.1073/pnas.94.25.13624; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	59	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34334	34345		10.1074/jbc.M703876200	http://dx.doi.org/10.1074/jbc.M703876200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17875648	hybrid			2022-12-27	WOS:000251145700049
J	Herbert, SP; Odell, AF; Ponnambalam, S; Walker, JH				Herbert, Shane P.; Odell, Adam F.; Ponnambalam, Sreenivasan; Walker, John H.			The confluence-dependent interaction of cytosolic phospholipase A(2)-alpha with annexin A1 regulates endothelial cell prostaglandin E-2 generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS; ENDOPLASMIC-RETICULUM; CONTACT INHIBITION; INTERACTION-MODEL; CATALYTIC DOMAIN; PROTEIN; A(2); LOCALIZATION; MEMBRANES; PROLIFERATION	The regulated generation of prostaglandins from endothelial cells is critical to vascular function. Here we identify a novel mechanism for the regulation of endothelial cell prostaglandin generation. Cytosolic phospholipase A(2)-alpha (cPLA(2)alpha) cleaves phospholipids in a Ca2+-dependent manner to yield free arachidonic acid and lysophospholipid. Arachidonic acid is then converted into prostaglandins by the action of cyclooxygenase enzymes and downstream synthases. By previously undefined mechanisms, nonconfluent endothelial cells generate greater levels of prostaglandins than confluent cells. Here we demonstrate that Ca2+-independent association of cPLA(2)alpha with the Golgi apparatus of confluent endothelial cells correlates with decreased prostaglandin synthesis. Golgi association blocks arachidonic acid release and prevents functional coupling between cPLA(2)alpha and COX-mediated prostaglandin synthesis. When inactivated at the Golgi apparatus of confluent endothelial cells, cPLA(2)alpha is associated with the phospholipid-binding protein annexin A1. Furthermore, the siRNA-mediated knockdown of endogenous annexin A1 significantly reverses the inhibitory effect of confluence on endothelial cell prostaglandin generation. Thus the confluence-dependent interaction of cPLA(2)alpha and annexin A1 at the Golgi acts as a novel molecular switch controlling cPLA(2)alpha activity and endothelial cell prostaglandin generation.	Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Walker, JH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	j.h.walker@leeds.ac.uk	Odell, Adam/J-1386-2012	Herbert, Shane/0000-0003-2517-1845; Ponnambalam, Sreenivasan/0000-0002-4452-7619	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Bunt G, 1997, J CELL SCI, V110, P2449; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dominguez M, 1999, J CELL BIOL, V145, P673, DOI 10.1083/jcb.145.4.673; EVANS CE, 1984, PROSTA LEUKOTR MED, V14, P255, DOI 10.1016/0262-1746(84)90209-9; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gao YS, 2002, EUR J CELL BIOL, V81, P391, DOI 10.1078/0171-9335-00260; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x; Grewal S, 2004, EUR J BIOCHEM, V271, P69, DOI 10.1046/j.1432-1033.2003.03903.x; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Grewal S, 2002, J CELL SCI, V115, P4533, DOI 10.1242/jcs.00146; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Jaffe EA, 1984, BIOL ENDOTHELIAL CEL, P1; Jiang HM, 2004, J BIOL CHEM, V279, P55905, DOI 10.1074/jbc.M406094200; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kim SW, 2001, FEBS LETT, V489, P243, DOI 10.1016/S0014-5793(00)02326-7; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lukowski S, 1996, J BIOL CHEM, V271, P24164, DOI 10.1074/jbc.271.39.24164; MORITA I, 1995, J BIOL CHEM, V273, P9886; Murakami M, 2003, FEBS LETT, V546, P251, DOI 10.1016/S0014-5793(03)00596-9; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NOVIKOFF PM, 1983, P NATL ACAD SCI-BIOL, V80, P4364, DOI 10.1073/pnas.80.14.4364; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sorby M, 1996, J BIOL CHEM, V271, P10963; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Tang LL, 2000, CIRC RES, V86, P663, DOI 10.1161/01.RES.86.6.663; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANE JR, 1990, NEW ENGL J MED, V323, P27; WHATLEY RE, 1994, J CLIN INVEST, V94, P1889, DOI 10.1172/JCI117539; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	56	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34468	34478		10.1074/jbc.M701541200	http://dx.doi.org/10.1074/jbc.M701541200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17873281	hybrid			2022-12-27	WOS:000251145700062
J	Rothenberg, E; Trakselis, MA; Bell, SD; Ha, T				Rothenberg, Eli; Trakselis, Michael A.; Bell, Stephen D.; Ha, Taekjip			MCM forked substrate specificity involves dynamic interaction with the 5 '-tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEAL DNA-REPLICATION; HEPATITIS-C VIRUS; COLI REP HELICASE; SINGLE-MOLECULE; SULFOLOBUS-SOLFATARICUS; ANOMALOUS DIFFUSION; UNWINDING MECHANISM; HEXAMERIC HELICASE; BACTERIOPHAGE T7; TRANSLOCATION	The archaeal minichromosome maintenance protein MCM forms a homohexameric complex that functions as the DNA replicative helicase and serves as a model system for its eukaryotic counterpart. Here, we applied single molecule fluorescence resonance energy transfer methods to probe the substrate specificity and binding mechanism of MCM from the hyperthermophilic Archaea Sulfolobus solfataricus on various DNA substrates. S. solfataricus MCM displays a binding preference for forked substrates relative to partial or full duplex substrates. Moreover, the nature of MCM binding to Y-shaped substrates is distinct in that MCM loads on the 3'-tail while interacting with the 5'-tail likely via the MCM surface. These results provide the first elucidation of a dynamic nature of interaction between a ring-shaped helicase interacting with an opposing single-stranded DNA tail. This interaction contributes to substrate selectivity and increases the stability of the forked DNA-MCM complex, with possible implications for the MCM unwinding mechanism.	Univ Illinois, Dept Phys, Howard Hughes Med Inst, Urbana, IL 61801 USA; Hutchison Med Res Council Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 2XZ, England	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Univ Illinois, Dept Phys, Howard Hughes Med Inst, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu	Rothenberg, Eli/A-6879-2009; Ha, Taekjip/B-9506-2009; Trakselis, Michael/V-3806-2019	Ha, Taekjip/0000-0003-2195-6258; Bell, Stephen/0000-0002-8474-6592; Trakselis, Michael/0000-0001-7054-8475; Rothenberg, Eli/0000-0002-1382-1380	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 065367, R01 GM065367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Barry ER, 2007, NUCLEIC ACIDS RES, V35, P988, DOI 10.1093/nar/gkl1117; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Ha T, 2007, CELL, V129, P1249, DOI 10.1016/j.cell.2007.06.007; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 1999, PHYS REV LETT, V82, P3563, DOI 10.1103/PhysRevLett.82.3563; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang H, 2002, J CHEM PHYS, V117, P10965, DOI 10.1063/1.1521154; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	47	74	74	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34229	34234		10.1074/jbc.M706300200	http://dx.doi.org/10.1074/jbc.M706300200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884823	hybrid			2022-12-27	WOS:000251145700038
J	Dharmasena, MN; Jewell, DA; Taylor, RK				Dharmasena, Madushini N.; Jewell, David A.; Taylor, Ronald K.			Development of peptide mimics of a protective epitope of Vibrio cholerae ogawa o-antigen and investigation of the structural basis of peptide mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE; ANTICARBOHYDRATE ANTIBODIES; MONOCLONAL-ANTIBODY; ADULT VOLUNTEERS; SEROTYPE INABA; VACCINE; MIMOTOPE; LIPOPOLYSACCHARIDE; MICE; INDUCTION	As an alternative approach toward the development of a cholera vaccine, the potential of peptide mimics of Vibrio cholerae lipopolysaccharide (LPS) to elicit cross-reactive immune responses against LPS was investigated. Two closely related protective monoclonal antibodies, S-20-4 and A-20-6, which are specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1, were used as the target antibodies (Abs) to pan phage display libraries under different elution conditions. Six phage clones identified from S-20-4 panning showed significant binding to both S-20-4 and A-20-6. Thus, it is likely that these phage-displayed peptides mimic an important conformational epitope of Ogawa antigens and are not simply functionally recognized by S-20-4. Each of the six phage clones that could bind to both monoclonal antibodies also competed with LPS for binding to S-20-4, suggesting that the peptides bind close to the paratope of the Ab. In order to predict how these peptide mimics interact with S-20-4 compared with its carbohydrate counterpart, one peptide mimic, 4P-8, which is one of the highest affinity binders and shares motifs with several other peptide mimics, was selected for further studies using computer modeling methods and site-directed mutagenesis. These studies suggest that 4P-8 is recognized as a hairpin structure that mimics some O-SP interactions with S-20-4 and also makes unique ligand interactions with S-20-4. In addition, 4P-8-KLH was able to elicit anti-LPS Abs in mice, but the immune response was not vibriocidal or protective. However, boosting with 4P-8-KLH after immunizing with LPS prolonged the LPS-reactive IgG and IgM Ab responses as well as vibriocidal titers and provided a much greater degree of protection than priming with LPS alone.	Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Taylor, RK (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Ronald.K.Taylor@dartmouth.edu		Jewell, David/0000-0001-5931-7588	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096, F32AI125096, R22AI025096, R37AI025096] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 25096, R37 AI025096] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; BompardGilles C, 1996, STRUCTURE, V4, P1441, DOI 10.1016/S0969-2126(96)00151-7; Boutonnier A, 2003, J MICROBIOL METH, V55, P745, DOI 10.1016/j.mimet.2003.08.010; Buchwald UK, 2005, INFECT IMMUN, V73, P325, DOI 10.1128/IAI.73.1.325-333.2005; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Chatterjee SN, 2006, BBA-MOL BASIS DIS, V1762, P1, DOI 10.1016/j.bbadis.2005.08.005; Chernyak A, 2002, J INFECT DIS, V185, P950, DOI 10.1086/339583; De Bolle X, 1999, J MOL BIOL, V294, P181, DOI 10.1006/jmbi.1999.3248; DeLano WL, 2005, PYMOL; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Gupta RK, 1998, INFECT IMMUN, V66, P3095, DOI 10.1128/IAI.66.7.3095-3099.1998; GUPTA RK, 1992, INFECT IMMUN, V60, P3201, DOI 10.1128/IAI.60.8.3201-3208.1992; Hafner C, 2005, J INVEST DERMATOL, V124, P125, DOI 10.1111/j.0022-202X.2004.23515.x; Hardy B, 2005, VACCINE, V23, P4283, DOI 10.1016/j.vaccine.2005.04.009; Harris SL, 1997, P NATL ACAD SCI USA, V94, P2454, DOI 10.1073/pnas.94.6.2454; Hill DR, 2006, LANCET INFECT DIS, V6, P361, DOI 10.1016/S1473-3099(06)70494-7; Hou YC, 2003, J IMMUNOL, V170, P4373, DOI 10.4049/jimmunol.170.8.4373; Hutchins WA, 1996, MOL IMMUNOL, V33, P503, DOI 10.1016/0161-5890(96)00012-0; Kieber-Emmons T, 1999, NAT BIOTECHNOL, V17, P660, DOI 10.1038/10870; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Lesinski GB, 2001, VACCINE, V19, P1717, DOI 10.1016/S0264-410X(00)00397-2; Maitta RW, 2004, INFECT IMMUN, V72, P196, DOI 10.1128/IAI.72.1.196-208.2004; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCDONALD IK, 1995, PROTEIN ENG, V8, P217, DOI 10.1093/protein/8.3.217; Monzavi-Karbassi B, 2003, VACCINE, V21, P753, DOI 10.1016/S0264-410X(02)00703-X; Monzavi-Karbassi B, 2002, TRENDS BIOTECHNOL, V20, P207, DOI 10.1016/S0167-7799(02)01940-6; Monzavi-Karbassi B, 2007, VACCINE, V25, P3022, DOI 10.1016/j.vaccine.2007.01.072; Neuberger MS, 2000, PHILOS T ROY SOC B, V355, P357, DOI 10.1098/rstb.2000.0573; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Phalipon A, 1997, EUR J IMMUNOL, V27, P2620, DOI 10.1002/eji.1830271022; Pincus SH, 1998, J IMMUNOL, V160, P293; Prinz DM, 2003, IMMUNOLOGY, V110, P242, DOI 10.1046/j.1365-2567.2003.01732.x; Provenzano D, 2006, MICROBIOL IMMUNOL, V50, P899, DOI 10.1111/j.1348-0421.2006.tb03866.x; Qadri F, 2005, J INFECT DIS, V192, P573, DOI 10.1086/432074; Ryan ET, 2006, EXPERT REV VACCINES, V5, P483, DOI 10.1586/14760584.5.4.483; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Shin JS, 2002, J IMMUNOL, V168, P6273, DOI 10.4049/jimmunol.168.12.6273; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vyas NK, 2003, P NATL ACAD SCI USA, V100, P15023, DOI 10.1073/pnas.2431286100; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wang J, 1998, J BIOL CHEM, V273, P2777, DOI 10.1074/jbc.273.5.2777	47	21	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33805	33816		10.1074/jbc.M707314200	http://dx.doi.org/10.1074/jbc.M707314200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881351	hybrid			2022-12-27	WOS:000250840200063
J	Hou, XW; Liu, RJ; Ross, S; Smart, EJ; Zhu, HN; Gong, WM				Hou, Xiaowei; Liu, Rujuan; Ross, Stuart; Smart, Eric J.; Zhu, Haining; Gong, Weimin			Crystallographic studies of human MitoNEET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; IRON-SULFUR PROTEIN; PIOGLITAZONE TREATMENT; THIAZOLIDINEDIONE; MODEL; SEQUENCE; ROSIGLITAZONE; PURIFICATION; EXPRESSION; AGONISTS	MitoNEET was identified as an outer mitochondrial membrane protein that can potentially bind the anti-diabetes drug pioglitazone. The crystal structure of the cytoplasmic mitoNEET (residues 33-108) is determined in this study. The structure presents a novel protein fold and contains a [2Fe-2S] cluster-binding domain. The [2Fe-2S] cluster is coordinated to the protein by Cys-72, Cys-74, Cys-83, and His-87 residues. This coordination is also novel compared with the traditional [2Fe-2S] cluster coordinated by four cysteines or two cysteines and two histidines. The cytoplasmic mitoNEET forms homodimers in solution and in crystal. The dimerization is mainly mediated by hydrophobic interactions as well as hydrogen bonds coordinated by two water molecules binding at the interface. His-87 residue, which plays an important role in the coordination of the [2Fe-2S] cluster, is exposed to the solvent on the dimer surface. It is proposed that mitoNEET dimer may interact with other proteins via the surface residues in close proximity to the [2Fe-2S] cluster.	Chinese Acad Sci, Inst Biophys, Ctr Struct & Mol Biol, Natl Key Lab Macrobiomol, Beijing 100101, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Dept Pediat, Coll Med, Kentucky Pediat Res Inst, Lexington, KY 40536 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Kentucky; University of Kentucky	Zhu, HN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone, Lexington, KY 40536 USA.	haining@uky.edu; wgong@ibp.ac.cn	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Liu, Ru-Juan/0000-0001-7459-3126; Hou, Xiaowei/0000-0002-6668-1115	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049126] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR015592] Funding Source: Medline; NIDDK NIH HHS [R01 DK077632] Funding Source: Medline; NINDS NIH HHS [R01NS049126] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEE JA, 1984, J BIOL CHEM, V259, P124; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Ghosh S, 2007, MOL PHARMACOL, V71, P1695, DOI 10.1124/mol.106.033845; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Klotz L, 2005, J IMMUNOL, V175, P4948, DOI 10.4049/jimmunol.175.8.4948; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Perez-Ortiz JM, 2007, MOL PHARMACOL, V72, P407, DOI 10.1124/mol.106.032458; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pershadsingh HA, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsoi TV, 1999, APPL ENVIRON MICROB, V65, P2151; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104	38	70	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33242	33246		10.1074/jbc.C700172200	http://dx.doi.org/10.1074/jbc.C700172200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17905743	hybrid			2022-12-27	WOS:000250840200002
J	Richter, S; Lindenstrauss, U; Lucke, C; Bayliss, R; Bruser, T				Richter, Silke; Lindenstrauss, Ute; Luecke, Christian; Bayliss, Richard; Brueser, Thomas			Functional tat transport of unstructured, small, hydrophilic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE TRANSLOCATION PATHWAY; GREEN FLUORESCENT PROTEIN; FXFG NUCLEOPORIN REPEATS; FOLDING QUALITY-CONTROL; ESCHERICHIA-COLI; SIGNAL PEPTIDE; ALPHA-SYNUCLEIN; SYSTEM; EXPORT; MEMBRANE	The twin-arginine translocation ( Tat) system is a protein translocation system that is adapted to the translocation of folded proteins across biological membranes. An understanding of the folding requirements for Tat substrates is of fundamental importance for the elucidation of the transport mechanism. We now demonstrate for the first time Tat transport for fully unstructured proteins, using signal sequence fusions to naturally unfolded FG repeats from the yeast Nsp1p nuclear pore protein. The transport of unfolded proteins becomes less efficient with increasing size, consistent with only a single interaction between the system and the substrate. Strikingly, the introduction of six residues from the hydrophobic core of a globular protein completely blocked translocation. Physiological data suggest that hydrophobic surface patches abort transport at a late stage, most likely by membrane interactions during transport. This study thus explains the observed restriction of the Tat system to folded globular proteins on a molecular level.	Univ Halle Wittenberg, Inst Biol Microbiol, D-06120 Halle, Germany; Max Planck Res Unit Enzmol Protein Folding, D-06120 Halle, Germany; Inst Canc Res, London SW3 6JB, England	Martin Luther University Halle Wittenberg; Max Planck Society; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bruser, T (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	brueser@mikrobiologie.uni-halle.de		Bruser, Thomas/0000-0002-5889-8306; Bayliss, Richard/0000-0003-0604-2773				Bayliss R, 2000, J STRUCT BIOL, V131, P240, DOI 10.1006/jsbi.2000.4297; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; HURT EC, 1989, J CELL SCI, P243; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Natarajan K, 1997, J AM CHEM SOC, V119, P4082, DOI 10.1021/ja9639729; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	43	54	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33257	33264		10.1074/jbc.M703303200	http://dx.doi.org/10.1074/jbc.M703303200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848553	hybrid			2022-12-27	WOS:000250840200005
J	Goulet, I; Gauvin, G; Boisvenue, S; Cote, J				Goulet, Isabelle; Gauvin, Gabrielle; Boisvenue, Sophie; Cote, Jocelyn			Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR DAL-1/4.1B; NUCLEAR-EXPORT SIGNALS; BREAST-CANCER CELLS; MESSENGER-RNA; IN-VIVO; N-METHYLTRANSFERASE; SM PROTEINS; ANDROGEN RECEPTOR; METHYLATION SITES; MAMMALIAN-CELLS	PRMT1 is the predominant member of a family of protein arginine methyltransferases (PRMTs) that have been implicated in various cellular processes, including transcription, RNA processing, and signal transduction. It was previously reported that the human PRMT1 pre-mRNA was alternatively spliced to yield three isoforms with distinct N-terminal sequences. Close inspection of the genomic organization in the 5'-end of the PRMT1 gene revealed that it can produce up to seven protein isoforms, all varying in their N-terminal domain. A detailed biochemical characterization of these variants revealed that unique N-terminal sequences can influence catalytic activity as well as substrate specificity. In addition, our results uncovered the presence of a functional nuclear export sequence in PRMT1v2. Finally, we find that the relative balance of PRMT1 isoforms is altered in breast cancer.	Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Cote, J (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	jcote@uottawa.ca	Cote, Jocelyn/O-2351-2018	Cote, Jocelyn/0000-0001-9551-2284				Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Altschuler L, 1999, J INTERF CYTOK RES, V19, P189, DOI 10.1089/107999099314333; ANCZUKOW O, 2007, IN PRESS HUM MUTAT, V22, P119; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Duriez C., 2004, B CANC, V91, P242; Edberg DD, 2004, BIOCHEMISTRY-US, V43, P11500, DOI 10.1021/bi049833i; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Ikenaka K, 2006, NEUROSCIENCE, V141, P1971, DOI 10.1016/j.neuroscience.2006.05.022; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jiang W, 2005, BIOCHEM BIOPH RES CO, V329, P522, DOI 10.1016/j.bbrc.2005.01.153; Jiang W, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-4; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lim IK, 1998, BIOCHEM MOL BIOL INT, V45, P871; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pawlak MR, 2002, J CELL BIOCHEM, V87, P394, DOI 10.1002/jcb.10307; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Scorilas A, 2000, BIOCHEM BIOPH RES CO, V278, P349, DOI 10.1006/bbrc.2000.3807; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	78	131	135	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33009	33021		10.1074/jbc.M704349200	http://dx.doi.org/10.1074/jbc.M704349200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848568	hybrid			2022-12-27	WOS:000250625400050
J	Hakimi, P; Yang, J; Casadesus, G; Massillon, D; Tolentino-Silva, F; Nye, CK; Cabrera, ME; Hagen, DR; Utter, CB; Baghdy, Y; Johnson, DH; Wilson, DL; Kirwan, JP; Kalhan, SC; Hanson, RW				Hakimi, Parvin; Yang, Jianqi; Casadesus, Gemma; Massillon, Duna; Tolentino-Silva, Fatima; Nye, Colleen K.; Cabrera, Marco E.; Hagen, David R.; Utter, Christopher B.; Baghdy, Yacoub; Johnson, David H.; Wilson, David L.; Kirwan, John P.; Kalhan, Satish C.; Hanson, Richard W.			Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE GENE; MITOCHONDRIAL BIOGENESIS; ACID CYCLE; TRANSGENIC MICE; ADIPOSE-TISSUE; PGC-1-ALPHA TRANSCRIPTION; CALORIE RESTRICTION; PROLONGED EXERCISE; INSULIN-RESISTANCE; EXPRESSION	Transgenic mice, containing a chimeric gene in which the cDNA for phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (EC 4.1.1.32) was linked to the alpha-skeletal actin gene promoter, express PEPCK-C in skeletal muscle (1-3 units/g). Breeding two founder lines together produced mice with an activity of PEPCK-C of 9 units/g of muscle (PEPCK-C-mus mice). These mice were seven times more active in their cages than controls. On a mouse treadmill, PEPCK-C-mus mice ran up to 6 km at a speed of 20 m/min, whereas controls stopped at 0.2 km. PEPCK-C-mus mice had an enhanced exercise capacity, with a VO2max of 156 +/- 8.0 ml/kg/min, a maximal respiratory exchange ratio of 0.91 +/- 0.03, and a blood lactate concentration of 3.7 +/- 1.0 mM after running for 32 min at a 25 degrees grade; the values for control animals were 112 +/- 21 ml/kg/min, 0.99 +/- 0.08, and 8.1 +/- 5.0 mM respectively. The PEPCK-C-mus mice ate 60% more than controls but had half the body weight and 10% the body fat as determined by magnetic resonance imaging. In addition, the number of mitochondria and the content of triglyceride in the skeletal muscle of PEPCK-C-mus mice were greatly increased as compared with controls. PEPCK-C-mus mice had an extended life span relative to control animals; mice up to an age of 2.5 years ran twice as fast as 6-12-month-old control animals. We conclude that overexpression of PEPCK-C repatterns energy metabolism and leads to greater longevity.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Gastroenterol Hepatol & Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Hanson, RW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	rwh@case.edu	Kirwan, John P/G-6942-2012; Johnson, David/AHI-8369-2022; Hakimi, Parvin/AAB-1643-2021; Hagen, David R/B-3911-2013	Hagen, David R/0000-0003-0992-8465; Casadesus, Gemma/0000-0002-5206-5637; Wilson, David/0000-0001-9763-1463; Kalhan, Satish/0000-0002-8012-4171	NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509, R01EB004070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, R01DK025541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM066309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG012834, R01AG012834] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA043703, CA 43703] Funding Source: Medline; NIA NIH HHS [R01 AG012834, AG 12834, R29 AG012834] Funding Source: Medline; NIBIB NIH HHS [EB 004070, T32 EB007509, R01 EB004070] Funding Source: Medline; NIDDK NIH HHS [R01 DK025541, DK 058620, DK 025541, R01 DK058620] Funding Source: Medline; NIGMS NIH HHS [GM 66309, P50 GM066309] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Boffi FM, 2002, EQUINE VET J, V34, P275; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; CANNON JG, 1990, AM J PHYSIOL, V259, pR1214, DOI 10.1152/ajpregu.1990.259.6.R1214; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; CRABTREE B, 1972, BIOCHEM J, V126, P49, DOI 10.1042/bj1260049; Cresci S, 1996, AM J PHYSIOL-CELL PH, V270, pC1413, DOI 10.1152/ajpcell.1996.270.5.C1413; DOHM GL, 1986, BIOCHEM MED METAB B, V35, P260, DOI 10.1016/0885-4505(86)90081-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gibala MJ, 1997, J PHYSIOL-LONDON, V502, P703, DOI 10.1111/j.1469-7793.1997.703bj.x; HAHN P, 1975, J LIPID RES, V16, P79; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hanson RW, 1994, P ENOLPYRUVATE CARBO, P203; HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; KIRWAN JP, 1986, EUR J APPL PHYSIOL O, V55, P330, DOI 10.1007/BF02343808; KIRWAN JP, 1992, J APPL PHYSIOL, V72, P2197, DOI 10.1152/jappl.1992.72.6.2197; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; LEE SH, 1979, J BIOL CHEM, V254, P420; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; MCGRANE MM, 1990, J BIOL CHEM, V265, P22371; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; McKee EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1870, DOI 10.1152/ajpcell.2000.279.6.C1870; NEWSHOLME EA, 1978, BIOCHEM J, V176, P623, DOI 10.1042/bj1760623; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; SAHLIN K, 1990, AM J PHYSIOL, V259, pC834, DOI 10.1152/ajpcell.1990.259.5.C834; SNELL K, 1977, BIOCHEM J, V162, P399, DOI 10.1042/bj1620399; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wieland O., 1965, METHODS ENZYMATIC AN, P211; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; YOOWARREN H, 1981, J BIOL CHEM, V256, P224; ZIMMER DB, 1990, J HISTOCHEM CYTOCHEM, V38, P171, DOI 10.1177/38.2.1688895	53	146	156	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32844	32855		10.1074/jbc.M706127200	http://dx.doi.org/10.1074/jbc.M706127200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17716967	Green Accepted, hybrid			2022-12-27	WOS:000250625400034
J	Germain, M; Duronio, V				Germain, Marc; Duronio, Vincent			The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BH3-ONLY PROTEINS; CELL-DEATH; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; SURVIVAL; BAK; PERMEABILIZATION; PHOSPHORYLATION; DEGRADATION	The BCL-2 homologue MCL-1 plays an important role in the regulation of cell fate by blocking apoptosis as well as regulating cell cycle. MCL-1 has an unusual N-terminal extension, which contains a PEST domain and several phosphorylation sites that have been suggested to regulate its turnover. Here we report that the first 79 amino acids of MCL-1 regulate its subcellular localization. Deletion of this domain impairs both its mitochondrial localization and its anti-apoptotic activity. Conversely, expression of the N terminus of MCL-1 promotes both the association of MCL-1 with mitochondria and cell survival in a fashion that is dependent on the presence of endogenous MCL-1. In addition, the N terminus of MCL-1 has an antagonistic effect on proliferation. Although MCL-1 decreases proliferation through binding to proliferating cell nuclear antigen and cyclin-dependent kinase 1 in the nucleus, the N terminus of MCL-1 accelerates cell division. On the other hand, deletion of this region further increases the anti-proliferative activity of MCL-1. These results suggest that the N terminus of MCL-1 plays a major regulatory role, regulating coordinately the mitochondrial ( anti-apoptotic) and nuclear ( anti-proliferative) functions of MCL-1.	Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada; Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Germain, M (corresponding author), Univ British Columbia, Dept Med, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	mgermain@interchange.ubc.ca						Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; GERMAIN M, 2003, SCI STKE; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Rinkenberger JL, 2000, GENE DEV, V14, P23; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou P, 1998, BLOOD, V92, P3226, DOI 10.1182/blood.V92.9.3226.421k49_3226_3239; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	34	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32233	32242		10.1074/jbc.M706408200	http://dx.doi.org/10.1074/jbc.M706408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823113	hybrid			2022-12-27	WOS:000250480300046
J	Liu, XS; Patterson, LD; Miller, MJ; Theil, EC				Liu, Xiaofeng S.; Patterson, Leslie D.; Miller, Marvin J.; Theil, Elizabeth C.			Peptides selected for the protein nanocage pores change the rate of iron recovery from the ferritin mineral	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATING MODIFIER TOXINS; DESFERRIOXAMINE-B; H-CHAIN; RELEASE; KINETICS; CHANNELS; MOBILIZATION; ANTIOXIDANT; FERROPORTIN; DERIVATIVES	Pores regulate access between ferric-oxy biomineral inside and reductants/chelators outside the ferritin protein nanocage to control iron demineralization rates. The pore helix/loop/helix motifs that are contributed by three subunits unfold independently of the protein cage, as observed by crystallography, Fe removal rates, and CD spectroscopy. Pore unfolding is induced in wild type ferritin by increased temperature or urea (1-10 mM), a physiological urea range, 0.1 mM guanidine, or mutation of conserved pore amino acids. A peptide selected for ferritin pore binding from a combinatorial, heptapeptide library increased the rate of Fe demineralization 3-fold (p < 0.001), similarly to a mutation that unfolded the pores. Conjugating the peptide to Desferal (R) (desferrioxamine B mesylate), a chelator in therapeutic use, increased the rates to 8-fold (p < 0.001). A second pore binding peptide had the opposite effect and decreased the rate of Fe demineralization 60% (p < 0.001). The peptides could have pharmacological uses and may model regulators of ferritin demineralization rates in vivo or peptide regulators of gated pores in membranes. The results emphasize that small peptides can exploit the structural plasticity of protein pores to modulate function.	CHORI, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Oakland, CA 94609 USA; Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of Notre Dame	Theil, EC (corresponding author), CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK020251, R56DK020251, R01DK020251] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 054193] Funding Source: Medline; NIDDK NIH HHS [DK20251] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAPA S, 1982, HELV CHIM ACTA, V65, P1818, DOI 10.1002/hlca.19820650617; Bertola F., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P93, DOI 10.2174/1568008043339893; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; CRICHTON RR, 1980, J MOL CATAL, V7, P267, DOI 10.1016/0304-5102(80)85024-3; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; De Domenico I, 2007, BLOOD, V109, P2205, DOI 10.1182/blood-2006-06-032516; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; DIONIS JB, 1989, J ORG CHEM, V54, P5623, DOI 10.1021/jo00284a044; Duong-Ly KC, 2005, PROTEIN SCI, V14, P856, DOI 10.1110/ps.041185805; Farkas E, 2001, J INORG BIOCHEM, V83, P107, DOI 10.1016/S0162-0134(00)00197-5; HERSCHEID JDM, 1984, EUR J NUCL MED, V9, P508, DOI 10.1007/BF00263255; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; JALAL MAF, 1985, J ORG CHEM, V50, P5642, DOI 10.1021/jo00350a043; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; LYNCH SR, 1974, IRON BIOCH MED, P563; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; Meersman F, 2006, CHEM SOC REV, V35, P908, DOI 10.1039/b517761h; Michael DJ, 2006, TRENDS ENDOCRIN MET, V17, P408, DOI 10.1016/j.tem.2006.10.011; MUETTERTIES KA, 1991, MAGNET RESON MED, V22, P88, DOI 10.1002/mrm.1910220110; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; PETO TEA, 1983, BRIT J HAEMATOL, V54, P623, DOI 10.1111/j.1365-2141.1983.tb02142.x; RODGERS SJ, 1983, J MED CHEM, V26, P439, DOI 10.1021/jm00357a022; Rodi DJ, 2002, CURR OPIN CHEM BIOL, V6, P92, DOI 10.1016/S1367-5931(01)00287-3; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil E. C., 2001, HDB METALLOPROTEINS, P771; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Vichinsky E, 2001, SEMIN HEMATOL, V38, P1, DOI 10.1016/S0037-1963(01)90053-8; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; WUSTEFELD C, 1982, FEBS LETT, V150, P43, DOI 10.1016/0014-5793(82)81301-X	43	55	57	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31821	31825		10.1074/jbc.C700153200	http://dx.doi.org/10.1074/jbc.C700153200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17785467	hybrid			2022-12-27	WOS:000250480300001
J	Neiers, F; Sonkaria, S; Olry, A; Boschi-Muller, S; Branlant, G				Neiers, Fabrice; Sonkaria, Sanjiv; Olry, Alexandre; Boschi-Muller, Sandrine; Branlant, Guy			Characterization of the amino acids from Neisseria meningitidis methionine sulfoxide reductase B involved in the chemical catalysis and substrate specificity of the reductase step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; KINETIC CHARACTERIZATION; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; MECHANISM; PROTEINS; REPAIR; SURVIVAL; RESIDUES; DAMAGE	Methionine sulfoxide reductases (Msrs) are antioxidant repair enzymes that catalyze the thioredoxin-dependent reduction of methionine sulfoxide back to methionine. The Msr family is composed of two structurally unrelated classes of enzymes named MsrA and MsrB, which display opposite stereoselectivities toward the S and R isomers of the sulfoxide function, respectively. Both classes of Msr share a similar three-step chemical mechanism involving first a reductase step that leads to the formation of a sulfenic acid intermediate. In this study, the invariant amino acids of Neisseria meningitidis MsrB involved in the reductase step catalysis and in substrate binding have been characterized by the structure-function relationship approach. Altogether the results show the following: 1) formation of the MsrB-substrate complex leads to an activation of the catalytic Cys-117 characterized by a decreased pK(app) of similar to 2.7 pH units; 2) the catalytic active MsrB form is the Cys-117(-)/His-103(+) species with a pKapp of 6.6 and 8.3, respectively; 3) His-103 and to a lesser extent His-100, Asn-119, and Thr-26 (via a water molecule) participate in the stabilization of the polarized form of the sulfoxide function and of the transition state; and 4) Trp-65 is essential for the catalytic efficiency of the reductase step by optimizing the position of the substrate in the active site. A scenario for the reductase step is proposed and discussed in comparison with that of MsrA.	Nancy Univ, CNRS, Fac Sci & Tech, UMR UHP 7567,Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, CNRS, Fac Sci & Tech, UMR UHP 7567,Maturat ARN & Enzymol Mol, Blvd Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	Guy.Branlant@maem.uhp-nancy.fr	Neiers, Fabrice/AAM-1637-2021	Neiers, Fabrice/0000-0002-8965-4929; Boschi, Sandrine/0000-0001-8962-4749				Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; EJIRI SI, 1979, J BACTERIOL, V139, P161, DOI 10.1128/JB.139.1.161-164.1979; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gand A, 2007, J BIOL CHEM, V282, P20484, DOI 10.1074/jbc.M702350200; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Kauffmann B, 2005, BBA-PROTEINS PROTEOM, V1703, P249, DOI 10.1016/j.bbapap.2004.09.008; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	26	24	25	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32397	32405		10.1074/jbc.M704730200	http://dx.doi.org/10.1074/jbc.M704730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17766244	hybrid, Green Published			2022-12-27	WOS:000250480300062
J	Zhang, YK; Brovkovych, V; Brovkovych, S; Tan, FL; Lee, BS; Sharma, T; Skidgel, RA				Zhang, Yongkang; Brovkovych, Viktor; Brovkovych, Svitlana; Tan, Fulong; Lee, Bao-Shiang; Sharma, Tiffany; Skidgel, Randal A.			Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of ser(745)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING-ENZYME INHIBITORS; BRADYKININ B-1 RECEPTOR; ENDOTHELIAL-CELLS; NADPH-CYTOCHROME-P450 OXIDOREDUCTASE; BINDING DOMAIN; PROTEIN; MECHANISMS; PHARMACOLOGY; PREDICTION; DIMERIZATION	Nitric oxide (NO) is a pleiotropic regulator of vascular function, and its overproduction by inducible nitric-oxide synthase (iNOS) in inflammatory conditions plays an important role in the pathogenesis of vascular diseases. iNOS activity is thought to be regulated primarily at the level of expression to generate "high output" NO compared with constitutive NO synthases. Here we show iNOS activity is acutely up-regulated by activation of the B-1-kinin receptor (B1R) in human endothelial cells or transfected HEK293 cells to generate 2.5-5-fold higher NO than that stimulated by Arg alone. Increased iNOS activity was dependent on B1R activation of the MAPK ERK. In HEK293 cells transfected with human iNOS and B1R, ERK phosphorylated iNOS on Ser(745) as determined by Western analysis using phospho-Ser antibody, in vitro kinase assays with activated ERK, and MALDI-TOF mass spectrometry. Mutation of Ser(745) to Ala did not affect basal iNOS activity but eliminated iNOS phosphorylation and activation in response to B1R agonist. Mutation of Ser(745) to Asp resulted in a basally hyperactive iNOS whose activity was not further increased by B1R agonist. ERK and phospho-ERK (after B1R activation) were co-localized with iNOS as determined by confocal fluorescence microscopy. Furthermore, ERK co-immunoprecipitated with iNOS. The discovery that iNOS can be phosphorylated by ERK and acutely activated by receptor-mediated signaling reveals a new level of regulation for this isoform. These findings provide a novel therapeutic target to explore in the treatment of vascular inflammatory diseases.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Prot Res Lab, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol M C 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu			NHLBI NIH HHS [P01 HL 60678] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreeva AV, 2006, MOL PHARMACOL, V69, P975, DOI 10.1124/mol.105.018846; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hausel P, 2006, ONCOGENE, V25, P198, DOI 10.1038/sj.onc.1209030; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Ignjatovic T, 2004, MOL PHARMACOL, V66, P1310, DOI 10.1124/mol.104.001990; Ignjatovic T, 2002, J BIOL CHEM, V277, P16847, DOI 10.1074/jbc.M200355200; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P451; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kubes Pal, 1995, Microcirculation (New York), V2, P235, DOI 10.3109/10739689509146769; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee BS, 2004, ANAL BIOCHEM, V334, P106, DOI 10.1016/j.ab.2004.06.041; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0; Masters BSS, 2005, BIOCHEM BIOPH RES CO, V338, P507, DOI 10.1016/j.bbrc.2005.09.165; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitchell DA, 2005, BIOCHEMISTRY-US, V44, P4636, DOI 10.1021/bi0474463; MONCADA S, 1991, PHARMACOL REV, V43, P109; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan JM, 1996, BIOCHEM J, V314, P889, DOI 10.1042/bj3140889; Papapetropoulos A, 1999, CARDIOVASC RES, V43, P509, DOI 10.1016/S0008-6363(99)00161-3; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Skidgel RA, 2006, BIOL CHEM, V387, P159, DOI 10.1515/BC.2006.021; Skidgel RA, 2002, AM J PHYSIOL-LUNG C, V282, pL1179, DOI 10.1152/ajplung.00045.2002; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tsutsui M, 2000, AM J PHYSIOL-HEART C, V278, pH367, DOI 10.1152/ajpheart.2000.278.2.H367; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhang YK, 1999, J BIOL CHEM, V274, P34657, DOI 10.1074/jbc.274.49.34657	50	49	50	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32453	32461		10.1074/jbc.M706242200	http://dx.doi.org/10.1074/jbc.M706242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804409	hybrid			2022-12-27	WOS:000250480300068
J	Koivunen, P; Tiainen, P; Hyvarinen, J; Williams, KE; Sormunen, R; Klaus, SJ; Kivirikko, KI; Myllyharju, J				Koivunen, Peppi; Tiainen, Paeivi; Hyvarinen, Jaana; Williams, Kim E.; Sormunen, Raija; Klaus, Stephen J.; Kivirikko, Kari I.; Myllyharju, Johanna			An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; PROLINE HYDROXYLATION; GENE-EXPRESSION; HIF-ALPHA; COLLAGEN; HIF-1-ALPHA; SUBUNIT; PATHWAY; ENZYMES; PHD2	Prolyl 4-hydroxylases (P4Hs) act on collagens (C-P4Hs) and the oxygen-dependent degradation domains (ODDDs) of hypoxia-inducible factor alpha subunits (HIF-P4Hs) leading to degradation of the latter. We report data on a human P4H possessing a transmembrane domain (P4H-TM). Its gene is also found in zebrafish but not in flies and nematodes. Its sequence more closely resembles those of the C-P4Hs than the HIF-P4Hs, but it lacks the peptide substrate-binding domain of the C-P4Hs. P4H-TM levels in cultured cells are increased by hypoxia, and P4H-TMisN-glycosylated and is located in endoplasmic reticulum membranes with its catalytic site inside the lumen, a location differing from those of the HIF-P4Hs. Despite this, P4H-TM overexpression in cultured neuroblastoma cells reduced HIF-alpha ODDD reporter construct levels, and its small interfering RNA increased HIF-1 alpha protein level, in the same way as those of HIF-P4Hs. Furthermore, recombinant P4H-TM hydroxylated the two critical prolines in HIF-1 alpha ODDD in vitro, with a preference for the C-terminal proline, whereas it did not hydroxylate any prolines in recombinant type I procollagen chains.	Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Collagen Res Unit, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; Univ Oulu, Collagen Res Unit, Dept Pathol, FIN-90014 Oulu, Finland; FibroGen Inc, San Francisco, CA 94080 USA	University of Oulu; University of Oulu; University of Oulu; FibroGen	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, Bioctr Oulu, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dann CE, 2005, BIOCHEM BIOPH RES CO, V338, P639, DOI 10.1016/j.bbrc.2005.08.140; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 2002, J BIOL CHEM, V277, P41750, DOI 10.1074/jbc.M207280200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KODITZ J, 2007, IN PRESS BLOOD; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C	41	109	115	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30544	30552		10.1074/jbc.M704988200	http://dx.doi.org/10.1074/jbc.M704988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726031	hybrid			2022-12-27	WOS:000250136300022
J	Sklan, EH; Serrano, RL; Einav, S; Pfeffer, SR; Lambright, DG; Glenn, JS				Sklan, Ella H.; Serrano, Ramon L.; Einav, Shirit; Pfeffer, Suzanne R.; Lambright, David G.; Glenn, Jeffrey S.			TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; ENDOPLASMIC-RETICULUM; LEGIONELLA-PNEUMOPHILA; MEMBRANE ASSOCIATION; VESICULAR TRANSPORT; GOLGI COMPARTMENTS; VIRAL REPLICATION; NS5A PROTEIN; DOMAIN; IDENTIFICATION	Like other viruses, productive hepatitis C virus (HCV) infection depends on certain critical host factors. We have recently shown that an interaction between HCV nonstructural protein NS5A and a host protein, TBC1D20, is necessary for efficient HCV replication. TBC1D20 contains a TBC (Tre-2, Bub2, and Cdc16) domain present in most known Rab GTPase-activating proteins ( GAPs). The latter are master regulators of vesicular membrane transport, as they control the activity of membrane-associated Rab proteins. To better understand the role of the NS5A-TBC1D20 interaction in the HCV life cycle, we used a biochemical screen to identify the TBC1D20 Rab substrate. TBC1D20 was found to be the first known GAP for Rab1, which is implicated in the regulation of anterograde traffic between the endoplasmic reticulum and the Golgi complex. Mutation of amino acids implicated in Rab GTPase activation by other TBC domain-containing GAPs abrogated the ability of TBC1D20 to activate Rab1 GTPase. Overexpression of TBC1D20 blocked the transport of exogenous vesicular stomatitis virus G protein from the endoplasmic reticulum, validating the involvement of TBC1D20 in this pathway. Rab1 depletion significantly decreased HCV RNA levels, suggesting a role for Rab1 in HCV replication. These results highlight a novel mechanism by which viruses can hijack host cell machinery and suggest an attractive model whereby the NS5A-TBC1D20 interaction may promote viral membrane-associated RNA replication.	Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Vet Affairs Med Ctr, Palo Alto, CA 94304 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Program Mol Med, Worcester, MA 01605 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Massachusetts System; University of Massachusetts Worcester	Glenn, JS (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, CCSR Bldg,Rm 3115,269 Campus Dr, Palo Alto, CA 94304 USA.	jeffrey.glenn@stanford.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037332, R01DK064223] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37-DK37332, R01-DK064223] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cho NJ, 2007, J VIROL, V81, P6682, DOI 10.1128/JVI.02783-06; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Einav S, 2004, J VIROL, V78, P11288, DOI 10.1128/JVI.78.20.11288-11295.2004; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pei L, 2002, CANCER RES, V62, P5420; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pfeffer S, 2005, NAT CELL BIOL, V7, P856, DOI 10.1038/ncb0905-856; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Sklan EH, 2007, J VIROL, V81, P11096, DOI 10.1128/JVI.01249-07; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Xue Q, 2007, ARCH VIROL, V152, P955, DOI 10.1007/s00705-006-0905-x; Zech B, 2003, J GEN VIROL, V84, P555, DOI 10.1099/vir.0.18801-0; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070	56	89	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36354	36361		10.1074/jbc.M705221200	http://dx.doi.org/10.1074/jbc.M705221200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17901050	hybrid			2022-12-27	WOS:000251458300026
J	Das, AV; James, J; Bhattacharya, S; Imbalzano, AN; Antony, ML; Hegde, G; Zhao, X; Mallya, K; Ahmad, F; Knudsen, E; Ahmad, I				Das, Ani V.; James, Jackson; Bhattacharya, Sumitra; Imbalzano, Anthony N.; Antony, Marie Lue; Hegde, Ganapati; Zhao, Xing; Mallya, Kavita; Ahmad, Faraz; Knudsen, Eric; Ahmad, Iqbal			SWI/SNF chromatin remodeling ATPase Brm regulates the differentiation of early retinal stem cells/progenitors by influencing Brn3b expression and notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE DETERMINATION; GANGLION-CELL; PROGENITOR CELLS; TRANSCRIPTION FACTORS; CYCLIN D1; IN-VITRO; MUSCLE DIFFERENTIATION; NEURAL DIFFERENTIATION; MAMMALIAN RETINA; GENE-EXPRESSION	Based on a variety of approaches, evidence suggests that different cell types in the vertebrate retina are generated by multipotential progenitors in response to interactions between cell intrinsic and cell extrinsic factors. The identity of some of the cellular determinants that mediate such interactions has emerged, shedding light on mechanisms underlying cell differentiation. For example, we know now that Notch signaling mediates the influence of the microenvironment on states of commitment of the progenitors by activating transcriptional repressors. Cell intrinsic factors such as the proneural basic helix-loop-helix and homeodomain transcription factors regulate a network of genes necessary for cell differentiation and maturation. What is missing from this picture is the role of developmental chromatin remodeling in coordinating the expression of disparate classes of genes for the differentiation of retinal progenitors. Here we describe the role of Brm, an ATPase in the SWI/SNF chromatin remodeling complex, in the differentiation of retinal progenitors into retinal ganglion cells. Using the perturbation of expression and function analyses, we demonstrate that Brm promotes retinal ganglion cell differentiation by facilitating the expression and function of a key regulator of retinal ganglion cells, Brn3b, and the inhibition of Notch signaling. In addition, we demonstrate that Brm promotes cell cycle exit during retinal ganglion cell differentiation. Together, our results suggest that Brm represents one of the nexus where diverse information of cell differentiation is integrated during cell differentiation.	Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45267 USA	University of Nebraska System; University of Nebraska Medical Center; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati	Ahmad, I (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, 4044 Durham Res Ctr, Omaha, NE 68198 USA.	iahmad@unmc.edu	Antony, Marie Lue/AAB-3952-2019	James, Jackson/0000-0002-7038-2687				Ahmad I, 1999, BRAIN RES, V831, P1, DOI 10.1016/S0006-8993(99)01376-1; Ahmad I, 1997, DEV BIOL, V185, P92, DOI 10.1006/dbio.1997.8546; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; CHRISTIE GA, 1964, J MORPHOL, V114, P263, DOI 10.1002/jmor.1051140207; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; DAS AV, 2005, STEM CELLS CNS DEV, P235; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dooley CM, 2003, J NEUROBIOL, V54, P313, DOI 10.1002/neu.10176; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hegde GV, 2007, EXP EYE RES, V84, P577, DOI 10.1016/j.exer.2006.11.012; Hempel William M, 2004, Methods Mol Biol, V287, P53; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Imbalzano AN, 2004, ADV PROTEIN CHEM, V67, P157; James J, 2003, J NEUROSCI, V23, P8193; James J, 2004, J NEUROBIOL, V61, P359, DOI 10.1002/neu.20064; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; LeGouy E, 1998, DEV DYNAM, V212, P38, DOI 10.1002/(SICI)1097-0177(199805)212:1<38::AID-AJA4>3.0.CO;2-3; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; RANDAZZO FM, 1994, DEV BIOL, V161, P229, DOI 10.1006/dbio.1994.1023; Rapaport DH, 1998, SEMIN CELL DEV BIOL, V9, P241, DOI 10.1006/scdb.1998.0232; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Schofield J, 1999, MECH DEVELOP, V80, P115, DOI 10.1016/S0925-4773(98)00207-X; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Sherr CJ, 2000, CANCER RES, V60, P3689; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sidman RL, 1961, STRUCTURE EYE, P487; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Wagner KD, 2003, GENE, V305, P217, DOI 10.1016/S0378-1119(02)01231-3; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996; Zraly CB, 2004, GENETICS, V168, P199, DOI 10.1534/genetics.104.029439	88	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35187	35201		10.1074/jbc.M706742200	http://dx.doi.org/10.1074/jbc.M706742200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855369	hybrid			2022-12-27	WOS:000251155200064
J	Amaral, JD; Castro, RE; Sola, S; Steer, CJ; Rodrigues, CMP				Amaral, Joana D.; Castro, Rui E.; Sola, Susana; Steer, Clifford J.; Rodrigues, Cecilia M. P.			p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER DOMAIN; RAT HEPATOCYTES; GLUCOCORTICOID-RECEPTOR; TUMOR-SUPPRESSOR; BILE-ACIDS; TRANSCRIPTIONAL ACTIVATION; TAUROURSODEOXYCHOLIC ACID; PERMEABILITY TRANSITION; NUCLEAR EXPORT; CYTOCHROME-C	p53 plays an important role in regulating expression of genes that mediate cell cycle progression and/or apoptosis. In addition, we have previously shown that the hydrophilic bile acid ursodeoxycholic acid (UDCA) prevents transforming growth factor beta 1-induced p53 stabilization and apoptosis in primary rat hepatocytes. Therefore, we hypothesized that p53 may represent an important target in bile acid-induced modulation of apoptosis and cell survival. In this study we demonstrated that UDCA reduces p53 transcriptional activity, thereby preventing its ability to induce Bax expression, mitochondrial translocation, cytochrome c release, and apoptosis in primary rat hepatocytes. More importantly, bile acid inhibition of p53-induced apoptosis was associated with decreased p53 DNA binding activity. Subcellular localization of p53 was also altered by UDCA. Both events appear to be related with increased association between p53 and its direct repressor, Mdm-2. In conclusion, these results further clarify the antiapoptotic mechanism of UDCA and suggest that modulation of Mdm-2/p53 interaction is a prime target for this bile acid.	Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Universidade de Lisboa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rodrigues, CMP (corresponding author), Univ Lisbon, Fac Pharm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Amaral, Joana/M-4660-2013; Rodrigues, Cecilia MP/M-3572-2013; Amaral, Joana São José Dias/M-7809-2019; Solá, Susana/AAI-4580-2021; Castro, Rui E/AAG-4179-2021; Castro, Rui E/I-2975-2013; Solá, Susana/M-5251-2013; iMed.ULisboa, CellFun/A-4244-2014	Amaral, Joana/0000-0001-9504-5102; Rodrigues, Cecilia MP/0000-0002-4829-754X; Amaral, Joana São José Dias/0000-0001-9504-5102; Solá, Susana/0000-0003-2036-797X; Castro, Rui E/0000-0002-7417-0091; Castro, Rui E/0000-0002-7417-0091; Solá, Susana/0000-0003-2036-797X; 				Amaral Joana D, 2007, Expert Rev Endocrinol Metab, V2, P487, DOI 10.1586/17446651.2.4.487; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Castro RE, 2005, J HEPATOL, V42, P897, DOI 10.1016/j.jhep.2005.01.026; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinoza-Fonseca LM, 2006, BIOPOLYMERS, V83, P365, DOI 10.1002/bip.20566; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; HAMADA K, 1994, CARCINOGENESIS, V15, P1911, DOI 10.1093/carcin/15.9.1911; HARPER JW, 1993, CELL, V75, P805; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Im E, 2005, NUTR CANCER, V51, P110, DOI 10.1207/s15327914nc5101_15; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kren BT, 2001, LIVER TRANSPLANT, V7, P321, DOI 10.1053/jlts.2001.23062; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miura T, 2001, J BIOL CHEM, V276, P47371, DOI 10.1074/jbc.M107098200; MIYASHITA T, 1995, CELL, V80, P293; Monte MJ, 2002, J HEPATOL, V36, P534, DOI 10.1016/S0168-8278(01)00296-3; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560; SCATES DK, 1995, CARCINOGENESIS, V16, P1489, DOI 10.1093/carcin/16.7.1489; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Sola S, 2005, HEPATOLOGY, V42, P925, DOI 10.1002/hep.20870; Sola S, 2004, BIOCHEMISTRY-US, V43, P8429, DOI 10.1021/bi049781x; Sola S, 2003, MOL MED, V9, P226, DOI 10.2119/2003-00042.Rodrigues; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; TANAKA H, 1992, BIOCHEM BIOPH RES CO, V188, P942, DOI 10.1016/0006-291X(92)91146-H; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189	64	65	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34250	34259		10.1074/jbc.M704075200	http://dx.doi.org/10.1074/jbc.M704075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17881359	hybrid			2022-12-27	WOS:000251145700040
J	Amat, R; Solanes, G; Giralt, M; Villarroya, F				Amat, Ramon; Solanes, Gemma; Giralt, Marta; Villarroya, Francesc			SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; HISTONE DEACETYLASE; THYROID-HORMONE; RETINOIC ACID; EXPRESSION; CELLS; MYOD; DIFFERENTIATION	UCP3 (uncoupling protein-3) is a mitochondrial membrane transporter expressed preferentially in skeletal muscle. UCP3 lowers mitochondrial membrane potential and protects muscle cells against an overload of fatty acids, and it probably reduces excessive production of reactive oxygen species. Accordingly, ucp3 gene transcription is highly sensitive to fatty acid-dependent stimulation and also to other unrelated stress signals. In this study, glucocorticoids are identified as major inducers of ucp3 gene transcription in muscle. Glucocorticoids activate the transcription of the ucp3 gene through a glucocorticoid receptor-binding site in the promoter region. Glucocorticoids are capable of inducing ucp3 gene transcription independently from the myogenic regulatory factor MyoD, in contrast with the transcriptional activation of the ucp3 gene through other nuclear hormone receptors. An interplay of regulatory factors modulates positively (p300) or negatively (histone deacetylases) the action of glucocorticoids on ucp3 gene transcription via histone acetylation or deacetylation processes, respectively. Among them, SIRT1 acts as a major repressor of ucp3 gene expression in response to glucocorticoids. The action of SIRT1 requires its deacetylase activity and results in histone deacetylation in the ucp3 promoter. Moreover, it involves a specific impairment of association of p300 with the glucocorticoid receptor. Agents activating SIRT1, such as resveratrol, repress ucp3 gene expression. The control of SIRT1 activity via the metabolic redox status of the cell points to a novel regulatory pathway of ucp3 gene transcription in response to metabolic and stress signaling in muscle cells.	Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Villarroya, F (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 645, E-08028 Barcelona, Spain.	fvillarroya@ub.edu	Amat, Ramon/F-2681-2010; Giralt, Marta/A-4756-2013; Villarroya, Francesc/K-4357-2014	Amat, Ramon/0000-0001-8284-2540; Giralt, Marta/0000-0001-7968-4190; Villarroya, Francesc/0000-0003-1266-9142				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bakhtiarova A, 2006, BIOCHEM BIOPH RES CO, V351, P481, DOI 10.1016/j.bbrc.2006.10.057; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRAUN T, 1992, GENE DEV, V6, P888, DOI 10.1101/gad.6.5.888; Brun S, 1999, FEBS LETT, V453, P205, DOI 10.1016/S0014-5793(99)00722-X; Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Busquets S, 2005, FEBS LETT, V579, P717, DOI 10.1016/j.febslet.2004.12.050; Carballo-Jane E, 2004, J STEROID BIOCHEM, V88, P191, DOI 10.1016/j.jsbmb.2003.11.012; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; Pedraza N, 2006, ENDOCRINOLOGY, V147, P4695, DOI 10.1210/en.2006-0226; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Sun XY, 2003, AM J PHYSIOL-ENDOC M, V285, pE512, DOI 10.1152/ajpendo.00446.2002; Tai H, 2000, BIOCHEM BIOPH RES CO, V267, P311, DOI 10.1006/bbrc.1999.1954; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; YANG H, 2006, AM J PHYSIOL, V292, pR337; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zhang QH, 2006, INT J MOL MED, V18, P1223	41	70	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34066	34076		10.1074/jbc.M707114200	http://dx.doi.org/10.1074/jbc.M707114200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884810	hybrid			2022-12-27	WOS:000251145700021
J	Simon, S; Fontaine, JM; Martin, JL; Sun, X; Hoppe, AD; Welsh, MJ; Benndorf, R; Vicart, P				Simon, Stephanie; Fontaine, Jean-Marc; Martin, Jody L.; Sun, Xiankui; Hoppe, Adam D.; Welsh, Michael J.; Benndorf, Rainer; Vicart, Patrick			Myopathy-associated alpha B-crystallin mutants - Abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR POLAR CATARACT; MARIE-TOOTH-DISEASE; BETA-CRYSTALLIN; HSP22 HSPB8; MUTATION; DESMIN; R120G; APOPTOSIS; GENE; R120G-ALPHA-B-CRYSTALLIN	Three mutations (R120G, Q151X, and 464delCT) in the small heat shock protein alpha B-crystallin cause inherited myofibrillar myopathy. In an effort to elucidate the molecular basis for the associated myopathy, we have determined the following for these mutant alpha B-crystallin proteins: (i) the formation of aggregates in transfected cells; (ii) the partition into different subcellular fractions; (iii) the phosphorylation status; and (iv) the ability to interact with themselves, with wild-type alpha B-crystallin, and with other small heat shock proteins that are abundant in muscles. We found that all three alpha B-crystallin mutants have an increased tendency to form cytoplasmic aggregates in transfected cells and significantly increased levels of phosphorylation when compared with the wildtype protein. Although wild-type alpha B-crystallin partitioned essentially into the cytosol and membranes/organelles fractions, mutant alpha B-crystallin proteins partitioned additionally into the nuclear and cytoskeletal fractions. By using various protein interaction assays, including quantitative fluorescence resonance energy transfer measurements in live cells, we found abnormal interactions of the various alpha B-crystallin mutants with wild-type alpha B-crystallin, with themselves, and with the other small heat shock proteins Hsp20, Hsp22, and possibly with Hsp27. The collected data suggest that each alpha B-crystallin mutant has a unique pattern of abnormal interaction properties. These distinct properties of the alpha B-crystallin mutants identified are likely to contribute to a better understanding of the gradual manifestation and clinical heterogeneity of the associated myopathy in patients.	Univ Paris 07, UFR Biochim, EA 300 Stress & Pathol Cytosquelette, F-75005 Paris, France; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Loyola Univ, Dept Med, Cardiovasc Inst, Maywood, IL 60153 USA	UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Loyola University Chicago	Simon, S (corresponding author), Univ Paris 07, UFR Biochim, EA 300 Stress & Pathol Cytosquelette, F-75005 Paris, France.	stef.labo@gmail.com	Welsh, Michael/B-1968-2008; Stephanie, Simon/A-3845-2013; Hoppe, Adam/U-8563-2019	Hoppe, Adam/0000-0003-4180-0840	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011188] Funding Source: NIH RePORTER; NIEHS NIH HHS [P01 ES 11188] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Boelens WC, 1998, J BIOL CHEM, V273, P28085, DOI 10.1074/jbc.273.43.28085; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Ganea E, 2001, CURR PROTEIN PEPT SC, V2, P205, DOI 10.2174/1389203013381107; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Inaguma Y, 2001, EUR J CELL BIOL, V80, P741, DOI 10.1078/0171-9335-00203; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Ito H, 2002, J BIOCHEM, V131, P593, DOI 10.1093/oxfordjournals.jbchem.a003139; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; KATO K, 1994, J BIOL CHEM, V269, P15302; Kijima K, 2005, J HUM GENET, V50, P473, DOI 10.1007/s10038-005-0280-6; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Liu Xiao-min, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P510; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Lutsch G, 1997, CIRCULATION, V96, P3466; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Martin JL, 2002, AM J PHYSIOL-HEART C, V283, pH85, DOI 10.1152/ajpheart.00512.2001; Pasta SY, 2004, MOL VIS, V10, P655; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; van de Klundert FAJM, 1998, EUR J BIOCHEM, V258, P1014, DOI 10.1046/j.1432-1327.1998.2581014.x; van den IJssel P, 2003, EXP CELL RES, V287, P249, DOI 10.1016/S0014-4827(03)00092-2; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang KY, 2000, EUR J BIOCHEM, V267, P4705, DOI 10.1046/j.1432-1327.2000.01521.x; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Zhang Fu-feng, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P361; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	69	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34276	34287		10.1074/jbc.M703267200	http://dx.doi.org/10.1074/jbc.M703267200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897943	hybrid			2022-12-27	WOS:000251145700043
J	Tamaki, H; Shimada, A; Ito, Y; Ohya, M; Takase, J; Miyashita, M; Miyagawa, H; Nozaki, H; Nakayama, R; Kumagai, H				Tamaki, Hisanori; Shimada, Atsushi; Ito, Yoshihiro; Ohya, Mihoko; Takase, Juri; Miyashita, Masahiro; Miyagawa, Hisashi; Nozaki, Hiroyuki; Nakayama, Reiko; Kumagai, Hidehiko			LPT1 encodes a membrane-bound O-acyltransferase involved in the acylation of lysophospholipids in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; PLATELET-ACTIVATING-FACTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; LYSO-PAF ACETYLTRANSFERASE; ESCHERICHIA-COLI; 1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; ACETYL-COA; BARTH-SYNDROME	Phospholipids are major components of cellular membranes that participate in a range of cellular processes. Phosphatidic acid (PA) is a key molecule in the phospholipid biosynthetic pathway. In Saccharomyces cerevisiae, SLC1 has been identified as the gene encoding lysophosphatidic acid acyltransferase, which catalyzes PA synthesis. However, despite the importance of PA, disruption of SLC1 does not affect cell viability (Nagiec, M. M., Wells, G. B., Lester, R. L., and Dickson, R. C. (1993) J. Biol. Chem. 268, 22156-22163). We originally aimed to identify the acetyl-CoA: lyso platelet-activating factor acetyltransferase (lysoPAF AT) gene in yeast. Screening of a complete set of yeast deletion clones (4741 homozygous diploid clones) revealed a single mutant strain, YOR175c, with a defect in lysoPAF AT activity. YOR175c has been predicted to be a member of the membrane-bound O-acyltransferase superfamily, and we designated the gene LPT1. An Lpt1-green fluorescent protein fusion protein localized at the endoplasmic reticulum. Other than lysoPAF AT activity, Lpt1 catalyzed acyltransferase activity with a wide variety of lysophospholipids as acceptors, including lysophosphatidic acid, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysophosphatidylinositol, and lysophosphatidylserine. A liquid chromatography-mass spectrometry analysis indicated that lysophosphatidylcholine and lysophosphatidylethanolamine accumulated in the Delta lpt1 mutant strain. Although the Delta lpt1 mutant strain did not show other detectable defects, the Delta lpt1 Delta slc1 double mutant strain had a synthetic lethal phenotype. These results indicate that, in concert with Slc1, Lpt1 plays a central role in PA biosynthesis, which is essential for cell viability.	Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, Kagoshima 8900065, Japan; Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; Kyoto Womens Univ, Dept Food Sci, Kyoto 606, Japan; Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Ishikawa 9218836, Japan	Kagoshima University; Kyoto University; Kyoto University; Kyoto Womens University; Ishikawa Prefecture University	Tamaki, H (corresponding author), Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	noritama@ms.kagoshima-u.ac.jp	Ito, Yoshihiro/T-1095-2019	Ito, Yoshihiro/0000-0002-1154-253X; Ito, Yoshihiro/0000-0001-7693-3593				Aguado B, 1997, BIOCHEM SOC T, V25, pS597, DOI 10.1042/bst025s597; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; BENGHEZAL M, 2007, J BIOL CHEM     0803; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fragopoulou E, 2005, MEDIAT INFLAMM, P263, DOI 10.1155/MI.2005.263; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOMEZCAMBRONERO J, 1986, BIOCHEM J, V237, P439, DOI 10.1042/bj2370439; GREEN PR, 1983, J BIOL CHEM, V258, P862; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holst B, 2000, MOL MICROBIOL, V37, P108, DOI 10.1046/j.1365-2958.2000.01968.x; Hong J, 2001, J BIOSCI BIOENG, V92, P434, DOI 10.1016/S1389-1723(01)80292-9; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; JAIN S, 2007, J BIOL CHEM     0828; KENNEDY EP, 1961, FED PROC, V20, P934; Kume K, 1997, BIOCHEM BIOPH RES CO, V237, P663, DOI 10.1006/bbrc.1997.7214; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1963, J BIOL CHEM, V238, P898; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; MATSUSHITA M, 1995, J BIOCHEM-TOKYO, V117, P447, DOI 10.1093/jb/117.2.447; MERKL I, 1963, J BIOL CHEM, V238, P905; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NAKAYAMA R, 1994, BBA-GEN SUBJECTS, V1199, P137, DOI 10.1016/0304-4165(94)90108-2; PINCKARD RN, 1979, J IMMUNOL, V123, P1847; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Taguchi R, 2000, J MASS SPECTROM, V35, P953, DOI 10.1002/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 2001, J BIOL CHEM, V276, P26745, DOI 10.1074/jbc.M101795200; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	62	67	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34288	34298		10.1074/jbc.M704509200	http://dx.doi.org/10.1074/jbc.M704509200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890783	hybrid			2022-12-27	WOS:000251145700044
J	Weng, Z; Signore, AP; Gao, Y; Wang, S; Zhang, F; Hastings, T; Yin, XM; Chen, J				Weng, Zhongfang; Signore, Armando P.; Gao, Yanqin; Wang, Suping; Zhang, Feng; Hastings, Teresa; Yin, Xiao-Ming; Chen, Jun			Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MESSENGER-RNA; JAK-STAT PATHWAY; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; RAT-BRAIN; CEREBRAL-ISCHEMIA; NEURONAL SURVIVAL; INDUCED APOPTOSIS; GENE DELIVERY	The death of midbrain dopaminergic neurons in sporadic Parkinson disease is of unknown etiology but may involve altered growth factor signaling. The present study showed that leptin, a centrally acting hormone secreted by adipocytes, rescued dopaminergic neurons, reversed behavioral asymmetry, and restored striatal catecholamine levels in the unilateral 6-hydroxydopamine (6-OHDA) mouse model of dopaminergic cell death. In vitro studies using the murine dopaminergic cell line MN9D showed that leptin attenuated 6-OHDA-induced apoptotic markers, including caspase-9 and caspase-3 activation, internucleosomal DNA fragmentation, and cytochrome c release. ERK1/2 phosphorylation (pERK1/2) was found to be critical for mediating leptin-induced neuroprotection, because inhibition of the MEK pathway blocked both the pERK1/2 response and the pro-survival effect of leptin in cultures. Knockdown of the downstream messengers JAK2 or GRB2 precluded leptin-induced pERK1/2 activation and neuroprotection. Leptin/pERK1/2 signaling involved phosphorylation and nuclear localization of CREB (pCREB), a well known survival factor for dopaminergic neurons. Leptin induced a marked MEK-dependent increase in pCREB that was essential for neuroprotection following 6-OHDA toxicity. Transfection of a dominant negative MEK protein abolished leptin-enhanced pCREB formation, whereas a dominant negative CREB or decoy oligonucleotide diminished both pCREB binding to its target DNA sequence and MN9D survival against 6-OHDA toxicity. Moreover, in the substantia nigra of mice, leptin treatment increased the levels of pERK1/2, pCREB, and the downstream gene product BDNF, which were reversed by the MEK inhibitor PD98059. Collectively, these data provide evidence that leptin prevents the degeneration of dopaminergic neurons by 6-OHDA and may prove useful in the treatment of Parkinson disease.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; Fudan Univ, Sch Med, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; Vet Affairs Pittsburgh Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Chen, J (corresponding author), Univ Pittsburgh, Dept Neurol, Sch Med, S-507,Biomed Sci tower, Pittsburgh, PA 15213 USA.	chenj2@upmc.edu	Gao, Yanqin/I-6790-2016; Zhang, Feng/X-2287-2019	Gao, Yanqin/0000-0002-4915-9819; Zhang, Feng/0000-0001-7275-9989; Chen, Jun/0000-0002-8077-3403	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044178, R01NS045048, R01NS043802] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 45048, NS 43802, NS 44178] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Bensadoun JC, 2000, EXP NEUROL, V164, P15, DOI 10.1006/exnr.2000.7409; Berhow MT, 1996, J NEUROSCI, V16, P8019; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chen J, 1998, J NEUROSCI, V18, P4914; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Cowen T, 2002, AUTON NEUROSCI-BASIC, V96, P20, DOI 10.1016/S1566-0702(01)00376-9; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Ditlevsen DK, 2007, EUR J NEUROSCI, V25, P1678, DOI 10.1111/j.1460-9568.2007.05436.x; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Hoda MR, 2007, BRIT J SURG, V94, P346, DOI 10.1002/bjs.5530; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066; Kurrimbux D, 2004, NEUROSCIENCE, V123, P527, DOI 10.1016/j.neuroscience.2003.08.061; Larsen KE, 2002, J NEUROSCI, V22, P8951; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Liang QH, 2004, J NEUROSCI RES, V77, P747, DOI 10.1002/jnr.20198; Lu JN, 2006, NEUROSCI LETT, V407, P240, DOI 10.1016/j.neulet.2006.08.053; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Mutze J, 2006, NEUROSCI LETT, V394, P105, DOI 10.1016/j.neulet.2005.10.031; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Park J, 2006, DIABETES, V55, pA18; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Troadec JD, 2002, MOL PHARMACOL, V62, P1043, DOI 10.1124/mol.62.5.1043; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	62	127	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34479	34491		10.1074/jbc.M705426200	http://dx.doi.org/10.1074/jbc.M705426200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17895242	hybrid			2022-12-27	WOS:000251145700063
J	Chon, SH; Zhou, YX; Dixon, JL; Storch, J				Chon, Su-Hyoun; Zhou, Yin Xiu; Dixon, Joseph L.; Storch, Judith			Intestinal monoacylglycerol metabolism - Developmental and nutritional regulation of monoacylglycerol lipase and monoacylglycerol acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; CARBOXYL ESTER LIPASE; FATTY-ACID; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DIETARY DIACYLGLYCEROL; RAT-LIVER; ACYL-COA; TISSUE DISTRIBUTION; CACO-2 CELLS; TRIACYLGLYCEROL	Intestinal monoacylglycerol (MG) metabolism is well known to involve its anabolic reesterification to triacylglycerol (TG). We recently provided evidence for enterocyte MG hydrolysis and demonstrated expression of the monoacylglycerol lipase (MGL) gene in human intestinal Caco-2 cells and rodent small intestinal mucosa. Despite the large quantities of MG derived from dietary TG, the regulation of MG metabolism in the intestine has not been previously explored. In the present studies, we examined the mRNA expression, protein expression, and activities of the two known MG-metabolizing enzymes, MGL and MGAT2, in C57BL/6 mouse small intestine, as well as liver and adipose tissues, during development and under nutritional modifications. Results demonstrate that MG metabolism undergoes tissue-specific changes during development. Marked induction of small intestinal MGAT2 protein expression and activity were found during suckling. Moreover, while substantial levels of MGL protein and activity were detected in adult intestine, its regulation during ontogeny was complex, suggesting post-transcriptional regulation of expression. In addition, during the suckling period MG hydrolytic activity is likely to derive from carboxyl ester lipase rather than MGL. In contrast to intestinal MGL, liver MGL mRNA, protein and activity all increased 5-10-fold during development, suggesting that transcriptional regulation is the primary mechanism for hepatic MGL expression. Three weeks of high fat feeding (40% kcal) significantly induced MGL expression and activity in small intestine relative to low fat feeding (10% kcal), but little change was observed upon starvation, suggesting a role for MGL in dietary lipid assimilation following a high fat intake.	Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu		Storch, Judith/0000-0001-5482-1777	NIDDK NIH HHS [R01 DK038389, DK38389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruneau N, 2001, EXP CELL RES, V271, P94, DOI 10.1006/excr.2001.5361; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; COLEMAN RA, 1984, J BIOL CHEM, V259, P8934; COLEMAN RA, 1983, J BIOL CHEM, V258, P450; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; DEJONG BJ, 1978, BIOCHIM BIOPHYS ACTA, V1393, P119; Di Carlo G, 2003, EXPERT OPIN INV DRUG, V12, P39, DOI 10.1517/eoid.12.1.39.21246; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Douglas DN, 2001, J BIOL CHEM, V276, P25621, DOI 10.1074/jbc.M103874200; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; GALLO LL, 1980, J LIPID RES, V21, P537; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; JAMDAR SC, 1978, J LIPID RES, V19, P763; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; KAMHPUIS M, 2002, AM J CLIN NUTR, V77, P1133; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Kim TS, 1996, J NUTR, V126, P611, DOI 10.1093/jn/126.3.611; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Lewin TM, 2001, ARCH BIOCHEM BIOPHYS, V396, P119, DOI 10.1006/abbi.2001.2604; LIDMER AS, 1995, GENOMICS, V29, P115, DOI 10.1006/geno.1995.1221; LIN MCM, 1994, J BIOL CHEM, V269, P29138; MANOWITZ NR, 1986, J LIPID RES, V27, P196; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Murase T, 2001, J LIPID RES, V42, P372; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792; Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Pinto L, 2002, PROSTAG LEUKOTR ESS, V66, P333, DOI 10.1054/plef.2001.0345; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; POPE JL, 1966, J BIOL CHEM, V241, P2306; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; SZTALRYD C, 1994, AM J PHYSIOL, V266, pE179, DOI 10.1152/ajpendo.1994.266.2.E179; Tso P, 2002, BIOCH PHYSL ASPECTS, P125; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WANG CS, 1983, J BIOL CHEM, V258, P9197; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; XIA T, 1993, AM J PHYSIOL, V265, pR414, DOI 10.1152/ajpregu.1993.265.2.R414; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	53	45	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33346	33357		10.1074/jbc.M706994200	http://dx.doi.org/10.1074/jbc.M706994200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848545	hybrid			2022-12-27	WOS:000250840200014
J	Keating, SE; Maloney, GM; Moran, EM; Bowie, AG				Keating, Sinead E.; Maloney, Geraldine M.; Moran, Ellen M.; Bowie, Andrew G.			IRAK-2 participates in multiple toll-like receptor signaling pathways to NF kappa B via activation of TRAF6 ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN-10; INTERFERON-ALPHA INDUCTION; VACCINIA-VIRUS; ADAPTER MOLECULE; PROTEIN-KINASE; MICE LACKING; IL-1; FAMILY; MYD88; REGULATOR	Toll-like receptor (TLR) signaling is known to involve interleukin-1 receptor-associated kinases (IRAKs), however the particular role of IRAK-2 has remained unclear. Further, although IRAK-1 was originally thought to be central for the TLR-NF kappa B signaling axis, recent data have shown that it is dispensable for NF kappa B activation for some TLRs and demonstrated an alternative role for it in interferon regulatory factor activation. Here we show that IRAK-2 is critical for the TLR-mediated NF kappa B activation pathway. The poxviral TLR antagonist A52 inhibited NF kappa B activation by TLR2, -3, -4, -5, -7, and -9 ligands, via its interaction with IRAK-2, while not affecting interferon regulatory factor activation. Knockdown of IRAK-2 expression by small interfering RNA suppressed TLR3, TLR4, and TLR8 signaling to NF kappa B in human cell lines, and importantly, TLR4-mediated chemokine production in primary human cells. IRAK-2 usage by different TLRs was distinct, because it acted downstream of the TLR adaptors MyD88 and Mal but upstream of TRIF. Expression of IRAK-2, but not IRAK-1, led to TRAF6 ubiquitination, an event critical for NF kappa B activation. Further, IRAK-2 loss-of-function mutants, which could not activate NF kappa B, were incapable of promoting TRAF6 ubiquitination. Thus we propose that IRAK-2 plays a more central role than IRAK-1 in TLR signaling to NF kappa B.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Moran, Ellen/H-7722-2019	Moran, Ellen/0000-0002-0743-0770; Bowie, Andrew/0000-0001-5316-4373				Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thomas JA, 1999, J IMMUNOL, V163, P978; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	163	172	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33435	33443		10.1074/jbc.M705266200	http://dx.doi.org/10.1074/jbc.M705266200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878161	hybrid			2022-12-27	WOS:000250840200023
J	Wu, S; Flint, JK; Rezvani, G; De Luca, F				Wu, Shufang; Flint, Janna K.; Rezvani, Geoffrey; De Luca, Francesco			RETRACTED: Nuclear Factor-kappa B p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis (Retracted article. See vol. 295, pg. 13691, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; MORPHOGENETIC PROTEINS; ACTIVATION; ALPHA; CHONDROGENESIS; LEADS; PHOSPHORYLATION; INHIBITION; CARTILAGE	NF-kappa B is a group of transcription factors involved in cell proliferation, differentiation, and apoptosis. Mice deficient in the NF-kappa B subunits p50 and p52 have retarded growth, suggesting that NF-kappa B is involved in bone growth. Yet, it is not clear whether the reduced bone growth of these mice depends on the lack of NF-kappa B activity in growth plate chondrocytes. Using cultured rat metatarsal bones and isolated growth plate chondrocytes, we studied the effects of two NF-kappa B inhibitors ( pyrrolidine dithiocarbamate ( PDTC) or BAY11-7082 (BAY)), p65 short interference RNA ( siRNA), and of the overexpression of p65 on chondrocyte proliferation, differentiation, and apoptosis. To further define the underlying mechanisms, we studied the functional interaction between NF-kappa B p65 and BMP-2 in chondrocytes. PDTC and BAY suppressed metatarsal linear growth. Such growth inhibition resulted from decreased chondrocyte proliferation and differentiation and from increased chondrocyte apoptosis. In cultured chondrocytes, the inhibition of NF-kappa B p65 activation (by PDTC and BAY) and expression (by p65 siRNA) led to the same findings observed in cultured metatarsal bones. In contrast, overexpression of p65 in cultured chondrocytes induced chondrocyte proliferation and differentiation and prevented apoptosis. Although PDTC, BAY, and p65 siRNA reduced the expression of BMP-2 in cultured growth plate chondrocytes, the overexpression of p65 increased it. The addition of Noggin, a BMP-2 antagonist, neutralized the stimulatory effects of p65 on chondrocyte proliferation and differentiation, as well as its anti-apoptotic effect. In conclusion, our findings indicate that NF-kappa B p65 expressed in growth plate chondrocytes facilitates growth plate chondrogenesis and longitudinal bone growth by inducing BMP-2 expression and activity.	Drexel Univ, Coll Med, St Christophers Hosp Children, Sectr Endocrinol & Diabetes,Dept Pediat, Philadelphia, PA 19134 USA	Drexel University	De Luca, F (corresponding author), Drexel Univ, Coll Med, St Christophers Hosp Children, Sectr Endocrinol & Diabetes,Dept Pediat, Erie Ave Front St, Philadelphia, PA 19134 USA.	francesco.deluca@drexel.edu						AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1493, DOI 10.1152/ajpcell.00016.2006; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x; FARNUM CE, 1987, MICROSCOP RES TECH, V28, P505; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Han JY, 2007, J CELL PHYSIOL, V211, P486, DOI 10.1002/jcp.20956; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Janssen R, 2004, J EXP MED, V200, P559, DOI 10.1084/jem.20040773; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Lunstrum GP, 1999, J HISTOCHEM CYTOCHEM, V47, P1, DOI 10.1177/002215549904700101; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Urist MR, 1997, J BONE MINER RES, V12, P343, DOI 10.1359/jbmr.1997.12.3.343; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Wu SF, 2004, J CHILD NEUROL, V19, P26, DOI 10.1177/088307380401900105011; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Wu SF, 2006, ENDOCRINOLOGY, V147, P3761, DOI 10.1210/en.2005-1672; Yazaki Y, 1998, ANTICANCER RES, V18, P2339; Zhang LH, 2001, J BIOL CHEM, V276, P43534, DOI 10.1074/jbc.M104257200	37	48	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33698	33706		10.1074/jbc.M702991200	http://dx.doi.org/10.1074/jbc.M702991200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17884819	hybrid			2022-12-27	WOS:000250840200051
J	Zhang, T; Zhuang, SH; Casteel, DE; Looney, DJ; Boss, GR; Pilz, RB				Zhang, Tong; Zhuang, Shunhui; Casteel, Darren E.; Looney, David J.; Boss, Gerry R.; Pilz, Renate B.			A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; REDUCES NEOINTIMA FORMATION; SOLUBLE GUANYLATE-CYCLASE; CYCLIC-GMP; CELL PHENOTYPE; NITRIC-OXIDE; VASCULAR INJURY; BALLOON INJURY; MARKER GENES; I-ALPHA	Vascular smooth muscle cells (VSMCs) undergo phenotypic modulation, changing from a differentiated, contractile to a dedifferentiated, synthetic phenotype; the change is associated with decreased expression of smooth muscle (SM)-specific genes and loss of cGMP-dependent protein kinase (PKG), but transfection of PKG into de-differentiated VSMCs restores SM-specific gene expression. Weshow that small interference RNA-mediated down-regulation or pharmacologic inhibition of PKG reduced SM-specific gene expression in differentiated VSMCs and provide a mechanism for cGMP/PKG regulation of SM-specific genes involving the cysteine-rich LIM-only protein CRP4. PKG associated with CRP4 and phosphorylated the protein in intact cells. CRP4 had no intrinsic transcriptional activity, but exhibited adaptor function, because it acted synergistically with serum response factor (SRF) and GATA6 to activate the SM-alpha-actin promoter. cGMP stimulation of the promoter required PKG and CRP4 co-expression with SRF and GATA6. A phosphorylation-deficient mutant CRP4 and a CRP4 deletion mutant deficient in PKG binding did not support cGMP/PKG stimulation of the SM-alpha-actin promoter. In the presence of wild-type but not mutant CRP4, cGMP/PKG enhanced SRF binding to a probe encoding the distal SM-alpha-actin promoter CArG (CC(AT)(6)GG) element. CRP4 and SRF associated with CArG elements of endogenous SM-specific genes in intact chromatin. Small interference RNA-mediated down-regulation of CRP4 prevented the positive effects of cGMP/PKG on SM-specific gene expression. In the presence of CRP4, cGMP/PKG increased SRF- and GATA6-dependent expression of endogenous SM-specific genes in pluripotent 10T1/2 cells. Thus, CRP4 mediates cGMP/PKG stimulation of SM-specific gene expression, and PKG plays an important role in regulating the phenotype of VSMCs.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Vet Adm Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	NIAID NIH HHS [P30-AI36214, T32-AI007469] Funding Source: Medline; NIAMS NIH HHS [R01-AR051300] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007469, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson PG, 2000, ARTERIOSCL THROM VAS, V20, P2192, DOI 10.1161/01.ATV.20.10.2192; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Brophy CM, 2002, J VASC RES, V39, P95, DOI 10.1159/000057758; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; CORNWELL TL, 1994, J VASC RES, V31, P330, DOI 10.1159/000159061; CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405, DOI 10.1152/ajpcell.1994.267.5.C1405; Dey NB, 1998, CIRC RES, V82, P139; Doi K, 2001, ARTERIOSCL THROM VAS, V21, P930, DOI 10.1161/01.ATV.21.6.930; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Hayashi T, 2004, CARDIOVASC RES, V61, P339, DOI 10.1016/j.cardiores.2003.09.027; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Huber A, 2000, J BIOL CHEM, V275, P5504, DOI 10.1074/jbc.275.8.5504; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Karim MA, 1996, GENOMICS, V31, P167, DOI 10.1006/geno.1996.0028; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kloiber K, 1999, J MOL BIOL, V292, P893, DOI 10.1006/jmbi.1999.3118; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Morris KV, 2004, MOL THER, V10, P181, DOI 10.1016/j.ymthe.2004.03.019; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; OKANO I, 1993, FEBS LETT, V333, P51, DOI 10.1016/0014-5793(93)80373-3; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Sinnaeve P, 2002, CIRCULATION, V105, P2911, DOI 10.1161/01.CIR.0000018169.59205.CA; Sinnaeve P, 2001, CIRC RES, V88, P103, DOI 10.1161/01.RES.88.1.103; Smith PJ, 2002, SIGHT SOUND, V12, P32; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tzeng E, 1996, MOL MED, V2, P211, DOI 10.1007/BF03401618; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wei J, 2005, CIRC RES, V97, P1323, DOI 10.1161/01.RES.0000194331.76925.5c; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Weiskirchen R, 2001, BIOCHEM J, V359, P485, DOI 10.1042/0264-6021:3590485; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Yao X, 1999, BIOCHEMISTRY-US, V38, P5701, DOI 10.1021/bi982036y; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhou WL, 2007, AM J PHYSIOL-LUNG C, V292, pL1459, DOI 10.1152/ajplung.00143.2006	64	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33367	33380		10.1074/jbc.M707186200	http://dx.doi.org/10.1074/jbc.M707186200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878170	hybrid			2022-12-27	WOS:000250840200016
J	Shin, M; Chetkovich, DM				Shin, Minyoung; Chetkovich, Dane M.			Activity-dependent regulation of h channel distribution in hippocampal CA1 pyramidal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING RAT HIPPOCAMPUS; ACTIVATED PACEMAKER CHANNELS; PROTEIN-KINASE-II; ANATOMICAL DATA; AMPA RECEPTORS; UP-REGULATION; ION CHANNELS; HCN CHANNELS; EXPRESSION; BRAIN	The hyperpolarization-activated cation current, I-h, plays an important role in regulating intrinsic neuronal excitability in the brain. In hippocampal pyramidal neurons, Ih is mediated by h channels comprised primarily of the hyperpolarization-activated cyclic nucleotide-gated ( HCN) channel subunits, HCN1 and HCN2. Pyramidal neuron h channels within hippocampal area CA1 are remarkably enriched in distal apical dendrites, and this unique distribution pattern is critical for regulating dendritic excitability. We utilized biochemical and immunohistochemical approaches in organotypic slice cultures to explore factors that control h channel localization in dendrites. We found that distal dendritic enrichment of HCN1 is first detectable at postnatal day 13, reaching maximal enrichment by the 3rd postnatal week. Interestingly we found that an intact entorhinal cortex, which projects to distal dendrites of CA1 but not area CA3, is critical for the establishment and maintenance of distal dendritic enrichment of HCN1. Moreover blockade of excitatory neurotransmission using tetrodotoxin, 6-cyano-7-nitroquinoxaline- 2,3-dione, or 2-aminophosphonovalerate redistributed HCN1 evenly throughout the dendrite without significant changes in protein expression levels. Inhibition of calcium/calmodulin-dependent protein kinase II activity, but not p38 MAPK, also redistributed HCN1 in CA1 pyramidal neurons. We conclude that activation of ionotropic glutamate receptors by excitatory temporoammonic pathway projections from the entorhinal cortex establishes and maintains the distribution pattern of HCN1 in CA1 pyramidal neuron dendrites by activating calcium/calmodulin-dependent protein kinase II-mediated downstream signals.	Northwestern Univ, Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Chetkovich, DM (corresponding author), Northwestern Univ, Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Chetkovich, Dane/AAV-5457-2021		NINDS NIH HHS [K02 NS055995-02, K02 NS055995, R21 NS052595, R21 NS 052595, R21 NS052595-02, K02 NS055995-01, R21 NS052595-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052595, K02NS055995] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bender RA, 2005, EUR J NEUROSCI, V22, P2669, DOI 10.1111/j.1460-9568.2005.04407.x; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Niesen CE, 1999, DEV NEUROSCI-BASEL, V21, P328, DOI 10.1159/000017382; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; WITTER MP, 1993, HIPPOCAMPUS, V3, P33	42	65	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33168	33180		10.1074/jbc.M703736200	http://dx.doi.org/10.1074/jbc.M703736200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848552	hybrid, Green Accepted			2022-12-27	WOS:000250625400064
J	Devaraj, SG; Wang, N; Chen, Z; Chen, Z; Tseng, M; Barretto, N; Lin, R; Peters, CJ; Tseng, CTK; Baker, SC; Li, K				Devaraj, Santhana G.; Wang, Nan; Chen, Zhongbin; Chen, Zihong; Tseng, Monica; Barretto, Naina; Lin, Rongtuan; Peters, Clarence J.; Tseng, Chien-Te K.; Baker, Susan C.; Li, Kui			Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; MOUSE HEPATITIS-VIRUS; RIG-I; ADAPTER PROTEIN; INTERFERON INDUCTION; ANTIVIRAL RESPONSES; CELLULAR-RESPONSE; IKK-EPSILON; ACTIVATION	Severe acute respiratory syndrome coronavirus ( SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality. Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons ( IFNs) in cell culture. However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses. We show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 ( IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis. Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus. In searching for a SARS-CoV protein capable of counteracting innate immunity, we identified the papain-like protease ( PLpro) domain as a potent IFN antagonist. The inhibition of the IFN response does not require the protease activity of PLpro. Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-associated gene 5 pathways. Our data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.	Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; Loyola Univ, Dept Microbiol & Immunol, Maywood, IL 60153 USA; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Loyola University Chicago; Lady Davis Institute; McGill University	Li, K (corresponding author), Univ Texas, Med Branch, Dept Microbiol & Immunol, 4-142G Blocker Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	kuli@utmb.edu	Chen, Zhongbin/C-5259-2009; Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503	NIAID NIH HHS [N01 AI030039-009, R01 AI045798, AI45798, P01 AI060915-030001, R01 AI069285, P01 AI060915, R01 AI069285-01A2, U54 AI057156, AI30039, AI069285, R01 AI045798-01A2, AI060915, U54 AI057156-05S10038, AI057156] Funding Source: Medline; NIDA NIH HHS [DA018054, R21 DA018054, R21 DA018054-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, N01AI030039, R01AI069285, N01AI30039, P01AI060915, R56AI069285, R01AI045798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA018054] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Goutagny N, 2006, NAT IMMUNOL, V7, P555, DOI 10.1038/ni0606-555; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Langford M P, 1981, Methods Enzymol, V78, P339; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li K, 2002, HEPATOLOGY, V35, P1237, DOI 10.1053/jhep.2002.32968; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MCKIMMBRESCHKIN JL, 1982, INFECT IMMUN, V36, P857, DOI 10.1128/IAI.36.3.857-863.1982; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Mossel EC, 2005, J VIROL, V79, P3846, DOI 10.1128/JVI.79.6.3846-3850.2005; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2006, ADV EXP MED BIOL, V581, P3	80	290	313	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32208	32221		10.1074/jbc.M704870200	http://dx.doi.org/10.1074/jbc.M704870200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761676	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000250480300044
J	Hanington, PC; Wang, T; Secombes, CJ; Belosevic, M				Hanington, Patrick C.; Wang, Tiehui; Secombes, Christopher J.; Belosevic, Miodrag			Growth factors of lower vertebrates - Characterization of goldfish (Carassius auratus L.) macrophage colony-stimulating factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-RECEPTOR; M-CSF; LANGSDORFII KIDNEY; CELLS; PROLIFERATION; CULTURES; VITRO	Colony-stimulating factor-1 (CSF-1) regulates mononuclear cell proliferation, differentiation, and survival. The functions of CSF-1 are well documented in mammals; however, little is known about CSF-1 biology in lower vertebrates. This is the first report on the identification and functional characterization of a fish CSF-1 molecule expressed highly in the spleen and in phorbol 12-myristate 13-acetate-stimulated monocytes. Goldfish CSF-1 is a 199-amino acid protein that possesses the required cysteine residues to form important intra-chain and inter-chain disulfide bonds that allow CSF-1 to form a functional homodimer and to interact with its high affinity receptor, CSF-1R. Recombinant goldfish CSF-1 formed a homodimer and bound to the soluble goldfish CSF-1R. The addition of the recombinant CSF-1 to sorted goldfish progenitor cells, monocytes, and macrophages induced the differentiation of monocytes into macrophages and the proliferation of monocyte-like cells. The proliferation of these cells was abrogated by addition of an anti-CSF-1R antibody as well as the soluble CSF1R. The ability of the soluble CSF-1R to inhibit CSF-1-induced proliferation represents a novel mechanism for the regulation of CSF-1 function.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2E9, Canada; Univ Aberdeen, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland	University of Alberta; University of Alberta; University of Aberdeen	Belosevic, M (corresponding author), Univ Alberta, Dept Biol Sci, CW-405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mike.belosevic@ualberta.ca	Belosevic, Mike/A-2617-2014; Belosevic, Miodrag/G-9396-2018; Belosevic, Miodrag/C-6729-2008	Belosevic, Mike/0000-0001-6512-3587; Belosevic, Miodrag/0000-0002-6412-8236; Belosevic, Miodrag/0000-0002-6412-8236; Wang, Tiehui/0000-0002-1148-8959; Hanington, Patrick/0000-0002-3964-5012				Barreda DR, 2005, DEV COMP IMMUNOL, V29, P879, DOI 10.1016/j.dci.2005.02.006; Barreda DR, 2001, FISH SHELLFISH IMMUN, V11, P169, DOI 10.1006/fsim.2000.0305; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; BECKER S, 1987, J IMMUNOL, V139, P3703; Belosevic M, 2006, FISH SHELLFISH IMMUN, V20, P152, DOI 10.1016/j.fsi.2004.10.010; GUILBERT LJ, 1980, J CELL BIOL, V85, P153, DOI 10.1083/jcb.85.1.153; Hanington PC, 2006, J BIOL CHEM, V281, P9963, DOI 10.1074/jbc.M600631200; Hanington PC, 2005, FISH SHELLFISH IMMUN, V18, P359, DOI 10.1016/j.fsi.2004.09.003; Honda T, 2005, MOL IMMUNOL, V42, P1, DOI 10.1016/j.molimm.2004.07.002; Kobayashi I, 2007, DEV COMP IMMUNOL, V31, P696, DOI 10.1016/j.dci.2006.10.003; Kobayashi I, 2006, DEV COMP IMMUNOL, V30, P1034, DOI 10.1016/j.dci.2006.01.005; Koths K, 1997, MOL REPROD DEV, V46, P31; Motoyoshi K, 1998, INT J HEMATOL, V67, P109; Neumann NF, 2000, FISH SHELLFISH IMMUN, V10, P1, DOI 10.1006/fsim.1999.0221; Neumann NF, 1998, DEV COMP IMMUNOL, V22, P417, DOI 10.1016/S0145-305X(98)00023-8; Oshibe T, 1999, J VET MED B, V46, P389, DOI 10.1046/j.1439-0450.1999.00245.x; PAMPFER S, 1991, BIOESSAYS, V13, P535, DOI 10.1002/bies.950131007; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Roca FJ, 2006, MOL IMMUNOL, V43, P1418, DOI 10.1016/j.molimm.2005.07.028; SHADLE PJ, 1989, J CELL BIOCHEM, V40, P91, DOI 10.1002/jcb.240400110; Shao XG, 1996, REPROD FERT DEVELOP, V8, P103, DOI 10.1071/RD9960103; SHERR CJ, 1989, BLOOD, V73, P1786; SHERR CJ, 1988, COLD SPRING HARB SYM, V53, P521, DOI 10.1101/SQB.1988.053.01.060; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Williams H, 2002, GENE, V295, P255, DOI 10.1016/S0378-1119(02)00736-9; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348	28	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31865	31872		10.1074/jbc.M706278200	http://dx.doi.org/10.1074/jbc.M706278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827160	hybrid			2022-12-27	WOS:000250480300006
J	Jacobs, A; Quraishi, O; Huang, XC; Bousquet-Gagnon, N; Nault, G; Francella, N; Alvord, WG; Pham, N; Soucy, C; Robitaille, M; Bridon, D; Blumenthal, R				Jacobs, Amy; Quraishi, Omar; Huang, Xicai; Bousquet-Gagnon, Nathalie; Nault, Genevieve; Francella, Nicholas; Alvord, W. Gregory; Pham, Nga; Soucy, Chantal; Robitaille, Martin; Bridon, Dominique; Blumenthal, Robert			A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CELL FUSION; 6-HELIX BUNDLE; PEPTIDE INHIBITOR; POTENT INHIBITORS; SYNTHETIC PEPTIDE; ATOMIC-STRUCTURE; MEMBRANE-FUSION; COILED-COIL; SOLUBLE CD4	Peptide inhibitors corresponding to sequences in the six helix bundle structure of the fusogenic portion (gp41) of the HIV envelope glycoprotein have been successfully implemented in preventing HIV entry. These peptides bind to regions in HIV gp41 transiently exposed during the fusion reaction. In an effort to improve upon these entry inhibitors, we have successfully designed and tested peptide analogs composed of chemical spacers and reactive moieties positioned strategically to facilitate covalent attachment. Using a temperature-arrested state prime wash in vitro assay we show evidence for the trapping of a pre-six helix bundle fusion intermediate by a covalent reaction with the specific anti-HIV-1 peptide. This is the first demonstration of the trapping of an intermediate conformation of a viral envelope glycoprotein during the fusion process that occurs in live cells. The permanent specific attachment of the covalent inhibitor is projected to improve the pharmacokinetics of administration in vivo and thereby improve the long-term sustainability of peptide entry inhibitor therapy and help to expand its applicability beyond salvage therapy.	Conjuchem Biotechnol Inc, Montreal, PQ H2X 3Y8, Canada; NCI, Ctr Canc Res Nanobiol Program, NIH, Frederick, MD 21702 USA; Data Management Serv Inc, NCI, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumenthal, R (corresponding author), Conjuchem Biotechnol Inc, 225 President Kennedy Ave,Ste PK-3950, Montreal, PQ H2X 3Y8, Canada.	blumenthalr@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC008303, ZIABC008303] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; DeLano W.L, PYMOL MOL GRAPHICS S; DELEAN A, 1979, MOL PHARMACOL, V15, P60; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DOMS RW, 1990, J VIROL, V64, P3537, DOI 10.1128/JVI.64.7.3537-3540.1990; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; DUBAY JW, 1991, ADV EXP MED BIOL, V303, P39; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gallo SA, 2004, J MOL BIOL, V340, P9, DOI 10.1016/j.jmb.2004.04.027; Gallo SA, 2004, BIOCHEMISTRY-US, V43, P8230, DOI 10.1021/bi049957v; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Hart TK, 1996, AIDS RES HUM RETROV, V12, P1305, DOI 10.1089/aid.1996.12.1305; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078; Leger R, 2004, BIOORG MED CHEM LETT, V14, P4395, DOI 10.1016/j.bmcl.2004.06.066; Leger R, 2004, BIOORG MED CHEM LETT, V14, P841, DOI 10.1016/j.bmcl.2003.12.025; Leger R, 2003, BIOORG MED CHEM LETT, V13, P3571, DOI 10.1016/S0960-894X(03)00790-X; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; MCKEATING JA, 1991, J VIROL, V65, P852, DOI 10.1128/JVI.65.2.852-860.1991; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Patel IH, 2005, CLIN PHARMACOKINET, V44, P175, DOI 10.2165/00003088-200544020-00003; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; Shai Y, 2000, BIOSCIENCE REP, V20, P535, DOI 10.1023/A:1010411021326; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Thibaudeau K, 2005, BIOCONJUGATE CHEM, V16, P1000, DOI 10.1021/bc050102k; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; [No title captured]	50	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32406	32413		10.1074/jbc.M705577200	http://dx.doi.org/10.1074/jbc.M705577200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17726011	hybrid			2022-12-27	WOS:000250480300063
J	Li, XY; Guo, F; Zhang, L; Kleiman, L; Cen, S				Li, Xiao-Yu; Guo, Fei; Zhang, Li; Kleiman, Lawrence; Cen, Shan			APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEOCAPSID PROTEIN; VIRAL-RNA; ANTIVIRAL ACTIVITY; VIF PROTEIN; SOR GENE; TYPE-1; MECHANISM; GAG; REPLICATION	Human APOBEC3G ( hA3G) has been identified as an anti-HIV-1 host factor. The presence of hA3G in HIV-1 strongly inhibits the ability of the virus to produce new viral DNA upon infection. In this report, we demonstrate that the reduction of late viral DNA synthesis is due to the inhibition by hA3G of the strand transfer steps that occur during reverse transcription. Analysis of viral cDNA intermediates in vivo reveals that hA3G causes an inhibition of the minus and plus strand transfers, without having a significant impact on DNA elongation. Using an in vitro system to measure minus strand transfer similarly shows a dose-dependent reduction of strand transfer by hA3G. This inhibition of strand transfer occurs independently the editing activity of hA3G and is correlated with its ability to prevent RNaseH degradation of the template RNA.	McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; Chinese Acad Med Sci, Dept Virol, Inst Med Biotechnol, Beijing 100050, Peoples R China	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS	Kleiman, L (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	lawrence.kleiman@mcgill.ca; shan.cen@mcgill.ca		Guo, Fei/0000-0003-3500-1006				Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bampi C, 2004, INT J BIOCHEM CELL B, V36, P1668, DOI 10.1016/j.biocel.2004.02.024; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gabor J, 2002, J VIROL, V76, P9096, DOI 10.1128/JVI.76.18.9096-9102.2002; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Guo XF, 2003, VIROLOGY, V307, P154, DOI 10.1016/S0042-6822(02)00068-5; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Li JL, 2004, J CELL BIOCHEM, V92, P560, DOI 10.1002/jcb.20082; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; WOHRL BM, 1993, J BIOL CHEM, V268, P13617; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	52	128	131	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32065	32074		10.1074/jbc.M703423200	http://dx.doi.org/10.1074/jbc.M703423200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17855362				2022-12-27	WOS:000250480300027
J	Burton, RL; Chen, SW; Xu, XL; Grant, GA				Burton, Rodney L.; Chen, Shawei; Xu, Xiao Lan; Grant, Gregory A.			A novel mechanism for substrate inhibition in mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACT DOMAIN	Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase undergoes significant inhibition of activity with increasing concentrations of its substrate, hydroxypyruvic acid phosphate. The enzyme also displays an unusual dual pH optimum. A significant decrease in the K-i for substrate inhibition at pH values corresponding to the valley between these optima is responsible for this phenomena. The change in Ki has an average pK of similar to 5.8 and involves two functional groups that are protonated and two functional groups that are unprotonated for optimal substrate inhibition to occur. Mutagenesis of positively charged amino acid residues at a putative anion binding site previously revealed by the x-ray structure, produces significant changes in the pH-dependent profile of substrate inhibition. Several single residue mutations eliminate the dual pH optima by reducing substrate inhibition between pH 5 and 7 and a triple mutation was identified that eliminates the substrate inhibition altogether. The mutagenesis data support the conclusion that the anion binding site represents a new allosteric site for the control of enzyme activity and functions in a novel mechanism for substrate inhibition.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Grant, GA (corresponding author), Washington Univ, Sch Med, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@wustl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cleland W W, 1979, Methods Enzymol, V63, P500; CORMACK B, 1991, CURRENT PROTOCOLS MO; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; Segel I, 1975, ENZYME KINETICS; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081	15	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31517	31524		10.1074/jbc.M704032200	http://dx.doi.org/10.1074/jbc.M704032200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761677	hybrid			2022-12-27	WOS:000250309200043
J	Gouttenoire, J; Valcourt, U; Bougault, C; Aubert-Foucher, E; Arnaud, E; Giraud, L; Mallein-Gerin, F				Gouttenoire, Jerome; Valcourt, Ulrich; Bougault, Carole; Aubert-Foucher, Elisabeth; Arnaud, Estelle; Giraud, Lionel; Mallein-Gerin, Frederic			Knockdown of the intraflagellar transport protein IFT46 stimulates selective gene expression in mouse chondrocytes and affects early development in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOVENTRAL PATTERN-FORMATION; ENDOCHONDRAL BONE-DEVELOPMENT; POLYCYSTIC KIDNEY-DISEASE; DIFFERENTIATION IN-VITRO; BARDET-BIEDL-SYNDROME; II COLLAGEN GENE; PRIMARY CILIUM; GROWTH-PLATE; LIMB DEVELOPMENT; MORPHOGENETIC PROTEIN-2	Bone morphogenetic proteins (BMPs) act as multifunctional regulators in morphogenesis during development. In particular they play a determinant role in the formation of cartilage molds and their replacement by bone during endochondral ossification. In cell culture, BMP-2 favors chondrogenic expression and promotes hypertrophic maturation of chondrocytes. In mouse chondrocytes we have identified a BMP-2-sensitive gene encoding a protein of 301 amino acids. This protein, named mIFT46, is the mouse ortholog of recently identified Caenorhabditis elegans and Chlamydomonas reinhardtii intraflagellar transport (IFT) proteins. After generation of a polyclonal antibody against mIFT46, we showed for the first time that the endogenous protein is located in the primary cilium of chondrocytes. We also found that mIFT46 is preferentially expressed in early hypertrophic chondrocytes located in the growth plate. Additionally, mIFT46 knockdown by small interfering RNA oligonucleotides in cultured chondrocytes specifically stimulated the expression of several genes related to skeletogenesis. Furthermore, Northern blotting analysis indicated that mIFT46 is also expressed before chondrogenesis in embryonic mouse development, suggesting that the role of mIFT46 might not be restricted to cartilage. To explore the role of IFT46 during early development, we injected antisense morpholino oligonucleotides in Danio rerio embryos to reduce zebrafish IFT46 protein (zIFT46) synthesis. Dramatic defects in embryonic development such as a dorsalization and a tail duplication were observed. Thus our results taken together indicate that the ciliary protein IFT46 has a specific function in chondrocytes and is also essential for normal development of vertebrates.	Univ Lyon, F-69003 Lyon, France; Univ Lyon 1, CNRS UMR 5086, Inst Biol & Chim Prot, IFR Biosci Gerland Lyon Sud 128, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mallein-Gerin, F (corresponding author), Univ Lyon, F-69003 Lyon, France.	f.mallein-gerin@ibcp.fr	Gouttenoire, Jérôme/G-7947-2017; Gouttenoire, Jérôme/AAQ-8353-2020; VALCOURT, Ulrich/ABB-3943-2021	Gouttenoire, Jérôme/0000-0002-7715-1494; Gouttenoire, Jérôme/0000-0002-7715-1494; VALCOURT, Ulrich/0000-0002-1727-4409				Alieva I B, 1999, Membr Cell Biol, V12, P895; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaud E, 2006, CELL DEATH DIFFER, V13, P1128, DOI 10.1038/sj.cdd.4401797; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P3244, DOI 10.1002/art.22167; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bluteau G, 2002, BIORHEOLOGY, V39, P247; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Dick A, 2000, DEVELOPMENT, V127, P343; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Evans MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1263, DOI 10.1152/ajplung.00180.2002; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; Gregory KE, 2001, J BONE MINER RES, V16, P2005, DOI 10.1359/jbmr.2001.16.11.2005; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149; Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hild M, 1999, DEVELOPMENT, V126, P2149; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leboy PS, 1997, J CELL BIOCHEM, V66, P394, DOI 10.1002/(SICI)1097-4644(19970901)66:3<394::AID-JCB11>3.0.CO;2-F; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695, DOI 10.1007/BF00158202; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Loones MT, 1998, CELL STRESS CHAPERON, V3, P237, DOI 10.1379/1466-1268(1998)003<0237:HACDDE>2.3.CO;2; Mallein-Gerin F, 2004, METH MOLEC MED, V100, P105; MALLEINGERIN F, 1990, ROUX ARCH DEV BIOL, V198, P363, DOI 10.1007/BF00383774; MALLEINGERIN F, 1988, DEV BIOL, V126, P337, DOI 10.1016/0012-1606(88)90144-3; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; McGlashan SR, 2007, MATRIX BIOL, V26, P234, DOI 10.1016/j.matbio.2006.12.003; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Mullins MC, 1996, DEVELOPMENT, V123, P81; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Mykytyn K, 2004, TRENDS MOL MED, V10, P106, DOI 10.1016/j.molmed.2004.01.003; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Brien KP, 2000, BIOCHEM BIOPH RES CO, V273, P90, DOI 10.1006/bbrc.2000.2910; Olsen B, 2005, MATRIX BIOL, V24, P449, DOI 10.1016/j.matbio.2005.09.003; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; SOKOLOV BP, 1994, NUCLEIC ACIDS RES, V22, P4009, DOI 10.1093/nar/22.19.4009; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Takagi M, 2000, HISTOCHEM J, V32, P175, DOI 10.1023/A:1004099324169; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tiffee JC, 2000, TISSUE CELL, V32, P141, DOI 10.1054/tice.2000.0097; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valcourt U, 1999, EXP CELL RES, V251, P264, DOI 10.1006/excr.1999.4584; Valcourt U, 2003, FEBS LETT, V545, P115, DOI 10.1016/S0014-5793(03)00510-6; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wang O, 2001, DEVELOPMENT, V128, P3867; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WILSMAN NJ, 1980, ANAT REC, V197, P355, DOI 10.1002/ar.1091970309; WILSMAN NJ, 1978, J ULTRA MOL STRUCT R, V64, P270, DOI 10.1016/S0022-5320(78)90036-9; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yeh LCC, 2002, J CELL PHYSIOL, V191, P298, DOI 10.1002/jcp.10094; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang L, 2003, J PHYSIOL-LONDON, V551, P765, DOI 10.1113/jphysiol.2003.041707; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	89	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30960	30973		10.1074/jbc.M705730200	http://dx.doi.org/10.1074/jbc.M705730200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17720815	hybrid			2022-12-27	WOS:000250136300064
J	Jang, SW; Yang, SJ; Srinivasan, S; Ye, KQ				Jang, Sung-Wuk; Yang, Seung-Ju; Srinivasan, Shanthi; Ye, Keqiang			Akt phosphorylates Mstl and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; CASPASE; APOPTOSIS; CLEAVAGE; INDUCTION; SURVIVAL	Oxidative stress can induce apoptosis through activation of MstI, subsequent phosphorylation of FOXO and nuclear translocation. MstI is a common component of apoptosis initiated by various stresses. MstI kinase activation requires autophosphorylation and proteolytic degradation by caspases. The role of Akt in regulating MstI activity has not been previously examined. Here, we show that MstI is a physiological substrate of Akt. Akt phosphorylation of MstI diminishes its apoptotic cleavage by caspases and prevents its kinase activity on FOXO3. MstI directly binds to Akt, which is regulated Akt kinase activity. Akt phosphorylates MstI on the Thr(387) residue and protects MstI from apoptotic cleavage in vitro and in apoptotic cells. Interestingly, Akt phosphorylation of MstI strongly inhibits its kinase activity on FOXO3. The phosphorylation mimetic mutant MST1 T387E blocks H2O2-triggered FOXO3 nuclear translocation and apoptosis. Thus, our findings support that Akt blocks MstI-triggered FOXO3 nuclear translocation by phosphorylating MstI, promoting cell survival.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Srinivasan, Shanthi/A-6133-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER; NINDS NIH HHS [R01, NS045627] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Blois JT, 2004, J BIOL CHEM, V279, P30123, DOI 10.1074/jbc.M402793200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; DEL PL, 1997, SCIENCE, V278, P687; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Renner O, 2007, CARCINOGENESIS, V28, P1418, DOI 10.1093/carcin/bgm059; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601	28	113	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30836	30844		10.1074/jbc.M704542200	http://dx.doi.org/10.1074/jbc.M704542200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726016	hybrid			2022-12-27	WOS:000250136300052
J	Lee, IH; Dinudom, A; Sanchez-Perez, A; Kumar, S; Cook, DI				Lee, Il-Ha; Dinudom, Anuwat; Sanchez-Perez, Angeles; Kumar, Sharad; Cook, David I.			Akt mediates the effect of insulin on epithelial sodium channels by inhibiting Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; HORMONAL-REGULATION; A6 CELLS; ENAC; ALDOSTERONE; SGK1; EXPRESSION; TRANSPORT	The epithelial sodium channel (ENaC) plays an important role in transepithelial Na+ absorption; hence its function is essential for maintaining Na (+) and fluid homeostasis and regulating blood pressure. Insulin is one of the hormones that regulates activity of ENaC. In this study, we investigated the contribution of two related protein kinases, Akt (also known as protein kinase B) and the serum-and glucocorticoid-dependent kinase (Sgk), on insulin-induced ENaC activity in Fisher rat thyroid cells expressing ENaC. Overexpression of Akt1 or Sgk1 significantly increased ENaC activity, whereas expression of a dominantnegative construct of Akt1, Akt1K179M, decreased basal activity of ENaC. Inhibition of the endogenous expression of Akt1 and Sgk1 by short interfering RNA not only inhibited ENaC but also disrupted the stimulatory effect on ENaC of insulin and of the downstream effectors of insulin, phosphatidylinositol 3-kinase and PDK1. Conversely, overexpression of Akt1 or Sgk1 increased expression of ENaC at the cell membrane and overcame the inhibitory effect of Nedd4-2 on ENaC. Furthermore, mutation of consensus phosphorylation sites on Nedd4-2 for Akt1 and Sgk1, Ser342 and Ser428, completely abolished the inhibitory effect of Sgk1 and Akt1 on Nedd4-2 action. Together these data suggest that both Akt and Sgk are components of an insulin signaling pathway that increases Na (+)absorption by upregulating membrane expression of ENaC via a regulatory system that involves inhibition of Nedd4-2.	Univ Sydney, Fac Med, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; Hanson Ctr Canc Res, Inst Med & Vet Sci, Adelaide, SA 500, Australia	University of Sydney; Institute Medical & Veterinary Science Australia	Cook, DI (corresponding author), Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2050, Australia.	davidc@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arteaga MF, 2005, AM J PHYSIOL-RENAL, V289, pF90, DOI 10.1152/ajprenal.00390.2004; Blazer-Yost BL, 2003, AM J PHYSIOL-CELL PH, V284, pC1645, DOI 10.1152/ajpcell.00372.2002; Blazer-Yost BL, 1998, AM J PHYSIOL-CELL PH, V274, pC1373, DOI 10.1152/ajpcell.1998.274.5.C1373; BLAZERYOST BL, 1989, AM J PHYSIOL, V257, pC612, DOI 10.1152/ajpcell.1989.257.4.C612; Boehmer C, 2003, BIOCHEM BIOPH RES CO, V306, P156, DOI 10.1016/S0006-291X(03)00921-5; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; HERRERA FRANCISCO C., 1965, AMER J PHYSIOL, V209, P819; Kim IS, 2000, BBA-MOL CELL RES, V1496, P333, DOI 10.1016/S0167-4889(00)00029-X; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392, DOI 10.1152/ajprenal.1992.263.3.F392; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Nizet A, 1976, Curr Probl Clin Biochem, V6, P262; NIZET A, 1971, PFLUG ARCH EUR J PHY, V323, P11, DOI 10.1007/BF00586561; Palmada M, 2006, DIABETES, V55, P421, DOI 10.2337/diabetes.55.02.06.db05-0720; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Record RD, 1998, AM J PHYSIOL-ENDOC M, V274, pE611, DOI 10.1152/ajpendo.1998.274.4.E611; Record RD, 1996, AM J PHYSIOL-CELL PH, V271, pC1079, DOI 10.1152/ajpcell.1996.271.4.C1079; Shane MA, 2006, GEN COMP ENDOCR, V147, P85, DOI 10.1016/j.ygcen.2005.11.010; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	36	112	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29866	29873		10.1074/jbc.M701923200	http://dx.doi.org/10.1074/jbc.M701923200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715136	hybrid			2022-12-27	WOS:000249981200015
J	Sohy, D; Parmentier, M; Springael, JY				Sohy, Denis; Parmentier, Marc; Springael, Jean-Yves			Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; CHEMOKINE RECEPTOR; NEGATIVE COOPERATIVITY; BREAST-CANCER; FACTOR-I; CXCR4; DIMERIZATION; EXPRESSION; CCR5; HOMODIMERIZATION	Chemokine receptors are presently used as targets for candidate drugs in the frame of inflammatory diseases and human immunodeficiency virus infection. They were shown to dimerize, but the functional relevance of dimerization in terms of drug action remains poorly understood. We reported previously the existence of negative binding cooperativity between the subunits of CCR2/CCR5 heterodimers. In the present study, we extend these observations to heterodimers formed by CCR2 and CXCR4, which are more distantly related. We also show that specific antagonists of one receptor inhibit the binding of chemokines to the other receptor as a consequence of their heterodimerization, both in recombinant cell lines and primary leukocytes. This resulted in a significant functional cross-inhibition in terms of calcium mobilization and chemotaxis. These data demonstrate that chemokine receptor antagonists regulate allosterically the functional properties of receptors on which they do not bind directly, with important implications on the effects of these potential therapeutic agents.	Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	Universite Libre de Bruxelles	Parmentier, M (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	mparment@ulb.ac.be		Parmentier, Marc/0000-0001-8081-4685				Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 1999, BLOOD, V94, P1899; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Dar WA, 2007, IMMUNOLOGY, V120, P467, DOI 10.1111/j.1365-2567.2006.02534.x; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frade JMR, 1997, J IMMUNOL, V159, P5576; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gao P, 2003, J LEUKOCYTE BIOL, V73, P273, DOI 10.1189/jlb.0602269; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; JIANG YL, 1992, J IMMUNOL, V148, P2423; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; LEVITZKI A, 1974, J THEOR BIOL, V44, P367, DOI 10.1016/0022-5193(74)90167-2; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Muller A, 2006, INT J CANCER, V118, P2147, DOI 10.1002/ijc.21514; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peacock JW, 1999, J IMMUNOL, V162, P215; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Rabin RL, 1999, J IMMUNOL, V162, P3840; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001	37	127	133	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30062	30069		10.1074/jbc.M705302200	http://dx.doi.org/10.1074/jbc.M705302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17715128	hybrid			2022-12-27	WOS:000249981200036
J	Chen, IJ; Chen, HL; Demetriou, M				Chen, I-Ju; Chen, Hung-Lin; Demetriou, Michael			Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and Microfilaments coordinate basal and activation signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; LIPID RAFTS; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; MEMBRANE MICRODOMAINS; PHYSICAL ASSOCIATION; PLASMA-MEMBRANE; LCK ACTIVITY; SURFACE; PHOSPHATASE	Lateral compartmentalization of membrane proteins into microdomains regulates signal transduction; however, structural determinants are incompletely understood. Membrane glycoproteins bind galectins in proportion to the number (i.e. NX( S/T) sites) and degree of GlcNAc branching within attached N-glycans, forming a molecular lattice that negatively regulates T cell function and autoimmunity. We find that in resting T cells, partition of CD45 inside and T cell receptor (TCR)/CD4-Lck/Zap-70 outside microdomains is positively and negatively regulated by the galectin lattice and actin cytoskeleton, respectively. In the absence of TCR ligands, the galectin lattice counteracts F-actin to retain CD45 in microdomains while concurrently blocking TCR/CD4-Lck/Zap-70 partition to microdomains by preventing a conformational change in the TCR that recruits Nck/Wiscott Aldrich Syndrome (WASp)/SLP76/F-actin/CD4 to TCR. The counterbalancing activities of the galectin lattice and actin cytoskeleton negatively and positively regulate Lck activity in resting cells and CD45 versus TCR clustering and signaling at the early immune synapse, respectively. Microdomain-localized CD45 inactivates Lck and inhibits TCR signaling at the early immune synapse. Thus, the galectin lattice and actin cytoskeleton interact on opposing sides of the plasma membrane to control microdomain structure and function, coupling basal growth signaling with thresholds to activation.	Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA.	mdemetri@uci.edu		Chen, Hung-Lin/0000-0001-7900-3391; Demetriou, Michael/0000-0002-2224-7798				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; BURNS CM, 1994, J BIOL CHEM, V269, P13594; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CHUCK RS, 1990, P NATL ACAD SCI USA, V87, P5021, DOI 10.1073/pnas.87.13.5021; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; D'Oro U, 1999, J IMMUNOL, V162, P1879; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Granovsky M, 2000, NAT MED, V6, P306; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hawash IY, 2002, BBA-MOL CELL RES, V1589, P140, DOI 10.1016/S0167-4889(02)00165-9; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LEE SU, 2007, J BIOL CHEM, V282; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Pace KE, 1999, J IMMUNOL, V163, P3801; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Zhang M, 2005, J IMMUNOL, V174, P1479, DOI 10.4049/jimmunol.174.3.1479	67	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35361	35372		10.1074/jbc.M706923200	http://dx.doi.org/10.1074/jbc.M706923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897956	Green Published, hybrid			2022-12-27	WOS:000251155200079
J	Vila-Carriles, WH; Zhou, ZH; Bubien, JK; Fuller, CM; Benos, DJ				Vila-Carriles, Wanda H.; Zhou, Zhen-Hong; Bubien, James K.; Fuller, Catherine M.; Benos, Dale J.			Participation of the chaperone Hsc70 in the trafficking and functional expression of ASIC2 in glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; ION CHANNELS; SODIUM-CHANNELS; PROTEIN; CFTR; PROLIFERATION; DEGRADATION; FAMILY	High-grade glioma cells express subunits of the ENaC/Deg superfamily, including members of ASIC subfamily. Our previous work has shown that glioma cells exhibit a basally active cation current, which is not present in low-grade tumor cells or normal astrocytes, and that can be blocked by amiloride. When ASIC2 is present within the channel complex in the plasma membrane, the channel is rendered non-functional because of inherent negative effectors that require ASIC2. We have previously shown that high-grade glioma cells functionally express this current because of the lack of ASIC2 in the plasma membrane. We now hypothesize that ASIC2 trafficking in glioma cells is regulated by a specific chaperone protein, namely Hsc70. Our results demonstrated that Hsc70 co-immunoprecipitates with ASIC2 and that it is overexpressed in glioma cells as compared with normal astrocytes. In contrast, there was no difference in the expression of calnexin, which also co-immunoprecipitates with ASIC2. In addition, glycerol and sodium 4-phenylbutyrate reduced the amount of Hsc70 expressed in glioma cells to levels found in normal astrocytes. Transfection of Hsc70 siRNA inhibited the constitutively activated amiloride-sensitive current, decreased migration, and increased ASIC2 surface expression in glioma cells. These results support an association between Hsc70 and ASIC2 that may underlie the increased retention of ASIC2 in the endoplasmic reticulum of glioma cells. The data also suggest that decreasing Hsc70 expression promotes reversion of a high-grade glioma cell to a more normal astrocytic phenotype.	Univ Alabama Birmingham, Dept Physiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), 1918 Univ Blvd,MCLM 704, Birmingham, AL 35294 USA.	benos@physiology.uab.edu	Fuller, Cathy/B-4046-2011		NATIONAL CANCER INSTITUTE [R01CA101952, P50CA097247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA 97247, CA 101952] Funding Source: Medline; NIDDK NIH HHS [DK 37206, R01 DK037206] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bercovich B, 1997, J BIOL CHEM, V272, P9002; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Clay JR, 2002, J NEUROSCI RES, V67, P745, DOI 10.1002/jnr.10182; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Giese A, 2003, ACT NEUR S, V88, P153; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; STAUB O, 1992, J CELL BIOL, V119, P1497, DOI 10.1083/jcb.119.6.1497; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Xia JZ, 2003, GENE, V313, P91, DOI 10.1016/S0378-1119(03)00633-4; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	27	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34381	34391		10.1074/jbc.M705354200	http://dx.doi.org/10.1074/jbc.M705354200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878160	hybrid			2022-12-27	WOS:000251145700054
J	Lee, SU; Grigorian, A; Pawling, J; Chen, IJ; Gao, G; Mozaffar, T; McKerlie, C; Demetriou, M				Lee, Sung-Uk; Grigorian, Ani; Pawling, Judy; Chen, I-Ju; Gao, Guoyan; Mozaffar, Tahseen; McKerlie, Colin; Demetriou, Michael			N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; ACETYLGLUCOSAMINYLTRANSFERASE-V; DISEASE; SUSCEPTIBILITY; GLYCOSYLATION	Multiple sclerosis ( MS) is characterized by inflammatory demyelination of axons and neurodegeneration, the latter inadequately modeled in experimental autoimmune encephalomyelitis (EAE). Susceptibility of inbred mouse strains to EAE is in part determined by major histocompatibility complex haplotype; however, other molecular mechanisms remain elusive. Galectins bind GlcNAc-branched N-glycans attached to surface glycoproteins, forming a molecular lattice that restricts lateral movement and endocytosis of glycoproteins. GlcNAc branching negatively regulates T cell activity and autoimmunity, and when absent in neurons, induces apoptosis in vivo in young adult mice. We find that EAE susceptible mouse strains PL/J, SJL, and NOD have reduced GlcNAc branching. PL/J mice display the lowest levels, partial deficiencies in N-acetylglucosaminyltransferase I, II, and V (i. e. Mgat1, -2, and -5), T cell hyperactivity and spontaneous late onset inflammatory demyelination and neurodegeneration; phenotypes markedly enhanced by Mgat5(+/-) and Mgat5(+/-) backgrounds in a gene dose-dependent manner. Spontaneous disease is transferable and characterized by progressive paralysis, tremor, dystonia, neuronophagia, and axonal damage in both demyelinated lesions and normal white matter, phenocopying progressive MS. Our data identify hypomorphic Golgi processing as an inherited trait that determines susceptibility to EAE, provides a unique spontaneous model of MS, and suggests GlcNAc-branching deficiency may promote T cell-mediated demyelination and neurodegeneration in MS.	Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu	Mozaffar, Tahseen/AAE-6971-2020	McKerlie, Colin/0000-0002-2232-0967; Demetriou, Michael/0000-0002-2224-7798				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENNUN A, 1982, J IMMUNOL, V129, P303; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dyment DA, 2004, HUM MOL GENET, V13, P1005, DOI 10.1093/hmg/ddh123; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Encinas JA, 1996, J IMMUNOL, V157, P2186; Filippi M, 2005, J NEUROL, V252, pV16, DOI 10.1007/s00415-005-5004-5; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Granovsky M, 2000, NAT MED, V6, P306; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Jabs C, 2002, EUR J IMMUNOL, V32, P2687, DOI 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Pace KE, 1999, J IMMUNOL, V163, P3801; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; TRANCHANT C, 1995, MOVEMENT DISORD, V10, P418, DOI 10.1002/mds.870100403; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	44	72	75	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33725	33734		10.1074/jbc.M704839200	http://dx.doi.org/10.1074/jbc.M704839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855338	Green Published, hybrid			2022-12-27	WOS:000250840200054
J	Vance, DE; Li, ZY; Jacobs, RL				Vance, Dennis E.; Li, Zhaoyu; Jacobs, Rene L.			Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOW-DENSITY LIPOPROTEINS; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; CHOLINE-DEFICIENT DIET; PLASMA HIGH-DENSITY; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOLIPID METHYLATION; RISK-FACTOR; RAT-LIVER; TARGETED DELETION; MEMBRANE-FRACTION		Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Li, Zhaoyu/0000-0002-1136-2758; Jacobs, Rene/0000-0002-5525-1355				BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P205, DOI 10.1016/0006-3002(61)90745-4; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; CUI Z, 1993, J BIOL CHEM, V268, P16655; de Vree JML, 1999, AM J CLIN NUTR, V70, P70; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dong H, 2007, J HEPATOL, V46, P915, DOI 10.1016/j.jhep.2006.12.012; DOWHAN W, 2002, BIOCH LIPIDS LIPOPRO, P1; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Kuipers F, 1997, Subcell Biochem, V28, P295; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P893, DOI 10.1016/j.bbalip.2007.04.009; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P486, DOI 10.1016/j.bbalip.2007.01.003; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; LOO G, 1986, J NUTR, V116, P2403, DOI 10.1093/jn/116.12.2403; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; MUDD SH, 1980, METABOLISM, V29, P707, DOI 10.1016/0026-0495(80)90192-4; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; PACKARD CJ, 1982, J LIPID RES, V23, P1081; Pan HJ, 2005, DIABETES, V54, P1854, DOI 10.2337/diabetes.54.6.1854; Pan HJ, 2006, VASC PHARMACOL, V45, P65, DOI 10.1016/j.vph.2005.11.011; Refsum H, 1998, CURR OPIN LIPIDOL, V9, P533, DOI 10.1097/00041433-199812000-00004; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Romeo S, 2006, FASEB J, V20, P2180, DOI 10.1096/fj.06-1004ufm; Selhub J, 2000, AM J CLIN NUTR, V71, p614S; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shields DJ, 2005, J BIOL CHEM, V280, P27339, DOI 10.1074/jbc.M504658200; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Stead LM, 2001, AM J PHYSIOL-ENDOC M, V281, pE1095, DOI 10.1152/ajpendo.2001.281.5.E1095; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Walkey CJ, 1996, J LIPID RES, V37, P2341; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, FASEB J, V20, P2181, DOI 10.1096/fj.06-1005ufm	63	58	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33237	33241		10.1074/jbc.R700028200	http://dx.doi.org/10.1074/jbc.R700028200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881348	hybrid			2022-12-27	WOS:000250840200001
J	Zhang, Y; Pu, H; Wang, QS; Cheng, S; Zhao, WX; Zhang, Y; Zhao, JD				Zhang, Ying; Pu, Hai; Wang, Qingsong; Cheng, Shu; Zhao, Weixing; Zhang, Yan; Zhao, Jindong			PII is important in regulation of nitrogen metabolism but not required for heterocyst formation in the cyanobacterium Anabaena sp PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; GLNB GENE-PRODUCT; P-II PROTEIN; SP STRAIN PCC-7942; SP PCC 7120; GLUTAMINE-SYNTHETASE; ESCHERICHIA-COLI; FILAMENTOUS CYANOBACTERIA; CELLULAR-DIFFERENTIATION; SUPEROXIDE-DISMUTASE	PII is an important signal protein for regulation of nitrogen metabolism in bacteria and plants. We constructed a mutant of glnB, encoding PII, in a heterocystous cyanobacterium, Anabaena sp. PCC 7120, with a cre-loxP system. The mutant (MP2 alpha) grew more slowly than the wild type under all nitrogen regimens. It excreted a large amount of ammonium when grown on nitrate due to altered activities of glutamine synthetase and nitrate reductase. MP2 alpha had a low nitrogenase activity but was able to form heterocysts under diazotrophic conditions, suggesting that PII is not required for heterocyst differentiation. Analysis of the PII with mass spectroscopy found tyrosine nitration at Tyr-51 under diazotrophic conditions while no phosphorylation at Ser-49 was detected. The strains 51F and 49A, which have PII with mutations of Y51F and S49A, respectively, were constructed to analyze the functions of the two key residues on the T-loop. Like MP2 alpha, they had low nitrogenase activity and grew slowly under diazotrophic conditions. 49A was also impaired in nitrate uptake and formed heterocysts in the presence of nitrate. The up-regulation of ntcA after nitrogen stepdown, which was present in the wild type, was not observed in 51F and 49A. While our results showed that the Ser-49 residue is important to the function of PII in Anabaena sp. PCC 7120, evidence from the PII pattern of the wild type and 49A in non-denaturing gel electrophoresis suggested that Ser-49 is not modified. The possible physiological roles of tyrosine nitration of PII are discussed.	Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University	Zhao, JD (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Genet Engn, Beijing 100871, Peoples R China.	jzhao@pku.edu.cn	zhao, weixing/H-3154-2013	zhao, weixing/0000-0001-5746-3696				Aldehni MF, 2003, J BACTERIOL, V185, P2582, DOI 10.1128/JB.185.8.2582-2591.2003; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; FRIAS JE, 1994, MOL MICROBIOL, V14, P823, DOI 10.1111/j.1365-2958.1994.tb01318.x; GHASSEMIAN M, 1994, MICROBIOL-UK, V140, P1151, DOI 10.1099/13500872-140-5-1151; Ghosh K, 2002, METHODS, V28, P374, DOI 10.1016/S1046-2023(02)00244-X; Hanson TE, 1998, MICROBIOL-SGM, V144, P1537, DOI 10.1099/00221287-144-6-1537; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; HERRERO A, 1981, J BACTERIOL, V145, P175, DOI 10.1128/JB.145.1.175-180.1981; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Hunsucker SW, 2004, BIOCHEM BIOPH RES CO, V317, P1121, DOI 10.1016/j.bbrc.2004.03.173; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Laurent S, 2005, P NATL ACAD SCI USA, V102, P9907, DOI 10.1073/pnas.0502337102; Laurent S, 2004, FEBS LETT, V576, P261, DOI 10.1016/j.febslet.2004.09.014; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Liotenberg S, 1996, FEMS MICROBIOL LETT, V144, P185, DOI 10.1016/0378-1097(96)00360-6; Liu YF, 2000, BBA-GENE STRUCT EXPR, V1491, P248, DOI 10.1016/S0167-4781(00)00022-1; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Martin-Figueroa E, 2000, FEBS LETT, V476, P282, DOI 10.1016/S0014-5793(00)01722-1; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Muro-Pastor AM, 2002, MOL MICROBIOL, V44, P1377, DOI 10.1046/j.1365-2958.2002.02970.x; NIFA AJ, 2005, CURR OPIN MICROBIOL, V8, P168; ORR J, 1981, J BIOL CHEM, V256, P3091; PANLNSKA KA, 2002, MICROBIOLOGY, V148, P2405; Paz-Yepes J, 2003, FEBS LETT, V543, P42, DOI 10.1016/S0014-5793(03)00384-3; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; SON HS, 1987, J BIOL CHEM, V262, P8690; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMAS J, 1977, J BACTERIOL, V129, P1545, DOI 10.1128/JB.129.3.1545-1555.1977; TSINOREMAS NF, 1991, P NATL ACAD SCI USA, V88, P4565, DOI 10.1073/pnas.88.11.4565; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; WEI TF, 1994, J BACTERIOL, V176, P4473, DOI 10.1128/JB.176.15.4473-4482.1994; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhao WX, 2007, PLANT CELL PHYSIOL, V48, P563, DOI 10.1093/pcp/pcm025; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhou RB, 1998, P NATL ACAD SCI USA, V95, P4959, DOI 10.1073/pnas.95.9.4959	53	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33641	10.1074/jbc.M706500200	http://dx.doi.org/10.1074/jbc.M706500200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17875643	hybrid			2022-12-27	WOS:000250840200045
J	Cordray, P; Doyle, K; Edes, K; Moos, PJ; Fitzpatrick, FA				Cordray, Pauline; Doyle, Kelly; Edes, Kornelia; Moos, Philip J.; Fitzpatrick, Frank A.			Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ALKYL HYDROPEROXIDE REDUCTASE; POLYUNSATURATED FATTY-ACIDS; THIOL-SPECIFIC ANTIOXIDANT; HYDROGEN-PEROXIDE; PLATELET 12-LIPOXYGENASE; REVERSIBLE OXIDATION; HUMAN-NEUTROPHILS; ESCHERICHIA-COLI; PEROXIREDOXIN-II	Human peroxiredoxins serve dual roles as anti- oxidants and regulators of H2O2- mediated cell signaling. The functional versatility of peroxiredoxins depends on progressive oxidation of key cysteine residues. The sulfinic or sulfonic forms of peroxiredoxin lose their peroxidase activity, which allows cells to accumulate H2O2 for signaling or pathogenesis in inflammation, cancer, and other disorders. We report that arachidonic acid lipid hydroperoxide metabolites of 5-, 12-, 15- lipoxygenase- 1, and cyclooxygenase- 2 oxidize the 2- Cysperoxiredoxins 1, 2, and 3 to their sulfinic and sulfonic forms. When added exogenously to cells, 5-, 12- and 15- hydroperoxyeicosatetraenoic acids also over- oxidized peroxiredoxins. Our results suggest that lipoxygenases and cyclooxygenases may affect 2- Cys peroxiredoxin signaling, analogous to NADPH oxidases in the " floodgate" model ( Wood, Z. A., Poole, L. B, and Karplus P. A. ( 2003) Science 300, 600 - 653). Peroxiredoxin- dependent mechanisms may modulate the receptor- dependent actions of autocoids derived from cellular lipoxygenase and cyclooxygenase catalysis.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fitzpatrick, FA (corresponding author), Univ Utah, Huntsman Canc Inst, 200 Circle Hoope, Salt Lake City, UT 84112 USA.	frank.fitzpatrick@hci.utah.edu		Moos, Philip/0000-0002-8223-442X	NATIONAL CANCER INSTITUTE [R01CA115616, P01CA073992] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 73992, R01 CA 115616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BABA A, 1989, J BIOL CHEM, V264, P15790; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1985, CIRCULATION, V72, P702, DOI 10.1161/01.CIR.72.4.702; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Christmas P, 1999, J BIOL CHEM, V274, P25594, DOI 10.1074/jbc.274.36.25594; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Lepley RA, 1998, ARCH BIOCHEM BIOPHYS, V356, P71, DOI 10.1006/abbi.1998.0744; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Lepley RA, 1996, J BIOL CHEM, V271, P6179, DOI 10.1074/jbc.271.11.6179; Lepley RA, 1996, ARCH BIOCHEM BIOPHYS, V331, P141, DOI 10.1006/abbi.1996.0292; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Poole LB, 1996, BIOCHEMISTRY-US, V35, P65, DOI 10.1021/bi951888k; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Smith WL, 2005, CURR OPIN CELL BIOL, V17, P174, DOI 10.1016/j.ceb.2005.02.005; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yu MK, 2004, J BIOL CHEM, V279, P28028, DOI 10.1074/jbc.M313939200	42	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32623	32629		10.1074/jbc.M704369200	http://dx.doi.org/10.1074/jbc.M704369200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855346	hybrid			2022-12-27	WOS:000250625400011
J	Maki, Y; Hashimoto, T; Zhou, M; Naganuma, T; Ohta, J; Nomura, T; Robinson, CV; Uchiumi, T				Maki, Yasushi; Hashimoto, Tetsuo; Zhou, Min; Naganuma, Takao; Ohta, Jun; Nomura, Takaomi; Robinson, Carol V.; Uchiumi, Toshio			Three binding sites for stalk protein dimers are generally present in ribosomes from archaeal organism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI RIBOSOME; GTPASE-ASSOCIATED CENTER; C-TERMINAL DOMAIN; ANGSTROM RESOLUTION; INTACT RIBOSOMES; P2 PROTEINS; RNA; ELONGATION; DYNAMICS	Ribosomes have a characteristic protuberance termed the stalk, which is indispensable for ribosomal function. The ribosomal stalk has long been believed to be a pentameric protein complex composed of two sets of protein dimers, L12-L12, bound to a single anchor protein, although ribosomes carrying three L12 dimers were recently discovered in a few thermophilic bacteria. Here we have characterized the stalk complex from Pyrococcus horikoshii, a thermophilic species of Archaea. This complex is known to be composed of proteins homologous to eukaryotic counterparts rather than bacterial ones. In truncation experiments of the C-terminal regions of the anchor protein Ph-P0, we surprisingly observed three Ph-L12 dimers bound to the C-terminal half of Ph-P0, and the binding site for the third dimer was unique to the archaeal homologs. The stoichiometry of the heptameric complex Ph-P0(Ph-L12)(2)(PhL12)(2)(Ph-L12)(2) was confirmed by mass spectrometry of the intact complex. In functional tests, ribosomes carrying a single Ph-L12 dimer had significant activity, but the addition of the second and third dimers increased the activity. A bioinformatics analysis revealed the evidence that ribosomes from all archaeal and also from many bacterial organisms may contain a heptameric complex at the stalk, whereas eukaryotic ribosomes seem to contain exclusively a pentameric stalk complex, thus modifying our view of the stalk structure significantly.	Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan	Niigata University; University of Tsukuba; University of Cambridge; Shinshu University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2-8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp		robinson, carol/0000-0001-7829-5505				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; CASIANO C, 1991, J BIOL CHEM, V266, P21578; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Griaznova O, 2000, BIOCHEMISTRY-US, V39, P4075, DOI 10.1021/bi992621e; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; GUDKOV AT, 1978, FEBS LETT, V93, P215, DOI 10.1016/0014-5793(78)81106-5; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hamman BD, 1996, BIOCHEMISTRY-US, V35, P16672, DOI 10.1021/bi9615001; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Iwasaki K, 1979, Methods Enzymol, V60, P657; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; MAASSEN JA, 1985, EUR J BIOCHEM, V149, P609, DOI 10.1111/j.1432-1033.1985.tb08968.x; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Moller W., 1986, STRUCTURE FUNCTION G, P309; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Uchiumi T, 2002, J BIOL CHEM, V277, P41401, DOI 10.1074/jbc.M207424200; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	43	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32827	32833		10.1074/jbc.M705412200	http://dx.doi.org/10.1074/jbc.M705412200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17804412	hybrid			2022-12-27	WOS:000250625400032
J	Sanders, MJ; Ali, ZS; Hegarty, BD; Heath, R; Snowden, MA; Carling, D				Sanders, Matthew J.; Ali, Zahabia S.; Hegarty, Bronwyn D.; Heath, Richard; Snowden, Michael A.; Carling, David			Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; FOOD-INTAKE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; CELLULAR-LOCALIZATION; CATALYTIC SUBUNIT; UPSTREAM KINASE; GAMMA-SUBUNITS; GLUCOSE-UPTAKE; BETA	AMP- activated protein kinase ( AMPK) plays a key role in maintaining energy homeostasis. Activation of AMPK in peripheral tissues has been shown to alleviate the symptoms of metabolic diseases, such as type 2 diabetes, and consequently AMPK is a target for treatment of these diseases. Recently, a small molecule activator ( A- 769662) of AMPK was identified that had beneficial effects on metabolism in ob/ ob mice. Here we show that A- 769662 activates AMPK both allosterically and by inhibiting dephosphorylation of AMPK on Thr- 172, similar to the effects of AMP. A- 769662 activates AMPK harboring a mutation in the gamma subunit that abolishes activation by AMP. An AMPK complex lacking the glycogen binding domain of the beta subunit abolishes the allosteric effect of A- 769662 but not the allosteric activation by AMP. Moreover, mutation of serine 108 to alanine, an autophosphorylation site within the glycogen binding domain of the 1 subunit, almost completely abolishes activation of AMPK by A-769662 in cells and in vitro, while only partially reducing activation by AMP. Based on our results we propose a model for activation of AMPK by A- 769662. Importantly, this model may provide clues for understanding the mechanism by which AMP leads to activation of AMPK, which in turn may help in the identification of other AMPK activators.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Cellular Stress Grp, London W12 0NN, England; GlaxoSmithKline Inc, Screenign & Cpds Profling, Harlow CM19 5AW, Essex, England	Imperial College London; GlaxoSmithKline	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci,Cellular Stress Grp, DuCane Rd, London W12 0NN, England.	dcarling@csc.mrc.ac.uk	Sanders, Matthew J/B-4077-2009; Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Sanders, Matthew James/0000-0001-6185-6337	Medical Research Council [MC_U120027537] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	48	259	264	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32539	32548		10.1074/jbc.M706543200	http://dx.doi.org/10.1074/jbc.M706543200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17728241	hybrid			2022-12-27	WOS:000250625400003
J	Criswell, TL; Arteaga, CL				Criswell, Tracy L.; Arteaga, Carlos L.			Modulation of NF kappa B activity and e-cadherin by the type III transforming growth factor ss receptor regulates cell growth and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SNAIL TRANSCRIPTION; CYTOPLASMIC DOMAIN; MAMMARY-TUMOR; EXPRESSION; METASTASIS; TARGET; ACTIVATION; INHIBITION	Transforming growth factor beta is growth-inhibitory in non-transformed epithelial cells but becomes growth-promoting during tumorigenesis. The role of the type I and II receptors in tumorigenesis has been extensively studied, but the role of the ubiquitously expressed type III receptor (T beta RIII) remains elusive. We developed short hairpin RNAs directed against T beta RIII to investigate the role of this receptor in breast cancer tumorigenesis. Nontumorigenic NMuMG mouse cells stably expressing short hairpin RNA specific to mouse T beta RIII (NM-kd) demonstrated increased cell growth, motility, and invasion as compared with control cells expressing shRNA to human T beta RIII (NM-con). Reconstitution of T beta RIII expression with rat T beta RIII abrogated the increased growth and motility seen in the NM-kd cells. In addition, the NM-kd cells exhibited marked reduction in the expression of the adherens junction protein, E-cadherin. This loss of E-cadherin was due to increased NF kappa B activity that, in turn, resulted in increased expression of the transcriptional repressors of E-cadherin such as Snail, Slug, Twist, and Sip1. Finally, NMuMG cells in which T beta RIII had been knocked down formed invasive tumors in athymic nude mice, whereas the control cells did not. These data indicate that T beta RIII acts as a tumor suppressor in nontumorigenic mammary epithelial cells at least in part by inhibiting NF kappa B-mediated repression of E-cadherin.	Vanderbilt Univ, Ctr Med, Div Oncol, Sch Med,Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Arteaga, CL (corresponding author), Vanderbilt Univ, Ctr Med, Div Oncol, Sch Med,Dept Canc Biol, 2220 Pierce Ave,777 PRB, Nashville, TN 37232 USA.	carlos.arteaga@vanderbilt.edu			NCI NIH HHS [R01 CA62212, P30 CA68485, T32 CA 09592, P50 CA98131, T32 CA009592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA062212, P50CA098131, P30CA068485, T32CA009592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Iolascon A, 2000, BRIT J CANCER, V82, P1171; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kaltschmidt B, 2001, MECH DEVELOP, V101, P11, DOI 10.1016/S0925-4773(00)00542-6; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Santander C, 2006, CELL SIGNAL, V18, P1482, DOI 10.1016/j.cellsig.2005.11.011; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sharifi N, 2007, PROSTATE, V67, P301, DOI 10.1002/pros.20526; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Sun LZ, 1997, J BIOL CHEM, V272, P25367, DOI 10.1074/jbc.272.40.25367; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Woszczyk D, 2004, MED SCI MONITOR, V10, pCR33; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	49	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32491	32500		10.1074/jbc.M704434200	http://dx.doi.org/10.1074/jbc.M704434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823118	hybrid			2022-12-27	WOS:000250480300072
J	Wang, L; Zhang, ZG; Gregg, SR; Zhang, RL; Jiao, ZX; LeTourneau, Y; Liu, XS; Feng, YF; Gerwien, J; Torup, L; Leist, M; Noguchi, CT; Chen, ZY; Chopp, M				Wang, Lei; Zhang, Zheng Gang; Gregg, Sara R.; Zhang, Rui Lan; Jiao, Zhongxian; LeTourneau, Yvonne; Liu, Xianshuang; Feng, Yifan; Gerwien, Jens; Torup, Lars; Leist, Marcel; Noguchi, Constance Tom; Chen, Zhi-Yong; Chopp, Michael			The sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; MAMMALIAN FOREBRAIN; SUBVENTRICULAR ZONE; IN-VIVO; SUBEPENDYMAL CELLS; PRECURSOR CELLS; CREST CELLS; NEUROGENESIS; STROKE; RAT	Carbamylated erythropoietin (CEPO), a well characterized erythropoietin (EPO) derivative, does not bind to the classical EPO receptor and does not stimulate erythropoiesis. Using neural progenitor cells derived from the subventricular zone of the adult mouse, we investigated the effect of CEPO on neurogenesis and the associated signaling pathways in vitro. We found that CEPO significantly increased neural progenitor cell proliferation and promoted neural progenitor cell differentiation into neurons, which was associated with up-regulation of Sonic hedgehog (Shh), its receptor ptc, and mammalian achaete-scute homolog 1 (Mash1), a pro-neuron basic helix-loop-helix protein transcription factor. Blockage of the Shh signaling pathway with a pharmacological inhibitor, cyclopamine, abolished the CEPO-induced neurogenesis. Attenuation of endogenous Mash1 expression by short-interfering RNA blocked CEPO-promoted neuronal differentiation. In addition, recombinant mouse Shh up-regulated Mash1 expression in neural progenitor cells. These results demonstrate that the Shh signaling pathway mediates CEPO-enhanced neurogenesis and Mash1 is a downstream target of the Shh signaling pathway that regulates CEPO-enhanced neuronal differentiation.	Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Sci Ctr, Detroit, MI 48202 USA; Oakland Univ, Dept Phys, Rochester, MI 48309 USA; H Lundbeck & Co AS, Drug Metab, DK-2500 Valby, Denmark; H Lundbeck & Co AS, Neurophamacol, DK-2500 Valby, Denmark; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; NIDDK, Mol Cell Biol Sect, Biol Chem Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Lundbeck Corporation; Lundbeck Corporation; University of Konstanz; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Sci Ctr, 2799 W Grand Blvd, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	Mordwinkin, Nicholas M/A-4347-2010; Leist, Marcel/D-2133-2010; zhang, zheng/HCH-9684-2022	Leist, Marcel/0000-0002-3778-8693; 	NHLBI NIH HHS [R01HL64766] Funding Source: Medline; NINDS NIH HHS [P01 NS23393, R01NS43324, P01 NS42345] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK025061, ZIADK025061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043324, P01NS023393, P01NS042345] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Charytoniuk D, 2002, EUR J NEUROSCI, V16, P2351, DOI 10.1046/j.1460-9568.2002.02412.x; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Goetz JA, 2002, BIOESSAYS, V24, P157, DOI 10.1002/bies.10056; Gutierrez-Frias C, 2004, J IMMUNOL, V173, P5046, DOI 10.4049/jimmunol.173.8.5046; IALTABA AR, 2002, NAT REV CANCER, V2, P361; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Ma QF, 1997, J NEUROSCI, V17, P3644; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Tanaka R, 2004, STROKE, V35, P1454, DOI 10.1161/01.STR.0000126480.40967.b3; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhang L, 2005, ARTIF INTELL MED, V33, P41, DOI 10.1016/j.artmed.2004.06.002; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	44	95	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32462	32470		10.1074/jbc.M706880200	http://dx.doi.org/10.1074/jbc.M706880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17804404	hybrid, Green Submitted			2022-12-27	WOS:000250480300069
J	Anderson, EJ; Yamazaki, H; Neufer, PD				Anderson, Ethan J.; Yamazaki, Hanae; Neufer, P. Darrell			Induction of endogenous uncoupling protein 3 suppresses mitochondrial oxidant emission during fatty acid-supported respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; OXYGEN SPECIES PRODUCTION; BROWN-ADIPOSE-TISSUE; GENE-EXPRESSION; INTERMYOFIBRILLAR MITOCHONDRIA; PROTON LEAK; TRANSCRIPTIONAL REGULATION; SUPEROXIDE-PRODUCTION; PHYSIOLOGICAL-ROLE; THYROID-HORMONE	Uncoupling protein 3 (UCP3) expression increases dramatically in skeletal muscle under metabolic states associated with elevated lipid metabolism, yet the function of UCP3 in a physiological context remains controversial. Here, in situ mitochondrial H2O2 emission and respiration were measured in permeabilized fiber bundles prepared from both rat and mouse (wild-type) gastrocnemius muscle after a single bout of exercise plus 18 h of recovery (Ex/R) that induced a similar to 2-4-fold increase in UCP3 protein. Elevated uncoupling activity (i.e. GDP inhibitable) was evident in Ex/R fibers only upon the addition of palmitate (known activator of UCP3) or under substrate conditions eliciting substantial rates of H2O2 production (i.e. respiration supported by succinate or palmitoyl-L-carnitine/malate but not pyruvate/malate), indicative of UCP3 activation by endogenous reactive oxygen species. In mice completely lacking UCP3 (ucp3(-/-)), Ex/R failed to induce uncoupling activity. Surprisingly, when UCP3 activity was inhibited by GDP (rats) or in the absence of UCP3 (ucp3(-/-)), H2O2 emission was significantly (p < 0.05) higher in Ex/R versus non-exercised control fibers. Collectively, these findings demonstrate that the oxidant emitting potential of mitochondria is increased in skeletal muscle during recovery from exercise, possibly as a consequence of prolonged reliance on lipid metabolism and/or altered mitochondrial biochemistry/morphology and that induction of UCP3 in vivo mediates an increase in uncoupling activity that restores mitochondrial H2O2 emission to non-exercised, control levels.	Yale Univ, John B Pierce Lab & Cellular & Mol Physiol, New Haven, CT 06519 USA; E Carolina Univ, Greenville, NC 27834 USA; Yale Univ, John B Pierce Lab & Cellular & Mol Physiol, New Haven, CT 06519 USA; E Carolina Univ, Greenville, NC 27834 USA	Yale University; The John B Pierce Laboratory, Inc; University of North Carolina; East Carolina University; Yale University; The John B Pierce Laboratory, Inc; University of North Carolina; East Carolina University	Neufer, PD (corresponding author), E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA.	neuferp@ecu.edu	Yamazaki, Hanae/V-9609-2019					Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Cortright RN, 1999, AM J PHYSIOL-ENDOC M, V276, pE217, DOI 10.1152/ajpendo.1999.276.1.E217; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Duval C, 2007, FEBS LETT, V581, P955, DOI 10.1016/j.febslet.2007.01.085; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Gong DW, 1999, BIOCHEM BIOPH RES CO, V256, P27, DOI 10.1006/bbrc.1999.0239; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; GRIFFITHS EJ, 1993, BIOCHEM J, V290, P489, DOI 10.1042/bj2900489; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Hildebrandt AL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1021, DOI 10.1152/ajpendo.00234.2003; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jezek P, 2004, PHYSIOL RES, V53, pS199; Jezek P, 1998, BBA-BIOENERGETICS, V1365, P319, DOI 10.1016/S0005-2728(98)00084-X; Jezek P, 1999, J BIOENERG BIOMEMBR, V31, P457, DOI 10.1023/A:1005496306893; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Jimenez M, 2002, EUR J BIOCHEM, V269, P2878, DOI 10.1046/j.1432-1033.2002.02953.x; Jones TE, 2003, AM J PHYSIOL-ENDOC M, V284, pE96, DOI 10.1152/ajpendo.00316.2002; Kiens B, 1998, AM J PHYSIOL-ENDOC M, V275, pE332, DOI 10.1152/ajpendo.1998.275.2.E332; Kimber NE, 2003, J PHYSIOL-LONDON, V548, P919, DOI 10.1113/jphysiol.2002.031179; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Kuznetsov AV, 2006, BBA-BIOENERGETICS, V1757, P686, DOI 10.1016/j.bbabio.2006.03.014; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Ljubicic V, 2004, J APPL PHYSIOL, V97, P976, DOI 10.1152/japplphysiol.00336.2004; LOCKE RM, 1982, EUR J BIOCHEM, V129, P373, DOI 10.1111/j.1432-1033.1982.tb07060.x; LOSSA S, 2002, PFLUEGERS ARCH EUR J, V445, P431; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Matsuda J, 1997, FEBS LETT, V418, P200, DOI 10.1016/S0014-5793(97)01381-1; Minnaard R, 2006, FEBS LETT, V580, P5172, DOI 10.1016/j.febslet.2006.08.066; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Mollica MP, 2006, CELL MOL LIFE SCI, V63, P358, DOI 10.1007/s00018-005-5443-2; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Noland RC, 2003, METABOLISM, V52, P152, DOI 10.1053/meta.2003.50021; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Pilegaard H, 2003, DIABETES, V52, P657, DOI 10.2337/diabetes.52.3.657; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; ROTTENBERG H, 1975, BIOCHEMISTRY-US, V14, P2675, DOI 10.1021/bi00683a017; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Silvestri E, 2005, FEBS LETT, V579, P1639, DOI 10.1016/j.febslet.2005.02.022; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Tsuboyama-Kasaoka N, 1998, BIOCHEM BIOPH RES CO, V247, P498, DOI 10.1006/bbrc.1998.8818; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	69	120	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31257	31266		10.1074/jbc.M706129200	http://dx.doi.org/10.1074/jbc.M706129200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17761668	hybrid			2022-12-27	WOS:000250309200015
J	Lee, JA; Pallas, DC				Lee, Jocelyn A.; Pallas, David C.			Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; ADENOVIRUS E4ORF4 PROTEIN; PP2A CATALYTIC SUBUNIT; POLYOMAVIRUS MIDDLE-T; MAP KINASE PATHWAY; B-ALPHA-SUBUNIT; METHYL ESTERIFICATION; SACCHAROMYCES-CEREVISIAE; REGULATORY SUBUNIT; OKADAIC ACID	Protein phosphatase 2A (PP2A) is a multifunctional phosphatase that plays important roles in many cellular processes including regulation of cell cycle and apoptosis. Because PP2A is involved in so many diverse processes, it is highly regulated by both non-covalent and covalent mechanisms that are still being defined. In this study we have investigated the importance of leucine carboxyl methyltransferase-1 (LCMT-1) for PP2A methylation and cell function. We show that reduction of LCMT-1 protein levels by small hairpin RNAs causes up to a 70% reduction in PP2A methylation in HeLa cells, indicating that LCMT-1 is the major mammalian PP2A methyltransferase. In addition, LCMT-1 knockdown reduced the formation of PP2A heterotrimers containing the B alpha regulatory subunit and, in a subset of the cells, induced apoptosis, characterized by caspase activation, nuclear condensation/fragmentation, and membrane blebbing. Knockdown of the PP2A B alpha regulatory subunit induced a similar amount of apoptosis, suggesting that LCMT-1 induces apoptosis in part by disrupting the formation of PP2A(B alpha AC) heterotrimers. Treatment with a pan-caspase inhibitor partially rescued cells from apoptosis induced by LCMT-1 or B alpha knockdown. LCMT-1 knockdown cells and B alpha knockdown cells were more sensitive to the spindle-targeting drug nocodazole, suggesting that LCMT-1 and B alpha are important for spindle checkpoint. Treatment of LCMT-1 and B alpha knockdown cells with thymidine dramatically reduced cell death, presumably by blocking progression through mitosis. Consistent with these results, homozygous gene trap knock-out of LCMT-1 in mice resulted in embryonic lethality. Collectively, our results indicate that LCMT-1 is important for normal progression through mitosis and cell survival and is essential for embryonic development in mice.	Emory Univ, Sch Med, Dept Biochem, Winship Canc Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, Winship Canc Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			NATIONAL CANCER INSTITUTE [R01CA057327] Funding Source: NIH RePORTER; NCI NIH HHS [CA57327, R01 CA057327, CA1236402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonness K, 2006, MOL CANCER THER, V5, P2727, DOI 10.1158/1535-7163.MCT-06-0273; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CAYLA X, 1993, EUR J BIOCHEM, V214, P281, DOI 10.1111/j.1432-1033.1993.tb17922.x; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Evans DRH, 2000, MOL GEN GENET, V264, P425; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; GLENN GM, 1995, J VIROL, V69, P3729, DOI 10.1128/JVI.69.6.3729-3736.1995; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; LEE TH, 1994, MOL BIOL CELL, V5, P323, DOI 10.1091/mbc.5.3.323; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Wang YC, 1997, MOL CELL BIOL, V17, P620, DOI 10.1128/MCB.17.2.620; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu T, 1997, ARCH BIOCHEM BIOPHYS, V339, P210, DOI 10.1006/abbi.1996.9835	54	47	53	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30974	30984		10.1074/jbc.M704861200	http://dx.doi.org/10.1074/jbc.M704861200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724024	Green Accepted, hybrid			2022-12-27	WOS:000250136300065
J	MacDonald, MJ; Smith, AD; Hasan, NM; Sabat, G; Fahien, LA				MacDonald, Michael J.; Smith, Andrew D., III; Hasan, Noaman M.; Sabat, Grzegorz; Fahien, Leonard A.			Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; NMR ISOTOPOMER ANALYSIS; METHYL SUCCINATE; RAT-LIVER; GLYCERALDEHYDE PHOSPHATE; METABOLISM; PYRUVATE; RELEASE; ISLETS; CITRATE	The mitochondria of pancreatic beta cells are believed to convert insulin secretagogues into products that are translocated to the cytosol where they participate in insulin secretion. We studied the hypothesis that short chain acyl-CoA ( SC-CoAs) might be some of these products by discerning the pathways of SC-CoA formation in beta cells. Insulin secretagogues acutely stimulated 1.5-5-fold increases in acetoacetyl-CoA, succinyl-CoA, malonyl-CoA, hydroxymethylglutaryl-CoA ( HMG-CoA), and acetyl-CoA in INS-1832/13 cells as judged from liquid chromatography-tandem mass spectrometry measurements. Studies of 12 relevant enzymes in rat and human pancreatic islets and INS-1832/13 cells showed the feasibility of at least two redundant pathways, one involving acetoacetate and the other citrate, for the synthesis SC-CoAs from secretagogue carbon in mitochondria and the transfer of their acyl groups to the cytosol where the acyl groups are converted to SC-CoAs. Knockdown of two key cytosolic enzymes in INS-1832/13 cells with short hairpin RNA supported the proposed scheme. Lowering ATP citrate lyase 88% did not inhibit glucose-induced insulin release indicating citrate is not the only carrier of acyl groups to the cytosol. However, lowering acetoacetyl-CoA synthetase 80% partially inhibited glucose-induced insulin release indicating formation of SC-CoAs from acetoacetate in the cytosol is important for insulin secretion. The results indicate beta cells possess enzyme pathways that can incorporate carbon from glucose into acetylCoA, acetoacetyl-CoA, and succinyl-CoA and carbon from leucine into these three SC-CoAs plus HMG-CoA in their mitochondria and enzymes that can form acetyl-CoA, acetoacetyl-CoA, malonyl-CoA, and HMG-CoA in their cytosol.	Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabetes Ctr, Madison, WI 53706 USA; Univ Wisconsin, Ctr Biotechnol, Mass Spectrometry Facil, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Rm 3459 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	mjmacdon@wisc.edu		Sabat, Grzegorz/0000-0001-7668-7767	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK28348, R01 DK028348] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; BERGSTROM JD, 1985, METHOD ENZYMOL, V110, P3; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Cheng HY, 2003, AM J PHYSIOL-ENDOC M, V285, pE287, DOI 10.1152/ajpendo.00535.2002; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ITO M, 1986, BIOCHIM BIOPHYS ACTA, V876, P280, DOI 10.1016/0005-2760(86)90285-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Kowluru A, 2001, DIABETOLOGIA, V44, P89, DOI 10.1007/s001250051584; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MACDONALD MJ, 1991, J BIOL CHEM, V266, P1335; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2004, MOL CELL BIOCHEM, V258, P201, DOI 10.1023/B:MCBI.0000012856.31929.91; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MACDONALD MJ, 1988, DIABETES, V37, P997, DOI 10.2337/diabetes.37.7.997; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; MIDDLETON B, 1974, BIOCHEM J, V139, P109, DOI 10.1042/bj1390109; Montague W, 1980, Horm Metab Res Suppl, VSuppl 10, P153; Poitout V, 2003, TRENDS ENDOCRIN MET, V14, P201, DOI 10.1016/S1043-2760(03)00086-9; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Veluthakal R, 2007, DIABETES, V56, P204, DOI 10.2337/db06-0668; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Yamada S, 2003, ENDOCRINOLOGY, V144, P5232, DOI 10.1210/en.2003-0719; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4	50	63	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30596	30606		10.1074/jbc.M702732200	http://dx.doi.org/10.1074/jbc.M702732200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724028	hybrid			2022-12-27	WOS:000250136300028
J	Mattison, CP; Old, WM; Steiner, E; Huneycutt, BJ; Resing, KA; Ahn, NG; Winey, M				Mattison, Christopher P.; Old, William M.; Steiner, Estelle; Huneycutt, Brenda J.; Resing, Katheryn A.; Ahn, Natalie G.; Winey, Mark			Mps1 activation loop autophosphorylation enhances kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; DUPLICATION GENE MPS1; PROTEIN-KINASE; KINETOCHORE LOCALIZATION; ASSEMBLY CHECKPOINT; CATALYTIC DOMAIN; MITOTIC ARREST; MAP KINASE; PHOSPHORYLATION; EXPRESSION	The Mps1 protein kinase is required for proper assembly of the mitotic spindle, checkpoint signaling, and several other aspects of cell growth and differentiation. Mps1 regulation is mediated by cell cycle-dependent changes in transcription and protein level. There is also a strong correlation between hyper-phosphorylated mitotic forms of Mps1 and increased kinase activity. We investigated the role that autophosphorylation plays in regulating human Mps1 (hMps1) protein kinase activity. Here we report that hyperphosphorylated hMps1 forms are not the only active forms of the kinase. However, autophosphorylation of hMps1 within the activation loop is required for full activity in vitro. Mass spectrometry analysis of de novo synthesized enzyme in Escherichia coli identified autophosphorylation sites at residues Thr(675), Thr(676), and Thr(686), but phosphatase-treated and reactivated enzyme was only phosphorylated on Thr(676). Mutation of Thr(676) in hMps1 or the corresponding Thr(591) residue within yeast Mps1 reduces kinase activity in vitro. We find that overexpression of an hMps1-T676A mutation inhibits centrosome duplication in RPE1 cells. Likewise, yeast cells harboring mps1-T591A as the sole MPS1 allele are not viable. Our data strongly support the conclusion that site-specific Mps1 autophosphorylation within the activation loop is required for full activity in vitro and function in vivo.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Winey, M (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	mark.winey@colorado.edu		OLD, WILLIAM/0000-0002-9499-8478	NCI NIH HHS [R01 CA87648] Funding Source: Medline; NIGMS NIH HHS [GM07135, GM51312] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, T32GM007135] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Carr SA, 2005, METHOD ENZYMOL, V405, P82, DOI 10.1016/S0076-6879(05)05005-6; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Gilliland WD, 2005, CURR BIOL, V15, P672; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; He XW, 1998, J CELL SCI, V111, P1635; HOGG D, 1994, ONCOGENE, V9, P89; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LINDBERG RA, 1993, ONCOGENE, V8, P351; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; POCH O, 1994, MOL GEN GENET, V243, P641, DOI 10.1007/BF00279573; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Szczepanowska J, 1998, P NATL ACAD SCI USA, V95, P4146, DOI 10.1073/pnas.95.8.4146; TRAFNY EAM, 2006, PROTEIN SCI, V3, P176; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Zappacosta F, 2006, MOL CELL PROTEOMICS, V5, P2019, DOI 10.1074/mcp.M600238-MCP200; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	45	68	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30553	30561		10.1074/jbc.M707063200	http://dx.doi.org/10.1074/jbc.M707063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728254	hybrid			2022-12-27	WOS:000250136300023
J	Adhikari, S; Uren, A; Roy, R				Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra			N-terminal extension of N-methylpurine DNA glycosylase is required for turnover in hypoxanthine excision reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; ENDONUCLEASE-III; REPAIR; SPECIFICITY; MECHANISM; RESIDUES; SITES; BASES	N-Methylpurine DNA glycosylase (MPG) initiates base excision repair in DNA by removing a wide variety of alkylated, deaminated, and lipid peroxidation-induced purine adducts. In this study we tested the role of N-terminal extension on MPG hypoxanthine (Hx) cleavage activity. Our results showed that MPG lacking N-terminal extension excises hypoxanthine with significantly reduced efficiency, one-third of that exhibited by full-length MPG under similar conditions. Steady-state kinetics showed full-length MPG has higher V-max and lower K-m than N Delta 100 MPG. Real time binding experiments by surface plasmon resonance spectroscopy suggested that truncation can substantially increase the equilibrium binding constant of MPG toward Hx, but under single-turnover conditions there is apparently no effect on catalytic chemistry; however, the truncation of the N-terminal tail affected the turnover of the enzyme significantly under multiple turnover conditions. Real time binding experiments by surface plasmon resonance spectroscopy further showed that N Delta 100 MPG binds approximately six times more tightly toward its product apurinic/apyrimidinic site than the substrate, whereas full-length MPG similarly binds to both the substrate and the product. We thereby conclude that the N-terminal tail in MPG plays a critical role in overcoming the product inhibition, which is achieved by reducing the differences of MPG binding affinity toward Hx and apurinic/apyrimidinic sites and thus is essential for the Hx cleavage reaction of MPG. The results from this study also affirm the need for reinvestigation of full-length MPG for its enzymatic and structural properties, which are currently available mostly for the truncated protein.	Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Roy, R (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, LL Level,S-122,3800 Reservoir Rd NW, Washington, DC 20057 USA.	rr228@georgetown.edu			NCI NIH HHS [R01 CA92306, R01 CA092306, R01CA108641] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092306, R01CA108641] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; BREIMER LH, 1984, J BIOL CHEM, V259, P5543; DOSANJH MK, 1994, BIOCHEMISTRY-US, V33, P1624, DOI 10.1021/bi00173a002; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P59; HATCHET Z, 1994, J BIOL CHEM, V269, P18814; HILLPERKINS M, 1986, MUTAT RES, V162, P153, DOI 10.1016/0027-5107(86)90081-3; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; LARSON K, 1985, MUTAT RES, V233, P211; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Mattes WB, 1996, CARCINOGENESIS, V17, P643, DOI 10.1093/carcin/17.4.643; Miao F, 1998, NUCLEIC ACIDS RES, V26, P4034, DOI 10.1093/nar/26.17.4034; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Roy R, 1996, J BIOL CHEM, V271, P23690, DOI 10.1074/jbc.271.39.23690; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302	25	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30078	30084		10.1074/jbc.M704051200	http://dx.doi.org/10.1074/jbc.M704051200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17716976	hybrid			2022-12-27	WOS:000249981200038
J	Barrett, CML; Freudl, R; Robinson, C				Barrett, Claire M. L.; Freudl, Roland; Robinson, Colin			Twin arginine translocation (Tat)-dependent export in the apparent absence of TatABC or TatA complexes using modified Escherichia coli TatA subunits that substitute for TatB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; BLUE NATIVE ELECTROPHORESIS; SIGNAL PEPTIDE; TRANSPORT SYSTEM; BACTERIAL; COMPONENT; PATHWAY; FORM; SEQUENCE; BACILLUS	The twin arginine translocation pathway exports folded proteins across the cytoplasmic membrane of many bacteria. In Escherichia coli and other Gram-negative bacteria, TatA, TatB, and TatC are all essential for efficient translocation, and current models suggest that separate TatABC and TatA complexes coalesce at the point of translocation. However, other microbes appear only to possess tatA and tatC genes. In Escherichia coli, virtually no translocation is observed when only TatA and TatC are present, but several mutations at the extreme N terminus of TatA were shown to support translocation. Here we show that these apparently bifunctional mutant TatA variants can function as typical TatA components because translocation is observed when they are co-expressed with TatBC, and they assemble into large, heterogeneous complexes that resemble wild type TatA complexes. However, cells expressing TatC plus the mutant TatA variants do not contain complexes that resemble the expected 370-kDa TatABC complex, clearly indicating that the mutant TatA forms cannot assemble efficiently, or stably, into this complex. The simultaneous expression of wild type TatA furthermore blocks translocation activity, suggesting that the mutant TatA forms preferentially bind to other TatA molecules rather than TatC. Surprisingly, we observe translocation in the absence of detectable free TatA, when translational fusions of the mutant TatAs with TatC are expressed. Transport can thus proceed in the simultaneous absence of TatABC and TatA complexes at detectable levels, and we conclude that the active translocon may be formed from dynamic twin arginine translocation complexes, one or more of which may await characterization.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	University of Warwick; Helmholtz Association; Research Center Julich	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	Colin.robinson@warwick.ac.uk	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P206; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	36	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36206	36213		10.1074/jbc.M704127200	http://dx.doi.org/10.1074/jbc.M704127200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17881358	hybrid			2022-12-27	WOS:000251458300010
J	Dalal, S; Klemba, M				Dalal, Seema; Klemba, Michael			Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGESTIVE VACUOLE; CYSTEINE PROTEASE; LEUCYL AMINOPEPTIDASE; FLUORESCENT PROTEIN; MALARIA PARASITE; M1 FAMILY; IN-VIVO; LOCALIZATION; DISRUPTION; DEGRADATION	During the erythrocytic stage of its life cycle, the human malaria parasite Plasmodium falciparum catabolizes large quantities of host-cell hemoglobin in an acidic organelle, the food vacuole. A current model for the catabolism of globin-derived oligopeptides invokes peptide transport out of the food vacuole followed by hydrolysis to amino acids by cytosolic aminopeptidases. To test this model, we have examined the roles of four parasite aminopeptidases during the erythrocytic cycle. Localization of tagged aminopeptidases, coupled with biochemical analysis of enriched food vacuoles, revealed the presence of amino acid-generating pathways in the food vacuole as well as the cytosol. Based on the localization data and in vitro assays, we propose a specific role for one of the plasmodial enzymes, aminopeptidase P, in the catabolism of proline-containing peptides in both the vacuole and the cytosol. We establish an apparent requirement for three of the four aminopeptidases ( including the two food vacuole enzymes) for efficient parasite proliferation. To gain insight into the impact of aminopeptidase inhibition on parasite development, we examined the effect of the presence of amino acids in the culture medium of the parasite on the toxicity of the aminopeptidase inhibitor bestatin. The ability of bestatin to block parasite replication was only slightly affected when 19 of 20 amino acids were withdrawn from the medium, indicating that exogenous amino acids cannot compensate for the loss of aminopeptidase activity. Together, these results support the development of aminopeptidase inhibitors as novel chemotherapeutics directed against malaria.	Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu						Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Allen RJW, 2004, TRENDS PARASITOL, V20, P7, DOI 10.1016/j.pt.2003.10.015; BALL EG, 1948, J BIOL CHEM, V175, P547; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Eksi S, 2004, MOL MICROBIOL, V53, P243, DOI 10.1111/j.1365-2958.2004.04108.x; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Florent I, 1998, MOL BIOCHEM PARASIT, V97, P149, DOI 10.1016/S0166-6851(98)00143-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Janse Chris J., 1994, V42, P295; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; Nankya-Kitaka MF, 1998, PARASITOL RES, V84, P552, DOI 10.1007/s004360050447; Omara-Opyene AL, 2004, J BIOL CHEM, V279, P54088, DOI 10.1074/jbc.M409605200; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P265; SHERMAN IW, 1970, INT J BIOCHEM, V1, P635, DOI 10.1016/0020-711X(70)90033-9; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; SLOMIANNY C, 1983, J PROTOZOOL, V30, P376, DOI 10.1111/j.1550-7408.1983.tb02934.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Thompson NE, 2003, ANAL BIOCHEM, V323, P171, DOI 10.1016/j.ab.2003.08.003; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TURNER AJ, 2004, HDB PROTEOLYTIC ENZY, P930; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	51	114	116	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35978	35987		10.1074/jbc.M703643200	http://dx.doi.org/10.1074/jbc.M703643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17895246	hybrid			2022-12-27	WOS:000251458100058
J	Wu, JW; Yang, YS; Zhang, JH; Ji, P; Du, WJ; Jiang, P; Xie, DH; Huang, HD; Wu, M; Zhang, GZ; Wu, JH; Shi, YY				Wu, Jiawen; Yang, Yinshan; Zhang, Jiahai; Ji, Peng; Du, Wenjing; Jiang, Peng; Xie, Dinghai; Huang, Hongda; Wu, Mian; Zhang, Guangzhao; Wu, Jihui; Shi, Yunyu			Domain-swapped dimerization of the second PDZ domain of ZO2 may provide a structural basis for the polymerization of claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; TUMOR-SUPPRESSOR PROTEIN; GUANYLATE KINASE DOMAINS; CRYSTAL-STRUCTURE; INTRAMOLECULAR INTERACTION; ZONULA OCCLUDENS; EPITHELIAL-CELLS; COMPLEX REVEALS; ZO-1; SEQUENCE	Zonula occludens proteins (ZOs), including ZO1/2/3, are tight junction-associated proteins. Each of them contains three PDZ domains. It has been demonstrated that ZO1 can form either homodimers or heterodimers with ZO2 or ZO3 through the second PDZ domain. However, the underlying structural basis is not well understood. In this study, the solution structure of the second PDZ domain of ZO2 (ZO2-PDZ2) was determined using NMR spectroscopy. The results revealed a novel dimerization mode for PDZ domains via three-dimensional domain swapping, which can be generalized to homodimers of ZO1-PDZ2 or ZO3-PDZ2 and heterodimers of ZO1-PDZ2/ZO2-PDZ2 or ZO1-PDZ2/ZO3-PDZ2 due to high conservation between PDZ2 domains in ZO proteins. Furthermore, GST pull-down experiments and immunoprecipitation studies demonstrated that interactions between ZO1-PDZ2 and ZO2-PDZ2 and their self-associations indeed exist both in vitro and in vivo. Chemical cross-linking and dynamic laser light scattering experiments revealed that both ZO1-PDZ2 and ZO2-PDZ2 can form oligomers in solution. This PDZ domain-mediated oligomerization of ZOs may provide a structural basis for the polymerization of claudins, namely the formation of tight junctions.	Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Anhui, Peoples R China; Anhui Coll Tradit Chinese Med, Sch Ch Western Med, Hefei 230038, Anhui, Peoples R China; INSERM, Ctr Biochim Struct, U554, F-34090 Montpellier, France; CNRS, UMR5048, F-34090 Montpellier, France	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University of Chinese Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Jiang, Peng/A-1946-2013; du, wenjing/A-2530-2013; Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	du, wenjing/0000-0002-3967-9984; Shi, Yunyu/0000-0002-1348-4759; Wu, Mian/0000-0002-2714-0500				Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Albright RA, 1996, BIOCHEMISTRY-US, V35, P735, DOI 10.1021/bi951958n; ANDERSON JM, 1995, BIOCHEM SOC T, V23, P470, DOI 10.1042/bst0230470; BALDA MS, 1993, J CELL BIOL, V123, P293, DOI 10.1083/jcb.123.2.293; BENNETT MJ, 1994, PROTEIN SCI, V3, P1464, DOI 10.1002/pro.5560030912; BERNE BJ, 1976, DYNAMIC LIGHT SCATTE, P11; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CEREIJIDO M, 1993, J CELL SCI, P127; CEREIJIDO M, 1989, J MEMBRANE BIOL, V110, P1, DOI 10.1007/BF01870987; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORTT AA, 1994, EUR J BIOCHEM, V221, P151, DOI 10.1111/j.1432-1033.1994.tb18724.x; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; MURRAY AJ, 1995, P NATL ACAD SCI USA, V92, P7337, DOI 10.1073/pnas.92.16.7337; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	56	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35988	35999		10.1074/jbc.M703826200	http://dx.doi.org/10.1074/jbc.M703826200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17897942	hybrid			2022-12-27	WOS:000251458100059
J	Baker, AM; Sauliere, A; Gaibelet, G; Lagane, B; Mazeres, S; Fourage, M; Bachelerie, F; Salome, L; Lopez, A; Dumas, F				Baker, Aurelie-Marie; Sauliere, Aude; Gaibelet, Gerald; Lagane, Bernard; Mazeres, Serge; Fourage, Marie; Bachelerie, Francoise; Salome, Laurence; Lopez, Andre; Dumas, Fabrice			CD4 interacts constitutively with multiple CCR5 at the plasma membrane of living cells - A fluorescence recovery after photobleaching at variable radii approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FRAP EXPERIMENTS; T-CELLS; RECEPTOR; DOMAINS; SURFACE; ENTRY; DIMERIZATION; ASSOCIATION; MICROVILLI	The entry of human immunodeficiency virus into target cells requires successive interactions of the viral envelope glycoprotein gp120 with CD4 and the chemokine receptors CCR5 or CXCR4. We previously demonstrated, by Forster resonance energy transfer experiments, the constitutive association of CD4 and CCR5 at the surface of living cells. We therefore speculated that this interaction may correlate with compartmentalization of CD4 and CCR5 within the plasma membrane. Here, we characterize the lateral distribution, the dynamics, and the stoichiometry of these receptors in living cells stably expressing CD4 and/or CCR5 by means of fluorescence recovery after photobleaching at variable radii experiments. We found that (i) these receptors expressed alone are confined into 1-mu m-sized domains, (ii) CD4-CCR5 associations occur outside and inside smaller domains, and (iii) these interactions involve multiple CCR5 molecules per CD4.	Univ Toulouse 3, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, F-31062 Toulouse, France; Inst Pasteur, Unite Pathogenie Virale Mol, INSERM, U819, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dumas, F (corresponding author), Univ Toulouse 3, Inst Pharmacol & Biol Struct, CNRS, UMR 5089, 205 Route Narbonne, F-31062 Toulouse, France.	Fabrice.Dumas@ipbs.fr	BACHELERIE, FRANCOISE/F-8823-2013; Lagane, Bernard/K-8446-2016; Fourage, Marie/AAA-5163-2021; Lagane, Bernard/AAA-2205-2019	BACHELERIE, FRANCOISE/0000-0002-0399-3277; Lagane, Bernard/0000-0002-3459-7867; SALOME, Laurence/0000-0001-9667-4154; Dumas, Fabrice/0000-0002-9164-4527				Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chang MI, 2005, J VIROL, V79, P14748, DOI 10.1128/JVI.79.23.14748-14755.2005; Desmetz C, 2006, IMMUNOLOGY, V119, P551, DOI 10.1111/j.1365-2567.2006.02470.x; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; Li S, 1998, IMMUNOL TODAY, V19, P455, DOI 10.1016/S0167-5699(98)01325-5; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Lynch GW, 1999, EUR J IMMUNOL, V29, P2590, DOI 10.1002/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; MONTI JA, 1978, J LIPID RES, V19, P222; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Platt EJ, 2001, J VIROL, V75, P12266, DOI 10.1128/JVI.75.24.12266-12278.2001; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496	26	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35163	35168		10.1074/jbc.M705617200	http://dx.doi.org/10.1074/jbc.M705617200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17855336	hybrid			2022-12-27	WOS:000251155200061
J	Bourhis, E; Hymowitz, SG; Cochran, AG				Bourhis, Eric; Hymowitz, Sarah G.; Cochran, Andrea G.			The mitotic regulator survivin binds as a monomer to its functional interactor borealin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; CRYSTAL-STRUCTURE; REVEALS; CENTROMERE; INHIBITOR; INCENP	Survivin is a member of the IAP ( (i) under bar nhibitor of (a) under bar poptosis) protein family, defined in part by the presence of a zinc-binding baculoviral inhibitory repeat (BIR) domain. Most BIR domains bind short sequences beginning with alanine, and in this manner, they recognize and block the action of key targets in apoptotic pathways. However, Survivin binds only very weakly to typical IAP ligands. Unique features of Survivin are the long C-terminal helix following the BIR domain and a short segment ( linking the helix and BIR domains) that mediates Survivin homodimerization. Despite this detailed knowledge of the structure of Survivin itself, there is a current lack of understanding about how Survivin recognizes cellular binding partners, and consequently, many questions about Survivin function remain unanswered. We determined two co-crystal structures of Survivin and a minimal binding fragment from the chromosomal passenger protein Borealin, a well validated functional interactor. The interaction between Survivin and Borealin involves extensive packing between the long C-terminal helix of Survivin and a long Borealin helix. Surprisingly, an additional important interaction occurs between the Survivin homodimerization interface and a short segment of Borealin. This segment both structurally mimics and displaces one Survivin monomer. The relevance of this unexpected interaction was tested by mutagenesis of two key Borealin residues. Mutant Borealin introduced into HeLa cells failed to localize properly during mitosis and also caused mislocalization of other chromosomal passenger proteins. This suggests that the mutant is dominant-negative and confirms the functional importance of the interaction surface identified in the crystal structures.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Cochran, AG (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way,MS 27, San Francisco, CA 94080 USA.	andrea@gene.com		Cochran, Andrea/0000-0001-6469-795X				Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; DeLano W.L, PYMOL MOL GRAPHICS S; Faragher AJ, 2007, MOL BIOL CELL, V18, P1337, DOI 10.1091/mbc.E06-05-0409; Franklin MC, 2003, BIOCHEMISTRY-US, V42, P8223, DOI 10.1021/bi034227t; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shi YG, 2000, NAT STRUCT BIOL, V7, P620, DOI 10.1038/77904; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	24	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35018	35023		10.1074/jbc.M706233200	http://dx.doi.org/10.1074/jbc.M706233200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881355	hybrid			2022-12-27	WOS:000251155200046
J	Laursen, KB; Mielke, E; Iannaccone, P; Fuchtbauer, EM				Laursen, Kristian Bruun; Mielke, Esther; Iannaccone, Philip; Fuechtbauer, Ernst-Martin			Mechanism of transcriptional activation by the proto-oncogene Twist1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAETHRE-CHOTZEN-SYNDROME; DNA-BINDING PROTEINS; LOOP-HELIX PROTEINS; BHLH PROTEIN; MAMMALIAN-CELLS; OSTEOBLAST DIFFERENTIATION; MUSCLE DIFFERENTIATION; DORSOVENTRAL PATTERN; REGULATORY ELEMENTS; DROSOPHILA EMBRYO	Mammalian Twist1, a master regulator in development and a key factor in tumorigenesis, is known to repress transcription by several mechanisms and is therefore considered to mediate its function mainly through inhibition. A role of Twist1 as transactivator has also been reported but, so far, without providing a mechanism for such an activity. Here we show that heterodimeric complexes of Twist1 and E12 mediate E-box-dependent transcriptional activation. We identify a novel Twist1 transactivation domain that coactivates together with the less potent E12 transactivation domain. We found three specific residues in the highly conserved WR domain to be essential for the transactivating function of murine Twist1 and suggest an alpha-helical structure of the transactivation domain.	Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Northwestern Univ, Childrens Mem Res Ctr, Dev Biol Program, Chicago, IL 60614 USA	Aarhus University; Northwestern University	Fuchtbauer, EM (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.	emf@mb.au.dk						Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; BODMER R, 1990, DEVELOPMENT, V110, P661; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Corsi AK, 2002, DEVELOPMENT, V129, P2761; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; ElGhouzzi V, 1997, NAT GENET, V15, P42; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Gullaud M, 2003, CELL DEATH DIFFER, V10, P641, DOI 10.1038/sj.cdd.4401222; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; HARLAND R, 1985, J CELL BIOL, V101, P1094, DOI 10.1083/jcb.101.3.1094; Hebrok M, 1997, EXP CELL RES, V232, P295, DOI 10.1006/excr.1997.3541; HEBROK M, 1994, DEV BIOL, V165, P537, DOI 10.1006/dbio.1994.1273; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee MS, 2000, BONE, V27, P591, DOI 10.1016/S8756-3282(00)00380-X; Lee YM, 1997, J BIOL CHEM, V272, P17531, DOI 10.1074/jbc.272.28.17531; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Massari ME, 1996, MOL CELL BIOL, V16, P121; MIRONCHIK Y, 2005, CANCER RES, V65, P1081; MITSUI K, 1993, J BIOL CHEM, V268, P24415; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Oshima A, 2002, J CELL BIOCHEM, V86, P792, DOI 10.1002/jcb.10272; Petropoulos H, 2000, J BIOL CHEM, V275, P25095, DOI 10.1074/jbc.M004251200; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rice DPC, 2000, DEVELOPMENT, V127, P1845; SALMINEN A, 1991, J CELL BIOL, V115, P905, DOI 10.1083/jcb.115.4.905; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMPSON P, 1983, GENETICS, V105, P615; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yousfi M, 2002, BIOCHEM BIOPH RES CO, V297, P641, DOI 10.1016/S0006-291X(02)02260-X; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; ZHOU JM, 1994, MOL CELL BIOL, V14, P6232, DOI 10.1128/MCB.14.9.6232; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	80	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34623	34633		10.1074/jbc.M707085200	http://dx.doi.org/10.1074/jbc.M707085200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17893140	hybrid			2022-12-27	WOS:000251155200004
J	Ahuja, N; Schwer, B; Carobbio, S; Waltregny, D; North, BJ; Castronovo, V; Maechler, P; Verdin, E				Ahuja, Nidhi; Schwer, Bjoern; Carobbio, Stefania; Waltregny, David; North, Brian J.; Castronovo, Vincenzo; Maechler, Pierre; Verdin, Eric			Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADING ENZYME; INCREASED DOSAGE; CELL-SURVIVAL; NAD; HOMOLOG; PROTEIN; P53; TRANSCRIPTION; RIBOSYLATION; DEACETYLASE	Sirtuins are homologues of the yeast transcriptional repressor Sir2p and are conserved from bacteria to humans. We report that human SIRT4 is localized to the mitochondria. SIRT4 is a matrix protein and becomes cleaved at amino acid 28 after import into mitochondria. Mass spectrometry analysis of proteins that coimmunoprecipitate with SIRT4 identified insulin degrading enzyme and the ADP/ATP carrier proteins, ANT2 and ANT3. SIRT4 exhibits no histone deacetylase activity but functions as an efficient ADP-ribosyltransferase on histones and bovine serum albumin. SIRT4 is expressed in islets of Langerhans and colocalizes with insulin-expressing beta cells. Depletion of SIRT4 from insulin-producing INS-1E cells results in increased insulin secretion in response to glucose. These observations define a new role for mitochondrial SIRT4 in the regulation of insulin secretion.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; Univ Geneva, Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; Univ Liege, Metastasis Res Lab, B-4000 Liege, Belgium	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Geneva; University of Liege	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	carobbio, stefania/E-7095-2018; Verdin, Eric/AAB-7999-2019	Maechler, Pierre/0000-0002-2005-1433; Verdin, Eric/0000-0003-3703-3183				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guarente L, 2000, GENE DEV, V14, P1021; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HARDY DL, 1992, BIOCHEM J, V283, P849, DOI 10.1042/bj2830849; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Maechler Pierre, 2003, Curr Opin Investig Drugs, V4, P1166; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mowbray J, 1996, FEBS LETT, V394, P61, DOI 10.1016/0014-5793(96)00921-0; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	50	307	323	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33583	10.1074/jbc.M705488200	http://dx.doi.org/10.1074/jbc.M705488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17715127	hybrid			2022-12-27	WOS:000250840200039
J	Coulon, V; L'Honore, A; Ouimette, JF; Dumontier, E; van den Munckhof, P; Drouin, J				Coulon, Vincent; L'Honore, Aurore; Ouimette, Jean-Francois; Dumontier, Emilie; van den Munckhof, Pepijn; Drouin, Jacques			A muscle-specific promoter directs Pitx3 gene expression in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; HOMEOBOX GENE; APHAKIA MICE; PITUITARY DEVELOPMENT; LENS DEVELOPMENT; PTX1; TRANSCRIPTION; HINDLIMB; DIFFERENTIATION; ISOFORMS	The Pitx homeobox transcription factor genes have been implicated in different developmental processes, including determination of hind limb identity for Pitx1, left-right asymmetry for Pitx2, and eye development and survival of midbrain dopaminergic neurons for Pitx3. Pitx1 and Pitx2 have partly redundant activities in craniofacial development, including in pituitary organogenesis, as indicated by their names. These genes also exhibit redundant activities in the control of hind limb bud growth. Recent studies have shown expression of the three Pitx genes in muscle, with Pitx3 being the most widely expressed in all skeletal muscles. We now report the identification of a muscle-specific promoter within the Pitx3 gene that is situated between the first exon for eye and brain expression and exon 2 that contains the initiator ATG codon. Sequences proximal to this muscle-specific exon 1 are essential and sufficient to confer muscle-specific expression in transgenic mice, they are responsive to myogenic basic helix-loop-helix regulatory factors, and they recruit these factors in vivo. In agreement with exclusive use of the muscle-specific promoter in aphakia mice that are deleted of the brain promoter, the trimethyl-lysine 4 histone H3 promoter signature shifts to this promoter in embryonic day 13 ak limb bud muscle cells. Myogenic basic helix-loop-helix regulatory factor activation of Pitx3 transcription may be part of a positive feedback loop contributing to establishment of the myogenic program.	Inst Rech Clin Montreal, Lab Genet Mol, Montreal, PQ H2W 1R7, Canada; Inst Mol Genet, CNRS, UMR 5535, F-34293 Montpellier 05, France; Univ Amsterdam, Acad Med Centrum, NL-1100 DD Amsterdam, Netherlands	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Amsterdam; Academic Medical Center Amsterdam	Drouin, J (corresponding author), Inst Rech Clin Montreal, Lab Genet Mol, 110 Ave Pins Quest, Montreal, PQ H2W 1R7, Canada.	jacques.drouin@ircm.qc.ca	Coulon, Vincent/B-2437-2009; Coulon, Vincent/AFF-7934-2022; van den Munckhof, Pepijn/AAY-9259-2020	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755; Drouin, Jacques/0000-0001-8226-5691; L'honore, Aurore/0000-0001-6371-4455				Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Forrester WC, 1999, GENE DEV, V13, P3003, DOI 10.1101/gad.13.22.3003; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Liu CY, 2002, DEVELOPMENT, V129, P5081; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; van den Munckhof P, 2006, J NEUROCHEM, V96, P160, DOI 10.1111/j.1471-4159.2005.03522.x; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	39	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33192	33200		10.1074/jbc.M706119200	http://dx.doi.org/10.1074/jbc.M706119200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848564	hybrid			2022-12-27	WOS:000250625400066
J	Khan, MT; Bhanumathy, CD; Schug, ZT; Joseph, SK				Khan, M. Tariq; Bhanumathy, Cunnigaiper D.; Schug, Zachary T.; Joseph, Suresh K.			Role of inositol 1,4,5-trisphosphate receptors in apoptosis in DT40 lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; CELL-DEATH; IP3 RECEPTORS; MOLECULAR DETERMINANTS; GENETIC-EVIDENCE; CALCIUM-RELEASE; CA2+ RELEASE; MEMBRANE; TYPE-1	The role of inositol 1,4,5-trisphosphate receptors (IP3R) in caspase-3 activation and cell death was investigated in DT40 chicken B-lymphocytes stably expressing various IP3R constructs. Both full-length type-I IP3R and a truncated construct corresponding to the caspase-3 cleaved "channel-only" fragment were able to support staurosporine (STS)-induced caspase-3 activation and cell death even when the IP3R construct harbored a mutation that inactivates the pore of the Ca2+ channel (D2550A). However, a full-length wild-type IP3R did not promote caspase-3 activation when the 159-amino acid cytosol-exposed C-terminal tail was deleted. STS caused an increase in cytosolic free Ca2+ in DT40 cells expressing wildtype or pore-dead IP3R mutants. However, in the latter case all the Ca2+ increase originated from Ca2+ entry across the plasma membrane. Caspase-3 activation of pore-dead DT40 cells was also more sensitive to extracellular Ca2+ chelation when compared with wild-type cells. STS-mediated release of cytochrome c into the cytosol and mitochondrial membrane potential depolarization could also be observed in DT40 cells lacking IP(3)Rs or containing the pore-dead mutant. We conclude that nonfunctional IP(3)Rs can sustain apoptosis in DT40 lymphocytes, because they facilitate Ca2+ entry mechanisms across the plasma membrane. Although the intrinsic ion-channel function of IP(3)Rs is dispensable for apoptosis induced by STS, the C-terminal tail of IP(3)Rs appears to be essential, possibly reflecting key protein-protein interactions with this domain.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@mail.tju.edu		Schug, Zachary/0000-0003-4197-8227	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDDK NIH HHS [R01 DK 34804] Funding Source: Medline; NINDS NIH HHS [R29 NS 051822] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2006, BIOCHEM BIOPH RES CO, V342, P573, DOI 10.1016/j.bbrc.2006.02.010; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hang LS, 2000, J NEUROCHEM, V75, P1852; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lui HM, 2003, MOL CANCER RES, V1, P508; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2006, J NEUROCHEM, V97, P1627, DOI 10.1111/j.1471-4159.2006.03985.x; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; QUITANA A, 2006, J BIOL CHEM, V281, P40302; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302	49	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32983	32990		10.1074/jbc.M705183200	http://dx.doi.org/10.1074/jbc.M705183200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17875645	hybrid			2022-12-27	WOS:000250625400047
J	Walden, CM; Sandhoff, R; Chuang, CC; Yildiz, Y; Butters, TD; Dwek, RA; Platt, FM; van der Spoel, AC				Walden, Charlotte M.; Sandhoff, Roger; Chuang, Chia-Chen; Yildiz, Yildiz; Butters, Terry D.; Dwek, Raymond A.; Platt, Frances M.; van der Spoel, Aarnoud C.			Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2 - Implications for spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYLATED IMINO SUGARS; ACID BETA-GLUCOSIDASE; N-BUTYLDEOXYNOJIRIMYCIN; NONLYSOSOMAL GLUCOSYLCERAMIDASE; GANGLIOSIDE BIOSYNTHESIS; MALE CONTRACEPTION; STORAGE DISEASE; MALE-FERTILITY; HUMAN LIVER; GERM-CELLS	One of the hallmarks of male germ cell development is the formation of a specialized secretory organelle, the acrosome. This process can be pharmacologically disturbed in C57BL/ 6 mice, and thus infertility can be induced, by small molecular sugar- like compounds ( alkylated imino sugars). Here the biochemical basis of this effect has been investigated. Our findings suggest that in vivo alkylated imino sugars primarily interact with the non- lysosomal glucosylceramidase. This enzyme cleaves glucosylceramide into glucose and ceramide, is sensitive to imino sugars in vitro, and has been characterized as beta- glucosidase 2 ( GBA2). Imino sugars raised the level of glucosylceramide in brain, spleen, and testis, in a dose- dependent fashion. In testis, multiple species of glucosylceramide were similarly elevated, those having long acyl chains ( C16 - 24), as well as those with very long polyunsaturated acyl chains ( C28 - 30: 5). Both of these GlcCer species were also increased in the testes from GBA2- deficient mice. When considering that the very long polyunsaturated sphingolipids are restricted to germ cells, these results indicate that in the testis GBA2 is present in both somatic and germ cells. Furthermore, in all mouse strains tested imino sugar treatment caused a rise in testicular glucosylceramide, even in a number of strains, of which the males remain fertile after drug administration. Therefore, it appears that acrosome formation can be derailed by accumulation of glucosylceramide in an extralysosomal localization, and that the sensitivity of male germ cells to glucosylceramide is genetically determined.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QU, England; German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; Univ Hosp Bonn, Dept Internal Med 1, D-53105 Bonn, Germany	University of Oxford; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn	van der Spoel, AC (corresponding author), Mansfield Rd, Oxford OX1 3QT, England.	aarnoud.vanderspoel@pharm.ox.ac.uk	Platt, Frances/G-1004-2010	Platt, Frances/0000-0001-7614-0403	NICHD NIH HHS [1U01 HD 45861] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045861] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CONZELMANN E, 1991, DEV NEUROSCI-BASEL, V13, P197, DOI 10.1159/000112160; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gunzer F, 2002, AM J CLIN PATHOL, V118, P364; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeyakumar M, 2002, NEUROBIOL DIS, V10, P201, DOI 10.1006/nbdi.2002.0511; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; MATERN H, 1992, FEBS LETT, V314, P183, DOI 10.1016/0014-5793(92)80970-R; Matern H, 2001, J BIOL CHEM, V276, P37929; Matern H, 1997, J BIOL CHEM, V272, P11261; Mellor HR, 2000, ANAL BIOCHEM, V284, P136, DOI 10.1006/abio.2000.4678; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Roy A, 2006, J CLIN INVEST, V116, P2860, DOI 10.1172/JCI30221; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Suganuma R, 2005, BIOL REPROD, V72, P805, DOI 10.1095/biolreprod.104.036053; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; van Meer G, 2003, PHILOS T ROY SOC B, V358, P869, DOI 10.1098/rstb.2003.1266; VANECHTEN G, 1989, J NEUROCHEM, V52, P207; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Walden CM, 2006, HUM REPROD, V21, P1309, DOI 10.1093/humrep/dei463; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	41	60	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					32655	32664		10.1074/jbc.M702387200	http://dx.doi.org/10.1074/jbc.M702387200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17848577	hybrid			2022-12-27	WOS:000250625400014
J	Keller, DM; McWeeney, S; Arsenlis, A; Drouin, J; Wright, CVE; Wang, H; Wollheim, CB; White, P; Kaestner, KH; Goodman, RH				Keller, David M.; McWeeney, Shannon; Arsenlis, Athanasios; Drouin, Jacques; Wright, Christopher V. E.; Wang, Haiyan; Wollheim, Claes B.; White, Peter; Kaestner, Klaus H.; Goodman, Richard H.			Characterization of pancreatic transcription factor pdx-1 binding sites using promoter Microarray and serial analysis of chromatin occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-PRODUCING CELLS; NUCLEAR FACTOR 3-BETA; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; REGULATORY REGION; BETA-CELLS; IN-VIVO; LIVER; DIFFERENTIATION; PROTEIN	The homeobox transcription factor Pdx-1 is necessary for pancreas organogenesis and beta cell function, however, most Pdx-1-regulated genes are unknown. To further the understanding of Pdx-1 in beta cell biology, we have characterized its genomic targets in NIT-1 cells, a mouse insulinoma cell line. To identify novel targets, we developed a microarray that includes traditional promoters as well as non-coding conserved elements, micro-RNAs, and elements identified through an unbiased approach termed serial analysis of chromatin occupancy. In total, 583 new Pdx-1 target genes were identified, many of which contribute to energy sensing and insulin release in pancreatic beta cells. By analyzing 31 of the protein-coding Pdx-1 target genes, we show that 29 are expressed in beta cells and, of these, 68% are down-or up-regulated in cells expressing a dominant negative mutant of Pdx-1. We additionally show that many Pdx-1 targets also interact with NeuroD1/BETA2, including the micro-RNA miR-375, a known regulator of insulin secretion.	Oregon Hlth & Sci Univ, Vollum Inst, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Div Biostat, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland; Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Oregon Health & Science University; Oregon Health & Science University; University of Pennsylvania; University of Pennsylvania; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Vanderbilt University; Roche Holding; University of Geneva	Keller, DM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Dept Publ Hlth & Prevent Med, 3181 S W Sam Jackson Pk Rd, Portland, OR 97239 USA.	kellerd@ohsu.edu	White, Peter/E-4301-2011	White, Peter/0000-0002-5218-5903; Drouin, Jacques/0000-0001-8226-5691	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056947, U01DK072477] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01-DK072477, U01-DK056947] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chae JH, 2004, MOL CELLS, V18, P271; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Friedman JR, 2004, P NATL ACAD SCI USA, V101, P12986, DOI 10.1073/pnas.0402875101; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kemp DM, 2003, REV ENDOCR METAB DIS, V4, P5, DOI 10.1023/A:1021809917576; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Miyatsuka T, 2003, BIOCHEM BIOPH RES CO, V310, P1017, DOI 10.1016/j.bbrc.2003.09.108; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P631, DOI 10.1016/j.bbrc.2004.04.071; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rozen S, 2000, Methods Mol Biol, V132, P365; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang XL, 1999, ENDOCRINOLOGY, V140, P4904, DOI 10.1210/en.140.10.4904; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100	64	85	90	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32084	32092		10.1074/jbc.M700899200	http://dx.doi.org/10.1074/jbc.M700899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17761679	hybrid, Green Published			2022-12-27	WOS:000250480300029
J	Shen, G; Balasubramanian, R; Wang, T; Wu, Y; Hoffart, LM; Krebs, C; Bryant, DA; Golbeck, JH				Shen, Gaozhong; Balasubramanian, Ramakrishnan; Wang, Tao; Wu, Yingxian; Hoffart, Lee M.; Krebs, Carsten; Bryant, Donald A.; Golbeck, John H.			SufR coordinates two [4Fe-4S](2+,1+) clusters and functions as a transcriptional repressor of the sufBCDS operon and an autoregulator of sufR in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; LIGAND 4FE-4S CLUSTER; SP STRAIN PCC-6803; FE-S PROTEINS; PHOTOSYSTEM-I; AZOTOBACTER-VINELANDII; SPECTROSCOPIC CHARACTERIZATION; DESULFOVIBRIO-AFRICANUS; ELECTRON-TRANSFER; 2FE-2S CLUSTERS	The sufR gene encodes a protein that functions as a transcriptional repressor of the suf regulon in cyanobacteria. It is predicted to contain an N- terminal helix loop helix DNA binding motif and a C- terminal Fe/S binding domain. Through immunoblotting assays of cell extracts, the sufR product in Synechocystis sp. PCC 6803 was shown to have a mass of similar to 25 kDa. This indicates that the second ATG in the open reading frame is the correct start codon and that sufR encodes a protein of 216 amino acids (SufR(216)) rather than the originally predicted 240 amino acids. Recombinant SufR(216) harbored [4Fe-4S](2+,1+) clusters, which were present in a mixture of S = 1/2 and 3/2 ground spin states, and the holoprotein was a homodimer, containing 3.7 of non- heme irons and 3.5 labile sulfides per monomer. Thus, two [4Fe-4S](2+,1+) clusters are coordinated by each SufR(216) homodimer. SufR(216) bound to two DNA sequences in the regulatory region between the divergently transcribed sufR gene and the sufBCDS operon, and its binding affinity depended on the presence and redox state of the [4Fe- 4S](2+,1+) clusters. A high affinity binding site, which controls sufBCDS expression, and a low affinity binding site, which controls sufR expression, were identified. The SufR binding sites, which are separated by 26 base pairs, each contain a perfect inverted repeat, CAAC- N6GTTG, and are highly conserved in cyanobacteria. The Fe/S protein SufR thus functions both as a transcriptional repressor of the sufBCDS operon and as an autoregulator of sufR.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Golbeck, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 3105 Frear Bldg, University Pk, PA 16802 USA.	jhg5@psu.edu	Balasubramanian, Ramakrishnan/C-7620-2011; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053				Antonkine ML, 2007, BBA-BIOENERGETICS, V1767, P712, DOI 10.1016/j.bbabio.2007.02.003; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Beinert H, 1978, Methods Enzymol, V54, P435; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Frazzon J, 2002, MET IONS BIOL SYST, V39, P163; Frazzon J, 2001, P NATL ACAD SCI USA, V98, P14751, DOI 10.1073/pnas.011579098; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; GOLBECK JH, 1978, ARCH BIOCHEM BIOPHYS, V188, P233, DOI 10.1016/S0003-9861(78)80005-8; Golbeck JH, 1999, PHOTOSYNTH RES, V61, P107, DOI 10.1023/A:1006281802710; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; KENNEDY MC, 1987, P NATL ACAD SCI USA, V84, P8854, DOI 10.1073/pnas.84.24.8854; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; LI N, 1991, BIOCHIM BIOPHYS ACTA, V1059, P215, DOI 10.1016/S0005-2728(05)80206-3; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MEHARI T, 1995, J BIOL CHEM, V270, P28108; Moore LJ, 2006, J BIOL CHEM, V281, P33268, DOI 10.1074/jbc.M608331200; Morimoto K, 2002, FEBS LETT, V519, P123, DOI 10.1016/S0014-5793(02)02736-9; NAKAI M, 2002, RECENT RES DEV PROTE, V1, P1; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seki A, 2006, FEBS LETT, V580, P5044, DOI 10.1016/j.febslet.2006.08.027; SHEN G, 2005, OXIDOREDUCTASE PHOTO, P529; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; VASSILIEV IR, 1995, BIOPHYS J, V69, P1544, DOI 10.1016/S0006-3495(95)80026-3; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; YU L, 1995, BIOCHEMISTRY-US, V34, P7861, DOI 10.1021/bi00024a010; YU LA, 1995, J BIOL CHEM, V270, P28118	44	62	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					31909	31919		10.1074/jbc.M705554200	http://dx.doi.org/10.1074/jbc.M705554200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17827500	hybrid			2022-12-27	WOS:000250480300011
J	Chandra, D; Choy, G; Tang, DG				Chandra, Dhyan; Choy, Grace; Tang, Dean G.			Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release - Evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; MEDIATED APOPTOSIS; HYDROXAMIC ACID; HEAT-SHOCK-PROTEIN-60; EXPRESSION; STRESS; DEATH; ACTIVATION	Most heat shock proteins (HSPs) have pro-survival functions. However, the role of HSP60, a mitochondrial matrix protein, is somewhat controversial with both pro-survival and pro-apoptotic functions reported. Here we show that in numerous apoptotic systems HSP60 protein accumulates in the cytosol. In BMD188-induced cell death, HSP60 accumulates in the cytosol with significant mitochondrial release. In contrast, in apoptosis induced by multiple other inducers, the cytosolic HSP60 accumulates without an apparent mitochondrial release. The short interfering RNA-mediated knockdown experiments revealed that in BMD188-induced apoptosis, HSP60 has a pro-death function and that the pro-death role of HSP60 seems to involve caspase-3 maturation and activation in the cytosol. In contrast, HSP60 appears to play a pro-survival role in other apoptotic systems where there is no apparent mitochondrial release as its knockdown promotes cell death. In these latter apoptotic systems HSP60 does not associate with active caspase-3. In both cases, HSP60 does not appreciably interact with Bax. Taken together, our results suggest the following: 1) cytosolic accumulation of HSP60 represents a common phenomenon during apoptosis induction; 2) cytosolic HSP60 accumulation during apoptosis occurs either with or without apparent mitochondrial release; and 3) the cytosolically accumulated HSP60 possesses either pro-survival or pro-death functions, which involves differential interactions with caspase-3.	Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA; Grad Sch Biomed Sci, PRogram Environm & Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Tang, DG (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, PO Box 389,1808 Pk Rd 1-C, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Chandra, Dhyan/0000-0001-7272-9384	NATIONAL CANCER INSTITUTE [K01CA123142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER; NCI NIH HHS [K012 CA123142] Funding Source: Medline; NIA NIH HHS [AG023374] Funding Source: Medline; NIEHS NIH HHS [ES15888, ES07784] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahn JH, 1999, MOL CELLS, V9, P200; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Castle PE, 2005, CANCER LETT, V229, P245, DOI 10.1016/j.canlet.2005.06.045; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chang AYW, 2006, J PHYSIOL-LONDON, V574, P547, DOI 10.1113/jphysiol.2006.110890; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cornford PA, 2000, CANCER RES, V60, P7099; Faried A, 2004, EUR J CANCER, V40, P2804, DOI 10.1016/j.ejca.2004.08.013; Hsu PL, 1998, CANCER RES, V58, P5507; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Joshi B, 1999, CANCER RES, V59, P4343; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Li L, 1999, ANTICANCER RES, V19, P51; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; MAILHOS C, 1993, NEUROSCIENCE, V55, P621, DOI 10.1016/0306-4522(93)90428-I; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nadin SB, 2003, CELL STRESS CHAPERON, V8, P361, DOI 10.1379/1466-1268(2003)008<0361:DADIBD>2.0.CO;2; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schneider J, 1999, ANTICANCER RES, V19, P2141; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Thomas X, 2005, LEUKEMIA RES, V29, P1049, DOI 10.1016/j.leukres.2005.02.010; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Zhang LX, 2004, EXP CELL RES, V292, P231, DOI 10.1016/j.yexcr.2003.08.012	40	181	190	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31289	31301		10.1074/jbc.M702777200	http://dx.doi.org/10.1074/jbc.M702777200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17823127	hybrid			2022-12-27	WOS:000250309200018
J	Cho, MH; Corea, ORA; Yang, H; Bedgar, DL; Laskar, DD; Anterola, AM; Moog-Anterola, FA; Hood, RL; Kohalmi, SE; Bernards, MA; Kang, C; Davin, LB; Lewis, NG				Cho, Man-Ho; Corea, Oliver R. A.; Yang, Hong; Bedgar, Diana L.; Laskar, Dhrubojyoti D.; Anterola, Aldwin M.; Moog-Anterola, Frances Anne; Hood, Rebecca L.; Kohalmi, Susanne E.; Bernards, Mark A.; Kang, ChulHee; Davin, Laurence B.; Lewis, Norman G.			Phenylalanine biosynthesis in Arabidopsis thaliana - Identification and characterization of arogenate dehydratases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; COLI P-PROTEIN; PREPHENATE DEHYDRATASE; ESCHERICHIA-COLI; SHIKIMATE PATHWAY; CYCLOHEXADIENYL DEHYDRATASE; CORYNEBACTERIUM-GLUTAMICUM; PHENYLPROPANOID METABOLISM; PSEUDOMONAS-AERUGINOSA; FEEDBACK INHIBITION	There is much uncertainty as to whether plants use arogenate, phenylpyruvate, or both as obligatory intermediates in Phe biosynthesis, an essential dietary amino acid for humans. This is because both prephenate and arogenate have been reported to undergo decarboxylative dehydration in plants via the action of either arogenate (ADT) or prephenate (PDT) dehydratases; however, neither enzyme(s) nor encoding gene(s) have been isolated and/or functionally characterized. An in silico data mining approach was thus undertaken to attempt to identify the dehydratase(s) involved in Phe formation in Arabidopsis, based on sequence similarity of PDT-like and ACT-like domains in bacteria. This data mining approach suggested that there are six PDT-like homologues in Arabidopsis, whose phylogenetic analyses separated them into three distinct subgroups. All six genes were cloned and subsequently established to be expressed in all tissues examined. Each was then expressed as a Nus fusion recombinant protein in Escherichia coli, with their substrate specificities measured in vitro. Three of the resulting recombinant proteins, encoded by ADT1 ( At1g11790), ADT2 (At3g07630), and ADT6 (At1g08250), more efficiently utilized arogenate than prephenate, whereas the remaining three, ADT3 (At2g27820), ADT4 (At3g44720), and ADT5 (At5g22630) essentially only employed arogenate. ADT1, ADT2, and ADT6 had k(cat)/K-m values of 1050, 7650, and 1560 M-1 s(-1) for arogenate versus 38, 240, and 16 M-1 s(-1) for prephenate, respectively. By contrast, the remaining three, ADT3, ADT4, and ADT5, had kcat/Km values of 1140, 490, and 620 M-1 s(-1), with prephenate not serving as a substrate unless excess recombinant protein (> 150 mu g/assay) was used. All six genes, and their corresponding proteins, are thus provisionally classified as arogenate dehydratases and designated ADT1-ADT6.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Western University (University of Western Ontario); Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu	Yang, Hong/C-2333-2012	Kang, ChulHee/0000-0002-0693-7860; Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066173] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66173] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; BERRY A, 1987, J GEN MICROBIOL, V133, P2147; BONNER CA, 1985, ARCH BIOCHEM BIOPHYS, V238, P237, DOI 10.1016/0003-9861(85)90161-4; BONNER CA, 1995, PLANT CELL PHYSIOL, V36, P1013, DOI 10.1093/oxfordjournals.pcp.a078843; BYNG GS, 1983, ARCH MICROBIOL, V136, P163, DOI 10.1007/BF00409838; BYNG GS, 1981, MOL CELL BIOL, V1, P426, DOI 10.1128/MCB.1.5.426; Chan MS, 1996, BIOCHEM BIOPH RES CO, V219, P537, DOI 10.1006/bbrc.1996.0269; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cochrane FC, 2004, PHYTOCHEMISTRY, V65, P1557, DOI 10.1016/j.phytochem.2004.05.006; COTTON R. G. H., 1968, BIOCHIM BIOPHYS ACTA, V156, P187, DOI 10.1016/0304-4165(68)90118-9; DAVIN LB, 2008, LIGNOCELLULOSE RECAL; DIXON RA, 1999, COMPREHENSIVE NATURA, V1, P713; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Ermolova NV, 2003, PROTEIN EXPRES PURIF, V29, P123, DOI 10.1016/S1046-5928(03)00014-7; FISCHER RS, 1993, ARCH MICROBIOL, V160, P440, DOI 10.1007/BF00245304; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Griesbach RJ, 2005, PL BRED RE, V25, P89; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HERRMANN KM, 1995, PLANT CELL, V7, P907; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hsu SK, 2004, ARCH MICROBIOL, V181, P237, DOI 10.1007/s00203-004-0649-5; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; JENSEN RA, 1977, J BACTERIOL, V132, P896, DOI 10.1128/JB.132.3.896-903.1977; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; Kleeb AC, 2006, BIOCHEMISTRY-US, V45, P14101, DOI 10.1021/bi061274n; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; Lewis N. G., 1999, COMPREHENSIVE NATURA, V1, P639, DOI DOI 10.1016/B978-0-08-091283-7.00027-8; Lewis N.G., 1999, COMPR NAT PROD CHEM, V3, P617, DOI [10.1016/B978-0-08-091283-7.00085-0, DOI 10.1016/B978-0-08-091283-7.00085-0]; Li MC, 2006, J BIOTECHNOL, V122, P334, DOI 10.1016/j.jbiotec.2005.11.019; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; LUDWIG SR, 1987, P NATL ACAD SCI USA, V84, P5833, DOI 10.1073/pnas.84.16.5833; PATEL N, 1977, J BIOL CHEM, V252, P5839; Pohnert G, 1999, BIOCHEMISTRY-US, V38, P12212, DOI 10.1021/bi991134w; Prakash P, 2005, J BIOL CHEM, V280, P20666, DOI 10.1074/jbc.M502107200; RAZAL RA, 1994, PHYTOCHEM ANALYSIS, V5, P98, DOI 10.1002/pca.2800050303; Razal RA, 1996, PHYTOCHEMISTRY, V41, P31, DOI 10.1016/0031-9422(95)00628-1; SCHMID J, 1995, PHYTOCHEMISTRY, V39, P737, DOI 10.1016/0031-9422(94)00962-S; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Singh S, 1998, J PLANT PHYSIOL, V153, P316, DOI 10.1016/S0176-1617(98)80157-0; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Turner P, 2005, PROTEIN EXPRES PURIF, V39, P54, DOI 10.1016/j.pep.2004.09.012; Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WHITAKER RJ, 1981, J BACTERIOL, V147, P526, DOI 10.1128/JB.147.2.526-534.1981; XIA TH, 1991, ARCH BIOCHEM BIOPHYS, V286, P461, DOI 10.1016/0003-9861(91)90066-R; ZAMIR LO, 1983, TETRAHEDRON LETT, V24, P2815, DOI 10.1016/S0040-4039(00)88031-4; ZAMIR LO, 1980, J AM CHEM SOC, V102, P4499, DOI 10.1021/ja00533a032; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248; Zhang S, 2000, BIOCHEMISTRY-US, V39, P4722, DOI 10.1021/bi9926680; ZHAO GS, 1992, J BIOL CHEM, V267, P2487	53	83	96	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30827	30835		10.1074/jbc.M702662200	http://dx.doi.org/10.1074/jbc.M702662200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726025	hybrid			2022-12-27	WOS:000250136300051
J	Lipson, RS; Clarke, SG				Lipson, Rebecca S.; Clarke, Steven G.			S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITORS; RAT-LIVER MICROSOMES; HUMAN CYTOCHROME-P450; IRREVERSIBLE BINDING; SIGNAL-TRANSDUCTION; ADDUCT FORMATION; IN-VITRO; CELLS; METABOLISM; MECHANISM	It has previously been shown that incubation of mammalian cell cytosolic extracts with the protein kinase inhibitor tyrphostin A25 results in enhanced transfer of methyl groups from S-adenosyl-[methyl-H-3] methionine to proteins. These findings were interpreted as demonstrating tyrphostin stimulation of a novel type of protein carboxyl methyltransferase. We find here, however, that tyrphostin A25 addition to mouse heart cytosol incubated with S-adenosyl-[methyl-H-3] methionine or S-adenosyl-[methyl-C-14] methionine stimulates the labeling of small molecules in addition to proteins. Base treatment of both protein and small molecule fractions releases volatile radioactivity, suggesting labile ester-like linkages of the labeled methyl group. Production of both the base-volatile product and labeled protein occurs with tyrphostins A25, A47, and A51, but not with thirteen other tyrphostin family members. These active tyrphostins all contain a catechol moiety and are good substrates for recombinant and endogenous catechol-O-methyltransferase. Inhibition of catechol-O-methyltransferase activity with tyrphostin AG1288 prevents both base-volatile product formation and protein labeling from methyl-labeled S-adenosylmethionine in heart, kidney, and liver, but not in testes or brain extracts. These results suggest that the incorporation of methyl groups into protein follows a complex pathway initiated by the methylation of select tyrphostins by endogenous catechol-O-methyltransferase. We suggest that the methylated tyrphostins are further modified in the cell extract and covalently attached to cellular proteins. The presence of endogenous catechols in cells suggests that similar reactions can also occur in vivo.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E,Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM026020, GM07185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bilodeau D, 1999, CELL SIGNAL, V11, P45, DOI 10.1016/S0898-6568(98)00030-8; BINDOLI A, 1992, FREE RADICAL BIO MED, V13, P391, DOI 10.1016/0891-5849(92)90182-G; Blackledge G, 2003, J UROLOGY, V170, pS77, DOI 10.1097/01.ju.0000095022.80033.d3; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; BOLT HM, 1974, J STEROID BIOCHEM, V5, P179, DOI 10.1016/0022-4731(74)90126-5; CADET JL, 1994, NEUROSCI BIOBEHAV R, V18, P457, DOI 10.1016/0149-7634(94)90001-9; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; Cuttle L, 2000, DRUG METAB DISPOS, V28, P945; GOTTLIEB AJ, 1974, BLOOD, V43, P85, DOI 10.1182/blood.V43.1.85.85; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Jaleel M, 2004, BIOCHEMISTRY-US, V43, P8247, DOI 10.1021/bi036234n; Lautala P, 2001, MOL PHARMACOL, V59, P393, DOI 10.1124/mol.59.2.393; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levitzki A, 2003, ACCOUNTS CHEM RES, V36, P462, DOI 10.1021/ar0201207; LEVITZKI A, 1992, FASEB J, V6, P3275, DOI 10.1096/fasebj.6.14.1426765; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; LIBERATO DJ, 1981, J MED CHEM, V24, P28, DOI 10.1021/jm00133a007; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; MAYER W, 1960, CHEM BER-RECL, V93, P2761, DOI 10.1002/cber.19600931203; Miranda TB, 2004, FEBS LETT, V577, P181, DOI 10.1016/j.febslet.2004.09.080; MONTINE TJ, 1995, J NEUROPATH EXP NEUR, V54, P311, DOI 10.1097/00005072-199505000-00004; Munns AJ, 1997, CHEM RES TOXICOL, V10, P1049, DOI 10.1021/tx9700836; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; RAMDAS L, 1995, ARCH BIOCHEM BIOPHYS, V323, P237, DOI 10.1006/abbi.1995.9969; Sagara Y, 2002, J BIOL CHEM, V277, P36204, DOI 10.1074/jbc.M203895200; SCHEULEN M, 1975, BIOCHEM BIOPH RES CO, V66, P1396, DOI 10.1016/0006-291X(75)90514-8; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; STOCK JB, 1992, J BIOL CHEM, V267, P19753; Svensson AW, 2006, METHOD ENZYMOL, V407, P144, DOI 10.1016/S0076-6879(05)07013-8; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008; WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Werner P, 2001, BRAIN RES, V893, P278, DOI 10.1016/S0006-8993(00)03298-4; WOLBRING G, 1994, J BIOL CHEM, V269, P22470; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu BT, 2004, INT J MOL MED, V13, P343; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	47	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					31094	31102		10.1074/jbc.M705456200	http://dx.doi.org/10.1074/jbc.M705456200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724020	hybrid			2022-12-27	WOS:000250136300077
J	Fresquet, M; Jowitt, TA; Ylostalo, J; Coffey, P; Meadows, RS; Ala-Kokko, L; Thornton, DJ; Briggs, MD				Fresquet, Maryline; Jowitt, Thomas A.; Yloestalo, Joni; Coffey, Paul; Meadows, Roger S.; Ala-Kokko, Leena; Thornton, David J.; Briggs, Michael D.			Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; OLIGOMERIC MATRIX PROTEIN; DUAL-POLARIZATION INTERFEROMETRY; VON-WILLEBRAND-FACTOR; COLLAGEN-IX; EXTRACELLULAR-MATRIX; ANALYTICAL ULTRACENTRIFUGATION; CONFORMATIONAL-CHANGES; FACTOR-B; CARTILAGE	Mutations in matrilin-3 result in multiple epiphyseal dysplasia, which is characterized by delayed and irregular bone growth and early onset osteoarthritis. The majority of disease-causing mutations are located within the beta-sheet of the single A-domain of matrilin-3, suggesting that they disrupt the structure and/or function of this important domain. Indeed, the expression of mutant matrilin-3 results in its intracellular retention within the rough endoplasmic reticulum of cells, where it elicits an unfolded protein response. To understand the folding characteristics of the matrilin-3 A-domain we determined its structure using CD, analytical ultracentrifugation, and dual polarization interferometry. This study defined novel structural features of the matrilin-3 A-domain and identified a conformational change induced by the presence or the absence of Zn2+. In the presence of Zn2+ the A-domain adopts a more stable "tighter" conformation. However, after the removal of Zn2+ a potential structural rearrangement of the metal ion-dependent adhesion site motif occurs, which leads to a more "relaxed" conformation. Finally, to characterize the interactions of the matrilin-3 A-domain we performed binding studies on a BIAcore using type II and IX collagen and cartilage oligomeric matrix protein. We were able to demonstrate that it binds to type II and IX collagen and cartilage oligomeric matrix protein in a Zn2+ -dependent manner. Furthermore, we have also determined that the matrilin-3 A-domain appears to bind exclusively to the COL3 domain of type IX collagen and that this binding is abolished in the presence of a disease causing mutation in type IX collagen.	Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Tulane Univ, Ctr Gene Therapy, New Orleans, LA 70118 USA; Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; Univ Oulu, Dept Med Biochem & Mol Biol, Collagen Res Unit, FIN-90014 Oulu, Finland; Connect Tissue Gene Tests, Allentown, PA 18103 USA	University of Manchester; Tulane University; University of Manchester; University of Oulu	Briggs, MD (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg, Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.briggs@manchester.ac.uk	Ylostalo, Joni/AAH-9457-2019	Ylostalo, Joni/0000-0001-9746-1994; Thornton, David/0000-0001-7148-1970; Fresquet, Maryline/0000-0001-9530-6392; Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust [071161] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Karim K, 2007, ANAL CHEM, V79, P3023, DOI 10.1021/ac051254b; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kennedy Jason, 2005, Hum Mutat, V25, P593, DOI 10.1002/humu.9342; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Ko YP, 2005, BIOCHEM J, V386, P367, DOI 10.1042/BJ20041486; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LEIGHTON MP, 2007, HUM MOL GENET; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Otten C, 2005, J MED GENET, V42, P774, DOI 10.1136/jmg.2004.029462; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Ricard-Blum S, 2006, ANAL BIOCHEM, V352, P252, DOI 10.1016/j.ab.2006.02.011; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shen ZX, 1995, MATRIX BIOL, V14, P773, DOI 10.1016/S0945-053X(05)80020-4; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Thompsett AR, 2007, BBA-PROTEINS PROTEOM, V1774, P920, DOI 10.1016/j.bbapap.2007.05.007; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WU J, 2004, DEP ORTHOPAEDICS SPO, P35	48	36	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34634	34643		10.1074/jbc.M705301200	http://dx.doi.org/10.1074/jbc.M705301200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17881354	hybrid, Green Accepted			2022-12-27	WOS:000251155200005
J	Srivastava, AK; Qin, XZ; Wedhas, N; Arnush, M; Linkhart, TA; Chadwick, RB; Kumar, A				Srivastava, Apurva K.; Qin, Xuezhong; Wedhas, Nia; Arnush, Marc; Linkhart, Thomas A.; Chadwick, Robert B.; Kumar, Ashok			Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1(TAK1)-dependent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; MATRIX METALLOPROTEINASES; INFLAMMATORY MYOPATHIES; TRANSCRIPTION FACTOR; TNF-ALPHA; MEDIATED ACTIVATION; MMP-9 EXPRESSION; GENE-EXPRESSION; HEART-FAILURE	We have investigated the effect of tumor necrosis factor-alpha (TNF-alpha) on the production of extracellular matrix-degrading proteases in skeletal muscles. Using microarray, quantitative PCR, Western blotting, and zymography, we found that TNF-alpha drastically increases the production of matrix metalloproteinase (MMP)-9 from C2C12 myotubes. In vivo administration of TNF-alpha in mice increased the transcript level of MMP-9 in skeletal muscle tissues. Although TNF-alpha activated all the three MAPKs (i.e. ERK1/2, JNK, and p38), inhibition of ERK1/2 or p38 but not JNK blunted the TNF-alpha-induced production of MMP-9 from myotubes. Inhibition of Akt also inhibited the TNF-alpha-induced production of MMP-9. TNF-alpha increased the activation of transcription factors NF-kappa B and AP-1 but not SP-1 in myotubes. Overexpression of a dominant negative inhibitor of NF-kappa B or AP-1 blocked the TNF-alpha-induced expression of MMP-9 in myotubes. Similarly, point mutations in AP-1- or NF-kappa B-binding sites in MMP-9 promoter inhibited the TNF-alpha-induced expression of a reporter gene. TNF-alpha increased the activity of transforming growth factor-beta-activating kinase-1 (TAK1). Furthermore, overexpression of a dominant negative mutant of TAK1 blocked the TNF-alpha-induced expression of MMP-9 and activation of NF-kappa B and AP-1. Our results also suggest that TNF-alpha induces MMP-9 expression in muscle cells through the recruitment of TRAF-2, Fas-associated protein with death domain, and TNF receptor-associated protein with death domain but not NIK or TRAF-6 proteins. We conclude that TAK1-mediated pathways are involved in TNF-alpha-induced MMP-9 production in skeletal muscle cells.	Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; Jerry L Pettis Mem Vet Adm Med Ctr, Loma Linda, CA 92357 USA; Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA	University of Louisville; Loma Linda University	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 S Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0002-2444-9529; Kumar, Ashok/0000-0001-8571-2848	NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG029623, R01 AG029623-01, R01 AG129623] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Behren A, 2005, CANCER RES, V65, P11613, DOI 10.1158/0008-5472.CAN-05-2672; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Carvalho RF, 2006, INT J EXP PATHOL, V87, P437, DOI 10.1111/j.1365-2613.2006.00497.x; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Choi YC, 2000, NEUROLOGY, V54, P65, DOI 10.1212/WNL.54.1.65; Cohen M, 2006, MOL HUM REPROD, V12, P225, DOI 10.1093/molehr/gal023; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Giannelli G, 2005, HISTOL HISTOPATHOL, V20, P99, DOI 10.14670/HH-20.99; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kieseier BC, 2001, BRAIN, V124, P341, DOI 10.1093/brain/124.2.341; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 1999, FEBS LETT, V462, P140, DOI 10.1016/S0014-5793(99)01487-8; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lewis MP, 2000, J MUSCLE RES CELL M, V21, P223, DOI 10.1023/A:1005670507906; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matthews CP, 2007, CANCER RES, V67, P2430, DOI 10.1158/0008-5472.CAN-06-0522; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Reznick AZ, 2003, MUSCLE NERVE, V27, P51, DOI 10.1002/mus.10277; Roach DM, 2002, EUR J VASC ENDOVASC, V23, P260, DOI 10.1053/ejvs.2002.1598; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; SATO H, 1993, J BIOL CHEM, V268, P23460; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schoser BGH, 2002, ACTA NEUROL SCAND, V105, P309, DOI 10.1034/j.1600-0404.2002.1o104.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Thorud HMS, 2005, AM J PHYSIOL-REG I, V289, pR389, DOI 10.1152/ajpregu.00067.2005; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	65	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35113	35124		10.1074/jbc.M705329200	http://dx.doi.org/10.1074/jbc.M705329200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897957	hybrid, Green Accepted			2022-12-27	WOS:000251155200056
J	Yeo, HJ; Beck, LH; Thompson, SR; Farach-Carson, MC; McDonald, JM; Clemens, TL; Zayzafoon, M				Yeo, Hyeonju; Beck, Lauren H.; Thompson, Sunnie R.; Farach-Carson, Mary C.; McDonald, Jay M.; Clemens, Thomas L.; Zayzafoon, Majd			Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; NUCLEAR FACTOR; NFAT; DIFFERENTIATION; CELLS; CALMODULIN; GROWTH; OSTEOCLASTOGENESIS; EXPRESSION; CALCIUM	We recently reported that the pharmacological inhibition of calcineurin (Cn) by low concentrations of cyclosporin A increases osteoblast differentiation in vitro and bone mass in vivo. To determine whether Cn exerts direct actions in osteoblasts, we generated mice lacking Cnb1 ( Cn regulatory subunit) in osteoblasts (Delta Cnb1(OB)) using Cre-mediated recombination methods. Transgenic mice expressing Cre recombinase, driven by the human osteocalcin promoter, were crossed with homozygous mice that express loxP-flanked Cnb1 (Cnb1(f/f)). Microcomputed tomography analysis of tibiae at 3 months showed that Delta Cnb1(OB) mice had dramatic increases in bone mass compared with controls. Histomorphometric analyses showed significant increases in mineral apposition rate (67%), bone volume (32%), trabecular thickness (29%), and osteoblast numbers (68%) as well as a 40% decrease in osteoclast numbers as compared with the values from control mice. To delete Cnb1 in vitro, primary calvarial osteoblasts, harvested from Cnb1(f/f) mice, were infected with adenovirus expressing the Cre recombinase. Cre-expressing osteoblasts had a complete inhibition of Cnb1 protein levels but differentiated and mineralized more rapidly than control, green fluorescent protein-expressing cells. Deletion of Cnb1 increased expression of osteoprotegerin and decreased expression of RANKL. Co-culturing Cnb1-deficient osteoblasts with wild type osteoclasts demonstrated that osteoblasts lacking Cnb1 failed to support osteoclast differentiation in vitro. Taken together, our findings demonstrate that the inhibition of Cnb1 in osteoblasts increases bone mass by directly increasing osteoblast differentiation and indirectly decreasing osteoclastogenesis.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Delaware	Zayzafoon, M (corresponding author), Univ Alabama Birmingham, Dept Pathol, 813 Shelby Biomed Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.	mzayzafo@uab.edu		Thompson, Sunnie/0000-0002-7338-8822; Farach-Carson, Mary/0000-0002-4526-3088	NCI NIH HHS [CA109119, P01-CA098912] Funding Source: Medline; NIAMS NIH HHS [R01-AR053898, AR050235] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA109119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050235, R01AR053898] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shin CS, 2005, J BONE MINER RES, V20, P2200, DOI 10.1359/JBMR.050809; Sullivan KMC, 2002, GENETICS, V161, P183; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zayzafoon M, 2004, J BIOL CHEM, V279, P3662, DOI 10.1074/jbc.M308158200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212	39	37	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35318	35327		10.1074/jbc.M702435200	http://dx.doi.org/10.1074/jbc.M702435200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17884821	hybrid			2022-12-27	WOS:000251155200075
J	Ambasta, RK; Ai, XB; Emerson, CP				Ambasta, Rashmi K.; Ai, Xingbin; Emerson, Charles P., Jr.			Quail sulf1 function requires asparagine-linked glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; BREAST-CANCER; TUNICAMYCIN; EXPRESSION; PROTEIN; CELLS	The heparan sulfate endosulfatases Sulf1 and Sulf2 are cellsurface enzymes that control growth factor signaling through regulation of the 6-O-sulfation states of cell-surface and matrix heparan sulfate proteoglycans. Here, we report that quail Sulf1 (QSulf1) is an asparagine-linked glycosylated protein. Domain mapping studies in combination with a protein glycosylation prediction program identified multiple asparagine-linked glycosylation sites in the enzymatic and C-terminal domains. Glycosylation inhibitor studies revealed that glycosylation of QSulf1 is essential for its enzymatic activity, membrane targeting, and secretion. Furthermore, N-glycanase cleavage of asparagine-linked sites in native QSulf1 provided direct evidence that these N-linked glycosylation sites are specifically required for QSulf1 heparin binding and its 6-O-desulfation activity, revealing that N-linked glycosylation has a key role in the control of sulfatase enzymatic function.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Emerson, CP (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	emersonc@bbri.org	Ambasta, Rashmi/K-8611-2019	Ai, Xingbin/0000-0002-2178-0080				Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Berger SB, 2006, IMMUNOLOGY, V119, P178, DOI 10.1111/j.1365-2567.2006.02419.x; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Branza-Nichita N, 2004, BIOCHEM BIOPH RES CO, V319, P655, DOI 10.1016/j.bbrc.2004.05.039; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; GIRAUD A, 1989, EUR J CELL BIOL, V48, P128; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Trombetta ES, 2002, ADV PROTEIN CHEM, V59, P303	20	22	22	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34492	34499		10.1074/jbc.M706744200	http://dx.doi.org/10.1074/jbc.M706744200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17855356	hybrid			2022-12-27	WOS:000251145700064
J	Cooper, WC; Jin, Y; Penning, TM				Cooper, William C.; Jin, Yi; Penning, Trevor M.			Elucidation of a complete kinetic mechanism for a mammalian hydroxysteroid dehydrogenase (HSD) and identification of all enzyme forms on the reaction coordinate - The example of rat liver 3 alpha-HSD (AKR1C9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; NICOTINAMIDE-ADENINE DINUCLEOTIDE; KETO REDUCTASE SUPERFAMILY; PRE-RECEPTOR REGULATION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; BINDING-SITE; CRYSTAL-STRUCTURE; REDOX STATE; INTERCONVERSION; METABOLISM	Hydroxysteroid dehydrogenases (HSDs) are essential for the biosynthesis and mechanism of action of all steroid hormones. We report the complete kinetic mechanism of a mammalian HSD using rat 3 alpha-HSD of the aldo-keto reductase superfamily (AKR1C9) with the substrate pairs androstane-3,17-dione and NADPH( reduction) and androsterone and NADP(+) ( oxidation). Steady-state, transient state kinetics, and kinetic isotope effects reconciled the ordered bi-bi mechanism, which contained 9 enzyme forms and permitted the estimation of 16 kinetic constants. In both reactions, loose association of the NADP( H) was followed by two conformational changes, which increased cofactor affinity by>86-fold. For androstane-3,17-dione reduction, the release of NADP(+) controlled k(cat), whereas the chemical event also contributed to this term. kcat was insensitive to [H-2]NADPH, whereas (D)k(cat)/K-m and the (D)k(lim) (ratio of the maximum rates of single turnover) were 1.06 and 2.06, respectively. Under multiple turnover conditions partial burst kinetics were observed. For androsterone oxidation, the rate of NADPH release dominated kcat, whereas the rates of the chemical event and the release of androstane-3,17-dione were 50-fold greater. Under multiple turnover conditions full burst kinetics were observed. Although the internal equilibrium constant favored oxidation, the overall K-eq favored reduction. The kinetic Haldane and free energy diagram confirmed that Keq was governed by ligand binding terms that favored the reduction reactants. Thus, HSDs in the aldo-keto reductase superfamily thermodynamically favor ketosteroid reduction.	Univ Penn, Dept Pharmacol, Ctr Excellence Environm Toxicol, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Ctr Excellence Environm Toxicol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@pharm.med.upenn.edu		Penning, Trevor/0000-0002-3937-1066	NIDDK NIH HHS [R01-DK47015, R01 DK047015] Funding Source: Medline; NIEHS NIH HHS [P30 ES013508] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASKONAS LJ, 1991, BIOCHEM J, V278, P835, DOI 10.1042/bj2780835; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; Heredia VV, 2004, BIOCHEMISTRY-US, V43, P12028, DOI 10.1021/bi0489762; Heredia VV, 2004, BIOCHEMISTRY-US, V43, P5832, DOI 10.1021/bi0499563; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1996, J BIOL CHEM, V271, P30190, DOI 10.1074/jbc.271.47.30190; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Liden M, 2003, MOL ASPECTS MED, V24, P403, DOI 10.1016/S0098-2997(03)00036-0; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; Papari-Zareei M, 2006, ENDOCRINOLOGY, V147, P1591, DOI 10.1210/en.2005-1141; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Penning TM, 2007, MOL CELL ENDOCRINOL, V265, P77, DOI 10.1016/j.mce.2006.12.007; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; RICIGLIANO JW, 1990, BIOCHEM J, V269, P749, DOI 10.1042/bj2690749; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; SEGEL IH, 1993, ENZYME KINETICS BEHA, P574; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; TALALAY P, 1959, CIBA FDN STUDY GROUP, P64; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514	40	45	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33484	10.1074/jbc.M703414200	http://dx.doi.org/10.1074/jbc.M703414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848571	hybrid			2022-12-27	WOS:000250840200029
J	Corbett, D; Bennett, HJ; Askar, H; Green, J; Roberts, IS				Corbett, David; Bennett, Hayley J.; Askar, Hamdia; Green, Jeffrey; Roberts, Ian S.			SlyA and H-NS regulate transcription of the Escherichia coli K5 capsule gene cluster, and expression of slyA in Escherichia coli is temperature-dependent, positively autoregulated, and independent of H-NS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-PSEUDOTUBERCULOSIS; SALMONELLA-TYPHIMURIUM; GLOBAL REGULATOR; STPA PROTEINS; DNA; VIRULENCE; ROVA; ORGANIZATION; RESISTANCE; BINDING	In this paper, we present the first evidence of a role for the transcriptional regulator SlyA in the regulation of transcription of the Escherichia coli K5 capsule gene cluster and demonstrate, using a combination of reporter gene fusions, DNase I footprinting, and electrophoretic mobility shift assays, the dependence of transcription on the functional interplay between H-NS and SlyA. Both SlyA and H-NS bind to multiple overlapping sites within the promoter in vitro, but their binding is not mutually exclusive, resulting in a remodeled nucleoprotein complex. In addition, we show that expression of the E. coli slyA gene is temperature-regulated, positively autoregulated, and independent of H-NS.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Mansoura, Fac Med, Dept Med Microbiol & Immunol, Mansoura, Egypt; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Manchester; Egyptian Knowledge Bank (EKB); Mansoura University; University of Sheffield	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	i.s.roberts@manchester.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Afflerbach H, 1999, J MOL BIOL, V286, P339, DOI 10.1006/jmbi.1998.2494; Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Donato GM, 1998, J BIOL CHEM, V273, P24030, DOI 10.1074/jbc.273.37.24030; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 1999, TRENDS MICROBIOL, V7, P124, DOI 10.1016/S0966-842X(99)01455-9; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Johansson J, 1998, J BACTERIOL, V180, P6117; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; Ludwig A, 1995, MOL GEN GENET, V249, P474, DOI 10.1007/BF00290573; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Maxam A M, 1980, Methods Enzymol, V65, P499; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Miller J. H, 1972, EXPT MOL GENETICS; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Pul U, 2005, MOL MICROBIOL, V58, P864, DOI 10.1111/j.1365-2958.2005.04873.x; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Schroder O, 2002, BIOL CHEM, V383, P945, DOI 10.1515/BC.2002.101; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Simpson DA, 1996, J BACTERIOL, V178, P6466, DOI 10.1128/jb.178.22.6466-6474.1996; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Starcic-Erjavec M, 2003, MOL GENET GENOMICS, V270, P94, DOI 10.1007/s00438-003-0908-1; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; STEVENS MP, 1994, FEMS MICROBIOL LETT, V124, P93, DOI 10.1111/j.1574-6968.1994.tb07267.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Williams RM, 1996, J BACTERIOL, V178, P4335, DOI 10.1128/jb.178.15.4335-4343.1996; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004	49	46	49	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33326	33335		10.1074/jbc.M703465200	http://dx.doi.org/10.1074/jbc.M703465200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17827501	hybrid			2022-12-27	WOS:000250840200012
J	Min, L; Leung, YM; Tomas, A; Watson, RT; Gaisano, HY; Halban, PA; Pessin, JE; Hou, JC				Min, Le; Leung, Yuk M.; Tomas, Alejandra; Watson, Robert T.; Gaisano, Herbert Y.; Halban, Philippe A.; Pessin, Jeffrey E.; Hou, June Chunqiu			Dynamin is functionally coupled to insulin granule exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANS-GOLGI NETWORK; SECRETORY GRANULES; COMPOUND EXOCYTOSIS; FLUORESCENT PROTEIN; SYNAPTOTAGMIN III; CA2+ CHANNELS; MEMBRANE; FUSION; SINGLE	The insulin granule integral membrane protein marker phogrin-green fluorescent protein was co-localized with insulin in Min6B1 beta-cell secretory granules but did not undergo plasma membrane translocation following glucose stimulation. Surprisingly, although expression of a dominant-interfering dynamin mutant (Dyn/K44A) inhibited transferrin receptor endocytosis, it had no effect on phogrin-green fluorescent protein localization in the basal or secretagogue-stimulated state. By contrast, co-expression of Dyn/ K44A with human growth hormone as an insulin secretory marker resulted in a marked inhibition of human growth hormone release by glucose, KCl, and a combination of multiple secretagogues. Moreover, serial pulse depolarization stimulated an increase in cell surface capacitance that was also blocked in cells expressing Dyn/ K44A. Similarly, small interference RNA-mediated knockdown of dynamin resulted in marked inhibition of glucose-stimulated insulin secretion. Together, these data suggest the presence of a selective kiss and run mechanism of insulin release. Moreover, these data indicate a coupling between endocytosis and exocytosis in the regulation of beta-cell insulin secretion.	SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; W China Univ Med Sci, Dept Physiol, Taichung 404, Taiwan; Ctr Med Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University of Toronto; University of Geneva	Hou, JC (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST8-140, Stony Brook, NY 11794 USA.	Hou@pharm.stonybrook.edu		Tomas, Alejandra/0000-0002-2290-8453	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R01DK055811, R37DK033823] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33823, DK55811] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Bokvist K, 2000, PFLUG ARCH EUR J PHY, V439, P634, DOI 10.1007/s004240050987; Brown H, 2000, DIABETES, V49, P383, DOI 10.2337/diabetes.49.3.383; Cheviet S, 2004, MOL ENDOCRINOL, V18, P117, DOI 10.1210/me.2003-0300; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Leung YM, 2002, BIOCHEM BIOPH RES CO, V292, P980, DOI 10.1006/bbrc.2002.6712; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Ma L, 2004, P NATL ACAD SCI USA, V101, P9266, DOI 10.1073/pnas.0403201101; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mizuta M, 1997, DIABETES, V46, P2002, DOI 10.2337/diabetes.46.12.2002; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Ohara-Imaizumi M, 2004, DIABETOLOGIA, V47, P2200, DOI 10.1007/s00125-004-1579-0; Ohara-Imaizumi M, 2002, BIOCHEM J, V363, P73, DOI 10.1042/0264-6021:3630073; ORCI L, 1980, DIABETES, V29, P943, DOI 10.2337/diab.29.11.943; ORCI L, 1973, SCIENCE, V179, P82, DOI 10.1126/science.179.4068.82; PROCINO G, 2005, AM J PHYSIOL, V290, pF985; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Tsuboi T, 2002, J BIOL CHEM, V277, P15957, DOI 10.1074/jbc.C200051200; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	41	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33530	33536		10.1074/jbc.M703402200	http://dx.doi.org/10.1074/jbc.M703402200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848579	hybrid, Green Published			2022-12-27	WOS:000250840200033
J	Townsend, M; Mehta, T; Selkoe, DJ				Townsend, Matthew; Mehta, Tapan; Selkoe, Dennis J.			Soluble A beta inhibits specific signal transduction cascades common to the insulin receptor pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; AMP RESPONSE ELEMENT; ALZHEIMERS-DISEASE; CALMODULIN-BINDING; NATURAL OLIGOMERS; NMDA RECEPTORS; MOUSE MODEL	Numerous studies have now shown that the amyloid beta-protein (A beta),the principal component of cerebral plaques in Alzheimer disease, rapidly and potently inhibits certain forms of synaptic plasticity. The amyloid (or A beta) hypothesis proposes that the continuous disruption of normal synaptic physiology by A beta contributes to the development of Alzheimer disease. However, there is little consensus about how A beta mediates this inhibition at the molecular level. Using mouse primary hippocampal neurons, we observed that a brief treatment with cell-derived, soluble, human A beta disrupted the activation of three kinases (Erk/MAPK, CaMKII, and the phosphatidylinositol 3-kinase-activated protein Akt/protein kinase B) that are required for long term potentiation, whereas two other kinases (protein kinase A and protein kinase C) were stimulated normally. An antagonist of the insulin receptor family of tyrosine kinases was found to mimic the pattern of A beta-mediated kinase inhibition. We then found that soluble A beta binds to the insulin receptor and interferes with its insulin-induced autophosphorylation. Taken together, these data demonstrate that physiologically relevant levels of naturally secreted A beta interfere with insulin receptor function in hippocampal neurons and prevent the rapid activation of specific kinases required for long term potentiation.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027443] Funding Source: NIH RePORTER; NIA NIH HHS [AG027443] Funding Source: Medline; NINDS NIH HHS [T32 NS07484-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; Daniels WMU, 2001, METAB BRAIN DIS, V16, P175, DOI 10.1023/A:1012541011123; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HEIDENREICH KA, 1988, J NEUROCHEM, V51, P878, DOI 10.1111/j.1471-4159.1988.tb01824.x; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HUANG HM, 1993, J BIOL CHEM, V268, P14616; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nelson TJ, 2005, BIOCHEM SOC T, V33, P1033, DOI 10.1042/BST0331033; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004	53	264	274	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33305	33312		10.1074/jbc.M610390200	http://dx.doi.org/10.1074/jbc.M610390200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17855343	hybrid			2022-12-27	WOS:000250840200010
J	Vincent, OD; Schwem, BE; Steed, PR; Jiang, W; Fillingame, RH				Vincent, Owen D.; Schwem, Brian E.; Steed, P. Ryan; Jiang, Warren; Fillingame, Robert H.			Fluidity of structure and swiveling of helices in the subunit c ring of Escherichia coli ATP synthase as revealed by cysteine-cysteine cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS CHANNELS; COUPLING H+ TRANSPORT; POLAR LOOP; PROTON TRANSLOCATION; GAMMA-SUBUNIT; ROTARY MOTOR; F-0; F1; EPSILON; SECTOR	Subunit c in the membrane-traversing F-o sector of Escherichia coli ATP synthase is known to fold with two transmembrane helices and form an oligomeric ring of 10 or more subunits in the membrane. Models for the E. coli ring structure have been proposed based upon NMR solution structures and intersubunit cross-linking of Cys residues in the membrane. The E. coli models differ from the recent x-ray diffraction structure of the isolated Ilyobacter tartaricus c-ring. Furthermore, key cross-linking results supporting the E. coli model prove to be incompatible with the I. tartaricus structure. To test the applicability of the I. tartaricus model to the E. coli c-ring, we compared the cross-linking of a pair of doubly Cys substituted c-subunits, each of which was compatible with one model but not the other. The key finding of this study is that both A21C/M65C and A21C/I66C doubly substituted c-subunits form high yield oligomeric structures, c(2), c(3)... c(10), via intersubunit disulfide bond formation. The results indicate that helical swiveling, with resultant interconversion of the two conformers predicted by the E. coli and I. tartaricus models, must be occurring over the time course of the cross-linking experiment. In the additional experiments reported here, we tried to ascertain the preferred conformation in the membrane to help define the most likely structural model. We conclude that both structures must be able to form in the membrane, but that the helical swiveling that promotes their interconversion may not be necessary during rotary function.	Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; BARIK S, 1996, METHOD MOL BIOL, V68, P203; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Fillingame RH, 2000, J EXP BIOL, V203, P9; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P7532; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2002, EMBO REP, V3, P1094, DOI 10.1093/embo-reports/kvf216; MILLER MJ, 1989, J BIOL CHEM, V264, P305; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Nakano T, 2006, J MOL BIOL, V358, P132, DOI 10.1016/j.jmb.2006.01.011; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schulenberg B, 1999, J BIOL CHEM, V274, P34233, DOI 10.1074/jbc.274.48.34233; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG Y, 1994, J BIOL CHEM, V269, P5473; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	44	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33788	33794		10.1074/jbc.M706904200	http://dx.doi.org/10.1074/jbc.M706904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17893141	hybrid			2022-12-27	WOS:000250840200061
J	Voltz, JW; Brush, M; Sikes, S; Steplock, D; Weinman, EJ; Shenolikar, S				Voltz, James W.; Brush, Matthew; Sikes, Suzanne; Steplock, Deborah; Weinman, Edward J.; Shenolikar, Shirish			Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER REGULATORY FACTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; PARATHYROID-HORMONE REGULATION; CAMP-MEDIATED INHIBITION; PROXIMAL TUBULE CELLS; OPOSSUM KIDNEY-CELLS; NA+-H+ EXCHANGER; FACTOR-I; 3 NHE3; PROTEIN	NHERF-1 ((N) under bara(+)-H+ (e) under bar xchanger (r) under bar egulatory (f) under bar actor (1) under bar, also known as EBP50 (e) under bar zrin-(b) under bar inding (p) under bar rotein of (5) under bar0 kDa) is a phosphoprotein that assembles multiprotein complexes via two PDZ domains and a C-terminal ezrin-binding domain. Current work utilized metabolic labeling in cultured cells expressing wild type GFP-NHERF-1 to define the physiological importance of NHERF-1 phosphorylation. Treatment of cells with phosphatase inhibitors calyculin A and okadaic acid enhanced NHERF-1 phosphorylation and inhibited its dimerization. Eliminating C-terminal serines abolished the modulation of NHERF-1 dimerization by phosphatase inhibitors and identified the phosphorylation of the PDZ1 domain that attenuated its binding to physiological targets, including beta(2)-adrenergic receptor, platelet-derived growth factor receptor, cystic fibrosis transmembrane conductance regulator, and sodium-phosphate cotransporter type IIa. The major covalent modification of PDZ1 was mapped to serine 77. Confocal microscopy of cultured cells suggested key roles for PDZ1 and ERM-binding domain in localizing NHERF-1 at the cell surface. The substitution S77A eliminated PDZ1 phosphorylation and increased NHERF-1 localization at the cell periphery. In contrast, S77D reduced NHERF-1 colocalization with cortical actin cytoskeleton. These data suggested that serine 77 phosphorylation played key role in modulating NHERF-1 association with plasma membrane targets and identified a novel mechanism by which PDZ1 phosphorylation may transduce hormonal signals to regulate the function of membrane proteins in epithelial tissues.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Maryland, Sch Med, Dept Vet Affairs, Dept Med, Baltimore, MD 21201 USA	Duke University; University System of Maryland; University of Maryland Baltimore	Shenolikar, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC C315,Res Dr, Durham, NC 27710 USA.	Sheno001@mc.duke.edu			NIDDK NIH HHS [DK55881] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Khundmiri SJ, 2005, J AM SOC NEPHROL, V16, P2598, DOI 10.1681/ASN.2004121049; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; WEINMAN EJ, 2007, IN PRESS J CLIN INVE; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	40	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33879	33887		10.1074/jbc.M703481200	http://dx.doi.org/10.1074/jbc.M703481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895247	hybrid			2022-12-27	WOS:000250840200069
J	Junne, T; Schwede, T; Goder, V; Spiess, M				Junne, Tina; Schwede, Torsten; Goder, Veit; Spiess, Martin			Mutations in the Sec61p channel affecting signal sequence recognition and membrane protein topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION CHANNEL; TRANSMEMBRANE ORIENTATION; ENDOPLASMIC-RETICULUM; CHARGED RESIDUES; ANCHOR PROTEINS; PLUG DOMAIN; EXPORT; DETERMINANTS; CONTRIBUTES; TRANSPORT	The orientation of most single-spanning membrane proteins obeys the "positive-insiderule", i.e. the flanking region of the transmembrane segment that is more positively charged remains in the cytosol. These membrane proteins are integrated by the Sec61/SecY translocon, but how their orientation is achieved is unknown. We have screened for mutations in yeast Sec61p that alter the orientation of single-spanning membrane proteins. We identified a class of mutants that are less efficient in retaining the positively charged flanking region in the cytosol. Surprisingly, these mutations are located at many different sites in the Sec61/SecY molecule, and they do not only involve charged amino acid residues. All these mutants have a prl phenotype that so far have only been seen in bacteria; they allow proteins with defective signal sequences to be translocated, likely because the Sec61p channel opens more easily. A similar correlation between topology defects and prl phenotype was also seen with previously identified yeast Sec61 mutants. Our results suggest a model in which the regulated opening of the translocon is required for the faithful orientation of membrane proteins.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	Martin.Spiess@unibas.ch	Goder, Veit/F-8092-2016; Schwede, Torsten/A-4650-2008	Schwede, Torsten/0000-0003-2715-335X; Spiess, Martin/0000-0001-7139-0550; Goder, Veit/0000-0003-0854-4873				Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; BELTZER JP, 1991, J BIOL CHEM, V266, P973; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Prinz WA, 1998, J BIOL CHEM, V273, P8419, DOI 10.1074/jbc.273.14.8419; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; UHLAND K, 1994, J BACTERIOL, V176, P4565, DOI 10.1128/JB.176.15.4565-4571.1994; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555	36	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33201	33209		10.1074/jbc.M707219200	http://dx.doi.org/10.1074/jbc.M707219200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17893139	hybrid			2022-12-27	WOS:000250625400067
J	Kovaleski, BJ; Kennedy, R; Khorchid, A; Kleiman, L; Matsuo, H; Musier-Forsyth, K				Kovaleski, Brandie J.; Kennedy, Robert; Khorchid, Ahmad; Kleiman, Lawrence; Matsuo, Hiroshi; Musier-Forsyth, Karin			Critical role of Helix 4 of HIV-1 capsid C-terminal domain in interactions with human lysyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR HOMOLOGY REGION; ESCHERICHIA-COLI; TRNA(LYS) INCORPORATION; DIMERIZATION DOMAIN; WILD-TYPE; PROTEIN; MUTANT; GAG; RECOGNITION	Human tRNA(Lys3) is used as the primer for human immunodeficiency virus type 1 ( HIV-1) reverse transcription. HIV-1 Gag and GagPol, as well as host cell factor lysyl-tRNA synthetase ( LysRS), are required for specific packaging of tRNALys into virions. Gag alone is sufficient for packaging of LysRS, and these two proteins have been shown to interact in vitro with an equilibrium binding constant of similar to 310 nM. The capsid ( CA) domain of Gag binds to LysRS with a similar affinity as full-length Gag. In this work, we report further characterization of the interaction between HIV-1 CA and human LysRS using truncation constructs and point mutations in the putative interaction helices. Fluorescence anisotropy binding measurements reveal that a LysRS variant lacking the N-terminal 219 residues still displays high affinity binding to CA. The CA C-terminal domain ( CTD) is also sufficient for binding to LysRS. Nuclear magnetic resonance spectroscopy studies using N-15-labeled CA-CTD reveal chemical shift perturbations of residues in and proximal to helix 4 of CA-CTD upon LysRS binding. A synthetic peptide that includes helix 4 binds to LysRS with high affinity, whereas peptides derived from the other three helical domains of CA-CTD do not. Alanine-scanning mutagenesis studies targeting residues in the helix 4 region support a direct interaction between this domain of CA-CTD and LysRS. The high resolution mapping studies reported here will facilitate future work aimed at disrupting the Gag-LysRS interaction, which represents a novel anti-viral strategy.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu	Kennedy, Robert T/G-9095-2016	Kennedy, Robert T/0000-0003-2447-7471	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700, F32GM069339] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054145] Funding Source: Medline; NIGMS NIH HHS [GM069339, T32-GM08700] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cen S, 2004, J VIROL, V78, P1595, DOI 10.1128/JVI.78.3.1595-1601.2004; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; GOODMAN M, 1962, J AM CHEM SOC, V84, P3770, DOI 10.1021/ja00878a036; Guo F, 2003, J VIROL, V77, P9817, DOI 10.1128/JVI.77.18.9817-9822.2003; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Kleiman L, 2004, INT J BIOCHEM CELL B, V36, P1776, DOI 10.1016/j.biocel.2004.02.022; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; POWERS R, 1992, BIOCHEMISTRY-US, V31, P4334, DOI 10.1021/bi00132a026; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Shiba K, 1997, J BIOL CHEM, V272, P22809, DOI 10.1074/jbc.272.36.22809; STRAMBIODECASTILLIA C, 1992, J VIROL, V66, P7021, DOI 10.1128/JVI.66.12.7021-7032.1992; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	26	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32274	32279		10.1074/jbc.M706256200	http://dx.doi.org/10.1074/jbc.M706256200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17724017	hybrid			2022-12-27	WOS:000250480300050
J	Lee, AYL; Liu, E; Wu, X				Lee, Alan Yueh-Luen; Liu, Enbo; Wu, Xiaohua			The mre11/Rad50/Nbs1 complex plays an important role in the prevention of DNA rereplication in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; REPLICATION PROTEIN-A; S-PHASE CHECKPOINT; ATM-DEPENDENT PHOSPHORYLATION; TELANGIECTASIA-LIKE DISORDER; ATAXIA-TELANGIECTASIA; DAMAGE RESPONSE; MRE11 COMPLEX; MRE11-RAD50-NBS1 COMPLEX; G(2)/M CHECKPOINT	The Mre11/Nbs1/Rad50 complex ( MRN) plays multiple roles in the maintenance of genome stability, including repair of double-stranded breaks ( DSBs) and activation of the S-phase checkpoint. Here we demonstrate that MRN is required for the prevention of DNA rereplication in mammalian cells. DNA replication is strictly regulated by licensing control so that the genome is replicated once and only once per cell cycle. Inactivation of Nbs1 or Mre11 leads to a substantial increase of DNA rereplication induced by overexpression of the licensing factor Cdt1. Our studies reveal that multiple mechanisms are likely involved in the MRN-mediated suppression of rereplication. First, both Mre11 and Nbs1 are required for facilitating ATR activation when Cdt1 is overexpressed, which in turn suppresses rereplication. Second, Cdt1 overexpression induces ATR-mediated phosphorylation of Nbs1 at Ser(343) and this phosphorylation depends on the FHA and BRCT domains of Nbs1. Mutations at Ser343 or in the FHA and BRCT domains lead to more severe rereplication when Cdt1 is overexpressed. Third, the interaction of the Mre11 complex with RPA is important for the suppression of rereplication. This suggests that modulating RPA activity via a direct interaction of MRN is likely one of the effector mechanisms to suppress rereplication. Moreover, we demonstrate that MRN is also required for preventing the accumulation of DSBs when rereplication is induced. Therefore, our studies suggest new roles of MRN in the maintenance of genome stability through preventing rereplication and rereplication-associated DSBs when licensing control is compromised.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Wu, X (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/A-9141-2010; Lee, Alan Yueh-Luen/B-1097-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	NATIONAL CANCER INSTITUTE [R01CA102361] Funding Source: NIH RePORTER; NCI NIH HHS [CA102361] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Guo WY, 2004, J RADIAT RES, V45, P269, DOI 10.1269/jrr.45.269; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ikui AE, 2007, GENETICS, V175, P1011, DOI 10.1534/genetics.106.068213; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LIU E, IN PRESS J CELL BIOL; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32243	32255		10.1074/jbc.M705486200	http://dx.doi.org/10.1074/jbc.M705486200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17715134	hybrid			2022-12-27	WOS:000250480300047
J	Roy, A; Liu, X; Pahan, K				Roy, Avik; Liu, Xiaojuan; Pahan, Kalipada			Myelin basic protein-primed T cells induce Neurotrophins in glial cells via alpha 5 beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PROINFLAMMATORY CYTOKINES; MICROGLIAL CELLS; ADOPTIVE TRANSFER; GENE-EXPRESSION; GROWTH-FACTOR; BRAIN; MICE	Increasing the level of neurotrophins within the central nervous system may have therapeutic efficacy in patients with various neurological diseases. Earlier we have demonstrated that myelin basic protein ( MBP)-primed T cells induce the expression of various proinflammatory molecules in glial cells via cell-to-cell contact. Here we describe that after Th2 polarization by gemfibrozil or other drugs, MBP-primed T cells induced the expression of neurotrophic molecules such as brain-derived neurotrophic factor ( BDNF) and neurotrophin-3 ( NT-3), but not proinflammatory molecules in microglia and astroglia via cell-to-cell contact. MBP-primed Th2 cells expressed alpha 5 and beta 3 integrins and functional blocking antibodies against both alpha 5 and beta 3 integrins inhibited the ability of MBP-primed Th2 cells to induce glial neurotrophins. On the other hand, glial cells expressed PDGF-R beta and neutralization of this glial receptor abrogated the ability of Th2 cells to induce neurotrophins in glia. Activation of glial cAMP response element-binding protein ( CREB) by MBP-primed Th2 cell contact and inhibition of contact-mediated expression of neurotrophins by antisense knockdown of glial CREB suggest that MBP-primed Th2 cell-glia contact induces the expression of neurotrophins through glial activation of CREB. Accordingly, blocking of either alpha 5 beta 3 integrins on T cells or PDGF-R beta on glial cells impaired the ability of MBP-primed Th2 cells to induce glial activation of CREB. Furthermore, we demonstrate that these MBP-primed Th2 cells entered into the central nervous system and increased the expression of neurotrophins in vivo in the brain. This study illuminates the importance of alpha 5 beta 3 and PDGF-R beta in guiding the novel neurotrophic property of neuroantigen-primed T cells via activation of CREB that may be of therapeutic importance in various neurological disorders.	Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Univ Nebraska, Coll Dent, Med Ctr, Dept Oral Biol,Sect Neurosci, Lincoln, NE 68583 USA	Rush University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Cohn Res Bldg,Suite 320,1735 W Harrison St, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			NINDS NIH HHS [R21 NS048923-03, R01 NS039940, NS48923, NS39940, R01 NS039940-08, R21 NS048923] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048923, R01NS039940] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Althaus HH, 2004, PROG BRAIN RES, V146, P415; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Chabot S, 1997, J CLIN INVEST, V100, P604, DOI 10.1172/JCI119571; Dasgupta S, 2005, J BIOL CHEM, V280, P32609, DOI 10.1074/jbc.M500299200; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2002, J BIOL CHEM, V277, P39327, DOI 10.1074/jbc.M111841200; DATE I, 1993, BRAIN RES, V621, P150, DOI 10.1016/0006-8993(93)90312-B; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Mellstrom Britt, 2004, Critical Reviews in Neurobiology, V16, P43, DOI 10.1615/CritRevNeurobiol.v16.i12.40; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Wolinsky Jerry S, 2006, Adv Neurol, V98, P273; Ziemssen T, 2002, BRAIN, V125, P2381, DOI 10.1093/brain/awf252	30	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32222	32232		10.1074/jbc.M702899200	http://dx.doi.org/10.1074/jbc.M702899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17823123	Green Accepted, hybrid			2022-12-27	WOS:000250480300045
J	Saito, T; Jones, CC; Huang, S; Czech, MP; Pilch, PF				Saito, Tsugumichi; Jones, Christine C.; Huang, Shaohui; Czech, Michael P.; Pilch, Paul F.			The interaction of akt with APPL1 is required for insulin-stimulated glut4 translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; GLUCOSE-TRANSPORT; PLASMA-MEMBRANE; FUSION; PHOSPHORYLATES; VESICLES; RECEPTOR; GENE; ENDOCYTOSIS; ACTIVATION	APPL1 (adaptor protein containing PHdomain, PTB domain, and leucine zipper motif 1) is an Akt/protein kinase B-binding protein involved in signal transduction and membrane trafficking pathways for various receptors, including receptor tyrosine kinases. Here, we establish a role for APPL1 in insulin signaling in which we demonstrate its interaction with Akt2 by co-immunoprecipitation and pulldown assays. In primary rat adipocytes and skeletal muscle, APPL1 and Akt2 formed a complex that was dissociated upon insulin stimulation in both tissues. To investigate possible APPL1 function in adipocytes, we analyzed Akt phosphorylation, 2-deoxyglucose uptake, and Glut4 translocation by immunofluorescence following APPL1 knockdown by small interfering and short hairpin RNAs. We show that APPL1 knockdown suppressed Akt phosphorylation, glucose uptake, and Glut4 translocation. We also tested the effect in 3T3-L1 adipocytes of expressing full-length APPL1 or an N-or a C-terminal APPL1 construct. Interestingly, expression of full-length APPL1 and its N terminus suppressed insulin-stimulated 2-deoxyglucose uptake and Glut4 translocation to roughly the same extent (40-60%). We confirmed by cellular fractionation that Glut4 translocation was substantially blocked in 3T3-L1 adipocytes transfected with full-length APPL1. By cellular fractionation, APPL1 was localized mainly in the cytosol, and it showed a small degree of re-localization to the light microsomes and nucleus in response to insulin. By immunofluorescence, we also show that APPL1 partially co-localized with Glut4. These data suggest that APPL1 plays an important role in insulin-stimulated Glut4 translocation in muscle and adipose tissues and that its N-terminal portion may be critical for APPL1 function.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01507 USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K-402, Boston, MA 02118 USA.	ppilch@bu.edu		Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564, R01DK056935, R01DK030425] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-30425, DK-60564, DK-56935] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coffer PJ, 1998, BIOCHEM J, V335, P1; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Simpson JC, 2005, BIOCHEM SOC SYMP, V72, P99, DOI 10.1042/bss0720099; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200	53	99	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32280	32287		10.1074/jbc.M704150200	http://dx.doi.org/10.1074/jbc.M704150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17848569	hybrid			2022-12-27	WOS:000250480300051
J	Fujinaka, Y; Takane, K; Yamashita, H; Vasavada, RC				Fujinaka, Yuichi; Takane, Karen; Yamashita, Hiroko; Vasavada, Rupangi C.			Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-X-L upregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; PLACENTAL-LACTOGEN; PANCREATIC-ISLETS; INSULIN-SECRETION; PROLACTIN RECEPTORS; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; GENE-EXPRESSION; RAT; GROWTH	One of the goals in the treatment for diabetes is to enhance pancreatic beta cell function, proliferation, and survival. This study explores the role of lactogenic hormones, prolactin ( PRL) and placental lactogen ( PL), in beta cell survival. We have previously shown that transgenic mice expressing mouse placental lactogen-1 ( mPL1) in beta cells under the rat insulin II promoter ( RIP) are resistant to the diabetogenic and cytotoxic effects of streptozotocin ( STZ) in vivo. The current study demonstrates that lactogens protect rat insulinoma ( INS-1) cells and primary mouse beta cells against two distinct beta cell death inducers, STZ and dexamethasone ( DEX), in vitro. Further, we identify the mechanism through which lactogens protect beta cells against DEX-induced death. The signaling pathway mediating this protective effect is the janus-activated-kinase-2/signal transducer and activator of transcription-5 ( JAK2/STAT5) pathway. This is demonstrated in INS-1 cells and primary mouse beta cells using three separate approaches, pharmacological inhibitors, JAK2-specific siRNAs and a dominant-negative STAT5 mutant. Furthermore, lactogens specifically and significantly increase the anti-apoptotic protein Bcl-X-L in insulinoma cells and mouse islets. Bcl-X-L-specific siRNA significantly inhibits lactogen-mediated protection against DEX-induced beta cell death. We believe this is the first direct demonstration of lactogens mediating their protective effect through the JAK2/STAT5 pathway in the beta cell and through Bcl-X-L in any cell type.	Univ Pittsburgh, Div Endocrinol, Pittsburgh, PA 15261 USA; Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya City University	Vasavada, RC (corresponding author), Univ Pittsburgh, Div Endocrinol, 200 Lothrop St BST E1140, Pittsburgh, PA 15261 USA.	vasavada@dom.pitt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072264] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-072264] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahonen TJ, 2002, ENDOCRINOLOGY, V143, P228, DOI 10.1210/en.143.1.228; Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Amaral MEC, 2003, HORM METAB RES, V35, P282; BISWAS R, 1987, CANCER RES, V47, P3509; Bordin S, 2004, MOL CELL ENDOCRINOL, V220, P41, DOI 10.1016/j.mce.2004.04.001; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Brelje TC, 2002, J HISTOCHEM CYTOCHEM, V50, P365, DOI 10.1177/002215540205000308; Buckley AR, 2000, ANN NY ACAD SCI, V917, P522; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Druilhe A, 2003, APOPTOSIS, V8, P481, DOI 10.1023/A:1025590308147; Fernandez ML, 2003, ARCH BIOCHEM BIOPHYS, V416, P249, DOI 10.1016/S0003-9861(03)00292-3; Fleenor D, 2000, PEDIATR RES, V47, P136, DOI 10.1203/00006450-200001000-00023; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Fujinaka Y, 2004, DIABETES, V53, P3120, DOI 10.2337/diabetes.53.12.3120; Goffin V, 1999, GENET ANAL-BIOMOL E, V15, P189, DOI 10.1016/S1050-3862(99)00025-X; Hoogwerf B, 1999, RHEUM DIS CLIN N AM, V25, P489, DOI 10.1016/S0889-857X(05)70083-1; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Kay TWH, 2000, TRENDS ENDOCRIN MET, V11, P11, DOI 10.1016/S1043-2760(99)00210-6; Krishnan N, 2001, ENDOCRINE, V15, P177, DOI 10.1385/ENDO:15:2:177; Leff MA, 1996, ENDOCRINOLOGY, V137, P5456, DOI 10.1210/en.137.12.5456; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; Matthews SG, 2002, ENDOCR RES, V28, P709, DOI 10.1081/ERC-120016991; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Ploszaj T, 1998, APOPTOSIS, V3, P295, DOI 10.1023/A:1009669427662; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Reichardt Holger M, 2006, Expert Rev Neurother, V6, P1657, DOI 10.1586/14737175.6.11.1657; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; Sorenson RL, 2001, ENDOCRIN UPDAT, V12, P297; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; TALAMANTES F, 1990, PROG CLIN BIOL RES, V342, P81; Tessier C, 2001, ENDOCRINOLOGY, V142, P4086, DOI 10.1210/en.142.9.4086; Tian YR, 2003, MOL CELL ENDOCRINOL, V204, P75, DOI 10.1016/S0303-7207(03)00126-6; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; VASAVADA RC, 2007, IN PRESS DIABETES; Wang LH, 1999, J IMMUNOL, V162, P3897; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277	45	59	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30707	30717		10.1074/jbc.M702607200	http://dx.doi.org/10.1074/jbc.M702607200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17728251	hybrid			2022-12-27	WOS:000250136300039
J	Miertzschke, M; Stanley, P; Bunney, TD; Rodrigues-Lima, F; Hogg, N; Katan, M				Miertzschke, Mandy; Stanley, Paula; Bunney, Tom D.; Rodrigues-Lima, Fernando; Hogg, Nancy; Katan, Matilda			Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTOR MOLECULE; PUTATIVE EFFECTOR; BINDING; ACTIVATION; ADHESION; LYMPHOCYTE; DOMAINS; INTEGRINS; KINASE; GTP	Using a model of integrin-triggered random migration of T cells, we show that stimulation of LFA-1 integrins leads to the activation of Rap1 and Rap2 small GTPases. We further show that Rap1 and Rap2 have distinct roles in adhesion and random migration of these cells and that an adapter protein from the Ras association domain family ( Rassf), RAPL, has a role downstream of Rap2 in addition to its link to Rap1. Further characterization of the RAPL protein and its interactions with small GTPases from the Ras family shows that RAPL forms more stable complexes with Rap2 and classical Ras proteins compared with Rap1. The different interaction pattern of RAPL with Rap1 and Rap2 is not affected by the disruption of the C-terminal SARAH domain that we identified as the alpha-helical region responsible for RAPL dimerization in vitro and in cells. Based on mutagenesis and three-dimensional modeling, we propose that interaction surfaces in RAPL-Rap1 and RAPL-Rap2 complexes are different and that a single residue in the switch I region of Rap proteins ( residue 39) contributes considerably to the different kinetics of these protein-protein interactions. Furthermore, the distinct role of Rap2 in migration of T cells is lost when this critical residue is converted to the residue present in Rap1. Together, these observations suggest a wider role for Rassf adapter protein RAPL and Rap GTPases in cell motility and show that subtle differences between highly similar Rap proteins could be reflected in distinct interactions with common effectors and their cellular function.	Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; Canc Res UK London Res Inst, Leukocyte Adhes Lab, London WC2A 3PX, England; Univ Paris 07, Lab Cytophysiol & Toxicol Cellulaire EA1553, F-75005 Paris, France; Univ Paris 07, UFR Biochim, F-75005 Paris, France	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Katan, M (corresponding author), Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, Fulham Rd, London SW3 6JB, England.	matilda.katan@icr.ac.uk		Bunney, Tom/0000-0002-0281-8813				Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bradley LM, 2003, CURR OPIN IMMUNOL, V15, P343, DOI 10.1016/S0952-7915(03)00043-8; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; COLICELLI J, 2004, SCI STKE 2004; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Jenei V, 2006, J BIOL CHEM, V281, P35008, DOI 10.1074/jbc.M601335200; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Nancy V, 1999, J BIOL CHEM, V274, P8737, DOI 10.1074/jbc.274.13.8737; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Santiago C, 2002, J BIOL CHEM, V277, P32294, DOI 10.1074/jbc.M202973200; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Stanley P, 2000, BIOCHEM J, V351, P79, DOI 10.1042/0264-6021:3510079; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429	52	31	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30629	30642		10.1074/jbc.M704361200	http://dx.doi.org/10.1074/jbc.M704361200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17716979	hybrid			2022-12-27	WOS:000250136300031
J	Merdek, KD; Yang, XQ; Taglienti, CA; Shaw, LM; Mercurio, AM				Merdek, Keith D.; Yang, Xiaoqing; Taglienti, Cherie A.; Shaw, Leslie M.; Mercurio, Arthur M.			Intrinsic signaling functions of the ss 4 integrin intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CALPAIN INHIBITOR CALPEPTIN; BREAST-CARCINOMA CELLS; COLON-CANCER CELLS; NF-KAPPA-B; ALPHA-6-BETA-4 INTEGRIN; ALPHA(6)BETA(4) INTEGRIN; CHEMOTACTIC MIGRATION; NEUROTROPHIC FACTORS; TETRASPANIN CD151	A key issue regarding the role of alpha 6 beta 4 in cancer biology is the mechanism by which this integrin exerts its profound effects on intracellular signaling, including growth factor-mediated signaling. Oneapproach is to evaluate the intrinsic signaling capacity of the unique beta 4 intracellular domain in the absence of contributions from the alpha 6 subunit and tetraspanins and to assess the ability of growth factor receptor signaling to cooperate with this domain. Here, we generated a chimeric receptor composed of the TrkB extracellular domain and the beta 4 transmembrane and intracellular domains. Expression of this chimeric receptor in beta 4-null cancer cells enabled us to assess the signaling potential of the beta 4 intracellular domain alone or in response to dimerization using brain-derived neurotrophic factor, the ligand for TrkB. Dimerization of the beta 4 intracellular domain results in the binding and activation of the tyrosine phosphatase SHP-2 and the activation of Src, events that also occur upon ligation of intact alpha 6 beta 4. In contrast to alpha 6 beta 4 signaling, however, dimerization of the chimeric receptor does not activate either Akt or Erk1/2. Growth factor stimulation induces tyrosine phosphorylation of the chimeric receptor but does not enhance its binding to SHP-2. The chimeric receptor is unable to amplify growth factormediated activation of Akt and Erk1/2, and growth factorstimulated migration. Collectively, these data indicate that the beta 4 intracellular domain has some intrinsic signaling potential, but it cannot mimic the full signaling capacity of alpha 6 beta 4. These data also question the putative role of the beta 4 intracellular domain as an "adaptor" for growth factor receptor signaling.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			NATIONAL CANCER INSTITUTE [F32CA117746, R01CA080789] Funding Source: NIH RePORTER; NCI NIH HHS [F32CA117746, R01 CA080789, CA80789] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Chao C, 1996, CANCER RES, V56, P4811; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Homan SM, 1998, J CELL SCI, V111, P2717; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kruttgen A, 2006, BRAIN PATHOL, V16, P304, DOI 10.1111/j.1750-3639.2006.00037.x; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MAKI M, 1989, J BIOL CHEM, V264, P18866; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Pouliot N, 2000, EXP CELL RES, V261, P360, DOI 10.1006/excr.2000.5065; PUMA P, 1983, J BIOL CHEM, V258, P3370; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sariola H, 2001, CELL MOL LIFE SCI, V58, P1061, DOI 10.1007/PL00000921; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; SHAW LM, 1993, J BIOL CHEM, V268, P11401; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	62	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30322	30330		10.1074/jbc.M703156200	http://dx.doi.org/10.1074/jbc.M703156200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711859	hybrid			2022-12-27	WOS:000249981200063
J	Bhat, N; Joe, A; PereiraPerrin, M; Ward, HD				Bhat, Najma; Joe, Angela; PereiraPerrin, Mercio; Ward, Honorine D.			Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; PARVUM SPOROZOITES; MICRONEME PROTEINS; CELL INVASION; HOST; PARASITE; IDENTIFICATION; GLYCOPROTEIN; ATTACHMENT; EXPRESSION	Cryptosporidium sp. cause human and animal diarrheal disease worldwide. The molecular mechanisms underlying Cryptosporidium attachment to, and invasion of, host cells are poorly understood. Previously, we described a surface-associated Gal/GalNAc-specific lectin activity in sporozoites of Cryptosporidium parvum. Here we describe p30, a 30-kDa Gal/GalNAc-specific lectin isolated from C. parvum and Cryptosporidium hominis sporozoites by Gal-affinity chromatography. p30 is encoded by a single copy gene containing a 906-bp open reading frame, the deduced amino acid sequence of which predicts a 302-amino acid, 31.8-kDa protein with a 22-amino acid N-terminal signal sequence. The p30 gene is expressed at 24-72 h after infection of intestinal epithelial cells. Antisera to recombinant p30 expressed in Escherichia coli react with an similar to 30-kDa protein in C. parvum and C. hominis. p30 is localized to the apical region of sporozoites and is predominantly intracellular in both sporozoites and intracellular stages of the parasite. p30 associates with gp900 and gp40, Gal/GalNAc-containing mucin-like glycoproteins that are also implicated in mediating infection. Native and recombinant p30 bind to Caco-2A cells in a dose-dependent, saturable, and Gal-inhibitable manner. Recombinant p30 inhibits C. parvum attachment to and infection of Caco-2A cells, whereas antisera to the recombinant protein also inhibit infection. Taken together, these findings suggest that p30 mediates C. parvum infection in vitro and raise the possibility that this protein may serve as a target for intervention.	Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Ward, HD (corresponding author), Tufts Univ, New England Med Ctr, Div Geog Med & Infect Dis, Box 041,750 Washington St, Boston, MA 02111 USA.	hward@tufts-nemc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R42AI045194, R41AI045194, R01AI052786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040574] Funding Source: NIH RePORTER; NIAID NIH HHS [AI52786, AI45194] Funding Source: Medline; NIDDK NIH HHS [P30 DK34928] Funding Source: Medline; NINDS NIH HHS [NS40574] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Barnes DA, 1998, MOL BIOCHEM PARASIT, V96, P93, DOI 10.1016/S0166-6851(98)00119-4; BHAT N, 2000, LECTINS PATHOLOGY, P173; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Cevallos AM, 2000, INFECT IMMUN, V68, P4108, DOI 10.1128/IAI.68.7.4108-4116.2000; Cevallos AM, 2000, INFECT IMMUN, V68, P5167, DOI 10.1128/IAI.68.9.5167-5175.2000; Chen XM, 2000, GASTROENTEROLOGY, V118, P368, DOI 10.1016/S0016-5085(00)70219-8; Dubremetz JF, 1998, TRENDS MICROBIOL, V6, P27, DOI 10.1016/S0966-842X(97)01165-7; FAYER R, 1990, INFECT IMMUN, V58, P2962, DOI 10.1128/IAI.58.9.2962-2965.1990; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; GOLDHAR J, 1994, METHOD ENZYMOL, V236, P211; HAMER DH, 1994, INFECT IMMUN, V62, P2208, DOI 10.1128/IAI.62.6.2208-2213.1994; Hashim A, 2006, INFECT IMMUN, V74, P99, DOI 10.1128/IAI.74.1.99-107.2006; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; JOE A, 1994, J EUKARYOT MICROBIOL, V41, pS44; Joe A, 1998, INFECT IMMUN, V66, P3429, DOI 10.1128/IAI.66.7.3429-3432.1998; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; Klein H, 2003, PARASITOL RES, V90, P84, DOI 10.1007/s00436-002-0600-0; Leav BA, 2003, CLIN INFECT DIS, V36, P903, DOI 10.1086/368194; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Meissner M, 2002, J CELL SCI, V115, P563; O'Connor RM, 2003, INFECT IMMUN, V71, P6027, DOI 10.1128/IAI.71.10.6027-6034.2003; O'Connor RM, 2002, MOL BIOCHEM PARASIT, V119, P203, DOI 10.1016/S0166-6851(01)00416-9; O'Connor RM, 2007, MOL BIOCHEM PARASIT, V156, P80, DOI 10.1016/j.molbiopara.2007.07.010; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Priest JW, 2001, MOL BIOCHEM PARASIT, V113, P117, DOI 10.1016/S0166-6851(00)00386-8; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sharon N, 1998, PROTEIN SCI, V7, P2042, DOI 10.1002/pro.5560070922; Silber AM, 2002, EXP PARASITOL, V100, P217, DOI 10.1016/S0014-4894(02)00013-9; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; THEA DM, 1992, J PARASITOL, V78, P886, DOI 10.2307/3283323; Tosini F, 2004, MOL BIOCHEM PARASIT, V134, P137, DOI 10.1016/j.molbiopara.2003.11.014; Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5; UPTON SJ, 1994, FEMS MICROBIOL LETT, V118, P233, DOI 10.1016/0378-1097(94)90509-6; Verdon R, 1997, J INFECT DIS, V175, P1268, DOI 10.1086/593695; Wanyiri J, 2006, FUTURE MICROBIOL, V1, P201, DOI 10.2217/17460913.1.2.201; Wanyiri JW, 2007, INFECT IMMUN, V75, P184, DOI 10.1128/IAI.00944-06; Ward H, 1998, ADV PARASIT, V40, P151, DOI 10.1016/S0065-308X(08)60120-7; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yu Jae-Ran, 2000, Korean Journal of Parasitology, V38, P59, DOI 10.3347/kjp.2000.38.2.59; Zardi EM, 2005, CHEMOTHERAPY, V51, P193, DOI 10.1159/000086920	50	37	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34877	34887		10.1074/jbc.M706950200	http://dx.doi.org/10.1074/jbc.M706950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17905738	hybrid			2022-12-27	WOS:000251155200030
J	Jain, P; Mostoller, K; Flaig, KE; Ahuja, J; Lepoutre, V; Alefantis, T; Khan, ZK; Wigdahl, B				Jain, Pooja; Mostoller, Kate; Flaig, Katherine E.; Ahuja, Jaya; Lepoutre, Veronique; Alefantis, Timothy; Khan, Zafar K.; Wigdahl, Brian			Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I TAX; NF-KAPPA-B; TRANSACTIVATOR PROTEIN TAX; CARRIER MEMBRANE-PROTEINS; CYTOTOXIC LYMPHOCYTES-T; APICAL PLASMA-MEMBRANE; NUCLEAR-PORE COMPLEX; CANINE KIDNEY-CELLS; ENDOPLASMIC-RETICULUM; CEREBROSPINAL-FLUID	Human T cell leukemia virus type 1 (HTLV-1) is the etiologic agent of a number of pathologic abnormalities, including adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The viral oncoprotein Tax has been implicated in the pathogenesis of these diseases. Recently, cell-free Tax was detected in the cerebrospinal fluid of HAM/TSP patients, implying that extracellular Tax may be relevant to neurologic disease. Additionally, the presence of a nuclear export signal within Tax and its active secretion has been demonstrated in vitro. However, the mechanism of Tax secretion remains to be established. Studies reported herein elucidate the process of Tax secretion and identify domains of Tax critical to its subcellular localization and secretion. Tax was shown to interact with a number of cellular secretory pathway proteins in both the model cell line BHK (baby hamster kidney)-21 and an HTLV-1-infected T cell line, C8166, physiologically relevant to HTLV-1-induced disease. Silencing of selected components of the secretory pathway affected Tax secretion, further confirming regulated secretion of Tax. Additionally, mutations in two putative secretory signals within Tax DHE and YTNI resulted in aberrant subcellular localization of Tax and significantly altered protein secretion. Together, these studies demonstrate that Tax secretion is a regulated event facilitated by its interactions with proteins of the cellular secretory pathway and the presence of secretory signals within the carboxyl-terminal domain of the protein.	Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Virol & Neuroimmunol,Ctr Canc Biol, Philadelphia, PA 19129 USA; Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Philadelphia, PA 19129 USA; Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; Vital Probes Inc, Mayfield, PA 18433 USA	Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Virol & Neuroimmunol,Ctr Canc Biol, 2900 Queen Ln, Philadelphia, PA 19129 USA.	bwigdahl@drexelmed.edu			NCI NIH HHS [2R01 CA 054559-13A1] Funding Source: Medline; NINDS NIH HHS [NS 044801] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS044801] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahuja J, 2006, J NEUROVIROL, V12, P47, DOI 10.1080/13550280600614981; Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200; Alefantis T, 2007, BIOMED PHARMACOTHER, V61, P194, DOI 10.1016/j.biopha.2007.02.005; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Barmak K, 2003, VIROLOGY, V308, P1, DOI 10.1016/S0042-6822(02)00091-0; BRADY JN, 1992, AIDS RES HUM RETROV, V8, P724; Burton M, 2000, J VIROL, V74, P2351, DOI 10.1128/JVI.74.5.2351-2364.2000; Cartier L, 2005, ARCH VIROL, V150, P743, DOI 10.1007/s00705-004-0443-3; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Cowan EP, 1997, J VIROL, V71, P6982, DOI 10.1128/JVI.71.9.6982-6989.1997; CRENON I, 1993, ONCOGENE, V8, P867; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; DHIBJALBUT S, 1994, ANN NEUROL, V36, P787, DOI 10.1002/ana.410360516; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Harhaj EW, 1999, ONCOGENE, V18, P1341, DOI 10.1038/sj.onc.1202405; Holaska JM, 1998, P NATL ACAD SCI USA, V95, P14739, DOI 10.1073/pnas.95.25.14739; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; JACOBSON S, 1992, ANN NEUROL, V32, P651, DOI 10.1002/ana.410320508; JACOBSON S, 1988, ANN NEUROL S, V23, P196; Jain P, 2007, J LEUKOCYTE BIOL, V82, P44, DOI 10.1189/jlb.1006641; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Kubota R, 2002, J NEUROVIROL, V8, P53, DOI 10.1080/135502802317247811; Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; LINDHOLM P F, 1990, New Biologist, V2, P1034; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; MARRIOTT SJ, 1991, NEW BIOL, V3, P678; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mostoller K, 2004, J NEUROVIROL, V10, P358, DOI 10.1080/13550280490521104; Ng PWP, 2001, ONCOGENE, V20, P4484, DOI 10.1038/sj.onc.1204513; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Singleton DR, 1997, J CELL SCI, V110, P2099; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SMITH MR, 1992, VIROLOGY, V187, P316, DOI 10.1016/0042-6822(92)90320-O; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu TT, 1997, J CELL SCI, V110, P1533; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	67	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34581	34593		10.1074/jbc.M707317200	http://dx.doi.org/10.1074/jbc.M707317200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897946	hybrid			2022-12-27	WOS:000251145700072
J	Segers, K; Dahlback, B; Bock, PE; Tans, G; Rosing, J; Nicolaes, GAF				Segers, Kenneth; Dahlbaeck, Bjoern; Bock, Paul E.; Tans, Guido; Rosing, Jan; Nicolaes, Gerry A. F.			The role of thrombin exosites I and II in the activation of human coagulation factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUSSELLS VIPER VENOM; BOVINE FACTOR-V; DNA APTAMER; FACTOR-XA; CATALYZED ACTIVATION; STUART FACTOR; CLEAVAGE REQUIREMENTS; BINDING EXOSITE; SNAKE-VENOM; LIGHT-CHAIN	Human blood coagulation Factor V(FV) is a plasma protein with little procoagulant activity. Limited proteolysis at Arg(709), Arg(1018), and Arg(1545) by thrombin or Factor Xa (FXa) results in the generation of activated FV, which serves as a cofactor of FXa in prothrombin activation. Both thrombin exosites I and II have been reported to be involved in FV activation, but the relative importance of these regions in the individual cleavages remains unclear. To investigate the role of each exosite in FV activation, we have used recombinant FV molecules with only one of the three activation cleavage sites available, in combination with exosite I- or II-specific aptamers. In addition, structural requirements for exosite interactions located in the B-domain of FV were probed using FV B-domain deletion mutants and comparison with FV activating enzymes from the venom of Russell's viper(RVV-V) and of Levant's viper (LVV-V) known to activate FV by specific cleavage at Arg(1545). Our results indicate that thrombin exosite II is not involved in cleavage at Arg(709) and that both thrombin exosites are important for recognition and cleavage at Arg(1545). Efficient thrombin- catalyzed FV activation requires both the N- and C-terminal regions of the B-domain, whereas only the latter is required by RVV-V and LVV-V. This indicates that proteolysis of FV by thrombin at Arg(709), Arg(1018), and Arg(1545) show different cleavage requirements with respect to interactions mediated by thrombin exosites and areas that surround the respective cleavage sites. In addition, interactions between exosite I of thrombin and FV are primarily responsible for the different cleavage site specificity as compared with activation by RVV-V or LVV-V.	Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Lund Univ, Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Maastricht University; Lund University; Skane University Hospital; Vanderbilt University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL038779-21, HL 038779, R01 HL038779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arocas V, 1998, THROMB HAEMOSTASIS, V79, P1157, DOI 10.1055/s-0037-1615033; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; ESMON CT, 1979, J BIOL CHEM, V254, P964; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; HIBBARD LS, 1980, J BIOL CHEM, V255, P638; HORTIN GL, 1990, BLOOD, V76, P946; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; KISIEL W, 1979, J BIOL CHEM, V254, P2230; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; MARQUETTE KA, 1995, BLOOD, V86, P3026; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; ROSING J, 1980, J BIOL CHEM, V255, P274; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Siigur E, 1999, BIOCHEM BIOPH RES CO, V262, P328, DOI 10.1006/bbrc.1999.1200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1994, J BIOL CHEM, V269, P15969; TANS G, 1991, J BIOL CHEM, V266, P21864; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TRACY PB, 1982, BLOOD, V60, P59; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; van der Neut Kolfschoten M, 2003, THROMB HAEMOSTASIS, V89, P429; WANG KY, 1993, BIOCHEMISTRY-US, V32, P11285, DOI 10.1021/bi00093a004; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	47	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33915	33924		10.1074/jbc.M701123200	http://dx.doi.org/10.1074/jbc.M701123200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17878169	Green Accepted, hybrid			2022-12-27	WOS:000251145700004
J	Waditee, R; Bhuiyan, NH; Hirata, E; Hibino, T; Tanaka, Y; Shikata, M; Takabe, T				Waditee, Rungaroon; Bhuiyan, Nazmul H.; Hirata, Emi; Hibino, Takashi; Tanaka, Yoshito; Shikata, Masamitsu; Takabe, Teruhiro			Metabolic engineering for betaine accumulation in microbes and plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM APHANOTHECE-HALOPHYTICA; GLYCINE BETAINE; ESCHERICHIA-COLI; 3-PHOSPHOGLYCERATE DEHYDROGENASE; FUNCTIONAL-CHARACTERIZATION; ALDEHYDE DEHYDROGENASE; CHOLINE MONOOXYGENASE; ABIOTIC-STRESS; ARABIDOPSIS; BIOSYNTHESIS	Plants accumulate a variety of osmoprotectants that improve their ability to combat abiotic stresses. Among them, betaine appears to play an important role in conferring resistance to stresses. Betaine is synthesized via either choline oxidation or glycine methylation. An increased betaine level in transgenic plants is one of the potential strategies to generate stress-tolerant crop plants. Here, we showed that an exogenous supply of serine or glycine to a halotolerant cyanobacterium Aphanothece halophytica, which synthesizes betaine from glycine by a three-step methylation, elevated intracellular accumulation of betaine under salt stress. The gene encoding 3-phosphoglycerate dehydrogenase (PGDH), which catalyzes the first step of the phosphorylated pathway of serine biosynthesis, was isolated from A. halophytica. Expression of the Aphanothece PGDH gene in Escherichia coli caused an increase in levels of betaine as well as glycine and serine. Expression of the Aphanothece PGDH gene in Arabidopsis plants, in which the betaine synthetic pathway was introduced via glycine methylation, further increased betaine levels and improved the stress tolerance. These results demonstrate that PGDH enhances the levels of betaine by providing the precursor serine for both choline oxidation and glycine methylation pathways.	Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; Shimadzu Co, Nakagyou Ku, Kyoto 6408511, Japan	Meijo University; Meijo University; Shimadzu Corporation	Takabe, T (corresponding author), Meijo Univ, Res Inst, Tenpaku Ku, Nagoya, Aichi 4688502, Japan.	takabe@ccmfs.meijo-u.ac.jp						Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BALLOU CE, 1956, J AM CHEM SOC, V78, P3718, DOI 10.1021/ja01596a045; Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Boch J, 1996, J BACTERIOL, V178, P5121, DOI 10.1128/jb.178.17.5121-5129.1996; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; CHERN MK, 1995, BIOCHEM BIOPH RES CO, V213, P561, DOI 10.1006/bbrc.1995.2168; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Hayashi H, 1997, PLANT J, V12, P133, DOI 10.1046/j.1365-313X.1997.12010133.x; Hibino T, 2002, J BIOL CHEM, V277, P41352, DOI 10.1074/jbc.M205965200; Hibino T, 1999, PLANT MOL BIOL, V40, P409, DOI 10.1023/A:1006273124726; Ho CL, 1999, J BIOL CHEM, V274, P397, DOI 10.1074/jbc.274.1.397; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nuccio ML, 2000, METAB ENG, V2, P300, DOI 10.1006/mben.2000.0158; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; SOMERVILLE CR, 1981, PLANT SCI LETT, V21, P89, DOI 10.1016/0304-4211(81)90073-0; SOROKIN A, 1993, MOL MICROBIOL, V10, P385, DOI 10.1111/j.1365-2958.1993.tb02670.x; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; WERETILNYK EA, 1990, P NATL ACAD SCI USA, V87, P2745, DOI 10.1073/pnas.87.7.2745; YAMADA H, 1979, AGR BIOL CHEM TOKYO, V43, P2173, DOI 10.1080/00021369.1979.10863769; Youssefian S, 2001, PLANT PHYSIOL, V126, P1001, DOI 10.1104/pp.126.3.1001; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	41	50	53	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34185	34193		10.1074/jbc.M704939200	http://dx.doi.org/10.1074/jbc.M704939200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17884813	hybrid			2022-12-27	WOS:000251145700033
J	Zhang, WW; Wu, YD; Wu, CY; Gunst, SJ				Zhang, Wenwu; Wu, Yidi; Wu, Chuanyue; Gunst, Susan J.			Integrin-linked kinase regulates N-WASp-mediated actin polymerization and tension development in tracheal smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; CELL-ADHESION; EXTRACELLULAR-MATRIX; TYROSINE PHOSPHORYLATION; CONTRACTILE STIMULATION; SIGNAL-TRANSDUCTION; FOCAL ADHESIONS; CH-ILKBP; PROTEIN; PINCH	The contractile stimulation of smooth muscle tissues stimulates the recruitment of proteins to membrane adhesion complexes and the initiation of actin polymerization. We hypothesized that integrin-linked kinase (ILK), a beta-integrin-binding scaffolding protein and serine/threonine kinase, and its binding proteins, PINCH, and alpha-parvin may be recruited to membrane adhesion sites during contractile stimulation of tracheal smooth muscle to mediate cytoskeletal processes required for tension development. Immunoprecipitation analysis indicted that ILK, PINCH, and alpha-parvin form a stable cytosolic complex and that the ILK.PINCH.alpha-parvin complex is recruited to integrin adhesion complexes in response to acetylcholine (ACh) stimulation where it associates with paxillin and vinculin. Green fluorescent protein (GFP)-ILK and GFP-PINCH were expressed in tracheal muscle tissues and both endogenous and recombinant ILK and PINCH were recruited to the membrane in response to ACh stimulation. The N-terminal LIM1 domain of PINCH binds to ILK and is required for the targeting of the ILK-PINCH complex to focal adhesion sites in fibroblasts during cell adhesion. We expressed the GFP-PINCH LIM1-2 fragment, consisting only of LIM1-2 domains, in tracheal smooth muscle tissues to competitively inhibit the interaction of ILK with PINCH. The PINCH LIM1-2 fragment inhibited the recruitment of endogenous ILK and PINCH to integrin adhesion sites and prevented their association of ILK with beta-integrins, paxillin, and vinculin. The PINCH LIM1-2 fragment also inhibited tension development, actin polymerization, and activation of the actin nucleation initiator, N-WASp. We conclude that the recruitment of the ILK.PINCH.alpha-parvin complex to membrane adhesion complexes is required to initiate cytoskeletal processes required for tension development in smooth muscle.	Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gunst, SJ (corresponding author), 635 Barnhill Dr,MS313, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL029289, R01HL074099, R01HL029289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074099, R01 HL074099-04, R01 HL029289, R01 HL029289-21A2, HL 29289, HL 074099] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barany M, 2001, J BIOL CHEM, V276, P48398, DOI 10.1074/jbc.M106227200; BARNES PJ, 1990, J APPL PHYSIOL, V68, P1777, DOI 10.1152/jappl.1990.68.5.1777; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hirshman CA, 1999, AM J PHYSIOL-LUNG C, V277, pL653, DOI 10.1152/ajplung.1999.277.3.L653; Jones KA, 1999, J PHYSIOL-LONDON, V519, P527, DOI 10.1111/j.1469-7793.1999.0527m.x; Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mishima W, 2004, GENES CELLS, V9, P193, DOI 10.1111/j.1356-9597.2004.00717.x; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; PAVALKO FM, 1995, AM J PHYSIOL-CELL PH, V268, pC563, DOI 10.1152/ajpcell.1995.268.3.C563; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Slack BE, 1998, P NATL ACAD SCI USA, V95, P7281, DOI 10.1073/pnas.95.13.7281; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 1999, J CELL SCI, V112, P4485; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; ZHANG W, 2008, IN PRESS P AM THORAC; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	51	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34568	34580		10.1074/jbc.M704966200	http://dx.doi.org/10.1074/jbc.M704966200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17897939	hybrid			2022-12-27	WOS:000251145700071
J	Chouinard, S; Barbier, O; Belanger, A				Chouinard, Sarah; Barbier, Olivier; Belanger, Alain			UDP-glucuronosyltransferase 2B15 ( UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; HOMEOBOX GENE NKX3.1; HUMAN LIVER; RECEPTOR; EXPRESSION; CDNA; LOCALIZATION; POLYMORPHISM; TISSUE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	Uridine diphosphate-glucuronosyltransferase 2 ( UGT2) B15 and B17 enzymes conjugate dihydrotestosterone ( DHT) and its metabolites androstane-3 alpha,17 beta-diol ( 3 alpha-DIOL) and androsterone (ADT). The presence of UGT2B15/B17 in the epithelial cells of the human prostate has been clearly demonstrated, and significant 3 alpha-DIOL glucuronide and ADT-glucuronide concentrations have been detected in this tissue. The human androgen-dependent cancer cell line, LNCaP, expresses UGT2B15 and -B17 and is also capable of conjugating androgens. To assess the impact of these two genes in the inactivation of androgens in LNCaP cells, their expression was inhibited using RNA interference. The efficient inhibitory effects of a UGT2B15/B17 small interfering RNA ( siRNA) probe was established by the 70% reduction of these UGT mRNA levels, which was further confirmed at the protein levels. The glucuronidation of dihydrotestosterone (DHT), 3 alpha-DIOL, and ADT by LNCaP cell homogenates was reduced by more than 75% in UGT2B15/B17 siRNA-transfected LNCaP cells when compared with cells transfected with a nontarget probe. In UGT2B15/B17-deficient LNCaP cells, we observe a stronger response to DHT than in control cells, as determined by cell proliferation and expression of eight known androgen-sensitive genes. As expected, the amounts of DHT in cell culture media from control cells were significantly lower than that from UGT2B15/B17 siRNA-treated cells, which was caused by a higher conversion to its corresponding glucuronide derivative. Taken together these data support the idea that UGT2B15 and -B17 are critical enzymes for the local inactivation of androgens and that glucuronidation is a major determinant of androgen action in prostate cells.	CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Belanger, A (corresponding author), CHU Laval, Res Ctr, Oncol & Mol Endocrinol Res Ctr, 2705 Laurier Blvd,Bloc T-3, Quebec City, PQ G1V 4G2, Canada.	alain.belanger@ap.ulaval.ca		Barbier, Olivier/0000-0002-3067-1134				Arnold JT, 2005, AM J PHYSIOL-ENDOC M, V288, pE573, DOI 10.1152/ajpendo.00454.2004; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Barbier O, 2000, J CLIN ENDOCR METAB, V85, P4819, DOI 10.1210/jc.85.12.4819; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; Beaulieu M, 1998, BIOCHEM BIOPH RES CO, V248, P44, DOI 10.1006/bbrc.1998.8908; Belanger A, 2003, TRENDS ENDOCRIN MET, V14, P473, DOI 10.1016/j.tem.2003.10.005; BELANGER A, 1990, ANN NY ACAD SCI, V595, P251, DOI 10.1111/j.1749-6632.1990.tb34299.x; BELANGER B, 1989, J STEROID BIOCHEM, V32, P695, DOI 10.1016/0022-4731(89)90514-1; BERNS EMJJ, 1986, PROSTATE, V9, P247, DOI 10.1002/pros.2990090305; CHEN S, 2007, IN PRESS J ANDROL; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; Chouinard S, 2006, ENDOCRINOLOGY, V147, P5431, DOI 10.1210/en.2006-0229; Couture JF, 2005, PROTEIN SCI, V14, P1485, DOI 10.1110/ps.051353205; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dutton G.F., 1980, GLUCURONIDATION DRUG; El-Alfy M, 1999, ENDOCRINOLOGY, V140, P1481, DOI 10.1210/en.140.3.1481; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; FARNSWORTH WE, 1976, ENDOCR RES COMMUN, V3, P105, DOI 10.3109/07435807609052926; GELLER J, 1987, UROL RES, V15, P151; GREEN MD, 1994, DRUG METAB DISPOS, V22, P799; Guillemette C, 1997, ENDOCRINOLOGY, V138, P2998, DOI 10.1210/en.138.7.2998; Guillemette C, 1996, ENDOCRINOLOGY, V137, P2872, DOI 10.1210/en.137.7.2872; GUILLEMETTE C, 1995, MOL CELL ENDOCRINOL, V107, P131, DOI 10.1016/0303-7207(94)03434-U; Hajdinjak T, 2004, PROSTATE, V59, P436, DOI 10.1002/pros.20024; HAMMOND GL, 1978, J ENDOCRINOL, V78, P7, DOI 10.1677/joe.0.0780007; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kanaya J, 2003, ASIAN J ANDROL, V5, P9; Kazmin D, 2006, MOL ENDOCRINOL, V20, P1201, DOI 10.1210/me.2005-0309; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Korkmaz KS, 2000, GENE, V260, P25, DOI 10.1016/S0378-1119(00)00453-4; Korkmaz KS, 2001, DNA CELL BIOL, V20, P435, DOI 10.1089/104454901750361497; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Levesque E, 1998, ENDOCRINOLOGY, V139, P2375, DOI 10.1210/en.139.5.2375; Levesque E, 1997, PHARMACOGENETICS, V7, P317, DOI 10.1097/00008571-199708000-00007; Lin BY, 1999, CANCER RES, V59, P4180; Liu H, 2005, J STEROID BIOCHEM, V94, P173, DOI 10.1016/j.jsbmb.2005.01.023; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MacLeod SL, 2000, ANN SURG ONCOL, V7, P777, DOI 10.1007/s10434-000-0777-3; Okugi H, 2006, CANCER DETECT PREV, V30, P262, DOI 10.1016/j.cdp.2006.04.004; Page ST, 2006, J CLIN ENDOCR METAB, V91, P4374, DOI 10.1210/jc.2006-1411; Park J, 2004, J UROLOGY, V171, P2484, DOI 10.1097/01.ju.0000117748.44313.43; Prescott J, 2007, PROSTATE, V67, P1371, DOI 10.1002/pros.20623; RITTMASTER RS, 1993, J CLIN ENDOCR METAB, V76, P977, DOI 10.1210/jc.76.4.977; SONNENSCHEIN C, 1989, CANCER RES, V49, P3474; Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Vandenput L, 2007, J BONE MINER RES, V22, P220, DOI 10.1359/JBMR.061018; Xu LL, 2000, J UROLOGY, V163, P972, DOI 10.1016/S0022-5347(05)67867-6; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	56	85	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33466	10.1074/jbc.M703370200	http://dx.doi.org/10.1074/jbc.M703370200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17848572	hybrid			2022-12-27	WOS:000250840200027
J	Monterroso, B; Minton, AP				Monterroso, Begona; Minton, Allen P.			Effect of high concentration of inert cosolutes on the refolding of an enzyme - Carbonic anhydrase B in sucrose and Ficoll 70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; PROTEIN STABILITY; DEXTRAN; STATE; DNA	The kinetics of refolding of carbonic anhydrase II following transfer from a buffer containing 5 M guanidinium chloride to a buffer containing 0.5 M guanidinium chloride were studied by measuring the time-dependent recovery of enzymatic activity. Experiments were carried out in buffer containing concentrations of two "inert" cosolutes, sucrose and Ficoll 70, a sucrose polymer, at concentrations up to 150 g/liter. Data analysis indicates that both cosolutes significantly accelerate the rate of refolding to native or compact near-native conformations, but decrease the fraction of catalytically active enzyme recovered in the limit of long time. According to the simplest model that fits the data, both cosolutes accelerate a competing side reaction yielding inactive compact species. Acceleration of the side reaction by Ficoll is significantly greater than that of sucrose at equal w/v concentrations.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Monterroso, B (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	monterrosob@niddk.nih.gov	Monterroso, Begoña/J-9748-2014	Monterroso, Begoña/0000-0003-2538-084X; Minton, Allen/0000-0001-8459-1247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024957, Z01DK024957] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bookchin RM, 1999, J BIOL CHEM, V274, P6689, DOI 10.1074/jbc.274.10.6689; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Derham BK, 2006, BBA-PROTEINS PROTEOM, V1764, P1000, DOI 10.1016/j.bbapap.2006.01.005; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; Gudiksen KL, 2004, ANAL CHEM, V76, P7151, DOI 10.1021/ac0488560; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JOHNSON WC, 1984, OPTICAL ACTIVITY STR, P245; Li J, 2001, J BIOL CHEM, V276, P34396, DOI 10.1074/jbc.M103392200; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; POCKER Y, 1967, BIOCHEMISTRY-US, V6, P668, DOI 10.1021/bi00855a005; Ren GP, 2003, J PROTEIN CHEM, V22, P431, DOI 10.1023/B:JOPC.0000005458.08802.11; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Safarian S, 2006, J BIOCHEM, V139, P1025, DOI 10.1093/jb/mvj115; Saito R, 2004, ACTA CRYSTALLOGR D, V60, P792, DOI 10.1107/S0907444904003166; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; WETLAUFER DB, 1995, PROTEIN SCI, V4, P1535, DOI 10.1002/pro.5560040811; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	29	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33452	33458		10.1074/jbc.M705157200	http://dx.doi.org/10.1074/jbc.M705157200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878163	Green Published, hybrid			2022-12-27	WOS:000250840200025
J	Sipila, L; Ruotsalainen, H; Sormunen, R; Baker, NL; Lamande, SR; Vapola, M; Wang, C; Sado, Y; Aszodi, A; Myllyla, R				Sipilae, Laura; Ruotsalainen, Heli; Sormunen, Raija; Baker, Naomi L.; Lamande, Shireen R.; Vapola, Miia; Wang, Chunguang; Sado, Yoshikazu; Aszodi, Attila; Myllylae, Raili			Secretion and assembly of type IV and VI collagens depend on glycosylation of hydroxylysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYSYL HYDROXYLASE; CONGENITAL MUSCULAR-DYSTROPHY; AMINO-ACID-SEQUENCE; ENDOPLASMIC-RETICULUM; BASEMENT-MEMBRANE; POSTTRANSLATIONAL MODIFICATIONS; LYSYL-HYDROXYLASE-3 LH3; EXTRACELLULAR-MATRIX; TISSUE DISTRIBUTION; MOLECULAR-CLONING	Most lysines in type IV and VI collagens are hydroxylated and glycosylated, but the functions of these unique galactosylhydroxylysyl and glucosylgalactosylhydroxylysyl residues are poorly understood. The formation of glycosylated hydroxy-lysines is catalyzed by multifunctional lysyl hydroxylase 3 (LH3) in vivo, and we have used LH3-manipulated mice and cells as models to study the function of these carbohydrates. These hydroxylysine-linked carbohydrates were shown recently to be indispensable for the formation of basement membranes (Ruotsalainen, H., Sipila , L., Vapola, M., Sormunen, R., Salo, A. M., Uitto, L., Mercer, D. K., Robins, S. P., Risteli, M., Aszodi, A., Fassler, R., and Myllyla, R. ( 2006) J. Cell Sci. 119, 625-635). Analysis of LH3 knock-out embryos and cells in this work indicated that loss of glycosylated hydroxylysines prevents the intracellular tetramerization of type VI collagen and leads to impaired secretion of type IV and VI collagens. Mice lacking the LH activity of LH3 produced slightly underglycosylated type IV and VI collagens with abnormal distribution. The altered distribution and aggregation of type VI collagen led to similar ultrastructural alterations in muscle to those detected in collagen VI knockout and some Ullrich congenital muscular dystrophy patients. Our results provide new information about the function of hydroxylysine-linked carbohydrates of collagens, indicating that they play an important role in the secretion, assembly, and distribution of highly glycosylated collagen types.	Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; Univ Oulu, Dept Pathol, FI-90014 Oulu, Finland; Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Shigei Med Res Inst, Div Immunol, Okayama 7010202, Japan; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Max Planck Society	Myllyla, R (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FI-90014 Oulu, Finland.	raili.myllyla@oulu.fi	Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Wang, Chunguang/0000-0001-5569-321X; Ruotsalainen, Heli/0000-0003-4923-5196; Salo, Miia/0000-0003-2085-7880; Lamande, Shireen/0000-0003-2938-2711				ARMSTRONG LC, 1995, BBA-GENE STRUCT EXPR, V1264, P93, DOI 10.1016/0167-4781(95)00130-9; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHU ML, 1988, J BIOL CHEM, V263, P18601; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishikawa H, 2004, NEUROLOGY, V62, P620, DOI 10.1212/01.WNL.0000113023.84421.00; KIELTY CM, 2002, CONNECTIVE TISSUE IT, P103; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1995, PRINCIPLES MED BIOL; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Robins SP, 2002, PRINCIPLES BONE BIOL, V1, P211; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Timpl R., 1994, EXTRACELLULAR MATRIX; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200	48	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33381	33388		10.1074/jbc.M704198200	http://dx.doi.org/10.1074/jbc.M704198200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17873278	hybrid			2022-12-27	WOS:000250840200017
J	Arpin-Andre, C; Mesnard, JM				Arpin-Andre, Charlotte; Mesnard, Jean-Michel			The PDZ domain-binding motif of the human T cell leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor hScrib in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HOMOLOG; SIGNALING PATHWAYS; HPV E6; SCRIBBLE; PROLIFERATION; ONCOPROTEIN; EXPRESSION; POLARITY; COMPLEX; GROWTH	Interactions with cellular PDZ domain-containing proteins obviously contribute to the tumorigenic potential of several viral oncoproteins. In this regard, the oncogenic potential of the human T cell leukemia virus type 1 Tax protein correlates with its binding capacity to the tumor suppressor hDlg. Recent results show that hDlg in T cells is associated to a network of scaffolding proteins including another PDZ domain-containing protein termed hScrib. Interestingly, previous studies have revealed complementary activities of both proteins in the control of epithelial cell polarity. Here, we demonstrate that Tax can bind to hScrib and that the resulting Tax/hScrib complex is present in human T cell leukemia virus type 1-infected T cells. By confocal microscopy, we show that Tax modifies the localization of hScrib in transfected COS cells as well as in infected T cell lines and targets hScrib to particular spots exhibiting a granular distribution, mainly distributed in the cytoplasm. Given that Tax sequesters hScrib to these particular structures, we postulate that Tax might inhibit hScrib activity. Providing further support to this idea, we find that transient overexpression of hScrib attenuates T cell receptor-induced NFAT activity but that the presence of Tax counteracts this negative effect on the NFAT pathway. The fact that hDlg and hScrib are both targeted by Tax underlies their importance in T cell function.	Inst Biol, Ctr Etudes Agents Pathogenes & Biotechnol Sante, CNRS, UM 1,UM 2,UMR 5236,IFR 122, F-34965 Montpellier 2, France	Centre National de la Recherche Scientifique (CNRS)	Mesnard, JM (corresponding author), Inst Biol, Ctr Etudes Agents Pathogenes & Biotechnol Sante, CNRS, UM 1,UM 2,UMR 5236,IFR 122, CS 69033,4 BD Henri IV, F-34965 Montpellier 2, France.	jean-michel.mesnard@univ-montp1.fr		Mesnard, Jean-Michel/0000-0003-3344-5367				Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hirata A, 2004, VIROLOGY, V318, P327, DOI 10.1016/j.virol.2003.10.006; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; MALEFYT RD, 1990, J IMMUNOL, V145, P2297; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Mesnard JM, 2006, PROGRESS IN VIRUS RESEARCH, P1; Mesnard JM, 1999, VIROLOGY, V257, P277, DOI 10.1006/viro.1999.9685; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; NOURRY C, 2003, SCI STKE, V179, P1; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Takizawa S, 2006, GENES CELLS, V11, P453, DOI 10.1111/j.1365-2443.2006.00954.x; Tsubata C, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-46; Weil R, 1999, J VIROL, V73, P3709, DOI 10.1128/JVI.73.5.3709-3717.1999; Wilkinson B, 2004, IMMUNOLOGY, V111, P368, DOI 10.1111/j.0019-2805.2004.01832.x; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333	51	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33132	33141		10.1074/jbc.M702279200	http://dx.doi.org/10.1074/jbc.M702279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17855372	hybrid, Green Published			2022-12-27	WOS:000250625400061
J	Hinz, M; Broemer, M; Arslan, SC; Otto, A; Mueller, EC; Dettmer, R; Scheidereit, C				Hinz, Michael; Broemer, Meike; Arslan, Seda Coel; Otto, Albrecht; Mueller, Eva-Christina; Dettmer, Rudolf; Scheidereit, Claus			Signal responsiveness of I kappa B kinases is determined by Cdc37-assisted transient interaction with Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-GAMMA; MOLECULAR CHAPERONE; COMPLEX ACTIVITY; VIVO FUNCTION; ATP BINDING; ACTIVATION; CDC37; ALPHA; PATHWAYS; TRANSCRIPTION	The I kappa B kinase (IKK) holocomplex, containing the kinases IKK alpha, IKK beta, and the scaffold NEMO (NF-kappa B essential modifier), mediates activation of NF-kappa B by numerous physiological stimuli. Heat shock protein 90 (Hsp90) and the co-chaperone Cdc37 have been indicated as additional subunits, but their specific functions in signal transduction are indistinct. Using an RNA interference approach, we demonstrate that Cdc37 recruits Hsp90 to the IKK complex in a transitory manner, preferentially via IKK alpha. Binding is conferred by N-terminal as well as C-terminal residues of Cdc37. Cdc37 is essential for the maturation of de novo synthesized IKKs into enzymatically competent kinases but not for assembly of an IKK holocomplex. Mature IKKs, T-loop-phosphorylated after stimulation either by receptor-mediated signaling or upon DNA damage, further require Hsp90-Cdc37 to generate an activated state. Thus, the present data denote Hsp90-Cdc37 as a transiently acting essential regulatory component of IKK signaling.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Scheidereit, C (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	scheidereit@mdc-berlin.de	Hinz, Michael/HCI-0550-2022	Hinz, Michael/0000-0003-2611-4121				Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pittet JF, 2005, J IMMUNOL, V174, P384, DOI 10.4049/jimmunol.174.1.384; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Santel A, 2006, GENE THER, V13, P1222, DOI 10.1038/sj.gt.3302777; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Sugita T, 1999, BIOCHEM MOL BIOL INT, V47, P587; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Voss AK, 2000, DEVELOPMENT, V127, P1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	48	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2007	282	44					32311	32319		10.1074/jbc.M705785200	http://dx.doi.org/10.1074/jbc.M705785200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	224WY	17728246	hybrid			2022-12-27	WOS:000250480300054
J	Jimenez-Sanchez, M; Cid, VJ; Molina, M				Jimenez-Sanchez, Maria; Cid, Victor J.; Molina, Maria			Retrophosphorylation of mkk1 and mkk2 MAPKKs by the Slt2 MAPK in the yeast cell integrity pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SITE-DIRECTED MUTAGENESIS; SIGNAL-REGULATED KINASE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; FEEDBACK PHOSPHORYLATION; SCAFFOLD PROTEIN; ERK ACTIVATION; MEK1; CASCADE	In Saccharomyces cerevisiae, a variety of stresses and aggressions to the cell wall stimulate the activation of the cell wall integrity MAPK pathway, which triggers the expression of a series of genes important for the maintenance of cell wall homeostasis. This MAPK module lies downstream of the Rho1 small GTPase and protein kinase C Pkc1 and consists of MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the Slt2 MAPK. In agreement with previous reports suggesting that Mkk1 and Mkk2 were functionally redundant, we show here that both Mkk1 and Mkk2 alone or even chimerical proteins constructed by interchanging their catalytic and regulatory domains are able to efficiently maintain signal transduction through the pathway. Both Mkk1 and Mkk2 are phosphorylated in vivo concomitant to activation of the cell integrity pathway. Interestingly, hyperphosphorylation of the MEKs required not only the upstream components of the pathway, but also a catalytically competent Slt2 MAPK downstream. Active Slt2 purified from yeast extracts was able to phosphorylate Mkk1 and Mkk2 in vitro. We have mapped Ser(50) as a direct phosphorylation target for Slt2 in Mkk2. However, substitution of all (Ser/Thr)-Pro canonical MAPK target sites with alanine did not totally abrogate Slt2-dependent Mkk2 phosphorylation. Mutation or deletion of a conserved MAPK-docking site at the N-terminal extension of Mkk2 precluded its interaction with Slt2 and negatively affected retrophosphorylation. Our data show that the cell wall integrity MAPKKs are targets for their downstream MAPK, suggesting the existence of complex feedback regulatory mechanisms at this	Univ Complutense Madrid, Fac Pharm, Dept Microbiol II, E-28040 Madrid, Spain; Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Pza Ramon Cajal S-N, E-28040 Madrid, Spain.	vicjcid@farm.ucm.es	JIMENEZ CID, VICTOR/ABC-4858-2021; CID, VICTOR JIMENEZ/I-1240-2015; Jimenez-Sanchez, Maria/ABH-7666-2020; Molina, Maria/ABE-7186-2021	JIMENEZ CID, VICTOR/0000-0002-3933-2016; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Jimenez-Sanchez, Maria/0000-0002-2287-1582; Molina, Maria/0000-0003-0074-3309				Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CHEN RE, 2007, BIOCHIM BIOPHYS ACTA, V1771, P353; CHOI KY, 1994, CELL, V78, P499; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; DOHLMAN HG, 2006, SCI STKE; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Errede B, 1996, PHILOS T ROY SOC B, V351, P143, DOI 10.1098/rstb.1996.0010; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; Paravicini G, 1996, MOL GEN GENET, V251, P682, DOI 10.1007/s004380050217; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; SOLER M, 1995, MOL MICROBIOL, V17, P833, DOI 10.1111/j.1365-2958.1995.mmi_17050833.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; van Drogen F, 2002, CURR BIOL, V12, P1698, DOI 10.1016/S0960-9822(02)01186-7; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	53	35	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31174	31185		10.1074/jbc.M706270200	http://dx.doi.org/10.1074/jbc.M706270200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17711850	hybrid			2022-12-27	WOS:000250309200007
J	Abell, AN; Granger, DA; Johnson, GL				Abell, Amy N.; Granger, Deborah A.; Johnson, Gary L.			MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; KINASE KINASE KINASE; NEURAL-TUBE CLOSURE; INDUCED ACTIVATION; TERMINAL KINASE; AXIN; JUN; APOPTOSIS; GSK3; GSK-3-BETA	The MAPK kinase kinase MEKK4 is required for neurulation and skeletal patterning during mouse development. MEKK4 phosphorylates and activates MKK4/MKK7 and MKK3/MKK6 leading to the activation of JNK and p38, respectively. MEKK4 is believed to be auto-inhibited, and its interaction with other proteins controls its dimerization and activation. TRAF4, GADD45, and Axin each bind and activate MEKK4, with TRAF4 and Axin binding to the kinase domain and GADD45 binding within the N-terminal regulatory domain. Here we show that similar to the interaction with TRAF4 and Axin, the kinase domain of MEKK4 interacts with the multifunctional serine/threonine kinase GSK3 beta. GSK3 beta binding to MEKK4 blocks MEKK4 dimerization that is required for MEKK4 activation, effectively inhibiting MEKK4 stimulation of the JNK and p38 MAPK pathways. Inhibition of GSK3 beta kinase activity with SB216763 results in enhanced MEKK4 kinase activity and increased JNK and p38 activation, indicating that an active state of GSK3 beta is required for binding and inhibition of MEKK4 dimerization. Furthermore, GSK3 beta phosphorylates specific serines and threonines in the N terminus of MEKK4. Together, these findings demonstrate that GSK3 beta binds to the kinase domain of MEKK4 and regulates MEKK4 dimerization. However, unlike TRAF4, Axin, and GADD45, GSK3 beta inhibits MEKK4 activity and prevents its activation of JNK and p38. Thus, control of MEKK4 dimerization is regulated both positively and negatively by its interaction with specific proteins.	Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Abell, AN (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, 1012 Mary Ellen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	amy_abell@med.unc.edu			NIGMS NIH HHS [GM30324] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030324, R37GM030324] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Abell AN, 2005, J BIOL CHEM, V280, P35793, DOI 10.1074/jbc.C500260200; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Chan-Hui PY, 1998, BIOCHEM J, V336, P599, DOI 10.1042/bj3360599; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Liu SY, 2004, J BIOL CHEM, V279, P51075, DOI 10.1074/jbc.M408607200; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; MIYAKE Z, 2007, J BIOL, V27, P2765; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	27	45	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30476	30484		10.1074/jbc.M705783200	http://dx.doi.org/10.1074/jbc.M705783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17726008	hybrid			2022-12-27	WOS:000250136300015
J	Collingwood, TS; Smirnova, EV; Bogush, M; Carpino, N; Annan, RS; Tsygankov, AY				Collingwood, Therese S.; Smirnova, Evgeniya V.; Bogush, Marina; Carpino, Nick; Annan, Roland S.; Tsygankov, Alexander Y.			T-cell ubiquitin ligand affects cell death through a functional interaction with apoptosis-inducing factor, a key factor of caspase-independent apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPESVIRUS-SAIMIRI; CONTAINING PROTEIN; DNA-DEGRADATION; FACTOR AIF; MITOCHONDRIAL; LYMPHOCYTES; RELEASE; IDENTIFICATION; INHIBITOR; PATHWAY	The lymphoid protein T-cell ubiquitin ligand (TULA)/suppressor of T-cell receptor signaling (Sts)-2 is associated with c-Cbl and ubiquitylated proteins and has been implicated in the regulation of signaling mediated by protein-tyrosine kinases. The results presented in this report indicate that TULA facilitates T-cell apoptosis independent of either T-cell receptor/CD3-mediated signaling or caspase activity. Mass spectrometry based analysis of protein-protein interactions of TULA demonstrates that TULA binds to the apoptosis-inducing protein AIF, which has previously been shown to function as a key factor of caspase-independent apoptosis. Using RNA interference, we demonstrate that AIF is essential for the apoptotic effect of TULA. Analysis of the subcellular localization of TULA and AIF together with the functional analysis of TULA mutants is consistent with the idea that TULA enhances the apoptotic effect of AIF by facilitating the interactions of AIF with its apoptotic co-factors, which remain to be identified. Overall, our results shed new light on the biological functions of TULA, a recently discovered protein, describing its role as one of very few known functional interactors of AIF.	Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; GlaxoSmithKline Inc, Proteom & Biol Mass Spectrometry Lab, King Of Prussia, PA 19406 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11738 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; GlaxoSmithKline; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsygankov, AY (corresponding author), Kresge Bldg,Rm 506,3400 N Broad St, Philadelphia, PA 19140 USA.	alexander.tsygankov@temple.edu	Smirnova, Evgeniya/ABA-7468-2021; Tsygankov, Alexander Y/K-6205-2017	Smirnova, Evgeniya/0000-0002-9744-952X; 	NCI NIH HHS [CA78499] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078499] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn HJ, 2004, J CELL BIOCHEM, V91, P1043, DOI 10.1002/jcb.20006; Artus C, 2006, ONCOGENE, V25, P5741, DOI 10.1038/sj.onc.1209581; Boisvieux-Ulrich E, 2005, EXP CELL RES, V307, P76, DOI 10.1016/j.yexcr.2005.02.005; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Dumont C, 2000, BLOOD, V96, P1030, DOI 10.1182/blood.V96.3.1030.015k21_1030_1038; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Hasham MG, 2004, VIROLOGY, V320, P313, DOI 10.1016/j.virol.2003.11.032; Ishitsuka K, 2005, ONCOGENE, V24, P5888, DOI 10.1038/sj.onc.1208739; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinkoski MJ, 2006, CURR DIRECT AUTOIMMU, V9, P55; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raymond AD, 2004, VIROLOGY, V324, P60, DOI 10.1016/j.virol.2004.03.021; Skoblenick KJ, 2006, APOPTOSIS, V11, P663, DOI 10.1007/s10495-006-5698-6; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tiwari M, 2006, CARCINOGENESIS, V27, P2047, DOI 10.1093/carcin/bgl051; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wattenhofer M, 2001, HUM GENET, V108, P140, DOI 10.1007/s004390000453; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687	43	34	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30920	30928		10.1074/jbc.M706870200	http://dx.doi.org/10.1074/jbc.M706870200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17709377	hybrid			2022-12-27	WOS:000250136300060
J	Sbodio, JI; Machamer, CE				Sbodio, Juan I.; Machamer, Carolyn E.			Identification of a redox-sensitive cysteine in GCP60 that regulates its interaction with golgin-160	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SULFENIC ACIDS; MOLECULAR CHARACTERIZATION; REVERSIBLE OXIDATION; S-NITROSYLATION; APOPTOSIS; MEMBRANE; COMPLEX; AUTOANTIGENS; EXOCYTOSIS; STEROIDOGENESIS	Golgin-160 is ubiquitously expressed in vertebrates. It localizes to the cytoplasmic side of the Golgi and has a large C-terminal coiled-coil domain. The noncoiled-coil N-terminal head domain contains Golgi targeting information, a cryptic nuclear localization signal, and three caspase cleavage sites. Caspase cleavage of the golgin-160 head domain generates different fragments that can translocate to the nucleus by exposing the nuclear localization signal. We have previously shown that GCP60, a Golgi resident protein, interacts weakly with the golgin160 head domain but has a strong interaction with one of the caspase-generated golgin-160 fragments ( residues 140-311). This preferential interaction increases the Golgi retention of the golgin-160 fragment in cells overexpressing GCP60. Here we studied the interaction of golgin-160-( 140-311) with GCP60 and identified a single cysteine residue in GCP60 ( Cys-463) that is critical for the interaction of the two proteins. Mutation of the cysteine blocked the interaction in vitro and disrupted the ability to retain the golgin-160 fragment at the Golgi in cells. We also found that Cys-463 is redox-sensitive; in its reduced form, interaction with golgin-160 was diminished or abolished, whereas oxidation of the Cys-463 by hydrogen peroxide restored the interaction. In addition, incubation with a nitric oxide donor promoted this interaction in vitro. These findings suggest that nuclear translocation of golgin-160-( 140-311) is a highly coordinated event regulated not only by cleavage of the golgin-160 head but also by the oxidation state of GCP60.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Machamer, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 Wolfe St, Baltimore, MD 21205 USA.	machamer@jhmi.edu			NIGMS NIH HHS [GM42522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantharaman V, 2002, GENOME BIOL, V3; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; BUNDIS F, 2003, CELL PHYSIOL BIOCHEM, V17, P1; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Forrester MT, 2007, AM J RESP CELL MOL, V36, P135, DOI 10.1165/rcmb.2006-001ED; FRITZLER MJ, 1993, J EXP MED, V178, P49, DOI 10.1084/jem.178.1.49; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Jacob C, 2006, BIOL CHEM, V387, P1385, DOI 10.1515/BC.2006.174; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowenstein CJ, 2006, BIOL CHEM, V387, P1377, DOI 10.1515/BC.2006.173; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Misumi Y, 1997, J BIOL CHEM, V272, P23851, DOI 10.1074/jbc.272.38.23851; Nozawa K, 2005, AUTOIMMUN REV, V4, P35, DOI 10.1016/j.autrev.2004.06.002; Nozawa K, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar422; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	39	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					29874	29881		10.1074/jbc.M705794200	http://dx.doi.org/10.1074/jbc.M705794200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711851	hybrid			2022-12-27	WOS:000249981200016
J	Mans, J; Natarajan, K; Balbo, A; Schuck, P; Eikel, D; Hess, S; Robinson, H; Simic, H; Jonjic, S; Tiemessen, CT; Margulies, DH				Mans, Janet; Natarajan, Kannan; Balbo, Andrea; Schuck, Peter; Eikel, Daniel; Hess, Sonja; Robinson, Howard; Simic, Hrvoje; Jonjic, Stipan; Tiemessen, Caroline T.; Margulies, David H.			Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE DNA-SEQUENCE; NATURAL-KILLER-CELLS; MOUSE CYTOMEGALOVIRUS; IMMUNOGLOBULIN SUPERFAMILY; IMMUNE EVASION; MOLECULES; RECEPTOR; LIGAND; ACTIVATION; HOMOLOG	Mouse cytomegalovirus (MCMV), a beta-herpesvirus that establishes latent and persistent infections in mice, is a valuable model for studying complex virus-host interactions. MCMV encodes the m145 family of putative immunoevasins with predicted major histocompatibility complex, class I (MHC-I) structure. Functions attributed to some family members include down-regulation of host MHC-I (m152) and NKG2D ligands (m145, m152, and m155) and interaction with inhibitory or activating NK receptors (m157). We present the cellular, biochemical, and structural characterization of m153, which is a heavily glycosylated homodimer, that does not require beta 2m or peptide and is expressed at the surface of MCMV-infected cells. Its 2.4-angstrom crystal structure confirms that this compact molecule preserves an MHC-I-like fold and reveals a novel mode of dimerization, confirmed by site-directed mutagenesis, and a distinctive disulfide-stabilized extended N terminus. The structure provides a useful framework for comparative analysis of the divergent members of the m145 family.	NIAID, Immunol Lab, Mol Biol Sect, Bethesda, MD 20892 USA; NIH, Off Director, Bethesda, MD 20892 USA; Prod Appl Lab, Ithaca, NY 14850 USA; CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka 51000, Croatia; Univ Witwatersrand, Dept Virol, ZA-2050 Johannesburg, South Africa; Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; California Institute of Technology; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Rijeka; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Margulies, DH (corresponding author), NIAID, Immunol Lab, Mol Biol Sect, 10 Ctr Dr, Bethesda, MD 20892 USA.	dhm@nih.gov	Jonjic, Stipan/C-5657-2016; Hess, Sonja/K-4842-2013; Schuck, Peter/AAA-6888-2020; Simic, Hrvoje/S-8491-2018	Jonjic, Stipan/0000-0001-5003-3108; Hess, Sonja/0000-0002-5904-9816; Schuck, Peter/0000-0002-8859-6966; Simic, Hrvoje/0000-0001-8477-3198; Tiemessen, Caroline/0000-0002-0991-1690; Margulies, David/0000-0001-8530-7375; Mans, Janet/0000-0001-6721-1177	Intramural NIH HHS [Z01 AI000622-16] Funding Source: Medline; Wellcome Trust [076352] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001028, Z01AI000622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [Z01EB000008] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chapman TL, 1998, J VIROL, V72, P460, DOI 10.1128/JVI.72.1.460-466.1998; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Hasan M, 2005, J VIROL, V79, P2920, DOI 10.1128/JVI.79.5.2920-2930.2005; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Krmpotic A, 2005, J EXP MED, V201, P211, DOI 10.1084/jem.20041617; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Lodoen MB, 2004, J EXP MED, V200, P1075, DOI 10.1084/jem.20040583; MARGULIES DH, IN PRESS FUNDAMENTAL; Mathys S, 2003, J INFECT DIS, V187, P988, DOI 10.1086/368094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natarajan K, 2006, J MOL BIOL, V358, P157, DOI 10.1016/j.jmb.2006.01.068; Natarajan K, 1999, Rev Immunogenet, V1, P32; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith LM, 2006, VIROLOGY, V352, P450, DOI 10.1016/j.virol.2006.04.031; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1989, COLD SH Q B, V54, P299; Vink C, 2000, J VIROL, V74, P7656, DOI 10.1128/JVI.74.16.7656-7665.2000; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Wills MR, 2005, J IMMUNOL, V175, P7457, DOI 10.4049/jimmunol.175.11.7457	49	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35247	35258		10.1074/jbc.M706782200	http://dx.doi.org/10.1074/jbc.M706782200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17897947	hybrid, Green Accepted			2022-12-27	WOS:000251155200069
J	Laufer, M; Nandula, SV; Modi, AP; Wang, S; Jasin, M; Murty, VVVS; Ludwig, T; Baer, R				Laufer, Marsha; Nandula, Subhadra V.; Modi, Ami P.; Wang, Shuang; Jasin, Maria; Murty, Vundavalli V. V. S.; Ludwig, Thomas; Baer, Richard			Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; CANCER-PREDISPOSING MUTATIONS; STRAND BREAK REPAIR; RING DOMAIN; BRCT DOMAINS; OVARIAN-CANCER; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; CYS557SER ALLELE; MAMMALIAN-CELLS	The BRCA1 tumor suppressor exists as a heterodimeric complex with BARD1, and this complex is thought to mediate many of the functions ascribed to BRCA1, including its role in tumor suppression. The two proteins share a common structural organization that features an N-terminal RING domain and two C-terminal BRCT motifs, whereas BARD1 alone also contains three tandem ankyrin repeats. In normal cells, the BRCA1/BARD1 heterodimer is believed to enhance chromosome stability by promoting homology-directed repair (HDR) of double strand DNA breaks. Here we have investigated the structural requirements for BARD1 in this process by complementation of Bard1-null mouse mammary carcinoma cells. Our results demonstrate that the ankyrin and BRCT motifs of BARD1 are each essential for both chromosome stability and HDR. Tandem BRCT motifs, including those found at the C terminus of BARD1, are known to form a phosphoprotein recognition module. Nonetheless, the HDR function of BARD1 was not perturbed by synthetic mutations predicted to ablate the phosphorecognition activity of its BRCT sequences, suggesting that some functions of the BRCT domains are not dependent on their ability to bind phosphorylated ligands. Also, cancer-associated missense mutations in the BRCT domains of BARD1 (e.g. C557S, Q564H, V695L, and S761N) have been observed in patients with breast, ovarian, and endometrial tumors. However, none of these was found to affect the HDR activity of BARD1, suggesting that any increased cancer risk conferred by these mutations is not because of defects in this repair mechanism.	Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pathol & Cell Biol,Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA	Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Baer, R (corresponding author), Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Pathol & Cell Biol,Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	rb670@columbia.edu	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585	NATIONAL CANCER INSTITUTE [P01CA094060, T32CA009503, P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 009503, P01 CA 97403, P01 CA097403, P01 CA 94060, P01 CA094060] Funding Source: Medline; NIGMS NIH HHS [R01 GM054668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ghimenti C, 2002, GENE CHROMOSOME CANC, V33, P235, DOI 10.1002/gcc.1223; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Karppinen SM, 2006, J MED GENET, V43, P856, DOI 10.1136/jmg.2006.041731; Karppinen SM, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020669; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Reidt W, 2006, EMBO J, V25, P4326, DOI 10.1038/sj.emboj.7601313; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sauer MK, 2005, J MED GENET, V42, P633, DOI 10.1136/jmg.2004.030049; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Vahteristo P, 2006, EUR J HUM GENET, V14, P167, DOI 10.1038/sj.ejhg.5201542; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	50	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34325	34333		10.1074/jbc.M705198200	http://dx.doi.org/10.1074/jbc.M705198200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17848578	Green Published, hybrid			2022-12-27	WOS:000251145700048
J	Nelson, MR; Luo, H; Vari, HK; Cox, BJ; Simmonds, AJ; Krause, HM; Lipshitz, HD; Smibert, CA				Nelson, Meryl R.; Luo, Hua; Vari, Heli K.; Cox, Brian J.; Simmonds, Andrew J.; Krause, Henry M.; Lipshitz, Howard D.; Smibert, Craig A.			A multiprotein complex that mediates translational enhancement in drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANOS MESSENGER-RNA; KH-DOMAIN PROTEIN; BINDING PROTEIN; HNRNPA/B HOMOLOG; AFFINITY TAGS; IN-VITRO; YEAST; SCP160P; HRP48; SMAUG	Modulating the efficiency of translation plays an important role in a wide variety of cellular processes and is often mediated by trans-acting factors that interact with cis-acting sequences within the mRNA. Here we show that a cis-acting element, the Hsp83 degradation element (HDE), within the 3'-untranslated region of the Drosophila Hsp83 mRNA functions as a translational enhancer. We show that this element is bound by a multiprotein complex, and we identify components using a novel affinity-based method called tandem RNA affinity purification tagging. Three proteins (DDP1, Hrp48, and poly(A)-binding protein) are components of the HDE-binding complex and function in translational enhancement. Our data support a model whereby the HDE is composed of several cis-acting subelements that represent binding sites for trans-acting factors, and the combined action of these trans-acting factors underlies the ability of the HDE to stimulate translation.	Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Smibert, CA (corresponding author), 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	c.smibert@utoronto.ca	Simmonds, Andrew J/D-3675-2009	Krause, Henry/0000-0002-6182-7074; Simmonds, Andrew/0000-0001-7165-9302; Lipshitz, Howard/0000-0002-7372-4419				Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Cortes A, 1999, EMBO J, V18, P3820, DOI 10.1093/emboj/18.13.3820; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Hirao I, 1998, MOL DIVERS, V4, P75, DOI 10.1023/A:1026401917416; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Kanamori H, 1998, MOL CELL BIOL, V18, P3991, DOI 10.1128/MCB.18.7.3991; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Lang BD, 2000, NUCLEIC ACIDS RES, V28, P1576, DOI 10.1093/nar/28.7.1576; Li AM, 2003, NUCLEIC ACIDS RES, V31, P1830, DOI 10.1093/nar/gkg284; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Srisawat C, 2002, METHODS, V26, P156, DOI 10.1016/S1046-2023(02)00018-X; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Wells DR, 1998, GENE DEV, V12, P3236, DOI 10.1101/gad.12.20.3236; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7	29	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34031	34038		10.1074/jbc.M706363200	http://dx.doi.org/10.1074/jbc.M706363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17890223	hybrid			2022-12-27	WOS:000251145700017
J	Chae, K; Zhang, K; Zhang, L; Morikis, D; Kim, ST; Mollet, JC; de la Rosa, N; Tan, K; Lord, EM				Chae, Keun; Zhang, Kangling; Zhang, Li; Morikis, Dimitrios; Kim, Sun Tae; Mollet, Jean-Claude; de la Rosa, Noelle; Tan, Kimberly; Lord, Elizabeth M.			Two SCA (stigma/style cysteine-rich adhesin) Isoforms show structural differences that correlate with their levels of in vitro pollen tube adhesion activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-TRANSFER PROTEIN; ANTIMICROBIAL PROTEIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ACYL-BINDING; SWISS-MODEL; MAIZE; FLUORESCENCE; EXPRESSION; ELECTROSTATICS	Lily pollen tubes grow adhering to an extracellular matrix produced by the transmitting tract epidermis in a hollow style. SCA, a small (similar to 9.4 kDa), basic protein plus low esterified pectin from this extracellular matrix are involved in the pollen tube adhesion event. The mode of action for this adhesion event is unknown. We partially separated three SCA iso-forms from the lily stigma in serial size exclusion column fractions (SCA1, 9370 Da; SCA2, 9384 Da; SCA3, 9484 Da). Peptide sequencing analysis allowed us to determine two amino acid variations in SCA3, compared with SCA1. For SCA2, however, there are more sequence variations yet to be identified. Our structural homology and molecular dynamics modeling results show that SCA isoforms have the plant nonspecific lipid transfer protein-like structure: a globular shape of the orthogonal 4-helix bundle architecture, four disulfide bonds, an internal hydrophobic and solvent-inaccessible cavity, and a long C-terminal tail. The Ala(71) in SCA3, replacing the Gly(71) in SCA1, has no predictable effect on structure. The Arg(26) in SCA3, replacing the Gly(26) in SCA1, is predicted to cause structural changes that result in a significantly reduced volume for the internal hydrophobic cavity in SCA3. The volume of the internal cavity fluctuates slightly during the molecular dynamics simulation, but overall, SCA1 displays a larger cavity than SCA3. SCA1 displays higher activity than SCA3 in the in vitro pollen tube adhesion assay. No differences were found between the two SCAs in a binding assay with pectin. The larger size of the hydrophobic cavity in SCA1 correlates with its higher adhesion activity.	Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Mass Spectrometry Facil, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea; Univ Rouen, CNRS, UMR 6037, IRFPM 23,Lab Glycobiol & Transports Chez Vegetaux, F-76821 Mont St Aignan, France	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Gyeongsang National University; Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie	Lord, EM (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	lord@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665; Mollet, Jean-Claude/0000-0001-8717-0034				Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Antosiewicz J, 1996, BIOCHEMISTRY-US, V35, P7819, DOI 10.1021/bi9601565; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNHARD WR, 1991, PLANT PHYSIOL, V95, P164, DOI 10.1104/pp.95.1.164; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAMMUE BRUNO PA, 1995, PLANT PHYSIOL, V109, P445, DOI 10.1104/pp.109.2.445; Capocchi A, 2005, J AGR FOOD CHEM, V53, P7976, DOI 10.1021/jf0580465; Castro MS, 2003, J CHROMATOGR B, V794, P109, DOI 10.1016/S1570-0232(03)00423-9; Charvolin D, 1999, EUR J BIOCHEM, V264, P562, DOI 10.1046/j.1432-1327.1999.00667.x; Da Silva P, 2005, PROTEINS, V59, P356, DOI 10.1002/prot.20405; Dominy BN, 1999, J PHYS CHEM B, V103, P3765, DOI 10.1021/jp984440c; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Douliez JP, 2000, BBA-BIOMEMBRANES, V1467, P65, DOI 10.1016/S0005-2736(00)00197-8; Douliez JP, 2001, EUR J BIOCHEM, V268, P384, DOI 10.1046/j.1432-1033.2001.01889.x; Douliez JP, 2001, EUR J BIOCHEM, V268, P1400, DOI 10.1046/j.1432-1327.2001.02007.x; Douliez JP, 2000, J CEREAL SCI, V32, P1, DOI 10.1006/jcrs.2000.0315; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; GILSON MK, 1993, PROTEINS, V15, P266, DOI 10.1002/prot.340150305; Gomar J, 1996, PROTEIN SCI, V5, P565; Gomar J, 1997, FOLD DES, V2, P183, DOI 10.1016/S1359-0278(97)00025-4; Gomar J, 1998, PROTEINS, V31, P160, DOI 10.1002/(SICI)1097-0134(19980501)31:2<160::AID-PROT6>3.0.CO;2-Q; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Han GW, 2001, J MOL BIOL, V308, P263, DOI 10.1006/jmbi.2001.4559; Heinemann B, 1996, PROTEIN SCI, V5, P13; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jauh GY, 1997, SEX PLANT REPROD, V10, P173, DOI 10.1007/s004970050085; Kader JC, 1997, TRENDS PLANT SCI, V2, P66, DOI 10.1016/S1360-1385(97)82565-4; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lerche MH, 1998, PROTEIN SCI, V7, P2490, DOI 10.1002/pro.5560071202; Lin KF, 2005, BIOCHEMISTRY-US, V44, P5703, DOI 10.1021/bi047608v; Liu YJ, 2002, BIOCHEM BIOPH RES CO, V294, P535, DOI 10.1016/S0006-291X(02)00509-0; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lord EM, 2003, J EXP BOT, V54, P47, DOI 10.1093/jxb/54.380.47; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Lord EM, 2001, SEX PLANT REPROD, V14, P57, DOI 10.1007/s004970100076; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Molina A, 1997, PLANT J, V12, P669, DOI 10.1046/j.1365-313X.1997.00669.x; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Mollet Jean-Claude, 2007, V25, P69, DOI 10.1002/9780470988824.ch4; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nieuwland J, 2005, PLANT CELL, V17, P2009, DOI 10.1105/tpc.105.032094; OSTERGAARD J, 1995, BBA-LIPID LIPID MET, V1254, P169, DOI 10.1016/0005-2760(94)00180-7; Park SY, 2003, PLANT MOL BIOL, V51, P183, DOI 10.1023/A:1021139502947; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Petsko G., 2004, PROTEIN STRUCTURE FU; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; Sodano P, 1997, FEBS LETT, V416, P130, DOI 10.1016/S0014-5793(97)01185-X; Tassin S, 1998, BIOCHEMISTRY-US, V37, P3623, DOI 10.1021/bi9723515; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VIGNOLS F, 1994, GENE, V142, P265, DOI 10.1016/0378-1119(94)90272-0; Wu JZ, 2006, FLUID PHASE EQUILIBR, V241, P317, DOI 10.1016/j.fluid.2005.12.044; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Zachowski A, 1998, EUR J BIOCHEM, V257, P443, DOI 10.1046/j.1432-1327.1998.2570443.x	65	27	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33845	33858		10.1074/jbc.M703997200	http://dx.doi.org/10.1074/jbc.M703997200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17878166	Green Published, hybrid			2022-12-27	WOS:000250840200066
J	Kurimoto, E; Suzuki, M; Amemiya, E; Yamaguchi, Y; Nirasawa, S; Shimba, N; Xu, N; Kashiwagi, T; Kawai, M; Suzuki, E; Kato, K				Kurimoto, Eiji; Suzuki, Maiko; Amemiya, Eiko; Yamaguchi, Yoshiki; Nirasawa, Satoru; Shimba, Nobuhisa; Xu, Ningchun; Kashiwagi, Tatsuki; Kawai, Misako; Suzuki, Ei-ichiro; Kato, Koichi			Curculin exhibits sweet-tasting and taste-modifying activities through its distinct molecular surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOTECHNOLOGICAL PRODUCTION; PROTEIN; NEOCULIN; PURIFICATION; BRAZZEIN; RECEPTOR; MONELLIN; REGIONS; SYSTEM; FRUIT	Curculin isolated from Curculigo latifolia, a plant grown in Malaysia, has an intriguing property of modifying sour taste into sweet taste. In addition to this taste-modifying activity, curculin itself elicits a sweet taste. Although these activities have been attributed to the heterodimeric isoform and not homodimers of curculin, the underlying mechanisms for the dual action of this protein have been largely unknown. To identify critical sites for these activities, we performed a mutational and structural study of recombinant curculin. Based on the comparison of crystal structures of curculin homo- and heterodimers, a series of mutants was designed and subjected to tasting assays. Mapping of amino acid residues on the three-dimensional structure according to their mutational effects revealed that the curculin heterodimer exhibits sweet-tasting and taste-modifying activities through its partially overlapping but distinct molecular surfaces. These findings suggest that the two activities of the curculin heterodimer are expressed through its two different modes of interactions with the T1R2-T1R3 heterodimeric sweet taste receptor.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; Natl Food Res Inst, Enzyme Lab, Tsukuba, Ibaraki 3058642, Japan; Ajinomoto Co Inc, Inst Life Sci, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan; Natl Inst Nat Sci, Inst Mol Sci, Aichi 4448787, Japan	Nagoya City University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Ajinomoto Co Inc; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp	Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439; Kato, Koichi/0000-0001-7187-9612				ABE K, 1992, BIOCHIM BIOPHYS ACTA, V1130, P232, DOI 10.1016/0167-4781(92)90537-A; ARIYOSHI Y, 1994, J SYN ORG CHEM JPN, V52, P359, DOI 10.5059/yukigoseikyokaishi.52.359; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Faus I, 2000, APPL MICROBIOL BIOT, V53, P145, DOI 10.1007/s002530050001; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Jin ZY, 2003, FEBS LETT, V544, P33, DOI 10.1016/S0014-5793(03)00383-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Masuda T, 2006, J BIOSCI BIOENG, V102, P375, DOI 10.1263/jbb.102.375; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shimizu-Ibuka A, 2006, J MOL BIOL, V359, P148, DOI 10.1016/j.jmb.2006.03.030; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; SOMOZA JR, 1995, CHEM SENSES, V20, P61, DOI 10.1093/chemse/20.1.61; Suzuki M, 2004, FEBS LETT, V573, P135, DOI 10.1016/j.febslet.2004.07.073; Temussi PA, 2006, CELL MOL LIFE SCI, V63, P1876, DOI 10.1007/s00018-006-6077-8; THEERASILP S, 1988, J BIOL CHEM, V263, P11536; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770; YAMASHITA H, 1995, CHEM SENSES, V20, P239, DOI 10.1093/chemse/20.2.239	24	24	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33252	33256		10.1074/jbc.C700174200	http://dx.doi.org/10.1074/jbc.C700174200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17895249	hybrid			2022-12-27	WOS:000250840200004
J	Scanzano, R; Segall, L; Blostein, R				Scanzano, Rosemarie; Segall, Laura; Blostein, Rhoda			Specific sites in the cytoplasmic N terminus modulate conformational transitions of the Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-ALPHA-1 NA,K-ATPASE; ALANINE MUTAGENESIS; CATALYTIC SUBUNIT; CLUSTERED CHARGE; EXPRESSION; SUBSTITUTIONS; CA2+-ATPASE; ALPHA-2	The cytoplasmic N terminus of the Na,K-ATPase is a highly charged and flexible structure that comprises three predicted helical regions including H1 spanning residues 27 to 33 and H2 spanning residues 42 to 50. Previous deletion mutagenesis experiments showed that deletion of residues up to and including most of H2 shifts the E-1/E-2 conformational equilibrium toward E-1. The present study describes a clustered charge-to-alanine mutagenesis approach designed to delineate specific sites within the N terminus that modulate the steady-state E-1 <-> E-2 and E1P <-> E2P poise. Criteria to assess shifts in poise include (i) sensitivity to inhibition by inorganic orthovanadate to assess overall poise; (ii) K+- sensitivity of Na-ATPase measured at micromolar ATP to assess changes in the E-2(K) + ATP -> E-1 center dot ATP + K+ rate; (iii) K'(ATP) for low-affinity ATP binding at the latter step; (iv) overall catalytic turnover, and (v) the E1P -> E2P transition. The results of alanine replacements in H1 (31KKE) suggest that this site stabilizes E2P and to a lesser extent E2. In H2, residues within 47HRK have a role in stabilizing E2 but not E2P as revealed with double mutants 31KKE 3 AAA/47H -> A and 31KKE -> AAA/47HRK -> AAA. Taken together, these observations suggest that sites 31KKE in H1 and 47HRK in H2 have distinct roles in modulating the enzyme's conformational transitions during the catalytic cycle of the enzyme.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Blostein, R (corresponding author), Montreal Gen Hosp, Res Inst, 1650 Cedar Ave,Rm L11-132, Montreal, PQ H3G 1A4, Canada.	Rhoda.Blostein@mcgill.ca						BENNETT WF, 1991, J BIOL CHEM, V266, P5191; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; DALY SE, 1994, J BIOL CHEM, V269, P23944; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Huang KN, 1997, MOL CELL BIOL, V17, P4654, DOI 10.1128/MCB.17.8.4654; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KLODOS I, 1994, J BIOL CHEM, V269, P1734; LANE LK, 1993, J BIOL CHEM, V268, P17930; LANE LK, 1993, BIOCHEM MOL BIOL INT, V31, P817; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Markwell M A, 1981, Methods Enzymol, V72, P296; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Segall L, 2002, J BIOL CHEM, V277, P35202, DOI 10.1074/jbc.M206115200; SHANBAKY NM, 1994, AM J PHYSIOL, V267, pC590, DOI 10.1152/ajpcell.1994.267.2.C590; SILENCE K, 1995, J BIOL CHEM, V270, P27192, DOI 10.1074/jbc.270.45.27192; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2003, ANN NY ACAD SCI, V986, P1, DOI 10.1111/j.1749-6632.2003.tb07131.x; TOYOSHIMA C, 2004, ANN REV BOCHEM, V277, P35202; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; [No title captured]	29	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46							33691	10.1074/jbc.M705899200	http://dx.doi.org/10.1074/jbc.M705899200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17881356	hybrid			2022-12-27	WOS:000250840200050
J	Voss, M; Vitavska, O; Walz, B; Wieczorek, H; Baumann, O				Voss, Martin; Vitavska, Olga; Walz, Bernd; Wieczorek, Helmut; Baumann, Otto			Stimulus-induced phosphorylation of vacuolar H+-ATPase by protein kinase a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOWFLY CALLIPHORA-VICINA; V-ATPASE; SUBUNIT-C; PLASMA-MEMBRANE; SALIVARY-GLANDS; CYCLIC-AMP; MALPIGHIAN TUBULES; PROTON PUMP; DROSOPHILA-MELANOGASTER; BONE-RESORPTION	Eukaryotic vacuolar-type H+-ATPases (V-ATPases) are regulated by the reversible disassembly of the active V1V0 holoenzyme into a cytosolic V-1 complex and a membrane-bound V-0 complex. The signaling cascades that trigger these events in response to changing cellular conditions are largely unknown. We report that the V-1 subunit C of the tobacco hornworm Manduca sexta interacts with protein kinase A and is the only V-ATPase subunit that is phosphorylated by protein kinase A. Subunit C can be phosphorylated as single polypeptide as well as a part of the V-1 complex but not as a part of the V1V0 holoenzyme. Both the phosphorylated and the unphosphorylated form of subunit C are able to reassociate with the V-1 complex from which subunit C had been removed before. Using salivary glands of the blowfly Calliphora vicina in which V-ATPase reassembly and activity is regulated by the neurohormone serotonin via protein kinase A, we show that the membrane-permeable cAMP analog 8-(4-chlorophenylthio) adenosine-3', 5'-cyclic monophosphate (8-CPT-cAMP) causes phosphorylation of subunit C in a tissue homogenate and that phosphorylation is reduced by incubation with antibodies against subunit C. Similarly, incubation of intact salivary glands with 8-CPT-cAMP or serotonin leads to the phosphorylation of subunit C, but this is abolished by H-89, an inhibitor of protein kinase A. These data suggest that subunit C binds to and serves as a substrate for protein kinase A and that this phosphorylation may be a regulatory switch for the formation of the active V1V0 holoenzyme.	Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; Univ Osnabruck, Fachbereich Biol & Chem, D-49076 Osnabruck, Germany	University of Potsdam; University Osnabruck	Baumann, O (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknech Str 24-25, D-14476 Potsdam, Germany.	obaumann@uni-potsdam.de						BERRIDGE MJ, 1971, PHILOS T ROY SOC B, V262, P111, DOI 10.1098/rstb.1971.0082; Beyenbach KW, 2001, NEWS PHYSIOL SCI, V16, P145; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Coast GM, 2001, J EXP BIOL, V204, P1795; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Drory O, 2006, BBA-BIOENERGETICS, V1757, P297, DOI 10.1016/j.bbabio.2006.03.011; Ehrenfeld J, 1997, J EXP BIOL, V200, P247; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; GOGARTEN JP, 1992, J EXP BIOL, V172, P137; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Karas K, 2005, J INSECT PHYSIOL, V51, P1041, DOI 10.1016/j.jinsphys.2005.05.002; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kirschner LB, 2004, J EXP BIOL, V207, P1439, DOI 10.1242/jeb.00907; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Onken H, 2000, J EXP BIOL, V203, P1373; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Rein J, 2006, J EXP BIOL, V209, P1716, DOI 10.1242/jeb.02187; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schlesinger PH, 1997, J BIOL CHEM, V272, P18636, DOI 10.1074/jbc.272.30.18636; Schoonderwoert VTG, 2001, J MEMBRANE BIOL, V182, P159, DOI 10.1007/s00232-001-0040-2; SCHWEIKL H, 1989, J BIOL CHEM, V264, P11136; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2003, GENE, V302, P147, DOI 10.1016/S0378-1119(02)01099-5; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilson JM, 2000, J EXP BIOL, V203, P2279; ZHANG Z, 2006, FEBS LETT, V580; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376	53	98	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33735	33742		10.1074/jbc.M703368200	http://dx.doi.org/10.1074/jbc.M703368200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17872947	hybrid			2022-12-27	WOS:000250840200055
J	Jomain, JB; Tallet, E; Broutin, I; Hoos, S; van Agthoven, J; Ducruix, A; Kelly, PA; Kragelund, BB; England, P; Goffin, V				Jomain, Jean-Baptiste; Tallet, Estelle; Broutin, Isabelle; Hoos, Sylviane; van Agthoven, Jan; Ducruix, Arnaud; Kelly, Paul A.; Kragelund, Birthe B.; England, Patrick; Goffin, Vincent			Structural and thermodynamic bases for the design of pure prolactin receptor antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; PLACENTAL-LACTOGEN; CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; BIOLOGICAL-PROPERTIES; EXTRACELLULAR DOMAIN; AUTOCRINE PROLACTIN; BINDING ENERGETICS; REGULATORY STEP; ANALOGS	Competitive antagonists of the human prolactin ( hPRL) receptor are a novel class of molecules of potential therapeutic interest in the context of cancer. We recently developed the pure antagonist Del1-9-G129R-hPRL by deleting the nine N-terminal residues of G129R-hPRL, a first generation partial antagonist. We determined the crystallographic structure of Del1-9-G129R-hPRL, which revealed no major change compared with wild type hPRL, indicating that its pure antagonistic properties are intrinsically due to the mutations. To decipher the molecular bases of pure antagonism, we compared the biological, physicochemical, and structural properties of numerous hPRL variants harboring N-terminal or Gly(129) mutations, alone or combined. The pure versus partial antagonistic properties of the multiple hPRL variants could not be correlated to differences in their affinities toward the hPRL receptor, especially at site 2 as determined by surface plasmon resonance. On the contrary, residual agonism of the hPRL variants was found to be inversely correlated to their thermodynamic stability, which was altered by all the Gly(129) mutations but not by those involving the N terminus. We therefore propose that residual agonism can be abolished either by further disrupting hormone site 2-receptor contacts by N-terminal deletion, as in Del1-9-G129R-hPRL, or by stabilizing hPRL and constraining its intrinsic flexibility, as in G129V-hPRL.	Equipe PRL GH & Tumeurs, Ctr Rech Croissance & Signalisat, INSERM, U845, F-75015 Paris, France; Univ Paris 05, Fac Med, F-75015 Paris, France; Univ Paris 05, Lab Cristallo & RMN Biol, CNRS, UMR 8015, F-75006 Paris, France; Dept Biol Struct & Chim, Inst Pasteur Plateforme Biophys Macromol & Leurs, F-75015 Paris, France; Univ Copenhagen, Dept Mol Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen	Goffin, V (corresponding author), Fac Med Necker Enfants Malad, Ctr Rech Croissance & Signalisat, INSERM, U845, 156 Rue Vaguirard, F-75730 Paris 15, France.	goffin@necker.fr	Broutin, Isabelle/A-2003-2017; GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; ENGLAND, Patrick/0000-0001-6410-5918				Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; Bernichtein S, 2003, MOL CELL ENDOCRINOL, V208, P11, DOI 10.1016/S0303-7207(03)00264-8; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2003, ENDOCRINE, V20, P177, DOI 10.1385/ENDO:20:1-2:177; Bernichtein S, 2001, ENDOCRINOLOGY, V142, P3950, DOI 10.1210/en.142.9.3950; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dagvadorj A, 2007, ENDOCRINOLOGY, V148, P3089, DOI 10.1210/en.2006-1761; DATTANI MT, 1995, J BIOL CHEM, V270, P9222, DOI 10.1074/jbc.270.16.9222; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; Elkins PA, 2000, NAT STRUCT BIOL, V7, P808, DOI 10.1038/79047; Eyal O, 2007, BIOL REPROD, V76, P777, DOI 10.1095/biolreprod.106.053058; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; FUH G, 1993, J BIOL CHEM, V268, P5376; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Glezer A, 2006, J CLIN ENDOCR METAB, V91, P1048, DOI 10.1210/jc.2005-1831; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goffin V, 1999, ENDOCRINOLOGY, V140, P3853, DOI 10.1210/en.140.8.3853; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 2007, RECENT PATENTS ENDOC, V1, P41, DOI 10.2174/187221407779814552; Goffin V, 2006, NAT CLIN PRACT ENDOC, V2, P571, DOI 10.1038/ncpendmet0270; Helman D, 1998, J BIOL CHEM, V273, P16067, DOI 10.1074/jbc.273.26.16067; Horn JR, 2006, BIOCHEMISTRY-US, V45, P8488, DOI 10.1021/bi0604328; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Keeler C, 2003, J MOL BIOL, V328, P1105, DOI 10.1016/S0022-2836(03)00367-X; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; KINET S, 2001, RRD ENDOCRINOL 1, V2, P1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P273; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Ma FY, 2005, ENDOCRINOLOGY, V146, P93, DOI 10.1210/en.2004-0800; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLIVEBERG M, 1994, BIOCHEMISTRY-US, V33, P8826, DOI 10.1021/bi00195a026; Osslund TD, 1998, PROTEIN SCI, V7, P1681, DOI 10.1002/pro.5560070803; PARIS N, 1990, BIOTECHNOL APPL BIOC, V12, P436; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sivaprasad U, 2004, BIOCHEMISTRY-US, V43, P13755, DOI 10.1021/bi049333p; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004; Zakrzewska M, 2006, BIOCHEMISTRY-US, V45, P15338, DOI 10.1021/bi0618114	55	54	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2007	282	45					33118	33131		10.1074/jbc.M704364200	http://dx.doi.org/10.1074/jbc.M704364200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	226YW	17785459	hybrid			2022-12-27	WOS:000250625400060
J	Bates, PD; Ohlrogge, JB; Pollard, M				Bates, Philip D.; Ohlrogge, John B.; Pollard, Mike			Incorporation of newly synthesized fatty acids into cytosolic glycerolipids in pea leaves occurs via acyl editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-SYNTHESIS; CHLOROPLAST ENVELOPE; IN-VIVO; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; PHOSPHATIDIC-ACID; COA THIOESTERASE; INNER MEMBRANE; METABOLISM; PHOSPHATIDYLCHOLINE; MICROSOMES	In expanding pea leaves, over 95% of fatty acids (FA) synthesized in the plastid are exported for assembly of eukaryotic glycerolipids. It is often assumed that the major products of plastid FA synthesis (18:1 and 16:0) are first incorporated into 16:0/18:1 and 18:1/18:1 molecular species of phosphatidic acid (PA), which are then converted to phosphatidylcholine (PC), the major eukaryotic phospholipid and site of acyl desaturation. However, by labeling lipids of pea leaves with [C-14] acetate, [C-14] glycerol, and [C-14] carbon dioxide, we demonstrate that acyl editing is an integral component of eukaryotic glycerolipid synthesis. First, no precursor-product relationship between PA and PC [C-14] acyl chains was observed at very early time points. Second, analysis of PC molecular species at these early time points showed that > 90% of newly synthesized [C-14] 18:1 and [C-14] 16:0 acyl groups were incorporated into PC alongside a previously synthesized unlabeled acyl group (18:2, 18:3, or 16:0). And third, [C-14] glycerol labeling produced PC molecular species highly enriched with 18:2, 18:3, and 16:0 FA, and not 18:1, the major product of plastid fatty acid synthesis. In conclusion, we propose that most newly synthesized acyl groups are not immediately utilized for PA synthesis, but instead are incorporated directly into PC through an acyl editing mechanism that operates at both sn-1 and sn-2 positions. Additionally, the acyl groups removed by acyl editing are largely used for the net synthesis of PC through glycerol 3-phosphate acylation.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Pollard, M (corresponding author), Michigan State Univ, Dept Plant Pathol, Wilson Rd, E Lansing, MI 48824 USA.	pollard9@msu.edu	Bates, Philip D/I-7550-2013; Bates, Philip David/O-9980-2019	Bates, Philip D/0000-0002-1291-3363; Bates, Philip David/0000-0002-1291-3363				ANDREWS J, 1983, PLANT PHYSIOL, V72, P735, DOI 10.1104/pp.72.3.735; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BERTRAMS M, 1981, Z NATURFORSCH C, V36, P62; BESSOULE JJ, 1995, EUR J BIOCHEM, V228, P490, DOI 10.1111/j.1432-1033.1995.tb20288.x; BLOCK MA, 1983, FEBS LETT, V153, P377, DOI 10.1016/0014-5793(83)80647-4; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; Christie W.W, 2003, LIPID ANAL ISOLATION, V3rd; DEMANDRE C, 1994, PHYTOCHEMISTRY, V35, P1171, DOI 10.1016/S0031-9422(00)94816-7; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; KHAN MU, 1977, J CHROMATOGR, V140, P179, DOI 10.1016/S0021-9673(00)88412-5; Kjellberg JM, 2000, BBA-MOL CELL BIOL L, V1485, P100, DOI 10.1016/S1388-1981(00)00040-8; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Mongrand S, 1997, BIOCHEM J, V327, P853, DOI 10.1042/bj3270853; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; Mongrand S, 2000, PLANT PHYSIOL, V122, P845, DOI 10.1104/pp.122.3.845; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; ROCHESTER CP, 1984, ARCH BIOCHEM BIOPHYS, V232, P249, DOI 10.1016/0003-9861(84)90541-1; ROUGHAN PG, 1980, BIOCHEM J, V188, P17, DOI 10.1042/bj1880017; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Schwender J, 2002, PLANT PHYSIOL, V130, P347, DOI 10.1104/pp.004275; SERGHINICAID H, 1988, PLANT SCI, V54, P93, DOI 10.1016/0168-9452(88)90086-6; SLACK CR, 1977, BIOCHEM J, V162, P289, DOI 10.1042/bj1620289; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; STYMNE S, 1983, BIOCHIM BIOPHYS ACTA, V752, P198, DOI 10.1016/0005-2760(83)90113-3; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Williams JP, 2000, BIOCHEM J, V349, P127, DOI 10.1042/0264-6021:3490127	35	159	174	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31206	31216		10.1074/jbc.M705447200	http://dx.doi.org/10.1074/jbc.M705447200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17728247	hybrid			2022-12-27	WOS:000250309200010
J	Bishop, B; Dasgupta, J; Klein, M; Garcea, RL; Christensen, ND; Zhao, R; Chen, XJS				Bishop, Brooke; Dasgupta, Jhimli; Klein, Michael; Garcea, Robert L.; Christensen, Neil D.; Zhao, Rui; Chen, Xiaojiang S.			Crystal structures of four types of human papillomavirus L1 capsid - Understanding the specificity of neutralizing monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; MEDIATED NEUTRALIZATION; PROTEIN; EPITOPE; INDUCE; EXPRESSION; INFECTION; RESIDUES; HPV-16	Human papillomaviruses (HPVs) are known etiologic agents of cervical cancer. Vaccines that contain virus-like particles (VLPs) made of L1 capsid protein from several high risk HPV types have proven to be effective against HPV infections. Raising high levels of neutralizing antibodies against each HPV type is believed to be the primary mechanism of protection, gained by vaccination. Antibodies elicited by a particular HPV type are highly specific to that particular HPV type and show little or no cross-reactivity between HPV types. With an intention to understand the interplay between the L1 structure of different HPV types and the type specificity of neutralizing antibodies, we have prepared the L1 pentamers of four different HPV types, HPV11, HPV16, HPV18, and HPV35. The pentamers only bind the type-specific neutralizing monoclonal antibodies (NmAbs) that are raised against the VLP of the corresponding HPV type, implying that the surface loop structures of the pentamers from each type are distinctive and functionally active as VLPs in terms of antibody binding. We have determined the crystal structures of all four L1 pentamers, and their comparisons revealed characteristic conformational differences of the surface loops that contain the known epitopes for the NmAbs. On the basis of these distinct surface loop structures, we have provided a molecular explanation for the type specificity of NmAbs against HPV infection.	Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat Hematol oncol, Aurora, CO 80045 USA; Penn State Coll med, Jake Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA; Penn State Coll med, Jake Gittlen Canc Res Fdn, Dept Microbiol, Hershey, PA 17033 USA; Penn State Coll med, Jake Gittlen Canc Res Fdn, Dept Immunol, Hershey, PA 17033 USA	University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chen, XJS (corresponding author), Univ So Calif, Dept Mol & Computat Biol, 1050 Childs Way,RRH201, Los Angeles, CA 90089 USA.	Xiaojiang.Chen@USC.edu		Dasgupta, Jhimli/0000-0002-8030-1262	NCI NIH HHS [R01 CA037667, CA47622, CA37667] Funding Source: Medline; NIAID NIH HHS [AI048747] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037667, R01CA047622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048747] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; CHRISTENSEN ND, 1990, J VIROL, V64, P3151, DOI 10.1128/JVI.64.7.3151-3156.1990; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; CHRISTENSEN ND, 1990, VIROLOGY, V175, P1, DOI 10.1016/0042-6822(90)90180-Y; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; CHRISTENSEN ND, 1994, VIROLOGY, V205, P329, DOI 10.1006/viro.1994.1649; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Howley PM, 2001, FIELDSVIROLOGY, V2, P2197; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Ludmerer SW, 1997, J VIROL, V71, P3834, DOI 10.1128/JVI.71.5.3834-3839.1997; Ludmerer SW, 1996, J VIROL, V70, P4791, DOI 10.1128/JVI.70.7.4791-4794.1996; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; ROSE RC, 1994, J GEN VIROL, V75, P2075, DOI 10.1099/0022-1317-75-8-2075; Sadeyen JR, 2003, VIROLOGY, V309, P32, DOI 10.1016/S0042-6822(02)00134-4; Slupetzky K, 2001, J GEN VIROL, V82, P2799, DOI 10.1099/0022-1317-82-11-2799; White WI, 1998, J VIROL, V72, P959, DOI 10.1128/JVI.72.2.959-964.1998; White WI, 1999, J VIROL, V73, P4882, DOI 10.1128/JVI.73.6.4882-4889.1999; ZHOU J, 1993, J GEN VIROL, V74, P763, DOI 10.1099/0022-1317-74-4-763	23	143	159	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2007	282	43					31803	31811		10.1074/jbc.M706380200	http://dx.doi.org/10.1074/jbc.M706380200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	222PK	17804402	hybrid			2022-12-27	WOS:000250309200070
J	Maher, RL; Bloom, LB				Maher, Robyn L.; Bloom, Linda B.			Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC ENDONUCLEASE; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; ALKYLADENINE DNA GLYCOSYLASE; HUMAN ABASIC ENDONUCLEASE; BASE EXCISION-REPAIR; EXONUCLEASE-III; APYRIMIDINIC ENDONUCLEASE; SINGLE-TURNOVER; SITE ANALOGS; CELLS	Human AP endonuclease 1 ( APE1, REF1) functions within the base excision repair pathway by catalyzing the hydrolysis of the phosphodiester bond 5' to a baseless sugar ( apurinic or apyrimidinic site). The AP endonuclease activity of this enzyme and two active site mutants were characterized using equilibrium binding and pre-steady-state kinetic techniques. Wild-typeAPE1 is a remarkably potent endonuclease and highly efficient enzyme. Incision 5' to AP sites is so fast that a maximal single-turnover rate could not be measured using rapid mixing/quench techniques and is at least 850 s(-1). The entire catalytic cycle is limited by a slow step that follows chemistry and generates a steady-state incision rate of about 2 s(-1). Site-directed mutation of His-309 to Asn and Asp-210 to Ala reduced the single turnover rate of incision 5' to AP sites by at least 5 orders of magnitude such that chemistry ( or a step following DNA binding and preceding chemistry) and not a step following chemistry became rate-limiting. Our results suggest that the efficiency with which APE1 can process an AP site in vivo is limited by the rate at which it diffuses to the site and that a slow step after chemistry may prevent APE1 from leaving the site of damage before the next enzyme arrives to continue the repair process.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055596] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM055596, R01 GM055596] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abner CW, 2001, J BIOL CHEM, V276, P13379, DOI 10.1074/jbc.M010641200; Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P60, DOI 10.1080/00913847.1992.11947449; KANE CM, 1981, J BIOL CHEM, V256, P3405; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lowry DF, 2003, J MOL BIOL, V329, P311, DOI 10.1016/S0022-2836(03)00382-6; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Maher RL, 2007, DNA REPAIR, V6, P71, DOI 10.1016/j.dnarep.2006.09.001; Masuda Y, 1998, J BIOL CHEM, V273, P30360, DOI 10.1074/jbc.273.46.30360; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mundle ST, 2004, DNA REPAIR, V3, P1447, DOI 10.1016/j.dnarep.2004.06.009; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Pope MA, 2005, DNA REPAIR, V4, P91, DOI 10.1016/j.dnarep.2004.08.004; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; SEKI S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P287, DOI 10.1016/0167-4781(92)90027-W; Shaw RW, 2004, DNA REPAIR, V3, P1273, DOI 10.1016/j.dnarep.2004.05.003; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200; Yoshida A, 2006, INT J HEMATOL, V84, P31, DOI 10.1007/BF03342699; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	41	74	76	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30577	30585		10.1074/jbc.M704341200	http://dx.doi.org/10.1074/jbc.M704341200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17724035	hybrid			2022-12-27	WOS:000250136300026
J	Mishra, R; Barthwal, MK; Sondarva, G; Rana, B; Wong, L; Chatterjee, M; Woodgett, JR; Rana, A				Mishra, Rajakishore; Barthwal, Manoj K.; Sondarva, Gautam; Rana, Basabi; Wong, Lucas; Chatterjee, Malay; Woodgett, James R.; Rana, Ajay			Glycogen synthase kinase-3 beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; N-TERMINAL KINASE; MIXED-LINEAGE KINASES; HIPPOCAMPAL-NEURONS; SIGNAL-TRANSDUCTION; ALZHEIMER-DISEASE; CEP-1347 KT7515; GROWTH-FACTOR; BETA-CATENIN; IN-VIVO	Mixed lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase member that activates the c-Jun N-terminal kinase (JNK) pathway. Aberrant activation of MLK3 has been implicated in neurodegenerative diseases. Similarly, glycogen synthase kinase (GSK)-3 beta has also been shown to activate JNK and contributetoneuronalapoptosis. Here, we show a functional interaction between MLK3 and GSK-3 beta during nerve growth factor (NGF) withdrawal-induced cell death in PC-12 cells. The protein kinase activities of GSK-3 beta, MLK3, and JNK were increased upon NGF withdrawal, which paralleled increased cell death in NGF-deprived PC-12 cells. NGF withdrawal-induced cell death and MLK3 activation were blocked by a GSK-3 beta-selective inhibitor, kenpaullone. However, the MLK family inhibitor, CEP-11004, although preventing PC-12 cell death, failed to inhibit GSK-3 beta activation, indicating that induction of GSK-3 beta lies upstream of MLK3. In GSK-3 beta-deficient murine embryonic fibroblasts, ultraviolet light was unable to activate MLK3 kinase activity, a defect that was restored upon ectopic expression of GSK-3 beta. The activation of MLK3 by GSK-3 beta occurred via phosphorylation of MLK3 on two amino acid residues, Ser(789) and Ser(793), that are located within the C-terminal regulatory domain of MLK3. Furthermore, the cell death induced by GSK-3 beta was mediated by MLK3 in a manner dependent on its phosphorylation of the specific residues within the C-terminal domain by GSK-3 beta. Taken together, our data provide a direct link between GSK-3 beta and MLK3 activation in a neuronal cell death pathway and identify MLK3 as a direct downstream target of GSK-3 beta. Inhibition of GSK-3 is thus a potential therapeutic strategy for neurodegenerative diseases caused by trophic factor deprivation.	Texas A&M Univ Syst HSC, Dept Internal Med, Cardiovasc & Canc Res Inst, Coll Med, Temple, TX 76504 USA; Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA; Texas A&M Univ Syst HSC, Dept Internal Med, Coll Med, Scott & White Clin, Temple, TX 76504 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Jadavpur Univ, Div Biochem, Dept Pharmaceut Technol, Kolkata 700032, W Bengal, India	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Jadavpur University	Rana, A (corresponding author), Loyola Univ, Dept Pharmacol, Med Ctr, Bldg 102,2160 S 1st Ave, Maywood, IL 60153 USA.	arana@lumc.edu	Mishra, Rajakishore/ABC-3550-2020; Rana, Ajay/ABE-3739-2020; Woodgett, Jim/F-1087-2010	Rana, Ajay/0000-0003-0951-2566; Woodgett, Jim/0000-0003-3731-5797; Mishra, Rajakishore/0000-0002-1735-2411	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [12043] Funding Source: Medline; NIGMS NIH HHS [R01 GM055835, GM55835] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Bhat RV, 2002, J ALZHEIMERS DIS, V4, P291, DOI 10.3233/JAD-2002-4404; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; BOZYCZKO JJ, 2001, EMBO J, V77, P849; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hetman M, 2000, J NEUROSCI, V20, P2567; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Imahori K, 1997, J BIOCHEM, V121, P179; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaneko M, 1997, J MED CHEM, V40, P1863, DOI 10.1021/jm970031d; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Liu SY, 2004, J BIOL CHEM, V279, P51075, DOI 10.1074/jbc.M408607200; Lorigados L, 1998, REV NEUROLOGIA, V26, P744, DOI 10.33588/rn.26153.98023; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Maroney AC, 1998, J NEUROSCI, V18, P104; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Mota M, 2001, J NEUROSCI, V21, P4949, DOI 10.1523/JNEUROSCI.21-14-04949.2001; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Vacratsis PO, 2002, BIOCHEMISTRY-US, V41, P5613, DOI 10.1021/bi016075c; Wang LH, 2005, J PHARMACOL EXP THER, V312, P1007, DOI 10.1124/jpet.104.077800; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; WOODGETT JR, 2001, SCI STKE, pRE112; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; 2004, NEUROLOGY, V62, P330	56	57	62	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2007	282	42					30393	30405		10.1074/jbc.M705895200	http://dx.doi.org/10.1074/jbc.M705895200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	220DE	17711861	Green Accepted, hybrid			2022-12-27	WOS:000250136300007
J	Greer, EL; Oskoui, PR; Banko, MR; Maniar, JM; Gygi, MP; Gygi, SP; Brunet, A				Greer, Eric L.; Oskoui, Philip R.; Banko, Max R.; Maniar, Jay M.; Gygi, Melanie P.; Gygi, Steven P.; Brunet, Anne			The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; OXIDATIVE-STRESS; LIFE-SPAN; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; FACTOR FKHR; INSULIN SENSITIVITY; CALORIC RESTRICTION; NUCLEAR EXCLUSION	The maintenance of homeostasis throughout an organism's life span requires constant adaptation to changes in energy levels. The AMP-activated protein kinase ( AMPK) plays a critical role in the cellular responses to low energy levels by switching off energy-consuming pathways and switching on energy-producing pathways. However, the transcriptional mechanisms by which AMPK acts to adjust cellular energy levels are not entirely characterized. Here, we find that AMPK directly regulates mammalian FOXO3, a member of the FOXO family of Forkhead transcription factors known to promote resistance to oxidative stress, tumor suppression, and longevity. We show that AMPK phosphorylates human FOXO3 at six previously unidentified regulatory sites. Phosphorylation by AMPK leads to the activation of FOXO3 transcriptional activity without affecting FOXO3 subcellular localization. Using a genome-wide microarray analysis, we identify a set of target genes that are regulated by FOXO3 when phosphorylated at these six regulatory sites in mammalian cells. The regulation of FOXO3 by AMPK may play a crucial role in fine tuning gene expression programs that control energy balance and stress resistance in cells throughout life.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School	Brunet, A (corresponding author), 300 Pasteur Dr,Alway M336, Stanford, CA 94305 USA.	anne.brunet@stanford.edu		Greer, Eric/0000-0002-7501-7371	NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026648] Funding Source: NIH RePORTER; NCI NIH HHS [CA 09302, T32 CA009302] Funding Source: Medline; NIA NIH HHS [AG026648-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Barthel A, 2002, ENDOCRINOLOGY, V143, P3183, DOI 10.1210/endo.143.8.8792; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Feng WK, 2006, J BIOL CHEM, V281, P681, DOI 10.1074/jbc.M506956200; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GREER EL, 2007, IN PRESS CURR BIOL; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lindquist PJG, 1998, EUR J BIOCHEM, V251, P631, DOI 10.1046/j.1432-1327.1998.2510631.x; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Murakami S, 1996, GENETICS, V143, P1207; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Solaz-Fuster MC, 2006, CELL SIGNAL, V18, P1702, DOI 10.1016/j.cellsig.2006.01.021; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	84	597	619	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2007	282	41					30107	30119		10.1074/jbc.M705325200	http://dx.doi.org/10.1074/jbc.M705325200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	217XS	17711846	hybrid			2022-12-27	WOS:000249981200041
